
@article{ WOS:000480272800008,
Author = {Khoury, Muin J. and Engelgau, Michael and Chambers, David A. and Mensah,
   George A.},
Title = {Beyond Public Health Genomics: Can Big Data and Predictive Analytics
   Deliver Precision Public Health?},
Journal = {PUBLIC HEALTH GENOMICS},
Year = {2018},
Volume = {21},
Number = {5-6},
Pages = {244-249},
Abstract = {The field of public health genomics has matured in the past two decades
   and is beginning to deliver genomic-based interventions for health and
   health care. In the past few years, the terms precision medicine and
   precision public health have been used to include information from
   multiple fields measuring biomarkers as well as environmental and other
   variables to provide tailored interventions. In the context of public
   health, precision implies delivering the right intervention to the right
   population at the right time, with the goal of improving health for all.
   In addition to genomics, precision public health can be driven by big
   data as identified by volume, variety, and variability in biomedical,
   sociodemographic, environmental, geographic, and other information. Most
   current big data applications in health are in elucidating pathobiology
   and tailored drug discovery. We explore how big data and predictive
   analytics can contribute to precision public health by improving public
   health surveillance and assessment, and efforts to promote uptake of
   evidence-based interventions, by including more extensive information
   related to place, person, and time. We use selected examples drawn from
   child health, cardiovascular disease, and cancer to illustrate the
   promises of precision public health, as well as current methodologic and
   analytic challenges to big data to fulfill these promises. (C) 2019 S.
   Karger AG, Basel},
Type = {Article},
Affiliation = {Khoury, MJ (Corresponding Author), Ctr Dis Control \& Prevent, Off Publ Hlth Genom, 1600 Clifton Rd, Atlanta, GA 30329 USA.
   Khoury, Muin J., Ctr Dis Control \& Prevent, Off Publ Hlth Genom, 1600 Clifton Rd, Atlanta, GA 30329 USA.
   Engelgau, Michael; Mensah, George A., NHLBI, Ctr Translat Res \& Implementat Sci, Bldg 10, Bethesda, MD 20892 USA.
   Chambers, David A., NCI, Div Canc Control \& Populat Sci, Bethesda, MD 20892 USA.},
DOI = {10.1159/000501465},
Keywords = {Big data; Genomics; Implementation science; Medicine; Predictive
   analytics; Public health},
Research-Areas = {Genetics \& Heredity; Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Genetics \& Heredity; Public, Environmental \& Occupational Health},
Author-Email = {muk1@cdc.gov},
Affiliations = {Centers for Disease Control \& Prevention - USA; National Institutes of
   Health (NIH) - USA; NIH National Heart Lung \& Blood Institute (NHLBI);
   National Institutes of Health (NIH) - USA; NIH National Cancer Institute
   (NCI)},
Cited-References = {Banda JM, 2019, NPJ DIGIT MED, V2, DOI 10.1038/s41746-019-0101-5.
   Chambers DA, 2018, ANNU REV PUBL HEALTH, V39, P1, DOI 10.1146/annurev-publhealth-110717-045850.
   Chowkwanyun M, 2018, NEW ENGL J MED, V379, P1398, DOI 10.1056/NEJMp1806634.
   Christodoulouy E, 2019, J CLIN EPIDEMIOL.
   Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523.
   Dolley S, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00068.
   Dowell SF, 2016, NATURE, V540, P189, DOI 10.1038/540189a.
   Dunn AG, 2018, NPJ DIGIT MED, V1, DOI 10.1038/s41746-018-0054-0.
   Engelgau MM, 2019, GLOB HEART, V14, P75, DOI 10.1016/j.gheart.2019.02.003.
   Flaxman AD, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002702.
   Golding N, 2017, LANCET, V390, P2171, DOI 10.1016/S0140-6736(17)31758-0.
   Horton R, 2018, LANCET, V392, P1504, DOI 10.1016/S0140-6736(18)32741-7.
   Khoury MJ, 2016, AM J PREV MED, V50, P398, DOI 10.1016/j.amepre.2015.08.031.
   Kind AJH, 2018, NEW ENGL J MED, V378, P2456, DOI 10.1056/NEJMp1802313.
   Knowles JW, 2017, JAMA-J AM MED ASSOC, V318, P381, DOI 10.1001/jama.2017.8543.
   Martin AR, 2019, NAT GENET, V51, P584, DOI 10.1038/s41588-019-0379-x.
   Morawski K, 2018, JAMA INTERN MED, V178, P802, DOI 10.1001/jamainternmed.2018.0447.
   National Cancer Institute National Institutes of Health, IMPL SCI CANC CONTR.
   National Heart Lung and Blood Institute, 2018, STIM T4 IMPL RES OPT.
   Nevin L, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002708.
   Parikh RB, 2016, JAMA-J AM MED ASSOC, V315, P651, DOI 10.1001/jama.2015.19417.
   Shah ND, 2018, JAMA-J AM MED ASSOC, V320, P27, DOI 10.1001/jama.2018.5602.
   Steinhubl SR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3487.
   Topol EJ, 2015, JAMA-J AM MED ASSOC, V313, P353, DOI 10.1001/jama.2014.17125.
   Yurgelun Matthew B, 2018, Am Soc Clin Oncol Educ Book, V38, P101, DOI 10.1200/EDBK\_208341.},
Number-of-Cited-References = {25},
Times-Cited = {22},
Unique-ID = {WOS:000480272800008},
}

@article{ WOS:000441781500012,
Author = {Ollier, William and Muir, Kenneth R. and Lophatananon, Artitaya and
   Verma, Arpana and Yuille, Martin},
Title = {Risk biomarkers enable precision in public health},
Journal = {PERSONALIZED MEDICINE},
Year = {2018},
Volume = {15},
Number = {4},
Pages = {329-342},
Month = {JUL},
Abstract = {Precision medicine uses biomarkers to diagnose disease. However, they
   can also be used to measure risk of disease. Thus, biomarkers herald a
   new addition to public health - Precision Public Health. We examine the
   implications. Risk biomarkers are identified by analyzing population
   cohorts. They constitute risk factors in mathematical Disease Risk
   Models'. The risk may be fixed as in a genetic biomarker or variable as
   in some protein biomarkers. They help monitor current risk of disease in
   an individual, thereby aiding efforts to reduce risk. In the UK, the NHS
   Health Check system is a universal system for assessing risk and for
   risk reduction. The system can now make use of modern biomarkers once
   appropriate infrastructure and governance are in place.},
Type = {Review},
Affiliation = {Ollier, W; Yuille, M (Corresponding Author), Univ Manchester, Div Populat Hlth, Ctr Epidemiol, Fac Biol Med \& Hlth, Stopford Bldg,99 Oxford Rd, Manchester M13 9PG, Lancs, England.
   Ollier, William; Muir, Kenneth R.; Lophatananon, Artitaya; Verma, Arpana; Yuille, Martin, Univ Manchester, Div Populat Hlth, Ctr Epidemiol, Fac Biol Med \& Hlth, Stopford Bldg,99 Oxford Rd, Manchester M13 9PG, Lancs, England.},
DOI = {10.2217/pme-2017-0068},
Keywords = {data management; health policy; NHS Health Check; noncommunicable
   chronic disease; obesity; precision medicine; prediction models; public
   policy; resource management; risk factors},
Keywords-Plus = {RANDOMIZED CONTROLLED-TRIAL; DNA METHYLATION; PRIMARY-CARE;
   PERIPHERAL-BLOOD; GENOME; CANCER; ASSOCIATION; OVERWEIGHT; MORTALITY;
   TELOMERES},
Research-Areas = {Pharmacology \& Pharmacy},
Web-of-Science-Categories  = {Pharmacology \& Pharmacy},
Author-Email = {Bill.Ollier@manchester.ac.uk
   martin.yuille@gmail.com},
Affiliations = {University of Manchester},
Cited-References = {{[}Anonymous], 2015, ANN REPORT CHIEF MED.
   {[}Anonymous], STAT OB PHYS ACT DIE.
   {[}Anonymous], PHE PUBL GAT.
   {[}Anonymous], OUR HLTH NAT CONTR H.
   {[}Anonymous], 2 INT STRAT M HUM GE.
   Cancer Research UK, 2016, TIPP SCAL WHY PREV O.
   Chambers JC, 2015, LANCET DIABETES ENDO, V3, P526, DOI 10.1016/S2213-8587(15)00127-8.
   Colditz GA, 2000, CANCER CAUSE CONTROL, V11, P477, DOI 10.1023/A:1008984432272.
   Collins FS, 2003, NATURE, V422, P835, DOI 10.1038/nature01626.
   Collins GS, 2013, BRIT J GEN PRACT, V63, pE636, DOI 10.3399/bjgp13X671623.
   Cook NR, 2008, CLIN CHEM, V54, P17, DOI 10.1373/clinchem.2007.096529.
   Dick KJ, 2014, LANCET, V383, P1990, DOI 10.1016/S0140-6736(13)62674-4.
   Feinberg AP, 2010, VIRCHOWS ARCH, V456, P13, DOI 10.1007/s00428-009-0847-2.
   Ganna A, 2015, LANCET, V386, P533, DOI 10.1016/S0140-6736(15)60175-1.
   Gao X, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0148-3.
   Geisser S., 1993, Predictive inference: An introduction.
   Gold L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015004.
   Hannum G, 2013, MOL CELL, V49, P359, DOI 10.1016/j.molcel.2012.10.016.
   Honig LS, 2012, ARCH NEUROL-CHICAGO, V69, P1332, DOI 10.1001/archneurol.2012.1541.
   Hosmer D, 2013, Applied logistic regression.
   Khoury MJ, 2015, GENOMICS HLTH I 0302.
   Khoury MJ, 2016, AM J PREV MED, V50, P398, DOI 10.1016/j.amepre.2015.08.031.
   Kopelman P, 2007, OBES REV, V8, P13, DOI 10.1111/j.1467-789X.2007.00311.x.
   Lau EY, 2014, J OBES, V2014, DOI 10.1155/2014/524939.
   Laverack G, 2007, UK HIGHER ED OUP HUM.
   Luppino FS, 2010, ARCH GEN PSYCHIAT, V67, P220, DOI 10.1001/archgenpsychiatry.2010.2.
   May S, 2006, PATIENT EDUC COUNS, V64, P235, DOI 10.1016/j.pec.2006.02.008.
   Needham BL, 2014, HEALTH PLACE, V28, P167, DOI 10.1016/j.healthplace.2014.04.009.
   Pavlou M, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3868.
   Poste G, 2011, NATURE, V469, P156, DOI 10.1038/469156a.
   Shiels PG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022521.
   Theall KP, 2013, SOC SCI MED, V85, P50, DOI 10.1016/j.socscimed.2013.02.030.
   Usher-Smith J, 2015, BRIT J CANCER, V113, P1645, DOI 10.1038/bjc.2015.409.
   Vaudano E, 2013, COMPUT STRUCT BIOTEC, V6, DOI 10.5936/csbj.201303017.
   West R, 1998, ADDICTION, V93, P1007, DOI 10.1046/j.1360-0443.1998.93710075.x.
   Wild CP, 2005, CANCER EPIDEM BIOMAR, V14, P1847, DOI 10.1158/1055-9965.EPI-05-0456.
   Woringer M, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2346-5.
   Yen YC, 2013, AGE AGEING, V42, P234, DOI 10.1093/ageing/afs122.
   Yuille M, 2017, BIOPRESERV BIOBANK, V15, P85, DOI 10.1089/bio.2017.29019.mjy.
   Yuille M, 2010, CELL TISSUE BANK, V11, P241, DOI 10.1007/s10561-009-9150-3.
   Zhang Y, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14617.
   Zhong J, 2016, CIRC RES, V118, P119, DOI 10.1161/CIRCRESAHA.115.305206.},
Number-of-Cited-References = {42},
Times-Cited = {0},
Unique-ID = {WOS:000441781500012},
}

@article{ WOS:000660582000001,
Author = {Roberts, Megan C. and Fohner, Alison E. and Landry, Latrice and Olstad,
   Dana Lee and Smit, Amelia K. and Turbitt, Erin and Allen, Caitlin G.},
Title = {Advancing precision public health using human genomics: examples from
   the field and future research opportunities},
Journal = {GENOME MEDICINE},
Year = {2021},
Volume = {13},
Number = {1},
Month = {JUN 1},
Abstract = {Precision public health is a relatively new field that integrates
   components of precision medicine, such as human genomics research, with
   public health concepts to help improve population health. Despite
   interest in advancing precision public health initiatives using human
   genomics research, current and future opportunities in this emerging
   field remain largely undescribed. To that end, we provide examples of
   promising opportunities and current applications of genomics research
   within precision public health and outline future directions within five
   major domains of public health: biostatistics, environmental health,
   epidemiology, health policy and health services, and social and
   behavioral science. To further extend applications of genomics within
   precision public health research, three key cross-cutting challenges
   will need to be addressed: developing policies that implement precision
   public health initiatives at multiple levels, improving data integration
   and developing more rigorous methodologies, and incorporating
   initiatives that address health equity. Realizing the potential to
   better integrate human genomics within precision public health will
   require transdisciplinary efforts that leverage the strengths of both
   precision medicine and public health.},
Type = {Article},
Affiliation = {Allen, CG (Corresponding Author), Emory Univ, Dept Behav Social \& Hlth Educ Sci, Rollins Sch Publ Hlth, 1518 Clifton Rd, Atlanta, GA 30322 USA.
   Roberts, Megan C., Univ N Carolina, Eshelman Sch Pharm, Div Pharmaceut Outcomes \& Policy, 301 Pharm Lane, Chapel Hill, NC 27515 USA.
   Fohner, Alison E., Univ Washington, Inst Publ Hlth Genet, 1959 NE Pacific Ave, Seattle, WA 98195 USA.
   Landry, Latrice, Harvard Med Sch, Harvard TH Chan Sch Publ Hlth, Brigham \& Womens Hosp, 450 Brookline Ave, Boston, MA 02215 USA.
   Landry, Latrice, Dana Farber Canc Inst, Div Populat Sci, 450 Brookline Ave, Boston, MA 02215 USA.
   Olstad, Dana Lee, Univ Calgary, Dept Community Hlth Sci, Cumming Sch Med, 3280 Hosp Dr NW, Calgary, AB T2N 4Z6, Canada.
   Smit, Amelia K., Univ Sydney, Canc Epidemiol \& Prevent Res, Sydney Sch Publ Hlth, Fac Med \& Hlth, 119-143 Missenden Rd, Camperdown, NSW 2050, Australia.
   Turbitt, Erin, Univ Technol Sydney, Discipline Genet Counselling, 100 Broadway, Ultimo, NSW 2008, Australia.
   Allen, Caitlin G., Emory Univ, Dept Behav Social \& Hlth Educ Sci, Rollins Sch Publ Hlth, 1518 Clifton Rd, Atlanta, GA 30322 USA.},
DOI = {10.1186/s13073-021-00911-0},
Article-Number = {97},
Keywords = {Precision medicine; Public health; Precision public health;
   Transdisciplinary research; Human genomics research},
Keywords-Plus = {EARLY CAREER INVESTIGATORS; CANCER PREVENTION; PARKINSONS-DISEASE;
   HEREDITARY BREAST; OVARIAN-CANCER; MEDICINE; RISK; POPULATION;
   PERSPECTIVES; CONTINUUM},
Research-Areas = {Genetics \& Heredity},
Web-of-Science-Categories  = {Genetics \& Heredity},
Author-Email = {calle27@emory.edu},
Affiliations = {University of North Carolina; University of North Carolina Chapel Hill;
   University of Washington; University of Washington Seattle; Harvard
   University; Harvard T.H. Chan School of Public Health; Brigham \&
   Women's Hospital; Harvard Medical School; Harvard University;
   Dana-Farber Cancer Institute; University of Calgary; University of
   Sydney; University of Technology Sydney; Emory University; Rollins
   School Public Health},
Cited-References = {Abul-Husn NS, 2021, GENOME MED, V13, DOI 10.1186/s13073-021-00832-y.
   Alegra-Torres JA, 2011, EPIGENOMICS-UK, V3, P267, DOI {[}10.2217/EPI.11.22, 10.2217/epi.11.22].
   Allen CG, 2021, TRANSL BEHAV MED, V11, P901, DOI 10.1093/tbm/ibaa076.
   Allen CG, 2019, AM J PUBLIC HEALTH, V109, P1186, DOI 10.2105/AJPH.2019.305199.
   Allen CG, 2019, LANCET, V394, P382, DOI 10.1016/S0140-6736(19)30498-2.
   {[}Anonymous], GENETIC ANAL WORKSHO.
   {[}Anonymous], CLIN PHARMACOGENETIC.
   {[}Anonymous], ALL SYNDROMES KNOWN.
   {[}Anonymous], CONCEPTUAL FRAMEWORK.
   Association of Schools and Programs of Public Health, AR STUD.
   Au NT, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201700746.
   Auton Brooks Durbin Garrison Kang A LD RM EP HM, 2015, Nature, V526, P68, DOI {[}10.1038/nature15393, DOI 10.1038/NATURE15393].
   Benson AB III, 2018, J NATL COMPR CANC NE, V16, P359, DOI 10.6004/jnccn.2018.0021.
   Bhatraju PK, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1546-4.
   Bowen DJ, 2019, CANCER CAUSE CONTROL, V30, P225, DOI 10.1007/s10552-018-1096-y.
   Brown TP, 2006, ENVIRON HEALTH PERSP, V114, P156, DOI 10.1289/ehp.8095.
   Burgard SA, 2013, AM BEHAV SCI, V57, P1105, DOI 10.1177/0002764213487347.
   Byrd AL, 2014, BIOL PSYCHIAT, V75, P9, DOI 10.1016/j.biopsych.2013.05.004.
   Callender T, 2019, PLOS MED, V16, DOI {[}10.1371/journal.pmed.1002998, 10.1371/journal.pmed.1002998.r001, 10.1371/journal.pmed.1002998.r002, 10.1371/journal.pmed.1002998.r003, 10.1371/journal.pmed.1002998.r004].
   Centers for Disease Control and Prevention, Tier 1 genomics applications and their importance to public health.
   Centers for Disease Control and Prevention, FAM HLTH HIST CHRON.
   Chowkwanyun M, 2018, NEW ENGL J MED, V379, P1398, DOI 10.1056/NEJMp1806634.
   Comission USEEO, GEN INF NOND ACT 200.
   Cust AE, 2018, J INVEST DERMATOL, V138, P2617, DOI 10.1016/j.jid.2018.05.023.
   Department of Health and Human Services, DISSEMINATION IMPLEM.
   Drolet BC, 2011, TRANSL RES, V157, P1, DOI 10.1016/j.trsl.2010.10.002.
   Evans DGR, 2019, BREAST CANCER RES TR, V176, P141, DOI 10.1007/s10549-019-05210-2.
   Evans MK, 2020, NEW ENGL J MED, V383, P274, DOI 10.1056/NEJMe2021693.
   Fahed AC, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17374-3.
   Fohner AE, 2019, CLIN PHARMACOL THER, V106, P488, DOI 10.1002/cpt.1508.
   Fohner AE, 2016, J NUTR, V146, P318, DOI 10.3945/jn.115.223388.
   Fox K, 2020, NEW ENGL J MED, V383, P411, DOI 10.1056/NEJMp1915987.
   Fuller KC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204127.
   Galea S, 2018, PERSPECT BIOL MED, V61, P527, DOI 10.1353/pbm.2018.0062.
   Glanz K, 2010, AM J PUBLIC HEALTH, V100, P735, DOI 10.2105/AJPH.2008.155705.
   Godard B, 2007, COMMUNITY GENET, V10, P147, DOI 10.1159/000101756.
   Gref A, 2017, AM J RESP CRIT CARE, V195, P1373, DOI 10.1164/rccm.201605-1026OC.
   Griesemer I, 2020, PERS MED, V17, P435, DOI 10.2217/pme-2020-0074.
   Hall M, 2005, JAMA-J AM MED ASSOC, V293, P1783, DOI 10.1001/jama.293.14.1783.
   Hamid Jemila S, 2009, Hum Genomics Proteomics, V2009, DOI 10.4061/2009/869093.
   IGNITE, IMPLEMENTATION GUIDE.
   Implementing Genomics in Practice, IMPLEMENTATION GUIDE.
   Jacobs EA, 2006, J GEN INTERN MED, V21, P642, DOI 10.1111/j.1525-1497.2006.00485.x.
   Kharazmi E, 2018, EUR J CANCER, V103, P1, DOI 10.1016/j.ejca.2018.07.139.
   Khera AV, 2018, NAT GENET, V50, P1219, DOI 10.1038/s41588-018-0183-z.
   Khoury MJ, 2007, GENET MED, V9, P665, DOI 10.1097/GIM.0b013e31815699d0.
   Khoury MJ, 2018, GENET MED, V20, P574, DOI 10.1038/gim.2017.211.
   Khoury MJ, 2016, JAMA-J AM MED ASSOC, V316, P1357, DOI 10.1001/jama.2016.12260.
   Khoury MJ, 2016, AM J PREV MED, V50, P398, DOI 10.1016/j.amepre.2015.08.031.
   Landau YE, 2014, J PEDIATR-US, V164, P14, DOI 10.1016/j.jpeds.2013.07.028.
   Landi MT, 2020, NAT GENET, V52, P494, DOI 10.1038/s41588-020-0611-8.
   Lee A, 2019, GENET MED, V21, P1708, DOI 10.1038/s41436-018-0406-9.
   Lunke S, 2020, JAMA-J AM MED ASSOC, V323, P2503, DOI 10.1001/jama.2020.7671.
   Marcus PM, 2016, CANCER EPIDEM BIOMAR, V25, P1449, DOI 10.1158/1055-9965.EPI-16-0555.
   Mavaddat N, 2019, AM J HUM GENET, V104, P21, DOI 10.1016/j.ajhg.2018.11.002.
   McBride CM, 2019, TRANSL BEHAV MED, V9, P1012, DOI 10.1093/tbm/ibz044.
   McBride CM, 2010, AM J PREV MED, V38, P556, DOI 10.1016/j.amepre.2010.01.027.
   Messerlian C, 2017, NAT REV ENDOCRINOL, V13, P740, DOI 10.1038/nrendo.2017.81.
   Narayan S, 2017, ENVIRON INT, V107, P266, DOI 10.1016/j.envint.2017.04.010.
   National Human Genome Research Institute, ETH LEG SOC IMPL RES.
   National Institute of Health, WHAT IS PREC MED.
   National Instututes of Health, ALL US RES PROGR.
   Nau C, 2015, HEALTH PLACE, V35, P136, DOI 10.1016/j.healthplace.2015.08.002.
   Olopade OI, 2004, CANCER EPIDEM BIOMAR, V13, P1683.
   Olstad DL, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-030279.
   Overby CL, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S9-S10.
   Pashayan N, 2018, JAMA ONCOL, V4, P1504, DOI 10.1001/jamaoncol.2018.1901.
   Pasick RJ, 2016, AM J PUBLIC HEALTH, V106, P1842, DOI 10.2105/AJPH.2016.303312.
   Prosperi M, 2018, BMC MED INFORM DECIS, V18, DOI 10.1186/s12911-018-0719-2.
   Rahm AK, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3636-2.
   Rasmussen LV, 2019, J AM MED INFORM ASSN, V26, P306, DOI 10.1093/jamia/ocy187.
   Roberts MC, 2019, ETHNIC DIS, V29, P187, DOI 10.18865/ed.29.S1.187.
   Roberts MC, 2018, JAMA ONCOL, V4, P1484, DOI 10.1001/jamaoncol.2018.1940.
   Roberts MC, 2018, HEALTH AFFAIR, V37, P801, DOI 10.1377/hlthaff.2017.1630.
   Roberts MC, 2017, GENET MED, V19, P858, DOI 10.1038/gim.2016.210.
   ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32.
   Roundtable on Translating Genomic-Based Research for H Board on Health Sciences P Institute of M. The National Academies Collection: reports funded by National Institutes of Health, 2015, GENOMICS ENABLED LEA.
   Schadt EE, 2010, NAT REV GENET, V11, P647, DOI 10.1038/nrg2857.
   Scherr CL, 2017, PATIENT EDUC COUNS, V100, P805, DOI 10.1016/j.pec.2016.10.026.
   Smit AK, 2018, CONTEMP CLIN TRIALS, V70, P106, DOI 10.1016/j.cct.2018.05.014.
   Stark Z, 2019, AM J HUM GENET, V105, P7, DOI 10.1016/j.ajhg.2019.06.003.
   Subramanian S, 2017, CANCER CAUSE CONTROL, V28, P299, DOI 10.1007/s10552-017-0864-4.
   Torkamani A, 2018, NAT REV GENET, V19, P581, DOI 10.1038/s41576-018-0018-x.
   Tremblay M, 2017, ANN HUM BIOL, V44, P357, DOI 10.1080/03014460.2017.1300326.
   Turbitt E, 2020, TRANSL BEHAV MED, V10, P451, DOI 10.1093/tbm/ibz018.
   Turnbull C, 2018, NAT GENET, V50, P1212, DOI 10.1038/s41588-018-0202-0.
   Wehby GL, 2018, J GERONTOL A-BIOL, V73, P477, DOI 10.1093/gerona/glx154.
   Woodahl EL, 2014, PHARMACOGENOMICS, V15, P1235, DOI {[}10.2217/PGS.14.91, 10.2217/pgs.14.91].
   Wray A, 2018, CITIES, V79, P53, DOI 10.1016/j.cities.2018.02.022.
   Yanes T, 2020, BREAST CANCER RES, V22, DOI 10.1186/s13058-020-01260-3.
   Nooraie RY, 2020, J CLIN TRANSL SCI, V4, P168, DOI 10.1017/cts.2020.10.},
Number-of-Cited-References = {91},
Times-Cited = {20},
Unique-ID = {WOS:000660582000001},
}

@article{ WOS:000901459400001,
Author = {Talias, Michael A. A. and Lamnisos, Demetris and Heraclides, Alexandros},
Title = {Editorial: Data science and health economics in precision public health},
Journal = {FRONTIERS IN PUBLIC HEALTH},
Year = {2022},
Volume = {10},
Month = {DEC 6},
Type = {Editorial Material},
Affiliation = {Talias, MA (Corresponding Author), Open Univ Cyprus, Sch Econ \& Management, Healthcare Management Postgrad Program, Latsia, Cyprus.
   Talias, Michael A. A., Open Univ Cyprus, Sch Econ \& Management, Healthcare Management Postgrad Program, Latsia, Cyprus.
   Lamnisos, Demetris; Heraclides, Alexandros, European Univ Cyprus, Dept Hlth Sci, Engomi, Cyprus.},
DOI = {10.3389/fpubh.2022.960282},
Article-Number = {960282},
Keywords = {health economics; health data science; decision support systems;
   precision public health; spatial epidemiology},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {michael.talias@ouc.ac.cy},
Affiliations = {Open University of Cyprus; European University Cyprus},
Cited-References = {Benke K, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15122796.
   Bhavnani SP, 2016, EUR HEART J, V37, P1428, DOI 10.1093/eurheartj/ehv770.
   Boulos MNK, 2019, INT J HEALTH GEOGR, V18, DOI 10.1186/s12942-019-0171-2.
   Chen YX, 2016, J PERS MED, V6, DOI 10.3390/jpm6040020.
   Colijn C, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00136.
   Graham S, 2019, CURR PSYCHIAT REP, V21, DOI 10.1007/s11920-019-1094-0.
   Johnson KB, 2021, CTS-CLIN TRANSL SCI, V14, P86, DOI 10.1111/cts.12884.
   Boulos MKN, 2021, INT J HEALTH GEOGR, V20, DOI 10.1186/s12942-021-00266-0.
   Kenney M, 2020, MED HUMANIT, V46, P192, DOI 10.1136/medhum-2018-011597.
   Kernick DP, 2003, POSTGRAD MED J, V79, P147, DOI 10.1136/pmj.79.929.147.
   Khoury MJ, 2016, AM J PREV MED, V50, P398, DOI 10.1016/j.amepre.2015.08.031.
   Kovalchuk SV, 2022, J BIOMED INFORM, V127, DOI 10.1016/j.jbi.2022.104013.
   Lomotey RK, 2017, PERVASIVE MOB COMPUT, V40, P692, DOI 10.1016/j.pmcj.2017.06.020.
   Mooney SJ, 2018, ANNU REV PUBL HEALTH, V39, P95, DOI 10.1146/annurev-publhealth-040617-014208.
   Odone Anna, 2019, Eur J Public Health, V29, P28, DOI 10.1093/eurpub/ckz161.
   Pearson TA, 2020, J AM COLL CARDIOL, V76, P306, DOI 10.1016/j.jacc.2020.05.043.
   Prager M, 2019, INT J HEALTH GEOGR, V18, DOI 10.1186/s12942-019-0177-9.
   Prosperi M, 2018, BMC MED INFORM DECIS, V18, DOI 10.1186/s12911-018-0719-2.
   Shaw Nicola, 2017, J Innov Health Inform, V24, P940, DOI 10.14236/jhi.v24i2.940.
   Wang FH, 2020, ANN GIS, V26, P1, DOI 10.1080/19475683.2019.1702099.
   Wang Lidong, 2020, Journal of Medical Engineering \& Technology, V44, P267, DOI 10.1080/03091902.2020.1769758.
   Weeramanthri TS, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00121.},
Number-of-Cited-References = {22},
Times-Cited = {1},
Unique-ID = {WOS:000901459400001},
}

@article{ WOS:000760940500027,
Author = {Bosward, Rebecca and Braunack-Mayer, Annette and Frost, Emma and Carter,
   Stacy},
Title = {Mapping precision public health definitions, terminology and
   applications: a scoping review protocol},
Journal = {BMJ OPEN},
Year = {2022},
Volume = {12},
Number = {2},
Month = {FEB},
Abstract = {Introduction Precision public health is an emerging and evolving field.
   Academic communities are divided regarding terminology and definitions,
   and what the scope, parameters and goals of precision public health
   should include. This protocol summarises the procedure for a scoping
   review which aims to identify and describe definitions, terminology,
   uses of the term and concepts in current literature. Methods and
   analysis A scoping review will be undertaken to gather existing
   literature on precision public health. We will search CINAHL, PubMed,
   Scopus, Web of Science and Google Scholar, and include all documents
   published in English that mention precision public health. A critical
   discourse analysis of the resulting papers will generate an account of
   precision public health terminology, definitions and uses of the term
   and the use and meaning of language. The analysis will occur in stages:
   first, descriptive information will be extracted and descriptive
   statistics will be calculated in order to characterise the literature.
   Second, occurrences of the phrase `precision public health' and
   alternative terms in documents will be enumerated and mapped, and
   definitions collected. The third stage of discourse analysis will
   involve analysis and interpretation of the meaning of precision public
   health, including the composition, organisation and function of
   discourses. Finally, discourse analysis of alternative phrases to
   precision public health will be undertaken. This will include analysis
   and interpretation of what alternative phrases to precision public
   health are used to mean, how the phrases relate to each other and how
   they are compared or contrasted to precision public health. Results will
   be grouped under headings according to how they answer the research
   questions. Ethics and dissemination No ethical approval will be required
   for the scoping review. Results of the scoping review will be used as
   part of a doctoral thesis, and may be published in journals, conference
   proceedings or elsewhere.},
Type = {Review},
Affiliation = {Bosward, R (Corresponding Author), Univ Wollongong, Sch Hlth \& Soc, Australian Ctr Hlth Engagement Evidence \& Values, Wollongong, NSW, Australia.
   Bosward, Rebecca; Braunack-Mayer, Annette; Frost, Emma; Carter, Stacy, Univ Wollongong, Sch Hlth \& Soc, Australian Ctr Hlth Engagement Evidence \& Values, Wollongong, NSW, Australia.},
DOI = {10.1136/bmjopen-2021-058069},
Article-Number = {e058069},
Keywords = {public health; qualitative research; statistics \& research methods},
Keywords-Plus = {QUALITATIVE RESEARCH; CHALLENGES},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Author-Email = {rbosward@uow.edu.au},
Affiliations = {University of Wollongong},
Cited-References = {{[}Anonymous], 2019, NAT MED, V25, P1177, DOI 10.1038/s41591-019-0556-6.
   {[}Anonymous], 2004, JBI Libr Syst Rev, V2, P1.
   {[}Anonymous], 2021, NVivo.
   Aromataris E, 2014, AM J NURS, V114, P49, DOI 10.1097/01.NAJ.0000446779.99522.f6.
   Barbour RS, 2001, BMJ-BRIT MED J, V322, P1115, DOI 10.1136/bmj.322.7294.1115.
   Bazerman C, 2004, WHAT WRITING DOES AND HOW IT DOES IT, P83.
   Belur J, 2021, SOCIOL METHOD RES, V50, P837, DOI 10.1177/0049124118799372.
   Birks Y., 2014, Health Services and Delivery Research, V2, DOI DOI 10.3310/HSDR02200.
   Bosward R., 2019, ETHICAL PERSPECT.
   Botelle R, 2020, BMC PREGNANCY CHILDB, V20, DOI 10.1186/s12884-020-2824-3.
   Braun V., 2006, Qualitative research in psychology, V3, P77, DOI DOI 10.1191/1478088706QP063OA.
   Carreiro S, 2017, J MED TOXICOL, V13, P166, DOI 10.1007/s13181-017-0611-y.
   Charles Sturt University, SYST SYST LIK REV.
   Dolley S, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00068.
   Edwards D, 1999, CULT PSYCHOL, V5, P271, DOI 10.1177/1354067X9953001.
   Eshelman School of Pharmacy, TRANSD C FUT LEAD PR.
   Eubank BH, 2016, BMC MED RES METHODOL, V16, DOI 10.1186/s12874-016-0165-8.
   Fairclough N., 2002, METHODS CRITICAL DIS, P121, DOI DOI 10.4135/9780857028020.
   Fairclough N., 1992, Discourse and Society, V3, P193, DOI DOI 10.1177/0957926592003002004.
   Fairclough N., 2013, CRITICAL DISCOURSE A.
   Gu DX, 2017, INT J MED INFORM, V98, P22, DOI 10.1016/j.ijmedinf.2016.11.006.
   Hodges BD, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a879.
   Horsley T, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000026.pub2.
   Insilica LLC, 2021, SYSREV.
   Jager S., 2011, METHODS CRITICAL DIS, DOI {[}10.4135/9780857028020, DOI 10.4135/9780857028020].
   Kee F, 2020, J EPIDEMIOL COMMUN H, V74, P311, DOI 10.1136/jech-2019-213311.
   Khoury M.J., 2015, Precision public health and precision medicine: two peas in a pod.
   Khoury MJ, 2018, GENET MED, V20, P574, DOI 10.1038/gim.2017.211.
   Malone JB, 2019, TROP MED INFECT DIS, V4, DOI 10.3390/tropicalmed4010015.
   Malterud K, 2001, LANCET, V358, P483, DOI 10.1016/S0140-6736(01)05627-6.
   Mc Mahon M., 2015, QUINTESSENTIALQUAL W.
   McGowan J, 2016, J CLIN EPIDEMIOL, V75, P40, DOI 10.1016/j.jclinepi.2016.01.021.
   McGregor C, 2018, TECHNOL INNOV MANAG, V8, P7, DOI 10.22215/timreview/1174.
   Meyer M., 2001, METHODS CRITICAL DIS, P14, DOI DOI 10.4135/9780857028020.N2.
   Meyer SL, 2020, J PUBLIC HEALTH DENT, V80, pS7, DOI 10.1111/jphd.12315.
   Milwid R, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00213.
   Olstad DL, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-030279.
   Pham MT, 2014, RES SYNTH METHODS, V5, P371, DOI 10.1002/jrsm.1123.
   Porter JamesE., 1986, RHETOR REV, V5, P34, DOI {[}10.1080/07350198609359131, DOI 10.1080/07350198609359131].
   Potter J., 1987, DISCOURSE SOCIAL PSY.
   Prosperi M, 2018, BMC MED INFORM DECIS, V18, DOI 10.1186/s12911-018-0719-2.
   Rozbroj T, 2019, VACCINE, V37, P5986, DOI {[}10.1016/j.vaccine.2019.08.023, 10.1016/j.vaccin].
   Rozbroj Tomas, 2020, BMJ Open, V10, pe037283, DOI 10.1136/bmjopen-2020-037283.
   Ruiz Ruiz J, 2009, FORUM QUAL SOC RES.
   Saw Swee Hock School of Public Health, PREC PUBL HLTH TRANS.
   Schneider F., 2013, POLITICS E ASIA BLOG.
   Scollon R., 2001, METHODS CRITICAL DIS.
   Sucharew H, 2019, J HOSP MED, V14, P416, DOI 10.12788/jhm.3248.
   Taylor-Robinson D, 2019, INT J EPIDEMIOL, V48, P1, DOI 10.1093/ije/dyy184.
   Thomas J, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-45.
   Tonidandel S, 2018, ORGAN RES METHODS, V21, P525, DOI 10.1177/1094428116677299.
   Tricco AC, 2018, ANN INTERN MED, V169, P467, DOI 10.7326/M18-0850.
   Tricco AC, 2016, BMC MED RES METHODOL, V16, DOI 10.1186/s12874-016-0116-4.
   University of California San Francisco, PREC PUBL HLTH SUMM.
   van Dijk T.A., 2001, METHODS CRITICAL DIS, P95.
   Wang W, 2006, THESIS U SYDNEY SYDN.
   Weeramanthri TS, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00121.
   Williamson PO, 2019, J MED LIBR ASSOC, V107, P16, DOI 10.5195/jmla.2019.433.
   Wodak R., 2009, METHODS CRITICAL DIS, V2, P1.},
Number-of-Cited-References = {59},
Times-Cited = {0},
Unique-ID = {WOS:000760940500027},
}

@article{ WOS:000880781000001,
Author = {Milko, Laura V. V. and Khoury, Muin J. J.},
Title = {Editorial: DNA-based population screening for precision public health},
Journal = {FRONTIERS IN GENETICS},
Year = {2022},
Volume = {13},
Month = {OCT 24},
Type = {Editorial Material},
Affiliation = {Milko, LV (Corresponding Author), Univ North Carolina Chapel Hill, Dept Genet, Chapel Hill, NC 27599 USA.
   Milko, Laura V. V., Univ North Carolina Chapel Hill, Dept Genet, Chapel Hill, NC 27599 USA.
   Khoury, Muin J. J., CDCP, Off Genom \& Precis Publ Hlth, Atlanta, GA USA.},
DOI = {10.3389/fgene.2022.1061329},
Article-Number = {1061329},
Keywords = {DNA; population screening; precision public health; health equity;
   implementation science; genome sequencing; expanded newborn screening},
Research-Areas = {Genetics \& Heredity},
Web-of-Science-Categories  = {Genetics \& Heredity},
Author-Email = {laura\_milko@med.unc.edu},
Affiliations = {University of North Carolina; University of North Carolina Chapel Hill;
   University of North Carolina School of Medicine; Centers for Disease
   Control \& Prevention - USA},
Cited-References = {Bangash H, 2021, J PERS MED, V11, DOI 10.3390/jpm11010019.
   Bean LJH, 2021, GENET MED, V23, P979, DOI 10.1038/s41436-020-01083-9.
   Brower A, 2022, FRONT GENET, V13, DOI 10.3389/fgene.2022.867337.
   Khoury MJ, 2018, GENET MED, V20, P574, DOI 10.1038/gim.2017.211.
   Khoury MJ, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002631.
   Murray MF, 2020, JAMA-J AM MED ASSOC, V323, P307, DOI 10.1001/jama.2019.18640.
   Roberts MC, 2019, ETHNIC DIS, V29, P187, DOI 10.18865/ed.29.S1.187.},
Number-of-Cited-References = {7},
Times-Cited = {2},
Unique-ID = {WOS:000880781000001},
}

@article{ WOS:000394219700001,
Author = {Mills, Edward J. and Kanters, Steve and Ford, Nathan},
Title = {The comparative effectiveness of antiretroviral therapies for HIV:
   evidence to inform precision public health},
Journal = {JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH},
Year = {2017},
Volume = {6},
Number = {2},
Pages = {85-87},
Month = {MAR},
Type = {Editorial Material},
Affiliation = {Mills, EJ (Corresponding Author), Univ Rwanda, Sch Publ Hlth, Kigali, Rwanda.
   Mills, Edward J., Univ Rwanda, Sch Publ Hlth, Kigali, Rwanda.
   Kanters, Steve, Univ British Columbia, Sch Populat \& Publ Hlth, Vancouver, BC, Canada.
   Ford, Nathan, World Hlth Org, Dept HIV AIDS, Geneva, Switzerland.},
DOI = {10.2217/cer-2016-0093},
Keywords = {comparative effectiveness; HIV/AIDS; precision public health},
Keywords-Plus = {NETWORK METAANALYSIS; INFECTION; DOLUTEGRAVIR; GUIDELINES; INHIBITORS},
Research-Areas = {Health Care Sciences \& Services},
Web-of-Science-Categories  = {Health Care Sciences \& Services},
Author-Email = {millsej@mcmaster.ca},
Affiliations = {University of Rwanda; University of British Columbia; World Health
   Organization},
Cited-References = {Doherty M, 2013, CURR OPIN HIV AIDS, V8, P528, DOI 10.1097/COH.0000000000000008.
   Dowell SF, 2016, NATURE, V540, P189, DOI 10.1038/540189a.
   Günthard HF, 2016, JAMA-J AM MED ASSOC, V316, P191, DOI 10.1001/jama.2016.8900.
   Kanters S, 2016, LANCET HIV, V3, pE510, DOI 10.1016/S2352-3018(16)30091-1.
   Kanters S, 2016, B WORLD HEALTH ORGAN, V94, P782, DOI 10.2471/BLT.16.174326.
   Kent DM, 2004, JAMA-J AM MED ASSOC, V292, P237, DOI 10.1001/jama.292.2.237.
   Mesplède T, 2014, ANN MED, V46, P123, DOI {[}10.3109/07853890.2014.883169, 10.3109/07853890.2014.883].
   Mills EJ, BMJ, V346, pf2914.
   Murray CJ, 2013, LANCET, V384.
   Pozniak AL, 2016, LANCET HIV, V3, pE500, DOI 10.1016/S2352-3018(16)30154-0.
   Raffi F, 2013, LANCET INFECT DIS, V13, P927, DOI 10.1016/S1473-3099(13)70257-3.
   UNAIDS, 2016, FACT SHEET.
   Walmsley SL, 2013, NEW ENGL J MED, V369, P1807, DOI 10.1056/NEJMoa1215541.
   Wang HD, 2016, LANCET HIV, V3, pE361, DOI 10.1016/S2352-3018(16)30087-X.
   WHO, 2013, GLOB UPD HIV TREATM.},
Number-of-Cited-References = {15},
Times-Cited = {0},
Unique-ID = {WOS:000394219700001},
}

@article{ WOS:000681374700012,
Author = {Ferryman, Kadija},
Title = {The Dangers of Data Colonialism in Precision Public Health},
Journal = {GLOBAL POLICY},
Year = {2021},
Volume = {12},
Number = {6, SI},
Pages = {90-92},
Month = {JUL},
Abstract = {Precision public health has been defined as using multi-level and
   relatively novel data types (such as patient-provided digital data from
   internet applications and digital medical records) in order to predict
   and track population level disease dynamics as well as develop targeted
   interventions (Khoury, 2015, Khoury et al., 2018). Despite the promises
   of precision public health, it is also important to examine the field's
   potential pitfalls, specifically its resonance with data colonialism.
   Without adequate attention to this emerging field's vulnerabilities,
   precision public health efforts may continue histories of extraction and
   marginalization.},
Type = {Article},
Affiliation = {Ferryman, K (Corresponding Author), NYU, Tandon Sch Engn, New York, NY 10003 USA.
   Ferryman, Kadija, NYU, Tandon Sch Engn, New York, NY 10003 USA.},
DOI = {10.1111/1758-5899.12953},
Research-Areas = {International Relations; Government \& Law},
Web-of-Science-Categories  = {International Relations; Political Science},
Affiliations = {New York University; New York University Tandon School of Engineering},
Cited-References = {Adams V, 2016, GLOB PUBLIC HEALTH, V11, P276, DOI 10.1080/17441692.2015.1021364.
   Biruk C, 2012, MED ANTHROPOL, V31, P347, DOI 10.1080/01459740.2011.631960.
   Chunara R, 2012, AM J TROP MED HYG, V86, P39, DOI 10.4269/ajtmh.2012.11-0597.
   Couldry N, 2019, TELEV NEW MEDIA, V20, P336, DOI 10.1177/1527476418796632.
   Erikson SL, 2012, MED ANTHROPOL, V31, P367, DOI 10.1080/01459740.2011.621908.
   Khoury M.J., 2015, ANN POP HLTH SCI C ANN POP HLTH SCI C.
   Khoury MJ, 2018, GENET MED, V20, P574, DOI 10.1038/gim.2017.211.
   Lazer D, 2014, SCIENCE, V343, P1203, DOI 10.1126/science.1248506.
   Maharana A, 2019, JAMIA OPEN, V2, P330, DOI 10.1093/jamiaopen/ooz030.
   Merry SE, 2011, CURR ANTHROPOL, V52, pS83, DOI 10.1086/657241.
   Obermeyer Z, 2019, SCIENCE, V366, P447, DOI 10.1126/science.aax2342.
   Räsänen M, 2013, SCI TECHNOL HUM VAL, V38, P655, DOI 10.1177/0162243913480049.
   Shaffer L, 2020, NAT MED, V26, P2, DOI 10.1038/s41591-019-0717-7.},
Number-of-Cited-References = {13},
Times-Cited = {6},
Unique-ID = {WOS:000681374700012},
}

@article{ WOS:000571867000010,
Author = {Rasmussen, Sonja A. and Khoury, Muin J. and del Rio, Carlos},
Title = {Precision Public Health as a Key Tool in the COVID-19 Response},
Journal = {JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION},
Year = {2020},
Volume = {324},
Number = {10},
Pages = {933-934},
Month = {SEP 8},
Abstract = {This Viewpoint provides examples of how applying precision public health
   operations can help curb the COVID-19 pandemic.},
Type = {Editorial Material},
Affiliation = {Rasmussen, SA (Corresponding Author), Univ Florida, 1600 SW Archer Rd,POB 100296, Gainesville, FL 32610 USA.
   Rasmussen, Sonja A., Univ Florida, Coll Med, Dept Pediat, Gainesville, FL USA.
   Rasmussen, Sonja A., Univ Florida, Coll Med, Dept Obstet \& Gynecol, Gainesville, FL 32610 USA.
   Rasmussen, Sonja A., Univ Florida, Coll Med, Dept Epidemiol, Gainesville, FL 32610 USA.
   Rasmussen, Sonja A., Coll Publ Hlth \& Hlth Profess, Gainesville, FL USA.
   Khoury, Muin J., Ctr Dis Control \& Prevent, Off Genom \& Precis Publ Hlth, Atlanta, GA USA.
   del Rio, Carlos, Emory Univ, Sch Med, Dept Med, Hubert Dept Global Hlth,Rollins Sch Publ Hlth,Div, Atlanta, GA USA.},
DOI = {10.1001/jama.2020.14992},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Author-Email = {sonja.rasmussen@peds.ufl.edu},
Affiliations = {State University System of Florida; University of Florida; State
   University System of Florida; University of Florida; State University
   System of Florida; University of Florida; Centers for Disease Control \&
   Prevention - USA; Emory University; Rollins School Public Health},
Cited-References = {Emeruwa UN, 2020, JAMA-J AM MED ASSOC, V324, P390, DOI 10.1001/jama.2020.11370.
   Katz I, 2019, JAMA-J AM MED ASSOC, V321, P1153, DOI 10.1001/jama.2019.1817.
   Khoury MJ, 2018, PUBLIC HEALTH GENOM, V21, P244, DOI 10.1159/000501465.
   Killerby ME, 2020, MMWR-MORBID MORTAL W, V69, P790, DOI 10.15585/mmwr.mm6925e1.
   Lasry A, 2020, MMWR-MORBID MORTAL W, V69, P451, DOI 10.15585/mmwr.mm6915e2.
   Oran DP, 2020, ANN INTERN MED, V173, P362, DOI 10.7326/M20-3012.
   Munnink BOB, 2020, NAT MED, V26, DOI 10.1038/s41591-020-0997-y.
   Roxby AC, 2020, JAMA INTERN MED, V180, P1101, DOI 10.1001/jamainternmed.2020.2233.
   Smith CD, 2020, PREV CHRONIC DIS, V17, DOI 10.5888/pcd17.200246.},
Number-of-Cited-References = {9},
Times-Cited = {42},
Unique-ID = {WOS:000571867000010},
}

@article{ WOS:000968293300001,
Author = {Baker, Jennifer L. and Bjerregaard, Lise G.},
Title = {Advancing precision public health for obesity in children},
Journal = {REVIEWS IN ENDOCRINE \& METABOLIC DISORDERS},
Year = {2023},
Volume = {24},
Number = {5, SI},
Pages = {1003-1010},
Month = {OCT},
Abstract = {Worldwide, far too many children and adolescents are living with the
   disease of obesity. Despite decades of public health initiatives, rates
   are still rising in many countries. This raises the question of whether
   precision public health may be a more successful approach to preventing
   obesity in youth. In this review, the objective was to review the
   literature on precision public health in the context of childhood
   obesity prevention and to discuss how precision public health may
   advance the field of childhood obesity prevention. As precision public
   health is a concept that is still evolving and not fully identifiable in
   the literature, a lack of published studies precluded a formal review.
   Therefore, the approach of using a broad interpretation of precision
   public health was used and recent advances in childhood obesity research
   in the areas of surveillance and risk factor identification as well as
   intervention, evaluation and implementation using selected studies were
   summarized. Encouragingly, big data from a multitude of designed and
   organic sources are being used in new and innovative ways to provide
   more granular surveillance and risk factor identification in obesity in
   children. Challenges were identified in terms of data access,
   completeness, and integration, ensuring inclusion of all members of
   society, ethics, and translation to policy. As precision public health
   advances, it may yield novel insights that can contribute to strong
   policies acting in concert that ultimately lead to the prevention of
   obesity in children.},
Type = {Article},
Affiliation = {Baker, JL (Corresponding Author), Copenhagen Univ Hosp Bispebjerg \& Frederiksberg, Ctr Clin Res \& Prevent, Frederiksberg, Denmark.
   Baker, Jennifer L.; Bjerregaard, Lise G., Copenhagen Univ Hosp Bispebjerg \& Frederiksberg, Ctr Clin Res \& Prevent, Frederiksberg, Denmark.},
DOI = {10.1007/s11154-023-09802-8},
EarlyAccessDate = {APR 2023},
Keywords = {Children; Obesity; Precision public health},
Keywords-Plus = {CHILDHOOD; RISK},
Research-Areas = {Endocrinology \& Metabolism},
Web-of-Science-Categories  = {Endocrinology \& Metabolism},
Author-Email = {Jennifer.lyn.baker@region.dk},
Affiliations = {University of Copenhagen; Bispebjerg Hospital},
Cited-References = {Aadland E, 2019, INT J BEHAV NUTR PHY, V16, DOI 10.1186/s12966-019-0836-z.
   Aarestrup J, 2020, INT J OBESITY, V44, P1546, DOI 10.1038/s41366-020-0523-9.
   Abul-Husn NS, 2021, GENOME MED, V13, DOI 10.1186/s13073-021-00832-y.
   {[}Anonymous], 1998, OB PREV MAN GLOB EP.
   Aris IM, 2022, JAMA NETW OPEN, V5, DOI 10.1001/jamanetworkopen.2022.47957.
   Arnold C, 2022, NATURE, V601, P18, DOI 10.1038/d41586-021-03819-2.
   Baker JL, 2007, NEW ENGL J MED, V357, P2329, DOI 10.1056/NEJMoa072515.
   Bjerregaard LG, 2018, NEW ENGL J MED, V378, P1302, DOI {[}10.1056/nejmoa1713231, 10.1056/NEJMoa1713231].
   Branca F, 2021, OBES REV, V22, DOI 10.1111/obr.13181.
   Breda J, 2021, OBES REV, V22, DOI 10.1111/obr.13215.
   Canfell OJ, 2022, FRONT PUBLIC HEALTH, V10, DOI 10.3389/fpubh.2022.854525.
   Canfell OJ, 2022, BMC PUBLIC HEALTH, V22, DOI 10.1186/s12889-022-12939-x.
   Catalán V, 2022, NUTRIENTS, V14, DOI 10.3390/nu14081597.
   Cathaoir KO, 2016, HEALTH HUM RIGHTS, V18, P249.
   Chowkwanyun M, 2018, NEW ENGL J MED, V379, P1398, DOI 10.1056/NEJMp1806634.
   Dolley S, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00068.
   Ezzati M, 2017, LANCET, V390, P2627, DOI {[}10.1016/S0140-6736(17)32129-3, 10.1016/s0140-6736(17)32129-3].
   Goedhart NS, 2022, POLICY INTERNET, V14, P824, DOI 10.1002/poi3.315.
   Groves Robert., 2011, `Designed Data' and `Organic Data'.
   Hadjiyannakis S, 2016, PAED CHILD HEALT-CAN, V21, P21, DOI 10.1093/pch/21.1.21.
   Han XK, 2022, COMMUN BIOL, V5, DOI 10.1038/s42003-022-04070-9.
   Harroud A, 2021, MULT SCLER J, V27, P2150, DOI 10.1177/13524585211001781.
   Horton R, 2018, LANCET, V392, P1504, DOI 10.1016/S0140-6736(18)32741-7.
   Institute of Medicine, 1988, Committee for the Study of the Future of Public Health. The Future of Public Health.
   Jensen BW, 2023, JNCI-J NATL CANCER I, V115, P43, DOI 10.1093/jnci/djac192.
   Kee F, 2020, J EPIDEMIOL COMMUN H, V74, P311, DOI 10.1136/jech-2019-213311.
   Kelly CJ, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1426-2.
   Kennedy OJ, 2023, INT J OBESITY, V47, P87, DOI 10.1038/s41366-022-01231-y.
   Khoury MJ, 2018, GENET MED, V20, P574, DOI 10.1038/gim.2017.211.
   Khoury MJ, 2018, PUBLIC HEALTH GENOM, V21, P244, DOI 10.1159/000501465.
   Khoury MJ, 2016, AM J PREV MED, V50, P398, DOI 10.1016/j.amepre.2015.08.031.
   Kinyoki DK, 2020, NAT MED, V26, P750, DOI 10.1038/s41591-020-0807-6.
   Kneale D., 2020, Precision public health - A critical review of the opportunities and obstacles.
   Liu F, 2022, BMC MED RES METHODOL, V22, DOI 10.1186/s12874-022-01768-6.
   Loos RJF, 2022, NAT REV GENET, V23, P120, DOI 10.1038/s41576-021-00414-z.
   Mhasawade V, 2021, NAT MACH INTELL, V3, P659, DOI 10.1038/s42256-021-00373-4.
   Naumova EN, 2022, J PUBLIC HEALTH POL, V43, P481, DOI 10.1057/s41271-022-00367-5.
   Nestle M, 2000, PUBLIC HEALTH REP, V115, P12, DOI 10.1093/phr/115.1.12.
   Nestle M, 2022, JAMA INTERN MED, V182, P973, DOI 10.1001/jamainternmed.2022.3039.
   Nury E, 2022, BMJ MED, V1, DOI 10.1136/bmjmed-2022-000346.
   Olstad DL, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-030279.
   Paalanen L, 2022, BMJ OPEN, V12, DOI 10.1136/bmjopen-2022-068748.
   Pang XQ, 2021, INT J MED INFORM, V150, DOI 10.1016/j.ijmedinf.2021.104454.
   Papadimitriou N, 2023, BMC MED, V21, DOI 10.1186/s12916-022-02702-9.
   Pérez-Escamilla R, 2021, OBES REV, V22, DOI 10.1111/obr.13247.
   Prosperi M, 2018, BMC MED INFORM DECIS, V18, DOI 10.1186/s12911-018-0719-2.
   Sacks G, 2009, OBES REV, V10, P76, DOI 10.1111/j.1467-789X.2008.00524.x.
   Shi X, 2021, BMC MED INFORM DECIS, V21, DOI 10.1186/s12911-021-01580-0.
   Summerbell CD, 2005, COCHRANE DB SYST REV, DOI {[}10.1002/14651858.CD001871.pub2, 10.1002/14651858.CD001871.pub4].
   Taylor-Robinson D, 2019, INT J EPIDEMIOL, V48, P1, DOI 10.1093/ije/dyy184.
   Timmins KA, 2018, INT J OBESITY, V42, P1951, DOI 10.1038/s41366-018-0153-7.
   Tufford AR, 2022, CURR DEV NUTR, V6, DOI 10.1093/cdn/nzac123.
   Vogel C, 2019, INT J OBESITY, V43, P2573, DOI 10.1038/s41366-018-0313-9.
   Weeramanthri TS, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00121.
   World Health Organization, 2022, ICD-11 for mortality and morbidity statistics-6B00 generalised anxiety disorder.
   World Health Organization, 2021, US.
   Xu H, 2020, J MANAGE, V46, P1257, DOI 10.1177/0149206319862027.
   Zhao SS, 2022, RMD OPEN, V8, DOI 10.1136/rmdopen-2022-002321.},
Number-of-Cited-References = {58},
Times-Cited = {1},
Unique-ID = {WOS:000968293300001},
}

@article{ WOS:000814954500001,
Author = {Roberts, Megan C. and Mader, June Mullaney and Turbitt, Erin and Smit,
   Amelia K. and Landry, Latrice and Olstad, Dana Lee and Passero, Lauren
   E. and Allen, Caitlin G.},
Title = {Using a Participatory Approach to Develop Research Priorities for Future
   Leaders in Cancer-Related Precision Public Health},
Journal = {FRONTIERS IN GENETICS},
Year = {2022},
Volume = {13},
Month = {JUN 9},
Abstract = {Precision public health is an emerging discipline combining principles
   and frameworks of precision health with the goal of improving population
   health. The development of research priorities drawing on the strengths
   of precision and public health is critical to facilitate the growth of
   the discipline to improve health outcomes. We held an interactive
   workshop during a virtual conference bringing together early-career
   researchers across public health disciplines to identify research
   priorities in precision public health. The workshop participants
   discussed and voted to identify three priority areas for future research
   and capacity building including 1) enhancing equity and access to
   precision public health research and resources, 2) improving tools and
   metrics for evaluation and 3) applying principles of implementation
   science to support sustainable practices. Participants also developed
   future objectives for achieving each priority. Future efforts by working
   groups will continue the process of identifying, revising, and advancing
   critical research priorities to grow the impact of precision public
   health.},
Type = {Article},
Affiliation = {Roberts, MC (Corresponding Author), Univ N Carolina, Div Pharmaceut Outcomes \& Policy, Chapel Hill, NC 27599 USA.
   Roberts, Megan C.; Passero, Lauren E., Univ N Carolina, Div Pharmaceut Outcomes \& Policy, Chapel Hill, NC 27599 USA.
   Mader, June Mullaney, GOFORWARD LLC, Durham, NC USA.
   Turbitt, Erin, Univ Technol Sydney, Grad Sch Hlth, Ultimo, NSW, Australia.
   Smit, Amelia K., Univ Sydney, Daffodil Ctr, Joint Venture Canc Council NSW, Sydney, NSW, Australia.
   Smit, Amelia K., Univ Sydney, Melanoma Inst Australia, Sydney, NSW, Australia.
   Landry, Latrice, Dana Farber Canc Inst, Program Canc Care Equ, Boston, MA 02115 USA.
   Olstad, Dana Lee, Univ Calgary, Cumming Sch Med, Dept Community Hlth Sci, Calgary, AB, Canada.
   Allen, Caitlin G., Med Univ South Carolina, Coll Med, Dept Publ Hlth Sci, Charleston, SC USA.},
DOI = {10.3389/fgene.2022.881527},
Article-Number = {881527},
Keywords = {precision public health; research priorities; cancer; conference;
   transdisciplinary research; equity; implementation science; evaluation},
Keywords-Plus = {EARLY CAREER INVESTIGATORS; IMPLEMENTATION SCIENCE; GENOMIC MEDICINE;
   CURRENT STATE},
Research-Areas = {Genetics \& Heredity},
Web-of-Science-Categories  = {Genetics \& Heredity},
Author-Email = {megan.roberts@unc.edu},
Affiliations = {University of North Carolina; University of North Carolina Chapel Hill;
   University of Technology Sydney; University of Sydney; University of
   Sydney; Melanoma Institute Australia; Harvard University; Dana-Farber
   Cancer Institute; University of Calgary; Medical University of South
   Carolina},
Cited-References = {Allen CG, 2019, AM J PUBLIC HEALTH, V109, P1186, DOI 10.2105/AJPH.2019.305199.
   Allen CG, 2019, LANCET, V394, P382, DOI 10.1016/S0140-6736(19)30498-2.
   CDC, 2021, ABOUT US.
   Chambers DA, 2016, JAMA-J AM MED ASSOC, V315, P1941, DOI 10.1001/jama.2016.3867.
   Cooperrider DavidL., 2005, APPRECIATIVE INQUIRY.
   Dharwadkar P, 2022, CLIN GASTROENTEROL H, V20, P353, DOI 10.1016/j.cgh.2020.12.025.
   Doran G.T., 1981, MANAG REV.
   Doyle DL, 2018, GENET MED, V20, P995, DOI 10.1038/gim.2017.229.
   Genomics, 2020, IMPL GEN PRACT IGNIT.
   Khoury MJ, 2021, GENOME MED, V13, DOI 10.1186/s13073-021-00886-y.
   Khoury MJ, 2016, AM J PREV MED, V50, P398, DOI 10.1016/j.amepre.2015.08.031.
   Korngiebel DM, 2017, TRENDS PHARMACOL SCI, V38, P8, DOI 10.1016/j.tips.2016.11.007.
   Landry LG, 2018, HEALTH AFFAIR, V37, P780, DOI 10.1377/hlthaff.2017.1595.
   Mapes BM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234962.
   Olstad DL, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-030279.
   Pearson TA, 2020, J AM COLL CARDIOL, V76, P306, DOI 10.1016/j.jacc.2020.05.043.
   Pharmalliance, 2022, PHARMALLIANCE.
   PharmSci, 2021, UNC ESH SCH PHARM.
   Robbins SM, 2021, GENET MED, V23, P222, DOI 10.1038/s41436-020-00962-5.
   Roberts MC, 2021, GENOME MED, V13, DOI 10.1186/s13073-021-00911-0.
   Roberts MC, 2019, GENET MED, V21, P1218, DOI 10.1038/gim.2017.180.
   Roberts MC, 2017, GENET MED, V19, P858, DOI 10.1038/gim.2016.210.
   Veterans Health Administration, 2021, PHASER PROGR NATL ON.
   Williams CD, 2019, J RACIAL ETHN HEALTH, V6, P570, DOI 10.1007/s40615-018-00556-7.
   Nooraie RY, 2020, J CLIN TRANSL SCI, V4, P168, DOI 10.1017/cts.2020.10.},
Number-of-Cited-References = {25},
Times-Cited = {2},
Unique-ID = {WOS:000814954500001},
}

@article{ WOS:000568192900014,
Author = {Kee, Frank and Taylor-Robinson, David},
Title = {Scientific challenges for precision public health},
Journal = {JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH},
Year = {2020},
Volume = {74},
Number = {4},
Pages = {311-314},
Month = {APR},
Abstract = {The notion of `precision' public health has been the subject of much
   debate, with recent articles coming to its defence following the
   publication of several papers questioning its value.
   Critics of precision public health raise the following problems and
   questionable assumptions: the inherent limits of prediction for
   individuals; the limits of approaches to prevention that rely on
   individual agency, in particular the potential for these approaches to
   widen inequalities; the undue emphasis on the supposed new information
   contained in individuals' molecules and their `big data' at the expense
   of their own preferences for a particular intervention strategy and the
   diversion of resources and attention from the social determinants of
   health.
   In order to refocus some of these criticisms of precision public health
   as scientific questions, this article outlines some of the challenges
   when defining risk for individuals; the limitations of current theory
   and study design for precision public health; and the potential for
   unintended harms.},
Type = {Article},
Affiliation = {Taylor-Robinson, D (Corresponding Author), Univ Liverpool, Publ Hlth \& Policy, Liverpool L69 3GB, Merseyside, England.
   Kee, Frank, Queens Univ Belfast, Ctr Stat Sci \& Operat Res CenSSOR, Belfast, Antrim, North Ireland.
   Taylor-Robinson, David, Univ Liverpool, Publ Hlth \& Policy, Liverpool L69 3GB, Merseyside, England.},
DOI = {10.1136/jech-2019-213311},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {dctr@liv.ac.uk},
Affiliations = {Queens University Belfast; University of Liverpool},
Cited-References = {Allem JP, 2018, AM J PUBLIC HEALTH, V108, P1005, DOI 10.2105/AJPH.2018.304512.
   {[}Anonymous], LEARN ON GEN RISK CH.
   {[}Anonymous], 51 PRED PREV DRIV PR.
   Asaria M, 2016, MED DECIS MAKING, V36, P8, DOI 10.1177/0272989X15583266.
   Bonell C, 2015, J EPIDEMIOL COMMUN H, V69, P95, DOI 10.1136/jech-2014-204671.
   Burke LE, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.7138.
   CDC, SAYS DST PREC PUBL H.
   Chatelan A, 2019, INT J EPIDEMIOL, V48, P332, DOI 10.1093/ije/dyy274.
   Cheung YK, 2017, METHOD INFORM MED, V56, P452, DOI 10.3414/ME16-02-0051.
   Chowkwanyun M, 2018, NEW ENGL J MED, V379, P1398, DOI 10.1056/NEJMp1806634.
   Crum AJ, 2011, HEALTH PSYCHOL, V30, P424, DOI 10.1037/a0023467.
   Davey G, 2017, LANCET, V390, P2126, DOI 10.1016/S0140-6736(17)32280-8.
   Davidson KW, 2017, HEALTH PSYCHOL REV, V11, P292, DOI 10.1080/17437199.2017.1347514.
   Emanuel EJ, 2019, JAMA-J AM MED ASSOC, V321, P2281, DOI 10.1001/jama.2019.4914.
   Fried LP, 2019, AM J PUBLIC HEALTH, V109, P1188, DOI 10.2105/AJPH.2019.305257.
   Galizzi M.M., 2019, FRONT PSYCHOL, V10.
   GOV.UK, PREV IS BETT CUR OUR.
   GOV.UK, CHIEF MED OFF ANN RE.
   GOV.UK, IMPR PEOPL HLTH APPL.
   GOV.UK, ADV OUR HLTH PREV 20.
   Holmes EA, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2015.207.
   Horton R, 2018, LANCET, V392, P1504, DOI 10.1016/S0140-6736(18)32741-7.
   Ioannidis JPA, 2018, JAMA-J AM MED ASSOC, V320, P969, DOI 10.1001/jama.2018.11025.
   Ioannidis JPA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001058.
   Kaplan M, 2018, NATURE, V563, P20, DOI 10.1038/d41586-018-07181-8.
   Khoury MJ, 2016, AM J PREV MED, V50, P398, DOI 10.1016/j.amepre.2015.08.031.
   Koslovsky MD, 2018, BIOMETRICS, V74, P636, DOI 10.1111/biom.12792.
   Leguia M, 2020, J INFECT DIS, V221, pS289, DOI 10.1093/infdis/jiz424.
   Liao Y, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.4954.
   Mandl KD, 2019, JAMA-J AM MED ASSOC, V321, P739, DOI 10.1001/jama.2019.0286.
   McDonald S, 2017, HEALTH PSYCHOL REV, V11, P307, DOI 10.1080/17437199.2017.1316672.
   McMichael AJ, 2017, VALUE HEALTH, V20, P126, DOI 10.1016/j.jval.2016.09.2395.
   Nahum-Shani I, 2018, ANN BEHAV MED, V52, P446, DOI 10.1007/s12160-016-9830-8.
   National Institute for Health and Care Excellence (NICE), 2007, Behaviour Change: general approaches.
   Olstad DL, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-030279.
   Rajkomar A, 2018, ANN INTERN MED, V169, P866, DOI 10.7326/M18-1990.
   Resnicow K, 2008, AM J PUBLIC HEALTH, V98, P1382, DOI 10.2105/AJPH.2007.129460.
   Ridenour TA, 2016, TRANSL BEHAV MED, V6, P125, DOI 10.1007/s13142-015-0357-5.
   Riley WT, 2011, TRANSL BEHAV MED, V1, P53, DOI 10.1007/s13142-011-0021-7.
   Schisterman EF, 2017, EPIDEMIOLOGY, V28, P47, DOI 10.1097/EDE.0000000000000554.
   SEDGWICK P, 2014, BMJ-BRIT MED J, V348, DOI DOI 10.1136/BMJ.G2674.
   Senn S, 2018, NATURE, V563, P619, DOI 10.1038/d41586-018-07535-2.
   Silberzahn R, 2018, ADV METH PRACT PSYCH, V1, P337, DOI 10.1177/2515245917747646.
   Steel N, 2018, LANCET, V392, P1647, DOI {[}10.1016/S0140-6736(18)32207-4, 10.1016/s0140-6736(18)32207-4].
   Taylor-Robinson D, 2019, INT J EPIDEMIOL, V48, P1, DOI 10.1093/ije/dyy184.
   van Gestel A, 2012, VALUE HEALTH, V15, P13, DOI 10.1016/j.jval.2011.07.015.
   Vieira R, 2017, HEALTH PSYCHOL REV, V11, P222, DOI 10.1080/17437199.2017.1343680.
   Walsh JC, 2016, JMIR MHEALTH UHEALTH, V4, DOI 10.2196/mhealth.5227.
   West R, 2019, NAT HUM BEHAV, V3, P526, DOI 10.1038/s41562-019-0561-2.
   Yardley L, 2016, AM J PREV MED, V51, P833, DOI 10.1016/j.amepre.2016.06.015.
   Zhou Z, 2019, STAT METHODS MED RES.
   Zucker DR, 2010, J CLIN EPIDEMIOL, V63, P1312, DOI 10.1016/j.jclinepi.2010.04.020.},
Number-of-Cited-References = {52},
Times-Cited = {12},
Unique-ID = {WOS:000568192900014},
}

@article{ WOS:000518704600003,
Author = {Gansky, Stuart A. and Shafik, Sarah},
Title = {At the crossroads of oral health inequities and precision public health},
Journal = {JOURNAL OF PUBLIC HEALTH DENTISTRY},
Year = {2020},
Volume = {80},
Number = {1, SI},
Pages = {S14-S22},
Month = {MAR},
Abstract = {Objectives This paper reviews the precision public health literature
   pertaining to oral health, identifies possible threats that could
   inadvertently increase health inequities, and proposes potential
   opportunities that precision public health could utilize to reduce oral
   health inequities.
   Methods The health sciences literature was reviewed and supplemented
   with new data to identify important issues relating to precision
   medicine, precision oral health, precision public health, and health
   equity.
   Results Examples from general health and oral health were provided to
   illustrate salient concepts.
   Conclusions Future precision public health should utilize
   multifactorial, multi-level conceptual frameworks and conceptual causal
   models with upstream social determinants and downstream health effects,
   as well as a proportionate universalism perspective; and proper analytic
   methods, including sufficient sample sizes, appropriate statistical
   competitors, health disparity indices, causal modeling, and internal and
   external validation.},
Type = {Article},
Affiliation = {Gansky, SA (Corresponding Author), Univ Calif San Francisco, Div Oral Epidemiol \& Dent Publ Hlth, Ctr Address Dispar Childrens Oral Hlth, Bakar Computat Hlth Sci Inst,Philip R Lee Inst Hl, Box 1361, San Francisco, CA 94143 USA.
   Gansky, Stuart A.; Shafik, Sarah, Univ Calif San Francisco, Ctr Address Dispar Childrens Oral Hlth, Div Oral Epidemiol \& Dent Publ Hlth, San Francisco, CA 94143 USA.},
DOI = {10.1111/jphd.12316},
Keywords = {precision medicine dental research; health disparities; health equity;
   public health},
Keywords-Plus = {MEDICINE; CARIES; DETERMINANTS; DISPARITIES; CHALLENGES; PARADOX; TRIAL;
   LEGAL; CARE},
Research-Areas = {Dentistry, Oral Surgery \& Medicine; Public, Environmental \&
   Occupational Health},
Web-of-Science-Categories  = {Dentistry, Oral Surgery \& Medicine; Public, Environmental \&
   Occupational Health},
Author-Email = {stuart.gansky@ucsf.edu},
Affiliations = {University of California System; University of California San Francisco},
Cited-References = {Alyass A, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0108-y.
   American Academy of Pediatric Dentistry Council on Clinical Affairs, 2005, Pediatr Dent, V27, P25.
   Beck AF, 2017, HEALTH AFFAIR, V36, P999, DOI 10.1377/hlthaff.2016.1425.
   Beck AF, 2012, PEDIATRICS, V130, P831, DOI 10.1542/peds.2012-0769.
   Bejan CA, 2018, J AM MED INFORM ASSN, V25, P61, DOI 10.1093/jamia/ocx059.
   Cerdá M, 2014, AM J PUBLIC HEALTH, V104, pS609, DOI 10.2105/AJPH.2014.302055.
   Cheng J, 2015, J DENT RES, V94, P44, DOI 10.1177/0022034514555365.
   Davis MM, 2017, CTS-CLIN TRANSL SCI, V10, P64, DOI 10.1111/cts.12453.
   Desmond-Hellmann S, 2016, PRECISION PUBLIC HLT.
   Fayyad U, 1996, ADV KNOWLEDGE DISCOV, P1, DOI 10.1609/aimag.v17i3.1230.
   Featherstone JDB, 2012, CARIES RES, V46, P118, DOI 10.1159/000337241.
   Fisher-Owens SA, 2007, PEDIATRICS, V120, pE510, DOI 10.1542/peds.2006-3084.
   Frohlich KL, 2008, AM J PUBLIC HEALTH, V98, P216, DOI 10.2105/AJPH.2007.114777.
   Gansky S A, 2003, Adv Dent Res, V17, P109.
   Garcia I, 2013, J DENT RES, V92, pS3, DOI 10.1177/0022034513487209.
   Gehlert S, 2008, HEALTH AFFAIR, V27, P339, DOI 10.1377/hlthaff.27.2.339.
   Goldstein A O, 1994, Arch Fam Med, V3, P514, DOI 10.1001/archfami.3.6.514.
   Graham GN, 2016, BREASTFEED MED, V11, P396, DOI 10.1089/bfm.2016.0113.
   LALONDE M, 1974, CAN J PUBLIC HEALTH, V65, P260.
   Lazar Ann A, 2013, J Dent Oral Craniofac Epidemiol, V1, P19.
   Lu D., 2015, Focus on: A proportionate approach to priority populations.
   Mejia GC, 2011, COMMUNITY DENT ORAL, V39, P318, DOI 10.1111/j.1600-0528.2010.00599.x.
   MIT Technology Review, 2001, MIT TECHNOLOGY REV.
   Moonesinghe R, 2009, ETHNIC DIS, V19, P473.
   National Research Council (US) Committee on a Framework for Developing a New Taxonomy of Disease, 2011, PREC MED BUILD KNOWL.
   Neutel CI, 1997, ANN EPIDEMIOL, V7, P517, DOI 10.1016/S1047-2797(97)00084-7.
   Nishi A, 2016, EXPERT REV MOL DIAGN, V16, P11, DOI 10.1586/14737159.2016.1115346.
   Oreskovic Nicolas Michel, 2017, JMIR Med Inform, V5, pe25, DOI 10.2196/medinform.8240.
   Pauwels E, 2015, SCI AM.
   Postman N, 2013, INFORM OURSELVES DEA.
   Rose G., 1993, STRATEGY PREVENTIVE.
   Sankar PL, 2017, GENET MED, V19, P743, DOI 10.1038/gim.2016.183.
   Schwarzer G, 2000, STAT MED, V19, P541, DOI 10.1002/(SICI)1097-0258(20000229)19:4<541::AID-SIM355>3.0.CO;2-V.
   Shiboski CH, 2003, J PUBLIC HEALTH DENT, V63, P38, DOI 10.1111/j.1752-7325.2003.tb03472.x.
   Weintraub JA, 2006, J DENT RES, V85, P172, DOI 10.1177/154405910608500211.},
Number-of-Cited-References = {35},
Times-Cited = {4},
Unique-ID = {WOS:000518704600003},
}

@article{ WOS:000427088300001,
Author = {Dolley, Shawn},
Title = {Big Data's Role in Precision Public Health},
Journal = {FRONTIERS IN PUBLIC HEALTH},
Year = {2018},
Volume = {6},
Month = {MAR 7},
Abstract = {Precision public health is an emerging practice to more granularly
   predict and understand public health risks and customize treatments for
   more specific and homogeneous subpopulations, often using new data,
   technologies, and methods. Big data is one element that has consistently
   helped to achieve these goals, through its ability to deliver to
   practitioners a volume and variety of structured or unstructured data
   not previously possible. Big data has enabled more widespread and
   specific research and trials of stratifying and segmenting populations
   at risk for a variety of health problems. Examples of success using big
   data are surveyed in surveillance and signal detection, predicting
   future risk, targeted interventions, and understanding disease. Using
   novel big data or big data approaches has risks that remain to be
   resolved. The continued growth in volume and variety of available data,
   decreased costs of data capture, and emerging computational methods mean
   big data success will likely be a required pillar of precision public
   health into the future. This review article aims to identify the
   precision public health use cases where big data has added value,
   identify classes of value that big data may bring, and outline the risks
   inherent in using big data in precision public health efforts.},
Type = {Review},
Affiliation = {Dolley, S (Corresponding Author), Cloudera Inc, Palo Alto, CA 94306 USA.
   Dolley, Shawn, Cloudera Inc, Palo Alto, CA 94306 USA.},
DOI = {10.3389/fpubh.2018.00068},
Article-Number = {68},
Keywords = {precision public health; big data; computational epidemiology;
   infectious disease surveillance; precision population health},
Keywords-Plus = {GENOME-WIDE ASSOCIATION; INFECTIOUS-DISEASE SURVEILLANCE; LATENT CLASS
   ANALYSIS; DATA ANALYTICS; ANTIMICROBIAL RESISTANCE; PERSONALIZED
   MEDICINE; DATA RESOURCE; SOCIAL MEDIA; ZIKA VIRUS; REAL-TIME},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {shawn.dolley@gmail.com},
Cited-References = {Aarestrupt FM, 2016, TRENDS MICROBIOL, V24, P241, DOI 10.1016/j.tim.2016.01.009.
   Ahmad S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006642.
   Alajajian SE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168893.
   Altaf-Ul-Amin M, 2014, BIOMED RES INT-UK, V2014, DOI 10.1155/2014/428570.
   Althani A., 2015, J TISSUE SCI ENG, V6, P157, DOI DOI 10.4172/2157-7552.1000157.
   Alyass A, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0108-y.
   Andrejevic M, 2014, INT J COMMUN-US, V8, P1673.
   Andreu-Perez J, 2015, IEEE J BIOMED HEALTH, V19, P1193, DOI 10.1109/JBHI.2015.2450362.
   Anney RJL, 2017, MOL AUTISM, V8, DOI 10.1186/s13229-017-0137-9.
   {[}Anonymous], 2012, NEW YORK TIMES.
   {[}Anonymous], 2016, P IEEE INT SMART CIT.
   {[}Anonymous], NIST SPEC PUBL.
   Arnett DK, 2016, DIABETES CARE, V39, P1870, DOI 10.2337/dc16-1763.
   Arzberger P., 2004, DATA SCI J, V3, P135, DOI {[}10.2481/dsj.3.135, DOI 10.2481/DSJ.3.135].
   Bansal S, 2016, J INFECT DIS, V214, pS375, DOI 10.1093/infdis/jiw400.
   Bar-Or A., 2004, ENG MED BIOL SOC 200, V2, P3101.
   Barber MF, 2014, SCIENCE, V346, P1362, DOI 10.1126/science.1259329.
   Barral MFM, 2017, AIDS RES HUM RETROV, V33, P465, DOI {[}10.1089/aid.2015.0376, 10.1089/AID.2015.0376].
   Barrett MA, 2013, BIG DATA-US, V1, P168, DOI 10.1089/big.2013.0027.
   Baynam G, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00031.
   Belgrave D, 2017, J ALLERGY CLIN IMMUN, V139, P400, DOI 10.1016/j.jaci.2016.11.003.
   Belle A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/370194.
   Ben-Menachem E, 2016, LANCET NEUROL, V15, P6, DOI 10.1016/S1474-4422(15)00356-7.
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5.
   Bonner S, 2015, PROCEEDINGS 2015 IEEE INTERNATIONAL CONFERENCE ON BIG DATA, P737, DOI 10.1109/BigData.2015.7363818.
   Bousema T, 2014, NAT REV MICROBIOL, V12, P833, DOI 10.1038/nrmicro3364.
   Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165.
   Bragazzi NL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166051.
   Brennan PF, 2015, J NURS SCHOLARSHIP, V47, P477, DOI 10.1111/jnu.12159.
   Burke-Garcia A, 2014, J PUBLIC HEALTH-UK, V36, P527, DOI 10.1093/pubmed/fdt125.
   Burton PR, 2009, INT J EPIDEMIOL, V38, P263, DOI 10.1093/ije/dyn147.
   Bustamante M, 2016, HUM MOL GENET, V25, P4127, DOI 10.1093/hmg/ddw264.
   Cai L., 2015, Data Science Journal, V14, P1.
   Carreiro S, 2017, J MED TOXICOL, V13, P166, DOI 10.1007/s13181-017-0611-y.
   Castro LA, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2394-9.
   Celi LA, 2013, AM J RESP CRIT CARE, V187, P1157, DOI 10.1164/rccm.201212-2311ED.
   Chan EH, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001206.
   Chatterjee N, 2016, NAT REV GENET, V17, P392, DOI 10.1038/nrg.2016.27.
   Chen CY, 2017, BIOL PSYCHIAT, V81, pS91, DOI 10.1016/j.biopsych.2017.02.236.
   Chen JY, 2017, INFORM SYST, V64, P281, DOI 10.1016/j.is.2016.03.011.
   Chen M, 2015, IEEE WIREL COMMUN, V22, P20, DOI 10.1109/MWC.2015.7054715.
   Chuang TW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046882.
   Chunara R, 2012, AM J TROP MED HYG, V86, P39, DOI 10.4269/ajtmh.2012.11-0597.
   Claesson A, 2017, RESUSCITATION, V114, P152, DOI 10.1016/j.resuscitation.2017.01.003.
   Clark A, 2016, SURV OPHTHALMOL, V61, P443, DOI 10.1016/j.survophthal.2016.01.003.
   Cochran G, 2017, RES SOC ADMIN PHARM, V13, P1055, DOI 10.1016/j.sapharm.2016.11.005.
   Colijn C, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00136.
   Collyer ML, 2015, HEREDITY, V115, P357, DOI 10.1038/hdy.2014.75.
   Consolvo S, 2008, CHI 2008: 26TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS VOLS 1 AND 2, CONFERENCE PROCEEDINGS, P1797.
   Correia RB, 2016, BIOCOMPUT-PAC SYM, P492.
   Croes K, 2014, INT J HYG ENVIR HEAL, V217, P239, DOI 10.1016/j.ijheh.2013.06.004.
   Cukier K, 2013, FOREIGN AFF, V92, P28.
   Daley D, 2016, CHILD ABUSE NEGLECT, V62, P29, DOI 10.1016/j.chiabu.2016.09.014.
   Danaei G, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002164.
   Davis JJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep27930.
   De Mauro A, 2015, AIP CONF PROC, V1644, P97, DOI 10.1063/1.4907823.
   Dilsizian SE, 2014, CURR CARDIOL REP, V16, DOI 10.1007/s11886-013-0441-8.
   Dowell SF, 2016, NATURE, V540, P189, DOI 10.1038/540189a.
   Ehret GB, 2016, NAT GENET, V48, P1171, DOI 10.1038/ng.3667.
   Escott-Price V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094661.
   Eysenbach G, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1157.
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036.
   Findley K, 2016, TRENDS MICROBIOL, V24, P847, DOI 10.1016/j.tim.2016.08.001.
   Finger F, 2016, P NATL ACAD SCI USA, V113, P6421, DOI 10.1073/pnas.1522305113.
   Finlayson SG, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.32.
   Fradkin JE, 2016, DIABETES CARE, V39, P1080, DOI 10.2337/dc16-0541.
   Fraenkel L, 2016, PATIENT, V9, P241, DOI 10.1007/s40271-015-0147-7.
   Franke J, 2015, GEOSPATIAL HEALTH, V10, P117, DOI 10.4081/gh.2015.335.
   Freifeld CC, 2014, DRUG SAFETY, V37, P343, DOI 10.1007/s40264-014-0155-x.
   Frisby J, 2017, J BIOMED INFORM, V65, P97, DOI 10.1016/j.jbi.2016.11.008.
   Fu Q, 2016, J COMMUN HEALTH, V41, P850, DOI 10.1007/s10900-016-0163-0.
   Gandon S, 2016, TRENDS ECOL EVOL, V31, P776, DOI 10.1016/j.tree.2016.07.010.
   Geethanjali C, 2016, INDIAN J SCI TECHNOL, V9, P99620, DOI DOI 10.17485/ijst/2016/v9i33/99620.
   Ghosh S, 2017, SCI REP-UK, V7, DOI 10.1038/srep40841.
   Gilbert M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5116.
   Gillies RJ, 2016, RADIOLOGY, V278, P563, DOI 10.1148/radiol.2015151169.
   Gligorijevic V, 2016, PROTEOMICS, V16, P741, DOI 10.1002/pmic.201500396.
   Glymour MM, 2013, AM J EPIDEMIOL, V178, P858, DOI 10.1093/aje/kwt145.
   Godman B, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-179.
   Gomez SL, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-201.
   Gomide J, 2011, P 3 INT WEB SCI C.
   Gorenshteyn D, 2015, IMMUNITY, V43, P605, DOI 10.1016/j.immuni.2015.08.014.
   Gu DX, 2017, INT J MED INFORM, V98, P22, DOI 10.1016/j.ijmedinf.2016.11.006.
   Gubler D J, 1989, Bull Pan Am Health Organ, V23, P397.
   Hall ES, 2014, MATERN CHILD HLTH J, V18, P316, DOI 10.1007/s10995-013-1236-7.
   Hamada T, 2017, J GASTROENTEROL, V52, P265, DOI 10.1007/s00535-016-1272-3.
   HAMMOND EC, 1967, AM J PUBLIC HEALTH N, V57, P1979, DOI 10.2105/AJPH.57.11.1979.
   Hansen M, 2015, HUM REPROD, V30, P2956, DOI 10.1093/humrep/dev247.
   Hay SI, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001413.
   Hemingway H, 2017, PROGRAMME GRANTS APP, V5, DOI {[}10.3310/pgfar05040, DOI 10.3310/PGFAR05040].
   HETHCOTE HW, 1982, MATH BIOSCI, V58, P93, DOI 10.1016/0025-5564(82)90053-0.
   Hood L, 2015, BMC MED, V13, DOI 10.1186/s12916-014-0238-7.
   Hose AJ, 2017, J ALLERGY CLIN IMMUN, V139, P1935, DOI 10.1016/j.jaci.2016.08.046.
   Hripcsak G, 2016, P NATL ACAD SCI USA, V113, P7329, DOI 10.1073/pnas.1510502113.
   Hu H, 2014, IEEE ACCESS, V2, P652, DOI 10.1109/ACCESS.2014.2332453.
   Huff A, 2016, PLOS CURR, V8, DOI {[}10.1371/currents.outbreaks.711379ace737b7c04c89765342a9a8c9, DOI 10.1371/CURRENTS.OTBREAKS.711379ACE737B7C04C89765342A9A8C9].
   Ireland ME, 2015, HEALTH PSYCHOL, V34, P1252, DOI 10.1037/hea0000279.
   Isdory A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142805.
   ISHAM V, 1988, J ROY STAT SOC A STA, V151, P5, DOI 10.2307/2982179.
   Ji X, 2017, J INF SCI, V43, P221, DOI 10.1177/0165551515625029.
   Jiang P, 2016, IEEE SYST J, V10, P1147, DOI 10.1109/JSYST.2014.2308324.
   Johnson SB, 2017, ANN EPIDEMIOL, V27, P361, DOI 10.1016/j.annepidem.2017.05.008.
   Johnstone IM, 2009, PHILOS T R SOC A, V367, P4237, DOI 10.1098/rsta.2009.0159.
   Joseph W, 2016, BIOELECTROMAGNETICS, V37, P195, DOI 10.1002/bem.21964.
   Jung T, 2008, SOC PERSONAL PSYCHOL, V2, P302, DOI 10.1111/j.1751-9004.2007.00054.x.
   Justice AE, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14977.
   Kao RR, 2014, TRENDS MICROBIOL, V22, P282, DOI 10.1016/j.tim.2014.02.011.
   Kent EE, 2016, J AM GERIATR SOC, V64, P186, DOI 10.1111/jgs.13888.
   Khoury MJ, 2016, JAMA-J AM MED ASSOC, V316, P1357, DOI 10.1001/jama.2016.12260.
   Khoury MJ, 2016, AM J PREV MED, V50, P398, DOI 10.1016/j.amepre.2015.08.031.
   Koning M, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3757-7.
   Kostkova P, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00007.
   Kraemer MUG, 2016, TRENDS PARASITOL, V32, P19, DOI 10.1016/j.pt.2015.09.006.
   Kringel D, 2017, PHARMACOGENOMICS J, V17, P419, DOI 10.1038/tpj.2016.28.
   Lal A, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13020186.
   Lalonde M., 1974, A new perspective on the health of Canadians.
   LANGMUIR AD, 1976, INT J EPIDEMIOL, V5, P13, DOI 10.1093/ije/5.1.13.
   Lardon J, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4304.
   Lavalle S, 2011, MIT SLOAN MANAGE REV, V52, P21.
   Lazer D, 2014, SCIENCE, V343, P1203, DOI 10.1126/science.1248506.
   Lin KJ, 2016, CLIN PHARMACOL THER, V100, P147, DOI 10.1002/cpt.359.
   Linthicum KJ, 1999, SCIENCE, V285, P397, DOI 10.1126/science.285.5426.397.
   Liu X, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-016-1137-3.
   Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177.
   Lopez AD, 2005, GLOBALIZATION HEALTH, V1, DOI 10.1186/1744-8603-1-5.
   Lupton D, 2015, HEALTH PROMOT INT, V30, P174, DOI 10.1093/heapro/dau091.
   MacFadden DR, 2016, J INFECT DIS, V214, pS393, DOI 10.1093/infdis/jiw343.
   Mari L, 2017, SCI REP-UK, V7, DOI {[}10.1038/s41598-017-00493-1, 10.1038/s41598-017-14510-w].
   Martínez P, 2016, COMPUT IND, V78, P43, DOI 10.1016/j.compind.2015.10.006.
   Mascalzoni D, 2015, EUR J HUM GENET, V23, P721, DOI 10.1038/ejhg.2014.197.
   Maxmen A, 2017, NATURE, V549, P15, DOI 10.1038/nature.2017.22545.
   McGough SF, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005295.
   McIntyre RS, 2014, BIPOLAR DISORD, V16, P531, DOI 10.1111/bdi.12162.
   Miani Celine, 2014, Rand Health Q, V4, P15.
   Millett ERC, 2016, J CLIN EPIDEMIOL, V75, P66, DOI 10.1016/j.jclinepi.2016.01.005.
   Mirnezami R, 2012, NEW ENGL J MED, V366, P489, DOI 10.1056/NEJMp1114866.
   Mooney SJ, 2015, EPIDEMIOLOGY, V26, P390, DOI 10.1097/EDE.0000000000000274.
   Naish S, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-167.
   Nandy A., 2017, J MOL PATHOL EPIDEMI, V2, pS1.
   Narayanan A, 2010, COMMUN ACM, V53, P24, DOI 10.1145/1743546.1743558.
   Newnham JP, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00066.
   Nguyen K. A., 2017, IEEE CUST INT CIRC C, P1.
   Nimmesgern E, 2017, CTS-CLIN TRANSL SCI, V10, P61, DOI 10.1111/cts.12446.
   Nishi A, 2016, EXPERT REV MOL DIAGN, V16, P11, DOI 10.1586/14737159.2016.1115346.
   Nsoesie EO, 2015, CELL HOST MICROBE, V17, P275, DOI 10.1016/j.chom.2015.02.004.
   Nsoesie EO, 2014, INFLUENZA OTHER RESP, V8, P309, DOI 10.1111/irv.12226.
   O'Shea J, 2017, INT J MED INFORM, V101, P15, DOI 10.1016/j.ijmedinf.2017.01.019.
   Obermeyer Z, 2016, NEW ENGL J MED, V375, P1216, DOI 10.1056/NEJMp1606181.
   Ohm P, 2010, UCLA LAW REV, V57, P1701.
   Ou JH, 2013, AM J CLIN NUTR, V98, P111, DOI 10.3945/ajcn.112.056689.
   Ozcaglar C, 2012, MATH BIOSCI, V236, P77, DOI 10.1016/j.mbs.2012.02.003.
   Passos IC, 2016, LANCET PSYCHIAT, V3, P13, DOI 10.1016/S2215-0366(15)00549-0.
   Pellegrino P, 2016, PHARMACOGENOMICS J, V16, P96, DOI 10.1038/tpj.2015.21.
   Pesala Samuli, 2017, JMIR Public Health Surveill, V3, pe19, DOI 10.2196/publichealth.6764.
   Peterson TA, 2013, J MOL BIOL, V425, P4047, DOI 10.1016/j.jmb.2013.08.008.
   Phan TP, 2014, BMJ OPEN DIAB RES CA, V2, DOI 10.1136/bmjdrc-2013-000012.
   Phillips RL, 2015, FAM MED, V47, P628.
   Poland GA, 2007, CLIN PHARMACOL THER, V82, P653, DOI 10.1038/sj.clpt.6100415.
   Poland GA, 2017, NAT VACC ADV COMM M.
   Poland GA, 2009, PHARMACOGENOMICS, V10, P837, DOI 10.2217/PGS.09.25.
   Predic B, 2013, INT CONF PERVAS COMP, P303.
   Pugach O, 2017, NICOTINE TOB RES, V19, P410, DOI 10.1093/ntr/ntw197.
   Qi BS, 2015, 2015 INTERNATIONAL CONFERENCE ON ICT CONVERGENCE (ICTC), P1297, DOI 10.1109/ICTC.2015.7354800.
   Quinn DM, 2009, J PERS SOC PSYCHOL, V97, P634, DOI 10.1037/a0015815.
   RICHERT CA, 1993, AM J PUBLIC HEALTH, V83, P520, DOI 10.2105/AJPH.83.4.520.
   Rose G, 2001, INT J EPIDEMIOL, V30, P427, DOI 10.1093/ije/30.3.427.
   Ross MC, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0072-y.
   Roth AM, 2015, SUBST USE MISUSE, V50, P205, DOI 10.3109/10826084.2014.962661.
   Rozek LS, 2014, ANNU REV PUBL HEALTH, V35, P105, DOI 10.1146/annurev-publhealth-032013-182513.
   Rujirojindakul Pairaya, 2015, Adv Hematol, V2015, P543027, DOI 10.1155/2015/543027.
   Sadler RC, 2017, AM J PUBLIC HEALTH, V107, P763, DOI 10.2105/AJPH.2017.303692.
   Salathé M, 2016, J INFECT DIS, V214, pS399, DOI 10.1093/infdis/jiw281.
   Saleheen D, 2017, CIRCULATION, V135, P2336, DOI 10.1161/CIRCULATIONAHA.116.022069.
   Sanmartin C, 2016, HEALTH REP, V27, P10.
   Santillana M, 2016, SCI REP-UK, V6, DOI 10.1038/srep25732.
   Schneeweiss S, 2016, CLIN PHARMACOL THER, V99, P262, DOI 10.1002/cpt.316.
   Scott RA, 2017, DIABETES, V66, P2888, DOI 10.2337/db16-1253.
   Setiawan VW, 2015, AM J EPIDEMIOL, V181, P917, DOI 10.1093/aje/kwv055.
   Severi G, 2014, BREAST CANCER RES TR, V148, P665, DOI 10.1007/s10549-014-3209-y.
   Shaikh AR, 2014, J MED INTERNET RES, V16, P143, DOI 10.2196/jmir.2496.
   Signorini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019467.
   Simonsen L, 2016, J INFECT DIS, V214, pS380, DOI 10.1093/infdis/jiw376.
   Slobogean Gerard P, 2015, J Orthop Trauma, V29 Suppl 12, pS43, DOI 10.1097/BOT.0000000000000463.
   Smith AH, 2017, MOL PSYCHIATR, V22, P346, DOI 10.1038/mp.2016.257.
   Speybroeck N, 2013, INT J ENV RES PUB HE, V10, P5750, DOI 10.3390/ijerph10115750.
   Stein P, 2016, FERTIL STERIL, V106, pE113, DOI 10.1016/j.fertnstert.2016.07.339.
   Stephens ZD, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002195.
   Stoddard ST, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000481.
   Strohbach M., 2016, NEW HORIZONS DATA DR.
   Sweeney L, 1997, J LAW MED ETHICS, V25, P98, DOI 10.1111/j.1748-720X.1997.tb01885.x.
   Tatem AJ, 2014, INT HEALTH, V6, P5, DOI 10.1093/inthealth/ihu006.
   Triantafyllidis AK, 2017, IEEE J BIOMED HEALTH, V21, P218, DOI 10.1109/JBHI.2015.2483902.
   U.S. Department of Health and Human Services, 2010, MULTIPLE CHRONIC CON.
   Vargas AJ, 2016, NAT REV CANCER, V16, P525, DOI 10.1038/nrc.2016.56.
   Vayena E, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1003904.
   Vazquez-Prokopec GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058802.
   Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029.
   Wesolowski A, 2016, J INFECT DIS, V214, pS414, DOI 10.1093/infdis/jiw273.
   Wesolowski Amy, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.0177e7fcf52217b8b634376e2f3efc5e.
   Wesolowski A, 2015, P NATL ACAD SCI USA, V112, P11887, DOI 10.1073/pnas.1504964112.
   Westra Bonnie L, 2015, Nurs Adm Q, V39, P304, DOI 10.1097/NAQ.0000000000000130.
   White SL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167846.
   Wilhelm M, 2014, NATURE, V509, P582, DOI 10.1038/nature13319.
   WILSON ME, 1995, EMERG INFECT DIS, V1, P39, DOI 10.3201/eid0102.950201.
   Wooden B, 2017, GASTROENTEROLOGY, V152, P53, DOI 10.1053/j.gastro.2016.09.065.
   Xiao JG, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00064.
   Xie L, 2017, ANNU REV PHARMACOL, V57, P245, DOI 10.1146/annurev-pharmtox-010716-104659.
   Yang SH, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2424-7.
   Zawati MH, 2015, J MED GENET, V52, P566, DOI 10.1136/jmedgenet-2014-102640.
   Zhang XZ, 2017, ETHNIC DIS, V27, P95, DOI 10.18865/ed.27.2.95.
   Zheng Y, 2013, 19TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING (KDD'13), P1436, DOI 10.1145/2487575.2488188.
   Zinszer K, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001992.},
Number-of-Cited-References = {212},
Times-Cited = {105},
Unique-ID = {WOS:000427088300001},
}

@article{ WOS:000497787600265,
Author = {Olstad, Dana Lee and McIntyre, Lynn},
Title = {Reconceptualising precision public health},
Journal = {BMJ OPEN},
Year = {2019},
Volume = {9},
Number = {9},
Month = {SEP},
Abstract = {As currently conceived, precision public health is at risk of becoming
   precision medicine at a population level. This paper outlines a
   framework for precision public health that, in contrast to its current
   operationalisation, is consistent with public health principles because
   it integrates factors at all levels, while illuminating social position
   as a fundamental determinant of health and health inequities. We review
   conceptual foundations of public health, outline a proposed framework
   for precision public health and describe its operationalisation within
   research and practice. Social position shapes individuals' unequal
   experiences of the social determinants of health. Thus, in our
   formulation, precision public health investigates how multiple
   dimensions of social position interact to confer health risk differently
   for precisely defined population subgroups according to the social
   contexts in which they are embedded, while considering relevant
   biological and behavioural factors. It leverages this information to
   uncover the precise and intersecting social structures that pattern
   health outcomes, and to identify actionable interventions within the
   social contexts of affected groups. We contend that studies informed by
   this framework offer greater potential to improve health than current
   conceptualisations of precision public health that do not address root
   causes. Moreover, expanding beyond master categories of social position
   and operationalising these categories in more precise ways across time
   and place can enrich public health research through greater attention to
   the heterogeneity of social positions, their causes and health effects,
   leading to the identification of points of intervention that are
   specific enough to be useful in reducing health inequities. Failure to
   attend to this level of particularity may mask the true nature of health
   risk, the causal mechanisms at play and appropriate interventions.
   Conceptualised thus, precision public health is a research endeavour
   with much to offer by way of understanding and intervening on the causes
   of poor health and health inequities. As currently conceived, precision
   public health is at risk of becoming precision medicine at a population
   level. This paper outlines a framework for precision public health that,
   in contrast to its current operationalization, is consistent with public
   health principles because it integrates factors at all levels, while
   illuminating social position as a fundamental determinant of health and
   health inequities. We review conceptual foundations of public health,
   outline a proposed framework for precision public health and describe
   its operationalization within research and practice. Social position
   shapes individuals' unequal experiences of the social determinants of
   health. Thus, in our formulation, precision public health investigates
   how multiple dimensions of social position interact to confer health
   risk differently for precisely defined population subgroups according to
   the social contexts in which they are embedded, while considering
   relevant biological and behavioural factors. It leverages this
   information to uncover the precise and intersecting social structures
   that pattern health outcomes, and to identify actionable interventions
   within the social contexts of affected groups. We contend that studies
   informed by this framework offer greater potential to improve health
   than current conceptualizations of precision public health that do not
   address root causes.
   Moreover, expanding beyond master categories of social position and
   operationalizing these categories in more precise ways across time and
   place can enrich public health research through greater attention to the
   heterogeneity of social positions, their causes and health effects,
   leading to identification of points of intervention that are specific
   enough to be useful in reducing health inequities. Failure to attend to
   this level of particularity may mask the true nature of health risk, the
   causal mechanisms at play and appropriate interventions. Conceptualized
   thus, precision public health is a research endeavour with much to offer
   by way of understanding and intervening on the causes of poor health and
   health inequities.},
Type = {Article},
Affiliation = {Olstad, DL (Corresponding Author), Univ Calgary, Cumming Sch Med, Calgary, AB, Canada.
   Olstad, Dana Lee; McIntyre, Lynn, Univ Calgary, Cumming Sch Med, Calgary, AB, Canada.},
DOI = {10.1136/bmjopen-2019-030279},
Article-Number = {e030279},
Keywords = {Precision public health; Social determinants of health; Health
   inequities; Social position; Social context},
Keywords-Plus = {SOCIAL-STATUS; SOCIOECONOMIC INEQUALITIES; HEART-DISEASE;
   INTERSECTIONALITY; EDUCATION; DISPARITIES; PERSISTENCE; INEQUITIES;
   MORTALITY; HIERARCHY},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Author-Email = {dana.olstad@ucalgary.ca},
Affiliations = {University of Calgary},
Cited-References = {Abichahine H, 2017, HEALTH PROMOT INT, V32, P691, DOI 10.1093/heapro/daw009.
   ADLER NE, 1993, JAMA-J AM MED ASSOC, V269, P3140, DOI 10.1001/jama.269.24.3140.
   ADLER NE, 1994, AM PSYCHOL, V49, P15, DOI 10.1037/0003-066X.49.1.15.
   Agar M.H., 1996, PROFESSIONAL STRANGE, VSecond.
   Altman DG, 2006, BRIT MED J, V332, P1080, DOI 10.1136/bmj.332.7549.1080.
   Andersson MA, 2015, SOC SCI RES, V52, P317, DOI 10.1016/j.ssresearch.2015.02.009.
   {[}Anonymous], SOC SCI MED.
   {[}Anonymous], 2017, J MGMT.
   {[}Anonymous], PROFESSIONAL GEOGRAP.
   {[}Anonymous], 2010, FAIR SOC HLTH LIVES.
   {[}Anonymous], 2000, INTRO PHENOMENOLOGY, DOI DOI 10.1017/CBO9780511809118.
   {[}Anonymous], POLITICS CNN.
   Barr B, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3310.
   Bauer GR, 2014, SOC SCI MED, V110, P10, DOI 10.1016/j.socscimed.2014.03.022.
   Beckie TM, 2012, BIOL RES NURS, V14, P311, DOI 10.1177/1099800412455688.
   Blackman T, 2013, SOC POLICY SOC, V12, P61, DOI 10.1017/S1474746412000358.
   Bourdieu P., 1984, DISTINCTION SOCIAL C.
   Braveman PA, 2005, JAMA-J AM MED ASSOC, V294, P2879, DOI 10.1001/jama.294.22.2879.
   Campbell M, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00230.
   Carey Gemma, 2017, J Epidemiol Community Health, V71, P303, DOI 10.1136/jech-2014-204311.
   Carey G, 2015, INT J EQUITY HEALTH, V14, DOI 10.1186/s12939-015-0207-6.
   Cole ER, 2009, AM PSYCHOL, V64, P170, DOI 10.1037/a0014564.
   Commission on Social Determinants of Health, 2008, CSDH FIN REP CLOS GA.
   Cutler D., 2006, NBER Working Paper Series.
   Dowell SF, 2016, NATURE, V540, P189, DOI 10.1038/540189a.
   Evangelatos N, 2018, INT J PUBLIC HEALTH, V63, P433, DOI 10.1007/s00038-017-1055-5.
   Evans CR, 2018, SOC SCI MED, V203, P64, DOI 10.1016/j.socscimed.2017.11.011.
   Frank LD, 2008, PREV MED, V47, P172, DOI 10.1016/j.ypmed.2008.04.004.
   Frohlich KL, 2008, AM J PUBLIC HEALTH, V98, P216, DOI 10.2105/AJPH.2007.114777.
   Galobardes B, 2006, J EPIDEMIOL COMMUN H, V60, P95, DOI 10.1136/jech.2004.028092.
   Garnett BR, 2014, J YOUTH ADOLESCENCE, V43, P1225, DOI 10.1007/s10964-013-0073-8.
   Gianfrancesco MA, 2018, JAMA INTERN MED, V178, P1544, DOI 10.1001/jamainternmed.2018.3763.
   Graham H, 2004, MILBANK Q, V82, P101, DOI 10.1111/j.0887-378X.2004.00303.x.
   Graham H, 2004, J SOC POLICY, V33, P115, DOI 10.1017/S0047279403007220.
   Graham H., 2004, HLTH INEQUALITIES CO.
   Hankivsky O., 2008, Critical Public Health, V18, P271, DOI 10.1080/09581590802294296.
   Hargrove TW, 2018, J HEALTH SOC BEHAV, V59, P56, DOI 10.1177/0022146517746672.
   Hinze SW, 2012, WOMEN HEALTH ISS, V22, pE91, DOI 10.1016/j.whi.2011.08.002.
   Ip EH, 2013, HEALTH EDUC BEHAV, V40, p123S, DOI 10.1177/1090198113493911.
   Khoury MJ, 2016, JAMA-J AM MED ASSOC, V316, P1357, DOI 10.1001/jama.2016.12260.
   Khoury MJ, 2016, AM J PREV MED, V50, P398, DOI 10.1016/j.amepre.2015.08.031.
   Kypridemos C, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2793.
   Lakerveld J, 2017, PREV MED, V101, P77, DOI 10.1016/j.ypmed.2017.05.015.
   LINK BG, 1995, J HEALTH SOC BEHAV, V35, P80, DOI 10.2307/2626958.
   Mackenbach JP, 2017, EUR J PUBLIC HEALTH, V27, P14, DOI 10.1093/eurpub/ckx160.
   Mackenbach JP, 2012, SOC SCI MED, V75, P761, DOI 10.1016/j.socscimed.2012.02.031.
   Mackenbach JP, 2010, SOC SCI MED, V71, P1249, DOI 10.1016/j.socscimed.2010.07.014.
   Mackenbach JP, 2003, INT J EPIDEMIOL, V32, P830, DOI 10.1093/ije/dyg209.
   MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K.
   MARMOT MG, 1978, J EPIDEMIOL COMMUN H, V32, P244, DOI 10.1136/jech.32.4.244.
   McLaren L, 2010, INT J EPIDEMIOL, V39, P372, DOI 10.1093/ije/dyp315.
   Mulinari S, 2018, CRIT PUBLIC HEALTH, V28, P177, DOI 10.1080/09581596.2017.1316831.
   Nuru-Jeter AM, 2018, ANNU REV PUBL HEALTH, V39, P169, DOI 10.1146/annurev-publhealth-040617-014230.
   O'Neill J, 2014, J CLIN EPIDEMIOL, V67, P56, DOI 10.1016/j.jclinepi.2013.08.005.
   Olstad DL, 2017, OBES REV, V18, P791, DOI 10.1111/obr.12546.
   Olstad DL, 2016, OBES REV, V17, P1198, DOI 10.1111/obr.12457.
   Pavela G, 2017, CLIN OBES, V7, P316, DOI 10.1111/cob.12198.
   Pearson-Stuttard J, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002311.
   Platt JM, 2017, SSM-POPUL HLTH, V3, P1, DOI 10.1016/j.ssmph.2016.11.002.
   Ramaswami R, 2018, ANNU REV PUBL HEALTH, V39, P153, DOI 10.1146/annurev-publhealth-040617-014158.
   ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32.
   Ross CE, 2012, DEMOGRAPHY, V49, P1157, DOI 10.1007/s13524-012-0130-z.
   Seng JS, 2012, SOC SCI MED, V75, P2437, DOI 10.1016/j.socscimed.2012.09.023.
   Shih M, 1999, PSYCHOL SCI, V10, P80, DOI 10.1111/1467-9280.00111.
   Singh-Manoux A, 2003, SOC SCI MED, V56, P1321, DOI 10.1016/S0277-9536(02)00131-4.
   Veenstra G, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-3.
   Warner LR, 2008, SEX ROLES, V59, P454, DOI 10.1007/s11199-008-9504-5.
   Weeramanthri TS, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00121.
   Wewers ME, 2012, J WOMENS HEALTH, V21, P548, DOI 10.1089/jwh.2011.3183.
   Williams DR, 2005, HEALTH AFFAIR, V24, P325, DOI 10.1377/hlthaff.24.2.325.
   WILLIAMS DR, 1995, ANNU REV SOCIOL, V21, P349, DOI 10.1146/annurev.so.21.080195.002025.
   WINKLEBY MA, 1994, AM J PUBLIC HEALTH, V84, P767, DOI 10.2105/AJPH.84.5.767.
   Yuval-Davis Nira., 2015, Raisons politiques N, V58, P91.
   Zajacova A, 2018, ANNU REV PUBL HEALTH, V39, P273, DOI 10.1146/annurev-publhealth-031816-044628.},
Number-of-Cited-References = {74},
Times-Cited = {35},
Unique-ID = {WOS:000497787600265},
}

@article{ WOS:001101994000015,
Author = {Allen, Caitlin G. and Olstad, Dana Lee and Kahkoska, Anna R. and Guan,
   Yue and Ramos, Paula S. and Steinberg, Julia and Staras, Stephanie A. S.
   and Lumpkins, Crystal Y. and Milko, V, Laura and Turbitt, Erin and Rahm,
   Alanna K. and Saylor, Katherine W. and Best, Stephanie and Hatch, Ashley
   and Santangelo, Isabella and Roberts, Megan C.},
Title = {Extending an Antiracism Lens to the Implementation of Precision Public
   Health Interventions},
Journal = {AMERICAN JOURNAL OF PUBLIC HEALTH},
Year = {2023},
Volume = {113},
Number = {11},
Pages = {1210-1218},
Month = {NOV},
Abstract = {Precision public health holds promise to improve disease prevention and
   health promotion strategies, allowing the right intervention to be
   delivered to the right population at the right time. Growing concerns
   underscore the potential for precision-based approaches to exacerbate
   health disparities by relying on biased data inputs and recapitulating
   existing access inequities. To achieve its full potential, precision
   public health must focus on addressing social and structural drivers of
   health and prominently incorporate equity-related concerns, particularly
   with respect to race and ethnicity. In this article, we discuss how an
   antiracism lens could be applied to reduce health disparities and health
   inequities through equity-informed research, implementation, and
   evaluation of precision public health interventions. (Am J Public
   Health. 2023;113(11):1210-1218. https://doi.org/10.2105/
   AJPH.2023.307386)},
Type = {Article},
Affiliation = {Allen, CG (Corresponding Author), Med Univ South Carolina, 22 West Edge St,Suite 213, Charleston, SC 29403 USA.
   Allen, Caitlin G.; Hatch, Ashley, Med Univ South Carolina, Coll Med, Dept Publ Hlth Sci, Charleston, SC 29403 USA.
   Ramos, Paula S., Med Univ South Carolina, Dept Med, Charleston, SC 29403 USA.
   Ramos, Paula S., Med Univ South Carolina, Dept Publ Hlth Sci, Charleston, SC 29403 USA.
   Olstad, Dana Lee, Univ Calgary, Cumming Sch Med, Dept Community Hlth Sci, Calgary, AB, Canada.
   Kahkoska, Anna R., Univ N Carolina, Dept Nutr, Chapel Hill, NC USA.
   Milko, Laura, V, Univ N Carolina, Dept Genet, Chapel Hill, NC USA.
   Roberts, Megan C., Univ N Carolina, Eshelman Sch Pharm, Chapel Hill, NC USA.
   Guan, Yue; Santangelo, Isabella, Emory Univ, Rollins Sch Publ Hlth, Dept Behav Social \& Hlth Educ Sci, Atlanta, GA USA.
   Steinberg, Julia, Univ Sydney, Daffodil Ctr, Sydney, Australia.
   Staras, Stephanie A. S., Univ Florida, Coll Med, Dept Hlth Outcome \& Biomed Informat, Gainesville, FL USA.
   Staras, Stephanie A. S., Univ Florida, Inst Child Hlth Policy, Gainesville, FL USA.
   Lumpkins, Crystal Y., Univ Utah, Huntsman Canc Inst, Dept Commun, Salt Lake City, UT USA.
   Turbitt, Erin, Univ Technol Sydney, Grad Sch Hlth, Ultimo, NSW, Australia.
   Rahm, Alanna K., Geisinger Med Ctr, Dept Genom Hlth, Danville, PA USA.
   Saylor, Katherine W., Univ Penn, Perelman Sch Med, Dept Med Eth \& Hlth Policy, Philadelphia, PA USA.
   Best, Stephanie, Peter MacCallum Canc Ctr, Melbourne, Vic, Australia.},
DOI = {10.2105/AJPH.2023.307386},
Keywords-Plus = {EARLY CAREER INVESTIGATORS; STRUCTURAL RACISM; PERSPECTIVES; GENOMICS;
   SCIENCE},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {allencat@musc.edu},
Affiliations = {Medical University of South Carolina; Medical University of South
   Carolina; Medical University of South Carolina; University of Calgary;
   University of North Carolina; University of North Carolina Chapel Hill;
   University of North Carolina; University of North Carolina Chapel Hill;
   University of North Carolina; University of North Carolina Chapel Hill;
   Emory University; Rollins School Public Health; University of Sydney;
   State University System of Florida; University of Florida; State
   University System of Florida; University of Florida; Utah System of
   Higher Education; University of Utah; Huntsman Cancer Institute;
   University of Technology Sydney; Geisinger Medical Center; University of
   Pennsylvania; Peter Maccallum Cancer Center},
Cited-References = {Abelson J, 2003, SOC SCI MED, V57, P239, DOI 10.1016/S0277-9536(02)00343-X.
   Allen CG, 2022, J PERS MED, V12, DOI 10.3390/jpm12081228.
   Allen Caitlin G, 2022, Implement Sci Commun, V3, P48, DOI 10.1186/s43058-022-00286-2.
   Allen CG, 2019, AM J PUBLIC HEALTH, V109, P1186, DOI 10.2105/AJPH.2019.305199.
   Allen CG, 2019, LANCET, V394, P382, DOI 10.1016/S0140-6736(19)30498-2.
   Alvidrez J, 2019, AM J PUBLIC HEALTH, V109, pS94, DOI {[}10.2105/AJPH.2018.304915, 10.2105/ajph.2018.304915].
   Braveman PA, 2022, HEALTH AFFAIR, V41, P171, DOI 10.1377/hlthaff.2021.01394.
   Burton H, 2009, PUBLIC HEALTH GENOM, V12, P11, DOI 10.1159/000153426.
   Collins FS, 2021, CELL, V184, P3075, DOI 10.1016/j.cell.2021.05.014.
   Damschroder LJ, 2022, IMPLEMENT SCI, V17, DOI 10.1186/s13012-022-01245-0.
   Flanagin A, 2021, JAMA-J AM MED ASSOC, V326, P621, DOI 10.1001/jama.2021.13304.
   Gaias LM, 2022, PSYCHOL SCHOOLS, V59, P2471, DOI 10.1002/pits.22515.
   Geneviève LD, 2022, JMIR PUBLIC HLTH SUR, V8, DOI 10.2196/33277.
   Guan Y, 2022, FRONT PUBLIC HEALTH, V10, DOI 10.3389/fpubh.2022.984926.
   Harkness Audrey, 2022, Implement Res Pract, V3, DOI 10.1177/26334895221096293.
   Horowitz CR, 2019, GENET MED, V21, P2364, DOI 10.1038/s41436-019-0498-x.
   Jeske M, 2022, PLOS ONE, V17, DOI 10.1371/journal.pone.0263750.
   Jones LK, 2022, FRONT GENET, V13, DOI 10.3389/fgene.2022.883073.
   Kerkhoff AD, 2022, IMPLEMENT SCI, V17, DOI 10.1186/s13012-022-01189-5.
   Khoury MJ, 2022, GENET MED, V24, P1630, DOI 10.1016/j.gim.2022.04.009.
   Khoury MJ, 2016, AM J PREV MED, V50, P398, DOI 10.1016/j.amepre.2015.08.031.
   Kim K, 2016, AM J PUBLIC HEALTH, V106, pE3, DOI 10.2105/AJPH.2015.302987.
   Lemke AA, 2022, AM J HUM GENET, V109, P1563, DOI 10.1016/j.ajhg.2022.08.005.
   Martschenko DO, 2022, FRONT GENET, V13, DOI 10.3389/fgene.2022.795992.
   Miranda J, 2003, HEALTH SERV RES, V38, P613, DOI 10.1111/1475-6773.00136.
   Murtagh Madeleine J, 2021, Wellcome Open Res, V6, P311, DOI 10.12688/wellcomeopenres.17233.1.
   Nobles M, 2022, NATURE, V610, P419, DOI 10.1038/d41586-022-03247-w.
   Nunn JS, 2019, FRONT PUBLIC HEALTH, V7, DOI 10.3389/fpubh.2019.00079.
   Proctor EK, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-139.
   Rasmussen SA, 2020, JAMA-J AM MED ASSOC, V324, P933, DOI 10.1001/jama.2020.14992.
   Roberts MC, 2019, ETHNIC DIS, V29, P187, DOI 10.18865/ed.29.S1.187.
   Saylor KW, 2020, AM J BIOETHICS, V20, P83, DOI 10.1080/15265161.2020.1730511.
   Senier L, 2019, GENET MED, V21, P373, DOI 10.1038/s41436-018-0056-y.
   Shaibi GQ, 2020, GENET MED, V22, P1552, DOI 10.1038/s41436-020-0806-5.
   Shelton Rachel C, 2021, Implement Res Pract, V2, p26334895211049482, DOI 10.1177/26334895211049482.
   Shelton RC, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00134.
   Snell-Rood C, 2021, TRANSL BEHAV MED, V11, P1617, DOI 10.1093/tbm/ibab008.
   Staras SAS, 2021, AM J PREV MED, V61, P812, DOI 10.1016/j.amepre.2021.05.016.
   Sullivan G, 2017, J HEALTH CARE POOR U, V28, P548, DOI 10.1353/hpu.2017.0039.
   Taylor-Robinson D, 2019, INT J EPIDEMIOL, V48, P1, DOI 10.1093/ije/dyy184.
   Thomas SP, 2021, HUM GENET GENOM ADV, V2, DOI 10.1016/j.xhgg.2021.100052.
   Valeriani G, 2022, POPUL HEALTH MANAG, V25, P517, DOI 10.1089/pop.2021.0364.
   Williams DR, 2019, ANNU REV PUBL HEALTH, V40, P105, DOI 10.1146/annurev-publhealth-040218-043750.
   Williams DR, 2013, AM BEHAV SCI, V57, P1152, DOI 10.1177/0002764213487340.
   Wood EH, 2023, HEALTH PROMOT PRACT, V24, P491, DOI 10.1177/15248399221096415.
   Woodward Eva N, 2021, Implement Sci Commun, V2, P61, DOI 10.1186/s43058-021-00146-5.
   Woodward EN, 2019, IMPLEMENT SCI, V14, DOI 10.1186/s13012-019-0861-y.},
Number-of-Cited-References = {47},
Times-Cited = {2},
Unique-ID = {WOS:001101994000015},
}

@article{ WOS:000466858700021,
Author = {Chowkwanyun, Merlin and Bayer, Ronald and Galea, Sandro},
Title = {Precision public health: pitfalls and promises},
Journal = {LANCET},
Year = {2019},
Volume = {393},
Number = {10183},
Pages = {1801},
Month = {MAY 4},
Type = {Letter},
Affiliation = {Chowkwanyun, M (Corresponding Author), Columbia Univ, Dept Sociomed Sci, New York, NY 10034 USA.
   Chowkwanyun, Merlin; Bayer, Ronald, Columbia Univ, Dept Sociomed Sci, New York, NY 10034 USA.
   Galea, Sandro, Boston Univ, Sch Publ Hlth, Off Dean, Boston, MA USA.},
DOI = {10.1016/S0140-6736(18)33187-8},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Author-Email = {mc2028@columbia.edu},
Affiliations = {Columbia University; Boston University},
Cited-References = {Chowkwanyun M, 2018, NEW ENGL J MED, V379, P1398, DOI 10.1056/NEJMp1806634.
   Golding N, 2017, LANCET, V390, P2171, DOI 10.1016/S0140-6736(17)31758-0.
   Horton R, 2018, LANCET, V392, P1504, DOI 10.1016/S0140-6736(18)32741-7.
   Wagner Z, 2018, LANCET, V392, P857, DOI 10.1016/S0140-6736(18)31437-5.},
Number-of-Cited-References = {4},
Times-Cited = {6},
Unique-ID = {WOS:000466858700021},
}

@article{ WOS:001177479300028,
Author = {Fleck, Leonard Michael},
Title = {Precision Public Health Equity: Another Utopian Mirage?},
Journal = {AMERICAN JOURNAL OF BIOETHICS},
Year = {2024},
Volume = {24},
Number = {3},
Pages = {98-100},
Month = {MAR 3},
Type = {Editorial Material},
Affiliation = {Fleck, LM (Corresponding Author), Michigan State Univ, Coll Human Med, Ctr Bioeth \& social Justice, 965 Wilson Rd, E Lansing, MI 48824 USA.
   Fleck, Leonard Michael, Michigan State Univ, E Lansing, MI USA.
   Fleck, Leonard Michael, Michigan State Univ, Coll Human Med, Ctr Bioeth \& social Justice, 965 Wilson Rd, E Lansing, MI 48824 USA.},
DOI = {10.1080/15265161.2024.2303134},
Research-Areas = {Social Sciences - Other Topics; Medical Ethics; Social Issues;
   Biomedical Social Sciences},
Web-of-Science-Categories  = {Ethics; Medical Ethics; Social Issues; Social Sciences, Biomedical},
Author-Email = {fleck@msu.edu},
Affiliations = {Michigan State University; Michigan State University; Michigan State
   University College of Human Medicine},
Cited-References = {Braveman PA, 2022, HEALTH AFFAIR, V41, P171, DOI 10.1377/hlthaff.2021.01394.
   Fleck L. M., 2022, Precision Medicine and Distributive Justice: Wicked Problems for Democratic Deliberation.
   Fleck LM, 2022, MED HEALTH CARE PHIL, V25, P191, DOI 10.1007/s11019-022-10067-2.
   Galasso I, 2024, AM J BIOETHICS, V24, P71, DOI 10.1080/15265161.2023.2180108.
   Lurie P. J., 2023, The Washington Post.
   Rawls John., 1996, POLITICAL LIBERALISM.
   Thompson D, 2023, The Atlantic.
   Vasan N, 2019, NATURE, V575, P299, DOI 10.1038/s41586-019-1730-1.
   Wu L. L., 2021, MedPage Today.},
Number-of-Cited-References = {9},
Times-Cited = {0},
Unique-ID = {WOS:001177479300028},
}

@article{ WOS:000446923400003,
Author = {Chowkwanyun, Merlin and Bayer, Ronald and Galea, Sandro},
Title = {``Precision{''} Public Health - Between Novelty and Hype},
Journal = {NEW ENGLAND JOURNAL OF MEDICINE},
Year = {2018},
Volume = {379},
Number = {15},
Pages = {1398-1400},
Month = {OCT 11},
Type = {Editorial Material},
Affiliation = {Chowkwanyun, M (Corresponding Author), Columbia Univ, Mailman Sch Publ Hlth, Dept Sociomed Sci, Ctr Hist \& Eth Publ Hlth, New York, NY 10027 USA.
   Chowkwanyun, Merlin; Bayer, Ronald, Columbia Univ, Mailman Sch Publ Hlth, Dept Sociomed Sci, Ctr Hist \& Eth Publ Hlth, New York, NY 10027 USA.
   Galea, Sandro, Boston Univ, Sch Publ Hlth, Boston, MA USA.},
DOI = {10.1056/NEJMp1806634},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Affiliations = {Columbia University; Boston University},
Cited-References = {Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523.
   Dowell SF, 2016, NATURE, V540, P189, DOI 10.1038/540189a.
   Khoury MJ, 2018, GENET MED, V20, P574, DOI 10.1038/gim.2017.211.
   National Research Council, 2011, PREC MED BUILD KNOWL.
   ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32.},
Number-of-Cited-References = {5},
Times-Cited = {77},
Unique-ID = {WOS:000446923400003},
}

@article{ WOS:000478698300020,
Author = {Allen, Caitlin G. and Fohner, Alison E. and Landry, Latrice and Paul,
   Jean and Smith, Samuel G. and Turbitt, Erin and Roberts, Megan C.},
Title = {Early career investigators and precision public health},
Journal = {LANCET},
Year = {2019},
Volume = {394},
Number = {10196},
Pages = {382-383},
Month = {AUG 3},
Type = {Letter},
Affiliation = {Allen, CG (Corresponding Author), Emory Univ, Rollins Sch Publ Hlth, Behav Sci \& Hlth Educ Dept, Atlanta, GA 30322 USA.
   Allen, Caitlin G., Emory Univ, Rollins Sch Publ Hlth, Behav Sci \& Hlth Educ Dept, Atlanta, GA 30322 USA.
   Fohner, Alison E., Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA.
   Landry, Latrice, Partners Med, Mol Med Lab, Boston, MA USA.
   Paul, Jean, Med Univ Innsbruck, Ludwig Boltzmann Gesellschaft, Mental Hlth Res Program, Village Res Project, Innsbruck, Austria.
   Smith, Samuel G., Univ Leeds, Leeds Inst Hlth Sci, Leeds, W Yorkshire, England.
   Turbitt, Erin, Univ Technol Sydney, Grad Sch Hlth, Discipline Genet Counselling, Sydney, NSW, Australia.
   Roberts, Megan C., Univ N Carolina, Eshelman Sch Pharm, Div Pharmaceut Outcomes \& Policy, Chapel Hill, NC 27515 USA.},
DOI = {10.1016/S0140-6736(19)30498-2},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Author-Email = {calle27@emory.edu},
Affiliations = {Emory University; Rollins School Public Health; University of
   Washington; University of Washington Seattle; Medical University of
   Innsbruck; University of Leeds; University of Technology Sydney;
   University of North Carolina; University of North Carolina Chapel Hill},
Cited-References = {Chowkwanyun M, 2018, NEW ENGL J MED, V379, P1398, DOI 10.1056/NEJMp1806634.
   Khoury MJ, 2016, JAMA-J AM MED ASSOC, V316, P1357, DOI 10.1001/jama.2016.12260.
   ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32.
   Taylor-Robinson D, 2018, INT J EPIDEMIOL, V47, P9, DOI 10.1093/ije/dyx196.},
Number-of-Cited-References = {4},
Times-Cited = {5},
Unique-ID = {WOS:000478698300020},
}

@article{ WOS:001057852300008,
Author = {Griffith, Derek M.},
Title = {Precision public health approaches to health equity},
Journal = {CANCER PREVENTION RESEARCH},
Year = {2023},
Volume = {16},
Number = {1, S},
Meeting = {IA014},
Month = {JAN 1},
Type = {Meeting Abstract},
DOI = {10.1158/1940-6215.PrecPrev22-IA014},
Research-Areas = {Oncology},
Web-of-Science-Categories  = {Oncology},
Number-of-Cited-References = {0},
Times-Cited = {0},
Unique-ID = {WOS:001057852300008},
}

@article{ WOS:000448414700013,
Author = {Horton, Richard},
Title = {Offline: In defence of precision public health},
Journal = {LANCET},
Year = {2018},
Volume = {392},
Number = {10157},
Pages = {1504},
Month = {OCT 27},
Type = {Editorial Material},
DOI = {10.1016/S0140-6736(18)32741-7},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Author-Email = {richard.horton@lancet.com},
Number-of-Cited-References = {0},
Times-Cited = {41},
Unique-ID = {WOS:000448414700013},
}

@article{ WOS:000487824300018,
Author = {Blower, Sally and Okano, Justin T.},
Title = {Precision public health and HIV in Africa},
Journal = {LANCET INFECTIOUS DISEASES},
Year = {2019},
Volume = {19},
Number = {10},
Pages = {1050-1052},
Month = {OCT},
Type = {Editorial Material},
Affiliation = {Blower, S (Corresponding Author), Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst Neurosci \& Human Behav, Ctr Biomed Modeling, Los Angeles, CA 90095 USA.
   Blower, Sally; Okano, Justin T., Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst Neurosci \& Human Behav, Ctr Biomed Modeling, Los Angeles, CA 90095 USA.},
DOI = {10.1016/S1473-3099(19)30474-8},
Keywords-Plus = {MIGRATION},
Research-Areas = {Infectious Diseases},
Web-of-Science-Categories  = {Infectious Diseases},
Author-Email = {sblower@mednet.ucla.edu},
Affiliations = {University of California System; University of California Los Angeles;
   University of California Los Angeles Medical Center; David Geffen School
   of Medicine at UCLA},
Cited-References = {Abeler-Dörner L, 2019, CURR OPIN HIV AIDS, V14, P173, DOI 10.1097/COH.0000000000000542.
   Coburn BJ, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag0019.
   Cuadros DF, 2019, AIDS, V33, P305, DOI {[}10.1097/QAD.0000000000002052, 10.1097/qad.0000000000002052].
   Dobra A, 2017, AIDS, V31, P137, DOI 10.1097/QAD.0000000000001292.
   Dwyer-Lindgren L, 2019, NATURE, V570, P189, DOI 10.1038/s41586-019-1200-9.
   Faria NR, 2014, SCIENCE, V346, P56, DOI 10.1126/science.1256739.
   Grabowski MK, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001610.
   Huybrechts Andre., 1970, TRANSPORTS STRUCTURE.
   Palk L, 2015, JAIDS-J ACQ IMM DEF, V68, P604, DOI 10.1097/QAI.0000000000000526.
   Ratmann O, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09139-4.
   Tanser F, 2015, CURR OPIN HIV AIDS, V10, P430, DOI 10.1097/COH.0000000000000192.
   UNAIDS, 2013, Location, Location: Connecting People Faster to HIV Services.},
Number-of-Cited-References = {12},
Times-Cited = {5},
Unique-ID = {WOS:000487824300018},
}

@article{ WOS:000389548700020,
Author = {Dowell, Scott F. and Blazes, David and Desmond-Hellmann, Susan},
Title = {Four steps to precision public health},
Journal = {NATURE},
Year = {2016},
Volume = {540},
Number = {7632},
Pages = {189-191},
Month = {DEC 8},
Type = {Editorial Material},
Affiliation = {Dowell, SF (Corresponding Author), Bill \& Melinda Gates Fdn, Surveillance \& Epidemiol, Seattle, WA 98109 USA.
   Dowell, Scott F.; Blazes, David, Bill \& Melinda Gates Fdn, Surveillance \& Epidemiol, Seattle, WA 98109 USA.
   Desmond-Hellmann, Susan, Bill \& Melinda Gates Fdn, Seattle, WA USA.},
DOI = {10.1038/540189a},
Keywords-Plus = {ELIMINATION; PROGRESS},
Research-Areas = {Science \& Technology - Other Topics},
Web-of-Science-Categories  = {Multidisciplinary Sciences},
Author-Email = {scott.dowell@gatesfoundation.org},
Affiliations = {Bill \& Melinda Gates Foundation; Bill \& Melinda Gates Foundation},
Cited-References = {Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535.
   Desmond-Hellmann S, 2016, SCIENCE, V353, P731, DOI 10.1126/science.aai7598.
   Ferguson NM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010370.
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347.
   Maïnassara HB, 2015, EMERG INFECT DIS, V21, P1322, DOI 10.3201/eid2108.141361.
   Olson DR, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003256.
   Quan V, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-151.
   Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1.
   Wassilak SGF, 2014, J INFECT DIS, V210, pS5, DOI 10.1093/infdis/jiu456.},
Number-of-Cited-References = {9},
Times-Cited = {104},
Unique-ID = {WOS:000389548700020},
}

@article{ WOS:000415642200006,
Author = {Davey, Gail and Deribe, Kebede},
Title = {Precision public health: mapping child mortality in Africa},
Journal = {LANCET},
Year = {2017},
Volume = {390},
Number = {10108},
Pages = {2126-2128},
Month = {NOV 11},
Type = {Editorial Material},
Affiliation = {Davey, G (Corresponding Author), Univ Sussex, Brighton \& Sussex Med Sch, Wellcome Trust Ctr Global Hlth Res, Brighton BN1 9PX, E Sussex, England.
   Davey, Gail; Deribe, Kebede, Univ Sussex, Brighton \& Sussex Med Sch, Wellcome Trust Ctr Global Hlth Res, Brighton BN1 9PX, E Sussex, England.},
DOI = {10.1016/S0140-6736(17)32280-8},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Author-Email = {g.davey@bsms.ac.uk},
Affiliations = {University of Sussex; University of Brighton},
Cited-References = {{[}Anonymous], LANCET.
   {[}Anonymous], 2017, The sustainable development goals report 2017.
   Bhatt S, 2016, IMPROVED PREDICTION.
   Burke M, 2016, LANCET GLOB HEALTH, V4, pE936, DOI {[}10.1016/S2214-109X(16)30212-1, 10.1016/s2214-109x(16)30212-1].
   Dowell SF, 2016, NATURE, V540, P189, DOI 10.1038/540189a.
   Liu L, 2016, LANCET, V388, P3027, DOI 10.1016/S0140-6736(16)31593-8.
   Rajaratnam JK, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000253.
   UN Inter-Agency Group for Child Mortality Estimation, 2013, LEVELS TRENDS CHILD.
   United Nations, 2015, Transforming our world: The 2030 Agenda For Sustainable Development, DOI {[}10.1201/b20466-7, DOI 10.1201/B20466-7].
   Wang HD, 2016, LANCET, V388, P1725, DOI 10.1016/S0140-6736(16)31575-6.
   You DZ, 2015, LANCET, V386, P2275, DOI 10.1016/S0140-6736(15)00120-8.},
Number-of-Cited-References = {11},
Times-Cited = {5},
Unique-ID = {WOS:000415642200006},
}

@article{ WOS:000840254100001,
Author = {de Sousa, Alvaro Francisco Lopes and de Sousa, Anderson Reis and
   Fronteira, Ines},
Title = {Monkeypox: between precision public health and stigma risk},
Journal = {REVISTA BRASILEIRA DE ENFERMAGEM},
Year = {2022},
Volume = {75},
Number = {5},
Type = {Editorial Material},
Affiliation = {de Sousa, FL (Corresponding Author), Univ Nova Lisboa, Inst Higiene \& Med Trop, Global Hlth \& Trop Med, Lisbon, Portugal.
   de Sousa, FL (Corresponding Author), Associacao Brasileira Enfermagem, Revista Brasileira Enfermagem, Brasilia, DF, Brazil.
   de Sousa, Alvaro Francisco Lopes; Fronteira, Ines, Univ Nova Lisboa, Inst Higiene \& Med Trop, Global Hlth \& Trop Med, Lisbon, Portugal.
   de Sousa, Alvaro Francisco Lopes; Fronteira, Ines, Associacao Brasileira Enfermagem, Revista Brasileira Enfermagem, Brasilia, DF, Brazil.
   de Sousa, Anderson Reis, Univ Fed Bahia, Assoc Brasileira Enfermagem, Dev Profess Practice \& Work Nursing, Salvador, BA, Brazil.},
DOI = {10.1590/0034-7167.2022750501},
Article-Number = {e750501},
Research-Areas = {Nursing},
Web-of-Science-Categories  = {Nursing},
Author-Email = {sousa.alvaromd@gmail.com},
Affiliations = {Universidade Nova de Lisboa; Institute of Hygiene \& Tropical Medicine -
   UNL; Universidade Federal da Bahia},
Cited-References = {{[}Anonymous], 2022, State of the World's Drinking Water: An Urgent Call to Action to Accelerate Progress on Ensuring Safe Drinking Water for All.
   de Sousa AR, 2022, REV BRAS ENFERM, V75, DOI 10.1590/0034-7167-2021-0038.
   European Centre for Disease Prevention and Control (ECDC), 2017, HEP OUTBR EU EEA MOS.
   Pinkstone J., 2022, TELEGRAPH.
   UNAIDS, 2022, PRESS REL UNAIDS WAR.
   World Health Organisation, 2021, Multi-country monkeypox outbreak: Situationupdate.
   World Health Organization, 2022, Monkeypox.},
Number-of-Cited-References = {7},
Times-Cited = {14},
Unique-ID = {WOS:000840254100001},
}

@article{ WOS:000853466500001,
Author = {Naumova, Elena N.},
Title = {Precision public health: is it all about the data?},
Journal = {JOURNAL OF PUBLIC HEALTH POLICY},
Year = {2022},
Volume = {43},
Number = {4},
Pages = {481-486},
Month = {DEC},
Type = {Editorial Material},
Affiliation = {Naumova, EN (Corresponding Author), Tufts Univ, Friedman Sch Nutr Sci \& Policy, Boston, MA 02111 USA.
   Naumova, Elena N., Tufts Univ, Friedman Sch Nutr Sci \& Policy, Boston, MA 02111 USA.},
DOI = {10.1057/s41271-022-00367-5},
EarlyAccessDate = {SEP 2022},
Research-Areas = {Health Care Sciences \& Services; Public, Environmental \& Occupational
   Health},
Web-of-Science-Categories  = {Health Care Sciences \& Services; Health Policy \& Services; Public,
   Environmental \& Occupational Health},
Author-Email = {elena.naumova@tufts.edu},
Affiliations = {Tufts University},
Cited-References = {{[}Anonymous], 2019, PRESS RELEASES.
   Arnold, 2022, NATURE NEWS FEA 0104.
   Cisneros, 2016, CAMPUS NEWS 0527.
   Khoury MJ, 2018, PUBLIC HEALTH GENOM, V21, P244, DOI 10.1159/000501465.
   Minor L., 2020, DISCOVERING PRECISIO, DOI DOI 10.1002/9781119672715.
   Rasmussen SA, 2020, JAMA-J AM MED ASSOC, V324, P933, DOI 10.1001/jama.2020.14992.
   U.S. Food and Drug Administration, PREC MED.},
Number-of-Cited-References = {7},
Times-Cited = {1},
Unique-ID = {WOS:000853466500001},
}

@article{ WOS:000855007600001,
Author = {Chen, Zhuo},
Title = {Precision Public Health in China: Opportunities and Challenges Foreword},
Journal = {CHINA CDC WEEKLY},
Year = {2022},
Volume = {4},
Number = {32},
Pages = {695-696},
Month = {AUG 1},
Type = {Editorial Material},
Affiliation = {Chen, Z (Corresponding Author), Univ Georgia, Coll Publ Hlth, Athens, GA 30602 USA.
   Chen, Z (Corresponding Author), Univ Nottingham Ningbo China, Ningbo, Zhejiang, Peoples R China.
   Chen, Zhuo, Univ Georgia, Coll Publ Hlth, Athens, GA 30602 USA.
   Chen, Zhuo, Univ Nottingham Ningbo China, Ningbo, Zhejiang, Peoples R China.},
DOI = {10.46234/ccdcw2022.145},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {zchen1@uga.edu},
Affiliations = {University System of Georgia; University of Georgia; University of
   Nottingham Ningbo China},
Cited-References = {Chen ZM, 2011, INT J EPIDEMIOL, V40, P1652, DOI 10.1093/ije/dyr120.
   Chen Z, 2022, CHINA CDC WEEKLY, V4, P706, DOI 10.46234/ccdcw2022.147.
   Chowkwanyun M, 2018, NEW ENGL J MED, V379, P1398, DOI 10.1056/NEJMp1806634.
   Collins FS, 2003, SCIENCE, V300, P286, DOI 10.1126/science.1084564.
   Evangelatos N, 2018, OMICS, V22, P190, DOI 10.1089/omi.2017.0192.
   Horton R, 2018, LANCET, V392, P1504, DOI 10.1016/S0140-6736(18)32741-7.
   Huang T, 2019, TWIN RES HUM GENET, V22, P482, DOI 10.1017/thg.2019.85.
   Illumina, 2021, VID GOLD AG CHIN NGS.
   Jiang S, 2022, CHINA CDC WEEKLY, V4, P697, DOI 10.46234/ccdcw2022.146.
   Karthikeyan S, 2022, NATURE, V609, P101, DOI 10.1038/s41586-022-05049-6.
   Khoury MJ, 2022, GENET MED, V24, P1630, DOI 10.1016/j.gim.2022.04.009.
   Khoury MJ, 2018, GENET MED, V20, P574, DOI 10.1038/gim.2017.211.
   Khoury MJ, 2018, PUBLIC HEALTH GENOM, V21, P244, DOI 10.1159/000501465.
   Liu PP, 2012, J GEN VIROL, V93, P2158, DOI 10.1099/vir.0.043554-0.
   Rasmussen SA, 2020, JAMA-J AM MED ASSOC, V324, P933, DOI 10.1001/jama.2020.14992.
   Saravanan KA, 2022, GENE, V823, DOI 10.1016/j.gene.2022.146387.
   Sun L, 2022, CHINA CDC WEEKLY, V4, P711, DOI 10.46234/ccdcw2022.148.
   Taylor-Robinson D, 2019, INT J EPIDEMIOL, V48, P1, DOI 10.1093/ije/dyy184.
   Weeramanthri TS, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00121.
   Zhu C, 2022, CHINA CDC WEEKLY, V4, P715, DOI 10.46234/ccdcw2022.149.},
Number-of-Cited-References = {20},
Times-Cited = {0},
Unique-ID = {WOS:000855007600001},
}

@article{ WOS:000370260300017,
Author = {Khoury, Muin J. and Iademarco, Michael F. and Riley, William T.},
Title = {Precision Public Health for the Era of Precision Medicine},
Journal = {AMERICAN JOURNAL OF PREVENTIVE MEDICINE},
Year = {2016},
Volume = {50},
Number = {3},
Pages = {398-401},
Month = {MAR},
Type = {Article},
Affiliation = {Khoury, MJ (Corresponding Author), CDC, Off Publ Hlth Genom, 1600 Clifton Rd, Atlanta, GA 30329 USA.
   Khoury, Muin J.; Iademarco, Michael F., CDC, Ctr Surveillance Epidemiol \& Lab Serv, Atlanta, GA 30333 USA.
   Khoury, Muin J.; Riley, William T., NCI, Div Canc Control \& Populat Sci, Rockville, MD USA.
   Iademarco, Michael F., US PHS, Commissioned Corps, Washington, DC 20201 USA.},
DOI = {10.1016/j.amepre.2015.08.031},
Research-Areas = {Public, Environmental \& Occupational Health; General \& Internal
   Medicine},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health; Medicine, General \&
   Internal},
Author-Email = {muk1@cdc.gov},
Affiliations = {Centers for Disease Control \& Prevention - USA; National Institutes of
   Health (NIH) - USA; NIH National Cancer Institute (NCI); United States
   Public Health Service},
Cited-References = {{[}Anonymous], STRAT IMPR CTR DIS C.
   {[}Anonymous], 2013, NATURE NEWS.
   {[}Anonymous], FUT FOOD SAF WHOL GE.
   Bowen MS, 2012, PUBLIC HEALTH GENOM, V15, P327, DOI 10.1159/000341889.
   Cairns M.D., 2015, J CLIN MICROBIOL.
   Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523.
   Khoury MJ, 2014, SCIENCE, V346, P1054, DOI 10.1126/science.aaa2709.
   Kohler BA, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv048.
   Olden K, 2014, AM J PUBLIC HEALTH, V104, P1816, DOI 10.2105/AJPH.2014.302130.
   Rubin R, 2015, JAMA-J AM MED ASSOC, V313, P1089, DOI 10.1001/jama.2015.0957.
   Shamsudeen F, 2015, EMERG INFECT DIS.
   Yoon PW, 2014, MMWR-MORBID MORTAL W, V63, P369.},
Number-of-Cited-References = {12},
Times-Cited = {326},
Unique-ID = {WOS:000370260300017},
}

@article{ WOS:000628749000001,
Author = {Newson, Ainsley J.},
Title = {The promise of public health ethics for precision medicine: the case of
   newborn preventive genomic sequencing},
Journal = {HUMAN GENETICS},
Year = {2022},
Volume = {141},
Number = {5, SI},
Pages = {1035-1043},
Month = {MAY},
Abstract = {Precision medicine aims to tailor medical treatment to match individual
   characteristics and to stratify individuals to concentrate benefits and
   avoid harm. It has recently been joined by precision public health-the
   application of precision medicine at population scale to decrease
   morbidity and optimise population health. Newborn preventive genomic
   sequencing (NPGS) provides a helpful case study to consider how we
   should approach ethical questions in precision public health. In this
   paper, I use NPGS as a case in point to argue that both precision
   medicine and precision public health need public health ethics. I make
   this argument in two parts. First, I claim that discussions of ethics in
   precision medicine and NPGS tend to focus on predominantly
   individualistic concepts from medical ethics such as autonomy and
   empowerment. This highlights some deficiencies, including overlooking
   that choice is subject to constraints and that an individual's place in
   the world might impact their capacity to `be responsible'. Second, I
   make the case for using a public health ethics approach when considering
   ethics and NPGS, and thus precision public health more broadly. I
   discuss how precision public health needs to be construed as a
   collective enterprise and not just as an aggregation of individual
   interests. I also show how analysing collective values and interests
   through concepts such as solidarity can enrich ethical discussion of
   NPGS and highlight previously overlooked issues. With this approach,
   bioethics can contribute to more just and more appropriate applications
   of precision medicine and precision public health, including NPGS.},
Type = {Review},
Affiliation = {Newson, AJ (Corresponding Author), Univ Sydney, Sydney Hlth Eth, Sydney Sch Publ Hlth, Fac Med \& Hlth, Level 1 Med Fdn Bldg,92-94 Parramatta Rd, Sydney, NSW 2006, Australia.
   Newson, Ainsley J., Univ Sydney, Sydney Hlth Eth, Sydney Sch Publ Hlth, Fac Med \& Hlth, Level 1 Med Fdn Bldg,92-94 Parramatta Rd, Sydney, NSW 2006, Australia.},
DOI = {10.1007/s00439-021-02269-0},
EarlyAccessDate = {MAR 2021},
Keywords-Plus = {GENETIC RISK; EMPOWERMENT; AUTONOMY; PERIL},
Research-Areas = {Genetics \& Heredity},
Web-of-Science-Categories  = {Genetics \& Heredity},
Author-Email = {ainsley.newson@sydney.edu.au},
Affiliations = {University of Sydney},
Cited-References = {Ackerman JP, 2016, MAYO CLIN PROC, V91, P1606, DOI 10.1016/j.mayocp.2016.08.008.
   Adams MC, 2016, GENET MED, V18, P593, DOI 10.1038/gim.2015.136.
   Adhikari AN, 2020, NAT MED, V26, DOI 10.1038/s41591-020-0966-5.
   Andermann A, 2008, B WORLD HEALTH ORGAN, V86, P317, DOI 10.2471/BLT.07.050112.
   Arnason V, 2012, ETHICAL PERSPECT, V19, P103, DOI 10.2143/EP.19.1.2152681.
   Bayer R, 2015, NEW ENGL J MED, V373, P499, DOI 10.1056/NEJMp1506241.
   Bilkey GA, 2019, FRONT PUBLIC HEALTH, V7, DOI 10.3389/fpubh.2019.00042.
   Bombard Y, 2009, NAT REV GENET, V10, P666, DOI 10.1038/nrg2666.
   Botkin Jeffrey R, 2016, Curr Genet Med Rep, V4, P1.
   Brothers KB, 2019, MAYO CLIN PROC, V94, P103, DOI 10.1016/j.mayocp.2018.08.028.
   Bunnik EM, 2015, J MED ETHICS, V41, P322, DOI 10.1136/medethics-2013-101887.
   Burger IM, 2009, AM J BIOETHICS, V9, P3, DOI 10.1080/15265160902790583.
   Burke W, 2018, JAMA-J AM MED ASSOC, V320, P1247, DOI 10.1001/jama.2018.11784.
   Chiapperino L, 2015, HEALTH PROMOT J AUST, V26, P210, DOI 10.1071/HE15035.
   Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523.
   Dawson A., 2012, Public Health Rev, V34, P65, DOI {[}DOI 10.1007/BF03391656, 10.1007/BF03391656].
   Dawson A, 2011, PUBLIC HEALTH ETH-UK, V4, P1, DOI 10.1093/phe/phr011.
   Dawson A, 2010, BIOETHICS, V24, P218, DOI 10.1111/j.1467-8519.2010.01814.x.
   Dive L, 2018, KENNEDY INST ETHIC J, V28, P171, DOI 10.1353/ken.2018.0013.
   Dondorp WJ, 2013, EUR J HUM GENET, V21, pS6, DOI 10.1038/ejhg.2013.73.
   Donnelly L., 2019, The Telegraph.
   Dove Edward S, 2017, Clin Ethics, V12, P150, DOI 10.1177/1477750917704156.
   Friedman JM, 2017, BMC MED GENOMICS, V10, DOI 10.1186/s12920-017-0247-4.
   Ginsburg GS, 2018, HEALTH AFFAIR, V37, P694, DOI 10.1377/hlthaff.2017.1624.
   Gray M, 2017, NEW BIOETH, V23, P87, DOI 10.1080/20502877.2017.1314891.
   Grody WW, 2019, GENET MED, V21, P1916, DOI 10.1038/s41436-019-0450-0.
   Harris, 2004, COMPANION GENETHICS, P455, DOI {[}10.1002/9780470756423.ch34, DOI 10.1002/9780470756423.CH34].
   Harris, 2016, WOULD YOU WANT KNOW.
   Hofmann B, 2008, J MED ETHICS, V34, P446, DOI 10.1136/jme.2006.019307.
   Hofmann BM, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h705.
   Howard HC, 2015, EUR J HUM GENET, V23, P1593, DOI 10.1038/ejhg.2014.289.
   Hunter DJ, 2019, NEW ENGL J MED, V380, P2391, DOI 10.1056/NEJMp1904511.
   Janssens ACJW, 2019, HUM MOL GENET, V28, pR143, DOI 10.1093/hmg/ddz205.
   Jennings B, 2015, HASTINGS CENT REP, V45, P31, DOI 10.1002/hast.490.
   Johnson SB, 2020, EUR J HUM GENET, V28, P147, DOI 10.1038/s41431-019-0507-1.
   Johnston J, 2018, HASTINGS CENT REP, V48, DOI 10.1002/hast.874.
   Jooma S, 2019, ETHNIC DIS, V29, P173, DOI 10.18865/ed.29.S1.173.
   Juengst ET, 2020, GENOME MED, V12, DOI 10.1186/s13073-020-00800-y.
   Juengst ET, 2012, HASTINGS CENT REP, V42, P34, DOI 10.1002/hast.65.
   Kemper AR, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2019-0904.
   Khoury MJ, 2016, AM J PREV MED, V50, P398, DOI 10.1016/j.amepre.2015.08.031.
   Kihlbom U, 2018, J RISK RES, V21, P222, DOI 10.1080/13669877.2016.1200653.
   Knoppers BM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008494.
   Kong C, 2017, AM J BIOETHICS, V17, P3, DOI 10.1080/15265161.2017.1284915.
   Laberge A-M., 2017, OBM GENET, DOI 10.21926/obm.genet.1703006.
   Lau Y, 2009, J BIOETHIC INQ, V6, P495, DOI 10.1007/s11673-009-9188-8.
   Manson NC, 2006, J APPL PHILOS, V23, P1, DOI 10.1111/j.1468-5930.2006.00317.x.
   Martin AR, 2019, NAT GENET, V51, P584, DOI 10.1038/s41588-019-0379-x.
   Maughan T, 2017, NEW BIOETH, V23, P13, DOI 10.1080/20502877.2017.1314886.
   Meagher KM, 2018, PERS MED, V15, P343, DOI 10.2217/pme-2018-0041.
   Millward M, 2020, EUR J MED GENET, V63, DOI 10.1016/j.ejmg.2020.103968.
   Morgan TM, 2018, J LAW MED ETHICS, V46, P541, DOI 10.1177/1073110518782963.
   Morrissey C, 2018, J MED PHILOS, V43, P22, DOI 10.1093/jmp/jhx034.
   Murray MF, 2018, ANN INTERN MED, V169, P407, DOI 10.7326/M18-1722.
   Novas C, 2000, ECON SOC, V29, P485.
   O'Neill Onora, 2002, Ethics Int Aff, V16, P35, DOI 10.1111/j.1747-7093.2002.tb00395.x.
   Olstad DL, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-030279.
   Pereira S, 2018, HASTINGS CENT REP, V48, pS43, DOI 10.1002/hast.885.
   Popejoy AB, 2016, NATURE, V538, P161, DOI 10.1038/538161a.
   Ross LF, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2019-1031.
   Rothstein MA, 2012, J LAW MED ETHICS, V40, P682, DOI 10.1111/j.1748-720X.2012.00699.x.
   Schaefer GO, 2020, BIOETHICS, V34, P849, DOI 10.1111/bioe.12757.
   Scott IA, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m14.
   Sirugo G, 2019, CELL, V177, P26, DOI {[}10.1016/j.cell.2019.02.048, 10.1016/j.cell.2019.04.032].
   Tarini BA, 2012, ANNU REV GENOM HUM G, V13, P381, DOI 10.1146/annurev-genom-090711-163741.
   Tengland PA, 2008, HEALTH CARE ANAL, V16, P77, DOI 10.1007/s10728-007-0067-3.
   van der Burg S, 2018, BIOETHICS, V32, P171, DOI 10.1111/bioe.12425.
   Verweij Marcel., 2007, ETHICS PREVENTION PU, P13.
   Virani AH, 2015, J GENET COUNS, V24, P428, DOI 10.1007/s10897-014-9781-9.
   Watson M, 2019, GENET MED, V21, P1467, DOI 10.1038/s41436-019-0502-5.
   Wilson BJ, 2017, J CLIN EPIDEMIOL, V92, P4, DOI 10.1016/j.jclinepi.2017.08.018.
   Wilson PM, 2007, HEALTH SOC CARE COMM, V15, P426, DOI 10.1111/j.1365-2524.2007.00701.x.
   Zimmern, 2007, GENETIC TEST EVALUAT.},
Number-of-Cited-References = {73},
Times-Cited = {13},
Unique-ID = {WOS:000628749000001},
}

@article{ WOS:000851421200001,
Author = {Prior, David},
Title = {Precision public health must be at the centre of modern healthcare},
Journal = {BMJ-BRITISH MEDICAL JOURNAL},
Year = {2022},
Volume = {378},
Month = {AUG 30},
Type = {Editorial Material},
Affiliation = {Prior, D (Corresponding Author), Cambridge Life Sci Council, Cambridge, England.
   Prior, David, NHS England, London, England.
   Prior, David, Cambridge Life Sci Council, Cambridge, England.},
DOI = {10.1136/bmj.o2119},
Article-Number = {o2119},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Cited-References = {Marmot M, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m693.},
Number-of-Cited-References = {1},
Times-Cited = {0},
Unique-ID = {WOS:000851421200001},
}

@article{ WOS:000507364502404,
Author = {Villegas, Leopoldo and Bretas, Gustavo and Vreden, Stephen},
Title = {COLLECTIVE INTELLIGENCE AND MALARIA: A PRECISION PUBLIC HEALTH-MALARIA
   ELIMINATION MODEL},
Journal = {AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE},
Year = {2019},
Volume = {101},
Number = {5},
Meeting = {404},
Pages = {123},
Type = {Meeting Abstract},
Affiliation = {Villegas, Leopoldo; Bretas, Gustavo, Global Dev One, Silver Spring, MD USA.
   Vreden, Stephen, Acad Ziekenhuis Paramaribo, Paramaribo, Suriname.},
Research-Areas = {Public, Environmental \& Occupational Health; Tropical Medicine},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health; Tropical Medicine},
Affiliations = {Anton de Kom Universiteit van Suriname; Academisch Ziekenhuis Paramaribo},
Number-of-Cited-References = {0},
Times-Cited = {0},
Unique-ID = {WOS:000507364502404},
}

@article{ WOS:000577495000730,
Author = {Odedina, Folakemi and CaPTC Investigators},
Title = {Addressing prostate cancer disparities through precision public health:
   The CaPTC experience},
Journal = {CANCER EPIDEMIOLOGY BIOMARKERS \& PREVENTION},
Year = {2020},
Volume = {29},
Number = {6, 1},
Meeting = {IA42},
Month = {JUN},
Type = {Meeting Abstract},
Affiliation = {Odedina, Folakemi, Univ Florida, Orlando, FL USA.
   CaPTC Investigators, Prostate Canc Transatlantic Consortium, Global, Bethesda, MD USA.},
DOI = {10.1158/1538-7755.DISP18-IA42},
Research-Areas = {Oncology; Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Oncology; Public, Environmental \& Occupational Health},
Affiliations = {State University System of Florida; University of Florida},
Number-of-Cited-References = {0},
Times-Cited = {0},
Unique-ID = {WOS:000577495000730},
}

@article{ WOS:000475736200021,
Author = {Meurer, John R. and Whittle, Jeffrey C. and Lamb, Kelsey M. and Kosasih,
   Matthew A. and Dwinell, Melinda R. and Urrutia, Raul A.},
Title = {Precision Medicine and Precision Public Health: Academic Education and
   Community Engagement},
Journal = {AMERICAN JOURNAL OF PREVENTIVE MEDICINE},
Year = {2019},
Volume = {57},
Number = {2},
Pages = {286-289},
Month = {AUG},
Type = {Article},
Affiliation = {Meurer, JR (Corresponding Author), Med Coll Wisconsin, Inst Hlth \& Equ, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.
   Meurer, John R., Med Coll Wisconsin, Inst Hlth \& Equ, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.
   Whittle, Jeffrey C., Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA.
   Lamb, Kelsey M.; Kosasih, Matthew A., Med Coll Wisconsin, Sch Med, Milwaukee, WI 53226 USA.
   Dwinell, Melinda R., Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA.
   Urrutia, Raul A., Med Coll Wisconsin, Dept Surg, Milwaukee, WI 53226 USA.
   Urrutia, Raul A., Med Coll Wisconsin, Genom Sci \& Precis Med Ctr, Milwaukee, WI 53226 USA.},
DOI = {10.1016/j.amepre.2019.03.010},
Research-Areas = {Public, Environmental \& Occupational Health; General \& Internal
   Medicine},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health; Medicine, General \&
   Internal},
Author-Email = {jmeurer@mcw.edu},
Affiliations = {Medical College of Wisconsin; Medical College of Wisconsin; Medical
   College of Wisconsin; Medical College of Wisconsin; Medical College of
   Wisconsin; Medical College of Wisconsin},
Cited-References = {Abnousi F, 2019, JAMA-J AM MED ASSOC, V321, P247, DOI 10.1001/jama.2018.19763.
   Bayer R, 2015, NEW ENGL J MED, V373, P499, DOI 10.1056/NEJMp1506241.
   Castaneda Christian, 2015, J Clin Bioinforma, V5, P4, DOI 10.1186/s13336-015-0019-3.
   CDC, PREC PUBL HLTH PREC.
   Chowkwanyun M, 2018, NEW ENGL J MED, V379, P1398, DOI 10.1056/NEJMp1806634.
   Dowell SF, 2016, NATURE, V540, P189, DOI 10.1038/540189a.
   Edmunds Margo, 2014, EGEMS (Wash DC), V2, P1156, DOI 10.13063/2327-9214.1156.
   Khoury MJ, 2018, GENET MED, V20, P574, DOI 10.1038/gim.2017.211.
   Khoury MJ, 2016, JAMA-J AM MED ASSOC, V316, P1357, DOI 10.1001/jama.2016.12260.
   Khoury MJ, 2016, AM J PREV MED, V50, P398, DOI 10.1016/j.amepre.2015.08.031.
   Khoury MJ, 2015, JAMA-J AM MED ASSOC, V313, P2117, DOI 10.1001/jama.2015.3382.
   Khoury MJ, 2011, AM J PREV MED, V40, P486, DOI 10.1016/j.amepre.2010.12.009.
   Kim JW, 2019, JMIR MHEALTH UHEALTH, V7, DOI 10.2196/12070.
   Lyles CR, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1585-5.
   May T, 2018, NEW ENGL J MED, V379, P410, DOI 10.1056/NEJMp1805870.
   McEwen JE, 2014, ANNU REV GENOM HUM G, V15, P481, DOI 10.1146/annurev-genom-090413-025327.
   McGrath S, 2016, BMC MED GENOMICS, V9, DOI 10.1186/s12920-016-0183-8.
   Molnár-Gábor F, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0449-6.
   NIH All of Us, CONS COMPR GEN STRAT.
   NIH National Human Genome Research Institute, ETH LEG SOC IMPL RES.
   Ramaswami R, 2018, ANNU REV PUBL HEALTH, V39, P153, DOI 10.1146/annurev-publhealth-040617-014158.
   Roper William L, 2006, Ann Fam Med, V4 Suppl 1, pS55, DOI 10.1370/afm.562.
   Rose G, 2001, INT J EPIDEMIOL, V30, P427, DOI 10.1093/ije/30.3.427.
   U. S. National Library of Medicine, GEN HOM REF WHAT IS.
   Vaithinathan Asokan G, 2017, J Evid Based Med, V10, P76, DOI 10.1111/jebm.12239.},
Number-of-Cited-References = {25},
Times-Cited = {2},
Unique-ID = {WOS:000475736200021},
}

@article{ WOS:000607511600005,
Author = {Moraes, Milton Ozorio and Dueppre, Nadia Cristina},
Title = {Leprosy post-exposure prophylaxis: innovation and precision public
   health},
Journal = {LANCET GLOBAL HEALTH},
Year = {2021},
Volume = {9},
Number = {1},
Pages = {E8-E9},
Month = {JAN},
Type = {Editorial Material},
Affiliation = {Moraes, MO (Corresponding Author), Fiocruz MS, Oswaldo Cruz Inst, Leprosy Lab, BR-21040360 Rio De Janeiro, Brazil.
   Moraes, Milton Ozorio; Dueppre, Nadia Cristina, Fiocruz MS, Oswaldo Cruz Inst, Leprosy Lab, BR-21040360 Rio De Janeiro, Brazil.},
Keywords-Plus = {BCG VACCINATION; CONTACTS},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {milton.moraes@fiocruz.br},
Affiliations = {Fundacao Oswaldo Cruz},
Cited-References = {Düppre NC, 2008, T ROY SOC TROP MED H, V102, P631, DOI 10.1016/j.trstmh.2008.04.015.
   Hacker MD, 2012, MEM I OSWALDO CRUZ, V107, P49, DOI 10.1590/S0074-02762012000900009.
   Manta FSN, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52640-5.
   Merle CSC, 2010, EXPERT REV VACCINES, V9, P209, DOI {[}10.1586/erv.09.161, 10.1586/ERV.09.161].
   Mieras LF, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3402-4.
   Moet FJ, 2008, BMJ-BRIT MED J, V336, P761, DOI 10.1136/bmj.39500.885752.BE.
   Nery JS, 2019, LANCET GLOB HEALTH, V7, pE1226, DOI {[}10.1016/s2214-109x(19)30260-8, 10.1016/S2214-109X(19)30260-8].
   Ortuno-Gutierrez N, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4649-0.
   Richardus JH, 2021, LANCET GLOB HEALTH, V9, pE81, DOI 10.1016/S2214-109X(20)30396-X.
   WHO, 2016, ACC LEPR FREE WORLD.},
Number-of-Cited-References = {10},
Times-Cited = {4},
Unique-ID = {WOS:000607511600005},
}

@article{ WOS:000472665500001,
Author = {Lacaze, Paul and Baynam, Gareth},
Title = {Public Health Genomics},
Journal = {FRONTIERS IN PUBLIC HEALTH},
Year = {2019},
Volume = {7},
Month = {JUN 6},
Type = {Editorial Material},
Affiliation = {Lacaze, P (Corresponding Author), Monash Univ, Dept Epidemiol \& Prevent Med, Publ Hlth Genom, Melbourne, Vic, Australia.
   Lacaze, Paul, Monash Univ, Dept Epidemiol \& Prevent Med, Publ Hlth Genom, Melbourne, Vic, Australia.
   Baynam, Gareth, King Edward Mem Hosp, Western Australian Register Dev Anomalies, Perth, WA, Australia.
   Baynam, Gareth, King Edward Mem Hosp, Genet Serv Western Australia, Perth, WA, Australia.
   Baynam, Gareth, Off Populat Hlth Genom, Publ \& Aboriginal Hlth Div, Perth, WA, Australia.
   Baynam, Gareth, Univ Western Australia, Fac Hlth \& Med Sci, Div Paediat, Perth, WA, Australia.
   Baynam, Gareth, Univ Western Australia, Telethon Kids Inst, Perth, WA, Australia.},
DOI = {10.3389/fpubh.2019.00142},
Article-Number = {142},
Keywords = {genomics; public health; precision medicine; precision public health;
   ELSI},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {Paul.Lacaze@monash.edu},
Affiliations = {Monash University; Melbourne Genomics Health Alliance; King Edward
   Memorial Hospital; King Edward Memorial Hospital; University of Western
   Australia; University of Western Australia; University of Western
   Australia; Telethon Kids Institute},
Cited-References = {Erlich Y, 2018, SCIENCE, V362, P690, DOI 10.1126/science.aau4832.
   Fransquet PD, 2018, ALZHEIMERS DEMENT, V14, P81, DOI 10.1016/j.jalz.2017.10.002.
   Horton R, 2018, LANCET, V392, P1504, DOI 10.1016/S0140-6736(18)32741-7.
   Lacaze P, 2017, J BIOETHIC INQ, V14, P585, DOI 10.1007/s11673-017-9817-6.
   Newson AJ, 2017, PUBLIC HEALTH GENOM, V20, P247, DOI 10.1159/000481450.
   Tandy-Connor S, 2018, GENET MED, V20, P1515, DOI 10.1038/gim.2018.38.
   Weeramanthri TS, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00121.
   Zhang L, 2019, GENET MED, V21, P1958, DOI 10.1038/s41436-019-0457-6.},
Number-of-Cited-References = {8},
Times-Cited = {0},
Unique-ID = {WOS:000472665500001},
}

@article{ WOS:000431648500001,
Author = {Weeramanthri, Tarun Stephen and Dawkins, Hugh J. S. and Baynam, Gareth
   and Bellgard, Matthew and Gudes, Ori and Semmens, James Bernard},
Title = {Editorial: Precision Public Health},
Journal = {FRONTIERS IN PUBLIC HEALTH},
Year = {2018},
Volume = {6},
Month = {APR 30},
Type = {Editorial Material},
Affiliation = {Weeramanthri, TS (Corresponding Author), Govt Western Australia, Western Australian Dept Hlth, Publ \& Aboriginal Hlth Div, Perth, WA, Australia.
   Weeramanthri, Tarun Stephen; Dawkins, Hugh J. S., Govt Western Australia, Western Australian Dept Hlth, Publ \& Aboriginal Hlth Div, Perth, WA, Australia.
   Baynam, Gareth, Genet Serv Western Australia, Subiaco, WA, Australia.
   Bellgard, Matthew, Queensland Univ Technol, eRes Directorate, Brisbane, Qld, Australia.
   Gudes, Ori, Univ New South Wales, Sydney, NSW, Australia.
   Semmens, James Bernard, Curtin Univ, Perth, WA, Australia.},
DOI = {10.3389/fpubh.2018.00121},
Article-Number = {121},
Keywords = {technology; data; GIS; equity; ethics; omics; prevention; policy},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {tarun.weeramanthri@health.wa.gov.au},
Affiliations = {University of Western Australia; Queensland University of Technology
   (QUT); University of New South Wales Sydney; Curtin University},
Cited-References = {Bayer R, 2015, NEW ENGL J MED, V373, P499, DOI 10.1056/NEJMp1506241.
   Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523.
   Dowell SF, 2016, NATURE, V540, P189, DOI 10.1038/540189a.
   Khoury MJ, 2018, GENET MED, V20, P574, DOI 10.1038/gim.2017.211.
   Khoury MJ, 2016, AM J PREV MED, V50, P398, DOI 10.1016/j.amepre.2015.08.031.},
Number-of-Cited-References = {5},
Times-Cited = {41},
Unique-ID = {WOS:000431648500001},
}

@article{ WOS:000567565500007,
Author = {Kenney, Martha and Mamo, Laura},
Title = {The imaginary of precision public health},
Journal = {MEDICAL HUMANITIES},
Year = {2020},
Volume = {46},
Number = {3},
Pages = {192-203},
Month = {SEP},
Abstract = {In recent years, precision medicine has emerged as a charismatic name
   for a growing movement to revolutionise biomedicine by bringing genomic
   knowledge and sequencing to clinical care. Increasingly, the precision
   revolution has also included a new paradigm called precision public
   health-part genomics, part informatics, part public health and part
   biomedicine. Advocates of precision public health, such as Sue
   Desmond-Hellmann, argue that adopting cutting-edge big data approaches
   will allow public health actors to precisely target populations who
   experience the highest burden of disease and mortality, creating more
   equitable health futures. In this article we analyse precision public
   health as a sociotechnical imaginary, examining how calls for precision
   shape which public health efforts are seen as necessary and desirable.
   By comparing the rhetoric of precision public health to precision
   warfare, we find that precision prescribes technical solutions to
   complex problems and promises data-driven futures free of uncertainty,
   unnecessary suffering and inefficient use of resources. We look at how
   these imagined futures shape the present as they animate public health
   initiatives in the Global South funded by powerful philanthropic
   organisations, such as the Bill \& Melinda Gates Foundation, as well as
   local efforts to address cancer disparities in San Francisco. Through
   our analysis of the imaginary of precision public health, we identify an
   emerging tension between health equity goals and precision's technical
   solutions. Using large datasets to target interventions with greater
   precision, we argue, fails to address the upstream social determinants
   of health that give rise to health disparities worldwide. Therefore, we
   urge caution around investing in precision without a complementary
   commitment to addressing the social and economic conditions that are the
   root cause of health inequality.},
Type = {Article},
Affiliation = {Kenney, M (Corresponding Author), San Francisco State Univ, Women \& Gender Studies, San Francisco, CA 94132 USA.
   Kenney, Martha, San Francisco State Univ, Women \& Gender Studies, San Francisco, CA 94132 USA.
   Mamo, Laura, San Francisco State Univ, Hlth Equ Inst, San Francisco, CA 94132 USA.},
DOI = {10.1136/medhum-2018-011597},
Keywords = {public health; sociotechnical imaginaries; precision medicine; military
   metaphors},
Keywords-Plus = {BIG-DATA; MEDICINE; CANCER; EQUITY},
Research-Areas = {Arts \& Humanities - Other Topics},
Web-of-Science-Categories  = {Humanities, Multidisciplinary},
Author-Email = {mkenney@sfsu.edu},
Affiliations = {California State University System; San Francisco State University;
   California State University System; San Francisco State University},
Cited-References = {Ackerman Spencer, 2016, GUARDIAN, V21, P2016.
   Adams V, 2009, SUBJECTIVITY, V28, P246, DOI 10.1057/sub.2009.18.
   Ahmed Sara., 2004, SOC TEXT, V22, P117, DOI {[}DOI 10.1215/01642472-22-2\_79-117, 10.1215/01642472-22-2\_79-117].
   Ahuja Neel., 2016, BIOINSECURITIES DIS.
   {[}Anonymous], 2016, OBAMA DRONE CASUALTY.
   {[}Anonymous], 2010, HLTH PEOPL 2020.
   Archer Nicole, 2014, WOMEN PERFORMANCE J, V24, P186, DOI DOI 10.1080/0740770X.2014.976501.
   Ashworth Alan, 2017, SF CAN CITY WORKING.
   Bayer R, 2015, NEW ENGL J MED, V373, P499, DOI 10.1056/NEJMp1506241.
   Beck AF, 2017, HEALTH AFFAIR, V36, P999, DOI 10.1377/hlthaff.2016.1425.
   Birn AE, 2005, LANCET, V366, P514, DOI 10.1016/S0140-6736(05)66479-3.
   Braveman PA, 2011, AM J PUBLIC HEALTH, V101, pS149, DOI 10.2105/AJPH.2010.300062.
   Braveman PA, 2011, AM J PREV MED, V40, pS4, DOI 10.1016/j.amepre.2010.10.002.
   Bridges K.M., 2011, Reproducing Race.
   Chowkwanyun M, 2018, NEW ENGL J MED, V379, P1398, DOI 10.1056/NEJMp1806634.
   Clarke AdeleE., 1992, RIGHT TOOLS JOB WORK.
   Cohler Deborah, 2017, HOMEFRONT FRONTLINES, V29, P71.
   Cooper M, 2006, THEOR CULT SOC, V23, P113, DOI 10.1177/0263276406065121.
   Coote JH, 2015, LANCET, V385, P1617, DOI 10.1016/S0140-6736(15)60786-3.
   Correll John T, 2010, AIR FORCE MAG, P63.
   Daniel MG, 2016, AM J CLIN ONCOL-CANC, V39, P210, DOI 10.1097/COC.0000000000000251.
   Desmond-Hellmann Sue, 2016, TED TALK.
   Dillon L., 2018, HASTINGS ENV LAWJOUR, V24, P227.
   Dolley S, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00068.
   Dowell SF, 2016, NATURE, V540, P189, DOI 10.1038/540189a.
   Dumit J., 2012, Drugs for life: How pharmaceutical companies define our health.
   Erikson SL, 2018, MED ANTHROPOL Q, V32, P315, DOI 10.1111/maq.12440.
   Eysenbach G, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1157.
   FUJIMURA JH, 1988, SOC PROBL, V35, P261, DOI 10.1525/sp.1988.35.3.03a00050.
   Fujimura Joan., 1996, Crafting Science: A Sociohistory of the Quest for the Genetics of Cancer.
   Grant Elaine, 2012, HARVARD PUBLIC H SPR.
   Gregory D, 2014, RADICAL PHILOS, P7.
   Haraway D., 1991, SIMIANS CYBORGS WOMA.
   Haraway Donna, 1997, Modest\_Witness@Second\_Millennium.FemaleMan\_Meets \_OncoMouse:Feminism and Technoscience.
   Hiatt RA, 2018, HEALTH AFFAIR, V37, P54, DOI 10.1377/hlthaff.2017.1260.
   Hiatt Robert A, 2016, SAN FRANCISCO CANC I.
   Hu H, 2017, EPIDEMIOLOGY, V28, P759, DOI {[}10.1097/ede.0000000000000711, 10.1097/EDE.0000000000000711].
   Iqbal SA, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002333.
   Jain SarahS. Lochlann., 2006, INJURY POLITICS PROD.
   Jain SL, 2013, MALIGNANT: HOW CANCER BECOMES US, P1.
   Jasanoff S, 2009, MINERVA, V47, P119, DOI 10.1007/s11024-009-9124-4.
   Jasanoff Sheila., 2015, Dreamscapes of Modernity: Sociotechnical Imaginaries and the Fabrication of Power, DOI DOI 10.7208/CHICAGO/9780226276663.001.0001.
   Joint United Nations Programme on HIV/AIDS, 2011, COUNTD ZER GLLOB PLA.
   Juengst E, 2016, HASTINGS CENT REP, V46, P21, DOI 10.1002/hast.614.
   Kaplan C, 2006, AM QUART, V58, P693, DOI 10.1353/aq.2006.0061.
   Khoury MJ, 2016, AM J PREV MED, V50, P398, DOI 10.1016/j.amepre.2015.08.031.
   KRIEGER N, 1994, SOC SCI MED, V39, P887, DOI 10.1016/0277-9536(94)90202-X.
   Krieger Nancy., 2021, Ecosocial Theory, Embodied Truths, and the People's Health.
   Lakoff A, 2008, CULT ANTHROPOL, V23, P399, DOI 10.1111/j.1548-1360.2008.00013.x.
   Lazer D, 2014, SCIENCE, V343, P1203, DOI 10.1126/science.1248506.
   Lee Sandra Soo-Jin, 2011, GENETICS UNSETTLED, P164.
   Ventura DDL, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00033316.
   Livingston J., 2012, Improvising Medicine in an African Oncology Ward.
   MacKenzie Donald., 1990, Inventing Accuracy: A Historical Sociology of Nuclear Missile Guidance.
   Mamdani Mahmood., 2002, American anthropologist, V104, P766, DOI DOI 10.1525/AA.2002.104.3.766.
   Mamo L, 2014, SOC SCI MED, V101, P155, DOI 10.1016/j.socscimed.2013.11.028.
   Mamo Laura, 2010, 3 SHOTS PREVENTION H, V127.
   Marmot M., 2005, Social determinants of health, DOI 10.1093/acprof:oso/9780198565895.001.0001.
   Marshall BL, 2009, SCI CULT-UK, V18, P133, DOI 10.1080/09505430902885466.
   Martin Emily., 1994, Flexible Bodies: Tracking Immunity in American CultureFrom the Days of Polio to the Age of AIDS.
   McNeil M., 2017, The Handbook of Science and Technology Studies, P435.
   Meagher KM, 2017, ANNU REV GENOM HUM G, V18, P369, DOI 10.1146/annurev-genom-091416-035222.
   Mulrine Anna., 2008, Air Force Magazine, V91, P44.
   Nixon Rob, 2011, SLOW VIOLENCE ENV PO.
   Patton Cindy., 2002, Globalizing AIDS.
   Phillips KA, 2009, CANCER-AM CANCER SOC, V115, P5166, DOI 10.1002/cncr.24574.
   Precision Public Health Summit, 2016, SUMM RPE JUN 6 7 201.
   Ramaswami R, 2018, ANNU REV PUBL HEALTH, V39, P153, DOI 10.1146/annurev-publhealth-040617-014158.
   Salathé M, 2016, J INFECT DIS, V214, pS399, DOI 10.1093/infdis/jiw281.
   Salathé M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002616.
   Scott James C., 1998, SEEING STATE CERTAIN.
   Shane Scott., 2011, The New York Times.
   Shostak S, 2003, SOC SCI MED, V56, P2327, DOI 10.1016/S0277-9536(02)00231-9.
   Shostak Sara., 2010, Biomedicalization: Technoscience, Health, P242.
   Sontag S., 1978, ILLNESS METAPHOR.
   Tekola-Ayele F, 2015, PUBLIC HEALTH GENOM, V18, P242, DOI 10.1159/000433518.
   Trosman JR, 2015, J NATL COMPR CANC NE, V13, P311, DOI 10.6004/jnccn.2015.0043.
   Tutton Richard., 2014, Genomics and the Reimagining of Personalized Medicine.
   UCSF, 2018, MISS VAL.
   Weeramanthri TS, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00121.
   Wilcox LaurenB., 2015, Bodies of Violence: Theorizing Embodied Subjects in International Relations.
   Woolf SH, 2017, HEALTH AFFAIR, V36, P984, DOI 10.1377/hlthaff.2017.0197.
   Yamada T, 2009, LANCET, V373, P2195, DOI 10.1016/S0140-6736(09)61181-8.},
Number-of-Cited-References = {83},
Times-Cited = {7},
Unique-ID = {WOS:000567565500007},
}

@article{ WOS:000594752100001,
Author = {Juengst, Eric T. and Van Rie, Annelies},
Title = {Transparency, trust, and community welfare: towards a precision public
   health ethics framework for the genomics era},
Journal = {GENOME MEDICINE},
Year = {2020},
Volume = {12},
Number = {1},
Month = {NOV 20},
Abstract = {Infectious disease control is experiencing a paradigm shift, as pathogen
   sequencing technologies and digital applications are increasingly
   implemented for control of diseases such as tuberculosis, Ebola, and
   COVID-19. A new ethical framework should be a critical part of this
   emerging paradigm to ensure that the benefit of precision public health
   interventions based on advances in genomics research is not outweighed
   by the risks they pose to individuals, families, and vulnerable segments
   of the population. We suggest that the ethical framework guiding
   practice in this domain combines standard precepts from public health
   ethics with emerging ethics principles from precision medicine.},
Type = {Editorial Material},
Affiliation = {Juengst, ET (Corresponding Author), Univ N Carolina, Ctr Bioeth, Sch Med, 333 MacNider Hall, Chapel Hill, NC 27599 USA.
   Juengst, Eric T., Univ N Carolina, Ctr Bioeth, Sch Med, 333 MacNider Hall, Chapel Hill, NC 27599 USA.
   Van Rie, Annelies, Univ Antwerp, Fac Med, Family Med \& Populat Hlth, Campus Drie Eiken R232,Univ Pl 1, B-2610 Antwerp, Belgium.},
DOI = {10.1186/s13073-020-00800-y},
Article-Number = {98},
Keywords = {Pathogen sequencing; Genomic epidemiology; Precision public health;
   Ethics},
Research-Areas = {Genetics \& Heredity},
Web-of-Science-Categories  = {Genetics \& Heredity},
Author-Email = {ejuengst@med.unc.edu},
Affiliations = {University of North Carolina School of Medicine; University of North
   Carolina; University of North Carolina Chapel Hill; University of
   Antwerp},
Cited-References = {Childress JF, 2002, J LAW MED ETHICS, V30, P170, DOI 10.1111/j.1748-720X.2002.tb00384.x.
   Dawson L, 2020, J INFECT DIS, V222, P1997, DOI 10.1093/infdis/jiaa107.
   Jackson C, 2019, BMC MED ETHICS, V20, DOI 10.1186/s12910-019-0380-z.
   Johnson SB, 2019, NAT REV GENET, V20, P313, DOI 10.1038/s41576-019-0109-3.
   Kao AC, 2018, AMA ETHICS J, V20, pE793.
   Ladner JT, 2019, NAT MED, V25, P206, DOI 10.1038/s41591-019-0345-2.
   Meagher KM, 2017, ANNU REV GENOM HUM G, V18, P369, DOI 10.1146/annurev-genom-091416-035222.
   Milne R, 2020, GENET MED, V22, P1464, DOI 10.1038/s41436-020-0861-y.
   Molldrem S, 2020, AM J BIOETHICS, V20, P10, DOI 10.1080/15265161.2020.1806373.
   Weeramanthri TS, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00121.},
Number-of-Cited-References = {10},
Times-Cited = {13},
Unique-ID = {WOS:000594752100001},
}

@article{ WOS:001101994000002,
Author = {Choate, Sara A.},
Title = {A Call for Course Correction: Applying an Antiracism Lens to Precision
   Public Health},
Journal = {AMERICAN JOURNAL OF PUBLIC HEALTH},
Year = {2023},
Volume = {113},
Number = {11},
Pages = {1141-1142},
Month = {NOV},
Type = {Editorial Material},
Affiliation = {Choate, SA (Corresponding Author), Univ Louisville, Dept Hlth Promot \& Behav Sci, Sch Publ Hlth \& Informat Sci, 485 E Gray St,Suite 203, Louisville, KY 40202 USA.
   Choate, Sara A., Univ Louisville, Dept Hlth Promot \& Behav Sci, Sch Publ Hlth \& Informat Sci, 485 E Gray St,Suite 203, Louisville, KY 40202 USA.},
DOI = {10.2105/AJPH.2023.307424},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {sara.choate@louisville.edu},
Affiliations = {University of Louisville},
Cited-References = {Akpan AM, 2013, Seattle J Soc Justice, V11.
   Bayer R, 2015, NEW ENGL J MED, V373, P499, DOI 10.1056/NEJMp1506241.
   Charlton J., 1998, Nothing about us without us: Disability oppression and empowerment, DOI DOI 10.1525/J.CTT1PNQN9.
   Crawford Kate, 2013, HARVARD BUSINESS REV.
   Dandar V, 2022, The power of collective action: assessing and advancing diversity, equity, and inclusion efforts at AAMC medical schools.
   Dawes DE., 2020, POLITICAL DETERMINAN, DOI {[}10.56021/9781421437903, DOI 10.56021/9781421437903].
   Eylem O, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-08964-3.
   Garfield R., 2019, UNINSURED ACA PRIMER.
   Hausmann LRM, 2008, MED CARE, V46, P905, DOI 10.1097/MLR.0b013e3181792562.
   Johnson-Mallard V, 2019, HEALTH EQUITY, V3, P297, DOI 10.1089/heq.2019.0026.
   Khoury M.J., 2015, Precision public health and precision medicine: two peas in a pod.
   Minkler M, 2012, Policy Link.
   National Archives and Records Administration, 2015, Fact sheet: President Obama's Precision Medicine initiative.
   Weeramanthri TS, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00121.
   Yearby R, 2020, J LAW MED ETHICS, V48, P518, DOI 10.1177/1073110520958876.},
Number-of-Cited-References = {15},
Times-Cited = {0},
Unique-ID = {WOS:001101994000002},
}

@article{ WOS:000642901000002,
Author = {Khoury, Muin J. and Holt, Kathryn E.},
Title = {The impact of genomics on precision public health: beyond the pandemic},
Journal = {GENOME MEDICINE},
Year = {2021},
Volume = {13},
Number = {1},
Month = {APR 23},
Type = {Editorial Material},
Affiliation = {Khoury, MJ (Corresponding Author), Ctr Dis Control \& Prevent, Off Genom \& Precis Publ Hlth, Atlanta, GA 30333 USA.
   Holt, KE (Corresponding Author), Monash Univ, Melbourne, Vic, Australia.
   Khoury, Muin J., Ctr Dis Control \& Prevent, Off Genom \& Precis Publ Hlth, Atlanta, GA 30333 USA.
   Holt, Kathryn E., Monash Univ, Melbourne, Vic, Australia.
   Holt, Kathryn E., London Sch Hyg \& Trop Med, London, England.},
DOI = {10.1186/s13073-021-00886-y},
Article-Number = {67},
Keywords-Plus = {POLYGENIC RISK SCORES},
Research-Areas = {Genetics \& Heredity},
Web-of-Science-Categories  = {Genetics \& Heredity},
Author-Email = {muk1@cdc.gov
   kathryn.holt@monash.edu},
Affiliations = {Centers for Disease Control \& Prevention - USA; Monash University;
   University of London; London School of Hygiene \& Tropical Medicine},
Cited-References = {Abul-Husn NS, 2021, GENOME MED, V13, DOI 10.1186/s13073-021-00832-y.
   Arredondo-Alonso S, 2021, GENOME MED, V13, DOI 10.1186/s13073-020-00825-3.
   Aschenbrenner AC, 2021, GENOME MED, V13, DOI 10.1186/s13073-020-00823-5.
   Baker DJ, 2021, GENOME MED, V13, DOI 10.1186/s13073-021-00839-5.
   Caban AB, 2020, GENOME MED, V12, DOI 10.1186/s13073-020-00798-3.
   Bylstra Y, 2021, GENOME MED, V13, DOI 10.1186/s13073-020-00819-1.
   Du PlessisL., 2021, SCIENCE, V371, P708.
   Gardy JL, 2018, NAT REV GENET, V19, P9, DOI 10.1038/nrg.2017.88.
   Geller G, 2020, GENOME MED, V12, DOI 10.1186/s13073-020-00792-9.
   Green RF, 2019, GENET MED, V21, P28, DOI 10.1038/s41436-018-0028-2.
   Isgut M, 2021, GENOME MED, V13, DOI 10.1186/s13073-021-00828-8.
   Juengst ET, 2020, GENOME MED, V12, DOI 10.1186/s13073-020-00800-y.
   Kachuri L, 2020, GENOME MED, V12, DOI 10.1186/s13073-020-00790-x.
   Khoury MJ, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003373.
   Khoury MJ, 2012, AM J PUBLIC HEALTH, V102, P34, DOI 10.2105/AJPH.2011.300299.
   Knight GM, 2021, ELIFE, V10, DOI 10.7554/eLife.64139.
   Lewis ACF, 2021, GENOME MED, V13, DOI 10.1186/s13073-021-00829-7.
   Lucey M, 2021, CLIN INFECT DIS, V72, pE727, DOI 10.1093/cid/ciaa1433.
   Rasmussen SA, 2020, JAMA-J AM MED ASSOC, V324, P933, DOI 10.1001/jama.2020.14992.
   Stranneheim H, 2021, GENOME MED, V13, DOI 10.1186/s13073-021-00855-5.},
Number-of-Cited-References = {20},
Times-Cited = {16},
Unique-ID = {WOS:000642901000002},
}

@article{ WOS:000786587002421,
Author = {Parker, Richard and Shearer, Jessica and Spencer, Jennifer and Wicks,
   Benjamin and Taylor, Adam and Dukes, Rachel and Rowe, Ian},
Title = {Risk factors for liver disease cluster geographically: precision public
   health analysis of a UK city},
Journal = {JOURNAL OF HEPATOLOGY},
Year = {2020},
Volume = {73},
Number = {1},
Meeting = {SAT338},
Pages = {S823-S824},
Month = {AUG},
Type = {Meeting Abstract},
Affiliation = {Parker, Richard; Shearer, Jessica; Wicks, Benjamin; Rowe, Ian, Leeds Teaching Hosp NHS Trust, Leeds Liver Unit, Leeds, W Yorkshire, England.
   Parker, Richard, St Jamess Univ Leeds, Leeds Inst Med Res, Leeds, W Yorkshire, England.
   Shearer, Jessica; Rowe, Ian, Univ Leeds, Leeds Inst Data Anal, Leeds, W Yorkshire, England.
   Spencer, Jennifer, Leeds Teaching Hosp NHS Trust, Blood Sci, Leeds, W Yorkshire, England.
   Taylor, Adam, Leeds CCG, Adults \& Hlth Directorate, Leeds, W Yorkshire, England.
   Dukes, Rachel, Leeds City Council, Adults \& Hlth Directorate, Leeds, W Yorkshire, England.},
Research-Areas = {Gastroenterology \& Hepatology},
Web-of-Science-Categories  = {Gastroenterology \& Hepatology},
Author-Email = {richardparker@nhs.net},
Affiliations = {University of Leeds; Saint James's University Hospital; University of
   Leeds; University of Leeds},
Number-of-Cited-References = {0},
Times-Cited = {0},
Unique-ID = {WOS:000786587002421},
}

@article{ WOS:001019605700011,
Author = {Schmidt, Silke},
Title = {Precision Public Health Opportunity: Heat-Associated Mortality Greater
   among Pilgrims during Hajj},
Journal = {ENVIRONMENTAL HEALTH PERSPECTIVES},
Year = {2023},
Volume = {131},
Number = {6},
Month = {JUN},
Type = {Editorial Material},
DOI = {10.1289/EHP13055},
Article-Number = {064001},
Keywords-Plus = {AMBIENT-TEMPERATURE; CLIMATE},
Research-Areas = {Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health; Toxicology},
Web-of-Science-Categories  = {Environmental Sciences; Public, Environmental \& Occupational Health;
   Toxicology},
Cited-References = {Alahmad B, 2023, CIRCULATION, V147, P35, DOI 10.1161/CIRCULATIONAHA.122.061832.
   Alahmad B, 2020, SCI TOTAL ENVIRON, V732, DOI 10.1016/j.scitotenv.2020.139289.
   Almuzaini Y, 2022, FRONT PUBLIC HEALTH, V10, DOI 10.3389/fpubh.2022.957576.
   Arbuthnott K, 2016, ENVIRON HEALTH-GLOB, V15, DOI 10.1186/s12940-016-0102-7.
   Bollyky TJ, 2022, POP STUD-J DEMOG, V76, P63, DOI 10.1080/00324728.2022.2034919.
   Cheng J, 2019, INT J BIOMETEOROL, V63, P1099, DOI 10.1007/s00484-019-01716-y.
   Gasparrini A, 2015, LANCET, V386, P369, DOI 10.1016/S0140-6736(14)62114-0.
   Guo YM, 2014, EPIDEMIOLOGY, V25, P781, DOI 10.1097/EDE.0000000000000165.
   Hajat S, 2023, LANCET PLANET HEALTH, V7, pE282, DOI 10.1016/S2542-5196(23)00045-1.
   Keatinge WR, 2000, BRIT MED J, V321, P670, DOI 10.1136/bmj.321.7262.670.
   Kidd SA, 2021, LANCET, V397, P1693, DOI 10.1016/S0140-6736(21)00834-5.
   Part C, 2022, ENVIRON RES, V212, DOI 10.1016/j.envres.2022.113596.
   Yezli S, 2023, ENVIRON HEALTH PERSP, V131, DOI 10.1289/EHP9838.
   Yezli S, 2023, REV ENVIRON HEALTH, V38, P33, DOI 10.1515/reveh-2021-0097.
   Yin Q, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12663-y.},
Number-of-Cited-References = {15},
Times-Cited = {0},
Unique-ID = {WOS:001019605700011},
}

@article{ WOS:000478079000511,
Author = {Cistola, Andrew S.},
Title = {Applying Precision Public Health Tools to Address Health Disparities
   Among African-Americans in Alachua County, Florida},
Journal = {CIRCULATION},
Year = {2019},
Volume = {139},
Number = {1},
Meeting = {P081},
Type = {Meeting Abstract},
Affiliation = {Cistola, Andrew S., Univ Florida, Gainesville, FL USA.},
DOI = {10.1161/circ.139.suppl\_1.P081},
Research-Areas = {Cardiovascular System \& Cardiology},
Web-of-Science-Categories  = {Cardiac \& Cardiovascular Systems; Peripheral Vascular Disease},
Affiliations = {State University System of Florida; University of Florida},
Number-of-Cited-References = {0},
Times-Cited = {0},
Unique-ID = {WOS:000478079000511},
}

@article{ WOS:000486144000030,
Author = {Allen, Caitlin G. and Fohner, Alison E. and Landry, Latrice and Paul,
   Jean L. and Smith, Samuel G. and Turbitt, Erin and Roberts, Megan C.},
Title = {Perspectives From Early Career Investigators Who Are ``Staying in the
   Game{''} of Precision Public Health Research},
Journal = {AMERICAN JOURNAL OF PUBLIC HEALTH},
Year = {2019},
Volume = {109},
Number = {9},
Pages = {1186-1187},
Month = {SEP},
Type = {Editorial Material},
Affiliation = {Allen, CG (Corresponding Author), Emory Univ, Dept Behav Sci \& Hlth Educ, 1518 Clifton Rd NE, Atlanta, GA 30322 USA.
   Allen, Caitlin G., Emory Univ, Rollins Sch Publ Hlth, Dept Behav Sci \& Hlth Educ, Atlanta, GA 30322 USA.
   Fohner, Alison E., Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA.
   Landry, Latrice, Harvard Sch Publ Hlth, Cambridge, MA USA.
   Paul, Jean L., Med Univ Innsbruck, Dept Psychiat Psychotherapy \& Psychosomat, Innsbruck, Austria.
   Smith, Samuel G., Univ Leeds, Leeds Inst Hlth Sci, Leeds, W Yorkshire, England.
   Turbitt, Erin, Univ Technol Sydney, Grad Sch Hlth, Ultimo, Australia.
   Roberts, Megan C., Univ N Carolina, Eshelman Sch Pharm, Div Pharmaceut Outcomes \& Policy, Chapel Hill, NC 27515 USA.},
DOI = {10.2105/AJPH.2019.305199},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {calle27@emory.edu},
Affiliations = {Emory University; Rollins School Public Health; University of
   Washington; University of Washington Seattle; Harvard University;
   Harvard T.H. Chan School of Public Health; Medical University of
   Innsbruck; University of Leeds; University of Technology Sydney;
   University of North Carolina; University of North Carolina Chapel Hill},
Cited-References = {Amobi C, 2019, ALL US RES IS RESTOR.
   Chowkwanyun M, 2018, NEW ENGL J MED, V379, P1398, DOI 10.1056/NEJMp1806634.
   Khoury MJ, 2016, JAMA-J AM MED ASSOC, V316, P1357, DOI 10.1001/jama.2016.12260.
   Krieger N, 2001, INT J EPIDEMIOL, V30, P668, DOI 10.1093/ije/30.4.668.
   Landry LG, 2018, HEALTH AFFAIR, V37, P780, DOI 10.1377/hlthaff.2017.1595.
   NIH, 2015, WHAT IS PREC MED.
   Taylor-Robinson D, 2018, INT J EPIDEMIOL.},
Number-of-Cited-References = {7},
Times-Cited = {5},
Unique-ID = {WOS:000486144000030},
}

@article{ WOS:000767891300029,
Author = {Prasad, D. S. and Kabir, Zubair},
Title = {Editorial Comment: Focus on the Global Burden of IHD from big data to
   precision public health},
Journal = {EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY},
Year = {2022},
Volume = {29},
Number = {2},
Pages = {417-419},
Month = {MAR 11},
Type = {Editorial Material},
Affiliation = {Prasad, DS (Corresponding Author), Sudhir Heart Ctr, Main Rd, Berhampur 760002, Odisha, India.
   Prasad, D. S., Sudhir Heart Ctr, Main Rd, Berhampur 760002, Odisha, India.
   Kabir, Zubair, Univ Coll Cork, Sch Publ Hlth, Publ Hlth \& Epidemiol, Western Rd, Cork T12 XF62, Ireland.},
DOI = {10.1093/eurjpc/zwac014},
Research-Areas = {Cardiovascular System \& Cardiology},
Web-of-Science-Categories  = {Cardiac \& Cardiovascular Systems},
Author-Email = {drdsprasad@gmail.com},
Affiliations = {University College Cork},
Cited-References = {Abbafati C, 2020, LANCET, V396, P1135, DOI 10.1016/S0140-6736(20)31404-5.
   Finegold JA, 2013, INT J CARDIOL, V168, P934, DOI 10.1016/j.ijcard.2012.10.046.
   Fuster V, 2014, J AM COLL CARDIOL, V64, P520, DOI 10.1016/j.jacc.2014.06.1151.
   Khan MAB, 2020, CUREUS J MED SCIENCE, V12, DOI 10.7759/cureus.9349.
   Marasigan V, 2020, INT J CARDIOL, V310, P159, DOI 10.1016/j.ijcard.2020.03.067.
   Prabhakaran D, 2018, LANCET GLOB HEALTH, V6, pE1339, DOI 10.1016/S2214-109X(18)30407-8.
   Prasad D.S., 2010, CVD Prev. Control, V5, P115.
   Roth GA, 2020, J AM COLL CARDIOL, V76, P2982, DOI 10.1016/j.jacc.2020.11.010.
   Safiri S., 2022, EUR J PREV CARDIOL, V29.
   Xavier Denis, 2008, Indian Heart J, V60, pB29.},
Number-of-Cited-References = {10},
Times-Cited = {1},
Unique-ID = {WOS:000767891300029},
}

@article{ WOS:000639017000022,
Author = {Sales, Chloe and Kim, Yeuen and Kim, Gloria and Lin, Bryant and
   Palaniappan, Latha},
Title = {Precision Public Health Matters: An International Assessment of
   Communication, Preparedness, and Coordination for Successful COVID-19
   Responses},
Journal = {AMERICAN JOURNAL OF PUBLIC HEALTH},
Year = {2021},
Volume = {111},
Number = {3},
Pages = {392-394},
Month = {MAR},
Type = {Editorial Material},
Affiliation = {Sales, C (Corresponding Author), Stanford Univ, Sch Med, Ctr Asian Hlth Res \& Educ, 1265 Welch Rd, Palo Alto, CA 94305 USA.
   Sales, Chloe, Stanford Univ, Ctr Asian Hlth Res \& Educ, Sch Med, Stanford, CA 94305 USA.
   Kim, Yeuen; Lin, Bryant; Palaniappan, Latha, Stanford Univ, Dept Med, Div Primary Care \& Populat Hlth, Sch Med, Stanford, CA 94305 USA.
   Kim, Gloria, Stanford Univ, Dept Cardiovasc Med, Div Primary Care \& Populat Hlth, Sch Med, Stanford, CA 94305 USA.},
DOI = {10.2105/AJPH.2020.306129},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {csales@stanford.edu},
Affiliations = {Stanford University; Stanford University; Stanford University},
Cited-References = {Centers for Disease Control and Prevention, CDC COVID DAT TRACK.
   Cousins S, 2020, LANCET, V395, P1474, DOI 10.1016/S0140-6736(20)31097-7.
   Evanega S., Coronavirus misinformation: quantifying sources andt hemes in the COVID-19'infodemic.
   Office of Governor Newsom, 2020, GOV NEWS TAK EM ACT.
   Palaniappan L., 2020, STANF INT COVID 19 C.
   Palomino J., WHY TESTING CORONAVI.
   Rasmussen SA, 2020, JAMA-J AM MED ASSOC, V324, P933, DOI 10.1001/jama.2020.14992.},
Number-of-Cited-References = {7},
Times-Cited = {3},
Unique-ID = {WOS:000639017000022},
}

@article{ WOS:000580647800290,
Author = {Gonzalez, Evelyn T. and Min Nguyen and Lynch, Shannon},
Title = {Application of precision public health approaches to maximize limited
   resources for community-based liver cancer prevention educational
   sessions},
Journal = {CANCER EPIDEMIOLOGY BIOMARKERS \& PREVENTION},
Year = {2020},
Volume = {29},
Number = {6, 2},
Meeting = {C056},
Month = {JUN},
Type = {Meeting Abstract},
Affiliation = {Gonzalez, Evelyn T.; Min Nguyen; Lynch, Shannon, Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA.},
DOI = {10.1158/1538-7755.DISP19-C056},
Research-Areas = {Oncology; Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Oncology; Public, Environmental \& Occupational Health},
Affiliations = {Fox Chase Cancer Center},
Number-of-Cited-References = {0},
Times-Cited = {0},
Unique-ID = {WOS:000580647800290},
}

@article{ WOS:000507364502094,
Author = {Hulland, Erin and Wiens, Kirsten and Shirude, Shreya and Bell, Beth and
   Rabinowitz, Peter and Wasserheit, Judith and Weiss, Daniel and Hay,
   Simon and Pigott, David},
Title = {PRECISION PUBLIC HEALTH AND PANDEMIC PREPAREDNESS: QUANTIFYING TRAVEL
   TIME TO HEALTH CARE AND LOCATIONS AT RISK FOR PATHOGEN TRANSMISSION},
Journal = {AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE},
Year = {2019},
Volume = {101},
Number = {5},
Meeting = {94},
Pages = {29-30},
Type = {Meeting Abstract},
Affiliation = {Hulland, Erin; Wiens, Kirsten; Shirude, Shreya; Hay, Simon; Pigott, David, Inst Hlth Metr \& Evaluat, Seattle, WA USA.
   Bell, Beth; Rabinowitz, Peter; Wasserheit, Judith, Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.
   Rabinowitz, Peter, Univ Washington, Sch Publ Hlth, Seattle, WA 98195 USA.
   Weiss, Daniel, Nuffield Dept Med, Big Data Inst, Oxford, England.},
Research-Areas = {Public, Environmental \& Occupational Health; Tropical Medicine},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health; Tropical Medicine},
Affiliations = {Institute for Health Metrics \& Evaluation; University of Washington;
   University of Washington Seattle; University of Washington; University
   of Washington Seattle; University of Oxford},
Number-of-Cited-References = {0},
Times-Cited = {0},
Unique-ID = {WOS:000507364502094},
}

@article{ WOS:000853674500039,
Author = {An, Jisun and Kwak, Haewoon and Qureshi, Hanya M. and Weber, Ingmar},
Title = {Precision Public Health Campaign: Delivering Persuasive Messages to
   Relevant Segments Through Targeted Advertisements on Social Media (vol
   5, e22313, 2021)},
Journal = {JMIR FORMATIVE RESEARCH},
Year = {2021},
Volume = {5},
Number = {10},
Month = {OCT},
Type = {Correction},
Affiliation = {An, JS (Corresponding Author), Singapore Management Univ, Sch Comp \& Informat Syst, 80 Stamford Rd, Singapore 178902, Singapore.
   An, Jisun; Kwak, Haewoon, Singapore Management Univ, Sch Comp \& Informat Syst, 80 Stamford Rd, Singapore 178902, Singapore.
   Qureshi, Hanya M., Yale Univ, Yale Sch Med, New Haven, CT USA.
   Weber, Ingmar, Hamad Bin Khalifa Univ, Qatar Comp Res Inst, Doha, Qatar.},
DOI = {10.2196/33922},
Article-Number = {e33922},
Research-Areas = {Health Care Sciences \& Services; Medical Informatics},
Web-of-Science-Categories  = {Health Care Sciences \& Services; Medical Informatics},
Author-Email = {an.jisun.221@gmail.com},
Affiliations = {Singapore Management University; Yale University; Qatar Foundation (QF);
   Hamad Bin Khalifa University-Qatar; Qatar Computing Research Institute},
Cited-References = {An JS, 2021, JMIR FORM RES, V5, DOI 10.2196/22313.},
Number-of-Cited-References = {1},
Times-Cited = {0},
Unique-ID = {WOS:000853674500039},
}

@article{ WOS:000853674000040,
Author = {An, Jisun and Kwak, Haewoon and Qureshi, Hanya M. and Weber, Ingmar},
Title = {Precision Public Health Campaign: Delivering Persuasive Messages to
   Relevant Segments Through Targeted Advertisements on Social Media},
Journal = {JMIR FORMATIVE RESEARCH},
Year = {2021},
Volume = {5},
Number = {9},
Month = {SEP},
Abstract = {Although established marketing techniques have been applied to design
   more effective health campaigns, more often than not, the same message
   is broadcasted to large populations, irrespective of unique
   characteristics. As individual digital device use has increased, so have
   individual digital footprints, creating potential opportunities for
   targeted digital health interventions. We propose a novel precision
   public health campaign framework to structure and standardize the
   process of designing and delivering tailored health messages to target
   particular population segments using social media-targeted advertising
   tools. Our framework consists of five stages: defining a campaign goal,
   priority audience, and evaluation metrics; splitting the target audience
   into smaller segments; tailoring the message for each segment and
   conducting a pilot test; running the health campaign formally; and
   evaluating the performance of the campaigns. We have demonstrated how
   the framework works through 2 case studies. The precision public health
   campaign framework has the potential to support higher population uptake
   and engagement rates by encouraging a more standardized, concise,
   efficient, and targeted approach to public health campaign development.},
Type = {Article},
Affiliation = {An, JS (Corresponding Author), Singapore Management Univ, Sch Comp \& Informat Syst, 80 Stamford Rd, Singapore 178902, Singapore.
   An, Jisun; Kwak, Haewoon, Singapore Management Univ, Sch Comp \& Informat Syst, 80 Stamford Rd, Singapore 178902, Singapore.
   Qureshi, Hanya M., Yale Univ, Yale Sch Med, New Haven, CT USA.
   Weber, Ingmar, Hamad Bin Khalifa Univ, Qatar Comp Res Inst, Doha, Qatar.},
DOI = {10.2196/22313},
Article-Number = {e22313},
Keywords = {precision public health; tailored health communication; social media
   advertising; Facebook advertising; public health campaigns;
   effectiveness of campaigns; public health; advertising},
Keywords-Plus = {MODEL; INTERVENTIONS; CANCER; ADS},
Research-Areas = {Health Care Sciences \& Services; Medical Informatics},
Web-of-Science-Categories  = {Health Care Sciences \& Services; Medical Informatics},
Author-Email = {jisun.an@acm.org},
Affiliations = {Singapore Management University; Yale University; Qatar Foundation (QF);
   Hamad Bin Khalifa University-Qatar; Qatar Computing Research Institute},
Cited-References = {Ahuja RD, 2007, J CONSUM MARK, V24, P151, DOI 10.1108/07363760710746157.
   {[}Anonymous], 2013, Facebook reports fourth quarter and full year 2012 results.
   {[}Anonymous], DYNAMIC CREATIVE.
   {[}Anonymous], Facebook Ad Benchmarks for YOUR Industry.
   {[}Anonymous], 2022, Who Should and Who Should NOT Get Vaccinated.
   Araújo M, 2017, PROCEEDINGS OF THE 2017 ACM WEB SCIENCE CONFERENCE (WEBSCI `17), P253, DOI 10.1145/3091478.3091513.
   Asbury LD, 2008, AM J PREV MED, V34, pS183, DOI 10.1016/j.amepre.2008.03.010.
   Atkin C.K., 2001, Public communication campaigns, P125.
   Brennan R, 2010, J MARKET MANAG-UK, V26, P635, DOI 10.1080/0267257X.2010.481177.
   Carrascosa J, 2015, P 11 ACM C EM NETW E, P1, DOI 10.1145/2716281.2836098.
   Carter-Harris L, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.5502.
   Dunn AG, 2018, NPJ DIGIT MED, V1, DOI 10.1038/s41746-018-0054-0.
   Evans WD, 2008, J HEALTH COMMUN, V13, P721, DOI 10.1080/10810730802487364.
   Fatehkia M, 2018, WORLD DEV, V107, P189, DOI 10.1016/j.worlddev.2018.03.007.
   Gilligan C, 2014, JMIR RES PROTOC, V3, DOI 10.2196/resprot.3317.
   Grunig J.E., 1989, Information campaigns: Balancing social values and social change, P199.
   Harris JK, 2013, AM J PUBLIC HEALTH, V103, P1700, DOI 10.2105/AJPH.2012.301166.
   Hollis C, 2017, J CHILD PSYCHOL PSYC, V58, P474, DOI 10.1111/jcpp.12663.
   Hopfer S, 2012, PREV SCI, V13, P173, DOI 10.1007/s11121-011-0254-1.
   How Facebook, TWITT SOC MED MAK MO.
   Johansson Olof, 2015, Internet Interventions, V2, P137, DOI 10.1016/j.invent.2015.02.006.
   Knowles SE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084323.
   Korolova A., 2010, Proceedings 2010 10th IEEE International Conference on Data Mining Workshops (ICDMW 2010), P474, DOI 10.1109/ICDMW.2010.137.
   KOTLER P, 1971, J MARKETING, V35, P3, DOI 10.2307/1249783.
   Kotler P, 2011, MARK MANAG, V14th, P1.
   Kreuter MW, 2003, HEALTH EDUC BEHAV, V30, P133, DOI 10.1177/1090198102251021.
   Lane TS, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4359.
   Larkey LK, 2010, J HEALTH COMMUN, V15, P114, DOI 10.1080/10810730903528017.
   LEFEBVRE RC, 1988, HEALTH EDUC QUART, V15, P299.
   Lewis RA, 2014, QME-QUANT MARK ECON, V12, P235, DOI 10.1007/s11129-014-9146-6.
   Lister C, 2015, AM J PUBLIC HEALTH, V105, P2245, DOI 10.2105/AJPH.2015.302669.
   Lustria MLA, 2009, PATIENT EDUC COUNS, V74, P156, DOI 10.1016/j.pec.2008.08.023.
   Matz SC, 2017, P NATL ACAD SCI USA, V114, P12714, DOI 10.1073/pnas.1710966114.
   Mejova Y, 2018, JMIR PUBLIC HLTH SUR, V4, P15, DOI 10.2196/publichealth.7217.
   Murphy ST, 2013, J COMMUN, V63, P116, DOI 10.1111/jcom.12007.
   Pedersen ER, 2015, JMIR RES PROTOC, V4, DOI 10.2196/resprot.3996.
   Platt Tevah, 2016, JMIR Public Health Surveill, V2, pe27, DOI 10.2196/publichealth.5623.
   Prescott TL, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.5602.
   Ramo DE, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.1878.
   Reaves AC, 2013, AM J MED GENET A, V161A, P951, DOI 10.1002/ajmg.a.35903.
   Reiter Paul L, 2017, JMIR Public Health Surveill, V3, pe33, DOI 10.2196/publichealth.7545.
   Ribeiro Filip N., 2018, P 12 INT AAAI C WEB.
   Serrano WC, 2016, JAMA DERMATOL, V152, P101, DOI 10.1001/jamadermatol.2015.3998.
   Slater M D, 1996, J Health Commun, V1, P267, DOI 10.1080/108107396128059.
   Slater MD, 1999, J STUD ALCOHOL, V60, P667, DOI 10.15288/jsa.1999.60.667.
   Smith RA, 2005, CA-CANCER J CLIN, V55, P31, DOI 10.3322/canjclin.55.1.31.
   Stewart DW, 2009, J BUS RES, V62, P636, DOI 10.1016/j.jbusres.2008.02.005.
   Subasinghe AK, 2016, JMIR RES PROTOC, V5, P207, DOI 10.2196/resprot.5679.
   Whitaker C, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.7071.
   Wolff LS, 2010, J HEALTH COMMUN, V15, P167, DOI 10.1080/10810730903528041.
   Wu YY, 2015, P NATL ACAD SCI USA, V112, P1036, DOI 10.1073/pnas.1418680112.
   Yom-Tov E, 2018, NPJ DIGIT MED, V1, DOI 10.1038/s41746-018-0031-7.
   Zhang BB, 2020, POLIT SCI RES METH, V8, P558, DOI 10.1017/psrm.2018.49.},
Number-of-Cited-References = {53},
Times-Cited = {10},
Unique-ID = {WOS:000853674000040},
}

@article{ WOS:000434409000002,
Author = {Khoury, Muin J. and Bowen, M. Scott and Clyne, Mindy and Dotson, W.
   David and Gwinn, Marta L. and Green, Ridgely Fisk and Kolor, Katherine
   and Rodriguez, Juan L. and Wulf, Anja and Yu, Wei},
Title = {From public health genomics to precision public health: a 20-year
   journey},
Journal = {GENETICS IN MEDICINE},
Year = {2018},
Volume = {20},
Number = {6},
Pages = {574-582},
Month = {JUN},
Abstract = {In this paper, we review the evolution of the field of public health
   genomics in the United States in the past two decades. Public health
   genomics focuses on effective and responsible translation of genomic
   science into population health benefits. We discuss the relationship of
   the field to the core public health functions and essential services,
   review its evidentiary foundation, and provide examples of current US
   public health priorities and applications. We cite examples of
   publications to illustrate how Genetics in Medicine reflected the
   evolution of the field. We also reflect on how public-health genomics is
   contributing to the emergence of ``precision public health{''} with
   near-term opportunities offered by the US Precision Medicine (AllofUs)
   Initiative.},
Type = {Review},
Affiliation = {Khoury, MJ (Corresponding Author), Ctr Dis Control \& Prevent, Off Publ Hlth Gen, Atlanta, GA USA.
   Khoury, Muin J.; Bowen, M. Scott; Dotson, W. David; Green, Ridgely Fisk; Kolor, Katherine; Wulf, Anja; Yu, Wei, Ctr Dis Control \& Prevent, Off Publ Hlth Gen, Atlanta, GA USA.
   Clyne, Mindy, NCI, Div Canc Control \& Populat Sci, Rockville, MD USA.
   Gwinn, Marta L., Ctr Dis Control \& Prevent, Off Adv Mol Detect, Natl Ctr Emerging \& Zoonot Infect Dis, Atlanta, GA USA.
   Rodriguez, Juan L., Ctr Dis Control \& Prevent, Div Canc Prevent \& Control, Natl Ctr Chron Dis Prevent \& Hlth Promot, Atlanta, GA USA.},
DOI = {10.1038/gim.2017.211},
Keywords = {genomics; precision medicine; precision public health; public health},
Keywords-Plus = {FAMILIAL HYPERCHOLESTEROLEMIA; GENETIC TESTS; MEDICAL GENETICS;
   DISEASE-CONTROL; CANCER; PREVENTION; IMPACT; STATE; CARE;
   RECOMMENDATIONS},
Research-Areas = {Genetics \& Heredity},
Web-of-Science-Categories  = {Genetics \& Heredity},
Author-Email = {muk1@cdc.gov},
Affiliations = {Centers for Disease Control \& Prevention - USA; National Institutes of
   Health (NIH) - USA; NIH National Cancer Institute (NCI); Centers for
   Disease Control \& Prevention - USA; Centers for Disease Control \&
   Prevention - USA},
Cited-References = {Abul-Husn NS, 2016, SCIENCE, V354, DOI 10.1126/science.aaf7000.
   {[}Anonymous], 1988, FUT PUBL HLTH.
   Association for State and Territorial Health Officials, 2010, 2010 STAT PUBL HLTH.
   Baynam G, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0462-7.
   Bellcross CA, 2012, GENET MED, V14, P152, DOI 10.1038/gim.0b013e31823375ea.
   Berg AO, 2009, GENET MED, V11, P35, DOI {[}10.1097/GIM.0b013e318181fa2ff, 10.1097/GIM.0b013e31818fa2ff].
   Berg JS, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2252.
   Beskow L.M., 2001, Community Genet, V4, P2, DOI 10.1159/000051150.
   Blum HE, 2017, ADV MED SCI-POLAND, V62, P414, DOI 10.1016/j.advms.2017.04.005.
   Bowen MS, 2012, PUBLIC HEALTH GENOM, V15, P327, DOI 10.1159/000341889.
   Boyle CA, 2014, PEDIATRICS, V133, P961, DOI 10.1542/peds.2013-3658.
   Burke W, 2006, GENET MED, V8, P451, DOI 10.1097/01.gim.0000228213.72256.8c.
   Calonge N, 2014, GENET MED, V16, P217, DOI 10.1038/gim.2013.110.
   Centers for Disease Control and Prevention, ACCE MOD PROC EV GEN.
   Ceyhan-Birsoy O, 2017, GENET MED, V19, P809, DOI 10.1038/gim.2016.193.
   Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523.
   Committee on the Evidence Base for Genetic Testing, 2017, EV FRAM GEN TEST.
   D'Andrea E, 2016, GENET MED, V18, P1171, DOI 10.1038/gim.2016.29.
   Danielsson K, 2014, EXPERT REV MOL DIAGN, V14, P469, DOI 10.1586/14737159.2014.904749.
   Deverka PA, 2012, GENET MED, V14, P656, DOI 10.1038/gim.2012.3.
   Dotson WD, 2014, CLIN PHARMACOL THER, V95, P394, DOI 10.1038/clpt.2013.226.
   Dowell SF, 2016, NATURE, V540, P189, DOI 10.1038/540189a.
   Evans JP, 2013, GENET MED, V15, P332, DOI 10.1038/gim.2013.11.
   Gwinn M, 2017, J CLIN MICROBIOL, V55, P703, DOI 10.1128/JCM.01967-16.
   Hunter JE, 2016, GENET MED, V18, P1258, DOI 10.1038/gim.2016.40.
   Kalia SS, 2017, GENET MED, V19, P249, DOI 10.1038/gim.2016.190.
   Kemper AR, 2014, GENET MED, V16, P183, DOI 10.1038/gim.2013.98.
   Khoury M.J., 2000, Genetics and Public Health in the 21st Century. Part I: Genetics and Public Health: An Overview.
   Khoury MJ, 2016, JAMA-J AM MED ASSOC, V316, P1357, DOI 10.1001/jama.2016.12260.
   Khoury MJ, 2016, AM J PREV MED, V50, P398, DOI 10.1016/j.amepre.2015.08.031.
   Khoury MJ, 2015, JAMA-J AM MED ASSOC, V313, P2117, DOI 10.1001/jama.2015.3382.
   Khoury Muin J., 2012, Journal of the National Cancer Institute Monographs, P112, DOI 10.1093/jncimonographs/lgs003.
   Khoury MJ, 2011, AM J PREV MED, V40, P486, DOI 10.1016/j.amepre.2010.12.009.
   Khoury MJ, 2011, GENET MED, V13, P206, DOI 10.1097/GIM.0b013e31821024ca.
   Khoury MJ, 2009, GENET MED, V11, P559, DOI 10.1097/GIM.0b013e3181b13a6c.
   Knowles JW, 2017, JAMA-J AM MED ASSOC, V318, P381, DOI 10.1001/jama.2017.8543.
   Kolor K, 2012, GENET MED, V14, P860, DOI 10.1038/gim.2012.67.
   Laufer Halpin A, 2016, CDC BLOG POST.
   Lemke JR, 2017, JAMA PEDIATR, V171, P833, DOI 10.1001/jamapediatrics.2017.1970.
   Lynch JA, 2017, GENET MED, V19, P890, DOI 10.1038/gim.2016.209.
   McBride CM, 2012, PUBLIC HEALTH GENOM, V15, P117, DOI 10.1159/000336597.
   Moyer VA, 2013, ANN INTERN MED, V159, P698, DOI {[}10.7326/0003-4819-159-10-201311190-00718, 10.7326/0003-4819-159-10-201311190-00717].
   National Cancer Institute, 2017, APPR BLUE RIBB PAN R.
   National Cancer Institute. Cancer Moonshot, 2016, CANC MOONSH BLUE RIB.
   Phillips M, 2017, GENET MED, V19, P834, DOI {[}10.1038/gim.2016.199, 10.1038/gim.2017.21].
   Plunkett-Rondeau J, 2015, GENET MED, V17, P927, DOI 10.1038/gim.2014.208.
   Richards CL, 2017, PUBLIC HEALTH REP, V132, P403, DOI 10.1177/0033354917709542.
   Roberts MC, 2017, GENET MED, V19, P858, DOI 10.1038/gim.2016.210.
   Rodriguez JL, 2016, MMWR-MORBID MORTAL W, V65, P1291, DOI 10.15585/mmwr.mm6546a3.
   Rubinstein WS, 2013, NUCLEIC ACIDS RES, V41, pD925, DOI 10.1093/nar/gks1173.
   Rubinstein WS, 2011, GENET MED, V13, P956, DOI 10.1097/GIM.0b013e3182241d88.
   Safarova MS, 2016, J CLIN LIPIDOL, V10, P1230, DOI 10.1016/j.jacl.2016.08.001.
   Sahai I, 2010, GENET MED, V12, pS220, DOI 10.1097/GIM.0b013e3181fe5d37.
   Scheuner MT, 2017, GENET MED, V19, P112, DOI 10.1038/gim.2016.73.
   Schully SD, 2015, GENET MED, V17, P63, DOI 10.1038/gim.2014.69.
   St Pierre J, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130267.
   Tan TY, 2017, JAMA PEDIATR, V171, P855, DOI 10.1001/jamapediatrics.2017.1755.
   Task Force on Genetic Testing, 1997, PROM SAF EFF GEN TES.
   Teutsch SM, 2009, GENET MED, V11, P3, DOI 10.1097/GIM.0b013e318184137c.
   The Secretary's Advisory Committee on Genetic Testing, 2000, ENH OV GEN TESTS REC.
   Trivers KF, 2015, HEALTHCARE-BASEL, V3, P948, DOI 10.3390/healthcare3040948.
   Valdez R, 2017, GENET MED, V19, P489, DOI 10.1038/gim.2016.166.
   Wald DS, 2016, NEW ENGL J MED, V375, P1628, DOI 10.1056/NEJMoa1602777.
   Wiesman C, 2017, GENET MED, V19, P529, DOI 10.1038/gim.2016.154.
   Yu W, 2016, GENET MED, V18, P1312, DOI 10.1038/gim.2016.63.},
Number-of-Cited-References = {65},
Times-Cited = {99},
Unique-ID = {WOS:000434409000002},
}

@article{ WOS:000596581500001,
Author = {Khoury, Muin J. and Armstrong, Gregory L. and Bunnell, Rebecca E. and
   Cyril, Juliana and Iademarco, Michael F.},
Title = {The intersection of genomics and big data with public health:
   Opportunities for precision public health},
Journal = {PLOS MEDICINE},
Year = {2020},
Volume = {17},
Number = {10},
Month = {OCT},
Type = {Review},
Affiliation = {Khoury, MJ (Corresponding Author), Ctr Dis Control \& Prevent, Off Genom \& Precis Publ Hlth, Off Sci, Atlanta, GA 30333 USA.
   Khoury, Muin J., Ctr Dis Control \& Prevent, Off Genom \& Precis Publ Hlth, Off Sci, Atlanta, GA 30333 USA.
   Armstrong, Gregory L., Ctr Dis Control \& Prevent, Off Adv Mol Detect, Natl Ctr Emerging \& Zoonot Infect Dis, Atlanta, GA USA.
   Bunnell, Rebecca E., Ctr Dis Control \& Prevent, Off Sci, Atlanta, GA USA.
   Cyril, Juliana, Ctr Dis Control \& Prevent, Off Technol \& Innovat, Off Sci, Atlanta, GA USA.
   Iademarco, Michael F., Ctr Dis Control \& Prevent, Ctr Surveillance Epidemiol \& Lab Serv, Atlanta, GA USA.},
DOI = {10.1371/journal.pmed.1003373},
Article-Number = {e1003373},
Keywords-Plus = {PREDICTIVE ANALYTICS; NATIONAL SURVEILLANCE; IMPLEMENTATION; ALGORITHM;
   MEDICINE; LUNG},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Author-Email = {muk1@cdc.gov},
Affiliations = {Centers for Disease Control \& Prevention - USA; Centers for Disease
   Control \& Prevention - USA; Centers for Disease Control \& Prevention -
   USA; Centers for Disease Control \& Prevention - USA; Centers for
   Disease Control \& Prevention - USA},
Cited-References = {Alan H, 2017, VACCINE, V35, P1104, DOI 10.1016/j.vaccine.2017.01.018.
   All Us Res Program Investigators, 2019, NEW ENGL J MED, V381, P668, DOI 10.1056/NEJMsr1809937.
   Andersen KG, 2020, NAT MED, V26, P450, DOI 10.1038/s41591-020-0820-9.
   {[}Anonymous], 2020, NAT MED, V26, P1, DOI 10.1038/s41591-019-0740-8.
   {[}Anonymous], 2018, FRONT PUBLIC HEALTH, DOI {[}10.3389/fpubh.2018.00121, DOI 10.3389/FPUBH.2018.00121].
   {[}Anonymous], 2018, DIABETES CARE S1, V4, pS4, DOI 10.2337/dc18-Srev01.
   {[}Anonymous], 2019, NAT MED, V25, P1117.
   {[}Anonymous], 2011, PREC MED BUILD KNOWL.
   {[}Anonymous], 2018, DATA SCI BLOG USING.
   Armstrong GL, 2019, NEW ENGL J MED, V381, P2569, DOI 10.1056/NEJMsr1813907.
   Bai X, 2020, PREDICTING COVID 19.
   Banks MA, 2020, NAT MED, V26, P5, DOI 10.1038/s41591-019-0703-0.
   Bocato MZ, 2019, J TOXICOL ENV HEAL B, V22, P131, DOI 10.1080/10937404.2019.1661588.
   Carleton H.A., 2016, Microbe, V11, P311.
   CDC Office of Genomics and Precision Public Health, CDC OFF GEN PREC PUB.
   Chowkwanyun M, 2018, NEW ENGL J MED, V379, P1398, DOI 10.1056/NEJMp1806634.
   Christodoulou E, 2019, J CLIN EPIDEMIOL, V110, P12, DOI 10.1016/j.jclinepi.2019.02.004.
   Cleemput S, 2020, BIOINFORMATICS, V36, P3552, DOI 10.1093/bioinformatics/btaa145.
   Dallman TJ, 2015, CLIN INFECT DIS, V61, P305, DOI 10.1093/cid/civ318.
   Dolley S, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00068.
   Dowell SF, 2016, NATURE, V540, P189, DOI 10.1038/540189a.
   Engelgau MM, 2019, GLOB HEART, V14, P75, DOI 10.1016/j.gheart.2019.02.003.
   Fauci AS, 2020, NEW ENGL J MED, V382, P1268, DOI 10.1056/NEJMe2002387.
   Flaxman AD, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002702.
   Frieden TR, 2015, NEW ENGL J MED, V373, P1748, DOI 10.1056/NEJMsa1511248.
   Golding N, 2017, LANCET, V390, P2171, DOI 10.1016/S0140-6736(17)31758-0.
   Grad YH, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0538-4.
   Green RF, 2019, GENET MED, V21, P28, DOI 10.1038/s41436-018-0028-2.
   Gulshan V, 2016, JAMA-J AM MED ASSOC, V316, P2402, DOI 10.1001/jama.2016.17216.
   Guthrie JL, 2020, EPIDEMIOL INFECT, V148, DOI 10.1017/S0950268820000072.
   Hartnett KP, 2020, NEW ENGL J MED, V382, P766, DOI 10.1056/NEJMsr1915313.
   Hernandez I, 2017, AM J HEALTH-SYST PH, V74, P1494, DOI 10.2146/ajhp161011.
   Hertz H, 2012, INNOVATION RESULTS I.
   Horton R, 2018, LANCET, V392, P1504, DOI 10.1016/S0140-6736(18)32741-7.
   Hou P., 2020, MED RXIV, DOI {[}10.1101/2020.03.17.20037572, DOI 10.1101/2020.03.17.20037572].
   Ienca M, 2020, NAT MED, V26, P463, DOI 10.1038/s41591-020-0832-5.
   Institute of Medicine, 1998, WHO WILL KEEP PUBLIC.
   Jackson BR, 2016, CLIN INFECT DIS, V63, P380, DOI 10.1093/cid/ciw242.
   Khoury MJ, 2017, CDC BLOG POSTINTEGRA.
   Khoury MJ, 2018, PUBLIC HEALTH GENOM, V21, P244, DOI 10.1159/000501465.
   Khoury MJ, 2016, JAMA-J AM MED ASSOC, V316, P1357, DOI 10.1001/jama.2016.12260.
   Khoury MJ, 2016, AM J PREV MED, V50, P398, DOI 10.1016/j.amepre.2015.08.031.
   Khoury MJ, 2014, SCIENCE, V346, P1054, DOI 10.1126/science.aaa2709.
   Kind AJH, 2018, NEW ENGL J MED, V378, P2456, DOI 10.1056/NEJMp1802313.
   Knowles JW, 2017, JAMA-J AM MED ASSOC, V318, P381, DOI 10.1001/jama.2017.8543.
   Kolak M, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2019.19928.
   Long JTB, 2020, J MED SYST, V44, DOI 10.1007/s10916-020-1536-6.
   Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8.
   Mac Kenzie WR, 2016, PUBLIC HEALTH REP, V131, P742, DOI 10.1177/0033354916670871.
   McKinney SM, 2020, NATURE, V577, P89, DOI 10.1038/s41586-019-1799-6.
   Merchant RM, 2020, JAMA-J AM MED ASSOC, V323, P411, DOI 10.1001/jama.2019.21084.
   Morawski K, 2018, JAMA INTERN MED, V178, P802, DOI 10.1001/jamainternmed.2018.0447.
   National Cancer Institute, CANC MOONSH PREV EAR.
   National Human Genome Research Institute, GEN MED.
   Nevin L, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002708.
   Newman Daniel., 2015, Forbes.
   Obermeyer Z, 2019, SCIENCE, V366, P447, DOI 10.1126/science.aax2342.
   Parikh RB, 2016, JAMA-J AM MED ASSOC, V315, P651, DOI 10.1001/jama.2015.19417.
   Radin JM, 2020, LANCET DIGIT HEALTH, V2, pE85, DOI 10.1016/S2589-7500(19)30222-5.
   Rasmussen SA, 2020, JAMA-J AM MED ASSOC, V324, P933, DOI 10.1001/jama.2020.14992.
   Richards CL, 2017, PUBLIC HEALTH REP, V132, P403, DOI 10.1177/0033354917709542.
   Richards CL, 2014, PUBLIC HEALTH REP, V129, P472, DOI 10.1177/003335491412900603.
   Roberts MC, 2019, ETHNIC DIS, V29, P513, DOI 10.18865/ed.29.3.513.
   Saunders J, 2001, WESTERN J MED, V174, P137, DOI 10.1136/ewjm.174.2.137.
   Servick K., 2020, WILL COVID 19 AFFECT.
   Shah ND, 2018, JAMA-J AM MED ASSOC, V320, P27, DOI 10.1001/jama.2018.5602.
   Sintchenko V, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1314.
   Taylor-Robinson D, 2019, INT J EPIDEMIOL, V48, P1, DOI 10.1093/ije/dyy184.
   Ting DSW, 2020, NAT MED, V26, P459, DOI 10.1038/s41591-020-0824-5.
   Topol EJ, 2015, JAMA-J AM MED ASSOC, V313, P353, DOI 10.1001/jama.2014.17125.
   Wang CJ, 2020, JAMA-J AM MED ASSOC, V323, P1341, DOI 10.1001/jama.2020.3151.
   Weeramanthri TS, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00121.
   Wu J., 2020, NY TIMES.
   Xu J, 2019, HUM GENET, V138, P109, DOI 10.1007/s00439-019-01970-5.
   Yoon PW, 2019, PUBL HLTH REP S, V132, p3S.
   2015, N ENGL J MED, V372, P793.},
Number-of-Cited-References = {76},
Times-Cited = {22},
Unique-ID = {WOS:000596581500001},
}

@article{ WOS:000792292700001,
Author = {Canfell, Oliver J. and Davidson, Kamila and Woods, Leanna and Sullivan,
   Clair and Cocoros, Noelle M. and Klompas, Michael and Zambarano, Bob and
   Eakin, Elizabeth and Littlewood, Robyn and Burton-Jones, Andrew},
Title = {Precision Public Health for Non-communicable Diseases: An Emerging
   Strategic Roadmap and Multinational Use Cases},
Journal = {FRONTIERS IN PUBLIC HEALTH},
Year = {2022},
Volume = {10},
Month = {APR 8},
Abstract = {Non-communicable diseases (NCDs) remain the largest global public health
   threat. The emerging field of precision public health (PPH) offers a
   transformative opportunity to capitalize on digital health data to
   create an agile, responsive and data-driven public health system to
   actively prevent NCDs. Using learnings from digital health, our aim is
   to propose a vision toward PPH for NCDs across three horizons of digital
   health transformation: Horizon 1-digital public health workflows;
   Horizon 2-population health data and analytics; Horizon 3-precision
   public health. This perspective provides a high-level strategic roadmap
   for public health practitioners and policymakers, health system
   stakeholders and researchers to achieving PPH for NCDs. Two
   multinational use cases are presented to contextualize our roadmap in
   pragmatic action: ESP and RiskScape (USA), a mature PPH platform for
   multiple NCDs, and PopHQ (Australia), a proof-of-concept population
   health informatics tool to monitor and prevent obesity. Our intent is to
   provide a strategic foundation to guide new health policy, investment
   and research in the rapidly emerging but nascent area of PPH to reduce
   the public health burden of NCDs.},
Type = {Article},
Affiliation = {Canfell, OJ (Corresponding Author), Univ Queensland, Fac Med, Ctr Hlth Serv Res, Brisbane, Qld, Australia.
   Canfell, OJ (Corresponding Author), Univ Queensland, Fac Business Econ \& Law, UQ Business Sch, Brisbane, Qld, Australia.
   Canfell, OJ (Corresponding Author), Australian Govt, Digital Hlth Cooperat Res Ctr, Sydney, NSW, Australia.
   Canfell, OJ (Corresponding Author), Queensland Govt, Hlth \& Wellbeing Queensland, State Queensland, Brisbane, Qld, Australia.
   Canfell, Oliver J.; Woods, Leanna; Sullivan, Clair, Univ Queensland, Fac Med, Ctr Hlth Serv Res, Brisbane, Qld, Australia.
   Canfell, Oliver J.; Davidson, Kamila; Burton-Jones, Andrew, Univ Queensland, Fac Business Econ \& Law, UQ Business Sch, Brisbane, Qld, Australia.
   Canfell, Oliver J.; Woods, Leanna, Australian Govt, Digital Hlth Cooperat Res Ctr, Sydney, NSW, Australia.
   Canfell, Oliver J.; Sullivan, Clair; Littlewood, Robyn, Queensland Govt, Hlth \& Wellbeing Queensland, State Queensland, Brisbane, Qld, Australia.
   Sullivan, Clair, Queensland Govt, Dept Hlth, Metro North Hosp \& Hlth Serv, Herston, Qld, Australia.
   Cocoros, Noelle M.; Klompas, Michael, Harvard Med Sch, Dept Populat Med, Boston, MA USA.
   Cocoros, Noelle M.; Klompas, Michael, Brigham \& Womens Hosp, Dept Med, Boston, MA USA.
   Zambarano, Bob, Commonwealth Informat Inc, Waltham, MA USA.
   Eakin, Elizabeth, Univ Queensland, Fac Med, Sch Publ Hlth, Brisbane, Qld, Australia.
   Harvard Pilgrim Hlth Care Inst, Boston, MA USA.},
DOI = {10.3389/fpubh.2022.854525},
Article-Number = {854525},
Keywords = {electronic health records; medical informatics; non-communicable
   diseases; preventive medicine; public health; public health informatics;
   precision public health; electronic medical records},
Keywords-Plus = {POPULATION HEALTH; SURVEILLANCE; SUPPORT; CHALLENGES; RECORDS},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {o.canfell@uq.edu.au},
Affiliations = {University of Queensland; University of Queensland; Digital Health
   Cooperative Research Centre (DHCRC); Queensland Health; Harvard
   University; Harvard Medical School; Harvard University; Brigham \&
   Women's Hospital; University of Queensland; Harvard Pilgrim Health Care},
Cited-References = {Abbafati C, 2020, LANCET, V396, P1204.
   Abbafati C, 2020, LANCET, V396, P1135, DOI 10.1016/S0140-6736(20)31404-5.
   Aliabadi A, 2020, J AM MED INFORM ASSN, V27, P1977, DOI 10.1093/jamia/ocaa186.
   Bambra C, 2020, J EPIDEMIOL COMMUN H, V74, P964, DOI 10.1136/jech-2020-214401.
   Bharel M., 2020, NEJM Catal, V1, DOI {[}10.1056/CAT.19.1118, DOI 10.1056/CAT.19.1118, 10.1056/cat.19.1118].
   Birkhead GS, 2015, ANNU REV PUBL HEALTH, V36, P345, DOI 10.1146/annurev-publhealth-031914-122747.
   Bodenheimer T, 2014, ANN FAM MED, V12, P573, DOI 10.1370/afm.1713.
   Canfell OJ, 2022, BMC PUBLIC HEALTH, V22, DOI 10.1186/s12889-022-12939-x.
   Canfell OJ, 2022, AUST HEALTH REV, V46, P279, DOI 10.1071/AH21063.
   Cocoros NM, 2021, AM J PUBLIC HEALTH, V111, P269, DOI 10.2105/AJPH.2020.305963.
   Dolley S, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00068.
   Etheredge LM, 2014, HEALTH AFFAIR, V33, P1155, DOI 10.1377/hlthaff.2014.0043.
   Firth Joseph, 2020, BMJ, V369, pm2382, DOI 10.1136/bmj.m2382.
   Government Q, 2018, YOUTH CANC QUEENSL.
   Groves Robert., 2011, `Designed Data' and `Organic Data'.
   Hardeman W, 2019, INT J BEHAV NUTR PHY, V16, DOI 10.1186/s12966-019-0792-7.
   Hekler E, 2020, ANN BEHAV MED, V54, P805, DOI 10.1093/abm/kaaa018.
   Kee F, 2020, J EPIDEMIOL COMMUN H, V74, P311, DOI 10.1136/jech-2019-213311.
   Kharrazi H, 2017, J AM MED INFORM ASSN, V24, P2, DOI 10.1093/jamia/ocv210.
   Khorma R, 2017, E MEDITERR HEALTH J, V23, P571, DOI 10.26719/2017.23.8.571.
   Khoury MJ, 2018, PUBLIC HEALTH GENOM, V21, P244, DOI 10.1159/000501465.
   Klompas M., 2008, Morbidity and Mortality Weekly Report, V57, P373.
   Klompas M, 2017, AM J PUBLIC HEALTH, V107, P1406, DOI 10.2105/AJPH.2017.303874.
   Kruse CS, 2018, J MED SYST, V42, DOI 10.1007/s10916-018-1075-6.
   Lazarus R, 2009, J AM MED INFORM ASSN, V16, P18, DOI 10.1197/jamia.M2848.
   Lix Lisa M, 2018, Int J Popul Data Sci, V3, P433, DOI 10.23889/ijpds.v3i3.433.
   MEG, 2019, STRAT PLAN 2020 2024.
   Metro North Hospital and Health Service, 2018, DIG METR N STRAT 201.
   Murray CJL, 2020, LANCET, V396, P1223, DOI {[}10.1016/S0140-6736(20)30752-2, 10.1016/S0140-6736(20)30925-9].
   National Association of Chronic Disease Directors, 2021, MENDS PROJ MAK PROGR.
   Odone A, 2019, EUR J PUBLIC HEALTH, V29, P28, DOI 10.1093/eurpub/ckz161.
   Olstad DL, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-030279.
   Pan American Health Organization, 2021, 8 GUID PRINC DIG TRA.
   Pan American Health Organization, 2021, 8 PRINC DIG TRANSF P.
   Predmore Z, 2019, POPUL HEALTH MANAG, V22, P488, DOI 10.1089/pop.2018.0151.
   Rasmussen SA, 2020, JAMA-J AM MED ASSOC, V324, P933, DOI 10.1001/jama.2020.14992.
   Shaban-Nejad A, 2017, ANN NY ACAD SCI, V1387, P44, DOI 10.1111/nyas.13271.
   Slattery P, 2020, HEALTH RES POLICY SY, V18, DOI 10.1186/s12961-020-0528-9.
   Smith N, 2020, AUST HEALTH REV, V44, P706, DOI 10.1071/AH19255.
   Steinwachs Donald M, 2014, EGEMS (Wash DC), V2, P1175, DOI 10.13063/2327-9214.1175.
   Sullivan C, 2021, APPL CLIN INFORM, V12, P229, DOI 10.1055/s-0041-1725186.
   Swinburn BA, 2019, LANCET, V393, P791, DOI 10.1016/S0140-6736(18)32822-8.
   Topol EJ, 2019, TOPOL REV PREPARING.
   Wang Y, 2020, BMC PUBLIC HEALTH, V20, DOI {[}10.1186/s12889-020-08890-4, 10.1186/s12872-020-01568-0, 10.1186/s12870-020-02562-6, 10.1186/s12872-020-01608-9].
   Weeramanthri TS, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00121.
   World Health Organization, 2021, FACT SHEETNON COMM D.
   World Health Organization, 2013, Global action plan for the prevention and control of noncommunicable diseases 2013-2020.
   Xu H, 2020, J MANAGE, V46, P1257, DOI 10.1177/0149206319862027.},
Number-of-Cited-References = {48},
Times-Cited = {10},
Unique-ID = {WOS:000792292700001},
}

@article{ WOS:000398145100001,
Author = {Sau, Arkaprabha},
Title = {A Simulation Study on Hypothetical Ebola Virus Transmission in India
   Using Spatiotemporal Epidemiological Modeler (STEM): A Way towards
   Precision Public Health},
Journal = {JOURNAL OF ENVIRONMENTAL AND PUBLIC HEALTH},
Year = {2017},
Volume = {2017},
Abstract = {Background. Precision public health is a state-of-the-art concept in
   public health research and its application in health care. Application
   of information technology in field of epidemiology paves the way to its
   transformation to digital epidemiology. A geospatial epidemiological
   model was simulated to estimate the spread of Ebola virus disease after
   a hypothetical outbreak in India. Methods. It was a simulation study
   based on SEIR (Susceptible-Exposed-Infectious-Recovered) compartmental
   model. Simulation was done in Spatiotemporal Epidemiological Modeler
   (STEM). Epidemiological profile of Ebola virus, that transmitted
   throughout the Sierra Leon in 2014-2016, was fitted into the SEIR
   deterministic compartment model designed for India. Result.
   Spatiotemporal distribution of EVD exposed, infectious, and recovered
   population at 4-month interval represented by different figures. It is
   estimated that if no intervention is taken to stop the spread, within 2
   years, almost half of the country will be effected by EVD and cumulative
   number of exposed individuals, infectious persons, and deaths will be
   106947760, 30651674, and 18391005, respectively. Conclusion. Precision
   public health may play the key role to achieve the health related
   targets in the Sustainable Development Goals. Policy makers, public
   health specialists, and data scientists need to put their hands together
   to make precision public health a reality.},
Type = {Article},
Affiliation = {Sau, A (Corresponding Author), RG Kar Med Coll \& Hosp, Dept Community Med, Kolkata, W Bengal, India.
   Sau, Arkaprabha, RG Kar Med Coll \& Hosp, Dept Community Med, Kolkata, W Bengal, India.},
DOI = {10.1155/2017/7602301},
Article-Number = {7602301},
Keywords-Plus = {DISEASES},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {arka.doctor@gmail.com},
Affiliations = {RG Kar Medical College \& Hospital},
Cited-References = {{[}Anonymous], 2015, MODELLING SPREAD EBO.
   {[}Anonymous], 2016, What is GIS?.
   {[}Anonymous], 2015, PREC PUBL HLTH PREC.
   {[}Anonymous], 2016, Ebola virus disease.
   {[}Anonymous], 2016, EB DAT STAT.
   Burghardt K, 2016, SCI REP-UK, V6, DOI 10.1038/srep34598.
   Chretien JP, 2015, ELIFE, V4, DOI 10.7554/eLife.09186.
   Desmond-Hellmann S, 2016, SCIENCE, V353, P731, DOI 10.1126/science.aai7598.
   Dowell SF, 2016, NATURE, V540, P189, DOI 10.1038/540189a.
   Fauci AS, 2005, ACAD MED, V80, P1079, DOI 10.1097/00001888-200512000-00002.
   Khoury MJ, 2016, AM J PREV MED, V50, P398, DOI 10.1016/j.amepre.2015.08.031.
   Levy-Lahad E, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju420.
   Merler S, 2015, LANCET INFECT DIS, V15, P204, DOI 10.1016/S1473-3099(14)71074-6.
   Park K., 2015, PARKS TXB PREVENTIVE, V23rd.
   Pigott DM, 2016, ELIFE, V5, DOI 10.7554/eLife.16412.
   Precision Public Health, 2016, FRONT RES TOP.
   Smith CM, 2015, EUROSURVEILLANCE, V20, P6, DOI 10.2807/1560-7917.ES.2015.20.39.30026.
   Snowden FM, 2008, IMMUNOL REV, V225, P9, DOI 10.1111/j.1600-065X.2008.00677.x.
   Wolrd Health Organization, 2016, SIT REP EB VIR DIS.
   Zeigler B. P., 2019, Theory of modeling and simulation, V3rd.},
Number-of-Cited-References = {20},
Times-Cited = {3},
Unique-ID = {WOS:000398145100001},
}

@article{ WOS:000641154100001,
Author = {Velmovitsky, Pedro Elkind and Bevilacqua, Tatiana and Alencar, Paulo and
   Cowan, Donald and Morita, Plinio Pelegrini},
Title = {Convergence of Precision Medicine and Public Health Into Precision
   Public Health: Toward a Big Data Perspective},
Journal = {FRONTIERS IN PUBLIC HEALTH},
Year = {2021},
Volume = {9},
Month = {APR 6},
Abstract = {The field of precision medicine explores disease treatments by looking
   at genetic, socio-environmental, and clinical factors, thus trying to
   provide a holistic view of a person's health. Public health, on the
   other hand, is focused on improving the health of populations through
   preventive strategies and timely interventions. With recent advances in
   technology, we are able to collect, analyze and store for the first-time
   large volumes of real-time, diverse and continuous health data.
   Typically, the field of precision medicine deals with a huge amount of
   data from few individuals; public health, on the other hand, deals with
   limited data from a population. With the coming of Big Data, the fields
   of precision medicine and public health are converging into precision
   public health, the study of biological and genetic factors supported by
   large amounts of population data. In this paper, we explore through a
   comprehensive review the data types and use cases found in precision
   medicine and public health. We also discuss how these data types and use
   cases can converge toward precision public health, as well as challenges
   and opportunities provided by research and analyses of health data.},
Type = {Review},
Affiliation = {Morita, PP (Corresponding Author), Univ Waterloo, Sch Publ Hlth \& Hlth Syst, Waterloo, ON, Canada.
   Morita, PP (Corresponding Author), Univ Toronto, Dalla Lana Sch Publ Hlth, Inst Hlth Policy Management \& Evaluat, Toronto, ON, Canada.
   Morita, PP (Corresponding Author), Univ Hlth Network, Techna Inst, eHlth Innovat, Toronto, ON, Canada.
   Velmovitsky, Pedro Elkind; Bevilacqua, Tatiana; Morita, Plinio Pelegrini, Univ Waterloo, Sch Publ Hlth \& Hlth Syst, Waterloo, ON, Canada.
   Alencar, Paulo; Cowan, Donald, Univ Waterloo, David R Cheriton Sch Comp Sci, Waterloo, ON, Canada.
   Alencar, Paulo; Cowan, Donald, Waterloo Artificial Intelligence Inst Waterloo Ai, Waterloo, ON, Canada.
   Morita, Plinio Pelegrini, Univ Toronto, Dalla Lana Sch Publ Hlth, Inst Hlth Policy Management \& Evaluat, Toronto, ON, Canada.
   Morita, Plinio Pelegrini, Univ Hlth Network, Techna Inst, eHlth Innovat, Toronto, ON, Canada.},
DOI = {10.3389/fpubh.2021.561873},
Article-Number = {561873},
Keywords = {precision medicine; public health; big data; data analytics; artificial
   intelligence; precision public health; systematic review},
Keywords-Plus = {CHALLENGES; SUPPORT},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {plinio.morita@uwaterloo.ca},
Affiliations = {University of Waterloo; University of Waterloo; University of Toronto;
   University of Toronto; University Health Network Toronto},
Cited-References = {Adams SA, 2016, J AM MED INFORM ASSN, V23, P787, DOI 10.1093/jamia/ocv215.
   Agarwala V, 2018, HEALTH AFFAIR, V37, P765, DOI 10.1377/hlthaff.2017.1579.
   Andreu-Perez J, 2015, IEEE J BIOMED HEALTH, V19, P1193, DOI 10.1109/JBHI.2015.2450362.
   {[}Anonymous], TIME.
   {[}Anonymous], 2017, Tumor DNA Sequencing in Cancer Treatment.
   {[}Anonymous], 2016, Catalyst.
   {[}Anonymous], PIPEDA in Brief-Office of the Privacy Commissioner of Canada.
   {[}Anonymous], What Is Social Data?.
   {[}Anonymous], What is public health?.
   {[}Anonymous], YOG.
   {[}Anonymous], 2018, GLOBAL SMARTWATCH UN.
   {[}Anonymous], 2015, GOOGLE DEVELOPERS BL.
   {[}Anonymous], Summary of Privacy Laws in Canada.
   Apple, 2018, RESEARCHKIT CAREKIT.
   Arora P, 2020, CHAOS SOLITON FRACT, V139, DOI 10.1016/j.chaos.2020.110017.
   Association CM, 2018, DATA PRIVACY WHAT CA.
   Ayyoubzadeh SM, 2020, JMIR PUBLIC HLTH SUR, V6, P192, DOI 10.2196/18828.
   Azaria A, 2016, PROCEEDINGS 2016 2ND INTERNATIONAL CONFERENCE ON OPEN AND BIG DATA - OBD 2016, P25, DOI 10.1109/OBD.2016.11.
   Azuaje F, 2019, NPJ PRECIS ONCOL, V3, DOI 10.1038/s41698-019-0078-1.
   Bardakjian Tanya, 2018, Handb Clin Neurol, V147, P93, DOI 10.1016/B978-0-444-63233-3.00008-7.
   Arrieta AB, 2020, INFORM FUSION, V58, P82, DOI 10.1016/j.inffus.2019.12.012.
   Barrett MA, 2013, BIG DATA-US, V1, P168, DOI 10.1089/big.2013.0027.
   Behjati S, 2013, ARCH DIS CHILDHOOD-E, V98, P236, DOI 10.1136/archdischild-2013-304340.
   Benke K, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15122796.
   Berry D., THERE IS NOTHING MOR.
   Bot BM, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.11.
   Bublitz FM, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16203847.
   Bunn J.A., 2017, INT J EXERC SCI, V11, P503.
   Canada Health Infoway, EL HLTH REC.
   Castelvecchi D, 2016, NATURE, V537, P20, DOI 10.1038/538020a.
   Cavoukian A., 2004, FREQUENTLY ASKED QUE, P1.
   Chamberlayne R, 1998, CAN J PUBLIC HEALTH, V89, P270, DOI 10.1007/BF03403934.
   Chen JL, 2020, ADDICT BIOL, V25, DOI 10.1111/adb.12718.
   Chimmula VKR, 2020, CHAOS SOLITON FRACT, V135, DOI 10.1016/j.chaos.2020.109864.
   Chowkwanyun M, 2019, LANCET, V393, P1801, DOI 10.1016/S0140-6736(18)33187-8.
   Chowkwanyun M, 2018, NEW ENGL J MED, V379, P1398, DOI 10.1056/NEJMp1806634.
   Connelly Lynne M, 2013, Medsurg Nurs, V22, P269.
   Deiner MS, 2016, JAMA OPHTHALMOL, V134, P1024, DOI 10.1001/jamaophthalmol.2016.2267.
   Dhillon A, 2018, 2018 IEEE INTERNATIONAL CONGRESS ON INTERNET OF THINGS (ICIOT), P180, DOI 10.1109/ICIOT.2018.00034.
   Dolley S, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00068.
   Ecobee, SMART HOME TECHNOLOG.
   El Emam K, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1139.
   Embleema, 2018, EMBL WHITEPAPER.
   Fafard P, 2020, EVID POLICY, V16, P165, DOI 10.1332/174426418X15212871808802.
   Ghassemi MM, 2014, INTENS CARE MED, V40, P1332, DOI 10.1007/s00134-014-3406-5.
   Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634.
   Goodfellow I. J., 2014, ARXIV14126572.
   Gordis L., 2014, Epidemiology, V5th ed.
   Grishin D., 2018, BLOCKCHAIN ENABLED G.
   Gulshan V, 2016, JAMA-J AM MED ASSOC, V316, P2402, DOI 10.1001/jama.2016.17216.
   Hicks JL, 2019, NPJ DIGIT MED, V2, DOI 10.1038/s41746-019-0121-1.
   Horton R, 2018, LANCET, V392, P1504, DOI 10.1016/S0140-6736(18)32741-7.
   Illumina, DEEP SEQ.
   Institute NHGR, 2020, FACT SHEETS GENOMICS.
   Iron K, 2019, HLTH SERVICES DATA S, P47.
   Jagsi Reshma, 2019, J Clin Oncol, V37, P3203, DOI 10.1200/JCO.19.01693.
   Jain SH, 2015, NAT BIOTECHNOL, V33, P462, DOI 10.1038/nbt.3223.
   Johnson AEW, 2016, P IEEE, V104, P444, DOI 10.1109/JPROC.2015.2501978.
   Juengst Eric T, 2018, AMA J Ethics, V20, pE881, DOI 10.1001/amajethics.2018.881.
   Khoury M. J., 2016, The shift from personalized medicine to precision medicine and precision public health: Words matter!.
   Khoury MJ., 2018, REFLECTIONS PRECISIO.
   Khoury MJ., PRECISION PUBLIC HLT.
   Khoury MJ, 2016, JAMA-J AM MED ASSOC, V316, P1357, DOI 10.1001/jama.2016.12260.
   Kulemin N, 2017, ZENOME PROJECT WHITE.
   LaRocca R, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-751.
   Leff DR, 2015, ENGINEERING-PRC, V1, P277, DOI 10.15302/J-ENG-2015075.
   Levac D, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-69.
   McGhin T, 2019, J NETW COMPUT APPL, V135, P62, DOI 10.1016/j.jnca.2019.02.027.
   Medeiros H., 2016, 57 POPULA O BRASILEI.
   MedlinePlus, 2020, WHAT IS DIFFERENCE P.
   MedlinePlus, WHAT IS PREC MED.
   Mougin F, 2018, METHODS, V132, P3, DOI 10.1016/j.ymeth.2017.08.012.
   Mullner RM., EPIDEMIOLOGY SOURCES.
   Nemati S, 2013, IEEE ENG MED BIO, P7104, DOI 10.1109/EMBC.2013.6611195.
   Nielsen, 2015, CONNECTED LIFE CANAD.
   O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/502007.
   O'Leary DE, 2013, IEEE INTELL SYST, V28, P96, DOI 10.1109/MIS.2013.39.
   O'Neil C, 2016, Weapons of math destruction.
   Odlum M, 2015, AM J INFECT CONTROL, V43, P563, DOI 10.1016/j.ajic.2015.02.023.
   Prosperi M, 2018, BMC MED INFORM DECIS, V18, DOI 10.1186/s12911-018-0719-2.
   PubVenn, 2021, PUBVENN SEARCH PERSO.
   Qin L, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17072365.
   Ram S, 2015, IEEE J BIOMED HEALTH, V19, P1216, DOI 10.1109/JBHI.2015.2404829.
   Ramaswami R, 2018, ANNU REV PUBL HEALTH, V39, P153, DOI 10.1146/annurev-publhealth-040617-014158.
   Reece AG, 2017, EPJ DATA SCI, V6, DOI 10.1140/epjds/s13688-017-0110-z.
   Rich J., Library Guides: Data Resources in the Health Sciences:Clinical Data.
   Sakr S, 2016, BIG DATA RES, V4, P44, DOI 10.1016/j.bdr.2016.05.002.
   Savage N, 2017, NATURE, V550, pS115, DOI 10.1038/550S115a.
   Sedayao Jeff, 2014, 2014 IEEE International Congress on Big Data (BigData Congress), P601, DOI 10.1109/BigData.Congress.2014.92.
   Shephard RJ, 2016, SPRINGER SER EPIDEMI, P1, DOI 10.1007/978-3-319-29577-0.
   Sivarajah U, 2017, J BUS RES, V70, P263, DOI 10.1016/j.jbusres.2016.08.001.
   Sushames A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161224.
   Thaker Vidhu V, 2017, Adolesc Med State Art Rev, V28, P379.
   Thorogood A., 2013, CAN J LAW TECHNOL, V14, P8.
   Tsimberidou Apostolia M, 2014, Am Soc Clin Oncol Educ Book, P61, DOI 10.14694/EdBook\_AM.2014.34.61.
   Velmovitsky PE, 2020, J MED INTERNET RES, V22, DOI 10.2196/20832.
   Ward SL., 2014, OMICS BIOINFORMATICS.
   Weeramanthri TS, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00121.
   Wu PY, 2017, IEEE T BIO-MED ENG, V64, P263, DOI 10.1109/TBME.2016.2573285.
   Yu XN, 2019, ENVIRON POLLUT, V252, P924, DOI 10.1016/j.envpol.2019.05.081.
   Zhu WJ, 2012, ATMOS ENVIRON, V51, P29, DOI 10.1016/j.atmosenv.2012.01.051.},
Number-of-Cited-References = {101},
Times-Cited = {20},
Unique-ID = {WOS:000641154100001},
}

@article{ WOS:000532467000142,
Author = {Persmark, Anna and Wemrell, Maria and Zettermark, Sofia and Leckie,
   George and Subramanian, S. V. and Merlo, Juan},
Title = {Precision public health: Mapping socioeconomic disparities in opioid
   dispensations at Swedish pharmacies by Multilevel Analysis of Individual
   Heterogeneity and Discriminatory Accuracy (MAIHDA) (vol 14, e0220322,
   2019)},
Journal = {PLOS ONE},
Year = {2019},
Volume = {14},
Number = {10},
Month = {OCT 10},
Type = {Correction},
DOI = {10.1371/journal.pone.0224008},
Article-Number = {e0224008},
Research-Areas = {Science \& Technology - Other Topics},
Web-of-Science-Categories  = {Multidisciplinary Sciences},
Cited-References = {Persmark A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220322.},
Number-of-Cited-References = {1},
Times-Cited = {1},
Unique-ID = {WOS:000532467000142},
}

@article{ WOS:000837997400001,
Author = {Khoshnood, Babak and Baynam, Gareth and Loane, Maria and Rissmann, Anke
   and Botto, Lorenzo},
Title = {Editorial: Congenital anomalies: State of the art and the new paradigms
   for a precision public health approach},
Journal = {FRONTIERS IN PEDIATRICS},
Year = {2022},
Volume = {10},
Month = {JUL 18},
Type = {Editorial Material},
Affiliation = {Khoshnood, B (Corresponding Author), Ctr Rech Epidemiol \& Stat, INSERM, U1153, Paris, France.
   Khoshnood, Babak, Ctr Rech Epidemiol \& Stat, INSERM, U1153, Paris, France.
   Baynam, Gareth, Univ Western Australia, Perth, WA, Australia.
   Loane, Maria, Ulster Univ, Fac Life \& Hlth Sci, Coleraine, Londonderry, North Ireland.
   Rissmann, Anke, Otto von Guericke Univ, Magdeburg, Germany.
   Botto, Lorenzo, Univ Utah, Med Ctr, Salt Lake City, UT USA.},
DOI = {10.3389/fped.2022.968923},
Article-Number = {968923},
Keywords = {congenital anomalies (CAs); epidemiology; precision medicine; public
   health; outcomes},
Research-Areas = {Pediatrics},
Web-of-Science-Categories  = {Pediatrics},
Author-Email = {babak.khoshnood@inserm.fr},
Affiliations = {Universite Paris Cite; Institut National de la Sante et de la Recherche
   Medicale (Inserm); University of Western Australia; Ulster University;
   Otto von Guericke University; Utah System of Higher Education;
   University of Utah},
Number-of-Cited-References = {0},
Times-Cited = {0},
Unique-ID = {WOS:000837997400001},
}

@article{ WOS:000918057800001,
Author = {Homayouni, Ramin and Hong, Huixiao and Manda, Prashanti and Nanduri,
   Bindu and Toby, Inimary T.},
Title = {Unleashing Innovation on Precision Public Health-Highlights From the
   MCBIOS and MAQC 2021 Joint Conference},
Journal = {FRONTIERS IN ARTIFICIAL INTELLIGENCE},
Year = {2022},
Volume = {5},
Month = {FEB 25},
Type = {Editorial Material},
Affiliation = {Homayouni, R (Corresponding Author), Oakland Univ, William Beaumont Sch Med, Rochester, MI 48309 USA.
   Homayouni, Ramin, Oakland Univ, William Beaumont Sch Med, Rochester, MI 48309 USA.
   Hong, Huixiao, US FDA, Natl Ctr Toxicol Res, Jefferson, AR USA.
   Manda, Prashanti, Univ North Carolina Greensboro, Greensboro, NC USA.
   Nanduri, Bindu, Mississippi State Univ, Coll Vet Med, Mississippi State, MS USA.
   Toby, Inimary T., Univ Dallas, Dept Biol, Irving, TX USA.},
DOI = {10.3389/frai.2022.859700},
Article-Number = {859700},
Keywords = {machine learning; genomics; adverse drug effects; alternatives to animal
   testing; artificial intelligence},
Research-Areas = {Computer Science},
Web-of-Science-Categories  = {Computer Science, Artificial Intelligence; Computer Science, Information
   Systems},
Author-Email = {rhomayouni@oakland.edu},
Affiliations = {Oakland University; US Food \& Drug Administration (FDA); University of
   North Carolina; University of North Carolina Greensboro; Mississippi
   State University},
Number-of-Cited-References = {0},
Times-Cited = {0},
Unique-ID = {WOS:000918057800001},
}

@article{ WOS:001026763200001,
Author = {Buhler, Nolwenn and Frahsa, Annika and Bourqui, Rejane Morand and Von
   Goetz, Natalie and Bochud, Murielle and Panese, Francesco},
Title = {Between data providers and concerned citizens: Exploring participation
   in precision public health in Switzerland},
Journal = {PUBLIC UNDERSTANDING OF SCIENCE},
Year = {2024},
Volume = {33},
Number = {1},
Pages = {105-120},
Month = {JAN},
Abstract = {This empirical article explores the dynamics of exchange and reciprocity
   between cohorters, that is, study organizers, and cohortees, that is,
   study participants. Drawing on literature on bioeconomy and valuation,
   we analyze cohortees' expectations in return for the ``clinical
   labor{''} they perform in the pilot phase of a Swiss precision public
   health study. Based on an ethnography of this cohort and data from seven
   focus groups with cohortees (n = 37), we identified four positions: (1)
   the good citizen participant, (2) the critical participant, (3) the
   concerned participant, and (4) the self-oriented participant. These
   reveal that cohortees' participation, still framed in altruistic terms,
   nevertheless engages expectations about reciprocal obligations of the
   state and science in terms of public health, confirming the deep
   entanglement of gift-based, financial, and moral economies of
   participation. The different values emerging from these
   expectations-robust scientific evidence about environmental exposure and
   a socially oriented public health-provide rich indications about stake
   making which might matter for the future of precision public health.},
Type = {Article},
Affiliation = {Bühler, N (Corresponding Author), Univ Lausanne, Inst Social Sci, Geopolis Bldg, CH-1015 Lausanne, Switzerland.
   Buhler, Nolwenn; Panese, Francesco, Univ Lausanne, Lausanne, Switzerland.
   Frahsa, Annika, Univ Bern, Bern, Switzerland.
   Bourqui, Rejane Morand; Von Goetz, Natalie, Fed Off Publ Hlth, Koniz, Switzerland.
   Bochud, Murielle, Univ Ctr Primary Care \& Publ Hlth, Unisante, Lausanne, Switzerland.
   Buhler, Nolwenn, Univ Lausanne, Inst Social Sci, Geopolis Bldg, CH-1015 Lausanne, Switzerland.},
DOI = {10.1177/09636625231183265},
EarlyAccessDate = {JUL 2023},
Keywords = {clinical labor; cohort; expectations; precision health; public
   participation; reciprocity; values},
Keywords-Plus = {INVOLVEMENT; GOVERNANCE; ENGAGEMENT; POLITICS; PATIENT},
Research-Areas = {Communication; History \& Philosophy of Science},
Web-of-Science-Categories  = {Communication; History \& Philosophy Of Science},
Author-Email = {nolwenn.buhler@unil.ch},
Affiliations = {University of Lausanne; University of Bern; University of Lausanne},
Cited-References = {Abel T, 2023, HEALTH EXPECT, V26, P237, DOI 10.1111/hex.13649.
   Audetat M., 2015, SCI TECHNOLOGIES EME.
   Barazzetti G, 2021, AM J BIOETHICS, V21, P88, DOI 10.1080/15265161.2021.1891338.
   Brall C, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0249141.
   Brown N., 2003, SCI STUD, V16, P3, DOI DOI 10.23987/STS.55152.
   Bühler N, 2022, BIOSOCIETIES, V17, P99, DOI 10.1057/s41292-020-00204-6.
   Bühler N, 2018, TECNOSCIENZA, V9, P109.
   Cooper Melinda., 2014, CLIN LABOR TISSUE DO.
   Burton SD, 2022, BIOSOCIETIES, V17, P391, DOI 10.1057/s41292-020-00220-6.
   Degli Esposti S, 2019, SOC SCI MED, V234, DOI 10.1016/j.socscimed.2019.112381.
   Desmond H, 2021, AM J BIOETHICS, V21, P80, DOI 10.1080/15265161.2021.1891345.
   Dussauge I., 2015, Value Practices in the Life Science and Medicine, P1, DOI DOI 10.1093/ACPROF:OSO/9780199689583.
   Dussauge I., 2015, Value Practices in the Life Science and Medicine, P267, DOI DOI 10.1093/ACPROF:OSO/9780199689583.001.0001.
   Elsig A., 2019, CAHIERS HIST MOUVEME, V35, P7.
   FULLER CJ, 1992, MAN, V27, P431, DOI 10.2307/2804090.
   Glisczinski D, 2018, J TRANSFORM EDUC, V16, P175, DOI 10.1177/1541344618777367.
   Gottweis H, 2008, BIOSOCIETIES, V3, P265, DOI 10.1017/S1745855208006194.
   Greenhalgh T, 2019, HEALTH EXPECT, V22, P785, DOI 10.1111/hex.12888.
   Hauskeller C, 2016, BIOSOCIETIES, V11, P415, DOI 10.1057/biosoc.2015.45.
   Helgesson C-F., 2015, VALUE PRACTICES LIFE, P224.
   Henry E, 2021, SCI TECHNOL HUM VAL, V46, P911, DOI 10.1177/01622439211026749.
   Hoeyer K, 2016, LEGISPRUDENCE LIBRAR, V4, P161, DOI 10.1007/978-3-319-33365-6\_10.
   Hoeyer K, 2009, BIOSOCIETIES, V4, P239, DOI 10.1017/S1745855209990159.
   Hoeyer KL, 2013, BIOPRESERV BIOBANK, V11, P397, DOI 10.1089/bio.2013.1163.
   Jasanoff Sheila, 2012, Science and Public Reason.
   Joly P.-B., 2008, Science as Culture, V17, P225, DOI {[}10.1080/09505430802280727, DOI 10.1080/09505430802280727].
   Kerasidou A, 2017, MED HEALTH CARE PHIL, V20, P43, DOI 10.1007/s11019-016-9721-6.
   Khoury MJ, 2016, AM J PREV MED, V50, P398, DOI 10.1016/j.amepre.2015.08.031.
   Knaapen L, 2016, SCI CULT-UK, V25, P239, DOI 10.1080/09505431.2015.1125875.
   Lee F., 2015, VALUE PRACTICES LIFE, P207.
   Lee SSJ, 2021, AM J BIOETHICS, V21, P57, DOI 10.1080/15265161.2020.1851813.
   Puerta LL, 2020, HEALTH EXPECT, V23, P759, DOI 10.1111/hex.13067.
   Mählmann L, 2017, PUBLIC HEALTH GENOM, V20, P293, DOI 10.1159/000486588.
   Mauss Marcel., 2002, The Gift: The form and reason for exchange in archaic societies.
   Meier-Abt PJ., 2018, SWISS MED WEEKLY, DOI {[}10.3929/ethz-b-000274911., DOI 10.3929/ETHZ-B-000274911].
   Mitchell R, 2010, SCI TECHNOL HUM VAL, V35, P330, DOI 10.1177/0162243909340267.
   Monod Stefanie, 2022, Rev Med Suisse, V18, P1617, DOI 10.53738/REVMED.2022.18.793.1617.
   Nowotny H, 2014, PUBLIC UNDERST SCI, V23, P16, DOI 10.1177/0963662513476220.
   Ochieng CA, 2021, BMC MED ETHICS, V22, DOI 10.1186/s12910-021-00648-w.
   Panese Francesco, 2022, Rev Med Suisse, V18, P552, DOI 10.53738/REVMED.2022.18.774.552.
   Petersen Alan., 2007, GENOMICS SOC POLICY, V3, P31, DOI {[}DOI 10.1186/1746-5354-3-1-31, 10.1186/1746-5354-3-1-31].
   Rabeharisoa V, 2014, BIOSOCIETIES, V9, P194, DOI 10.1057/biosoc.2014.4.
   Rajan KS, 2005, AM ANTHROPOL, V107, P19, DOI 10.1525/aa.2005.107.1.019.
   Remund A, 2019, INT J PUBLIC HEALTH, V64, P1173, DOI 10.1007/s00038-019-01290-5.
   Resnik David B, 2015, Medicoleg Bioeth, V5, P35.
   Rochat J, 2020, STUD HEALTH TECHNOL, V270, P1098, DOI 10.3233/SHTI200332.
   Ruckenstein M, 2017, ANNU REV ANTHROPOL, V46, P261, DOI 10.1146/annurev-anthro-102116-041244.
   Sheikh Z, 2018, MED HEALTH CARE PHIL, V21, P169, DOI 10.1007/s11019-017-9795-9.
   Stilgoe J, 2014, PUBLIC UNDERST SCI, V23, P4, DOI 10.1177/0963662513518154.
   Tupasela A, 2006, NEW GENET SOC, V25, P33, DOI 10.1080/14636770600603469.
   Tupasela Aaro, 2015, Life Sci Soc Policy, V11, P5, DOI 10.1186/s40504-015-0024-0.
   van Oudheusden M, 2014, J RESPONSIBLE INNOV, V1, P67, DOI 10.1080/23299460.2014.882097.
   Vayena E., 2019, OXFORD HDB PUBLIC HL, P354, DOI DOI 10.1093/OXFORDHB/9780190245191.013.31.
   Voss JP, 2016, SOC STUD SCI, V46, P749, DOI 10.1177/0306312716641350.
   Wild CP, 2012, INT J EPIDEMIOL, V41, P24, DOI 10.1093/ije/dyr236.},
Number-of-Cited-References = {55},
Times-Cited = {2},
Unique-ID = {WOS:001026763200001},
}

@article{ WOS:000468808900002,
Author = {Ponte, Amy and Greenberg, Samantha and Greendale, Karen and Senier,
   Laura},
Title = {Moving the Needle on Action Around Evidence-Based Screening for
   Hereditary Conditions: Preparing State Chronic Disease Directors to
   Advance Precision Public Health},
Journal = {PUBLIC HEALTH REPORTS},
Year = {2019},
Volume = {134},
Number = {3},
Pages = {228-233},
Month = {MAY-JUN},
Type = {Editorial Material},
Affiliation = {Ponte, A (Corresponding Author), Walden Univ, Coll Hlth Sci, Minneapolis, MN 55401 USA.
   Ponte, Amy, Walden Univ, Coll Hlth Sci, Minneapolis, MN 55401 USA.
   Greenberg, Samantha, Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA.
   Greendale, Karen, SUNY Albany, Sch Publ Hlth, Dept Hlth Policy Management \& Behav, Albany, NY USA.
   Senier, Laura, Northeastern Univ, Dept Sociol \& Anthropol, Boston, MA 02115 USA.
   Senier, Laura, Northeastern Univ, Dept Hlth Sci, Boston, MA 02115 USA.},
DOI = {10.1177/0033354919834588},
Keywords = {genomics; cancer; cardiovascular disease; preventive medicine; public
   health practice},
Keywords-Plus = {PREVENTION; PROGRAMS; GENOMICS; RISK},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {amy.h.ponte@gmail.com},
Affiliations = {Walden University; Utah System of Higher Education; University of Utah;
   Huntsman Cancer Institute; State University of New York (SUNY) System;
   State University of New York (SUNY) Albany; Northeastern University;
   Northeastern University},
Cited-References = {Allen P, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-141.
   American Cancer Society, CANC FACTS FIG 2018.
   {[}Anonymous], US and World Population Clock.
   {[}Anonymous], HEART DIS STROK STAT.
   Association for State and Territorial Health Officials, 2010, 2010 STAT PUBL HLTH.
   Centers for Disease Control and Prevention, 2014, TIER 1 GEN APPL TOOL.
   D'Andrea E, 2016, GENET MED, V18, P1171, DOI 10.1038/gim.2016.29.
   Dotson WD, 2014, CLIN PHARMACOL THER, V95, P394, DOI 10.1038/clpt.2013.226.
   George R, 2015, J GENET COUNS, V24, P388, DOI 10.1007/s10897-014-9805-5.
   Green RF, 2015, HEALTHCARE-BASEL, V3, P830, DOI 10.3390/healthcare3030830.
   Guillén-Ponce C, 2012, EXPERT REV ANTICANC, V12, P1359, DOI {[}10.1586/ERA.12.114, 10.1586/era.12.114].
   Hampel H, 2011, CANCER PREV RES, V4, P1, DOI 10.1158/1940-6207.CAPR-10-0345.
   Kashyap Meghana V, 2015, J Carcinog, V14, P6, DOI 10.4103/1477-3163.165158.
   Khoury MJ, 2018, GENET MED, V20, P574, DOI 10.1038/gim.2017.211.
   Khoury MJ, 2016, AM J PREV MED, V50, P398, DOI 10.1016/j.amepre.2015.08.031.
   Khoury MJ, 2011, GENET MED, V13, P206, DOI 10.1097/GIM.0b013e31821024ca.
   Khoury MJ, 2010, GENET MED, V12, P680, DOI 10.1097/GIM.0b013e3181f9ad55.
   Kolor K, 2012, GENET MED, V14, P860, DOI 10.1038/gim.2012.67.
   Laufman JD, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.120190.
   Maylahn C, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.130003.
   Millar MM, 2011, PUBLIC OPIN QUART, V75, P249, DOI 10.1093/poq/nfr003.
   Modell SM, 2016, HEALTHCARE-BASEL, V4, DOI 10.3390/healthcare4010014.
   National Organization for Rare Disorders, 2016, FAM HYP.
   Ned Renee M, 2011, PLoS Curr, V3, pRRN1238, DOI 10.1371/currents.RRN1238.
   Office of Disease Prevention and Health Promotion US Department of Health and Human Services, 2016, HLTH PEOPL.
   Office of Public Health Genomics, TIER TABL DAT.
   Office of Public Health Genomics, 2017, STAT PUBL HLTH GEN P.
   Patel Swati G, 2012, Curr Gastroenterol Rep, V14, P428, DOI 10.1007/s11894-012-0280-6.
   Petrucelli N, GENEREVIEWS, P1993.
   Senier L, 2019, GENET MED, V21, P373, DOI 10.1038/s41436-018-0056-y.
   Senier L, 2015, HEALTHCARE-BASEL, V3, P995, DOI 10.3390/healthcare3040995.
   St Pierre J, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130267.
   Trivers KF, 2015, HEALTHCARE-BASEL, V3, P948, DOI 10.3390/healthcare3040948.
   University of Washington Center for Genomics and Public Health, 2011, TIM FAM HIST GEN QUE.
   Zimmern RL, 2012, PUBLIC HEALTH GENOM, V15, P118, DOI 10.1159/000334840.},
Number-of-Cited-References = {35},
Times-Cited = {2},
Unique-ID = {WOS:000468808900002},
}

@article{ WOS:000440027700001,
Author = {Lyles, Courtney R. and Lunn, Mitchell R. and Obedin-Maliver, Juno and
   Bibbins-Domingo, Kirsten},
Title = {The new era of precision population health: insights for the <i>All of
   Us</i> Research Program and beyond},
Journal = {JOURNAL OF TRANSLATIONAL MEDICINE},
Year = {2018},
Volume = {16},
Month = {JUL 27},
Abstract = {Although precision medicine has made advances in individualized patient
   treatments, there needs to be continued attention on tailored population
   health and prevention strategies (often termed ``precision population
   health{''}). As we continue to link datasets and use ``big data{''}
   approaches in medicine, inclusion of diverse populations and a focus on
   disparities reduction are key components within a precision population
   health framework. Specific recommendations from the All of Us Research
   Program and the Precision Public Health Summit provide examples for
   moving this field forward.},
Type = {Editorial Material},
Affiliation = {Lyles, CR (Corresponding Author), Univ Calif San Francisco, Ctr Vulnerable Populat, San Francisco, CA 94143 USA.
   Lyles, CR (Corresponding Author), Univ Calif San Francisco, Zuckerberg San Francisco Gen Hosp, Dept Med, Div Gen Internal Med, San Francisco, CA 94143 USA.
   Lyles, Courtney R.; Lunn, Mitchell R.; Obedin-Maliver, Juno; Bibbins-Domingo, Kirsten, Univ Calif San Francisco, Ctr Vulnerable Populat, San Francisco, CA 94143 USA.
   Lyles, Courtney R.; Bibbins-Domingo, Kirsten, Univ Calif San Francisco, Zuckerberg San Francisco Gen Hosp, Dept Med, Div Gen Internal Med, San Francisco, CA 94143 USA.
   Lunn, Mitchell R., Univ Calif San Francisco, Dept Med, Div Nephrol, San Francisco, CA 94143 USA.
   Obedin-Maliver, Juno, Univ Calif San Francisco, Dept Obstet Gynecol \& Gynecol Subspecialties, San Francisco, CA 94143 USA.
   Bibbins-Domingo, Kirsten, Univ Calif San Francisco, Dept Epidemiol \& Biostat, San Francisco, CA 94143 USA.},
DOI = {10.1186/s12967-018-1585-5},
Article-Number = {211},
Keywords = {Precision medicine; Population health; Precision public health;
   Precision population health; Community engagement; Personalized medicine},
Keywords-Plus = {MEDICINE},
Research-Areas = {Research \& Experimental Medicine},
Web-of-Science-Categories  = {Medicine, Research \& Experimental},
Author-Email = {Courtney.lyles@ucsf.edu},
Affiliations = {University of California System; University of California San Francisco;
   University of California System; University of California San Francisco;
   University of California System; University of California San Francisco;
   University of California System; University of California San Francisco;
   University of California System; University of California San Francisco},
Cited-References = {{[}Anonymous], 2017, ALL US RES PROGR ANN.
   Bayer R, 2015, NEW ENGL J MED, V373, P499, DOI 10.1056/NEJMp1506241.
   Beck AF, 2013, J PEDIATR-US, V163, P574, DOI 10.1016/j.jpeds.2013.01.064.
   Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523.
   McGuire J., 2017, PAYING POPULATION HL.
   Oh SS, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001918.
   Rand L, 2017, CALIFORNIA PRETERM B.
   Silva PJ, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1401-2.
   United Kingdom Northern Health Science Alliance, CONN HLTH CIT.
   University of California San Francisco, PREC PUBL HLTH SUMM.},
Number-of-Cited-References = {10},
Times-Cited = {40},
Unique-ID = {WOS:000440027700001},
}

@article{ WOS:000443963600001,
Author = {Bergquist, Sharon Horesh and Lobelo, Felipe},
Title = {The Limits and Potential Future Applications of Personalized Medicine to
   Prevent Complex Chronic Disease},
Journal = {PUBLIC HEALTH REPORTS},
Year = {2018},
Volume = {133},
Number = {5},
Pages = {519-522},
Month = {SEP-OCT},
Type = {Editorial Material},
Affiliation = {Bergquist, SH (Corresponding Author), Emory Univ, Sch Med, 1365 Clifton Rd,A1400, Atlanta, GA 30322 USA.
   Bergquist, Sharon Horesh, Emory Univ, Sch Med, Dept Med, Atlanta, GA 30322 USA.
   Lobelo, Felipe, Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA.
   Lobelo, Felipe, Exercise Is Med Global Res \& Collaborat Ctr, Atlanta, GA USA.},
DOI = {10.1177/0033354918781568},
Keywords = {precision medicine; personalized medicine; precision public health;
   genetic susceptibility; chronic disease prevention},
Keywords-Plus = {GENOME-WIDE ASSOCIATION; PRECISION MEDICINE; LIFE-STYLE; HEALTH; DIET;
   PROMOTE; RISK},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {shoresh@emory.edu},
Affiliations = {Emory University; Emory University; Rollins School Public Health},
Cited-References = {Allan J, 2017, OBES REV, V18, P214, DOI 10.1111/obr.12470.
   Andersen LH, 2016, J CLIN LIPIDOL, V10, P1297, DOI 10.1016/j.jacl.2016.09.009.
   Bloss CS, 2011, NEW ENGL J MED, V364, P524, DOI 10.1056/NEJMoa1011893.
   Carlsten C, 2006, JAMA-J AM MED ASSOC, V296, P2480, DOI 10.1001/jama.296.20.2480.
   Carlsten C, 2014, EMBO REP, V15, P736, DOI 10.15252/embr.201438480.
   Chaufan C, 2013, INT J HEALTH SERV, V43, P281, DOI 10.2190/HS.43.2.f.
   Gref A, 2017, AM J RESP CRIT CARE, V195, P1373, DOI 10.1164/rccm.201605-1026OC.
   Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106.
   Hollands GJ, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1102.
   Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492.
   Janssens ACJW, 2008, HUM MOL GENET, V17, pR166, DOI 10.1093/hmg/ddn250.
   Khoury MJ, 2016, AM J PREV MED, V50, P398, DOI 10.1016/j.amepre.2015.08.031.
   Khoury MJ, 2012, AM J PREV MED, V42, P639, DOI 10.1016/j.amepre.2012.02.012.
   Langenberg C, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001647.
   LeFevre ML, 2014, ANN INTERN MED, V161, P587, DOI 10.7326/M14-1796.
   MacArthur J, 2017, NUCLEIC ACIDS RES, V45, pD896, DOI 10.1093/nar/gkw1133.
   Marteau TM, 2012, SCIENCE, V337, P1492, DOI 10.1126/science.1226918.
   McGinnis JM, 2002, HEALTH AFFAIR, V21, P78, DOI 10.1377/hlthaff.21.2.78.
   Pokorska-Bocci A, 2014, PERS MED, V11, P197, DOI 10.2217/pme.13.107.
   Riley WT, 2015, TRANSL BEHAV MED, V5, P243, DOI 10.1007/s13142-015-0320-5.
   Schork NJ, 2009, CURR OPIN GENET DEV, V19, P212, DOI 10.1016/j.gde.2009.04.010.
   Smith GD, 2008, BIOSOCIAL SURVEYS, P1.
   Smith Jennifer A, 2015, Curr Epidemiol Rep, V2, P180.
   Stampfer MJ, 2000, NEW ENGL J MED, V343, P16, DOI 10.1056/NEJM200007063430103.
   Yoon PW, 2014, MMWR-MORBID MORTAL W, V63, P369.},
Number-of-Cited-References = {25},
Times-Cited = {5},
Unique-ID = {WOS:000443963600001},
}

@article{ WOS:000415920000003,
Author = {Riddle, Mark S.},
Title = {Big Data Meet Precision Public Health: The Modeling of Acute
   Gastroenteritis, Norovirus and Its Present and Future Utility},
Journal = {JOURNAL OF INFECTIOUS DISEASES},
Year = {2017},
Volume = {216},
Number = {8},
Pages = {929-931},
Month = {OCT 15},
Type = {Editorial Material},
Affiliation = {Riddle, MS (Corresponding Author), Dept Prevent Med \& Biostat, Room A-1034,4301 Jones Bridge Rd, Bethesda, MD 20814 USA.
   Riddle, Mark S., Uniformed Serv Univ Hlth Sci, Dept Prevent Med \& Biostat, Bethesda, MD USA.},
DOI = {10.1093/infdis/jix412},
Keywords = {rotavirus; public health; modeling; medical databases; time-series},
Keywords-Plus = {INFECTIOUS INTESTINAL DISEASE; GENERAL-PRACTICE; SURVEILLANCE;
   COMMUNITY; VACCINE; RECORD; CHILDREN; RATES},
Research-Areas = {Immunology; Infectious Diseases; Microbiology},
Web-of-Science-Categories  = {Immunology; Infectious Diseases; Microbiology},
Author-Email = {mark.riddle@usuhs.edu},
Affiliations = {Uniformed Services University of the Health Sciences - USA},
Cited-References = {Angier H, 2014, MATERN CHILD HLTH J, V18, P2025, DOI 10.1007/s10995-014-1453-8.
   Bartsch SM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151219.
   Choudhry A, 2016, VACCINE, V34, P4558, DOI 10.1016/j.vaccine.2016.07.033.
   Gastanaduy PA, 2013, JAMA-J AM MED ASSOC, V309, P706, DOI {[}10.1001/jama.2013.193, DOI 10.1001/JAMA.2013.193].
   Gastañaduy PA, 2013, J INFECT DIS, V207, P1058, DOI 10.1093/infdis/jis942.
   Leshem E, 2015, JAMA-J AM MED ASSOC, V313, P2282, DOI 10.1001/jama.2015.5571.
   Lombardo J, 2003, J URBAN HEALTH, V80, pI32.
   Lopman BA, 2011, CLIN INFECT DIS, V52, P466, DOI 10.1093/cid/ciq163.
   Marder EP, 2017, MMWR-MORBID MORTAL W, V66, P397, DOI 10.15585/mmwr.mm6615a1.
   Paneth-Pollak R, 2010, AM J PUBLIC HEALTH, V100, P586, DOI 10.2105/AJPH.2009.175349.
   Rha B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148505.
   Riddle MS, 2016, VACCINE, V34, P2895, DOI 10.1016/j.vaccine.2016.03.077.
   Ruffin Marshall, 2002, Physician Exec, V28, P28.
   SCHENTHAL J E, 1962, Bull Sch Med Univ Md, V47, P53.
   Tam CC, 2012, GUT, V61, P69, DOI 10.1136/gut.2011.238386.
   Verstraeten T, 2017, J INFECT DIS, V216, P957, DOI 10.1093/infdis/jix410.
   Wheeler JG, 1999, BMJ-BRIT MED J, V318, P1046, DOI 10.1136/bmj.318.7190.1046.
   Wilson K, 2014, J TELEMED TELECARE, V20, P476, DOI 10.1177/1357633X14537771.},
Number-of-Cited-References = {18},
Times-Cited = {0},
Unique-ID = {WOS:000415920000003},
}

@article{ WOS:001067753900001,
Author = {Guan, Yue and McBride, Colleen M. and Pathak, Sarita and Gornick,
   Michele C.},
Title = {Just Dissemination of Genomics-Informed Public Health Applications: Time
   to Deepen Our Public Engagement Approaches},
Journal = {PUBLIC HEALTH GENOMICS},
Year = {2023},
Volume = {26},
Number = {1},
Pages = {165-170},
Month = {JAN-DEC},
Type = {Article},
Affiliation = {Guan, Y (Corresponding Author), Emory Univ, Rollins Sch Publ Hlth, Dept Behav Social \& Hlth Educ Sci, Atlanta, GA 30322 USA.
   Guan, Yue; McBride, Colleen M.; Pathak, Sarita; Gornick, Michele C., Emory Univ, Rollins Sch Publ Hlth, Dept Behav Social \& Hlth Educ Sci, Atlanta, GA 30322 USA.},
DOI = {10.1159/000534080},
EarlyAccessDate = {SEP 2023},
Keywords = {Cancer; Cancer genetics; Community-based participatory research; Public
   engagement; Community engagement; Precision public health; Public health
   genomics},
Keywords-Plus = {BREAST-CANCER; DISPARITIES; WOMEN; RISK; SAMPLE},
Research-Areas = {Genetics \& Heredity; Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Genetics \& Heredity; Public, Environmental \& Occupational Health},
Author-Email = {yue.guan@emory.edu},
Affiliations = {Emory University; Rollins School Public Health},
Cited-References = {Abelson J, 2003, SOC SCI MED, V57, P239, DOI 10.1016/S0277-9536(02)00343-X.
   Adams LB, 2017, J COMMUN HEALTH, V42, P1044, DOI 10.1007/s10900-017-0339-2.
   Chaiken S., 2011, HDB THEORIES SOCIAL, P246, DOI DOI 10.4135/9781446249215.N13.
   Cragun D, 2017, CANCER-AM CANCER SOC, V123, P2497, DOI 10.1002/cncr.30621.
   Daly B, 2015, CA-CANCER J CLIN, V65, P221, DOI 10.3322/caac.21271.
   Dietze EC, 2015, NAT REV CANCER, V15, P248, DOI 10.1038/nrc3896.
   Fisher ER, 2020, MOL GENET GENOM MED, V8, DOI 10.1002/mgg3.1099.
   Force U.S.P.S.T., 2015, Am Fam Physician, V91.
   Guan Y, 2022, FRONT PUBLIC HEALTH, V10, DOI 10.3389/fpubh.2022.984926.
   Guan Y, 2021, AM J PREV MED, V60, pE85, DOI 10.1016/j.amepre.2020.08.029.
   Guan Y, 2019, PUBLIC HEALTH GENOM, V22, P102, DOI 10.1159/000503129.
   Hall MJ, 2006, J CLIN ONCOL, V24, P2197, DOI 10.1200/JCO.2006.05.5889.
   Hann KEJ, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4375-8.
   Jones T, 2017, CANCER MED-US, V6, P1787, DOI 10.1002/cam4.1120.
   Khoury MJ, 2018, GENET MED, V20, P574, DOI 10.1038/gim.2017.211.
   Linnenbringer E, 2017, AIMS PUBLIC HEALTH, V4, P526, DOI 10.3934/publichealth.2017.5.526.
   Monticciolo DL, 2018, J AM COLL RADIOL, V15, P408, DOI 10.1016/j.jacr.2017.11.034.
   Nikolaidis C, 2019, GENET MED, V21, P1363, DOI 10.1038/s41436-018-0349-1.
   Nunn JS, 2019, FRONT PUBLIC HEALTH, V7, DOI 10.3389/fpubh.2019.00079.
   Pal T, 2013, BREAST J, V19, P189, DOI 10.1111/tbj.12083.
   Passmore SR, 2021, FIELD METHOD, V33, P159, DOI {[}10.1177/1525822x20982089, 10.1177/1525822X20982089].
   Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166.
   Sullivan G, 2017, J HEALTH CARE POOR U, V28, P548, DOI 10.1353/hpu.2017.0039.
   Veitinger JK, 2022, AM J PUBLIC HEALTH, V112, P1249, DOI 10.2105/AJPH.2022.306932.},
Number-of-Cited-References = {24},
Times-Cited = {0},
Unique-ID = {WOS:001067753900001},
}

@article{ WOS:000510978300001,
Author = {Cappelli, David},
Title = {Introduction: the advent of precision public health and the future of
   dental public health},
Journal = {JOURNAL OF PUBLIC HEALTH DENTISTRY},
Year = {2020},
Volume = {80},
Number = {1, SI},
Pages = {S5-S6},
Month = {MAR},
Abstract = {On the surface, the precision oral health movement seems to be at odds
   with dental public health. After all, precision oral health care focuses
   on the individual patient, where dental public health addresses the oral
   health needs of populations.
   Objective The American Institute of Dental Public Health (AIDPH)
   convened a colloquium to discuss the role of dental public health in the
   future of precision oral health.
   Methods On January 25 and 26, 2018, nine thought leaders from across the
   US outlined the potential role of public health, and more specifically
   dental public health, in the world of precision public health. Six of
   the speakers were invited to share their thoughts in this special
   edition.
   Results The special issue of the Journal of Public Health Dentistry
   shares the knowledge and insight provided by the speakers at the
   colloquium. It is with gratitude for their contribution, as well as, the
   contribution of the reviewers, organizers of the colloquium, and those
   in attendance who contributed their collective knowledge that we present
   this issue. Special thanks to HRSA for their support of this work
   (D88HP28510).},
Type = {Article},
Affiliation = {Cappelli, D (Corresponding Author), Univ Nevada Las Vegas, Sch Dent Med, Biomed Sci, 1001 Shadow Lane,MS 7412, Las Vegas, NV 89106 USA.
   Cappelli, David, Univ Nevada Las Vegas, Sch Dent Med, Biomed Sci, 1001 Shadow Lane,MS 7412, Las Vegas, NV 89106 USA.},
DOI = {10.1111/jphd.12359},
EarlyAccessDate = {FEB 2020},
Keywords = {precision public health; dental public health},
Research-Areas = {Dentistry, Oral Surgery \& Medicine; Public, Environmental \&
   Occupational Health},
Web-of-Science-Categories  = {Dentistry, Oral Surgery \& Medicine; Public, Environmental \&
   Occupational Health},
Author-Email = {david.cappelli@unlv.edu},
Affiliations = {Nevada System of Higher Education (NSHE); University of Nevada Las Vegas},
Cited-References = {Khoury MJ, 2015, JAMA-J AM MED ASSOC, V313, P2117, DOI 10.1001/jama.2015.3382.},
Number-of-Cited-References = {1},
Times-Cited = {1},
Unique-ID = {WOS:000510978300001},
}

@article{ WOS:000408603800001,
Author = {Baynam, Gareth and Bauskis, Alicia and Pachter, Nicholas and Schofield,
   Lyn and Verhoef, Hedwig and Palmer, Richard L. and Kung, Stefanie and
   Helmholz, Petra and Ridout, Michael and Walker, Caroline E. and Hawkins,
   Anne and Goldblatt, Jack and Weeramanthri, Tarun S. and Dawkins, Hugh J.
   S. and Molster, Caron M.},
Title = {3-Dimensional Facial Analysis-Facing Precision Public Health},
Journal = {FRONTIERS IN PUBLIC HEALTH},
Year = {2017},
Volume = {5},
Month = {APR 10},
Abstract = {Precision public health is a new field driven by technological advances
   that enable more precise descriptions and analyses of individuals and
   population groups, with a view to improving the overall health of
   populations. This promises to lead to more precise clinical and public
   health practices, across the continuum of prevention, screening,
   diagnosis, and treatment. A phenotype is the set of observable
   characteristics of an individual resulting from the interaction of a
   genotype with the environment. Precision (deep) phenotyping applies
   innovative technologies to exhaustively and more precisely examine the
   discrete components of a phenotype and goes beyond the information
   usually included in medical charts. This form of phenotyping is a
   critical component of more precise diagnostic capability and
   3-dimensional facial analysis (3DFA) is a key technological enabler in
   this domain. In this paper, we examine the potential of 3DFA as a public
   health tool, by viewing it against the 10 essential public health
   services of the ``public health wheel,{''} developed by the US Centers
   for Disease Control. This provides an illustrative framework to gage
   current and emergent applications of genomic technologies for
   implementing precision public health.},
Type = {Article},
Affiliation = {Baynam, G (Corresponding Author), Govt Western Australia, Genet Serv Western Australia, Dept Hlth, Perth, WA, Australia.
   Baynam, G (Corresponding Author), Western Australian Register Dev Anomalies, Perth, WA, Australia.
   Baynam, G (Corresponding Author), Govt Western Australia, Publ Hlth Div, Dept Hlth, Off Populat Hlth Genom, Perth, WA, Australia.
   Baynam, G (Corresponding Author), Univ Western Australia, Sch Paediat \& Child Hlth, Perth, WA, Australia.
   Baynam, G (Corresponding Author), Murdoch Univ, Inst Immunol \& Dis, Perth, WA, Australia.
   Baynam, G (Corresponding Author), Telethon Kids Inst, Perth, WA, Australia.
   Baynam, G (Corresponding Author), Curtin Univ, Dept Sci \& Engn, Spatial Sci, Perth, WA, Australia.
   Baynam, Gareth; Pachter, Nicholas; Schofield, Lyn; Hawkins, Anne; Goldblatt, Jack, Govt Western Australia, Genet Serv Western Australia, Dept Hlth, Perth, WA, Australia.
   Baynam, Gareth, Western Australian Register Dev Anomalies, Perth, WA, Australia.
   Baynam, Gareth; Bauskis, Alicia; Walker, Caroline E.; Dawkins, Hugh J. S.; Molster, Caron M., Govt Western Australia, Publ Hlth Div, Dept Hlth, Off Populat Hlth Genom, Perth, WA, Australia.
   Baynam, Gareth; Pachter, Nicholas; Goldblatt, Jack, Univ Western Australia, Sch Paediat \& Child Hlth, Perth, WA, Australia.
   Baynam, Gareth, Murdoch Univ, Inst Immunol \& Dis, Perth, WA, Australia.
   Baynam, Gareth, Telethon Kids Inst, Perth, WA, Australia.
   Baynam, Gareth, Curtin Univ, Dept Sci \& Engn, Spatial Sci, Perth, WA, Australia.
   Pachter, Nicholas; Dawkins, Hugh J. S., Univ Western Australia, Sch Pathol, Perth, WA, Australia.
   Pachter, Nicholas; Dawkins, Hugh J. S., Univ Western Australia, Lab Med, Perth, WA, Australia.
   Schofield, Lyn; Dawkins, Hugh J. S., Murdoch Univ, Ctr Comparat Genom, Perth, WA, Australia.
   Verhoef, Hedwig, Cooperat Res Ctr Spatial Informat, Perth, WA, Australia.
   Palmer, Richard L.; Kung, Stefanie; Helmholz, Petra; Ridout, Michael, Curtin Univ, Sch Spatial Sci, Perth, WA, Australia.
   Weeramanthri, Tarun S., Govt Western Australia, Publ Hlth Div, Dept Hlth, Perth, WA, Australia.
   Dawkins, Hugh J. S., Curtin Univ Technol, Curtin Hlth Innovat Res Inst, Ctr Populat Hlth Res, Perth, WA, Australia.},
DOI = {10.3389/fpubh.2017.00031},
Article-Number = {31},
Keywords = {public health; 3D facial scan; rare diseases; spatial information;
   genomics and genetics; developmental disabilities},
Keywords-Plus = {DISEASES; THERAPY; RARE},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {gareth.baynam@health.wa.gov.au},
Affiliations = {University of Western Australia; Murdoch University; University of
   Western Australia; Telethon Kids Institute; Curtin University;
   University of Western Australia; University of Western Australia;
   Murdoch University; Curtin University; Curtin University},
Cited-References = {Ayme S, 2013, REPORT STATE ART RAR.
   Baynam G, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0462-7.
   Baynam G, 2013, HUM MUTAT, V34, P14, DOI 10.1002/humu.22219.
   Baynam GS, 2013, TWIN RES HUM GENET, V16, P840, DOI 10.1017/thg.2013.49.
   Centers for Disease Control and Prevention, 2016, PUBL HLTH SYST 10 ES.
   Claes P, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004224.
   Deardorff MA., 1993, GeneReviews.
   Department of Health Western Australia, 2010, FET ALC SPECTR DIS O.
   Department of Health Western Australia, 2016, HEALTHVIEW MAGAZINE, P15.
   Department of Health Western Australian, 2016, W AUSTR REG DEV AN.
   European Organisation for Rare Diseases, 2005, RAR DIS UND PUBL HLT.
   European Surveillance of Congential Anomalies, 2012, CONG AN MAJ CAUS MAI.
   Fetal Alcohol Syndrome Diagnostic and Prevention Network, 2016, LIP PHILT GUID.
   Gahl WA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004980.
   Hammond P, 2012, AM J MED GENET A, V158A, P1368, DOI 10.1002/ajmg.a.35346.
   Kung S, 2015, JIMD REP, V22, P99, DOI 10.1007/8904\_2015\_417.
   McWalter K, 2015, J GENET COUNS, V24, P375, DOI 10.1007/s10897-015-9825-9.
   Molster C, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-50.
   Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4.
   National Institutes of Health, 2016, NIH WID STRAT PLAN T.
   Office of Population Health Genomics, 2015, WARARE DIS STRAT FRA.
   Schieppati A, 2008, LANCET, V371, P2039, DOI 10.1016/S0140-6736(08)60872-7.
   Sorensen G., 2014, WHITE PAPER DIAGNOSI.
   Suttie M, 2013, PEDIATRICS, V131, pE779, DOI 10.1542/peds.2012-1371.
   Tan WH, 2014, AM J MED GENET A, V164, P975, DOI 10.1002/ajmg.a.36416.
   Taruscio D, 2015, MOL GENET METAB, V116, P223, DOI 10.1016/j.ymgme.2015.11.003.
   Tomblin JB, 1997, J SPEECH LANG HEAR R, V40, P1245, DOI 10.1044/jslhr.4006.1245.
   VALDEZ R, 2016, PREV CHRONIC DIS, V13, DOI DOI 10.5888/PCD13.150491.
   Walker CE, 2017, GENET MED, V19, P546, DOI 10.1038/gim.2016.143.
   Western Australian Health Translation Network, 2015, FAC W AUSTR.},
Number-of-Cited-References = {30},
Times-Cited = {13},
Unique-ID = {WOS:000408603800001},
}

@article{ WOS:000780029100011,
Author = {Genevieve, Lester Darryl and Martani, Andrea and Wangmo, Tenzin and
   Elger, Bernice Simone},
Title = {Precision Public Health and Structural Racism in the United States:
   Promoting Health Equity in the COVID-19 Pandemic Response},
Journal = {JMIR PUBLIC HEALTH AND SURVEILLANCE},
Year = {2022},
Volume = {8},
Number = {3},
Month = {MAR},
Abstract = {The COVID-19 pandemic has revealed deeply entrenched structural
   inequalities that resulted in an excess of mortality and morbidity in
   certain racial and ethnic groups in the United States. Therefore, this
   paper examines from the US perspective how structural racism and
   defective data collection on racial and ethnic minorities can negatively
   influence the development of precision public health (PPH) approaches to
   tackle the ongoing COVID-19 pandemic. Importantly, the effects of
   structural and data racism on the development of fair and inclusive
   data-driven components of PPH interventions are discussed, such as with
   the use of machine learning algorithms to predict public health risks.
   The objective of this viewpoint is thus to inform public health
   policymaking with regard to the development of ethically sound PPH
   interventions against COVID-19. Particular attention is given to
   components of structural racism (eg, hospital segregation, implicit and
   organizational bias, digital divide, and sociopolitical influences) that
   are likely to hinder such approaches from achieving their social justice
   and health equity goals.},
Type = {Article},
Affiliation = {Geneviève, LD (Corresponding Author), Univ Basel, Inst Biomed Eth, Bernoullistr 28, CH-4056 Basel, Switzerland.
   Genevieve, Lester Darryl; Martani, Andrea; Wangmo, Tenzin; Elger, Bernice Simone, Univ Basel, Inst Biomed Eth, Bernoullistr 28, CH-4056 Basel, Switzerland.
   Elger, Bernice Simone, Univ Geneva, Univ Ctr Legal Med, Geneva, Switzerland.},
DOI = {10.2196/33277},
Article-Number = {e33277},
Keywords = {precision public health; structural racism; COVID-19; pandemic; social
   justice; health equity; SARS-CoV-2; stigma; discrimination; disparity;
   inequality; precision health; public health; racism; equity; mortality;
   morbidity},
Keywords-Plus = {US; BIAS},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {lester.genevieve@unibas.ch},
Affiliations = {University of Basel; University of Geneva},
Cited-References = {Anand S, 2020, LANCET, V396, P1335, DOI 10.1016/S0140-6736(20)32009-2.
   {[}Anonymous], 2020, NAT MACH INTELL, V2, P363, DOI 10.1038/s42256-020-0210-5.
   {[}Anonymous], Machine learning.
   {[}Anonymous], Risk for COVID-19 Infection, Hospitalization, and Death By Race/Ethnicity.
   {[}Anonymous], 2020, ARE WE TIPPING POINT.
   {[}Anonymous], 2020, COVID 19 RAC ETHN HL.
   {[}Anonymous], INTERNETBROADBAND FA.
   {[}Anonymous], COLOR CORONAVIRUS CO.
   {[}Anonymous], 2016, TERMS YOU SHOULD KNO.
   Bailey ZD, 2017, LANCET, V389, P1453, DOI 10.1016/S0140-6736(17)30569-X.
   Bibbins-Domingo K, 2020, LOS ANGELES TIMES.
   Campos-Castillo C, 2020, J MED INTERNET RES, V22, DOI 10.2196/20472.
   Chander S., DATA RACISM NEW FRON.
   Chowkwanyun M, 2018, NEW ENGL J MED, V379, P1398, DOI 10.1056/NEJMp1806634.
   Dowling MK, 2020, JAMA-J AM MED ASSOC, V324, P229, DOI 10.1001/jama.2020.10531.
   El Naqa I, 2015, MACHINE LEARNING RAD, DOI 10.1007/978-3-319-18305-3\_4.
   Farmer Blake., 2020, NPR.
   Feagin J, 2014, SOC SCI MED, V103, P7, DOI 10.1016/j.socscimed.2013.09.006.
   Friston K, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-003978.
   Garg S, 2020, JMIR PUBLIC HLTH SUR, V6, P221, DOI 10.2196/18795.
   Geneviève LD, 2020, BMC MED ETHICS, V21, DOI 10.1186/s12910-020-0457-8.
   Geneviève LD, 2019, J MED INTERNET RES, V21, DOI 10.2196/12273.
   Glastris P, 2020, WASH POST.
   Gravlee CC, 2020, AM J HUM BIOL, V32, DOI 10.1002/ajhb.23482.
   Griffith DM, 2007, J COMMUNITY PSYCHOL, V35, P287, DOI 10.1002/jcop.20149.
   Hall WJ, 2015, AM J PUBLIC HEALTH, V105, pE60, DOI 10.2105/AJPH.2015.302903.
   Horton R, 2018, LANCET, V392, P1504, DOI 10.1016/S0140-6736(18)32741-7.
   Khoury MJ, 2021, GENOME MED, V13, DOI 10.1186/s13073-021-00886-y.
   Khoury MJ, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003373.
   Khoury MJ, 2018, PUBLIC HEALTH GENOM, V21, P244, DOI 10.1159/000501465.
   Krieger N, 2020, LANCET, V396, pE81, DOI 10.1016/S0140-6736(20)32220-0.
   Krieger N, 2020, AM J PUBLIC HEALTH, V110, P1620, DOI 10.2105/AJPH.2020.305886.
   Leong N, 2013, HARVARD LAW REV, V126, P2151.
   Martin CA, 2020, ECLINICALMEDICINE, V25, DOI 10.1016/j.eclinm.2020.100466.
   Mulchan SS, 2021, J PEDIATR PSYCHOL, V46, P138, DOI 10.1093/jpepsy/jsaa131.
   Munnink BOB, 2020, NAT MED, V26, DOI 10.1038/s41591-020-0997-y.
   Poteat T, 2020, ANN EPIDEMIOL, V47, P1, DOI 10.1016/j.annepidem.2020.05.004.
   Rasmussen SA, 2020, JAMA-J AM MED ASSOC, V324, P933, DOI 10.1001/jama.2020.14992.
   Richardson J., 2020, LASTING IMPACT HIST.
   Richardson R., 2019, NEW YORK U LAW REV.
   Robinson WR, 2020, BIOSTATISTICS, V21, P339, DOI 10.1093/biostatistics/kxz040.
   Roscigno VJ, 2007, ANN AM ACAD POLIT SS, V609, P16, DOI 10.1177/0002716206294898.
   Rose G, 2001, INT J EPIDEMIOL, V30, P427, DOI 10.1093/ije/30.3.427.
   Servick K., 2020, WILL COVID 19 AFFECT.
   Taylor-Robinson D, 2019, INT J EPIDEMIOL, V48, P1, DOI 10.1093/ije/dyy184.
   Wachter S., 2021, W VA LAW REV, V123, DOI {[}10.2139/ssrn.3792772, DOI 10.2139/SSRN.3792772].
   Wade L., 2020, Science News , May 14, DOI 10.1126/science.abc7832.
   Weeramanthri TS, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00121.
   Wiecek WM, 2014, LA LAW REV.
   Wiens J, 2019, NAT MED, V25, P1337, DOI 10.1038/s41591-019-0548-6.
   Williams DR, 2020, JAMA-J AM MED ASSOC, V323, P2478, DOI 10.1001/jama.2020.8051.
   Williams RA, 2007, ELIMINATING HEALTHCA, P3.
   Yearby R, 2020, J LAW MED ETHICS, V48, P518, DOI 10.1177/1073110520958876.
   Yearby R, 2020, J LAW BIOSCI, V7, DOI 10.1093/jlb/lsaa036.},
Number-of-Cited-References = {54},
Times-Cited = {3},
Unique-ID = {WOS:000780029100011},
}

@article{ WOS:000443786000002,
Author = {Molster, Caron M. and Bowman, Faye L. and Bilkey, Gemma A. and Cho,
   Angela S. and Burns, Belinda L. and Nowak, Kristen J. and Dawkins, Hugh
   J. S.},
Title = {The Evolution of Public Health Genomics: Exploring Its Past, Present,
   and Future},
Journal = {FRONTIERS IN PUBLIC HEALTH},
Year = {2018},
Volume = {6},
Month = {SEP 4},
Abstract = {Public health genomics has evolved to responsibly integrate advancements
   in genomics into the fields of personalized medicine and public health.
   Appropriate, effective and sustainable integration of genomics into
   healthcare requires an organized approach. This paper outlines the
   history that led to the emergence of public health genomics as a
   distinguishable field. In addition, a range of activities are described
   that illustrate how genomics can be incorporated into public health
   practice. Finally, it presents the evolution of public health genomics
   into the new era of ``precision public health.{''}},
Type = {Review},
Affiliation = {Bowman, FL (Corresponding Author), Western Australian Dept Hlth, Publ \& Aboriginal Hlth Div, Off Populat Hlth Genom, East Perth, WA, Australia.
   Molster, Caron M.; Bowman, Faye L.; Bilkey, Gemma A.; Cho, Angela S.; Burns, Belinda L.; Nowak, Kristen J.; Dawkins, Hugh J. S., Western Australian Dept Hlth, Publ \& Aboriginal Hlth Div, Off Populat Hlth Genom, East Perth, WA, Australia.
   Bilkey, Gemma A., Western Australian Dept Hlth, Off Chief Hlth Officer, Publ \& Aboriginal Hlth Div, East Perth, WA, Australia.
   Nowak, Kristen J.; Dawkins, Hugh J. S., Univ Western Australia, Sch Biomed Sci, Fac Hlth \& Med Sci, Crawley, WA, Australia.
   Nowak, Kristen J., QEII Med Ctr, Harry Perkins Inst Med Res, Nedlands, WA, Australia.
   Dawkins, Hugh J. S., Murdoch Univ, Sir Walter Murdoch Sch Policy \& Int Affairs, Murdoch, WA, Australia.
   Dawkins, Hugh J. S., Curtin Univ Technol, Sch Publ Hlth, Bentley, WA, Australia.},
DOI = {10.3389/fpubh.2018.00247},
Article-Number = {247},
Keywords = {public health genomics; precision public health; genomics; population
   genetics; population health},
Keywords-Plus = {FOR-DISEASE-CONTROL; POPULATION HEALTH; UNITED-STATES; MEDICINE; CARE;
   PREVENTION; GENETICS; POLICY; AGENDA; ERA},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {faye.bowman@health.wa.gov.au},
Affiliations = {University of Western Australia; Queen Elizabeth II Medical Centre;
   Harry Perkins Institute of Medical Research; University of Western
   Australia; Murdoch University; Curtin University},
Cited-References = {Aarden E, 2011, SCAND J PUBLIC HEALT, V39, P634, DOI 10.1177/1403494811414241.
   Alber K, 2017, BMC FAM PRACT, V18, DOI 10.1186/s12875-017-0667-4.
   {[}Anonymous], 1988, FUT PUBL HLTH.
   {[}Anonymous], 2009, Statements from Global Conferences.
   {[}Anonymous], 2016, OV HUM GEN PROJ.
   {[}Anonymous], 100000 GEN PROJ.
   {[}Anonymous], ITAL J PUBLIC HLTH.
   Awofeso N, 2004, AM J PUBLIC HEALTH, V94, P705, DOI 10.2105/AJPH.94.5.705.
   Baynam G, 2017, ADV EXP MED BIOL, V1031, P511, DOI 10.1007/978-3-319-67144-4\_27.
   Beskow L.M., 2001, Community Genet, V4, P2, DOI 10.1159/000051150.
   Boccia S, 2014, EUR J PUBLIC HEALTH, V24, P877, DOI 10.1093/eurpub/cku142.
   Boccia S, 2009, MUTAT RES-FUND MOL M, V667, P27, DOI 10.1016/j.mrfmmm.2008.10.003.
   Bowen MS, 2012, PUBLIC HEALTH GENOM, V15, P327, DOI 10.1159/000341889.
   Brodersen J, 2014, APMIS, V122, P683, DOI 10.1111/apm.12278.
   Bunnik EM, 2011, BMC MED ETHICS, V12, DOI 10.1186/1472-6939-12-11.
   Burke W, 2006, GENET MED, V8, P451, DOI 10.1097/01.gim.0000228213.72256.8c.
   Burke W, 2010, GENET MED, V12, P785, DOI 10.1097/GIM.0b013e3182011222.
   Burton H, 2014, BRIT MED BULL, V112, P37, DOI 10.1093/bmb/ldu032.
   Burton H, 2009, PUBLIC HEALTH GENOM, V12, P11, DOI 10.1159/000153426.
   Bustamante CD, 2011, NATURE, V475, P163, DOI 10.1038/475163a.
   Camp Kathryn M, 2014, J Acad Nutr Diet, V114, P299, DOI 10.1016/j.jand.2013.12.001.
   Caulfield T, 2012, ANNU REV MED, V63, P23, DOI 10.1146/annurev-med-062110-123753.
   Cleeren E, 2011, ARCH PUBLIC HEALTH, V69, DOI 10.1186/0778-7367-69-8.
   Covolo L, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4378.
   D'Andrea E, 2018, EUR J HUM GENET, V26, P518, DOI 10.1038/s41431-017-0083-1.
   {*}DEP HLTH, 2017, NAT HLTH GEN POL FRA.
   Dyer O, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k2001.
   El-Sayed AM, 2013, AM J PUBLIC HEALTH, V103, pS14, DOI 10.2105/AJPH.2012.301127.
   Fears R, 2013, EUR J HUM GENET, V21, P703, DOI 10.1038/ejhg.2012.238.
   Galea S., 2016, PRECISION MED POPULA.
   Genome-based research and population health, 2005, WORKSH HELD ROCK FDN.
   Gilmour MW, 2013, PUBLIC HEALTH GENOM, V16, P25, DOI 10.1159/000342709.
   Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657.
   Green RF, 2015, HEALTHCARE-BASEL, V3, P830, DOI 10.3390/healthcare3030830.
   Guttmacher AE, 2007, NAT REV GENET, V8, P151, DOI 10.1038/nrg2007.
   Gwinn M, 2006, COMMUNITY GENET, V9, P21, DOI 10.1159/000090689.
   Horn EJ, 2011, GENET TEST MOL BIOMA, V15, P741, DOI 10.1089/gtmb.2011.1525.
   House of Commons Science and Technology Committee, 2018, GEN GEN ED NHS 3 REP.
   Ianuale C, 2014, BMC MED EDUC, V14, DOI 10.1186/1472-6920-14-213.
   Jamoulle M.e., 1995, Quaternary prevention.
   Khoury M, 2016, GENOMICS HLTH IMPACT.
   Khoury MJ, 2009, PUBLIC HEALTH GENOM, V12, P20, DOI 10.1159/000153427.
   Khoury MJ, 2007, GENET MED, V9, P665, DOI 10.1097/GIM.0b013e31815699d0.
   Khoury MJ, 2007, AM J PREV MED, V33, P310, DOI 10.1016/j.amepre.2007.05.010.
   Khoury Muin J, 2005, Prev Chronic Dis, V2, pA05.
   Khoury MJ, 2018, GENET MED, V20, P574, DOI 10.1038/gim.2017.211.
   Khoury MJ, 2016, JAMA-J AM MED ASSOC, V316, P1357, DOI 10.1001/jama.2016.12260.
   Khoury MJ, 2015, AM J EPIDEMIOL, V182, P977, DOI 10.1093/aje/kwv228.
   Khoury MJ, 2011, CANCER EPIDEM BIOMAR, V20, P2105, DOI 10.1158/1055-9965.EPI-11-0481.
   Khoury MJ, 2011, AM J PREV MED, V40, P486, DOI 10.1016/j.amepre.2010.12.009.
   Khoury MJ, 2010, AM J EPIDEMIOL, V172, P517, DOI 10.1093/aje/kwq211.
   Knoppers BM, 2010, PUBLIC HEALTH GENOM, V13, P224, DOI 10.1159/000279624.
   Lecuit M, 2015, EXPERT REV MOL DIAGN, V15, P1517, DOI 10.1586/14737159.2015.1111140.
   Manamperi A, 2008, ASIA-PAC J PUBLIC HE, V20, P242, DOI 10.1177/1010539508316783.
   Manrai AK, 2016, NEW ENGL J MED, V375, P655, DOI 10.1056/NEJMsa1507092.
   Martins C, 2018, EUR J GEN PRACT, V24, P106, DOI 10.1080/13814788.2017.1422177.
   Marzuillo C, 2014, QJM-INT J MED, V107, P93, DOI 10.1093/qjmed/hct190.
   Mazzucco W, 2017, EUR J PUBLIC HEALTH, V27, P931, DOI 10.1093/eurpub/ckw155.
   Mazzucco W, 2012, EPIDEMIOL BIOSTAT PU, V9, DOI 10.2427/8673.
   McGrath BB, 2012, PUBLIC HEALTH GENOM, V15, P125, DOI 10.1159/000335551.
   McGuire AL, 2011, PUBLIC HEALTH GENOM, V14, P53, DOI 10.1159/000321962.
   McWalter K, 2015, J GENET COUNS, V24, P375, DOI 10.1007/s10897-015-9825-9.
   Metcalfe SA, 2009, PUBLIC HEALTH GENOMI, V12, P121, DOI 10.1159/000160666.
   Michelazzo MB, 2015, EPIDEMIOL BIOSTAT PU, V12, DOI 10.2427/11516.
   Noonan AS, 2002, GENET MED, V4, p72S, DOI 10.1097/00125817-200211001-00016.
   Noonan AS, 2002, GENET MED, V4, p68S, DOI 10.1097/00125817-200211001-00015.
   Nowak KJ, 2018, EUR J HUM GENET, V26, P616, DOI 10.1038/s41431-018-0101-y.
   Precision Public Health Summit, 2016, SUMM REP.
   Public Health Functions Steering Committee, 1994, VIS PUBL HLTH AM HLT.
   Riley WT, 2015, TRANSL BEHAV MED, V5, P243, DOI 10.1007/s13142-015-0320-5.
   Roberts JS, 2014, ANNU REV GENOM HUM G, V15, P461, DOI 10.1146/annurev-genom-090413-025514.
   Rogowski WH, 2009, NAT REV GENET, V10, P489, DOI 10.1038/nrg2606.
   Sankar PL, 2017, GENET MED, V19, P743, DOI 10.1038/gim.2016.183.
   Sboner A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-125.
   Simone B, 2013, HEALTH POLICY, V110, P214, DOI 10.1016/j.healthpol.2013.01.015.
   St Pierre J, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130267.
   Stein LD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-207.
   Tesser CD, 2017, REV SAUDE PUBL, V51, DOI {[}10.11606/S1518-8787.2017051000041, 10.11606/s1518-8787.2017051000041].
   Weeramanthri TS, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00121.
   Wilkinson JR, 2011, PUBLIC HEALTH GENOM, V14, P35, DOI 10.1159/000294170.
   Williamson R., 2018, FUTURE PRECISION MED.
   Zimmern RL, 2011, J PUBLIC HEALTH-UK, V33, P477, DOI 10.1093/pubmed/fdr080.},
Number-of-Cited-References = {82},
Times-Cited = {33},
Unique-ID = {WOS:000443786000002},
}

@article{ WOS:000888746700002,
Author = {Canfell, Oliver J. and Kodiyattu, Zack and Eakin, Elizabeth and
   Burton-Jones, Andrew and Wong, Ides and Macaulay, Caroline and Sullivan,
   Clair},
Title = {Real-world data for precision public health of noncommunicable diseases:
   a scoping review},
Journal = {BMC PUBLIC HEALTH},
Year = {2022},
Volume = {22},
Number = {1},
Month = {NOV 24},
Abstract = {Background Global public health action to address noncommunicable
   diseases (NCDs) requires new approaches. NCDs are primarily prevented
   and managed in the community where there is little investment in digital
   health systems and analytics; this has created a data chasm and
   relatively silent burden of disease. The nascent but rapidly emerging
   area of precision public health offers exciting new opportunities to
   transform our approach to NCD prevention. Precision public health uses
   routinely collected real-world data on determinants of health (social,
   environmental, behavioural, biomedical and commercial) to inform
   precision decision-making, interventions and policy based on social
   position, equity and disease risk, and continuously monitors outcomes -
   the right intervention for the right population at the right time. This
   scoping review aims to identify global exemplars of precision public
   health and the data sources and methods of their aggregation/application
   to NCD prevention. Methods The Preferred Reporting Items for Systematic
   Reviews and Meta-Analyses extension for scoping reviews (PRISMA-ScR) was
   followed. Six databases were systematically searched for articles
   published until February 2021. Articles were included if they described
   digital aggregation of real-world data and `traditional' data for
   applied community, population or public health management of NCDs.
   Real-world data was defined as routinely collected (1) Clinical,
   Medication and Family History (2) Claims/Billing (3) Mobile Health (4)
   Environmental (5) Social media (6) Molecular profiling (7)
   Patient-centred (e.g., personal health record). Results were analysed
   descriptively and mapped according to the three horizons framework for
   digital health transformation. Results Six studies were included.
   Studies developed population health surveillance methods and tools using
   diverse real-world data (e.g., electronic health records and health
   insurance providers) and traditional data (e.g., Census and
   administrative databases) for precision surveillance of 28 NCDs.
   Population health analytics were applied consistently with descriptive,
   geospatial and temporal functions. Evidence of using surveillance tools
   to create precision public health models of care or improve policy and
   practice decisions was unclear. Conclusions Applications of real-world
   data and designed data to address NCDs are emerging with greater
   precision. Digital transformation of the public health sector must be
   accelerated to create an efficient and sustainable predict-prevent
   healthcare system.},
Type = {Review},
Affiliation = {Canfell, OJ (Corresponding Author), Univ Queensland, Fac Med, Ctr Hlth Serv Res, St Lucia, Qld, Australia.
   Canfell, OJ (Corresponding Author), Univ Queensland, Fac Business Econ \& Law, UQ Business Sch, St Lucia, Qld, Australia.
   Canfell, OJ (Corresponding Author), Australian Govt, Digital Hlth Cooperat Res Ctr, Sydney, NSW, Australia.
   Canfell, OJ (Corresponding Author), Queensland Govt, State Queensland, Hlth \& Wellbeing Queensland, Milton, Qld, Australia.
   Canfell, OJ (Corresponding Author), Univ Queensland, Fac Med, Queensland Digital Hlth Ctr, Herston, Qld, Australia.
   Canfell, Oliver J.; Sullivan, Clair, Univ Queensland, Fac Med, Ctr Hlth Serv Res, St Lucia, Qld, Australia.
   Canfell, Oliver J.; Burton-Jones, Andrew, Univ Queensland, Fac Business Econ \& Law, UQ Business Sch, St Lucia, Qld, Australia.
   Canfell, Oliver J., Australian Govt, Digital Hlth Cooperat Res Ctr, Sydney, NSW, Australia.
   Canfell, Oliver J.; Macaulay, Caroline; Sullivan, Clair, Queensland Govt, State Queensland, Hlth \& Wellbeing Queensland, Milton, Qld, Australia.
   Canfell, Oliver J.; Sullivan, Clair, Univ Queensland, Fac Med, Queensland Digital Hlth Ctr, Herston, Qld, Australia.
   Kodiyattu, Zack, Univ Queensland, Fac Med, Sch Clin Med, St Lucia, Qld, Australia.
   Eakin, Elizabeth, Univ Queensland, Fac Med, Sch Publ Hlth, St Lucia, Qld, Australia.
   Wong, Ides, Queensland Govt, Dept Hlth, Off Chief Clin Informat Officer, Clin Excellence Queensland, Brisbane, Qld, Australia.
   Sullivan, Clair, Queensland Govt, Dept Hlth, Metro North Hosp \& Hlth Serv, Herston, Qld, Australia.},
DOI = {10.1186/s12889-022-14452-7},
Article-Number = {2166},
Keywords = {Public health; Health promotion; Preventive medicine; Public health
   informatics; Medical informatics; Chronic disease; Noncommunicable
   diseases},
Keywords-Plus = {SURVEILLANCE; RECORDS},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {o.canfell@uq.edu.au},
Affiliations = {University of Queensland; University of Queensland; Digital Health
   Cooperative Research Centre (DHCRC); University of Queensland;
   University of Queensland; University of Queensland; Queensland Health;
   Queensland Health},
Cited-References = {Abbafati C, 2020, LANCET, V396, P1135, DOI 10.1016/S0140-6736(20)31404-5.
   Aliabadi A, 2020, J AM MED INFORM ASSN, V27, P1977, DOI 10.1093/jamia/ocaa186.
   Australian Institute of Health and Welfare, 2021, Australian burden of disease study: impact and causes of illness and death in Australia 2018.
   Bambra C, 2020, J EPIDEMIOL COMMUN H, V74, P964, DOI 10.1136/jech-2020-214401.
   Birkhead GS, 2015, ANNU REV PUBL HEALTH, V36, P345, DOI 10.1146/annurev-publhealth-031914-122747.
   Bray GA, 2017, OBES REV, V18, P715, DOI 10.1111/obr.12551.
   Budd J, 2020, NAT MED, V26, P1183, DOI 10.1038/s41591-020-1011-4.
   Canfell O, 2022, REAL WORLD DATA PREC.
   Canfell OJ, 2022, FRONT PUBLIC HEALTH, V10, DOI 10.3389/fpubh.2022.854525.
   Canfell OJ, 2022, BMC PUBLIC HEALTH, V22, DOI 10.1186/s12889-022-12939-x.
   Canfell OJ, 2022, AUST HEALTH REV, V46, P279, DOI 10.1071/AH21063.
   Cocoros NM, 2021, AM J PUBLIC HEALTH, V111, P269, DOI 10.2105/AJPH.2020.305963.
   Dolley S, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00068.
   Enticott J, 2021, BMC HEALTH SERV RES, V21, DOI 10.1186/s12913-021-06215-8.
   Fareed N, 2020, APPL CLIN INFORM, V11, P515, DOI 10.1055/s-0040-1714249.
   Glidewell J, 2018, BIRTH DEFECTS RES, V110, P1395, DOI 10.1002/bdr2.1400.
   Groves Robert., 2011, `Designed Data' and `Organic Data'.
   Guilbert Theresa W, 2012, WMJ, V111, P124.
   Hatef E, 2019, INT J MED INFORM, V124, P86, DOI 10.1016/j.ijmedinf.2019.01.012.
   Hekler E, 2020, ANN BEHAV MED, V54, P805, DOI 10.1093/abm/kaaa018.
   Ji X, 2017, J INF SCI, V43, P221, DOI 10.1177/0165551515625029.
   Kruse CS, 2018, J MED SYST, V42, DOI 10.1007/s10916-018-1075-6.
   Lewinter KE, 2020, NPJ DIGIT MED, V3, DOI 10.1038/s41746-020-00368-2.
   Li SX, 2020, J MED INTERNET RES, V22, DOI 10.2196/17340.
   Lix Lisa M, 2018, Int J Popul Data Sci, V3, P433, DOI 10.23889/ijpds.v3i3.433.
   Murray CJL, 2020, LANCET, V396, P1223, DOI {[}10.1016/S0140-6736(20)30752-2, 10.1016/S0140-6736(20)30925-9].
   Murray CJL, 2020, LANCET PUBLIC HEALTH, V5, pE469, DOI 10.1016/S2468-2667(20)30187-0.
   Olstad DL, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-030279.
   Paul MM, 2015, POPUL HEALTH MANAG, V18, P209, DOI 10.1089/pop.2014.0093.
   Peters MDJ, 2015, INT J EVID-BASED HEA, V13, P141, DOI 10.1097/XEB.0000000000000050.
   Peterson ED, 2019, JAMA-J AM MED ASSOC, V322, P2283, DOI 10.1001/jama.2019.17831.
   Predmore Z, 2019, POPUL HEALTH MANAG, V22, P488, DOI 10.1089/pop.2018.0151.
   Shaban-Nejad A, 2017, ANN NY ACAD SCI, V1387, P44, DOI 10.1111/nyas.13271.
   Steinwachs Donald M, 2014, EGEMS (Wash DC), V2, P1175, DOI 10.13063/2327-9214.1175.
   Sullivan C, 2021, APPL CLIN INFORM, V12, P229, DOI 10.1055/s-0041-1725186.
   Swift B, 2018, CTS-CLIN TRANSL SCI, V11, P450, DOI 10.1111/cts.12559.
   Tricco AC, 2018, ANN INTERN MED, V169, P467, DOI 10.7326/M18-0850.
   Veritas Health Innovations, Covidence systematics review software Melbourne, Australia.
   Vos T, 2020, LANCET, V396, P1562.
   WHO, 2021, FACT SHEET NONC DIS.
   World Health Organization, 2013, Global action plan for the prevention and control of noncommunicable diseases 2013-2020.},
Number-of-Cited-References = {41},
Times-Cited = {2},
Unique-ID = {WOS:000888746700002},
}

@article{ WOS:000517442200008,
Author = {Huang, Tao and Gao, Wenjing and Lv, Jun and Yu, Canqing and Wu, Tao and
   Wang, Shengfeng and Liao, Chunxiao and Meng, Lu and Wang, Dongmeng and
   Wang, Zhaonian and Pang, Zengchang and Yu, Min and Wang, Hua and Wu,
   Xianping and Dong, Zhong and Wu, Fan and Jiang, Guohong and Wang,
   Xiaojie and Liu, Yu and Deng, Jian and Lu, Lin and Cao, Weihua and Li,
   Liming},
Title = {The Chinese National Twin Registry: A Unique Data Source for Systems
   Epidemiology of Complex Disease},
Journal = {TWIN RESEARCH AND HUMAN GENETICS},
Year = {2019},
Volume = {22},
Number = {6, SI},
Pages = {482-485},
Month = {DEC},
Abstract = {The Chinese National Twin Registry (CNTR), initiated in 2001, has now
   become the largest twin registry in Asia. From 2015 to 2018, the CNTR
   continued to receive Chinese government funding and had recruited 61,566
   twin-pairs by 2019 to study twins discordant for specific exposures such
   as environmental factors, and twins discordant for disease outcomes or
   measures of morbidity. Omic data, including genetics, genomics,
   metabolomics, and proteomics, and gut microbiome will be tested. The
   integration of omics and digital technologies in public health will
   advance our understanding of precision public health. This review
   introduces the updates of the CNTR, including study design, sample size,
   biobank, zygosity assessment, advances in research and future systems
   epidemiologic research.},
Type = {Article},
Affiliation = {Li, LM (Corresponding Author), Peking Univ, Sch Publ Hlth, Dept Epidemiol \& Biostat, Beijing, Peoples R China.
   Huang, Tao; Gao, Wenjing; Lv, Jun; Yu, Canqing; Wu, Tao; Wang, Shengfeng; Liao, Chunxiao; Meng, Lu; Wang, Dongmeng; Wang, Zhaonian; Cao, Weihua; Li, Liming, Peking Univ, Sch Publ Hlth, Dept Epidemiol \& Biostat, Beijing, Peoples R China.
   Pang, Zengchang, Qingdao Ctr Dis Control \& Prevent, Qingdao, Peoples R China.
   Yu, Min, Zhejiang Ctr Dis Control \& Prevent, Hangzhou, Peoples R China.
   Wang, Hua, Jiangsu Ctr Dis Control \& Prevent, Nanjing, Peoples R China.
   Wu, Xianping, Sichuan Ctr Dis Control \& Prevent, Chengdu, Peoples R China.
   Dong, Zhong, Beijing Ctr Dis Control \& Prevent, Beijing, Peoples R China.
   Wu, Fan, Shanghai Ctr Dis Control \& Prevent, Shanghai, Peoples R China.
   Jiang, Guohong, Tianjin Ctr Dis Control \& Prevent, Tianjin, Peoples R China.
   Wang, Xiaojie, Qinghai Ctr Dis Control \& Prevent, Xining, Peoples R China.
   Liu, Yu, Heilongjiang Agr Ctr Dis Control \& Prevent, Harbin, Peoples R China.
   Deng, Jian, Handan Ctr Dis Control \& Prevent, Handan, Peoples R China.
   Lu, Lin, Yunnan Ctr Dis Control \& Prevent, Kunming, Yunnan, Peoples R China.},
DOI = {10.1017/thg.2019.85},
Article-Number = {PII S1832427419000859},
Keywords = {Omic data; precision public health; systems epidemiology; twin
   discordance; twins},
Keywords-Plus = {BMI},
Research-Areas = {Genetics \& Heredity; Obstetrics \& Gynecology},
Web-of-Science-Categories  = {Genetics \& Heredity; Obstetrics \& Gynecology},
Author-Email = {lmlee@vip.163.com},
Affiliations = {Peking University; Jiangsu Provincial Center for Disease Control \&
   Prevention; Shanghai Center for Disease Control \& Prevention; Tianjin
   Center for Disease Control \& Prevention},
Cited-References = {Gao WJ, 2006, TWIN RES HUM GENET, V9, P266, DOI 10.1375/twin.9.2.266.
   Li LM, 2006, TWIN RES HUM GENET, V9, P747, DOI 10.1375/twin.9.6.747.
   Li LM, 2013, TWIN RES HUM GENET, V16, P86, DOI 10.1017/thg.2012.148.
   Liao CX, 2018, TWIN RES HUM GENET, V21, P126, DOI 10.1017/thg.2018.8.
   Liao CX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140595.
   Liu QQ, 2015, TWIN RES HUM GENET, V18, P571, DOI 10.1017/thg.2015.63.
   Wang BQ, 2016, OBESITY, V24, P750, DOI 10.1002/oby.21402.
   Wang BQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123992.
   Yang HY, 2002, TWIN RES, V5, P347, DOI 10.1375/136905202320906075.},
Number-of-Cited-References = {9},
Times-Cited = {5},
Unique-ID = {WOS:000517442200008},
}

@article{ WOS:001022158000006,
Author = {Rocha, Paulo and Pinheiro, Diego and Monteiro, Rodrigo de Paula and
   Tubert, Ela and Romero, Erick and Bastos-Filho, Carmelo and Nuno, Miriam
   and Cadeiras, Martin},
Title = {Adaptive Content Tuning of Social Network Digital Health Interventions
   Using Control Systems Engineering for Precision Public Health: Cluster
   Randomized Controlled Trial},
Journal = {JOURNAL OF MEDICAL INTERNET RESEARCH},
Year = {2023},
Volume = {25},
Month = {MAY 31},
Abstract = {Background: Social media has emerged as an effective tool to mitigate
   preventable and costly health issues with social network interventions
   (SNIs), but a precision public health approach is still lacking to
   improve health equity and account for population disparities.Objective:
   This study aimed to (1) develop an SNI framework for precision public
   health using control systems engineering to improve the delivery of
   digital educational interventions for health behavior change and (2)
   validate the SNI framework to increase organ donation awareness in
   California, taking into account underlying population
   disparities.Methods: This study developed and tested an SNI framework
   that uses publicly available data at the ZIP Code Tabulation Area (ZCTA)
   level to uncover demographic environments using clustering analysis,
   which is then used to guide digital health interventions using the Meta
   business platform. The SNI delivered 5 tailored organ donation-related
   educational contents through Facebook to 4 distinct demographic
   environments uncovered in California with and without an Adaptive
   Content Tuning (ACT) mechanism, a novel application of the Proportional
   Integral Derivative (PID) method, in a cluster randomized trial (CRT)
   over a 3-month period. The daily number of impressions (ie, exposure to
   educational content) and clicks (ie, engagement) were measured as a
   surrogate marker of awareness. A stratified analysis per demographic
   environment was conducted.Results: Four main clusters with distinctive
   sociodemographic characteristics were identified for the state of
   California. The ACT mechanism significantly increased the overall click
   rate per 1000 impressions (\& beta;=.2187; P<.001), with the highest
   effect on cluster 1 (\& beta;=.3683; P<.001) and the lowest effect on
   cluster 4 (\& beta;=.0936; P=.053). Cluster 1 is mainly composed of a
   population that is more likely to be rural, White, and have a higher
   rate of Medicare beneficiaries, while cluster 4 is more likely to be
   urban, Hispanic, and African American, with a high employment rate
   without high income and a higher proportion of Medicaid
   beneficiaries.Conclusions: The proposed SNI framework, with its ACT
   mechanism, learns and delivers, in real time, for each distinct
   subpopulation, the most tailored educational content and establishes a
   new standard for precision public health to design novel health
   interventions with the use of social media, automation, and machine
   learning in a form that is efficient and equitable.},
Type = {Article},
Affiliation = {Rocha, P (Corresponding Author), Univ Calif Davis, Div Cardiovasc Med, Dept Internal Med, 4860 Y St,ACC Bldg Suite 2820, Sacramento, CA 94817 USA.
   Rocha, Paulo; Tubert, Ela; Romero, Erick; Cadeiras, Martin, Univ Calif Sacramento, Dept Internal Med, Div Cardiovasc Med, Sacramento, CA USA.
   Pinheiro, Diego; Monteiro, Rodrigo de Paula, Univ Catolica Pernambuco, Int Sch, Recife, Brazil.
   Bastos-Filho, Carmelo, Univ Pernambuco, Polytech Sch Pernambuco, Recife, Brazil.
   Nuno, Miriam, Univ Calif Davis, Dept Publ Hlth Sci, Div Biostat, Davis, CA USA.
   Rocha, Paulo, Univ Calif Davis, Div Cardiovasc Med, Dept Internal Med, 4860 Y St,ACC Bldg Suite 2820, Sacramento, CA 94817 USA.},
DOI = {10.2196/43132},
Article-Number = {e43132},
Keywords = {psychosocial intervention; social network; SNI; social network
   intervention; precision medicine; precision public health; organ
   donation; organ procurement; public awareness; social media; systems
   analysis; tissue and organ procurement; adaptive clinical trial;
   proportional integral derivative; patient education; digital health},
Keywords-Plus = {DESIGN},
Research-Areas = {Health Care Sciences \& Services; Medical Informatics},
Web-of-Science-Categories  = {Health Care Sciences \& Services; Medical Informatics},
Author-Email = {phrocha@ucdavis.edu},
Affiliations = {California State University System; California State University
   Sacramento; Universidade Catolica de Pernambuco; Universidade de
   Pernambuco (UPE); University of California System; University of
   California Davis; University of California System; University of
   California Davis},
Cited-References = {Alolod GP, 2023, J RACIAL ETHN HEALTH, V10, P1478, DOI 10.1007/s40615-022-01333-3.
   American Community Survey (U.S. Census Bureau), about us.
   Andrade AQ, 2022, J MED INTERNET RES, V24, DOI 10.2196/33873.
   {[}Anonymous], 2017, Facebook About.
   Borase RP, 2021, INT J DYNAM CONTROL, V9, P818, DOI 10.1007/s40435-020-00665-4.
   Breza E, 2021, NAT MED, V27, P1622, DOI 10.1038/s41591-021-01487-3.
   Calinski T., 1974, COMMUN STAT, V3, P1, DOI DOI 10.1080/03610927408827101.
   Carlemalm HC, 2004, COMP AID CH, V17, P306.
   Chen HF, 2021, MDM POLICY PRACT, V6, DOI 10.1177/23814683211063418.
   Chevance G, 2021, TRANSL BEHAV MED, V11, P676, DOI 10.1093/tbm/ibaa026.
   Conroy DE, 2020, EXERC SPORT SCI REV, V48, P170, DOI 10.1249/JES.0000000000000232.
   DAVIES DL, 1979, IEEE T PATTERN ANAL, V1, P224, DOI 10.1109/TPAMI.1979.4766909.
   Donate Life Registration California, US.
   Gordon EJ, 2022, AM J TRANSPLANT, V22, P474, DOI 10.1111/ajt.16857.
   Huyett LM, 2015, IND ENG CHEM RES, V54, P10311, DOI 10.1021/acs.iecr.5b01237.
   Jessup DL, 2018, J MED INTERNET RES, V20, DOI 10.2196/jmir.8932.
   Johnson M. A., 2005, PID Control.
   Khoury MJ, 2016, JAMA-J AM MED ASSOC, V316, P1357, DOI 10.1001/jama.2016.12260.
   Khoury MJ, 2016, AM J PREV MED, V50, P398, DOI 10.1016/j.amepre.2015.08.031.
   Kirkland EB, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.008731.
   Laranjo L, 2015, J AM MED INFORM ASSN, V22, P243, DOI 10.1136/amiajnl-2014-002841.
   Lu KD, 2018, J FRANKLIN I, V355, P2197, DOI 10.1016/j.jfranklin.2017.12.034.
   MacQueen J. B., 1967, P 5 BERK S MATH STAT, V1, P281.
   Mehedi IM, 2021, J HEALTHC ENG, V2021, DOI 10.1155/2021/7118711.
   Meppelink CS, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.3979.
   Mohanty Mohan Debarchan, 2019, Proceedings of International Conference on Intelligent Computing and Applications (ICICA 2018). Advances in Intelligent Systems and Computing (AISC 846), P97, DOI 10.1007/978-981-13-2182-5\_10.
   Murphy MD, 2020, J MED INTERNET RES, V22, DOI 10.2196/14605.
   Papanicolas I, 2018, JAMA-J AM MED ASSOC, V319, P1024, DOI 10.1001/jama.2018.1150.
   Patzer RE, 2019, KIDNEY INT REP, V4, P1285, DOI 10.1016/j.ekir.2019.05.771.
   Rasmussen CE, 2000, ADV NEUR IN, V12, P554.
   Rasmussen SA, 2020, JAMA-J AM MED ASSOC, V324, P933, DOI 10.1001/jama.2020.14992.
   Rocha P, 2020, 33 INT FLAIRS C.
   ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7.
   Schwartz P, 2022, AM J HEALTH PROMOT, V36, P296, DOI 10.1177/08901171211044594.
   Siminoff LA, 2022, J HEALTH COMMUN, V27, P450, DOI 10.1080/10810730.2022.2119445.
   Siminoff LA, 2020, J RACIAL ETHN HEALTH, V7, P72, DOI 10.1007/s40615-019-00635-3.
   Sorensen Th A, 1948, Biol. Skar., V5, P1, DOI DOI 10.1234/12345678.
   Theiss Sunita Kapahi, 2016, Mhealth, V2, DOI 10.21037/mhealth.2016.10.02.
   Waterman AD, 2010, SEMIN NEPHROL, V30, P90, DOI 10.1016/j.semnephrol.2009.10.010.
   Wright JS, 2018, JAMA-J AM MED ASSOC, V320, P1857, DOI 10.1001/jama.2018.13326.
   Young LE, 2020, PREV MED REP, V19, DOI 10.1016/j.pmedr.2020.101158.
   Zhao QP, 2014, DATA KNOWL ENG, V92, P77, DOI 10.1016/j.datak.2014.07.008.},
Number-of-Cited-References = {42},
Times-Cited = {0},
Unique-ID = {WOS:001022158000006},
}

@article{ WOS:000459844500010,
Author = {Whitsel, Laurie P. and Wilbanks, John and Huffman, Mark D. and Hall,
   Jennifer L.},
Title = {The Role of Government in Precision Medicine, Precision Public Health
   and the Intersection With Healthy Living},
Journal = {PROGRESS IN CARDIOVASCULAR DISEASES},
Year = {2019},
Volume = {62},
Number = {1},
Pages = {50-54},
Month = {JAN-FEB},
Abstract = {This paper focuses on the significant role of government in promoting
   precision medicine and public health and the potential intersection with
   healthy living (HL) and population health. Recent research has
   highlighted the interplay between genes, environments and different
   exposures individuals and populations experience over a lifetime. These
   interactions between longitudinal behaviors, epigenetics, and expression
   of the human genome have the potential to transform health and
   well-being, even within a single generation. Precision medicine can
   elucidate these longitudinal interactions with a granularity that has
   not been previously possible across the exposome. Understanding the
   interactions between genes, epigenetics, proteins, metabolites, and the
   exposome may inform more evidence-based, effective policy, system, and
   environmental change to optimize individual and population health.
   Government has an important role in helping to fund primary research in
   precision medicine and precision public health, as well as creating and
   enforcing standards related to food systems, air quality, and access to
   health care, defining and optimizing measures of health care quality and
   safety, and ensuring data privacy standards and protections,
   interoperability, and integration with surveillance systems. Government
   partnership and collaboration with the non-profit and private sectors
   can optimize precision medicine and precision public health for the
   benefit of the United States and global population. (C) 2018 Elsevier
   Inc. All rights reserved.},
Type = {Review},
Affiliation = {Whitsel, LP (Corresponding Author), Amer Heart Assoc, 1150 Connecticut Ave NW,Suite 300, Washington, DC 20036 USA.
   Whitsel, Laurie P., Amer Heart Assoc, Dept Policy Res \& Translat, Washington, DC USA.
   Wilbanks, John, Sage Bionetworks, Seattle, WA USA.
   Huffman, Mark D., Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA.
   Huffman, Mark D., George Inst Global Hlth, Sydney, NSW, Australia.
   Hall, Jennifer L., Amer Heart Assoc, Inst Precis Cardiovasc Med, Dallas, DC USA.
   Hall, Jennifer L., Univ Minnesota, Dept Med, Box 736 UMHC, Minneapolis, MN 55455 USA.
   Hall, Jennifer L., Univ Texas Southwestern Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA.
   Wilbanks, John, Ewing Marion Kauffman Fdn, Kansas City, MO USA.
   Wilbanks, John, Faster Cures, Washington, DC USA.
   Huffman, Mark D., Northwestern Univ, Dept Med, Feinberg Sch Med, Chicago, IL 60611 USA.},
DOI = {10.1016/j.pcad.2018.12.002},
Keywords = {Precision medicine; Population health; Public health; Policy; Government},
Keywords-Plus = {POPULATION HEALTH; BIOBANK; EPIGENETICS},
Research-Areas = {Cardiovascular System \& Cardiology},
Web-of-Science-Categories  = {Cardiac \& Cardiovascular Systems},
Author-Email = {laurie.whitsel@heart.org},
Affiliations = {Northwestern University; Feinberg School of Medicine; University of
   Sydney; George Institute for Global Health; University of Minnesota
   System; University of Minnesota Twin Cities; University of Texas System;
   University of Texas Southwestern Medical Center Dallas; Northwestern
   University; Feinberg School of Medicine},
Cited-References = {Allen N, 2012, HEALTH POLICY TECHN, V1, P123, DOI 10.1016/j.hlpt.2012.07.003.
   {[}Anonymous], 2018, INFORM DANISH NATL B, P1.
   Antman EM, 2016, NAT REV CARDIOL, V13, P591, DOI 10.1038/nrcardio.2016.101.
   Arno PS, 2011, J PUBLIC HEALTH POL, V32, P234, DOI 10.1057/jphp.2011.2.
   Chen ZM, 2011, INT J EPIDEMIOL, V40, P1652, DOI 10.1093/ije/dyr120.
   Choi JK, 2007, GENETICS, V175, P1607, DOI 10.1534/genetics.106.069047.
   Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523.
   Dowell S, 2016, NATURE, V540.
   Dupont C, 2009, SEMIN REPROD MED, V27, P351, DOI 10.1055/s-0029-1237423.
   Gaziano JM, 2016, J CLIN EPIDEMIOL, V70, P214, DOI 10.1016/j.jclinepi.2015.09.016.
   Hughes K, 2017, LANCET PUBLIC HEALTH, V2, pE356, DOI 10.1016/S2468-2667(17)30118-4.
   Institute of Medicine, 2001, ENV IND GEN EXPR.
   Kass-Hout TA, 2018, CIRCULATION, V137, P647, DOI 10.1161/CIRCULATIONAHA.117.032041.
   Kimmelman J, 2018, NAT REV CLIN ONCOL, V15, P341, DOI 10.1038/s41571-018-0016-0.
   Ma J., 2020, R-ECONOMY, V6, P271, DOI DOI 10.15826/RECON.2020.6.4.024.
   Marshall M, 2016, JAMA INTERN MED, V176, P9, DOI 10.1001/jamainternmed.2015.6054.
   Million Veterans Program, 2017, MILL VET PROGR INS N, P1.
   National Institutes of Health, 2015, PREC MED IN PRIV TRU.
   Psaty BM, 2018, JAMA-J AM MED ASSOC, V320, P751, DOI 10.1001/jama.2018.8377.
   Rappaport SM, 2011, J EXPO SCI ENV EPID, V21, P5, DOI 10.1038/jes.2010.50.
   Smith GD, 2011, INT J EPIDEMIOL, V40, P537, DOI 10.1093/ije/dyr117.
   Sokolowsky A, 2017, J COMMUN HEALTH, V42, P730, DOI 10.1007/s10900-016-0311-6.
   Sussex J, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0564-z.
   Timpson NJ, 2018, NAT REV GENET, V19, P110, DOI 10.1038/nrg.2017.101.
   Vaithinathan Asokan G, 2017, J Evid Based Med, V10, P76, DOI 10.1111/jebm.12239.
   Whitsel LP, 2017, PROG CARDIOVASC DIS, V59, P492, DOI 10.1016/j.pcad.2017.01.003.},
Number-of-Cited-References = {26},
Times-Cited = {10},
Unique-ID = {WOS:000459844500010},
}

@article{ WOS:000855007600005,
Author = {Zhu, Chen},
Title = {Demand for Direct-to-Consumer Genetic Testing Services in China and Its
   Implications for Precision Public Health - China, 2021},
Journal = {CHINA CDC WEEKLY},
Year = {2022},
Volume = {4},
Number = {32},
Pages = {715-719},
Month = {AUG 1},
Abstract = {Introduction: In China, the direct-to-consumer genetic testing (DTC-GT)
   industry has been undergoing exponential growth during the past few
   years. This study intends to assess characteristics of DTC-GT users in
   China, estimate the price elasticity of demand, quantify monetary values
   of DTC-GT features, and discuss its implications to the development of
   precision public health. Methods: A total of 629 participants with an
   average age of 28.8 years were collected from an online survey conducted
   in November 2021. A discrete choice experiment and a mixed logit
   modelling approach were used to elucidate consumer preferences to DTC-GT
   services and evaluate monetary values of certain features. Results:
   DTC-GT users were found to have a higher level of income on average. The
   price elasticity of DTC-GT services was estimated to be -0.72 (95\% CI
   -0.73 to -0.70). The willingness-to-pay to genetic testing features of
   physical traits, personality, and dietary recommendation were estimated
   to be 90, 107, and 220 CNY, respectively. Discussion: The nature of big
   genomic data makes DTC-GT have the potential to aid in the advancement
   of precision public health through more precise disease prevention and
   control strategies. The study also notes the need for addressing
   potential drawbacks of DTC-GT and protecting genetic privacy.},
Type = {Article},
Affiliation = {Zhu, C (Corresponding Author), China Agr Univ, Coll Econ \& Management, Beijing, Peoples R China.
   Zhu, Chen, China Agr Univ, Coll Econ \& Management, Beijing, Peoples R China.},
DOI = {10.46234/ccdcw2022.149},
Keywords-Plus = {GENOMICS},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {zhuchen@cau.edu.cn},
Affiliations = {China Agricultural University},
Cited-References = {Burton H, 2012, EPIDEMIOL BIOSTAT PU, V9, DOI 10.2427/8665.
   de Bekker-Grob EW, 2012, HEALTH ECON, V21, P145, DOI 10.1002/hec.1697.
   Dearing JW, 2018, HEALTH AFFAIR, V37, P183, DOI 10.1377/hlthaff.2017.1104.
   Du L, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.00416.
   Gerdtham UG, 2000, HANDB ECON, V17, P11.
   Guasch-Ferré M, 2018, ADV NUTR, V9, P128, DOI 10.1093/advances/nmy001.
   Kang K, 2021, QUANT BIOL, V9, P201, DOI 10.1007/s40484-020-0209-2.
   Khoury MJ, 2018, GENET MED, V20, P574, DOI 10.1038/gim.2017.211.
   Máarquez-Luna C, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-25171-9.
   Oh Bermseok, 2019, Genomics \& Informatics, V17, pe33, DOI 10.5808/GI.2019.17.3.e33.
   Ramos E, 2018, AM J MED GENET C, V178, P89, DOI 10.1002/ajmg.c.31603.
   Roberts MC, 2021, GENOME MED, V13, DOI 10.1186/s13073-021-00911-0.
   Shelton JF, 2021, PUBLIC HEALTH NUTR, V24, P2952, DOI 10.1017/S1368980020001251.
   Weeramanthri TS, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00121.
   Zhou ZL, 2011, HEALTH POLICY, V103, P255, DOI 10.1016/j.healthpol.2011.09.005.},
Number-of-Cited-References = {15},
Times-Cited = {3},
Unique-ID = {WOS:000855007600005},
}

@article{ WOS:000458017600016,
Author = {Senier, Laura and Tan, Catherine and Smollin, Leandra and Lee, Rachael},
Title = {Understanding the potential of state-based public health genomics
   programs to mitigate disparities in access to clinical genetic services},
Journal = {GENETICS IN MEDICINE},
Year = {2019},
Volume = {21},
Number = {2},
Pages = {373-381},
Month = {FEB},
Abstract = {Purpose: State health agencies (SHAs) have developed public health
   genomics (PHG) programs that play an instrumental role in advancing
   precision public health, but there is limited research on their
   approaches. This study examines how PHG programs attempt to mitigate or
   forestall health disparities and inequities in the utilization of
   genomic medicine.
   Methods: We compared PHG programs in three states: Connecticut,
   Michigan, and Utah. We analyzed 85 in-depth interviews with SHA internal
   and external collaborators and program documents. We employed a
   qualitative coding process to capture themes relating to health
   disparities and inequities.
   Results: Each SHA implemented population-level approaches to identify
   individuals who carry genetic variants that increase risk of hereditary
   cancers. However, each SHA developed a unique strategy-which we label
   public health action repertoires-to reach specific subgroups who faced
   barriers in accessing genetic services. These strategies varied across
   states given demographics of the state population, state-level
   partnerships, and availability of healthcare services.
   Conclusion: Our findings illustrate the imperative of tailoring PHG
   programs to local demographic characteristics and existing community
   resources. Furthermore, our study highlights how integrating genomics
   into precision public health will require multilevel, multisector
   collaboration to optimize efficacy and equity.},
Type = {Article},
Affiliation = {Senier, L (Corresponding Author), Northeastern Univ, Dept Sociol \& Anthropol, 360 Huntington Ave, Boston, MA 02115 USA.
   Senier, L (Corresponding Author), Northeastern Univ, Dept Hlth Sci, 360 Huntington Ave, Boston, MA 02115 USA.
   Senier, Laura; Tan, Catherine; Lee, Rachael, Northeastern Univ, Dept Sociol \& Anthropol, 360 Huntington Ave, Boston, MA 02115 USA.
   Senier, Laura, Northeastern Univ, Dept Hlth Sci, 360 Huntington Ave, Boston, MA 02115 USA.
   Smollin, Leandra, SUNY Coll Potsdam, Dept Sociol \& Criminal Justice, 44 Pierrepont Ave, Potsdam, NY 13676 USA.},
DOI = {10.1038/s41436-018-0056-y},
Keywords = {Public health genomics; Precision public health; Health disparities;
   Determinants of health; Implementation},
Keywords-Plus = {HEREDITARY BREAST; SICK INDIVIDUALS; OPPORTUNITIES; POPULATIONS;
   EDUCATION; MEDICINE; AGENCIES; IMPACT; BRCA},
Research-Areas = {Genetics \& Heredity},
Web-of-Science-Categories  = {Genetics \& Heredity},
Author-Email = {l.senier@northeastern.edu},
Affiliations = {Northeastern University; Northeastern University; State University of
   New York (SUNY) System},
Cited-References = {{[}Anonymous], IMPL GEN PUBL HLTH.
   Burton H, 2012, EPIDEMIOL BIOSTAT PU, V9, DOI 10.2427/8665.
   Carter-Pokras O, 2002, PUBLIC HEALTH REP, V117, P426, DOI 10.1093/phr/117.5.426.
   Centers for Disease Control and Prevention, 2017, PUBL HLTH GEN KNOWL.
   Chan L, 2006, J RURAL HEALTH, V22, P140, DOI 10.1111/j.1748-0361.2006.00022.x.
   Charmaz K., 2014, Constructing ground theory, V2nd.
   Cragun D, 2015, BREAST CANCER RES TR, V151, P169, DOI 10.1007/s10549-015-3374-7.
   Doyle YG, 2006, J EPIDEMIOL COMMUN H, V60, P396, DOI 10.1136/jech.2005.042770.
   Duquette D, 2012, PUBLIC HEALTH GENOM, V15, P92, DOI 10.1159/000334267.
   Forman AD, 2009, BREAST J, V15, pS56, DOI 10.1111/j.1524-4741.2009.00798.x.
   Frieden TR, 2010, AM J PUBLIC HEALTH, V100, P590, DOI 10.2105/AJPH.2009.185652.
   Frohlich KL, 2008, AM J PUBLIC HEALTH, V98, P216, DOI 10.2105/AJPH.2007.114777.
   Hawkins AK, 2011, GENET MED, V13, P197, DOI 10.1097/GIM.0b013e31820c056e.
   Health Resources and Services Administration, 2016, HRSA17082 US DEP HLT.
   Khoury MJ, 2007, AM J PREV MED, V33, P310, DOI 10.1016/j.amepre.2007.05.010.
   Khoury MJ, 2018, GENET MED, V20, P574, DOI 10.1038/gim.2017.211.
   Krieger N, 2012, MILBANK Q, V90, P634, DOI 10.1111/j.1468-0009.2012.00678.x.
   Largo TW, 2011, PUBLIC HEALTH REP, V126, P14, DOI 10.1177/00333549111260S104.
   McLaren L, 2010, INT J EPIDEMIOL, V39, P372, DOI 10.1093/ije/dyp315.
   Phelan JC, 2013, AM SOCIOL REV, V78, P167, DOI 10.1177/0003122413476034.
   Razak F, 2016, AM J CLIN NUTR, V104, P1497, DOI 10.3945/ajcn.115.127357.
   Roberts MC, 2017, GENET MED, V19, P858, DOI 10.1038/gim.2016.210.
   ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32.
   Rose G., 1992, STRATEGY PREVENTIVE.
   Sankar P, 2004, JAMA-J AM MED ASSOC, V291, P2985, DOI 10.1001/jama.291.24.2985.
   Senier L, 2017, SOC SCI MED, V186, P113, DOI 10.1016/j.socscimed.2017.06.007.
   Senier Laura, 2015, Adv Med Sociol, V16, P269.
   Senier L, 2015, HEALTHCARE-BASEL, V3, P995, DOI 10.3390/healthcare3040995.
   St Pierre J, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130267.
   Trivers KF, 2015, HEALTHCARE-BASEL, V3, P948, DOI 10.3390/healthcare3040948.
   United States Census Bureau, 2010, QUICK FACTS.
   US Preventive Services Task Force, 2013, REC PRIM CAR PRACT.
   West KM, 2017, JAMA-J AM MED ASSOC, V317, P1831, DOI 10.1001/jama.2017.3096.
   WHITEHEAD M, 1992, INT J HEALTH SERV, V22, P429, DOI 10.2190/986L-LHQ6-2VTE-YRRN.
   Wisinski C, 2007, PUBLIC HLTH GENOMICS.},
Number-of-Cited-References = {35},
Times-Cited = {10},
Unique-ID = {WOS:000458017600016},
}

@article{ WOS:000408605800001,
Author = {Newnham, John P. and Kemp, Matthew W. and White, Scott W. and Arrese,
   Catherine A. and Hart, Roger J. and Keelan, Jeffrey A.},
Title = {Applying Precision Public Health to Prevent Preterm Birth},
Journal = {FRONTIERS IN PUBLIC HEALTH},
Year = {2017},
Volume = {5},
Month = {APR 4},
Abstract = {Preterm birth (PTB) is one of the major health-care challenges of our
   time. Being born too early is associated with major risks to the child
   with potential for serious consequences in terms of life-long disability
   and health-care costs. Discovering how to prevent PTB needs to be one of
   our greatest priorities. Recent advances have provided hope that a
   percentage of cases known to be related to risk factors may be amenable
   to prevention; but the majority of cases remain of unknown cause, and
   there is little chance of prevention. Applying the principle of
   precision public health may offer opportunities previously unavailable.
   Presented in this article are ideas that may improve our abilities in
   the fields of studying the effects of migration and of populations in
   transition, public health programs, tobacco control, routine measurement
   of length of the cervix in mid-pregnancy by ultrasound imaging,
   prevention of non-medically indicated late PTB, identification of
   pregnant women for whom treatment of vaginal infection may be of
   benefit, and screening by genetics and other ``omics.{''} Opening new
   research in these fields, and viewing these clinical problems through a
   prism of precision public health, may produce benefits that will affect
   the lives of large numbers of people.},
Type = {Review},
Affiliation = {Newnham, JP (Corresponding Author), Univ Western Australia, Sch Womens \& Infants Hlth, Crawley, WA, Australia.
   Newnham, JP (Corresponding Author), King Edward Mem Hosp, Dept Maternal Fetal Med, Subiaco, WA, Australia.
   Newnham, John P.; Kemp, Matthew W.; White, Scott W.; Arrese, Catherine A.; Hart, Roger J.; Keelan, Jeffrey A., Univ Western Australia, Sch Womens \& Infants Hlth, Crawley, WA, Australia.
   Newnham, John P.; White, Scott W., King Edward Mem Hosp, Dept Maternal Fetal Med, Subiaco, WA, Australia.},
DOI = {10.3389/fpubh.2017.00066},
Article-Number = {66},
Keywords = {preterm birth; cervix length; progesterone; smoking; genomics;
   proteomics; transcriptomics; screening},
Keywords-Plus = {QUANTITATIVE FETAL FIBRONECTIN; ABNORMAL VAGINAL FLORA; GEOGRAPHIC
   INFORMATION-SYSTEMS; CERVICAL LENGTH MEASUREMENT; BACTERIAL VAGINOSIS;
   MATERNAL SMOKING; GESTATIONAL-AGE; DOUBLE-BLIND; INTRAAMNIOTIC
   INFLAMMATION; INTRAUTERINE INFECTION},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {john.newnham@uwa.edu.au},
Affiliations = {University of Western Australia; King Edward Memorial Hospital;
   University of Western Australia},
Cited-References = {Abbott DS, 2015, OBSTET GYNECOL, V125, P1168, DOI 10.1097/AOG.0000000000000754.
   Abbott LC, 2012, CRIT REV TOXICOL, V42, P279, DOI 10.3109/10408444.2012.658506.
   Abramovici A, 2015, AM J PERINAT, V32, P1119, DOI 10.1055/s-0035-1549294.
   ANDERSEN HF, 1990, AM J OBSTET GYNECOL, V163, P859, DOI 10.1016/0002-9378(90)91084-P.
   {[}Anonymous], 2016, LANCET, V388, P2323, DOI 10.1016/S0140-6736(16)32170-5.
   {[}Anonymous], HLTH BEN SMOK CESS.
   {[}Anonymous], AM J OBSTET GYNECOLO, DOI {[}10.1016/j.ajog.2015.09.006, DOI 10.1016/J.AJOG.2015.09.006].
   {[}Anonymous], 2015, WHO report on the global tobacco epidemic.
   {[}Anonymous], 2010, GLOBAL STATUS REPORT.
   {[}Anonymous], 2010, AM J OBSTET GYNECOL, DOI DOI 10.1155/2012/252676.5.K0REN.
   {[}Anonymous], 2015, LANCET, DOI DOI 10.1016/S0140-6736(14)61698-6.
   {[}Anonymous], INT J OBESITY.
   {[}Anonymous], 2012, World Health Report.
   Banderali G, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0690-y.
   Bartholomew KS, 2016, MATERN CHILD HLTH J, V20, P1526, DOI 10.1007/s10995-016-1952-x.
   Been JV, 2014, LANCET, V383, P1549, DOI 10.1016/S0140-6736(14)60082-9.
   Benowitz NL, 2000, TOB CONTROL, V9, P91, DOI 10.1136/tc.9.suppl\_3.iii91.
   Bergen AW, 2013, PHARMACOGENET GENOM, V23, P94, DOI 10.1097/FPC.0b013e32835cdabd.
   Blankenstein T, 2015, ARCH GYNECOL OBSTET, V292, P355, DOI 10.1007/s00404-014-3613-x.
   Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4.
   Breugelmans M, 2010, ACTA OBSTET GYN SCAN, V89, P256, DOI 10.3109/00016340903418769.
   Brocklehurst P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000262.pub4.
   Brown HK, 2014, INT J EPIDEMIOL, V43, P802, DOI 10.1093/ije/dyt251.
   Brubaker D, 2016, HUM MOL GENET, V25, P5254, DOI 10.1093/hmg/ddw325.
   Buhimschi CS, 2007, PLOS MED, V4, P84, DOI 10.1371/journal.pmed.0040018.
   Capoccia R, 2013, CURR OPIN INFECT DIS, V26, P231, DOI 10.1097/QCO.0b013e328360db58.
   Chaemsaithong P, 2016, J MATERN-FETAL NEO M, V29, P349, DOI 10.3109/14767058.2015.1006620.
   Chan A, 2001, MED J AUSTRALIA, V174, P389, DOI 10.5694/j.1326-5377.2001.tb143339.x.
   Chang HH, 2013, LANCET, V381, P1356, DOI 10.1016/S0140-6736(13)60878-8.
   Chang HH, 2013, LANCET, V381, P223, DOI 10.1016/S0140-6736(12)61856-X.
   Clausson B, 2000, BRIT J OBSTET GYNAEC, V107, P375, DOI 10.1111/j.1471-0528.2000.tb13234.x.
   Cnattingius S, 2004, NICOTINE TOB RES, V6, pS125, DOI 10.1080/14622200410001669187.
   Cobo T, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.12.036.
   Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523.
   Combs CA, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.11.032.
   Cunnington M, 2013, CURR OPIN INFECT DIS, V26, P219, DOI 10.1097/QCO.0b013e328360dc31.
   da Fonseca EB, 2003, AM J OBSTET GYNECOL, V188, P419, DOI 10.1067/mob.2003.41.
   Davidoff MJ, 2006, SEMIN PERINATOL, V30, P8, DOI 10.1053/j.semperi.2006.01.009.
   DejinKarlsson E, 1996, J EPIDEMIOL COMMUN H, V50, P33, DOI 10.1136/jech.50.1.33.
   DiGiulio DB, 2012, SEMIN FETAL NEONAT M, V17, P2, DOI 10.1016/j.siny.2011.10.001.
   Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE.
   Donders GG, 2009, BJOG-INT J OBSTET GY, V116, P1315, DOI 10.1111/j.1471-0528.2009.02237.x.
   Donders GGG, 2015, BJOG-INT J OBSTET GY, V122, P219, DOI 10.1111/1471-0528.13109.
   Dudley O, 2007, EARLY HUM DEV, V83, P471, DOI 10.1016/j.earlhumdev.2006.09.002.
   Ebener S, 2015, INT J HEALTH GEOGR, V14, DOI 10.1186/s12942-015-0012-x.
   Eidem HR, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0099-8.
   Einerson BD, 2016, AM J OBSTET GYNECOL, V215, DOI 10.1016/j.ajog.2016.01.192.
   Elsenbruch S, 2007, HUM REPROD, V22, P869, DOI 10.1093/humrep/del432.
   Engle WA, 2007, PEDIATRICS, V120, P1390, DOI 10.1542/peds.2007-2952.
   Ergin I, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-325.
   Farr A, 2015, BIRTH-ISS PERINAT C, V42, P173, DOI 10.1111/birt.12154.
   Fleisch AF, 2015, EPIDEMIOLOGY, V26, P43, DOI 10.1097/EDE.0000000000000203.
   Froen JF, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0801-7.
   Gahl WA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004980.
   Glavind J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084744.
   Glueck M, 2017, IEEE T VIS COMPUT GR, V23, P191, DOI 10.1109/TVCG.2016.2598469.
   Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007.
   Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4.
   Gravett MG, 2007, J PROTEOME RES, V6, P89, DOI 10.1021/pr060149v.
   Gray RF, 2004, PEDIATRICS, V114, P736, DOI 10.1542/peds.2003-1150-L.
   Griffin C, 2015, AUST NZ J OBSTET GYN, V55, P201, DOI 10.1111/ajo.12303.
   Groza T, 2015, AM J HUM GENET, V97, P111, DOI 10.1016/j.ajhg.2015.05.020.
   Haas DM, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6226.
   Hadzi-Lega M, 2015, J PERINAT MED, V43, P545, DOI 10.1515/jpm-2014-0275.
   Hamilton Brady E, 2016, Natl Vital Stat Rep, V65, P1.
   Hassan SS, 2011, ULTRASOUND OBST GYN, V38, P18, DOI 10.1002/uog.9017.
   Hassan SS, 2000, AM J OBSTET GYNECOL, V182, P1458, DOI 10.1067/mob.2000.106851.
   Heaman MI, 2005, J OBSTET GYNAECOL CA, V27, P237, DOI 10.1016/S1701-2163(16)30516-3.
   Heng YJJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155191.
   Hernández-Núñez J, 2015, INT J WOMENS HEALTH, V7, P385, DOI 10.2147/IJWH.S79577.
   Hezelgrave NL, 2016, OBSTET GYNECOL, V127, P255, DOI 10.1097/AOG.0000000000001240.
   Hibbs S, 2016, MATERN CHILD HLTH J, V20, P1432, DOI 10.1007/s10995-016-1941-0.
   Honest H, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13430.
   Hoyme UB, 2010, GYNECOL OBSTET INVES, V70, P286, DOI 10.1159/000314019.
   Hu Y, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/4130861.
   Iams JD, 2014, NEW ENGL J MED, V370, P254, DOI 10.1056/NEJMcp1103640.
   Iams JD, 2010, AM J OBSTET GYNECOL, V203, P89, DOI 10.1016/j.ajog.2010.02.004.
   Iams JD, 1996, NEW ENGL J MED, V334, P567, DOI 10.1056/NEJM199602293340904.
   Ireland DJ, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00624.
   Jaddoe VWV, 2008, PAEDIATR PERINAT EP, V22, P162, DOI 10.1111/j.1365-3016.2007.00916.x.
   Jha P, 2000, BRIT MED J, V321, P358, DOI 10.1136/bmj.321.7257.358.
   Jia P, 2017, OBES REV, V18, P400, DOI 10.1111/obr.12495.
   Jwala S, 2016, ACTA OBSTET GYN SCAN, V95, P948, DOI 10.1111/aogs.12907.
   Karumanchi SA, 2010, HYPERTENSION, V55, P1100, DOI 10.1161/HYPERTENSIONAHA.109.148973.
   Kataoka S, 2006, J CLIN MICROBIOL, V44, P51, DOI 10.1128/JCM.44.1.51-55.2006.
   Keelan JA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00111.
   Kemp MW, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00574.
   Khoury MJ, 2016, AM J PREV MED, V50, P398, DOI 10.1016/j.amepre.2015.08.031.
   Kim SM, 2016, J MATERN-FETAL NEO M, V29, P2414, DOI 10.3109/14767058.2015.1094049.
   Kim SM, 2012, J MATERN-FETAL NEO M, V25, P1212, DOI 10.3109/14767058.2011.629256.
   Kuhrt K, 2016, ULTRASOUND OBST GYN, V47, P210, DOI 10.1002/uog.14894.
   Lamont RF, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00566.
   Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5.
   Levy D, 2016, NICOTINE TOB RES, V18, P1240, DOI 10.1093/ntr/ntv178.
   Liabsuetrakul T, 2017, HEALTH INFORM J, V23, P109, DOI 10.1177/1460458216628312.
   LIGGINS GC, 1972, PEDIATRICS, V50, P515.
   Liong S, 2015, BJOG-INT J OBSTET GY, V122, P370, DOI 10.1111/1471-0528.12993.
   Liong S, 2013, REPRODUCTION, V146, P335, DOI 10.1530/REP-13-0175.
   Lionti T, 2015, AM J MED GENET A, V167, P371, DOI 10.1002/ajmg.a.36845.
   Macklaim Jean M., 2015, Microbial Ecology in Health and Disease, V26, P27799, DOI 10.3402/mehd.v26.27799.
   MacQuillan EL, 2017, J COMMUN HEALTH, V42, P633, DOI 10.1007/s10900-016-0298-z.
   Majumder S, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17010130.
   Makanga PT, 2016, INT J GYNECOL OBSTET, V134, P13, DOI 10.1016/j.ijgo.2015.11.022.
   Malak TM, 1996, BRIT J OBSTET GYNAEC, V103, P648, DOI 10.1111/j.1471-0528.1996.tb09832.x.
   Mangham LJ, 2009, PEDIATRICS, V123, pE312, DOI 10.1542/peds.2008-1827.
   Mayer BT, 2015, J INFECT DIS, V212, P793, DOI 10.1093/infdis/jiv079.
   McCabe ERB, 2014, PEDIATRICS, V134, P1193, DOI 10.1542/peds.2014-2541.
   McDonald HM, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000262.pub3.
   Mei-Dan E, 2015, J PERINAT MED, V43, P553, DOI 10.1515/jpm-2014-0299.
   Mendz GL, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00058.
   Mercer B, 2012, OBSTET GYN CLIN N AM, V39, P65, DOI 10.1016/j.ogc.2011.12.007.
   Metsälä J, 2015, CLIN EXP ALLERGY, V45, P137, DOI 10.1111/cea.12356.
   Miramontes R, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17010176.
   Mitchell E. A., 2006, Reviews on Environmental Health, V21, P81.
   Morken NH, 2014, PAEDIATR PERINAT EP, V28, P11, DOI 10.1111/ppe.12087.
   Morris JM, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.06.082.
   Mysorekar IU, 2014, SEMIN REPROD MED, V32, P50, DOI 10.1055/s-0033-1361830.
   Newnham JP, 2017, AM J OBSTET GYNECOL, V216, P434, DOI 10.1016/j.ajog.2016.11.1037.
   Newnham JP, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00584.
   Newnham JP, 2011, AUST NZ J OBSTET GYN, V51, P426, DOI 10.1111/j.1479-828X.2011.01327.x.
   Ngabo F, 2012, PAN AFR MED J, V13.
   Nicholson JM, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2016.02.019.
   Norman JE, 2016, LANCET, V387, P2106, DOI 10.1016/S0140-6736(16)00350-0.
   Oken E, 2008, INT J OBESITY, V32, P201, DOI 10.1038/sj.ijo.0803760.
   Oliver RS, 2013, J OBSTET GYNAECOL, V33, P768, DOI 10.3109/01443615.2013.842963.
   Parets SE, 2015, APPL CLIN GENET, V8, P283, DOI 10.2147/TACG.S58612.
   Pauly JR, 2008, ACTA PAEDIATR, V97, P1331, DOI 10.1111/j.1651-2227.2008.00852.x.
   Payne MS, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1110-x.
   Pendharkar S, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0971-3.
   Pigini L, 2017, GERONTOLOGY, V63, P281, DOI 10.1159/000455168.
   Robinson M, 2013, AUST NZ J OBSTET GYN, V53, P143, DOI 10.1111/ajo.12012.
   Romero R, 2016, ULTRASOUND OBST GYN, V48, P308, DOI 10.1002/uog.15953.
   Romero R, 2007, NUTR REV, V65, pS194, DOI 10.1301/nr.2007.dec.S194-S202.
   Romero R, 2014, AM J REPROD IMMUNOL, V72, P458, DOI 10.1111/aji.12296.
   Romero R, 2014, SCIENCE, V345, P760, DOI 10.1126/science.1251816.
   Romero R, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-18.
   Salihu HM, 2007, EARLY HUM DEV, V83, P713, DOI 10.1016/j.earlhumdev.2007.08.002.
   Sananès N, 2014, J OBSTET GYNAECOL, V34, P457, DOI 10.3109/01443615.2014.896325.
   Shahshahan Zahra, 2014, Adv Biomed Res, V3, P126, DOI 10.4103/2277-9175.133243.
   Shapiro-Mendoza CK, 2016, MMWR-MORBID MORTAL W, V65, P826, DOI 10.15585/mmwr.mm6532a4.
   Shapiro-Mendoza CK, 2012, SEMIN FETAL NEONAT M, V17, P120, DOI 10.1016/j.siny.2012.01.007.
   Sheikh IA, 2015, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3089-0.
   Simcox R, 2007, AUST NZ J OBSTET GYN, V47, P368, DOI 10.1111/j.1479-828X.2007.00759.x.
   Simmons LE, 2010, SEMIN PERINATOL, V34, P408, DOI 10.1053/j.semperi.2010.09.005.
   Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945.
   Soilly AL, 2014, PUBLIC HEALTH, V128, P43, DOI 10.1016/j.puhe.2013.09.014.
   Son M, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2015.12.020.
   Spong CY, 2013, JAMA-J AM MED ASSOC, V309, P2445, DOI 10.1001/jama.2013.6235.
   Subramaniam Akila, 2012, Infect Dis Obstet Gynecol, V2012, P157159, DOI 10.1155/2012/157159.
   Taylor BD, 2013, HUM REPROD, V28, P942, DOI 10.1093/humrep/det019.
   Thinkhamrop J, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002250.pub3.
   Troe EJWM, 2008, NICOTINE TOB RES, V10, P1373, DOI 10.1080/14622200802238944.
   Trujillano D, 2017, MOL GENET GENOM MED, V5, P66, DOI 10.1002/mgg3.262.
   Urquia ML, 2010, BJOG-INT J OBSTET GY, V117, P591, DOI 10.1111/j.1471-0528.2010.02523.x.
   Urquia ML, 2010, J EPIDEMIOL COMMUN H, V64, P243, DOI 10.1136/jech.2008.083535.
   Uzun A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155021.
   van de Mheen L, 2014, J OBSTET GYNAECOL CA, V36, P309, DOI 10.1016/S1701-2163(15)30606-X.
   Vandermolen BI, 2016, AM J OBSTET GYNECOL, V215, DOI 10.1016/j.ajog.2016.05.020.
   Vicedo-Cabrera AM, 2016, TOB CONTROL, V25, pE135, DOI 10.1136/tobaccocontrol-2015-052739.
   Vogel JP, 2015, LANCET GLOB HEALTH, V3, pE589, DOI 10.1016/S2214-109X(15)00183-7.
   von Schöning D, 2015, J PERINAT MED, V43, P531, DOI 10.1515/jpm-2014-0356.
   Wagijo MA, 2017, PAEDIATR RESPIR REV, V22, P3, DOI 10.1016/j.prrv.2015.09.002.
   Walker WA, 2013, ANN NUTR METAB, V63, P8, DOI 10.1159/000354907.
   Wangler MF, 2005, AM J MED GENET A, V134A, P187, DOI 10.1002/ajmg.a.30595.
   Werner EF, 2011, ULTRASOUND OBST GYN, V38, P32, DOI 10.1002/uog.8911.
   Wikström AK, 2010, HYPERTENSION, V55, P1254, DOI 10.1161/HYPERTENSIONAHA.109.147082.
   Wills RA, 2008, MED J AUSTRALIA, V189, P490, DOI 10.5694/j.1326-5377.2008.tb02141.x.
   Witkin SS, 2015, BJOG-INT J OBSTET GY, V122, P213, DOI 10.1111/1471-0528.13115.
   Yazdy MM, 2015, BIRTH DEFECTS RES A, V103, P544, DOI 10.1002/bdra.23375.},
Number-of-Cited-References = {169},
Times-Cited = {30},
Unique-ID = {WOS:000408605800001},
}

@article{ WOS:000605601300006,
Author = {Johnson, Walter G.},
Title = {Using Precision Public Health to Manage Climate Change: Opportunities,
   Challenges, and Health Justice},
Journal = {JOURNAL OF LAW MEDICINE \& ETHICS},
Year = {2020},
Volume = {48},
Number = {4, SI},
Pages = {681-693},
Month = {DEC},
Abstract = {Amid public health concerns over climate change, ``precision public
   health{''} (PPH) is emerging in next generation approaches to practice.
   These novel methods promise to augment public health operations by using
   ever larger and more robust health datasets combined with new tools for
   collecting and analyzing data. Precision strategies to protecting the
   public health could more effectively or efficiently address the systemic
   threats of climate change, but may also propagate or exacerbate health
   disparities for the populations most vulnerable in a changing climate.
   How PPH interventions collect and aggregate data, decide what to
   measure, and analyze data pose potential issues around privacy,
   neglecting social determinants of health, and introducing algorithmic
   bias into climate responses. Adopting a health justice framework, guided
   by broader social and climate justice tenets, can reveal principles and
   policy actions which may guide more responsible implementation of PPH in
   climate responses.},
Type = {Article},
Affiliation = {Johnson, WG (Corresponding Author), Arizona State Univ, Sandra Day OConnor Coll Law, Tempe, AZ 85287 USA.
   Johnson, Walter G., Arizona State Univ, Sandra Day OConnor Coll Law, Tempe, AZ 85287 USA.},
DOI = {10.1177/1073110520979374},
Keywords-Plus = {ARTIFICIAL-INTELLIGENCE; RISK; MEDICINE; PRIVACY; IMPACT},
Research-Areas = {Social Sciences - Other Topics; Government \& Law; Medical Ethics; Legal
   Medicine},
Web-of-Science-Categories  = {Ethics; Law; Medical Ethics; Medicine, Legal},
Affiliations = {Arizona State University; Arizona State University-Tempe},
Cited-References = {Adadi A, 2018, IEEE ACCESS, V6, P52138, DOI 10.1109/ACCESS.2018.2870052.
   Amnesty International, 2020, COVID 19 SURV THREAT.
   {[}Anonymous], 2017, LANCET GLOB HEALTH, V5, pE1, DOI 10.1016/S2214-109X(16)30339-4.
   {[}Anonymous], 2020, NATURE CLIMATE CHANG, DOI DOI 10.1073/pnas.1910114117.
   {[}Anonymous], 2018, CLIMATE CHANGE HLTH.
   Barros VR, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT B: REGIONAL ASPECTS, P1133.
   Bayer R, 2015, NEW ENGL J MED, V373, P499, DOI 10.1056/NEJMp1506241.
   Benfer Emily A, 2015, Am Univ Law Rev, V65, P275.
   Benjamin R, 2019, SCIENCE, V366, P421, DOI 10.1126/science.aaz3873.
   Benjamin Ruha, 2019, Race after Technology: Abolitionist Tools for the New Jim Code.
   Burstein R, 2019, NATURE, V574, P353, DOI 10.1038/s41586-019-1545-0.
   Chan, 2016, BMJ HEALTH CARE INFO, V23, P627.
   Chowkwanyun M, 2018, NEW ENGL J MED, V379, P1398, DOI 10.1056/NEJMp1806634.
   Clark J., 2017, IBM INTERNET TH 1107.
   Cohen IG, 2019, JAMA-J AM MED ASSOC, V322, P1141, DOI 10.1001/jama.2019.11365.
   Cooper R, 2020, ISSUES SCI TECHNOL, V36, P64.
   Council of Europe, 2018, ALG HUM RIGHTS STUD.
   Crawford K., 2019, AI Now 2019 Report.
   Dolley S, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00068.
   Dowell SF, 2016, NATURE, V540, P189, DOI 10.1038/540189a.
   Ebi K.L., 2005, INTEGR PUBLIC HLTH A, P1.
   Egede LE, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMp2023616.
   Ellis, 2020, WIRED 0402.
   Erikson SL, 2018, MED ANTHROPOL Q, V32, P315, DOI 10.1111/maq.12440.
   Frumkin H, 2008, AM J PUBLIC HEALTH, V98, P435, DOI 10.2105/AJPH.2007.119362.
   Gates M., 2020, STAT NEWS.
   Ginsburg GS, 2018, HEALTH AFFAIR, V37, P694, DOI 10.1377/hlthaff.2017.1624.
   Gostin L.O., 2014, GLOBAL HLTH LAW, P19.
   Gostin LO, 2001, AM J PUBLIC HEALTH, V91, P1388, DOI 10.2105/AJPH.91.9.1388.
   GSMA, 2019, CONN WOM MOB GEND GA.
   Haines A, 2019, NEW ENGL J MED, V380, P263, DOI 10.1056/NEJMra1807873.
   Hansen A, 2017, LANCET PLANET HEALTH, V1, pE353, DOI 10.1016/S2542-5196(17)30160-2.
   Hodge GA, 2014, SCI PUBL POLICY, V41, P1, DOI 10.1093/scipol/sct029.
   Hodge J.G., 2019, University of Michigan Journal of Law Reform, V53, P173.
   Hodge JG, 2018, J LAW MED ETHICS, V46, P1031, DOI 10.1177/1073110518822004.
   Horton R, 2018, LANCET, V392, P1504, DOI 10.1016/S0140-6736(18)32741-7.
   Hu J.C., 2020, SLATE FUTURE TE 0406.
   Ienca M, 2020, NAT MED, V26, P463, DOI 10.1038/s41591-020-0832-5.
   Janeja V., 2020, CONVERSATION 0303.
   Johnson KN, 2019, GEORGE WASH LAW REV, V87, P1214.
   Karp P., 2020, GUARDIAN 0423.
   Katyal SK, 2019, UCLA LAW REV, V66, P54.
   Kee F, 2020, J EPIDEMIOL COMMUN H, V74, P311, DOI 10.1136/jech-2019-213311.
   Khoury M.J., 2018, PRECISION PUBLIC HLT.
   Khoury MJ, 2018, GENET MED, V20, P574, DOI 10.1038/gim.2017.211.
   Khoury MJ, 2016, AM J PREV MED, V50, P398, DOI 10.1016/j.amepre.2015.08.031.
   Kobie Nicole., 2019, Wired.
   Kshetri N, 2014, TELECOMMUN POLICY, V38, P1134, DOI 10.1016/j.telpol.2014.10.002.
   Lazer D, 2014, SCIENCE, V343, P1203, DOI 10.1126/science.1248506.
   Leach M., 2005, Science and citizens: Globalization and the challenge of engagement, P3.
   LeCun Y., 2015, Deep learning. nature, V521, P436, DOI 10.1038/nature14539.
   Liptak Adam., 2017, NEW YORK TIMES.
   Liu C, 2019, NEW ENGL J MED, V381, P705, DOI 10.1056/NEJMoa1817364.
   Loftis JD, 2018, MAR TECHNOL SOC J, V52, P56, DOI 10.4031/MTSJ.52.2.7.
   Mamo, 2019, MED HUMANIT, V46, P192.
   McGovern A, 2017, B AM METEOROL SOC, V98, P2073, DOI 10.1175/BAMS-D-16-0123.1.
   Miller T, 2019, ARTIF INTELL, V267, P1, DOI 10.1016/j.artint.2018.07.007.
   Molster CM, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00247.
   Obermeyer Z, 2019, SCIENCE, V366, P447, DOI 10.1126/science.aax2342.
   Palmer T, 2014, NATURE, V515, P338, DOI 10.1038/515338a.
   Parmet W.E., 2009, POPULATIONS PUBLIC H, P13.
   Pascal M, 2012, PUBLIC HEALTH, V126, P660, DOI 10.1016/j.puhe.2012.04.013.
   Ram N, 2020, J LAW BIOSCI, V7, DOI 10.1093/jlb/lsaa023.
   Ross C., 2020, STAT NEWS.
   Rudolph L., Health in All Policies: A Guide for State and Local Governments.
   Schlosberg D, 2014, WIRES CLIM CHANGE, V5, P359, DOI 10.1002/wcc.275.
   Sell SK, 2019, GLOBALIZATION HEALTH, V15, DOI 10.1186/s12992-019-0517-3.
   Solove DJ, 2006, U PENN LAW REV, V154, P477, DOI 10.2307/40041279.
   Stoeger K, 2020, J LAW BIOSCI, V7, DOI 10.1093/jlb/lsaa041.
   Thorpe JH, 2015, PUBLIC HEALTH REP, V130, P171, DOI 10.1177/003335491513000211.
   Ting DSW, 2020, NAT MED, V26, P459, DOI 10.1038/s41591-020-0824-5.
   Topol Eric J, 2014, Cell, V157, P241, DOI 10.1016/j.cell.2014.02.012.
   U.K. Royal Society, 2019, EXPL AI BAS.
   U.S. Department of Health and Human Services, 2014, PRIM PROT ENH HLTH C.
   U.S. Global Change Research Program, 2016, IMPACTS CLIMATE CHAN.
   U.S. National Science \& Technology Council, 2020, ARTIFICIAL INTELLIGE.
   Venkatapuram S., 2011, HLTH JUSTICE ARGUMEN, P4.
   Vyas DA, 2020, NEW ENGL J MED, V383, P874, DOI 10.1056/NEJMms2004740.
   Warzel C., 2019, Privacy is too big to understand.
   Weeramanthri TS, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00121.
   WHO, 2015, OP FRAM BUILD CLIM R.
   Wiley L.F., 2016, CARD LAW REV, V37, P833.
   Wiley L.F., 2010, WIDENER LAW REV, V15, P483.
   Wiley Lindsay F, 2014, Cornell J Law Public Policy, V24, P47.
   World Health Organization, 2014, QUANTITATIVE RISK AS.
   World Health Organization, 2003, CLIMATE CHANGE HLTH.},
Number-of-Cited-References = {86},
Times-Cited = {2},
Unique-ID = {WOS:000605601300006},
}

@article{ WOS:000867811700001,
Author = {Arriaga-Canon, Cristian and Contreras-Espinosa, Laura and Rebollar-Vega,
   Rosa and Montiel-Manriquez, Rogelio and Cedro-Tanda, Alberto and Antonio
   Garcia-Gordillo, Jose and Maria Alvarez-Gomez, Rosa and Jimenez-Trejo,
   Francisco and Castro-Hernandez, Clementina and Herrera, Luis A.},
Title = {Transcriptomics and RNA-Based Therapeutics as Potential Approaches to
   Manage SARS-CoV-2 Infection},
Journal = {INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES},
Year = {2022},
Volume = {23},
Number = {19},
Month = {OCT},
Abstract = {SARS-CoV-2 is a coronavirus family member that appeared in China in
   December 2019 and caused the disease called COVID-19, which was declared
   a pandemic in 2020 by the World Health Organization. In recent months,
   great efforts have been made in the field of basic and clinical research
   to understand the biology and infection processes of SARS-CoV-2. In
   particular, transcriptome analysis has contributed to generating new
   knowledge of the viral sequences and intracellular signaling pathways
   that regulate the infection and pathogenesis of SARS-CoV-2, generating
   new information about its biology. Furthermore, transcriptomics
   approaches including spatial transcriptomics, single-cell
   transcriptomics and direct RNA sequencing have been used for clinical
   applications in monitoring, detection, diagnosis, and treatment to
   generate new clinical predictive models for SARS-CoV-2. Consequently,
   RNA-based therapeutics and their relationship with SARS-CoV-2 have
   emerged as promising strategies to battle the SARS-CoV-2 pandemic with
   the assistance of novel approaches such as CRISPR-CAS, ASOs, and siRNA
   systems. Lastly, we discuss the importance of precision public health in
   the management of patients infected with SARS-CoV-2 and establish that
   the fusion of transcriptomics, RNA-based therapeutics, and precision
   public health will allow a linkage for developing health systems that
   facilitate the acquisition of relevant clinical strategies for rapid
   decision making to assist in the management and treatment of the
   SARS-CoV-2-infected population to combat this global public health
   problem.},
Type = {Review},
Affiliation = {Arriaga-Canon, C; Herrera, LA (Corresponding Author), Univ Nacl Autonoma Mexico, Inst Invest Biomed, Inst Nacl Cancerol, Unidad Invest Biomed Canc, Ave San Fernando 22 ColC Secc 16, Mexico City 14080, DF, Mexico.
   Herrera, LA (Corresponding Author), Inst Nacl Med Genom, Perifer Sur 4809, Mexico City 14610, DF, Mexico.
   Arriaga-Canon, Cristian; Contreras-Espinosa, Laura; Montiel-Manriquez, Rogelio; Castro-Hernandez, Clementina; Herrera, Luis A., Univ Nacl Autonoma Mexico, Inst Invest Biomed, Inst Nacl Cancerol, Unidad Invest Biomed Canc, Ave San Fernando 22 ColC Secc 16, Mexico City 14080, DF, Mexico.
   Rebollar-Vega, Rosa, Univ Nacl Autonoma Mexico, Genom Lab, Red Apoyo Invest, Vasco de Quiroga 15,Belisario Dominguez Secc 16, Mexico City 14080, DF, Mexico.
   Cedro-Tanda, Alberto; Herrera, Luis A., Inst Nacl Med Genom, Perifer Sur 4809, Mexico City 14610, DF, Mexico.
   Antonio Garcia-Gordillo, Jose, Inst Nacl Cancerol, Oncol Med, Ave San Fernando 22 Col Secc 16, Mexico City 14080, DF, Mexico.
   Maria Alvarez-Gomez, Rosa, Inst Nacl Cancerol, Clin Canc Hereditario, Ave San Fernando 22 Col Secc 16, Mexico City 14080, DF, Mexico.
   Jimenez-Trejo, Francisco, Inst Nacl Pediat, Insurgentes Sur 3700-C, Mexico City 04530, DF, Mexico.},
DOI = {10.3390/ijms231911058},
Article-Number = {11058},
Keywords = {SARS-CoV-2; transcriptomics; RNA therapeutics; precision medicine;
   precision public health},
Keywords-Plus = {SARS CORONAVIRUS; SPIKE PROTEIN; HEPATITIS-B; SEQ; CRISPR; THERAPY;
   INTERFERENCE; TARGET; SIRNA; RESISTANCE},
Research-Areas = {Biochemistry \& Molecular Biology; Chemistry},
Web-of-Science-Categories  = {Biochemistry \& Molecular Biology; Chemistry, Multidisciplinary},
Author-Email = {carriagac@incan.edu.mx
   lherrera@inmegen.gob.mx},
Affiliations = {Instituto Nacional de Cancerologia (INCAN); Universidad Nacional
   Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Instituto
   Nacional de Medicina Genomica; Instituto Nacional de Cancerologia
   (INCAN); Instituto Nacional de Cancerologia (INCAN)},
Cited-References = {Abbott TR, 2020, CELL, V181, P865, DOI 10.1016/j.cell.2020.04.020.
   Abu-Baker A, 2019, MOL THER-NUCL ACIDS, V15, P12, DOI 10.1016/j.omtn.2019.02.003.
   Adams D, 2018, NEW ENGL J MED, V379, P11, DOI 10.1056/NEJMoa1716153.
   Adams D, 2021, LANCET NEUROL, V20, P49, DOI 10.1016/S1474-4422(20)30368-9.
   Agrawal S, 2020, TRENDS MOL MED, V26, P1061, DOI 10.1016/j.molmed.2020.08.007.
   Ahmed JQ, 2022, J INFECT PUBLIC HEAL, V15, P788, DOI 10.1016/j.jiph.2022.06.012.
   Ahn DG, 2011, ANTIVIR RES, V91, P1, DOI 10.1016/j.antiviral.2011.04.009.
   Al Khatib HA, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.575613.
   Al-Aly Z, 2021, NATURE, V594, P259, DOI 10.1038/s41586-021-03553-9.
   Aldridge S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18158-5.
   Alshaer W, 2021, EUR J PHARMACOL, V905, DOI 10.1016/j.ejphar.2021.174178.
   Ameres SL, 2007, CELL, V130, P101, DOI 10.1016/j.cell.2007.04.037.
   Amzat J, 2020, INT J INFECT DIS, V98, P218, DOI 10.1016/j.ijid.2020.06.067.
   Andrews TS, 2021, NAT PROTOC, V16, P1, DOI 10.1038/s41596-020-00409-w.
   Annavajhala MK, 2021, medRxiv, DOI {[}10.1101/2021.02.23.21252259, 10.1101/2021.02.23.21252259, DOI 10.1101/2021.02.23.21252259].
   {[}Anonymous], CHIP CALCULATOR.
   {[}Anonymous], JAMA-J AM MED ASSOC.
   {[}Anonymous], 2021, 10X GENOMICS GETTING.
   {[}Anonymous], Sequencing Support - Coverage Calculator.
   {[}Anonymous], CDC NEWSROOM.
   {[}Anonymous], SARS COV 2 RES USING.
   {[}Anonymous], bcl2fastq Conversion Software.
   {[}Anonymous], CORONAVIRUS SEQUENCI.
   {[}Anonymous], Nanopore sequencing accuracy.
   {[}Anonymous], 2021, SARS-CoV-2 Variant Classifications and Definitions.
   {[}Anonymous], Illumina COVIDSeq test.
   {[}Anonymous], ION GENESTUDIO S5 SP.
   {[}Anonymous], PRECISION MED PRECIS.
   {[}Anonymous], PRODUCT COMP.
   Ari S., 2016, PLANT OMICS TRENDS A, P109, DOI DOI 10.1007/978-3-319-31703-8\_5.
   Arnold C, 2022, NATURE, V601, P18, DOI 10.1038/d41586-021-03819-2.
   Ashley EA, 2016, NAT REV GENET, V17, P507, DOI 10.1038/nrg.2016.86.
   Athanasopoulou K, 2022, LIFE-BASEL, V12, DOI 10.3390/life12010030.
   Barh D, 2020, COMPUT BIOL MED, V126, DOI 10.1016/j.compbiomed.2020.104051.
   {[}Barrangou R. BarrangouR. and van der OostJ. BarrangouR. and van der OostJ.], 2013, CRISPR-Cas Systems.
   Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140.
   Bartel DP, 2018, CELL, V173, P20, DOI 10.1016/j.cell.2018.03.006.
   Bautista-Sánchez D, 2020, MOL THER-NUCL ACIDS, V20, P409, DOI 10.1016/j.omtn.2020.03.003.
   Behr M, 2021, ACTA PHARM SIN B, V11, P2150, DOI 10.1016/j.apsb.2021.05.020.
   Belfort R, 2002, AM J OPHTHALMOL, V133, P467.
   Berber B, 2021, GENE THER, V28, P290, DOI 10.1038/s41434-020-00209-7.
   Bernal AJ, 2022, NEW ENGL J MED, V386, P509, DOI 10.1056/NEJMoa2116044.
   Bhoyar RC, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0247115.
   Bilkey GA, 2019, FRONT PUBLIC HEALTH, V7, DOI 10.3389/fpubh.2019.00042.
   Billioud G, 2016, J HEPATOL, V64, P781, DOI 10.1016/j.jhep.2015.11.032.
   Blanchard EL, 2021, NAT BIOTECHNOL, V39, P717, DOI 10.1038/s41587-021-00822-w.
   Bojkova D, 2020, NATURE, V583, P469, DOI 10.1038/s41586-020-2332-7.
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170.
   Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096.
   Callaway E, 2022, NATURE, V602, P556, DOI 10.1038/d41586-022-00471-2.
   Campos JHC, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13112108.
   Cao CC, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22785-x.
   Carter LJ, 2020, ACS CENTRAL SCI, V6, P591, DOI 10.1021/acscentsci.0c00501.
   Chaudhry M.Z., 2020, J VIROL, V2020, DOI {[}10.241414, DOI 10.1101/2020.08.10.241414].
   Chen AT, 2021, ELIFE, V10, DOI 10.7554/eLife.63409.
   Chery J, 2018, NUCLEIC ACID THER, V28, P273, DOI 10.1089/nat.2018.0722.
   Chow MYT, 2020, TRENDS PHARMACOL SCI, V41, P715, DOI 10.1016/j.tips.2020.08.002.
   Christensen EE, 2021, J INTERN MED, V290, P677, DOI 10.1111/joim.13310.
   Chua RL, 2020, NAT BIOTECHNOL, V38, P970, DOI 10.1038/s41587-020-0602-4.
   Clark D.P., 2019, MOL BIOL+, P132.
   Cocquet J, 2006, GENOMICS, V88, P127, DOI 10.1016/j.ygeno.2005.12.013.
   Coelho T, 2013, NEW ENGL J MED, V369, P819, DOI 10.1056/NEJMoa1208760.
   Conesa A, 2019, SCI DATA, V6, DOI 10.1038/s41597-019-0258-4.
   Cox DBT, 2017, SCIENCE, V358, P1019, DOI 10.1126/science.aaq0180.
   Crooke ST, 2017, NUCLEIC ACID THER, V27, P70, DOI 10.1089/nat.2016.0656.
   da Rosa RL, 2021, ACS OMEGA, V6, P3238, DOI 10.1021/acsomega.0c05701.
   Danecek P, 2021, GIGASCIENCE, V10, DOI 10.1093/gigascience/giab008.
   Davies NG, 2021, SCIENCE, V372, P149, DOI 10.1126/science.abg3055.
   De Sabato L, 2021, bioRxiv, DOI {[}10.1101/2021.01.16.425365, 10.1101/2021.01.16.425365, DOI 10.1101/2021.01.16.425365].
   De Wel B, 2021, J NEUROL, V268, P923, DOI 10.1007/s00415-020-10223-9.
   Deas TS, 2007, ANTIMICROB AGENTS CH, V51, P2470, DOI 10.1128/AAC.00069-07.
   Delorey T M., bioRxiv, DOI DOI 10.1101/2021.02.25.430130.
   DeMerle K, 2021, JAMA-J AM MED ASSOC, V325, P2041, DOI 10.1001/jama.2021.5248.
   Deng XD, 2021, medRxiv, DOI {[}10.1101/2021.03.07.21252647, 10.1101/2021.03.07.21252647, DOI 10.1101/2021.03.07.21252647].
   Desai N, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-20139-7.
   DeVos SL, 2013, NEUROTHERAPEUTICS, V10, P486, DOI 10.1007/s13311-013-0194-5.
   Di Filippo L, 2021, NAT REV ENDOCRINOL, V17, P445, DOI 10.1038/s41574-021-00516-y.
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635.
   Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404.
   Dohm JC, 2020, NAR GENOM BIOINFORM, V2, DOI 10.1093/nargab/lqaa037.
   Dolgin E, 2021, NATURE, V597, P318, DOI 10.1038/d41586-021-02483-w.
   Domingo E, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008271.
   Doshi P, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4037.
   Dowdy SF, 2017, NAT BIOTECHNOL, V35, P222, DOI 10.1038/nbt.3802.
   Drain PK, 2022, NEW ENGL J MED, V386, P264, DOI 10.1056/NEJMcp2117115.
   Du LY, 2009, NAT REV MICROBIOL, V7, P226, DOI 10.1038/nrmicro2090.
   Dufait I, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/694137.
   Dulla K, 2021, MOL THER, V29, P2441, DOI 10.1016/j.ymthe.2021.04.024.
   Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301.
   Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107.
   Elbe S, 2017, GLOB CHALL, V1, P33, DOI 10.1002/gch2.1018.
   Emanuel EJ, 2020, NEW ENGL J MED, V382, P2049, DOI 10.1056/NEJMsb2005114.
   Fareh M, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-24577-9.
   Finkel RS, 2017, NEW ENGL J MED, V377, P1723, DOI 10.1056/NEJMoa1702752.
   Finkel Y, 2021, NATURE, V589, P125, DOI 10.1038/s41586-020-2739-1.
   Francisco V, 2021, METHODS, V190, P13, DOI 10.1016/j.ymeth.2020.12.002.
   Fuchs O, 2019, SINGLE-CELL OMICS: TECHNOLOGICAL ADVANCES AND APPLICATIONS, VOL 1: TECHNOLOGICAL ADVANCES, P231, DOI 10.1016/B978-0-12-814919-5.00012-9.
   Fuentes-Prior P, 2021, J BIOL CHEM, V296, DOI 10.1074/jbc.REV120.015980.
   Gahlawat AW, 2022, BRIT J CANCER, V127, P1550, DOI 10.1038/s41416-022-01925-0.
   Gao CX, 2020, CURR GENOMICS, V21, P602, DOI 10.2174/1389202921999200625220812.
   Garalde DR, 2018, NAT METHODS, V15, P201, DOI {[}10.1038/NMETH.4577, 10.1038/nmeth.4577].
   Garcia-Beltran WF, 2022, CELL, V185, P457, DOI {[}10.1101/2021.12.14.21267755, 10.1016/j.cell.2021.12.033].
   Garcia-Beltran WF, 2021, CELL, V184, P2372, DOI {[}10.1016/j.cell.2021.03.013, 10.1016/j.cell.2021.04.006, 10.1101/2021.02.14.21251704].
   Garcia-Gordillo JA, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0248357.
   Gouni-Berthold I, 2017, ATHEROSCLEROSIS SUPP, V30, P19, DOI 10.1016/j.atherosclerosissup.2017.05.003.
   Greaney AJ, 2021, CELL HOST MICROBE, V29, P463, DOI 10.1016/j.chom.2021.02.003.
   Hammond J, 2022, NEW ENGL J MED, V386, P1397, DOI 10.1056/NEJMoa2118542.
   Hao FY, 2020, TRANSL PSYCHIAT, V10, DOI 10.1038/s41398-020-01039-2.
   Hasan MM, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0243645.
   Hennig T, 2022, NATURE, V605, P539, DOI 10.1038/s41586-022-04667-4.
   Hille F, 2018, CELL, V172, P1239, DOI 10.1016/j.cell.2017.11.032.
   Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052.
   Husso T, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.48.
   Hwang B, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0071-8.
   Gallicano GI, 2022, GENE THER, V29, P304, DOI 10.1038/s41434-020-00210-0.
   Idris A, 2021, MOL THER, V29, P2219, DOI 10.1016/j.ymthe.2021.05.004.
   Jacobsen LB, 2004, METHODS, V33, P104, DOI 10.1016/j.ymeth.2003.11.002.
   Jalkanen P, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-24285-4.
   Jangra S, 2021, LANCET MICROBE, V2, pE283, DOI 10.1016/S2666-5247(21)00068-9.
   Janssen HLA, 2013, NEW ENGL J MED, V368, P1685, DOI 10.1056/NEJMoa1209026.
   Ji ZC, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw430.
   Jin K, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2021.103115.
   Juliano RL, 2014, NUCLEIC ACID THER, V24, P101, DOI 10.1089/nat.2013.0463.
   Juliano RL, 2016, NUCLEIC ACIDS RES, V44, P6518, DOI 10.1093/nar/gkw236.
   Kalil AC, 2021, NEW ENGL J MED, V384, P795, DOI 10.1056/NEJMoa2031994.
   Kashif A, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-92717-8.
   Kc GB, 2021, NAT MACH INTELL, V3, P527, DOI 10.1038/s42256-021-00335-w.
   Kelly JA, 2021, VIROLOGY, V554, DOI 10.1016/j.virol.2020.12.010.
   Khaitov M, 2021, ALLERGY, V76, P2840, DOI 10.1111/all.14850.
   Khan MAA, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.00765.
   Khoury MJ, 2021, GENOME MED, V13, DOI 10.1186/s13073-021-00886-y.
   Khoury MJ, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003373.
   Kim D, 2019, NAT BIOTECHNOL, V37, P907, DOI 10.1038/s41587-019-0201-4.
   Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36.
   Kim D, 2020, CELL, V181, P914, DOI 10.1016/j.cell.2020.04.011.
   Kim JH, 2021, NAT MED, V27, P205, DOI 10.1038/s41591-021-01230-y.
   Klim JR, 2019, INT J BIOCHEM CELL B, V110, P149, DOI 10.1016/j.biocel.2019.03.009.
   König IR, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.00391-2017.
   Kole R, 2012, NAT REV DRUG DISCOV, V11, P125, DOI 10.1038/nrd3625.
   Koonin EV, 2017, CURR OPIN MICROBIOL, V37, P67, DOI 10.1016/j.mib.2017.05.008.
   Korber B, 2020, CELL, V182, P812, DOI 10.1016/j.cell.2020.06.043.
   Krishnamoorthy P, 2021, COMPUT BIOL MED, V128, DOI 10.1016/j.compbiomed.2020.104123.
   Kumar N, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101526.
   Lam JKW, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.23.
   Lam SM, 2021, NAT METAB, V3, P909, DOI 10.1038/s42255-021-00425-4.
   Langmead B, 2012, NAT METHODS, V9, P357, DOI {[}10.1038/NMETH.1923, 10.1038/nmeth.1923].
   Lara-Ureña N, 2021, BIOMOLECULES, V11, DOI 10.3390/biom11081126.
   Le BT, 2019, MOL THER-NUCL ACIDS, V14, P142, DOI 10.1016/j.omtn.2018.11.007.
   Ledford H, 2018, NATURE, V560, P291, DOI 10.1038/d41586-018-05867-7.
   Legrand M, 2021, NAT REV NEPHROL, V17, P751, DOI 10.1038/s41581-021-00452-0.
   Lenartowicz E, 2016, NUCLEIC ACID THER, V26, P277, DOI 10.1089/nat.2016.0619.
   Li BJ, 2005, NAT MED, V11, P944, DOI 10.1038/nm1280.
   Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323.
   Li CX, 2021, MEDIAT INFLAMM, V2021, DOI 10.1155/2021/6635925.
   Li CX, 2020, J CLIN LAB ANAL, V34, DOI 10.1002/jcla.23590.
   Li H, 2018, BIOINFORMATICS, V34, P3094, DOI 10.1093/bioinformatics/bty191.
   Li QS, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01954-x.
   Liao HK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7413.
   Lim KH, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17093-9.
   Lin XQ, 2021, CELL REP MED, V2, DOI 10.1016/j.xcrm.2021.100245.
   Liu BX, 2020, J MED INTERNET RES, V22, DOI 10.2196/22299.
   Liu C, 2020, ACS CENTRAL SCI, V6, P315, DOI 10.1021/acscentsci.0c00272.
   Liu L, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/251364.
   Liu YF, 2021, CELL, V184, P3452, DOI 10.1016/j.cell.2021.05.032.
   Loman NJ, 2015, NAT METHODS, V12, P733, DOI {[}10.1038/NMETH.3444, 10.1038/nmeth.3444].
   Longo SK, 2021, NAT REV GENET, V22, P627, DOI 10.1038/s41576-021-00370-8.
   Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8.
   Luecken MD, 2019, MOL SYST BIOL, V15, DOI 10.15252/msb.20188746.
   Mallapaty S, 2022, NATURE, V602, P26, DOI 10.1038/d41586-022-00215-2.
   Margaroli C, 2021, CELL REP MED, V2, DOI 10.1016/j.xcrm.2021.100242.
   Martin M., 2011, EMBNET J, V17, DOI {[}10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200].
   Maulding ND, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-022-05342-4.
   McCaskill J, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.22.
   McDonald I, 2021, NPJ VACCINES, V6, DOI 10.1038/s41541-021-00336-1.
   Medaka, 2022, MEDAKA OXFORD NANOPO.
   Méndez-Mancilla A, 2022, CELL CHEM BIOL, V29, P321, DOI 10.1016/j.chembiol.2021.07.011.
   Mignardi M, 2014, GENOME MED, V6, DOI 10.1186/gm548.
   Mirfazeli FS, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-78050-6.
   Mizrahi B, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-20053-y.
   Moffett HF, 2017, NAT IMMUNOL, V18, P791, DOI 10.1038/ni.3755.
   Moor AE, 2017, CURR OPIN BIOTECH, V46, P126, DOI 10.1016/j.copbio.2017.02.004.
   Mueller YM, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-28621-0.
   Muus C, 2021, NAT MED, V27, P546, DOI 10.1038/s41591-020-01227-z.
   Nalbandian A, 2021, NAT MED, V27, P601, DOI 10.1038/s41591-021-01283-z.
   Neil Erin E, 2019, J Pediatr Pharmacol Ther, V24, P194, DOI 10.5863/1551-6776-24.3.194.
   Niktab I, 2021, META GENE, V29, DOI 10.1016/j.mgene.2021.100910.
   Nishiga M, 2020, NAT REV CARDIOL, V17, P543, DOI 10.1038/s41569-020-0413-9.
   NOWAK MA, 1992, TRENDS ECOL EVOL, V7, P118, DOI 10.1016/0169-5347(92)90145-2.
   Nyholm L, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101414.
   Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934.
   Pacific Biosciences Estimating Library, 2015, PACIFIC BIOSCIENCES.
   Panda M, 2022, LIFE SCI, V305, DOI 10.1016/j.lfs.2022.120761.
   Patel AK, 2019, ADV MATER, V31, DOI 10.1002/adma.201805116.
   Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122.
   Pillay S, 2020, GENES-BASEL, V11, DOI 10.3390/genes11080949.
   Ren HQ, 2021, EUR J PHARM SCI, V162, DOI 10.1016/j.ejps.2021.105832.
   Ren XW, 2021, CELL, V184, P1895, DOI 10.1016/j.cell.2021.01.053.
   Sahin U, 2020, NATURE, V585, P107, DOI 10.1038/s41586-020-2537-9.
   Salgado-Albarran M, 2021, NPJ SYST BIOL APPL, V7, DOI 10.1038/s41540-021-00181-x.
   Samy A, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-022-15898-w.
   See P, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02425.
   Sen K, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.733539.
   Sequencing Platforms|Compare, SEQUENCING PLATFORMS.
   Shang J, 2020, P NATL ACAD SCI USA, V117, P11727, DOI 10.1073/pnas.2003138117.
   Sheikh A, 2021, LANCET, V397, P2461, DOI 10.1016/S0140-6736(21)01358-1.
   Shi Y, 2005, CELL RES, V15, P193, DOI 10.1038/sj.cr.7290286.
   Shin J, 2015, CELL STEM CELL, V17, P360, DOI 10.1016/j.stem.2015.07.013.
   Shu YL, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.13.30494.
   Siemieniuk RAC, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2980.
   Singh M, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.108175.
   Sioud M., 2020, METHODS MOL BIOL, V2115.
   Skowronski DM, 2021, NEW ENGL J MED, V384, P1576, DOI 10.1056/NEJMc2036242.
   Slack FJ, 2019, CELL, V179, P1033, DOI 10.1016/j.cell.2019.10.017.
   Smargon AA, 2020, NAT CELL BIOL, V22, P143, DOI 10.1038/s41556-019-0454-7.
   Soares F, 2021, BLOOD, V137, P2171, DOI 10.1182/blood.2019004108.
   Steinbach JM, 2012, J CONTROL RELEASE, V162, P102, DOI 10.1016/j.jconrel.2012.06.008.
   Strand SH, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-67320-y.
   Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031.
   Sun L, 2021, CELL, V184, P1865, DOI 10.1016/j.cell.2021.02.008.
   Sungnak W, 2020, NAT MED, V26, P681, DOI 10.1038/s41591-020-0868-6.
   Supady A, 2021, LANCET RESP MED, V9, P430, DOI 10.1016/S2213-2600(20)30580-4.
   Svensson V, 2018, NAT PROTOC, V13, P599, DOI 10.1038/nprot.2017.149.
   Tang AD, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15171-6.
   Teichmann S, 2020, NAT REV MOL CELL BIO, V21, P415, DOI 10.1038/s41580-020-0267-3.
   Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016.
   Tregoning JS, 2021, NAT REV IMMUNOL, V21, P626, DOI 10.1038/s41577-021-00592-1.
   Tyson JR, 2020, bioRxiv, DOI {[}10.1101/2020.09.04.283077, 10.1101/2020.09.04.283077, DOI 10.1101/2020.09.04.283077].
   Vacca D, 2022, LIFE-BASEL, V12, DOI 10.3390/life12010069.
   van de Berg D, 2021, NPJ VACCINES, V6, DOI 10.1038/s41541-021-00322-7.
   Vandelli A, 2020, NUCLEIC ACIDS RES, V48, P11270, DOI 10.1093/nar/gkaa864.
   Viehweger A, 2019, GENOME RES, V29, P1545, DOI 10.1101/gr.247064.118.
   Waltz E, 2022, NATURE, V609, P240, DOI 10.1038/d41586-022-02824-3.
   Wang PF, 2021, CELL HOST MICROBE, V29, P747, DOI 10.1016/j.chom.2021.04.007.
   Wang PF, 2021, NATURE, V593, P130, DOI 10.1038/s41586-021-03398-2.
   Wang S, 2021, NAT CELL BIOL, V23, P1314, DOI 10.1038/s41556-021-00796-6.
   Wang Y, 2022, J MED VIROL, V94, P5304, DOI 10.1002/jmv.28012.
   Wang Z, 2004, J VIROL, V78, P7523, DOI 10.1128/JVI.78.14.7523-7527.2004.
   Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484.
   Watson J, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1808.
   Weirather Jason L, 2017, F1000Res, V6, P100, DOI 10.12688/f1000research.10571.1.
   Wick RR, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1727-y.
   Williams I, 2021, BMJ GLOB HEALTH, V6, DOI 10.1136/bmjgh-2020-004686.
   Wolock SL, 2019, CELL SYST, V8, P281, DOI 10.1016/j.cels.2018.11.005.
   Workman RE, 2021, CELL, V184, P675, DOI 10.1016/j.cell.2020.12.017.
   World Health Organization, 2021, Genomic Sequencing of SARS-CoV-2: A Guide to Implementation for Maximum Impact on Public Health.
   Wu CJ, 2005, ANTIVIR RES, V65, P45, DOI 10.1016/j.antiviral.2004.09.005.
   Wu SY, 2009, PHARM RES-DORDR, V26, P512, DOI 10.1007/s11095-008-9766-1.
   Wyman D, 2019, bioRxiv, DOI {[}10.1101/672931, DOI 10.1101/672931, 10.1101/672931].
   Yin D, 2021, NAT BIOTECHNOL, V39, P567, DOI 10.1038/s41587-020-00781-8.
   Yin LJ, 2020, MOL THER-NUCL ACIDS, V21, P147, DOI 10.1016/j.omtn.2020.05.030.
   Young MD, 2020, GIGASCIENCE, V9, DOI 10.1093/gigascience/giaa151.
   Yuen MF, 2020, J HEPATOL, V73, pS51.
   Zeballos CMA, 2021, TRENDS BIOTECHNOL, V39, P692, DOI 10.1016/j.tibtech.2020.10.010.
   Zeggini E, 2019, SCIENCE, V365, P1409, DOI 10.1126/science.aax4588.
   Zeming KK, 2016, LAB CHIP, V16, P75, DOI 10.1039/c5lc01051a.
   Zhang JY, 2020, NAT IMMUNOL, V21, P1107, DOI 10.1038/s41590-020-0762-x.
   Zhang JQ, 2020, CLIN TRANSL MED, V10, DOI 10.1002/ctm2.117.
   Zhang SC, 2021, METHODS, V194, P94, DOI 10.1016/j.ymeth.2021.04.023.
   Zheng GXY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14049.
   Zorzi F, 2013, DIGEST LIVER DIS, V45, P552, DOI 10.1016/j.dld.2012.11.011.},
Number-of-Cited-References = {260},
Times-Cited = {2},
Unique-ID = {WOS:000867811700001},
}

@article{ WOS:000712033000001,
Author = {Niemchick, Karen L. and Goerge, Ally and Ponte, Amy H.},
Title = {Are We Prepared for Precision Public Health? An Examination of Genomics
   Content in Graduate Public Health Programs},
Journal = {PUBLIC HEALTH REPORTS},
Year = {2022},
Volume = {137},
Number = {6},
Pages = {1242-1247},
Month = {NOV},
Abstract = {Objective With the completion of the Human Genome Project and swift
   development of genomic technologies, public health practitioners can use
   these advancements to more precisely target disease interventions to
   populations at risk. To integrate these innovations into better health
   outcomes, public health professionals need to have at least a basic
   understanding of genomics within various disciplines of public health.
   This descriptive study focused on the current level of genomics content
   in accredited master of public health (MPH) programs in the United
   States. Methods We conducted an internet search on all 171 Council on
   Education for Public Health (CEPH)-accredited MPH programs in the United
   States for genomics content in required and elective courses using the
   search terms ``genetics,{''} ``genomics,{''} and ``molecular.{''}
   Results Of the 171 CEPH-accredited MPH programs examined, 52 (30.4\%)
   schools and programs in 34 states offered some type of genomics
   education. Thirty-five (20.5\%) schools and programs had a course in
   genetic epidemiology, 29 (16.9\%) had a course in genetic biostatistics
   or bioinformatics, and 17 (9.9\%) had a course in general public health
   genomics. The remaining 119 offered no course with a focus on genetics
   or genomics. In addition, some electives or specifically focused courses
   related to genomics were offered. Conclusion We found inadequate
   training in public health genomics for MPH students. To realize the
   promise of precision public health and to increase the understanding of
   genomics among the public health workforce, MPH programs need to find
   ways to integrate genomics education into their curricula.},
Type = {Article},
Affiliation = {Niemchick, KL (Corresponding Author), Grand Valley State Univ, 500 Lafayette Ave NE,Ste 204, Grand Rapids, MI 49503 USA.
   Niemchick, Karen L.; Goerge, Ally, Grand Valley State Univ, Publ Hlth Program, Grand Rapids, MI 49503 USA.
   Ponte, Amy H., Genedu Hlth Solut, Beaufort, SC USA.},
DOI = {10.1177/00333549211055708},
EarlyAccessDate = {OCT 2021},
Article-Number = {00333549211055708},
Keywords = {genetics; public health education; workforce; genomics; precision public
   health},
Keywords-Plus = {EDUCATORS},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {niemchik@gvsu.edu},
Affiliations = {Grand Valley State University},
Cited-References = {Abrahams E, 2008, CTS-CLIN TRANSL SCI, V1, P11, DOI 10.1111/j.1752-8062.2008.00003.x.
   Allen CG, 2021, TRANSL BEHAV MED, V11, P901, DOI 10.1093/tbm/ibaa076.
   Allen CG, 2016, J HEALTH COMMUN, V21, P25, DOI 10.1080/10810730.2016.1196272.
   Brand A, 2008, EUR J HUM GENET, V16, P5, DOI 10.1038/sj.ejhg.5201942.
   Centers for Disease Control and Prevention, 2010, GEN WORKF COMP.
   Centers for Disease Control and Prevention, GEN PREC PUBL HLTH.
   Chen LS, 2008, AM J PUBLIC HEALTH, V98, P1651, DOI 10.2105/AJPH.2007.122663.
   Chen LS, 2007, GENET MED, V9, P496, DOI 10.1097/GIM.0b013e31812e95b5.
   Chen LS, 2021, PERS MED, V18, P55, DOI 10.2217/pme-2020-0093.
   Chen LS, 2014, GENET MED, V16, P271, DOI 10.1038/gim.2013.100.
   Gebbie K, 2003, WHO WILL KEEP THE PUBLIC HEALTHY?, P27.
   Gwinn M, 2017, J CLIN MICROBIOL, V55, P703, DOI 10.1128/JCM.01967-16.
   Hernandez LM, 2005, Implications of genomics for public health: workshop summary.
   Khoury M. J., 2014, Geography, genetics and leading causes of death.
   Khoury MJ, 2018, GENET MED, V20, P574, DOI 10.1038/gim.2017.211.
   Khoury MJ, 2016, AM J PREV MED, V50, P398, DOI 10.1016/j.amepre.2015.08.031.
   London, 2013, CRITICAL ANAL CONT P.
   Marzuillo C, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-239.
   Roberts JS, 2014, ANNU REV GENOM HUM G, V15, P461, DOI 10.1146/annurev-genom-090413-025514.
   Rosso A., 2017, EPIDEMIOL BIOSTAT PU, V14, P1, DOI {[}10.2427/12531, DOI 10.2427/12531].
   Shortell SM, 2004, AM J PUBLIC HEALTH, V94, P1671, DOI 10.2105/AJPH.94.10.1671.
   US Department of Health and Human Services, 2011, Secretary's Advisory Committee on Genetics, Health, and Society. Genetics Education and Training.
   US Department of Health and Human Services Office of Disease Prevention and Health Promotion, 2020, HLTH PEOPLE 2020 GEN.
   Whitley KV, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21030768.},
Number-of-Cited-References = {24},
Times-Cited = {0},
Unique-ID = {WOS:000712033000001},
}

@article{ WOS:000565461300001,
Author = {Vegter, Mira W. and Landeweerd, Laurens and Zwart, Hub A. E.},
Title = {N = many me's: self-surveillance for Precision Public Health},
Journal = {BIOSOCIETIES},
Year = {2022},
Volume = {17},
Number = {1},
Pages = {78-98},
Month = {MAR},
Abstract = {This paper focuses on Precision Public Health (PPH), described in the
   scientific literature as an effort to broaden the scope of precision
   medicine by extrapolating it towards public health. By means of the
   ``All of Us{''} (AoU) research program, launched by the National
   Institutes of Health in the U.S., PPH is being developed based on health
   data shared through a broad range of digital tools. PPH is an emerging
   idea to harness the data collected for precision medicine to be able to
   tailor preventive interventions for at-risk groups. The character of
   these data concern genetic identity, lifestyle and overall health and
   therefore affect the `intimacy' of personhood. Through the concept of
   biological citizenship, we elucidate how AoU and its recruitment
   tactics, by resonating `diversity', at the same time appeal to and
   constitute identity, defining individuals as `data sharing subjects'.
   Although PPH is called for; the type of bio-citizenship that is enacted
   here, has a particular definition, where participant recruitment focuses
   on `citizenship' in terms of empowerment (front), it is the `bio' prefix
   that has become the main focus in terms of research. i.e.
   biosubjectivities vs biocapital. This raises the question whether the
   societal challenges that often underlie public health issues can be
   sufficiently dealt with based on the way `diversity' is accounted for in
   the program. We suggest that the AoU still risks of harming
   underrepresented groups based on the preconditions and the design of the
   program.},
Type = {Article},
Affiliation = {Vegter, MW (Corresponding Author), Wageningen Univ \& Res, Dept Social Sci, POB 8130, NL-6700 EW Wageningen, Netherlands.
   Vegter, Mira W., Wageningen Univ \& Res, Dept Social Sci, POB 8130, NL-6700 EW Wageningen, Netherlands.
   Landeweerd, Laurens, Radboud Univ Nijmegen, Inst Sci Soc, Postbus 9010, NL-6500 GL Nijmegen, Netherlands.
   Zwart, Hub A. E., Erasmus Univ, Erasmus Sch Philosophy, Postbus 1738, NL-3000 DR Rotterdam, Netherlands.},
DOI = {10.1057/s41292-020-00202-8},
EarlyAccessDate = {SEP 2020},
Keywords = {Precision public health; All of Us research program; Biocitizenship;
   Diversity; Identity; Data sharing subjects},
Keywords-Plus = {MEDICINE},
Research-Areas = {Biomedical Social Sciences},
Web-of-Science-Categories  = {Social Sciences, Biomedical},
Author-Email = {mira.vegter@wur.nl},
Affiliations = {Wageningen University \& Research; Radboud University Nijmegen; Erasmus
   University Rotterdam - Excl Erasmus MC; Erasmus University Rotterdam},
Cited-References = {{[}Anonymous], 2018, AM FACTFINDER RESULT.
   {[}Anonymous], 2017, ALL US ANTHEM.
   Beier K, 2019, BMC MED INFORM DECIS, V19, DOI 10.1186/s12911-019-0799-7.
   Birch K, 2017, CULT STUD SCI EDUCAT, V12, P915, DOI 10.1007/s11422-017-9842-0.
   Blasimme A, 2016, PERSPECT BIOL MED, V59, P172, DOI 10.1353/pbm.2017.0002.
   BRANDT AM, 1978, HASTINGS CENT REP, V8, P21, DOI 10.2307/3561468.
   Chadwick R, 2001, NAT REV GENET, V2, P318, DOI 10.1038/35066094.
   Chowkwanyun M, 2018, NEW ENGL J MED, V379, P1398, DOI 10.1056/NEJMp1806634.
   Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523.
   Department of Health and Human Services and All of Us Research Program, 2018, OP PROT V1 SUMM.
   Dolley S, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00068.
   Facher Lev, 2017, ADV PRECISION MED.
   Foucault Michel., 1978, HIST SEXUALITY.
   Garza R, 2019, GOT DNA NIH BUS VISI.
   Greene DanielMarcus., 2015, TRIPLEC, V13, P25.
   Hamburg MA, 2010, NEW ENGL J MED, V363, P301, DOI 10.1056/NEJMp1006304.
   Heath Deborah., 2007, A Companion to the Anthropology of Politics, P152.
   Hood L, 2011, NAT REV CLIN ONCOL, V8, P184, DOI 10.1038/nrclinonc.2010.227.
   Horton R, 2018, DEFENCE PRECISION PU, P392, DOI {[}10.1016/S0140-6736(18)32741-7., DOI 10.1016/S0140-6736(18)32741-7].
   Hughes RC, 2012, J MED ETHICS, V38, P626, DOI 10.1136/medethics-2011-100171.
   Hummel P, 2019, PHILOS STUD SER, V137, P23, DOI 10.1007/978-3-030-04363-6\_3.
   Khoury M.J., 2015, CDC.
   Lee SSJ, 2019, GENET MED, V21, P107, DOI 10.1038/s41436-018-0032-6.
   Li X, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2001402.
   Lucivero F, 2015, APPL TRANSL GENOM, V4, P44, DOI 10.1016/j.atg.2015.02.001.
   Lupton D, 2013, CRIT PUBLIC HEALTH, V23, P393, DOI 10.1080/09581596.2013.794931.
   Lyles CR, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1585-5.
   Mayer-Schonberger Viktor, 2013, BIG DATA REVOLUTION.
   Mulvihill JJ, 2017, BRIT MED BULL, V122, P17, DOI 10.1093/bmb/ldx002.
   NIH, 2015, WHAT IS DIFF PREC ME.
   NIH, 2019, DAT SNAPSH ALL US RE.
   NIH, 2018, ALL US GEN CUONS RES.
   Obama B, 2015, PRESIDENT OBAMA SPEA.
   Petryna Adriana., 2002, LIFE EXPOSED BIOL CI.
   Plows A., 2006, GENOMICS SOC POLICY, V2, P115, DOI {[}DOI 10.1186/1746-5354-2-3-115, 10.1186/1746-5354-2-3-115].
   Prainsack B, 2019, PHILOS STUD SER, V137, P9, DOI 10.1007/978-3-030-04363-6\_2.
   Prainsack Barbara., 2011, Solidarity: Reflections on an Emerging Concept in Bioethics.
   Price ND, 2017, NAT BIOTECHNOL, V35, P747, DOI 10.1038/nbt.3870.
   Rabinow Paul., 1996, ESSAYS ANTHR REASON.
   Rich E, 2014, SOCIETIES, V4, P296, DOI 10.3390/soc4020296.
   Rose N, 2001, THEOR CULT SOC, V18, P1, DOI 10.1177/02632760122052020.
   Rose N., 1996, Inventing Our Selves: Psychology, Power, and Personhood, DOI DOI 10.1002/9780470696569.CH23.
   Rose N., 2008, MIT PRESS J.
   Rose N, 2007, POLITICS OF LIFE ITSELF: BIOMEDICINE, POWER, AND SUBJECTIVITY IN THE TWENTY-FIRST CENTURY, P1.
   Sadowski J, 2019, BIG DATA SOC, V6, DOI 10.1177/2053951718820549.
   Sankar P, 2005, HEALTH AFFAIR, V24, pW5455, DOI 10.1377/hlthaff.W5.455.
   Schork NJ, 2015, NATURE, V520, P609, DOI 10.1038/520609a.
   Sharon T, 2014, PHILOS ENG TECHNOL, V14, P1, DOI 10.1007/978-94-007-7554-1.
   Sharon T, 2018, BIG DATA SOC, V5, DOI 10.1177/2053951718819032.
   Taylor-Robinson D, 2019, INT J EPIDEMIOL, V48, P1, DOI 10.1093/ije/dyy184.
   Truog RD, 2012, SCIENCE, V337, P37, DOI 10.1126/science.1216888.
   U.S. Department of Health and Human Services, FREQ ASK QUEST FAQ O.
   van Dijck J, 2014, SURVEILL SOC, V12, P197, DOI 10.24908/ss.v12i2.4776.
   Vegter MW, 2018, MED HEALTH CARE PHIL, V21, P443, DOI 10.1007/s11019-018-9828-z.
   Vogt H, 2018, NAT BIOTECHNOL, V36, P678, DOI 10.1038/nbt.4210.
   Weeramanthri TS, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00121.
   Whitsel LP, 2019, PROG CARDIOVASC DIS, V62, P50, DOI 10.1016/j.pcad.2018.12.002.
   Yakowitz Jane., 2011, Harvard Journal of Law and Technology, V25, P1, DOI DOI 10.2139/SSRN.1789749.},
Number-of-Cited-References = {58},
Times-Cited = {4},
Unique-ID = {WOS:000565461300001},
}

@article{ WOS:000916159300001,
Author = {Andrade, Andre Q. and Calabretto, Jean-Pierre and Pratt, Nicole L. and
   Kalisch-Ellett, Lisa M. and Le Blanc, Lisa T. and Roughead, Elizabeth E.},
Title = {Precision public-health intervention for care coordination: a real-world
   study},
Journal = {BRITISH JOURNAL OF GENERAL PRACTICE},
Year = {2023},
Volume = {73},
Number = {728},
Pages = {E220-E230},
Month = {MAR},
Abstract = {Background
   Health emergencies disproportionally affect vulnerable populations.
   Digital tools can help primary care providers find, and reach, the right
   patients.
   Aim
   To evaluate whether digital interventions delivered directly to GPs'
   clinical software were more effective at promoting primary care
   appointments during the COVID-19 pandemic than interventions delivered
   by post.
   Design and setting
   Real-world, non-randomised, interventional study involving GP practices
   in all Australian states.
   Method
   Intervention material was developed to promote care coordination for
   vulnerable older veterans during the COVID-19 pandemic, and sent to GPs
   either digitally to the clinical practice software system or in the
   post. The intervention material included patient-specific information
   sent to GPs to support care coordination, and education material sent
   via post to veterans identified in the administrative claims database.
   To evaluate the impact of intervention delivery modalities on outcomes,
   the time to first appointment with the primary GP was measured; a Cox
   proportional hazards model was used, adjusting for differences and
   accounting for pre-intervention appointment numbers.
   Results
   The intervention took place in April 2020, during the first weeks of
   COVID-19 social distancing restrictions in Australia. GPs received
   digital messaging for 51 052 veterans and postal messaging for 26 859
   veterans. The digital group was associated with earlier appointments
   (adjusted hazard ratio 1.38 {[}1.34 to 1.41]).
   Conclusion
   Data-driven digital solutions can promote care coordination at scale
   during national emergencies, opening up new perspectives for precision
   public-health initiatives.},
Type = {Article},
Affiliation = {Andrade, AQ (Corresponding Author), Univ South Australia, Qual Use Med \& Pharm Res Ctr, Clin \& Hlth Sci, GPO Box 2471, Adelaide, SA 5001, Australia.
   Andrade, Andre Q.; Calabretto, Jean-Pierre; Pratt, Nicole L.; Kalisch-Ellett, Lisa M.; Le Blanc, Lisa T.; Roughead, Elizabeth E., Univ South Australia, Qual Use Med \& Pharm Res Ctr, Clin \& Hlth Sci, GPO Box 2471, Adelaide, SA 5001, Australia.},
DOI = {10.3399/BJGP.2022.0067},
EarlyAccessDate = {JAN 2023},
Keywords = {audit and feedback; care coordination; digital health; general practice;
   intervention study; precision public health; veterans},
Keywords-Plus = {NONCOMMUNICABLE DISEASES; CLINICAL CHARACTERISTICS;
   INFORMATION-TECHNOLOGY; PREVENTION; DISASTERS},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Primary Health Care; Medicine, General \& Internal},
Author-Email = {andre.andrade@unisa.edu.au},
Affiliations = {University of South Australia},
Cited-References = {Andrade AQ, 2022, J MED INTERNET RES, V24, DOI 10.2196/33873.
   Andrade AQ, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-038016.
   {[}Anonymous], 2010, MMWR-MORBID MORTAL W.
   Australian Government Department of Health and Aged Care, 2020, COR COVID 19 HLTH PA.
   Australian Government Department of Health and Aged Care, 1 1 BILL SUPP MOR ME.
   Australian Institute of Health and Welfare, Impacts of COVID- 19 on Medicare benefits scheme and pharmaceutical benefits scheme service use.
   Bajgain KT, 2021, AM J INFECT CONTROL, V49, P238, DOI 10.1016/j.ajic.2020.06.213.
   BANDURA A, 1989, AM PSYCHOL, V44, P1175, DOI 10.1037/0003-066X.44.9.1175.
   Bauer UE, 2014, LANCET, V384, P45, DOI 10.1016/S0140-6736(14)60648-6.
   Chen T, 2020, BMJ-BRIT MED J, V368, DOI {[}10.1136/bmj.m1295, 10.1136/bmj.m1091].
   Coker TR, 2019, PEDIATRICS, V143, DOI 10.1542/peds.2018-2738.
   Czeisler MÉ, 2020, MMWR-MORBID MORTAL W, V69, P1250, DOI 10.15585/mmwr.mm6936a4.
   Dempsey TM, 2019, CRIT CARE CLIN, V35, P677, DOI 10.1016/j.ccc.2019.06.010.
   Ellett LMK, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3443-9.
   Ellett Lisa M. Kalisch, 2018, Journal of Pharmacy Practice and Research, V48, P222, DOI 10.1002/jppr.1379.
   European Centre for Disease Prevention and Control, Coronavirus disease 2019 (COVID- 19) pandemic: increased transmission in the EU/ EEA and the UK-seventh update.
   Fagherazzi G, 2020, J MED INTERNET RES, V22, DOI 10.2196/19284.
   Fisher JRW, 2020, MED J AUSTRALIA, V213, P458, DOI 10.5694/mja2.50831.
   Geboy AG, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216459.
   Green LW., 2005, HLTH PROGRAM PLANNIN.
   Greenhalgh T, 2004, MILBANK Q, V82, P581, DOI 10.1111/j.0887-378X.2004.00325.x.
   Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032.
   Guan WJ, 2020, EUR RESPIR J, V55, DOI {[}10.1183/13993003.00547-2020, 10.1371/journal.pone.0240308, 10.1183/13993003.00597-2020].
   Gunasekeran DV, 2021, NPJ DIGIT MED, V4, DOI 10.1038/s41746-021-00412-9.
   Harrison SL, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003321.
   Jha AK, 2008, INT J MED INFORM, V77, P848, DOI 10.1016/j.ijmedinf.2008.06.007.
   Judson TJ, 2020, J AM MED INFORM ASSN, V27, P860, DOI 10.1093/jamia/ocaa051.
   Kluge HHP, 2020, LANCET, V395, P1678, DOI 10.1016/S0140-6736(20)31067-9.
   Kopp JB, 2007, CLIN J AM SOC NEPHRO, V2, P814, DOI 10.2215/CJN.03481006.
   Liang WH, 2020, LANCET ONCOL, V21, P335, DOI 10.1016/S1470-2045(20)30096-6.
   Man RXG, 2018, LANCET ONCOL, V19, pE482, DOI 10.1016/S1470-2045(18)30412-1.
   Michie S, 2013, ANN BEHAV MED, V46, P81, DOI 10.1007/s12160-013-9486-6.
   Moynihan R, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-045343.
   Pratt NL, 2017, INT J QUAL HEALTH C, V29, P75, DOI 10.1093/intqhc/mzw138.
   Pratt NL, 2015, SOC SCI MED, V145, P1, DOI 10.1016/j.socscimed.2015.09.019.
   PROCHASKA JO, 1994, HEALTH PSYCHOL, V13, P39, DOI 10.1037/0278-6133.13.1.39.
   Roberton T, 2020, LANCET GLOB HEALTH, V8, pE901, DOI 10.1016/S2214-109X(20)30229-1.
   Roughead EE, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-514.
   Royal Australian College of General Practitioners, General practice: health of the nation 2019.
   Santos-Burgoa C, 2018, LANCET PLANET HEALTH, V2, pE478, DOI {[}10.1016/S2542-5196(18)30209-2, 10.1016/s2542-5196(18)30209-2].
   Schlieter H, 2022, J MED INTERNET RES, V24, DOI 10.2196/24582.
   Shade SB, 2015, J AM MED INFORM ASSN, V22, pE104, DOI 10.1136/amiajnl-2013-002623.
   Slama S, 2017, LANCET, V389, P326, DOI 10.1016/S0140-6736(16)31404-0.
   Taylor CJ, 2016, BRIT J GEN PRACT, V66, P428, DOI 10.3399/bjgp16X686377.
   Tomio J, 2014, OPEN ACCESS EMERG M, V6, P69, DOI 10.2147/OAEM.S48532.
   Verity R, 2020, LANCET INFECT DIS, V20, P669, DOI 10.1016/S1473-3099(20)30243-7.
   Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585.
   Whitelaw S, 2020, LANCET DIGIT HEALTH, V2, pE435, DOI 10.1016/S2589-7500(20)30142-4.
   Willis VC, 2022, JMIR MED INF, V10, DOI 10.2196/33518.
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648.
   Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5.
   Yoo SM, 2021, J PREV MED PUBLIC HL, V54, P17, DOI 10.3961/jpmph.20.594.
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3.},
Number-of-Cited-References = {53},
Times-Cited = {0},
Unique-ID = {WOS:000916159300001},
}

@article{ WOS:000457554400038,
Author = {Alshehri, Abdulrahim Abdullah and Ambrosino, Elena},
Title = {OPPORTUNITIES FOR PRECISION MEDICINE AND PRECISION PUBLIC HEALTH IN
   SAUDI ARABIA},
Journal = {INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES},
Year = {2019},
Volume = {6},
Number = {1},
Pages = {2118-2127},
Month = {JAN},
Abstract = {Precision approaches in health stem from innovations in basic sciences
   and - omic technologies and rely on individuals' genomic structure to
   develop tailored treatment and prevention opportunities. Saudi Arabia
   has recently shown increasing interest in implementing precision
   approaches to improve healthcare and tackle its major health challenges.
   This study investigated opportunities, requirements and barriers in the
   implementation of precision approaches in health in Saudi Arabia.
   A narrative literature review included resources published in English
   and Arabic after 1995 if identified by search terms.
   Opportunities for implementation of precision approaches were identified
   in the context of the main local health issues. Requirements for
   precision medicine implementation were identified, including the ability
   to collect and process data. In addition, barriers and challenges, as
   lack of awareness of the field amongst health staff, were pointed out.
   The outcome offers relevant information to implementation attempts in
   the field and may help guiding policy-making efforts.},
Type = {Article},
Affiliation = {Alshehri, AA (Corresponding Author), Maastricht Univ, Fac Hlth Med \& Life Sci, Maastricht, Netherlands.
   Alshehri, Abdulrahim Abdullah, Maastricht Univ, Fac Hlth Med \& Life Sci, Maastricht, Netherlands.
   Ambrosino, Elena, Maastricht Univ, Fac Hlth Med \& Life Sci, Cluster Genet \& Cell Biol, Sch Oncol \& Dev Biol GROW,Inst Publ Hlth Genom, Maastricht, Netherlands.},
DOI = {10.5281/zenodo.2551139},
Keywords = {Precision medicine; Precision public health; Genomics; KSA},
Keywords-Plus = {PERSONALIZED MEDICINE; GENOMIC MEDICINE; PHARMACOGENOMICS;
   IMPLEMENTATION; BIOMARKERS; INHIBITOR; GENOTYPES; HAPLOTYPE; RESPONSES;
   GENETICS},
Research-Areas = {Pharmacology \& Pharmacy},
Web-of-Science-Categories  = {Chemistry, Medicinal},
Author-Email = {a.alshehri@student.maastrichtuniversity.nl},
Affiliations = {Maastricht University; Maastricht University},
Cited-References = {Abu-Elmagd M, 2015, BMC MED GENOMICS, V8, DOI 10.1186/1755-8794-8-S1-S3.
   Alkuraya FS, 2014, MOL GENET GENOM MED, V2, P369, DOI 10.1002/mgg3.97.
   Alsulame K, 2016, HEALTH POLICY TECHN, V5, P204, DOI 10.1016/j.hlpt.2016.02.005.
   Altayyari ST, 2017, J HEAL SPEC.
   Anney RJL, 2014, LANCET NEUROL, V13, P893, DOI 10.1016/S1474-4422(14)70171-1.
   {[}Anonymous], 2014, BRCA1 and BRCA2: Cancer risk and genetic testing.
   Arrington CB, 2012, CIRC CARDIOVASC GENE.
   Auer PL, 2015, JAMA NEUROL, V72, P781, DOI 10.1001/jamaneurol.2015.0582.
   Chia Stephen K, 2015, Am Soc Clin Oncol Educ Book, pe41, DOI 10.14694/EdBook\_AM.2015.35.e41.
   Costigan M, 2010, BRAIN, V133, P2519, DOI 10.1093/brain/awq195.
   Cramer PE, 2012, SCIENCE, V335, P1503, DOI 10.1126/science.1217697.
   Dawood S, 2009, J CLIN ONCOL, V27, pE38, DOI 10.1200/JCO.2009.21.8271.
   Dean L., 2015, CLOPIDOGREL THERAPY.
   Douillard JY, 2013, NEW ENGL J MED, V369, P1023, DOI 10.1056/NEJMoa1305275.
   Drazen JM, 2000, BRIT MED BULL, V56, P1054, DOI 10.1258/0007142001903535.
   Eleuterio NM, 2015, PREGNANCY HYPERTENS, V5, P205, DOI 10.1016/j.preghy.2015.03.001.
   Epstein RS, 2010, J AM COLL CARDIOL, V55, P2804, DOI 10.1016/j.jacc.2010.03.009.
   Eroglu Z, 2014, ONCOLOGIST, V19, P135, DOI 10.1634/theoncologist.2013-0283.
   Flynn JF, 2009, J ONCOL, V2009, DOI 10.1155/2009/526963.
   Gandal MJ, 2018, SCIENCE, V359, P693, DOI 10.1126/science.aad6469.
   GREEN SA, 1995, AM J RESP CELL MOL, V13, P25, DOI 10.1165/ajrcmb.13.1.7598936.
   Guerreiro R, 2013, CELL, V155, P968, DOI 10.1016/j.cell.2013.10.037.
   Han MK, 2010, AM J RESP CRIT CARE, V182, P598, DOI 10.1164/rccm.200912-1843CC.
   Hasanain R A., 2015, Journal of Health Informatics in Developing Countries, V9, P23.
   Hawkins GA, 2006, AM J RESP CRIT CARE, V174, P1101, DOI 10.1164/rccm.200509-1405OC.
   Hicks JK, 2013, CLIN PHARMACOL THER, V93, P402, DOI 10.1038/clpt.2013.2.
   Hinman JD, 2017, J NEUROL NEUROSUR PS, V88, P54, DOI 10.1136/jnnp-2016-314587.
   Horgan D, 2014, PUBLIC HEALTH GENOM, V17, P287, DOI 10.1159/000368034.
   Hulot JS, 2010, J AM COLL CARDIOL, V56, P134, DOI 10.1016/j.jacc.2009.12.071.
   Jia WP, 2013, FRONT MED-PRC, V7, P1, DOI 10.1007/s11684-013-0241-y.
   Kamide K, 2013, PHARMACOGENOMICS, V14, P1709, DOI 10.2217/pgs.13.161.
   Kato M, 2010, MOL PSYCHIATR, V15, P473, DOI 10.1038/mp.2008.116.
   Khoury MJ, 2016, AM J PREV MED, V50, P398, DOI 10.1016/j.amepre.2015.08.031.
   Kim Y, 2017, BLOOD RES, V52, P84, DOI 10.5045/br.2017.52.2.84.
   Kindt I, 2017, CURR OPIN LIPIDOL, V28, P152, DOI 10.1097/MOL.0000000000000398.
   Klein ME, 2017, J PHARM SCI-US, V106, P2368, DOI 10.1016/j.xphs.2017.04.051.
   Loth E, 2017, MOL AUTISM, V8, DOI 10.1186/s13229-017-0146-8.
   Manolio TA, 2013, GENET MED, V15, P258, DOI 10.1038/gim.2012.157.
   Manolopoulos VG, 2011, PHARMACOGENOMICS, V12, P1161, DOI {[}10.2217/PGS.11.65, 10.2217/pgs.11.65].
   McGrath S, 2016, BMC MED GENOMICS, V9, DOI 10.1186/s12920-016-0183-8.
   McMahon FJ, 2012, NEURON, V74, P773, DOI 10.1016/j.neuron.2012.05.004.
   Meschia JF, 2009, STROKE, V40, P3641, DOI 10.1161/STROKEAHA.109.562231.
   Morgan AA, 2016, BIOCOMPUT-PAC SYM, P243.
   Nielsen CS, 2012, CLIN GENET, V82, P331, DOI 10.1111/j.1399-0004.2012.01938.x.
   Northrop-Clewes CA, 2013, J BLOOD MED, V4, P11, DOI 10.2147/JBM.S29212.
   Porter LF, 2014, CLIN GENET, V86, P1, DOI 10.1111/cge.12389.
   Relling MV, 2011, CLIN PHARMACOL THER, V89, P387, DOI 10.1038/clpt.2010.320.
   Romero R, 2010, AM J OBSTET GYNECOL, V202.
   Russell CB, 2014, J IMMUNOL, V192, P3828, DOI 10.4049/jimmunol.1301737.
   Safi O., 2016, INDIAN J APPL RES, V6.
   SAHI, 2017, WHO WE AR.
   Saudi Genome Project Team, 2015, IEEE PULSE, V6, P22, DOI 10.1109/MPUL.2015.2476541.
   SchmittEgenolf M, 1996, J INVEST DERMATOL, V106, P711, DOI 10.1111/1523-1747.ep12345600.
   Shu Y, 2007, J CLIN INVEST, V117, P1422, DOI 10.1172/JCI30558.
   Sinicrope FA, 2016, CLIN GASTROENTEROL H, V14, P651, DOI 10.1016/j.cgh.2016.02.008.
   Stoller JK, 2012, AM J RESP CRIT CARE, V185, P246, DOI 10.1164/rccm.201108-1428CI.
   Szefler SJ, 2002, J ALLERGY CLIN IMMUN, V109, P410, DOI 10.1067/mai.2002.122635.
   Szefler SJ, 2005, J ALLERGY CLIN IMMUN, V115, P233, DOI 10.1016/j.jaci.2004.11.014.
   Thomas PPM, 2016, PERS MED, V13, P381, DOI 10.2217/pme-2016-0029.
   Tian SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044274.
   VadilloOrtega F, 1996, AM J OBSTET GYNECOL, V174, P1371, DOI 10.1016/S0002-9378(96)70687-7.
   Vardeh D, 2016, J PAIN, V17, pT50, DOI 10.1016/j.jpain.2016.03.001.
   Voora D, 2009, J AM COLL CARDIOL, V54, P1609, DOI 10.1016/j.jacc.2009.04.053.},
Number-of-Cited-References = {63},
Times-Cited = {0},
Unique-ID = {WOS:000457554400038},
}

@article{ WOS:001096267200004,
Author = {Moore, Harriet and Hill, Bartholomew and Emery, Jay and Gussy, Mark and
   Siriwardena, Aloysius Niroshan and Spaight, Robert and Tanser, Frank},
Title = {An early warning precision public health approach for assessing COVID-19
   vulnerability in the UK: the Moore-Hill Vulnerability Index (MHVI)},
Journal = {BMC PUBLIC HEALTH},
Year = {2023},
Volume = {23},
Number = {1},
Month = {NOV 2},
Abstract = {BackgroundMost COVID-19 vulnerability indices rely on measures that are
   biased by rates of exposure or are retrospective like mortality rates
   that offer little opportunity for intervention. The Moore-Hill
   Vulnerability Index (MHVI) is a precision public health early warning
   alternative to traditional infection fatality rates that presents
   avenues for mortality prevention.MethodsWe produced an
   infection-severity vulnerability index by calculating the proportion of
   all recorded positive cases that were severe and attended by ambulances
   at small area scale for the East Midlands of the UK between May 2020 and
   April 2022. We produced maps identifying regions with high and low
   vulnerability, investigated the accuracy of the index over shorter and
   longer time periods, and explored the utility of the MHVI compared to
   other common proxy measures and indices. Analysis included exploring the
   correlation between our novel index and the Index of Multiple
   Deprivation (IMD).ResultsThe MHVI captures geospatial dynamics that
   single metrics alone often overlook, including the compound health
   challenges associated with disadvantaged and declining coastal towns
   inhabited by communities with post-industrial health legacies. A
   moderate negative correlation between MHVI and IMD reflects spatial
   analysis which suggests that high vulnerability occurs in affluent rural
   as well as deprived coastal and urban communities. Further, the MHVI
   estimates of severity rates are comparable to infection fatality rates
   for COVID-19.ConclusionsThe MHVI identifies regions with known high
   rates of poor health outcomes prior to the pandemic that case rates or
   mortality rates alone fail to identify. Pre-hospital early warning
   measures could be utilised to prevent mortality during a novel pandemic.},
Type = {Article},
Affiliation = {Moore, H (Corresponding Author), Univ Lincoln, Dept Geog, Lincoln, England.
   Moore, H (Corresponding Author), Dev Inequal Resilience \& Environm Res Grp, Lincoln, England.
   Moore, H (Corresponding Author), EDGE Consortium, Lincoln, ON, Canada.
   Moore, H (Corresponding Author), EDGE Consortium, Lincoln, England.
   Moore, Harriet; Emery, Jay, Univ Lincoln, Dept Geog, Lincoln, England.
   Moore, Harriet; Emery, Jay, Dev Inequal Resilience \& Environm Res Grp, Lincoln, England.
   Moore, Harriet; Hill, Bartholomew; Gussy, Mark; Siriwardena, Aloysius Niroshan; Spaight, Robert; Tanser, Frank, EDGE Consortium, Lincoln, ON, Canada.
   Moore, Harriet; Hill, Bartholomew; Gussy, Mark; Siriwardena, Aloysius Niroshan; Spaight, Robert; Tanser, Frank, EDGE Consortium, Lincoln, England.
   Hill, Bartholomew, Loughborough Univ, WATERWISER WEDC, Loughborough, England.
   Gussy, Mark, Lincoln Int Inst Rural Hlth, Lincoln, England.
   Siriwardena, Aloysius Niroshan; Spaight, Robert, Univ Lincoln, Sch Hlth \& Social Care, Community \& Hlth Res Unit, Lincoln, England.
   Spaight, Robert, East Midlands Ambulance Serv NHS Trust, Nottingham, England.
   Tanser, Frank, Stellenbosch Univ, Sch Data Sci \& Computat Thinking, Stellenbosch, South Africa.},
DOI = {10.1186/s12889-023-17092-7},
Article-Number = {2147},
Keywords = {COVID-19; Vulnerability index; Precision public health; Ambulance data},
Keywords-Plus = {MANAGEMENT; MIGRATION; MORTALITY; EPIDEMIC; CHOLERA; RISK},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Affiliations = {University of Lincoln; Loughborough University; University of Lincoln;
   Stellenbosch University},
Cited-References = {Abou Ghayda R, 2020, INT J INFECT DIS, V100, P302, DOI 10.1016/j.ijid.2020.08.065.
   Abtahi M, 2021, ENVIRON RES, V197, DOI 10.1016/j.envres.2021.111039.
   Acharya R, 2020, LANCET GLOB HEALTH, V8, pE1142, DOI 10.1016/S2214-109X(20)30300-4.
   Aguiar M, 2020, PUBLIC HEALTH, V188, P18, DOI 10.1016/j.puhe.2020.08.021.
   Martinez-Juarez LA, 2020, ECLINICALMEDICINE, V23, DOI 10.1016/j.eclinm.2020.100376.
   Amram O, 2020, HEALTH PLACE, V64, DOI 10.1016/j.healthplace.2020.102377.
   {[}Anonymous], 2019, English indices of deprivation 2019.
   ArcGIS Pro, 2023, Version 3.1. Redlands.
   Asquith J, 2020, PEOPLE HAVE BEEN FLO.
   Atherton A, 2009, Secondary centres of economic activity in the East Midlands.
   Azizi Mh, 2010, Middle East J Dig Dis, V2, P51.
   Bach-Mortensen AM, 2021, J EPIDEMIOL COMMUN H, V75, P624, DOI 10.1136/jech-2020-215039.
   Bamweyana I., 2020, Journal of Geographic Information System, V12, P302, DOI DOI 10.4236/JGIS.2020.124019.
   BBC, 2020, Coronavirus: Second-home owners `claiming £10,000 in virus support.
   Beatty C., 2014, Seaside towns in the age of austerity: Recent trends in employment in seaside tourism in England and Wales.
   Beatty C.S. Fothergill., 2016, Jobs, Welfare and Austerity: how the destruction of industrial Britain casts a shadow over the present-day public finances.
   Beatty C, 2020, REG STUD, V54, P1238, DOI 10.1080/00343404.2019.1699651.
   Botan V, 2021, DIABETIC MED, V38, DOI 10.1111/dme.14612.
   Breman JG, 2002, NEW ENGL J MED, V346, P1300, DOI 10.1056/NEJMra020025.
   Chaney P, 2000, J RURAL STUD, V16, P79, DOI 10.1016/S0743-0167(99)00019-4.
   Cuneo CN, 2017, HEALTH HUM RIGHTS, V19, P249.
   Daras K, 2021, J EPIDEMIOL COMMUN H, V75, P729, DOI 10.1136/jech-2020-215227.
   Davenport A, 2020, The geography of the COVID-19 crisis in England, pp3.
   De Smith MJ., 2018, Geospatial analysis: a comprehensive guide to principles, V6th ed..
   DeCaprio D, 2020, arXiv.
   Department of Environment Food and Affairs R, 2021, 2011 Rural Urban Classification lookup tables for all geographies.
   Derbyshire CC, 2011, Ripley: Stages of life. Age Structure, Policy and research division.
   East Lindsey District Council, 2022, Plans for £50 million investment in Mablethorpe and Skegness presented to Government.
   Emery, 2019, J URBAN CULTURAL STU, V6, P219, DOI DOI 10.1386/JUCS\_00011\_1.
   Emery J, 2022, SOC CULT GEOGR, V23, P639, DOI 10.1080/14649365.2020.1809011.
   Esteve A, 2020, P NATL ACAD SCI USA, V117, P16118, DOI 10.1073/pnas.2008764117.
   EVANS RJ, 1988, PAST PRESENT, P123, DOI 10.1093/past/120.1.123.
   Faezipour M, 2020, TELEMED E-HEALTH, V26, P1202, DOI 10.1089/tmj.2020.0114.
   Fitzpatrick D, 2022, SCAND J TRAUMA RESUS, V30, DOI 10.1186/s13049-022-00995-6.
   Freese KE, 2021, J HEALTH CARE POOR U, V32, P245, DOI 10.1353/hpu.2021.0022.
   Gao ZK, 2022, MODEL EARTH SYST ENV, V8, P2525, DOI 10.1007/s40808-021-01244-y.
   Hridoy AE, 2022, SPAT INF RES, V30, P23, DOI 10.1007/s41324-021-00409-2.
   Hughes MM, 2021, MMWR-MORBID MORTAL W, V70, P431, DOI 10.15585/mmwr.mm7012e1.
   Stier AJ, 2020, Arxiv, DOI arXiv:2003.10376.
   Jagodnik KM, 2020, medRxiv, P2020.
   Jennings W., 2017, Political Insight, V8, P4.
   Jensen PKM, 2021, APMIS, V129, P421, DOI 10.1111/apm.13102.
   Judson SD, 2020, PAN AFR MED J, V37, DOI 10.11604/pamj.supp.2020.37.16.26167.
   Kalantaridis C, 2010, J RURAL STUD, V26, P418, DOI 10.1016/j.jrurstud.2010.03.001.
   Khan SQ, 2021, F1000Research, P10.
   Kim SJ, 2020, HEALTH EDUC BEHAV, V47, P509, DOI 10.1177/1090198120929677.
   Knighton AJ, 2018, J HEALTH CARE POOR U, V29, P81, DOI 10.1353/hpu.2018.0009.
   Kulu H, 2020, medRxiv.
   Kuo CL, 2021, J GERONTOL A-BIOL, V76, pE133, DOI 10.1093/gerona/glab060.
   Lancet T., 2020, Lancet, V395, P1089, DOI DOI 10.1016/S0140-6736(20)30757-1.
   Liao QY, 2021, EMERG INFECT DIS, V27, P1935, DOI 10.3201/eid2707.204076.
   Lone NI, 2021, LANCET REG HEALTH-EU, V1, DOI 10.1016/j.lanepe.2020.100005.
   Macharia PM, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-003014.
   Marmot M, 2020, J EPIDEMIOL COMMUN H, V74, P681, DOI 10.1136/jech-2020-214720.
   McQueenie R, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238091.
   Melvin SC, 2020, PREV CHRONIC DIS, V17, DOI 10.5888/pcd17.200256.
   Meyerowitz-Katz G, 2020, INT J INFECT DIS, V101, P138, DOI 10.1016/j.ijid.2020.09.1464.
   Mohanty SK, 2020, LANCET GLOB HEALTH, V8, pE1104, DOI 10.1016/S2214-109X(20)30329-6.
   Moore HE, 2022, LANDSCAPE URBAN PLAN, V219, DOI 10.1016/j.landurbplan.2021.104299.
   Moore HE, 2022, LANDSCAPE URBAN PLAN, V217, DOI 10.1016/j.landurbplan.2021.104265.
   Moore HE, 2021, BJPSYCH OPEN, V7, DOI 10.1192/bjo.2021.973.
   Nafilyan V, 2021, J ROY SOC MED, V114, P182, DOI 10.1177/0141076821999973.
   Nayak Aditi, 2020, medRxiv, DOI 10.1101/2020.04.10.20060962.
   Niksic M, 2015, BRIT J CANCER, V113, P533, DOI 10.1038/bjc.2015.164.
   Office of National Statistics, 2022, Census 2021: Demography and migration: Census 2021 in England and Wales.
   Olsen W, 2020, EUR J DEV RES, V32, P1476, DOI 10.1057/s41287-020-00333-5.
   Paton A., 2020, Submission of evidence on the disproportionate impact of COVID 19, and the UK government response.
   Printza A, 2020, EUR ARCH OTO-RHINO-L, V277, P2625, DOI 10.1007/s00405-020-06069-6.
   Reps JM, 2021, JMIR MED INF, V9, DOI 10.2196/21547.
   Rodríguez-Pose A, 2018, CAMB J REG ECON SOC, V11, P189, DOI 10.1093/cjres/rsx024.
   Rowe F, 2022, Popul Space Place, P37.
   Shadeed S, 2021, INT J DISAST RISK RE, V64, DOI 10.1016/j.ijdrr.2021.102483.
   Skou ST, 2022, NAT REV DIS PRIMERS, V8, DOI 10.1038/s41572-022-00376-4.
   Smith DP, 2021, POPUL SPACE PLACE, V27, DOI 10.1002/psp.2496.
   Smittenaar P, 2021, MedRxiv, P2021.
   Snooks H, 2021, JACEP OPEN, V2, DOI 10.1002/emp2.12492.
   Snyder BF, 2020, HEALTH PLACE, V66, DOI 10.1016/j.healthplace.2020.102471.
   Soltan AAS, 2021, LANCET DIGIT HEALTH, V3, pe78, DOI 10.1016/S2589-7500(20)30274-0.
   Sorci G, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-75848-2.
   South Holland District Council, 2017, Holbeach Town Ward Profile.
   Strangleman T, 2001, INT J URBAN REGIONAL, V25, P253, DOI 10.1111/1468-2427.00310.
   Teller J, 2021, Build Cities, V2.
   The Health Foundation, 2020, NHS Test and Trace: the journey so far.
   The Newsroom O National World Publishing Ltd., 2018, End of era as Derbyshire Miners' Convalescent Home near Skegness closes.
   Thomas GM, 2016, HEALTH PLACE, V38, P1, DOI 10.1016/j.healthplace.2015.12.001.
   Tiwari A, 2021, SCI TOTAL ENVIRON, V773, DOI 10.1016/j.scitotenv.2021.145650.
   UK Government, 2020, COR COVID 19 UK.
   University of Cambridge, 2022, COVID-19 Sounds App.
   Wee LE, 2020, EUR ARCH OTO-RHINO-L, V277, P2389, DOI 10.1007/s00405-020-05999-5.
   Welsh CE, 2022, LANCET REG HEALTH-EU, V14, DOI 10.1016/j.lanepe.2021.100296.
   Wheeler BW, 2012, HEALTH PLACE, V18, P1198, DOI 10.1016/j.healthplace.2012.06.015.
   Witteveen D, 2020, RES SOC STRAT MOBIL, V69, DOI 10.1016/j.rssm.2020.100551.
   Wolkin A, 2022, PUBLIC HEALTH REP, V137, P803, DOI 10.1177/00333549221090262.
   Wyatt S, 2021, LANCET REG HEALTH-EU, V2, DOI 10.1016/j.lanepe.2021.100034.
   Zayet S, 2020, MICROBES INFECT, V22, P481, DOI 10.1016/j.micinf.2020.05.016.
   Zogal V, 2020, J Tourism Futures.},
Number-of-Cited-References = {96},
Times-Cited = {0},
Unique-ID = {WOS:001096267200004},
}

@article{ WOS:000585692500001,
Author = {Guo, Shuaijun and Yu, Xiaoming and Okan, Orkan},
Title = {Moving Health Literacy Research and Practice towards a Vision of Equity,
   Precision and Transparency},
Journal = {INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH},
Year = {2020},
Volume = {17},
Number = {20},
Month = {OCT},
Abstract = {Over the past two decades, health literacy research has gained
   increasing attention in global health initiatives to reduce health
   disparities. While it is well-documented that health literacy is
   associated with health outcomes, most findings are generated from
   cross-sectional data. Along with the increasing importance of health
   literacy in policy, there is a lack of specificity and transparency
   about how to improve health literacy in practice. In this study, we are
   calling for a shift of current research paradigms from judging health
   literacy levels towards observing how health literacy skills are
   developed over the life course and practised in the real world. This
   includes using a life-course approach, integrating the rationale of
   precision public health, applying open science practice, and promoting
   actionable knowledge translation strategies. We show how a greater
   appreciation for these paradigms promises to advance health literacy
   research and practice towards an equitable, precise, transparent, and
   actionable vision.},
Type = {Article},
Affiliation = {Guo, SJ (Corresponding Author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Ctr Community Child Hlth, Melbourne, Vic 3052, Australia.
   Guo, SJ (Corresponding Author), Univ Melbourne, Dept Pediat, Melbourne, Vic 3010, Australia.
   Guo, Shuaijun, Royal Childrens Hosp, Murdoch Childrens Res Inst, Ctr Community Child Hlth, Melbourne, Vic 3052, Australia.
   Guo, Shuaijun, Univ Melbourne, Dept Pediat, Melbourne, Vic 3010, Australia.
   Yu, Xiaoming, Peking Univ, Inst Child \& Adolescent Hlth, Sch Publ Hlth, Beijing 100191, Peoples R China.
   Okan, Orkan, Bielefeld Univ, Fac Educ Sci, Ctr Prevent \& Intervent Childhood \& Adolescence C, D-33615 Bielefeld, Germany.},
DOI = {10.3390/ijerph17207650},
Article-Number = {7650},
Keywords = {health literacy; life course; precision public health; open science;
   knowledge translation},
Keywords-Plus = {GLOBAL HEALTH; CHILD HEALTH; BIG DATA; ADOLESCENT; BEHAVIORS; LIFE},
Research-Areas = {Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health},
Web-of-Science-Categories  = {Environmental Sciences; Public, Environmental \& Occupational Health},
Author-Email = {jun.guo@mcri.edu.au
   yxm@bjmu.edu.cn
   orkan.okan@uni-bielefeld.de},
Affiliations = {Melbourne Genomics Health Alliance; Murdoch Children's Research
   Institute; Royal Children's Hospital Melbourne; University of Melbourne;
   Melbourne Bioinformatics; Peking University; University of Bielefeld},
Cited-References = {Aarts AA, 2015, SCIENCE, V349, DOI 10.1126/science.aac4716.
   Ali MY, 2020, ASIA-PAC J PUBLIC HE, V32, P168, DOI 10.1177/1010539520927261.
   Allen Christopher, 2019, PLoS Biol, V17, pe3000246, DOI 10.1371/journal.pbio.3000246.
   Allott ML, 2018, AUST HEALTH REV, V42, P31, DOI 10.1071/AH17059.
   {[}Anonymous], 2019, LANCET CHILD ADOLESC, V3, P749, DOI 10.1016/S2352-4642(19)30299-8.
   {[}Anonymous], 2018, IMPR HLTH SAF YOUNG.
   {[}Anonymous], 2014, ANN 2014 REPORT COMM, P1.
   Ashley EA, 2015, JAMA-J AM MED ASSOC, V313, P2119, DOI 10.1001/jama.2015.3595.
   Australian Commission on Safety and Quality in Health Care, 2014, NAT STAT HLTH LIT.
   Azugbene E., 2017, Ann Glob Health, V83, P94.
   Barton CJ, 2019, BRIT J SPORT MED, V53, DOI 10.1136/bjsports-2017-098367.
   Basili C, 2017, CHANDOS INF PROF SER, P229, DOI 10.1016/B978-0-08-100673-3.00009-5.
   Batterham RW, 2016, PUBLIC HEALTH, V132, P3, DOI 10.1016/j.puhe.2016.01.001.
   Batterham Roy W, 2014, BMC Public Health, V14, P694, DOI 10.1186/1471-2458-14-694.
   Berkman ND, 2011, ANN INTERN MED, V155, P97, DOI 10.7326/0003-4819-155-2-201107190-00005.
   Bröder J, 2020, HEALTH PROMOT INT, V35, P575, DOI 10.1093/heapro/daz041.
   Caballero A, 2020, FRONT COMMUN, V5, DOI 10.3389/fcomm.2020.00056.
   Camerer CF, 2018, NAT HUM BEHAV, V2, P637, DOI 10.1038/s41562-018-0399-z.
   Canadian government Canadian Institutes of Health Research, 2004, KNOWL TRANSL STRAT 2.
   Chesser Amy K, 2016, Gerontol Geriatr Med, V2, p2333721416630492, DOI 10.1177/2333721416630492.
   Clouston SAP, 2017, AGE AGEING, V46, P493, DOI 10.1093/ageing/afw229.
   Cooper A, 2019, LANCET CHILD ADOLESC, V3, P299, DOI 10.1016/S2352-4642(19)30085-9.
   Crondahl K, 2016, SAGE OPEN, V6, DOI 10.1177/2158244016646410.
   Dadaczynski K., 2020, HLTH LITERACY SCH.
   Dadaczynski K., 2020, DIGITAL HLTH LITERAC.
   Department of Health, 2019, NAT ACT PLAN HLTH CH.
   Dietscher C, 2019, EUR J PUBLIC HEALTH, V29.
   Dietscher C., 2019, EUROPEAN HLTH INFORM, V5, P65.
   Dolley S, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00068.
   Evans GW, 2013, PSYCHOL BULL, V139, P1342, DOI 10.1037/a0031808.
   Farmanova E, 2018, INQUIRY-J HEALTH CAR, V55, DOI 10.1177/0046958018757848.
   Flahault A, 2020, LANCET DIGIT HEALTH, V2, pE58, DOI 10.1016/S2589-7500(19)30240-7.
   FlearY SA, 2018, J ADOLESCENCE, V62, P116, DOI 10.1016/j.adolescence.2017.11.010.
   Franco A, 2014, SCIENCE, V345, P1502, DOI 10.1126/science.1255484.
   Fretian A, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051720.
   Gagliardi Anna R, 2016, Implement Sci, V11, P38, DOI 10.1186/s13012-016-0399-1.
   Geboers B, 2016, QUAL LIFE RES, V25, P2869, DOI 10.1007/s11136-016-1298-2.
   Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473.
   Goldfeld S, 2019, HEALTH EQUITY, V3, P489, DOI 10.1089/heq.2019.0045.
   Grimshaw JM, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-50.
   Guo SJ, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020080.
   Habersaat KB, 2020, NAT HUM BEHAV, V4, P677, DOI 10.1038/s41562-020-0906-x.
   Harnett S, 2017, J CONS HLTH INTERNET, V21, P78, DOI 10.1080/15398285.2017.1280344.
   Harper S, 2019, AM J EPIDEMIOL, V188, P840, DOI 10.1093/aje/kwy280.
   Health Canada, 2017, KNOWL TRANSL PLANN, P1.
   Hernán MA, 2016, AM J EPIDEMIOL, V183, P758, DOI 10.1093/aje/kwv254.
   HernanHerni MA M A, 2020, Causal Inference: What If.
   Hickey GL, 2018, EUR J CARDIO-THORAC, V54, P4, DOI 10.1093/ejcts/ezy169.
   Hudson J., 2020, JGCR, V7, P43.
   Kasemsap K., 2019, ADV METHODOLOGIES TE, P185.
   Kevin D., HLTH LITERACY TIMES.
   Khoury MJ, 2016, AM J PREV MED, V50, P398, DOI 10.1016/j.amepre.2015.08.031.
   Koh HK, 2013, J HEALTH COMMUN, V18, P1, DOI 10.1080/10810730.2013.759029.
   Koir U., 2020, PUBLIC HLTH, DOI 10.1177/1757913920936717.
   L'Heureux A, 2017, IEEE ACCESS, V5, P7776, DOI 10.1109/ACCESS.2017.2696365.
   LaRocca R, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-751.
   Luengo-Oroz M, 2020, NAT MACH INTELL, V2, P295, DOI 10.1038/s42256-020-0184-3.
   Mantwill S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145455.
   Margarita M.-B., 2020, ANAL PLAN TEMPLATE L.
   Matsumoto M, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-016-3971-3.
   McClintock H, 2017, LANCET GLOB HEALTH, V5, P18.
   Mooney SJ, 2018, ANNU REV PUBL HEALTH, V39, P95, DOI 10.1146/annurev-publhealth-040617-014208.
   Moreno-Betancur M., 2019, ARXIV190706734.
   Morris ZS, 2011, J ROY SOC MED, V104, P510, DOI 10.1258/jrsm.2011.110180.
   Nash R, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5558-7.
   National Health and Medical Research Council, 2018, OP ACC POL.
   Nilsen P, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0242-0.
   Nosek BA, 2015, SCIENCE, V348, P1422, DOI 10.1126/science.aab2374.
   Nosek BA, 2018, P NATL ACAD SCI USA, V115, P2600, DOI 10.1073/pnas.1708274114.
   Nutbeam D, 2000, HEALTH PROMOT INT, V15, P259, DOI 10.1093/heapro/15.3.259.
   Nutbeam D, 2020, STUD HEALTH TECHNOL, V269, P115, DOI 10.3233/SHTI200026.
   Nutbeam D, 2009, INT J PUBLIC HEALTH, V54, P303, DOI 10.1007/s00038-009-0050-x.
   Nutbeam D, 2008, SOC SCI MED, V67, P2072, DOI 10.1016/j.socscimed.2008.09.050.
   O'Conor R, 2019, RESP MED, V160, DOI 10.1016/j.rmed.2019.02.006.
   Office of Disease Prevention Health Promotion National Action Plan, 2010, IMPR HLTH LIT.
   Okan O., 2019, Public Health Panorama, V5, P170.
   Okan O., 2019, INT HDB HLTH LITERAC.
   Okan O., HLTH LITERATE SCH WH.
   Okan O, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17155503.
   Okan O, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5054-0.
   Ozturk FO, 2020, J PEDIATR NURS, V54, pE31, DOI 10.1016/j.pedn.2020.04.019.
   Paakkari L, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17103543.
   Paakkari L, 2020, LANCET PUBLIC HEALTH, V5, pE249, DOI 10.1016/S2468-2667(20)30086-4.
   Paakkari L, 2017, SCAND J PUBLIC HEALT, V45, P854, DOI 10.1177/1403494817714189.
   Paakkari LT, 2019, EUR J PUBLIC HEALTH, V29, P919, DOI 10.1093/eurpub/ckz011.
   Paasche-Orlow MK, 2010, J HEALTH COMMUN, V15, P5, DOI 10.1080/10810730.2010.499995.
   Papen U, 2008, LIT NUMER STUD, V16, P19.
   Peltzer S, 2020, SOC SCI MED, V245, DOI 10.1016/j.socscimed.2019.112711.
   Peng RD, 2006, AM J EPIDEMIOL, V163, P783, DOI 10.1093/aje/kwj093.
   Pinheiro P, 2019, INT HDB HLTH LITERAC, P555.
   Pleasant A., 2011, NEW DIRECTIONS ADULT, P43, DOI DOI 10.1002/ACE.409.
   Pleasant A, 2020, STUD HEALTH TECHNOL, V269, P481, DOI {[}10.3233/SHTI200057, 10.3233/ISU-200080].
   Pleasant A, 2011, J HEALTH COMMUN, V16, P11, DOI 10.1080/10810730.2011.604392.
   Pudrovska T, 2014, J GERONTOL B-PSYCHOL, V69, P451, DOI 10.1093/geronb/gbt122.
   Rajah R, 2019, PUBLIC HEALTH, V167, P8, DOI 10.1016/j.puhe.2018.09.028.
   Rasmussen SA, 2020, JAMA-J AM MED ASSOC, V324, P933, DOI 10.1001/jama.2020.14992.
   Rowlands G, 2017, HEALTH PROMOT INT, V32, P130, DOI 10.1093/heapro/dav093.
   Rushmer R., 2019, KNOWLEDGE TRANSLATIO, P127.
   Russ SA, 2014, MATERN CHILD HLTH J, V18, P497, DOI 10.1007/s10995-013-1284-z.
   Saboga Nunes L., 2020, HLTH LITERACY ANTHOL.
   Schaefer N., 2019, APHAS 2019 ANN M EXP.
   Schaeffer D, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17124403.
   Sentell T, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17093010.
   Shanahan L, 2011, PSYCHOL MED, V41, P2265, DOI 10.1017/S0033291711000675.
   Shang XW, 2020, NUTR J, V19, DOI 10.1186/s12937-020-00611-2.
   Shih SF, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2879-2.
   Smith JA, 2020, HEALTH PROMOT J AUST, V31, P158, DOI 10.1002/hpja.333.
   Sorensen K., 2019, PUBLIC HLTH PANORAMA, P259.
   Sorensen K, 2015, EUR J PUBLIC HEALTH, V25, P1053, DOI 10.1093/eurpub/ckv043.
   Sorensen K, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-80.
   Stielke A., 2019, EUR J PUBLIC HEALTH, V29, pckz186, DOI {[}10.1093/eurpub/ckz186.390, DOI 10.1093/EURPUB/CKZ186.390].
   Tabak RG, 2012, AM J PREV MED, V43, P337, DOI 10.1016/j.amepre.2012.05.024.
   Taylor-Robinson D, 2019, INT J EPIDEMIOL, V48, P1, DOI 10.1093/ije/dyy184.
   Trezona A, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15071554.
   Vamos S, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17041436.
   Vernon J.A., 2017, LUMOS, P1.
   Visscher BB, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6331-7.
   Walters R, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-08991-0.
   WHO, 2018, REG OFF EUR WHAT IS.
   Williams TC, 2018, PEDIATR RES, V84, P487, DOI 10.1038/s41390-018-0071-3.
   World Health Organization, 2016, Shanghai Declaration on Promoting Health in the 2030 Agenda for Sustainable Development.
   Zarocostas J, 2020, LANCET, V395, P676, DOI 10.1016/S0140-6736(20)30461-X.
   Zhang L, 2020, JMIR MED INF, V8, DOI 10.2196/16850.
   Zhou LN, 2017, NEUROCOMPUTING, V237, P350, DOI 10.1016/j.neucom.2017.01.026.
   Zibellini J, 2021, WOMEN BIRTH, V34, P180, DOI 10.1016/j.wombi.2020.01.010.},
Number-of-Cited-References = {125},
Times-Cited = {6},
Unique-ID = {WOS:000585692500001},
}

@article{ WOS:000855007600003,
Author = {Chen, Zhuo and Jiang, Wei and Xu, Jianhong and Jiang, Lan and Wang,
   Guoyu},
Title = {Ethical, Legal, and Social Implications of Genomics in China: A Scoping
   Review and Implications for Precision Public Health},
Journal = {CHINA CDC WEEKLY},
Year = {2022},
Volume = {4},
Number = {32},
Pages = {706+},
Month = {AUG 1},
Abstract = {We conducted a scoping review of Chinese language studies on the
   ethical, legal, and social implications of genomics and identified four
   broad themes: ethical considerations, regulatory framework, perceptions
   of genomics and precision medicine, and future directions of genomics.
   Ethical, legal, and social implications of genomics are growing in
   importance and are highly relevant to public health in China.},
Type = {Review},
Affiliation = {Chen, Z (Corresponding Author), Univ Georgia, Coll Publ Hlth, Dept Hlth Policy \& Management, Athens, GA 30602 USA.
   Chen, Z (Corresponding Author), Univ Nottingham Ningbo China, Fac Humanities \& Social Sci, Sch Econ, Ningbo, Zhejiang, Peoples R China.
   Wang, GY (Corresponding Author), Fudan Univ, Sch Philosophy, Shanghai, Peoples R China.
   Wang, GY (Corresponding Author), Fudan Univ, Ctr Biomed Ethics, Shanghai, Peoples R China.
   Chen, Zhuo, Univ Georgia, Coll Publ Hlth, Dept Hlth Policy \& Management, Athens, GA 30602 USA.
   Chen, Zhuo; Jiang, Wei; Xu, Jianhong; Jiang, Lan, Univ Nottingham Ningbo China, Fac Humanities \& Social Sci, Sch Econ, Ningbo, Zhejiang, Peoples R China.
   Wang, Guoyu, Fudan Univ, Sch Philosophy, Shanghai, Peoples R China.
   Wang, Guoyu, Fudan Univ, Ctr Biomed Ethics, Shanghai, Peoples R China.},
DOI = {10.46234/ccdcw2022.147},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {zchen1@uga.edu
   wguoyu@fudan.edu.cn},
Affiliations = {University System of Georgia; University of Georgia; University of
   Nottingham Ningbo China; Fudan University; Fudan University},
Cited-References = {{[}Anonymous], 2011, PREC MED BUILD KNOWL, DOI {[}DOI 10.17226/13284, https://doi.org/10.17226/13284].
   Calonge N, 2014, GENET MED, V16, P217, DOI 10.1038/gim.2013.110.
   Cao SY, 2020, CHIN HLTH RESOUR, V23, P468.
   Chen Y, 2010, MED PHILOS HUM SOC M, V31, P23.
   Cui FF, 2021, J MED POSTGRA, V34, P282, DOI {[}10.16571/j.cnki.1008-8199.2021.03.012, DOI 10.16571/J.CNKI.1008-8199.2021.03.012].
   Da, 2013, CHIN HOSP MANAGE, V33, P29.
   Khoury MJ, 2021, GENOME MED, V13, DOI 10.1186/s13073-021-00886-y.
   Khoury MJ, 2018, GENET MED, V20, P574, DOI 10.1038/gim.2017.211.
   Khoury MJ, 2018, PUBLIC HEALTH GENOM, V21, P244, DOI 10.1159/000501465.
   Li JinTao Li JinTao, 2010, Progress in Modern Biomedicine, V10, P925.
   Liu JL., 2015, TRIB POLITICAL SCI L, V33, P48.
   Qiu RZ, 2017, CHIN MED ETHICS, V30, P401.
   Rasmussen SA, 2020, JAMA-J AM MED ASSOC, V324, P933, DOI 10.1001/jama.2020.14992.
   {[}陶应时 Tao Yingshi], 2020, {[}科学学研究, Studies in Science of Science], V38, P961.
   Wang C, 2019, LANCET, V393, P25, DOI 10.1016/S0140-6736(18)33080-0.
   Wang Q, 2019, STUD SCI SCI, V37, P11, DOI {[}10.16192/j.cnki.1003-2053.2019.04.001, DOI 10.16192/J.CNKI.1003-2053.2019.04.001].
   Wu JR, 2021, MED PHILOS, V42, P20.
   Wu JR, 2021, MED PHILOS, V42, P10, DOI {[}10.12014/j.issn.1002-0772.2021.20.01, DOI 10.12014/J.ISSN.1002-0772.2021.20.01].
   Wu JR, MED PHILOS, V42, P30, DOI {[}10.12014/j.issn.1002-0772.2021.21.05, DOI 10.12014/J.ISSN.1002-0772.2021.21.05].
   Xu Y, 2018, J GUANGDONG PHARM U, V34, P637.
   Xue D, 2015, CHIN HOSP MANAGE, V35, P74.
   Yang Yong Koo, 2015, {[}Journal of Korea Safety Management \& Science, 대한안전경영과학회지], V17, P87, DOI 10.12812/ksms.2015.17.4.87.
   Zhang, 2015, PRACT PREV MED, V22, P13.
   Zhao, 2002, J BEIJING POLYTECH U, V2, P6.
   Zhong A, 2021, GENET MED, V23, P2270, DOI 10.1038/s41436-018-0090-9.},
Number-of-Cited-References = {25},
Times-Cited = {1},
Unique-ID = {WOS:000855007600003},
}

@article{ WOS:000689398400001,
Author = {Boulos, Maged N. Kamel and Zhang, Peng},
Title = {Digital Twins: From Personalised Medicine to Precision Public Health},
Journal = {JOURNAL OF PERSONALIZED MEDICINE},
Year = {2021},
Volume = {11},
Number = {8},
Month = {AUG},
Abstract = {A digital twin is a virtual model of a physical entity, with dynamic,
   bi-directional links between the physical entity and its corresponding
   twin in the digital domain. Digital twins are increasingly used today in
   different industry sectors. Applied to medicine and public health,
   digital twin technology can drive a much-needed radical transformation
   of traditional electronic health/medical records (focusing on
   individuals) and their aggregates (covering populations) to make them
   ready for a new era of precision (and accuracy) medicine and public
   health. Digital twins enable learning and discovering new knowledge, new
   hypothesis generation and testing, and in silico experiments and
   comparisons. They are poised to play a key role in formulating highly
   personalised treatments and interventions in the future. This paper
   provides an overview of the technology's history and main concepts. A
   number of application examples of digital twins for personalised
   medicine, public health, and smart healthy cities are presented,
   followed by a brief discussion of the key technical and other challenges
   involved in such applications, including ethical issues that arise when
   digital twins are applied to model humans.},
Type = {Review},
Affiliation = {Boulos, MNK (Corresponding Author), Sun Yat Sen Univ, Informat Management Sch, Guangzhou 510006, Peoples R China.
   Boulos, Maged N. Kamel, Sun Yat Sen Univ, Informat Management Sch, Guangzhou 510006, Peoples R China.
   Zhang, Peng, Vanderbilt Univ, Data Sci Inst, Nashville, TN 37240 USA.
   Zhang, Peng, Vanderbilt Univ, Dept Comp Sci, Nashville, TN 37240 USA.},
DOI = {10.3390/jpm11080745},
Article-Number = {745},
Keywords = {digital twins; human digital twins; precision medicine; personalised
   medicine; precision public health},
Research-Areas = {Health Care Sciences \& Services; General \& Internal Medicine},
Web-of-Science-Categories  = {Health Care Sciences \& Services; Medicine, General \& Internal},
Author-Email = {mnkboulos@ieee.org
   peng.zhang@vanderbilt.edu},
Affiliations = {Sun Yat Sen University; Vanderbilt University; Vanderbilt University},
Cited-References = {Arup, 2019, DIGITAL TWIN MEANING.
   Bagaria N., 2020, Connected Health in Smart Cities, P143.
   Björnsson B, 2019, GENOME MED, V12, DOI 10.1186/s13073-019-0701-3.
   Boulos MNK, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-10.
   Braun M, 2021, J MED ETHICS, V47, P394, DOI 10.1136/medethics-2020-106134.
   Bruynseels K, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00031.
   Canzoneri M, 2021, ADV BIOCHEM ENG BIOT, V177, P167, DOI 10.1007/10\_2020\_157.
   Cho SW, 2021, J PERS MED, V11, DOI 10.3390/jpm11030203.
   Corral-Acero J, 2020, EUR HEART J, V41, P4556, DOI 10.1093/eurheartj/ehaa159.
   Croatti A, 2020, J MED SYST, V44, DOI 10.1007/s10916-020-01623-5.
   El Azzaoui Abir, 2021, Advanced Multimedia and Ubiquitous Engineering. MUE-FutureTech 2020. Lecture Notes in Electrical Engineering (LNEE 716), P107, DOI 10.1007/978-981-15-9309-3\_15.
   Gelernter D., 1993, MIRROR WORLDS DAY SO.
   Gillette K, 2021, MED IMAGE ANAL, V71, DOI 10.1016/j.media.2021.102080.
   Glaessgen E., 2012, 53 AIAA ASME ASCE AH, P1818.
   Grieves M., 2005, PRODUCT LIFECYCLE MA, V1st.
   Grieves M, MANUFACTURING EXCELL.
   Grieves M. W., 2005, International Journal of Product Development, V2, P71, DOI 10.1504/IJPD.2005.006669.
   Grisso, 2019, STRUCTURAL HLTH MONI, V2019.
   Lehrach H., FUTURE HLTH CARE DEE.
   Li DR, 2021, COMPUT URBAN SCI, V1, DOI 10.1007/s43762-021-00005-y.
   Lloyd-Price J, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0307-y.
   Marr Bernard, 2018, Forbes.
   Masison J, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2024287118.
   Mittelstadt B, 2021, J MED ETHICS, V47, P405, DOI 10.1136/medethics-2021-107449.
   Patrick B, 2018, ESRI NEWSROOM BLOG.
   Piplani S, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-92388-5.
   Portela RMC, 2021, ADV BIOCHEM ENG BIOT, V176, P35, DOI 10.1007/10\_2020\_138.
   Rao D.J., 2019, Digital Twin approach to Clinical DSS with Explainable AI.
   Schwartz SM, 2020, FRONT COMP SCI-SWITZ, V2, DOI 10.3389/fcomp.2020.00031.
   Scoles S., 2016, SLATE.
   Sivalingam K, 2018, PROCEEDINGS OF 2018 2ND INTERNATIONAL CONFERENCE ON GREEN ENERGY AND APPLICATIONS (ICGEA), P197, DOI 10.1109/ICGEA.2018.8356292.
   Subramanian K, 2020, J INDIAN I SCI, V100, P653, DOI 10.1007/s41745-020-00185-2.
   Tao Fei, 2019, Computer Integrated Manufacturing Systems, V25, P1, DOI 10.13196/j.cims.2019.01.001.
   Telenti A, 2016, P NATL ACAD SCI USA, V113, P11901, DOI 10.1073/pnas.1613365113.
   Tretter M, 2021, J MED ETHICS, V47, P410, DOI 10.1136/medethics-2021-107460.
   U.S. FDA, 2013, PAVING WAY PERSONALI.
   Voigt I, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.669811.
   Walsh JR., 2020, ARXIV.
   World Health Organization, 2021, ETH GOV ART INT HLTH.
   Zhang P., 2020, PRECISION MED INVEST, P519.
   Zhang P, 2018, ADV COMPUT, V111, P1, DOI 10.1016/bs.adcom.2018.03.006.},
Number-of-Cited-References = {41},
Times-Cited = {109},
Unique-ID = {WOS:000689398400001},
}

@article{ WOS:000444740600002,
Author = {McGregor, Carolyn},
Title = {Using Constructive Research to Structure the Path to Transdisciplinary
   Innovation and Its Application for Precision Public Health with Big Data
   Analytics},
Journal = {TECHNOLOGY INNOVATION MANAGEMENT REVIEW},
Year = {2018},
Volume = {8},
Number = {8},
Pages = {7-15},
Month = {AUG},
Abstract = {New approaches to complex societal challenges require a diverse mix of
   resources and skillsets from different disciplines to create solutions
   that are of a transdisciplinary innovation nature. The constructive
   research method enables the purposeful creation of methods, modules,
   tools, and techniques that have applicability well beyond the case study
   that motivated their creation. This research presents a bottom-up
   approach that follows a structured path to transdisciplinary innovation.
   A method is presented that demonstrates how a set of innovative research
   collaborations progress from disciplinary innovation to
   multidisciplinary innovation and ultimately onto interdisciplinary
   innovation. Anchored in overlapping computer science concepts, drawing
   on the constructive research methodology for purposeful synthesis and
   integration between the projects, a greater transdisciplinary goal can
   emerge. This method is demonstrated through a case study involving a set
   of big data analytics research projects involving diverse disciplines
   such as computer science, critical care medicine, aerospace, tactical
   operations, and public health. The resultant collective vision for
   transdisciplinary innovation that has resulted offers new approaches to
   maintaining individual wellness within communities across their entire
   lifespan on earth and in space.},
Type = {Article},
Affiliation = {McGregor, C (Corresponding Author), Univ Ontario Inst Technol, Hlth Informat, Oshawa, ON, Canada.
   McGregor, Carolyn, Univ Ontario Inst Technol, Hlth Informat, Oshawa, ON, Canada.},
DOI = {10.22215/timreview/1174},
Keywords = {transdisciplinary innovation; big data; critical care; resilience;
   adaption; precision public health},
Keywords-Plus = {NEONATAL INTENSIVE-CARE},
Research-Areas = {Business \& Economics},
Web-of-Science-Categories  = {Management},
Affiliations = {Ontario Tech University},
Cited-References = {Baevsky RM, 2011, ACTA ASTRONAUT, V69, P1148, DOI 10.1016/j.actaastro.2011.07.011.
   Baynam G, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00031.
   Blount M., 2010, P 1 ACM INT HLTH INF, P647, DOI DOI 10.1145/1882992.1883094.
   Djanibekov N, 2012, J AGRIC EDUC EXT, V18, P409, DOI 10.1080/1389224X.2012.691785.
   Dolley S, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00068.
   Grossman D., 2000, Psychological effects of combat.
   Kasanen E., 1993, J MANAG ACCOUNT RES, V5, P243.
   Koshy E., 2011, ACTION RES HLTHCARE, DOI {[}10.4135/9781446288696.n1, DOI 10.4135/9781446288696.N1].
   McGregor C., 2002, Proceedings of the 35th Annual Hawaii International Conference on System Sciences, P3018, DOI 10.1109/HICSS.2002.994282.
   McGregor C., 2009, Patent WO, Patent No. {[}2011009211A1, 2011009211].
   McGregor C., 2017, P 5 INT C SER GAM AP, P1, DOI {[}DOI 10.1109/SEGAH.2017.7939256, 10.1109/SeGAH.2017.7939256].
   McGregor C., 2012, Proc. - IEEE Symp. Comput. Med. Syst, P1, DOI DOI 10.1109/CBMS.2012.6266385.
   McGregor C., 2018, SIGNAL PROCESSING MA.
   McGregor C., 2013, IEEE Aerosp. Conf. Proc, DOI DOI 10.1109/AERO.2013.6497382.
   McGregor C, 2017, IEEE CONSUM ELECTR M, V6, P92, DOI 10.1109/MCE.2017.2715519.
   McGregor C, 2015, COMP MED SY, P169, DOI 10.1109/CBMS.2015.44.
   McGregor C, 2013, STUD HEALTH TECHNOL, V192, P362, DOI 10.3233/978-1-61499-289-9-362.
   McGregor C, 2013, COMPUTER, V46, P54, DOI 10.1109/MC.2013.157.
   Orlov O., 2017, 68 INT ASTR C IAC 20.
   Palem G, 2014, TECHNOL INNOV MANAG, P25.
   Pohl C., 2010, Transdiciplinary Journal of Engineering Science, V1, P65, DOI {[}10.22545/2010/0006, DOI 10.22545/2010/0006].
   ROSENFIELD PL, 1992, SOC SCI MED, V35, P1343, DOI 10.1016/0277-9536(92)90038-R.},
Number-of-Cited-References = {22},
Times-Cited = {1},
Unique-ID = {WOS:000444740600002},
}

@article{ WOS:000855692500003,
Author = {Raz, Aviad and Timmermans, Stefan and Eyal, Gil and Brothers, Kyle and
   Minari, Jusaku},
Title = {Challenges for precision public health communication in the era of
   genomic medicine},
Journal = {GENETICS IN MEDICINE},
Year = {2022},
Volume = {24},
Number = {9},
Pages = {1814-1820},
Month = {SEP},
Abstract = {Although still in the early stages of development, the advent of fast,
   high-output, and cost-effective next-generation DNA sequencing
   technology is moving precision medicine into public health. Before this
   shift toward next-generation sequencing in public health settings,
   individual patients met geneticists after showing symptoms and through
   limited family screening. In the new era of precision public health,
   everyone is a possible participant in genetic sequencing, simply by
   being born (newborn screening), by donating blood (biobanking), or
   through population screening. These initiatives are increasingly offered
   to individuals throughout their life and more individuals are
   encountering opportunities to use DNA sequencing. This article raises
   awareness of these growing areas and calls for different models of
   public engagement and communication about genomics, including screening
   asymptomatic populations, obtaining consent for unspecified and
   unforeseen future uses of genomic data, and managing variants of
   uncertain significance. Given that such communication challenges loom
   large, established norms of practice in genomic medicine and research
   should be reconsidered. (C) 2022 American College of Medical Genetics
   and Genomics. Published by Elsevier Inc. All rights reserved.},
Type = {Article},
Affiliation = {Raz, A (Corresponding Author), Ben Gurion Univ Nagev, Dept Sociol \& Anthropol, IL-8410501 Beer Sheva, Israel.
   Raz, Aviad, Ben Gurion Univ Nagev, Dept Sociol \& Anthropol, IL-8410501 Beer Sheva, Israel.
   Timmermans, Stefan, UCLA, Dept Sociol, Los Angeles, CA 90024 USA.
   Eyal, Gil, Columbia Univ, Dept Sociol, Precis Med \& Soc Program, New York, NY 10027 USA.
   Brothers, Kyle, Univ Louisville, Sch Med, Dept Pediat, Louisville, KY 40292 USA.
   Minari, Jusaku, Kyoto Univ, Ctr iPS Cell Res \& Applicat CiRA, Uehiro Res Div iPS Cell Eth, Kyoto, Japan.},
DOI = {10.1016/j.gim.2022.05.010},
EarlyAccessDate = {SEP 2022},
Keywords = {Biobanking; Communication; Newborn screening; New generation sequencing;
   Precision medicine},
Keywords-Plus = {POLYGENIC RISK; CANCER; GENETICS; MODELS; SCORE},
Research-Areas = {Genetics \& Heredity},
Web-of-Science-Categories  = {Genetics \& Heredity},
Author-Email = {aviadraz@bgu.ac.il},
Affiliations = {University of California System; University of California Los Angeles;
   Columbia University; University of Louisville; Kyoto University},
Cited-References = {Ahmed E, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.01107.
   Allen CG, 2021, PUBLIC HEALTH GENOM, V24, P67, DOI 10.1159/000512485.
   Bates Benjamin R, 2005, J Genet Couns, V14, P423, DOI 10.1007/s10897-005-4845-5.
   Beaton A, 2017, GENET MED, V19, P345, DOI 10.1038/gim.2016.111.
   Bell CJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001756.
   Brossard D, 2010, NEW AGENDAS COMMUN, P11.
   Bubela T, 2009, NAT BIOTECHNOL, V27, P514, DOI 10.1038/nbt0609-514.
   Claw KG, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05188-3.
   Critchley C, 2015, PUBLIC HEALTH GENOM, V18, P160, DOI 10.1159/000375441.
   David KL, 2019, GENET MED, V21, P769, DOI 10.1038/s41436-018-0391-z.
   Doerr Megan, 2021, AJOB Empir Bioeth, V12, P72, DOI 10.1080/23294515.2020.1847214.
   Dougherty M., 2014, Current Genetic Medicine Reports, V2, P48, DOI {[}10.1007/s40142-014-0037-7, DOI 10.1007/S40142-014-0037-7].
   Elliott J, 2020, JAMA-J AM MED ASSOC, V323, P636, DOI 10.1001/jama.2019.22241.
   Fox K, 2020, NEW ENGL J MED, V383, P411, DOI 10.1056/NEJMp1915987.
   Fridman AL, 2022, J COMMUN GENET, V13, P13, DOI 10.1007/s12687-021-00556-x.
   Friedman JM, 2017, BMC MED GENOMICS, V10, DOI 10.1186/s12920-017-0247-4.
   Garofalo DC, 2022, GENET MED, V24, P712, DOI 10.1016/j.gim.2021.11.015.
   Gordon AS, 2020, GENET MED, V22, P1470, DOI 10.1038/s41436-020-0810-9.
   Guglielmi G, 2019, NATURE, V568, P290, DOI 10.1038/d41586-019-01166-x.
   Ho WK, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17680-w.
   Howard HC, 2015, EUR J HUM GENET, V23, P1593, DOI 10.1038/ejhg.2014.289.
   Jocelyn K, 2016, SCIENCE, DOI {[}10.1126/science.aal0279, DOI 10.1126/SCIENCE.AAL0279].
   Johnston J, 2018, HASTINGS CENT REP, V48, DOI 10.1002/hast.874.
   Jones L, 2018, ETHNIC DIS, V28, P503, DOI 10.18865/ed.28.S2.503.
   Juengst E, 2016, HASTINGS CENT REP, V46, P21, DOI 10.1002/hast.614.
   Kaufman DJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160461.
   Kelty C, 2014, GENOME MED, V6, DOI 10.1186/gm525.
   Khoury MJ, 2018, GENET MED, V20, P574, DOI 10.1038/gim.2017.211.
   Kraft SA, 2019, GENET MED, V21, P790, DOI 10.1038/s41436-018-0273-4.
   Kurian AW, 2020, J CLIN ONCOL, V38, P1371, DOI 10.1200/JCO.20.00140.
   LIPPMAN A, 1992, SOC SCI MED, V35, P1469, DOI 10.1016/0277-9536(92)90049-V.
   Manchanda R, 2018, JNCI-J NATL CANCER I, V110, P714, DOI 10.1093/jnci/djx265.
   Marchant G, 2020, J LAW MED ETHICS, V48, P11, DOI 10.1177/1073110520916994.
   Menko FH, 2019, FAM CANCER, V18, P127, DOI 10.1007/s10689-018-0089-z.
   Middleton A, 2020, AM J HUM GENET, V107, P743, DOI 10.1016/j.ajhg.2020.08.023.
   Miller DT, 2021, GENET MED, V23, P1381, DOI 10.1038/s41436-021-01172-3.
   Newson AJ, 2022, HUM GENET, V141, P1035, DOI 10.1007/s00439-021-02269-0.
   Offit K, 2020, J CLIN ONCOL, V38, P1398, DOI 10.1200/JCO.19.02010.
   Petersen Alan., 2007, GENOMICS SOC POLICY, V3, P31, DOI {[}DOI 10.1186/1746-5354-3-1-31, 10.1186/1746-5354-3-1-31].
   Platt J, 2014, GENET MED, V16, P11, DOI 10.1038/gim.2013.59.
   Prainsack B., 2017, Personalized medicine: empowered patients in the 21st century.
   Prior TW, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0062-x.
   Raz AE, 2020, NEW GENET SOC, V39, P459, DOI 10.1080/14636778.2020.1755636.
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30.
   Roberts MC, 2021, GENOME MED, V13, DOI 10.1186/s13073-021-00911-0.
   Ross LF, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2019-1031.
   Schupmann W, 2021, GENET MED, V23, P2281, DOI 10.1038/s41436-021-01271-1.
   Skolbekken J-A., 2005, CRIT PUBLIC HLTH, V15, P335, DOI DOI 10.1080/09581590500523319.
   Taylor-Robinson D, 2019, INT J EPIDEMIOL, V48, P1, DOI 10.1093/ije/dyy184.
   Thomas M, 2020, AM J HUM GENET, V107, P432, DOI 10.1016/j.ajhg.2020.07.006.
   Timmermans S., 2013, Saving babies? : The consequences of newborn genetic screening, V1st.
   Timmermans S, 2010, J HEALTH SOC BEHAV, V51, P408, DOI 10.1177/0022146510386794.
   Trinidad SB, 2022, GENET MED, V24, P622, DOI 10.1016/j.gim.2021.11.003.
   van Campen JC, 2019, INT J NEONAT SCREEN, V5, DOI 10.3390/ijns5040040.
   Wailoo KeithStephen Gregory Pemberton., 2006, The Troubled Dream of Genetic Medicine: Ethnicity and Innovation in Tay-Sachs, Cystic Fibrosis, and Sickle Cell Disease.
   WILSON JMG, 1968, B OFIC SANIT PANAM, V65, P281.
   Wojcik MH, 2021, GENET MED, V23, P1372, DOI 10.1038/s41436-021-01146-5.
   Woodbury RB, 2020, FRONT COMMUN, V5, DOI 10.3389/fcomm.2020.00070.
   Wray NR, 2021, JAMA PSYCHIAT, V78, P101, DOI 10.1001/jamapsychiatry.2020.3049.
   Zlotogora J, 2019, ISR J HEALTH POLICY, V8, DOI 10.1186/s13584-019-0345-1.},
Number-of-Cited-References = {60},
Times-Cited = {2},
Unique-ID = {WOS:000855692500003},
}

@article{ WOS:000565367400002,
Author = {Makurumidze, Richard and Decroo, Tom and Lynen, Lutgarde and
   Chinwadzimba, Zororo Kudzaishe and Van Damme, Wim and Hakim, James and
   Rusakaniko, Simbarashe},
Title = {District-level strategies to control the HIV epidemic in Zimbabwe: a
   practical example of precision public health},
Journal = {BMC RESEARCH NOTES},
Year = {2020},
Volume = {13},
Number = {1},
Month = {AUG 26},
Abstract = {ObjectiveWe conducted a descriptive cross-sectional study using survey
   and programme data to assess district-level performance along the HIV
   care cascade (HIV testing target achievement, linkage to ART and ART
   coverage) in order to formulate district-specific recommendations,
   taking into consideration prevalence and yield of testing.ResultsData
   from 60 districts were analysed. Forty-eight districts (80.0\%)
   surpassed 90\% of their 2018 HIV testing targets. Linkage to ART was
   less than 90\% in 40 districts (83.3\%). Thirty districts (50.0\%) had
   ART coverage above 90\%. Of the 30 districts with suboptimal (<90\%) ART
   coverage, 18 districts had achieved high HIV testing target but with
   suboptimal linkage to ART, 6 had achieved high HIV testing targets and
   high linkage to ART, 4 had both suboptimal HIV testing target
   achievement and linkage to ART and 2 had suboptimal HIV testing target
   achievement and high linkage to ART. Priority should be given to
   districts with suboptimal ART coverage. Remediation strategies should be
   tailored to address the poorly performing stage of the cascade in each
   of the districts.},
Type = {Article},
Affiliation = {Makurumidze, R (Corresponding Author), Univ Zimbabwe, Coll Hlth Sci, Harare, Zimbabwe.
   Makurumidze, R (Corresponding Author), Inst Trop Med, Antwerp, Belgium.
   Makurumidze, R (Corresponding Author), Free Univ Brussels VUB, Fac Med \& Pharm, Gerontol, Brussels, Belgium.
   Makurumidze, Richard; Hakim, James; Rusakaniko, Simbarashe, Univ Zimbabwe, Coll Hlth Sci, Harare, Zimbabwe.
   Makurumidze, Richard; Decroo, Tom; Lynen, Lutgarde; Van Damme, Wim, Inst Trop Med, Antwerp, Belgium.
   Decroo, Tom, Res Fdn Flanders, Brussels, Belgium.
   Makurumidze, Richard; Van Damme, Wim, Free Univ Brussels VUB, Fac Med \& Pharm, Gerontol, Brussels, Belgium.
   Chinwadzimba, Zororo Kudzaishe, Minist Hlth \& Child Care, Geog Informat Syst Dept, Harare, Zimbabwe.},
DOI = {10.1186/s13104-020-05234-8},
Article-Number = {393},
Keywords = {HIV testing; Linkage to care; ART coverage; 90-90-90 targets;
   Implementation; Precision public health; Zimbabwe},
Keywords-Plus = {CARE; LINKAGE; SERVICES; BARRIERS; ADULTS},
Research-Areas = {Life Sciences \& Biomedicine - Other Topics; Science \& Technology -
   Other Topics},
Web-of-Science-Categories  = {Biology; Multidisciplinary Sciences},
Author-Email = {rmakurumidze@ext.itg.be},
Affiliations = {University of Zimbabwe; Institute of Tropical Medicine (ITM); Vrije
   Universiteit Brussel},
Cited-References = {Ahmed S, 2017, TROP MED INT HEALTH, V22, P1021, DOI 10.1111/tmi.12900.
   {[}Anonymous], 2017, ZIMB POP BAS HIV IMP.
   Decroo T, 2013, INT HEALTH, V5, P169, DOI 10.1093/inthealth/iht016.
   Decroo T, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-6.
   Dwyer-Lindgren L, 2019, NATURE, V570, P189, DOI 10.1038/s41586-019-1200-9.
   European Centre for Disease Prevention and Control (ECDC), 2017, THEM REP CONT HIV CA.
   Giordano Thomas P, 2018, Top Antivir Med, V26, P62.
   Govindasamy D, 2012, AIDS, V26, P2059, DOI 10.1097/QAD.0b013e3283578b9b.
   ICAP, 2017, ICAP APPR STRAT HIV.
   Joint United Nations Programme on HIV/AIDS (UNAIDS) International Organization for Migration (IOM), 2003, MOB POP HIV AIDS SO.
   Jubilee M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212762.
   Kayigamba FR, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1355-z.
   Labhardt ND, 2018, JAMA-J AM MED ASSOC, V319, P1103, DOI 10.1001/jama.2018.1818.
   Lasry A, 2019, MMWR-MORBID MORTAL W, V68, P474, DOI 10.15585/mmwr.mm6821a2.
   MacPherson P, 2014, JAMA-J AM MED ASSOC, V312, P372, DOI 10.1001/jama.2014.6493.
   Mahachi N, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25321.
   Makurumidze R, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0222309.
   Medecins Sans Frontieres, 2019, URG BOOST REAL CHECK.
   Ministry of Health and Child Care (MOHCC), 2015, ZIMB ZIMB NAT HIV ES.
   Ministry of Health and Child Care (MOHCC), 2018, ZIMB NAT PROGR ART S.
   Ministry of Health and Child Care (MOHCC)-Zimbabwe, 2019, ZIMB POP BAS HIV IMP.
   Ministry of Health and Child Care (MOHCC)-Zimbabwe, 2020, EXT ZIMB NAT AIDS ST.
   Sharma M, 2018, AIDS, V32, P233, DOI 10.1097/QAD.0000000000001697.
   Southern African Development Community (SADC), 2013, SADC HIV AIDS CROSS.
   Taylor BS, 2011, MT SINAI J MED, V78, P342, DOI 10.1002/msj.20255.
   The United States President's Emergency Plan for AIDS Relief (PEPFAR), 2019, 2019 ANN C.
   The United States President's Emergency Plan for AIDS Relief (PEPFAR), 2018, ZIMB COUNTR OP PLAN.
   Tweya H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0188488.
   UNAIDS, 2014, 90 90 90 AMB TREATM.
   Vearey J, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25137.
   World Health Organization, 2014, MARCH 2014 SUPPL 201.
   World Health Organization (WHO), 2016, Guidelines on HIV self-testing and partner notification: supplement to consolidated guidelines on HIV testing services.
   Zimbabwe National AIDS Council Zimbabwe Ministry of Health and Child Welfare UNAIDS World Food Programme VAM Food Security Analysis CDC, 2015, WORLD FOOD PROGR VAM.},
Number-of-Cited-References = {33},
Times-Cited = {2},
Unique-ID = {WOS:000565367400002},
}

@incollection{ WOS:000443800300005,
Author = {Baynam, Gareth and Bowman, Faye and Lister, Karla and Walker, Caroline
   E. and Pachter, Nicholas and Goldblatt, Jack and Boycott, Kym M. and
   Gahl, William A. and Kosaki, Kenjiro and Adachi, Takeya and Ishii, Ken
   and Mahede, Trinity and McKenzie, Fiona and Townshend, Sharron and Slee,
   Jennie and Kiraly-Borri, Cathy and Vasudevan, Anand and Hawkins, Anne
   and Broley, Stephanie and Schofield, Lyn and Verhoef, Hedwig and Groza,
   Tudor and Zankl, Andreas and Robinson, Peter N. and Haendel, Melissa and
   Brudno, Michael and Mattick, John S. and Dinger, Marcel E. and Roscioli,
   Tony and Cowley, Mark J. and Olry, Annie and Hanauer, Marc and Alkuraya,
   Fowzan S. and Taruscio, Domenica and Posada de la Paz, Manuel and
   Lochmuller, Hanns and Bushby, Kate and Thompson, Rachel and Hedley,
   Victoria and Lasko, Paul and Mina, Kym and Beilby, John and Tifft,
   Cynthia and Davis, Mark and Laing, Nigel G. and Julkowska, Daria and Le
   Cam, Yann and Terry, Sharon F. and Kaufmann, Petra and Eerola, Iiro and
   Norstedt, Irene and Rath, Ana and Suematsu, Makoto and Groft, Stephen C.
   and Austin, Christopher P. and Draghia-Akli, Ruxandra and Weeramanthri,
   Tarun S. and Molster, Caron and Dawkins, Hugh J. S.},
Editor = {DeLaPaz, MP and Taruscio, D and Groft, SC},
Title = {Improved Diagnosis and Care for Rare Diseases through Implementation of
   Precision Public Health Framework},
Booktitle = {RARE DISEASES EPIDEMIOLOGY: UPDATE AND OVERVIEW, 2ND EDITION},
Series = {Advances in Experimental Medicine and Biology},
Year = {2017},
Volume = {1031},
Pages = {55-94},
Abstract = {Public health relies on technologies to produce and analyse data, as
   well as effectively develop and implement policies and practices. An
   example is the public health practice of epidemiology, which relies on
   computational technology to monitor the health status of populations,
   identify disadvantaged or at risk population groups and thereby inform
   health policy and priority setting. Critical to achieving health
   improvements for the underserved population of people living with rare
   diseases is early diagnosis and best care. In the rare diseases field,
   the vast majority of diseases are caused by destructive but previously
   difficult to identify protein-coding gene mutations. The reduction in
   cost of genetic testing and advances in the clinical use of genome
   sequencing, data science and imaging are converging to provide more
   precise understandings of the `person-time-place' triad. That is: who is
   affected (people); when the disease is occurring (time); and where the
   disease is occurring (place). Consequently we are witnessing a paradigm
   shift in public health policy and practice towards `precision public
   health'.
   Patient and stakeholder engagement has informed the need for a national
   public health policy framework for rare diseases. The engagement
   approach in different countries has produced highly comparable outcomes
   and objectives. Knowledge and experience sharing across the
   international rare diseases networks and partnerships has informed the
   development of the Western Australian Rare Diseases Strategic Framework
   2015-2018 (RD Framework) and Australian government health briefings on
   the need for a National plan.
   The RD Framework is guiding the translation of genomic and other
   technologies into the Western Australian health system, leading to
   greater precision in diagnostic pathways and care, and is an example of
   how a precision public health framework can improve health outcomes for
   the rare diseases population.
   Five vignettes are used to illustrate how policy decisions provide the
   scaffolding for translation of new genomics knowledge, and catalyze
   transformative change in delivery of clinical services. The vignettes
   presented here are from an Australian perspective and are not intended
   to be comprehensive, but rather to provide insights into how a new and
   emerging `precision public health' paradigm can improve the experiences
   of patients living with rare diseases, their caregivers and families.
   The conclusion is that genomic public health is informed by the
   individual and family needs, and the population health imperatives of an
   early and accurate diagnosis; which is the portal to best practice care.
   Knowledge sharing is critical for public health policy development and
   improving the lives of people living with rare diseases.},
Type = {Article; Book Chapter},
Affiliation = {Dawkins, HJS (Corresponding Author), Govt Western Australia, Off Populat Hlth Genom, Publ Hlth Div, Dept Hlth, Perth, WA, Australia.
   Dawkins, HJS (Corresponding Author), Univ Western Australia, Sch Pathol \& Lab Med, Perth, WA, Australia.
   Dawkins, HJS (Corresponding Author), Murdoch Univ, Sir Walter Murdoch Sch Publ Hlth \& Int Affairs, Perth, WA, Australia.
   Dawkins, HJS (Corresponding Author), Curtin Univ Technol, Curtin Hlth Innovat Res Inst, Ctr Populat Hlth Res, Perth, WA, Australia.
   Baynam, Gareth, King Edward Mem Hosp, Genet Serv Western Australia, Subiaco, WA, Australia.
   Baynam, Gareth, Western Australian Register Dev Anomalies, Subiaco, WA, Australia.
   Baynam, Gareth, Undiagnosed Dis Program, Subiaco, WA, Australia.
   Bowman, Faye; Lister, Karla; Walker, Caroline E.; Mahede, Trinity; Molster, Caron; Dawkins, Hugh J. S., Govt Western Australia, Off Populat Hlth Genom, Publ Hlth Div, Dept Hlth, Perth, WA, Australia.
   Pachter, Nicholas; Goldblatt, Jack; McKenzie, Fiona; Townshend, Sharron; Slee, Jennie; Kiraly-Borri, Cathy; Vasudevan, Anand; Hawkins, Anne; Broley, Stephanie; Schofield, Lyn, Govt Western Australia, Genet Serv Western Australia, Dept Hlth, Perth, WA, Australia.
   Pachter, Nicholas; Goldblatt, Jack; McKenzie, Fiona, Univ Western Australia, Sch Paediat \& Child Hlth, Perth, WA, Australia.
   Pachter, Nicholas, Univ Western Australia, Sch Med \& Pharmacol, Perth, WA, Australia.
   Boycott, Kym M., Univ Ottawa, Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON K1H 8L1, Canada.
   Gahl, William A.; Tifft, Cynthia, NIH, Undiagnosed Dis Program, Common Fund, Rockville, MD USA.
   Gahl, William A., NHGRI, NIH, Bethesda, MD 20892 USA.
   Kosaki, Kenjiro, Keio Univ, Sch Med, Shinjuku Ku, 35 Shinanomachi, Tokyo, Japan.
   Adachi, Takeya; Ishii, Ken; Suematsu, Makoto, Japan Agcy Med Res \& Dev, Tokyo, Japan.
   Verhoef, Hedwig, Curtin Univ, Dept Sci \& Engn, Spatial Sci, Perth, WA, Australia.
   Verhoef, Hedwig, Cooperat Res Ctr Spatial Informat, Melbourne, WA, Australia.
   Groza, Tudor; Mattick, John S.; Dinger, Marcel E.; Roscioli, Tony; Cowley, Mark J., Garvan Inst Med Res, Kinghorn Ctr Clin Genom, Darlinghurst, NSW 2010, Australia.
   Groza, Tudor; Mattick, John S.; Dinger, Marcel E.; Roscioli, Tony; Cowley, Mark J., Univ New South Wales UNSW, St Vincents Clin Sch, Fac Med, Sydney, NSW 2052, Australia.
   Zankl, Andreas, Univ Sydney, Sydney Med Sch, Discipline Genet Med, Sydney, NSW, Australia.
   Zankl, Andreas, Sydney Childrens Hosp Network Westmead, Acad Dept Med Genet, Westmead, NSW, Australia.
   Robinson, Peter N., Jackson Lab Genom Med, Farmington, CT 06032 USA.
   Robinson, Peter N., Univ Connecticut, Inst Syst Genom, Farmington, CT 06032 USA.
   Haendel, Melissa, Oregon Hlth \& Sci Univ, Lib \& Dept Med Informat \& Clin Epidemiol, Portland, OR 97239 USA.
   Brudno, Michael, Univ Toronto, Dept Comp Sci, Toronto, ON M5S 2E4, Canada.
   Brudno, Michael, Hosp Sick Children, Ctr Computat Med, Toronto, ON M5G 1L7, Canada.
   Brudno, Michael, Hosp Sick Children, Genet \& Genome Biol Program, Toronto, ON M5G 1L7, Canada.
   Olry, Annie; Hanauer, Marc; Rath, Ana, INSERM, US14, Paris, France.
   Alkuraya, Fowzan S., King Faisal Specialist Hosp \& Res Ctr, Dept Genet, Riyadh, Saudi Arabia.
   Alkuraya, Fowzan S., Alfaisal Univ, Coll Med, Dept Anat \& Cell Biol, Riyadh, Saudi Arabia.
   Taruscio, Domenica, Ist Super Sanita, Ctr Nazl Malattie Rare, Viale Regina Elena 299, I-00161 Rome, Italy.
   Posada de la Paz, Manuel, Inst Salud Carlos III, RDR, Madrid, Spain.
   Posada de la Paz, Manuel, Inst Salud Carlos III, CIBERER, Madrid, Spain.
   Lochmuller, Hanns; Bushby, Kate; Thompson, Rachel; Hedley, Victoria, Newcastle Univ, Inst Med Genet, John Walton Muscular Dystrophy Res Ctr, Newcastle Upon Tyne, Tyne \& Wear, England.
   Lasko, Paul, McGill Univ, Dept Biol, Montreal, PQ, Canada.
   Mina, Kym; Beilby, John; Davis, Mark; Laing, Nigel G., Govt Western Australia, Dept Hlth, PathWest, Diagnost Genom, Perth, WA, Australia.
   Mina, Kym; Dawkins, Hugh J. S., Univ Western Australia, Sch Pathol \& Lab Med, Perth, WA, Australia.
   Laing, Nigel G., Univ Western Australia, Harry Perkins Inst Med Res, QEII Med Ctr, Med Res Ctr, Perth, WA, Australia.
   Julkowska, Daria, Agence Natl Rech ANR, Paris, France.
   Le Cam, Yann, European Org Rare Dis EURORDIS, Paris, France.
   Terry, Sharon F., Genet Alliance, Washington, DC USA.
   Kaufmann, Petra; Groft, Stephen C.; Austin, Christopher P., NIH, Natl Ctr Adv Translat Sci, Bethesda, MD 20892 USA.
   Eerola, Iiro; Norstedt, Irene; Draghia-Akli, Ruxandra, European Commiss, Directorate Hlth, Directorate Gen Res \& Innovat DG RTD, Brussels, Belgium.
   Weeramanthri, Tarun S.; Dawkins, Hugh J. S., Murdoch Univ, Sir Walter Murdoch Sch Publ Hlth \& Int Affairs, Perth, WA, Australia.
   Weeramanthri, Tarun S., Govt Western Australia, Dept Hlth, Publ Hlth Div, Perth, WA, Australia.
   Dawkins, Hugh J. S., Curtin Univ Technol, Curtin Hlth Innovat Res Inst, Ctr Populat Hlth Res, Perth, WA, Australia.},
DOI = {10.1007/978-3-319-67144-4\_4},
Keywords = {Public health; Policy; Translation; Information sharing; Translation;
   New knowledge; Community engagement},
Keywords-Plus = {HUMAN PHENOTYPE ONTOLOGY; WESTERN-AUSTRALIA; MEDICINE; GENE; GENERATION;
   NEED; TRANSLATION; DISCOVERY; GENOMICS; END},
Research-Areas = {Public, Environmental \& Occupational Health; Research \& Experimental
   Medicine},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health; Medicine, Research \&
   Experimental},
Author-Email = {Gareth.Baynam@health.wa.gov.au
   Faye.Bowman@health.wa.gov.au
   Karla.Lister@safetyandquality.gov.au
   Caroline.Walker@health.wa.gov.au
   Nicholas.pachter@health.wa.gov.au
   jack.goldblatt@health.wa.gov.au
   kboycott@cheo.on.ca
   Tokyo.kkosaki@keio.jp
   Takeya-Adachi@amed.go.jp
   ken-ishii@amed.go.jp
   Trinity.mahede@health.wa.gov.au
   Fiona.McKenzie@health.wa.gov.au
   Sharon.townsend@health.wa.gov.au
   Jenny.Slee@health.wa.gov.au
   Cathy.kiraly-borri@health.wa.gov.au
   Anand.Vasudevan@health.wa.gov.au
   Anne.Hawkins@health.wa.gov.au
   Stephanie.Broley@health.wa.gov.au
   Lyn.Schofield@health.wa.gov.au
   andreas.zankl@gmail.com
   peter.robinson@jax.org
   haendel@ohsu.edu
   brudno@cs.toronto.edu
   Sydney.j.mattick@garvan.org.au
   Australia.m.dinger@garvan.org.au
   t.roscioli@garvan.org.au
   m.cowley@garvan.org.au
   ana.rath@inserm.fr
   falkuraya@Kfshrc.edu.sa
   hanns.lochmuller@ncl.ac.uk
   Kate.bushby@ncl.ac.uk
   rachel.thompson@ncl.ac.uk
   Victoria.hedley@ncl.ac.uk
   paul.lasko@mcgill.ca
   Kym.Mina@health.wa.gov.au
   John.beilby@health.wa.gov.au
   ctifft@nih.gov
   Mark.davis@health.wa.gov.au
   nigel.laing@uwa.edu.au
   daria.julkowska@anr.fr
   yann.lecam@eurordis.org
   sterry@geneticalliance.org
   Petra.Kaufman@nih.gov
   Iiro.eerola@ec.europa.eu
   Irene.Norstedt@ec.europa.eu
   makoto-suematsu@amed.go.jp
   stephen.groft@nih.gov
   austinc@mail.nih.gov
   ruxandra.draghia@merck.com
   Tarun.weeramanthri@health.wa.gov.au
   Caron.Molster@health.wa.gov.au
   hugh.dawkins@health.wa.gov.au},
Affiliations = {University of Western Australia; King Edward Memorial Hospital;
   University of Western Australia; University of Western Australia;
   University of Ottawa; Children's Hospital of Eastern Ontario; National
   Institutes of Health (NIH) - USA; National Institutes of Health (NIH) -
   USA; NIH National Human Genome Research Institute (NHGRI); Keio
   University; Curtin University; Garvan Institute of Medical Research;
   University of New South Wales Sydney; University of Sydney; NSW Health;
   Sydney Childrens Hospitals Network; Jackson Laboratory; University of
   Connecticut; Oregon Health \& Science University; University of Toronto;
   University of Toronto; Hospital for Sick Children (SickKids); University
   of Toronto; Hospital for Sick Children (SickKids); Institut National de
   la Sante et de la Recherche Medicale (Inserm); King Faisal Specialist
   Hospital \& Research Center; Alfaisal University; Istituto Superiore di
   Sanita (ISS); Instituto de Salud Carlos III; CIBER - Centro de
   Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III;
   Newcastle University - UK; McGill University; University of Western
   Australia; University of Western Australia; University of Western
   Australia; Harry Perkins Institute of Medical Research; National
   Institutes of Health (NIH) - USA; NIH National Center for Advancing
   Translational Sciences (NCATS); Murdoch University; Government of
   Western Australia; Curtin University},
Cited-References = {Abouelhoda M, 2017, GENET MED, V17, P235, DOI {[}10.1186/s13059016-11021, DOI 10.1186/S13059016-11021].
   Adachi T, 2017, EUR J HUM GENET, V25, P1025, DOI 10.1038/ejhg.2017.106.
   Ales M, 2016, GENET MED, V18, P1102, DOI 10.1038/gim.2016.22.
   Amberger JS, 2015, NUCLEIC ACIDS RES, V43, pD789, DOI 10.1093/nar/gku1205.
   {[}Anonymous], WA RAR DIS STRAT FRA.
   {[}Anonymous], 2016, PRECISION PUBLIC HLT.
   {[}Anonymous], 2016, MON HLTH IMP MAND FO.
   {[}Anonymous], 1983, Orphan Drug Act of 1983. In.
   {[}Anonymous], 2016, FRONTIERS RES TOPIC.
   {[}Anonymous], 2005, RAR DIS UND THIS PUB.
   Austin CP, 2017, NATURE, V548, P158, DOI 10.1038/548158c.
   Austin CP, 2017, CTS-CLIN TRANSL SCI, DOI {[}10.1111/cts.12500/full, DOI 10.1111/CTS.12500/FULL].
   Ayme S, 2011, STATE ART REPORTS EU.
   Ayme S, 2015, INT CONSORTIUM HUMAN.
   Ayme S, 2011, EUCERD REPORT STATE.
   Aymé S, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0251-8.
   Baynam G, 2016, W AUSTR REGISTER DEV.
   Baynam G, 2015, ANN TRANSL MED  S2, V3, DOI {[}10.3978/j.issn.2305-5839.2015.ab002, DOI 10.3978/J.ISSN.2305-5839.2015.AB002].
   Baynam G, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00031.
   Baynam G, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0462-7.
   Baynam G, 2015, J PAEDIATR CHILD H, V51, P381, DOI 10.1111/jpc.12705.
   Baynam G, 2013, HUM MUTAT, V34, P14, DOI 10.1002/humu.22219.
   Baynam GS, 2013, TWIN RES HUM GENET, V16, P840, DOI 10.1017/thg.2013.49.
   Baynam GS, 2012, MED J AUSTRALIA, V196, P313, DOI 10.5694/mja11.11459.
   Beaulieu CL, 2014, AM J HUM GENET, V94, P809, DOI 10.1016/j.ajhg.2014.05.003.
   Beskow L.M., 2001, Community Genet, V4, P2, DOI 10.1159/000051150.
   Biesecker LG, 2004, NAT GENET, V36, P323, DOI 10.1038/ng0404-323.
   Bower C, 2004, PAEDIATR PERINAT EP, V18, P277, DOI 10.1111/j.1365-3016.2004.00567.x.
   BOWER C, 2004, CLIN MOL TERATOL, V70, P842, DOI DOI 10.1002/BDRA.20074.
   Boycott KM, 2013, NAT REV GENET, V14, P681, DOI 10.1038/nrg3555.
   Burke W, 2010, GENET MED, V12, P785, DOI 10.1097/GIM.0b013e3182011222.
   Buske OJ, 2015, HUM MUTAT, V36, P931, DOI 10.1002/humu.22851.
   {[}Chief Medical Officer Department of Health UK], 2009, STAT PUBL HLTH ANN R.
   Dawkins H, 2011, MED FOR MED FOR MAG, P37.
   Dawkins H, 2017, PROGR RARE DIS RES 2, DOI {[}10.1111/cts.12501/full, DOI 10.1111/CTS.12501/FULL].
   Dawkins HJS, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-57.
   De Vrueh R, 2013, PRIORITY MED EUROPE, P46.
   Department of Health Western Australia, 2013, SCOP PAP NEED NAT RA.
   Dewey FE, 2014, JAMA-J AM MED ASSOC, V311, P1035, DOI 10.1001/jama.2014.1717.
   Dye DE, 2011, PUBLIC HEALTH GENOM, V14, P153, DOI 10.1159/000321767.
   Dye DE, 2011, J COMMUN GENET, V2, P81, DOI 10.1007/s12687-011-0043-3.
   European Commission, 2013, NAT PLANS STRAT RAR.
   {[}European Commission EC regulation on orphan medicinal products], 2011, EC REG ORPH MED PROD.
   European Commission, 2010, NEWS AL EUR COMM US.
   Europlan, 2010, REC DEV NAT PLANS RA.
   Gahl WA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004980.
   Gahl WA, 2011, JAMA-J AM MED ASSOC, V305, P1904, DOI 10.1001/jama.2011.613.
   Girdea M, 2013, HUM MUTAT, V34, P1057, DOI 10.1002/humu.22347.
   Graham C., 2014, J Biorepos Sci Appl Med, V2, P49, DOI {[}10.2147/BSAM.S46707, DOI 10.2147/BSAM.S46707].
   Greer KL, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.8.
   Groft SC, 2010, ADV EXP MED BIOL, V686, P3, DOI 10.1007/978-90-481-9485-8\_1.
   Groza T, 2015, AM J HUM GENET, V97, P111, DOI 10.1016/j.ajhg.2015.05.020.
   Hammond P, 2012, HUM MUTAT, V33, P817, DOI 10.1002/humu.22054.
   Hansson MG, 2016, EUR J HUM GENET, V24, P1553, DOI 10.1038/ejhg.2016.52.
   Hennekam RCM, 2012, HUM MUTAT, V33, P884, DOI 10.1002/humu.22048.
   Holman CDJ, 2008, AUST HEALTH REV, V32, P766, DOI 10.1071/AH080766.
   IRDiRC, 2011, EUR UN COMM EXP R 3, V2. 3, P35.
   Jaffé A, 2005, THORAX, V60, P892, DOI 10.1136/thx.2005.050187.
   Jaffe A, 2010, J PAEDIATR CHILD H, V46, P2, DOI 10.1111/j.1440-1754.2009.01608.x.
   Khoury MJ, 2007, GENET MED, V9, P665, DOI 10.1097/GIM.0b013e31815699d0.
   Khoury MJ, 2016, AM J PREV MED, V50, P398, DOI 10.1016/j.amepre.2015.08.031.
   Khoury MJ, 2015, AM J EPIDEMIOL, V182, P977, DOI 10.1093/aje/kwv228.
   Khoury MJ, 2015, JAMA-J AM MED ASSOC, V313, P2117, DOI 10.1001/jama.2015.3382.
   Köhler S, 2017, NUCLEIC ACIDS RES, V45, pD865, DOI 10.1093/nar/gkw1039.
   Kohler S, 2014, F1000RESEARCH, V2, P30, DOI DOI 10.12688/F1000RESEARCH.2-30.V2.
   Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248.
   Lee IH, 2014, HUM MUTAT, V35, P537, DOI 10.1002/humu.22520.
   Lochmuller H, 2017, EUR J HUM GENET.
   Lochmüller H, 2017, EUR J HUM GENET, V25, P162, DOI 10.1038/ejhg.2016.137.
   Mallal S, 2008, NEW ENGL J MED, V358, P568, DOI 10.1056/NEJMoa0706135.
   Manrai AK, 2016, NEW ENGL J MED, V375, P655, DOI 10.1056/NEJMsa1507092.
   Mascalzoni D, 2015, EUR J HUM GENET, V23, P721, DOI 10.1038/ejhg.2014.197.
   Mascalzoni D, 2013, NAT REV GENET, V14, P372, DOI 10.1038/nrg3494.
   McCormack P, 2016, EUR J HUM GENET, V24, P1403, DOI 10.1038/ejhg.2016.30.
   Molster C, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0409-z.
   Molster C, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-50.
   Molster C, 2013, HEALTH EXPECT, V16, P211, DOI 10.1111/j.1369-7625.2011.00701.x.
   Molster C, 2012, PUBLIC HEALTH GENOM, V15, P82, DOI 10.1159/000334104.
   Office of Population Health Genomics, 2015, W AUSTR RAR DIS STRA.
   Orphanet, 2017, ORPH REP SER.
   Orphanet, 2014, REP COLL ORPH REP CO.
   Philippakis AA, 2015, HUM MUTAT, V36, P915, DOI 10.1002/humu.22858.
   Rath A., 2010, ORPHANET J RARE DIS, V5, pP1, DOI DOI 10.1186/1750-1172-5-S1-P1.
   Rath A, 2012, HUM MUTAT, V33, P803, DOI 10.1002/humu.22078.
   Retterer K, 2016, GENET MED, V18, P696, DOI 10.1038/gim.2015.148.
   Riley WT, 2015, TRANSL BEHAV MED, V5, P243, DOI 10.1007/s13142-015-0320-5.
   Robinson PN, 2010, CLIN GENET, V77, P525, DOI 10.1111/j.1399-0004.2010.01436.x.
   Robinson PN, 2008, AM J HUM GENET, V83, P610, DOI 10.1016/j.ajhg.2008.09.017.
   Robinson PN, 2012, HUM MUTAT, V33, P777, DOI 10.1002/humu.22080.
   Sawyer SL, 2016, CLIN GENET, V89, P275, DOI 10.1111/cge.12654.
   Shamseldin HE, 2017, GENET MED, V19, P593, DOI 10.1038/gim.2016.155.
   Smith CE, 2016, HEALTH AFFAIR, V35, P1367, DOI 10.1377/hlthaff.2015.1476.
   Sorensen G, 2014, DIAGNOSIS MISDIAGNOS.
   Tang D, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.23.
   Taruscio D, 2015, MOL GENET METAB, V116, P223, DOI 10.1016/j.ymgme.2015.11.003.
   Taruscio D, 2015, PUBLIC HEALTH GENOM, V18, P184, DOI 10.1159/000379739.
   Thompson R, 2014, J GEN INTERN MED, V29, pS780, DOI 10.1007/s11606-014-2908-8.
   Topol EJ, 2014, CELL, V157, P241, DOI 10.1016/j.cell.2014.02.012.
   UK Health Departments, 2013, UK STRAT RAR DIS.
   UK Health Departments, 2012, CONS UK PLAN RAR DIS.
   VALDEZ R, 2016, PREV CHRONIC DIS, V13, DOI DOI 10.5888/PCD13.150491.
   van Weely S., 2004, priority medicines for Europe and the world. A public health approach to innovation.
   Vasant D., 2014, P ISMB, V30.
   Walker CE, 2017, GENET MED, V19, P546, DOI 10.1038/gim.2016.143.
   Wilton SD, 2011, CURR GENE THER, V11, P259.
   Yang YP, 2014, JAMA-J AM MED ASSOC, V312, P1870, DOI 10.1001/jama.2014.14601.
   2010, ADV EXPT MED BIOL, V686, P1.},
Number-of-Cited-References = {107},
Times-Cited = {15},
Unique-ID = {WOS:000443800300005},
}

@article{ WOS:000436471200005,
Author = {Preston, Michael A. and Mays, Glen P. and Bursac, Zoran and Thomas,
   Billy R. and Laryea, Jonathan and Tilford, J. Mick and Odlum, Michelle
   and Smith, Sharla A. and Henry-Tillman, Ronda S.},
Title = {Insurance coverage mandates: Impact of physician utilization in
   moderating colorectal cancer screening rates},
Journal = {AMERICAN JOURNAL OF SURGERY},
Year = {2018},
Volume = {215},
Number = {6},
Pages = {1004-1010},
Month = {JUN},
Abstract = {Precision public health requires research that supports innovative
   systems and health delivery approaches, programs, and policies that are
   part of this vision. This study estimated the effects of health
   insurance mandate (HiM) variations and the effects of physician
   utilization on moderating colorectal cancer (CRC) screening rates. A
   time-series analysis using a difference-in-difference-in-differences
   (DDD) approach was conducted on CRC screenings (1997-2014) using a
   multivariate logistic framework. Key variables of interest were HiM, CRC
   screening status, and physician utilization. The adjusted average
   marginal effects from the DDD model indicate that physician utilization
   increased the probability of being ``up-to-date{''} vs. non-compliance
   by 9.9\% points (p = 0.007), suggesting that an estimated 8.85 million
   additional age-eligible persons would receive a CRC screening with HiM
   and routine physician visits. Routine physician visits and mandates that
   lower out-of-pocket expenses constitute an effective approach to
   increasing CRC screenings for persons ready to take advantage of such
   policies. (C) 2018 Elsevier Inc. All rights reserved.},
Type = {Article},
Affiliation = {Preston, MA (Corresponding Author), Univ Arkansas Med Sci, Coll Med, Dept Surg, Hlth Initiat \& Dispar Res, 4301 West Markham St 827, Little Rock, AR 72205 USA.
   Preston, Michael A.; Laryea, Jonathan; Henry-Tillman, Ronda S., Univ Arkansas Med Sci, Dept Surg, Hlth Initiat \& Dispar Res, 4301 West Markham St 827, Little Rock, AR 72205 USA.
   Mays, Glen P., Univ Kentucky, Coll Publ Hlth, Dept Hlth Management \& Policy, 111 Washington Ave 201, Lexington, KY 40536 USA.
   Bursac, Zoran, Univ TN Hlth Sci Ctr, Ctr Populat Sci, Dept Prevent Med, 66 N Pauline St,Suite 307, Memphis, TN 38163 USA.
   Thomas, Billy R., Univ Arkansas Med Sci, Coll Med, Dept Pediat Neonatol, 4301 West Markham St, Little Rock, AR 72205 USA.
   Tilford, J. Mick, Univ Arkansas Med Sci, Coll Publ Hlth, Dept Hlth Policy \& Management, 4301 West Markham St, Little Rock, AR 72205 USA.
   Odlum, Michelle, Columbia Univ, Sch Nursing, 617 West 168th St,Rm 225, New York, NY 10032 USA.
   Smith, Sharla A., Univ Kansas, Sch Med Wichita, Dept Prevent Med \& Publ Hlth, 1010 N Kansas St, Wichita, KS 67214 USA.},
DOI = {10.1016/j.amjsurg.2018.02.026},
Keywords = {Health services research; Health care reform; Health care delivery;
   Preventive health services; Precision public health},
Keywords-Plus = {PREVENTIVE SERVICES; HEALTH; DISPARITIES; ADULTS; STATES},
Research-Areas = {Surgery},
Web-of-Science-Categories  = {Surgery},
Author-Email = {mapreston@uams.edu
   glen.mays@uky.edu
   zbursac@uthsc.edu
   BillyRThomas@uams.edu
   JALaryea@uams.edu
   TilfordMickJ@uams.edu
   mlo12@cumc.columbia.edu
   ssmith37@kumc.edu
   HenryRondaS@uams.edu},
Affiliations = {University of Arkansas System; University of Arkansas Medical Sciences;
   University of Kentucky; University of Tennessee System; University of
   Tennessee Health Science Center; University of Arkansas System;
   University of Arkansas Medical Sciences; University of Arkansas System;
   University of Arkansas Medical Sciences; Columbia University; University
   of Kansas; University of Kansas Medical Center},
Cited-References = {Adepoju OE, 2015, AM J PUBLIC HEALTH, V105, pS665, DOI 10.2105/AJPH.2015.302611.
   Agrawal S, 2005, AM J GASTROENTEROL, V100, P515, DOI 10.1111/j.1572-0241.2005.41829.x.
   American Cancer Society, 2013, CANC FACTS FIG 2013.
   American Cancer Society, 2012, CANC FACTS FIG 2012.
   American Cancer Society, 2014, CANC FACTS FIG 2014.
   {[}Anonymous], 2016, Cancer Facts Figures 2016.
   Atherly A, 2012, HEALTH SERV RES, V47, P939, DOI 10.1111/j.1475-6773.2011.01376.x.
   Ball JK, 1996, MED CARE, V34, P970, DOI 10.1097/00005650-199609000-00008.
   Baquet C R, 1999, J Assoc Acad Minor Phys, V10, P51.
   Baquet CR, 2009, J HEALTH CARE POOR U, V20, P24, DOI 10.1353/hpu.0.0156.
   Bazargan M, 2009, PATIENT EDUC COUNS, V76, P240, DOI 10.1016/j.pec.2008.12.005.
   Bertrand M, 2004, Q J ECON, V119, P249, DOI 10.1162/003355304772839588.
   {*}CDCP, 2013, OV BRFSS 2011.
   Centers for Disease Control and Prevention, 2013, CANC PREV CONTR.
   Centers for Disease Prevention and Control, 2013, OV BRFSS 2009.
   Cogan JA, 2011, J LAW MED ETHICS, V39, P355, DOI 10.1111/j.1748-720X.2011.00605.x.
   Cokkinides V, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-19.
   Edwards BK, 2005, JNCI-J NATL CANCER I, V97, P1407, DOI 10.1093/jnci/dji289.
   Fedewa SA, 2015, CANCER-AM CANCER SOC, V121, P3272, DOI 10.1002/cncr.29494.
   Han WJ, 2009, J POLICY ANAL MANAG, V28, P29, DOI 10.1002/pam.20398.
   Khatami S, 2012, CLIN GASTROENTEROL H, V10, P761, DOI 10.1016/j.cgh.2012.02.027.
   Mays GP, 2011, HEALTH AFFAIR, V30, P1585, DOI 10.1377/hlthaff.2011.0196.
   Meester RGS, 2015, CANCER-AM CANCER SOC, V121, P2281, DOI 10.1002/cncr.29336.
   Nicholas JA, 2011, MT SINAI J MED, V78, P498, DOI 10.1002/msj.20275.
   Preston MA, 2014, HLTH SYSTEM REFORM D.
   Preston MA, 2018, AM J SURG, V216, P245, DOI 10.1016/j.amjsurg.2017.08.004.
   Preston MA, 2014, J HEALTH CARE POOR U, V25, P139, DOI 10.1353/hpu.2014.0069.
   Rathore SS, 2000, AM J PREV MED, V19, P71, DOI 10.1016/S0749-3797(00)00179-3.
   Russell Rodriguez S, 2010, MMWR-MORBID MORTAL W, V2011, P1348.
   Steele CB, 2013, MMWR-MORBID MORTAL W, V62, P53.
   U.S. Preventive Services Task Force, 2013, USPSTF A B REC.
   Van der Wees PJ, 2013, MILBANK Q, V91, P663, DOI 10.1111/1468-0009.12029.},
Number-of-Cited-References = {32},
Times-Cited = {4},
Unique-ID = {WOS:000436471200005},
}

@article{ WOS:000600644200003,
Author = {Lynch, Shannon M. and Wiese, Daniel and Ortiz, Angel and Sorice, Kristen
   A. and Nguyen, Minhhuyen and Gonzalez, Evelyn T. and Henry, Kevin A.},
Title = {Towards precision public health: Geospatial analytics and
   sensitivity/specificity assessments to inform liver cancer prevention},
Journal = {SSM-POPULATION HEALTH},
Year = {2020},
Volume = {12},
Month = {DEC},
Abstract = {Objectives: Liver cancer (LC) continues to rise, partially due to
   limited resources for prevention. To test the precision public health
   (PPH) hypothesis that fewer areas in need of LC prevention could be
   identified by combining existing surveillance data, we compared the
   sensitivity/specificity of standard recommendations to target geographic
   areas using U.S. Census demographic data only (percent (\%) Hispanic,
   Black, and those born 1950-1959) to an alternative approach that couples
   additional geospatial data, including neighborhood socioeconomic status
   (nSES), with LC disease statistics.
   Methods: Pennsylvania Cancer Registry data from 2007-2014 were linked to
   2010 U.S. Census data at the Census tract (CT) level. CTs in the top
   80th percentile for 3 standard demographic variables, \%Hispanic,
   \%Black, \%born 1950-1959, were identified. Spatial scan statistics
   (SatScan) identified CTs with significantly elevated incident LC rates
   (p-value<0.05), adjusting for age, gender, diagnosis year. Sensitivity,
   specificity, and positive predictive value (PPV) of a CT being located
   in an elevated risk cluster and/or testing positive/negative for at
   least one standard variable were calculated. nSES variables
   (deprivation, stability, segregation) significantly associated with LC
   in regression models (p < 0.05) were systematically evaluated for
   improvements in sensitivity/specificity.
   Results: 9,460 LC cases were diagnosed across 3,217 CTs. 1,596 CTs were
   positive for at least one of 3 standard variables. 5 significant
   elevated risk clusters (CTs = 402) were identified. 324 CTs were
   positive for a high risk cluster AND standard variable (sensitivity =
   92\%; specificity = 37\%; PPV = 17.4\%). Incorporation of 3 new nSES
   variables with one standard variable (\%Black) further improved
   sensitivity (93\%), specificity (62.9\%), and PPV (26.3\%).
   Conclusions: We introduce a quantitative assessment of PPH by applying
   established sensitivity/specificity assessments to geospatial data.
   Coupling existing disease cluster and nSES data can more precisely
   identify intervention targets with a liver cancer burden than standard
   demographic variables. Thus, this approach may inform prioritization of
   limited resources for liver cancer prevention.},
Type = {Article},
Affiliation = {Lynch, SM (Corresponding Author), Fox Chase Canc Ctr, Canc Prevent \& Control, Young Pavil P4159,333 Cottman Ave, Philadelphia, PA 19111 USA.
   Lynch, Shannon M.; Ortiz, Angel; Sorice, Kristen A.; Nguyen, Minhhuyen; Gonzalez, Evelyn T.; Henry, Kevin A., Fox Chase Canc Ctr, Canc Prevent \& Control, Young Pavil P4159,333 Cottman Ave, Philadelphia, PA 19111 USA.
   Wiese, Daniel; Henry, Kevin A., Temple Univ, Geog \& Urban Studies, Philadelphia, PA 19122 USA.},
DOI = {10.1016/j.ssmph.2020.100640},
Article-Number = {100640},
Keywords = {Geospatial; Liver cancer; Sensitivity; Specificity; Neighborhood;
   Disparities; Precision public health},
Keywords-Plus = {POPULATION-ATTRIBUTABLE FRACTIONS; HEPATOCELLULAR-CARCINOMA;
   RISK-FACTORS; DISPARITIES; SEGREGATION; MORTALITY; DISEASE; INDEX},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {Shannon.Lynch@fccc.edu
   tug30358@temple.edu
   Angel.Ortiz@fccc.edu
   Kristen.Sorice@fccc.edu
   Minhhuyen.Nguyen@fccc.edu
   Evelyn.Gonzalez@fccc.edu
   khenry1@temple.edu},
Affiliations = {Fox Chase Cancer Center; Pennsylvania Commonwealth System of Higher
   Education (PCSHE); Temple University},
Cited-References = {Altekruse SF, 2014, AM J GASTROENTEROL, V109, P542, DOI 10.1038/ajg.2014.11.
   American Cancer Society, 2018, PENNS GLANC.
   Blake KD, 2019, CANCER EPIDEM BIOMAR, V28, P428, DOI 10.1158/1055-9965.EPI-18-0811.
   Boscoe FP, 2014, CANCER-AM CANCER SOC, V120, P2191, DOI 10.1002/cncr.28632.
   Chang ET, 2010, CANCER EPIDEM BIOMAR, V19, P3106, DOI 10.1158/1055-9965.EPI-10-0863.
   Dowell SF, 2016, NATURE, V540, P189, DOI 10.1038/540189a.
   El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061.
   Erwin PC, 2011, J PUBLIC HEALTH MAN, V17, P406, DOI 10.1097/PHH.0b013e318211b49f.
   Goldberg DW, 2008, GEOCODING BEST PRACT.
   Gomez SL, 2015, CANCER-AM CANCER SOC, V121, P2314, DOI 10.1002/cncr.29345.
   Han J, 2016, INT J HEALTH GEOGR, V15, DOI 10.1186/s12942-016-0056-6.
   Kanarek N, 2011, J PUBLIC HEALTH MAN, V17, P401, DOI 10.1097/PHH.0b013e318205413c.
   Krieger N, 2002, AM J EPIDEMIOL, V156, P471, DOI 10.1093/aje/kwf068.
   Krieger N, 2016, AM J PUBLIC HEALTH, V106, P256, DOI 10.2105/AJPH.2015.302955.
   Kulldorff M, 2006, STAT MED, V25, P3929, DOI 10.1002/sim.2490.
   Kulldorff M, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-58.
   Lynch SM, 2013, CANCER EPIDEM BIOMAR, V22, P485, DOI 10.1158/1055-9965.EPI-13-0010.
   Makarova-Rusher OV, 2016, CANCER-AM CANCER SOC, V122, P1757, DOI 10.1002/cncr.29971.
   Massey D, 2001, DOES IT TAKE A VILLAGE?, P41.
   MASSEY DS, 1990, AM J SOCIOL, V96, P329, DOI 10.1086/229532.
   NCCN N. C. C. N., 2017, HEP CARC CLIN PRACT.
   Nguyen GC, 2008, HEPATOLOGY, V47, P1058, DOI 10.1002/hep.22223.
   Oliver TR, 2010, PREV CHRONIC DIS, V7.
   Ozdenerol Esra, 2005, Int J Health Geogr, V4, P19, DOI 10.1186/1476-072X-4-19.
   Petrick JL, 2016, J CLIN ONCOL, V34, P1787, DOI 10.1200/JCO.2015.64.7412.
   Rice LJ, 2014, INT J ENV RES PUB HE, V11, P5510, DOI 10.3390/ijerph110505510.
   Roux AVD, 2010, ANN NY ACAD SCI, V1186, P125, DOI 10.1111/j.1749-6632.2009.05333.x.
   Ryerson AB, 2016, CANCER-AM CANCER SOC, V122, P1312, DOI 10.1002/cncr.29936.
   Sahar L, 2019, CANCER-AM CANCER SOC, V125, P2544, DOI 10.1002/cncr.32052.
   Sherman RL, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130264.
   Singal AG, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001624.
   Sperling J, 2012, CITYSCAPE, V14, P219.
   Thornton-Wells TA, 2004, TRENDS GENET, V20, P640, DOI 10.1016/j.tig.2004.09.007.
   TUNSTALL H, 2005, INT J EPIDEMIOL, V34, P231, DOI DOI 10.1093/IJE/DYH387.
   Wang SC, 2016, ONCOTARGET, V7, P59820, DOI 10.18632/oncotarget.10930.
   Warnecke RB, 2008, AM J PUBLIC HEALTH, V98, P1608, DOI 10.2105/AJPH.2006.102525.
   Welzel TM, 2013, AM J GASTROENTEROL, V108, P1314, DOI 10.1038/ajg.2013.160.
   Wiese D, 2019, CANCER EPIDEM BIOMAR, V28, P1958, DOI 10.1158/1055-9965.EPI-19-0416.},
Number-of-Cited-References = {38},
Times-Cited = {14},
Unique-ID = {WOS:000600644200003},
}

@article{ WOS:001176092400001,
Author = {Pitini, Erica and Baccolini, Valentina and Isonne, Claudia and Maran,
   Paola and Marzuillo, Carolina and Villari, Paolo and Galeone, Daniela
   and Vaia, Francesco},
Title = {Public health genomics research in Italy: an overview of ongoing
   projects},
Journal = {FRONTIERS IN PUBLIC HEALTH},
Year = {2024},
Volume = {12},
Month = {FEB 21},
Abstract = {Public health genomics (PHG) aims to integrate advances in genomic
   sciences into healthcare for the benefit of the general population. As
   in many countries, there are various research initiatives in this field
   in Italy, but a clear picture of the national research portfolio has
   never been sketched. Thus, we aimed to provide an overview of current
   PHG research projects at the national or international level by
   consultation with Italian institutional and academic experts. We
   included 68 PHG projects: the majority were international projects in
   which Italian researchers participated (n = 43), mainly funded by the
   European Commission, while the remainder were national initiatives (N =
   25), mainly funded by central government. Funding varied considerably,
   from euro 50,000 to euro 80,803,177. Three main research themes were
   identified: governance (N = 20); precision medicine (PM; N = 46); and
   precision public health (N = 2). We found that research activities are
   preferentially aimed at the clinical application of PM, while other
   efforts deal with the governance of the complex translation of genomic
   innovation into clinical and public health practice. To align such
   activities with national and international priorities, the development
   of an updated research agenda for PHG is needed.},
Type = {Article},
Affiliation = {Pitini, E (Corresponding Author), Minist Hlth, Directorate Gen Hlth Prevent, Rome, Italy.
   Pitini, Erica; Maran, Paola; Galeone, Daniela; Vaia, Francesco, Minist Hlth, Directorate Gen Hlth Prevent, Rome, Italy.
   Baccolini, Valentina; Isonne, Claudia; Marzuillo, Carolina; Villari, Paolo, Sapienza Univ Rome, Dept Publ Hlth \& Infect Dis, Rome, Italy.
   Baccolini, Valentina, Sapienza Univ Rome, Dept Translat \& Precis Med, Rome, Italy.},
DOI = {10.3389/fpubh.2024.1343509},
Article-Number = {1343509},
Keywords = {public health genomics; research; precision medicine; precision public
   health; governance; Italy},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {e.pitini@sanita.it},
Affiliations = {Sapienza University Rome; Sapienza University Rome},
Cited-References = {Accelerator Award, Portfolio of funded projects and outputs.
   AIFA, 2018, Study protocol.
   alleanzacontroilcancro, GerSom.
   alleanzacontroilcancro.it, Health Big Data I Alleanza contro il cancro.
   {[}Anonymous], Beyond 1M Genomes | B1MG | Project | Fact sheet | H2020 | CORDIS.
   {[}Anonymous], Definizione e promozione di programmi per l'implementazione delle azioni centrali di supporto al ``Piano per l'innovazione del sistema sanitario basata sulle scienze omiche.
   {[}Anonymous], Toward PrecisiOn Medicine for the Prediction of Treatment response in major depressive disorder through stratification of combined clinical and -omics signatures.
   {[}Anonymous], Genomics and Personalized Medicine for all though Artificial Intelligence in Haematological Diseases | GenoMed4ALL | Project | Fact sheet | H2020 | CORDIS.
   {[}Anonymous], NGS diagnostics in 21st century oncology: the best, for all, at all times | oncNGS | Project | Fact sheet | H2020 | CORDIS.
   {[}Anonymous], Multiple manifestations of genetic and non-genetic factors in Multiple Sclerosis disentangled with a multi-omics approach to accelerate personalised medicine | MultipleMS | Project | Fact sheet | H2020 | CORDIS.
   {[}Anonymous], Innovative strategies for cancer prevention with focus on sex hormone signaling and chronic inflammation | CANCERPREV | Project | Fact sheet | H2020 | CORDIS.
   {[}Anonymous], Strategies to overcome acquired resistance to targeted therapies in colorectal cancer.
   {[}Anonymous], International consortium for integrative genomics prediction | INTERVENE | Project | Fact sheet | H2020 | CORDIS.
   {[}Anonymous], Implementation of personalised management in nephrotic syndrome.
   {[}Anonymous], Identification of markers for personal phenotyping in Acne Inversa.
   {[}Anonymous], IndividualizedPaediatricCure: Cloud-based virtual-patient models for precision paediatric oncology | iPC | Project | Fact sheet | H2020 | CORDIS.
   {[}Anonymous], PARP1 and immune checkpoint inhibition after chemotherapy induction in leiomyosarcoma: a model to unleash immunoresponse.
   {[}Anonymous], A genomic-driven diagnosis to deliver bespoke therapeutic strategies in HER2-low breast cancer patients.
   {[}Anonymous], Integrating China in the International Consortium for Personalised Medicine | IC2PerMed | Project | Fact sheet | H2020 | CORDIS.
   {[}Anonymous], INTEGRATED APPROACH.
   {[}Anonymous], Defining stratification of patients with C3 Glomerulopathies /Immune complex -mediated glomerular diseases for better diagnosis and tailored treatment.
   {[}Anonymous], Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions | 3TR | Project | Fact sheet | H2020 | CORDIS.
   {[}Anonymous], A Machine learning approach to Identify patients with Resected non-small-cell lung cAnCer with high risk of reLapsE.
   {[}Anonymous], Gut OncoMicrobiome Signatures (GOMS) associated with cancer incidence, prognosis and prediction of treatment response. | ONCOBIOME | Project | Fact sheet | H2020 | CORDIS.
   {[}Anonymous], Subpopulation heterogeneitY and MicroenvironMental Engagement as predictors for Treatment Resistance in lYmphoma.
   {[}Anonymous], Tumore della prostata, diventate protagonisti della ricerca.
   {[}Anonymous], Supporting Personalized Treatment Decisions in Head and Neck Cancer through Big Data.
   {[}Anonymous], A PeRsOnalized Prevention roadmap for the future HEalThcare | PROPHET | Project | Fact sheet | HORIZON | CORDIS.
   {[}Anonymous], Integrative Personal Omics Profiles in Glioblastoma Recurrence and Therapy Resistance.
   {[}Anonymous], Epigenetic modeling/remodeling of cancer metastases and tumor immune contexture to improve efficacy of immunotherapy.
   {[}Anonymous], Rethinking personalized cancer therapy: targeting minimal residual disease in high-risk lymphoma patients.
   {[}Anonymous], Personalization of Long term Treatment in Bipolar Disorder.
   {[}Anonymous], A Functional Precision Medicine Platform In Adult Leukemia.
   {[}Anonymous], Interregional Coordination for a fast and deep uptake of personalised health | REGIONS4PERMED | Project | Fact sheet | H2020 | CORDIS.
   {[}Anonymous], Methylation based liquid biopsy to predict molecular residual disease and risk of recurrence in colon cancer patients.
   {[}Anonymous], Actionable targets in clonal progression and systemic spreading of myeloid neoplasms.
   {[}Anonymous], Optimizing response to Li treatment through personalized evaluation of individuals with bipolar I disorder: the R-LiNK initiative | R-LiNK | Project | Fact sheet | H2020 | CORDIS.
   {[}Anonymous], Stratification of heart failure patients for cardiac recovery upon cardiac unloading by left ventricular assist device therapy: addressing the molecular, epigenetic, and proteomic changes associated with reverse cardiac remodelling.
   {[}Anonymous], European network staff eXchange for integrAting precision health in the health Care sysTems | ExACT | Project | Fact sheet | H2020 | CORDIS.
   {[}Anonymous], PERsonalised MedicIne Trials | PERMIT | Project | Fact sheet | H2020 | CORDIS.
   {[}Anonymous], Widening Sino-EU policy and research cooperation in Personalised Medicine | SINO-EU-PerMed | Project | Fact sheet | H2020 | CORDIS.
   {[}Anonymous], Metabolic vulnerabilities for personalized therapeutic approaches in acute myeloid leukemia.
   {[}Anonymous], AI for new signatures and models for tailored organ preservation approaches in laryngeal and hypopharyngeal cancer.
   {[}Anonymous], Plasma extracellular vesicles (EVs): the key for precision medicine in Glioblastoma.
   {[}Anonymous], To the NEXT level of risk prediction in patients with Long QT Syndrome.
   {[}Anonymous], Epigenomic and machine learning models to predict pancreatic cancer: development of a new algorithm to integrate clinical, omics, DNA methylation biomarkers and environmental data for early detection of pancreatic cancer in high-risk individuals.
   areapubblica.cbim.it, Italian Ministry of Health Research Project Portal.
   Beyond 1M Genomes, 2022, Policy Brief. Genomics in Healthcare Key issues for implementation.
   Burke W, 2006, GENET MED, V8, P451, DOI 10.1097/01.gim.0000228213.72256.8c.
   Burns BL., 2019, Front Public Health, V7, P425346, DOI {[}10.3389/FPUBH.2019.00041/BIBTEX, DOI 10.3389/FPUBH.2019.00041/BIBTEX].
   CAN, HEAL: Building the EU Cancer and Public Health Genomics platform.
   Carrasco-Ramiro F, 2017, GENE THER, V24, P551, DOI 10.1038/gt.2017.77.
   ccm-network.it, Caratterizzazione molecolare del virus pandemico SARSCoV-2 in Italia | CCM-Network.
   ccm-network.it, CCM-Network.
   EOSC4Cancer, A European-wide foundation to accelerate Data-driven Cancer Research.
   European, 1+ Million Genomes{''}Initiative | Shaping Europe's digital future.
   fondazionetempia, Risultati promettenti dallo studio sui tumori al seno tripli negativi | Edo ed Elvo Tempia: per la lotta contro i tumori.
   GDI, Genomic Data Infrastructure.
   Italian Ministry of Health, 2022, Directorate General for Health Prevention. Directorial Decree 24 October 2022.
   Italian Ministry of Health, 2022, Le priorita del Piano Nazionale della Genomica.
   Italian Ministry of Health, 2022, Piano per l'innovazione del sistema sanitario basata sulle scienze omiche.
   Italian Ministry of Research, 2023, HEAL ITALIA.
   Italian Multiple Sclerosis Foundation, 2022, Research on multiple sclerosis funded by the Italian Multiple Sclerosis FoundationFoundation.
   Khoury MJ, 2022, GENET MED, V24, P1630, DOI 10.1016/j.gim.2022.04.009.
   Khoury MJ, 2018, GENET MED, V20, P574, DOI 10.1038/gim.2017.211.
   Khoury MJ, 2016, AM J PREV MED, V50, P398, DOI 10.1016/j.amepre.2015.08.031.
   Molster CM, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00247.
   Nakagawa H, 2018, CANCER SCI, V109, P513, DOI 10.1111/cas.13505.
   Onstwedder SM, 2022, FRONT GENET, V13, DOI 10.3389/fgene.2022.865799.
   Personalized medicine, Advancing chemical and genomic strategies for relapsed/refractory T-ALL | Fondazione Ginema.
   Personalized Mitochondrial Medicine (PerMiM), Optimizing diagnostics and treatment for patients with mitochondrial diseases.
   Pitini E, 2020, J ROY SOC MED, V113, P310, DOI 10.1177/0141076820910325.
   prin.mur.gov.it, Italian Ministry of University and Research Project Portal.
   Secretariat for the International Consortium for Personalised Medicine (ICPerMed), ICPerMed Secretariat | Project | Fact sheet | H2020 | CORDIS | European Commission.
   THRuST, Transcan-2 translational cancer research program.
   TOPMESO, Transcan-2 translational cancer research program.
   Wang XD, 2022, CLIN TRANSL MED, V12, DOI 10.1002/ctm2.135.},
Number-of-Cited-References = {77},
Times-Cited = {0},
Unique-ID = {WOS:001176092400001},
}

@article{ WOS:000680963500001,
Author = {Sun, Shirley and Ching, Ann Hui},
Title = {Social systems matter: Precision medicine, public health, and the
   medical model},
Journal = {EAST ASIAN SCIENCE TECHNOLOGY AND SOCIETY-AN INTERNATIONAL JOURNAL},
Year = {2021},
Volume = {15},
Number = {4},
Pages = {439-466},
Month = {OCT 2},
Abstract = {Drawing on data from semi-structured interviews conducted in Singapore,
   Canada, and the United States, this paper shows that biomedical experts
   are deeply concerned about the shortcomings of the biomedical model of
   health. Precision public health, when anchored in genomics, can be
   considered a twenty-first century version of the medical model of
   health, which originated from nineteenth century germ theory. First,
   concerns regarding the adoption of genetic testing to identify disease
   susceptibility, and limitations of genome-based disease prevention
   exist. This includes limited evidence of the utility of screening
   measures in reducing mortality, lack of reimbursement for genetic
   screening, negative implications of genetic screening, and limitations
   of race/ethnicity-based genetic screening. Second, there are also
   concerns regarding the treatment of diseases, particularly the
   management of the costs of treatment and genetic testing in the context
   of national public health systems. Ultimately, it was found that
   healthcare-related inequities can be reduced in a universal, publicly
   funded, single-payer healthcare setting. These findings provide strong
   evidence supporting the social model of health by highlighting the key
   role of social systems and non-clinical interventions in precision
   public health to improve health outcomes for all.},
Type = {Article},
Affiliation = {Sun, S (Corresponding Author), Nanyang Technol Univ, Sch Social Sci, Singapore, Singapore.
   Sun, Shirley, Nanyang Technol Univ, Sch Social Sci, Singapore, Singapore.
   Ching, Ann Hui, Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore.},
DOI = {10.1080/18752160.2021.1938440},
EarlyAccessDate = {JUL 2021},
Keywords = {precision medicine; public health; medical model; social model of
   health; cancer},
Keywords-Plus = {UNITED-STATES; CARE; CANCER; PHARMACOGENOMICS; CANADA},
Research-Areas = {Area Studies; History \& Philosophy of Science; Asian Studies},
Web-of-Science-Categories  = {Area Studies; History \& Philosophy Of Science; Asian Studies},
Author-Email = {HLSUN@ntu.edu.sg
   annhui.ching@u.nus.edu},
Affiliations = {Nanyang Technological University; National University of Singapore},
Cited-References = {ALLAN JD, 1988, ADV NURS SCI, V10, P22, DOI 10.1097/00012272-198804000-00004.
   {[}Anonymous], 2015, FACT SHEET PRESIDENT.
   {[}Anonymous], 2010, FRAMEWORKS CHOICE PR.
   Bleyer A, 2012, NEW ENGL J MED, V367, P1998, DOI 10.1056/NEJMoa1206809.
   Braun V., 2006, Qualitative research in psychology, V3, P77, DOI DOI 10.1191/1478088706QP063OA.
   Bylstra Y, 2019, NPJ GENOM MED, V4, DOI 10.1038/s41525-019-0085-8.
   Canada, 2018, GENOME CANADA 0604.
   Canadian Civil Liberties Association, 2018, GEN NOND ACT AN OV.
   Cardinal Health, 2018, ONC INS VIEWS PREC M.
   Chin J. J., 2002, SMJ Singapore Medical Journal, V43, P152.
   Chong HY, 2018, BMC MED GENOMICS, V11, DOI 10.1186/s12920-018-0420-4.
   Clarke JN, 2006, SOC SCI MED, V62, P2591, DOI 10.1016/j.socscimed.2005.11.021.
   Cooper R.S., 2004, Critical Perspectives on Racial and Ethnic Differences in Health in Late Life, P269.
   Crowe K., 2018, CBC News.
   Department of Health Government of Australia, 2017, PHARM BEN SCHEM WHAT.
   Dias MM, 2017, PHARM RES-DORDR, V34, P1544, DOI 10.1007/s11095-017-2128-0.
   Donelan K, 1999, HEALTH AFFAIR, V18, P206, DOI 10.1377/hlthaff.18.3.206.
   Duncan, 2010, KEY CONCEPTS HLTH ST, DOI {[}10.4135/9781446251676, DOI 10.4135/9781446251676].
   Duster Troy., 2003, BACKDOOR EUGENICS, V2nd.
   Goodman Roger., 1998, E ASIAN WELFARE MODE.
   Government of Canada, 2019, GOVT CANADA.
   Haga SB, 2012, CLIN GENET, V82, P388, DOI 10.1111/j.1399-0004.2012.01908.x.
   Hey SP, 2016, SCIENCE, V353, P448, DOI 10.1126/science.aaf5101.
   Holtzman NA, 1998, BMJ-BRIT MED J, V316, P852, DOI 10.1136/bmj.316.7134.852.
   Hussey P, 2003, HEALTH POLICY, V66, P215, DOI 10.1016/S0168-8510(03)00050-2.
   Janssens ACJW, 2014, CLIN PHARMACOL THER, V96, P652, DOI 10.1038/clpt.2014.186.
   JECKER NS, 1994, THEOR MED, V15, P181, DOI 10.1007/BF00994024.
   Khoury M.J., 2016, CTR DIS CONTR PREV.
   Khoury MJ, 2018, GENET MED, V20, P574, DOI 10.1038/gim.2017.211.
   Khoury MJ, 2016, AM J PREV MED, V50, P398, DOI 10.1016/j.amepre.2015.08.031.
   King JR, 2018, OBSTET GYN CLIN N AM, V45, P83, DOI 10.1016/j.ogc.2017.10.010.
   Krieger N, 2001, INT J EPIDEMIOL, V30, P668, DOI 10.1093/ije/30.4.668.
   Krieger N, 2012, MILBANK Q, V90, P634, DOI 10.1111/j.1468-0009.2012.00678.x.
   Lasser KE, 2006, AM J PUBLIC HEALTH, V96, P1300, DOI 10.2105/AJPH.2004.059402.
   Martin D, 2018, LANCET, V391, P1718, DOI 10.1016/S0140-6736(18)30181-8.
   Ministry of Health Singapore, 2019, COMMUNICATION.
   Ministry of Health Singapore, 2018, COD PRACT STAND PROV.
   Ministry of Health Singapore, 2017, COMMUNICATION.
   Moaddeb J, 2013, THER ADV DRUG SAF, V4, P155, DOI 10.1177/2042098613485595.
   Monaghan, 2013, KEY CONCEPTS MED SOC, P111.
   Moreno PG, 2019, FACETS, V4, P1, DOI 10.1139/facets-2018-0034.
   Morgan M., 1985, SOCIOLOGICAL APPROAC.
   Mossialos E., 2017, International profiles of health care systems.
   Moyer AM, 2017, EXPERT REV PHARM OUT, V17, P567, DOI 10.1080/14737167.2017.1385395.
   National Human Genome Institute, 2008, POL ISS GEN DISCR.
   National Institute of Health National Library of Medicine, 2020, NATL I HLTH.
   Offit K, 2007, SEMIN ONCOL, V34, P435, DOI 10.1053/j.seminoncol.2007.07.007.
   Organisation for Economic Cooperation and Development, 2017, NEW HLTH TECHN MAN A, DOI {[}10.1787/9789264266438-en, DOI 10.1787/9789264266438-EN].
   Paris V., 2014, Value in Pharmaceutical Pricing Country Profile: Canada.
   Parsons T., 1951, The Social System.
   Peterson JF, 2016, PHARMACOGENOMICS J, V16, P393, DOI 10.1038/tpj.2015.57.
   Pfizer, 2008, PFIZ FACTS BURD CANC.
   Prasad V., 2016, BMJ, P352, DOI {[}DOI 10.1136/BMJ.H6080, 10.1136/bmj.h6080].
   Ramaswami R, 2018, ANNU REV PUBL HEALTH, V39, P153, DOI 10.1146/annurev-publhealth-040617-014158.
   Ramesh M., 2017, GLOBAL IS ASIAN 0516.
   Relling MV, 2015, NATURE, V526, P343, DOI 10.1038/nature15817.
   Rose N., 2013, Procedia - Social and Behavioral Sciences, V77, P341, DOI DOI 10.1016/J.SBSPRO.2013.03.092.
   Starfield B, 2000, JAMA-J AM MED ASSOC, V284, P483, DOI 10.1001/jama.284.4.483.
   Toh DSL, 2014, PHARMACOGENOMICS J, V14, P316, DOI 10.1038/tpj.2013.46.
   WHO, 2020, REP WHO CHIN JOINT M.
   Wilkinson R., 2003, Social determinants of health: the solid facts.
   Williams SJ, 2001, SOCIOL HEALTH ILL, V23, P135, DOI 10.1111/1467-9566.00245.},
Number-of-Cited-References = {62},
Times-Cited = {1},
Unique-ID = {WOS:000680963500001},
}

@article{ WOS:000447923900014,
Author = {Williams, Janet L. and Chung, Wendy K. and Fedotov, Alex and Kiryluk,
   Krzysztof and Weng, Chunhua and Connolly, John J. and Harr, Margaret and
   Hakonarson, Hakon and Leppig, Kathleen A. and Larson, Eric B. and
   Jarvik, Gail P. and Veenstra, David L. and Hoell, Christin and Smith,
   Maureen E. and Holm, Ingrid A. and Peterson, Josh F. and Williams, Marc
   S.},
Title = {Harmonizing Outcomes for Genomic Medicine: Comparison of eMERGE Outcomes
   to ClinGen Outcome/Intervention Pairs},
Journal = {HEALTHCARE},
Year = {2018},
Volume = {6},
Number = {3},
Month = {SEP},
Abstract = {Genomic medicine is moving from research to the clinic. There is a lack
   of evidence about the impact of genomic medicine interventions on health
   outcomes. This is due in part to a lack of standardized outcome measures
   that can be used across different programs to evaluate the impact of
   interventions targeted to specific genetic conditions. The eMERGE
   Outcomes working group (OWG) developed measures to collect information
   on outcomes following the return of genomic results to participants for
   several genetic disorders. These outcomes were compared to outcome
   intervention pairs for genetic disorders developed independently by the
   ClinGen Actionability working group (AWG). In general, there was
   concordance between the defined outcomes between the two groups. The
   ClinGen outcomes tended to be from a higher level and the AWG scored
   outcomes represented a subset of outcomes referenced in the accompanying
   AWG evidence review. eMERGE OWG outcomes were more detailed and
   discrete, facilitating a collection of relevant information from the
   health records. This paper demonstrates that common outcomes for genomic
   medicine interventions can be identified. Further work is needed to
   standardize outcomes across genomic medicine implementation projects and
   to make these publicly available to enhance dissemination and assist in
   making precision public health a reality.},
Type = {Article},
Affiliation = {Williams, MS (Corresponding Author), Geisinger, Genom Med Inst, Danville, PA 17822 USA.
   Williams, Janet L.; Williams, Marc S., Geisinger, Genom Med Inst, Danville, PA 17822 USA.
   Chung, Wendy K., Columbia Univ, Dept Pediat, New York, NY 10025 USA.
   Chung, Wendy K., Columbia Univ, Dept Med, New York, NY 10025 USA.
   Fedotov, Alex, Columbia Univ, Irving Inst Clin \& Translat Res, New York, NY 10025 USA.
   Kiryluk, Krzysztof, Columbia Univ, Div Nephrol, Dept Med, New York, NY 10025 USA.
   Weng, Chunhua, Columbia Univ, Dept Biomed Informat, New York, NY 10025 USA.
   Connolly, John J.; Harr, Margaret; Hakonarson, Hakon, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA.
   Hakonarson, Hakon, Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA.
   Leppig, Kathleen A., Kaiser Permanente Washington, Genet Serv, Seattle, WA 98101 USA.
   Larson, Eric B., Kaiser Permanente Washington Hlth Res Inst, Seattle, WA 98101 USA.
   Jarvik, Gail P., Univ Washington, Dept Med Med Genet, Seattle, WA 98195 USA.
   Jarvik, Gail P., Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.
   Veenstra, David L., Univ Washington, Dept Pharm, Seattle, WA 98195 USA.
   Hoell, Christin; Smith, Maureen E., Northwestern Univ, Ctr Genet Med, Chicago, IL 60611 USA.
   Holm, Ingrid A., Boston Childrens Hosp, Div Genet \& Genom, Boston, MA 02115 USA.
   Holm, Ingrid A., Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA.
   Peterson, Josh F., Vanderbilt Univ, Sch Med, Dept Biomed Informat, Nashville, TN 37232 USA.
   Peterson, Josh F., Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37232 USA.},
DOI = {10.3390/healthcare6030083},
Article-Number = {83},
Keywords = {genomics; genomic medicine; health outcomes; evidence; standards;
   eMERGE; ClinGen; precision public health},
Keywords-Plus = {PHARMACOGENOMICS},
Research-Areas = {Health Care Sciences \& Services},
Web-of-Science-Categories  = {Health Care Sciences \& Services; Health Policy \& Services},
Author-Email = {Jlwilliams3@geisinger.edu
   wkc15@cumc.columbia.edu
   avf2117@cumc.columbia.edu
   kk473@cumc.columbia.edu
   chunhua@columbia.edu
   connollyj1@chop.edu
   harrm@email.chop.edu
   hakonarson@email.chop.edu
   leppig.k@ghc.org
   larson.e@ghc.org
   gjarvik@medicine.washington.edu
   veenstra@uw.edu
   christin.hoell@northwestern.edu
   m-smith6@northwestern.edu
   Ingrid.Holm@childrens.harvard.edu
   josh.peterson@Vanderbilt.Edu
   mswilliams1@geisinger.edu},
Affiliations = {Columbia University; Columbia University; Columbia University; Columbia
   University; Columbia University; University of Pennsylvania;
   Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of
   Pennsylvania; Kaiser Permanente; Kaiser Permanente; University of
   Washington; University of Washington Seattle; University of Washington;
   University of Washington Seattle; University of Washington; University
   of Washington Seattle; Northwestern University; Harvard University;
   Boston Children's Hospital; Harvard University; Harvard Medical School;
   Vanderbilt University; Vanderbilt University},
Cited-References = {Castelli W P, 1992, Ann Epidemiol, V2, P23, DOI 10.1016/1047-2797(92)90033-M.
   Haslem DS, 2017, J ONCOL PRACT, V13, pE108, DOI 10.1200/JOP.2016.011486.
   Horgan D, 2014, PUBLIC HEALTH GENOM, V17, P287, DOI 10.1159/000368034.
   Hunter JE, 2016, GENET MED, V18, P1258, DOI 10.1038/gim.2016.40.
   Khan A.A., 2017, BMJ OPEN QUAL, V6, DOI 10.1136/bmjoq-2017-000020.
   Kohlmann W., 2018, GeneReviews.
   Levinson SS, 2019, CLIN CHIM ACTA, V489, P189, DOI 10.1016/j.cca.2017.11.001.
   Manolio TA, 2013, GENET MED, V15, P258, DOI 10.1038/gim.2012.157.
   McDonald-McGinn D.M., 2018, GENEREVIEWS.
   Phillips KA, 2017, GENET MED, V19, P1, DOI 10.1038/gim.2017.21.
   Relling MV, 2015, NATURE, V526, P343, DOI 10.1038/nature15817.
   STAMLER J, 1986, JAMA-J AM MED ASSOC, V256, P2823, DOI 10.1001/jama.256.20.2823.
   Stark Z, 2019, GENET MED, V21, P173, DOI 10.1038/s41436-018-0006-8.
   Williams MS, 2018, HEALTH AFFAIR, V37, P757, DOI 10.1377/hlthaff.2017.1557.},
Number-of-Cited-References = {14},
Times-Cited = {15},
Unique-ID = {WOS:000447923900014},
}

@article{ WOS:001133037300001,
Author = {Buhler, Nolwenn},
Title = {Precision public health in the making: examining the becoming of the
   ``social{''} in a Swiss environmental health population-based cohort},
Journal = {FRONTIERS IN SOCIOLOGY},
Year = {2023},
Volume = {8},
Month = {DEC 15},
Abstract = {Expanding the concept of ``precision{''} or ``personalized{''} medicine,
   personalized health and precision public health designate the use of
   various kinds of data-genomic, other omics, clinical, or those produced
   by individuals themselves through self-tracking-to optimize health
   interventions benefiting the whole population. This paper draws on an
   ethnography of the implementation of a population-based environmental
   health cohort to shed light on the reconfigurations brought about by the
   ``personalization{''} of public health in Switzerland. Combining human
   biomonitoring and molecular epidemiology, this cohort aims to advance
   the science of the exposome, a notion referring to the totality of
   exposures to which individuals are subjected over their lifecourse.
   Addressing the tension between holism and reductionism, this paper
   points to the important gap between the promissory horizon of the
   exposome and the realities of practices. Situations of reductionism are
   defined as moments of friction and negotiation between different
   rationales and values, exposing what makes the science of the exposome,
   including its material, economic, institutional, and methodological
   constraints, as well as its imaginaries and values. Rather than opposing
   holism and reductionism, I emphasize that they constitute two sides of
   the same coin, as they both pragmatically enable action and produce
   situated versions of the social. This empirical case shows how
   reductionism operates at the chemical, biological, and populational
   levels to produce public health scientific and social values. It thus
   contributes to contextualizing the pragmatic and strategic choices made
   by scientists, as well as the values they favor, in a research
   environment marked by the predominance of biomedicine over public
   health. It shows how the reductionism of the ``social environment{''}
   was made for a better social integration of the cohort into the Swiss
   political and scientific landscape of public health. Bringing together
   actors involved in public health and questions of environmental
   exposures, this cohort can be interpreted as a biomedicalization of
   public health research, as well as an attempt to socialize it through
   the broad category of the exposome.},
Type = {Article},
Affiliation = {Bühler, N (Corresponding Author), Univ Lausanne, Inst Social Sci, STSLab, Lausanne, Switzerland.
   Buhler, Nolwenn, Univ Lausanne, Inst Social Sci, STSLab, Lausanne, Switzerland.},
DOI = {10.3389/fsoc.2023.1219275},
Article-Number = {1219275},
Keywords = {precision public health; exposome; biomedicalization; reductionism;
   holism; environment; cohort},
Keywords-Plus = {EXPOSOME; MEDICALIZATION; EPIGENETICS; MEDICINE; HOLISM},
Research-Areas = {Sociology},
Web-of-Science-Categories  = {Sociology},
Author-Email = {nolwenn.buhler@unil.ch},
Affiliations = {University of Lausanne},
Cited-References = {Ackerman SL, 2016, SCI TECHNOL HUM VAL, V41, P194, DOI 10.1177/0162243915595462.
   Adams Vincanne., 2023, Glyphosate and the Swirl: An Agroindustrial Chemical on the Move.
   Bauer S, 2008, STUD HIST PHI PART C, V39, P415, DOI 10.1016/j.shpsc.2008.09.008.
   Bourqui RM, 2023, PLOS ONE, V18, DOI 10.1371/journal.pone.0289181.
   Bühler N, 2024, PUBLIC UNDERST SCI, V33, P105, DOI 10.1177/09636625231183265.
   Canali S, 2022, STUD HIST PHILOS SCI, V93, P203, DOI 10.1016/j.shpsa.2022.04.006.
   Canali S, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082879.
   Chiapperino L, 2021, HIST SCI, V59, P3, DOI 10.1177/0073275319876839.
   Chowkwanyun M, 2018, NEW ENGL J MED, V379, P1398, DOI 10.1056/NEJMp1806634.
   Clifford James., 1986, WRITING CULTURE, P1, DOI DOI 10.1525/9780520946286-003.
   CONRAD P, 1975, SOC PROBL, V23, P12, DOI 10.1525/sp.1975.23.1.03a00020.
   Creager ANH, 2018, STUD HIST PHILOS SCI, V70, P70, DOI 10.1016/j.shpsa.2018.05.010.
   De Pietro C, 2015, HEALT SYST TRANSIT, V17, P1.
   Dussauge I., 2015, Value Practices in the Life Sciences and Medicine.
   FOPH, 2023, Human biomonitoring HBM.
   Gibbon S., 2019, Somatosphere.
   Giroux E., 2023, Integr. Approach. Environ. Health Exp. Res, DOI {[}10.1007/978-3-031-28432-8\_6, DOI 10.1007/978-3-031-28432-8\_6].
   Giroux É, 2021, M S-MED SCI, V37, P774, DOI 10.1051/medsci/2021092.
   Guchet X., 2019, Multitudes, V75, P72.
   Hoeyer K, 2019, SOC STUD SCI, V49, P531, DOI 10.1177/0306312719858697.
   Jerak-Zuiderent S, 2015, SOCIOL REV, V63, P897, DOI 10.1111/1467-954X.12221.
   Khoury MJ, 2016, AM J PREV MED, V50, P398, DOI 10.1016/j.amepre.2015.08.031.
   Krieger N, 1999, INT J HEALTH SERV, V29, P295, DOI 10.2190/M11W-VWXE-KQM9-G97Q.
   Kuss O, 2022, EUR J EPIDEMIOL, V37, P429, DOI 10.1007/s10654-022-00880-7.
   Lambiel X., 2017, Le Temps.
   Landecker H, 2013, ANNU REV SOCIOL, V39, P333, DOI 10.1146/annurev-soc-071312-145707.
   Latour B, 2004, CRIT INQUIRY, V30, P225, DOI 10.1086/421123.
   Leonelli S, 2021, SYNTHESE, V198, P2485, DOI 10.1007/s11229-018-1844-2.
   Lock M, 2018, J ROY ANTHROPOL INST, V24, P449, DOI 10.1111/1467-9655.12855.
   Louvel S, 2022, SOC SCI MED, V314, DOI 10.1016/j.socscimed.2022.115470.
   Marques SCS, 2020, JMIR RES PROTOC, V9, DOI 10.2196/14997.
   Meier-Abt P., 2016, Bulletin ASSM, V2, P1.
   Meloni M., 2018, The Palgrave handbook of biology and society, P1.
   Mitchell R, 2010, SCI TECHNOL HUM VAL, V35, P330, DOI 10.1177/0162243909340267.
   Monod Stefanie, 2022, Rev Med Suisse, V18, P1617, DOI 10.53738/REVMED.2022.18.793.1617.
   Müller R, 2017, EMBO REP, V18, P1677, DOI 10.15252/embr.201744953.
   Niewöhner J, 2018, BIOSOCIETIES, V13, P681, DOI 10.1057/s41292-017-0089-5.
   Niewöhner J, 2015, NEW GENET SOC, V34, P219, DOI 10.1080/14636778.2015.1036154.
   Parvex M., 2014, Le Temps.
   Penkler M, 2022, STUD HIST PHILOS SCI, V93, P1, DOI 10.1016/j.shpsa.2022.02.004.
   Penkler M, 2022, J DEV ORIG HLTH DIS, V13, P413, DOI 10.1017/S204017442100060X.
   Pinel C, 2022, SCI CULT-UK, V31, P311, DOI 10.1080/09505431.2022.2043840.
   Rappaport SM, 2011, J EXPO SCI ENV EPID, V21, P5, DOI 10.1038/jes.2010.50.
   Richardson SarahS., 2015, POSTGENOMICS PERSPEC.
   Roberts EFS, 2017, CULT ANTHROPOL, V32, P592, DOI 10.14506/ca32.4.07.
   Senier Laura, 2017, Environ Sociol, V3, P107, DOI 10.1080/23251042.2016.1220848.
   Serviant-Fine T, 2023, BIOSOCIETIES, DOI 10.1057/s41292-023-00303-0.
   Shostak Sara., 2013, EXPOSED SCI GENEEN.
   Sillé FCM, 2020, ALTEX-ALTERN ANIM EX, V37, P3, DOI 10.14573/altex.2001051.
   Stengers D. D., 2021, Multitudes.
   Thieme S, 2022, MED ANTHROPOL, V41, P460, DOI 10.1080/01459740.2022.2037082.
   Vineis P, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00118.
   Vogt H, 2016, MED HEALTH CARE PHIL, V19, P307, DOI 10.1007/s11019-016-9683-8.
   Washburn R, 2013, SOCIOL COMPASS, V7, P162, DOI 10.1111/soc4.12012.
   Whitmarsh I, 2013, MED ANTHROPOL Q, V27, P489, DOI 10.1111/maq.12061.
   Wild CP, 2012, INT J EPIDEMIOL, V41, P24, DOI 10.1093/ije/dyr236.
   Wild CP, 2005, CANCER EPIDEM BIOMAR, V14, P1847, DOI 10.1158/1055-9965.EPI-05-0456.
   Yates-Doerr E, 2020, MED ANTHROPOL Q, V34, P378, DOI 10.1111/maq.12586.
   ZOLA IK, 1972, SOCIOL REV, V20, P487, DOI 10.1111/j.1467-954X.1972.tb00220.x.},
Number-of-Cited-References = {59},
Times-Cited = {0},
Unique-ID = {WOS:001133037300001},
}

@article{ WOS:001036769900001,
Author = {Bedsaul-Fryer, Jacquelyn R. and van Zutphen-Kuffer, Kesso G. G. and
   Monroy-Gomez, Jimena and Clayton, Diane E. and Gavin-Smith, Breda and
   Worth, Celine and Schwab, Christian Nils and Freymond, Mathilda and
   Surowska, Anna and Martins, Lais Bhering and Senn-Jakobsen, Christina
   and Kraemer, Klaus},
Title = {Precision Nutrition Opportunities to Help Mitigate Nutrition and Health
   Challenges in Low- and Middle-Income Countries: An Expert Opinion Survey},
Journal = {NUTRIENTS},
Year = {2023},
Volume = {15},
Number = {14},
Month = {JUL},
Abstract = {Precision nutrition involves several data collection methods and tools
   that aim to better inform nutritional recommendations and improve
   dietary intake, nutritional status, and health outcomes. While the
   benefits of collecting precise data and designing well-informed
   interventions are vast, it is presently unclear whether precision
   nutrition is a relevant approach for tackling nutrition challenges
   facing populations in low- and middle-income countries (LMIC),
   considering infrastructure, affordability, and accessibility of
   approaches. The Swiss Food \& Nutrition Valley (SFNV) Precision
   Nutrition for LMIC project working group assessed the relevance of
   precision nutrition for LMIC by first conducting an expert opinion
   survey and then hosting a workshop with nutrition leaders who live or
   work in LMIC. The experts were interviewed to discuss four topics:
   nutritional problems, current solutions, precision nutrition, and
   collaboration. Furthermore, the SFNV Precision Nutrition for LMIC
   Virtual Workshop gathered a wider group of nutrition leaders to further
   discuss precision nutrition relevance and opportunities. Our study
   revealed that precision public health nutrition, which has a clear focus
   on the stratification of at-risk groups, may offer relevant support for
   nutrition and health issues in LMIC. However, funding, affordability,
   resources, awareness, training, suitable tools, and safety are essential
   prerequisites for implementation and to equitably address nutrition
   challenges in low-resource communities.},
Type = {Article},
Affiliation = {Bedsaul-Fryer, JR; Kraemer, K (Corresponding Author), Sight \& Life, POB 2116, CH-4002 Basel, Switzerland.
   Kraemer, K (Corresponding Author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21218 USA.
   Bedsaul-Fryer, Jacquelyn R.; van Zutphen-Kuffer, Kesso G. G.; Monroy-Gomez, Jimena; Gavin-Smith, Breda; Freymond, Mathilda; Kraemer, Klaus, Sight \& Life, POB 2116, CH-4002 Basel, Switzerland.
   van Zutphen-Kuffer, Kesso G. G., Wageningen Univ \& Res, Dept Human Nutr \& Hlth, NL-6708 PB Wageningen, Netherlands.
   Clayton, Diane E., York Consumer Hlth, Route Charmin 15, CH-1648 Hauteville, Switzerland.
   Worth, Celine, Nestle Corp R\&D, Ave Nestle 55, CH-1800 Vevey, Switzerland.
   Schwab, Christian Nils, Ecole Polytech Fed Lausanne, Integrat Food \& Nutr Ctr, Rte Cantonale, CH-1015 Lausanne, Switzerland.
   Surowska, Anna, Ecole Polytech Fed Lausanne, EssentialTech Ctr, Rte Cantonale, CH-1015 Lausanne, Switzerland.
   Martins, Lais Bhering; Senn-Jakobsen, Christina, Swiss Food \& Nutr Valley, Stn 12,EPFL Innovat Pk, CH-1015 Lausanne, Switzerland.
   Kraemer, Klaus, Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21218 USA.},
DOI = {10.3390/nu15143247},
Article-Number = {3247},
Keywords = {precision nutrition; precision public health nutrition; LMIC;
   malnutrition},
Keywords-Plus = {SUPPLEMENTATION; MORTALITY; CHILDREN; IRON},
Research-Areas = {Nutrition \& Dietetics},
Web-of-Science-Categories  = {Nutrition \& Dietetics},
Author-Email = {jbedsau1@jhmi.edu
   kesso.vanzutphen@sightandlife.org
   jimena.monroy@sightandlife.org
   dianeclayton@bluewin.ch
   breda.gavinsmith@outlook.com
   celine.worth@nestle.com
   christian.schwab@epfl.ch
   mathilda\_freymond@sightandlife.org
   anna.surowska@gmail.com
   lais@sfnv.ch
   christina@sfnv.ch
   klaus.kraemer@sightandlife.org},
Affiliations = {Wageningen University \& Research; Swiss Federal Institutes of
   Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss
   Federal Institutes of Technology Domain; Ecole Polytechnique Federale de
   Lausanne; Swiss Federal Institutes of Technology Domain; Ecole
   Polytechnique Federale de Lausanne; Johns Hopkins University; Johns
   Hopkins Bloomberg School of Public Health},
Cited-References = {Abdill RJ, 2022, PLOS BIOL, V20, DOI 10.1371/journal.pbio.3001536.
   Adams SH, 2020, ADV NUTR, V11, P25, DOI 10.1093/advances/nmz086.
   Adebisi YA, 2022, INT J PUBLIC HEALTH, V67, DOI 10.3389/ijph.2022.1605418.
   {[}Anonymous], WHO FACT SHEETS MALN.
   {[}Anonymous], 2022, The State of Food Security and Nutrition in the World 2022: Repurposing food and agricultural Policies to make healthy diets more affordable, DOI {[}10.4060/cc0639en, DOI 10.4060/CC0639EN, 10.4060/cb4474-n].
   {[}Anonymous], 2003, Bayesian Inference: Parameter Estimation and Decisions.
   Arab L, 2011, EUR J CLIN NUTR, V65, P1156, DOI 10.1038/ejcn.2011.75.
   Beesabathuni K., 2023, SCI INNOVATIONS FOOD, P455.
   Berciano S, 2022, FRONT NUTR, V9, DOI 10.3389/fnut.2022.979665.
   Bergman P, 2020, NUTRIENTS, V12, DOI 10.3390/nu12061682.
   Bourassa MW, 2019, ANN NY ACAD SCI, V1444, P6, DOI 10.1111/nyas.14121.
   Brittenham GM, 2012, NESTLE NUTR WORKS SE, V70, P117, DOI 10.1159/000337674.
   Caswell BL, 2021, MATERN CHILD NUTR, V17, DOI 10.1111/mcn.13196.
   Center for Disease Control and Prevention, IMPR PROF DEV OFF ST.
   Charani Esmita, 2022, PLOS Glob Public Health, V2, pe0000583, DOI 10.1371/journal.pgph.0000583.
   Chen RY, 2021, NEW ENGL J MED, V384, P1517, DOI 10.1056/NEJMoa2023294.
   Crowley CR, 2012, ADV NUTR, V3, P560, DOI 10.3945/an.111.001149.
   Cuiccio C., 2018, Needs assessment guidebook: Supporting the development of district and school needs assessments.
   de Toro-Martín J, 2017, NUTRIENTS, V9, DOI 10.3390/nu9080913.
   Ferraboschi C, 2022, NUTRIENTS, V14, DOI 10.3390/nu14102003.
   Fialkowski MK, 2022, NUTRIENTS, V14, DOI 10.3390/nu14051075.
   Fransis A., 1886, GENUINE WORKS HIPPOC.
   Gannon BM, 2019, CURR RES BIOTECHNOL, V1, P41, DOI 10.1016/j.crbiot.2019.09.002.
   Gavin-Smith B., 2022, PRECISION NUTR LOW M, P1, DOI {[}10.52439/PRCJ5543, DOI 10.52439/PRCJ5543].
   Gonzales GB, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-68143-7.
   Hodson Daniel Z, 2023, PLOS Glob Public Health, V3, pe0001418, DOI 10.1371/journal.pgph.0001418.
   Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687.
   Ivanova S, 2021, FOODS, V10, DOI 10.3390/foods10123052.
   Kahleova H, 2017, NUTRIENTS, V9, DOI 10.3390/nu9080848.
   Kirk D, 2021, COMPUT BIOL MED, V133, DOI 10.1016/j.compbiomed.2021.104365.
   Lee S, 2016, LAB CHIP, V16, P2408, DOI 10.1039/c6lc00393a.
   Livingstone KM, 2022, TRENDS FOOD SCI TECH, V128, P253, DOI 10.1016/j.tifs.2022.08.017.
   Merritt RK, 2021, INT J PUBLIC HEALTH, V66, DOI 10.3389/ijph.2021.1604390.
   Monroy-Gomez J, 2022, NUTRIENTS, V14, DOI 10.3390/nu14183837.
   Mostafa I, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-8330-8.
   Najjar RS, 2019, NUTRIENTS, V11, DOI 10.3390/nu11112712.
   Nicoletti CF, 2017, NUTRIENTS, V9, DOI 10.3390/nu9090974.
   Fong JNV, 2022, NUTRIENTS, V14, DOI 10.3390/nu14020268.
   Norwitz NG, 2021, NUTRIENTS, V13, DOI 10.3390/nu13041362.
   Ntila SL, 2020, S AFR J BOT, V129, P238, DOI 10.1016/j.sajb.2019.07.021.
   O'Neil S, 2021, DIGIT HEALTH, V7, DOI 10.1177/20552076211061922.
   Portner H.- O., 2022, WORKING GROUP 2 CONT, DOI {[}10.1017/9781009325844, DOI 10.1017/9781009325844].
   Qi L, 2022, OBESITY, V30, P1335, DOI 10.1002/oby.23448.
   Rickard J, 2019, J SURG EDUC, V76, P9, DOI 10.1016/j.jsurg.2018.07.010.
   Riedl A, 2017, BRIT J NUTR, V117, P1631, DOI 10.1017/S0007114517001611.
   Romney V., 1996, STRATEGIC PLANNING N.
   ROUDA RH, 1995, TAPPI J, V78, P255.
   Sazawal S, 2006, LANCET, V367, P133, DOI 10.1016/S0140-6736(06)67962-2.
   Schmidt CO, 2021, BMC MED RES METHODOL, V21, DOI 10.1186/s12874-021-01252-7.
   Semba RD, 2016, EBIOMEDICINE, V6, P246, DOI 10.1016/j.ebiom.2016.02.030.
   Shane B, 2023, AM J CLIN NUTR, V117, P844, DOI 10.1016/j.ajcnut.2023.03.008.
   Shija AE, 2019, FOOD SCI NUTR, V7, P2584, DOI 10.1002/fsn3.1110.
   Shumba C S., 2021, J Global Health Econ Policy, V1, DOI {[}10.52872/001c.25802, DOI 10.52872/001C.25802].
   Six BL, 2010, J AM DIET ASSOC, V110, P74, DOI 10.1016/j.jada.2009.10.010.
   SOMMER A, 1986, LANCET, V1, P1169.
   Srinivasan B, 2019, EBIOMEDICINE, V42, P504, DOI 10.1016/j.ebiom.2019.03.017.
   Srinivasan B, 2017, CURR OPIN BIOTECH, V44, P103, DOI 10.1016/j.copbio.2016.12.001.
   Stewart CP, 2019, AM J CLIN NUTR, V110, P1026, DOI 10.1093/ajcn/nqz163.
   Tobey D., 2005, Needs assessment basics.
   United Nations. Department of Economic and Social Affairs, World population prospects 2019.
   White MD, 2006, LIBR TRENDS, V55, P22, DOI 10.1353/lib.2006.0053.
   Zoe Global Limited, PREDICT 2 PERS RESP, P2.},
Number-of-Cited-References = {62},
Times-Cited = {1},
Unique-ID = {WOS:001036769900001},
}

@article{ WOS:000791844000044,
Author = {Alfiya, M. and Shenoy, Rekha P. and Jodalli, Praveen and Pasha, Imran
   and Junaid and Supriya, A.},
Title = {PRECISION PUBLIC HEALTH-NEED OF THE HOUR},
Journal = {INTERNATIONAL JOURNAL OF EARLY CHILDHOOD SPECIAL EDUCATION},
Year = {2022},
Volume = {14},
Number = {3},
Pages = {1691-1696},
Abstract = {The Precision Public Health (PPH) is a new field driven by technological
   advances that enable more precise descriptions and analyses of
   individuals and population groups, with a view to improving the overall
   health of populations. PPH can be simply viewed as delivering the right
   intervention to the right population at the right time. It draws on a
   broad range of disciplines including genomics, spatial data, data
   linkage, epidemiology, health informatics, big data, predictive
   analytics and communications. Beyond genomics, all kinds of data can be
   used in measuring determinants of health and impact of interventions. A
   priority for public health is the use of information technology and data
   science in enhancing public health surveillance and tracking. Top
   priorities included: early detection of outbreaks, modernizing
   surveillance, and targeted health interventions. To achieve such
   improvements, comprehensive and real-time data to learn from are
   necessary. A recent application of PPH is the rapid emergence of a novel
   corona virus has facilitated an accelerated use of the applications of
   ``big data{''} tools and technologies like use of whole-genome
   sequencing to track the virus origin and spread; detailed geographic
   information to track spread at the global, country, and local levels ;
   the use of smart phone-based tracking and control ; and rapid
   characterization of risk factors related to severe disease such as age,
   underlying medical conditions to tackle the spread of COVID 19.},
Type = {Article},
Affiliation = {Shenoy, RP (Corresponding Author), Yenepoya Univ, Dept Publ Hlth Dent, Yenepoya Dent Coll, Univ Rd, Mangalore 575018, India.
   Alfiya, M.; Shenoy, Rekha P.; Jodalli, Praveen; Pasha, Imran; Junaid; Supriya, A., Yenepoya Univ, Dept Publ Hlth Dent, Yenepoya Dent Coll, Univ Rd, Mangalore 575018, India.},
DOI = {10.9756/INT-JECSE/V14I3.199},
Keywords = {big data; covid 19; genomics; precision medicine},
Keywords-Plus = {HOSPITAL OUTBREAK; EPIDEMIOLOGY; GENOMICS; MEDICINE},
Research-Areas = {Education \& Educational Research},
Web-of-Science-Categories  = {Education, Special},
Author-Email = {merekhap@gmail.com},
Affiliations = {Yenepoya (Deemed to be University)},
Cited-References = {Bayer R, 2015, NEW ENGL J MED, V373, P499, DOI 10.1056/NEJMp1506241.
   Bempong NE, 2019, J GLOB HEALTH, V9, P1.
   Bowen MS, 2012, PUBLIC HEALTH GENOM, V15, P327, DOI 10.1159/000341889.
   Cairns MD, 2015, J CLIN MICROBIOL, V53, P3141, DOI 10.1128/JCM.00648-15.
   Chowkwanyun M, 2018, NEW ENGL J MED, V379, P1398, DOI 10.1056/NEJMp1806634.
   Dolley S, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00068.
   Fagbo SF, 2015, EMERG INFECT DIS, V21, P1981, DOI 10.3201/eid2111.150944.
   Horton R, 2018, LANCET, V392, P1504, DOI 10.1016/S0140-6736(18)32741-7.
   Kenney M, 2020, MED HUMANIT, V46, P192, DOI 10.1136/medhum-2018-011597.
   Khoury MJ, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003373.
   Khoury MJ, 2018, GENET MED, V20, P574, DOI 10.1038/gim.2017.211.
   Khoury MJ, 2018, PUBLIC HEALTH GENOM, V21, P244, DOI 10.1159/000501465.
   Khoury MJ, 2016, AM J PREV MED, V50, P398, DOI 10.1016/j.amepre.2015.08.031.
   Khoury MJ, 2014, SCIENCE, V346, P1054, DOI 10.1126/science.aaa2709.
   Killerby ME, 2020, MMWR-MORBID MORTAL W, V69, P790, DOI 10.15585/mmwr.mm6925e1.
   Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8.
   Olden K, 2014, AM J PUBLIC HEALTH, V104, P1816, DOI 10.2105/AJPH.2014.302130.
   Ramaswami R, 2018, ANNU REV PUBL HEALTH, V39, P153, DOI 10.1146/annurev-publhealth-040617-014158.
   Rasmussen SA, 2020, JAMA-J AM MED ASSOC, V324, P933, DOI 10.1001/jama.2020.14992.
   Ting DSW, 2020, NAT MED, V26, P459, DOI 10.1038/s41591-020-0824-5.
   Weeramanthri TS, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00121.},
Number-of-Cited-References = {21},
Times-Cited = {0},
Unique-ID = {WOS:000791844000044},
}

@article{ WOS:000462165800001,
Author = {Deepali Nagar, Shashwat and Melissa Moreno, A. and Norris, Emily T. and
   Rishishwar, Lavanya and Conley, Andrew B. and O'Neal, Kelly L. and
   Velez-Gomez, Sara and Montes-Rodriguez, Camila and Jaraba-Alvarez, V,
   Wendy and Torres, Isaura and Medina-Rivas, Miguel A. and
   Valderrama-Aguirre, Augusto and King Jordan, I and Esteban Gallo, Juan},
Title = {Population Pharmacogenomics for Precision Public Health in Colombia},
Journal = {FRONTIERS IN GENETICS},
Year = {2019},
Volume = {10},
Month = {MAR 22},
Abstract = {While genomic approaches to precision medicine hold great promise, they
   remain prohibitively expensive for developing countries. The precision
   public health paradigm, whereby healthcare decisions are made at the
   level of populations as opposed to individuals, provides one way for the
   genomics revolution to directly impact health outcomes in the developing
   world. Genomic approaches to precision public health require a deep
   understanding of local population genomics, which is still missing for
   many developing countries. We are investigating the population genomics
   of genetic variants that mediate drug response in an effort to inform
   healthcare decisions in Colombia. Our work focuses on two neighboring
   populations with distinct ancestry profiles: Antioquia and Choco.
   Antioquia has primarily European genetic ancestry followed by Native
   American and African components, whereas Choco shows mainly African
   ancestry with lower levels of Native American and European admixture. We
   performed a survey of the global distribution of pharmacogenomic
   variants followed by a more focused study of pharmacogenomic allele
   frequency differences between the two Colombian populations. Worldwide,
   we found pharmacogenomic variants to have both unusually high minor
   allele frequencies and high levels of population differentiation. A
   number of these pharmacogenomic variants also show anomalous effect
   allele frequencies within and between the two Colombian populations, and
   these differences were found to be associated with their distinct
   genetic ancestry profiles. For example, the C allele of the single
   nucleotide polymorphism (SNP) rs4149056 {[} Solute Carrier Organic Anion
   Transporter Family Member 1B1 (SLCO1B1){*}5], which is associated with
   an increased risk of toxicity to a commonly prescribed statin, is found
   at relatively high frequency in Antioquia and is associated with
   European ancestry. In addition to pharmacogenomic alleles related to
   increased toxicity risk, we also have evidence that alleles related to
   dosage and metabolism have large frequency differences between the two
   populations, which are associated with their specific ancestries. Using
   these findings, we have developed and validated an inexpensive
   allele-specific PCR assay to test for the presence of such
   population-enriched pharmacogenomic SNPs in Colombia. These results
   serve as an example of how population-centered approaches to
   pharmacogenomics can help to realize the promise of precision medicine
   in resource-limited settings.},
Type = {Article},
Affiliation = {Jordan, IK (Corresponding Author), Georgia Inst Technol, Sch Biol Sci, Atlanta, GA 30332 USA.
   Jordan, IK (Corresponding Author), IHRC Georgia Tech Appl Bioinforrnat Lab, Atlanta, GA 30332 USA.
   Jordan, IK; Gallo, JE (Corresponding Author), PanAmer Bioinforrnat Inst, Cali, Colombia.
   Gallo, JE (Corresponding Author), Univ CES, GenomaCES, Medellin, Colombia.
   Deepali Nagar, Shashwat; Norris, Emily T.; O'Neal, Kelly L.; Valderrama-Aguirre, Augusto; King Jordan, I, Georgia Inst Technol, Sch Biol Sci, Atlanta, GA 30332 USA.
   Deepali Nagar, Shashwat; Norris, Emily T.; Rishishwar, Lavanya; Conley, Andrew B.; King Jordan, I, IHRC Georgia Tech Appl Bioinforrnat Lab, Atlanta, GA 30332 USA.
   Deepali Nagar, Shashwat; Norris, Emily T.; Rishishwar, Lavanya; Conley, Andrew B.; Medina-Rivas, Miguel A.; Valderrama-Aguirre, Augusto; King Jordan, I; Esteban Gallo, Juan, PanAmer Bioinforrnat Inst, Cali, Colombia.
   Melissa Moreno, A.; Velez-Gomez, Sara; Montes-Rodriguez, Camila; Jaraba-Alvarez, Wendy, V; Torres, Isaura; Esteban Gallo, Juan, Univ CES, GenomaCES, Medellin, Colombia.
   Medina-Rivas, Miguel A., Univ Tecnol Choca, Ctr Invest Biodiversidad \& Habitat, Quibdo, Colombia.
   Valderrama-Aguirre, Augusto, Biomed Res Inst, Cali, Colombia.},
DOI = {10.3389/fgene.2019.00241},
Article-Number = {241},
Keywords = {pharmacogenomics; pharmacogenetics; precision medicine; genetic
   ancestry; admixture; Colombia; Antioquia; Choco},
Keywords-Plus = {GENETIC-VARIATION; GLYCEMIC CONTROL; ANCESTRY; MEDICINE; GENOMICS;
   METFORMIN; ADMIXTURE; VARIANTS; VKORC1; CYP2C9},
Research-Areas = {Genetics \& Heredity},
Web-of-Science-Categories  = {Genetics \& Heredity},
Author-Email = {king.jordan@biology.gatech.edu
   jegallo@ces.edu.co},
Affiliations = {University System of Georgia; Georgia Institute of Technology; IHRC,
   Inc.; Universidad CES},
Cited-References = {Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109.
   Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393.
   Appelbaum NancyP., 2016, MAPPING COUNTRY REGI.
   Bhatia G, 2013, GENOME RES, V23, P1514, DOI 10.1101/gr.154831.113.
   Bonifaz-Peña V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112640.
   Bryc K, 2010, P NATL ACAD SCI USA, V107, P8954, DOI 10.1073/pnas.0914618107.
   Chande AT, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17380-4.
   Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523.
   Conley AB, 2017, G3-GENES GENOM GENET, V7, P3435, DOI 10.1534/g3.117.1118.
   Conrad DF, 2006, NAT GENET, V38, P1251, DOI 10.1038/ng1911.
   CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330.
   De Castro M, 2015, MOL GENET GENOM MED, V3, P84, DOI 10.1002/mgg3.139.
   Fung E, 2012, SEMIN THROMB HEMOST, V38, P893, DOI 10.1055/s-0032-1328891.
   Gallo Juan Esteban, 2017, Rev. Colomb. Cardiol., V24, P1, DOI 10.1016/j.rccar.2016.10.044.
   Gibson G, 2019, NAT REV GENET, V20, P1, DOI 10.1038/s41576-018-0061-7.
   Hariprakash JM, 2018, PHARMACOGENOMICS, V19, P227, DOI 10.2217/pgs-2017-0101.
   He YJ, 2011, TRENDS MOL MED, V17, P244, DOI 10.1016/j.molmed.2011.01.007.
   Jameson JL, 2015, NEW ENGL J MED, V372, P2229, DOI 10.1056/NEJMsb1503104.
   Johnson JA, 2011, CLIN PHARMACOL THER, V90, P625, DOI 10.1038/clpt.2011.185.
   Karlberg JPE, 2008, NAT REV DRUG DISCOV, V7, P639, DOI 10.1038/nrd2618.
   Khoury MJ, 2018, GENET MED, V20, P574, DOI 10.1038/gim.2017.211.
   Khoury MJ, 2016, AM J PREV MED, V50, P398, DOI 10.1016/j.amepre.2015.08.031.
   Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111.
   Lakiotaki K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182138.
   Lauschke VM, 2018, AAPS J, V20, DOI 10.1208/s12248-017-0161-x.
   Lee C.G.L, 2013, Current Genetic Medicine Reports, V1, P162, DOI 10.1007/s40142-013-0017-3.
   Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057.
   Li H, 2009, BIOINFORMATICS, V25, P1094, DOI {[}10.1093/bioinformatics/btp324, 10.1093/bioinformatics/btp100].
   Ma Q, 2011, PHARMACOL REV, V63, P437, DOI 10.1124/pr.110.003533.
   Martin AR, 2017, AM J HUM GENET, V100, P635, DOI 10.1016/j.ajhg.2017.03.004.
   Medina-Rivas Miguel A., 2016, Revista Biodiversidad Neotropical, V6, P45, DOI 10.18636/bioneotropical.v6i1.341.
   MILLER SA, 1988, NUCLEIC ACIDS RES, V0016.
   Mora G. C., 2014, Making Hispanics: How activists, bureaucrats, and media constructed a new American.
   Moreno-Estrada A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003925.
   Nordling L, 2017, NATURE, V544, P20, DOI 10.1038/544020a.
   O'Donnell-Luria AH, 2016, HUM GENET, V135, P643, DOI 10.1007/s00439-016-1662-x.
   Petrovski S, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1016-y.
   Popejoy AB, 2016, NATURE, V538, P161, DOI 10.1038/538161a.
   Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795.
   Ramos E, 2014, PHARMACOGENOMICS J, V14, P217, DOI 10.1038/tpj.2013.24.
   Rishishwar L, 2015, SCI REP-UK, V5, DOI 10.1038/srep12376.
   Roden DM, 2006, ANN INTERN MED, V145, P749, DOI 10.7326/0003-4819-145-10-200611210-00007.
   Ruiz-Linares A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004572.
   Steffan-Dewenter I., 2002, Ecology, V83, P1421, DOI 10.1890/0012-9658(2002)083{[}1421:SDEOLC]2.0.CO;2.
   Stirling C, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-122.
   Szabo L., 2018, PRICEY PRECISION MED.
   Thiers F. A., 2008, TRENDS GLOBALIZATION.
   Thorvaldsdóttir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017.
   Wade P., 2017, DEGREES MIXTURE DEGR, P99.
   Wang S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000037.
   Wangkumhang P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-275.
   Weeramanthri TS, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00121.
   Weinshilboum RM, 2006, ANNU REV GENOM HUM G, V7, P223, DOI 10.1146/annurev.genom.6.080604.162315.
   Whirl-Carrillo M, 2012, CLIN PHARMACOL THER, V92, P414, DOI 10.1038/clpt.2012.96.
   Williams LK, 2014, J CLIN ENDOCR METAB, V99, P3160, DOI 10.1210/jc.2014-1539.
   Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134.
   Zhang C, 2015, DIABETES METAB, V41, P173, DOI 10.1016/j.diabet.2015.01.003.
   Zhou KX, 2011, NAT GENET, V43, P117, DOI 10.1038/ng.735.},
Number-of-Cited-References = {58},
Times-Cited = {24},
Unique-ID = {WOS:000462165800001},
}

@article{ WOS:000787298500002,
Author = {Yu, Wei and Drzymalla, Emily and Gwinn, Marta and Khoury, Muin J.},
Title = {COVID-19 GPH: tracking the contribution of genomics and precision health
   to the COVID-19 pandemic response},
Journal = {BMC INFECTIOUS DISEASES},
Year = {2022},
Volume = {22},
Number = {1},
Month = {APR 25},
Abstract = {The scientific response to the COVID-19 pandemic has produced an
   abundance of publications, including peer-reviewed articles and
   preprints, across a wide array of disciplines, from microbiology to
   medicine and social sciences. Genomics and precision health (GPH)
   technologies have had a particularly prominent role in medical and
   public health investigations and response; however, these domains are
   not simply defined and it is difficult to search for relevant
   information using traditional strategies. To quantify and track the
   ongoing contributions of GPH to the COVID-19 response, the Office of
   Genomics and Precision Public Health at the Centers for Disease Control
   and Prevention created the COVID-19 Genomics and Precision Health
   database (COVID-19 GPH), an open access knowledge management system and
   publications database that is continuously updated through machine
   learning and manual curation. As of February 11, 2022, COVID-GPH
   contained 31,597 articles, mostly on pathogen and human genomics (72\%).
   The database also includes articles describing applications of machine
   learning and artificial intelligence to the investigation and control of
   COVID-19 (28\%). COVID-GPH represents about 10\% (22983/221241) of the
   literature on COVID-19 on PubMed. This unique knowledge management
   database makes it easier to explore, describe, and track how the
   pandemic response is accelerating the applications of genomics and
   precision health technologies. COVID-19 GPH can be freely accessed via
   https://phgkb.cdc.gov/PHGKB/coVInfoStartPage.action.},
Type = {Article; Data Paper},
Affiliation = {Yu, W (Corresponding Author), Ctr Dis Control \& Prevent, Off Genom \& Precis Publ Hlth, Off Sci, Atlanta, GA 30333 USA.
   Yu, Wei; Drzymalla, Emily; Gwinn, Marta; Khoury, Muin J., Ctr Dis Control \& Prevent, Off Genom \& Precis Publ Hlth, Off Sci, Atlanta, GA 30333 USA.},
DOI = {10.1186/s12879-022-07219-3},
Article-Number = {402},
Keywords = {COVID-19; Database; SARS-CoV-2; Genomics; Precision Public Health},
Research-Areas = {Infectious Diseases},
Web-of-Science-Categories  = {Infectious Diseases},
Author-Email = {wby0@cdc.gov},
Affiliations = {Centers for Disease Control \& Prevention - USA},
Cited-References = {Aminpour M, 2021, BMC PHARMACOL TOXICO, V22, DOI 10.1186/s40360-021-00519-5.
   {[}Anonymous], ENTREZ PROGRAMMING U.
   {[}Anonymous], JAV J2EE.
   Boyarsky BJ, 2021, JAMA-J AM MED ASSOC, V325, P2204, DOI 10.1001/jama.2021.7489.
   Chen QY, 2021, NUCLEIC ACIDS RES, V49, pD1534, DOI 10.1093/nar/gkaa952.
   Davies NG, 2021, SCIENCE, V372, P149, DOI 10.1126/science.abg3055.
   Elmore SA, 2018, TOXICOL PATHOL, V46, P252, DOI 10.1177/0192623318758294.
   Ito K, 2022, J MED VIROL, V94, P2265, DOI {[}10.3390/vaccines10060859, 10.1002/jmv.27560].
   Khoury MJ, 2021, GENOME MED, V13, DOI 10.1186/s13073-021-00886-y.
   Konings F, 2021, NAT MICROBIOL, V6, P821, DOI 10.1038/s41564-021-00932-w.
   Li SS, 2021, AGING-US, V13, P9265, DOI 10.18632/aging.202877.
   Liu YC, 2020, BIOMED J, V43, P328, DOI 10.1016/j.bj.2020.04.007.
   McCoy D, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-90827-x.
   Minucci A, 2020, MOL BIOL REP, V47, P4857, DOI 10.1007/s11033-020-05479-3.
   Niemi MEK, 2021, NATURE, V600, P472, DOI 10.1038/s41586-021-03767-x.
   Papanikolaou V, 2022, GENE, V814, DOI 10.1016/j.gene.2021.146134.
   Pati A., 2021, J INFECT DIS, V5.
   Rasmussen SA, 2020, JAMA-J AM MED ASSOC, V324, P933, DOI 10.1001/jama.2020.14992.
   Saponi-Cortes JMR, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-00747-z.
   Schönfelder K, 2021, CYTOKINE, V142, DOI 10.1016/j.cyto.2021.155492.
   Shinde V, 2021, NEW ENGL J MED, V384, P1899, DOI 10.1056/NEJMoa2103055.
   Syrowatka A, 2021, NPJ DIGIT MED, V4, DOI 10.1038/s41746-021-00459-8.
   Thompson CN, 2021, MMWR-MORBID MORTAL W, V70, P712, DOI 10.15585/mmwr.mm7019e1.
   Tramuto F, 2021, FRONT PUBLIC HEALTH, V9, DOI 10.3389/fpubh.2021.632645.
   van Oers NSC, 2021, CLIN IMMUNOL, V224, DOI 10.1016/j.clim.2020.108662.
   Wei CH, 2013, NUCLEIC ACIDS RES, V41, pW518, DOI 10.1093/nar/gkt441.
   WHO, GLOB RES COR DIS COV.
   Yang W, 2021, DYN GAMES APPL, V11, P892, DOI 10.1007/s13235-021-00382-3.
   Yu W, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-436.
   Yu W, 2007, BMC MED INFORM DECIS, V7, DOI 10.1186/1472-6947-7-17.
   Yu W, 2016, GENET MED, V18, P1312, DOI 10.1038/gim.2016.63.},
Number-of-Cited-References = {31},
Times-Cited = {1},
Unique-ID = {WOS:000787298500002},
}

@article{ WOS:000540222300127,
Author = {Sariola, Salla and Gilbert, Scott F.},
Title = {Toward a Symbiotic Perspective on Public Health: Recognizing the
   Ambivalence of Microbes in the Anthropocene},
Journal = {MICROORGANISMS},
Year = {2020},
Volume = {8},
Number = {5},
Month = {MAY},
Abstract = {Microbes evolve in complex environments that are often fashioned, in
   part, by human desires. In a global perspective, public health has
   played major roles in structuring how microbes are perceived,
   cultivated, and destroyed. The germ theory of disease cast microbes as
   enemies of the body and the body politic. Antibiotics have altered
   microbial development by providing stringent natural selection on
   bacterial species, and this has led to the formation of
   antibiotic-resistant bacterial strains. Public health perspectives such
   as ``Precision Public Health{''} and ``One Health{''} have recently been
   proposed to further manage microbial populations. However, neither of
   these take into account the symbiotic relationships that exist between
   bacterial species and between bacteria, viruses, and their eukaryotic
   hosts. We propose a perspective on public health that recognizes
   microbial evolution through symbiotic associations (the hologenome
   theory) and through lateral gene transfer. This perspective has the
   advantage of including both the pathogenic and beneficial interactions
   of humans with bacteria, as well as combining the outlook of the ``One
   Health{''} model with the genomic methodologies utilized in the
   ``Precision Public Health{''} model. In the Anthropocene, the conditions
   for microbial evolution have been altered by human interventions, and
   public health initiatives must recognize both the beneficial (indeed,
   necessary) interactions of microbes with their hosts as well as their
   pathogenic interactions.},
Type = {Article},
Affiliation = {Gilbert, SF (Corresponding Author), Swarthmore Coll, Dept Biol, Swarthmore, PA 19081 USA.
   Sariola, Salla, Univ Helsinki, Fac Social Sci, Sociol, Helsinki 00014, Finland.
   Gilbert, Scott F., Swarthmore Coll, Dept Biol, Swarthmore, PA 19081 USA.},
DOI = {10.3390/microorganisms8050746},
Article-Number = {746},
Keywords = {microbial evolution; public health; symbiosis; drug resistance;
   hologenome; AMR; allergy; anthropocene; plantationocene},
Keywords-Plus = {GUT MICROBIOTA; ANTIMICROBIAL RESISTANCE; INTESTINAL EPITHELIUM;
   BRAIN-DEVELOPMENT; BACTERIA; CHALLENGES; VIRUSES; DOXYCYCLINE;
   DYSBIOSIS; EVOLUTION},
Research-Areas = {Microbiology},
Web-of-Science-Categories  = {Microbiology},
Author-Email = {salla.sariola@helsinki.fi
   sgilber1@swarthmore.edu},
Affiliations = {University of Helsinki; Swarthmore College},
Cited-References = {Alivisatos AP, 2015, SCIENCE, V350, P507, DOI 10.1126/science.aac8480.
   {[}Anonymous], 2014, Missing microbes: How killing bacteria creates modern plagues.
   {[}Anonymous], BioRxiv, DOI DOI 10.1101/2020.02.17.951335.
   Ardeshir A, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008791.
   Auta A, 2019, J INFECTION, V78, P8, DOI 10.1016/j.jinf.2018.07.001.
   Baker DM, 2018, ISME J, V12, P921, DOI 10.1038/s41396-018-0046-8.
   Baldwin RL, 2018, GENE REGUL SYST BIO, V12, DOI 10.1177/1177625018774798.
   Baldwin RL, 2017, VET CLIN N AM-FOOD A, V33, P427, DOI 10.1016/j.cvfa.2017.06.001.
   Bar-On YM, 2018, P NATL ACAD SCI USA, V115, P6506, DOI 10.1073/pnas.1711842115.
   Bastiaanssen TFS, 2020, HARVARD REV PSYCHIAT, V28, P26, DOI 10.1097/HRP.0000000000000243.
   Bello MGD, 2018, SCIENCE, V362, P33, DOI 10.1126/science.aau8816.
   Bernabé KJ, 2017, INT J ANTIMICROB AG, V50, P629, DOI 10.1016/j.ijantimicag.2017.07.002.
   Blum WEH, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7090287.
   Bongaarts J, 2019, POPUL DEV REV, V45, P680, DOI 10.1111/padr.12283.
   Border R, 2019, AM J PSYCHIAT, V176, P376, DOI 10.1176/appi.ajp.2018.18070881.
   Camp JG, 2014, GENOME RES, V24, P1504, DOI 10.1101/gr.165845.113.
   Cantorna MT, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01772.
   Caragata EP, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007443.
   Carmody RN, 2015, CELL HOST MICROBE, V17, P72, DOI 10.1016/j.chom.2014.11.010.
   Caulfield T., PROBLEM PERSONALISED.
   Cavicchioli R, 2019, NAT REV MICROBIOL, V17, P569, DOI 10.1038/s41579-019-0222-5.
   Cebra JJ, 1999, AM J CLIN NUTR, V69, p1046S, DOI 10.1093/ajcn/69.5.1046s.
   Chaplin-Kramer R, 2019, SCIENCE, V366, P255, DOI 10.1126/science.aaw3372.
   Chen YZ, 2018, J EXP MED, V215, P1397, DOI 10.1084/jem.20171761.
   Chiu L., 2020, PHENOTYPIC SWITCHING.
   Chiu L, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01678.
   Chiu L, 2015, BIOSEMIOTICS-NETH, V8, P191, DOI 10.1007/s12304-015-9232-5.
   Chlids B., 2003, GENETIC MED LOGIC DI.
   Chowdhary A, 2016, J HOSP INFECT, V94, P209, DOI 10.1016/j.jhin.2016.08.004.
   Chowdhary A, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006290.
   Clemente JC, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500183.
   Collignon P, 2018, LANCET PLANET HEALTH, V2, pE398, DOI 10.1016/S2542-5196(18)30186-4.
   Cooper R, 2020, ISSUES SCI TECHNOL, V36, P64.
   Cordero D, 2004, J CLIN INVEST, V114, P485, DOI 10.1172/JCI200419596.
   Costello EK, 2012, SCIENCE, V336, P1255, DOI 10.1126/science.1224203.
   Coulibaly YI, 2009, NEW ENGL J MED, V361, P1448, DOI 10.1056/NEJMoa0900863.
   Crabtree B, 2007, BIOCHEMISTRY-US, V46, P2431, DOI 10.1021/bi062158n.
   Crosby A. W., 1972, The Columbian Exchange Biological Consequences of 1492.
   Cryan JF, 2020, LANCET NEUROL, V19, P179, DOI 10.1016/S1474-4422(19)30356-4.
   Cryan JF, 2019, PHYSIOL REV, V99, P1877, DOI 10.1152/physrev.00018.2018.
   De Kruif Paul., 1926, MICROBE HUNTERS.
   De Vadder Filipe, 2018, Proc Natl Acad Sci U S A, V115, P6458, DOI 10.1073/pnas.1720017115.
   Nagar SD, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00241.
   Dempsey PP, 2014, BMC FAM PRACT, V15, DOI 10.1186/s12875-014-0194-5.
   Desbonnet L, 2014, MOL PSYCHIATR, V19, P146, DOI 10.1038/mp.2013.65.
   Desbonnet L, 2010, NEUROSCIENCE, V170, P1179, DOI 10.1016/j.neuroscience.2010.08.005.
   Dey P, 2019, PHARMACOL RES, V147, DOI 10.1016/j.phrs.2019.104367.
   Eberl G, 2010, MUCOSAL IMMUNOL, V3, P450, DOI 10.1038/mi.2010.20.
   Ellul Jacques., 1964, TECHNOLOGICAL SOC.
   Ennamorati M, 2020, P NATL ACAD SCI USA, V117, P2570, DOI 10.1073/pnas.1915047117.
   Essack SY, 2018, LANCET PLANET HEALTH, V2, pE238, DOI 10.1016/S2542-5196(18)30124-4.
   Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110.
   Feyerabend P., 1991, 3 DIALOGUES KNOWLEDG.
   Baizabal-Carvallo JF, 2020, NEUROSCIENCE, V432, P160, DOI 10.1016/j.neuroscience.2020.02.030.
   Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947.
   Fletcher S, 2015, ENVIRON HEALTH PREV, V20, P243, DOI 10.1007/s12199-015-0468-0.
   Forsberg KJ, 2018, CURR BIOL, V28, pR361, DOI 10.1016/j.cub.2018.02.053.
   Forsberg KJ, 2012, SCIENCE, V337, P1107, DOI 10.1126/science.1220761.
   Frazao N, 2019, P NATL ACAD SCI USA, V116, P17906, DOI 10.1073/pnas.1906958116.
   FREIREMAIA N, 1975, HUM HERED, V25, P302, DOI 10.1159/000152739.
   Friese C, 2017, CRIT PUBLIC HEALTH, V27, P303, DOI 10.1080/09581596.2017.1294246.
   Funkhouser LJ, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001631.
   Gibbs EPJ, 2014, VET REC, V174, P85, DOI 10.1136/vr.g143.
   Gilbert S., 2018, ORG J BIOL SCI, V2, P43, DOI {[}10.13133/2532-5876\_3.11, DOI 10.13133/2532-5876\_3.11].
   Gilbert S.F., 2015, Ecological developmental biology: the environmental regulation of development, health, and evolution.
   Gilbert SF, 2020, EVOL DEV, V22, P154, DOI 10.1111/ede.12291.
   Gilbert SF, 2012, Q REV BIOL, V87, P325, DOI 10.1086/668166.
   Gillings MR, 2014, ANTHROPOCENE, V5, P1, DOI 10.1016/j.ancene.2014.06.004.
   Gillings MR, 2012, TRENDS ECOL EVOL, V27, P346, DOI 10.1016/j.tree.2012.02.006.
   GODLEE F, 2018, BMJ-BRIT MED J, V362, DOI DOI 10.1136/bmj.k3020.
   Green RC, 2008, NEW ENGL J MED, V359, P2192, DOI 10.1056/NEJMp0808100.
   Hanski I, 2012, P NATL ACAD SCI USA, V109, P8334, DOI 10.1073/pnas.1205624109.
   Haraway D, 2016, ETHNOS, V81, P535, DOI 10.1080/00141844.2015.1105838.
   Haraway D, 2015, ENVIRON HUMANITIES, V6, P159, DOI 10.1215/22011919-3615934.
   Harmsen HJM, 2000, J PEDIATR GASTR NUTR, V30, P61, DOI 10.1097/00005176-200001000-00019.
   Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108.
   Hill JH, 2016, ELIFE, V5, DOI 10.7554/eLife.20145.
   Hoegh-Guldberg O., 2015, Reviving the Ocean Economy: The Case for Action 2015.
   Hoerauf A, 2003, MICROBES INFECT, V5, P261, DOI 10.1016/S1286-4579(03)00026-1.
   Högberg LD, 2010, TRENDS PHARMACOL SCI, V31, P509, DOI 10.1016/j.tips.2010.08.002.
   Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881.
   Hughes TP, 2018, NATURE, V556, P492, DOI 10.1038/s41586-018-0041-2.
   Hughes TP, 2017, NATURE, V543, P373, DOI 10.1038/nature21707.
   Hussein IH, 2015, FRONT PUBLIC HEALTH, V3, DOI 10.3389/fpubh.2015.00269.
   Imai Y, 2019, NATURE, V576, P459, DOI 10.1038/s41586-019-1791-1.
   INED, LIF EXP FRANC.
   Ishaq SL, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000536.
   Jackson A, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01245.
   Jenny R., 2017, POSTGENOMIC CONDITIO.
   Kamenshchikova A, 2021, CRIT PUBLIC HEALTH, V31, P306, DOI 10.1080/09581596.2019.1684442.
   Kapoor R, 2016, EUR J HUM GENET, V24, P1651, DOI 10.1038/ejhg.2016.114.
   Kee F, 2020, J EPIDEMIOL COMMUN H, V74, P311, DOI 10.1136/jech-2019-213311.
   Kelly AH, 2011, BIOSOCIETIES, V6, P71, DOI 10.1057/biosoc.2010.42.
   Kenney M, 2020, MED HUMANIT, V46, P192, DOI 10.1136/medhum-2018-011597.
   Khan MS, 2018, LANCET PLANET HEALTH, V2, pE264, DOI 10.1016/S2542-5196(18)30084-6.
   Khoury MJ, 2018, GENET MED, V20, P574, DOI 10.1038/gim.2017.211.
   Khoury MJ, 2018, PUBLIC HEALTH GENOM, V21, P244, DOI 10.1159/000501465.
   Kimura I, 2020, SCIENCE, V367, P1002, DOI 10.1126/science.aaw8429.
   Kirjavainen PV, 2019, NAT MED, V25, P1089, DOI 10.1038/s41591-019-0469-4.
   Klein EY, 2018, P NATL ACAD SCI USA, V115, pE3463, DOI 10.1073/pnas.1717295115.
   Kokkoris V, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02420.
   Kokkoris V, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221037.
   Krusche J, 2019, J ALLERGY CLIN IMMUN, V144, P1684, DOI 10.1016/j.jaci.2019.07.029.
   Landecker H, 2016, BODY SOC, V22, P19, DOI 10.1177/1357034X14561341.
   Landmann F, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002351.
   Larsson DGJ, 2018, ENVIRON INT, V117, P132, DOI 10.1016/j.envint.2018.04.041.
   Latour B., 1993, WE HAVE NEVER BEEN M.
   Latour B., 1988, PASTERURIZATION FRAN.
   Latour B, 2019, CRIT INQUIRY, V45, P659, DOI 10.1086/702611.
   Lee YK, 2010, SCIENCE, V330, P1768, DOI 10.1126/science.1195568.
   LeValley SL, 2020, MSPHERE, V5, DOI 10.1128/mSphere.00585-19.
   Lopez-Vazquez P, 2012, J EVAL CLIN PRACT, V18, P473, DOI 10.1111/j.1365-2753.2010.01610.x.
   Mancabelli L, 2017, ENVIRON MICROBIOL, V19, P1379, DOI 10.1111/1462-2920.13692.
   Margulis Lynn., 1997, SLANTED TRUTHS ESSAY.
   Marin IA, 2017, SCI REP-UK, V7, DOI 10.1038/srep43859.
   Martín-Robles N, 2018, NEW PHYTOL, V218, P322, DOI 10.1111/nph.14962.
   McDermott A, 2020, P NATL ACAD SCI USA, V117, P2232, DOI 10.1073/pnas.1921846117.
   McFall-Ngai M, 2013, P NATL ACAD SCI USA, V110, P3229, DOI 10.1073/pnas.1218525110.
   McKibben B., 2006, END NATURE.
   McNeill W. H., 1976, Plagues and peoples..
   Meek RW, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002266.
   Mills JG, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00550.
   Min L., BOOMERANG PROJECT DE.
   Mitman Gregg., Reflections on the Plantationocene: A Conversation with Donna Haraway and Anna Tsing.
   Mor N., GUT MICROBES ARE CRI.
   Moraïs S, 2019, TRENDS MICROBIOL, V27, P538, DOI 10.1016/j.tim.2018.12.011.
   Morton A., GREAT BARRIER REEFS.
   MUSCATINE L, 1984, PROC R SOC SER B-BIO, V222, P181, DOI 10.1098/rspb.1984.0058.
   National Institutes of Health, {*}{*}NON-TRADITIONAL{*}{*}.
   Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813.
   Nijhout HF, 1997, AM NAT, V149, P394, DOI 10.1086/285996.
   Obata Y, 2020, NATURE, V578, P284, DOI 10.1038/s41586-020-1975-8.
   Office of Science (OS) Office of Genomics and Precision Public Health, OFF GEN PREC PUBL HT.
   ONeill J, 2016, Review on Antimicrobial Resistance.
   Park K, 2006, ISIS, V97, P487, DOI 10.1086/508078.
   Patterson AD, 2014, CELL METAB, V20, P761, DOI 10.1016/j.cmet.2014.07.002.
   Pazoki R, 2018, CIRCULATION, V137, P653, DOI 10.1161/CIRCULATIONAHA.117.030898.
   Pennisi E., 2019, SCIENCE, DOI {[}10.1126/science.aay7095, DOI 10.1126/SCIENCE.AAY7095].
   Pradeau T., 2012, The Limits of the Self: Immunology and Biological Identity.
   Pradeu T, 2019, ELEM PHIL BIOL, P1, DOI 10.1017/9781108616706.
   Pradeu T, 2016, STUD HIST PHI PART C, V59, P80, DOI 10.1016/j.shpsc.2016.02.007.
   Rabinowitz PM, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-001137.
   Raulff Ulrich., 2018, Farewell to the Horse: A Cultural History.
   Rea K, 2020, NEUROPSYCHOBIOLOGY, V79, P50, DOI 10.1159/000504495.
   Reshef L, 2006, ENVIRON MICROBIOL, V8, P2068, DOI 10.1111/j.1462-2920.2006.01148.x.
   Rhee KJ, 2004, J IMMUNOL, V172, P1118, DOI 10.4049/jimmunol.172.2.1118.
   Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214.
   Ripple WJ, 2017, BIOSCIENCE, V67, P1026, DOI 10.1093/biosci/bix125.
   Robinson TP, 2016, T ROY SOC TROP MED H, V110, P377, DOI 10.1093/trstmh/trw048.
   Rodrigues AT, 2013, INT J ANTIMICROB AG, V41, P203, DOI 10.1016/j.ijantimicag.2012.09.003.
   Romero L.S., SCI LINK OUTBREAKS S.
   Roossinck MJ, 2017, ANNU REV VIROL, V4, P123, DOI 10.1146/annurev-virology-110615-042323.
   Roossinck MJ, 2015, J VIROL, V89, P6532, DOI 10.1128/JVI.02974-14.
   Rose D.B., 2017, Arts of Living on Damaged Planet: Ghosts and Monsters of the Anthropocene, P51.
   Rosenberg E, 2019, RAMBAM MAIMONIDES ME, V10, DOI 10.5041/RMMJ.10359.
   Rosenberg E, 2016, MBIO, V7, DOI 10.1128/mBio.01395-15.
   Rosenberg E, 2011, BIRTH DEFECTS RES C, V93, P56, DOI 10.1002/bdrc.20196.
   Roussi A, 2020, NATURE, V579, P330, DOI 10.1038/d41586-020-00725-x.
   Ruokolainen L, 2017, CLIN EXP ALLERGY, V47, P665, DOI 10.1111/cea.12895.
   Ryan FP, 2004, J ROY SOC MED, V97, P560, DOI 10.1258/jrsm.97.12.560.
   Sampson TR, 2015, CELL HOST MICROBE, V17, P565, DOI 10.1016/j.chom.2015.04.011.
   Schnorr SL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4654.
   Scott KA, 2017, BRAIN BEHAV IMMUN, V65, P20, DOI 10.1016/j.bbi.2017.02.004.
   Servick K, 2019, SCIENCE, V366, P1056, DOI 10.1126/science.366.6469.1056.
   Sgritta M, 2019, NEURON, V101, P246, DOI 10.1016/j.neuron.2018.11.018.
   Shao Y, 2019, NATURE, V574, P117, DOI 10.1038/s41586-019-1560-1.
   Sharon G, 2019, CELL, V177, P1600, DOI 10.1016/j.cell.2019.05.004.
   Singer AC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01728.
   Sinha SR, 2020, CELL HOST MICROBE, V27, P659, DOI 10.1016/j.chom.2020.01.021.
   Smith MI, 2013, SCIENCE, V339, P548, DOI 10.1126/science.1229000.
   Song XY, 2020, NATURE, V577, P410, DOI 10.1038/s41586-019-1865-0.
   Stappenbeck TS, 2002, P NATL ACAD SCI USA, V99, P15451, DOI 10.1073/pnas.202604299.
   Stein MM, 2016, NEW ENGL J MED, V375, P411, DOI 10.1056/NEJMoa1508749.
   Stilling RM, 2018, ELIFE, V7, DOI 10.7554/eLife.33070.
   Sun JH, 2013, ANNU REV ENTOMOL, V58, P293, DOI 10.1146/annurev-ento-120811-153624.
   Svoboda E, 2020, NATURE, V577, pS14, DOI 10.1038/d41586-020-00198-y.
   Taerum SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078126.
   Tauber Alfred, 2016, STANFORD ENCY PHILOS.
   Tauber AI, 2008, PHILOS SCI, V75, P224, DOI 10.1086/590200.
   Tauber AlfredI., 2017, IMMUNITY EVOLUTION I.
   Theis KR, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00028-16.
   Pham TPT, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45611-3.
   Tian L, 2019, RICE, V12, DOI 10.1186/s12284-019-0287-9.
   Trinh P, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00235.
   Turroni S, 2016, SCI REP-UK, V6, DOI 10.1038/srep32826.
   United Nations, 2019, REPORT SECRETARY GEN, DOI DOI 10.1017/S0305004100015644.
   Vågene ÅJ, 2018, NAT ECOL EVOL, V2, P520, DOI 10.1038/s41559-017-0446-6.
   Valles-Colomer M, 2019, NAT MICROBIOL, V4, P623, DOI 10.1038/s41564-018-0337-x.
   Van Boeckel TP, 2014, LANCET INFECT DIS, V14, P742, DOI 10.1016/S1473-3099(14)70780-7.
   van Bruggen AHC, 2019, SCI TOTAL ENVIRON, V664, P927, DOI 10.1016/j.scitotenv.2019.02.091.
   van de Guchte M, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0466-8.
   van de Wouw M, 2019, ACS CHEM NEUROSCI, V10, P3953, DOI 10.1021/acschemneuro.9b00414.
   van Staden C, 2020, NAT HUM BEHAV, V4, P443, DOI 10.1038/s41562-020-0852-7.
   Viaud S, 2014, CANCER RES, V74, P4217, DOI 10.1158/0008-5472.CAN-14-0987.
   Viaud S, 2013, SCIENCE, V342, P971, DOI 10.1126/science.1240537.
   Wampach L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07631-x.
   Wesemann DR, 2013, NATURE, V501, DOI 10.1038/nature12496.
   West-Eberhard MJ, 2019, P NATL ACAD SCI USA, V116, P723, DOI 10.1073/pnas.1809046116.
   Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884.
   Whitmee S, 2015, LANCET, V386, P1973, DOI 10.1016/S0140-6736(15)60901-1.
   WHO, 2014, ANT RES GLOB REP SUR.
   Willis LD, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2019-001590.
   Wolf U, 1997, HUM GENET, V100, P305, DOI 10.1007/s004390050509.
   WOLF U, 1995, HUM GENET, V95, P127.
   Wong Matthew C, 2020, bioRxiv, DOI 10.1101/2020.02.07.939207.
   Wooldridge SA, 2009, MAR FRESHWATER RES, V60, P483, DOI 10.1071/MF08251.
   Xu LT, 2016, INSECT SCI, V23, P183, DOI 10.1111/1744-7917.12255.
   Yang J, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2018.8341.
   Yano JM, 2015, CELL, V161, P264, DOI 10.1016/j.cell.2015.02.047.
   Zhang T, 2020, CURR BIOL, V30, P1346, DOI 10.1016/j.cub.2020.03.022.
   Zhu YG, 2017, SCIENCE, V357, P1099, DOI 10.1126/science.aao3007.
   Zivkovic AM, 2011, P NATL ACAD SCI USA, V108, P4653, DOI 10.1073/pnas.1000083107.},
Number-of-Cited-References = {212},
Times-Cited = {19},
Unique-ID = {WOS:000540222300127},
}

@article{ WOS:000454618600001,
Author = {Prosperi, Mattia and Min, Jae S. and Bian, Jiang and Modave, Francois},
Title = {Big data hurdles in precision medicine and precision public health},
Journal = {BMC MEDICAL INFORMATICS AND DECISION MAKING},
Year = {2018},
Volume = {18},
Month = {DEC 29},
Abstract = {BackgroundNowadays, trendy research in biomedical sciences juxtaposes
   the term precision' to medicine and public health with companion words
   like big data, data science, and deep learning. Technological
   advancements permit the collection and merging of large heterogeneous
   datasets from different sources, from genome sequences to social media
   posts or from electronic health records to wearables. Additionally,
   complex algorithms supported by high-performance computing allow one to
   transform these large datasets into knowledge. Despite such progress,
   many barriers still exist against achieving precision medicine and
   precision public health interventions for the benefit of the individual
   and the population.Main bodyThe present work focuses on analyzing both
   the technical and societal hurdles related to the development of
   prediction models of health risks, diagnoses and outcomes from
   integrated biomedical databases. Methodological challenges that need to
   be addressed include improving semantics of study designs: medical
   record data are inherently biased, and even the most advanced deep
   learning's denoising autoencoders cannot overcome the bias if not
   handled a priori by design. Societal challenges to face include
   evaluation of ethically actionable risk factors at the individual and
   population level; for instance, usage of gender, race, or ethnicity as
   risk modifiers, not as biological variables, could be replaced by
   modifiable environmental proxies such as lifestyle and dietary habits,
   household income, or access to educational resources.ConclusionsData
   science for precision medicine and public health warrants an
   informatics-oriented formalization of the study design and
   interoperability throughout all levels of the knowledge inference
   process, from the research semantics, to model development, and
   ultimately to implementation.},
Type = {Article},
Affiliation = {Prosperi, M (Corresponding Author), Univ Florida, Coll Med, Dept Epidemiol, Gainesville, FL 32610 USA.
   Prosperi, M (Corresponding Author), Univ Florida, Coll Publ Hlth \& Hlth Profess, Gainesville, FL 32610 USA.
   Prosperi, Mattia; Min, Jae S., Univ Florida, Coll Med, Dept Epidemiol, Gainesville, FL 32610 USA.
   Prosperi, Mattia; Min, Jae S., Univ Florida, Coll Publ Hlth \& Hlth Profess, Gainesville, FL 32610 USA.
   Bian, Jiang, Univ Florida, Coll Med, Dept Hlth Outcomes \& Biomed Informat, Gainesville, FL 32610 USA.
   Modave, Francois, Loyola Univ Chicago, Ctr Hlth Outcomes \& Informat Res, Maywood, IL 60153 USA.},
DOI = {10.1186/s12911-018-0719-2},
Article-Number = {139},
Keywords-Plus = {SEMANTIC INTEROPERABILITY; WIDE ASSOCIATION; DISEASE; PREDICTION;
   INTERNET; THINGS; CARE; RANDOMIZATION; ALZHEIMERS; MORTALITY},
Research-Areas = {Medical Informatics},
Web-of-Science-Categories  = {Medical Informatics},
Author-Email = {m.prosperi@ufl.edu},
Affiliations = {State University System of Florida; University of Florida; State
   University System of Florida; University of Florida; State University
   System of Florida; University of Florida; Loyola University Chicago},
Cited-References = {Adams SA, 2016, J AM MED INFORM ASSN, V23, P787, DOI 10.1093/jamia/ocv215.
   Angwin Julia, 2016, PROPUBLICA.
   {[}Anonymous], 2018, NAT BIOTECHNOL, V36, P205, DOI 10.1038/nbt.4107.
   Arking D, 2015, CURR OPIN GENET DEV, V33, P77, DOI 10.1016/j.gde.2015.10.001.
   Arvanitis TN, 2014, STUD HEALTH TECHNOL, V202, P5, DOI 10.3233/978-1-61499-423-7-5.
   Barker RW, 2017, PERS MED, V14, P459, DOI 10.2217/pme-2017-0060.
   Belhajjame K, 2015, J WEB SEMANT, V32, P16, DOI 10.1016/j.websem.2015.01.003.
   Bersanelli M, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-015-0857-9.
   Bhatt M, 2009, J WEB SEMANT, V7, P317, DOI 10.1016/j.websem.2009.05.004.
   Bizouarn P, 2012, REV EPIDEMIOL SANTE, V60, P59, DOI 10.1016/j.respe.2011.08.067.
   Bourzac K, 2016, NATURE, V537, pS66, DOI 10.1038/537S66a.
   Buchan I., 2009, The fourth paradigm: data-intensive scientific discovery, P91.
   Butler D, 2013, NATURE, V494, P155, DOI 10.1038/494155a.
   Cargnin S, 2014, PHARMACOGENOMICS, V15, P963, DOI 10.2217/pgs.14.52.
   Castrillo JI, 2016, METHODS MOL BIOL, V1303, P3, DOI 10.1007/978-1-4939-2627-5\_1.
   Choi Edward, 2016, JMLR Workshop Conf Proc, V56, P301.
   Codina L, 2011, PROF INFORM, V20, P555, DOI 10.3145/epi.2011.sep.10.
   Collins GS, 2015, ANN INTERN MED, V162, P735, DOI 10.7326/L15-5093-2.
   Cusanovich DA, 2016, HUM MOL GENET, V25, P2104, DOI 10.1093/hmg/ddw061.
   Custovic A, 2015, THORAX, V70, P799, DOI 10.1136/thoraxjnl-2015-206781.
   de Vlaming R, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006495.
   Dean K, 2017, BIODRUGS, V31, P393, DOI 10.1007/s40259-017-0242-5.
   Delude CM, 2015, NATURE, V527, pS14, DOI 10.1038/527S14a.
   Denny JC, 2016, ANNU REV GENOM HUM G, V17, P353, DOI 10.1146/annurev-genom-090314-024956.
   Dentler Kathrin, 2013, Process Support and Knowledge Representation in Health Care. BPM 2012 Joint Workshop. ProHealth 2012/KR4HC 2012. Revised Selected Papers, P85, DOI 10.1007/978-3-642-36438-9\_6.
   Dettling M, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r88.
   Dwork C, 2013, FOUND TRENDS THEOR C, V9, P211, DOI 10.1561/0400000042.
   Dwyer-Lindgren L, 2017, JAMA INTERN MED, V177, P1003, DOI 10.1001/jamainternmed.2017.0918.
   Ebadi H, 2015, ACM SIGPLAN NOTICES, V50, P69, DOI {[}10.1145/2676726.2677005, 10.1145/2775051.2677005].
   Eysenbach G, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1157.
   Feero WG, 2018, JAMA-J AM MED ASSOC, V319, P1979, DOI 10.1001/jama.2018.2925.
   Flanagan JM, 2015, METHODS MOL BIOL, V1238, P51, DOI 10.1007/978-1-4939-1804-1\_3.
   Fraccaro P, 2015, BMC OPHTHALMOL, V15, DOI 10.1186/1471-2415-15-10.
   Gilbert JA, 2016, NATURE, V535, P94, DOI 10.1038/nature18850.
   Gligorijevic V, 2016, PROTEOMICS, V16, P741, DOI 10.1002/pmic.201500396.
   Golding N, 2017, LANCET, V390, P2171, DOI 10.1016/S0140-6736(17)31758-0.
   Gottlieb Laura M, 2018, Perm J, V22, P18, DOI 10.7812/TPP/18-078.
   Graim K, 2017, BMC MED GENOMICS, V10, DOI 10.1186/s12920-017-0256-3.
   Gruska DP, 2016, FUND INFORM, V143, P73, DOI 10.3233/FI-2016-1304.
   Harris PA, 2012, ACAD MED, V87, P66, DOI 10.1097/ACM.0b013e31823ab7d2.
   Hasin Y, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1215-1.
   He Z, 2015, ARTIF INTELL MED, V64, P29, DOI 10.1016/j.artmed.2015.03.002.
   Holmberg C, 2016, APPETITE, V99, P121, DOI 10.1016/j.appet.2016.01.009.
   Hripcsak G, 2015, STUD HEALTH TECHNOL, V216, P574, DOI 10.3233/978-1-61499-564-7-574.
   Huang B, 2014, EPIGENOMICS-UK, V6, P73, DOI 10.2217/epi.13.72.
   Huang J, 2016, FRONT GENET, V7, DOI {[}10.3389/fgene.2016.00084, 10.3389/fgene.2017.00084].
   Hussain-Gambles M, 2004, HEALTH SOC CARE COMM, V12, P382, DOI 10.1111/j.1365-2524.2004.00507.x.
   Jain SH, 2015, NAT BIOTECHNOL, V33, P462, DOI 10.1038/nbt.3223.
   Jameson JL, 2015, NEW ENGL J MED, V372, P2229, DOI 10.1056/NEJMsb1503104.
   Khoury MJ, 2018, GENET MED, V20, P574, DOI 10.1038/gim.2017.211.
   Khoury MJ, 2016, JAMA-J AM MED ASSOC, V316, P1357, DOI 10.1001/jama.2016.12260.
   Kim JH, 2014, HEALTHC INFORM RES, V20, P1, DOI 10.4258/hir.2014.20.1.1.
   Knight W., MIT TECHNOLOGY REV.
   Kohane IS, 2015, SCIENCE, V349, P37, DOI 10.1126/science.aab1328.
   Kohane IS, 2014, GENOME BIOL, V15, DOI 10.1186/gb4175.
   Krause J, 2016, 34TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, CHI 2016, P5686, DOI 10.1145/2858036.2858529.
   Krier J, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0272-5.
   Lade SJ, 2017, NAT RESOUR MODEL, V30, DOI 10.1111/nrm.12129.
   Landers RN, 2016, PSYCHOL METHODS, V21, P475, DOI 10.1037/met0000081.
   Laney D., 2001, META group research note, V6, P1, DOI DOI 10.1016/J.INFS0F.2008.09.005.
   Lazer D, 2014, SCIENCE, V343, P1203, DOI 10.1126/science.1248506.
   Lin C, 2016, J MED SYST, V40, DOI 10.1007/s10916-016-0446-0.
   Liu Katherine A., 2016, Pharmacy Pract (Granada), V14.
   Liyanage Harshana, 2015, J Innov Health Inform, V22, P309, DOI 10.14236/jhi.v22i2.159.
   Maniadi E, 2013, IEEE INT C BIOINF BI, DOI 10.1109/bibe.2013.6701560.
   Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494.
   Marco-Ruiz L, 2015, STUD HEALTH TECHNOL, V216, P958, DOI 10.3233/978-1-61499-564-7-958.
   Matney Susan A, 2016, Nursing, V46, P23, DOI 10.1097/01.NURSE.0000490225.92179.69.
   Mensaert K, 2014, ENVIRON MOL MUTAGEN, V55, P155, DOI 10.1002/em.21841.
   Miotto R, 2016, SCI REP-UK, V6, DOI 10.1038/srep26094.
   Moreno-Conde A, 2015, J AM MED INFORM ASSN, V22, P925, DOI 10.1093/jamia/ocv008.
   Naveed M, 2015, ACM COMPUT SURV, V48, DOI 10.1145/2767007.
   Ned Mmsc Phd Renee M, 2010, PLoS Curr, V2, DOI 10.1371/currents.RRN1180.
   Noy NF, 2004, SIGMOD REC, V33, P65, DOI 10.1145/1041410.1041421.
   Olden JD, 2002, ECOL MODEL, V154, P135, DOI 10.1016/S0304-3800(02)00064-9.
   Overhage JM, 2012, J AM MED INFORM ASSN, V19, P54, DOI 10.1136/amiajnl-2011-000376.
   Patel CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010746.
   Paternoster L, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006944.
   Pirracchio R, 2015, LANCET RESP MED, V3, P42, DOI 10.1016/S2213-2600(14)70239-5.
   Rajkomar A, 2018, NPJ DIGIT MED, V1, DOI 10.1038/s41746-018-0029-1.
   Reading MJ, 2018, J AM MED INFORM ASSN, V25, P759, DOI 10.1093/jamia/ocy006.
   Reece AG, 2017, EPJ DATA SCI, V6, DOI 10.1140/epjds/s13688-017-0110-z.
   Rehm HL, 2017, NAT REV GENET, V18, P259, DOI 10.1038/nrg.2016.162.
   Ren Y, 2017, SEARCHING JOIN UNPUB.
   Reps JM, 2018, J AM MED INFORM ASSN, V25, P969, DOI 10.1093/jamia/ocy032.
   Robinson PN, 2012, HUM MUTAT, V33, P777, DOI 10.1002/humu.22080.
   Robkin M, 2015, 2015 IEEE SYMPOSIUM ON PRODUCT COMPLIANCE ENGINEERING (ISPCE 2015).
   Schork NJ, 2015, NATURE, V520, P609, DOI 10.1038/520609a.
   Schroeder SA, 2007, NEW ENGL J MED, V357, P1221, DOI 10.1056/NEJMsa073350.
   Shickel B, 2018, IEEE J BIOMED HEALTH, V22, P1589, DOI 10.1109/JBHI.2017.2767063.
   Showell C, 2016, STUD HEALTH TECHNOL, V221, P31, DOI 10.3233/978-1-61499-633-0-31.
   Sieverink F, 2016, STUD HEALTH TECHNOL, V221, P129, DOI 10.3233/978-1-61499-633-0-129.
   Skeem JL, 2016, CRIMINOLOGY, V54, P680, DOI 10.1111/1745-9125.12123.
   Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070.
   SNOMED, CLIN TERMS CT.
   Sparks JA, 2018, ARTHRIT CARE RES, V70, P823, DOI 10.1002/acr.23411.
   Strobl C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-25.
   Suárez A, 1999, IEEE T PATTERN ANAL, V21, P1297, DOI 10.1109/34.817409.
   Vaithinathan Asokan G, 2017, J Evid Based Med, V10, P76, DOI 10.1111/jebm.12239.
   van der Laan MJ, 2007, STAT APPL GENET MOL, V6, DOI 10.2202/1544-6115.1309.
   Vapnik V. N., 2015, Measures of complexity: festschrift for alexey chervonenkis, P11.
   Vassiliou A, 2011, ANN INDIAN ACAD NEUR, V14, P12, DOI 10.4103/0972-2327.78043.
   World health Organization, INT CLASS DIS ICD.
   Wu X, AUTOMATED INFERENCE.
   Yih WK, 2014, NEW ENGL J MED, V370, P503, DOI 10.1056/NEJMoa1303164.
   Zick CD, 2005, HEALTH AFFAIR, V24, P483, DOI 10.1377/hlthaff.24.2.483.},
Number-of-Cited-References = {106},
Times-Cited = {88},
Unique-ID = {WOS:000454618600001},
}

@article{ WOS:000518704600002,
Author = {Meyer, Sarah L.},
Title = {Toward precision public health},
Journal = {JOURNAL OF PUBLIC HEALTH DENTISTRY},
Year = {2020},
Volume = {80},
Number = {1, SI},
Pages = {S7-S13},
Month = {MAR},
Abstract = {Objectives The information in this article is based on a presentation
   given at the American Institute of Dental Public Health's 2018
   Colloquium on Precision Public Health (PPH). A brief introduction to
   precision medicine provides context for PPH. Precision medicine tailors
   treatment and prevention strategies for individual patients based on
   variability of genetic, lifestyle, and environmental factors. An
   overview of PPH with examples of pilot studies with different research
   approaches bridges a discussion on an initiative undertaken by the
   University of Florida to build infrastructure and expertise for PPH
   research.
   Methods PPH use better and more precise data to target disease
   prevention and control in the right population at the right time. To
   facilitate the identification of relevant open access data sources for
   PPH research a ``one-stop{''} shop was created and tested. Case studies
   were conducted to validate the data portal's usefulness in identifying
   at-risk populations.
   Results Details of portal data types, research challenges, and
   university-wide integrated programs are included. Case studies indicated
   that providing a ``one-stop shop{''} of relevant data sources is an
   effective tool to aid researchers in identifying at-risk populations.
   Conclusions Research studies undertaken by University of Florida
   graduate students illustrate how PPH aligns with essential public health
   services including community engagement to reduce disparities in health
   care. Assurance of a competent workforce in PPH research approaches may
   be improved by training new researchers graduating from health science
   programs with knowledge of data and tools. The move toward PPH is in
   early stages and much work lies ahead.},
Type = {Article},
Affiliation = {Meyer, SL (Corresponding Author), Univ Florida Hlth Sci Lib, POB 100206, Gainesville, FL 32610 USA.
   Meyer, Sarah L., Univ Florida Hlth Sci Lib, Lib \& Informat Sci, Gainesville, FL USA.},
DOI = {10.1111/jphd.12315},
Keywords = {precision medicine; precision health; genomics; oral health and data
   analysis},
Keywords-Plus = {BIG DATA; GENOMICS},
Research-Areas = {Dentistry, Oral Surgery \& Medicine; Public, Environmental \&
   Occupational Health},
Web-of-Science-Categories  = {Dentistry, Oral Surgery \& Medicine; Public, Environmental \&
   Occupational Health},
Author-Email = {meyer.sarah@ufl.edu},
Cited-References = {American Dental Association, 2019, EL HLTH REC.
   {[}Anonymous], 2008, PRIOR PERS MED.
   {[}Anonymous], 2018, PUBL HLTH SYST 10 ES.
   Asche CV, 2017, PHARMACOECONOMICS, V35, P759, DOI 10.1007/s40273-017-0513-5.
   Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523.
   Divaris K, 2018, METAGENOMICS EARLY C.
   Divaris Kimon, 2017, Compend Contin Educ Dent, V38, P30.
   Dowell SF, 2016, NATURE, V540, P189, DOI 10.1038/540189a.
   Glick M, 2015, J AM DENT ASSOC, V146, P793, DOI 10.1016/j.adaj.2015.09.002.
   Hall MA, 2014, BIOCOMPUT-PAC SYM, P200.
   Halpin AL, 2017, PRECISION PUBLIC HLT.
   Kalenderian E, 2016, J PUBLIC HEALTH DENT, V76, P152, DOI 10.1111/jphd.12124.
   Kerr J., 2015, ADV SALIVARY DIAGNOS, P83.
   Khoury MJ, 2018, GENET MED, V20, P574, DOI 10.1038/gim.2017.211.
   Khoury MJ, 2016, AM J PREV MED, V50, P398, DOI 10.1016/j.amepre.2015.08.031.
   Khoury MJ, 2014, SCIENCE, V346, P1054, DOI 10.1126/science.aaa2709.
   Manrai AK, 2016, NEW ENGL J MED, V375, P655, DOI 10.1056/NEJMsa1507092.
   National Institutes of Health, NAT I HLTH ALL US RE.
   National Research Council (US) Committee on A Framework for Developing a New Taxonomy of Disease, 2011, SICHUAN BUILD RES.
   Olson MV, 2017, GENOM PROTEOM BIOINF, V15, P3, DOI 10.1016/j.gpb.2017.01.002.
   Popejoy AB, 2016, NATURE, V538, P161, DOI 10.1038/538161a.
   Program N.G.S, 2017, DNA SEQUENCING COSTS.
   Sackett DL., 2000, EVIDENCE BASED MED P, V2nd ed.
   University of California SF, 2016, PREC PUBL HLTH SUMM.
   University of Florida, HEALTHSTREET.
   University of Florida College of Public Health and Health Professions and College of Medicine Department of Epidemiology, 2018 COMM HLTH NEEDS.
   Wilkinson MD, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.18.},
Number-of-Cited-References = {27},
Times-Cited = {5},
Unique-ID = {WOS:000518704600002},
}

@article{ WOS:000553461000001,
Author = {Leguia, Mariana and Vila-Sanjurjo, Anton and Chain, Patrick S. G. and
   Berry, Irina Maljkovic and Jarman, Richard G. and Pollett, Simon},
Title = {Precision Medicine and Precision Public Health in the Era of Pathogen
   Next-Generation Sequencing},
Journal = {JOURNAL OF INFECTIOUS DISEASES},
Year = {2020},
Volume = {221},
Number = {3},
Pages = {S289-S291},
Month = {APR 15},
Abstract = {This brief report serves as an introduction to a supplement of the
   Journal of Infectious Diseases entitled ``Next-Generation Sequencing
   (NGS) Technologies to Advance Global Infectious Disease Research:{''} We
   briefly discuss the history of NGS technologies and describe how the
   techniques developed during the past 40 years have impacted our
   understanding of infectious diseases. Our focus is on the application of
   NGS in the context of pathogen genomics. Beyond obvious clinical and
   public health applications, we also discuss the challenges that still
   remain within this rapidly evolving field.},
Type = {Article},
Affiliation = {Leguia, M (Corresponding Author), Pontificia Univ Catolica Peru PUCP, Lab Genom, Lima, Peru.
   Leguia, Mariana, Pontificia Univ Catolica Peru, Lab Genom, Lima, Peru.
   Vila-Sanjurjo, Anton, Univ A Coruna, Fac Ciencias, Dept Biol Celular \& Mol, La Coruna, Spain.
   Chain, Patrick S. G., Los Alamos Natl Lab, Biosci Div, Los Alamos, NM USA.
   Berry, Irina Maljkovic; Jarman, Richard G.; Pollett, Simon, Walter Reed Army Inst Res, Silver Spring, MD USA.
   Pollett, Simon, Uniformed Serv Univ Hlth Sci, Dept Prevent Med \& Biostat, Bethesda, MD 20814 USA.},
DOI = {10.1093/infdis/jiz424},
Keywords = {infectious diseases; next-generation sequencing; pathogen genomics},
Keywords-Plus = {REAL-TIME; DNA},
Research-Areas = {Immunology; Infectious Diseases; Microbiology},
Web-of-Science-Categories  = {Immunology; Infectious Diseases; Microbiology},
Author-Email = {mariana.leguia@pucp.edu.pe},
Affiliations = {Pontificia Universidad Catolica del Peru; Universidade da Coruna; United
   States Department of Energy (DOE); Los Alamos National Laboratory;
   United States Department of Defense; United States Army; Walter Reed
   Army Institute of Research (WRAIR); Uniformed Services University of the
   Health Sciences - USA},
Cited-References = {Avery OT, 1944, J EXP MED, V79, P137, DOI 10.1084/jem.79.2.137.
   Batty EM, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006566.
   Dahm R, 2005, DEV BIOL, V278, P274, DOI 10.1016/j.ydbio.2004.11.028.
   PROBER JM, 1987, SCIENCE, V238, P336, DOI 10.1126/science.2443975.
   Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996.
   Ronaghi M, 1996, ANAL BIOCHEM, V242, P84, DOI 10.1006/abio.1996.0432.
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463.
   SMITH LM, 1986, NATURE, V321, P674, DOI 10.1038/321674a0.
   WATSON JD, 1953, COLD SPRING HARB SYM, V18, P123, DOI 10.1101/SQB.1953.018.01.020.},
Number-of-Cited-References = {9},
Times-Cited = {5},
Unique-ID = {WOS:000553461000001},
}

@article{ WOS:000768064000001,
Author = {Ribot-Rodriguez, Rosa and Higuera-Gomez, Andrea and San-Cristobal,
   Rodrigo and Martin-Hernandez, Roberto and Mico, Victor and
   Espinosa-Salinas, Isabel and Ramirez de Molina, Ana and Martinez, J.
   Alfredo},
Title = {Cardiometabolic Health Status, Ethnicity and Health-Related Quality of
   Life (HRQoL) Disparities in an Adult Population: NutrIMDEA Observational
   Web-Based Study},
Journal = {INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH},
Year = {2022},
Volume = {19},
Number = {5},
Month = {MAR},
Abstract = {Precision public health supported on online tools is increasingly
   emerging as a potential strategy to achieve health promotion and disease
   prevention. Our aim was to assess the relationships of sociodemographic
   variables, anthropometric data, dietary habits and lifestyle factors
   with health-related quality of life (HRQoL), cardiometabolic health
   status and ethnicity in an online recruited adult population (NutrIMDEA
   Study). NutrIMDEA Study is a web-based cross-sectional survey that
   included 17,333 adults. Self-reported sociodemographic characteristics,
   anthropometric data, clinical and family history of cardiometabolic
   illnesses, dietary habits, lifestyle factors and HRQoL features were
   collected. Diseased individuals showed significative poorer MedDiet and
   worse HRQoL than those in the healthy cardiometabolic status group (p <
   0.05). In comparison, European/Caucasian individuals reported a
   significantly better HRQoL, higher MedDiet and HRQoL values compared
   with those of other ethnicities (p < 0.05). We obtained a total of
   16.8\% who reported poor/fair, 56.5\% good and 26.6\% very
   good/excellent HRQoL. Respondents with very good/excellent HRQoL showed
   lower BMI, greater adherence to a Mediterranean diet (MedDiet) and
   higher physical activity. The results suggest the presence of
   interactions between the mental and physical components of HRQoL with
   obesity, sedentarism and dietary intake, which were dependent on disease
   status and ethnicity. Online HRQoL assessment could contribute to wider
   implementation of precision public health strategies to promote health
   targeted interventions with policy implications to community health
   promotion.},
Type = {Article},
Affiliation = {San-Cristobal, R (Corresponding Author), IMDEA Food Inst Madrid Inst Adv Studies, Precis Nutr \& Cardiometab Hlth, Campus Int Excellence CEI UAM CSIC, Madrid 28049, Spain.
   Ribot-Rodriguez, Rosa; Higuera-Gomez, Andrea; San-Cristobal, Rodrigo; Martin-Hernandez, Roberto; Mico, Victor; Martinez, J. Alfredo, IMDEA Food Inst Madrid Inst Adv Studies, Precis Nutr \& Cardiometab Hlth, Campus Int Excellence CEI UAM CSIC, Madrid 28049, Spain.
   Martin-Hernandez, Roberto, CEI UAM CSIC, Madrid Inst Adv Studies IMDEA Food, Bioinformat \& Biostat Unit, Madrid 28049, Spain.
   Espinosa-Salinas, Isabel, UAM CSIC, Res Inst Food \& Hlth Sci IMDEA Food, Nutr Genom \& Hlth Unit, Madrid 28049, Spain.
   Ramirez de Molina, Ana, UAM CSIC, Res Inst Food \& Hlth Sci IMDEA Food, Mol Oncol Grp, Madrid 28049, Spain.
   Martinez, J. Alfredo, Inst Hlth Carlos III ISCIII, CIBERobn Physiopathol Obes \& Nutr, Madrid 28029, Spain.},
DOI = {10.3390/ijerph19052948},
Article-Number = {2948},
Keywords = {precision nutrition; web-based health surveys; HRQoL; nutrimeter; public
   health},
Keywords-Plus = {BODY-MASS INDEX; PERSONALIZED NUTRITION; MEDITERRANEAN DIET;
   PHYSICAL-ACTIVITY; PARTICIPANTS; MARGIN; ERROR; SF-36; SF-12; AGE},
Research-Areas = {Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health},
Web-of-Science-Categories  = {Environmental Sciences; Public, Environmental \& Occupational Health},
Author-Email = {rosa.rib.rod@gmail.com
   andrea.hg92@gmail.com
   rodrigo.sancristobal@imdea.org
   roberto.martin@imdea.org
   victor.mico@imdea.org
   mariaisabel.espinosa@imdea.org
   ana.ramirez@imdea.org
   jalfredo.martinez@imdea.org},
Affiliations = {IMDEA Food Institute; Consejo Superior de Investigaciones Cientificas
   (CSIC); IMDEA Food Institute; Consejo Superior de Investigaciones
   Cientificas (CSIC); IMDEA Food Institute; IMDEA Food Institute; Consejo
   Superior de Investigaciones Cientificas (CSIC); CIBER - Centro de
   Investigacion Biomedica en Red; CIBEROBN},
Cited-References = {Abd El-Wahab Ekram W, 2019, J Prim Care Community Health, V10, p2150132719882760, DOI 10.1177/2150132719882760.
   Akay A, 2017, J POPUL ECON, V30, P265, DOI 10.1007/s00148-016-0618-8.
   Salinero-Fort MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122318.
   {[}Anonymous], 2018, GLOB REF LIST 100 CO.
   Apple R, 2018, OBES SCI PRACT, V4, P417, DOI 10.1002/osp4.292.
   Ardisson Korat Andres V, 2014, Curr Nutr Rep, V3, P345.
   Arias-Fernández L, 2022, EUR J NUTR, V61, P2365, DOI 10.1007/s00394-022-02808-z.
   Arrospide A, 2019, HEALTH QUAL LIFE OUT, V17, DOI 10.1186/s12955-019-1134-9.
   Bankauskaite V., 2007, METHODOLOGICAL ISSUE, V125-137, P14.
   Bassett DR, 2003, MED SCI SPORT EXER, V35, P1396, DOI 10.1249/01.MSS.0000078923.96621.1D.
   Bhui K, 2008, DIS MANAG HEALTH OUT, V16, P411, DOI 10.2165/0115677-200816060-00006.
   Busutil R, 2017, HEALTH QUAL LIFE OUT, V15, DOI 10.1186/s12955-017-0773-y.
   Celis-Morales C, 2017, INT J EPIDEMIOL, V46, P578, DOI 10.1093/ije/dyw186.
   Corbaton-Anchuelo A., 2018, INT J HYPERTENS, V2018, P1.
   Curtin Lester R, 2012, Vital Health Stat 2, P1.
   Daimiel L, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-59458-6.
   de Cuevillas B, 2019, NUTR HOSP, V36, P862, DOI 10.20960/nh.02532.
   De Oliveira D., 2012, Summa Psicologica UST, V9, P33, DOI DOI 10.18774/448X.2012.9.96.
   FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1.
   Galilea-Zabalza I, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198974.
   García-Conesa MT, 2020, NUTRIENTS, V12, DOI 10.3390/nu12102960.
   Girón P, 2012, CENT EUR J PUBL HEAL, V20, P185, DOI 10.21101/cejph.a3690.
   Godos J, 2019, NUTRIENTS, V11, DOI 10.3390/nu11050981.
   Hagell P, 2017, RES NURS HEALTH, V40, P378, DOI 10.1002/nur.21806.
   Haraldstad K, 2019, QUAL LIFE RES, V28, P2641, DOI 10.1007/s11136-019-02214-9.
   Hu F B, 2001, J Nutr Health Aging, V5, P132.
   Huang YC, 2020, ETHNIC HEALTH, V25, P465, DOI 10.1080/13557858.2018.1432752.
   Huisingh-Scheetz MJ, 2013, QUAL LIFE RES, V22, P1565, DOI 10.1007/s11136-012-0305-5.
   Jacob C.M., 2017, The Importance of a Life Course Approach to Health: Chronic Disease Risk from Preconception through Adolescence and Adulthood, P41.
   James DE, 2015, ASSESS EVAL HIGH EDU, V40, P1123, DOI 10.1080/02602938.2014.972338.
   Jeong M, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17239058.
   Johnson M., 2019, J. Cardiol. Cardiovasc. Sci, V3, P4, DOI {[}10.29245/2578-3025/2019/2.1168, DOI 10.29245/2578-3025/2019/2.1168].
   Khoury MJ, 2018, PUBLIC HEALTH GENOM, V21, P244, DOI 10.1159/000501465.
   Laxy M, 2018, INT J OBESITY, V42, P318, DOI 10.1038/ijo.2017.252.
   Livingstone KM, 2020, BRIT J NUTR, V123, P1396, DOI 10.1017/S0007114520000653.
   Marks L., 2011, A CONCEPT PAPER, P60.
   Martinez J., 2020, Revista EDUCARE-UPEL-IPB-Segunda Nueva Etapa 2.0, V24.
   Martínez-González MA, 2002, NUTR NEUROSCI, V5, P65, DOI 10.1080/10284150290007047.
   Menéndez E, 2016, REV ESP CARDIOL, V69, P572, DOI {[}10.1016/j.rec.2015.11.034, 10.1016/j.recesp.2015.11.036].
   Mindell JS, 2014, J EPIDEMIOL COMMUN H, V68, P1133, DOI 10.1136/jech-2014-203927.
   Ministerio de Sanidad Consumo y Bienestar Social, 2017, ENCUESTA NACL SALUD.
   Napierala J, 2017, DEMOGRAPHY, V54, P285, DOI 10.1007/s13524-016-0545-z.
   Okosun IS, 2013, DIABETES METAB SYND, V7, P154, DOI 10.1016/j.dsx.2013.06.007.
   Pano O, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17113897.
   Patnode CD, 2017, JAMA-J AM MED ASSOC, V318, P175, DOI 10.1001/jama.2017.3303.
   Podadera-Herreros A, 2022, CLIN NUTR, V41, P552, DOI 10.1016/j.clnu.2021.12.041.
   Publications Office of the European Union, 2018, EUR HLTH INT SURV EH, V2018.
   Saboya PP, 2016, REV LAT-AM ENFERM, V24, DOI 10.1590/1518-8345.1573.2848.
   San-Cristobal R, 2015, NUTRIENTS, V7, P9523, DOI 10.3390/nu7115482.
   Saunders TJ, 2020, APPL PHYSIOL NUTR ME, V45, pS197, DOI 10.1139/apnm-2020-0272.
   Sayón-Orea C, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15102104.
   Teh JKL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091328.
   Trichopoulou A, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-112.
   Truthmann J, 2017, HEALTH QUAL LIFE OUT, V15, DOI 10.1186/s12955-017-0688-7.
   Vadiveloo MK., ADV NUTR.
   Vang ZM, 2017, ETHNIC HEALTH, V22, P209, DOI 10.1080/13557858.2016.1246518.
   Vilagut G, 2008, MED CLIN-BARCELONA, V130, P726, DOI 10.1157/13121076.
   Wang Y, 2020, BMC PUBLIC HEALTH, V20, DOI {[}10.1186/s12889-020-08890-4, 10.1186/s12872-020-01568-0, 10.1186/s12870-020-02562-6, 10.1186/s12872-020-01608-9].
   Westergren A, 2014, J NEUROSCI NURS, V46, P34, DOI 10.1097/JNN.0000000000000027.
   Wiklund I, 1990, Scand J Prim Health Care Suppl, V1, P15.
   World Health Organization, 2012, WHOQOL-measuring quality of life|.
   Zhang L, 2014, DIABETES EDUCATOR, V40, P496, DOI 10.1177/0145721714530573.},
Number-of-Cited-References = {62},
Times-Cited = {6},
Unique-ID = {WOS:000768064000001},
}

@article{ WOS:000707545600004,
Author = {Zhou, Yitian and Lauschke, Volker M.},
Title = {Population pharmacogenomics: an update on ethnogeographic differences
   and opportunities for precision public health},
Journal = {HUMAN GENETICS},
Year = {2022},
Volume = {141},
Number = {6, SI},
Pages = {1113-1136},
Month = {JUN},
Abstract = {Both safety and efficacy of medical treatment can vary depending on the
   ethnogeographic background of the patient. One of the reasons underlying
   this variability is differences in pharmacogenetic polymorphisms in
   genes involved in drug disposition, as well as in drug targets.
   Knowledge and appreciation of these differences is thus essential to
   optimize population-stratified care. Here, we provide an extensive
   updated analysis of population pharmacogenomics in ten pharmacokinetic
   genes (CYP2D6, CYP2C19, DPYD, TPMT, NUDT15 and SLC22A1), drug targets
   (CFTR) and genes involved in drug hypersensitivity (HLA-A, HLA-B) or
   drug-induced acute hemolytic anemia (G6PD). Combined, polymorphisms in
   the analyzed genes affect the pharmacology, efficacy or safety of 141
   different drugs and therapeutic regimens. The data reveal pronounced
   differences in the genetic landscape, complexity and variant frequencies
   between ethnogeographic groups. Reduced function alleles of CYP2D6,
   SLC22A1 and CFTR were most prevalent in individuals of European descent,
   whereas DPYD and TPMT deficiencies were most common in Sub-Saharan
   Africa. Oceanian populations showed the highest frequencies of CYP2C19
   loss-of-function alleles while their inferred CYP2D6 activity was among
   the highest worldwide. Frequencies of HLA-B{*}15:02 and HLA-B{*}58:01
   were highest across Asia, which has important implications for the risk
   of severe cutaneous adverse reactions upon treatment with carbamazepine
   and allopurinol. G6PD deficiencies were most frequent in Africa, the
   Middle East and Southeast Asia with pronounced differences in variant
   composition. These variability data provide an important resource to
   inform cost-effectiveness modeling and guide population-specific
   genotyping strategies with the goal of optimizing the implementation of
   precision public health.},
Type = {Review},
Affiliation = {Lauschke, VM (Corresponding Author), Karolinska Inst, Dept Physiol \& Pharmacol, S-17177 Stockholm, Sweden.
   Lauschke, VM (Corresponding Author), Dr Margarete Fischer Bosch Inst Clin Pharmacol, Stuttgart, Germany.
   Zhou, Yitian; Lauschke, Volker M., Karolinska Inst, Dept Physiol \& Pharmacol, S-17177 Stockholm, Sweden.
   Lauschke, Volker M., Dr Margarete Fischer Bosch Inst Clin Pharmacol, Stuttgart, Germany.},
DOI = {10.1007/s00439-021-02385-x},
EarlyAccessDate = {OCT 2021},
Keywords-Plus = {THIOPURINE S-METHYLTRANSFERASE; IMPLEMENTATION CONSORTIUM GUIDELINES;
   DIHYDROPYRIMIDINE DEHYDROGENASE GENE; ADVERSE DRUG-REACTIONS;
   GLUCOSE-6-PHOSPHATE-DEHYDROGENASE G6PD MUTATIONS; FLUOROURACIL PLUS
   LEUCOVORIN; METASTATIC COLORECTAL-CANCER; INFLAMMATORY-BOWEL-DISEASE;
   TOXIC EPIDERMAL NECROLYSIS; CYP2D6 GENE},
Research-Areas = {Genetics \& Heredity},
Web-of-Science-Categories  = {Genetics \& Heredity},
Author-Email = {volker.lauschke@ki.se},
Affiliations = {Karolinska Institutet; Eberhard Karls University of Tubingen; Eberhard
   Karls University Hospital},
Cited-References = {Adehin A., 2017, POL ANN MED, V24, P144, DOI {[}10.1016/j.poamed.2016.06.007, DOI 10.1016/J.POAMED.2016.06.007].
   Agundez JAG, 1997, PHARMACOGENETICS, V7, P337, DOI 10.1097/00008571-199708000-00010.
   Aklillu E, 2002, PHARMACOGENETICS, V12, P375, DOI 10.1097/00008571-200207000-00005.
   Aklillu E, 1996, J PHARMACOL EXP THER, V278, P441.
   Al-Allawi Nasir, 2010, BMC Blood Disord, V10, P6, DOI 10.1186/1471-2326-10-6.
   Albuquerque J, 2013, PERS MED, V10, P709, DOI {[}10.2217/pme.13.56, 10.2217/PME.13.56].
   AlFadhli S, 2005, ARCH PATHOL LAB MED, V129, P1144.
   Ameyaw MM, 1999, HUM MOL GENET, V8, P367, DOI 10.1093/hmg/8.2.367.
   Amstutz U, 2009, PHARMACOGENOMICS, V10, P931, DOI 10.2217/PGS.09.28.
   {[}Anonymous], 2015, Nature, DOI {[}DOI 10.1038/NATURE15393, DOI 10.1038/nature15393].
   Antunes MV, 2012, THER DRUG MONIT, V34, P422, DOI 10.1097/FTD.0b013e318260b46e.
   Arimany-Nardi C, 2015, PHARMACOGENOMICS J, V15, P473, DOI 10.1038/tpj.2015.78.
   Aslam AA, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012040.pub2.
   Assefa A, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2538-4.
   Awandu SS, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2271-z.
   Aydin M, 2005, CELL BIOCHEM FUNCT, V23, P133, DOI 10.1002/cbf.1222.
   Aynacioglu AS, 1999, CLIN PHARMACOL THER, V66, P185, DOI 10.1053/cp.1999.v66.100072001.
   Bahari A, 2010, NUCLEOS NUCLEOT NUCL, V29, P237, DOI 10.1080/15257771003720418.
   Bannister WP, 2008, ANTIVIR THER, V13, P687.
   Beer B, 2011, ANAL BIOANAL CHEM, V400, P2361, DOI 10.1007/s00216-010-4597-4.
   Ben Zeglam H, 2015, LIBYAN J MED, V10, DOI 10.3402/ljm.v10.27053.
   Beutler E, 2002, BLOOD CELL MOL DIS, V28, P93, DOI 10.1006/bcmd.2002.0490.
   BOKKERINK JPM, 1993, BIOCHEM PHARMACOL, V45, P1455, DOI 10.1016/0006-2952(93)90045-X.
   Carano F, 2018, ANN HUM BIOL, V45, P66, DOI 10.1080/03014460.2017.1378368.
   Caudle KE, 2013, CLIN PHARMACOL THER, V94, P640, DOI 10.1038/clpt.2013.172.
   Céspedes-Garro C, 2014, REV BIOL TROP, V62, P1659, DOI 10.15517/rbt.v62i4.12916.
   Chalvam R, 2007, BRIT J HAEMATOL, V136, P512, DOI 10.1111/j.1365-2141.2006.06463.x.
   Chang JG, 2002, PHARMACOGENETICS, V12, P191, DOI 10.1097/00008571-200204000-00003.
   Chao K, 2017, INFLAMM BOWEL DIS, V23, P1592, DOI 10.1097/MIB.0000000000001148.
   Chen LG, 2014, P NATL ACAD SCI USA, V111, P9983, DOI 10.1073/pnas.1314939111.
   Chen LG, 2010, J PHARMACOL EXP THER, V335, P42, DOI 10.1124/jpet.110.170159.
   Cheong HS, 2011, J HUM GENET, V56, P666, DOI 10.1038/jhg.2011.77.
   Chu CS, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2248-y.
   Chung WH, 2004, NATURE, V428, P486, DOI 10.1038/428486a.
   Correia C, 2009, CELL BIOCHEM FUNCT, V27, P251, DOI 10.1002/cbf.1561.
   Crews KR, 2021, CLIN PHARMACOL THER, V110, P888, DOI 10.1002/cpt.2149.
   Dandara C, 2001, EUR J CLIN PHARMACOL, V57, P11, DOI 10.1007/s002280100282.
   De Araujo C, 2006, HAEMATOL-HEMATOL J, V91, P262.
   De Boeck K, 2014, J CYST FIBROS, V13, P403, DOI 10.1016/j.jcf.2013.12.003.
   Dechyotin S, 2021, MEDITERR J HEMATOL I, V13, DOI 10.4084/MJHID.2021.029.
   Devendra R, 2020, INFECT GENET EVOL, V86, DOI 10.1016/j.meegid.2020.104597.
   Dodgen T, 2016, PHARMACOGENOMICS J, V16, P566, DOI 10.1038/tpj.2015.76.
   Dorji PW, 2019, J CLIN PHARM THER, V44, P508, DOI 10.1111/jcpt.12835.
   Drogemöller BI, 2010, PHARMACOGENOMICS, V11, P1095, DOI {[}10.2217/pgs.10.90, 10.2217/PGS.10.90].
   Elraiyah T, 2017, CLIN PHARMACOL THER, V101, P382, DOI 10.1002/cpt.531.
   Ezzeldin Hany, 2004, Clin Colorectal Cancer, V4, P181, DOI 10.3816/CCC.2004.n.018.
   Ferreira GMA, 2020, PHARMACOGENET GENOM, V30, P184, DOI 10.1097/FPC.0000000000000411.
   Friedrich DC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110691.
   Fujikura K, 2015, PHARMACOGENET GENOM, V25, P584, DOI 10.1097/FPC.0000000000000172.
   Fuselli S, 2004, EUR J HUM GENET, V12, P916, DOI 10.1038/sj.ejhg.5201243.
   Gaedigk A, 2017, GENET MED, V19, P69, DOI 10.1038/gim.2016.80.
   GANCZAKOWSKI M, 1995, AM J HUM GENET, V56, P294.
   Ganoci Lana, 2017, Drug Metabolism and Personalized Therapy, V32, P11, DOI 10.1515/dmpt-2016-0024.
   Gawronska-Szklarz B, 2012, EUR J CLIN PHARMACOL, V68, P1267, DOI 10.1007/s00228-012-1252-3.
   Genin E, 2014, PHARMACOGENOMICS J, V14, P281, DOI 10.1038/tpj.2013.40.
   Goetz MP, 2018, CLIN PHARMACOL THER, V103, P770, DOI 10.1002/cpt.1007.
   Goldman A, 2001, CLIN GENET, V59, P37, DOI 10.1034/j.1399-0004.2001.590106.x.
   Rodrigues JCG, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231651.
   Griese EU, 1999, PHARMACOGENETICS, V9, P715, DOI 10.1097/01213011-199912000-00006.
   Hall D, 1999, PHARMACOGENETICS, V9, P591, DOI 10.1097/00008571-199910000-00006.
   Hamdy SI, 2003, BRIT J CLIN PHARMACO, V55, P560, DOI 10.1046/j.1365-2125.2003.01786.x.
   Hamid MMA., 2019, BMJ GLOB HEALTH, V4, pA62, DOI {[}10.1136/bmjgh-2019-EDC.164, DOI 10.1136/BMJGH-2019-EDC.164].
   Hariprakash JM, 2018, PHARMACOGENOMICS, V19, P227, DOI 10.2217/pgs-2017-0101.
   He Y, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-74200-y.
   Helsby NA, 2016, BRIT J CLIN PHARMACO, V82, P1303, DOI 10.1111/bcp.13045.
   Herraez E, 2013, HEPATOLOGY, V58, P1065, DOI 10.1002/hep.26425.
   Hetherington S, 2001, CLIN THER, V23, P1603, DOI 10.1016/S0149-2918(01)80132-6.
   Hiratsuka M, 2000, MUTAT RES-FUND MOL M, V448, P91, DOI 10.1016/S0027-5107(00)00004-X.
   Hoff PM, 2001, J CLIN ONCOL, V19, P2282, DOI 10.1200/JCO.2001.19.8.2282.
   Hon YY, 1999, HUM MOL GENET, V8, P371, DOI 10.1093/hmg/8.2.371.
   Howes RE, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-418.
   Hung SL, 2005, P NATL ACAD SCI USA, V102, P4134, DOI 10.1073/pnas.0409500102.
   Illing PT, 2012, NATURE, V486, P554, DOI 10.1038/nature11147.
   Inamochi H, 1999, J EXP CLIN CANC RES, V18, P417.
   Ingelman-Sundberg M, 2005, PHARMACOGENOMICS J, V5, P6, DOI 10.1038/sj.tpj.6500285.
   Ionova Y, 2020, CTS-CLIN TRANSL SCI, V13, P1298, DOI 10.1111/cts.12830.
   Isaza C, 2003, METHOD FIND EXP CLIN, V25, P423, DOI 10.1358/mf.2003.25.6.769646.
   Isaza CA, 2000, METHOD FIND EXP CLIN, V22, P695, DOI 10.1358/mf.2000.22.9.802286.
   Jaime LKM, 2013, PHARMACOGENOMICS, V14, P261, DOI {[}10.2217/PGS.12.207, 10.2217/pgs.12.207].
   Jalloh A, 2008, J HUM GENET, V53, P675, DOI 10.1007/s10038-008-0294-y.
   Jamornthanyawat N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088605.
   Jarrar Yazun Bashir, 2019, Asian Pac J Cancer Prev, V20, P801.
   Johnson MK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007246.
   Jorge LF, 1999, PHARMACOGENETICS, V9, P217.
   Kaneko A, 1997, LANCET, V349, P921, DOI 10.1016/S0140-6736(05)62696-7.
   Kaneko A, 1999, PHARMACOGENETICS, V9, P581, DOI 10.1097/01213011-199910000-00005.
   Karim H, 2013, BIOCHEM BIOPH RES CO, V437, P280, DOI 10.1016/j.bbrc.2013.06.067.
   Karimi M, 2003, HAEMATOLOGICA, V88, P346.
   Kerem E, 2020, EXPERT OPIN INV DRUG, V29, P1347, DOI 10.1080/13543784.2020.1828862.
   Khalaj Z, 2019, J RES MED SCI, V24, DOI 10.4103/jrms.JRMS\_1076\_18.
   Kham SKY, 2002, J PEDIAT HEMATOL ONC, V24, P353, DOI 10.1097/00043426-200206000-00006.
   Kim HT, 2017, PHARMACOGENET GENOM, V27, P197, DOI 10.1097/FPC.0000000000000274.
   Kohlrausch FB, 2009, PHARMACOGENOMICS, V10, P1457, DOI 10.2217/PGS.09.76.
   Koopmans AB, 2021, TRANSL PSYCHIAT, V11, DOI 10.1038/s41398-020-01129-1.
   Koromina M, 2021, PHARMACOL RES, V173, DOI 10.1016/j.phrs.2021.105904.
   Kounelis F, 2020, HUM MUTAT, V41, P1112, DOI 10.1002/humu.24018.
   Lacombe PS, 1996, DRUGS, V51, P552, DOI 10.2165/00003495-199651040-00004.
   Ladic A, 2016, ACTA CLIN CROAT, V55, P16.
   Langmia IM, 2021, FRONT GENET, V12, DOI 10.3389/fgene.2021.692234.
   Laróvere LE, 2003, ANN CLIN BIOCHEM, V40, P388, DOI 10.1258/000456303766477039.
   Lauschke VM, 2019, PHARMACOL THERAPEUT, V197, P122, DOI 10.1016/j.pharmthera.2019.01.002.
   Lauschke VM, 2018, AAPS J, V20, DOI 10.1208/s12248-017-0161-x.
   Lauschke VM, 2016, PHARMACOGENOMICS, V17, P917, DOI 10.2217/pgs-2016-0023.
   Lazarou J, 1998, JAMA-J AM MED ASSOC, V279, P1200, DOI 10.1001/jama.279.15.1200.
   Lee SS, 2008, CLIN CHIM ACTA, V398, P82, DOI 10.1016/j.cca.2008.08.014.
   LLerena A, 2012, PHARMACOGENOMICS J, V12, P176, DOI 10.1038/tpj.2010.85.
   Loennechen T, 2001, CLIN PHARMACOL THER, V70, P183, DOI 10.1067/mcp.2001.117445.
   Lonjou C, 2008, PHARMACOGENET GENOM, V18, P99, DOI 10.1097/FPC.0b013e3282f3ef9c.
   Luo Huai-Rong, 2004, Am J Pharmacogenomics, V4, P395, DOI 10.2165/00129785-200404060-00006.
   Macek M, 1997, AM J HUM GENET, V60, P1122.
   Mallal S, 2008, NEW ENGL J MED, V358, P568, DOI 10.1056/NEJMoa0706135.
   Masimirembwa C, 1996, BRIT J CLIN PHARMACO, V42, P713, DOI 10.1046/j.1365-2125.1996.00489.x.
   Matsuoka H, 2005, J HUM GENET, V50, P468, DOI 10.1007/s10038-005-0279-z.
   Matsuoka H, 2004, J HUM GENET, V49, P544, DOI 10.1007/s10038-004-0187-7.
   May J, 2000, TROP MED INT HEALTH, V5, P119, DOI 10.1046/j.1365-3156.2000.00529.x.
   McLellan RA, 1997, PHARMACOGENETICS, V7, P187, DOI 10.1097/00008571-199706000-00003.
   McLeod HL, 1999, PHARMACOGENETICS, V9, P773, DOI 10.1097/00008571-199912000-00012.
   Melaouhia S, 2012, CLIN RES HEPATOL GAS, V36, P178, DOI 10.1016/j.clinre.2011.12.001.
   Mesbah-Namin SA, 2002, BRIT J HAEMATOL, V117, P763, DOI 10.1046/j.1365-2141.2002.03483.x.
   Mette L, 2012, PHARMACOGENOMICS, V13, P803, DOI {[}10.2217/PGS.12.52, 10.2217/pgs.12.52].
   Mizzi C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162866.
   Molden E, 2002, CLIN PHARMACOL THER, V72, P333, DOI 10.1067/mcp.2002.127396.
   Moriyama T, 2016, NAT GENET, V48, P367, DOI 10.1038/ng.3508.
   Nkhoma ET, 2009, BLOOD CELL MOL DIS, V42, P267, DOI 10.1016/j.bcmd.2008.12.005.
   Offer SM, 2013, CLIN PHARMACOL THER, V94, P158, DOI 10.1038/clpt.2013.69.
   Ostrov DA, 2012, P NATL ACAD SCI USA, V109, P9959, DOI 10.1073/pnas.1207934109.
   Owusu SK, 2020, J CYST FIBROS, V19, P540, DOI 10.1016/j.jcf.2019.09.007.
   Pavlos R, 2015, ANNU REV MED, V66, P439, DOI 10.1146/annurev-med-050913-022745.
   Pedersen RS, 2005, CLIN PHARMACOL THER, V77, P458, DOI 10.1016/j.clpt.2005.01.014.
   Pernaute-Lau L, 2021, ANTIMICROB AGENTS CH, V65, DOI 10.1128/AAC.00275-21.
   Petrovic J, 2020, EUR J HUM GENET, V28, P88, DOI 10.1038/s41431-019-0480-8.
   Phillips EJ, 2016, BRIT J CLIN PHARMACO, V81, P10, DOI 10.1111/bcp.12749.
   Phompradit P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-368.
   Pimenoff VN, 2012, PHARMACOGENET GENOM, V22, P846, DOI 10.1097/FPC.0b013e32835a3a6d.
   Pirmohamed M, 2004, BMJ-BRIT MED J, V329, P15, DOI 10.1136/bmj.329.7456.15.
   Poppe D, 2006, J IMMUNOL, V176, P640, DOI 10.4049/jimmunol.176.1.640.
   Poulussen FCP, 2019, PHARMACOGENET GENOM, V29, P179, DOI 10.1097/FPC.0000000000000381.
   Doss CGP, 2016, SCI REP-UK, V6, DOI 10.1038/srep37284.
   Qin SY, 2008, GENOMICS, V92, P152, DOI 10.1016/j.ygeno.2008.05.004.
   Qumsieh RY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028943.
   Raida M, 2001, CLIN CANCER RES, V7, P2832.
   Rasmussen JO, 2006, SCAND J CLIN LAB INV, V66, P129, DOI 10.1080/00365510500469702.
   Rehling D, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100568.
   Relling MV, 2011, CLIN PHARMACOL THER, V89, P387, DOI 10.1038/clpt.2010.320.
   Roberts MC, 2021, GENOME MED, V13, DOI 10.1186/s13073-021-00911-0.
   Rossino R, 2006, J CLIN PHARM THER, V31, P283, DOI 10.1111/j.1365-2710.2006.00736.x.
   Russell LE, 2021, DRUG METAB REV, V53, P253, DOI 10.1080/03602532.2021.1909613.
   Sabbagh A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018507.
   Salgueiro N, 2004, GENET MED, V6, P102, DOI 10.1097/01.GIM.0000118061.66602.A5.
   Sanephonasa A, 2021, MALARIA J, V20, DOI 10.1186/s12936-020-03560-7.
   Sathupak S, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-82477-w.
   Satyagraha AW, 2021, PLOS NEGLECT TROP D, V15, DOI 10.1371/journal.pntd.0009610.
   Satyagraha AW, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003602.
   Schaeffeler E, 2004, PHARMACOGENETICS, V14, P407, DOI 10.1097/01.fpc.0000114745.08559.db.
   Schaeffeler E, 2019, GENET MED, V21, P2145, DOI 10.1038/s41436-019-0448-7.
   Schaller L, 2019, HUM GENET, V138, P1359, DOI 10.1007/s00439-019-02081-x.
   Schrijver I, 2016, J MOL DIAGN, V18, P39, DOI 10.1016/j.jmoldx.2015.07.005.
   Schulz JT, 2000, J BURN CARE REHABIL, V21, P199, DOI 10.1097/00004630-200021030-00004.
   Scott SA, 2013, CLIN PHARMACOL THER, V94, P317, DOI 10.1038/clpt.2013.105.
   Scott S, 2007, PHARMACOGENOMICS, V8, P721, DOI 10.2217/14622416.8.7.721.
   Seitz T, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0172-0.
   Serin A, 2012, FORENSIC SCI INT, V222, P332, DOI 10.1016/j.forsciint.2012.07.012.
   Shah Swarup A. V., 2018, Drug Metabolism and Personalized Therapy, V33, P57, DOI 10.1515/dmpt-2017-0038.
   Shekhani R, 2020, CLIN PHARMACOL THER, V107, P1240, DOI 10.1002/cpt.1720.
   Sipeky C, 2013, MOL BIOL REP, V40, P4727, DOI 10.1007/s11033-013-2569-4.
   Sistonen J, 2007, PHARMACOGENET GENOM, V17, P93.
   Sistonen J, 2009, PHARMACOGENET GENOM, V19, P170, DOI 10.1097/FPC.0b013e32831ebb30.
   Suarez-Kurtz G, 2019, CLIN PHARMACOL THER, V105, P1321, DOI 10.1002/cpt.1379.
   Sulzyc-Bielicka V, 2008, PHARMACOL REP, V60, P238.
   Tanaka Y, 2015, BRIT J HAEMATOL, V171, P109, DOI 10.1111/bjh.13518.
   Teh LK, 2001, J CLIN PHARM THER, V26, P205, DOI 10.1046/j.1365-2710.2001.00347.x.
   Toft N, 2006, ACTA PAEDIATR, V95, P1665, DOI 10.1080/08035250600743788.
   Trivedi MH, 2006, AM J PSYCHIAT, V163, P28, DOI 10.1176/appi.ajp.163.1.28.
   Tzvetkov MV, 2011, CLIN PHARMACOL THER, V90, P143, DOI 10.1038/clpt.2011.56.
   Tzvetkov MV, 2013, BIOCHEM PHARMACOL, V86, P666, DOI 10.1016/j.bcp.2013.06.019.
   Uetrecht J, 2013, PHARMACOL REV, V65, P779, DOI 10.1124/pr.113.007450.
   Uzunkoy A, 2007, ANTICANCER RES, V27, P3899.
   Van Cutsem E, 2001, J CLIN ONCOL, V19, P4097, DOI 10.1200/JCO.2001.19.21.4097.
   van Kuilenburg ABP, 2001, CLIN CANCER RES, V7, P1149.
   van Kuilenburg ABP, 2010, HUM GENET, V128, P529, DOI 10.1007/s00439-010-0879-3.
   Vicente J, 2014, MOL BIOL REP, V41, P1267, DOI 10.1007/s11033-013-2971-y.
   von Ahsen N, 2010, INT J MOL EPIDEMIOL, V1, P310.
   Vreken P, 1996, J INHERIT METAB DIS, V19, P645, DOI 10.1007/BF01799841.
   Wahlund M, 2020, J PEDIATR-US, V216, P150, DOI 10.1016/j.jpeds.2019.09.024.
   Watanabe T, 2021, ALLERGOL INT, V70, P229, DOI 10.1016/j.alit.2020.11.004.
   Watson J, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006440.
   Watson Michael S, 2004, Genet Med, V6, P387, DOI 10.1097/01.GIM.0000139506.11694.7C.
   Wennerholm A, 2001, PHARMACOGENETICS, V11, P417, DOI 10.1097/00008571-200107000-00005.
   Xiao QY, 2021, NPJ GENOM MED, V6, DOI 10.1038/s41525-021-00203-x.
   Yang CY, 2015, JAMA INTERN MED, V175, P1550, DOI 10.1001/jamainternmed.2015.3536.
   Yang JJ, 2015, J CLIN ONCOL, V33, P1235, DOI 10.1200/JCO.2014.59.4671.
   Yang SK, 2014, NAT GENET, V46, P1017, DOI 10.1038/ng.3060.
   Yasuda SU, 2008, CLIN PHARMACOL THER, V84, P417, DOI 10.1038/clpt.2008.141.
   Yin SJ, 2012, J CLIN PHARM THER, V37, P364, DOI 10.1111/j.1365-2710.2011.01298.x.
   Zanger UM, 2013, PHARMACOL THERAPEUT, V138, P103, DOI 10.1016/j.pharmthera.2012.12.007.
   Zazuli Z, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21186627.
   Zhang Jian-Ping, 2003, Ai Zheng, V22, P385.
   Zheng YZ, 2020, MOL GENET GENOM MED, V8, DOI 10.1002/mgg3.1540.
   Zhou Y, 2017, CLIN PHARMACOL THER, V102, P688, DOI 10.1002/cpt.690.
   Zhou Y., 2021, Sci Adv.
   Zhou YT, 2020, BRIT J CANCER, V123, P1782, DOI 10.1038/s41416-020-01084-0.
   Zhou YT, 2021, CLIN PHARMACOL THER, V109, P160, DOI 10.1002/cpt.1944.
   Zhou YT, 2018, J MED GENET, V55, P617, DOI 10.1136/jmedgenet-2018-105429.},
Number-of-Cited-References = {203},
Times-Cited = {13},
Unique-ID = {WOS:000707545600004},
}

@article{ WOS:000791346600001,
Author = {Laaksonen, Mari and Airikkala, Elisa and Halkoaho, Arja},
Title = {The Development of Education of Public Health Nurses for Applying
   Genomics in Preventive Health Care},
Journal = {FRONTIERS IN GENETICS},
Year = {2022},
Volume = {13},
Month = {APR 8},
Abstract = {Genetics and genomics have become one of the most important development
   areas in healthcare. For this reason, it is essential that nursing
   professionals take their role to offer their skills in implementing
   genomics in health promotion. The education of public health nurses is
   taking vital steps in training the health promoters who are able to take
   the genome-based knowledge into account in precision healthcare. Tampere
   University of Applied Sciences managed to integrate genomics into the
   studies of public health nursing. This article describes the process of
   development and lays emphasis on the importance of genomic education of
   public health nurses.},
Type = {Article},
Affiliation = {Laaksonen, M (Corresponding Author), Tampere Univ Appl Sci, Sch Social Serv \& Hlth Care, Tampere, Finland.
   Laaksonen, Mari; Airikkala, Elisa; Halkoaho, Arja, Tampere Univ Appl Sci, Sch Social Serv \& Hlth Care, Tampere, Finland.},
DOI = {10.3389/fgene.2022.849232},
Article-Number = {849232},
Keywords = {education; health promotion; public health nurse; precision public
   health; genomics},
Keywords-Plus = {INTEGRATING GENETICS; NURSING STAFF; COMPETENCE},
Research-Areas = {Genetics \& Heredity},
Web-of-Science-Categories  = {Genetics \& Heredity},
Author-Email = {mari.laaksonen@tuni.fi},
Affiliations = {Tampere University; Tampere University of Applied Sciences TAMK},
Cited-References = {{[}Anonymous], 2021, FINNISH CLIN BIOBANK.
   {[}Anonymous], 2010, HLTH CARE ACT 132620.
   Broetje S, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.00084.
   Calzone KA, 2016, J NURS MEAS, V24, P54, DOI 10.1891/1061-3749.24.1.54.
   Calzone KA, 2014, J NURS REGUL, V5, P40, DOI 10.1016/S2155-8256(15)30098-3.
   Camak DJ, 2016, NURS EDUC TODAY, V44, P86, DOI 10.1016/j.nedt.2016.05.018.
   Consensus Panel, 2009, ESS GEN GEN NURS COM, V2nd.
   Daack-Hirsch S, 2013, NURS CLIN N AM, V48, P661, DOI 10.1016/j.cnur.2013.08.005.
   European Commission, 2022, European Credit Transfer and Accumulation System (ECTS).
   Finnish Institute for Health and Welfare, 2021, P6 GEN HEALTHC.
   Genomic Nursing Competency Implementation Strategic Plan 2014-2020, 2014, REP GEN NURS COMP ST.
   Goda H, 2019, BMC NURS, V18, DOI 10.1186/s12912-019-0391-6.
   Godino JG, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002185.
   Haron Y, 2019, PUBLIC HEALTH NURS, V36, P79, DOI 10.1111/phn.12578.
   Hasson H, 2008, J CLIN NURS, V17, P468, DOI 10.1111/j.1365-2702.2006.01803.x.
   Hollands GJ, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1102.
   Hurle B, 2013, GENET MED, V15, P658, DOI 10.1038/gim.2013.14.
   Kawasaki H, 2021, BMC NURS, V20, DOI 10.1186/s12912-021-00549-8.
   Mabhala MA, 2015, INT J EQUITY HEALTH, V14, DOI 10.1186/s12939-015-0146-2.
   McBride CM, 2018, TRANSL BEHAV MED, V8, P54, DOI 10.1093/tbm/ibx051.
   Mills R, 2014, J GENET COUNS, V23, P689, DOI 10.1007/s10897-013-9641-z.
   Ministry of Social Affairs and Health, 2015, IMPR HLTH US GEN DAT.
   Newcomb Patricia, 2019, Nurs Manage, V50, P18, DOI 10.1097/01.NUMA.0000550445.94504.de.
   OSF (Official Statistics of Finland), 2019, EMPL E PUBL.
   OSF (Official Statistics of Finland), 2021, STUD QUAL E PUBL.
   Pairo-Castineira E, 2021, NATURE, V591, P92, DOI 10.1038/s41586-020-03065-y.
   Rogers E.M., 2003, Diffusion of innovation, V5th.
   Saleh M, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.01066.
   Savonia, 2020, COMP REQ CONT 180 EC.
   Skirton H, 2012, J ADV NURS, V68, P2387, DOI 10.1111/j.1365-2648.2012.06034.x.
   Stark Z, 2019, AM J HUM GENET, V104, P13, DOI 10.1016/j.ajhg.2018.11.014.
   Syurina EV, 2011, PUBLIC HEALTH GENOM, V14, P201, DOI 10.1159/000324238.
   Terry PE, 2020, AM J HEALTH PROMOT, V34, P235, DOI 10.1177/0890117120903129.
   Whitley KV, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21030768.
   Williams T, 2016, J NURS EDUC, V55, P574, DOI 10.3928/01484834-20160914-06.
   Wright H, 2019, J NURS SCHOLARSHIP, V51, P40, DOI 10.1111/jnu.12440.},
Number-of-Cited-References = {36},
Times-Cited = {3},
Unique-ID = {WOS:000791346600001},
}

@article{ WOS:000449682600001,
Author = {Dunn, Adam G. and Mandl, Kenneth D. and Coiera, Enrico},
Title = {Social media interventions for precision public health: promises and
   risks},
Journal = {NPJ DIGITAL MEDICINE},
Year = {2018},
Volume = {1},
Month = {SEP 19},
Abstract = {Social media data can be used with digital phenotyping tools to profile
   the attitudes, behaviours, and health outcomes of people. While there
   are a growing number of examples demonstrating the performance of
   digital phenotyping tools using social media data, little is known about
   their capacity to support the delivery of targeted and personalised
   behaviour change interventions to improve health. Similar tools are
   already used in marketing and politics, using individual profiling to
   manipulate purchasing and voting behaviours. The coupling of digital
   phenotyping tools and behaviour change interventions may play a more
   positive role in preventive medicine to improve health behaviours, but
   potential risks and unintended consequences may come from embedding
   behavioural interventions in social spaces.},
Type = {Article},
Affiliation = {Dunn, AG (Corresponding Author), Macquarie Univ, Australian Inst Hlth Innovat, Ctr Hlth Informat, Sydney, NSW 2109, Australia.
   Dunn, Adam G.; Coiera, Enrico, Macquarie Univ, Australian Inst Hlth Innovat, Ctr Hlth Informat, Sydney, NSW 2109, Australia.
   Mandl, Kenneth D., Boston Childrens Hosp, Computat Hlth Informat Program, Boston, MA 02115 USA.
   Mandl, Kenneth D., Harvard Med Sch, Dept Biomed Informat, Boston, MA 02115 USA.
   Mandl, Kenneth D., Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA.},
DOI = {10.1038/s41746-018-0054-0},
Keywords-Plus = {INFORMATION; QUALITY; NETWORK; SCIENCE; SPREAD},
Research-Areas = {Health Care Sciences \& Services; Medical Informatics},
Web-of-Science-Categories  = {Health Care Sciences \& Services; Medical Informatics},
Author-Email = {adam.dunn@mq.edu.au},
Affiliations = {Macquarie University; Harvard University; Boston Children's Hospital;
   Harvard University; Harvard Medical School; Harvard University; Harvard
   Medical School},
Cited-References = {Althoff T, 2017, PROCEEDINGS OF THE 26TH INTERNATIONAL CONFERENCE ON WORLD WIDE WEB (WWW'17), P113, DOI 10.1145/3038912.3052637.
   Althoff T, 2017, NATURE, V547, P336, DOI 10.1038/nature23018.
   Althoff T, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.6759.
   Brewer NT, 2017, PSYCHOL SCI PUBL INT, V18, P149, DOI 10.1177/1529100618760521.
   Centola D, 2013, CIRCULATION, V127, P2135, DOI 10.1161/CIRCULATIONAHA.112.101816.
   Choudhury M., 2014, P 17 ACM C COMP SUPP, P626, DOI DOI 10.1145/2531602.2531675.
   Christakis NA, 2008, NEW ENGL J MED, V358, P2249, DOI 10.1056/NEJMsa0706154.
   Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082.
   Coiera E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3007.
   Colditz JB, 2018, AM J PUBLIC HEALTH, V108, P1009, DOI 10.2105/AJPH.2018.304497.
   Coman A, 2016, P NATL ACAD SCI USA, V113, P8171, DOI 10.1073/pnas.1525569113.
   De Choudhury M., 2013, ICWSM, P1.
   De Choudhury M, 2016, 34TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, CHI 2016, P2098, DOI 10.1145/2858036.2858207.
   Dunn AG, 2017, VACCINE, V35, P3033, DOI 10.1016/j.vaccine.2017.04.060.
   Dunn AG, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4343.
   Eichstaedt JC, 2015, PSYCHOL SCI, V26, P159, DOI 10.1177/0956797614557867.
   Fowler JH, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2338.
   Gebru T, 2017, P NATL ACAD SCI USA, V114, P13108, DOI 10.1073/pnas.1700035114.
   Kosinski M, 2015, AM PSYCHOL, V70, P543, DOI 10.1037/a0039210.
   Kosinski M, 2013, P NATL ACAD SCI USA, V110, P5802, DOI 10.1073/pnas.1218772110.
   Kramer ADI, 2014, P NATL ACAD SCI USA, V111, P10779, DOI 10.1073/pnas.1412583111.
   Kramer ADI, 2014, P NATL ACAD SCI USA, V111, P8788, DOI 10.1073/pnas.1320040111.
   Markovikj D., 2013, Proceedings of the International AAAI Conference on Web and Social Media, V7, P23.
   Marlinspike M., 2013, WE SHOULD ALL HAVE S.
   Matz SC, 2017, P NATL ACAD SCI USA, V114, P12714, DOI 10.1073/pnas.1710966114.
   Mellon J, 2017, RES POLITICS, V4, DOI 10.1177/2053168017720008.
   Michie S, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.7126.
   Monsted B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184148.
   Nyhan B, 2014, PEDIATRICS, V133, pE835, DOI 10.1542/peds.2013-2365.
   Qiu XY, 2017, NAT HUM BEHAV, V1, DOI 10.1038/s41562-017-0132.
   Rosenberg M., 2018, The New York Times.
   Rothman KJ, 2013, INT J EPIDEMIOL, V42, P1012, DOI 10.1093/ije/dys223.
   Schwartz HA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073791.
   Shirado H, 2017, NATURE, V545, P370, DOI 10.1038/nature22332.
   Torous J, 2018, NPJ DIGIT MED, V1, DOI 10.1038/s41746-018-0022-8.
   Tufekci Z., 2014, Proceedings of the Eighth International AAAI Conference on Weblogs and Social Media, P505.
   Tufekci Zeynep, 2017, TWITTER TEAR GAS POW.
   Vosoughi S, 2018, SCIENCE, V359, P1146, DOI 10.1126/science.aap9559.
   Westerman D, 2014, J COMPUT-MEDIAT COMM, V19, P171, DOI 10.1111/jcc4.12041.
   Whitaker C, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.7071.
   Wu YY, 2015, P NATL ACAD SCI USA, V112, P1036, DOI 10.1073/pnas.1418680112.
   Yom-Tov E, 2018, NPJ DIGIT MED, V1, DOI 10.1038/s41746-018-0031-7.},
Number-of-Cited-References = {42},
Times-Cited = {36},
Unique-ID = {WOS:000449682600001},
}

@article{ WOS:000466548500001,
Author = {Boulos, Maged N. Kamel and Peng, Guochao and Trang VoPham},
Title = {An overview of GeoAI applications in health and healthcare},
Journal = {INTERNATIONAL JOURNAL OF HEALTH GEOGRAPHICS},
Year = {2019},
Volume = {18},
Month = {MAY 2},
Abstract = {The moulding together of artificial intelligence (AI) and the
   geographic/geographic information systems (GIS) dimension creates GeoAI.
   There is an emerging role for GeoAI in health and healthcare, as
   location is an integral part of both population and individual health.
   This article provides an overview of GeoAI technologies (methods, tools
   and software), and their current and potential applications in several
   disciplines within public health, precision medicine, and Internet of
   Things-powered smart healthy cities. The potential challenges currently
   facing GeoAI research and applications in health and healthcare are also
   briefly discussed.},
Type = {Editorial Material},
Affiliation = {Boulos, MNK (Corresponding Author), Sun Yat Sen Univ, Sch Informat Management, East Campus, Guangzhou 510006, Guangdong, Peoples R China.
   Boulos, Maged N. Kamel; Peng, Guochao, Sun Yat Sen Univ, Sch Informat Management, East Campus, Guangzhou 510006, Guangdong, Peoples R China.
   Trang VoPham, Brigham \& Womens Hosp, Dept Med, Channing Div Network Med, 181 Longwood Ave, Boston, MA 02115 USA.
   Trang VoPham, Harvard Med Sch, 181 Longwood Ave, Boston, MA 02115 USA.},
DOI = {10.1186/s12942-019-0171-2},
Article-Number = {7},
Keywords = {Artificial intelligence; Big data; Deep learning; GeoAI; GIS;
   Geomedicine; Health; Healthcare; Internet of Things; Machine learning;
   Precision medicine; Public health; Smart healthy cities},
Keywords-Plus = {PM2.5 CONCENTRATIONS; AIR-POLLUTION; SMART CITIES; ENVIRONMENT;
   PREDICTION; INTERNET; OBESITY; CHINA},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {mnkboulos@mail.sysu.edu.cn},
Affiliations = {Sun Yat Sen University; Harvard University; Brigham \& Women's Hospital;
   Harvard University; Harvard Medical School},
Cited-References = {Albert J, 2014, GEOSPATIAL ANAL TOOL.
   {[}Anonymous], SCHIZ RISK GEN AR NO.
   {[}Anonymous], ALL US RES PROGR.
   Apte JS, 2017, ENVIRON SCI TECHNOL, V51, P6999, DOI 10.1021/acs.est.7b00891.
   Bellinger C, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4914-3.
   Bhavsar NA, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.2716.
   Bi WL, 2019, CA-CANCER J CLIN, V69, P127, DOI 10.3322/caac.21552.
   Boulos MNK, 2018, INT J HEALTH GEOGR, V17, DOI 10.1186/s12942-018-0144-x.
   Boulos MNK, 2016, INT J HEALTH GEOGR, V15, DOI 10.1186/s12942-016-0033-0.
   Boulos MNK, 2015, INT J HEALTH GEOGR, V14, DOI 10.1186/1476-072X-14-3.
   Boulos MNK, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-10.
   Brazil N, 2016, AM J EPIDEMIOL, V184, P192, DOI 10.1093/aje/kww062.
   Brdar S, 2016, SCI REP-UK, V6, DOI 10.1038/srep19342.
   Burns MN, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1838.
   Byrnes J, 2015, PEDIATR RES, V77, P836, DOI 10.1038/pr.2015.55.
   Casey JA, 2016, ANNU REV PUBL HEALTH, V37, P61, DOI 10.1146/annurev-publhealth-032315-021353.
   Chen GB, 2018, SCI TOTAL ENVIRON, V636, P52, DOI 10.1016/j.scitotenv.2018.04.251.
   Choi EPH, 2018, SEX ABUSE-J RES TR, V30, P343, DOI 10.1177/1079063216672168.
   Cooper M, 2018, HEALTH INFORM SER, P169, DOI 10.1007/978-3-319-61446-5\_12.
   D'Angelo N, 2017, FUTURE LOCATION ANAL.
   Davis MM, 2017, CTS-CLIN TRANSL SCI, V10, P64, DOI 10.1111/cts.12453.
   Di Q, 2017, NEW ENGL J MED, V376, P2513, DOI 10.1056/NEJMoa1702747.
   Di Q, 2016, ENVIRON SCI TECHNOL, V50, P4712, DOI 10.1021/acs.est.5b06121.
   Dunseath S, 2018, NPJ DIGIT MED, V1, DOI 10.1038/s41746-017-0001-5.
   Folger Peter., 2009, Geospatial information and geographic information systems (GIS): Current issues and future challenges.
   Goldstein BA, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.1568.
   Goodfellow I, 2016, ADAPT COMPUT MACH LE, P1.
   Guo P, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005973.
   Hall AK, 2015, ANNU REV PUBL HEALTH, V36, P393, DOI 10.1146/annurev-publhealth-031914-122855.
   Hu HP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23075-1.
   Hu XF, 2017, ENVIRON SCI TECHNOL, V51, P6936, DOI 10.1021/acs.est.7b01210.
   Hu Y., 2018, SIGSPATIAL SPECIAL, V10, P16, DOI DOI 10.1145/3307599.3307609.
   Istepanian RSH, 2018, METHODS, V151, P34, DOI 10.1016/j.ymeth.2018.05.015.
   James P, 2016, AM J PREV MED, V51, P792, DOI 10.1016/j.amepre.2016.06.006.
   Johnston FH, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aab1e6.
   Jontz S, 2016, NGA SETS SAIL BLUE W.
   Kilbride MK, 2018, JAMA-J AM MED ASSOC, V320, P1973, DOI 10.1001/jama.2018.14382.
   Krittanawong C, 2017, J AM COLL CARDIOL, V69, P2657, DOI 10.1016/j.jacc.2017.03.571.
   Kumar S, 2017, IEEE PERVAS COMPUT, V16, P18, DOI 10.1109/MPRV.2017.29.
   Larkin A, 2018, J EXPO SCI ENV EPIDE.
   Leaffer D, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16030308.
   Leese CB, 2017, US NAVY MUST KEEP GE.
   Liang T, 2019, LIB INF SERV, V63.
   Lu FS, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08082-0.
   Maharana A, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.1535.
   McAllister K, 2017, AM J EPIDEMIOL, V186, P753, DOI 10.1093/aje/kwx227.
   Mesko Bertalan, 2017, ROLE ARTIFICIAL INTE.
   Mohr DC, 2017, ANNU REV CLIN PSYCHO, V13, P23, DOI 10.1146/annurev-clinpsy-032816-044949.
   Nori M, 2017, LOCATION ANAL USE CA.
   Poon L, 2015, NEW YORK CITY IS TUR.
   Rajkomar A, 2018, NPJ DIGIT MED, V1, DOI 10.1038/s41746-018-0029-1.
   Sadilek A, 2018, NPJ DIGIT MED, V1, DOI 10.1038/s41746-018-0045-1.
   SAS, 2017, ENH YOUR BI SYST LOC.
   Seligman B, 2018, SSM-POPUL HLTH, V4, P95, DOI 10.1016/j.ssmph.2017.11.008.
   Serban O, 2019, INFORM PROCESS MANAG, V56, P1166, DOI 10.1016/j.ipm.2018.04.011.
   Shaban-Nejad Arash., 2018, HLTH INTELLIGENCE AR.
   Smart Dublin, 2016, SMART BINS IN DUBL.
   Strubel J, 2017, BODY IMAGE, V21, P34, DOI 10.1016/j.bodyim.2017.02.006.
   TechCrunch, TIND NOW HAS 4 1M PA.
   TechCrunch, LYFT IS NOW COMPL ON.
   Timmermans E, 2017, COMPUT HUM BEHAV, V70, P341, DOI 10.1016/j.chb.2017.01.028.
   Topol EJ, 2019, NAT MED, V25, P44, DOI 10.1038/s41591-018-0300-7.
   Velez AFJ, 2017, IEEE FOUTH INT C EDE, DOI {[}10.1109/cibd.2014.7011525, DOI 10.1109/CIBD.2014.7011525].
   Venna SR, 2019, IEEE ACCESS, V7, P7691, DOI 10.1109/ACCESS.2018.2888585.
   VoPham T, 2018, ENVIRON HEALTH-GLOB, V17, DOI 10.1186/s12940-018-0386-x.
   Vrijheid M, 2014, THORAX, V69, P876, DOI 10.1136/thoraxjnl-2013-204949.
   WHO, 2016, EB OUTBR 2014 PRES O.
   Yuan JY, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.217.
   Zhan Y, 2017, ATMOS ENVIRON, V155, P129, DOI 10.1016/j.atmosenv.2017.02.023.
   Zou J, 2019, NAT GENET, V51, P12, DOI 10.1038/s41588-018-0295-5.},
Number-of-Cited-References = {70},
Times-Cited = {57},
Unique-ID = {WOS:000466548500001},
}

@article{ WOS:000462619700008,
Author = {Cummings, Matthew J. and Tokarz, Rafal and Bakamutumaho, Barnabas and
   Kayiwa, John and Byaruhanga, Timothy and Owor, Nicholas and Namagambo,
   Barbara and Wolf, Allison and Mathema, Barun and Lutwama, Julius J. and
   Schluger, Neil W. and Lipkin, W. Ian and O'Donnell, Max R.},
Title = {Precision Surveillance for Viral Respiratory Pathogens: Virome Capture
   Sequencing for the Detection and Genomic Characterization of Severe
   Acute Respiratory Infection in Uganda},
Journal = {CLINICAL INFECTIOUS DISEASES},
Year = {2019},
Volume = {68},
Number = {7},
Pages = {1118-1125},
Month = {APR 1},
Abstract = {Background Precision public health is a novel set of methods to target
   disease prevention and mitigation interventions to high-risk
   subpopulations. We applied a precision public health strategy to
   syndromic surveillance for severe acute respiratory infection (SARI) in
   Uganda by combining spatiotemporal analytics with genomic sequencing to
   detect and characterize viral respiratory pathogens with epidemic
   potential.
   Methods Using a national surveillance network we identified patients
   with unexplained, influenza-negative SARI from 2010 to 2015.
   Spatiotemporal analyses were performed retrospectively to identify
   clusters of unexplained SARI. Within clusters, respiratory viruses were
   detected and characterized in naso- and oropharyngeal swab samples using
   a novel oligonucleotide probe capture (VirCapSeq-VERT) and
   high-throughput sequencing platform. Linkage to conventional
   epidemiologic strategies further characterized transmission dynamics of
   identified pathogens.
   Results Among 2901 unexplained SARI cases, 9 clusters were detected,
   accounting for 301 (10.4\%) cases. Clusters were more likely to occur in
   urban areas and during biannual rainy seasons. Within detected clusters,
   we identified an unrecognized outbreak of measles-associated SARI;
   sequence analysis implicated cocirculation of endemic genotype B3 and
   genotype D4 likely imported from England. We also detected a likely
   nosocomial SARI cluster associated with a novel picobirnavirus most
   closely related to swine and dromedary viruses.
   Conclusions Using a precision approach to public health surveillance, we
   detected and characterized the genomics of vaccine-preventable and
   zoonotic respiratory viruses associated with clusters of severe
   respiratory infections in Uganda. Future studies are needed to assess
   the feasibility, scalability, and impact of applying similar approaches
   during real-time public health surveillance in low-income settings.
   Precision surveillance strategies incorporating spatiotemporal analytics
   and genomic sequencing can enhance detection and molecular
   characterization of unrecognized viral respiratory pathogens. Future
   studies are needed to assess the performance of similar strategies in
   the context of real-time public health surveillance in low-income
   settings.},
Type = {Article},
Affiliation = {O'Donnell, MR (Corresponding Author), Columbia Univ, Med Ctr, Div Pulm Allergy \& Crit Care Med, 622 West 168th St,PH 8E 101, New York, NY 10032 USA.
   Cummings, Matthew J.; Wolf, Allison; Schluger, Neil W.; O'Donnell, Max R., Columbia Univ, Med Ctr, Div Pulm Allergy \& Crit Care Med, 622 West 168th St,PH 8E 101, New York, NY 10032 USA.
   Tokarz, Rafal; Lipkin, W. Ian, Columbia Univ, Mailman Sch Publ Hlth, Ctr Infect \& Immun, New York, NY USA.
   Bakamutumaho, Barnabas; Kayiwa, John; Byaruhanga, Timothy; Owor, Nicholas; Namagambo, Barbara; Lutwama, Julius J., Uganda Virus Res Inst, Natl Influenza Ctr, Entebbe, Uganda.
   Mathema, Barun; Schluger, Neil W.; O'Donnell, Max R., Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA.
   Schluger, Neil W., Columbia Univ, Mailman Sch Publ Hlth, Dept Environm Hlth Sci, New York, NY USA.},
DOI = {10.1093/cid/ciy656},
Keywords = {acute respiratory infection; surveillance; sequencing; Africa South of
   the Sahara},
Keywords-Plus = {OUTBREAKS; DISEASES; MEASLES},
Research-Areas = {Immunology; Infectious Diseases; Microbiology},
Web-of-Science-Categories  = {Immunology; Infectious Diseases; Microbiology},
Author-Email = {mo2130@columbia.edu},
Affiliations = {Columbia University; Columbia University; Uganda Virus Research
   Institute; Columbia University; Columbia University},
Cited-References = {Abat C, 2016, INT J INFECT DIS, V48, P22, DOI 10.1016/j.ijid.2016.04.021.
   Baliraine FN, 2011, EMERG INFECT DIS, V17, P110, DOI 10.3201/eid1701.100753.
   Blake IM, 2016, EMERG INFECT DIS, V22, P449, DOI 10.3201/eid2203.151394.
   Briese T, 2015, MBIO, V6, DOI 10.1128/mBio.01491-15.
   Coleman M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-68.
   Cummings MJ, 2016, ANN AM THORAC SOC, V13, P2159, DOI 10.1513/AnnalsATS.201607-561OC.
   Dowell SF, 2016, NATURE, V540, P189, DOI 10.1038/540189a.
   Fasina FO, 2007, LANCET INFECT DIS, V7, P696, DOI 10.1016/S1473-3099(07)70244-X.
   Ganesh B, 2012, REV MED VIROL, V22, P245, DOI 10.1002/rmv.1707.
   Greene SK, 2016, EMERG INFECT DIS, V22, P1808, DOI 10.3201/eid2210.160097.
   Huiming YM, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001479.pub3.
   Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536.
   Khoury MJ, 2016, AM J PREV MED, V50, P398, DOI 10.1016/j.amepre.2015.08.031.
   Kulldorff M, 2005, PLOS MED, V2, P216, DOI 10.1371/journal.pmed.0020059.
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI {[}10.1093/molbev/msw054, 10.1093/molbev/msv279].
   Lefterova MI, 2015, J MOL DIAGN, V17, P623, DOI 10.1016/j.jmoldx.2015.07.004.
   Lipkin WI, 2010, MICROBIOL MOL BIOL R, V74, P363, DOI 10.1128/MMBR.00007-10.
   Lutwama JJ, 2012, J INFECT DIS, V206, pS87, DOI 10.1093/infdis/jis578.
   Madhi SA, 2006, DISEASE AND MORTALITY IN SUB-SAHARAN AFRICA, 2ND EDITION, P149.
   McCloskey B, 2014, LANCET INFECT DIS, V14, P1001, DOI 10.1016/S1473-3099(14)70846-1.
   Muscat M, 2014, CLIN MICROBIOL INFEC, V20, P12, DOI 10.1111/1469-0691.12584.
   Nsubuga P, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P997.
   Orenstein W, 2014, NEW ENGL J MED, V371, P1661, DOI 10.1056/NEJMp1408696.
   Penedos AR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143081.
   Rafailidis PI, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-47.
   Restrepo-Gualteros SM, 2014, VIRUSES-BASEL, V6, P2038, DOI 10.3390/v6052038.
   Shek Lynette Pei-Chi, 2003, Paediatr Respir Rev, V4, P105, DOI 10.1016/S1526-0542(03)00024-1.
   Doan TTM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-424.
   Troeger C, 2017, LANCET INFECT DIS, V17, P1133, DOI 10.1016/S1473-3099(17)30396-1.
   Uganda Bureau of Statistics, 2014, NAT POP HOUS CENS.
   United Nations Children's Fund, 2017, UNICEF WHO EST NAT I.
   Williams BG, 2002, LANCET INFECT DIS, V2, P25, DOI 10.1016/S1473-3099(01)00170-0.
   Woo PCY, 2014, VIROLOGY, V471, P117, DOI 10.1016/j.virol.2014.09.020.
   World Health Organization, 2012, WHO GLOB EP SURV STA.
   World Health Organization (WHO), 2015, ACC PROGR HIV TUB MA.
   Zhao YQ, 2011, BIOMETRICS, V67, P1508, DOI 10.1111/j.1541-0420.2011.01585.x.
   Zumla A, 2014, LANCET INFECT DIS, V14, P910, DOI 10.1016/S1473-3099(14)70899-0.},
Number-of-Cited-References = {37},
Times-Cited = {15},
Unique-ID = {WOS:000462619700008},
}

@article{ WOS:000477864100045,
Author = {Rieger, Matthias and Karina Trommlerova, Sofia and Ban, Radu and
   Jeffers, Kristen and Hutmacher, Matthew},
Title = {Temporal stability of child growth associations in Demographic and
   Health Surveys in 25 countries},
Journal = {SSM-POPULATION HEALTH},
Year = {2019},
Volume = {7},
Month = {APR},
Abstract = {Background: Socio-economic and demographic determinants of child growth
   at ages 0-5 years in developing countries are well documented. However,
   Precision Public Health interventions and population targeting require
   more finely grained knowledge about the existence and character of
   temporal changes in child growth associations.
   Methods: We evaluated the temporal stability of associations between
   height-for-age z-score (HAZ) of children aged 0-59 months and child,
   parental, household, and community and infrastructure factors by
   following 25 countries over time (1991-2014) in repeated cross-sections
   of 91 Demographic and Health Surveys using random effect models and Wald
   tests.
   Results: We found that child growth displayed relatively more time
   stable associations with child, parental, and household factors than
   with community and infrastructure factors. Among the unstable
   associations, there was no uniform geographical pattern in terms of
   where they consistently increased or decreased over time. There were
   differences between countries in the extent of temporal instability but
   there was no apparent regional grouping or geographic pattern. The
   instability was positively and significantly correlated with annual
   changes in HAZ.
   Conclusions: These findings inform about the generalizability of results
   stemming from cross-sectional studies that do not consider time
   variation - results regarding effects of child, parental, and household
   factors on HAZ do not necessarily need to be re-evaluated over time
   whereas results regarding the effects of infrastructure and community
   variables need to be monitored more frequently as they are expected to
   change. In addition, the study may improve the Precision Public Health
   population targeting of interventions in different regions and times -
   whereas the temporal dimension seems to be important for precision
   targeting of community and infrastructure factors, it is not the case
   for child, parental, and household factors. In general, the existence of
   temporal instability and the direction of change varies across countries
   with no apparent regional pattern.},
Type = {Article},
Affiliation = {Rieger, M (Corresponding Author), Erasmus Univ, Int Inst Social Studies, POB 29776, NL-2502 LT The Hague, Netherlands.
   Rieger, Matthias, Erasmus Univ, Int Inst Social Studies, POB 29776, NL-2502 LT The Hague, Netherlands.
   Karina Trommlerova, Sofia, Univ Pompeu Fabra, Placa Merce 10, Barcelona 08002, Spain.
   Ban, Radu, Bill \& Melinda Gates Fdn, 500 Fifth Ave North, Seattle, WA 98109 USA.
   Jeffers, Kristen, Univ Minnesota, Minnesota Populat Ctr, 50 Willey Hall,225 19th Ave South, Minneapolis, MN 55455 USA.
   Hutmacher, Matthew, Ann Arbor Pharmacometr Grp, 900 Victors Way 328, Ann Arbor, MI 48108 USA.},
DOI = {10.1016/j.ssmph.2019.100352},
Article-Number = {100352},
Keywords = {Temporal stability; Height-for-age; Stunting; Demographic and Health
   Surveys},
Keywords-Plus = {UNDERNUTRITION; NUTRITION; EDUCATION; INCOME},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {matthias.rieger@graduateinstitute.ch
   sofia.trommlerova@graduateinstitute.ch
   radu.ban@gatesfoundation.org
   kjeffers@umn.edu},
Affiliations = {Erasmus University Rotterdam - Excl Erasmus MC; Erasmus University
   Rotterdam; Pompeu Fabra University; Bill \& Melinda Gates Foundation;
   University of Minnesota System; University of Minnesota Twin Cities},
Cited-References = {Black RE, 2008, LANCET, V371, P243, DOI {[}10.1016/S0140-6736(07)61690-0, 10.1016/S0140-6736(13)60937-X].
   Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X.
   Desai S, 1998, DEMOGRAPHY, V35, P71, DOI 10.2307/3004028.
   Desmond-Hellmann S, 2016, SCIENCE, V353, P731, DOI 10.1126/science.aai7598.
   Fotso JC, 2007, HEALTH PLACE, V13, P205, DOI 10.1016/j.healthplace.2006.01.004.
   Glewwe P, 2008, HBK ECON, V9, P3561, DOI 10.1016/S1573-4471(07)04056-9.
   Hathi P, 2017, DEMOGRAPHY, V54, P337, DOI 10.1007/s13524-016-0538-y.
   HBGDki, 2018, GLOB HLTH SAV IMPR L.
   Headey D, 2016, MATERN CHILD NUTR, V12, P210, DOI 10.1111/mcn.12274.
   Headey D, 2015, WORLD DEV, V66, P749, DOI 10.1016/j.worlddev.2014.09.022.
   Headey DD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145738.
   Hoddinott J, 2008, LANCET, V371, P411, DOI 10.1016/S0140-6736(08)60205-6.
   Hoddinott J, 2013, AM J CLIN NUTR, V98, P1170, DOI 10.3945/ajcn.113.064584.
   ICF International, 2016, DEM HLTH SURV VAR DA.
   Jumbé NL, 2016, NEW ENGL J MED, V374, P2415, DOI 10.1056/NEJMp1605441.
   Mendez MA, 1999, J NUTR, V129, P1555, DOI 10.1093/jn/129.8.1555.
   Özaltin E, 2010, JAMA-J AM MED ASSOC, V303, P1507, DOI 10.1001/jama.2010.450.
   Rabbani A, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0477-7.
   Rieger M, 2016, DEMOGRAPHY, V53, P241, DOI 10.1007/s13524-015-0449-3.
   Strauss J, 1998, J ECON LIT, V36, P766.
   THOMAS D, 1991, J HUM RESOUR, V26, P183, DOI 10.2307/145920.
   UNICEF-WHO-The World Bank Group, 2016, JOINT CHILD MALN EST.
   Van de Poel E, 2007, SOC SCI MED, V65, P1986, DOI 10.1016/j.socscimed.2007.06.032.
   {[}WHO child growth standards World Health Organization], 2006, WHO CHILD GROWTH STA.},
Number-of-Cited-References = {24},
Times-Cited = {2},
Unique-ID = {WOS:000477864100045},
}

@article{ WOS:000581644800002,
Author = {Huang, Vincent S. and Morris, Kasey and Jain, Mokshada and Ramesh,
   Banadakoppa Manjappa and Kemp, Hannah and Blanchard, James and Isac,
   Shajy and Sarkar, Bidyut and Gothalwal, Vikas and Namasivayam,
   Vasanthakumar and Kumar, Pankaj and Sgaier, Sema K.},
Title = {Closing the gap on institutional delivery in northern India: a case
   study of how integrated machine learning approaches can enable precision
   public health},
Journal = {BMJ GLOBAL HEALTH},
Year = {2020},
Volume = {5},
Number = {10},
Abstract = {Introduction Meeting ambitious global health goals with limited
   resources requires a precision public health (PxPH) approach. Here we
   describe how integrating data collection optimisation, traditional
   analytics and causal artificial intelligence/machine learning (ML) can
   be used in a use case for increasing hospital deliveries of newborns in
   Uttar Pradesh, India. Methods Using a systematic behavioural framework
   we designed a large-scale survey on perceptual, interpersonal and
   structural drivers of women's behaviour around childbirth (n=5613).
   Multivariate logistic regression identified factors associated with
   institutional delivery (ID). Causal ML determined the cause-and-effect
   ordering of these factors. Variance decomposition was used to parse
   sources of variation in delivery location, and a supervised learning
   algorithm was used to distinguish population subgroups. Results Among
   the factors found associated with ID, the causal model showed that
   having a delivery plan (OR=6.1, 95\% CI 6.0 to 6.3), believing the
   hospital is safer than home (OR=5.4, 95\% CI 5.1 to 5.6) and awareness
   of financial incentives were direct causes of ID (OR=3.4, 95\% CI 3.3 to
   3.5). Distance to the hospital, borrowing delivery money and the primary
   decision-maker were not causal. Individual-level factors contributed
   69\% of variance in delivery location. The segmentation analysis showed
   four distinct subgroups differentiated by ID risk perception, parity and
   planning. Conclusion These findings generate a holistic picture of the
   drivers and barriers to ID in Uttar Pradesh and suggest distinct
   intervention points for different women. This demonstrates data
   optimised to identify key behavioural drivers, coupled with traditional
   and ML analytics, can help design a PxPH approach that maximise the
   impact of limited resources.},
Type = {Article},
Affiliation = {Sgaier, SK (Corresponding Author), Surgo Fdn, Washington, DC 20001 USA.
   Sgaier, SK (Corresponding Author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.
   Sgaier, SK (Corresponding Author), Harvard Univ, TH Chan Sch Publ Hlth, Dept Global Hlth \& Populat, Boston, MA 02115 USA.
   Huang, Vincent S.; Morris, Kasey; Jain, Mokshada; Kemp, Hannah; Sgaier, Sema K., Surgo Fdn, Washington, DC 20001 USA.
   Ramesh, Banadakoppa Manjappa; Blanchard, James; Isac, Shajy; Sarkar, Bidyut; Gothalwal, Vikas; Namasivayam, Vasanthakumar, Univ Manitoba, Dept Community Hlth Sci, Ctr Global Publ Hlth, Winnipeg, MB, Canada.
   Isac, Shajy, India Hlth Act Trust, New Delhi, India.
   Sarkar, Bidyut; Gothalwal, Vikas, India Hlth Act Trust, Lucknow, Uttar Pradesh, India.
   Kumar, Pankaj, Govt Uttar Pradesh, Natl Hlth Mission, Lucknow, Uttar Pradesh, India.
   Sgaier, Sema K., Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.
   Sgaier, Sema K., Harvard Univ, TH Chan Sch Publ Hlth, Dept Global Hlth \& Populat, Boston, MA 02115 USA.},
DOI = {10.1136/bmjgh-2020-002340},
Article-Number = {e002340},
Keywords = {mathematical modelling; child health; maternal health; health services
   research; cross-sectional survey},
Keywords-Plus = {CAUSAL DIAGRAMS; MORTALITY},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {semasgaier@surgofoundation.org},
Affiliations = {University of Manitoba; University of Washington; University of
   Washington Seattle; Harvard University; Harvard T.H. Chan School of
   Public Health},
Cited-References = {Alegana VA, 2016, SCI REP-UK, V6, DOI 10.1038/srep29628.
   Arora P, 2019, VALUE HEALTH, V22, P439, DOI 10.1016/j.jval.2019.01.006.
   Athey S, 2016, P NATL ACAD SCI USA, V113, P7353, DOI 10.1073/pnas.1510489113.
   Bishop CM., 2007, PATTERN RECOGN, V16, P049901, DOI {[}10.1117/1.2819119, DOI 10.1117/1.2819119].
   Butcher B, 2019, C NEUR INF PROC SYST.
   Centre for Operations Research and Training (CORT), 2007, ASS JAN SUR YOJ UTT.
   Chowkwanyun M, 2018, NEW ENGL J MED, V379, P1398, DOI 10.1056/NEJMp1806634.
   Desmond-Hellmann S, 2016, SCIENCE, V353, P731, DOI 10.1126/science.aai7598.
   Dey A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204810.
   Dolley S, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00068.
   Dwyer-Lindgren L, 2019, NATURE, V570, P189, DOI 10.1038/s41586-019-1200-9.
   Engl E, 2018, 32 C NEUR INF PROC S.
   Engl Elisabeth, 2019, Gates Open Res, V3, P886, DOI 10.12688/gatesopenres.12923.2.
   Flaxman AD, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002702.
   Gendelman R, 2017, CANCER RES, V77, P1575, DOI 10.1158/0008-5472.CAN-16-0512.
   Golding N, 2017, LANCET, V390, P2171, DOI 10.1016/S0140-6736(17)31758-0.
   Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008.
   Heckerman D., 2008, A tutorial on learning with Bayesian networks.
   International Institute for Population Sciences, 2010, PERC BARR UT MAT HLT.
   Joe W, 2018, HEALTH POLICY PLANN, V33, P645, DOI 10.1093/heapol/czy029.
   Kass GV, 1980, Applied Statistics, V29, P119, DOI {[}DOI 10.2307/2986296, 10.2307/2986296].
   Kattula D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160706.
   Kesterton AJ, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-30.
   Khoury MJ, 2016, AM J PREV MED, V50, P398, DOI 10.1016/j.amepre.2015.08.031.
   Kotsiantis SB, 2013, ARTIF INTELL REV, V39, P261, DOI 10.1007/s10462-011-9272-4.
   Kumar G, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2473-6.
   Kumar S, 2014, APPL ECON, V46, P4091, DOI 10.1080/00036846.2014.950836.
   Laishram Ladusingh Laishram Ladusingh, 2007, Asian Population Studies, V3, P79, DOI 10.1080/17441730701270897.
   Mansournia MA, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k757.
   Ministry of Health and Family Welfare, 2006, JAN SUR YOJ REV GUID.
   Ministry of Health and Family Welfare, 2006, JAN SUR YOJ FEAT FRE.
   Mohanty SK, 2009, J BIOSOC SCI, V41, P381, DOI 10.1017/S002193200800309X.
   Mooney SJ, 2018, ANNU REV PUBL HEALTH, V39, P95, DOI 10.1146/annurev-publhealth-040617-014208.
   Mutheneni Srinivasa Rao, 2018, Parasite Epidemiol Control, V3, P52, DOI 10.1016/j.parepi.2016.11.001.
   Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x.
   Office of the Registrar General of India (ORGI), 2019, SPEC B SAMPL REG SYS.
   Office of the Registrar General of India (ORGI), 2018, SPEC B MAT MORT IND.
   Pearl J, 1995, BIOMETRIKA, V82, P669, DOI 10.2307/2337329.
   Pearl J., 2000, CAUSALITY MODELS REA.
   Piot P, 2019, MACHINE LEARNING CAN.
   Randive B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067452.
   Russell S., 2016, Artificial Intelligence: A Modern Approach.
   Sahoo J, 2015, J EPIDEMIOL GLOB HEA, V5, pS27, DOI 10.1016/j.jegh.2015.05.002.
   Seth A, 2017, INT J EQUITY HEALTH, V16, DOI 10.1186/s12939-017-0538-6.
   Sgaier SK, 2017, ELIFE, V6, DOI {[}10.7554/eLife.25923, 10.7554/elife.25923].
   Sgaier SK, 2016, JAIDS-J ACQ IMM DEF, V72, pS257, DOI 10.1097/QAI.0000000000001155.
   Sgaier SK., 2018, SSIR, P48, DOI {[}10.48558/ghdj-w903, DOI 10.48558/GHDJ-W903].
   Singh-Manoux A, 2008, EPIDEMIOLOGY, V19, P294, DOI 10.1097/EDE.0b013e3181632c75.
   Smittenaar P BMR, 2020, IMPROVING PRECISION.
   Sridharan S, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1287493.
   Tatem AJ, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-52.
   Thind A, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-29.
   Uttar Pradesh Technical Support Unit, 2015, COMM BEH TRACK SURV.
   Varma DS., 2010, J FAM WELFARE, V56, P23, DOI 10.1016/j.apmr.2015.12.003.
   Wahl B, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-000798.
   Xing H, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001105.},
Number-of-Cited-References = {56},
Times-Cited = {2},
Unique-ID = {WOS:000581644800002},
}

@article{ WOS:000710055700001,
Author = {Preston, Michael A. and Cadet, Debbie and Hunley, Rachel and Retnam,
   Reuben and Arezo, Sarah and Sheppard, Vanessa B.},
Title = {Health Equity and Colorectal Cancer Awareness: a Community Health
   Educator Initiative},
Journal = {JOURNAL OF CANCER EDUCATION},
Year = {2023},
Volume = {38},
Number = {1},
Pages = {225-230},
Month = {FEB},
Abstract = {Disparities in colorectal cancer (CRC) incidence and mortality persist
   in rural and underserved communities. Our Community Outreach and
   Engagement (COE) activities are grounded in a bi-directional
   Community-to-Bench model in which the National Outreach Network
   Community Health Educator (NON CHE) Screen to Save (S2S) initiative was
   implemented. In this study, we assessed the impact of the NON CHE S2S in
   rural and underserved communities. Descriptive and comparative analyses
   were used to examine the role of the NON CHE S2S on CRC knowledge and
   CRC screening intent. Data included demographics, current CRC knowledge,
   awareness, and future CRC health plans. A multivariate linear regression
   was fit to survey scores for CRC knowledge. The NON CHE S2S engaged 441
   participants with 170 surveys completed. The difference in participants'
   CRC knowledge before and after the NON CHE S2S intervention had an
   overall mean of 0.92 with a standard deviation of 2.56. At baseline,
   White participants had significantly higher CRC knowledge scores,
   correctly answering 1.94 (p = 0.007) more questions on average than
   Black participants. After the NON CHE S2S intervention, this difference
   was not statistically significant. Greater than 95\% of participants
   agreed that the NON CHE S2S sessions impacted their intent to get
   screened for CRC. Equity of access to health information and the health
   care system can be achieved with precision public health strategies. The
   COE bi-directional Community-to-Bench model facilitated community
   connections through the NON CHE and increased awareness of CRC risk
   reduction, screening, treatment, and research. The NON CHE combined with
   S2S is a powerful tool to engage communities with the greatest health
   care needs and positively impact an individual's intent to ``get
   screened{''} for CRC.},
Type = {Article},
Affiliation = {Preston, MA (Corresponding Author), Virginia Commonwealth Univ, Dept Hlth Behav \& Policy, Off Hlth Equ \& Dispar Res Community Outreach \& En, POB 980149,830 East Main St, Richmond, VA 23298 USA.
   Preston, Michael A.; Cadet, Debbie; Hunley, Rachel; Retnam, Reuben; Arezo, Sarah; Sheppard, Vanessa B., Virginia Commonwealth Univ, Dept Hlth Behav \& Policy, Off Hlth Equ \& Dispar Res Community Outreach \& En, POB 980149,830 East Main St, Richmond, VA 23298 USA.},
DOI = {10.1007/s13187-021-02102-2},
EarlyAccessDate = {OCT 2021},
Keywords = {Equity of access; Rural health; Community health educator; Cancer
   prevention and control; Precision public health; Implementation research
   in cancer disparities},
Keywords-Plus = {AFRICAN-AMERICANS; DISPARITIES; KNOWLEDGE; IMPACT; PREVENTION; BARRIERS;
   CARE; RECOMMENDATION; INTERVENTIONS; COALITIONS},
Research-Areas = {Oncology; Education \& Educational Research; Public, Environmental \&
   Occupational Health},
Web-of-Science-Categories  = {Oncology; Education, Scientific Disciplines; Public, Environmental \&
   Occupational Health},
Author-Email = {prestonm2@vcu.edu},
Affiliations = {Virginia Commonwealth University},
Cited-References = {Ayanian JZ, 2005, J CLIN ONCOL, V23, P6576, DOI 10.1200/JCO.2005.06.102.
   Balzora S, 2020, GASTROINTEST ENDOSC, V92, P946, DOI 10.1016/j.gie.2020.06.042.
   Baquet C R, 1999, J Assoc Acad Minor Phys, V10, P51.
   Baquet CR, 2012, J HEALTH CARE POOR U, V23, P1806, DOI 10.1353/hpu.2012.0155.
   Butterfoss FD, 1996, HEALTH EDUC QUART, V23, P65, DOI 10.1177/109019819602300105.
   Campo S, 2008, HEALTH EDUC BEHAV, V35, P749, DOI 10.1177/1090198108320358.
   Cole AM, 2013, J PRIM CARE COMMUNIT, V4, P106, DOI 10.1177/2150131912463244.
   Coughlin SS, 2006, CANCER-AM CANCER SOC, V107, P1196, DOI 10.1002/cncr.22017.
   Curry WJ, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-112.
   Davis TC, 2012, J RURAL HEALTH, V28, P306, DOI 10.1111/j.1748-0361.2011.00402.x.
   Fawcett SB, 1997, HEALTH EDUC BEHAV, V24, P812, DOI 10.1177/109019819702400614.
   Fedewa SA, 2015, CANCER-AM CANCER SOC, V121, P3272, DOI 10.1002/cncr.29494.
   Fyffe DC, 2008, J NATL MED ASSOC, V100, P1161, DOI 10.1016/S0027-9684(15)31478-4.
   Goldsmith Geoffrey, 2008, J Fam Pract, V57, pE2.
   Gorodeski EZ, 2020, J CARD FAIL, V26, P448, DOI 10.1016/j.cardfail.2020.04.008.
   Guerra CE, 2005, J HEALTH COMMUN, V10, P651, DOI 10.1080/10810730500267720.
   Hamlyn S, 2008, GASTROENTEROL NURS, V31, P39, DOI 10.1097/01.SGA.0000310935.39304.6d.
   Harris Jeffrey R, 2005, Prev Chronic Dis, V2, pA21.
   Hines R, 2014, AM J PUBLIC HEALTH, V104, pE63, DOI 10.2105/AJPH.2013.301572.
   Hines RB, 2012, J RURAL HEALTH, V28, P296, DOI 10.1111/j.1748-0361.2011.00390.x.
   Institute of Medicine Committee on Assuring the Health of the Public in the 21st C, FUT PUBL HLTH 21 CEN.
   Kerner JF, 2005, CANCER CAUSE CONTROL, V16, P27, DOI 10.1007/s10552-005-0488-y.
   Kerner JF, 2009, TUMORI, V95, P610.
   Lasser KE, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-37.
   Laurencin CT, 2020, J RACIAL ETHN HEALTH, V7, P398, DOI 10.1007/s40615-020-00756-0.
   Lawsin C, 2007, J URBAN HEALTH, V84, P32, DOI 10.1007/s11524-006-9126-6.
   Lemon SC, 2006, AM J PUBLIC HEALTH, V96, P626, DOI 10.2105/AJPH.2004.057976.
   Luque JS, 2011, ANN ANTHROPL PRACT, V35, P112, DOI 10.1111/j.2153-9588.2011.01085.x.
   Meester RGS, 2015, CANCER-AM CANCER SOC, V121, P2281, DOI 10.1002/cncr.29336.
   Mullins CD, 2005, AM J HEALTH-SYST PH, V62, P1873, DOI 10.2146/ajhp050064.
   Paskett ED, 2002, CANCER PRACT, V10, P28, DOI 10.1046/j.1523-5394.2002.101006.x.
   Preston MA, 2018, AM J SURG, V216, P245, DOI 10.1016/j.amjsurg.2017.08.004.
   Rodday AM, 2015, CANCER-AM CANCER SOC, V121, P4025, DOI 10.1002/cncr.29612.
   Rutledge W, 2006, CANCER-AM CANCER SOC, V107, P2052, DOI 10.1002/cncr.22147.
   Sabatino SA, 2008, AM J PREV MED, V35, pS67, DOI 10.1016/j.amepre.2008.04.008.
   Sarfaty M, 2005, PREV MED, V41, P703, DOI 10.1016/j.ypmed.2005.07.005.
   Shokar NK, 2008, J AM BOARD FAM MED, V21, P414, DOI 10.3122/jabfm.2008.05.070266.
   Siegel RL, 2018, CA-CANCER J CLIN, V68, P329, DOI 10.3322/caac.21460.
   Siegel RL, 2015, CANCER EPIDEM BIOMAR, V24, P1151, DOI 10.1158/1055-9965.EPI-15-0082.
   Sutton A, 2019, AM J PUBLIC HEALTH, V109, P1762, DOI 10.2105/AJPH.2019.305318.
   Tabbarah M, 2005, J COMMUN HEALTH, V30, P55, DOI 10.1007/s10900-004-6095-0.
   Theuer CP, 2001, GASTROENTEROLOGY, V120, P848, DOI 10.1053/gast.2001.22535.
   Tossas KY, 2020, EBIOMEDICINE, V53, DOI 10.1016/j.ebiom.2020.102688.
   Tsoh JY, 2018, CANCER-AM CANCER SOC, V124, P1560, DOI 10.1002/cncr.31097.
   van Dorn A, 2020, LANCET, V395, P1243, DOI 10.1016/S0140-6736(20)30893-X.
   Whitaker DE, 2020, CANCER EPIDEM BIOMAR, V29, P910, DOI 10.1158/1055-9965.EPI-19-0972.
   Yeary K, 2011, PREV CHRONIC DIS, V8.
   Zahnd WE, 2018, CANCER EPIDEM BIOMAR, V27, P1265, DOI 10.1158/1055-9965.EPI-17-0430.},
Number-of-Cited-References = {48},
Times-Cited = {1},
Unique-ID = {WOS:000710055700001},
}

@article{ WOS:001152744900009,
Author = {Venkatesh, Kaushik P. and Brito, Gabriel and Boulos, Maged N. Kamel},
Title = {Health Digital Twins in Life Science and Health Care Innovation},
Journal = {ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY},
Year = {2024},
Volume = {64},
Pages = {159-170},
Abstract = {Health digital twins (HDTs) are virtual representations of real
   individuals that can be used to simulate human physiology, disease, and
   drug effects. HDTs can be used to improve drug discovery and development
   by providing a data-driven approach to inform target selection, drug
   delivery, and design of clinical trials. HDTs also offer new
   applications into precision therapies and clinical decision making.The
   deployment ofHDTs at scale could bring a precision approach to public
   health monitoring and intervention. Next steps include challenges such
   as addressing socioeconomic barriers and ensuring the representativeness
   of the technology based on the training and validation data sets.
   Governance and regulation of HDT technology are still in the early
   stages.},
Type = {Review},
Affiliation = {Boulos, MNK (Corresponding Author), Univ Lisbon, Sch Med, Lisbon, Portugal.
   Venkatesh, Kaushik P.; Brito, Gabriel, Harvard Med Sch, Boston, MA 02115 USA.
   Boulos, Maged N. Kamel, Univ Lisbon, Sch Med, Lisbon, Portugal.},
DOI = {10.1146/annurev-pharmtox-022123-022046},
Keywords = {artificial intelligence; health digital twins; drug discovery; precision
   medicine; personalized medicine; precision public health},
Keywords-Plus = {FRAMEWORK; MEDICINE; SUCCESS},
Research-Areas = {Pharmacology \& Pharmacy; Toxicology},
Web-of-Science-Categories  = {Pharmacology \& Pharmacy; Toxicology},
Author-Email = {mnkboulos@ieee.org},
Affiliations = {Harvard University; Harvard Medical School; Universidade de Lisboa},
Cited-References = {Abràmoff MD, 2022, NPJ DIGIT MED, V5, DOI 10.1038/s41746-022-00621-w.
   Abràmoff MD, 2020, AM J OPHTHALMOL, V214, P134, DOI 10.1016/j.ajo.2020.02.022.
   Acosta JN, 2022, NAT MED, V28, P1773, DOI 10.1038/s41591-022-01981-2.
   {[}Anonymous], 2018, Step 3: Clinical Research.
   {*}APPL SUPP, 2023, US CRASH DET IPHONE.
   {*}APPL SUPP, 2023, US FALL DET APPL WAT.
   Armeni P, 2022, J PERS MED, V12, DOI 10.3390/jpm12081255.
   Asan O, 2020, J MED INTERNET RES, V22, DOI 10.2196/15154.
   BARRICELLI BR, 2019, IEEE ACCESS, V71.
   Beauchamp T. L., 2009, Principles of Biomedical Ethics, V6th.
   Boulos MNK, 2021, J PERS MED, V11, DOI 10.3390/jpm11080745.
   Boulos MNK, 2021, MHEALTH, V7, DOI 10.21037/mhealth.2020.01.01.
   Bove LA, 2019, JNP-J NURSE PRACT, V15, P535, DOI 10.1016/j.nurpra.2019.03.018.
   Chen MM, 2021, RADIOL-ARTIF INTELL, V3, DOI 10.1148/ryai.2021210030.
   Coorey G, 2022, NPJ DIGIT MED, V5, DOI 10.1038/s41746-022-00640-7.
   Cuevas-Trisan R, 2017, PHYS MED REH CLIN N, V28, P727, DOI 10.1016/j.pmr.2017.06.006.
   Cunningham C, 2020, SCAND J MED SCI SPOR, V30, P816, DOI 10.1111/sms.13616.
   DUTTON G, 2022, BIOSPACE        0316.
   {*}EDITH CSA, 2023, EDITH EUR VIRT HUM T.
   El Azzaoui Abir, 2021, Advanced Multimedia and Ubiquitous Engineering. MUE-FutureTech 2020. Lecture Notes in Electrical Engineering (LNEE 716), P107, DOI 10.1007/978-981-15-9309-3\_15.
   {*}FDA, 2013, PAV WAY PERS MED FDA.
   {*}FDAREVIEW, 2023, DRUG DEV APPR PROC.
   FENG Y, 2018, SIGNIFICANCES BIOENG.
   Feng Y, 2018, 2018 DESIGN OF MEDICAL DEVICES CONFERENCE, DOI 10.1115/DMD2018-6928.
   Fisher CK, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49656-2.
   Fogel DB, 2018, CONT CLIN TRIAL COMM, V11, P156, DOI 10.1016/j.conctc.2018.08.001.
   Glaessgen E., 2012, 53 AIAA ASME ASCE AH, P1818.
   Grieves M. W., 2005, International Journal of Product Development, V2, P71, DOI 10.1504/IJPD.2005.006669.
   Hingorani AD, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54849-w.
   HOU J, 2022, ARXIV.
   Lal A, 2022, ANN TRANSL MED, V10, DOI 10.21037/atm-22-4203.
   Laubenbacher R, 2021, SCIENCE, V371, P1105, DOI 10.1126/science.abf3370.
   Li DR, 2021, COMPUT URBAN SCI, V1, DOI 10.1007/s43762-021-00005-y.
   Li XX, 2022, GENOME MED, V14, DOI 10.1186/s13073-022-01048-4.
   Manocha A, 2023, KNOWL-BASED SYST, V260, DOI 10.1016/j.knosys.2022.110138.
   Pfister DG, 2004, J CLIN ONCOL, V22, P330, DOI 10.1200/JCO.2004.09.053.
   {*}PMC, 2020, PERS MED REP 2020 OP.
   Popa EO, 2021, LIFE SCI SOC POLICY, V17, DOI 10.1186/s40504-021-00113-x.
   Schuett M, 2022, EUR J PHARM SCI, V179, DOI 10.1016/j.ejps.2022.106310.
   Schwartz SM, 2020, FRONT COMP SCI-SWITZ, V2, DOI 10.3389/fcomp.2020.00031.
   Su DN, 2021, JMIR MHEALTH UHEALTH, V9, DOI 10.2196/25451.
   Subramanian K, 2020, J INDIAN I SCI, V100, P653, DOI 10.1007/s41745-020-00185-2.
   Sun DX, 2022, ACTA PHARM SIN B, V12, P3049, DOI 10.1016/j.apsb.2022.02.002.
   {*}USP, 2023, DISS DRUG REL TESTS.
   Venkatesh KP, 2022, NPJ DIGIT MED, V5, DOI 10.1038/s41746-022-00694-7.
   Venkatesh KP, 2022, NPJ DIGIT MED, V5, DOI 10.1038/s41746-022-00662-1.
   Voigt I, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.669811.
   Yodpijit N, 2017, 2017 3RD INTERNATIONAL CONFERENCE ON CONTROL, AUTOMATION AND ROBOTICS (ICCAR), P543, DOI 10.1109/ICCAR.2017.7942756.
   Zhang P, 2022, INT J ENV RES PUB HE, V19, DOI 10.3390/ijerph191911876.},
Number-of-Cited-References = {49},
Times-Cited = {6},
Unique-ID = {WOS:001152744900009},
}

@article{ WOS:001145603300001,
Author = {La Cerda, Isela De and Bauer, Cici X. and Zhang, Kehe and Lee, Miryoung
   and Jones, Michelle and Rodriguez, Arturo and Mccormick, Joseph B. and
   Fisher-Hoch, Susan P.},
Title = {Evaluation of a Targeted COVID-19 Community Outreach Intervention: Case
   Report for Precision Public Health},
Journal = {JMIR PUBLIC HEALTH AND SURVEILLANCE},
Year = {2023},
Volume = {9},
Abstract = {Background: Cameron County, a low-income south Texas-Mexico border
   county marked by severe health disparities, was consistently among the
   top counties with the highest COVID-19 mortality in Texas at the onset
   of the pandemic. The disparity in COVID-19 burden within Texas counties
   revealed the need for effective interventions to address the specific
   needs of local health departments and their communities. Publicly
   available COVID-19 surveillance data were not sufficiently timely or
   granular to deliver such targeted interventions. An agency-academic
   collaboration in Cameron used novel geographic information science
   methods to produce granular COVID-19 surveillance data. These data were
   used to strategically target an educational outreach intervention named
   ``Boots on the Ground{''} (BOG) in the City of Brownsville (COB).
   Objective: This study aimed to evaluate the impact of a spatially
   targeted community intervention on daily COVID-19 test counts. Methods:
   The agency-academic collaboration between the COB and UTHealth Houston
   led to the creation of weekly COVID-19 epidemiological reports at the
   census tract level. These reports guided the selection of census tracts
   to deliver targeted BOG between April 21 and June 8, 2020. Recordkeeping
   of the targeted BOG tracts and the intervention dates, along with
   COVID-19 daily testing counts per census tract, provided data for
   intervention evaluation. An interrupted time series design was used to
   evaluate the impact on COVID-19 test counts 2 weeks before and after
   targeted BOG. A piecewise Poisson regression analysis was used to
   quantify the slope (sustained) and intercept (immediate) change between
   pre-and post-BOG COVID-19 daily test count trends. Additional analysis
   of COB tracts that did not receive targeted BOG was conducted for
   comparison purposes.Results: During the intervention period, 18 of the
   48 COB census tracts received targeted BOG. Among these, a significant
   change in the slope between pre-and post-BOG daily test counts was
   observed in 5 tracts, 80\% (n=4) of which had a positive slope change. A
   positive slope change implied a significant increase in daily COVID-19
   test counts 2 weeks after targeted BOG compared to the testing trend
   observed 2 weeks before intervention. In an additional analysis of the
   30 census tracts that did not receive targeted BOG, significant slope
   changes were observed in 10 tracts, of which positive slope changes were
   only observed in 20\% (n=2). In summary, we found that BOG-targeted
   tracts had mostly positive daily COVID-19 test count slope changes,
   whereas untargeted tracts had mostly negative daily COVID-19 test count
   slope changes. Conclusions: Evaluation of spatially targeted community
   interventions is necessary to strengthen the evidence base of this
   important approach for local emergency preparedness. This report
   highlights how an academic-agency collaboration established and
   evaluated the impact of a real-time, targeted intervention delivering
   precision public health to a small community.},
Type = {Article},
Affiliation = {Fisher-Hoch, SP (Corresponding Author), Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth Brownsville Campus, Dept Epidemiol Human Genet \& Environm Sci, 780 Ringgold Rd, Brownsville, TX 78520 USA.
   Bauer, Cici X.; Zhang, Kehe, Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth Brownsville Campus, Dept Epidemiol Human Genet \& Environm Sci, Brownsville, TX USA.
   Jones, Michelle; Rodriguez, Arturo, Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Dept Biostat \& Data Sci, Houston, TX USA.
   Fisher-Hoch, Susan P., Publ Hlth Dept, Brownsville, TX USA.
   Fisher-Hoch, Susan P., Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth Brownsville Campus, Dept Epidemiol Human Genet \& Environm Sci, 780 Ringgold Rd, Brownsville, TX 78520 USA.},
DOI = {10.2196/47981},
Article-Number = {e47981},
Keywords = {community interventions; emergency preparedness; health disparities;
   intervention evaluation; precision public health; public health
   informatics; public health intervention; public health; spatial
   epidemiology; surveillance},
Keywords-Plus = {INTERRUPTED TIME-SERIES; REGRESSION},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {Susan.P.Fisher-Hoch@uth.tmc.edu},
Affiliations = {University of Texas System; University of Texas Health Science Center
   Houston; University of Texas System; University of Texas Health Science
   Center Houston; University of Texas School Public Health; University of
   Texas System; University of Texas Health Science Center Houston},
Cited-References = {{[}Anonymous], 2018, U.S. Census Bureau.
   Bernal JL, 2017, INT J EPIDEMIOL, V46, P348, DOI 10.1093/ije/dyw098.
   Biglan A, 2000, Prev Sci, V1, P31, DOI 10.1023/A:1010024016308.
   Blackburn CC, 2022, J HUMANIST PSYCHOL, DOI 10.1177/00221678221118708.
   Bottomley Christian, 2019, Epidemiol Method, V8, DOI {[}DOI 10.1515/EM-2018-0010, 10.1515/em-2018-0010].
   Brownsville Cares, 2021, ABOUT US.
   Buckeridge David L, 2020, Yearb Med Inform, V29, P226, DOI 10.1055/s-0040-1701989.
   Cargo K, Corpus Christi Caller-Times.
   Fisher-Hoch SP, 2010, PREV CHRONIC DIS, V7.
   Gebbie K, 2003, WHO WILL KEEP THE PUBLIC HEALTHY?, P27.
   Kee F, 2020, J EPIDEMIOL COMMUN H, V74, P311, DOI 10.1136/jech-2019-213311.
   Khullar D, 2021, JAMA-HEALTH FORUM, V2, DOI 10.1001/jamahealthforum.2021.0290.
   Khundi M, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-044715.
   Lindholm L, 2000, J EPIDEMIOL COMMUN H, V54, P617, DOI 10.1136/jech.54.8.617.
   McCormick JB, 2010, BIOSECUR BIOTERROR, V8, P233, DOI 10.1089/bsp.2010.0014.
   Muggeo V.M.R., 2008, R news, V8, P20.
   Posit, 2022, ABOUT US.
   Texas Department of State Health Services, Historical Texas COVID-19 data.
   TX-Municipal Government, 2022, ABOUT US.
   U.S. Census Bureau, QuickFacts: Brownsville city, Texas.
   Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x.
   Walker Kyle, 2024, CRAN.},
Number-of-Cited-References = {22},
Times-Cited = {0},
Unique-ID = {WOS:001145603300001},
}

@article{ WOS:000455473700015,
Author = {Lu, Fred S. and Hattab, Mohammad W. and Leonardo Clemente, Cesar and
   Biggerstaff, Matthew and Santillana, Mauricio},
Title = {Improved state-level influenza nowcasting in the United States
   leveraging Internet-based data and network approaches},
Journal = {NATURE COMMUNICATIONS},
Year = {2019},
Volume = {10},
Month = {JAN 11},
Abstract = {In the presence of health threats, precision public health approaches
   aim to provide targeted, timely, and population-specific interventions.
   Accurate surveillance methodologies that can estimate infectious disease
   activity ahead of official healthcare-based reports, at relevant spatial
   resolutions, are important for achieving this goal. Here we introduce a
   methodological framework which dynamically combines two distinct
   influenza tracking techniques, using an ensemble machine learning
   approach, to achieve improved state-level influenza activity estimates
   in the United States. The two predictive techniques behind the ensemble
   utilize (1) a self-correcting statistical method combining
   influenza-related Google search frequencies, information from electronic
   health records, and historical flu trends within each state, and (2) a
   network-based approach leveraging spatio-temporal synchronicities
   observed in historical influenza activity across states. The ensemble
   considerably outperforms each component method in addition to previously
   proposed state-specific methods for influenza tracking, with higher
   correlations and lower prediction errors.},
Type = {Article},
Affiliation = {Lu, FS; Santillana, M (Corresponding Author), Boston Childrens Hosp, Computat Hlth Informat Program, Boston, MA 02115 USA.
   Santillana, M (Corresponding Author), Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA.
   Lu, Fred S.; Santillana, Mauricio, Boston Childrens Hosp, Computat Hlth Informat Program, Boston, MA 02115 USA.
   Hattab, Mohammad W., Harvard Med Sch, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA.
   Leonardo Clemente, Cesar, Tecnol Monterrey, Monterrey 64849, NL, Mexico.
   Biggerstaff, Matthew, Ctr Dis Control \& Prevent, Influenza Div, Natl Ctr Immunizat \& Resp Dis, Atlanta, GA 30333 USA.
   Santillana, Mauricio, Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA.},
DOI = {10.1038/s41467-018-08082-0},
Article-Number = {147},
Research-Areas = {Science \& Technology - Other Topics},
Web-of-Science-Categories  = {Multidisciplinary Sciences},
Author-Email = {fredlu.flac@gmail.com
   msantill@g.harvard.edu},
Affiliations = {Harvard University; Boston Children's Hospital; Harvard University;
   Harvard Medical School; Tecnologico de Monterrey; Centers for Disease
   Control \& Prevention - USA; Harvard University; Harvard Medical School},
Cited-References = {{[}Anonymous], 2018, OV INFL SURV US SEAS.
   {[}Anonymous], 2018, DIS BURD INFL SEAS I.
   Brooks LC, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004382.
   Charu V, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005382.
   Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523.
   Davidson MW, 2015, SCI REP-UK, V5, DOI 10.1038/srep08154.
   Dolley S, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00068.
   Dukic V, 2012, J AM STAT ASSOC, V107, P1410, DOI 10.1080/01621459.2012.713876.
   Gog JR, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003635.
   Kandula S, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.7486.
   Khoury MJ, 2016, AM J PREV MED, V50, P398, DOI 10.1016/j.amepre.2015.08.031.
   Lampos V, 2015, SCI REP-UK, V5, DOI 10.1038/srep12760.
   Lu F., 2018, REPLICATION DATA IMP, DOI {[}10.7910/DVN/L5NT70, DOI 10.7910/DVN/L5NT70].
   Lu FS, 2018, JMIR PUBLIC HLTH SUR, V4, P31, DOI 10.2196/publichealth.8950.
   McGough SF, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005295.
   Moss R, 2017, EPIDEMIOL INFECT, V145, P156, DOI 10.1017/S0950268816002053.
   Moss R, 2018, AUST NZ J PUBL HEAL, V42, P69, DOI 10.1111/1753-6405.12750.
   Olson DR, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003256.
   Pedregosa F, 2011, J MACH LEARN RES, V12, P2825.
   Santillana M, 2016, SCI REP-UK, V6, DOI 10.1038/srep25732.
   Santillana M, 2017, CLIN INFECT DIS, V64, P42, DOI 10.1093/cid/ciw660.
   Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237.
   Wei T., 2017, R PACKAGE CORRPLOT V.
   Wickham H., 2016, GGPLOT2 ELEGANT GRAP, DOI {[}DOI 10.1007/978-3-319-24277-4, 10.1007/978-3-319-24277-4].
   Yang SH, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005607.
   Yang SH, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2424-7.
   Yang SH, 2015, P NATL ACAD SCI USA, V112, P14473, DOI 10.1073/pnas.1515373112.
   Yang W, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005201.
   Yang W, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004383.
   Yang W, 2015, P NATL ACAD SCI USA, V112, P2723, DOI 10.1073/pnas.1415012112.
   Yang W, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003583.
   Zou B, 2018, WEB CONFERENCE 2018: PROCEEDINGS OF THE WORLD WIDE WEB CONFERENCE (WWW2018), P87, DOI 10.1145/3178876.3186050.},
Number-of-Cited-References = {32},
Times-Cited = {52},
Unique-ID = {WOS:000455473700015},
}

@article{ WOS:000527333300005,
Author = {Conrad, Karsten and Shoenfeld, Yehuda and Fritzler, Marvin J.},
Title = {Precision health: A pragmatic approach to understanding and addressing
   key factors in autoimmune diseases},
Journal = {AUTOIMMUNITY REVIEWS},
Year = {2020},
Volume = {19},
Number = {5},
Month = {MAY},
Abstract = {The past decade has witnessed a significant paradigm shift in the
   clinical approach to autoimmune diseases, lead primarily by initiatives
   in precision medicine, precision health and precision public health
   initiatives. An understanding and pragmatic implementation of these
   approaches require an understanding of the drivers, gaps and limitations
   of precision medicine. Gaining the trust of the public and patients is
   paramount but understanding that technologies such as artificial
   intelligences and machine learning still require context that can only
   be provided by human input or what is called augmented machine learning.
   The role of genomics, the microbiome and proteomics, such as
   autoantibody testing, requires continuing refinement through research
   and pragmatic approaches to their use in applied precision medicine.},
Type = {Review},
Affiliation = {Fritzler, MJ (Corresponding Author), Univ Calgary, Cumming Sch Med, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.
   Conrad, Karsten, Tech Univ Dresden, Med Fac Carl Gustav Carus, Inst Immunol, Dresden, Germany.
   Shoenfeld, Yehuda, Sheba Med Ctr, Zabludowicz Ctr Autoimmune Dis, Tel Hashomer, Israel.
   Shoenfeld, Yehuda, Sheba Med Ctr, Dept Med, Tel Hashomer, Israel.
   Shoenfeld, Yehuda, Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel.
   Fritzler, Marvin J., Univ Calgary, Cumming Sch Med, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.},
DOI = {10.1016/j.autrev.2020.102508},
Article-Number = {102508},
Keywords = {Precision medicine; Precision health; Autoinflammatory diseases;
   Autoimmune diseases; Autoantibodies; Biomarker},
Keywords-Plus = {PATIENT DATA OWNERSHIP; INTERNATIONAL CONSENSUS; MEDICINE;
   AUTOANTIBODIES; ANTIBODIES; DISORDERS; PATHWAYS; DEATH; INFLAMMATION;
   METAANALYSIS},
Research-Areas = {Immunology},
Web-of-Science-Categories  = {Immunology},
Author-Email = {fritzler@ucalgary.ca},
Affiliations = {Technische Universitat Dresden; Carl Gustav Carus University Hospital;
   Chaim Sheba Medical Center; Chaim Sheba Medical Center; Tel Aviv
   University; Sackler Faculty of Medicine; University of Calgary},
Cited-References = {American College of Rheumatology, 2011, POS STAT METH TEST A.
   Anaya Juan-Manuel, 2007, Expert Rev Clin Immunol, V3, P623, DOI 10.1586/1744666X.3.4.623.
   {[}Anonymous], 2019, PRECISION MED 2019.
   Arbuckle MR, 2003, NEW ENGL J MED, V349, P1526, DOI 10.1056/NEJMoa021933.
   Aringer M, 2019, ANN RHEUM DIS, V78, P1151, DOI 10.1136/annrheumdis-2018-214819.
   Aringer M, 2019, ARTHRITIS RHEUMATOL, V71, P1400, DOI {[}10.1136/annrheumdis-2018-214819, 10.1002/art.40930].
   Auffray C, 2016, GENOME MED, V8, DOI {[}10.1186/s13073-016-0265-4, 10.1186/s13073-016-0323-y].
   Barbhaiya M, 2018, ANN RHEUM DIS, V77, P196, DOI 10.1136/annrheumdis-2017-211675.
   Bastiaansen AEM, 2017, CURR OPIN NEUROL, V30, P302, DOI 10.1097/WCO.0000000000000444.
   Baxi S, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k793.
   Bernatsky S, 2011, J RHEUMATOL, V38, P1612, DOI 10.3899/jrheum.101149.
   Bizzaro N, 2020, ANN RHEUM DIS, V79, DOI 10.1136/annrheumdis-2018-214805.
   Bizzaro N, 2018, AUTOIMMUN REV, V17, P541, DOI 10.1016/j.autrev.2017.12.007.
   Blank M, 2008, J AUTOIMMUN, V30, P1, DOI 10.1016/j.jaut.2007.11.015.
   Bossuyt X, 2017, NAT REV RHEUMATOL, V13, P683, DOI 10.1038/nrrheum.2017.140.
   Bradshaw MJ, 2018, SEMIN NEUROL, V38, P330, DOI 10.1055/s-0038-1660821.
   Brown EM, 2019, ANNU REV IMMUNOL, V37, P599, DOI 10.1146/annurev-immunol-042718-041841.
   Bruscolini A, 2018, AUTOIMMUN REV, V17, P195, DOI 10.1016/j.autrev.2018.01.001.
   Castaneda Christian, 2015, J Clin Bioinforma, V5, P4, DOI 10.1186/s13336-015-0019-3.
   Ceccarelli F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207926.
   Chan EKL, 2016, LUPUS, V25, P797, DOI 10.1177/0961203316640920.
   Choi MY, 2019, LUPUS, V28, P1285, DOI 10.1177/0961203319868531.
   Choi MY, 2016, LUPUS, V25, P838, DOI 10.1177/0961203316640367.
   Choi MY, 2019, ARTHRIT CARE RES, V71, P893, DOI 10.1002/acr.23712.
   Choi MY, 2016, CURR OPIN RHEUMATOL, V28, P586, DOI 10.1097/BOR.0000000000000325.
   Claessens J, 2018, AUTOIMMUN REV, V17, P533, DOI 10.1016/j.autrev.2018.03.002.
   Colón-Franco JM, 2018, CLIN CHEM, V64, P885, DOI 10.1373/clinchem.2017.275677.
   Cortese A, 2019, NEUROL NEUROIMMUNOL, V7.
   Cotsapas C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002254.
   Damoiseaux J, 2016, AUTOIMMUN HIGHLIGHTS, V7, DOI 10.1007/s13317-016-0075-0.
   Das B, 2019, J BIOSCIENCES, V44, DOI 10.1007/s12038-019-9926-y.
   Davies B, 2020, BIOETHICS, V34, P459, DOI 10.1111/bioe.12693.
   Day S, 2017, ADV EXP MED BIOL, V1031, P207, DOI 10.1007/978-3-319-67144-4\_12.
   de Amorim JC, 2018, BEST PRACT RES CL RH, V32, P623, DOI 10.1016/j.berh.2019.01.020.
   de Bock L, 2016, EUR J NEUROL, V23, P722, DOI 10.1111/ene.12925.
   Dehner C, 2019, CURR OPIN RHEUMATOL, V31, P201, DOI 10.1097/BOR.0000000000000574.
   Esposito S, 2019, AUTOIMMUN REV, V18, P155, DOI 10.1016/j.autrev.2018.08.009.
   Fischer A, 2015, EUR RESPIR J, V46, P976, DOI 10.1183/13993003.00150-2015.
   Fitch-Rogalsky C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093812.
   Forbes JD, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0603-4.
   Fritzler MJ, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02682.
   Fritzler MJ, 2018, NAT REV RHEUMATOL, V14, P451, DOI 10.1038/s41584-018-0035-3.
   Fritzler MJ, 2016, AUTOIMMUN REV, V15, P272, DOI 10.1016/j.autrev.2015.12.002.
   Fritzler MJ, 2019, J RHEUMATOL RES, V1, P10.
   Fröhlich H, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1122-7.
   Gamo NJ, 2017, NEUROSCI RES, V115, P1, DOI 10.1016/j.neures.2016.11.003.
   Garg N, 2019, EUR J NEUROL, V26, P1121, DOI 10.1111/ene.13953.
   Geng GJ, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2019.102422.
   Gershwin ME, 2008, AUTOIMMUN REV, V7, P161, DOI 10.1016/j.autrev.2007.11.021.
   Ghaly S, 2019, EXPERT REV GASTROENT, V13, P1039, DOI 10.1080/17474124.2019.1685874.
   Gilbert DL, 2019, J CHILD NEUROL, V34, P598, DOI 10.1177/0883073819848635.
   Gray TF, 2019, INT J NURS STUD, V92, P79, DOI 10.1016/j.ijnurstu.2019.01.006.
   Gutierrez-Arcelus M, 2016, NAT REV GENET, V17, P160, DOI 10.1038/nrg.2015.33.
   Hamburg MA, 2010, NEW ENGL J MED, V363, P301, DOI 10.1056/NEJMp1006304.
   Hayter SM, 2012, AUTOIMMUN REV, V11, P754, DOI 10.1016/j.autrev.2012.02.001.
   Hazlewood GS, 2018, RHEUM DIS CLIN N AM, V44, P337, DOI 10.1016/j.rdc.2018.01.009.
   He Y, 2018, CURR OPIN RHEUMATOL, V30, P490, DOI 10.1097/BOR.0000000000000522.
   Höftberger R, 2015, CURR OPIN ONCOL, V27, P489, DOI 10.1097/CCO.0000000000000222.
   Hudson J, 2013, DRUG DISCOV TODAY, V18, P610, DOI 10.1016/j.drudis.2013.01.012.
   Hudson M, 2013, CLIN RHEUMATOL, V86, P127.
   Iorio R, 2019, SEMIN DIAGN PATHOL, V36, P279, DOI 10.1053/j.semdp.2019.06.005.
   Jaiswal SJ, 2019, LANCET, V393, P639, DOI 10.1016/S0140-6736(19)30240-5.
   James JA, 2020, RHEUMATOLOGY, V59, P860, DOI 10.1093/rheumatology/kez335.
   Jangi S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12015.
   JELLUM E, 1993, SCI TOTAL ENVIRON, V140, P527, DOI 10.1016/0048-9697(93)90049-C.
   Jeppesen R, 2019, FRONT PSYCHIATRY, V10, DOI 10.3389/fpsyt.2019.00131.
   Jha S, 2018, J AM COLL RADIOL, V15, P509, DOI 10.1016/j.jacr.2017.12.025.
   Khoury MJ, 2016, AM J PREV MED, V50, P398, DOI 10.1016/j.amepre.2015.08.031.
   Koneczny I, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8070671.
   Konstantinidou MK, 2017, MOL DIAGN THER, V21, P601, DOI 10.1007/s40291-017-0291-y.
   Kostine M, 2019, RHEUMATOLOGY, V58, P68, DOI 10.1093/rheumatology/kez295.
   Lewis MJ, 2018, J AUTOIMMUN, V91, P1, DOI 10.1016/j.jaut.2018.02.009.
   Li QZ, 2010, CLIN EXP IMMUNOL, V159, P281, DOI 10.1111/j.1365-2249.2009.04057.x.
   Magos-Lopez C, 1992, Salud Publica Mex, V34, P136.
   Mahler M, 2020, ANN RHEUM DIS, V79, DOI 10.1136/annrheumdis-2019-216000.
   Mahler M, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00848.
   Mahler M, 2014, J RHEUMATOL, V41, P1260, DOI 10.3899/jrheum.140480.
   Mahler M, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/315179.
   Mariampillai K, 2018, JAMA NEUROL, V75, P1528, DOI 10.1001/jamaneurol.2018.2598.
   McClain MT, 2004, ARTHRITIS RHEUM-US, V50, P1226, DOI 10.1002/art.20120.
   Meffre E, 2019, IMMUNOL REV, V292, P90, DOI 10.1111/imr.12821.
   Meroni PL, 2018, CLIN CHEM LAB MED, V56, P1743, DOI 10.1515/cclm-2018-0066.
   Meroni PL, 2019, ANN RHEUM DIS, V78, DOI 10.1136/annrheumdis-2018-213440.
   Meroni PL, 2014, NAT REV RHEUMATOL, V10, P35, DOI 10.1038/nrrheum.2013.180.
   Meroni PL, 2010, ANN RHEUM DIS, V69, P1420, DOI 10.1136/ard.2009.127100.
   Michot JM, 2016, EUR J CANCER, V54, P139, DOI 10.1016/j.ejca.2015.11.016.
   Mikk KA, 2018, JAMA-J AM MED ASSOC, V319, P935, DOI 10.1001/jama.2017.21688.
   Mikk KA, 2017, JAMA-J AM MED ASSOC, V318, P1433, DOI 10.1001/jama.2017.12145.
   Moritz CP, 2020, J PROTEOMICS, V212, DOI 10.1016/j.jprot.2019.103575.
   Muse ED, 2018, LANCET, V391, P2405, DOI 10.1016/S0140-6736(18)31272-8.
   Nakamura RM, 1984, LAB MED, V15, P190.
   Nogueira AR, 2019, CURR OPIN RHEUMATOL, V31, P471, DOI 10.1097/BOR.0000000000000628.
   Olsen NJ, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1380-3.
   Orme ME, 2018, BEST PRACT RES CL RH, V32, P521, DOI 10.1016/j.berh.2019.03.005.
   Papadakis GZ, 2019, BIOMED REP, V10, P215, DOI 10.3892/br.2019.1199.
   Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239.
   Pérez D, 2018, AUTOIMMUN REV, V17, P548, DOI 10.1016/j.autrev.2017.12.008.
   Pérez-De-Lis M, 2017, EXPERT OPIN DRUG SAF, V16, P1255, DOI 10.1080/14740338.2017.1372421.
   Pezo RC, 2019, THER ADV GASTROENTER, V12, DOI 10.1177/1756284819870911.
   Pianta A, 2017, J CLIN INVEST, V127, P2946, DOI 10.1172/JCI93450.
   Pianta A, 2017, ARTHRITIS RHEUMATOL, V69, P964, DOI 10.1002/art.40003.
   Pinal-Fernandez I, 2020, ANN RHEUM DIS, V79, DOI 10.1136/annrheumdis-2019-215852.
   Pisetsky DS, 2018, ANN RHEUM DIS, V77, P911, DOI 10.1136/annrheumdis-2017-212599.
   Pisetsky DS, 2019, ARTHRIT CARE RES, V71, P696, DOI 10.1002/acr.23559.
   Pisetsky DS, 2017, NAT REV RHEUMATOL, V13, P495, DOI 10.1038/nrrheum.2017.74.
   Pisetsky DS, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3878.
   Raj P, 2016, ELIFE, V5, DOI 10.7554/eLife.12089.
   Rajkomar A, 2019, NEW ENGL J MED, V380, P1347, DOI 10.1056/NEJMra1814259.
   Ramos-Casals M, 2010, AUTOIMMUN REV, V9, P188, DOI 10.1016/j.autrev.2009.10.003.
   Rifai N, 2015, CLIN CHEM, V61, P1129, DOI 10.1373/clinchem.2015.243667.
   Rohr UP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149856.
   Salazar GA, 2015, SEMIN ARTHRITIS RHEU, V44, P680, DOI 10.1016/j.semarthrit.2014.11.006.
   Sawalha AH, 2018, ARTHRITIS RHEUMATOL, V70, P330, DOI 10.1002/art.40371.
   Scherer HU, 2013, Z RHEUMATOL, V72, P20, DOI 10.1007/s00393-011-0884-5.
   Schiff GD, 2009, ARCH INTERN MED, V169, P1881, DOI 10.1001/archinternmed.2009.333.
   Sepúlveda M, 2018, MULT SCLER J, V24, P1753, DOI 10.1177/1352458517731914.
   Sheldon J, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00194.
   Shepshelovich D, 2006, LUPUS, V15, P183, DOI 10.1191/0961203306lu2274rr.
   Shoenfeld Y, 2019, CLIN IMMUNOL, V199, P1, DOI 10.1016/j.clim.2018.12.003.
   Shreffler WG, 2019, ANN ALLERG ASTHMA IM, V123, P534, DOI 10.1016/j.anai.2019.10.009.
   Smoldt RK, 2007, MAYO CLIN PROC, V82, P210.
   Spellerberg M, 2017, PATHOLOGY, V49, P565, DOI 10.1016/j.pathol.2017.07.006.
   Spielmann L, 2019, ANN RHEUM DIS, V78, P1101, DOI 10.1136/annrheumdis-2018-214439.
   Stinton LM, 2004, CLIN IMMUNOL, V110, P30, DOI 10.1016/j.clim.2003.10.005.
   Swedo SE, 2017, J CHILD ADOLESC PSYC, P10.
   Tarassenko L, 2018, JAMA-J AM MED ASSOC, V320, P2309, DOI 10.1001/jama.2018.16558.
   Tekturk P, 2018, BRAIN DEV-JPN, V40, P909, DOI 10.1016/j.braindev.2018.06.002.
   Topol EJ, 2019, NAT MED, V25, P44, DOI 10.1038/s41591-018-0300-7.
   Topol EJ, 2014, CELL, V157, P241, DOI 10.1016/j.cell.2014.02.012.
   Torkamani A, 2017, CELL, V170, P828, DOI 10.1016/j.cell.2017.08.007.
   Uncini A, 2018, J NEUROL NEUROSUR PS, V89, P627, DOI 10.1136/jnnp-2017-317192.
   Ungureanu A, 2018, REV NEUROL-FRANCE, V174, P675, DOI 10.1016/j.neurol.2018.01.378.
   Vaglio A, 2018, AUTOIMMUN REV, V17, P912, DOI 10.1016/j.autrev.2018.03.016.
   Virkud YV, 2019, ANN ALLERG ASTHMA IM, V123, P558, DOI 10.1016/j.anai.2019.09.017.
   Vural A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01029.
   Wasko NJ, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2019.102430.
   Weinmann SC, 2019, RHEUMATOLOGY, V58, P59, DOI 10.1093/rheumatology/kez308.
   Wilbur C, 2019, PAED CHILD HEALT-CAN, V24, P85, DOI 10.1093/pch/pxy145.
   Xu HH, 2019, J IMMUNOL RES, V2019, DOI 10.1155/2019/7546047.
   Yaniv G, 2015, AUTOIMMUN REV, V14, P75, DOI 10.1016/j.autrev.2014.10.003.
   Yoon PW, 2014, MMWR-MORBID MORTAL W, V63, P369.
   Zheng JF, 2013, HUM IMMUNOL, V74, P986, DOI 10.1016/j.humimm.2013.04.034.
   Zitnik IP, 2018, CLIN CHEM LAB MED, V56, P1981, DOI 10.1515/cclm-2018-0181.},
Number-of-Cited-References = {143},
Times-Cited = {21},
Unique-ID = {WOS:000527333300005},
}

@article{ WOS:000458381700005,
Author = {Thaler, David S. and Head, Michael G. and Horsley, Andrew},
Title = {Precision public health to inhibit the contagion of disease and move
   toward a future in which microbes spread health},
Journal = {BMC INFECTIOUS DISEASES},
Year = {2019},
Volume = {19},
Month = {FEB 6},
Abstract = {Antimicrobial resistance continues to outpace the development of new
   chemotherapeutics. Novel pathogens continue to evolve and emerge. Public
   health innovation has the potential to open a new front in the war of
   our wits against their genes (Joshua Lederberg). Dense sampling coupled
   to next generation sequencing can increase the spatial and temporal
   resolution of microbial characterization while sensor technologies
   precisely map physical parameters relevant to microbial survival and
   spread. Microbial, physical, and epidemiological big data could be
   combined to improve prospective risk identification. However, applied in
   the wrong way, these approaches may not realize their maximum potential
   benefits and could even do harm. Minimizing microbial-human interactions
   would be a mistake. There is evidence that microbes previously thought
   of at best benign may actually enhance human health. Benign and
   health-promoting microbiomes may, or may not, spread via mechanisms
   similar to pathogens. Infectious vaccines are approaching readiness to
   make enhanced contributions to herd immunity. The rigorously defined
   nature of infectious vaccines contrasts with indigenous benign or
   health-promoting microbiomes but they may converge. A microbial
   Neolithic revolution is a possible future in which human
   microbial-associations are understood and managed analogously to the
   macro-agriculture of plants and animals. Tradeoffs need to be framed in
   order to understand health-promoting potentials of benign, and/or
   health-promoting microbiomes and infectious vaccines while also
   discouraging pathogens. Super-spreaders are currently defined as
   individuals who play an outsized role in the contagion of infectious
   disease. A key unanswered question is whether the super-spreader concept
   may apply similarly to health-promoting microbes. The complex
   interactions of individual rights, community health, pathogen contagion,
   the spread of benign, and of health-promoting microbiomes including
   infectious vaccines require study. Advancing the detailed understanding
   of heterogeneity in microbial spread is very likely to yield important
   insights relevant to public health.},
Type = {Article},
Affiliation = {Thaler, DS (Corresponding Author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
   Thaler, David S., Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
   Head, Michael G., Univ Southampton, Univ Hosp Southampton, Clin Informat Res Unit, Fac Med, Coxford Rd, Southampton SO16 6YD, Hants, England.
   Horsley, Andrew, Australian Natl Univ, Res Sch Phys \& Engn, Mills Rd, Canberra, ACT 2601, Australia.},
DOI = {10.1186/s12879-019-3715-y},
Article-Number = {120},
Keywords = {Precision medicine; Vaccines; Infectious vaccines; Public health;
   Precision public health; Infectious disease; Epidemiology; Bioethics;
   Microbiome; Healthy buildings},
Keywords-Plus = {EAST RESPIRATORY SYNDROME; CLIMATE FACTORS; ENVIRONMENT; TRANSMISSION;
   HUMIDITY; OUTBREAK; GROWTH; INFECTIONS; INFLUENZA; MEDICINE},
Research-Areas = {Infectious Diseases},
Web-of-Science-Categories  = {Infectious Diseases},
Author-Email = {david.thaler@unibas.ch},
Affiliations = {University of Basel; University of Southampton; Australian National
   University},
Cited-References = {Adams RI, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0347-6.
   Alcaïs A, 2010, ANN NY ACAD SCI, V1214, P18, DOI 10.1111/j.1749-6632.2010.05834.x.
   Alimenti F, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17061388.
   Aly HAA, 2015, WHO TECH REP SER, V994, P1.
   {[}Anonymous], 2013, IMPACT LIVESTOCK DIS.
   Armstrong GL, 1999, JAMA-J AM MED ASSOC, V281, P61, DOI 10.1001/jama.281.1.61.
   Balaras CA, 2002, ENERG BUILDINGS, V34, P171, DOI 10.1016/S0378-7788(01)00105-0.
   Bokulich NA, 2016, CURR OPIN BIOTECH, V37, P182, DOI 10.1016/j.copbio.2015.12.008.
   Bope A, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0552-y.
   Bull JJ, 2018, TRENDS MICROBIOL, V26, P6, DOI 10.1016/j.tim.2017.09.007.
   Callewaert C, 2014, APPL ENVIRON MICROB, V80, P6611, DOI 10.1128/AEM.01422-14.
   Canadell JG, 2007, P NATL ACAD SCI USA, V104, P18866, DOI 10.1073/pnas.0702737104.
   Capineri L, 2017, MEAS SCI TECHNOL, V28, DOI 10.1088/1361-6501/28/1/014008.
   Cassell JA, 2018, LANCET INFECT DIS, V18, P894, DOI 10.1016/S1473-3099(18)30347-5.
   Cato KD, 2016, J EMPIR RES HUM RES, V11, P214, DOI 10.1177/1556264616661611.
   Chang CY, 2017, SENSORS BASEL, V17.
   Chong KC, 2015, INT J ENV RES PUB HE, V12, P1560, DOI 10.3390/ijerph120201560.
   Chowkwanyun M, 2018, NEW ENGL J MED, V379, P1398, DOI 10.1056/NEJMp1806634.
   Clift C, 2017, VACCINE, V35, P6591, DOI 10.1016/j.vaccine.2017.09.053.
   Czaplewski L, 2016, LANCET INFECT DIS, V16, P239, DOI 10.1016/S1473-3099(15)00466-1.
   Dai DJ, 2017, ENVIRON SCI TECHNOL, V51, P7759, DOI 10.1021/acs.est.7b01097.
   Dawkins Richard, 1989, The Selfish Gene, V2.
   DEDUVE C, 1981, J CELL BIOL, V91, pS293, DOI 10.1083/jcb.91.3.293s.
   Dubos Rene., 1965, MAN ADAPTING.
   Dugarova E., 2017, Ageing, older persons and the 2030 agenda for sustainable development.
   Farahani H, 2014, SENSORS-BASEL, V14, P7881, DOI 10.3390/s140507881.
   Friedrich M, 2017, WATER SCI TECHNOL, V75, P501, DOI 10.2166/wst.2016.439.
   Gates B, 2018, ANN LETT.
   Ginsburg AS, 2017, LANCET GLOB HEALTH, V5, pE1176, DOI 10.1016/S2214-109X(17)30364-9.
   Godfrey A, 2018, MATURITAS, V113, P40, DOI 10.1016/j.maturitas.2018.04.012.
   Godlee F, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3907.
   Gopinath S, 2014, P NATL ACAD SCI USA, V111, P15780, DOI 10.1073/pnas.1409968111.
   Gopinath S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003408.
   Grinshpun SA, 2017, J OCCUP ENVIRON HYG, V14, P583, DOI 10.1080/15459624.2017.1304645.
   GRODY NC, 1976, IEEE T ANTENN PROPAG, V24, P155, DOI 10.1109/TAP.1976.1141324.
   Handorean A, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0132-3.
   Hanley BP, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-98.
   Harari Y. N., 2019, 21 lessons for the 21st century.
   Head M. G., 2015, PUBLIC HLTH ETHICS, V10, P90.
   Holl PM, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.183901.
   Horsley A, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3720-1.
   Horton R, 2018, LANCET, V392, P1504, DOI 10.1016/S0140-6736(18)32741-7.
   Hyvärinen A, 2001, AEROSOL SCI TECH, V35, P688, DOI 10.1080/027868201316900016.
   Hyytiäinen HK, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0405-8.
   International Vaccine Task Force TWB Innovations CfEP, 2018, MON MICR STRENGTH CL, V75.
   Järvi K, 2018, INDOOR AIR, V28, P287, DOI 10.1111/ina.12440.
   Jayaprakash B, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0356-5.
   Johnson JT, 2009, IEEE T GEOSCI REMOTE, V47, P1281, DOI 10.1109/TGRS.2008.2009438.
   Johnson M, 2009, IEEE SENSOR, P1439, DOI 10.1109/ICSENS.2009.5398442.
   Katani R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182940.
   Kelsey G, 2017, SCIENCE, V358, P69, DOI 10.1126/science.aan6826.
   Kennedy DA, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2016.2562.
   Klepeis NE, 2001, J EXPO ANAL ENV EPID, V11, P231, DOI 10.1038/sj.jea.7500165.
   Kumar V, 2017, P IEEE INT S CIRC SY, P2.
   Lederberg J, 2000, SCIENCE, V288, P287, DOI 10.1126/science.288.5464.287.
   LEDERBERG J, 1989, GENETICS, V121, P395.
   LEDERBERG J, 1952, J BACTERIOL, V63, P399, DOI 10.1128/JB.63.3.399-406.1952.
   Lee J, 2016, J THEOR BIOL, V408, P118, DOI 10.1016/j.jtbi.2016.08.009.
   Leivo V, 2018, SCI TOTAL ENVIRON, V621, P398, DOI 10.1016/j.scitotenv.2017.11.227.
   Lemfack MC, 2018, NUCLEIC ACIDS RES, V46, pD1261, DOI 10.1093/nar/gkx1016.
   Leppanen HK, 2018, J EXPO SCI ENV EPID, V28, P231, DOI 10.1038/jes.2017.24.
   Lun Kwok-Chan, 2018, Yearb Med Inform, V27, P234, DOI 10.1055/s-0038-1641199.
   Luongo JC, 2017, INDOOR AIR, V27, P338, DOI 10.1111/ina.12302.
   Luongo JC, 2016, INDOOR AIR, V26, P666, DOI 10.1111/ina.12267.
   Mamo Y, 2018, CLIN INFECT DIS, V66, P1705, DOI 10.1093/cid/cix1097.
   McKenna A, 2016, SCIENCE, V353, DOI 10.1126/science.aaf7907.
   Mehand Massinissa Si, 2018, Emerg Infect Dis, V24, DOI 10.3201/eid2409.171427.
   Mendell MJ, 2018, INDOOR AIR, V28, P488, DOI 10.1111/ina.12464.
   Moyer MW, 2018, NY TIMES.
   Munns KD, 2014, FOODBORNE PATHOG DIS, V11, P329, DOI 10.1089/fpd.2013.1621.
   Munoz Egea Mari Carmen, 2017, Pathogens, V6, DOI 10.3390/pathogens6030042.
   NEWCOMBE HB, 1949, NATURE, V164, P150, DOI 10.1038/164150a0.
   Norris SL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198125.
   Nuismer SL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196978.
   O'Neill J., 2016, Tackling drug-resistant infections globally: final report and recommendations.
   Palle D, 2016, 2016 INTERNATIONAL CONFERENCE ON ELECTRICAL, ELECTRONICS, AND OPTIMIZATION TECHNIQUES (ICEEOT), P3116, DOI 10.1109/ICEEOT.2016.7755275.
   Park GE, 2016, ANN INTERN MED, V165, P87, DOI 10.7326/M15-2495.
   Paul A, 2017, SCIENCE, V356, P1383, DOI 10.1126/science.aal3839.
   Piceno YM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177626.
   Qi M, 2017, ACS CHEM NEUROSCI.
   Ramaswami R, 2018, ANNU REV PUBL HEALTH, V39, P153, DOI 10.1146/annurev-publhealth-040617-014158.
   Rosenkrantz B, 1977, THE CARRIER STATE.
   Saito M, 2018, MICROSYST NANOENG, V4, DOI 10.1038/micronano.2017.83.
   Salthammer T, 2016, INDOOR AIR, V26, P25, DOI 10.1111/ina.12173.
   Schroeder TC, 2012, FOOD POLICY, V37, P31, DOI 10.1016/j.foodpol.2011.10.005.
   Schwendner P, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0345-8.
   Seto J, 2018, EPIDEMIOL INFECT, V146, P1707, DOI 10.1017/S095026881800211X.
   Settles GS, 2017, MEAS SCI TECHNOL, V28, DOI 10.1088/1361-6501/aa5748.
   Shrager J, 2016, SCIENCE, V353, P1216, DOI 10.1126/science.aai8483.
   Shultz JM, 2016, B ATOM SCI, V72, P304, DOI 10.1080/00963402.2016.1216515.
   Spangler R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007010.
   Sukovich DJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep39385.
   Tang JW, 2010, EPIDEMIOL INFECT, V138, P226, DOI 10.1017/S0950268809990410.
   Tang JW, 2017, LANCET INFECT DIS, V17, pE320, DOI 10.1016/S1473-3099(17)30238-4.
   Tang JLW, 2014, REV MED VIROL, V24, P15, DOI 10.1002/rmv.1771.
   Tang JW, 2010, J MED VIROL, V82, P1958, DOI 10.1002/jmv.21892.
   Tang JW, 2009, J R SOC INTERFACE, V6, pS737, DOI 10.1098/rsif.2009.0227.focus.
   Tans P, 2018, WE MEASURE BACKGROUN.
   Taylor-Robinson D, 2018, INT J EPIDEMIOL.
   Teolis BD, 2010, SCIENCE, V330, P1813, DOI 10.1126/science.1198366.
   Thaler DS, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0157-2.
   Towers S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129179.
   Trust W, 2017, GLOB PARTN LAUNCH PR.
   Valentiner-Branth P, 2017, BUILDING TRUST MANAG.
   Velak J, 2017, SMART CIT S PRAG SCS.
   Verreault D, 2015, APPL ENVIRON MICROB, V81, P7305, DOI 10.1128/AEM.02484-15.
   Wang SX, 2006, EPIDEMIOL INFECT, V134, P786, DOI 10.1017/S095026880500556X.
   Weeramanthri TS, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00121.
   Wilson J, 2011, IEEE T MOBILE COMPUT, V10, P612, DOI 10.1109/TMC.2010.175.
   Wood R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106622.
   Wu TR, 2018, ENVIRON SCI TECHNOL, V52, P237, DOI 10.1021/acs.est.7b04183.
   Wurie FB, 2016, THORAX, V71, P549, DOI 10.1136/thoraxjnl-2015-207295.
   Ypma RJF, 2013, J INFECT DIS, V207, P730, DOI 10.1093/infdis/jis757.
   Yun J, 2012, SENSORS-BASEL, V12, P13458, DOI 10.3390/s121013458.
   Zanella A, 2014, IEEE INTERNET THINGS, V1, P22, DOI 10.1109/JIOT.2014.2306328.},
Number-of-Cited-References = {115},
Times-Cited = {7},
Unique-ID = {WOS:000458381700005},
}

@incollection{ WOS:000501500000005,
Author = {Sivadas, Ambily and Scaria, Vinod},
Editor = {Kumar, D},
Title = {Population-scale genomics-Enabling precision public health},
Booktitle = {ADVANCES IN GENETICS, VOL 103},
Series = {Advances in Genetics},
Year = {2019},
Volume = {103},
Pages = {119-161},
Abstract = {The current excitement for affordable genomics technologies and national
   precision medicine initiatives marks a turning point in worldwide
   healthcare practices. The last decade of global population sequencing
   efforts has defined the enormous extent of genetic variation in the
   human population resulting in insights into differential disease burden
   and response to therapy within and between populations. Population-scale
   pharmacogenomics helps to provide insights into the choice of optimal
   therapies and an opportunity to estimate, predict and minimize adverse
   events. Such an approach can potentially empower countries to formulate
   national selection and dosing policies for therapeutic agents thereby
   promoting public health with precision. We review the breadth and depth
   of worldwide population-scale sequencing efforts and its implications
   for the implementation of clinical pharmacogenetics toward making
   precision medicine a reality.},
Type = {Review; Book Chapter},
Affiliation = {Scaria, V (Corresponding Author), CSIR IGIB, GN Ramachandran Knowledge Ctr Genome Informat, New Delhi, India.
   Scaria, V (Corresponding Author), Acad Sci \& Innovat Res AcSIR, New Delhi, India.
   Sivadas, Ambily; Scaria, Vinod, CSIR IGIB, GN Ramachandran Knowledge Ctr Genome Informat, New Delhi, India.
   Sivadas, Ambily; Scaria, Vinod, Acad Sci \& Innovat Res AcSIR, New Delhi, India.},
DOI = {10.1016/bs.adgen.2018.09.001},
Keywords-Plus = {IMPLEMENTATION CONSORTIUM GUIDELINES; NATIVE-AMERICAN POPULATIONS;
   DRUG-METABOLIZING-ENZYMES; GENETIC-VARIATION; CLINICAL IMPLEMENTATION;
   ROSUVASTATIN PHARMACOKINETICS; CHOLINESTERASE DEFICIENCY; WARFARIN
   PHARMACOGENETICS; PERSONALIZED MEDICINE; CYP2C19 GENOTYPE},
Research-Areas = {Genetics \& Heredity},
Web-of-Science-Categories  = {Genetics \& Heredity},
Author-Email = {vinods@igib.in},
Affiliations = {Council of Scientific \& Industrial Research (CSIR) - India; CSIR -
   Institute of Genomics \& Integrative Biology (IGIB); Academy of
   Scientific \& Innovative Research (AcSIR)},
Cited-References = {Abdulla MA, 2009, SCIENCE, V326, P1541, DOI 10.1126/science.1177074.
   Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248.
   Al-Ali M, 2018, J HUM GENET, V63, P533, DOI 10.1038/s10038-017-0402-y.
   Al-Rubae'i SHN, 2017, GENOM DATA, V11, P55, DOI 10.1016/j.gdata.2016.11.019.
   Alkan C, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-963.
   Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393.
   Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298.
   Alzahrani AM, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/315980.
   Ameur A, 2017, EUR J HUM GENET, V25, P1253, DOI 10.1038/ejhg.2017.130.
   Aminkeng F, 2014, PHARMACOGENOMICS J, V14, P160, DOI 10.1038/tpj.2013.13.
   Bazan NS, 2012, INT J CLIN PHARM-NET, V34, P837, DOI 10.1007/s11096-012-9678-3.
   Birmingham BK, 2015, EUR J CLIN PHARMACOL, V71, P329, DOI 10.1007/s00228-014-1800-0.
   Bonifaz-Peña V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112640.
   Brahmachari SK, 2005, HUM GENET, V118, P1, DOI 10.1007/s00439-005-0009-9.
   Brunham LR, 2014, PHARMACOGENOMICS J, V14, P555, DOI 10.1038/tpj.2014.22.
   Daniel SB, 2011, NEW ENGL J MED, V365, P2002, DOI 10.1056/NEJMsa1103053.
   Burt T, 2013, PHARMACOGENOMICS, V14, P1085, DOI {[}10.2217/PGS.13.81, 10.2217/pgs.13.81].
   Bush WS, 2016, CLIN PHARMACOL THER, V100, P160, DOI 10.1002/cpt.350.
   Cai N, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.11.
   Caraballo PJ, 2017, GENET MED, V19, P421, DOI 10.1038/gim.2016.120.
   Caudle KE, 2017, GENET MED, V19, P215, DOI 10.1038/gim.2016.87.
   Cazzola M, 2015, EXPERT OPIN DRUG MET, V11, P1089, DOI 10.1517/17425255.2015.1047341.
   Cespedes-Garro Carolina, 2015, Drug Metabolism and Personalized Therapy, V30, P19, DOI 10.1515/dmdi-2014-0025.
   Céspedes-Garro C, 2014, REV BIOL TROP, V62, P1659, DOI 10.15517/rbt.v62i4.12916.
   Chambers JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102645.
   Chan SL, 2016, PHARMACOGENET GENOM, V26, P28, DOI 10.1097/FPC.0000000000000182.
   Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8.
   Cheng RH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141105.
   Chheda H, 2017, EUR J HUM GENET, V25, P477, DOI 10.1038/ejhg.2016.205.
   Choudhury A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00663-9.
   Cohen J, 2013, PHARMACOGENOMICS J, V13, P378, DOI 10.1038/tpj.2011.63.
   Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523.
   CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330.
   Cyranoski D, 2016, NATURE, V529, P7584.
   Dalabira E, 2014, PUBLIC HEALTH GENOM, V17, P265, DOI 10.1159/000365895.
   Daly Ann K., 2015, Drug Metabolism and Personalized Therapy, V30, P165, DOI 10.1515/dmdi-2014-0034.
   Dandara C, 2014, EXPERT OPIN DRUG MET, V10, P769, DOI 10.1517/17425255.2014.894020.
   David SM, 2015, GENE, V555, P409, DOI 10.1016/j.gene.2014.11.040.
   De Andrés F, 2016, OMICS, V20, P699, DOI 10.1089/omi.2016.0148.
   Dhoro M, 2015, BMC PHARMACOL TOXICO, V16, DOI 10.1186/s40360-015-0004-2.
   Dogan M, 2012, ASIAN PAC J CANCER P, V13, P1553, DOI 10.7314/APJCP.2012.13.4.1553.
   Dowell SF, 2016, NATURE, V540, P189, DOI 10.1038/540189a.
   Dries DL, 1999, NEW ENGL J MED, V340, P609, DOI 10.1056/NEJM199902253400804.
   Ehmann F, 2015, PHARMACOGENOMICS J, V15, P201, DOI 10.1038/tpj.2014.86.
   Elliott LS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170905.
   Fakhro Khalid A, 2016, Hum Genome Var, V3, P16016, DOI 10.1038/hgv.2016.16.
   Fohner A, 2013, PHARMACOGENET GENOM, V23, P403, DOI 10.1097/FPC.0b013e3283629ce9.
   Francioli LC, 2014, NAT GENET, V46, P818, DOI 10.1038/ng.3021.
   Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258.
   Frick Amber, 2013, Methods Mol Biol, V1015, P263, DOI 10.1007/978-1-62703-435-7\_17.
   Fricke-Galindo Ingrid, 2016, Drug Metabolism and Personalized Therapy, V31, P61, DOI 10.1515/dmpt-2015-0030.
   Fujikura K, 2015, PHARMACOGENET GENOM, V25, P584, DOI 10.1097/FPC.0000000000000172.
   Fuselli S, 2007, PHARMACOGENOMICS J, V7, P144, DOI 10.1038/sj.tpj.6500407.
   Gage BF, 2008, CLIN PHARMACOL THER, V84, P326, DOI 10.1038/clpt.2008.10.
   Gamazon Eric R, 2013, Methods Mol Biol, V1015, P213, DOI 10.1007/978-1-62703-435-7\_14.
   Gamazon ER, 2010, PHARMACOGENET GENOM, V20, P269, DOI 10.1097/FPC.0b013e328337b8d6.
   Garrod AE, 1902, LANCET, V2, P1616.
   Gershon ES, 2014, DIALOGUES CLIN NEURO, V16, P567.
   Giri AK, 2014, PHARMACOGENOMICS, V15, P1337, DOI {[}10.2217/PGS.14.88, 10.2217/pgs.14.88].
   Giri AK, 2014, PHARMACOGENOMICS, V15, P643, DOI 10.2217/pgs.13.241.
   Gordon AS, 2016, PHARMACOGENET GENOM, V26, P161, DOI 10.1097/FPC.0000000000000202.
   Gudbjartsson DF, 2015, NAT GENET, V47, P435, DOI 10.1038/ng.3247.
   Guo YY, 2005, PHARMACOGENOMICS, V6, P857, DOI 10.2217/14622416.6.8.857.
   Gurdasani D, 2015, NATURE, V517, P327, DOI 10.1038/nature13997.
   Haas DW, 2014, J ANTIMICROB CHEMOTH, V69, P2175, DOI 10.1093/jac/dku110.
   Hariprakash JM, 2018, PHARMACOGENOMICS, V19, P227, DOI 10.2217/pgs-2017-0101.
   Hoffman JM, 2014, AM J MED GENET C, V166, P45, DOI 10.1002/ajmg.c.31391.
   Hon YY, 1999, HUM MOL GENET, V8, P371, DOI 10.1093/hmg/8.2.371.
   Hovelson DH, 2017, PHARMACOGENET GENOM, V27, P89, DOI 10.1097/FPC.0000000000000260.
   Hresko A, 2012, J PERS MED, V2, P201, DOI 10.3390/jpm2040201.
   Ipe J, 2017, CTS-CLIN TRANSL SCI, V10, P67, DOI 10.1111/cts.12440.
   Jaja C, 2008, COMMUNITY GENET, V11, P141, DOI 10.1159/000113876.
   Jittikoon J, 2016, J HUM GENET, V61, P119, DOI 10.1038/jhg.2015.115.
   Johnson JA, 2011, CLIN PHARMACOL THER, V90, P625, DOI 10.1038/clpt.2011.185.
   Johnson JA, 2015, TRENDS CARDIOVAS MED, V25, P33, DOI 10.1016/j.tcm.2014.09.001.
   Johnson JA, 2012, CIRCULATION, V125, P1964, DOI 10.1161/CIRCULATIONAHA.112.100628.
   Kaback M, 2010, GENET MED, V12, P628, DOI 10.1097/GIM.0b013e3181edef5b.
   Kaiser J, 2015, SCIENCE, V349, P1433, DOI 10.1126/science.349.6255.1475.
   Kaplun A, 2016, PHARMACOGENOMICS J, V16, P124, DOI 10.1038/tpj.2015.32.
   Khoury MJ, 2016, AM J PREV MED, V50, P398, DOI 10.1016/j.amepre.2015.08.031.
   Kim IW, 2012, PHARMACOGENET GENOM, V22, P829, DOI 10.1097/FPC.0b013e328358dd70.
   Kim J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23837-x.
   Klein TE, 2018, CLIN PHARMACOL THER, V104, P19, DOI 10.1002/cpt.928.
   Koshy R, 2017, J HUM GENET, V62, P889, DOI 10.1038/jhg.2017.67.
   Kozyra M, 2017, GENET MED, V19, P20, DOI 10.1038/gim.2016.33.
   Kwong JC, 2016, J CLIN MICROBIOL, V54, P333, DOI 10.1128/JCM.02344-15.
   Lacaze P., 2018, BIORXIV, DOI {[}10.1101/274019, DOI 10.1101/274019].
   Lakiotaki K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182138.
   Lakiotaki K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162801.
   Law V, 2014, NUCLEIC ACIDS RES, V42, pD1091, DOI 10.1093/nar/gkt1068.
   Lee E, 2005, CLIN PHARMACOL THER, V78, P330, DOI 10.1016/j.clpt.2005.06.013.
   Leitsalu L, 2015, INT J EPIDEMIOL, V44, P1137, DOI 10.1093/ije/dyt268.
   Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057.
   Li J, 2012, PHARMACOGENOMICS, V13, P555, DOI {[}10.2217/PGS.11.160, 10.2217/pgs.11.160].
   Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717.
   Li MJ, 2016, NUCLEIC ACIDS RES, V44, pD869, DOI 10.1093/nar/gkv1317.
   Li YF, 2015, BMC CARDIOVASC DISOR, V15, DOI 10.1186/1471-2261-15-6.
   Liggett SB, 2008, NAT MED, V14, P510, DOI 10.1038/nm1750.
   Liggett SB, 2006, P NATL ACAD SCI USA, V103, P11288, DOI 10.1073/pnas.0509937103.
   LLerena A, 2012, PHARMACOGENOMICS J, V12, P176, DOI 10.1038/tpj.2010.85.
   Low-Kam C, 2016, HUM GENET, V135, P1213, DOI 10.1007/s00439-016-1702-6.
   Lu DS, 2016, AM J HUM GENET, V99, P580, DOI 10.1016/j.ajhg.2016.07.002.
   Luizon MR, 2015, PHARMACOGENOMICS, V16, P1829, DOI 10.2217/pgs.15.121.
   Makeeva O, 2008, PHARMACOGENOMICS, V9, P847, DOI 10.2217/14622416.9.7.847.
   Mallick S, 2016, NATURE, V538, P201, DOI 10.1038/nature18964.
   Mallouk N, 2012, THROMB HAEMOSTASIS, V107, P494, DOI 10.1160/TH11-03-0202.
   Man M, 2010, J CLIN PHARMACOL, V50, P929, DOI 10.1177/0091270009355161.
   Manoharan I, 2006, PHARMACOGENET GENOM, V16, P461.
   Maretty L, 2017, NATURE, V548, P87, DOI 10.1038/nature23264.
   Marsh S, 2015, PHARMACOGENOMICS, V16, P441, DOI {[}10.2217/PGS.15.10, 10.2217/pgs.15.10].
   McLellan RA, 1997, PHARMACOGENETICS, V7, P187, DOI 10.1097/00008571-199706000-00003.
   Mega JL, 2010, JAMA-J AM MED ASSOC, V304, P1821, DOI 10.1001/jama.2010.1543.
   Mizzi C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162866.
   Moya G, 2017, PHARMACOGENOMICS J, V17, P378, DOI 10.1038/tpj.2016.27.
   Moyer AM, 2017, EXPERT REV PHARM OUT, V17, P567, DOI 10.1080/14737167.2017.1385395.
   Mukonzo JK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086919.
   Nagasaki M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9018.
   Namazi S, 2010, CLIN THER, V32, P1050, DOI 10.1016/j.clinthera.2010.06.010.
   Nassar S, 2014, META GENE, V2, P314, DOI 10.1016/j.mgene.2014.01.009.
   Nebert DW, 1999, CLIN GENET, V56, P247, DOI 10.1034/j.1399-0004.1999.560401.x.
   Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509.
   Ngamphiw C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021451.
   Niu NF, 2015, PHARMACOGENOMICS, V16, P273, DOI 10.2217/pgs.14.170.
   O'Donnell PH, 2012, CLIN PHARMACOL THER, V92, P446, DOI 10.1038/clpt.2012.117.
   O'Donnell PH, 2014, AM J MED GENET C, V166, P68, DOI 10.1002/ajmg.c.31385.
   Oleksyk TK, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0095-0.
   Ossaily Safaa, 2014, Drug Metabolism and Drug Interactions, V29, P81, DOI 10.1515/dmdi-2013-0058.
   Pandit JJ, 2011, EUR J ANAESTH, V28, P550, DOI 10.1097/EJA.0b013e3283457cfb.
   Pasha Ayesha, 2013, OMICS PERSONALIZED M, P187.
   Pathare AV, 2012, HUM BIOL, V84, P67, DOI 10.3378/027.084.0103.
   Pulley JM, 2012, CLIN PHARMACOL THER, V92, P87, DOI 10.1038/clpt.2011.371.
   Qumsieh RY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028943.
   Rajman I, 2017, EBIOMEDICINE, V17, P67, DOI 10.1016/j.ebiom.2017.02.017.
   Rasmussen-Torvik LJ, 2014, CLIN PHARMACOL THER, V96, P482, DOI 10.1038/clpt.2014.137.
   Reis M, 2003, PHARMACOGENETICS, V13, P371, DOI 10.1097/00008571-200306000-00009.
   Reuter MS, 2018, CAN MED ASSOC J, V190, pE126, DOI 10.1503/cmaj.171151.
   Rodriguez-Flores JL, 2016, GENOME RES, V26, P151, DOI 10.1101/gr.191478.115.
   Rodriguez-Flores JL, 2014, HUM MUTAT, V35, P105, DOI 10.1002/humu.22460.
   Rosenman MB, 2017, VALUE HEALTH, V20, P54, DOI 10.1016/j.jval.2016.08.727.
   Rubinstein WS, 2013, NUCLEIC ACIDS RES, V41, pD925, DOI 10.1093/nar/gks1173.
   Samwald M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164972.
   Saudi Genome Project Team, 2015, IEEE PULSE, V6, P22, DOI 10.1109/MPUL.2015.2476541.
   Schildcrout JS, 2012, CLIN PHARMACOL THER, V92, P235, DOI 10.1038/clpt.2012.66.
   Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890.
   SCOTT EM, 1976, AM J HUM GENET, V28, P253.
   Scott EM, 2016, NAT GENET, V48, P1071, DOI 10.1038/ng.3592.
   Scott SA, 2013, CLIN PHARMACOL THER, V94, P317, DOI 10.1038/clpt.2013.105.
   Shuldiner AR, 2009, JAMA-J AM MED ASSOC, V302, P849, DOI 10.1001/jama.2009.1232.
   Sidore C, 2015, NAT GENET, V47, P1272, DOI 10.1038/ng.3368.
   Sivadas A, 2017, PHARMACOGENOMICS J, V17, P461, DOI 10.1038/tpj.2016.39.
   Sivadas A, 2018, PHARMACOGENOMICS J, V18, P590, DOI 10.1038/s41397-018-0022-8.
   Sivadas A, 2016, PHARMACOGENOMICS, V17, P1891, DOI 10.2217/pgs-2016-0130.
   SNYDER LAURENCE H., 1932, OHIO JOUR SCI, V32, P436.
   Starren J, 2013, JAMA-J AM MED ASSOC, V309, P1237, DOI 10.1001/jama.2013.1579.
   Suarez-Kurtz G, 2014, PHARMACOGENOMICS, V15, P209, DOI 10.2217/pgs.13.238.
   Suarez-Kurtz G, 2010, FRONT PHARMACOL, V1, DOI 10.3389/fphar.2010.00118.
   Suarez-Kurtz Guilherme, 2008, Expert Rev Clin Pharmacol, V1, P337, DOI 10.1586/17512433.1.3.337.
   Surendiran A, 2008, INDIAN J PHARMACOL, V40, P137, DOI 10.4103/0253-7613.43158.
   Tang CSM, 2018, HUM GENET, V137, P31, DOI 10.1007/s00439-017-1852-1.
   Telenti A, 2016, P NATL ACAD SCI USA, V113, P11901, DOI 10.1073/pnas.1613365113.
   Teo YY, 2009, GENOME RES, V19, P2154, DOI 10.1101/gr.095000.109.
   Turnbull C, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k1687.
   Tzeng TB, 2008, CURR MED RES OPIN, V24, P2575, DOI 10.1185/03007990802312807 .
   van der Wouden CH, 2017, CLIN PHARMACOL THER, V101, P341, DOI {[}10.1002/cpt.602, 10.1002/cpt.725].
   Van Driest SL, 2014, CLIN PHARMACOL THER, V95, P423, DOI 10.1038/clpt.2013.229.
   Verbelen M, 2017, PHARMACOGENOMICS J, V17, P395, DOI 10.1038/tpj.2017.21.
   Vivot A, 2016, GENET MED, V18, P796, DOI 10.1038/gim.2015.165.
   Vogel F., 1959, ERG INN MED KINDERHK, P52, DOI DOI 10.1007/978-3-642-94744-5\_2.
   Walter K, 2015, NATURE, V526, P82, DOI 10.1038/nature14962.
   Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603.
   Wechsler ME, 2011, AM J RESP CRIT CARE, V184, P1247, DOI 10.1164/rccm.201103-0514OC.
   Welsh M, 2009, PHARMACOL REV, V61, P413, DOI 10.1124/pr.109.001461.
   Wheeler HE, 2012, PHARMACOGENOMICS, V13, P55, DOI {[}10.2217/PGS.11.121, 10.2217/pgs.11.121].
   Whirl-Carrillo M, 2012, CLIN PHARMACOL THER, V92, P414, DOI 10.1038/clpt.2012.96.
   Wong LP, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004377.
   Wong LP, 2013, AM J HUM GENET, V92, P52, DOI 10.1016/j.ajhg.2012.12.005.
   Wright GEB, 2018, PHARMACOGENOMICS J, V18, P187, DOI 10.1038/tpj.2016.77.
   Yamaguchi-Kabata Y, 2018, J HUM GENET, V63, P213, DOI 10.1038/s10038-017-0347-1.
   Yang W, 2016, CLIN PHARMACOL THER, V100, P380, DOI 10.1002/cpt.411.
   Yang Yao, 2014, Drug Metabolism and Drug Interactions, V29, P221, DOI 10.1515/dmdi-2013-0069.
   Zhang GL, 2016, DRUG DELIV, V23, P1393, DOI 10.3109/10717544.2015.1054052.
   Zhang WQ, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S11-S6.},
Number-of-Cited-References = {182},
Times-Cited = {7},
Unique-ID = {WOS:000501500000005},
}

@article{ WOS:000447923900024,
Author = {Modell, Stephen M. and Citrin, Toby and Kardia, Sharon L. R.},
Title = {Laying Anchor: Inserting Precision Health into a Public Health Genetics
   Policy Course},
Journal = {HEALTHCARE},
Year = {2018},
Volume = {6},
Number = {3},
Month = {SEP},
Abstract = {The United States Precision Medicine Initiative (PMI) was announced by
   then President Barack Obama in January 2015. It is a national effort
   designed to take into account genetic, environmental, and lifestyle
   differences in the development of individually tailored forms of
   treatment and prevention. This goal was implemented in March 2015 with
   the formation of an advisory committee working group to provide a
   framework for the proposed national research cohort of one million or
   more participants. The working group further held a public workshop on
   participant engagement and health equity, focusing on the design of an
   inclusive cohort, building public trust, and identifying active
   participant engagement features for the national cohort. Precision
   techniques offer medical and public health practitioners the opportunity
   to personally tailor preventive and therapeutic regimens based on
   informatics applied to large volume genotypic and phenotypic data. The
   PMI's (All of Us Research Program's) medical and public health promise,
   its balanced attention to technical and ethical issues, and its nuanced
   advisory structure made it a natural choice for inclusion in the
   University of Michigan course ``Issues in Public Health Genetics{''}
   (HMP 517), offered each fall by the University's School of Public
   Health. In 2015, the instructors included the PMI as the recurrent case
   study introduced at the beginning and referred to throughout the course,
   and as a class exercise allowing students to translate issues into
   policy. In 2016, an entire class session was devoted to precision
   medicine and precision public health. In this article, we examine the
   dialogues that transpired in these three course components, evaluate
   session impact on student ability to formulate PMI policy, and share our
   vision for next-generation courses dealing with precision health.
   Methodology: Class materials (class notes, oral exercise transcripts,
   class exercise written hand-ins) from the three course components were
   inspected and analyzed for issues and policy content. The purpose of the
   analysis was to assess the extent to which course components have
   enabled our students to formulate policy in the precision public health
   area. Analysis of student comments responding to questions posed during
   the initial case study comprised the initial or ``pre-{''} categories.
   Analysis of student responses to the class exercise assignment, which
   included the same set of questions, formed the ``post-{''} categories.
   Categories were validated by cross-comparison among the three authors,
   and inspected for frequency with which they appeared in student
   responses. Frequencies steered the selection of illustrative quotations,
   revealing the extent to which students were able to convert issue areas
   into actual policies. Lecture content and student comments in the
   precision health didactic session were inspected for degree to which
   they reinforced and extended the derived categories. Results: The case
   study inspection yielded four overarching categories: (1) assurance
   (access, equity, disparities); (2) participation (involvement,
   representativeness); (3) ethics (consent, privacy, benefit sharing); and
   (4) treatment of people (stigmatization, discrimination). Class exercise
   inspection and analysis yielded three additional categories: (5)
   financial; (6) educational; and (7) trust-building. The first three
   categories exceeded the others in terms of number of student mentions
   (8-14 vs. 4-6 mentions). Three other categories were considered and
   excluded because of infrequent mention.
   Students suggested several means of trust-building, including PMI
   personnel working with community leaders, stakeholder consultation,
   networking, and use of social media. Student representatives prioritized
   participant and research institution access to PMI information over
   commercial access. Multiple schemes were proposed for participant
   consent and return of results. Both pricing policy and Medicaid coverage
   were touched on. During the didactic session, students commented on the
   importance of provider training in precision health. Course evaluation
   highlighted the need for clarity on the organizations involved in the
   PMI, and leaving time for student-student interaction. Conclusions:
   While some student responses during the exercise were terse, an
   evolution was detectable over the three course components in student
   ability to suggest tangible policies and steps for implementation.
   Students also gained surety in presenting policy positions to a peer
   audience. Students came up with some very creative suggestions, such as
   use of an electronic platform to assure participant involvement in the
   disposition of their biological sample and personal health information,
   and alternate examples of ways to manage large volumes of data. An
   examination of socio-ethical issues and policies can strengthen student
   understanding of the directions the Precision Medicine Initiative is
   taking, and aid in training for the application of more varied precision
   medicine and public health techniques, such as tier 1 genetic testing
   and whole genome and exome sequencing. Future course development may
   reflect additional features of the ongoing All of Us Research Program,
   and further articulate precision public health approaches applying to
   populations as opposed to single individuals.},
Type = {Article},
Affiliation = {Modell, SM (Corresponding Author), Univ Michigan, Sch Publ Hlth, Dept Hlth Management \& Policy, 1415Washington Hts, Ann Arbor, MI 48109 USA.
   Modell, Stephen M.; Citrin, Toby, Univ Michigan, Sch Publ Hlth, Dept Hlth Management \& Policy, 1415Washington Hts, Ann Arbor, MI 48109 USA.
   Kardia, Sharon L. R., Univ Michigan, Sch Publ Hlth, Dept Epidemiol, M5174,SPH 2,1415Washington Hts, Ann Arbor, MI 48109 USA.},
DOI = {10.3390/healthcare6030093},
Article-Number = {93},
Keywords = {precision medicine; precision public health; education; genetics;
   cancer; cardiovascular disease; population health; race; health
   disparities; health policy},
Keywords-Plus = {INCIDENTAL FINDINGS; MEDICINE; GENOMICS; IMPLEMENTATION; ASSOCIATION;
   PERSPECTIVE; EDUCATION},
Research-Areas = {Health Care Sciences \& Services},
Web-of-Science-Categories  = {Health Care Sciences \& Services; Health Policy \& Services},
Author-Email = {mod@umich.edu
   tcitrin@umich.edu
   skardia@umich.edu},
Affiliations = {University of Michigan System; University of Michigan; University of
   Michigan System; University of Michigan},
Cited-References = {ACMG Board of Directors, 2013, Genet Med, V15, P748, DOI 10.1038/gim.2013.94.
   American Public Health Association, STRENGTH GEN GEN LIT.
   Bayer R, 2015, NEW ENGL J MED, V373, P499, DOI 10.1056/NEJMp1506241.
   Biswas A, 2018, GENE, V660, P151, DOI 10.1016/j.gene.2018.03.062.
   Bonham VL, 2009, J HEALTH POLIT POLIC, V34, P325, DOI 10.1215/03616878-2009-009.
   Brody H, 2006, ANN FAM MED, V4, P556, DOI 10.1370/afm.582.
   Centers for Disease Control and Prevention Office of Public Health Genomics, OFF PUBL HLTH GEN PU.
   Chang KL, 2015, AM FAM PHYSICIAN, V92, P588.
   Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523.
   CRAWSHAW R, 1990, WESTERN J MED, V152, P441.
   Dalke K., AFRICAN AM BIOBANK W.
   Dankwa-Mullan I, 2015, AM J PUBLIC HEALTH, V105, pS368, DOI 10.2105/AJPH.2015.302755.
   Denny JC, 2016, ANNU REV GENOM HUM G, V17, P353, DOI 10.1146/annurev-genom-090314-024956.
   Desmond-Hellmann S, 2016, SCIENCE, V353, P731, DOI 10.1126/science.aai7598.
   Dolan ME, 2013, PHARMACOGENOMICS, V14, P1383, DOI 10.2217/pgs.13.134.
   Dron JS, 2017, J LIPID RES, V58, P2162, DOI 10.1194/jlr.M079822.
   Erskine J.A., 2003, Teaching with cases.
   Eskenazi K., 4 NYC MED CTR RECEIV.
   Ferryman K., DATA SOC FAIRNESS PR.
   Fleischer JA, 2014, CLIN CHEM, V60, P1243, DOI {[}10.1373/clinchem.2014.226563, 10.1373/clinchem.2014.226076].
   Genetic Alliance, PLATF ENG EV RESP PE.
   Green RF, 2015, HEALTHCARE-BASEL, V3, P830, DOI 10.3390/healthcare3030830.
   Green RC, 2013, GENET MED, V15, P565, DOI 10.1038/gim.2013.73.
   Gutmann A, 1997, HASTINGS CENT REP, V27, P38, DOI 10.2307/3528667.
   Hemingway H, 2018, EUR HEART J, V39, P1481, DOI 10.1093/eurheartj/ehx487.
   Hennekens C.H., 1987, Epidemiology in medicine, P153.
   Institute of Medicine Committee on Assuring the Health of the Public in the 21st Century, 2013, FUT PUBL HLTH 21 CEN.
   Jaff S, 2015, LANCET, V385, P2448, DOI 10.1016/S0140-6736(15)61124-2.
   Kaiser J., NIH CANCELS MASSIVE.
   Katsila T, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00061.
   Khoury MJ, 2018, GENET MED, V20, P574, DOI 10.1038/gim.2017.211.
   Khoury MJ, 2016, JAMA-J AM MED ASSOC, V316, P1357, DOI 10.1001/jama.2016.12260.
   Khoury MJ, 2015, JAMA-J AM MED ASSOC, V313, P2117, DOI 10.1001/jama.2015.3382.
   Knoppers BM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008494.
   Linderman MD, 2018, BMC MED GENOMICS, V11, DOI 10.1186/s12920-018-0319-0.
   Marcus PM, 2016, CANCER EPIDEM BIOMAR, V25, P1449, DOI 10.1158/1055-9965.EPI-16-0555.
   Michigan Department of Health and Human Services Michigan BioTrust for Health, RES US MICH RES BLOO.
   Mirnezami R, 2012, NEW ENGL J MED, V366, P489, DOI 10.1056/NEJMp1114866.
   Modell S.M., 2015, PATIENT RIGHTS ETHIC, P1.
   Modell S.M., 2017, ADV GENET RES NOVA B, V17, P107.
   Modell SM, 2002, HEALTH EDUC BEHAV, V29, P43, DOI 10.1177/109019810202900106.
   Mokdad AH, 2017, JAMA-J AM MED ASSOC, V317, P388, DOI 10.1001/jama.2016.20324.
   Natarajan P, 2017, CIRCULATION, V135, P2091, DOI 10.1161/CIRCULATIONAHA.116.024436.
   National Institutes of Health, 2015, ALL US RES PROGR PRE.
   National Institutes of Health, ACD PREC MED IN WORK.
   National Institutes of Health, ALL US RES PROGR GEN.
   National Institutes of Health, CANC GEN ATL BIOSP C.
   NIH, ALL US RES PROGR.
   Office of Public Health Genomics Centers for Disease Control and Prevention, LYNCH SYNDR PHAS 1.
   Payne PW, 2007, J AM ACAD ORTHOP SUR, V15, pS95, DOI 10.5435/00124635-200700001-00020.
   Purshouse K, 2017, CSH MOL CASE STUD, V3, DOI 10.1101/mcs.a001362.
   Reardon S, 2015, NATURE, V523, P391, DOI 10.1038/523391a.
   Ritchie MD, 2012, HUM GENET, V131, P1615, DOI 10.1007/s00439-012-1221-z.
   Roberts MC, 2018, HEALTH AFFAIR, V37, P801, DOI 10.1377/hlthaff.2017.1630.
   San Francisco Medical Center University of California, PREC HLTH SUMM.
   Sawyer SL, 2016, CLIN GENET, V89, P275, DOI 10.1111/cge.12654.
   Secretary's Advisory Committee on Genetics Health and Society, POL ISS ASS UND NEW.
   Steinsbekk KS, 2013, MED HEALTH CARE PHIL, V16, P151, DOI 10.1007/s11019-011-9353-9.
   The White House Office of the Press Secretary, FACT SHEET PRES OB P.
   Thomas JC, 2005, AM J PUBLIC HEALTH, V95, P2139, DOI 10.2105/AJPH.2005.066878.
   Thomas L., COLORECTAL CANC SCRE.
   US Department of Health and Human Services Agency for Healthcare Research and Quality (AHRQ), 2016, NAT HEALTHC QUAL DIS.
   Watson M, 2013, GENET MED, V15, P664, DOI 10.1038/gim.2013.82.
   Whitehouse, PREC MED IN.},
Number-of-Cited-References = {64},
Times-Cited = {1},
Unique-ID = {WOS:000447923900024},
}

@article{ WOS:000485049000005,
Author = {Persmark, Anna and Wemrell, Maria and Zettermark, Sofia and Leckie,
   George and Subramanian, V, S. and Merlo, Juan},
Title = {Precision public health: Mapping socioeconomic disparities in opioid
   dispensations at Swedish pharmacies by Multilevel Analysis of Individual
   Heterogeneity and Discriminatory Accuracy (MAIHDA)},
Journal = {PLOS ONE},
Year = {2019},
Volume = {14},
Number = {8},
Month = {AUG 27},
Abstract = {Background
   In light of the opioid epidemic in the United States, there is growing
   concern about the use of opioids in Sweden as it may lead to misuse and
   overuse and, in turn, severe public health problems. However, little is
   known about the distribution of opioid use across different demographic
   and socioeconomic dimensions in the Swedish general population.
   Therefore, we applied an intersectional Multilevel Analysis of
   Individual Heterogeneity and Discriminatory Accuracy (MAIHDA), to obtain
   an improved mapping of the risk heterogeneity of and socioeconomic
   inequalities in opioid prescription receipt.
   Methods and findings
   Using data from 6,846,106 residents in Sweden aged 18 and above, we
   constructed 72 intersectional strata from combinations of gender, age,
   income, cohabitation status, and presence or absence of psychological
   distress. We modelled the absolute risk (AR) of opioid prescription
   receipt in a series of multilevel logistic regression models
   distinguishing between additive and interaction effects. By means of the
   Variance Partitioning Coefficient (VPC) and the area under the receiver
   operating characteristic curve (AUC), we quantified the discriminatory
   accuracy (DA) of the intersectional strata for discerning those who
   received opioid prescriptions from those who did not.
   The AR of opioid prescription receipt ranged from 2.77\% (95\% CI
   2.69-2.86) among low-income men aged 18-34, living alone, without
   psychological distress, to 28.25\% (95\% CI 27.95-28.56) among
   medium-income women aged 65 and older, living alone, with psychological
   distress. In a model that conflated both additive and interaction
   effects, the intersectional strata had a fair DA for discerning opioid
   users from non-users (VPC = 13.2\%, AUC = 0.68). However, in the model
   that decomposed total effects into additive and interaction effects, the
   VPC was very low (0.42\%) indicating the existence of small interaction
   effects for a number of the intersectional strata.
   Conclusions
   The intersectional MAIHDA approach aligns with the aims of precision
   public health, through improving the evidence base for health policy by
   increasing understanding of both health inequalities and individual
   heterogeneity. This approach is particularly relevant for
   socioeconomically conditioned outcomes such as opioid prescription
   receipt. We have identified intersections of social position within the
   Swedish population at greater risk for opioid prescription receipt.},
Type = {Article},
Affiliation = {Persmark, A; Wemrell, M (Corresponding Author), Lund Univ, Fac Med, Unit Social Epidemiol, Malmo, Sweden.
   Wemrell, M (Corresponding Author), Lund Univ, Fac Social Sci, Dept Gender Studies, Lund, Sweden.
   Persmark, Anna; Wemrell, Maria; Zettermark, Sofia; Leckie, George; Merlo, Juan, Lund Univ, Fac Med, Unit Social Epidemiol, Malmo, Sweden.
   Wemrell, Maria, Lund Univ, Fac Social Sci, Dept Gender Studies, Lund, Sweden.
   Leckie, George, Univ Bristol, Ctr Multilevel Modelling, Bristol, Avon, England.
   Subramanian, S., V, Harvard TH Chan Sch Publ Hlth, Dept Social \& Behav Sci, Boston, MA USA.
   Merlo, Juan, Ctr Primary Hlth Care Res, Malmo, Sweden.},
DOI = {10.1371/journal.pone.0220322},
Article-Number = {e0220322},
Keywords-Plus = {BRIEF CONCEPTUAL TUTORIAL; SOCIAL EPIDEMIOLOGY; MENTAL-HEALTH;
   INTERSECTIONALITY THEORY; USE DISORDERS; RISK-FACTORS; POPULATION;
   DETERMINANTS; ASSOCIATION; MORTALITY},
Research-Areas = {Science \& Technology - Other Topics},
Web-of-Science-Categories  = {Multidisciplinary Sciences},
Author-Email = {apersmark@gmail.com
   maria.wemrell@med.lu.se},
Affiliations = {Lund University; Lund University; University of Bristol; Harvard
   University; Harvard T.H. Chan School of Public Health},
Cited-References = {{[}Anonymous], 2015, PRESCRIPTION OPIOID.
   {[}Anonymous], 2000, Social Epidemiology.
   Backryd E., 2017, Lakartidningen, V114.
   Bauer GR, 2014, SOC SCI MED, V110, P10, DOI 10.1016/j.socscimed.2014.03.022.
   Bayer R, 2015, NEW ENGL J MED, V373, P499, DOI 10.1056/NEJMp1506241.
   Bohnert ASB, 2011, JAMA-J AM MED ASSOC, V305, P1315, DOI 10.1001/jama.2011.370.
   Bonnie RJ, 2017, JAMA-J AM MED ASSOC, V318, P423, DOI 10.1001/jama.2017.10046.
   Browne W.J., 2017, MCMC Estimation in MLwiN v3.00.
   Charlton C., 2017, MLWIN VERSION 3 00.
   Choo HY, 2010, SOCIOL THEOR, V28, P129, DOI 10.1111/j.1467-9558.2010.01370.x.
   Crenshaw Kimberle., 1989, Demarginalizing the Intersection of Race and Sex: A Black Feminist Critique of Antidiscrimination Doctrine, Feminist Theory and Antiracist Policies, V139.
   CRUTCHFIELD RD, 1984, SOC SCI MED, V18, P503, DOI 10.1016/0277-9536(84)90008-X.
   Degenhardt L, 2014, ADDICTION, V109, P1320, DOI 10.1111/add.12551.
   Edlund MJ, 2010, CLIN J PAIN, V26, P1, DOI 10.1097/AJP.0b013e3181b99f35.
   Evans C.R., 2015, Innovative approaches to investigating social determinants of health - social networks, environmental effects and intersectionality.
   Evans CR, 2019, SOC SCI MED, V220, P1, DOI 10.1016/j.socscimed.2018.10.019.
   Evans CR, 2018, SOC SCI MED, V203, P64, DOI 10.1016/j.socscimed.2017.11.011.
   Fisk SA, 2018, SSM-POPUL HLTH, V4, P334, DOI 10.1016/j.ssmph.2018.03.005.
   Fugelstad A, 2015, SOCIALMEDICINSK TIDS, V92.
   Galea S, 2004, EPIDEMIOL REV, V26, P36, DOI 10.1093/epirev/mxh007.
   Galobardes B, 2007, BRIT MED BULL, V81-82, P21, DOI 10.1093/bmb/ldm001.
   Ghith N, 2016, PLOS ONE, V11.
   Goldstein H., 2002, Understanding Statistics, V1, P223, DOI 10.1207/S15328031US0104\_02.
   Green MA, 2017, SOC SCI MED, V178, P214, DOI 10.1016/j.socscimed.2017.02.029.
   Gustafsson A, 2011, BERAKNINGSDEFINITION.
   Han B, 2017, ANN INTERN MED, V167, pI24, DOI 10.7326/P17-9042.
   Hancock Ange-Marie., 2013, University of California Irvine Law Review, V3, P259.
   Hernández-Yumar A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208624.
   Hudson TJ, 2008, J PAIN SYMPTOM MANAG, V36, P280, DOI 10.1016/j.jpainsymman.2007.10.003.
   Imtiaz S, 2014, SUBST ABUSE TREAT PR, V9, DOI 10.1186/1747-597X-9-43.
   Ivert AK, 2016, ETHNIC HEALTH, V21, P578, DOI 10.1080/13557858.2016.1143090.
   Jones K., 2016, METHODOL INNOV ONLIN, V9, P1, DOI DOI 10.1177/2059799116672874.
   Juárez SP, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005388.
   Katz C, 2013, DRUG ALCOHOL DEPEN, V132, P107, DOI 10.1016/j.drugalcdep.2013.01.010.
   Khoury MJ, 2016, JAMA-J AM MED ASSOC, V316, P1357, DOI 10.1001/jama.2016.12260.
   Khoury MJ, 2016, AM J PREV MED, V50, P398, DOI 10.1016/j.amepre.2015.08.031.
   King NB, 2014, AM J PUBLIC HEALTH, V104, pE32, DOI 10.2105/AJPH.2014.301966.
   Kolodny A, 2015, ANNU REV PUBL HEALTH, V36, P559, DOI 10.1146/annurev-publhealth-031914-122957.
   Leckie G, 2013, J STAT SOFTW, V52, P1.
   Link BG, 2006, LANCET, V367, P528, DOI 10.1016/S0140-6736(06)68184-1.
   Ludvigsson JF, 2016, EUR J EPIDEMIOL, V31, P125, DOI 10.1007/s10654-016-0117-y.
   MANCHIKANTI L, 2012, PAIN PHYS S, V15, pES.
   McCall L, 2005, SIGNS, V30, P1771, DOI 10.1086/426800.
   Merlo J, 2005, MED CARE, V43, P1092, DOI 10.1097/01.mlr.0000182484.14608.b9.
   Merlo J, 2005, J EPIDEMIOL COMMUN H, V59, P729, DOI 10.1136/jech.2004.023929.
   Merlo J, 2004, AM J EPIDEMIOL, V159, P1168, DOI 10.1093/aje/kwh160.
   Merlo J, 2009, J EPIDEMIOL COMMUN H, V63, P1043, DOI 10.1136/jech.2009.088310.
   Merlo J, 2003, J EPIDEMIOL COMMUN H, V57, P550, DOI 10.1136/jech.57.8.550.
   Merlo J, 2006, J EPIDEMIOL COMMUN H, V60, P290, DOI 10.1136/jech.2004.029454.
   Merlo J, 2013, EUR J EPIDEMIOL, V28, P135.
   Merlo J, 2015, EC SALUD BOLETI INFO, V84.
   Merlo J., 2013, Eur. J. Epidemiol., V28, P148, DOI {[}10.1007/s10654-013-9820-0, DOI 10.1007/S10654-013-9820-0].
   Merlo J, 2018, SOC SCI MED, V203, P74, DOI 10.1016/j.socscimed.2017.12.026.
   Merlo J, 2017, SSM-POPUL HLTH, V3, P684, DOI 10.1016/j.ssmph.2017.08.005.
   Merlo J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153778.
   Merlo J, 2015, EUR J PUBLIC HEALTH, V25, P910, DOI 10.1093/eurpub/ckv209.
   Merlo J, 2014, AM J EPIDEMIOL, V180, P208, DOI 10.1093/aje/kwu108.
   Mulinari S, 2018, CRIT PUBLIC HEALTH, V28, P177, DOI 10.1080/09581596.2017.1316831.
   Mulinari S, 2015, EUR J PUBLIC HEALTH, V25, P911, DOI 10.1093/eurpub/ckv099.
   Ohlsson H, 2011, MED CARE, V49, P327, DOI 10.1097/MLR.0b013e31820325c5.
   Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101.
   Rasbash J., 2017, USERS GUIDE MLWIN V3.
   Rhodin A, 2014, LAKARTIDNINGEN, V111, pCZW3.
   Scherbaum N, 2008, INT J METH PSYCH RES, V17, pS39, DOI 10.1002/mpr.244.
   Seal KH, 2012, JAMA-J AM MED ASSOC, V307, P940, DOI 10.1001/jama.2012.234.
   Seng JS, 2012, SOC SCI MED, V75, P2437, DOI 10.1016/j.socscimed.2012.09.023.
   Shah A, 2017, J PAIN, V18, P1374, DOI 10.1016/j.jpain.2017.06.010.
   Socialstyrelsen, STAT LAK 2017.
   Socialstyrelsen, 2017, STAT LAK 2016.
   Subramanian SV, 2004, SOC SCI MED, V58, P1961, DOI 10.1016/S0277-9536(03)00415-5.
   Subramanian SV., 2007, MACROSOCIAL DETERMIN, P301, DOI DOI 10.1007/978-0-387-70812-6\_15.
   Svendsen K, 2014, ACTA ANAESTH SCAND, V58, P437, DOI 10.1111/aas.12281.
   Tjäderborn M, 2009, PHARMACOEPIDEM DR S, V18, P1192, DOI 10.1002/pds.1838.
   VanderWeele T. J., 2014, EPIDEMIOLOGIC METHOD, V3, P33, DOI DOI 10.1515/EM-2013-0005.
   Wagner P, 2015, INT J EPIDEMIOL, V44, P49.
   Wemrell M, 2017, SOC SCI MED, V178, P217, DOI 10.1016/j.socscimed.2017.02.040.
   Wemrell M, 2017, SOC SCI MED, V177, P213, DOI 10.1016/j.socscimed.2017.01.050.
   Wettermark B, 2007, PHARMACOEPIDEM DR S, V16, P726, DOI 10.1002/pds.1294.},
Number-of-Cited-References = {78},
Times-Cited = {30},
Unique-ID = {WOS:000485049000005},
}

@article{ WOS:000720344100001,
Author = {Alfredo Martinez, J. and Sassi, Franco and Moreno, Luis A. and Tur,
   Josep A.},
Title = {Position guidelines and evidence base concerning determinants of
   childhood obesity with a European perspective},
Journal = {OBESITY REVIEWS},
Year = {2022},
Volume = {23},
Number = {1, SI},
Month = {JAN},
Abstract = {Childhood obesity is one of the most pressing global public health
   issues, with rates increasing fastest in countries at low levels of
   income. Obesity occurring during childhood is likely to persist
   throughout the life course, and it is a cause of increased disease risk
   from the early years of life. This supplement is the result of
   collaborations involving a large and multidisciplinary group of
   researchers that were established in the context of the ongoing European
   Horizon 2020 project Science and Technology in childhood Obesity Policy
   (STOP). The aim, as in the entire STOP project, is to generate evidence
   that can support better policies to tackle the problem of childhood
   obesity in Europe and elsewhere. Quality of life and health well-being
   concerning children needs to consider personalized, population, and
   planetary facets to tackle childhood obesity at early stages of life,
   for in-deep phenotyping, integrating personalized medicine and precision
   public health interventions at global levels. This supplement
   contributes to this aim.},
Type = {Article},
Affiliation = {Tur, JA (Corresponding Author), Univ Balearic Isl IUNICS \& IDISBA, Res Grp Community Nutr \& Oxidat Stress, E-07122 Palma De Mallorca, Spain.
   Alfredo Martinez, J.; Moreno, Luis A.; Tur, Josep A., CIBEROBN Physiopathol Obes \& Nutr, Madrid, Spain.
   Alfredo Martinez, J., CEI UAM CSIC, IMDEA Food, Cardiomet Precis Nutr Program, Madrid, Spain.
   Sassi, Franco, Imperial Coll Business Sch, Ctr Hlth Econ \& Policy Innovat CHEPI, London, England.
   Moreno, Luis A., Univ Zaragoza, GENUD Growth Exercise Nutr \& Dev Res Grp, Agrifood Inst Aragon IA2, Zaragoza, Spain.
   Moreno, Luis A., Univ Zaragoza, Inst Hlth Res Aragon IIS Aragon, Zaragoza, Spain.
   Tur, Josep A., Univ Balearic Isl IUNICS \& IDISBA, Res Grp Community Nutr \& Oxidat Stress, E-07122 Palma De Mallorca, Spain.},
DOI = {10.1111/obr.13391},
EarlyAccessDate = {NOV 2021},
Article-Number = {e13391},
Keywords = {childhood; determinants; obesity; STOP project},
Research-Areas = {Endocrinology \& Metabolism},
Web-of-Science-Categories  = {Endocrinology \& Metabolism},
Author-Email = {pep.tur@uib.es},
Affiliations = {CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Consejo
   Superior de Investigaciones Cientificas (CSIC); IMDEA Food Institute;
   Imperial College London; University of Zaragoza; University of Zaragoza},
Cited-References = {Branca F, 2021, OBES REV, V22, DOI 10.1111/obr.13181.
   Cox B, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.4662.
   European Commission, CORDIS EU Research Results.
   Ezzati M, 2017, LANCET, V390, P2627, DOI {[}10.1016/S0140-6736(17)32129-3, 10.1016/s0140-6736(17)32129-3].
   González-Muniesa P, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.34.
   Howe LD, 2020, INT J EPIDEMIOL, V49, P1173, DOI 10.1093/ije/dyz240.
   Larqué E, 2019, NAT REV ENDOCRINOL, V15, P456, DOI 10.1038/s41574-019-0219-1.},
Number-of-Cited-References = {7},
Times-Cited = {1},
Unique-ID = {WOS:000720344100001},
}

@article{ WOS:000423757000001,
Author = {Franchini, Michela and Pieroni, Stefania and Passino, Claudio and Emdin,
   Michele and Molinaro, Sabrina},
Title = {The <i>CARPEDIEM</i> algorithm: a rule-Based system for identifying
   heart Failure Phenotype with a Precision Public health approach},
Journal = {FRONTIERS IN PUBLIC HEALTH},
Year = {2018},
Volume = {6},
Month = {JAN 29},
Abstract = {Modern medicine remains dependent on the accurate evaluation of a
   patient's health state, recognizing that disease is a process that
   evolves over time and interacts with many factors unique to that
   patient. The CARPEDIEM project represents a concrete attempt to address
   these issues by developing reproducible algorithms to support the
   accuracy in detection of complex diseases. This study aims to establish
   and validate the CARPEDIEM approach and algorithm for identifying those
   patients presenting with or at risk of heart failure (HF) by studying
   153,393 subjects in Italy, based on patient information flow databases
   and is not reliant on the electronic health record to accomplish its
   goals. The resulting algorithm has been validated in a two-stage
   process, comparing predicted results with (1) HF diagnosis as identified
   by general practitioners (GPs) among the reference cohort and (2) HF
   diagnosis as identified by cardiologists within a randomly sampled
   subpopulation of 389 patients. The sources of data used to detect HF
   cases are numerous and were standardized for this study. The accuracy
   and the predictive values of the algorithm with respect to the GPs and
   the clinical standards are highly consistent with those from previous
   studies. In particular, the algorithm is more efficient in detecting the
   more severe cases of HF according to the GPs' validation (specificity
   increases according to the number of comorbidities) and external
   validation (NYHA: II-IV; HF severity index: 2, 3). Positive and negative
   predictive values reveal that the CARPEDIEM algorithm is most consistent
   with clinical evaluation performed in the specialist setting, while it
   presents a greater ability to rule out false-negative HF cases within
   the GP practice, probably as a consequence of the different HF
   prevalence in the two different care settings. Further development
   includes analyzing the clinical features of false-positive and -
   negative predictions, to explore the natural clustering of markers of
   chronic conditions by adding additional methodologies, e.g., Social
   Network Analysis. CARPEDIEM establishes the potential that an
   algorithmic approach, based on integrating administrative data with
   other public data sources, can enable the development of low cost and
   high value population-based evaluations for improving public health and
   impacting public health policies.},
Type = {Article},
Affiliation = {Molinaro, S (Corresponding Author), CNR, Inst Clin Physiol, Pisa, Italy.
   Franchini, Michela; Pieroni, Stefania; Molinaro, Sabrina, CNR, Inst Clin Physiol, Pisa, Italy.
   Passino, Claudio; Emdin, Michele, Fdn Toscana Gabriele Monasterio, Div Cardiol \& Cardiovasc Med, Pisa, Italy.
   Passino, Claudio; Emdin, Michele, Scuola Super Sant Anna, Inst Life Sci, Pisa, Italy.},
DOI = {10.3389/fpubh.2018.00006},
Article-Number = {6},
Keywords = {algorithm; phenotype; precision public health; heart failure; accuracy;
   predictive measures},
Keywords-Plus = {DIAGNOSTIC-TEST; PRIMARY-CARE; GUIDELINES; SOCIETY; BURDEN},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {sabrina.molinaro@ifc.cnr.it},
Affiliations = {Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica
   (IFC-CNR); Scuola Superiore Sant'Anna},
Cited-References = {{[}Anonymous], IMPR DIAGN HLTH CAR.
   Cerra C, 2004, PHARMACOECONOMICS IT, V6, P141, DOI DOI 10.1007/BF03320632.
   Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523.
   Cook C, 2014, INT J CARDIOL, V171, P368, DOI 10.1016/j.ijcard.2013.12.028.
   Deeks JJ, 2004, BRIT MED J, V329, P168, DOI 10.1136/bmj.329.7458.168.
   Ferrandis MJ, 2013, UPSALA J MED SCI, V118, P75, DOI 10.3109/03009734.2012.751471.
   Flores-Le Roux JA, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-39.
   Franceschi C, 2007, NUTR REV, V65, pS173, DOI {[}10.1111/j.1753-4887.2007.tb00358.x, 10.1301/nr.2007.dec.S173-S176].
   Franceschi C, 2014, J GERONTOL A-BIOL, V69, pS4, DOI 10.1093/gerona/glu057.
   Franchini M, 2015, CURR PHARM DESIGN, V21, P791.
   Grimes DA, 2005, LANCET, V365, P1500, DOI 10.1016/S0140-6736(05)66422-7.
   Hripcsak G, 2013, J AM MED INFORM ASSN, V20, pE311, DOI 10.1136/amiajnl-2013-001922.
   Hunt SA, 2009, J AM COLL CARDIOL, V53, pE1, DOI 10.1016/j.jacc.2008.11.013.
   JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P703, DOI 10.1001/jama.271.9.703.
   Jonnagaddala J, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/636371.
   Khan KS, 1999, AM J OBSTET GYNECOL, V181, P112, DOI 10.1016/S0002-9378(99)70445-X.
   Khoury MJ, 2016, AM J PREV MED, V50, P398, DOI 10.1016/j.amepre.2015.08.031.
   Maggioni AP, 2013, EUR J HEART FAIL, V15, P1173, DOI 10.1093/eurjhf/hft134.
   Makary MA, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2139.
   McCormick N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104519.
   Moons KGM, 1997, EPIDEMIOLOGY, V8, P12, DOI 10.1097/00001648-199701000-00002.
   National Research Council, 2011, PREC MED BUILD KNOWL.
   Pathak J, 2013, J AM MED INFORM ASSN, V20, pE206, DOI 10.1136/amiajnl-2013-002428.
   Piccinni C, 2017, HIGH BLOOD PRESS CAR, V24, P171, DOI 10.1007/s40292-017-0193-4.
   Schultz SE, 2013, CHRON DIS INJ CAN, V33, P160.
   Fernáadez-Breis JT, 2013, J AM MED INFORM ASSN, V20, pE288, DOI 10.1136/amiajnl-2013-001923.
   Wagner E H, 1998, Eff Clin Pract, V1, P2.
   Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269.
   Wright A, 2011, J AM MED INFORM ASSN, V18, P859, DOI 10.1136/amiajnl-2011-000121.},
Number-of-Cited-References = {29},
Times-Cited = {5},
Unique-ID = {WOS:000423757000001},
}

@article{ WOS:000766781800004,
Author = {Andrade, Andre Q. and Calabretto, Jean-Pierre and Pratt, Nicole L. and
   Kalisch-Ellett, Lisa M. and Kassie, Gizat M. and LeBlanc, Vanessa T. and
   Ramsay, Emmae and Roughead, Elizabeth E.},
Title = {Implementation and Evaluation of a Digitally Enabled Precision Public
   Health Intervention to Reduce Inappropriate Gabapentinoid Prescription:
   Cluster Randomized Controlled Trial},
Journal = {JOURNAL OF MEDICAL INTERNET RESEARCH},
Year = {2022},
Volume = {24},
Number = {1},
Month = {JAN 10},
Abstract = {Background: Digital technologies can enable rapid targeted delivery of
   audit and feedback interventions at scale. Few studies have evaluated
   how mode of delivery affects clinical professional behavior change and
   none have assessed the feasibility of such an initiative at a national
   scale.
   Objective: The aim of this study was to develop and evaluate the effect
   of audit and feedback by digital versus postal (letter) mode of delivery
   on primary care physician behavior.
   Methods: This study was developed as part of the Veterans' Medicines
   Advice and Therapeutics Education Services (MATES) program, an
   intervention funded by the Australian Government Department of Veterans'
   Affairs that provides targeted education and patient-specific audit with
   feedback to Australian general practitioners, as well as educational
   material to veterans and other health professionals. We performed a
   cluster randomized controlled trial of a multifaceted intervention to
   reduce inappropriate gabapentinoid prescription, comparing digital and
   postal mode of delivery. All veteran patients targeted also received an
   educational intervention (postal delivery). Efficacy was measured using
   a linear mixed-effects model as the average number of gabapentinoid
   prescriptions standardized by defined daily dose (individual level), and
   number of veterans visiting a psychologist in the 6 and 12 months
   following the intervention.
   Results: The trial involved 2552 general practitioners in Australia and
   took place in March 2020. Both intervention groups had a significant
   reduction in total gabapentinoid prescription by the end of the study
   period (digital: mean reduction of 11.2\%, P=.004; postal: mean
   reduction of 11.2\%, P=.001). We found no difference between digital and
   postal mode of delivery in reduction of gabapentinoid prescriptions at
   12 months (digital: -0.058, postal: -0.058, P=.98). Digital delivery
   increased initiations to psychologists at 12 months (digital: 3.8\%,
   postal: 2.0\%, P=.02).
   Conclusions: Our digitally delivered professional behavior change
   intervention was feasible, had comparable effectiveness to the postal
   intervention with regard to changes in medicine use, and had increased
   effectiveness with regard to referrals to a psychologist. Given the
   logistical benefits of digital delivery in nationwide programs, the
   results encourage exploration of this mode in future interventions.},
Type = {Article},
Affiliation = {Andrade, AQ (Corresponding Author), Univ South Australia, Qual Use Med \& Pharm Res Ctr, UniSA Clin \& Med Sci, GPO Box 2471, Adelaide, SA 5001, Australia.
   Andrade, Andre Q.; Calabretto, Jean-Pierre; Pratt, Nicole L.; Kalisch-Ellett, Lisa M.; Kassie, Gizat M.; LeBlanc, Vanessa T.; Ramsay, Emmae; Roughead, Elizabeth E., Univ South Australia, Qual Use Med \& Pharm Res Ctr, UniSA Clin \& Med Sci, GPO Box 2471, Adelaide, SA 5001, Australia.
   Calabretto, Jean-Pierre, Australian Med Handbook Pty Ltd, Adelaide, SA, Australia.},
DOI = {10.2196/33873},
Article-Number = {e33873},
Keywords = {audit and feedback; digital health; precision public health; digital
   intervention; primary care; physician; health professional; health
   education},
Keywords-Plus = {QUALITY IMPROVEMENT PROGRAM; FEEDBACK INTERVENTIONS; PREGABALIN; AUDIT},
Research-Areas = {Health Care Sciences \& Services; Medical Informatics},
Web-of-Science-Categories  = {Health Care Sciences \& Services; Medical Informatics},
Author-Email = {andre.andrade@unisa.edu},
Affiliations = {University of South Australia},
Cited-References = {Andrade AQ, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-038016.
   BANDURA A, 1989, AM PSYCHOL, V44, P1175, DOI 10.1037/0003-066X.44.9.1175.
   Bergman U, 2006, PHARMACOEPIDEM DR S, V15, P95, DOI 10.1002/pds.1171.
   Black N, 2020, ADDICTION, V115, P1607, DOI 10.1111/add.14969.
   Candlish J, 2018, BMC MED RES METHODOL, V18, DOI 10.1186/s12874-018-0559-x.
   Colquhoun HL, 2017, IMPLEMENT SCI, V12, DOI 10.1186/s13012-017-0646-0.
   Davidson-Pilon C., 2019, J OPEN SOURCE SOFTW, V4, P1317, DOI DOI 10.21105/JOSS.01317.
   Desborough J, 2020, MED J AUSTRALIA, V213, P104, DOI 10.5694/mja2.50693.
   Dombrowski SU, 2016, BRIT J HEALTH PSYCH, V21, P733, DOI 10.1111/bjhp.12203.
   Ellett LMK, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3443-9.
   Ellett Lisa M. Kalisch, 2018, Journal of Pharmacy Practice and Research, V48, P222, DOI 10.1002/jppr.1379.
   Ellett LMK, 2017, ARCH OSTEOPOROS, V12, DOI 10.1007/s11657-017-0309-4.
   Goodman CW, 2017, NEW ENGL J MED, V377, P411, DOI 10.1056/NEJMp1704633.
   Green LW., 2005, HLTH PROGRAM PLANNIN.
   Greenhalgh T, 2004, MILBANK Q, V82, P581, DOI 10.1111/j.0887-378X.2004.00325.x.
   Grimshaw JM, 2019, BMJ QUAL SAF, V28, P416, DOI 10.1136/bmjqs-2018-008355.
   Ivers N, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000259.pub3.
   Ivers NM, 2014, J GEN INTERN MED, V29, P1534, DOI 10.1007/s11606-014-2913-y.
   Jha AK, 2008, INT J MED INFORM, V77, P848, DOI 10.1016/j.ijmedinf.2008.06.007.
   Landis-Lewis Z, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-014-0203-z.
   McKee M, 2019, EUR J PUBLIC HEALTH, V29, P3, DOI 10.1093/eurpub/ckz160.
   Morrison EE, 2017, J ROY COLL PHYS EDIN, V47, P310, DOI 10.4997/JRCPE.2017.402.
   Odone Anna, 2019, Eur J Public Health, V29, P28, DOI 10.1093/eurpub/ckz161.
   Pratt NL, 2017, INT J QUAL HEALTH C, V29, P75, DOI 10.1093/intqhc/mzw138.
   Pratt NL, 2015, SOC SCI MED, V145, P1, DOI 10.1016/j.socscimed.2015.09.019.
   PROCHASKA JO, 1994, HEALTH PSYCHOL, V13, P39, DOI 10.1037/0278-6133.13.1.39.
   Quality Use of Medicines and Pharmacy Research Centre, REC PAIN STRAT CAN H.
   Quality Use of Medicines and Pharmacy Research Centre, 2021, VET MATES.
   Roughead EE, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-514.
   Royal Australian College of General Practitioners, 2019, GEN PRACT HLTH NAT.
   Seabold S., 2010, SciPy, P92, DOI DOI 10.25080/MAJORA-92BF1922-011.
   Tuti T, 2017, IMPLEMENT SCI, V12, DOI 10.1186/s13012-017-0590-z.
   van Genugten L, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.4218.
   Webb TL, 2010, J MED INTERNET RES, V12, DOI 10.2196/jmir.1376.},
Number-of-Cited-References = {34},
Times-Cited = {4},
Unique-ID = {WOS:000766781800004},
}

@article{ WOS:000505560800015,
Author = {Armstrong, Gregory L. and MacCannell, Duncan R. and Taylor, Jill and
   Carleton, Heather A. and Neuhaus, Elizabeth B. and Bradbury, Richard S.
   and Posey, James E. and Gwinn, Marta},
Title = {Pathogen Genomics in Public Health},
Journal = {NEW ENGLAND JOURNAL OF MEDICINE},
Year = {2019},
Volume = {381},
Number = {26},
Pages = {2569-2580},
Month = {DEC 26},
Abstract = {Rapid advances in DNA sequencing technology ({''}next-generation
   sequencing{''}) have inspired optimism about the potential of human
   genomics for ``precision medicine.{''} Meanwhile, pathogen genomics is
   already delivering ``precision public health{''} through more effective
   investigations of outbreaks of foodborne illnesses, better-targeted
   tuberculosis control, and more timely and granular influenza
   surveillance to inform the selection of vaccine strains. In this
   article, we describe how public health agencies have been adopting
   pathogen genomics to improve their effectiveness in almost all domains
   of infectious disease. This momentum is likely to continue, given the
   ongoing development in sequencing and sequencing-related technologies.
   The development of next-generation sequencing technology has had a major
   effect on a wide range of infectious diseases that affect public health.
   Next-generation sequencing promises to facilitate the diagnosis of
   outbreaks, the detection of drug resistance, and the selection of
   vaccine approaches and has many other applications.},
Type = {Article},
Affiliation = {Armstrong, GL (Corresponding Author), Ctr Dis Control \& Prevent, 1600 Clifton Rd NE, Atlanta, GA 30329 USA.
   Armstrong, Gregory L.; MacCannell, Duncan R.; Carleton, Heather A., Ctr Dis Control \& Prevent, Natl Ctr Emerging \& Zoonot Infect Dis, Atlanta, GA USA.
   Neuhaus, Elizabeth B., Ctr Dis Control \& Prevent, Natl Ctr Immunizat \& Resp Dis, Atlanta, GA USA.
   Bradbury, Richard S., Ctr Dis Control \& Prevent, Ctr Global Hlth, Atlanta, GA USA.
   Posey, James E., Ctr Dis Control \& Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD \& TB Preven, Atlanta, GA USA.
   Gwinn, Marta, CFOL Int, Atlanta, GA USA.
   Taylor, Jill, New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12237 USA.},
DOI = {10.1056/NEJMsr1813907},
Keywords-Plus = {INDEPENDENT DIAGNOSTIC-TESTS; ACTIVE SURVEILLANCE NETWORK;
   RISK-ASSESSMENT TOOL; 10 US SITES; MYCOBACTERIUM-TUBERCULOSIS;
   UNITED-STATES; FOODBORNE DISEASES; REAL-TIME; ANTIMICROBIAL RESISTANCE;
   DRUG-RESISTANCE},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Author-Email = {garmstrong@cdc.gov},
Affiliations = {Centers for Disease Control \& Prevention - USA; Centers for Disease
   Control \& Prevention - USA; Centers for Disease Control \& Prevention -
   USA; Centers for Disease Control \& Prevention - USA; State University
   of New York (SUNY) System; Wadsworth Center},
Cited-References = {Alan H, 2017, VACCINE, V35, P1104, DOI 10.1016/j.vaccine.2017.01.018.
   Aldridge RW, 2019, LANCET PUBLIC HEALTH, V4, pE373, DOI 10.1016/S2468-2667(19)30112-4.
   Allard MW, 2018, CURR OPIN BIOTECH, V49, P224, DOI 10.1016/j.copbio.2017.11.002.
   Allard MW, 2016, J CLIN MICROBIOL, V54, P1975, DOI 10.1128/JCM.00081-16.
   Allix-Béguec C, 2018, NEW ENGL J MED, V379, P1403, DOI 10.1056/NEJMoa1800474.
   Althomsons SP, 2018, EMERG INFECT DIS, V24, P573, DOI 10.3201/eid2403.171613.
   {[}Anonymous], 2020, WDEL 0221.
   {[}Anonymous], 2011, BLUE RIBB PAN FUT ST.
   Argimón S, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000093.
   Ashton PM, 2016, PEERJ, V4, DOI 10.7717/peerj.1752.
   Bale J, 2016, J MED MICROBIOL, V65, P1074, DOI 10.1099/jmm.0.000325.
   Barratt JLN, 2019, PARASITOLOGY, V146, P1275, DOI 10.1017/S0031182019000581.
   Berenger BM, 2015, EUROSURVEILLANCE, V20, P19, DOI 10.2807/1560-7917.ES.2015.20.47.30073.
   Besser J, 2018, CLIN MICROBIOL INFEC, V24, P335, DOI 10.1016/j.cmi.2017.10.013.
   Blanton L, 2019, MMWR-MORBID MORTAL W, V68, P125, DOI 10.15585/mmwr.mm6806a1.
   Burke SA, 2018, EMERG INFECT DIS, V24, P471, DOI 10.3201/eid2403.171852.
   Carleton H.A., 2016, Microbe, V11, P311.
   Cartwright EJ, 2013, EMERG INFECT DIS, V19, P1, DOI {[}10.3201/eid1908.121511, 10.3201/eid1901.120393].
   Chattaway MA, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00258.
   Chochua S, 2017, MBIO, V8, DOI {[}10.1128/mbio.01422-17, 10.1128/mBio.01422-17].
   Chow NA, 2018, LANCET INFECT DIS, V18, P1377, DOI 10.1016/S1473-3099(18)30597-8.
   Clark SA, 2018, INT J MED MICROBIOL, V308, P256, DOI 10.1016/j.ijmm.2017.11.004.
   Cox NJ, 2014, CURR TOP MICROBIOL, V385, P119, DOI 10.1007/82\_2014\_419.
   Crisan A, 2019, BIOINFORMATICS, V35, P1668, DOI 10.1093/bioinformatics/bty832.
   Crowe SJ, 2017, J FOOD PROTECT, V80, P654, DOI 10.4315/0362-028X.JFP-16-364.
   Dallman TJ, 2015, CLIN INFECT DIS, V61, P305, DOI 10.1093/cid/civ318.
   David S, 2018, MICROB GENOMICS, V4, DOI 10.1099/mgen.0.000226.
   Dolinger David L, 2016, Int J Mycobacteriol, V5 Suppl 1, pS27, DOI 10.1016/j.ijmyco.2016.09.021.
   Doyle RM, 2018, J CLIN MICROBIOL, V56, DOI {[}10.1128/JCM.00666-18, 10.1128/jcm.00666-18].
   Dudas G, 2017, NATURE, V544, P309, DOI 10.1038/nature22040.
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401.
   Flaherty BR, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0540-2.
   Flannery B, 2016, J INFECT DIS, V214, P1010, DOI 10.1093/infdis/jiw181.
   Gardy JL, 2018, NAT REV GENET, V19, P9, DOI 10.1038/nrg.2017.88.
   Gardy JL, 2011, NEW ENGL J MED, V364, P730, DOI 10.1056/NEJMoa1003176.
   Glebova O, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4274-5.
   Goodwin S, 2016, NAT REV GENET, V17, P333, DOI 10.1038/nrg.2016.49.
   Grad YH, 2016, J INFECT DIS, V214, P1579, DOI 10.1093/infdis/jiw420.
   Grad YH, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0538-4.
   Greninger AL, 2019, J CLIN MICROBIOL, V57, pe01914.
   Grubaugh ND, 2019, CELL, V178, P1057, DOI 10.1016/j.cell.2019.07.018.
   Guthrie JL, 2019, EPIDEMIOL INFECT, V147, DOI {[}10.1017/S0950268819000670, 10.1017/s0950268819000670].
   Guthrie JL, 2018, J INFECT DIS, V218, P1155, DOI 10.1093/infdis/jiy278.
   Guthrie JL, 2017, ANN NY ACAD SCI, V1388, P59, DOI 10.1111/nyas.13273.
   Gwinn M, 2019, JAMA-J AM MED ASSOC, V321, P893, DOI 10.1001/jama.2018.21669.
   Hadfield J, 2018, BIOINFORMATICS, V34, P4121, DOI 10.1093/bioinformatics/bty407.
   Huang JY, 2016, MMWR-MORBID MORTAL W, V65, P368, DOI 10.15585/mmwr.mm6514a2.
   Iwamoto M, 2015, MMWR-MORBID MORTAL W, V64, P252.
   Jajou R, 2018, PLOS ONE, V13, pe0195413.
   Jenkins C., 2019, Euro surveillance: bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, P24.
   Joensen KG, 2015, J CLIN MICROBIOL, V53, P2410, DOI 10.1128/JCM.00008-15.
   Joensen KG, 2014, J CLIN MICROBIOL, V52, P1501, DOI 10.1128/JCM.03617-13.
   Köser CU, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002824.
   Kostkova P, 2018, LIFE SCI SOC POLICY, V14, DOI 10.1186/s40504-018-0078-x.
   Lapierre P, 2017, EMERG INFECT DIS, V23, P1784, DOI 10.3201/eid2311.170308.
   Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242.
   Lévesque S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103852.
   Lindsey RL, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00766.
   Lockhart SR, 2017, CLIN INFECT DIS, V64, P134, DOI 10.1093/cid/ciw691.
   Longmire AG, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4268-3.
   Luo T, 2014, TUBERCULOSIS, V94, P434, DOI 10.1016/j.tube.2014.04.005.
   Maccannell D, 2019, MICROBIOL SPECTR, V7, DOI 10.1128/microbiolspec.AME-0005-2018.
   Marder EP, 2017, MMWR-MORBID MORTAL W, V66, P397, DOI 10.15585/mmwr.mm6615a1.
   McDermott PF, 2016, ANTIMICROB AGENTS CH, V60, P5515, DOI 10.1128/AAC.01030-16.
   Metcalf BJ, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2016.08.001.
   Metcalf BJ, 2017, CLIN MICROBIOL INFEC, V23, DOI 10.1016/j.cmi.2017.02.021.
   Mook P, 2018, EPIDEMIOL INFECT, V146, P1452, DOI 10.1017/S0950268818001589.
   National Human Genome Research Institute, 2019, DNA SEQUENCING COSTS.
   Olmstead AD, 2015, INFECT GENET EVOL, V33, P101, DOI 10.1016/j.meegid.2015.04.017.
   Oster AM, 2018, JAIDS-J ACQ IMM DEF, V79, P543, DOI 10.1097/QAI.0000000000001856.
   Oster AM, 2018, JAMA-J AM MED ASSOC, V319, P1657, DOI 10.1001/jama.2018.1513.
   Papaventsis D, 2017, CLIN MICROBIOL INFEC, V23, P61, DOI 10.1016/j.cmi.2016.09.008.
   Parvaresh L, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3164-z.
   Pond SLK, 2018, MOL BIOL EVOL, V35, P1812, DOI 10.1093/molbev/msy016.
   Popovich KJ, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0570-0.
   Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996.
   Qvarnstrom Y, 2018, GUT PATHOG, V10, DOI 10.1186/s13099-018-0272-7.
   Ribot EM, 2016, EMBO REP, V17, P1499, DOI 10.15252/embr.201643128.
   Riveron JM, 2017, G3-GENES GENOM GENET, V7, P1819, DOI 10.1534/g3.117.040147.
   Russell CA, 2014, ELIFE, V3, pe03883.
   Satta G, 2018, CLIN MICROBIOL INFEC, V24, P604, DOI 10.1016/j.cmi.2017.10.030.
   Shea J, 2017, J CLIN MICROBIOL, V55, P1871, DOI 10.1128/JCM.00298-17.
   Sintchenko V, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1314.
   Snitkin ES, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004129.
   Talundzic E, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.02474-17.
   Topaz N, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3324-1.
   Tyson GH, 2017, J ADOLESCENT HEALT S, V61, pe02140.
   Tyson GH, 2015, J ANTIMICROB CHEMOTH, V70, P2763, DOI 10.1093/jac/dkv186.
   Uyeki TM, 2017, LANCET, V389, P2172, DOI 10.1016/S0140-6736(17)31274-6.
   Votintseva AA, 2017, J CLIN MICROBIOL, V55, P1285, DOI 10.1128/JCM.02483-16.
   Walker TM, 2013, LANCET INFECT DIS, V13, P137, DOI 10.1016/S1473-3099(12)70277-3.
   Weetman D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21265-5.
   Wilson JR, 2017, VIROLOGY, V511, P214, DOI 10.1016/j.virol.2017.08.016.
   World Health Organization, 2021, Recommended composition of influenza virus vaccines for use in the 2021-2022 northern hemisphere influenza season.
   Zhong DB, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2337-y.
   Zhou B, 2014, J CLIN MICROBIOL, V52, P1330, DOI 10.1128/JCM.03265-13.
   Zhou B, 2009, J VIROL, V83, P10309, DOI 10.1128/JVI.01109-09.
   Ziegler T, 2018, INFLUENZA OTHER RESP, V12, P558, DOI 10.1111/irv.12570.},
Number-of-Cited-References = {98},
Times-Cited = {112},
Unique-ID = {WOS:000505560800015},
}

@article{ WOS:001178579700001,
Author = {Sivadas, Ambily and Rathore, Surabhi and Sahana, S. and Jolly, Bani and
   Bhoyar, Rahul C. and Jain, Abhinav and Sharma, Disha and Imran, Mohamed
   and Senthilvel, Vigneshwar and Divakar, Mohit Kumar and Mishra, Anushree
   and Sivasubbu, Sridhar and Scaria, Vinod},
Title = {The genomic landscape of <i>CYP2D6</i> variation in the Indian
   population},
Journal = {PHARMACOGENOMICS},
Year = {2024},
Volume = {25},
Number = {3},
Pages = {147-160},
Month = {FEB},
Abstract = {Aim: The CYP2D6 gene is highly polymorphic, causing large
   interindividual variability in the metabolism of several clinically
   important drugs. Materials \& methods: The authors investigated the
   diversity and distribution of CYP2D6 alleles in Indians using whole
   genome sequences (N = 1518). Functional consequences were assessed using
   pathogenicity scores and molecular dynamics simulations. Results: The
   analysis revealed population-specific CYP2D6 alleles ({*}86, {*}7,
   {*}111, {*}112, {*}113, {*}99) and remarkable differences in variant and
   phenotype frequencies with global populations. The authors observed that
   one in three Indians could benefit from a dose alteration for
   psychiatric drugs with accurate CYP2D6 phenotyping. Molecular dynamics
   simulations revealed large conformational fluctuations, confirming the
   predicted reduced function of {*}86 and {*}113 alleles. Conclusion: The
   findings emphasize the utility of comprehensive CYP2D6 profiling for
   aiding precision public health.},
Type = {Article},
Affiliation = {Sivadas, A (Corresponding Author), St Johns Natl Acad Hlth Sci, Div Nutr, St Johns Res Inst, Bangalore 560034, Karnataka, India.
   Scaria, V (Corresponding Author), CSIR, Inst Genom \& Integrat Biol, Mathura Rd, New Delhi 110025, India.
   Scaria, V (Corresponding Author), Acad Sci \& Innovat Res AcSIR, Ghaziabad 201002, Uttar Pradesh, India.
   Scaria, V (Corresponding Author), Vishwanath Canc Care Fdn, B 702,7th Floor,Neelkanth Business Pk Kirol Villag, Vidya Vihar 400086, West Mumbai, India.
   Sivadas, Ambily, St Johns Natl Acad Hlth Sci, Div Nutr, St Johns Res Inst, Bangalore 560034, Karnataka, India.
   Rathore, Surabhi; Sahana, S.; Jolly, Bani; Bhoyar, Rahul C.; Jain, Abhinav; Sharma, Disha; Imran, Mohamed; Senthilvel, Vigneshwar; Divakar, Mohit Kumar; Mishra, Anushree; Sivasubbu, Sridhar; Scaria, Vinod, CSIR, Inst Genom \& Integrat Biol, Mathura Rd, New Delhi 110025, India.
   Rathore, Surabhi; Sahana, S.; Jolly, Bani; Jain, Abhinav; Imran, Mohamed; Senthilvel, Vigneshwar; Divakar, Mohit Kumar; Mishra, Anushree; Sivasubbu, Sridhar; Scaria, Vinod, Acad Sci \& Innovat Res AcSIR, Ghaziabad 201002, Uttar Pradesh, India.
   Sivasubbu, Sridhar; Scaria, Vinod, Vishwanath Canc Care Fdn, B 702,7th Floor,Neelkanth Business Pk Kirol Villag, Vidya Vihar 400086, West Mumbai, India.},
DOI = {10.2217/pgs-2023-0233},
EarlyAccessDate = {MAR 2024},
Keywords = {cytochrome P450; drug metabolism; genomics; Indian population; molecular
   dynamics simulation; personalized medicine; pharmacogenomics;
   pharmacology; polymorphism},
Keywords-Plus = {DRUG-METABOLIZING-ENZYMES; GENETIC-POLYMORPHISM; POOR METABOLIZERS;
   CRYSTAL-STRUCTURE; IN-SILICO; WILD-TYPE; DEBRISOQUINE; VARIANTS;
   IDENTIFICATION; FREQUENCY},
Research-Areas = {Pharmacology \& Pharmacy},
Web-of-Science-Categories  = {Pharmacology \& Pharmacy},
Author-Email = {ambily.s@sjri.res.in
   vinod.scaria@vishwanathcancercare.org},
Affiliations = {St. John's National Academy of Health Sciences; St. John's Research
   Institute; Council of Scientific \& Industrial Research (CSIR) - India;
   CSIR - Institute of Genomics \& Integrative Biology (IGIB); Academy of
   Scientific \& Innovative Research (AcSIR)},
Cited-References = {Abraham BK, 2000, ACTA PHARMACOL SIN, V21, P494.
   Adithan C, 2003, EUR J CLIN PHARMACOL, V59, P517, DOI 10.1007/s00228-003-0657-4.
   Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393.
   Angélil R, 2015, J CHEM PHYS, V143, DOI 10.1063/1.4928055.
   Bertilsson L, 2002, BRIT J CLIN PHARMACO, V53, P111, DOI 10.1046/j.0306-5251.2001.01548.x.
   Chang X, 2012, J MED GENET, V49, P433, DOI 10.1136/jmedgenet-2012-100918.
   Chen X, 2021, PHARMACOGENOMICS J, V21, P251, DOI 10.1038/s41397-020-00205-5.
   Choudhury Shamima, 2014, Current Pharmacogenomics \& Personalized Medicine, V12, P123.
   Daly Ann K., 2015, Drug Metabolism and Personalized Therapy, V30, P165, DOI 10.1515/dmdi-2014-0034.
   Dehouck Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-151.
   Del Tredici AL, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00305.
   Dodgen TM, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-20.
   Don CG, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202534.
   EVERT B, 1994, N-S ARCH PHARMACOL, V350, P434.
   Fukuyoshi S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152946.
   GAEDIGK A, 1991, AM J HUM GENET, V48, P943.
   Gaedigk A, 2018, CLIN PHARMACOL THER, V103, P399, DOI 10.1002/cpt.910.
   Gaedigk A, 2017, GENET MED, V19, P69, DOI 10.1038/gim.2016.80.
   GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862.
   Handa K, 2014, DRUG METAB PHARMACOK, V29, P52, DOI 10.2133/dmpk.DMPK-13-RG-044.
   Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H.
   Jaime LKM, 2018, PHARMACOGENOMICS, V19, P197, DOI 10.2217/pgs-2017-0142.
   Jain A, 2021, NUCLEIC ACIDS RES, V49, pD1225, DOI 10.1093/nar/gkaa923.
   KAGIMOTO M, 1990, J BIOL CHEM, V265, P17209.
   KIMURA S, 1989, AM J HUM GENET, V45, P889.
   Kuznetsov IB, 2008, BIOINFORMATION, V3, P134, DOI 10.6026/97320630003134.
   Lamba V, 1998, EUR J CLIN PHARMACOL, V54, P787, DOI 10.1007/s002280050552.
   Lauschke VM, 2020, NPJ GENOM MED, V5, DOI 10.1038/s41525-020-0119-2.
   Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057.
   LLerena A, 2012, PHARMACOGENOMICS J, V12, P176, DOI 10.1038/tpj.2010.85.
   Malde AK, 2011, J CHEM THEORY COMPUT, V7, P4026, DOI 10.1021/ct200196m.
   Muroi Y, 2014, DRUG METAB PHARMACOK, V29, P360, DOI 10.2133/dmpk.DMPK-14-RG-014.
   Nakatsuka N, 2017, NAT GENET, V49, P1403, DOI 10.1038/ng.3917.
   NELSON DR, 1993, DNA CELL BIOL, V12, P1, DOI 10.1089/dna.1993.12.1.
   Nimrod G, 2005, BIOINFORMATICS, V21, pI328, DOI 10.1093/bioinformatics/bti1023.
   Paradkar Minal U, 2018, Drug Metab Pers Ther, V33, P141, DOI 10.1515/dmpt-2018-0011.
   PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693.
   Pettersen EF, 2021, PROTEIN SCI, V30, P70, DOI 10.1002/pro.3943.
   Preeprem T, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00082.
   Rowland P, 2006, J BIOL CHEM, V281, P7614, DOI 10.1074/jbc.M511232200.
   SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626.
   Schmid N, 2011, EUR BIOPHYS J BIOPHY, V40, P843, DOI 10.1007/s00249-011-0700-9.
   Shapovalov MV, 2011, STRUCTURE, V19, P844, DOI 10.1016/j.str.2011.03.019.
   Sistonen J, 2007, PHARMACOGENET GENOM, V17, P93.
   Stern Sydney, 2024, Drug Metab Dispos, V52, P159, DOI 10.1124/dmd.123.001512.
   Theophilus NA, 2006, BIOL PHARM BULL, V29, P1655, DOI 10.1248/bpb.29.1655.
   Umamaheswaran G, 2014, INDIAN J MED RES, V139, P27.
   Van Durme J, 2011, BIOINFORMATICS, V27, P1711, DOI 10.1093/bioinformatics/btr254.
   Wang A, 2012, J BIOL CHEM, V287, P10834, DOI 10.1074/jbc.M111.307918.
   Wass MN, 2010, NUCLEIC ACIDS RES, V38, pW469, DOI 10.1093/nar/gkq406.
   Whirl-Carrillo M, 2012, CLIN PHARMACOL THER, V92, P414, DOI 10.1038/clpt.2012.96.
   Zhou Y, 2017, CLIN PHARMACOL THER, V102, P688, DOI 10.1002/cpt.690.},
Number-of-Cited-References = {52},
Times-Cited = {0},
Unique-ID = {WOS:001178579700001},
}

@incollection{ WOS:000443800300028,
Author = {Baynam, Gareth and Molster, Caron and Bauskis, Alicia and Kowal, Emma
   and Savarirayan, Ravi and Kelaher, Margaret and Easteal, Simon and
   Massey, Libby and Garvey, Gail and Goldblatt, Jack and Pachter, Nicholas
   and Weeramanthri, Tarun S. and Dawkins, Hugh J. S.},
Editor = {DeLaPaz, MP and Taruscio, D and Groft, SC},
Title = {Indigenous Genetics and Rare Diseases: Harmony, Diversity and Equity},
Booktitle = {RARE DISEASES EPIDEMIOLOGY: UPDATE AND OVERVIEW, 2ND EDITION},
Series = {Advances in Experimental Medicine and Biology},
Year = {2017},
Volume = {1031},
Pages = {511-520},
Abstract = {Advances in our understanding of genetic and rare diseases are changing
   the face of healthcare. Crucially, the global community must implement
   these advances equitably to reduce health disparities, including between
   Indigenous and non-Indigenous peoples. We take an Australian perspective
   to illustrate some key areas that are fundamental to the equitable
   translation of new knowledge for the improved diagnosis of genetic and
   rare diseases for Indigenous people. Specifically, we focus on
   inequalities in access to clinical genetics services and the lack of
   genetic and phenomic reference data to inform diagnoses. We provide
   examples of ways in which these inequities are being addressed through
   Australian partnerships to support a harmonious and inclusive approach
   to ensure that benefits from traditional wisdom, community knowledge and
   shared experiences are interwoven to support and inform implementation
   of new knowledge from genomics and precision public health. This will
   serve to deliver benefits to all of our diverse citizens, including
   Indigenous populations.},
Type = {Article; Book Chapter},
Affiliation = {Baynam, G (Corresponding Author), King Edward Mem Hosp, Genet Serv Western Australia, Subiaco, WA, Australia.
   Baynam, G (Corresponding Author), Western Australian Register Dev Anomalies, Subiaco, WA, Australia.
   Baynam, G (Corresponding Author), Undiagnosed Dis Program, Subiaco, WA, Australia.
   Baynam, Gareth, King Edward Mem Hosp, Genet Serv Western Australia, Subiaco, WA, Australia.
   Baynam, Gareth, Western Australian Register Dev Anomalies, Subiaco, WA, Australia.
   Baynam, Gareth, Undiagnosed Dis Program, Subiaco, WA, Australia.
   Molster, Caron; Bauskis, Alicia; Dawkins, Hugh J. S., Govt Western Australia, Off Populat Hlth Genom, Publ Hlth Div, Dept Hlth, Perth, WA, Australia.
   Kowal, Emma, Deakin Univ, Alfred Deakin Inst Citizenship \& Globalisat, Melbourne, Vic, Australia.
   Kowal, Emma; Easteal, Simon; Massey, Libby, Australian Natl Univ, Natl Ctr Indigenous Genom, Canberra, ACT, Australia.
   Savarirayan, Ravi, Victorian Clin Genet Serv, Parkville, Vic, Australia.
   Savarirayan, Ravi, Univ Melbourne, Dept Paediat, Melbourne, Vic 3010, Australia.
   Savarirayan, Ravi, Northern Terr Clin Genet Serv, Darwin, NT 9000, Australia.
   Kelaher, Margaret, Univ Melbourne, Melbourne Sch Populat \& Global Hlth, Melbourne, Vic 3010, Australia.
   Easteal, Simon; Massey, Libby, Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT, Australia.
   Garvey, Gail, Charles Darwin Univ, Menzies Sch Hlth Res, Wellbeing \& Preventable Chron Dis Div, Darwin, NT 0811, Australia.
   Goldblatt, Jack; Pachter, Nicholas, Govt Western Australia, Genet Serv Western Australia, Dept Hlth, Perth, WA, Australia.
   Goldblatt, Jack, Univ Western Australia, Sch Paediat \& Child Hlth, Perth, WA, Australia.
   Pachter, Nicholas, Univ Western Australia, Sch Paediat \& Child Hlth, Perth, WA, Australia.
   Pachter, Nicholas, Univ Western Australia, Sch Med \& Pharmacol, Perth, WA, Australia.
   Weeramanthri, Tarun S., Murdoch Univ, Sir Walter Murdoch Sch Publ Hlth \& Int Affairs, Perth, WA, Australia.},
DOI = {10.1007/978-3-319-67144-4\_27},
Keywords = {Indigenous; Aboriginal; Genomics; Genetics; Phenotyping; Phenomics;
   Equity; Innovation; Facial},
Research-Areas = {Public, Environmental \& Occupational Health; Research \& Experimental
   Medicine},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health; Medicine, Research \&
   Experimental},
Author-Email = {Gareth.Baynam@health.wa.gov.au
   Caron.Molster@health.wa.gov.au
   Alicia.bauskis@health.wa.gov.au
   emma.kowal@deakin.edu.au
   ravi.savarirayan@vcgs.org.au
   mkelaher@unimelb.edu.au
   Simon.Easteal@anu.edu.au
   Gail.Garvey@menzies.edu.au
   jack.goldblatt@health.wa.gov.au
   Nicholas.pachter@health.wa.gov.au
   Tarun.weeramanthri@health.wa.gov.au
   hugh.dawkins@health.wa.gov.au},
Affiliations = {University of Western Australia; King Edward Memorial Hospital; Deakin
   University; Melbourne Genomics Health Alliance; Australian National
   University; University of Melbourne; Melbourne Bioinformatics; Melbourne
   Genomics Health Alliance; University of Melbourne; Australian National
   University; John Curtin School of Medical Research; Charles Darwin
   University; Menzies School of Health Research; University of Western
   Australia; University of Western Australia; University of Western
   Australia; Murdoch University},
Cited-References = {{[}Anonymous], NHMRC ROAD MAP.
   Australian Bureau of Statistics, 2015, AUSTR DEM STAT.
   Australian Bureau of Statistics, 2011, EST AB TORR STRAIT I.
   Ayme S, 2011, REPORT STATE ART R 1.
   Baynam G, 2015, AM J MED GENET A, V9999A, P1.
   Baynam G, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0462-7.
   Baynam G, 2015, J PAEDIATR CHILD H, V51, P381, DOI 10.1111/jpc.12705.
   Baynam G, 2013, HUM MUTAT, V34, P14, DOI 10.1002/humu.22219.
   Baynam GS, 2013, TWIN RES HUM GENET, V16, P840, DOI 10.1017/thg.2013.49.
   Baynam GS, 2012, MED J AUSTRALIA, V196, P313, DOI 10.5694/mja11.11459.
   Bustamante CD, 2011, NATURE, V475, P163, DOI 10.1038/475163a.
   Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523.
   European Commission, 2013, NAT PLANS STRAT RAR.
   European Commission, 2011, COUNC REC ACT FIELD.
   European Organisation for Rare Diseases, 2011, JOINT DECL RAR DIS I.
   Ferry Q, 2014, ELIFE, V3, DOI 10.7554/eLife.02020.
   Gravel S, 2011, P NATL ACAD SCI USA, V108, P11983, DOI 10.1073/pnas.1019276108.
   Hudson K., 2015, PRECISION MED INITIA.
   Khoury MJ, 2016, AM J PREV MED, V50, P398, DOI 10.1016/j.amepre.2015.08.031.
   Kowal E., 2011, Genetic Research in Aboriginal and Torres Strait Islander Communities: Beginning the Conversation.
   Kowal E, 2015, J GENET COUNS, V24, P597, DOI 10.1007/s10897-014-9782-8.
   Kowal Emma, 2016, AUSTRALAS SCI, P18.
   Kowal EE, 2012, MED J AUSTRALIA, V197, P19, DOI 10.5694/mja12.10531.
   Manolio TA, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab0194.
   Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494.
   Manrai AK, 2016, NEW ENGL J MED, V375, P655, DOI 10.1056/NEJMsa1507092.
   Molster C, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0409-z.
   Mroske C, 2015, BMC MED GENET, V16, DOI 10.1186/s12881-015-0240-8.
   Muenke M, 2016, GENET MED, V18, P1085, DOI 10.1038/gim.2016.3.
   National Research Council, 2011, PREC MED BUILD KNOWL.
   Office of Science and Technology, 2012, NAT BIOEC BLUEPR.
   Rath A., 2010, ORPHANET J RARE DIS, V5, pP1, DOI DOI 10.1186/1750-1172-5-S1-P1.
   Remuzzi G, 2008, LANCET, V371, P1978, DOI 10.1016/S0140-6736(08)60847-8.
   Schieppati A, 2008, LANCET, V371, P2039, DOI 10.1016/S0140-6736(08)60872-7.
   Smith CE, 2016, HEALTH AFFAIR, V35, P1367, DOI 10.1377/hlthaff.2015.1476.
   Tang D, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.23.
   Thomas DP, 2014, MED J AUSTRALIA, V201, pS15, DOI 10.5694/mja14.00114.
   Topol EJ, 2014, CELL, V157, P241, DOI 10.1016/j.cell.2014.02.012.
   VALDEZ R, 2016, PREV CHRONIC DIS, V13, DOI DOI 10.5888/PCD13.150491.},
Number-of-Cited-References = {39},
Times-Cited = {15},
Unique-ID = {WOS:000443800300028},
}

@article{ WOS:000535825200001,
Author = {Bilkey, Gemma A. and Burns, Belinda L. and Coles, Emily P. and Mahede,
   Trinity and Baynam, Gareth and Nowak, Kristen J.},
Title = {Optimizing Precision Medicine for Public Health},
Journal = {FRONTIERS IN PUBLIC HEALTH},
Year = {2019},
Volume = {7},
Month = {MAR 7},
Abstract = {Advances in precision medicine have presented challenges to traditional
   public health decision-making paradigms. Historical methods of
   allocating healthcare funds based on safety, efficacy, and efficiency,
   are challenged in a healthcare delivery model that focuses on
   individualized variations in pathology that form the core of precision
   medicine. Public health policy and decision-makingmust adapt to this new
   frontier of healthcare delivery to ensure that the broad public health
   goals of reducing healthcare disparities and improving the health of
   populations are achieved, through effective and equitable allocation of
   healthcare funds. This paper discusses contemporary applications of
   precisionmedicine, and the potential impacts of these on public health
   policy and decision-making, with particular focus on patients living
   with rare diseases and rare cancers. The authors then reconcile these,
   presenting precision public health as the bridge between these seemingly
   competing fields.},
Type = {Review},
Affiliation = {Bilkey, GA (Corresponding Author), Govt Western Australia, Dept Hlth, Publ \& Aboriginal Hlth Div, Off Populat Hlth Genom, Perth, WA, Australia.
   Bilkey, GA (Corresponding Author), Govt Western Australia, Dept Hlth, Publ \& Aboriginal Hlth Div, Off Chief Hlth Officer, Perth, WA, Australia.
   Bilkey, Gemma A.; Burns, Belinda L.; Coles, Emily P.; Mahede, Trinity; Baynam, Gareth; Nowak, Kristen J., Govt Western Australia, Dept Hlth, Publ \& Aboriginal Hlth Div, Off Populat Hlth Genom, Perth, WA, Australia.
   Bilkey, Gemma A., Govt Western Australia, Dept Hlth, Publ \& Aboriginal Hlth Div, Off Chief Hlth Officer, Perth, WA, Australia.
   Baynam, Gareth, Govt Western Australia, Dept Hlth, King Edward Mem Hosp, Genet Serv Western Australia, Perth, WA, Australia.
   Baynam, Gareth, Govt Western Australia, Dept Hlth, King Edward Mem Hosp, Western Australian Register Dev Anomalies, Perth, WA, Australia.
   Nowak, Kristen J., Univ Western Australia, Fac Hlth \& Med Sci, Sch Biomed Sci, Perth, WA, Australia.
   Nowak, Kristen J., Queen Elizabeth II Med Ctr, Harry Perkins Inst Med Res, Perth, WA, Australia.},
DOI = {10.3389/fpubh.2019.00042},
Article-Number = {42},
Keywords = {genomics; public health; policy; precision medicine; genomic testing;
   molecular diagnostics; genetic disease; genetic therapies},
Keywords-Plus = {ONCOLOGY; TRIAL; CHALLENGES; GENOMICS; DRUGS; LEGAL; CARE; KNOWLEDGE;
   MUTATION; ETHICS},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {Gemma.Bilkey@health.wa.gov.au},
Affiliations = {King Edward Memorial Hospital; King Edward Memorial Hospital; University
   of Western Australia; Harry Perkins Institute of Medical Research},
Cited-References = {Amoasii L, 2018, SCIENCE, V362, P86, DOI 10.1126/science.aau1549.
   {[}Anonymous], AN CANC OUTC SCREEN.
   {[}Anonymous], 2013, Table of Pharmacogenomic Biomarkers in Drug Labels.
   {[}Anonymous], FDA GRANTS MARK APPR.
   {[}Anonymous], FDA APPR 1 BIOS TREA.
   {[}Anonymous], PREC MED.
   {[}Anonymous], KYMR TIS 2018.
   {[}Anonymous], PERS MED FDA 2017 PR.
   {[}Anonymous], FDA APPR 1 DRUG SPIN.
   {[}Anonymous], AP EXCLUSIVE US SCIE.
   {[}Anonymous], 2017, GUID CANC EARL DIAGN.
   {[}Anonymous], AUSTR GOV LIST NUS P.
   {[}Anonymous], FDA UNV STREAML PATH.
   {[}Anonymous], NIC WOULD WELC FURTH.
   {[}Anonymous], NHS ENGL ANN GROUNDB.
   {[}Anonymous], CANC SCREEN 2016.
   Ashley EA, 2015, JAMA-J AM MED ASSOC, V313, P2119, DOI 10.1001/jama.2015.3595.
   Australian Health Ministers' Advisory Council, 2017, NAT HLTH GEN POL FRA.
   Baynam G, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00031.
   Baynam GS, 2013, TWIN RES HUM GENET, V16, P840, DOI 10.1017/thg.2013.49.
   Bernard V, 2019, GASTROENTEROLOGY, V156, P108, DOI 10.1053/j.gastro.2018.09.022.
   Borry P, 2018, J COMMUN GENET, V9, P103, DOI 10.1007/s12687-017-0331-7.
   Brock A, 2017, CANCER RES, V77, P6473, DOI 10.1158/0008-5472.CAN-17-0448.
   Brownson RC., 2017, EVIDENCE BASED PUBLI.
   Callaway E, 2017, NAT NEWS.
   Chow SC, 2014, ANNU REV MED, V65, P405, DOI 10.1146/annurev-med-092012-112310.
   Chowkwanyun M, 2018, NEW ENGL J MED, V379, P1398, DOI 10.1056/NEJMp1806634.
   Clayton EW, 2003, NEW ENGL J MED, V349, P562, DOI 10.1056/NEJMra012577.
   Cohen JD, 2018, SCIENCE, V359, P926, DOI 10.1126/science.aar3247.
   Drozda K, 2018, JACC-BASIC TRANSL SC, V3, P545, DOI 10.1016/j.jacbts.2018.06.001.
   Drummond MF, 2015, METHODS EC EVALUATIO.
   Drummond M, 2009, J POPUL THER CLIN PH, V16, pE273.
   Dzau VJ, 2016, JAMA-J AM MED ASSOC, V316, P1659, DOI 10.1001/jama.2016.14117.
   Fiore RN, 2016, CURR OPIN ONCOL, V28, P83, DOI 10.1097/CCO.0000000000000247.
   Francis LP, 2014, APPL TRANSL GENOM, V3, P111, DOI 10.1016/j.atg.2014.09.003.
   Greden JF, 2019, J PSYCHIATR RES, V111, P59, DOI 10.1016/j.jpsychires.2019.01.003.
   Heckman-Stoddard Brandy M, 2014, Semin Oncol Nurs, V30, P109, DOI 10.1016/j.soncn.2014.03.004.
   IJzerman MJ, 2018, EXPERT REV PHARM OUT, V18, P593, DOI 10.1080/14737167.2018.1505505.
   Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI {[}10.3322/caac.21492, 10.3322/caac.20107, 10.3322/caac.20115].
   Khoury MJ, 2018, GENET MED, V20, P574, DOI 10.1038/gim.2017.211.
   Kurtz DM, 2018, J CLIN ONCOL, V36, P2845, DOI 10.1200/JCO.2018.78.5246.
   Kurzrock R, 2015, CELL CYCLE, V14, P2219, DOI 10.1080/15384101.2015.1041695.
   Lee JH, 2019, PROG RETIN EYE RES, V68, P31, DOI 10.1016/j.preteyeres.2018.08.003.
   Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725.
   Long CZ, 2014, SCIENCE, V345, P1184, DOI 10.1126/science.1254445.
   Lyles CR, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1585-5.
   Ma H, 2017, NATURE, V548, P413, DOI 10.1038/nature23305.
   Marzuillo C, 2013, PREV MED, V57, P477, DOI 10.1016/j.ypmed.2013.06.022.
   Maude SL, 2018, NEW ENGL J MED, V378, P439, DOI 10.1056/NEJMoa1709866.
   Middleton A, 2018, HUM MOL GENET, V27, pR8, DOI 10.1093/hmg/ddy084.
   Molster CM, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00247.
   Moosa S, 2017, AM J MED GENET A, V173, P264, DOI 10.1002/ajmg.a.37999.
   Nakamura S, 2018, INT J HEMATOL, V108, P402, DOI 10.1007/s12185-018-2487-2.
   Naveed M, 2015, ACM COMPUT SURV, V48, DOI 10.1145/2767007.
   Palmirotta R, 2018, THER ADV MED ONCOL, V10, P1, DOI 10.1177/1758835918794630.
   Park G, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30100-w.
   Prasad V, 2016, NATURE, V537, pS63, DOI 10.1038/537S63a.
   Proctor EK, 2009, ADM POLICY MENT HLTH, V36, P24, DOI 10.1007/s10488-008-0197-4.
   Qasim W, 2015, BLOOD, V126, P2046, DOI DOI 10.1182/BLOOD.V126.23.2046.2046.
   Redig AJ, 2015, J CLIN ONCOL, V33, P975, DOI 10.1200/JCO.2014.59.8433.
   Ricciardi W, 2017, EUR J PUBLIC HEALTH, V27, P36, DOI 10.1093/eurpub/ckx164.
   Sankar PL, 2017, GENET MED, V19, P743, DOI 10.1038/gim.2016.183.
   Schuster SJ, 2017, N Engl J Med, V377, P2545, DOI {[}DOI 10.1056/NEJMOA1708566, 10.1056/NEJMoa1708566].
   Sculpher MJ, 2006, HEALTH ECON, V15, P677, DOI 10.1002/hec.1093.
   Shin SH, 2017, NPJ PRECIS ONCOL, V1, DOI 10.1038/s41698-017-0016-z.
   Shulman DS, 2018, BRIT J CANCER, V119, P615, DOI 10.1038/s41416-018-0212-9.
   Simoens S, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-42.
   Simoens S, 2009, INT J ENV RES PUB HE, V6, P2950, DOI 10.3390/ijerph6122950.
   Simon R, 2017, CLIN PHARMACOL THER, V102, P934, DOI 10.1002/cpt.814.
   Springer SU, 2018, ELIFE, V7, DOI 10.7554/eLife.32143.
   Thorlund K, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k698.
   Turnbull C, 2018, ANN ONCOL, V29, P784, DOI 10.1093/annonc/mdy054.
   U.S. Food \& Drug Administration, FDA grants accelerated approval to tafasitamab-cxix for diffuse large B-cell lymphoma.
   Weeramanthri TS, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00121.
   Weinstein MC, 2009, VALUE HEALTH, V12, pS5, DOI 10.1111/j.1524-4733.2009.00515.x.
   Winquist E, 2014, J GEN INTERN MED, V29, pS774, DOI 10.1007/s11606-014-2885-y.
   Wolf SM, 2015, J LAW MED ETHICS, V43, P486, DOI 10.1111/jlme.12291.
   Wyatt R., 2016, ACHIEVING HLTH EQUIT.},
Number-of-Cited-References = {78},
Times-Cited = {43},
Unique-ID = {WOS:000535825200001},
}

@article{ WOS:000435007200010,
Author = {Supplee, Lauren H. and Parekh, Jenita and Johnson, Makedah},
Title = {Principles of Precision Prevention Science for Improving Recruitment and
   Retention of Participants},
Journal = {PREVENTION SCIENCE},
Year = {2018},
Volume = {19},
Number = {5, SI},
Pages = {689-694},
Month = {JUL},
Abstract = {Precision medicine and precision public health focus on identifying and
   providing the right intervention to the right population at the right
   time. Expanding on the concept, precision prevention science could allow
   the field to examine prevention programs to identify ways to make them
   more efficient and effective at scale, including addressing issues
   related to engagement and retention of participants. Research to date on
   engagement and retention has often focused on demographics and risk
   factors. The current paper proposes using McCurdy and Daro (Family
   Relations, 50, 113-121, 2001) model that posits a complex mixture of
   individual, provider, program, and community-level factors
   synergistically affect enrollment, engagement, and retention. The paper
   concludes recommending the use of research-practice partnerships and
   innovative, rapid cycle methods to design and improve prevention
   programs related to participant engagement and retention at scale.},
Type = {Editorial Material},
Affiliation = {Supplee, LH (Corresponding Author), Child Trends, 7315 Wisconsin Ave,Suite 1200W, Bethesda, MD 20814 USA.
   Supplee, Lauren H.; Parekh, Jenita; Johnson, Makedah, Child Trends, 7315 Wisconsin Ave,Suite 1200W, Bethesda, MD 20814 USA.},
DOI = {10.1007/s11121-018-0884-7},
Keywords = {Precision prevention science; Participant engagement; Participant
   retention; Research-practice partnerships; Rapid cycle methods},
Keywords-Plus = {NURSE-FAMILY PARTNERSHIP; DRUG-ABUSE PREVENTION; CLIENT ENGAGEMENT;
   INTERVENTION; SERVICES; PROGRAMS; IMPLEMENTATION; PREDICTORS; ATTRITION;
   FIDELITY},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {lsupplee@childtrends.org},
Cited-References = {Allard SW, 2003, URBAN AFF REV, V38, P787, DOI 10.1177/1078087403038006002.
   {[}Anonymous], 2009, PREVENTING MENTAL EM.
   Bernal G, 2009, FAM PROCESS, V48, P169, DOI 10.1111/j.1545-5300.2009.01275.x.
   Broome KM, 2007, J SUBST ABUSE TREAT, V33, P149, DOI 10.1016/j.jsat.2006.12.030.
   Cardona JRP, 2012, FAM PROCESS, V51, P56, DOI 10.1111/j.1545-5300.2012.01386.x.
   CATALANO RF, 1993, J CONSULT CLIN PSYCH, V61, P804, DOI 10.1037/0022-006X.61.5.804.
   Coatsworth JD, 2018, PREV SCI, V19, P609, DOI 10.1007/s11121-017-0781-5.
   Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523.
   Damashek A, 2012, CHILD MALTREATMENT, V17, P56, DOI 10.1177/1077559511423570.
   Damashek A, 2011, CHILD MALTREATMENT, V16, P9, DOI 10.1177/1077559510388507.
   Dawson-McClure S, 2017, PREV SCI, V18, P660, DOI 10.1007/s11121-017-0763-7.
   Duggan AK, 2009, J CONSULT CLIN PSYCH, V77, P788, DOI 10.1037/a0015709.
   Durlak JA, 2008, AM J COMMUN PSYCHOL, V41, P327, DOI 10.1007/s10464-008-9165-0.
   Dusenbury L, 2003, HEALTH EDUC RES, V18, P237, DOI 10.1093/her/18.2.237.
   Gonzales NA, 2017, PREV SCI, V18, P689, DOI 10.1007/s11121-017-0808-y.
   Greene KM, 2013, J YOUTH ADOLESCENCE, V42, P1557, DOI 10.1007/s10964-012-9814-3.
   Holland ML, 2018, PREV SCI, V19, P516, DOI 10.1007/s11121-017-0829-6.
   Holtrop K, 2014, PREV SCI, V15, P745, DOI 10.1007/s11121-013-0401-y.
   Howe GW, 2010, PREV SCI, V11, P343, DOI 10.1007/s11121-010-0177-2.
   Ingoldsby EM, 2013, PREV SCI, V14, P525, DOI 10.1007/s11121-013-0410-x.
   Jabaley JJ, 2011, J FAM VIOLENCE, V26, P377, DOI 10.1007/s10896-011-9372-6.
   Kelsey M, 2014, J ADOLESCENT HEALTH, V54, pS45, DOI 10.1016/j.jadohealth.2013.12.024.
   Khoury MJ, 2016, AM J PREV MED, V50, P398, DOI 10.1016/j.amepre.2015.08.031.
   Kumpfer Karol L, 2002, Prev Sci, V3, P241, DOI 10.1023/A:1019902902119.
   KUMPFER KL, 1995, DRUG ABUSE PREVENTIO, P255.
   Lam Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158759.
   Latimore AD, 2017, PREV SCI, V18, P577, DOI 10.1007/s11121-017-0767-3.
   Mallinson RK, 2007, AIDS PATIENT CARE ST, V21, pS77, DOI 10.1089/apc.2007.9984.
   Matheson GO, 2015, BRIT J SPORT MED, V49, P1483, DOI 10.1136/bjsports-2014-094261.
   Mauricio AM, 2018, PREV SCI, V19, P620, DOI 10.1007/s11121-017-0783-3.
   Mayer SE., 2015, USING BEHAV INSIGHTS.
   McCurdie Tara, 2012, Biomed Instrum Technol, VSuppl, P49, DOI 10.2345/0899-8205-46.s2.49.
   McCurdy K, 2001, FAM RELAT, V50, P113, DOI 10.1111/j.1741-3729.2001.00113.x.
   McGuigan WM, 2003, FAM RELAT, V52, P271, DOI 10.1111/j.1741-3729.2003.00271.x.
   Michalopoulos C., 2015, A REPORT TO C.
   Miller Gaubert Jennifer, 2012, SUPPORTING HLTH MARR.
   O'Connell Mary Ellen, 2009, BOARDON CHILDREN YOU.
   O'Brien RA, 2012, PREV SCI, V13, P219, DOI 10.1007/s11121-012-0287-0.
   OAH, 2016, BUILD YOUR PROGR THE.
   Pasnik S., 2015, Supporting parent-child experiences with PEG+CAT early math concepts: Report to the CPB-PBS Ready to Learn initiative.
   Perou R, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-691.
   Perrino T, 2018, PREV SCI, V19, P630, DOI 10.1007/s11121-016-0711-y.
   Prado G, 2006, J PEDIATR PSYCHOL, V31, P874, DOI 10.1093/jpepsy/jsj046.
   Sandstrom H., 2015, Approaches to father engagement and fathers' experiences in home visiting programs.
   Smith EP, 2018, PREV SCI, V19, P159, DOI 10.1007/s11121-017-0820-2.
   Spoth R., 2000, J PRIM PREV, V21, P267, DOI {[}10.1023/A:1007039421026, DOI 10.1023/A:1007039421026].
   Spoth R, 2013, AM J PUBLIC HEALTH, V103, P665, DOI 10.2105/AJPH.2012.301209.
   Stirman SW, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-65.
   Vaithinathan Asokan G, 2017, J Evid Based Med, V10, P76, DOI 10.1111/jebm.12239.
   Wallerstein N, 2010, AM J PUBLIC HEALTH, V100, pS40, DOI 10.2105/AJPH.2009.184036.
   Winslow EB, 2018, PREV SCI, V19, P674, DOI 10.1007/s11121-017-0791-3.
   Zaveri H., 2015, PARENTS CHILDREN TOG.},
Number-of-Cited-References = {52},
Times-Cited = {31},
Unique-ID = {WOS:000435007200010},
}

@article{ WOS:000426247600028,
Author = {Osgood-Zimmerman, Aaron and Millear, Anoushka I. and Stubbs, Rebecca W.
   and Shields, Chloe and Pickering, Brandon V. and Earl, Lucas and Graetz,
   Nicholas and Kinyoki, Damaris K. and Ray, Sarah E. and Bhatt, Samir and
   Browne, Annie J. and Burstein, Roy and Cameron, Ewan and Casey, Daniel
   C. and Deshpande, Aniruddha and Fullman, Nancy and Gething, Peter W. and
   Gibson, Harry S. and Henry, Nathaniel J. and Herrero, Mario and Krause,
   L. Kendall and Letourneau, Ian D. and Levine, Aubrey J. and Liu, Patrick
   Y. and Longbottom, Joshua and Mayala, Benjamin K. and Mosser, Jonathan
   F. and Noor, Abdisalan M. and Pigott, David M. and Piwoz, Ellen G. and
   Rao, Puja and Rawat, Rahul and Reiner, Jr., Robert C. and Smith, David
   L. and Weiss, Daniel J. and Wiens, Kirsten E. and Mokdad, Ali H. and
   Lim, Stephen S. and Murray, Christopher J. L. and Kassebaum, Nicholas J.
   and Hay, Simon I.},
Title = {Mapping child growth failure in Africa between 2000 and 2015},
Journal = {NATURE},
Year = {2018},
Volume = {555},
Number = {7694},
Pages = {41+},
Month = {MAR 1},
Abstract = {Insufficient growth during childhood is associated with poor health
   outcomes and an increased risk of death. Between 2000 and 2015, nearly
   all African countries demonstrated improvements for children under 5
   years old for stunting, wasting, and underweight, the core components of
   child growth failure. Here we show that striking subnational
   heterogeneity in levels and trends of child growth remains. If current
   rates of progress are sustained, many areas of Africa will meet the
   World Health Organization Global Targets 2025 to improve maternal,
   infant and young child nutrition, but high levels of growth failure will
   persist across the Sahel. At these rates, much, if not all of the
   continent will fail to meet the Sustainable Development Goal target-to
   end malnutrition by 2030. Geospatial estimates of child growth failure
   provide a baseline for measuring progress as well as a precision public
   health platform to target interventions to those populations with the
   greatest need, in order to reduce health disparities and accelerate
   progress.},
Type = {Article},
Affiliation = {Kassebaum, NJ; Hay, SI (Corresponding Author), Univ Washington, Inst Hlth Metr \& Evaluat, Seattle, WA 98121 USA.
   Hay, SI (Corresponding Author), Univ Oxford, Big Data Inst, Li Ka Shing Ctr Hlth Informat \& Discovery, Oxford OX3 7FZ, England.
   Kassebaum, NJ (Corresponding Author), Seattle Childrens Hosp, Dept Anesthesiol \& Pain Med, Seattle, WA 98105 USA.
   Osgood-Zimmerman, Aaron; Millear, Anoushka I.; Stubbs, Rebecca W.; Shields, Chloe; Pickering, Brandon V.; Earl, Lucas; Graetz, Nicholas; Kinyoki, Damaris K.; Ray, Sarah E.; Burstein, Roy; Casey, Daniel C.; Deshpande, Aniruddha; Fullman, Nancy; Henry, Nathaniel J.; Letourneau, Ian D.; Levine, Aubrey J.; Liu, Patrick Y.; Mayala, Benjamin K.; Mosser, Jonathan F.; Pigott, David M.; Rao, Puja; Reiner, Robert C., Jr.; Smith, David L.; Wiens, Kirsten E.; Mokdad, Ali H.; Lim, Stephen S.; Murray, Christopher J. L.; Kassebaum, Nicholas J.; Hay, Simon I., Univ Washington, Inst Hlth Metr \& Evaluat, Seattle, WA 98121 USA.
   Bhatt, Samir, Imperial Coll London, Dept Infect Dis Epidemiol, London SW7 2AZ, England.
   Browne, Annie J.; Cameron, Ewan; Gething, Peter W.; Gibson, Harry S.; Longbottom, Joshua; Weiss, Daniel J.; Hay, Simon I., Univ Oxford, Big Data Inst, Li Ka Shing Ctr Hlth Informat \& Discovery, Oxford OX3 7FZ, England.
   Herrero, Mario, CSIRO, St Lucia, Qld, Australia.
   Krause, L. Kendall; Piwoz, Ellen G.; Rawat, Rahul, Bill \& Mlinda Gates Fdn, Seattle, WA 98109 USA.
   Noor, Abdisalan M., Kenya Med Res Inst Wellcome Trust Collaborat Pro, Nairobi, Kenya.
   Noor, Abdisalan M., Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med \& Global Hlth, Oxford OX3 7FZ, England.
   Kassebaum, Nicholas J., Seattle Childrens Hosp, Dept Anesthesiol \& Pain Med, Seattle, WA 98105 USA.},
DOI = {10.1038/nature25760},
Keywords-Plus = {HEALTH SYSTEM PERFORMANCE; PLASMODIUM-FALCIPARUM; INTERVENTIONS;
   MALNUTRITION; NIGERIA; DISEASE; TRENDS; INLA},
Research-Areas = {Science \& Technology - Other Topics},
Web-of-Science-Categories  = {Multidisciplinary Sciences},
Author-Email = {nickjk@uw.edu
   sihay@uw.edu},
Affiliations = {University of Washington; University of Washington Seattle; Institute
   for Health Metrics \& Evaluation; Imperial College London; University of
   Oxford; Commonwealth Scientific \& Industrial Research Organisation
   (CSIRO); University of Oxford; Seattle Children's Hospital},
Cited-References = {{[}Anonymous], 2010, MULT IND CLUST SURV.
   {[}Anonymous], 2016, LEV TRENDS CHILD MAL.
   {[}Anonymous], 2017, LANCET, DOI DOI 10.1016/S0140-6736(17)32152-9.
   {[}Anonymous], LANCET.
   {[}Anonymous], 2017, NOUR SDGS.
   Arlappa N, 2015, HUM HEALT HANDB, V10, P337, DOI 10.3920/978-90-8686-806-3\_20.
   Assaf S., 2015, DHS Methodological Reports No. 16.
   Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535.
   Bhatt S, 2017, J R SOC INTERFACE, V14, DOI 10.1098/rsif.2017.0520.
   Bhutta ZA, 2010, LANCET, V375, P2032, DOI 10.1016/S0140-6736(10)60678-2.
   Black RE, 2008, LANCET, V371, P243, DOI {[}10.1016/S0140-6736(07)61690-0, 10.1016/S0140-6736(13)60937-X].
   BOHLE HG, 1994, GLOBAL ENVIRON CHANG, V4, P37, DOI 10.1016/0959-3780(94)90020-5.
   Bosco C, 2017, J R SOC INTERFACE, V14, DOI 10.1098/rsif.2016.0825.
   de Onis M, 2013, MATERN CHILD NUTR, V9, P6, DOI 10.1111/mcn.12075.
   Dieleman JL, 2016, LANCET, V387, P2536, DOI 10.1016/S0140-6736(16)30168-4.
   Dowell SF, 2016, NATURE, V540, P189, DOI 10.1038/540189a.
   Forouzanfar MH, 2015, LANCET, V386, P2287, DOI 10.1016/S0140-6736(15)00128-2.
   Fullman N, 2017, LANCET, V390, P1423, DOI {[}10.1016/S0140-6736(18)30994-2, 10.1016/s0140-6736(18)30994-2].
   Gakidou E, 2017, LANCET, V390, P1345, DOI 10.1016/S0140-6736(17)32366-8.
   Gething PW, 2016, NEW ENGL J MED, V375, P2435, DOI 10.1056/NEJMoa1606701.
   Gething PW, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000724.
   Global Administrative Areas, 2015, GADM DAT GLOB ADM AR.
   Global Health Data Exchange, CORE WELFARE INDICAT.
   Graetz N, 2018, NATURE, V555, P48, DOI 10.1038/nature25761.
   Hagos S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170785.
   ICF, 1998, DHS PROGR DAT.
   Indrayan A, 2014, INDIAN PEDIATR, V51, P37, DOI 10.1007/s13312-014-0310-6.
   International Food Policy Research Institute (IFPRI), 2016, GLOB NUTR REP 2016 P, DOI 10.2499/9780896295841.
   Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4.
   Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1.
   Kandala NB, 2009, POPUL SPACE PLACE, V15, P461, DOI 10.1002/psp.524.
   Khatab K, 2010, AM J TROP MED HYG, V82, P653, DOI 10.4269/ajtmh.2010.09-0501.
   Kinyoki DK, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2016-000262.
   Kinyoki DK, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009854.
   Leaning J, 2013, NEW ENGL J MED, V369, P1836, DOI {[}10.1056/NEJMra1109877, 10.1056/NEJMc1315507].
   Lehner B, 2004, J HYDROL, V296, P1, DOI 10.1016/j.jhydrol.2004.03.028.
   Lindgren F, 2011, J ROY STAT SOC B, V73, P423, DOI 10.1111/j.1467-9868.2011.00777.x.
   LP DAAC, COMB MODIS 5 1 DAT.
   Lumley T., 2004, J Stat Software, V9, P1, DOI 10.18637/jss.v009.i08.
   Lumley Thomas., 2010, COMPLEX SURVEYS, P17.
   Magalhaes RJS, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000438.
   Martins TG, 2013, COMPUT STAT DATA AN, V67, P68, DOI 10.1016/j.csda.2013.04.014.
   Mtambo OPL, 2015, SPAT SPATIO-TEMPORAL, V13, P7, DOI 10.1016/j.sste.2015.04.001.
   Murray CJL, 2015, NEW ENGL J MED, V373, P1390, DOI 10.1056/NEJMp1510082.
   Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6.
   Ng M, 2017, AM J TROP MED HYG, V97, P58, DOI 10.4269/ajtmh.15-0315.
   Nilsson M, 2016, NATURE, V534, P320, DOI 10.1038/534320a.
   Patil AP, 2011, TRENDS PARASITOL, V27, P245, DOI 10.1016/j.pt.2011.01.003.
   Pelletier DL, 2003, J NUTR, V133, P107, DOI 10.1093/jn/133.1.107.
   Roberts DA, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0518-x.
   Roberts L, 2017, SCIENCE, V356, P18, DOI 10.1126/science.356.6333.18.
   Rue H, 2009, J ROY STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x.
   Stein M.L., 1999, Springer Series in Statistics.
   Svedberg P, 2011, ANNU REV NUTR, V31, P263, DOI 10.1146/annurev-nutr-081810-160805.
   Tatem AJ, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.4.
   UN Secretary-General, 2017, FULL TRANSCR SECR GE.
   Waller L, 2010, CH CRC HANDB MOD STA, P217.
   Wang Y., 2012, Handbook of Anthropometry: Physical Measures of Human Form in Health and Disease, P29, DOI {[}DOI 10.1007/978-1-4419-1788-1\_2, 10.1007/978-1-4419-1788-1\_2].
   Wollum A, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0438-9.
   World Bank Group, 2016, LIV STAND MEAS SURV.
   World Health Organization, 2017, COMPR IMPL PLAN MAT.
   World Health Organization, 2009, WHO CHILD GROWTH STA.
   World Wildlife Fund, 2004, GLOB LAK WETL DAT LE.
   WorldPop, WORLDPOP DAT.},
Number-of-Cited-References = {64},
Times-Cited = {150},
Unique-ID = {WOS:000426247600028},
}

@article{ WOS:001001498900021,
Author = {Kotnik, Urska and Maver, Ales and Peterlin, Borut and Lovrecic, Luca},
Title = {Assessment of pathogenic variation in gynecologic cancer genes in a
   national cohort},
Journal = {SCIENTIFIC REPORTS},
Year = {2023},
Volume = {13},
Number = {1},
Month = {MAR 31},
Abstract = {Population-based estimates of pathogenic variation burden in gynecologic
   cancer predisposition genes are a prerequisite for the development of
   effective precision public health strategies. This study aims to reveal
   the burden of pathogenic variants in a comprehensive set of clinically
   relevant breast, ovarian, and endometrial cancer genes in a large
   population-based study. We performed a rigorous manual classification
   procedure to identify pathogenic variants in a panel of 17 gynecologic
   cancer predisposition genes in a cohort of 7091 individuals,
   representing 0.35\% of the general population. The population burden of
   pathogenic variants in hereditary gynecologic cancer-related genes in
   our study was 2.14\%. Pathogenic variants in genes ATM, BRCA1, and CDH1
   are significantly enriched and the burden of pathogenic variants in
   CHEK2 is decreased in our population compared to the control population.
   We have identified a high burden of pathogenic variants in several
   gynecologic cancer-related genes in the Slovenian population, most
   importantly in the BRCA1 gene.},
Type = {Article},
Affiliation = {Kotnik, U (Corresponding Author), Univ Med Ctr Ljubljana, Clin Inst Genom Med, Ljubljana, Slovenia.
   Kotnik, U (Corresponding Author), Univ Ljubljana, Biotech Fac, Ljubljana, Slovenia.
   Kotnik, Urska; Maver, Ales; Peterlin, Borut; Lovrecic, Luca, Univ Med Ctr Ljubljana, Clin Inst Genom Med, Ljubljana, Slovenia.
   Maver, Ales; Peterlin, Borut; Lovrecic, Luca, Univ Ljubljana, Fac Med, Ljubljana, Slovenia.
   Kotnik, Urska, Univ Ljubljana, Biotech Fac, Ljubljana, Slovenia.},
DOI = {10.1038/s41598-023-32397-8},
Article-Number = {5307},
Keywords-Plus = {LYNCH SYNDROME; BREAST-CANCER; MUTATION SPECTRUM; VARIANTS; PANEL;
   PREDISPOSITION; IDENTIFICATION; MANAGEMENT; GENOMICS; OVARIAN},
Research-Areas = {Science \& Technology - Other Topics},
Web-of-Science-Categories  = {Multidisciplinary Sciences},
Author-Email = {urska.kotnik@kclj.si},
Affiliations = {University Medical Centre Ljubljana; University of Ljubljana; University
   of Ljubljana},
Cited-References = {Abou Tayoun AN, 2018, HUM MUTAT, V39, P1517, DOI 10.1002/humu.23626.
   Abul-Husn NS, 2019, GENOME MED, V12, DOI 10.1186/s13073-019-0691-1.
   Ales M, 2016, GENET MED, V18, P1102, DOI 10.1038/gim.2016.22.
   Angeli D, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21031128.
   Bateman A, 2021, NUCLEIC ACIDS RES, V49, pD480, DOI 10.1093/nar/gkaa1100.
   Bellosillo B, 2005, CANCER GENET CYTOGEN, V161, P93, DOI 10.1016/j.cancergencyto.2005.01.016.
   Besic N, 2020, J CLIN ONCOL, V38.
   Biesecker LG, 2018, GENET MED, V20, P1687, DOI 10.1038/gim.2018.42.
   Blatnik A, 2020, J CLIN ONCOL, V38.
   Blay P, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-243.
   Chirita-Emandi A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-57080-9.
   Clinical Genome Recource, 2022, CLINGEN HER BREAST O.
   Clinical Genome Resource, 2019, CLINGEN GEN SEQ VAR.
   Clinical Genome Resource, 2020, SVI REC ABS RAR PM2.
   Couch FJ, 2017, JAMA ONCOL, V3, P1190, DOI 10.1001/jamaoncol.2017.0424.
   Culver J., 2007, BREAST DIS, V27, P5, DOI {[}10.3233/BD-2007-27102, DOI 10.3233/BD-2007-27102].
   Daly MB, 2021, J NATL COMPR CANC NE, V19, P77, DOI 10.6004/jnccn.2021.0001.
   de Andrade KC, 2019, HUM MUTAT, V40, P97, DOI 10.1002/humu.23673.
   de Wert G, 2021, EUR J HUM GENET, V29, P365, DOI 10.1038/s41431-020-00758-w.
   Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215.
   Dominguez-Valentin M, 2020, GENET MED, V22, P15, DOI 10.1038/s41436-019-0596-9.
   Espenschied CR, 2017, J CLIN ONCOL, V35, P2568, DOI 10.1200/JCO.2016.71.9260.
   Fernandes GC, 2016, ONCOTARGET, V7, P80465, DOI 10.18632/oncotarget.12610.
   Fujita M, 2022, CLIN GASTROENTEROL H, V20, P2132, DOI 10.1016/j.cgh.2020.12.007.
   Goidescu Iulian Gabriel, 2018, Clujul Med, V91, P157, DOI 10.15386/cjmed-894.
   Green RF, 2019, GENET MED, V21, P28, DOI 10.1038/s41436-018-0028-2.
   Hamel N, 2011, EUR J HUM GENET, V19, P300, DOI 10.1038/ejhg.2010.203.
   Hampel H, 2011, CANCER PREV RES, V4, P1, DOI 10.1158/1940-6207.CAPR-10-0345.
   Haraldsdottir S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14755.
   Hu CL, 2021, NEW ENGL J MED, V384, P440, DOI 10.1056/NEJMoa2005936.
   Janavicius R, 2010, EPMA J, V1, P397, DOI 10.1007/s13167-010-0037-y.
   Jian XQ, 2014, NUCLEIC ACIDS RES, V42, P13534, DOI 10.1093/nar/gku1206.
   Karczewski KJ, 2020, NATURE, V581, P434, DOI 10.1038/s41586-020-2308-7.
   Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102.
   Khoury MJ, 2018, GENET MED, V20, P574, DOI 10.1038/gim.2017.211.
   Kopanos C, 2019, BIOINFORMATICS, V35, P1978, DOI 10.1093/bioinformatics/bty897.
   Kraemer D., 2019, SWISS MEDWKLY, V149.
   Krajc M, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-83.
   Kuchenbaecker KB, 2017, JAMA-J AM MED ASSOC, V317, P2402, DOI 10.1001/jama.2017.7112.
   Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113.
   Lu KH, 2008, FAM CANCER, V7, P53, DOI 10.1007/s10689-007-9144-x.
   Machackova E, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-140.
   Manchanda R, 2018, JNCI-J NATL CANCER I, V110, P714, DOI 10.1093/jnci/djx265.
   Martin AR, 2019, NAT GENET, V51, P1560, DOI 10.1038/s41588-019-0528-2.
   Maxwell KN, 2016, J CLIN ONCOL, V34, P4183, DOI 10.1200/JCO.2016.67.0554.
   Milne RL, 2017, NAT GENET, V49, P1767, DOI 10.1038/ng.3785.
   Mohamad S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117104.
   Molster CM, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00247.
   Momozawa Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06581-8.
   Neto N, 2015, INSIGHTS IMAGING, V6, P545, DOI 10.1007/s13244-015-0425-x.
   Petridis C, 2019, BREAST CANCER RES, V21, DOI 10.1186/s13058-019-1143-y.
   Pruthi S, 2010, MAYO CLIN PROC, V85, P1111, DOI 10.4065/mcp.2010.0414.
   Rashid MU, 2019, HERED CANCER CLIN PR, V17, DOI 10.1186/s13053-019-0128-2.
   Rehm HL, 2015, NEW ENGL J MED, V372, P2235, DOI 10.1056/NEJMsr1406261.
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30.
   Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050.
   Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005.
   Sjursen W, 2016, MOL GENET GENOM MED, V4, P223, DOI 10.1002/mgg3.198.
   Sjursen W, 2010, J MED GENET, V47, P579, DOI 10.1136/jmg.2010.077677.
   Smith MJ, 2016, HUM MUTAT, V37, P250, DOI 10.1002/humu.22938.
   Southey MC, 2021, NPJ BREAST CANCER, V7, DOI 10.1038/s41523-021-00360-3.
   Stegel V, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-9.
   Tang CSM, 2018, HUM GENET, V137, P31, DOI 10.1007/s00439-017-1852-1.
   Tavtigian SV, 2018, GENET MED, V20, P1054, DOI 10.1038/gim.2017.210.
   Thompson ER, 2016, J CLIN ONCOL, V34, P1455, DOI 10.1200/JCO.2015.63.7454.
   Yamaguchi-Kabata Y, 2018, J HUM GENET, V63, P213, DOI 10.1038/s10038-017-0347-1.
   Yang Y, 2012, ASIAN PAC J CANCER P, V13, P3501, DOI 10.7314/APJCP.2012.13.7.3501.
   Zhang L, 2022, J MED GENET, V59, P652, DOI 10.1136/jmedgenet-2021-107886.},
Number-of-Cited-References = {68},
Times-Cited = {0},
Unique-ID = {WOS:001001498900021},
}

@article{ WOS:000772812800006,
Author = {Canfell, Oliver J. and Davidson, Kamila and Sullivan, Clair and Eakin,
   Elizabeth and Burton-Jones, Andrew},
Title = {Data sources for precision public health of obesity: a scoping review,
   evidence map and use case in Queensland, Australia},
Journal = {BMC PUBLIC HEALTH},
Year = {2022},
Volume = {22},
Number = {1},
Month = {MAR 24},
Abstract = {Background Global action to reduce obesity prevalence requires digital
   transformation of the public health sector to enable precision public
   health (PPH). Useable data for PPH of obesity is yet to be identified,
   collated and appraised and there is currently no accepted approach to
   creating this single source of truth. This scoping review aims to
   address this globally generic problem by using the State of Queensland
   (Australia) (population > 5 million) as a use case to determine (1)
   availability of primary data sources usable for PPH for obesity (2)
   quality of identified sources (3) general implications for public health
   policymakers. Methods The Preferred Reporting Items for Systematic
   Review and Meta-Analyses extension for scoping reviews (PRISMA-ScR) was
   followed. Unique search strategies were implemented for `designed' (e.g.
   surveys) and `organic' (e.g. electronic health records) data sources.
   Only primary sources of data (with stratification to Queensland) with
   evidence-based determinants of obesity were included. Primary data
   source type, availability, sample size, frequency of collection and
   coverage of determinants of obesity were extracted and curated into an
   evidence map. Data source quality was qualitatively assessed. Results We
   identified 38 primary sources of preventive data for obesity: 33
   designed and 5 organic. Most designed sources were survey (n 20) or
   administrative (n 10) sources and publicly available but generally were
   not contemporaneous (> 2 years old) and had small sample sizes (10-100
   k) relative to organic sources (> 1 M). Organic sources were identified
   as the electronic medical record (ieMR), wearables, environmental
   (Google Maps, Crime Map) and billing/claims. Data on social, biomedical
   and behavioural determinants of obesity typically co-occurred across
   sources. Environmental and commercial data was sparse and interpreted as
   low quality. One organic source (ieMR) was highly contemporaneous
   (routinely updated), had a large sample size (5 M) and represented all
   determinants of obesity but is not currently used for public health
   decision-making in Queensland. Conclusions This review provides a (1)
   comprehensive data map for PPH for obesity in Queensland and (2)
   globally translatable framework to identify, collate and appraise
   primary data sources to advance PPH for obesity and other
   noncommunicable diseases. Significant challenges must be addressed to
   achieve PPH, including: using designed and organic data harmoniously,
   digital infrastructure for high-quality organic data, and the ethical
   and social implications of using consumer-centred health data to improve
   public health.},
Type = {Review},
Affiliation = {Canfell, OJ (Corresponding Author), Univ Queensland, Fac Business Econ \& Law, UQ Business Sch, St Lucia, Qld, Australia.
   Canfell, OJ (Corresponding Author), Univ Queensland, Fac Med, Ctr Hlth Serv Res, Herston, Qld, Australia.
   Canfell, OJ (Corresponding Author), Australian Govt, Digital Hlth Cooperat Res Ctr, Sydney, NSW, Australia.
   Canfell, OJ (Corresponding Author), Queensland Govt, Hlth \& Wellbeing Queensland, Milton, Qld, Australia.
   Canfell, Oliver J.; Davidson, Kamila; Burton-Jones, Andrew, Univ Queensland, Fac Business Econ \& Law, UQ Business Sch, St Lucia, Qld, Australia.
   Canfell, Oliver J.; Sullivan, Clair, Univ Queensland, Fac Med, Ctr Hlth Serv Res, Herston, Qld, Australia.
   Canfell, Oliver J., Australian Govt, Digital Hlth Cooperat Res Ctr, Sydney, NSW, Australia.
   Canfell, Oliver J.; Sullivan, Clair, Queensland Govt, Hlth \& Wellbeing Queensland, Milton, Qld, Australia.
   Sullivan, Clair, Queensland Govt, Dept Hlth, Metro North Hosp \& Hlth Serv, Herston, Qld, Australia.
   Eakin, Elizabeth, Univ Queensland, Fac Med, Sch Publ Hlth, Herston, Qld, Australia.},
DOI = {10.1186/s12889-022-12939-x},
Article-Number = {584},
Keywords = {Public health; Public health informatics; Medical informatics; Obesity;
   Noncommunicable diseases; Decision making},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {o.canfell@uq.edu.au},
Affiliations = {University of Queensland; University of Queensland; Digital Health
   Cooperative Research Centre (DHCRC); Queensland Health; University of
   Queensland},
Cited-References = {Abbafati C, 2020, LANCET, V396, P1135, DOI 10.1016/S0140-6736(20)31404-5.
   {[}Anonymous], 2008, HLTH KIDS QUEENSLAND.
   {[}Anonymous], 2018, Fact sheet.
   {[}Anonymous], 2021, HOUSEHOLD INCOME LAB, DOI {[}10.26193/3QRFMZ, DOI 10.26193/3QRFMZ].
   Apple Inc, 2021, APPL WATCH SER 3.
   Australian Bureau of Statistics, DAT DOWNL DIS AG CAR.
   Australian Bureau of Statistics, NATL ABORIGINAL TORR.
   Australian Bureau of Statistics, PRESCHOOL ED.
   Australian Bureau of Statistics, 2021, STAT AR LEV 1 AUSTR.
   Australian Bureau of Statistics, 2017, 2016 CENS CENS.
   Australian Bureau of Statistics, DAT DOWNL CHILDR PAR.
   Australian Bureau of Statistics, 2019, 47140 AUSTR BUR STAT.
   Australian Bureau of Statistics, 2020, MULT HOUS SURV.
   Australian Bureau of Statistics, 2017, 2016 CENS QUICKSTATS.
   Australian Bureau of Statistics, DAT DOWNL NAT HLTH S.
   Australian Bureau of Statistics, DAT DOWNL.
   Australian Bureau of Statistics, 2021, 2021 CENS DAT REL TI.
   Australian Bureau of Statistics, REC CRIM VICT.
   Australian Bureau of Statistics, CONS PRIC IND.
   Australian Bureau of Statistics, REC CRIM OFF.
   Australian Bureau of Statistics, PERS SAF AUSTR.
   Australian Digital Health Agency, CHOOS YOUR DAT IS US.
   Australian Government, 2012, FED REG LEG MY HLTH.
   Australian Government, AUSTR EARL DEV CENS.
   Australian Government, DSS PAYM DEM DAT.
   Australian Institute of Health and Welfare, 2010 AUSTR NAT INF F.
   Australian Institute of Health and Welfare, 2021, CATALOGUE NO BOD 30.
   Australian Institute of Health and Welfare, 2013, NAT AG CAR DAT CLEAR.
   Australian Institute of Health and Welfare, HOM SERV 2021.
   Australian Institute of Health and Welfare, 2021, DAT TABL CHILD PROT.
   Australian Institute of Health Welfare, 2011, 2010 AUSTR NAT INF F.
   Australian Sweetpotato Growers Inc, 2021, SWEETPOTATO GROWING.
   Barnett A, 2019, AUST HEALTH REV, V43, P656, DOI 10.1071/AH18125.
   Bates DW, 2018, HEALTH POLICY TECHN, V7, P211, DOI 10.1016/j.hlpt.2018.04.006.
   Bray GA, 2017, OBES REV, V18, P715, DOI 10.1111/obr.12551.
   Brisbane North Primary Health Network, NEEDS ASS SUBM DEP H.
   Brisbane South Primary Health Network, NEEDS ASS 2019 2022.
   Cai L., 2015, Data Science Journal, V14, P1.
   Canfell OJ, 2022, AUST HEALTH REV, V46, P279, DOI 10.1071/AH21063.
   Central Queensland WB Sunshine Coast Primary Health Network, PRIM HLTH NETW NEEDS.
   Darling Downs and West Moreton Primary Health Network, HLTH NEEDS ASS 2019.
   Department of Education Skills and Employment, INT STUD DAT 2021.
   Department of Health, MBS ONL MED BEN SCH.
   Department of Health, PHARM BEN SCHEM.
   Dolley S, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00068.
   Enticott J, 2021, BMC HEALTH SERV RES, V21, DOI 10.1186/s12913-021-06215-8.
   Finch C, 2020, OFTEN DOES GOOGLE MA.
   Fitbit Inc, 2011, FITB INSP 2.
   Fitbit Inc, 2021, RES FAQ FITBIT INC.
   Friel S., 2019, ADDRESSING SOCIAL CO.
   Garmin, VIVOSMART R 4.
   Garmin LTD, 2021, HLTH API FEAT GARM C.
   Gold Coast Primary Health Network, GOLD COAST REG HLTH.
   Google, 2021, GOOGL MAPS GOOGL.
   Groves Robert., 2011, `Designed Data' and `Organic Data'.
   Hatef E, 2018, POPUL HEALTH MANAG, V21, P261, DOI 10.1089/pop.2017.0112.
   Howe Iii Edmund G, 2020, Innov Clin Neurosci, V17, P24.
   Iwig W., 2013, Data Quality Assessment Tool for Administrative Data.
   Kickbusch I, 2016, LANCET GLOB HEALTH, V4, pE895, DOI 10.1016/S2214-109X(16)30217-0.
   Lee A., 2019, ENDOTEXT.
   Lewinter KE, 2020, NPJ DIGIT MED, V3, DOI 10.1038/s41746-020-00368-2.
   McGuire J, 2021, BEST FITNESS TRACKER.
   Munn Z, 2018, BMC MED RES METHODOL, V18, DOI 10.1186/s12874-018-0611-x.
   National Centre for Vocational Education Research, VET STUD OUTC 2021.
   National Disability Insurance Scheme (NDIS), DAT DOWNL 2021.
   Northern Queensland Primary Health Network, HLTH NEEDS ASS 2019.
   Odone A, 2019, EUR J PUBLIC HEALTH, V29, P28, DOI 10.1093/eurpub/ckz161.
   Olstad DL, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-030279.
   Parise I, 2020, AUST J GEN PRACT, V49, P226, DOI 10.31128/AJGP-10-19-5102.
   Peters MDJ, 2015, INT J EVID-BASED HEA, V13, P141, DOI 10.1097/XEB.0000000000000050.
   Peterson ED, 2019, JAMA-J AM MED ASSOC, V322, P2283, DOI 10.1001/jama.2019.17831.
   phdpe.net, ENV FACT 2020.
   Queensland Government, 2017, INT FACTS QUEENSL BR.
   Queensland Government, 2021, UNIVERSAL EARLY CHIL, DOI DOI 10.35542/OSF.IO/ZRCTW.
   Queensland Government, QUEENSL HOUS TRAV SU, V2021.
   Queensland Government, 2019, INT EL MED REC IEMR.
   Queensland Government Statistician's Office. Queensland Treasury. Queensland Government, 2018, PRIC IND RET PRIC IN.
   Queensland Health, 2021, PER DAT COLL PDC MAN.
   Queensland Health, 2020, HLTH QUEENSL 2020 RE.
   Queensland Health, 2016, QUEENSL INF FEED SUR.
   Queensland Health, DET QUEENSL REG PREV.
   Queensland Health, 2014, HLTH FOOD ACC BASK S.
   Queensland Police Service, QUEENSL POL SERV ONL.
   Russell E., 2019, 9 THINGS KNOW GOOGLE.
   Services Australia, 2021, MED STAT PHARM BEN S.
   Services Australia. Medicare Statistics, 2021, MED IT REP.
   Steinwachs Donald M, 2014, EGEMS (Wash DC), V2, P1175, DOI 10.13063/2327-9214.1175.
   Sullivan C, 2018, AUST HEALTH REV, V42, P294, DOI 10.1071/AH16294.
   Sullivan C, 2016, MED J AUSTRALIA, V205, P386, DOI 10.5694/mja16.00476.
   Tricco AC, 2018, ANN INTERN MED, V169, P467, DOI 10.7326/M18-0850.
   WHO, 2021, DET HLTH.},
Number-of-Cited-References = {91},
Times-Cited = {4},
Unique-ID = {WOS:000772812800006},
}

@article{ WOS:000414767300018,
Author = {Messerlian, Carmen and Martinez, Rosie M. and Hauser, Russ and
   Baccarelli, Andrea A.},
Title = {`Omics' and endocrine-disrupting chemicals - new paths forward},
Journal = {NATURE REVIEWS ENDOCRINOLOGY},
Year = {2017},
Volume = {13},
Number = {12},
Pages = {740-748},
Month = {DEC},
Abstract = {The emerging field of omics - large-scale data-rich biological
   measurements of the genome - provides new opportunities to advance and
   strengthen research into endocrine-disrupting chemicals (EDCs). Although
   some EDCs have been associated with adverse health effects in humans,
   our understanding of their impact remains incomplete. Progress in the
   field has been primarily limited by our inability to adequately estimate
   and characterize exposure and identify sensitive and measurable outcomes
   during windows of vulnerability. Evolving omics technologies in
   genomics, epigenomics and mitochondriomics have the potential to
   generate data that enhance exposure assessment to include the exposome -
   the totality of the lifetime exposure burden - and provide biology-based
   estimates of individual risks. Applying omics technologies to expand our
   knowledge of individual risk and susceptibility will augment biological
   data in the prediction of variability and response to disease, thereby
   further advancing EDC research. Together, refined exposure
   characterization and enhanced disease-risk prediction will help to
   bridge crucial gaps in EDC research and create opportunities to move the
   field towards a new vision - precision public health.},
Type = {Article},
Affiliation = {Baccarelli, AA (Corresponding Author), Columbia Mailman Sch Publ Hlth, Dept Environm Hlth Sci, Lab Precis Environm Biosci, New York, NY 10032 USA.
   Messerlian, Carmen; Martinez, Rosie M.; Hauser, Russ, Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.
   Martinez, Rosie M.; Baccarelli, Andrea A., Columbia Mailman Sch Publ Hlth, Dept Environm Hlth Sci, Lab Precis Environm Biosci, New York, NY 10032 USA.},
DOI = {10.1038/nrendo.2017.81},
Keywords-Plus = {MITOCHONDRIAL-DNA DAMAGE; BISPHENOL-A; METHYLTRANSFERASE EZH2; MATERNAL
   SMOKING; AIR-POLLUTION; METHYLATION; GENE; SUSCEPTIBILITY; EXPOSURE;
   EPIGENETICS},
Research-Areas = {Endocrinology \& Metabolism},
Web-of-Science-Categories  = {Endocrinology \& Metabolism},
Author-Email = {andrea.baccarelli@columbia.edu},
Affiliations = {Harvard University; Harvard T.H. Chan School of Public Health},
Cited-References = {Adams J, 2010, ESSENTIALS CELL BIOL.
   Alam G, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00327.
   {[}Anonymous], FACT SHEET PRES OB P.
   Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190.
   Attene-Ramos MS, 2015, ENVIRON HEALTH PERSP, V123, P49, DOI 10.1289/ehp.1408642.
   Attina TM, 2016, LANCET DIABETES ENDO, V4, P996, DOI 10.1016/S2213-8587(16)30275-3.
   Baccarelli A, 2000, J ENDOCRINOL INVEST, V23, P771, DOI 10.1007/BF03345069.
   Baccarelli A, 2016, EPIGENETICS GLOSSARY.
   Baccarelli A, 2009, CURR OPIN PEDIATR, V21, P243, DOI 10.1097/MOP.0b013e32832925cc.
   Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22.
   Belinsky SA, 2002, CANCER RES, V62, P2370.
   Bhan A, 2014, J MOL BIOL, V426, P3426, DOI 10.1016/j.jmb.2014.07.025.
   Bi YF, 2016, J CLIN ENDOCR METAB, V101, P142, DOI 10.1210/jc.2015-3039.
   Blake GET, 2016, CURR OPIN CHEM BIOL, V33, P101, DOI 10.1016/j.cbpa.2016.06.008.
   Brokken LJS, 2014, ASIAN J ANDROL, V16, P89, DOI 10.4103/1008-682X.122193.
   Byun HM, 2015, TOXICOLOGY, V328, P152, DOI 10.1016/j.tox.2014.12.019.
   Byun HM, 2014, HUM GENET, V133, P247, DOI 10.1007/s00439-013-1417-x.
   Casati L, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00037.
   Chen BH, 2016, AGING-US, V8, P1844, DOI 10.18632/aging.101020.
   Chen JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126403.
   Chen SC, 2010, MOL HUM REPROD, V16, P361, DOI 10.1093/molehr/gaq004.
   Christensen BC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000602.
   CRICK F H, 1958, Symp Soc Exp Biol, V12, P138.
   Cui H, 2013, GENET MED, V15, P388, DOI 10.1038/gim.2012.144.
   Dao T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138815.
   DAWID IB, 1974, SCIENCE, V184, P80, DOI 10.1126/science.184.4132.80.
   Diamanti-Kandarakis E, 2009, ENDOCR REV, V30, P293, DOI 10.1210/er.2009-0002.
   Doherty Leo F., 2010, Hormones \& Cancer, V1, P146, DOI 10.1007/s12672-010-0015-9.
   Dolinoy DC, 2007, REPROD TOXICOL, V23, P297, DOI 10.1016/j.reprotox.2006.08.012.
   Dunaway KW, 2016, CELL REP, V17, P3035, DOI 10.1016/j.celrep.2016.11.058.
   Furda A, 2014, METHODS MOL BIOL, V1105, P419, DOI 10.1007/978-1-62703-739-6\_31.
   Giwercman YL, 2016, HORM RES PAEDIAT, V86, P264, DOI 10.1159/000443686.
   GOPALKRISHNAN K, 1995, INT J ANDROL, V18, P67, DOI 10.1111/j.1365-2605.1995.tb00642.x.
   Gorber SC, 2009, NICOTINE TOB RES, V11, P12, DOI 10.1093/ntr/ntn010.
   Gore AC, 2015, ENDOCR REV, V36, pE1, DOI 10.1210/er.2015-1010.
   Guarnieri M, 2014, LANCET, V383, P1581, DOI 10.1016/S0140-6736(14)60617-6.
   Guerrero-Bosagna C, 2016, EPIGENOME AND DEVELOPMENTAL ORIGINS OF HEALTH AND DISEASE, P425, DOI 10.1016/B978-0-12-801383-0.00021-9.
   Guerrero-Bosagna C, 2012, REPROD TOXICOL, V34, P694, DOI 10.1016/j.reprotox.2012.09.005.
   Guyot R, 2014, TOXICOLOGY, V325, P125, DOI 10.1016/j.tox.2014.08.007.
   Heard E, 2014, CELL, V157, P95, DOI 10.1016/j.cell.2014.02.045.
   Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115.
   Hung WT, 2013, CHEMOSPHERE, V90, P2358, DOI 10.1016/j.chemosphere.2012.10.026.
   Illumina, 2016, INTR METH ARR AN.
   Joehanes R, 2016, CIRC-CARDIOVASC GENE, V9, P436, DOI 10.1161/CIRCGENETICS.116.001506.
   Joubert BR, 2016, AM J HUM GENET, V98, P680, DOI 10.1016/j.ajhg.2016.02.019.
   Joubert BR, 2012, ENVIRON HEALTH PERSP, V120, P1425, DOI 10.1289/ehp.1205412.
   Kapoor V, 2014, ENVIRON SCI TECHNOL, V48, P10648, DOI 10.1021/es503189g.
   Kaur K, 2014, FREE RADICAL BIO MED, V76, P25, DOI 10.1016/j.freeradbiomed.2014.07.030.
   Kaye J, 2010, EUR J HUM GENET, V18, P398, DOI 10.1038/ejhg.2009.191.
   Kourou K, 2015, COMPUT STRUCT BIOTEC, V13, P8, DOI 10.1016/j.csbj.2014.11.005.
   Kumar V, 2010, CHEMOSPHERE, V81, P464, DOI 10.1016/j.chemosphere.2010.07.067.
   Kurdyukov S, 2016, BIOL BASEL, V5, pE3, DOI DOI 10.3390/BI0L0GY5010003.
   Liu BJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep23421.
   Lövkvist C, 2016, NUCLEIC ACIDS RES, V44, P5123, DOI 10.1093/nar/gkw124.
   Manikkam M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102091.
   Martínez-Nava GA, 2013, BIOMARKERS, V18, P493, DOI 10.3109/1354750X.2013.816776.
   Meyer JN, 2013, TOXICOL SCI, V134, P1, DOI 10.1093/toxsci/kft102.
   National Institutes of Health, 2016, ALL US RES PROGR.
   Nature Publishing Group, 2016, NATURE.
   NIEHS, 2017, END DISR.
   Olden K, 2000, NAT REV GENET, V1, P149, DOI 10.1038/35038586.
   Ornostay A, 2013, COMP BIOCHEM PHYS D, V8, P263, DOI 10.1016/j.cbd.2013.08.001.
   Ottman R, 1996, PREV MED, V25, P764, DOI 10.1006/pmed.1996.0117.
   Pant N, 2008, TOXICOL APPL PHARM, V231, P112, DOI 10.1016/j.taap.2008.04.001.
   Philibert RA, 2012, EPIGENETICS-US, V7, P1331, DOI 10.4161/epi.22520.
   Piasecka M, 2003, FOLIA HISTOCHEM CYTO, V41, P125.
   Pidsley R, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1066-1.
   Prins GS, 2007, REPROD TOXICOL, V23, P374, DOI 10.1016/j.reprotox.2006.10.001.
   Richards EJ, 2006, NAT REV GENET, V7, P395, DOI 10.1038/nrg1834.
   Rivera CM, 2013, CELL, V155, P39, DOI 10.1016/j.cell.2013.09.011.
   Rooney JP, 2015, METHODS MOL BIOL, V1241, P23, DOI 10.1007/978-1-4939-1875-1\_3.
   Schug TT, 2011, J STEROID BIOCHEM, V127, P204, DOI 10.1016/j.jsbmb.2011.08.007.
   Schwartz D A, 2011, G Ital Med Lav Ergon, V33, P31.
   Sheehan David, 2007, Reviews on Environmental Health, V22, P175.
   Shock LS, 2011, P NATL ACAD SCI USA, V108, P3630, DOI 10.1073/pnas.1012311108.
   Skinner MK, 2015, ENVIRON EPIGENETICS, V1, DOI 10.1093/eep/dvv004.
   Skinner MK, 2016, NAT REV ENDOCRINOL, V12, P68, DOI 10.1038/nrendo.2015.206.
   Stel J, 2015, ENDOCRINOLOGY, V156, P3466, DOI 10.1210/en.2015-1434.
   Stirzaker C, 2014, TRENDS GENET, V30, P75, DOI 10.1016/j.tig.2013.11.004.
   Strong AL, 2015, ENVIRON HEALTH PERSP, V123, P42, DOI 10.1289/ehp.1408188.
   Vidyasagar M, 2015, ANNU REV PHARMACOL, V55, P15, DOI 10.1146/annurev-pharmtox-010814-124502.
   Wang GG, 2007, TRENDS MOL MED, V13, P363, DOI 10.1016/j.molmed.2007.07.003.
   Wang LF, 2010, P NATL ACAD SCI USA, V107, P7317, DOI 10.1073/pnas.1000031107.
   Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484.
   Wu MC, 2010, AM J HUM GENET, V86, P929, DOI 10.1016/j.ajhg.2010.05.002.
   Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514.
   Yauk C, 2008, P NATL ACAD SCI USA, V105, P605, DOI 10.1073/pnas.0705896105.
   Yoshida R, 2005, J CLIN ENDOCR METAB, V90, P4716, DOI 10.1210/jc.2005-0211.
   Zhang J, 2015, ENVIRON SCI TECHNOL, V49, P10099, DOI 10.1021/acs.est.5b01742.},
Number-of-Cited-References = {89},
Times-Cited = {39},
Unique-ID = {WOS:000414767300018},
}

@article{ WOS:000850394000001,
Author = {Zhou, Yitian and Lauschke, Volker M.},
Title = {The genetic landscape of major drug metabolizing cytochrome P450
   genes-an updated analysis of population-scale sequencing data},
Journal = {PHARMACOGENOMICS JOURNAL},
Year = {2022},
Volume = {22},
Number = {5-6},
Pages = {284-293},
Month = {DEC},
Abstract = {Genes encoding cytochrome P450 enzymes (CYPs) are extremely polymorphic
   and multiple CYP variants constitute clinically relevant biomarkers for
   the guidance of drug selection and dosing. We previously reported the
   distribution of the most relevant CYP alleles using population-scale
   sequencing data. Here, we update these findings by making use of the
   increasing wealth of data, incorporating whole exome and whole genome
   sequencing data from 141,614 unrelated individuals across 12 human
   populations. We furthermore extend our previous studies by
   systematically considering also uncharacterized rare alleles and reveal
   that they contribute between 1.5\% and 17.5\% to the overall genetically
   encoded functional variability. By using established guidelines, we
   aggregate and translate the available sequencing data into
   population-specific patterns of metabolizer phenotypes. Combined, the
   presented data refine the worldwide landscape of ethnogeographic
   variability in CYP genes and aspire to provide a relevant resource for
   the optimization of population-specific genotyping strategies and
   precision public health.},
Type = {Article},
Affiliation = {Lauschke, VM (Corresponding Author), Karolinska Inst, Dept Physiol \& Pharmacol, S-17177 Stockholm, Sweden.
   Lauschke, VM (Corresponding Author), Dr Margarete Fischer Bosch Inst Clin Pharmacol, Stuttgart, Germany.
   Lauschke, VM (Corresponding Author), Univ Tubingen, Tubingen, Germany.
   Zhou, Yitian; Lauschke, Volker M., Karolinska Inst, Dept Physiol \& Pharmacol, S-17177 Stockholm, Sweden.
   Lauschke, Volker M., Dr Margarete Fischer Bosch Inst Clin Pharmacol, Stuttgart, Germany.
   Lauschke, Volker M., Univ Tubingen, Tubingen, Germany.},
DOI = {10.1038/s41397-022-00288-2},
EarlyAccessDate = {SEP 2022},
Keywords-Plus = {FUNCTIONAL-CHARACTERIZATION; CYP2C8 VARIANTS; IN-VITRO;
   PHARMACOGENETICS; VARIABILITY; ALLELES; POLYMORPHISM; PACLITAXEL;
   GENOTYPE; THERAPY},
Research-Areas = {Genetics \& Heredity; Pharmacology \& Pharmacy},
Web-of-Science-Categories  = {Genetics \& Heredity; Pharmacology \& Pharmacy},
Author-Email = {volker.lauschke@ki.se},
Affiliations = {Karolinska Institutet; Eberhard Karls University of Tubingen; Eberhard
   Karls University Hospital; Eberhard Karls University of Tubingen},
Cited-References = {Borrego-Soto G, 2020, PHARMACOGENOMICS J, V20, P586, DOI 10.1038/s41397-020-0147-4.
   Bush WS, 2016, CLIN PHARMACOL THER, V100, P160, DOI 10.1002/cpt.350.
   Céspedes-Garro C, 2015, EXPERT OPIN DRUG MET, V11, P1893, DOI 10.1517/17425255.2015.1111871.
   Crews KR, 2021, CLIN PHARMACOL THER, V110, P888, DOI 10.1002/cpt.2149.
   Dalton R, 2020, CTS-CLIN TRANSL SCI, V13, P147, DOI 10.1111/cts.12695.
   Desta Z, 2021, CLIN PHARMACOL THER, V110, P82, DOI 10.1002/cpt.2166.
   Desta Z, 2019, CLIN PHARMACOL THER, V106, P726, DOI 10.1002/cpt.1477.
   Eichelbaum M, 2006, ANNU REV MED, V57, P119, DOI 10.1146/annurev.med.56.082103.104724.
   El-Boraie A, 2022, CTS-CLIN TRANSL SCI, V15, P204, DOI 10.1111/cts.13135.
   Fricke-Galindo I, 2016, PHARMACOGENOMICS J, V16, P113, DOI 10.1038/tpj.2015.70.
   Fujikura K, 2015, PHARMACOGENET GENOM, V25, P584, DOI 10.1097/FPC.0000000000000172.
   Gaedigk A, 2018, CLIN PHARMACOL THER, V103, P399, DOI 10.1002/cpt.910.
   Gaedigk A, 2017, GENET MED, V19, P69, DOI 10.1038/gim.2016.80.
   Gao YW, 2010, XENOBIOTICA, V40, P467, DOI 10.3109/00498254.2010.487163.
   Ingelman-Sundberg M, 2004, TRENDS PHARMACOL SCI, V25, P193, DOI 10.1016/j.tips.2004.02.007.
   Ingelman-Sundberg M, 2018, HUM GENOMICS, V12, DOI 10.1186/s40246-018-0157-3.
   Jukic MM, 2018, AM J PSYCHIAT, V175, P463, DOI 10.1176/appi.ajp.2017.17050550.
   Karczewski KJ, 2020, NATURE, V581, P434, DOI 10.1038/s41586-020-2308-7.
   Kaspera R, 2010, PHARMACOGENET GENOM, V20, P619, DOI 10.1097/FPC.0b013e32833ecace.
   Klein K, 2005, PHARMACOGENET GENOM, V15, P861, DOI 10.1097/01213011-200512000-00004.
   Koopmans AB, 2021, TRANSL PSYCHIAT, V11, DOI 10.1038/s41398-020-01129-1.
   Kozyra M, 2017, GENET MED, V19, P20, DOI 10.1038/gim.2016.33.
   Langmia IM, 2021, FRONT GENET, V12, DOI 10.3389/fgene.2021.692234.
   Lauschke VM, 2019, EUR J PHARM SCI, V130, P65, DOI 10.1016/j.ejps.2019.01.024.
   Lee CR, 2022, CLIN PHARMACOL THER, V112, P959, DOI 10.1002/cpt.2526.
   Machiela MJ, 2015, BIOINFORMATICS, V31, P3555, DOI 10.1093/bioinformatics/btv402.
   Martínez C, 2005, BRIT J CLIN PHARMACO, V59, P62, DOI 10.1111/j.1365-2125.2004.02183.x.
   Matthaei J, 2015, CLIN PHARMACOL THER, V98, P611, DOI 10.1002/cpt.258.
   Milosavljevic F, 2021, JAMA PSYCHIAT, V78, P270, DOI 10.1001/jamapsychiatry.2020.3643.
   Mizzi C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162866.
   Muschler E, 2009, BASIC CLIN PHARMACOL, V105, P374, DOI 10.1111/j.1742-7843.2009.00457.x.
   Nelson MR, 2012, SCIENCE, V337, P100, DOI 10.1126/science.1217876.
   Petrovic J, 2020, EUR J HUM GENET, V28, P88, DOI 10.1038/s41431-019-0480-8.
   Ramsey LB, 2012, GENOME RES, V22, P1, DOI 10.1101/gr.129668.111.
   Rieger JK, 2013, DRUG METAB DISPOS, V41, P1752, DOI 10.1124/dmd.113.052126.
   Rodríguez-Antona C, 2008, PHARMACOGENOMICS J, V8, P268, DOI 10.1038/sj.tpj.6500482.
   Sistonen J, 2007, PHARMACOGENET GENOM, V17, P93.
   Speed WC, 2009, PHARMACOGENOMICS J, V9, P283, DOI 10.1038/tpj.2009.10.
   Theken KN, 2020, CLIN PHARMACOL THER, V108, P191, DOI 10.1002/cpt.1830.
   Tsukada C, 2015, DRUG METAB PHARMACOK, V30, P366, DOI 10.1016/j.dmpk.2015.07.003.
   Twist GP, 2016, NPJ GENOM MED, V1, DOI 10.1038/npjgenmed.2015.7.
   Wang HJ, 2011, DRUG METAB DISPOS, V39, P830, DOI 10.1124/dmd.110.037549.
   Wang YC, 2018, HEREDITAS, V155, DOI 10.1186/s41065-018-0057-5.
   Xiao QY, 2020, HUM GENET, V139, P623, DOI 10.1007/s00439-020-02150-6.
   Yasar U, 2002, BIOCHEM BIOPH RES CO, V299, P25, DOI 10.1016/S0006-291X(02)02592-5.
   Zanger UM, 2013, PHARMACOL THERAPEUT, V138, P103, DOI 10.1016/j.pharmthera.2012.12.007.
   Zhou SF, 2009, DRUG METAB REV, V41, P89, DOI 10.1080/03602530902843483.
   Zhou Y, 2017, CLIN PHARMACOL THER, V102, P688, DOI 10.1002/cpt.690.
   Zhou YT, 2022, HUM GENET, V141, P1113, DOI 10.1007/s00439-021-02385-x.
   Zhou YT, 2021, CLIN PHARMACOL THER, V110, P626, DOI 10.1002/cpt.2289.
   Zhou YT, 2019, PHARMACOGENOMICS J, V19, P115, DOI 10.1038/s41397-018-0044-2.},
Number-of-Cited-References = {51},
Times-Cited = {25},
Unique-ID = {WOS:000850394000001},
}

@article{ WOS:000671452100002,
Author = {Alghamdi, Jahad and Alaamery, Manal and Barhoumi, Tlili and Rashid,
   Mamoon and Alajmi, Hala and Aljasser, Nasser and Alhendi, Yaseen and
   Alkhalaf, Hind and Alqahtani, Hanadi and Algablan, Omer and Alshaya, I,
   Abdulraham and Tashkandi, Nabiha and Massadeh, Salam and Almuzzaini,
   Bader and Ehaideb, Salleh N. and Bosaeed, Mohammad and Ayoub, Kamal and
   Yezli, Saber and Khan, Anas and Alaskar, Ahmed and Bouchama, Abderrezak},
Title = {Interferon-induced transmembrane protein-3 genetic variant rs12252 is
   associated with COVID-19 mortality},
Journal = {GENOMICS},
Year = {2021},
Volume = {113},
Number = {4},
Pages = {1733-1741},
Month = {JUL},
Abstract = {Interferon-induced membrane proteins (IFITM) 3 gene variants are known
   risk factor for severe viral diseases. We examined whether IFITM3
   variant may underlie the heterogeneous clinical outcomes of SARS-CoV-2
   infection-induced COVID-19 in large Arab population. We genotyped 880
   Saudi patients; 93.8\% were PCR-confirmed SARS-CoV-2 infection,
   encompassing most COVID-19 phenotypes. Mortality at 90 days was 9.1\%.
   IFITM3-SNP, rs12252-G allele was associated with hospital admission (OR
   = 1.65 {[}95\% CI; 1.01-2.70], P = 0.04]) and mortality (OR = 2.2
   {[}95\% CI; 1.16-4.20], P = 0.01). Patients less than 60 years old had a
   lower survival probability if they harbor this allele (log-rank test P =
   0.002). Plasma levels of IFN gamma were significantly lower in a subset
   of patients with AG/GG genotypes than patients with AA genotype (P =
   0.00016). Early identification of these individuals at higher risk of
   death may inform precision public health response.},
Type = {Article},
Affiliation = {Alghamdi, J (Corresponding Author), King Saud Bin Abdulaziz Univ Hlth Sci, King Abdullah Int Med Res Ctr, Minist Natl Guard Hlth Affairs, Saudi Biobank, Riyadh, Saudi Arabia.
   Bouchama, A (Corresponding Author), King Saud bin Abdulaziz Univ Hlth Sci, King Abdullah Int Med Res Ctr, Expt Med Dept, Minist Natl Guard Hlth Affairs, Riyadh, Saudi Arabia.
   Alghamdi, Jahad; Alajmi, Hala; Aljasser, Nasser; Alhendi, Yaseen; Alkhalaf, Hind; Alqahtani, Hanadi; Algablan, Omer, King Saud Bin Abdulaziz Univ Hlth Sci, King Abdullah Int Med Res Ctr, Minist Natl Guard Hlth Affairs, Saudi Biobank, Riyadh, Saudi Arabia.
   Alaamery, Manal; Massadeh, Salam, King Saud Bin Abdulaziz Univ Hlth Sci, King Abdullah Int Med Res Ctr, Dev Med Dept, Minist Natl Guard Hlth Affairs,King Abdulaziz Med, Riyadh, Saudi Arabia.
   Alaamery, Manal; Massadeh, Salam, King Abdulaziz City Sci \& Technol KACST, Joint Ctr Excellence Program, KACST BWH Ctr Excellence Biomed, Riyadh, Saudi Arabia.
   Alaamery, Manal; Massadeh, Salam, King Abdulaziz City Sci \& Technol KACST, Minist Natl Guard Hlth Affairs MNG HA, Saudi Human Genome Project SHGP, Satellite Lab,King Abdulaziz Med City KAMC, Riyadh, Saudi Arabia.
   Barhoumi, Tlili, King Saud Bin Abdulaziz Univ Hlth Sci, King Abdullah Int Med Res Ctr, Minist Natl Guard Hlth Affairs, Core Facil \& Res Platforms, Riyadh, Saudi Arabia.
   Rashid, Mamoon, King Saud Bin Abdulaziz Univ Hlth Sci, King Abdullah Int Med Res Ctr, Dept Bioinformat, Minist Natl Guard Hlth Affairs, Riyadh, Saudi Arabia.
   Alshaya, Abdulraham, I, King Saud bin Abdulaziz Univ Hlth Sci, Coll Pharm, King Abdullah Int Med Res Ctr, Minist Natl Guard Hlth Affairs, Riyadh, Saudi Arabia.
   Tashkandi, Nabiha, King Saud bin Abdulaziz Univ Hlth Sci, King Abdullah Int Med Res Ctr, Nursing Serv, Minist Natl Guard Hlth Affairs, Riyadh, Saudi Arabia.
   Almuzzaini, Bader, King Saud bin Abdulaziz Univ Hlth Sci, King Abdullah Int Med Res Ctr, Med Genom Res Dept, Minist Natl Guard Hlth Affairs, Riyadh, Saudi Arabia.
   Ehaideb, Salleh N.; Bouchama, Abderrezak, King Saud bin Abdulaziz Univ Hlth Sci, King Abdullah Int Med Res Ctr, Expt Med Dept, Minist Natl Guard Hlth Affairs, Riyadh, Saudi Arabia.
   Bosaeed, Mohammad, Minist Natl Guard Hlth Affairs, Dept Med, Riyadh, Saudi Arabia.
   Bosaeed, Mohammad, King Saud bin Abdulaziz Univ Hlth Sci, Coll Med, King Abdullah Int Med Res Ctr, Riyadh, Saudi Arabia.
   Ayoub, Kamal, King Saud bin Abdulaziz Univ Hlth Sci, King Abdulaziz Cardiac Ctr, King Abdullah Int Med Res Ctr, Minist Natl Guard Hlth Affairs, Riyadh, Saudi Arabia.
   Yezli, Saber; Khan, Anas, Minist Hlth, Global Ctr Mass Gatherings Med, Riyadh, Saudi Arabia.
   Khan, Anas, King Saud Univ, Coll Med, Riyadh, Saudi Arabia.
   Alaskar, Ahmed, King Saud bin Abdulaziz Univ Hlth Sci, King Abdullah Int Med Res Ctr, Oncol Dept, Minist Natl Guard Hlth Affairs, Riyadh, Saudi Arabia.},
DOI = {10.1016/j.ygeno.2021.04.002},
EarlyAccessDate = {APR 2021},
Keywords = {COVID-19; Genetics; Interferon; SARS-Cov-2},
Keywords-Plus = {IFITM3; INFLUENZA},
Research-Areas = {Biotechnology \& Applied Microbiology; Genetics \& Heredity},
Web-of-Science-Categories  = {Biotechnology \& Applied Microbiology; Genetics \& Heredity},
Author-Email = {alghamdija@ngha.med.sa
   bouchamaab@ngha.med.sa},
Affiliations = {King Saud Bin Abdulaziz University for Health Sciences; King Abdullah
   International Medical Research Center (KAIMRC); Ministry of National
   Guard - Health Affairs; King Saud Bin Abdulaziz University for Health
   Sciences; King Abdullah International Medical Research Center (KAIMRC);
   Ministry of National Guard - Health Affairs; King Saud Bin Abdulaziz
   University for Health Sciences; Ministry of National Guard - Health
   Affairs; King Saud Bin Abdulaziz University for Health Sciences;
   Ministry of National Guard - Health Affairs; King Abdullah International
   Medical Research Center (KAIMRC); King Saud Bin Abdulaziz University for
   Health Sciences; King Abdullah International Medical Research Center
   (KAIMRC); Ministry of National Guard - Health Affairs; King Saud Bin
   Abdulaziz University for Health Sciences; King Abdullah International
   Medical Research Center (KAIMRC); Ministry of National Guard - Health
   Affairs; King Saud Bin Abdulaziz University for Health Sciences;
   Ministry of National Guard - Health Affairs; King Abdullah International
   Medical Research Center (KAIMRC); King Saud Bin Abdulaziz University for
   Health Sciences; King Abdullah International Medical Research Center
   (KAIMRC); Ministry of National Guard - Health Affairs; King Saud Bin
   Abdulaziz University for Health Sciences; King Abdullah International
   Medical Research Center (KAIMRC); Ministry of National Guard - Health
   Affairs; King Saud Bin Abdulaziz University for Health Sciences;
   Ministry of National Guard - Health Affairs; King Saud Bin Abdulaziz
   University for Health Sciences; King Abdullah International Medical
   Research Center (KAIMRC); King Saud Bin Abdulaziz University for Health
   Sciences; King Abdullah International Medical Research Center (KAIMRC);
   Ministry of National Guard - Health Affairs; King Abdulaziz Cardiac
   Center (KACC); Ministry of Health - Saudi Arabia; King Saud University;
   King Saud Bin Abdulaziz University for Health Sciences; Ministry of
   National Guard - Health Affairs; King Abdullah International Medical
   Research Center (KAIMRC)},
Cited-References = {Allen EK, 2017, NAT MED, V23, P975, DOI 10.1038/nm.4370.
   Auton Brooks Durbin Garrison Kang A LD RM EP HM, 2015, Nature, V526, P68, DOI {[}10.1038/nature15393, DOI 10.1038/NATURE15393].
   Bailey CC, 2014, ANNU REV VIROL, V1, P261, DOI 10.1146/annurev-virology-031413-085537.
   Bailey CC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002909.
   Benetti E, 2020, EUR J HUM GENET, V28, P1602, DOI 10.1038/s41431-020-0691-z.
   Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017.
   Chesarino NM, 2014, J BIOL CHEM, V289, P11986, DOI 10.1074/jbc.M114.557694.
   David S, 2018, IMMUNOGENETICS, V70, P169, DOI 10.1007/s00251-017-1026-2.
   Ellinghaus D, 2020, NEW ENGL J MED, V383, P1522, DOI 10.1056/NEJMoa2020283.
   Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921.
   Gómez J, 2021, CYTOKINE, V137, DOI 10.1016/j.cyto.2020.155354.
   Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1574, DOI 10.1001/jama.2020.5394.
   Huang IC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001258.
   Jia R, 2012, J VIROL, V86, P13697, DOI 10.1128/JVI.01828-12.
   Jin JM, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00152.
   Kenney AD, 2019, P NATL ACAD SCI USA, V116, P18607, DOI 10.1073/pnas.1900784116.
   Nikoloudis D, 2020, PEERJ, V8, DOI 10.7717/peerj.10402.
   Novelli A, 2020, HUM GENOMICS, V14, DOI 10.1186/s40246-020-00279-z.
   Pairo-Castineira E, 2021, NATURE, V591, P92, DOI 10.1038/s41586-020-03065-y.
   Pan Y, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00294.
   Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795.
   Randolph AG, 2017, J INFECT DIS, V216, P14, DOI 10.1093/infdis/jix242.
   Shelton J.F., 2020, 20202009200420188318.
   Spence JS, 2019, NAT CHEM BIOL, V15, P259, DOI 10.1038/s41589-018-0213-2.
   Torre-Fuentes L, 2021, J MED VIROL, V93, P863, DOI 10.1002/jmv.26319.
   Wang ZF, 2014, P NATL ACAD SCI USA, V111, P769, DOI 10.1073/pnas.1321748111.
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648.
   Zhang Q, 2020, SCIENCE, V370, DOI 10.1126/science.abd4570.
   Zhang X., NATURE, V583.
   Zhang YH, 2020, J INFECT DIS, V222, P34, DOI 10.1093/infdis/jiaa224.
   Zhang YH, 2015, AIDS, V29, P889, DOI 10.1097/QAD.0000000000000632.
   Zhang YZ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2830.
   Zheng XY, 2017, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00535.
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI {[}10.1056/NEJMoa2001017, 10.1172/JCI89857].},
Number-of-Cited-References = {34},
Times-Cited = {34},
Unique-ID = {WOS:000671452100002},
}

@article{ WOS:000578795500001,
Author = {Deka, Mark A.},
Title = {Mapping the Geographic Distribution of Tungiasis in Sub-Saharan Africa},
Journal = {TROPICAL MEDICINE AND INFECTIOUS DISEASE},
Year = {2020},
Volume = {5},
Number = {3},
Month = {SEP},
Abstract = {The geographic distribution of tungiasis is poorly understood, despite
   the frequent occurrence of the disease in marginalized populations of
   low socioeconomic status. To date, little work is available to define
   the geography of this neglected tropical disease (NTD). This exploratory
   study incorporated geostatistical modeling to map the suitability for
   tungiasis transmission in sub-Saharan Africa (SSA). In SSA,
   environmental suitability is predicted in 44 countries, including
   Angola, Nigeria, Ghana, Cameroon, Cote de Ivoire, Mali, Ethiopia, the
   Democratic Republic of the Congo, Kenya, Gabon, Uganda, Rwanda,
   Tanzania, Zambia, Zimbabwe, Madagascar, and South Africa. In total, an
   estimated 668 million people live in suitable areas, 46\% (304 million)
   of which reside in East Africa. These evidence-based maps provide vital
   evidence of the potential geographic extent in SSA. They will help to
   guide disease control programs, inform policymakers, and raise awareness
   at the global level. Likewise, these results will hopefully provide
   decisionmakers with the pertinent information necessary to lessen
   morbidity and mortality in communities located in environmentally
   suitable areas.},
Type = {Article},
Affiliation = {Deka, MA (Corresponding Author), Texas State Univ, Dept Geog, 601 Univ Dr, San Marcos, TX 78666 USA.
   Deka, Mark A., Texas State Univ, Dept Geog, 601 Univ Dr, San Marcos, TX 78666 USA.},
DOI = {10.3390/tropicalmed5030122},
Article-Number = {122},
Keywords = {tungiasis; GIS; disease mapping; neglected tropical disease; precision
   public health; medical geography},
Keywords-Plus = {SPECIES DISTRIBUTION MODELS; FLEA TUNGA-PENETRANS; LAGOS-STATE; CASE
   SERIES; DISEASE; COMMUNITIES; PREVALENCE; MORBIDITY; EPIDEMIOLOGY;
   INFESTATION},
Research-Areas = {Infectious Diseases; Parasitology; Tropical Medicine},
Web-of-Science-Categories  = {Infectious Diseases; Parasitology; Tropical Medicine},
Author-Email = {mad214@txstate.edu},
Affiliations = {Texas State University System; Texas State University San Marcos},
Cited-References = {ADESERRANO MA, 1981, ANN TROP MED PARASIT, V75, P471, DOI 10.1080/00034983.1981.11687469.
   Ahadi Kenya Trust, 2011, JIGG MEN KEN ANTIJIG, P2.
   Alfred K., 2009, RAPID APPRAISAL REPO.
   Alkire S., 2011, MULTIDIMENSIONAL POV.
   Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x.
   Ames C., 1934, Gazetteers of the Northern Provinces of Nigeria vol. IV: The Highland Chieftaincies (Plateau Province), VIV.
   Amzat J., 2017, SOCIOLOGY HLTH DISCO.
   Anderson C, 2014, BIOSTATISTICS, V15, P457, DOI 10.1093/biostatistics/kxu005.
   {[}Anonymous], 2015, THESIS.
   Araújo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010.
   ARENE FOI, 1984, PUBLIC HEALTH, V98, P282, DOI 10.1016/S0033-3506(84)80004-9.
   Balk DL, 2006, ADV PARASIT, V62, P119, DOI 10.1016/S0065-308X(05)62004-0.
   Barbet-Massin M, 2012, METHODS ECOL EVOL, V3, P327, DOI 10.1111/j.2041-210X.2011.00172.x.
   Barbosa MM, 2019, NEW ENGL J MED, V380, pE19, DOI 10.1056/NEJMicm1810588.
   Barbot J., 1732, DESCRIPTION COASTS G.
   Bavia ME, 2001, ACTA TROP, V79, P79, DOI 10.1016/S0001-706X(01)00105-X.
   Bentley W.H., 1900, PIONEERING CONGO REL, V1.
   Bindloss Harold., 1898, In the Niger Country.
   Bourée P, 2012, MED SANTE TROP, V22, P440, DOI 10.1684/mst.2013.0134.
   Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324.
   Brooker S, 2002, B WORLD HEALTH ORGAN, V80, P783.
   Carlson CJ, 2019, NAT MICROBIOL, V4, P1337, DOI 10.1038/s41564-019-0435-4.
   Chadee DD, 1998, ANN TROP MED PARASIT, V92, P107, DOI 10.1080/00034989860238.
   Chelimo J.J., 2015, THESIS.
   Chen CW, 2011, DERMATOL SIN, V29, P29, DOI 10.1016/j.dsi.2011.01.004.
   Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523.
   Collins G, 2009, INT J COLLAB RES INT, V1, P1.
   Crawford Dan., 1912, Thinking Black: Twenty-Two Years Without a Break in the Long Grass of Central Africa.
   Danson FM, 2008, PARASITE, V15, P463, DOI 10.1051/parasite/2008153463.
   Dassoni F, 2014, J INFECT DEV COUNTR, V8, P1456, DOI 10.3855/jidc.4324.
   Decle Lionel., 1898, 3 YEARS SAVAGE AFRIC.
   Deka MA, 2018, TROP MED INFECT DIS, V3, DOI 10.3390/tropicalmed3020057.
   Dent D, 2017, ENCYCLOPEDIA OF SOIL SCIENCE, VOLS I-III, 3RD EDITION, P1232, DOI 10.1081/E-ESS3-120041260.
   DIAS JR, 1981, J AFR HIST, V22, P349, DOI 10.1017/S0021853700019575.
   Eberhard FE, 2020, ELIFE, V9, DOI 10.7554/eLife.52072.
   Eisele M, 2003, PARASITOL RES, V90, P87, DOI 10.1007/s00436-002-0817-y.
   Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x.
   Elith J, R DOCUMENTATION.
   Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x.
   Elson L, 2017, TROP MED INFECT DIS, V2, DOI 10.3390/tropicalmed2030033.
   Engels D, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-0630-9.
   Escobar LE, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01174.
   Feitelson E., 2002, WATER POL, V4, P263, DOI {[}DOI 10.1016/S1366-7017(02)00029-6, 10.1016/S1366-7017(02)00029-6].
   Feldmeier H, 2003, EMERG INFECT DIS, V9, P949.
   Feldmeier H., 2015, PERSONAL OBSERVATION.
   Feldmeier H, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003133.
   Gadisa E, 2019, BMC COMPLEM ALTERN M, V19, DOI 10.1186/s12906-019-2429-4.
   Gama M, 2016, ECOL MODEL, V319, P163, DOI 10.1016/j.ecolmodel.2015.06.001.
   Geigy J.R., 1949, HYPERTROPHIE ORGANE.
   Gething PW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-378.
   Gibbons A.S.H., 1904, AFRICA S N MAROTSELA.
   Girma M, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3373-5.
   Guisan A, 2002, ECOL MODEL, V157, P89, DOI 10.1016/S0304-3800(02)00204-1.
   Han BA, 2016, TRENDS PARASITOL, V32, P565, DOI 10.1016/j.pt.2016.04.007.
   Hay SI, 2006, ADV PARASIT, V62, P37, DOI 10.1016/S0065-308X(05)62002-7.
   Hesse P., 1899, Geographische Zeitschrift, P522.
   Heukelbach J, 2004, MED VET ENTOMOL, V18, P329, DOI 10.1111/j.0269-283X.2004.00532.x.
   Heukelbach J., 2007, Niger J Parasitol, V28, P1, DOI DOI 10.4314/NJPAR.V28I1.37849.
   HOEPPLI R., 1963, ACTA TROP, V20, P143.
   Hooton E.A., 1937, APES MEN MORONS GP.
   Hotez Peter, 2013, FORGOTTEN PEOPLE FOR.
   Huete A, 2002, REMOTE SENS ENVIRON, V83, P195, DOI 10.1016/S0034-4257(02)00096-2.
   Hutton William., 1821, A Voyage to Africa Including a Narrative of an Embassy to One of the Interior Kingdoms in the Year 1820 ; with Remarks on the Course and Termination of the Niger, and Other Principal Rivers in That Country.
   Jeffreys M., 1952, S AFR J SCI, V48, P249.
   Johnson EE, 2019, TRENDS ECOL EVOL, V34, P655, DOI 10.1016/j.tree.2019.03.004.
   Johnston Harry., 1906, LIBERIA, V1.
   Johnston HH., 1895, RIVER CONGO ITS MOUT.
   Kafadar K, 1999, STAT MED, V18, P3167, DOI 10.1002/(SICI)1097-0258(19991215)18:23<3167::AID-SIM308>3.0.CO;2-N.
   Kaimbo DKW, 2007, OPHTHALMOLOGICA, V221, P439, DOI 10.1159/000107508.
   Karuga J., 2013, THESIS.
   Karunamoorthi K, 2013, PARASITOL RES, V112, P3635, DOI 10.1007/s00436-013-3551-8.
   Khoury MJ, 2016, AM J PREV MED, V50, P398, DOI 10.1016/j.amepre.2015.08.031.
   Kimotho S, 2015, COMMUNICAT-S AFR J C, V41, P523, DOI 10.1080/02500167.2015.1100646.
   Koirala S, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12020727.
   Koppen W., 1884, METEOROL Z, V1, P226, DOI DOI 10.1127/0941-2948/2011/105.
   Linard PM, 2010, ANN TROP MED PARASIT, V104, P337, DOI 10.1179/136485910X12743554759902.
   Lugard L., 1905, TROPICAL DEPENDENCY.
   Maco V, 2011, EMERG INFECT DIS, V17, P855, DOI 10.3201/eid1705.100542.
   Manandhar S, 2012, WATER RESOUR MANAG, V26, P89, DOI 10.1007/s11269-011-9907-x.
   Mazigo HD, 2011, J PUBLIC HEALTH AFR, V2, P87, DOI 10.4081/jphia.2011.e21.
   Mazigo HD, 2010, J INFECT DEV COUNTR, V4, P187, DOI 10.3855/jidc.680.
   Miller H, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007068.
   MOCKLER-FERRYMAN A.F., 1900, BRIT W AFRICA ITS RI.
   Mollien Gaspard Theodore comte de, 1820, TRAVELS INTERIOR AFR.
   Monteiro J.J., 1876, ANGOLA RIVER.
   Moran AE, 2012, GLOB HEART, V7, P315, DOI 10.1016/j.gheart.2012.10.004.
   MOrkve, 2013, GETT RID PLAG JIGG R.
   Mulambya N.L., 2018, HLTH PRESS ZAMB B, V2, P8.
   Mullen G.R., 2009, MED VET ENTOMOL.
   Mutebi F, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1320-0.
   Mutebi F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004126.
   Mwai J., 2018, J HEALTH SCI, V3, P1.
   Mwakanyamale J.G., 2015, IMTU MED J, V6, P54.
   Mwangi M.M., 2015, THESIS.
   Nagy N, 2007, PARASITOL RES, V101, pS233, DOI 10.1007/s00436-007-0683-8.
   Nair SK, 2016, INT J INTG MED SCI, V3, P211.
   Villagrana SMN, 2019, OXF MED CASE REP, P267, DOI 10.1093/omcr/omz049.
   Nyangacha RM, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007244.
   Nyangacha RM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005901.
   Obengui I., 1989, DAKAR MED, V34, P44.
   Okely M, 2020, ACTA TROP, V203, DOI 10.1016/j.actatropica.2019.105319.
   Osgood-Zimmerman A, 2018, NATURE, V555, P41, DOI 10.1038/nature25760.
   Pampiglione S., 1998, Revue d'Elevage et de Medecine Veterinaire des Pays Tropicaux, V51, P201.
   Pampiglione S, 2009, MED VET ENTOMOL, V23, P172, DOI 10.1111/j.1365-2915.2009.00807.x.
   Partridge Charles., 1905, Cross River Natives.
   Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026.
   Pigott DM, 2014, ELIFE, V3, DOI {[}10.7554/eLife.02851, 10.7554/eLife.04395].
   Pilger D, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000324.
   Proctor E M, 1994, Can J Infect Dis, V5, P82.
   Pruss-Ustun A., 2008, Safer water, better health: costs, benefits and sustainability of interventions to protect and promote health.
   Qiao HJ, 2016, ECOGRAPHY, V39, P805, DOI 10.1111/ecog.01961.
   R Core Team, 2013, OPEN J STAT, V6, P3.
   Reiner RC, 2018, NEW ENGL J MED, V379, P1128, DOI 10.1056/NEJMoa1716766.
   REISS F, 1966, ARCH DERMATOL, V93, P404, DOI 10.1001/archderm.93.4.404.
   Richardson D.J., 2016, Journal of the Arkansas Academy of Science, V70, P199.
   Riedel N, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-37.
   Rood EJJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186987.
   Ruttoh S.K., 2012, J ENV SCI ENG B, P1.
   Samy AM, 2018, ACTA TROP, V188, P108, DOI 10.1016/j.actatropica.2018.08.014.
   Samy AM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003250.
   Schur N, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001194.
   Sentongo E, 2014, BMC ORAL HEALTH, V14, DOI 10.1186/1472-6831-14-112.
   Shrivastav Shreya, 2018, J Nepal Health Res Counc, V15, P295.
   Sim J, 2005, PHYS THER, V85, P257.
   Spencer H. A., 1912, Transvaal Medical Journal., V8, pp.
   Stanley HenryMorton., 1889, Through the Dark Continent or, the Sources of the Nile, around the Great Lakes of Equatorial Africa, and down the Livingstone River to the Atlantic Ocean.
   Tadele H, 2017, ETHIOP J HEALTH SCI, V27, P559, DOI 10.4314/ejhs.v27i5.14.
   Takahashi S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15585.
   Thielecke M, 2013, AM J TROP MED HYG, V89, P932, DOI 10.4269/ajtmh.13-0244.
   Thielecke M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002426.
   Thuiller W T., 2016, Ensemble Platform for Species Distribution Modeling.
   Title PO, 2018, ECOGRAPHY, V41, P291, DOI 10.1111/ecog.02880.
   Ugbomoiko US, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000087.
   Ugbomoiko US, 2007, INT J DERMATOL, V46, P475, DOI 10.1111/j.1365-4632.2007.03245.x.
   Ugbomoiko Uade Samuel, 2008, BMC Vet Res, V4, P49, DOI 10.1186/1746-6148-4-49.
   Ukonu Agwu Bob, 2012, Glob J Health Sci, V4, P148, DOI 10.5539/gjhs.v4n3p148.
   Wafula ST, 2016, PAN AFR MED J, V24, DOI 10.11604/pamj.2016.24.77.8916.
   Walker SL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005808.
   Waruguru C, 2015, INT J HLTH SCI RES, V5, P434.
   WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1.
   Wiener L., 1922, AFRICA DISCOVERY AM, V3.
   Wiese S, 2015, TROP MED INT HEALTH, V20, P114.
   Winter B, 2009, J INFECT DEV COUNTR, V3, P458, DOI 10.3855/jidc.418.
   Zabron W., 2017, THESIS.},
Number-of-Cited-References = {144},
Times-Cited = {16},
Unique-ID = {WOS:000578795500001},
}

@article{ WOS:000933956900001,
Author = {Wand, Hannah A. and Martschenko, Daphne O. K. and Smitherman, Annamaria
   A. and Michelson, Sheryl and Pun, Ting and Witte, John S. and Scott,
   Stuart A. and Cho, Mildred K. and Ashley, Euan A.},
Title = {Re-envisioning community genetics: community empowerment in preventive
   genomics},
Journal = {JOURNAL OF COMMUNITY GENETICS},
Year = {2023},
Volume = {14},
Number = {5, SI},
Pages = {459-469},
Month = {OCT},
Abstract = {As genomic technologies rapidly develop, polygenic scores (PGS) are
   entering into a growing conversation on how to improve precision in
   public health and prevent chronic disease. While the integration of PGS
   into public health and clinical services raises potential benefits, it
   also introduces potential harms. In particular, there is a high level of
   uncertainty about how to incorporate PGS into clinical settings in a
   manner that is equitable, just, and aligned with the long-term goals of
   many healthcare systems to support person-centered and value-based care.
   This paper argues that any conversation about whether and how to design
   and implement PGS clinical services requires dynamic engagement with
   local communities, patients, and families. These parties often face the
   consequences, both positive and negative, of such uncertainties and
   should therefore drive clinical translation. As a collaborative effort
   between hospital stakeholders, community partners, and researchers, this
   paper describes a community-empowered co-design process for addressing
   uncertainty and making programmatic decisions about the implementation
   of PGS into clinical services. We provide a framework for others
   interested in designing clinical programs that are responsive to, and
   inclusive and respectful of, local communities.},
Type = {Article},
Affiliation = {Wand, H (Corresponding Author), Stanford Med, Dept Cardiol, Stanford, CA 94305 USA.
   Wand, H (Corresponding Author), Stanford Hlth Care, Ctr Inherited Cardiovasc Dis, Palo Alto, CA 94305 USA.
   Wand, H (Corresponding Author), Stanford Med, Biomed Data Sci \& Genet By Courtesy, Stanford, CA 94305 USA.
   Wand, Hannah A.; Ashley, Euan A., Stanford Med, Dept Cardiol, Stanford, CA 94305 USA.
   Wand, Hannah A.; Ashley, Euan A., Stanford Hlth Care, Ctr Inherited Cardiovasc Dis, Palo Alto, CA 94305 USA.
   Wand, Hannah A.; Witte, John S.; Ashley, Euan A., Stanford Med, Biomed Data Sci \& Genet By Courtesy, Stanford, CA 94305 USA.
   Martschenko, Daphne O. K.; Cho, Mildred K., Stanford Med, Stanford Ctr Biomed Ethics, Stanford, CA USA.
   Smitherman, Annamaria A.; Michelson, Sheryl; Pun, Ting, Stanford Hlth Care, Patient \& Family Partner Program, Palo Alto, CA USA.
   Witte, John S., Stanford Med, Dept Epidemiol \& Populat Hlth, Stanford, CA USA.
   Witte, John S., Stanford Med, Stanford Canc Inst, Stanford, CA USA.
   Scott, Stuart A., Stanford Univ, Dept Pathol, Stanford, CA USA.
   Scott, Stuart A., Stanford Hlth Care, Clin Genom Lab, Palo Alto, CA USA.},
DOI = {10.1007/s12687-023-00638-y},
EarlyAccessDate = {FEB 2023},
Keywords = {Community engagement; Polygenic scores; Precision public health; Program
   development; Implementation science},
Keywords-Plus = {RISK; ENGAGEMENT; HEALTH; SCORES; CARE},
Research-Areas = {Genetics \& Heredity},
Web-of-Science-Categories  = {Genetics \& Heredity},
Author-Email = {hwand@stanfordhealthcare.org},
Affiliations = {Stanford University; Stanford University; Stanford Cancer Institute;
   Stanford University; Stanford University},
Cited-References = {Adeyemo A, 2021, NAT MED, V27, P1876, DOI 10.1038/s41591-021-01549-6.
   Aragam KG, 2020, CIRC RES, V126, P1159, DOI 10.1161/CIRCRESAHA.120.315928.
   Brummel-Smith K, 2016, J AM GERIATR SOC, V64, P15, DOI 10.1111/jgs.13866.
   Brunton G, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4958-4.
   Carver T, 2021, CANCER EPIDEM BIOMAR, V30, P469, DOI 10.1158/1055-9965.EPI-20-1319.
   Dar-Nimrod I, 2011, PSYCHOL BULL, V137, P800, DOI 10.1037/a0021860.
   Davis KW, 2021, PATIENT EDUC COUNS, V104, P936, DOI 10.1016/j.pec.2020.10.021.
   Edick M, 2022, RARE DIS RES ENGAGEM.
   Guckenheimer D, 2020, Virtual event participation is key for accessibility.
   Hall J, 2021, INT J QUAL METH, V20, DOI 10.1177/16094069211010087.
   Holzer JK, 2014, J INVEST MED, V62, P851, DOI 10.1097/JIM.0000000000000097.
   Hong SJ, 2020, J HEALTH COMMUN, V25, P531, DOI 10.1080/10810730.2020.1788677.
   Hopwood P, 2000, BREAST CANCER RES, V2, P387, DOI 10.1186/bcr83.
   Lewis ACF, 2021, GENOME MED, V13, DOI 10.1186/s13073-021-00829-7.
   Martin AR, 2019, NAT GENET, V51, P584, DOI 10.1038/s41588-019-0379-x.
   Mavaddat N, 2019, AM J HUM GENET, V104, P21, DOI 10.1016/j.ajhg.2018.11.002.
   Mehta RN, 2023, PS-POLIT SCI POLIT, V56, P133, DOI 10.1017/S1049096522000841.
   PCORI (Patient-Centered Outcomes Research Institute), 2014, PCORI ENG RUBR.
   Peck L, 2022, EUR J HUM GENET, V30, P81, DOI 10.1038/s41431-021-00929-3.
   ROGERS CR, 1979, EDUCATION, V100, P98.
   Sabatello M, 2022, SCIENCE, V378, P141, DOI 10.1126/science.abq6851.
   Sheridan S, 2017, ANN FAM MED, V15, P165, DOI 10.1370/afm.2042.
   Smit AK, 2021, CLIN GENET, V100, P430, DOI 10.1111/cge.14025.
   Stanford Healthcare, PAT FAM PARTN PROGR.
   Staniszewska S, 2017, Res Involv Engagem, V3, P13, DOI {[}10.1136/bmj.j3453, 10.1186/s40900-017-0062-2].
   Vassy JL, 2018, J GEN INTERN MED, V33, P877, DOI 10.1007/s11606-017-4295-4.
   WALLERSTEIN N, 1994, HEALTH EDUC QUART, V21, P141, DOI 10.1177/109019819402100202.
   Wand H, 2021, NATURE, V591, P211, DOI 10.1038/s41586-021-03243-6.
   Wong-Gates R, AM J PREV MED.
   Yen Peggy H, 2019, Fed Pract, V36, P284.},
Number-of-Cited-References = {30},
Times-Cited = {2},
Unique-ID = {WOS:000933956900001},
}

@article{ WOS:000896747900001,
Author = {Wagner, Jennifer K. and Tanniru, Juhi K. and Chane, Courtney A. and
   Meyer, Michelle N.},
Title = {Exploring access to genomic risk information and the contours of the
   HIPAA public health exception},
Journal = {JOURNAL OF LAW AND THE BIOSCIENCES},
Year = {2022},
Volume = {9},
Number = {2},
Month = {JUL 1},
Abstract = {Considerable resources have been invested in research to identify
   pathogenic and likely pathogenic variants that cause morbidity and
   mortality and also in returning these results to patients. The public
   health impact and cost-effectiveness of these efforts are maximized when
   probands' relatives are informed of their risk and offered testing.
   However, such `Traceback' cascade testing programs face multiple
   obstacles, including perceived or actual legal and regulatory hurdles.
   Here, using genetic cancer syndromes as a test case, we explore the
   contours of the Public Health Exception to the HIPAA Privacy Rule to
   assess whether it is a viable pathway for implementing a Traceback
   program. After examining the Privacy Rule as well as state laws and
   regulations for reportable conditions and genetic privacy, we conclude
   that this is not currently a viable approach for Traceback programs. We
   conclude by reflecting on ethical considerations of leveraging HIPAA's
   public health exception to disclose PHI directly to at-risk relatives
   and offering insights for how legal hurdles to such a Traceback program
   could be overcome, if desired.},
Type = {Article},
Affiliation = {Wagner, JK (Corresponding Author), Penn State Univ, Sch Engn Design \& Innovat, Huck Inst Life Sci, University Pk, PA 16802 USA.
   Wagner, JK (Corresponding Author), Penn State Univ, Huck Inst Life Sci, Dept Biomed Engn, University Pk, PA 16802 USA.
   Wagner, JK (Corresponding Author), Penn State Univ, Huck Inst Life Sci, Penn State Law, University Pk, PA 16802 USA.
   Wagner, JK (Corresponding Author), Penn State Univ, Rock Ethics Inst, Huck Inst Life Sci, University Pk, PA 16802 USA.
   Wagner, JK (Corresponding Author), Penn State Univ, Inst Computat \& Data Sci, University Pk, PA 16802 USA.
   Wagner, JK (Corresponding Author), Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA.
   Wagner, Jennifer K., Penn State Univ, Sch Engn Design \& Innovat, Huck Inst Life Sci, University Pk, PA 16802 USA.
   Wagner, Jennifer K., Penn State Univ, Huck Inst Life Sci, Dept Biomed Engn, University Pk, PA 16802 USA.
   Wagner, Jennifer K., Penn State Univ, Huck Inst Life Sci, Penn State Law, University Pk, PA 16802 USA.
   Wagner, Jennifer K., Penn State Univ, Rock Ethics Inst, Huck Inst Life Sci, University Pk, PA 16802 USA.
   Wagner, Jennifer K., Penn State Univ, Inst Computat \& Data Sci, University Pk, PA 16802 USA.
   Wagner, Jennifer K., Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA.
   Tanniru, Juhi K., Penn State Univ, University Pk, PA USA.
   Geisinger, Steele Inst Hlth Innovat, Ctr Translat Bioeth \& Hlth Care Policy, Danville, PA USA.
   Meyer, Michelle N., Geisinger, Ctr Translat Bioeth \& Hlth Care Policy, Danville, PA USA.
   Wagner, Jennifer K., Penn State Univ, Law Policy Engn, University Pk, PA USA.
   Tanniru, Juhi K., Penn State Univ majoring Econ, University Pk, PA USA.
   Chane, Courtney A., Penn State Univ, Bachelor Sci Psychol Neurosci, University Pk, PA USA.
   Meyer, Michelle N., Geisinger, Steele Inst Hlth Innovat, Ctr Translat Bioeth \& HealthCare Policy, Res Ethics, Danville, PA USA.
   Meyer, Michelle N., Geisinger, Steele Inst Hlth Innovat, Fac Codirector Behav Insights Team, Danville, PA USA.},
DOI = {10.1093/jlb/lsac034},
Article-Number = {lsac034},
Keywords = {Precision public health; Public Health Genomics; HIPAA; Public Health;
   Privacy; Genetic Testing},
Keywords-Plus = {OVARIAN-CANCER; CLINICAL EXOME; ETHICS; RECOMMENDATIONS; MEDICINE;
   GENETICS; GUIDELINES; STATEMENT; FRAMEWORK; SYSTEM},
Research-Areas = {Social Sciences - Other Topics; Government \& Law; Medical Ethics; Legal
   Medicine},
Web-of-Science-Categories  = {Ethics; Law; Medical Ethics; Medicine, Legal},
Author-Email = {jkw131@psu.edu
   jmt6550@psu.edu
   cac6524@psu.edu
   mmeyer@geisinger.edu},
Affiliations = {Pennsylvania Commonwealth System of Higher Education (PCSHE);
   Pennsylvania State University; Pennsylvania State University -
   University Park; Pennsylvania Commonwealth System of Higher Education
   (PCSHE); Pennsylvania State University; Pennsylvania State University -
   University Park; Pennsylvania Commonwealth System of Higher Education
   (PCSHE); Pennsylvania State University; Pennsylvania State University -
   University Park; Pennsylvania Commonwealth System of Higher Education
   (PCSHE); Pennsylvania State University; Pennsylvania State University -
   University Park; Pennsylvania Commonwealth System of Higher Education
   (PCSHE); Pennsylvania State University; Pennsylvania State University -
   University Park; Pennsylvania Commonwealth System of Higher Education
   (PCSHE); Pennsylvania State University; Pennsylvania State University -
   University Park; Pennsylvania Commonwealth System of Higher Education
   (PCSHE); Pennsylvania State University; Pennsylvania State University -
   University Park; Pennsylvania Commonwealth System of Higher Education
   (PCSHE); Pennsylvania State University; Pennsylvania State University -
   University Park; Pennsylvania Commonwealth System of Higher Education
   (PCSHE); Pennsylvania State University; Pennsylvania State University -
   University Park},
Cited-References = {Allen CG, 2021, PUBLIC HEALTH GENOM, V24, P67, DOI 10.1159/000512485.
   {[}Anonymous], 2013, Fed Regist, V78, P5565.
   {[}Anonymous], 2000, Fed Regist, V65, P82462.
   {[}Anonymous], SACHRP RECOMMENDATIO.
   {[}Anonymous], 1936, HLTH INFORM PORTABIL.
   {[}Anonymous], 1996, SAFER V ESTATE PACK.
   {[}Anonymous], GENETIC DISORDERS.
   {[}Anonymous], 2004, MOLLOY V MEIER C9 02.
   {[}Anonymous], 1994, Assessing genetic risks: Implications for health and social policy.
   {[}Anonymous], ANOTHER METHOD CHECK.
   {[}Anonymous], 2020, M SECR ADV COMM HUM.
   {[}Anonymous], GENETIC INFORM NONDI.
   {[}Anonymous], 2009, HLTH INFORM TECHNOLO.
   {[}Anonymous], GENETIC CONDITIONS.
   {[}Anonymous], 2004, HARV L REV, V118, P810.
   {[}Anonymous], 2013, BROOKLYN LAW REV.
   Auffray C, 2010, GENOME MED, V2, DOI 10.1186/gm178.
   Beskow L.M., 2001, Community Genet, V4, P2, DOI 10.1159/000051150.
   Buchbinder Mara, 2022, AJOB Empir Bioeth, V13, P205, DOI 10.1080/23294515.2022.2063997.
   cdc.gov, About us.
   Childress JF, 2002, J LAW MED ETHICS, V30, P170, DOI 10.1111/j.1748-720X.2002.tb00384.x.
   Clayton EW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204417.
   Costain G, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.18109.
   cste.org, US.
   Demsky R, 2013, GYNECOL ONCOL, V130, P329, DOI 10.1016/j.ygyno.2013.05.003.
   Department of Homeland Security, 2017, Fed Regist, V82, P7149.
   Dheensa S, 2016, GENET MED, V18, P290, DOI 10.1038/gim.2015.72.
   DHHS, 1999, FED REGISTER, V64, P918.
   DiNucci A, 2021, J PERS MED, V11, DOI 10.3390/jpm11060543.
   Doerr M, 2020, J LAW BIOSCI, V7, DOI 10.1093/jlb/lsaa028.
   Dugan RB, 2003, AM J MED GENET C, V119C, P27, DOI 10.1002/ajmg.c.10005.
   Duquette Debra, 2022, PERSONAL COMMUNICATI.
   Eccles DM, 2016, ADV THER, V33, P129, DOI 10.1007/s12325-016-0281-1.
   Garrison NA, 2019, AM J BIOETHICS, V19, P51, DOI 10.1080/15265161.2018.1544304.
   geisinger.org, US.
   Godard B, 2006, FAM CANCER, V5, P103, DOI 10.1007/s10689-005-2581-5.
   Gordon DR, 2022, NEW GENET SOC, V41, P23, DOI 10.1080/14636778.2021.2007065.
   Green J, 1997, J Genet Couns, V6, P45, DOI 10.1023/A:1025611818643.
   Green RC, 2013, GENET MED, V15, P565, DOI 10.1038/gim.2013.73.
   Haas CB, 2021, HEALTH POLICY TECHN, V10, DOI 10.1016/j.hlpt.2021.100511.
   Heck PR, 2019, MED CLIN N AM, V103, P1077, DOI 10.1016/j.mcna.2019.08.004.
   Henrikson NB, 2021, J LAW BIOSCI, V7, DOI 10.1093/jlb/lsaa071.
   HHS.gov, About us.
   Hood LA, 2008, PHYS BIOL ATOMS MED, P337, DOI DOI 10.1142/9781848162013\_0014.
   Hood L, 2012, NEW BIOTECHNOL, V29, P613, DOI 10.1016/j.nbt.2012.03.004.
   Hood L, 2011, NAT REV CLIN ONCOL, V8, P184, DOI 10.1038/nrclinonc.2010.227.
   Horwitz LI, 2019, NEW ENGL J MED, V381, P1175, DOI 10.1056/NEJMsb1900856.
   Institute of Medicine, 2015, GEN EN LEARN HLTH CA.
   Juengst E, 2016, HASTINGS CENT REP, V46, P21, DOI 10.1002/hast.614.
   Kalia SS, 2017, GENET MED, V19, P249, DOI 10.1038/gim.2016.190.
   Kass NE, 2001, AM J PUBLIC HEALTH, V91, P1776, DOI 10.2105/AJPH.91.11.1776.
   Khoury M.J., 2000, Genetics and Public Health in the 21st Century. Part I: Genetics and Public Health: An Overview.
   Khoury MJ, 2022, GENET MED, V24, P1630, DOI 10.1016/j.gim.2022.04.009.
   Khoury MJ, 2018, GENET MED, V20, P574, DOI 10.1038/gim.2017.211.
   Khoury MJ, 2016, AM J PREV MED, V50, P398, DOI 10.1016/j.amepre.2015.08.031.
   Khoury MJ, 2012, AM J PREV MED, V42, P639, DOI 10.1016/j.amepre.2012.02.012.
   Khoury MJ, 2011, GENET MED, V13, P206, DOI 10.1097/GIM.0b013e31821024ca.
   Klingler C, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4200-4.
   Knoppers BM, 1998, AM J HUM GENET, V62, P474.
   Kuntsman A, 2019, DIGIT HEALTH, V5, DOI 10.1177/2055207619880671.
   Ladabaum U, 2011, ANN INTERN MED, V155, P69, DOI 10.7326/0003-4819-155-2-201107190-00002.
   Lancaster JM, 2015, GYNECOL ONCOL, V138, P765, DOI 10.1016/j.ygyno.2015.06.007.
   Lancaster JM, 2015, GYNECOL ONCOL, V136, P3, DOI 10.1016/j.ygyno.2014.09.009.
   Lee LM, 2017, AM J BIOETHICS, V17, P5, DOI 10.1080/15265161.2017.1353164.
   Lee LM, 2012, AM J PUBLIC HEALTH, V102, P38, DOI 10.2105/AJPH.2011.300297.
   Mcgee J, 2017, INT J GYNECOL CANCER, V27, P437, DOI 10.1097/IGC.0000000000000907.
   Metcalfe KA, 2009, GYNECOL ONCOL, V112, P68, DOI 10.1016/j.ygyno.2008.10.007.
   Miller DT, 2021, GENET MED, V23, P1391, DOI 10.1038/s41436-021-01171-4.
   NCCN Clinical practice guidelines in oncology, 2018, GEN FAM HIGH RISK AS.
   Office for Civil Rights, 2009, HIPAA PRIV RUL MAY H.
   Office for Civil Rights H. H. S, 2002, Final Rule Federal Register, V67, P53181.
   Phillips A, 2021, GENET MED, V23, P2038, DOI 10.1038/s41436-021-01248-0.
   President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Biobehavioral Research, 1998, SCREEN COUNS GEN CON.
   Samimi G, 2017, J CLIN ONCOL, V35, P2329, DOI 10.1200/JCO.2016.70.3439.
   Schmidlen T, 2022, J GENET COUNS, V31, P1219, DOI 10.1002/jgc4.1592.
   Simmons-Duffin Selena, 2021, NPR.
   St Pierre J, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130267.
   Swain GR, 2008, J PUBLIC HEALTH MAN, V14, P354, DOI 10.1097/01.PHH.0000324563.87780.67.
   Taylor L, 2017, BIG DATA SOC, V4, DOI 10.1177/2053951717736335.
   U.S. Dept. of Health and Human Services, 2002, DOES HIPAA PRIV RUL.
   U.S. Dept. of Health and Human Services Office of Human Research Protections, ACT DEEM NOT RES PUB.
   van Dijck J, 2014, SURVEILL SOC, V12, P197, DOI 10.24908/ss.v12i2.4776.
   Vergote I, 2016, EUR J CANCER, V69, P127, DOI 10.1016/j.ejca.2016.10.006.
   Weller S, 2022, SOC SCI MED, V297, DOI 10.1016/j.socscimed.2022.114806.
   Weston AD, 2004, J PROTEOME RES, V3, P179, DOI 10.1021/pr0499693.
   whitehouse.gov, STATEMENTS RELEASES.
   whitehouse.gov, CANCERMOONSHOT.
   whitehouse.gov, About us.
   Williams MS, 2022, ANNU REV GENOM HUM G, V23, P549, DOI 10.1146/annurev-genom-111221-115239.
   Williams MS, 2018, HEALTH AFFAIR, V37, P757, DOI 10.1377/hlthaff.2017.1557.
   Yang YT, 2018, AM J MANAG CARE, V24, P356.},
Number-of-Cited-References = {91},
Times-Cited = {0},
Unique-ID = {WOS:000896747900001},
}

@article{ WOS:000374860100001,
Author = {Southey, Melissa C. and Winship, Ingrid and Tu Nguyen-Dumont},
Title = {PALB2: research reaching to clinical outcomes for women with breast
   cancer},
Journal = {HEREDITARY CANCER IN CLINICAL PRACTICE},
Year = {2016},
Volume = {14},
Month = {APR 19},
Abstract = {PALB2 has taken its place with bona fide breast cancer susceptibility
   genes. It is now well established that women who carry loss-of-function
   mutations in the PALB2 gene are at similarly elevated breast cancer
   risks to those who carry mutations in BRCA2. Information about PALB2 is
   now being used in breast cancer clinical genetics practice and is
   routinely included in breast cancer predisposition gene panel tests.
   Tens of thousands of women worldwide have now had genetic tests for
   PALB2 mutations in the context of breast cancer susceptibility. However,
   prospective data related to the clinical outcomes of PALB2 mutation
   carriers is lacking and very little information (beyond mutation
   penetrance) is available to guide current clinical management for
   carriers (affected and unaffected by cancer). In addition, clinical
   classification of the vast array of non-loss-of-function genetic
   variants identified in PALB2 is in its infancy. These are key areas of
   current research efforts and are important foundations on which to move
   information about PALB2 into the precision public health arena.},
Type = {Review},
Affiliation = {Southey, MC (Corresponding Author), Univ Melbourne, Genet Epidemiol Lab, Dept Pathol, Parkville, Vic 3010, Australia.
   Southey, Melissa C.; Tu Nguyen-Dumont, Univ Melbourne, Genet Epidemiol Lab, Dept Pathol, Parkville, Vic 3010, Australia.
   Winship, Ingrid, Univ Melbourne, Dept Med, Parkville, Vic 3010, Australia.
   Winship, Ingrid, Royal Melbourne Hosp, Parkville, Vic 3050, Australia.},
DOI = {10.1186/s13053-016-0049-2},
Article-Number = {9},
Keywords = {PALB2; Breast cancer susceptibility; Cancer susceptibility; Familial
   cancer},
Keywords-Plus = {BRCA2-INTERACTING PROTEIN PALB2; MISSENSE SUBSTITUTIONS;
   FUNCTIONAL-ANALYSIS; GERMLINE MUTATIONS; PANCREATIC-CANCER; BRCA2
   MUTATIONS; FAMILY-HISTORY; RISK; HEREDITARY; VARIANTS},
Research-Areas = {Oncology},
Web-of-Science-Categories  = {Oncology},
Author-Email = {msouthey@unimelb.edu.au},
Affiliations = {University of Melbourne; University of Melbourne; Royal Melbourne
   Hospital},
Cited-References = {Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033.
   Antoniou AC, 2014, NEW ENGL J MED, V371, P1651, DOI {[}10.1056/NEJMc1410673, 10.1056/NEJMoa1400382, 10.1056/NEJMc1410673\#SA1].
   Casadei S, 2011, CANCER RES, V71, P2222, DOI 10.1158/0008-5472.CAN-10-3958.
   Cybulski C, 2015, LANCET ONCOL, V16, P638, DOI 10.1016/S1470-2045(15)70142-7.
   Cybulski C, 2015, NAT GENET, V47, P643, DOI 10.1038/ng.3284.
   Dansonka-Mieszkowska A, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-20.
   Desmond A, 2015, JAMA ONCOL, V1, P943, DOI 10.1001/jamaoncol.2015.2690.
   Easton DF, 2015, NEW ENGL J MED, V372, P2243, DOI 10.1056/NEJMsr1501341.
   Erkko H, 2008, CLIN CANCER RES, V14, P4667, DOI 10.1158/1078-0432.CCR-08-0210.
   Erkko H, 2007, NATURE, V446, P316, DOI 10.1038/nature05609.
   Foulkes WD, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1828.
   Ghiorzo P, 2012, FAM CANCER, V11, P41, DOI 10.1007/s10689-011-9483-5.
   Guidugli L, 2013, CANCER RES, V73, P265, DOI 10.1158/0008-5472.CAN-12-2081.
   Harinck F, 2012, EUR J HUM GENET, V20, P577, DOI 10.1038/ejhg.2011.226.
   Heikkinen T, 2009, CLIN CANCER RES, V15, P3214, DOI 10.1158/1078-0432.CCR-08-3128.
   Hofstatter EW, 2011, FAM CANCER, V10, P225, DOI 10.1007/s10689-011-9426-1.
   Jhuraney A, 2015, J MED GENET, V52, P224, DOI 10.1136/jmedgenet-2014-102766.
   Keogh LA, 2004, CANCER EPIDEM BIOMAR, V13, P2258.
   Kurian AW, 2014, J CLIN ONCOL, V32, P2001, DOI 10.1200/JCO.2013.53.6607.
   Le Calvez-Kelm F, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2810.
   Lovelock PK, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1826.
   Mantere T, 2015, CLIN GENET, V88, P68, DOI 10.1111/cge.12447.
   Meeks HD, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv315.
   Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563.
   Millot GA, 2012, HUM MUTAT, V33, P1526, DOI 10.1002/humu.22150.
   Nguyen-Dumont T, 2015, AIMS GENET, V2, P281, DOI 10.3934/genet.2015.4.281.
   Norquist BM, 2016, JAMA ONCOL, V2, P482, DOI 10.1001/jamaoncol.2015.5495.
   Pakkanen S, 2009, J NEGAT RESULTS BIOM, V8, DOI 10.1186/1477-5751-8-12.
   Park JY, 2014, ONCOGENE, V33, P4803, DOI 10.1038/onc.2013.421.
   Peterlongo P, 2015, HUM MOL GENET, V24, P5345, DOI 10.1093/hmg/ddv251.
   Peterlongo P, 2011, BREAST CANCER RES TR, V126, P825, DOI 10.1007/s10549-010-1305-1.
   Quiles F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061302.
   Rahman N, 2007, NAT GENET, V39, P165, DOI 10.1038/ng1959.
   Ramus SJ, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv214.
   Salo-Mullen EE, 2015, CANCER-AM CANCER SOC, V121, P4382, DOI 10.1002/cncr.29664.
   Scott CL, 2003, HUM GENET, V112, P542, DOI 10.1007/s00439-003-0908-6.
   Slater EP, 2010, CLIN GENET, V78, P490, DOI 10.1111/j.1399-0004.2010.01425.x.
   Southey MC, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3434.
   Southey MC, 2013, APPL CLIN GENET, V6, P43, DOI 10.2147/TACG.S34116.
   Southey MC, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2796.
   Spurdle AB, 2012, J MED GENET, V49, P525, DOI 10.1136/jmedgenet-2012-101037.
   Spurdle AB, 2012, HUM MUTAT, V33, P2, DOI 10.1002/humu.21628.
   Tavtigian SV, 2014, BIOMARK MED, V8, P589, DOI 10.2217/bmm.13.143.
   Tavtigian SV, 2009, AM J HUM GENET, V85, P427, DOI 10.1016/j.ajhg.2009.08.018.
   Teo ZL, 2013, BRIT J CANCER, V109, P154, DOI 10.1038/bjc.2013.295.
   Teo ZL, 2013, FAM CANCER, V12, P587, DOI 10.1007/s10689-013-9620-4.
   Teo ZL, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3392.
   Thompson ER, 2016, J CLIN ONCOL, V34, P1455, DOI 10.1200/JCO.2015.63.7454.
   Tischkowitz M, 2008, PROSTATE, V68, P675, DOI 10.1002/pros.20729.
   Tischkowitz M, 2012, HUM MUTAT, V33, P674, DOI 10.1002/humu.22022.
   Tischkowitz M, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-257.
   Tischkowitz MD, 2009, GASTROENTEROLOGY, V137, P1183, DOI 10.1053/j.gastro.2009.06.055.
   Vietri MT, 2015, ONCOL REP, V33, P1243, DOI 10.3892/or.2014.3685.
   Waddell N, 2015, NATURE, V518, P495, DOI 10.1038/nature14169.
   Zentner D, 2015, MED J AUSTRALIA, V203, DOI 10.5694/mja14.01674.},
Number-of-Cited-References = {55},
Times-Cited = {23},
Unique-ID = {WOS:000374860100001},
}

@article{ WOS:000548854700011,
Author = {Pearson, Thomas A. and Califf, Robert M. and Roper, Rebecca and
   Engelgau, Michael M. and Khoury, Muin J. and Alcantara, Carmela and
   Blakely, Craig and Boyce, Cheryl Anne and Brown, Marishka and Croxton,
   Thomas L. and Fenton, Kathleen and Parker, Melissa C. Green and
   Hamilton, Andrew and Helmchen, Lorens and Hsu, Lucy L. and Kent, David
   M. and Kind, Amy and Kravitz, John and Papanicolaou, George John and
   Prosperi, Mattia and Quinn, Matt and Price, LeShawndra N. and Shireman,
   Paula K. and Smith, Sharon M. and Szczesniak, Rhonda and Goff, Jr.,
   David Calvin and Mensah, George A.},
Title = {Precision Health Analytics With Predictive Analytics and Implementation
   Research <i>JACC</i> State-of-the-Art Review},
Journal = {JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY},
Year = {2020},
Volume = {76},
Number = {3},
Pages = {306-320},
Month = {JUL 21},
Abstract = {Emerging data science techniques of predictive analytics expand the
   quality and quantity of complex data relevant to human health and
   provide opportunities for understanding and control of conditions such
   as heart, lung, blood, and sleep disorders. To realize these
   opportunities, the information sources, the data science tools that use
   the information, and the application of resulting analytics to health
   and health care issues will require implementation research methods to
   define benefits, harms, reach, and sustainability; and to understand
   related resource utilization implications to inform policymakers. This
   JACC State-of-the-Art Review is based on a workshop convened by the
   National Heart, Lung, and Blood Institute to explore predictive
   analytics in the context of implementation science. It highlights
   precision medicine and precision public health as complementary and
   compelling applications of predictive analytics, and addresses future
   research and training endeavors that might further foster the
   application of predictive analytics in clinical medicine and public
   health. (c) 2020 the American College of Cardiology Foundation.
   Published by Elsevier. All rights reserved.},
Type = {Review},
Affiliation = {Pearson, TA (Corresponding Author), Univ Florida, Hlth Sci Ctr, Coll Med, Gainesville, FL 32610 USA.
   Pearson, TA (Corresponding Author), Univ Florida, Hlth Sci Ctr, Coll Publ Hlth \& Hlth Profess, Gainesville, FL 32610 USA.
   Mensah, GA (Corresponding Author), NHLBI, Ctr Translat Res \& Implementat Sci, NIH, Bldg 10, Bethesda, MD 20892 USA.
   Pearson, Thomas A.; Prosperi, Mattia, Univ Florida, Hlth Sci Ctr, Coll Med, Gainesville, FL 32610 USA.
   Pearson, Thomas A.; Prosperi, Mattia, Univ Florida, Hlth Sci Ctr, Coll Publ Hlth \& Hlth Profess, Gainesville, FL 32610 USA.
   Califf, Robert M., Duke Univ, Sch Med, Durham, NC USA.
   Califf, Robert M., Duke Univ, Duke Clin Res Inst, Durham, NC USA.
   Roper, Rebecca; Engelgau, Michael M.; Boyce, Cheryl Anne; Fenton, Kathleen; Parker, Melissa C. Green; Price, LeShawndra N.; Mensah, George A., NHLBI, Ctr Translat Res \& Implementat Sci, NIH, Bldg 10, Bethesda, MD 20892 USA.
   Khoury, Muin J., Ctr Dis Control \& Prevent, Off Genom \& Precis Publ Hlth, Atlanta, GA USA.
   Alcantara, Carmela, Columbia Univ, Sch Social Work, New York, NY USA.
   Blakely, Craig, Univ Louisville, Sch Publ Hlth \& Informat Sci, Louisville, KY 40292 USA.
   Brown, Marishka; Croxton, Thomas L., NHLBI, Div Lung Dis, NIH, Bldg 10, Bethesda, MD 20892 USA.
   Hamilton, Andrew, AllianceChicago, Chicago, IL USA.
   Helmchen, Lorens, George Washington Univ, Milken Inst Sch Publ Hlth, Hlth Policy \& Management, Washington, DC USA.
   Hsu, Lucy L.; Papanicolaou, George John; Goff, David Calvin, Jr., NHLBI, Div Cardiovasc Sci, NIH, Bldg 10, Bethesda, MD 20892 USA.
   Kent, David M., Tufts Univ, Tufts Med Ctr, Sackler Sch Grad Biomed Sci, Predict Analyt \& Comparat Effectiveness PACE Ctr, Boston, MA 02111 USA.
   Kind, Amy, Univ Wisconsin, Dept Med, Hlth Serv \& Care Res Program, Sch Med \& Publ Hlth, Madison, WI USA.
   Kravitz, John, Geisinger Hlth Syst, Danville, PA USA.
   Quinn, Matt, Hlth Technol Telemed \& Adv Technol Res Ctr, Frederick, MD USA.
   Shireman, Paula K., Univ Texas Hlth Sci Ctr San Antonio, Sch Med, San Antonio, TX 78229 USA.
   Shireman, Paula K., South Texas Vet Hlth Care Syst, San Antonio, TX 78229 USA.
   Smith, Sharon M., NHLBI, Div Blood Dis \& Resources, NIH, Bldg 10, Bethesda, MD 20892 USA.
   Szczesniak, Rhonda, Univ Cincinnati, Dept Pediat, Cincinnati Childrens Hosp, Div Biostat \& Epidemiol,Div Pulm Med, Cincinnati, OH USA.},
DOI = {10.1016/j.jacc.2020.05.043},
Keywords = {exposome; genome; implementation research; predictive analytics; social
   determinants},
Keywords-Plus = {ENVIRONMENT-WIDE ASSOCIATION; US COUNTIES; OPPORTUNITIES; MORTALITY;
   FRAILTY; TRENDS; LUNG; GENOMICS; SCIENCE; SURGERY},
Research-Areas = {Cardiovascular System \& Cardiology},
Web-of-Science-Categories  = {Cardiac \& Cardiovascular Systems},
Author-Email = {tapearson@ufl.edu
   george.mensah@nih.gov},
Affiliations = {State University System of Florida; University of Florida; State
   University System of Florida; University of Florida; Duke University;
   Duke University; National Institutes of Health (NIH) - USA; NIH National
   Heart Lung \& Blood Institute (NHLBI); Centers for Disease Control \&
   Prevention - USA; Columbia University; University of Louisville;
   National Institutes of Health (NIH) - USA; NIH National Heart Lung \&
   Blood Institute (NHLBI); George Washington University; National
   Institutes of Health (NIH) - USA; NIH National Heart Lung \& Blood
   Institute (NHLBI); Tufts University; Tufts Medical Center; University of
   Wisconsin System; University of Wisconsin Madison; Geisinger Health
   System; University of Texas System; University of Texas Health Science
   Center at San Antonio; US Department of Veterans Affairs; Veterans
   Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital;
   National Institutes of Health (NIH) - USA; NIH National Heart Lung \&
   Blood Institute (NHLBI); University System of Ohio; University of
   Cincinnati; Cincinnati Children's Hospital Medical Center},
Cited-References = {{[}Anonymous], 2016, CHART FUT TOG NHLBI.
   Arya S, 2019, ANN SURG.
   Arya S, 2016, ANN VASC SURG, V35, P19, DOI 10.1016/j.avsg.2016.01.052.
   Califf RM, 2018, BEHAV SCI POLICY, V4, P27.
   Califf RM, 2018, J AM COLL CARDIOL, V72, P3301, DOI 10.1016/j.jacc.2018.09.079.
   Chan WV, 2017, J AM COLL CARDIOL, V69, P1076, DOI 10.1016/j.jacc.2016.11.004.
   Chowkwanyun M, 2018, NEW ENGL J MED, V379, P1398, DOI 10.1056/NEJMp1806634.
   Collins FS, 2014, J AM MED INFORM ASSN, V21, P576, DOI 10.1136/amiajnl-2014-002864.
   Collins FS, 2015, TWEET.
   Dwyer-Lindgren L, 2017, JAMA INTERN MED, V177, P1003, DOI 10.1001/jamainternmed.2017.0918.
   Feero WG, 2018, JAMA-J AM MED ASSOC, V319, P1979, DOI 10.1001/jama.2018.2925.
   Goff DC, 2019, CIRC RES, V124, P491, DOI 10.1161/CIRCRESAHA.118.314338.
   Hu JH, 2018, AM J MED QUAL, V33, P493, DOI 10.1177/1062860617753063.
   Khoury MJ, 2018, GENET MED, V20, P574, DOI 10.1038/gim.2017.211.
   Khoury MJ, 2016, AM J PREV MED, V50, P398, DOI 10.1016/j.amepre.2015.08.031.
   Kind AJH, 2018, NEW ENGL J MED, V378, P2456, DOI 10.1056/NEJMp1802313.
   Kindig DA, 2013, HEALTH AFFAIR, V32, P451, DOI 10.1377/hlthaff.2011.0892.
   Kohane IS, 2015, SCIENCE, V349, P37, DOI 10.1126/science.aab1328.
   Maddox KEJ, 2019, HEALTH SERV RES, V54, P327, DOI 10.1111/1475-6773.13133.
   McIsaac DI, 2016, JAMA SURG, V151, P538, DOI 10.1001/jamasurg.2015.5085.
   Mensah GA, 2019, ETHNIC DIS, V29, P57, DOI 10.18865/ed.29.S1.57.
   Meyer S, PRECISION PUBLIC HLT.
   Murray CJL, 2006, PLOS MED, V3, P1513, DOI 10.1371/journal.pmed.0030260.
   Patel CJ, 2014, JAMA-J AM MED ASSOC, V311, P2173, DOI 10.1001/jama.2014.4129.
   Pearson TA, 2008, JAMA-J AM MED ASSOC, V299, P1335, DOI 10.1001/jama.299.11.1335.
   Prosperi M, 2018, BMC MED INFORM DECIS, V18, DOI 10.1186/s12911-018-0719-2.
   Psaty BM, 2018, JAMA-J AM MED ASSOC, V320, P751, DOI 10.1001/jama.2018.8377.
   Record NB, 2015, JAMA-J AM MED ASSOC, V313, P147, DOI 10.1001/jama.2014.16969.
   Revening LM, 2013, J AM COLL SURGEONS, V217.
   Roberts MC, 2017, GENET MED, V19, P858, DOI 10.1038/gim.2016.210.
   Robinson TN, 2013, AM J SURG, V206, P544, DOI 10.1016/j.amjsurg.2013.03.012.
   Roth GA, 2017, JAMA-J AM MED ASSOC, V317, P1976, DOI 10.1001/jama.2017.4150.
   Schroeder SA, 2007, NEW ENGL J MED, V357, P1221, DOI 10.1056/NEJMsa073350.
   Schwab K., 2017, 4 IND REVOLUTION WHA.
   Shah ND, 2018, JAMA-J AM MED ASSOC, V320, P27, DOI 10.1001/jama.2018.5602.
   Steckling N, 2018, ENVIRON RES, V164, P597, DOI 10.1016/j.envres.2018.02.041.
   Stein EM, 2017, AM J PUBLIC HEALTH, V107, P1541, DOI {[}10.2105/ajph.2017.303941, 10.2105/AJPH.2017.303941].
   Szczesniak RD, 2018, IEEE J TRANSL ENG HL.
   Szczesniak RD, 2019, IEEE J TRANSL ENG HE, V7, DOI 10.1109/JTEHM.2018.2878534.
   Szczesniak RD, 2017, AM J RESP CRIT CARE, V196, P471, DOI 10.1164/rccm.201612-2574OC.
   Szczesniak RD, 2013, ANN EPIDEMIOL, V23, P771, DOI 10.1016/j.annepidem.2013.08.009.
   U.S. Census Bureau, AM COMM SURV DES MET.
   West KM, 2017, JAMA-J AM MED ASSOC, V317, P1831, DOI 10.1001/jama.2017.3096.
   Zheng Y, 2020, ENVIRON RES, V183, DOI 10.1016/j.envres.2020.109275.},
Number-of-Cited-References = {44},
Times-Cited = {18},
Unique-ID = {WOS:000548854700011},
}

@article{ WOS:000576844500001,
Author = {Hay, Georgia J. and Klonek, Florian E. and Thomas, Cati S. and Bauskis,
   Alicia and Baynam, Gareth and Parker, Sharon K.},
Title = {SMART Work Design: Accelerating the Diagnosis of Rare Diseases in the
   Western Australian Undiagnosed Diseases Program},
Journal = {FRONTIERS IN PEDIATRICS},
Year = {2020},
Volume = {8},
Month = {SEP 18},
Abstract = {The accurate and efficient diagnosis of rare diseases, many of which
   include congenital anomalies, depends largely on the specialists who
   diagnose them - including their ability to work alongside specialists
   from other fields and to take full advantage of cutting-edge precision
   medicine technologies and precision public health approaches. However,
   highly specialized clinicians operating within a historically-siloed
   healthcare system is antithetical to the multi-disciplinary,
   collaborative, and creative approach that facilitates the diagnosis of
   rare diseases. The Western Australian Undiagnosed Diseases Program
   (UDP-WA) successfully re-designed the work of the involved clinicians to
   facilitate teamworking across silos. To understand the effectiveness of
   the Western Australian program, we draw on a SMART work design
   perspective (i.e., work that involves Stimulation, Mastery, Agency,
   Relations, and Tolerable demands). We propose that the redesign was
   successful in part because it improved crucial psychosocial work
   characteristics that are less prevalent in the broader work system, as
   identified in the SMART model. Based on the effectiveness of UDP-WA and
   its SMART design, we provide a framework that clinicians, healthcare
   managers, and policymakers can consider when they re-design work so that
   they can create SMART jobs within healthcare.},
Type = {Article},
Affiliation = {Hay, GJ (Corresponding Author), Curtin Univ, Future Work Inst, Ctr Transformat Work Design, Grad Sch Business, Perth, WA, Australia.
   Hay, GJ (Corresponding Author), Univ Western Australia, Sch Business, Perth, WA, Australia.
   Hay, Georgia J.; Klonek, Florian E.; Thomas, Cati S.; Parker, Sharon K., Curtin Univ, Future Work Inst, Ctr Transformat Work Design, Grad Sch Business, Perth, WA, Australia.
   Hay, Georgia J., Univ Western Australia, Sch Business, Perth, WA, Australia.
   Bauskis, Alicia, Govt Western Australia, Dept Hlth, Off Populat Hlth Genom, Perth, WA, Australia.
   Baynam, Gareth, Govt Western Australia, Dept Hlth, Genet Serv Western Australia, Perth, WA, Australia.
   Baynam, Gareth, Govt Western Australia, Dept Hlth, Western Australian Register Dev Anomalies, Perth, WA, Australia.
   Baynam, Gareth, Univ Western Australia, Fac Hlth \& Med, Div Pediat, Perth, WA, Australia.
   Baynam, Gareth, Univ Western Australia, Telethon Kids Inst, Perth, WA, Australia.
   Baynam, Gareth, Univ Notre Dame, Fac Med, Fremantle, WA, Australia.
   Baynam, Gareth, Curtin Univ, Fac Sci \& Engn, Spatial Sci, Perth, WA, Australia.},
DOI = {10.3389/fped.2020.00582},
Article-Number = {582},
Keywords = {rare disease (RD); diagnos{*}; work redesign; teamwork; congenital
   abnomarlities; genomics},
Keywords-Plus = {HEALTH; IMPACT; CARE},
Research-Areas = {Pediatrics},
Web-of-Science-Categories  = {Pediatrics},
Author-Email = {georgia.hay@curtin.edu.au},
Affiliations = {Curtin University; University of Western Australia; University of
   Western Australia; University of Western Australia; Telethon Kids
   Institute; The University of Notre Dame Australia; Curtin University},
Cited-References = {{[}Anonymous], 2017, FAQS RAR DIS.
   Auvin S, 2019, ORPHANET J RARE DIS, V14, DOI 10.1186/s13023-019-1072-y.
   Ayme S, 2014, REPORT STATE ART RAR.
   Baynam G, 2017, ORPHANET J RARE DIS, V12, DOI 10.1186/s13023-017-0619-z.
   Baynam G, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0462-7.
   Centre for Transformative Work Design, 2020, WHAT IS SMART WORK D.
   Gurses AP, 2009, HEALTH SERV RES, V44, P422, DOI 10.1111/j.1475-6773.2008.00934.x.
   Haendel M, 2020, NAT REV DRUG DISCOV, V19, P77, DOI 10.1038/d41573-019-00180-y.
   Hay GJ, 2020, APPL ERGON, V86, DOI 10.1016/j.apergo.2020.103095.
   Holden RJ, 2013, ERGONOMICS, V56, P1669, DOI 10.1080/00140139.2013.838643.
   Kaplan R. S, 2011, HARVARD BUSINESS REV.
   Klonek FE, 2020, SMALL GR RES, V51, P303, DOI 10.1177/1046496420904126.
   Kothur K, 2018, SEIZURE-EUR J EPILEP, V59, P132, DOI 10.1016/j.seizure.2018.05.005.
   Meneses R, 2018, 11 ANN C EUR AC BUS.
   Molster C, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0409-z.
   Orphanet, 2020, PREV INC RAR DIS BIB.
   Parker SK, 2017, J APPL PSYCHOL, V102, P403, DOI 10.1037/apl0000106.
   Parker SK, 2014, ANNU REV PSYCHOL, V65, P661, DOI 10.1146/annurev-psych-010213-115208.
   Rare Disease UK, 2018, WHAT IS RAR DIS.
   Spillmann RC, 2017, ORPHANET J RARE DIS, V12, DOI 10.1186/s13023-017-0623-3.
   Stark Z, 2019, GENET MED, V21, P173, DOI 10.1038/s41436-018-0006-8.
   Wakap SN, 2020, EUR J HUM GENET, V28, P165, DOI 10.1038/s41431-019-0508-0.
   Walker CE, 2017, GENET MED, V19, P546, DOI 10.1038/gim.2016.143.},
Number-of-Cited-References = {23},
Times-Cited = {3},
Unique-ID = {WOS:000576844500001},
}

@article{ WOS:000477832700001,
Author = {Nellaker, Christoffer and Alkuraya, Fowzan S. and Baynam, Gareth and
   Bernier, Raphael A. and Bernier, Francois P. J. and Boulangerw, Vanessa
   and Brudno, Michael and Brunner, Han G. and Clayton-Smith, Jill and
   Cogne, Benjamin and Dawkins, Hugh J. S. and deVries, Bert B. A. and
   Douzgou, Sofia and Dudding-Byth, Tracy and Eichler, Evan E. and
   Ferlaino, Michael and Fieggen, Karen and Firth, V, Helen and
   FitzPatrick, David R. and Gration, Dylan and Groza, Tudor and Haende,
   Melissa and Hallowel, Nina and Hamosh, Ada and Hehir-Kwa, Jayne and
   Hitz, Marc-Phillip and Hughes, Mark and Kini, Usha and Kleefstra,
   Tjitske and Kooy, R. Frank and Krawitz, Peter and Kury, Sebastien and
   Lees, Melissa and Lyon, Gholson J. and Lyonnet, Stanislas and Marcadier,
   Julien L. and Meyn, Stephen and Moslerova, Veronika and Politei, Juan M.
   and Poulton, Cathryn C. and Raymond, F. Lucy and Reijnders, Margot R. F.
   and Robinson, Peter N. and Romano, Corrado and Rose, Catherine M. and
   Sainsbury, David C. G. and Schofield, Lyn and Sutton, Vernon R. and
   Tumovec, Marek and Van Dijck, Anke and Van Esch, Hilde and Witkie,
   Andrew O. M. and Minerva Consortium},
Title = {Enabling Global Clinical Collaborations on Identifiable Patient Data:
   The Minerva Initiative},
Journal = {FRONTIERS IN GENETICS},
Year = {2019},
Volume = {10},
Month = {JUL 29},
Abstract = {The clinical utility of computational phenotyping for both genetic and
   rare diseases is increasingly appreciated; however, its true potential
   is yet to be fully realized. Alongside the growing clinical and research
   availability of sequencing technologies, precise deep and scalable
   phenotyping is required to serve unmet need in genetic and rare
   diseases. To improve the lives of individuals affected with rare
   diseases through deep phenotyping, global big data interrogation is
   necessary to aid our understanding of disease biology, assist diagnosis,
   and develop targeted treatment strategies. This includes the application
   of cutting-edge machine learning methods to image data. As with most
   digital tools employed in health care, there are ethical and data
   governance challenges associated with using identifiable personal image
   data. There are also risks with failing to deliver on the patient
   benefits of these new technologies, the biggest of which is posed by
   data siloing. The Minerva Initiative has been designed to enable the
   public good of deep phenotyping while mitigating these ethical risks.
   Its open structure, enabling collaboration and data sharing between
   individuals, clinicians, researchers and private enterprise, is key for
   delivering precision public health.},
Type = {Article},
Affiliation = {Nellåker, C (Corresponding Author), Univ Oxford, Nuffield Dept Womens \& Reprod Hlth, Oxford, England.
   Nellåker, C (Corresponding Author), Univ Oxford, Big Data Inst, Oxford, England.
   Nellåker, C (Corresponding Author), Univ Oxford, Inst Biomed Engn, Oxford, England.
   Nellaker, Christoffer; Ferlaino, Michael, Univ Oxford, Nuffield Dept Womens \& Reprod Hlth, Oxford, England.
   Nellaker, Christoffer; Ferlaino, Michael; Hallowel, Nina, Univ Oxford, Big Data Inst, Oxford, England.
   Nellaker, Christoffer, Univ Oxford, Inst Biomed Engn, Oxford, England.
   Alkuraya, Fowzan S., King Faisal Specialist Hosp \& Res Ctr, Dept Genet, Riyadh, Saudi Arabia.
   Baynam, Gareth, King Edward Mem, Western Australian Register Dev Anomalies \& Genet, Subiaco, WA, Australia.
   Baynam, Gareth, Univ Western Australia, Telethon Kids Inst, Perth, WA, Australia.
   Baynam, Gareth, Univ Western Australia, Sch Paediat \& Child Hlth, Perth, WA, Australia.
   Baynam, Gareth, Curtin Univ, Spatial Sci Sci \& Engn, Perth, WA, Australia.
   Bernier, Raphael A., Univ Washington, Sch Med, Dept Psychiat \& Behav Sci, Seattle, WA 98195 USA.
   Bernier, Francois P. J.; Marcadier, Julien L., Alberta Childrens Hosp Res Inst, Calgary, AB, Canada.
   Boulangerw, Vanessa, Natl Org Rare Disorders, Danbury, CT USA.
   Brudno, Michael; Meyn, Stephen, Univ Toronto, Dept Comp Sci, Toronto, ON, Canada.
   Brudno, Michael; Meyn, Stephen, Hosp Sick Children, Toronto, ON, Canada.
   Brunner, Han G.; deVries, Bert B. A.; Kleefstra, Tjitske, Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, Nijmegen, Netherlands.
   Clayton-Smith, Jill; Douzgou, Sofia, Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Ctr Genom Med, Manchester, Lancs, England.
   Cogne, Benjamin; Kury, Sebastien, CHU Nantes, Serv Genet Med, Nantes, France.
   Dawkins, Hugh J. S., Off Populat Hlth Genom, Pub \& Aboriginal Hlth Div, Dept Hlth Govt Western Australia, Perth, WA, Australia.
   Dawkins, Hugh J. S., Murdoch Univ, Sir Walter Murdoch Sch Policy \& Int Affairs, Perth, WA, Australia.
   Dawkins, Hugh J. S., Curtin Univ Technol, Ctr Populat Hlth Res, Perth, WA, Australia.
   Dudding-Byth, Tracy, Hunter Genet, Waratah, NSW, Australia.
   Eichler, Evan E., Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA.
   Eichler, Evan E., Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA.
   Fieggen, Karen, Univ Cape Town, Fac Hlth Sci, Inst Infect Dis \& Mol Med, Wernher \& Beit North,Div Human Genet, Level 3, Observatory, South Africa.
   Firth, Helen, V, Welcome Trust Sanger Inst, Cambridge, England.
   FitzPatrick, David R., Univ Edinburgh, Western Gen Hosp, IGMM, MRC Human Genet Unit, Edinburgh, Midlothian, Scotland.
   Gration, Dylan; Schofield, Lyn, King Edward Mem Hosp, Genet Serv Western Australia, Subiaco, WA, Australia.
   Groza, Tudor, Garvan Inst, Sydney, NSW, Australia.
   Haende, Melissa, Oregon Hlth \& Sci Univ, Portland, OR 97201 USA.
   Hallowel, Nina, Univ Oxford, Wellcome Ctr Eth \& Humanities, Oxford, England.
   Hallowel, Nina, Univ Oxford, Nuffield Dept Populat Hlth, Ethox Ctr, Oxford, England.
   Hamosh, Ada, Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Baltimore, MD USA.
   Hehir-Kwa, Jayne, Princess Maxima Ctr Pediat Oncol, Utrecht, Netherlands.
   Hitz, Marc-Phillip, Univ Hosp Schleswig Holstein, Dept Congenital Heart Dis \& Pediat Cardiol, Campus Kiel, Kiel, Germany.
   Hughes, Mark, Western Gen Hosp, Dept Clin Neurosci, Edinburgh, Midlothian, Scotland.
   Kini, Usha, Oxford Ctr Genom Med, Oxford, England.
   Kooy, R. Frank; Van Dijck, Anke, Univ Antwerp, Dept Med Genet, Antwerp, Belgium.
   Krawitz, Peter, Rheinische Friedrich Wilhelms Univ, Univ Kinikum Bonn, Inst Genom Stat \& Bioinformat, Bonn, Germany.
   Lees, Melissa, Great Ormond St Hosp Sick Children, Children NHS Fdn Trust, London, England.
   Lyon, Gholson J., George A Jervis Clin, Staten Isl, NY USA.
   Lyon, Gholson J., Inst Basic Res Dev Disabil IBR, Staten Isl, NY USA.
   Lyonnet, Stanislas, Imagine Inst, Paris, France.
   Moslerova, Veronika; Tumovec, Marek, Charles Univ Prague, Fac Med 2, Dept Biol \& Med Genet, Prague, Czech Republic.
   Moslerova, Veronika; Tumovec, Marek, Univ Hosp, Prague, Czech Republic.
   Politei, Juan M., Entres Congenitos Metab, Lab Chamoles, Buenos Aires, DF, Argentina.
   Poulton, Cathryn C., Fiona Stanley Hosp, Dept Paediat \& Neonates, Perth, WA, Australia.
   Raymond, F. Lucy, CIMR Welcome Trust, MRC Bldg, Cambridge, England.
   Reijnders, Margot R. F., Maastricht Univ, Med Ctr, Dept Clin Genet, Maastricht, Netherlands.
   Robinson, Peter N., Jackson Lab, Farmington, CT USA.
   Romano, Corrado, IRCCS, Oasi Res Inst, Troina, Italy.
   Rose, Catherine M., Royal Childrens Hosp, Victorian Clin Genet Serv, Parkville, Vic, Australia.
   Rose, Catherine M., Royal Childrens Hosp, Murdoch Children Res Inst, Parkville, Vic, Australia.
   Sainsbury, David C. G., Royal Victoria Infirm, Northem \& Yorkshire Cleft Lip \& Palate Serv, Newcastle Upon Tyne, Tyne \& Wear, England.
   Sutton, Vernon R., Baylor Coll Med, Dept Mol \& Human Genet, Houston, TX 77030 USA.
   Van Dijck, Anke, Univ Hosp Antwerp, Antwerp, Belgium.
   Van Esch, Hilde, Univ Leuven, Univ Hosp Leuven, Ctr Human Genet, Leuven, Belgium.
   Witkie, Andrew O. M., Univ Oxford, John Radcliffe Hosp, MRC Weatherall Inst Mol Med, Clin Genet Grp, Oxford, England.},
DOI = {10.3389/fgene.2019.00611},
Article-Number = {611},
Keywords = {data sharing; phenotyping; patient information; data protection; rare
   disease; Faces},
Keywords-Plus = {DE-NOVO MUTATIONS; FACIAL DYSMORPHOLOGY; MATCHMAKER EXCHANGE; RARE;
   PHENOTYPE; RECOGNITION; INDIVIDUALS; GENOTYPE; THERAPY; GENOMES},
Research-Areas = {Genetics \& Heredity},
Web-of-Science-Categories  = {Genetics \& Heredity},
Author-Email = {christoffer.nellaker@wrh.ox.ac.uk},
Affiliations = {University of Oxford; University of Oxford; University of Oxford; King
   Faisal Specialist Hospital \& Research Center; University of Western
   Australia; Telethon Kids Institute; University of Western Australia;
   Curtin University; University of Washington; University of Washington
   Seattle; University of Toronto; University of Toronto; Hospital for Sick
   Children (SickKids); Radboud University Nijmegen; University of
   Manchester; Nantes Universite; CHU de Nantes; Murdoch University; Curtin
   University; Hunter New England Local Health District; Hunter Genetics;
   University of Washington; University of Washington Seattle; Howard
   Hughes Medical Institute; University of Washington; University of
   Washington Seattle; University of Cape Town; Wellcome Trust Sanger
   Institute; University of Edinburgh; University of Western Australia;
   King Edward Memorial Hospital; Garvan Institute of Medical Research;
   Oregon Health \& Science University; University of Oxford; University of
   Oxford; Johns Hopkins University; University of Kiel; Schleswig Holstein
   University Hospital; University of Edinburgh; University of Antwerp;
   University of Bonn; University of London; University College London;
   Great Ormond Street Hospital for Children NHS Foundation Trust;
   Universite Paris Cite; Charles University Prague; South Metropolitan
   Health Service; Fiona Stanley Fremantle Hospitals Group; Fiona Stanley
   Hospital; Maastricht University; Jackson Laboratory; Royal Children's
   Hospital Melbourne; Royal Children's Hospital Melbourne; Murdoch
   Children's Research Institute; Newcastle University - UK; Baylor College
   of Medicine; University of Antwerp; KU Leuven; University Hospital
   Leuven; University of Oxford},
Cited-References = {Adachi T, 2017, EUR J HUM GENET, V25, P1025, DOI 10.1038/ejhg.2017.106.
   Akle S, 2015, HUM MUTAT, V36, P998, DOI 10.1002/humu.22847.
   Ansari M, 2014, J MED GENET, V51, P659, DOI 10.1136/jmedgenet-2014-102573.
   Balliu B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109033.
   Basel-Vanagaite L, 2016, CLIN GENET, V89, P557, DOI 10.1111/cge.12716.
   Baynam G, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00031.
   Baynam G, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0462-7.
   Baynam G, 2013, HUM MUTAT, V34, P14, DOI 10.1002/humu.22219.
   Baynam GS, 2013, TWIN RES HUM GENET, V16, P840, DOI 10.1017/thg.2013.49.
   Bengani H, 2017, GENET MED, V19, P900, DOI 10.1038/gim.2016.211.
   Bone WP, 2016, GENET MED, V18, P608, DOI 10.1038/gim.2015.137.
   Boycott KM, 2017, AM J HUM GENET, V100, P695, DOI 10.1016/j.ajhg.2017.04.003.
   Buske OJ, 2015, HUM MUTAT, V36, P931, DOI 10.1002/humu.22851.
   Buske OJ, 2015, HUM MUTAT, V36, P922, DOI 10.1002/humu.22850.
   Caulfield M., 2017, The 100,000 genomes project protocol, DOI {[}DOI 10.6084/M9.FIGSHARE.4530893.V2, 10.6084/M9.FIGSHARE.4530893.V2.].
   Chong JX, 2015, AM J HUM GENET, V97, P199, DOI 10.1016/j.ajhg.2015.06.009.
   Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523.
   de Montjoye YA, 2015, SCIENCE, V347, P536, DOI 10.1126/science.1256297.
   Dorschner MO, 2013, AM J HUM GENET, V93, P631, DOI 10.1016/j.ajhg.2013.08.006.
   Dudding-Byth T, 2017, BMC BIOTECHNOL, V17, DOI 10.1186/s12896-017-0410-1.
   Dyke SOM, 2017, HUM MUTAT, V38, P1281, DOI 10.1002/humu.23278.
   Ferry Q, 2014, ELIFE, V3, DOI 10.7554/eLife.02020.
   Firth HV, 2011, DEV MED CHILD NEUROL, V53, P702, DOI 10.1111/j.1469-8749.2011.04032.x.
   Galton F., 1879, The Journal of the Anthropological Institute of Great Britain and Ireland, V8, P132.
   Gardner OK, 2017, CLEFT PALATE-CRAN J, V54, P739, DOI 10.1597/15-151.
   Gripp KW, 2016, AM J MED GENET A, V170, P1754, DOI 10.1002/ajmg.a.37672.
   Gurovich Y, 2019, NAT MED, V25, P60, DOI 10.1038/s41591-018-0279-0.
   Gymrek M, 2013, SCIENCE, V339, P321, DOI 10.1126/science.1229566.
   Hadj-Rabia S, 2017, AM J MED GENET A, V173, P2408, DOI 10.1002/ajmg.a.38343.
   Hammond P, 2005, AM J HUM GENET, V77, P999, DOI 10.1086/498396.
   Hammond P, 2004, AM J MED GENET A, V126A, P339, DOI 10.1002/ajmg.a.20665.
   Hammond P, 2012, AM J MED GENET A, V158A, P1368, DOI 10.1002/ajmg.a.35346.
   Hamosh A, 2013, HUM MUTAT, V34, P566, DOI 10.1002/humu.22283.
   Hennessy RJ, 2010, SCHIZOPHR RES, V122, P63, DOI 10.1016/j.schres.2010.05.001.
   HERPERS R, 1993, ST HEAL T, V10, P481.
   Javed A, 2014, NAT METHODS, V11, P935, DOI {[}10.1038/NMETH.3046, 10.1038/nmeth.3046].
   Kaye J, 2015, EUR J HUM GENET, V23, P141, DOI 10.1038/ejhg.2014.71.
   Knaus A, 2018, GENOME MED, V10, DOI 10.1186/s13073-017-0510-5.
   Köhler S, 2017, NUCLEIC ACIDS RES, V45, pD865, DOI 10.1093/nar/gkw1039.
   Krawitz P, 2015, HUM MUTAT, V36, P989, DOI 10.1002/humu.22848.
   Kruszka P, 2018, AM J MED GENET A, V176, P1128, DOI 10.1002/ajmg.a.38672.
   Kruszka P, 2017, AM J MED GENET A, V173, P2323, DOI 10.1002/ajmg.a.38362.
   Kruszka P, 2017, AM J MED GENET A, V173, P879, DOI 10.1002/ajmg.a.38199.
   Kruszka P, 2017, AM J MED GENET A, V173, P42, DOI 10.1002/ajmg.a.38043.
   Kung S, 2015, JIMD REP, V22, P99, DOI 10.1007/8904\_2015\_417.
   Landrum MJ, 2016, NUCLEIC ACIDS RES, V44, pD862, DOI 10.1093/nar/gkv1222.
   Liehr T, 2018, CLIN GENET, V93, P378, DOI 10.1111/cge.13087.
   Loos HS, 2003, EUR J HUM GENET, V11, P555, DOI 10.1038/sj.ejhg.5200997.
   Lumaka A, 2017, CLIN GENET, V92, P166, DOI 10.1111/cge.12948.
   MacArthur DG, 2010, HUM MOL GENET, V19, pR125, DOI 10.1093/hmg/ddq365.
   Manousaki D, 2015, AM J MED GENET A, V167, P1525, DOI 10.1002/ajmg.a.37069.
   Mcrae JF, 2017, NATURE, V542, P433, DOI 10.1038/nature21062.
   Mells GF, 2011, NAT GENET, V43, P329, DOI 10.1038/ng.789.
   Nielsen M., 2011, Reinventing discovery: The new era of networked science, DOI {[}https://doi.org/10.2307/j.ctt7s4vx, DOI 10.2307/J.CTT7S4VX, 10.2307/j.ctt7s4vx].
   Pantel JT, 2018, J INHERIT METAB DIS, V41, P533, DOI 10.1007/s10545-018-0174-3.
   Pena LDM, 2018, GENET MED, V20, P464, DOI 10.1038/gim.2017.128.
   Pengelly RJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13841-y.
   Philippakis AA, 2015, HUM MUTAT, V36, P915, DOI 10.1002/humu.22858.
   Rehm HL, 2015, NEW ENGL J MED, V372, P2235, DOI 10.1056/NEJMsr1406261.
   Reijnders MRF, 2018, AM J HUM GENET, V102, P1195, DOI 10.1016/j.ajhg.2018.04.014.
   Reijnders MRF, 2018, J MED GENET, V55, P104, DOI 10.1136/jmedgenet-2017-104946.
   Robinson PN, 2015, CSH MOL CASE STUD, V1, DOI 10.1101/mcs.a000372.
   Robinson PN, 2014, GENOME RES, V24, P340, DOI 10.1101/gr.160325.113.
   Sheldon W. H., 1945, VARIETIES HUMAN PHYS.
   Shukla P, 2017, IEEE WINT CONF APPL, P705, DOI 10.1109/WACV.2017.84.
   Sifrim A, 2013, NAT METHODS, V10, P1083, DOI {[}10.1038/NMETH.2656, 10.1038/nmeth.2656].
   Singleton MV, 2014, AM J HUM GENET, V94, P599, DOI 10.1016/j.ajhg.2014.03.010.
   SMITH DW, 1966, J PEDIATR-US, V69, P1150, DOI 10.1016/S0022-3476(66)80311-6.
   Sobreira Nara, 2015, Hum Mutat, V36, P928, DOI 10.1002/humu.22844.
   Taruscio D, 2015, MOL GENET METAB, V116, P223, DOI 10.1016/j.ymgme.2015.11.003.
   Valentine M, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2016-2028.
   Vollmar T, 2008, EUR J MED GENET, V51, P44, DOI 10.1016/j.ejmg.2007.10.002.
   Weeramanthri TS, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00121.
   Woelfle M, 2011, NAT CHEM, V3, P745, DOI 10.1038/nchem.1149.
   Wright CF, 2018, NAT REV GENET, V19, P327.
   Xiangyu Zhu Z. L., 2015, HIGH FIDELITY POSE E, P787, DOI {[}10.1109/CVPR.2015.7298679, DOI 10.1109/CVPR.2015.7298679].
   Zarate YA, 2018, AM J MED GENET A, V176, P925, DOI 10.1002/ajmg.a.38630.},
Number-of-Cited-References = {77},
Times-Cited = {11},
Unique-ID = {WOS:000477832700001},
}

@article{ WOS:000436789500013,
Author = {Frings, Michael and Lakes, Tobia and Mueller, Daniel and Khan, M. M. H.
   and Epprecht, Michael and Kipruto, Samuel and Galea, Sandro and
   Gruebner, Oliver},
Title = {Modeling and mapping the burden of disease in Kenya},
Journal = {SCIENTIFIC REPORTS},
Year = {2018},
Volume = {8},
Month = {JUN 29},
Abstract = {Precision public health approaches are crucial for targeting health
   policies to regions most affected by disease. We present the first
   sub-national and spatially explicit burden of disease study in Africa.
   We used a cross-sectional study design and assessed data from the Kenya
   population and housing census of 2009 for calculating YLLs (years of
   life lost) due to premature mortality at the division level (N = 612).
   We conducted spatial autocorrelation analysis to identify spatial
   clusters of YLLs and applied boosted regression trees to find
   statistical associations between locational risk factors and YLLs. We
   found statistically significant spatial clusters of high numbers of YLLs
   at the division level in western, northwestern, and northeastern areas
   of Kenya. Ethnicity and household crowding were the most important and
   significant risk factors for YLL. Further positive and significantly
   associated variables were malaria endemicity, northern geographic
   location, and higher YLL in neighboring divisions. In contrast, higher
   rates of married people and more precipitation in a division were
   significantly associated with less YLL. We provide an evidence base and
   a transferable approach that can guide health policy and intervention in
   sub-national regions afflicted by disease burden in Kenya and other
   areas of comparable settings.},
Type = {Article},
Affiliation = {Gruebner, O (Corresponding Author), Humboldt Univ, Dept Geog, Berlin, Germany.
   Gruebner, O (Corresponding Author), Univ Zurich, EBPI, Zurich, Switzerland.
   Frings, Michael; Lakes, Tobia; Mueller, Daniel; Gruebner, Oliver, Humboldt Univ, Dept Geog, Berlin, Germany.
   Mueller, Daniel, Leibniz Inst Agr Dev Transit Econ IAMO, Halle, Saale, Germany.
   Khan, M. M. H., Univ Bielefeld, Sch Publ Hlth, Dept Publ Hlth Med, Bielefeld, Germany.
   Epprecht, Michael, Univ Bern, CDE, Bern, Switzerland.
   Kipruto, Samuel, Kenya Natl Bur Stat, Nairobi, Kenya.
   Galea, Sandro, Boston Univ, Dept Epidemiol, Boston, MA 02215 USA.
   Gruebner, Oliver, Univ Zurich, EBPI, Zurich, Switzerland.},
DOI = {10.1038/s41598-018-28266-4},
Article-Number = {9826},
Keywords-Plus = {ADJUSTED LIFE YEARS; SOCIAL DETERMINANTS; MORTALITY; HEALTH; MALARIA;
   REGRESSION; INJURY; ASSOCIATION; VARIABILITY; SECURITY},
Research-Areas = {Science \& Technology - Other Topics},
Web-of-Science-Categories  = {Multidisciplinary Sciences},
Author-Email = {oliver.gruebner@geo.hu-berlin.de},
Affiliations = {Humboldt University of Berlin; Leibniz Institut fur Agrarentwicklung in
   Transformationsokonomien (IAMO); University of Bielefeld; University of
   Bern; Boston University; University of Zurich},
Cited-References = {Adler NE, 2002, HEALTH AFFAIR, V21, P60, DOI 10.1377/hlthaff.21.2.60.
   {[}Anonymous], J PHYS ACT HEAL.
   {[}Anonymous], INT J.
   {[}Anonymous], 2013, R: A Language and Environment for Statistical Computing.
   {[}Anonymous], KEN NAT POP HOUS CEN.
   {[}Anonymous], INT HUM DIMENS PROGR.
   {[}Anonymous], GLOBAL BURDEN INFECT.
   {[}Anonymous], E AFR LIV ENC.
   {[}Anonymous], JARVIS HOLE FILLED S.
   {[}Anonymous], GBD DAT VIS.
   {[}Anonymous], PACKAGE APOS GBM APO.
   {[}Anonymous], PACKAGE APOS DISMO A.
   {[}Anonymous], 2008, CLOSING GAP GENERATI.
   {[}Anonymous], KEN COUNTR PROF.
   {[}Anonymous], JMAJ.
   ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x.
   Baker M, 2008, J EPIDEMIOL COMMUN H, V62, P715, DOI 10.1136/jech.2007.063610.
   Balayla J, 2011, WOMEN HEALTH ISS, V21, P361, DOI 10.1016/j.whi.2011.04.001.
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060.
   Bivand R., 2009, spdep: Spatial dependence: weighting schemes, statistics and models.
   Breiman L, 2001, STAT SCI, V16, P199, DOI 10.1214/ss/1009213726.
   Caminade C, 2014, P NATL ACAD SCI USA, V111, P3286, DOI 10.1073/pnas.1302089111.
   Cheong YL, 2014, SPAT SPATIO-TEMPORAL, V10, P75, DOI 10.1016/j.sste.2014.05.002.
   Crase B, 2012, ECOGRAPHY, V35, P879, DOI 10.1111/j.1600-0587.2011.07138.x.
   Depoortere E, 2004, LANCET, V364, P1315, DOI 10.1016/S0140-6736(04)17187-0.
   Dodhia H, 2008, J PUBLIC HEALTH-UK, V30, P313, DOI 10.1093/pubmed/fdn015.
   Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x.
   Eshetu EB, 2011, AFR HEALTH SCI, V11, P108.
   Galea S, 2005, SOC SCI MED, V60, P1017, DOI 10.1016/j.socscimed.2004.06.036.
   Gething PW, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001814.
   Gething PW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-378.
   Gruebner O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139545.
   Hassan E., 2006, Recall bias can be a threat to retrospective and prospective research designs.
   HASTIE T., ELEMENTS STAT LEARNI.
   Herrin WE, 2013, SOC SCI MED, V81, P115, DOI 10.1016/j.socscimed.2012.12.017.
   Hoffmann W, 2005, GESUNDHEITSWESEN, V67, P217, DOI 10.1055/s-2004-813850.
   Horton R, 2012, LANCET, V380, P2053, DOI 10.1016/S0140-6736(12)62133-3.
   Jolliffe I, 2002, PRINCIPAL COMPONENT.
   Kasara K, 2013, J POLIT, V75, P921, DOI 10.1017/S0022381613000777.
   Kimani-Murage EW, 2014, HEALTH PLACE, V29, P95, DOI 10.1016/j.healthplace.2014.06.003.
   Kleinschmidt I, 2009, AM J TROP MED HYG, V80, P882, DOI 10.4269/ajtmh.2009.80.882.
   Kumssa A, 2009, INT J SOC ECON, V36, P1008, DOI 10.1108/03068290910984786.
   Leff J, 2009, INT J CONFL VIOLENCE, V3, P188.
   MacNab YC, 2007, STAT MED, V26, P4746, DOI 10.1002/sim.2890.
   MacNab YC, 2009, STAT MED, V28, P1369, DOI 10.1002/sim.3547.
   Manda SOM, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14091072.
   Mariotti S, 2003, EUR J EPIDEMIOL, V18, P513, DOI 10.1023/A:1024635401206.
   Marmot M, 2008, LANCET, V372, P1661, DOI 10.1016/S0140-6736(08)61690-6.
   Moshiro C, 2005, INJURY PREV, V11, P48, DOI 10.1136/ip.2004.005645.
   Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4.
   Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6.
   Mwagore D., 2003, LAND USE KENYA CASE.
   Odhiambo FO, 2012, INT J EPIDEMIOL, V41, P977, DOI 10.1093/ije/dys108.
   Ombok M, 2010, TROP MED INT HEALTH, V15, P423, DOI 10.1111/j.1365-3156.2010.02467.x.
   Pebesma E, 2013, APPL SPATIAL DATA AN, V2nd ed..
   Polinder S, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-21.
   Rumisha SF, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-124.
   Schellenberg JA, 1998, INT J EPIDEMIOL, V27, P323, DOI 10.1093/ije/27.2.323.
   Schumann B, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.20153.
   Selemani M, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0905-y.
   Sewe M, 2015, INT J ENV RES PUB HE, V12, P1983, DOI 10.3390/ijerph120201983.
   Shaffer DN, 2010, JAIDS-J ACQ IMM DEF, V53, P514, DOI 10.1097/QAI.0b013e3181bcdae0.
   Smith-Greenaway E, 2014, DEMOGRAPHY, V51, P341, DOI 10.1007/s13524-013-0262-9.
   Stevens KB, 2011, SPAT SPATIO-TEMPORAL, V2, P125, DOI 10.1016/j.sste.2011.07.007.
   Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029.
   Wachira B, 2011, AFR J EMERG MED, V1, P160, DOI 10.1016/j.afjem.2011.10.008.
   Zhou Shang-Cheng, 2011, Environmental Health and Preventive Medicine, V16, P148, DOI 10.1007/s12199-010-0176-8.},
Number-of-Cited-References = {67},
Times-Cited = {9},
Unique-ID = {WOS:000436789500013},
}

@article{ WOS:000609329300001,
Author = {Allen, Caitlin G. and Green, Ridgely Fisk and Bowen, Scott and Dotson,
   W. David and Yu, Wei and Khoury, Muin J.},
Title = {Challenges and Opportunities for Communication about the Role of
   Genomics in Public Health},
Journal = {PUBLIC HEALTH GENOMICS},
Year = {2021},
Volume = {24},
Number = {1-2},
Pages = {67-73},
Month = {FEB},
Abstract = {Despite growing awareness about the potential for genomic information to
   improve population health, lingering communication challenges remain in
   describing the role of genomics in public health programs. Identifying
   and addressing these challenges provide an important opportunity for
   appropriate communication to ensure the translation of genomic
   discoveries for public health benefits. In this commentary, we describe
   5 common communication challenges encountered by the Centers for Disease
   Control and Prevention's Office of Genomics and Precision Public Health
   based on over 20 years of experience in the field. These include (1)
   communicating that using genomics to assess rare diseases can have an
   impact on public health; (2) providing evidence that genetic factors can
   add important information to environmental, behavioral, and social
   determinants of health; (3) communicating that although genetic factors
   are nonmodifiable, they can increase the impact of public health
   programs and communication strategies; (4) addressing the concern that
   genomics is not ready for clinical practice; and (5) communicating that
   genomics is valuable beyond the domain of health care and can be
   integrated as part of public health programs. We discuss opportunities
   for addressing these communication challenges and provide examples of
   ongoing approaches to communication about the role of genomics in public
   health to the public, researchers, and practitioners.},
Type = {Editorial Material},
Affiliation = {Khoury, MJ (Corresponding Author), Ctr Dis Control \& Prevent, Off Genom \& Precis Publ Hlth, Off Sci, 4770 Buford Highway NE, Atlanta, GA 30341 USA.
   Allen, Caitlin G., Emory Univ, Rollins Sch Publ Hlth, Dept Behav Social \& Hlth Educ Sci, Atlanta, GA 30322 USA.
   Green, Ridgely Fisk; Bowen, Scott; Dotson, W. David; Yu, Wei; Khoury, Muin J., Ctr Dis Control \& Prevent, Off Genom \& Precis Publ Hlth, Off Sci, 4770 Buford Highway NE, Atlanta, GA 30341 USA.},
DOI = {10.1159/000512485},
EarlyAccessDate = {JAN 2021},
Keywords = {Communication; Genomics; Medicine; Public health},
Keywords-Plus = {IMPLEMENTATION SCIENCE; PRECISION MEDICINE; INTEGRATION; CANCER},
Research-Areas = {Genetics \& Heredity; Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Genetics \& Heredity; Public, Environmental \& Occupational Health},
Author-Email = {muk1@cdc.gov},
Affiliations = {Emory University; Rollins School Public Health; Centers for Disease
   Control \& Prevention - USA},
Cited-References = {Allen CG, 2019, AM J PUBLIC HEALTH, V109, P1186, DOI 10.2105/AJPH.2019.305199.
   Allen CG, 2019, LANCET, V394, P382, DOI 10.1016/S0140-6736(19)30498-2.
   ALLEN CG, 2020, TRANSL BEHAV MED.
   {[}Anonymous], 2018, HER COL COL CANC FAM.
   {[}Anonymous], 2019, ADV MOL DET RESP INF.
   {[}Anonymous], 2020, GEN PREC HLTH DOES H.
   Best A, 2008, PATIENT EDUC COUNS, V71, P319, DOI 10.1016/j.pec.2008.02.013.
   Bowen DJ, 2019, CANCER CAUSE CONTROL, V30, P225, DOI 10.1007/s10552-018-1096-y.
   Centers for Disease Control and Prevention, 2019, PUBL HLTH GEN PREC H.
   Centers for Disease Control and Prevention, 2020, GEN PREC HLTH WEEKL.
   Centers for Disease Control and Prevention, 2020, FAM HLTH HIST.
   Centers for Disease Control and Prevention, 2017, TOOLS BID CANC REG R.
   Centers for Disease Control and Prevention, 2019, VIS ABSTR.
   Centers for Disease Control and Prevention, 2020, INF DIS PHGKB.
   Centers for Disease Control and Prevention, 2016, 5 MISC ROL GEN PUBL.
   Centers for Disease Control and Prevention, 2020, HER BREAST OV CANC.
   Centers for Disease Control and Prevention, 2019, PUBL HLTH GEN GEM PR.
   Centers for Disease Control and Prevention, 2014, TIER 1 GEN APPL THEI.
   Centers for Disease Control and Prevention, 2016, NEWB SCREEN SEV COMB.
   Centers for Disease Control and Prevention, 2016, HAPP THANKSG COLL AC.
   Centers for Disease Control and Prevention, 2020, LYNCH SYNDROME.
   Centers for Disease Control and Prevention, 2019, INTR RAR DIS GEN PRE.
   Centers for Disease Control and Prevention, 2017, HER BREAST OV CANC F.
   Centers for Disease Control and Prevention, 2019, PUBL HLTH GEN WEEKL.
   Centers for Disease Control and Prevention, 2019, RAR DIS.
   Centers for Disease Control and Prevention, 2019, CDCS NEWB SCREEN PRO.
   Centers for Disease Control and Prevention, 2019, BRING YOUR BRAV.
   Centers for Disease Control and Prevention, 2011, SHALL WE HAV PIE STE.
   Centers for Disease Control and Prevention, 2014, TIER 1 GEN APPL TOOL.
   Centers for Disease Control and Prevention, 2017, FAM HLTH HIST BRCA1.
   Centers for Disease Control Prevention, 2018, TIER TABL DAT.
   Chambers DA, 2018, ANNU REV PUBL HEALTH, V39, P1, DOI 10.1146/annurev-publhealth-110717-045850.
   Chambers DA, 2016, JAMA-J AM MED ASSOC, V315, P1941, DOI 10.1001/jama.2016.3867.
   Chowkwanyun M, 2018, NEW ENGL J MED, V379, P1398, DOI 10.1056/NEJMp1806634.
   DAVIES NM, 2018, BMJ BRIT MED J, V362.
   Dotson WD, 2014, CLIN PHARMACOL THER, V95, P394, DOI 10.1038/clpt.2013.226.
   Galea S, 2018, PERSPECT BIOL MED, V61, P527, DOI 10.1353/pbm.2018.0062.
   Green RF, 2014, FAMILY HLTH HIST IS.
   Hesselgrave Barbara L, 2003, Manag Care Q, V11, P1.
   Institute N.H.G.R, 2019, COV REIMB.
   Khoury MJ, 2018, GENET MED, V20, P574, DOI 10.1038/gim.2017.211.
   Khoury MJ, 2016, AM J PREV MED, V50, P398, DOI 10.1016/j.amepre.2015.08.031.
   Khoury MJ, 2011, CANCER EPIDEM BIOMAR, V20, P2105, DOI 10.1158/1055-9965.EPI-11-0481.
   Khoury MJ, 2011, AM J PREV MED, V40, P486, DOI 10.1016/j.amepre.2010.12.009.
   Krieger N, 2001, INT J EPIDEMIOL, V30, P668, DOI 10.1093/ije/30.4.668.
   Leavitt M, 2001, MedGenMed, V3, P2.
   Prevention. C.f.D.C.a, 2019, NEWBORN SCREENING PO.
   Rahm AK, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3636-2.
   U.S. Department of health and human services, 2015, 2020 TOP OBJ GEN.
   U.S. Preventive Services Task Force, 2019, FIN REC STAT BRCAR C.
   Valdex R, 2017, NEED NEXT GENERATION.
   Valdez R, 2017, GENET MED, V19, P489, DOI 10.1038/gim.2016.166.
   Valdez R, 2016, PREV CHRONIC DIS, V13, DOI 10.5888/pcd13.150491.},
Number-of-Cited-References = {53},
Times-Cited = {3},
Unique-ID = {WOS:000609329300001},
}

@article{ WOS:000572609100001,
Author = {Zhou, Yitian and Dagli Hernandez, Carolina and Lauschke, Volker M.},
Title = {Population-scale predictions of DPD and TPMT phenotypes using a
   quantitative pharmacogene-specific ensemble classifier},
Journal = {BRITISH JOURNAL OF CANCER},
Year = {2020},
Volume = {123},
Number = {12},
Pages = {1782-1789},
Month = {DEC 8},
Abstract = {Background Inter-individual differences in dihydropyrimidine
   dehydrogenase (DPYDencoding DPD) and thiopurine S-methyltransferase
   (TPMT) activity are important predictors for fluoropyrimidine and
   thiopurine toxicity. While several variants in these genes are known to
   decrease enzyme activities, many additional genetic variations with
   unclear functional consequences have been identified, complicating
   informed clinical decision-making in the respective carriers. Methods We
   used a novel pharmacogenetically trained ensemble classifier to
   analyseDPYDandTPMTgenetic variability based on sequencing data from
   138,842 individuals across eight populations. Results The algorithm
   accurately predicted in vivo consequences ofDPYDandTPMTvariants
   (accuracy 91.4\% compared to 95.3\% in vitro). Further analysis showed
   high genetic complexity of DPD deficiency, advocating for
   sequencing-basedDPYDprofiling, whereas genotyping of four variants
   inTPMTwas sufficient to explain >95\% of phenotypic TPMT variability.
   Lastly, we provided population-scale profiles of ethnogeographic
   variability in DPD and TPMT phenotypes, and revealed striking
   interethnic differences in frequency and genetic constitution of DPD and
   TPMT deficiency. Conclusion These results provide the most comprehensive
   data set ofDPYDandTPMTvariability published to date with important
   implications for population-adjusted genetic profiling strategies of
   fluoropyrimidine and thiopurine risk factors and precision public
   health.},
Type = {Article},
Affiliation = {Lauschke, VM (Corresponding Author), Karolinska Inst, Dept Physiol \& Pharmacol, S-17177 Stockholm, Sweden.
   Zhou, Yitian; Dagli Hernandez, Carolina; Lauschke, Volker M., Karolinska Inst, Dept Physiol \& Pharmacol, S-17177 Stockholm, Sweden.
   Dagli Hernandez, Carolina, Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin \& Toxicol Anal, BR-05508000 Sao Paulo, Brazil.},
DOI = {10.1038/s41416-020-01084-0},
EarlyAccessDate = {SEP 2020},
Keywords-Plus = {S-METHYLTRANSFERASE GENE; DIHYDROPYRIMIDINE DEHYDROGENASE GENE; SINGLE
   NUCLEOTIDE POLYMORPHISMS; DPYD VARIANT Y186C; CLINICAL-RELEVANCE;
   5-FLUOROURACIL SENSITIVITY; FUNCTIONAL-ANALYSIS; PRECISION MEDICINE;
   ALLELIC VARIANTS; TOXICITY},
Research-Areas = {Oncology},
Web-of-Science-Categories  = {Oncology},
Author-Email = {volker.lauschke@ki.se},
Affiliations = {Karolinska Institutet; Universidade de Sao Paulo},
Cited-References = {Ameur A, 2017, EUR J HUM GENET, V25, P1253, DOI 10.1038/ejhg.2017.130.
   Amstutz U, 2018, CLIN PHARMACOL THER, V103, P210, DOI 10.1002/cpt.911.
   Amstutz U, 2011, PHARMACOGENOMICS, V12, P1321, DOI {[}10.2217/pgs.11.72, 10.2217/PGS.11.72].
   Appell ML, 2010, PHARMACOGENET GENOM, V20, P700, DOI 10.1097/FPC.0b013e3283402ee4.
   Boige V, 2016, JAMA ONCOL, V2, P655, DOI 10.1001/jamaoncol.2015.5392.
   Bycroft C, 2018, NATURE, V562, P203, DOI 10.1038/s41586-018-0579-z.
   Coenen MJH, 2015, GASTROENTEROLOGY, V149, P907, DOI 10.1053/j.gastro.2015.06.002.
   Cooper SC, 2008, PHARMACOGENOMICS, V9, P303, DOI 10.2217/14622416.9.3.303.
   Dankar FK, 2018, HUM GENOMICS, V12, DOI 10.1186/s40246-018-0147-5.
   Deenen MJ, 2016, J CLIN ONCOL, V34, P227, DOI 10.1200/JCO.2015.63.1325.
   Deenen MJ, 2011, CLIN CANCER RES, V17, P3455, DOI 10.1158/1078-0432.CCR-10-2209.
   Del Re M, 2019, PHARMACOGENOMICS J, V19, P556, DOI 10.1038/s41397-019-0077-1.
   Elraiyah T, 2017, CLIN PHARMACOL THER, V101, P382, DOI 10.1002/cpt.531.
   Feng QP, 2010, BIOCHEM PHARMACOL, V79, P1053, DOI 10.1016/j.bcp.2009.11.016.
   Ford L, 2006, ANN CLIN BIOCHEM, V43, P354, DOI 10.1258/000456306778520070.
   Garat A, 2008, BIOCHEM PHARMACOL, V76, P404, DOI 10.1016/j.bcp.2008.05.009.
   Gentile G, 2016, PHARMACOGENOMICS J, V16, P320, DOI 10.1038/tpj.2015.56.
   Gisbert JP, 2007, DIGEST DIS SCI, V52, P1262, DOI 10.1007/s10620-006-9119-z.
   Hamdan-Khalil R, 2005, BIOCHEM PHARMACOL, V69, P525, DOI 10.1016/j.bcp.2004.10.011.
   Hamdan-Khalil R, 2003, BIOCHEM BIOPH RES CO, V309, P1005, DOI 10.1016/j.bbrc.2003.08.103.
   He YF, 2008, J CLIN PHARM THER, V33, P307, DOI 10.1111/j.1365-2710.2008.00898.x.
   Henricks LM, 2018, LANCET ONCOL, V19, P1459, DOI 10.1016/S1470-2045(18)30686-7.
   Holme SA, 2002, QJM-INT J MED, V95, P439, DOI 10.1093/qjmed/95.7.439.
   Hon YY, 1999, HUM MOL GENET, V8, P371, DOI 10.1093/hmg/8.2.371.
   Ingelman-Sundberg M, 2018, HUM GENOMICS, V12, DOI 10.1186/s40246-018-0157-3.
   Kozyra M, 2017, GENET MED, V19, P20, DOI 10.1038/gim.2016.33.
   Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113.
   Lauschke VM, 2020, NPJ GENOM MED, V5, DOI 10.1038/s41525-020-0119-2.
   Lauschke VM, 2018, CLIN PHARMACOL THER, V103, P745, DOI 10.1002/cpt.976.
   Lauschke VM, 2018, AAPS J, V20, DOI 10.1208/s12248-017-0161-x.
   Lauschke VM, 2016, TRENDS PHARMACOL SCI, V37, P85, DOI 10.1016/j.tips.2015.10.006.
   Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057.
   Li JC, 2018, NUCLEIC ACIDS RES, V46, P7793, DOI 10.1093/nar/gky678.
   Lunenburg CATC, 2016, EUR J CANCER, V54, P40, DOI 10.1016/j.ejca.2015.11.008.
   Machiela MJ, 2015, BIOINFORMATICS, V31, P3555, DOI 10.1093/bioinformatics/btv402.
   Matreyek KA, 2018, NAT GENET, V50, P874, DOI 10.1038/s41588-018-0122-z.
   Mattison LK, 2006, CLIN CANCER RES, V12, P5491, DOI 10.1158/1078-0432.CCR-06-0747.
   Meulendijks D, 2015, LANCET ONCOL, V16, P1639, DOI 10.1016/S1470-2045(15)00286-7.
   Morel A, 2006, MOL CANCER THER, V5, P2895, DOI 10.1158/1535-7163.MCT-06-0327.
   Offer SM, 2013, CLIN PHARMACOL THER, V94, P158, DOI 10.1038/clpt.2013.69.
   Offer SM, 2014, CANCER RES, V74, P2545, DOI 10.1158/0008-5472.CAN-13-2482.
   Offer SM, 2013, CANCER RES, V73, P1958, DOI 10.1158/0008-5472.CAN-12-3858.
   Öfverholm A, 2010, CLIN BIOCHEM, V43, P331, DOI 10.1016/j.clinbiochem.2009.09.024.
   Peterson TA, 2013, J MOL BIOL, V425, P4047, DOI 10.1016/j.jmb.2013.08.008.
   Reisberg S, 2019, GENET MED, V21, P1345, DOI 10.1038/s41436-018-0337-5.
   Relling MV, 2011, CLIN PHARMACOL THER, V89, P387, DOI 10.1038/clpt.2010.320.
   Relling MV, 2019, CLIN PHARMACOL THER, V105, P1095, DOI 10.1002/cpt.1304.
   Rosmarin D, 2014, J CLIN ONCOL, V32, P1031, DOI 10.1200/JCO.2013.51.1857.
   Roy LM, 2016, PHARMACOGENOMICS, V17, P633, DOI 10.2217/pgs.16.12.
   Saif MW, 2014, MAYO CLIN PROC, V89, P131, DOI 10.1016/j.mayocp.2013.09.008.
   Salavaggione OE, 2005, PHARMACOGENET GENOM, V15, P801, DOI 10.1097/01.fpc.0000174788.69991.6b.
   Schaeffeler E, 2004, PHARMACOGENETICS, V14, P407, DOI 10.1097/01.fpc.0000114745.08559.db.
   Shrestha S, 2018, CLIN PHARMACOL THER, V104, P709, DOI 10.1002/cpt.1020.
   Terrazzino S, 2013, PHARMACOGENOMICS, V14, P1255, DOI 10.2217/pgs.13.116.
   TINEL M, 1991, BRIT J CLIN PHARMACO, V32, P729.
   Ujiie S, 2008, PHARMACOGENET GENOM, V18, P887, DOI 10.1097/FPC.0b013e3283097328.
   van Kuilenburg ABP, 2000, CLIN CANCER RES, V6, P4705.
   Wagih O, 2018, MOL SYST BIOL, V14, DOI 10.15252/msb.20188430.
   WEINSHILBOUM RM, 1980, AM J HUM GENET, V32, P651.
   Wheeler HE, 2013, NAT REV GENET, V14, P23, DOI 10.1038/nrg3352.
   Zaanan A, 2014, CLIN PHARMACOL THER, V95, P136, DOI 10.1038/clpt.2013.183.
   Zhou YT, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01437.
   Zhou YT, 2019, PHARMACOGENOMICS J, V19, P115, DOI 10.1038/s41397-018-0044-2.
   Zhou YT, 2018, J MED GENET, V55, P617, DOI 10.1136/jmedgenet-2018-105429.},
Number-of-Cited-References = {64},
Times-Cited = {21},
Unique-ID = {WOS:000572609100001},
}

@article{ WOS:000530076100001,
Author = {Nunez, Pablo A. and Fernandez, Maria Soledad and Turjanski, Pablo and
   Perez, Adriana and Rivero, Maria Romina and De Angelo, Carlos and
   Salomon, Oscar D. and Cueto, Gerardo},
Title = {Substantial reduction in child stunting is differentially associated to
   geographical and socioeconomic disparities in Misiones Province,
   Argentina},
Journal = {TROPICAL MEDICINE \& INTERNATIONAL HEALTH},
Year = {2020},
Volume = {25},
Number = {7},
Pages = {874-885},
Month = {JUL},
Abstract = {Objective To estimate trends in the prevalence of child stunting in the
   population of children under 5 years of age covered by public health
   programmes, between 2009 and 2014 in Misiones, Argentina.
   Methods Using Bayesian model-based geostatistics, we evaluated 724 872
   anthropometric measurements corresponding to 110 633 children. In order
   to identify disparities at local scale, we evaluated the hypotheses of a
   differential reduction of stunting according to the geographical
   location (at two-level spatial resolution) and to the socioeconomic
   level in a rural or urban environment.
   Results The prevalence of stunting had fallen significantly in the
   province overall. Sex and age defined gender disparities at individual
   level, and there were regional disparities with higher prevalence values
   in the north and northeast regions. In these areas, stunting decreased
   to a greater degree during the studied period, although the spatial
   pattern remained smoother. Stunting increased in peripheral urban and
   dispersed rural areas that are socioeconomically vulnerable.
   Conclusions The spatial multi-level geostatistical estimates of child
   undernutrition provide a precision public health tool to target public
   policies to those populations with the greatest need, in order to reduce
   health disparities.},
Type = {Article},
Affiliation = {Nuñez, PA (Corresponding Author), Univ Buenos Aires, Fac Ciencias Exactas \& Nat, Grp Bioestadist Aplicada, Intendente Guiraldes 2160,C1428EGA, Buenos Aires, DF, Argentina.
   Nunez, Pablo A.; Fernandez, Maria Soledad; Perez, Adriana; Cueto, Gerardo, Univ Buenos Aires, Fac Ciencias Exactas \& Nat, Grp Bioestadist Aplicada, Intendente Guiraldes 2160,C1428EGA, Buenos Aires, DF, Argentina.
   Nunez, Pablo A.; Fernandez, Maria Soledad; Turjanski, Pablo; Perez, Adriana; Cueto, Gerardo, Consejo Nacl Invest Cient \& Tecn, Buenos Aires, DF, Argentina.
   Nunez, Pablo A.; Rivero, Maria Romina; Salomon, Oscar D., Inst Nacl Med Trop, Puerto Iguazu, Argentina.
   Turjanski, Pablo, Univ Buenos Aires, Fac Ciencias Exactas \& Nat, Dept Computac, Buenos Aires, DF, Argentina.
   De Angelo, Carlos, Univ Nacl Rio Cuarto, Inst Ciencias Tierra Biodiversidad \& Ambiente, Rio Cuarto, Argentina.
   De Angelo, Carlos, Consejo Nacl Invest Cient \& Tecn, Rio Cuarto, Argentina.},
DOI = {10.1111/tmi.13400},
EarlyAccessDate = {MAY 2020},
Keywords = {child; stunting; inequalities; Integrated Nested Laplace Approximations;
   Argentina},
Keywords-Plus = {UNDERNUTRITION; GROWTH; HEALTH; AFRICA},
Research-Areas = {Public, Environmental \& Occupational Health; Tropical Medicine},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health; Tropical Medicine},
Author-Email = {pb.nunez@gmail.com},
Affiliations = {University of Buenos Aires; Consejo Nacional de Investigaciones
   Cientificas y Tecnicas (CONICET); University of Buenos Aires;
   Universidad Nacional Rio Cuarto; Consejo Nacional de Investigaciones
   Cientificas y Tecnicas (CONICET)},
Cited-References = {Adin A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203382.
   Alderman H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195904.
   {[}Anonymous], 1992, WILEY SERIES in PROBABILITY and STATISTICS: APPLIED PROBABILITY and STATIST ICS SECTION Series.
   Atun R, 2015, LANCET, V385, P1230, DOI 10.1016/S0140-6736(14)61646-9.
   Bertonatti C., 2000, Situacion Ambiental Argentina.
   Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6.
   Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8.
   Black RE, 2008, LANCET, V371, P243, DOI {[}10.1016/S0140-6736(07)61690-0, 10.1016/S0140-6736(13)60937-X].
   BLANGIARDO M, 2015, SPAT SPAT BAYES MOD, P1.
   Cappa C, 2011, LANCET, V378, P1122, DOI 10.1016/S0140-6736(11)61303-2.
   Caulfield LE, 2004, AM J CLIN NUTR, V80, P193.
   COLE TJ, 1992, STAT MED, V11, P1305, DOI 10.1002/sim.4780111005.
   Cooper MW, 2019, P NATL ACAD SCI USA, V116, P17219, DOI 10.1073/pnas.1905228116.
   de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548.
   Dowell SF, 2016, NATURE, V540, P189, DOI 10.1038/540189a.
   FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1.
   Frenk J, 2015, LANCET, V385, P1352, DOI 10.1016/S0140-6736(14)61467-7.
   Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4.
   Hosseinpoor AR, 2018, GLOBAL HEALTH ACTION, V11, P70, DOI 10.1080/16549716.2017.1392216.
   INDEC, 2010, CENS NAC POBL VIV.
   Knorr-Held L, 2000, STAT MED, V19, P2555, DOI 10.1002/1097-0258(20000915/30)19:17/18<2555::AID-SIM587>3.0.CO;2-\#.
   Kshatriya GK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158308.
   Landmann-Szwarcwald C, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0462-1.
   Lloyd SJ, 2018, ENVIRON HEALTH PERSP, V126, DOI 10.1289/EHP2916.
   Nuñez PA, 2016, AM J PUBLIC HEALTH, V106, P720, DOI 10.2105/AJPH.2016.303056.
   Osgood-Zimmerman A, 2018, NATURE, V555, P41, DOI 10.1038/nature25760.
   Pelletier DL, 2003, J NUTR, V133, P107, DOI 10.1093/jn/133.1.107.
   Reiner RC, 2018, NEW ENGL J MED, V379, P1128, DOI 10.1056/NEJMoa1716766.
   Rivero MR, 2018, ACTA TROP, V187, P248, DOI 10.1016/j.actatropica.2018.08.015.
   Rivero MR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006098.
   Rue H, 2009, J ROY STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x.
   Schmidt CW, 2019, ENVIRON HEALTH PERSP, V127, DOI 10.1289/EHP5049.
   Steffan-Dewenter I., 2002, Ecology, V83, P1421, DOI 10.1890/0012-9658(2002)083{[}1421:SDEOLC]2.0.CO;2.
   Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4.
   Wamani H., 2007, BMC pediatrics, V7, P1, DOI {[}DOI 10.1186/1471-2431-7-17, 10.1186/1471-2431-7-17].},
Number-of-Cited-References = {35},
Times-Cited = {3},
Unique-ID = {WOS:000530076100001},
}

@article{ WOS:000727874900001,
Author = {Zijlstra, Eduard E.},
Title = {Precision Medicine in Control of Visceral Leishmaniasis Caused by <i>L.
   donovani</i>},
Journal = {FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY},
Year = {2021},
Volume = {11},
Month = {NOV 9},
Abstract = {Precision medicine and precision global health in visceral leishmaniasis
   (VL) have not yet been described and could take into account how all
   known determinants improve diagnostics and treatment for the individual
   patient. Precision public health would lead to the right intervention in
   each VL endemic population for control, based on relevant
   population-based data, vector exposures, reservoirs, socio-economic
   factors and other determinants. In anthroponotic VL caused by L.
   donovani, precision may currently be targeted to the regional level in
   nosogeographic entities that are defined by the interplay of the
   circulating parasite, the reservoir and the sand fly vector. From this 5
   major priorities arise: diagnosis, treatment, PKDL, asymptomatic
   infection and transmission. These 5 priorities share the immune
   responses of infection with L. donovani as an important final common
   pathway, for which innovative new genomic and non-genomic tools in
   various disciplines have become available that provide new insights in
   clinical management and in control. From this, further precision may be
   defined for groups (e.g. children, women, pregnancy, HIV-VL
   co-infection), and eventually targeted to the individual level.},
Type = {Review},
Affiliation = {Zijlstra, EE (Corresponding Author), Rotterdam Ctr Trop Med, Clin Sci, Rotterdam, Netherlands.
   Zijlstra, Eduard E., Rotterdam Ctr Trop Med, Clin Sci, Rotterdam, Netherlands.},
DOI = {10.3389/fcimb.2021.707619},
Article-Number = {707619},
Keywords = {precision medicine and public heath; visceral leishmaniasis; diagnosis;
   treatment; PKDL; asymptomatic infection; transmission and infection;
   immune responses},
Keywords-Plus = {AZAR DERMAL LEISHMANIASIS; LINKED-IMMUNOSORBENT-ASSAY; KALA-AZAR;
   INFECTIOUS-DISEASES; DIAGNOSIS; PARASITES; HISTORY; SUDAN;
   PHARMACOGENOMICS; EVOLUTIONARY},
Research-Areas = {Immunology; Microbiology},
Web-of-Science-Categories  = {Immunology; Microbiology},
Author-Email = {e.e.zijlstra@roctm.com},
Cited-References = {Abeijon C, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008246.
   Adaui V, 2016, J INFECT DIS, V213, P112, DOI 10.1093/infdis/jiv354.
   Adriaensen W, 2020, EBIOMEDICINE, V55, DOI 10.1016/j.ebiom.2020.102748.
   Aklilu E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175308.
   Akopyants NS, 2009, SCIENCE, V324, P265, DOI 10.1126/science.1169464.
   Akuffo H, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006375.
   Alkhaldy HY, 2020, IDCases, V21, DOI 10.1016/j.idcr.2020.e00804.
   Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671.
   Alves F, 2018, CLIN MICROBIOL REV, V31, DOI 10.1128/CMR.00048-18.
   {[}Anonymous], SEAVBC85 WHO SEARO.
   {[}Anonymous], 2012, POSTK AZ DERM LEISHM.
   Ansari NA, 2008, CLIN EXP IMMUNOL, V154, P391, DOI 10.1111/j.1365-2249.2008.03761.x.
   Ansari NA, 2008, T ROY SOC TROP MED H, V102, P1160, DOI 10.1016/j.trstmh.2008.05.015.
   Antinori S, 2007, CLIN INFECT DIS, V44, P1602, DOI 10.1086/518167.
   Baker JL, 2017, PHARMACOGENOMICS J, V17, P112, DOI 10.1038/tpj.2016.78.
   Bern C, 2006, AM J TROP MED HYG, V75, P744, DOI 10.4269/ajtmh.2006.75.744.
   Bern C, 2006, INDIAN J MED RES, V123, P275.
   Bern C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000599.
   Blackwell JM, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.590888.
   Blackwell JM, 2020, HUM GENET, V139, P813, DOI 10.1007/s00439-020-02130-w.
   Boelaert M, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009135.pub2.
   Bolia R, 2021, INDIAN J PEDIATR, V88, P73, DOI 10.1007/s12098-020-03361-5.
   Botana L, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007461.
   Bourdeau P, 2020, VET PARASITOL, V287, DOI 10.1016/j.vetpar.2020.109237.
   Brodskyn CI, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00245.
   Campolina TB, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008666.
   Carnielli JBT, 2019, AM J TROP MED HYG, V101, P789, DOI 10.4269/ajtmh.18-0949.
   Carnielli JBT, 2018, EBIOMEDICINE, V36, P83, DOI 10.1016/j.ebiom.2018.09.029.
   Chakravarty J, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007216.
   Chapman LAC, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006803.
   Chapman LAC, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006453.
   Chaudhry M, 2016, APPL TRANSL GENOM, V9, P3, DOI 10.1016/j.atg.2016.04.001.
   Cloots K, 2021, FRONT CELL INFECT MI, V11, DOI 10.3389/fcimb.2021.645121.
   Cloots K, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0007995.
   Colomba C, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3947-x.
   Dedet JP, 1995, T ROY SOC TROP MED H, V89, P644, DOI 10.1016/0035-9203(95)90427-1.
   Dey A, 2007, INFECT GENET EVOL, V7, P219, DOI 10.1016/j.meegid.2006.09.001.
   Dey R, 2018, CELL HOST MICROBE, V23, P134, DOI 10.1016/j.chom.2017.12.002.
   Diro E, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0006988.
   Diro E, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002869.
   Ditgen D, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/964350.
   El Hassan AM, 2013, CASE REP MED, V2013, DOI 10.1155/2013/351579.
   Elnaiem DEA, 2011, J VECTOR ECOL, V36, pS23, DOI 10.1111/j.1948-7134.2011.00109.x.
   Fakiola M, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007673.
   Fakiola M, 2013, NAT GENET, V45, P208, DOI 10.1038/ng.2518.
   Faleiro RJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002914.
   Fararouei M, 2018, J INFECT DEV COUNTR, V12, P1045, DOI 10.3855/jidc.10185.
   Farouk S, 2010, PUBLIC HEALTH GENOM, V13, P362, DOI 10.1159/000272457.
   Flahault Antoine, 2017, Rev Prat, V67, P25.
   Flahault A, 2017, SWISS MED WKLY, V147, DOI 10.4414/smw.2017.14423.
   Gedda MR, 2021, WIRES NANOMED NANOBI, V13, DOI 10.1002/wnan.1675.
   Ghosh M, 2013, J ANTIMICROB CHEMOTH, V68, P2834, DOI 10.1093/jac/dkt262.
   Ghosh S, 2012, J CLIN MICROBIOL, V50, P2774, DOI 10.1128/JCM.00966-12.
   Ginouvès M, 2021, CLIN MICROBIOL INFEC, V27, DOI 10.1016/j.cmi.2020.04.037.
   Goyal V, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008429.
   GRAMICCIA M, 1990, T ROY SOC TROP MED H, V84, P371, DOI 10.1016/0035-9203(90)90322-6.
   Griffin DE, 2010, IMMUNOL REV, V236, P176, DOI 10.1111/j.1600-065X.2010.00925.x.
   Grybchuk D, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12020168.
   Hailu A, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000709.
   Ibarra-Meneses AV, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17315-z.
   Jaber HT, 2018, INFECT GENET EVOL, V65, P80, DOI 10.1016/j.meegid.2018.07.016.
   Kamhawi S, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00099.
   Karmakar S, 2021, FUTURE MICROBIOL, V16, P657, DOI {[}10.2217/fmb-2020-0239, 10.2217/fmb-2020-0239C].
   Khalil EAG, 2000, LANCET, V356, P1565, DOI 10.1016/S0140-6736(00)03128-7.
   Khalil Eltahir Awad Gasim, 2013, J Trop Med, V2013, P275253, DOI 10.1155/2013/275253.
   Khoury MJ, 2016, AM J PREV MED, V50, P398, DOI 10.1016/j.amepre.2015.08.031.
   Kip AE, 2021, J ANTIMICROB CHEMOTH, V76, P1258, DOI 10.1093/jac/dkab013.
   Kip AE, 2018, CLIN PHARMACOKINET, V57, P151, DOI 10.1007/s40262-017-0570-0.
   Ko ER, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4462-9.
   Koopmans AB, 2021, TRANSL PSYCHIAT, V11, DOI 10.1038/s41398-020-01129-1.
   Kuhls K, 2007, MICROBES INFECT, V9, P334, DOI 10.1016/j.micinf.2006.12.009.
   Kumar R, 2001, CLIN DIAGN LAB IMMUN, V8, P1220, DOI 10.1128/CDLI.8.6.1220-1224.2001.
   Kumar R, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01492.
   Kushwaha AK, 2022, TRANSBOUND EMERG DIS, V69, P268, DOI 10.1111/tbed.14061.
   Le Rutte EA, 2019, TRENDS PARASITOL, V35, P590, DOI 10.1016/j.pt.2019.06.007.
   Lestinova T, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005600.
   Li N, 2021, SMALL METHODS, V5, DOI 10.1002/smtd.202000792.
   Lima ID, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006164.
   Lockard RD, 2019, J IMMUNOL RES, V2019, DOI 10.1155/2019/4103819.
   Louzir H., 1993, Archives de l'Institut Pasteur de Tunis, V70, P357.
   Lu HY, 2016, GENOM PROTEOM BIOINF, V14, P265, DOI 10.1016/j.gpb.2016.05.004.
   Lukes J, 2007, P NATL ACAD SCI USA, V104, P9375, DOI 10.1073/pnas.0703678104.
   Macedo DH, 2016, MOL BIOCHEM PARASIT, V210, P50, DOI 10.1016/j.molbiopara.2016.08.005.
   Mandell MA, 2017, P NATL ACAD SCI USA, V114, pE801, DOI 10.1073/pnas.1619265114.
   Martínez DY, 2020, OPEN FORUM INFECT DI, V7, DOI 10.1093/ofid/ofaa155.
   Matimba A, 2008, EUR J HUM GENET, V16, P780, DOI 10.1038/ejhg.2008.49.
   Mauvais-Jarvis F, 2020, LANCET, V396, P565, DOI 10.1016/S0140-6736(20)31561-0.
   Mbui J, 2019, CLIN INFECT DIS, V68, P1530, DOI 10.1093/cid/ciy747.
   McSorley HJ, 2012, CLIN MICROBIOL REV, V25, P585, DOI 10.1128/CMR.05040-11.
   Miller E, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003288.
   Mina MJ, 2019, SCIENCE, V366, P599, DOI 10.1126/science.aay6485.
   Mishra J, 2013, PARASITOL RES, V112, P1001, DOI 10.1007/s00436-012-3222-1.
   Mitropoulos K, 2015, HUM GENOMICS, V9, DOI 10.1186/s40246-015-0033-3.
   Mohapatra TM, 2010, J INFECT DEV COUNTR, V4, P114, DOI 10.3855/jidc.544.
   Molina R, 2017, CLIN INFECT DIS, V65, P150, DOI 10.1093/cid/cix245.
   Mondal D, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007653.
   Mondal D, 2019, CLIN INFECT DIS, V69, P251, DOI 10.1093/cid/ciy891.
   Mondal D, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1572-8.
   Bermudi PMM, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-05125-0.
   Moulik S, 2018, CLIN INFECT DIS, V66, P404, DOI 10.1093/cid/cix808.
   Mukherjee S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37144-y.
   Mukhopadhyay D, 2012, T ROY SOC TROP MED H, V106, P668, DOI 10.1016/j.trstmh.2012.07.005.
   Musa A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001674.
   Musa AM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000855.
   Musa AM, 2008, T ROY SOC TROP MED H, V102, P58, DOI 10.1016/j.trstmh.2007.08.006.
   Musa AM, 2005, ANN TROP MED PARASIT, V99, P563, DOI 10.1179/136485905X514127.
   Musa AM, 2002, ANN TROP MED PARASIT, V96, P765, DOI 10.1179/000349802125002211.
   Nandy A, 1998, TROP MED INT HEALTH, V3, P76, DOI 10.1046/j.1365-3156.1998.00176.x.
   Neu KE, 2017, TRENDS IMMUNOL, V38, P140, DOI 10.1016/j.it.2016.12.001.
   Nuel G, 2021, MALARIA J, V20, DOI 10.1186/s12936-020-03530-z.
   Okwor I, 2008, IMMUNOL RES, V41, P123, DOI 10.1007/s12026-008-8016-2.
   Ostyn B, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001284.
   Ozdemir V, 2006, NAT BIOTECHNOL, V24, P942, DOI 10.1038/nbt0806-942.
   Palic S, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.02507-18.
   Das VNR, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008272.
   Raju BVS, 2008, PARASITOLOGY, V135, P23, DOI 10.1017/S0031182007003484.
   Ramesh V, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004093.
   Rijal S, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.k5224.
   Roden DM, 2019, LANCET, V394, P521, DOI 10.1016/S0140-6736(19)31276-0.
   Rossi M, 2018, INT IMMUNOL, V30, P103, DOI 10.1093/intimm/dxx075.
   Rossi M, 2017, P NATL ACAD SCI USA, V114, P4987, DOI 10.1073/pnas.1621447114.
   Saha P, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005391.
   Salotra P, 2001, J CLIN MICROBIOL, V39, P849, DOI 10.1128/JCM.39.3.849-854.2001.
   Salotra P, 2006, MICROBES INFECT, V8, P637, DOI 10.1016/j.micinf.2005.08.018.
   Samarasinghe SR, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-5271-z.
   SCHAEFER KU, 1994, AM J TROP MED HYG, V50, P78, DOI 10.4269/ajtmh.1994.50.78.
   Singh OP, 2021, LANCET MICROBE, V2, pE23, DOI 10.1016/S2666-5247(20)30166-X.
   Singh OP, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008363.
   Singh OP, 2021, J INFECT DIS, V223, P517, DOI 10.1093/infdis/jiaa381.
   Singh OP, 2019, NANOMEDICINE-UK, V14, P1911, DOI 10.2217/nnm-2018-0448.
   Snider H, 2009, NEUROIMMUNOMODULAT, V16, P106, DOI 10.1159/000180265.
   SOKAL JE, 1975, NEW ENGL J MED, V293, P501, DOI 10.1056/NEJM197509042931013.
   Sundar S, 2018, MOL DIAGN THER, V22, P443, DOI 10.1007/s40291-018-0343-y.
   Sundar S, 2011, LANCET, V377, P477, DOI 10.1016/S0140-6736(10)62050-8.
   Tajebe F, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005727.
   Tanak AS, 2021, BIOSENS BIOELECTRON, V171, DOI 10.1016/j.bios.2020.112726.
   Tekola-Ayele F, 2015, PUBLIC HEALTH GENOM, V18, P242, DOI 10.1159/000433518.
   Telleria EL, 2018, PARASITOLOGY, V145, P1336, DOI 10.1017/S0031182018001014.
   Thakur L, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.00345.
   Topno RK, 2020, AM J TROP MED HYG, V103, P2257, DOI 10.4269/ajtmh.20-0301.
   van den Bogaart E, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-332.
   van der Auwera G, 2015, CLIN MICROBIOL REV, V28, P265, DOI 10.1128/CMR.00104-14.
   van Griensven J, 2014, CLIN MICROBIOL INFEC, V20, P286, DOI 10.1111/1469-0691.12556.
   van Griensven J, 2018, OPEN FORUM INFECT DI, V5, DOI 10.1093/ofid/ofy059.
   van Griensven J, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003011.
   van Griensven J, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003023.
   Verma N, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/745062.
   Verma N, 2013, J CLIN MICROBIOL, V51, P4217, DOI 10.1128/JCM.01482-13.
   Verma S, 2013, DIAGN MICR INFEC DIS, V75, P390, DOI 10.1016/j.diagmicrobio.2013.01.011.
   Verrest L, 2021, CLIN INFECT DIS, V73, P775, DOI 10.1093/cid/ciab124.
   Vijayamahantesh, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154117.
   Wasunna M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004880.
   WHO, 2011, SEACD239 WHO.
   WHO, 2017, SELF LEARN ONL COURS.
   WHO, 2013, POSTKAL AZ DERM LEIS.
   Williams E, 2020, AM J TROP MED HYG, V103, P1930, DOI 10.4269/ajtmh.19-0841.
   World Health Organisation, 2020, WEEKLY EPIDEMIOL REC, V95, P265.
   Wu Y, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.581639.
   Younis BM, 2016, INT J RES MED SCI, V3, P16.
   Younis BM, 2021, MOL THER, V29, P2366, DOI 10.1016/j.ymthe.2021.03.020.
   Zackay A, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007133.
   Zackay A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002031.
   Zijistra EE, 2003, LANCET INFECT DIS, V3, P87, DOI 10.1016/S1473-3099(03)00517-6.
   Zijlstra EE, 2020, PARASITE VECTOR, V13, DOI 10.1186/s13071-020-04011-7.
   Zijlstra EE, 2020, AM J TROP MED HYG, V102, P286, DOI 10.4269/ajtmh.19-0370.
   Zijlstra EE, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00228.
   Zijlstra EE, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1721-0.
   Zijlstra EE, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003258.
   ZIJLSTRA EE, 1993, T ROY SOC TROP MED H, V87, P425, DOI 10.1016/0035-9203(93)90024-K.
   ZIJLSTRA EE, 1994, AM J TROP MED HYG, V51, P826, DOI 10.4269/ajtmh.1994.51.826.
   Zijlstra EE, 1998, CLIN DIAGN LAB IMMUN, V5, P717, DOI 10.1128/CDLI.5.5.717-720.1998.
   Zijlstra EE, 2001, T ROY SOC TROP MED H, V95, pS27, DOI 10.1016/S0035-9203(01)90218-4.},
Number-of-Cited-References = {172},
Times-Cited = {2},
Unique-ID = {WOS:000727874900001},
}

@article{ WOS:000806099300001,
Author = {Xie, Shanghong and Wang, Wenbo and Wang, Qinxia and Wang, Yuanjia and
   Zeng, Donglin},
Title = {Evaluating effectiveness of public health intervention strategies for
   mitigating COVID-19 pandemic},
Journal = {STATISTICS IN MEDICINE},
Year = {2022},
Volume = {41},
Number = {19},
Pages = {3820-3836},
Month = {AUG 30},
Abstract = {Coronavirus disease 2019 (COVID-19) pandemic is an unprecedented global
   public health challenge. In the United States (US), state governments
   have implemented various non-pharmaceutical interventions (NPIs), such
   as physical distance closure (lockdown), stay-at-home order, mandatory
   facial mask in public in response to the rapid spread of COVID-19. To
   evaluate the effectiveness of these NPIs, we propose a nested
   case-control design with propensity score weighting under the
   quasi-experiment framework to estimate the average intervention effect
   on disease transmission across states. We further develop a method to
   test for factors that moderate intervention effect to assist precision
   public health intervention. Our method takes account of the underlying
   dynamics of disease transmission and balance state-level
   pre-intervention characteristics. We prove that our estimator provides
   causal intervention effect under assumptions. We apply this method to
   analyze US COVID-19 incidence cases to estimate the effects of six
   interventions. We show that lockdown has the largest effect on reducing
   transmission and reopening bars significantly increase transmission.
   States with a higher percentage of non-White population are at greater
   risk of increased Rt\$\$ \{R\}\_t \$\$ associated with reopening bars.},
Type = {Article},
Affiliation = {Xie, SH (Corresponding Author), Southwestern Univ Finance \& Econ, Sch Stat, Chengdu, Peoples R China.
   Wang, YJ (Corresponding Author), Columbia Univ, Dept Biostat, Mailman Sch Publ Hlth, New York, NY 10027 USA.
   Zeng, DL (Corresponding Author), Univ N Carolina, Dept Biostat, Chapel Hill, NC 27515 USA.
   Xie, Shanghong, Southwestern Univ Finance \& Econ, Sch Stat, Chengdu, Peoples R China.
   Xie, Shanghong; Wang, Qinxia; Wang, Yuanjia, Columbia Univ, Dept Biostat, Mailman Sch Publ Hlth, New York, NY 10027 USA.
   Wang, Wenbo; Zeng, Donglin, Univ N Carolina, Dept Biostat, Chapel Hill, NC 27515 USA.},
DOI = {10.1002/sim.9482},
EarlyAccessDate = {JUN 2022},
Keywords = {COVID-19; difference-in-difference; heterogeneity of treatment effect;
   infectious disease modeling; non-pharmaceutical interventions;
   quasi-experiments},
Keywords-Plus = {TRANSMISSION},
Research-Areas = {Mathematical \& Computational Biology; Public, Environmental \&
   Occupational Health; Medical Informatics; Research \& Experimental
   Medicine; Mathematics},
Web-of-Science-Categories  = {Mathematical \& Computational Biology; Public, Environmental \&
   Occupational Health; Medical Informatics; Medicine, Research \&
   Experimental; Statistics \& Probability},
Author-Email = {xiesh@swufe.edu.cn
   yw2016@cumc.columbia.edu
   dzeng@email.unc.edu},
Affiliations = {Southwestern University of Finance \& Economics - China; Columbia
   University; University of North Carolina; University of North Carolina
   Chapel Hill},
Cited-References = {Abadie A, 2010, J AM STAT ASSOC, V105, P493, DOI 10.1198/jasa.2009.ap08746.
   Auger KA, 2020, JAMA-J AM MED ASSOC, V324, P859, DOI 10.1001/jama.2020.14348.
   CDC, 2020, Social Vulnerability Index (SVI) data and documentation download.
   Cho SW, 2020, ECONOMET J, V23, P323, DOI 10.1093/ectj/utaa025.
   Davies NG, 2020, LANCET PUBLIC HEALTH, V5, pE375, DOI 10.1016/S2468-2667(20)30133-X.
   Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1.
   ERNSTER VL, 1994, PREV MED, V23, P587, DOI 10.1006/pmed.1994.1093.
   Eubank S, 2020, B MATH BIOL, V82, DOI 10.1007/s11538-020-00726-x.
   Flaxman S, 2020, NATURE, V584, P257, DOI 10.1038/s41586-020-2405-7.
   Hahn JY, 2001, ECONOMETRICA, V69, P201, DOI 10.1111/1468-0262.00183.
   HealthData, 2020, COVID 19 REP PAT IMP.
   Jérémie S, 2020, SWISS MED WKLY, V150, DOI 10.4414/smw.2020.20271.
   Leatherdale ST, 2019, INT J SOC RES METHOD, V22, P19, DOI 10.1080/13645579.2018.1488449.
   Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316.
   Nishiura H, 2020, INT J INFECT DIS, V93, P284, DOI 10.1016/j.ijid.2020.02.060.
   Oran DP, 2020, ANN INTERN MED, V173, P362, DOI 10.7326/M20-3012.
   Pei S, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abd6370.
   Rader B, 2021, LANCET DIGIT HEALTH, V3, pE148, DOI 10.1016/S2589-7500(20)30293-4.
   Rader B, 2020, NAT MED, V26, DOI 10.1038/s41591-020-1104-0.
   Ray EL., ENSEMBLE FORECASTS C, DOI 10.1101/2020.08.19.20177493.
   Wallinga J, 2007, P ROY SOC B-BIOL SCI, V274, P599, DOI 10.1098/rspb.2006.3754.
   Wang QX, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00325.
   Wing C, 2018, ANNU REV PUBL HEALTH, V39, P453, DOI 10.1146/annurev-publhealth-040617-013507.},
Number-of-Cited-References = {23},
Times-Cited = {3},
Unique-ID = {WOS:000806099300001},
}

@article{ WOS:000792850500001,
Author = {Brown, Anne and Hellem, Tracy and Schreiber, James and Buerhaus, Peter
   and Colbert, Alison},
Title = {Suicide and altitude: A systematic review of global literature},
Journal = {PUBLIC HEALTH NURSING},
Year = {2022},
Volume = {39},
Number = {5},
Pages = {1167-1179},
Month = {SEP},
Abstract = {Objective The purpose of this systematic review was to synthesize the
   existing global literature examining the relationship between altitude
   and suicide. Method Using the electronic databases PubMed, CINAHL,
   EMBASE, and PsychInofo published articles in English that addressed the
   relationship between altitude and suicide as a primary or secondary aim,
   and included human subjects, where identified. Studies were assessed for
   quality based on methodological approach and data relevance on a
   three-point scale (strong, moderate, or weak). Results Of the 19 studies
   related to the purpose and aims, 17 reported evidence of a positive
   correlation between altitude and increased suicide. Vast design
   differences were employed within the literature, individual-level
   suicide data was identified as the preferred level of analysis.
   Discussion The relationship between altitude and suicide is an evolving
   science with a small but growing body of literature suggesting altitude
   is associated with an increased risk of suicide. This review identifies
   the need for additional studies examining both individual-level suicide
   data and improving geographic precision. Public health nurses have a
   responsibility to carefully examine the quality of studies and the
   strength of the evidence when addressing variables associated with
   suicide.},
Type = {Review},
Affiliation = {Brown, A (Corresponding Author), Montana State Univ, Anna Pearl Sherrick Hall,POB 173560, Bozeman, MT 59717 USA.
   Brown, Anne; Hellem, Tracy; Buerhaus, Peter, Montana State Univ, Anna Pearl Sherrick Hall,POB 173560, Bozeman, MT 59717 USA.
   Schreiber, James; Colbert, Alison, Duquesne Univ, Pittsburgh, PA 15219 USA.},
DOI = {10.1111/phn.13090},
EarlyAccessDate = {MAY 2022},
Keywords = {altitude; environmental health; geographic information systems (GIS);
   global health; international health; population-based nursing; public
   health nursing; suicide},
Keywords-Plus = {UNITED-STATES; RATES; IMPACT; DEATH},
Research-Areas = {Public, Environmental \& Occupational Health; Nursing},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health; Nursing},
Author-Email = {Anne.brown1@montana.edu},
Affiliations = {Montana State University System; Montana State University Bozeman;
   Duquesne University},
Cited-References = {Asirdizer M, 2018, J FORENSIC LEG MED, V54, P91, DOI 10.1016/j.jflm.2017.12.012.
   Betz ME, 2011, SUICIDE LIFE-THREAT, V41, P562, DOI 10.1111/j.1943-278X.2011.00054.x.
   Bocchetta Alberto, 2017, Clin Pract Epidemiol Ment Health, V13, P246, DOI 10.2174/1745017901713010246.
   Brenner B, 2011, HIGH ALT MED BIOL, V12, P31, DOI 10.1089/ham.2010.1058.
   Case A, 2017, BROOKINGS PAP ECO AC, P397.
   Centers for Disease Control, 2019, WISQARS FAT INJ REP.
   Centers for Disease Control, 2019, PREV SUIC.
   Cheng D, 2010, WILD ENVIRON MED, V21, P177, DOI 10.1016/j.wem.2010.01.004.
   Cooper PN, 1995, MED SCI LAW, V35, P319, DOI 10.1177/002580249503500409.
   Covidence, 2020, Better Systematic Review Management.
   Cromley E.K., 2012, GIS PUBLIC HLTH, V2nd.
   de Beurs DP, 2016, J AFFECT DISORDERS, V196, P218, DOI 10.1016/j.jad.2016.02.033.
   Florence C, 2015, MMWR-MORBID MORTAL W, V64, P1074, DOI 10.15585/mmwr.mm6438a4.
   Fontanella CA, 2015, JAMA PEDIATR, V169, P466, DOI 10.1001/jamapediatrics.2014.3561.
   Frutos AM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206992.
   Gopalakrishnan S, 2013, J Family Med Prim Care, V2, P9, DOI 10.4103/2249-4863.109934.
   Ha HH, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15040671.
   Haws CA, 2009, MED HYPOTHESES, V73, P587, DOI 10.1016/j.mehy.2009.05.040.
   Helbich M, 2013, GEOSPATIAL HEALTH, V7, P209, DOI 10.4081/gh.2013.81.
   Huber RS, 2014, MED HYPOTHESES, V82, P377, DOI 10.1016/j.mehy.2014.01.006.
   Kim J, 2014, PSYCHIAT INVEST, V11, P492, DOI 10.4306/pi.2014.11.4.492.
   Kim N, 2011, AM J PSYCHIAT, V168, P49, DOI 10.1176/appi.ajp.2010.10020289.
   Kious B, 2020, HIGH ALT MED BIOL, V21, P206, DOI 10.1089/ham.2019.0085.
   Kious BM, 2019, INT REV PSYCHIATR, V31, P637, DOI 10.1080/09540261.2019.1586324.
   Lester D, 1999, PERCEPT MOTOR SKILL, V89, P1036, DOI 10.2466/PMS.89.7.1036-1036.
   Merrill RM, 2019, J ENVIRON PUBLIC HEA, V2019, DOI 10.1155/2019/6942787.
   Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005.
   Oka M, 2015, PSYCHIAT CLIN NEUROS, V69, P375, DOI 10.1111/pcn.12254.
   Ortiz-Prado E, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-017-1502-0.
   Priscopo K., 2016, NSDUH DATA REV.
   Riblet NB, 2019, PSYCHIAT RES, V273, P247, DOI 10.1016/j.psychres.2019.01.040.
   Rylander M, 2014, AM J DRUG ALCOHOL AB, V40, P269, DOI 10.3109/00952990.2014.910520.
   Sabic H, 2019, HIGH ALT MED BIOL, V20, P171, DOI 10.1089/ham.2018.0130.
   Selek S, 2013, PSYCHIAT INVEST, V10, P89, DOI 10.4306/pi.2013.10.1.89.
   Shepard DS, 2016, SUICIDE LIFE-THREAT, V46, P352, DOI 10.1111/sltb.12225.
   Stone DM, 2018, MMWR-MORBID MORTAL W, V67, P617, DOI 10.15585/mmwr.mm6722a1.
   TOBLER WR, 1970, ECON GEOGR, V46, P234, DOI 10.2307/143141.
   Tollefsen IM, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-9.
   Trgovac AB, 2015, APPL GEOGR, V62, P201, DOI 10.1016/j.apgeog.2015.04.005.
   Ward M.D., 2019, SPATIAL REGRESSION M.
   Whittemore R, 2005, J ADV NURS, V52, P546, DOI 10.1111/j.1365-2648.2005.03621.x.
   World Health Organization, 2021, TRACK SARS COV 2 VAR.},
Number-of-Cited-References = {42},
Times-Cited = {1},
Unique-ID = {WOS:000792850500001},
}

@article{ WOS:000397010000001,
Author = {Colijn, Caroline and Jones, Nick and Johnston, Iain G. and Yaliraki,
   Sophia and Barahona, Mauricio},
Title = {Toward Precision Healthcare: Context and Mathematical Challenges},
Journal = {FRONTIERS IN PHYSIOLOGY},
Year = {2017},
Volume = {8},
Month = {MAR 21},
Abstract = {Precision medicine refers to the idea of delivering the right treatment
   to the right patient at the right time, usually with a focus on a
   data-centered approach to this task. In this perspective piece, we use
   the term ``precision healthcare{''} to describe the development of
   precision approaches that bridge from the individual to the population,
   taking advantage of individual-level data, but also taking the social
   context into account. These problems give rise to a broad spectrum of
   technical, scientific, policy, ethical and social challenges, and new
   mathematical techniques will be required to meet them. To ensure that
   the science underpinning ``precision{''} is robust, interpretable and
   well-suited to meet the policy, ethical and social questions that such
   approaches raise, the mathematical methods for data analysis should be
   transparent, robust, and able to adapt to errors and uncertainties. In
   particular, precision methodologies should capture the complexity of
   data, yet produce tractable descriptions at the relevant resolution
   while preserving intelligibility and traceability, so that they can be
   used by practitioners to aid decision-making. Through several case
   studies in this domain of precision healthcare, we argue that this
   vision requires the development of new mathematical frameworks, both in
   modeling and in data analysis and interpretation.},
Type = {Article},
Affiliation = {Colijn, C; Barahona, M (Corresponding Author), Imperial Coll London, Dept Math, London, England.
   Colijn, Caroline; Jones, Nick; Barahona, Mauricio, Imperial Coll London, Dept Math, London, England.
   Colijn, Caroline; Jones, Nick; Johnston, Iain G.; Yaliraki, Sophia; Barahona, Mauricio, Imperial Coll London, EPSRC Ctr Math Precis Healthcare, London, England.
   Johnston, Iain G., Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England.
   Yaliraki, Sophia, Imperial Coll London, Dept Chem, London, England.},
DOI = {10.3389/fphys.2017.00136},
Article-Number = {136},
Keywords = {precision medicine; precision healthcare; data science; precision public
   health; mathematical modeling},
Keywords-Plus = {MITOCHONDRIAL-DNA; LUNG-CANCER; REAL-TIME; MEDICINE; DISEASES; PROMISE;
   FUTURE; HYPERTENSION; RESISTANCE; POPULATION},
Research-Areas = {Physiology},
Web-of-Science-Categories  = {Physiology},
Author-Email = {c.colijn@imperial.ac.uk
   m.barahona@imperial.ac.uk},
Affiliations = {Imperial College London; Imperial College London; UK Research \&
   Innovation (UKRI); Engineering \& Physical Sciences Research Council
   (EPSRC); University of Birmingham; Imperial College London},
Cited-References = {Adler NE, 2016, JAMA-J AM MED ASSOC, V316, P1641, DOI 10.1001/jama.2016.14058.
   Amor BR, 2016, DYNAMIC NETWORKS CYB, P111, DOI DOI 10.1142/9781786340757\_0005.
   Antman EM, 2016, NAT REV CARDIOL, V13, P591, DOI 10.1038/nrcardio.2016.101.
   Arnedos M, 2015, NAT REV CLIN ONCOL, V12, P693, DOI 10.1038/nrclinonc.2015.123.
   Arnett DK, 2016, DIABETES CARE, V39, P1870, DOI 10.2337/dc16-1763.
   Barnett D, 2008, NAT REV MICROBIOL, V6, pS7, DOI 10.1038/nrmicro1998.
   Bayer R, 2015, NEW ENGL J MED, V373, P499, DOI 10.1056/NEJMp1506241.
   Beerenwinkel N, 2015, SYST BIOL, V64, pE1, DOI 10.1093/sysbio/syu081.
   Begley CG, 2012, NATURE, V483, P531, DOI 10.1038/483531a.
   Beguerisse-Díaz M, 2017, DIGIT HEALTH, V3, DOI 10.1177/2055207616688841.
   Beguerisse-Díaz M, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0940.
   Beguerisse-Díaz M, 2013, IEEE GLOB CONF SIG, P937, DOI 10.1109/GlobalSIP.2013.6737046.
   Burgstaller JP, 2015, MOL HUM REPROD, V21, P11, DOI 10.1093/molehr/gau090.
   Burgstaller JP, 2014, CELL REP, V7, P2031, DOI 10.1016/j.celrep.2014.05.020.
   Castaneda Christian, 2015, J Clin Bioinforma, V5, P4, DOI 10.1186/s13336-015-0019-3.
   Centola D, 2010, SCIENCE, V329, P1194, DOI 10.1126/science.1185231.
   Chan Zuckerberg Initiative-Advancing human potential and promoting equal opportunity, 2017, ADV HUM POT PROM EQ.
   Chen R, 2013, WIRES SYST BIOL MED, V5, P73, DOI 10.1002/wsbm.1198.
   Chen R, 2012, CELL, V148, P1293, DOI 10.1016/j.cell.2012.02.009.
   Christakis NA, 2013, STAT MED, V32, P556, DOI 10.1002/sim.5408.
   Ciardiello F, 2014, ANN ONCOL, V25, P1673, DOI 10.1093/annonc/mdu217.
   Cisneros L., 2016, WHITE HOUSE GATES FD.
   Cloney R, 2017, NAT REV GENET, V18, P2, DOI 10.1038/nrg.2016.151.
   Cohn EG, 2017, GENET MED, V19, P157, DOI 10.1038/gim.2016.92.
   Colijn C, 2016, LANCET RESP MED, V4, P6, DOI 10.1016/S2213-2600(15)00510-X.
   Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523.
   de Figueiredo A, 2015, LANCET GLOB HEALTH, V3, P20.
   De Maio N, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005130.
   Delvenne JC, 2010, P NATL ACAD SCI USA, V107, P12755, DOI 10.1073/pnas.0903215107.
   Derks S, 2014, CANCER METAST REV, V33, P161, DOI 10.1007/s10555-013-9462-4.
   Desmond-Hellmann S, 2016, SCIENCE, V353, P731, DOI 10.1126/science.aai7598.
   Didelot X, 2017, MOL BIOL EVOL, V34, P997, DOI 10.1093/molbev/msw275.
   Dimauro S, 2005, ANN MED, V37, P222, DOI 10.1080/07853890510007368.
   Dorrestein PC, 2014, IMMUNITY, V40, P824, DOI 10.1016/j.immuni.2014.05.015.
   Duffy DJ, 2016, BRIEF BIOINFORM, V17, P494, DOI 10.1093/bib/bbv060.
   El Shamieh S, 2012, CLIN CHIM ACTA, V414, P259, DOI 10.1016/j.cca.2012.09.018.
   Friedman AA, 2015, NAT REV CANCER, V15, P747, DOI 10.1038/nrc4015.
   Garber AM, 2009, NEW ENGL J MED, V360, P1925, DOI 10.1056/NEJMp0901355.
   Gardy J, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0726-x.
   Gilbert JA, 2016, NATURE, V535, P94, DOI 10.1038/nature18850.
   Goodman SN, 1999, ANN INTERN MED, V130, P995, DOI 10.7326/0003-4819-130-12-199906150-00008.
   Hall M, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004613.
   Hiley C, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0453-8.
   Hjelm M, 2006, J COMPUT BIOL, V13, P853, DOI 10.1089/cmb.2006.13.853.
   Hood L, 2011, NAT REV CLIN ONCOL, V8, P184, DOI 10.1038/nrclinonc.2010.227.
   Hyslop LA, 2016, NATURE, V534, P383, DOI {[}10.1038/nature18303, 10.1038/nature183030].
   Ignatiadis M, 2014, ANN ONCOL, V25, P2304, DOI 10.1093/annonc/mdu480.
   Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124.
   Jameson JL, 2015, OBSTET GYNECOL SURV, V70, P612, DOI 10.1097/01.ogx.0000472121.21647.38.
   Johnston IG, 2016, MITOCHONDRIAL DNA A, V27, P3423, DOI 10.3109/19401736.2015.1022732.
   Johnston IG, 2016, CELL SYST, V2, P101, DOI 10.1016/j.cels.2016.01.013.
   Jombart T, 2014, EPIDEMICS-NETH, V7, P28, DOI 10.1016/j.epidem.2014.04.003.
   Juengst ET, 2012, HASTINGS CENT REP, V42, P34, DOI 10.1002/hast.65.
   Kao RR, 2014, TRENDS MICROBIOL, V22, P282, DOI 10.1016/j.tim.2014.02.011.
   Khoury MJ, 2016, AM J PREV MED, V50, P398, DOI 10.1016/j.amepre.2015.08.031.
   Khoury MJ, 2012, AM J PREV MED, V42, P639, DOI 10.1016/j.amepre.2012.02.012.
   Klinkenberg D., 2016, BIORXIV, DOI {[}10.1101/069195, DOI 10.1101/069195].
   Lambiotte R, 2015, IEEE T NETWORK SCI E, V1, P76, DOI DOI 10.1109/TNSE.2015.2391998.
   Larson HJ, 2016, EBIOMEDICINE, V12, P295, DOI 10.1016/j.ebiom.2016.08.042.
   Liu YY, 2016, REV MOD PHYS, V88, DOI 10.1103/RevModPhys.88.035006.
   Loohuis LO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108358.
   Mallat S, 2016, PHILOS T R SOC A, V374, DOI 10.1098/rsta.2015.0203.
   Marmot M, 2007, LANCET, V370, P1153, DOI 10.1016/S0140-6736(07)61385-3.
   Mirnezami R, 2012, NEW ENGL J MED, V366, P489, DOI 10.1056/NEJMp1114866.
   Muraro A, 2016, J ALLERGY CLIN IMMUN, V137, P1347, DOI 10.1016/j.jaci.2016.03.010.
   Navin NE, 2015, GENOME RES, V25, P1499, DOI 10.1101/gr.191098.115.
   Noveck B.S., 2015, Smart Citizens, Smarter State: The Technologies of Expertise and the Future of Governing: Beth Simone Noveck: 9780674286054.
   Nyhan B, 2014, PEDIATRICS, V133, pE835, DOI 10.1542/peds.2013-2365.
   O'Neil C, 2016, Weapons of math destruction.
   Onnela JP, 2016, SOC SCI MED, V153, P99, DOI 10.1016/j.socscimed.2016.01.024.
   Pagel M, 2006, AM NAT, V167, P808, DOI 10.1086/503444.
   Palmisano A, 2017, BRIEF BIOINFORM, V18, P723, DOI 10.1093/bib/bbw059.
   Perez F, 2016, EXPERT OPIN PHARMACO, V17, P761, DOI 10.1517/14656566.2016.1145658.
   Pickett KE, 2015, SOC SCI MED, V128, P316, DOI 10.1016/j.socscimed.2014.12.031.
   Prinz F, 2011, NAT REV DRUG DISCOV, V10, P712, DOI 10.1038/nrd3439-c1.
   Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996.
   Rosell R, 2013, NAT REV CLIN ONCOL, V10, P549, DOI 10.1038/nrclinonc.2013.152.
   Rost B, 2016, FEBS LETT, V590, P2327, DOI 10.1002/1873-3468.12307.
   Roychowdhury S, 2013, J CLIN ONCOL, V31, P1866, DOI 10.1200/JCO.2012.45.3662.
   Royrvik EC, 2016, MOL HUM REPROD, V22, P809, DOI 10.1093/molehr/gaw062.
   Rubin MA, 2015, NATURE, V520, P290, DOI 10.1038/520290a.
   Salathé M, 2008, J R SOC INTERFACE, V5, P1505, DOI 10.1098/rsif.2008.0271.
   Sboner A, 2016, BRIEF BIOINFORM, V17, P145, DOI 10.1093/bib/bbv032.
   Schaub MT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032210.
   Schork NJ, 2015, NATURE, V520, P609, DOI 10.1038/520609a.
   Servant N, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00152.
   Shalizi CR, 2011, SOCIOL METHOD RES, V40, P211, DOI 10.1177/0049124111404820.
   Snyder-Mackler N, 2016, SCIENCE, V354, P1041, DOI 10.1126/science.aah3580.
   Stover DG, 2015, CURR ONCOL REP, V17, DOI 10.1007/s11912-015-0438-0.
   Trusheim MR, 2011, NAT REV DRUG DISCOV, V10, P817, DOI 10.1038/nrd3557.
   Vanderkooi OG, 2005, CLIN INFECT DIS, V40, P1288, DOI 10.1086/429242.
   Vargas AJ, 2016, NAT REV CANCER, V16, P525, DOI 10.1038/nrc.2016.56.
   Wang Z, 2016, PHYS REP, V664, P1, DOI 10.1016/j.physrep.2016.10.006.
   Williams BP, 2013, ELIFE, V2, DOI 10.7554/eLife.00961.
   Wills QF, 2015, HUM MOL GENET, V24, pR74, DOI 10.1093/hmg/ddv235.
   Worby C. J., 2015, BIORXIV, DOI {[}10.1101/032458, DOI 10.1101/032458].
   Worby CJ, 2016, ANN APPL STAT, V10, P395, DOI 10.1214/15-AOAS898.
   Xiao T, 2015, PROC CVPR IEEE, P2691, DOI 10.1109/CVPR.2015.7298885.
   Yamada M, 2016, CELL STEM CELL, V18, P749, DOI 10.1016/j.stem.2016.04.001.
   Yarchoan M, 2014, DIABETES, V63, P2253, DOI 10.2337/db14-0287.
   Zhang WC, 2015, PREV CHRONIC DIS, V12, DOI 10.5888/pcd12.150192.
   Ziliak Stephen T., 2008, The cult of statistical significance: how the standard error costs us jobs, justice, and lives.},
Number-of-Cited-References = {102},
Times-Cited = {19},
Unique-ID = {WOS:000397010000001},
}

@article{ WOS:000599795500001,
Author = {Ge, Hui and Fan, Debao and Wan, Ming and Jin, Lizhu and Wang, Xiaofeng
   and Du, Xuejie and Yang, Xu},
Title = {How to Determine the Early Warning Threshold Value of Meteorological
   Factors on Influenza through Big Data Analysis and Machine Learning},
Journal = {COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE},
Year = {2020},
Volume = {2020},
Month = {DEC 2},
Abstract = {Infectious diseases are a major health challenge for the worldwide
   population. Since their rapid spread can cause great distress to the
   real world, in addition to taking appropriate measures to curb the
   spread of infectious diseases in the event of an outbreak, proper
   prediction and early warning before the outbreak of the threat of
   infectious diseases can provide an important basis for early and
   reasonable response by the government health sector, reduce morbidity
   and mortality, and greatly reduce national losses. However, if only
   traditional medical data is involved, it may be too late or too
   difficult to implement prediction and early warning of an infectious
   outbreak. Recently, medical big data has become a research hotspot and
   has played an increasingly important role in public health, precision
   medicine, and disease prediction. In this paper, we focus on exploring a
   prediction and early warning method for influenza with the help of
   medical big data. It is well known that meteorological conditions have
   an influence on influenza outbreaks. So, we try to find a way to
   determine the early warning threshold value of influenza outbreaks
   through big data analysis concerning meteorological factors. Results
   show that, based on analysis of meteorological conditions combined with
   influenza outbreak history data, the early warning threshold of
   influenza outbreaks could be established with reasonable high accuracy.},
Type = {Article},
Affiliation = {Yang, X (Corresponding Author), Beijing Inst Technol, Sch Comp Sci \& Technol, Beijing 100081, Peoples R China.
   Ge, Hui; Wan, Ming; Jin, Lizhu; Wang, Xiaofeng; Du, Xuejie, Chinese Ctr Dis Control \& Prevent, Beijing 102206, Peoples R China.
   Fan, Debao; Yang, Xu, Beijing Inst Technol, Sch Comp Sci \& Technol, Beijing 100081, Peoples R China.},
DOI = {10.1155/2020/8845459},
Article-Number = {8845459},
Research-Areas = {Mathematical \& Computational Biology},
Web-of-Science-Categories  = {Mathematical \& Computational Biology},
Author-Email = {gehui@chinacdc.cn
   3220180792@bit.edu.cn
   wangming@chinacdc.cn
   jinlz@chinacdc.cn
   wangxf@chinacdc.cn
   duxj@chinacdc.cn
   yangxu@tsinghua.edu.cn},
Affiliations = {Chinese Center for Disease Control \& Prevention; Beijing Institute of
   Technology},
Cited-References = {Chen TH, 2018, 2018 IEEE 3RD INTERNATIONAL CONFERENCE ON CLOUD COMPUTING AND BIG DATA ANALYSIS (ICCCBDA), P304, DOI 10.1109/ICCCBDA.2018.8386532.
   CHOI K, 1981, AM J EPIDEMIOL, V113, P227, DOI 10.1093/oxfordjournals.aje.a113091.
   Conesa D, 2015, STAT METHODS MED RES, V24, P206, DOI 10.1177/0962280211414853.
   Dai X., 2017, P IEEE SOUTHEASTCON, DOI DOI 10.1109/SECON.2017.7925400.
   Feng-Yun G., 2019, OCCUPATION HLTH.
   Jhuo SL, 2019, I S INTELL SIG PROC, DOI 10.1109/ispacs48206.2019.8986244.
   Jie Zhang, 2011, Proceedings 2011 IEEE Symposium on Computational Intelligence in Multicriteria Decision-Making (2011 MDCM), P190, DOI 10.1109/SMDCM.2011.5949278.
   Lin WM, 2015, J SYST SOFTWARE, V102, P192, DOI 10.1016/j.jss.2014.05.068.
   Marquez E, 2019, IEEE INT AUT MEET, DOI 10.1109/ropec48299.2019.9057056.
   Mihalik A, 2020, BIOL PSYCHIAT, V87, P368, DOI 10.1016/j.biopsych.2019.12.001.
   Paul M, 2011, STAT MED, V30, P1118, DOI 10.1002/sim.4177.
   Robinson M, 2013, EPIDEMICS-NETH, V5, P111, DOI 10.1016/j.epidem.2013.01.001.
   Rodriguez CR, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-31.
   Saberian F, 2014, IRAN CONF ELECTR ENG, P1921, DOI 10.1109/IranianCEE.2014.6999855.
   Schoenbaum SC, 2004, J PUBLIC HEALTH POL, V25, P435, DOI 10.1057/palgrave.jphp.3190041.
   Ugarte MD, 2010, ENVIRONMETRICS, V21, P270, DOI 10.1002/env.1011.
   Venna SR, 2019, IEEE ACCESS, V7, P7691, DOI 10.1109/ACCESS.2018.2888585.
   WHO, 2020, WHO REP GLOB SURV EP.
   Willem L, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2699-8.
   Windridge D., 2014, KERNEL BASED FRAMEWO.
   Xue HX, 2018, IEEE ACCESS, V6, DOI 10.1109/ACCESS.2017.2771798.
   Yao Q, 2015, J MED SYST, V39, DOI 10.1007/s10916-015-0220-8.},
Number-of-Cited-References = {22},
Times-Cited = {0},
Unique-ID = {WOS:000599795500001},
}

@article{ WOS:000799141300001,
Author = {Diep Thi Hoang and Tran Van Hiep and Thao Thi Phuong Nguyen and Hoang
   Thi My Nhung and Kien Trung Tran and Le Sy Vinh},
Title = {Exploring the Kinh Vietnamese genomic database for the polymorphisms of
   the P450 genes towards precision public health},
Journal = {ANNALS OF HUMAN BIOLOGY},
Year = {2022},
Volume = {49},
Number = {2},
Pages = {152-155},
Month = {FEB 17},
Abstract = {Background Human cytochrome P450 (CYPs) genes are essential in
   metabolising drugs. Due to their high polymorphism, population-specific
   studies are of great interest. Aim This research examined the six CYP
   genes, including CYP2B6, CYP2C9, CYP2C19, CYP2D6, CYP3A5, and CYP4F2 in
   the Kinh Vietnamese (KHV) for population-scale precision medicine.
   Subjects and methods We processed data from a genomics database of 206
   healthy and unrelated KHV individuals to calculate CYP allele
   frequencies. First, we compared the CYP genes of the KHV to six other
   populations retrieved from the 1000 Genomes Project. Second, we searched
   the PharmGBK database for drug-CYP interaction data to compile a drug
   dosage recommendation for the KHV. Results We observed the diverging
   trends in genetic variations of CYP2B6, CYP2D6, and CYP3A5 in the KHV.
   Regarding phenotypic drug responses in the KHV, CYP2C19 exhibited all
   metabolic phenotypes at a non-trivial frequency. In addition, CYP3A5
   metabolised drugs at a lower rate compared to the other five CYPs.
   Conclusion This is the first large-scale study to investigate multiple
   CYP genes in the KHV for precision medicine from a public health
   perspective. Differences found in the distributions of metabolizers for
   the KHV suggest careful prescriptions for CYP2C19 and CYP3A5-metabolised
   drugs.},
Type = {Article},
Affiliation = {Vinh, L (Corresponding Author), Vietnam Natl Univ Hanoi, VNU Univ Engn \& Technol, 144 Xuan Thuy, Hanoi, Vietnam.
   Diep Thi Hoang; Le Sy Vinh, Vietnam Natl Univ Hanoi, VNU Univ Engn \& Technol, 144 Xuan Thuy, Hanoi, Vietnam.
   Tran Van Hiep; Hoang Thi My Nhung, Vietnam Natl Univ Hanoi, VNU Univ Sci, Hanoi, Vietnam.
   Thao Thi Phuong Nguyen, Vietnam Acad Sci \& Technol, Inst Informat Technol, Hanoi, Vietnam.
   Hoang Thi My Nhung; Kien Trung Tran, Vinmec Res Inst Stem Cell \& Gene Technol, Hanoi, Vietnam.},
DOI = {10.1080/03014460.2022.2052961},
EarlyAccessDate = {MAY 2022},
Keywords = {CYP450; pharmacogenetics; KHV; drug dosing; next-generation sequencing},
Keywords-Plus = {PHARMACOGENETICS IMPLEMENTATION CONSORTIUM; CPIC GUIDELINE},
Research-Areas = {Anthropology; Life Sciences \& Biomedicine - Other Topics; Public,
   Environmental \& Occupational Health},
Web-of-Science-Categories  = {Anthropology; Biology; Public, Environmental \& Occupational Health},
Author-Email = {vinhls@vnu.edu.vn},
Affiliations = {Vietnam National University Hanoi; Vietnam National University Hanoi;
   Vietnam Academy of Science \& Technology (VAST)},
Cited-References = {Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393.
   Birdwell KA, 2015, CLIN PHARMACOL THER, V98, P19, DOI 10.1002/cpt.113.
   Brown JT, 2019, CLIN PHARMACOL THER, V106, P94, DOI 10.1002/cpt.1409.
   Browning BL, 2018, AM J HUM GENET, V103, P338, DOI 10.1016/j.ajhg.2018.07.015.
   Crow JF, 1999, GENETICS, V152, P821.
   Desta Z, 2019, CLIN PHARMACOL THER, V106, P726, DOI 10.1002/cpt.1477.
   DUNN OJ, 1959, ANN MATH STAT, V30, P192, DOI 10.1214/aoms/1177706374.
   Gaedigk A, 2019, CLIN PHARMACOL THER, V105, P29, DOI 10.1002/cpt.1275.
   Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313.
   Nguyen HH, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000015891.
   Hicks JK, 2017, CLIN PHARMACOL THER, V102, P37, DOI 10.1002/cpt.597.
   Hicks JK, 2015, CLIN PHARMACOL THER, V98, P127, DOI 10.1002/cpt.147.
   Johnson JA, 2017, CLIN PHARMACOL THER, V102, P397, DOI 10.1002/cpt.668.
   Khoury MJ, 2021, GENOME MED, V13, DOI 10.1186/s13073-021-00886-y.
   Koopmans AB, 2021, TRANSL PSYCHIAT, V11, DOI 10.1038/s41398-020-01129-1.
   Lakiotaki K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182138.
   Lee SS, 2005, THER DRUG MONIT, V27, P208, DOI 10.1097/01.ftd.0000153402.91854.42.
   NEI M, 1977, THEOR POPUL BIOL, V11, P307, DOI 10.1016/0040-5809(77)90014-4.
   Vu NP, 2019, ANN HUM BIOL, V46, P491, DOI 10.1080/03014460.2019.1687750.
   Nordling L, 2017, NATURE, V544, P20, DOI 10.1038/544020a.
   Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720.
   Relling MV, 2011, CLIN PHARMACOL THER, V89, P464, DOI 10.1038/clpt.2010.279.
   Roberts MC, 2021, GENOME MED, V13, DOI 10.1186/s13073-021-00911-0.
   RStudio Team, 2019, R Studio: Integrated Development for R.
   Sivadas A, 2019, ADV GENET, V103, P119, DOI 10.1016/bs.adgen.2018.09.001.
   Theken KN, 2020, CLIN PHARMACOL THER, V108, P191, DOI 10.1002/cpt.1830.
   Le VS, 2019, HUM MUTAT, V40, P1664, DOI 10.1002/humu.23835.
   Whirl-Carrillo M, 2012, CLIN PHARMACOL THER, V92, P414, DOI 10.1038/clpt.2012.96.},
Number-of-Cited-References = {28},
Times-Cited = {0},
Unique-ID = {WOS:000799141300001},
}

@article{ WOS:000631928700006,
Author = {Van Rie, A. and de Viedma, D. G. and Meehan, C. and Comas, I and
   Heupink, T. H. and De Vos, E. and de Onate, W. A. and Mathys, V and
   Ceyssens, P-J and Groenen, G. and Gonzalez-Candelas, F. and Forier, A.
   and Juengst, E.},
Title = {Whole-genome sequencing for TB source investigations: principles of
   ethical precision public health},
Journal = {INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE},
Year = {2021},
Volume = {25},
Number = {3},
Pages = {222+},
Month = {MAR 1},
Abstract = {BACKGROUND: Whole-genome sequencing (WGS) of Mycobacterium tuberculosis
   allows rapid, accurate inferences about the sources, location and timing
   of transmission. However, in an era of heightened concern for personal
   privacy and science distrust, such inferences could result in unintended
   harm and undermine the public's trust.
   METHODS: We held interdisciplinary stakeholder discussions and performed
   ethical analyses of real-world illustrative cases to identify principles
   that optimise benefit and mitigate harm of M. tuberculosis WGSdriven TB
   source investigations.
   RESULTS: The speed and precision with which real-time WGS can be used to
   associate M. tuberculosis strains with sensitive information has raised
   important concerns. While detailed understanding of transmission events
   could mitigate harm to vulnerable patients and communities when
   otherwise unfairly blamed for TB outbreaks, the precision of WGS can
   also identify transmission events resulting in social blame, fear,
   discrimination, individual or location stigma, and the use of defaming
   language by the public, politicians and scientists. Public health
   programmes should balance the need to safeguard privacy with public
   health goals, transparency and individual rights, including the right to
   know who infects whom or where.
   CONCLUSIONS: Ethical challenges raised by real-time WGS-driven TB source
   investigation requires public health authorities to move beyond their
   current legal mandate and embrace transparency, privacy and community
   engagement.},
Type = {Article},
Affiliation = {Van Rie, A (Corresponding Author), Univ Antwerp, Fac Med, Epidemiol \& Social Med, Campus Drie Eiken R232,Univ Pl 1, B-2610 Antwerp, Belgium.
   Van Rie, A.; Heupink, T. H.; De Vos, E., Univ Antwerp, Fac Med, Dept Family Med \& Populat Hlth, Antwerp, Belgium.
   de Viedma, D. G., Inst Invest Sanitaria Gregorio Maranon, Madrid, Spain.
   Meehan, C., Univ Bradford, Sch Chem \& Biosci, Bradford, W Yorkshire, England.
   Comas, I, Fdn Fomento Invest Sanitaria \& Biomed FISABIO Pub, Valencia, Spain.
   de Onate, W. A., Flemish Assoc Resp Hlth \& TB Control, Antwerp, Belgium.
   Mathys, V; Ceyssens, P-J, Belgian Lung \& TB Assoc, Brussels, Belgium.
   Groenen, G., Sciensano, Natl Reference Ctr TB \& Mycobacteria, Infect Dis Humans, Brussels, Belgium.
   Gonzalez-Candelas, F., Univ Valencia, I2SysBio, Joint Res Unit Infect \& Publ Hlth FISABIO, Valencia, Spain.
   Gonzalez-Candelas, F., CIBER Epidemiol \& Publ Hlth, Valencia, Spain.
   Forier, A., Govt Flanders, Agcy Care \& Hlth, Brussels, Belgium.
   Juengst, E., Univ North Carolina Chapel Hill, Dept Social Med, Chapel Hill, NC USA.},
DOI = {10.5588/ijtld.20.0886},
Keywords = {KEY WORDS; epidemiology; tuberculosis; source in-vestigation;
   whole-genome sequencing; ethics},
Keywords-Plus = {RESISTANT MYCOBACTERIUM-TUBERCULOSIS; TRANSMISSION; OUTBREAK; MEDICINE},
Research-Areas = {Infectious Diseases; Respiratory System},
Web-of-Science-Categories  = {Infectious Diseases; Respiratory System},
Author-Email = {Annelies.Vanrie@uantwerpen.be},
Affiliations = {University of Antwerp; University of Bradford; Sciensano; University of
   Valencia; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP;
   University of North Carolina School of Medicine; University of North
   Carolina; University of North Carolina Chapel Hill},
Cited-References = {Tomás BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082440.
   Abascal E, 2019, EUROSURVEILLANCE, V24, P19, DOI 10.2807/1560-7917.ES.2019.24.4.1800005.
   Alaridah N, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39971-z.
   {[}Anonymous], 2019, FILIP WINTER.
   {[}Anonymous], NEW YORK TIMES.
   Arandjelovic I, 2019, EMERG INFECT DIS, V25, P555, DOI 10.3201/eid2503.181220.
   Bjorn-Mortensen K, 2016, SCI REP-UK, V6, DOI 10.1038/srep33180.
   Childress JF, 2002, J LAW MED ETHICS, V30, P170, DOI 10.1111/j.1748-720X.2002.tb00384.x.
   Collins AB, 2019, SOC SCI MED, V234, DOI 10.1016/j.socscimed.2019.112384.
   Comas I., 2018, ENFERM EMERG, V7, P145.
   Craig GM, 2017, INT J INFECT DIS, V56, P90, DOI 10.1016/j.ijid.2016.10.011.
   Daftary A, 2018, AM J TROP MED HYG, V99, P1114, DOI 10.4269/ajtmh.18-0591.
   Francés-Cuesta C, 2019, FORENSIC SCI INT-GEN, V42, P141, DOI 10.1016/j.fsigen.2019.07.003.
   Gardy JL, 2011, NEW ENGL J MED, V364, P730, DOI 10.1056/NEJMoa1003176.
   Genestet C, 2019, EMERG INFECT DIS, V25, P589, DOI 10.3201/eid2503.181124.
   González-Candelas F, 2003, J INFECT DIS, V187, P352, DOI 10.1086/367965.
   González-Candelas F, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-76.
   Gröschel MI, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007297.
   Guthrie JL, 2018, J INFECT DIS, V218, P1155, DOI 10.1093/infdis/jiy278.
   Jackson C, 2019, BMC MED ETHICS, V20, DOI 10.1186/s12910-019-0380-z.
   Johnson SB, 2019, NAT REV GENET, V20, P313, DOI 10.1038/s41576-019-0109-3.
   Juengst E, 2016, HASTINGS CENT REP, V46, P21, DOI 10.1002/hast.614.
   Juengst ET, 2020, GENOME MED, V12, DOI 10.1186/s13073-020-00800-y.
   Kato-Maeda M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058235.
   Khoury MJ, 2016, AM J PREV MED, V50, P398, DOI 10.1016/j.amepre.2015.08.031.
   Korngiebel DM, 2017, TRENDS PHARMACOL SCI, V38, P8, DOI 10.1016/j.tips.2016.11.007.
   Metzker ML, 2002, P NATL ACAD SCI USA, V99, P14292, DOI 10.1073/pnas.222522599.
   Pérez-Lago L, 2016, J CLIN MICROBIOL, V54, P2969, DOI 10.1128/JCM.01718-16.
   Pinet G., 2001, Good practice in legislation and regulations for TB control: An indicator of political will.
   Roetzer A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001387.
   Stop TB., 2019, DECLARATION RIGHTS P.
   van der Werf MJ, 2019, FRONT PUBLIC HEALTH, V7, DOI 10.3389/fpubh.2019.00087.
   Walker TM, 2013, CLIN MICROBIOL INFEC, V19, P796, DOI 10.1111/1469-0691.12183.
   Walker TM, 2018, LANCET INFECT DIS, V18, P431, DOI 10.1016/S1473-3099(18)30004-5.
   Warren JL, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1111-x.
   Weeramanthri TS, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00121.},
Number-of-Cited-References = {36},
Times-Cited = {1},
Unique-ID = {WOS:000631928700006},
}

@article{ WOS:000507800800006,
Author = {Graetz, Nicholas and Woyczynski, Lauren and Wilson, Katherine F. and
   Hall, Jason B. and Abate, Kalkidan Hassen and Abd-Allah, Foad and
   Adebayo, Oladimeji M. and Adekanmbi, Victor and Afshari, Mahdi and
   Ajumobi, Olufemi and Akinyemiju, Tomi and Alahdab, Fares and Al-Aly,
   Ziyad and Alcalde Rabanal, Jacqueline Elizabeth and Alijanzadeh, Mehran
   and Alipour, Vahid and Altirkawi, Khalid and Amiresmaili, Mohammadreza
   and Anber, Nahla Hamed and Andrei, Catalina Liliana and Anjomshoa, Mina
   and Antonio, Carl Abelardo T. and Arabloo, Jalal and Aremu, Olatunde and
   Aryal, Krishna K. and Asadi-Aliabadi, Mehran and Atique, Suleman and
   Ausloos, Marcel and Awasthi, Ashish and Ayala Quintanilla, Beatriz
   Paulina and Azari, Samad and Badawi, Alaa and Banoub, Joseph Adel Mattar
   and Barker-Collo, Suzanne Lyn and Barnett, Anthony and Bedi, Neeraj and
   Bennett, Derrick A. and Bhattacharjee, Natalia V. and Bhattacharyya,
   Krittika and Bhattarai, Suraj and Bhutta, Zulfiqar A. and Bijani, Ali
   and Bikbov, Boris and Britton, Gabrielle and Burstein, Roy and Butt,
   Zahid A. and Cardenas, Rosario and Carvalho, Felix and
   Castaneda-Orjuela, Carlos A. and Castro, Franz and Cerin, Ester and
   Chang, Jung-Chen and Collison, Michael L. and Cooper, Cyrus and Cork,
   Michael A. and Daoud, Farah and Das Gupta, Rajat and Weaver, Nicole
   Davis and De Neve, Jan-Walter and Deribe, Kebede and Desalegn, Beruk
   Berhanu and Deshpande, Aniruddha and Desta, Melaku and Dhimal, Meghnath
   and Diaz, Daniel and Dinberu, Mesfin Tadese and Djalalinia, Shirin and
   Dubey, Manisha and Dubljanin, Eleonora and Duraes, Andre R. and
   Dwyer-Lindgren, Laura and Earl, Lucas and Kalan, Mohammad Ebrahimi and
   El-Khatib, Ziad and Eshrati, Babak and Faramarzi, Mahbobeh and Fareed,
   Mohammad and Faro, Andre and Fereshtehnejad, Seyed-Mohammad and
   Fernandes, Eduarda and Filip, Irina and Fischer, Florian and Fukumoto,
   Takeshi and Garcia, Jose A. and Gill, Paramjit Singh and Gill, Tiffany
   K. and Gona, Philimon N. and Gopalani, Sameer Vali and Grada, Ayman and
   Guo, Yuming and Gupta, Rajeev and Gupta, Vipin and Haj-Mirzaian, Arvin
   and Haj-Mirzaian, Arya and Hamadeh, Randah R. and Hamidi, Samer and
   Hasan, Mehedi and Hassen, Hamid Yimam and Hendrie, Delia and Henok,
   Andualem and Henry, Nathaniel J. and Hernandez Prado, Bernardo and
   Herteliu, Claudiu and Hole, Michael K. and Hossain, Naznin and
   Hosseinzadeh, Mehdi and Hu, Guoqing and Ilesanmi, Olayinka Stephen and
   Irvani, Seyed Sina Naghibi and Islam, Sheikh Mohammed Shariful and
   Izadi, Neda and Jakovljevic, Mihajlo and Jha, Ravi Prakash and Ji, John
   S. and Jonas, Jost B. and Shushtari, Zahra Jorjoran and Jozwiak, Jacek
   Jerzy and Kanchan, Tanuj and Kasaeian, Amir and Karyani, Ali Kazemi and
   Keiyoro, Peter Njenga and Kesavachandran, Chandrasekharan Nair and
   Khader, Yousef Saleh and Khafaie, Morteza Abdullatif and Khan, Ejaz
   Ahmad and Khater, Mona M. and Kiadaliri, Aliasghar A. and Kiirithio,
   Daniel N. and Kim, Yun Jin and Kimokoti, Ruth W. and Kinyoki, Damaris K.
   and Kisa, Adnan and Kosen, Soewarta and Koyanagi, Ai and Krishan, Kewal
   and Defo, Barthelemy Kuate and Kumar, Manasi and Kumar, Pushpendra and
   Lami, Faris Hasan and Lee, Paul H. and Levine, Aubrey J. and Li,
   Shanshan and Liao, Yu and Lim, Lee-Ling and Listl, Stefan and Lopez,
   Jaifred Christian F. and Majdan, Marek and Majdzadeh, Reza and Majeed,
   Azeem and Malekzadeh, Reza and Mansournia, Mohammad Ali and
   Martins-Melo, Francisco Rogerlandio and Masaka, Anthony and Massenburg,
   Benjamin Ballard and Mayala, Benjamin K. and Mehta, Kala M. and Mendoza,
   Walter and Mensah, George A. and Meretoja, Tuomo J. and Mestrovic,
   Tomislav and Miller, Ted R. and Mini, G. K. and Mirrakhimov, Erkin M.
   and Moazen, Babak and Mohammad, Dara K. and Darwesh, Aso Mohammad and
   Mohammed, Shafiu and Mohebi, Farnam and Mokdad, Ali H. and Monasta,
   Lorenzo and Moodley, Yoshan and Moosazadeh, Mahmood and Moradi, Ghobad
   and Moradi-Lakeh, Maziar and Moraga, Paula and Morawska, Lidia and
   Morrison, Shane Douglas and Mosser, Jonathan F. and Mousavi, Seyyed
   Meysam and Murray, Christopher J. L. and Mustafa, Ghulam and Nahvijou,
   Azin and Najafi, Farid and Nangia, Vinay and Ndwandwe, Duduzile Edith
   and Negoi, Ionut and Negoi, Ruxandra Irina and Ngunjiri, Josephine W.
   and Cuong Tat Nguyen and Long Hoang Nguyen and Ningrum, Dina Nur
   Anggraini and Noubiap, Jean Jacques and Shiadeh, Malihe Nourollahpour
   and Nyasulu, Peter S. and Ogbo, Felix Akpojene and Olagunju, Andrew T.
   and Olusanya, Bolajoko Olubukunola and Olusanya, Jacob Olusegun and
   Onwujekwe, Obinna E. and Ortega-Altamirano, Doris D. V. and
   Ortiz-Panozo, Eduardo and Overland, Simon and Mahesh, P. A. and Pana,
   Adrian and Panda-Jonas, Songhomitra and Pati, Sanghamitra and Patton,
   George C. and Perico, Norberto and Pigott, David M. and Pirsaheb,
   Meghdad and Postma, Maarten J. and Pourshams, Akram and Prakash, Swayam
   and Puri, Parul and Qorbani, Mostafa and Radfar, Amir and Rahim, Fakher
   and Rahimi-Movaghar, Vafa and Rahman, Mohammad Hifz Ur and Rajati,
   Fatemeh and Ranabhat, Chhabi Lal and Rawaf, David Laith and Rawaf,
   Salman and Reiner, Jr., Robert C. and Remuzzi, Giuseppe and Renzaho,
   Andre M. N. and Rezaei, Satar and Rezapour, Aziz and Rios-Gonzalez,
   Carlos and Roever, Leonardo and Ronfani, Luca and Roshandel, Gholamreza
   and Rostami, Ali and Rubagotti, Enrico and Sadat, Nafis and Sadeghi,
   Ehsan and Safari, Yahya and Sagar, Rajesh and Salam, Nasir and Salamati,
   Payman and Salimi, Yahya and Salimzadeh, Hamideh and Samy, Abdallah M.
   and Sanabria, Juan and Milicevic, Milena M. Santric and Sartorius, Benn
   and Sathian, Brijesh and Sawant, Arundhati R. and Schaeffer, Lauren E.
   and Schipp, Megan F. and Schwebel, David C. and Senbeta, Anbissa Muleta
   and Sepanlou, Sadaf G. and Shaikh, Masood Ali and Shams-Beyranvand,
   Mehran and Shamsizadeh, Morteza and Sharafi, Kiomars and Sharma, Rajesh
   and She, Jun and Sheikh, Aziz and Shigematsu, Mika and Siabani, Soraya
   and Silveira, Dayane Gabriele Alves and Singh, Jasvinder A. and Sinha,
   Dhirendra Narain and Skirbekk, Vegard and Sligar, Amber and Sobaih, Badr
   Hasan and Soofi, Moslem and Soriano, Joan B. and Soyiri, Ireneous N. and
   Sreeramareddy, Chandrashekhar T. and Sudaryanto, Agus and Sufiyan,
   Mu'awiyyah Babale and Sutradhar, Ipsita and Sylaja, Pn and
   Tabares-Seisdedos, Rafael and Tadesse, Birkneh Tilahun and Temsah,
   Mohamad-Hani and Terkawi, Abdullah Sulieman and Tessema, Belay and
   Tessema, Zemenu Tadesse and Thankappan, Kavumpurathu Raman and
   Topor-Madry, Roman and Tovani-Palone, Marcos Roberto and Tran, Bach Xuan
   and Car, Lorainne Tudor and Ullah, Irfan and Uthman, Olalekan A. and
   Valdez, Pascual R. and Veisani, Yousef and Violante, Francesco S. and
   Vlassov, Vasily and Vollmer, Sebastian and Vu, Giang Thu and Waheed,
   Yasir and Wang, Yuan-Pang and Wilkinson, John C. and Winkler, Andrea
   Sylvia and Wolfe, Charles D. A. and Yamada, Tomohide and Yeshaneh, Alex
   and Yip, Paul and Yisma, Engida and Yonemoto, Naohiro and Younis,
   Mustafa Z. and Yousefifard, Mahmoud and Yu, Chuanhua and Bin Zaman,
   Sojib and Zhang, Jianrong and Zhang, Yunquan and Zodpey, Sanjay and
   Gakidou, Emmanuela and Hay, Simon I. and Local Burden Dis Educ
   Attainment C},
Title = {Mapping disparities in education across low- and middle-income countries},
Journal = {NATURE},
Year = {2020},
Volume = {577},
Number = {7789},
Pages = {235-238},
Month = {JAN 9},
Abstract = {Analyses of the proportions of individuals who have completed key levels
   of schooling across all low- and middle-income countries from 2000 to
   2017 reveal inequalities across countries as well as within populations.
   Educational attainment is an important social determinant of maternal,
   newborn, and child health(1-3). As a tool for promoting gender equity,
   it has gained increasing traction in popular media, international aid
   strategies, and global agenda-setting(4-6). The global health agenda is
   increasingly focused on evidence of precision public health, which
   illustrates the subnational distribution of disease and illness(7,8);
   however, an agenda focused on future equity must integrate comparable
   evidence on the distribution of social determinants of health(9-11).
   Here we expand on the available precision SDG evidence by estimating the
   subnational distribution of educational attainment, including the
   proportions of individuals who have completed key levels of schooling,
   across all low- and middle-income countries from 2000 to 2017. Previous
   analyses have focused on geographical disparities in average attainment
   across Africa or for specific countries, but-to our knowledge-no
   analysis has examined the subnational proportions of individuals who
   completed specific levels of education across all low- and middle-income
   countries(12-14). By geolocating subnational data for more than 184
   million person-years across 528 data sources, we precisely identify
   inequalities across geography as well as within populations.},
Type = {Article},
Affiliation = {Hay, SI (Corresponding Author), Univ Washington, Inst Hlth Metr \& Evaluat, Seattle, WA 98195 USA.
   Hay, SI (Corresponding Author), Univ Washington, Sch Med, Dept Hlth Metr Sci, Seattle, WA 98195 USA.
   Graetz, Nicholas; Woyczynski, Lauren; Wilson, Katherine F.; Hall, Jason B.; Bhattacharjee, Natalia V.; Burstein, Roy; Collison, Michael L.; Cork, Michael A.; Daoud, Farah; Weaver, Nicole Davis; Deshpande, Aniruddha; Dwyer-Lindgren, Laura; Earl, Lucas; Henry, Nathaniel J.; Kinyoki, Damaris K.; Levine, Aubrey J.; Mayala, Benjamin K.; Mokdad, Ali H.; Mosser, Jonathan F.; Murray, Christopher J. L.; Pigott, David M.; Reiner, Robert C., Jr.; Sadat, Nafis; Schaeffer, Lauren E.; Schipp, Megan F.; Sligar, Amber; Wilkinson, John C.; Hay, Simon I., Univ Washington, Inst Hlth Metr \& Evaluat, Seattle, WA 98195 USA.
   Abate, Kalkidan Hassen, Jimma Univ, Dept Populat \& Family Hlth, Jimma, Ethiopia.
   Abd-Allah, Foad, Cairo Univ, Dept Neurol, Cairo, Egypt.
   Adebayo, Oladimeji M., Univ Coll Hosp, Dept Med, Ibadan, Nigeria.
   Adekanmbi, Victor, Cardiff Univ, Sch Med, Cardiff, Wales.
   Afshari, Mahdi, Zabol Univ Med Sci, Dept Community Med, Zabol, Iran.
   Ajumobi, Olufemi, Univ Nevada, Sch Community Hlth Sci, Reno, NV 89557 USA.
   Ajumobi, Olufemi, Fed Minist Hlth, Natl Malaria Eliminat Program, Abuja, Nigeria.
   Akinyemiju, Tomi, Duke Univ, Duke Global Hlth Inst, Durham, NC USA.
   Akinyemiju, Tomi, Duke Univ, Dept Populat Hlth Sci, Durham, NC USA.
   Alahdab, Fares, Mayo Clin Fdn Med Educ \& Res, Evidence Based Practice Ctr, Rochester, MN USA.
   Al-Aly, Ziyad, Washington Univ, Internal Med Dept, St Louis, MO 63110 USA.
   Al-Aly, Ziyad, VA St Louis Hlth Care Syst, Dept Vet Affairs, Clin Epidemiol Ctr, St Louis, MO USA.
   Alcalde Rabanal, Jacqueline Elizabeth; Ortega-Altamirano, Doris D. V., Natl Inst Publ Hlth, Ctr Hlth Syst Res, Cuernavaca, Morelos, Mexico.
   Alijanzadeh, Mehran, Qazvin Univ Med Sci, Qazvin, Iran.
   Alipour, Vahid; Arabloo, Jalal; Azari, Samad; Rezapour, Aziz, Iran Univ Med Sci, Hlth Management \& Econ Res Ctr, Tehran, Iran.
   Altirkawi, Khalid, King Saud Univ, Riyadh, Saudi Arabia.
   Amiresmaili, Mohammadreza, Kerman Univ Med Sci, Dept Hlth Management Policy \& Econ, Kerman, Iran.
   Anber, Nahla Hamed, Mansoura Univ, Fac Med, Mansoura, Egypt.
   Andrei, Catalina Liliana, Carol Davila Univ Med \& Pharm, Bucharest, Romania.
   Anjomshoa, Mina, Rafsanjan Univ Med Sci, Social Determinants Hlth Res Ctr, Rafsanjan, Iran.
   Antonio, Carl Abelardo T., Univ Philippines Manila, Dept Hlth Policy \& Adm, Manila, Philippines.
   Antonio, Carl Abelardo T., Hong Kong Polytech Univ, Dept Appl Social Sci, Hong Kong, Peoples R China.
   Aremu, Olatunde, Birmingham City Univ, Sch Hlth Sci, Birmingham, W Midlands, England.
   Aryal, Krishna K., ABT Associates Nepal, Monitoring Evaluat \& Operat Res Project, Lalitpur, Nepal.
   Asadi-Aliabadi, Mehran; Moradi-Lakeh, Maziar, Iran Univ Med Sci, Prevent Med \& Publ Hlth Res Ctr, Tehran, Iran.
   Atique, Suleman, Univ Hail, Dept Hlth Informat, Hail, Saudi Arabia.
   Ausloos, Marcel; Herteliu, Claudiu; Pana, Adrian, Bucharest Univ Econ Studies, Dept Stat \& Econometr, Bucharest, Romania.
   Awasthi, Ashish; Zodpey, Sanjay, Publ Hlth Fdn India, Indian Inst Publ Hlth, Gurugram, India.
   Ayala Quintanilla, Beatriz Paulina, La Trobe Univ, Judith Lumley Ctr, Melbourne, Vic, Australia.
   Ayala Quintanilla, Beatriz Paulina, Peruvian Natl Inst Hlth, Gen Off Res \& Technol Transfer, Lima, Peru.
   Badawi, Alaa, Publ Hlth Agcy Canada, Publ Hlth Risk Sci Div, Toronto, ON, Canada.
   Badawi, Alaa, Univ Toronto, Dept Nutr Sci, Toronto, ON, Canada.
   Banoub, Joseph Adel Mattar, Alexandria Univ, Fac Med, Alexandria, Egypt.
   Barker-Collo, Suzanne Lyn, Univ Auckland, Sch Psychol, Auckland, New Zealand.
   Barnett, Anthony; Cerin, Ester, Australian Catholic Univ, Mary MacKillop Inst Hlth Res, Melbourne, Vic, Australia.
   Bedi, Neeraj, Gandhi Med Coll Bhopal, Dept Community Med, Bhopal, India.
   Bedi, Neeraj, Jazan Univ, Jazan, Saudi Arabia.
   Bennett, Derrick A., Univ Oxford, Nuffield Dept Populat Hlth, Oxford, England.
   Bhattacharyya, Krittika, Natl Inst Biomed Genom, Dept Stat \& Computat Genom, Kalyani, W Bengal, India.
   Bhattacharyya, Krittika, Univ Calcutta, Dept Stat, Kolkata, India.
   Bhattarai, Suraj, Global Inst Interdisciplinary Studies, Dept Global Hlth, Kathmandu, Nepal.
   Bhutta, Zulfiqar A., Univ Toronto, Ctr Global Child Hlth, Toronto, ON, Canada.
   Bhutta, Zulfiqar A., Aga Khan Univ, Ctr Excellence Women \& Child Hlth, Karachi, Pakistan.
   Bijani, Ali, Babol Univ Med Sci, Social Determinants Hlth Res Ctr, Babol Sar, Iran.
   Bikbov, Boris, Ist Ric Farmacol Mario Negri IRCCS, Ranica, Italy.
   Britton, Gabrielle, Inst Invest Cient \& Serv Alta Tecnol INDICASAT AI, Ctr Neurosci, Panama City, Panama.
   Butt, Zahid A., Univ Waterloo, Sch Publ Hlth \& Hlth Syst, Waterloo, ON, Canada.
   Butt, Zahid A., Al Shifa Trust Eye Hosp, Al Shifa Sch Publ Hlth, Rawalpindi, Pakistan.
   Cardenas, Rosario, Metropolitan Autonomous Univ, Dept Populat \& Hlth, Mexico City, DF, Mexico.
   Carvalho, Felix, Univ Porto, Inst Publ Hlth, Porto, Portugal.
   Carvalho, Felix, Univ Porto, Appl Mol Biosci Unit, Porto, Portugal.
   Castaneda-Orjuela, Carlos A., Natl Inst Hlth, Colombian Natl Hlth Observ, Bogota, Colombia.
   Castaneda-Orjuela, Carlos A., Univ Nacl Colombia, Epidemiol \& Publ Hlth Evaluat Grp, Bogota, Colombia.
   Castro, Franz, Gorgas Mem Inst Hlth Studies, Panama City, Panama.
   Cerin, Ester, Univ Hong Kong, Sch Publ Hlth, Hong Kong, Peoples R China.
   Chang, Jung-Chen, Natl Taiwan Univ, Coll Med, Taipei, Taiwan.
   Cooper, Cyrus, Univ Southampton, Med Res Council, Lifecourse Epidemiol Unit, Southampton, Hants, England.
   Cooper, Cyrus, Univ Oxford, Dept Rheumatol, Oxford, England.
   Das Gupta, Rajat, Univ South Carolina, Dept Epidemiol \& Biostat, Columbia, SC 29208 USA.
   Das Gupta, Rajat; Hasan, Mehedi; Sutradhar, Ipsita, Brac Univ, James P Grant Sch Publ Hlth, Dhaka, Bangladesh.
   De Neve, Jan-Walter; Moazen, Babak; Mohammed, Shafiu, Heidelberg Univ, Heidelberg Inst Global Hlth, Heidelberg, Germany.
   Deribe, Kebede, Brighton \& Sussex Med Sch, Dept Global Hlth \& Infect, Brighton, E Sussex, England.
   Deribe, Kebede, Addis Ababa Univ, Sch Publ Hlth, Addis Ababa, Ethiopia.
   Desalegn, Beruk Berhanu, Hawassa Univ, Sch Nutr Food Sci \& Technol, Hawassa, Ethiopia.
   Desta, Melaku, Debre Markos Univ, Dept Midwifery, Debre, Markos, Ethiopia.
   Desta, Melaku; Diaz, Daniel, Autonomous Univ Sinaloa, Fac Vet Med \& Zootech, Culiacan Rosales, Mexico.
   Dhimal, Meghnath, Nepal Hlth Res Council, Hlth Res Sect, Kathmandu, Nepal.
   Diaz, Daniel, Univ Nacl Autonoma Mexico, Ctr Complex Sci, Mexico City, DF, Mexico.
   Dinberu, Mesfin Tadese, Debre Berhan Univ, Dept Midwifery, Debre Berhan, Ethiopia.
   Djalalinia, Shirin, Minist Hlth \& Med Educ, Deputy Res \& Technol, Tehran, Iran.
   Dubey, Manisha, United Nations World Food Programme, New Delhi, India.
   Dubljanin, Eleonora, Univ Belgrade, Fac Med, Belgrade, Serbia.
   Duraes, Andre R., Bahia Sch Med \& Publ Hlth, Dept Internal Med, Salvador, BA, Brazil.
   Duraes, Andre R., Roberto Santos Gen Hosp, Med Board, Salvador, BA, Brazil.
   Dwyer-Lindgren, Laura; Kinyoki, Damaris K.; Mokdad, Ali H.; Murray, Christopher J. L.; Pigott, David M.; Reiner, Robert C., Jr.; Sartorius, Benn; Hay, Simon I., Univ Washington, Sch Med, Dept Hlth Metr Sci, Seattle, WA 98195 USA.
   Kalan, Mohammad Ebrahimi, Florida Int Univ, Epidemiol Dept, Miami, FL 33199 USA.
   El-Khatib, Ziad, Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden.
   El-Khatib, Ziad, Univ Quebec Abitibi Temiscamingue, World Hlth Programme, Rouyn Noranda, PQ, Canada.
   Eshrati, Babak, Minist Hlth \& Med Educ, Ctr Communicable Dis Control, Tehran, Iran.
   Eshrati, Babak, Arak Univ Med Sci, Sch Publ Hlth, Arak, Iran.
   Faramarzi, Mahbobeh, Babol Univ Med Sci, Babol Sar, Iran.
   Fareed, Mohammad, Imam Mohammad Ibn Saud Islamic Univ, Coll Med, Riyadh, Saudi Arabia.
   Faro, Andre, Univ Fed Sergipe, Dept Psychol, Sao Cristovao, Brazil.
   Fereshtehnejad, Seyed-Mohammad, Karolinska Inst, Dept Neurobiol Care Sci \& Soc, Stockholm, Sweden.
   Fereshtehnejad, Seyed-Mohammad, Univ Ottawa, Div Neurol, Ottawa, ON, Canada.
   Fernandes, Eduarda, Univ Porto, REQUIMTE LAQV, Porto, Portugal.
   Filip, Irina, Kaiser Permanente, Psychiatry Dept, Fontana, CA USA.
   Filip, Irina, AT Still Univ, Dept Hlth Sci, Mesa, AZ 85206 USA.
   Fischer, Florian, Bielefeld Univ, Dept Populat Med \& Hlth Serv Res, Bielefeld, Germany.
   Fukumoto, Takeshi, Kobe Univ, Dept Dermatol, Kobe, Hyogo, Japan.
   Fukumoto, Takeshi, Wistar Inst Anat \& Biol, Gene Express \& Regulat Program, 3601 Spruce St, Philadelphia, PA 19104 USA.
   Garcia, Jose A., Ramon de la Fuente Muniz Natl Inst Psychiat, Mexico City, DF, Mexico.
   Gill, Paramjit Singh, Univ Warwick, Unit Acad Primary Care, Coventry, W Midlands, England.
   Gill, Tiffany K., Univ Adelaide, Adelaide Med Sch, Adelaide, SA, Australia.
   Gona, Philimon N., Univ Massachusetts, Nursing \& Hlth Sci Dept, Boston, MA 02125 USA.
   Gopalani, Sameer Vali, Univ Oklahoma, Dept Biostat \& Epidemiol, Oklahoma City, OK USA.
   Gopalani, Sameer Vali, Govt Federated States Micronesia, Dept Hlth \& Social Affairs, Palikir, Micronesia.
   Grada, Ayman, Boston Univ, Sch Med, Boston, MA 02118 USA.
   Guo, Yuming; Li, Shanshan; Meretoja, Tuomo J., Monash Univ, Sch Publ Hlth \& Prevent Med, Melbourne, Vic, Australia.
   Guo, Yuming; Mestrovic, Tomislav, Zhengzhou Univ, Dept Epidemiol \& Biostat, Zhengzhou, Peoples R China.
   Gupta, Rajeev; Mestrovic, Tomislav, Rajasthan Univ Hlth Sci, Acad \& Res Dept, Jaipur, Rajasthan, India.
   Gupta, Rajeev; Miller, Ted R., Mahatma Gandhi Univ Med Sci \& Technol, Dept Med, Jaipur, Rajasthan, India.
   Gupta, Vipin, Univ Delhi, Dept Anthropol, Delhi, India.
   Haj-Mirzaian, Arvin; Haj-Mirzaian, Arya, Univ Tehran Med Sci, Dept Pharmacol, Tehran, Iran.
   Haj-Mirzaian, Arvin, Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Obes Res Ctr, Tehran, Iran.
   Haj-Mirzaian, Arya, Johns Hopkins Univ, Dept Radiol, Baltimore, MD USA.
   Hamadeh, Randah R., Arabian Gulf Univ, Dept Family \& Community Med, Manama, Bahrain.
   Hamidi, Samer, Hamdan Bin Mohammed Smart Univ, Sch Hlth \& Environm Studies, Dubai, U Arab Emirates.
   Hassen, Hamid Yimam; Henok, Andualem, Mizan Tepi Univ, Dept Publ Hlth, Tepi, Ethiopia.
   Hassen, Hamid Yimam, Univ Hosp Antwerp, Unit Epidemiol \& Social Med, Antwerp, Belgium.
   Hendrie, Delia; Miller, Ted R., Curtin Univ, Sch Publ Hlth, Perth, WA, Australia.
   Hole, Michael K., Univ Texas Austin, Dept Pediat, Austin, TX 78712 USA.
   Hossain, Naznin, Dhaka Med Coll, Dept Pharmacol \& Therapeut, Dhaka, Bangladesh.
   Hossain, Naznin, Bangladesh Ind Gases Ltd, Dept Pharmacol, Tangail, Bangladesh.
   Hosseinzadeh, Mehdi, Islamic Azad Univ, Dept Comp Engn, Tehran, Iran.
   Hosseinzadeh, Mehdi, Univ Human Dev, Comp Sci Dept, Sulaimaniyah, Iraq.
   Hu, Guoqing, Cent South Univ, Dept Epidemiol \& Hlth Stat, Changsha, Peoples R China.
   Ilesanmi, Olayinka Stephen, Univ Ibadan, Dept Community Med, Ibadan, Nigeria.
   Irvani, Seyed Sina Naghibi, Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Tehran, Iran.
   Islam, Sheikh Mohammed Shariful, Deakin Univ, Inst Phys Act \& Nutr, Burwood, Vic, Australia.
   Islam, Sheikh Mohammed Shariful, Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia.
   Izadi, Neda, Shahid Beheshti Univ Med Sci, Dept Epidemiol, Tehran, Iran.
   Jakovljevic, Mihajlo, Sechenov First Moscow State Med Univ, Dept Hlth Care \& Publ Hlth, Moscow, Russia.
   Jha, Ravi Prakash, Banaras Hindu Univ, Dept Community Med, Varanasi, Uttar Pradesh, India.
   Ji, John S., Duke Kunshan Univ, Environm Res Ctr, Kunshan, Peoples R China.
   Ji, John S., Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA.
   Jonas, Jost B., Heidelberg Univ, Dept Ophthalmol, Heidelberg, Germany.
   Jonas, Jost B., Beijing Tongren Hosp, Beijing Inst Ophthalmol, Beijing, Peoples R China.
   Shushtari, Zahra Jorjoran, Univ Social Welf \& Rehabil Sci, Social Determinants Hlth Res Ctr, Tehran, Iran.
   Jozwiak, Jacek Jerzy, Univ Opole, Dept Family Med \& Publ Hlth, Opole, Poland.
   Kanchan, Tanuj, All India Inst Med Sci, Dept Forens Med \& Toxicol, Jodhpur, Rajasthan, India.
   Kasaeian, Amir, Univ Tehran Med Sci, Hematol Oncol \& Stem Cell Transplantat Res Ctr, Tehran, Iran.
   Kasaeian, Amir, Iran Univ Med Sci, Pars Adv \& Minimally Invas Med Manners Res Ctr, Tehran, Iran.
   Karyani, Ali Kazemi; Pirsaheb, Meghdad; Rajati, Fatemeh; Rezaei, Satar; Sadeghi, Ehsan; Sharafi, Kiomars, Kermanshah Univ Med Sci, Res Ctr Environm Determinants Hlth, Kermanshah, Iran.
   Keiyoro, Peter Njenga, Univ Nairobi, ODeL Campus, Nairobi, Kenya.
   CSIR, Indian Inst Toxicol Res, Lucknow, Uttar Pradesh, India.
   Kesavachandran, Chandrasekharan Nair; Khader, Yousef Saleh, Jordan Univ Sci \& Technol, Dept Publ Hlth, Irbid, Jordan.
   Khafaie, Morteza Abdullatif, Ahvaz Jundishapur Univ Med Sci, Social Determinants Hlth Res Ctr, Ahvaz, Iran.
   Khan, Ejaz Ahmad, Hlth Serv Acad, Epidemiol \& Biostat Dept, Islamabad, Pakistan.
   Khater, Mona M., Cairo Univ, Dept Med Parasitol, Cairo, Egypt.
   Kiadaliri, Aliasghar A., Lund Univ, Clin Epidemiol Unit, Lund, Sweden.
   Kiirithio, Daniel N., Synotech Consultants, Res \& Data Solut, Nairobi, Kenya.
   Kim, Yun Jin, Xiamen Univ Malaysia, Sch Med, Sepang, Malaysia.
   Kimokoti, Ruth W., Simmons Univ, Dept Nutr, Boston, MA USA.
   Kisa, Adnan, Kristiania Univ Coll, Sch Hlth Sci, Oslo, Norway.
   Koyanagi, Ai, CIBERSAM, San Juan Dios Sanitary Pk, St Boi De Llobregat, Spain.
   Koyanagi, Ai, Catalan Inst Res \& Adv Studies ICREA, Barcelona, Spain.
   Krishan, Kewal, Panjab Univ, Dept Anthropol, Chandigarh, India.
   Defo, Barthelemy Kuate, Univ Montreal, Dept Social \& Prevent Med, Montreal, PQ, Canada.
   Defo, Barthelemy Kuate, Univ Montreal, Dept Demog, Montreal, PQ, Canada.
   Kumar, Manasi, Univ Nairobi, Dept Psychiat, Nairobi, Kenya.
   Kumar, Manasi, UCL, Div Psychol \& Language Sci, London, England.
   Kumar, Pushpendra, Int Inst Populat Sci, Mumbai, Maharashtra, India.
   Lami, Faris Hasan, Univ Baghdad, Dept Community \& Family Med, Baghdad, Iraq.
   Lee, Paul H., Hong Kong Polytech Univ, Sch Nursing, Hong Kong, Peoples R China.
   Liao, Yu, Sun Yat Sen Univ, Dept Med Stat \& Epidemiol, Guangzhou, Peoples R China.
   Liao, Yu; Lopez, Jaifred Christian F., Alliance Improving Hlth Outcomes Inc, Quezon City, Philippines.
   Lim, Lee-Ling, Univ Malaya, Dept Med, Kuala Lumpur, Malaysia.
   Lim, Lee-Ling, Chinese Univ Hong Kong, Dept Med \& Therapeut, Shatin, Hong Kong, Peoples R China.
   Listl, Stefan, Radboud Univ Nijmegen, Dept Dent, Nijmegen, Netherlands.
   Listl, Stefan, Heidelberg Univ Hosp, Sect Translat Hlth Econ, Heidelberg, Germany.
   Lopez, Jaifred Christian F., Univ Philippines Manila, Dept Epidemiol \& Biostat, Manila, Philippines.
   Majdan, Marek, Trnava Univ, Dept Publ Hlth, Trnava, Slovakia.
   Majdzadeh, Reza, Univ Tehran Med Sci, Community Based Participatory Res Ctr CBPR, Tehran, Iran.
   Majdzadeh, Reza, Univ Tehran Med Sci, KURC, Tehran, Iran.
   Majeed, Azeem; Rawaf, Salman, Imperial Coll London, Dept Primary Care \& Publ Hlth, London, England.
   Malekzadeh, Reza; Pourshams, Akram; Roshandel, Gholamreza; Salimzadeh, Hamideh; Sepanlou, Sadaf G., Univ Tehran Med Sci, Digest Dis Res Inst, Tehran, Iran.
   Malekzadeh, Reza; Mensah, George A.; Noubiap, Jean Jacques; Sepanlou, Sadaf G., Shiraz Univ Med Sci, Noncommunicable Dis Res Ctr, Shiraz, Iran.
   Mansournia, Mohammad Ali, Univ Tehran Med Sci, Dept Epidemiol \& Biostat, Tehran, Iran.
   Martins-Melo, Francisco Rogerlandio, Fed Inst Educ Sci \& Technol Ceara, Campus Caucaia, Caucaia, Brazil.
   Masaka, Anthony, Botho Univ Botswana, Publ Hlth Dept, Gaborone, Botswana.
   Massenburg, Benjamin Ballard, Univ Washington, Div Plast Surg, Seattle, WA 98195 USA.
   Mehta, Kala M., Univ Calif San Francisco, Dept Epidemiol \& Biostat, San Francisco, CA 94143 USA.
   Hernandez Prado, Bernardo; Mendoza, Walter; Gakidou, Emmanuela, United Nations Populat Fund UNFPA, Peru Country Off, Lima, Peru.
   Mensah, George A., NIH, Ctr Translat Res \& Implementat Sci, Bldg 10, Bethesda, MD 20892 USA.
   Univ Cape Town, Dept Med, Cape Town, South Africa.
   Meretoja, Tuomo J., Helsinki Univ Hosp, Breast Surg Unit, Helsinki, Finland.
   Univ Helsinki, Helsinki, Finland.
   Dr Zora Profozic Polyclin, Clin Microbiol \& Parasitol Unit, Zagreb, Croatia.
   Univ North, Univ Ctr Varazdin, Varazhdin, Croatia.
   Pacific Inst Res \& Evaluat, Calverton, MD USA.
   Mini, G. K., Sree Chitra Tirunal Inst Med Sci \& Technol, Achutha Menon Ctr Hlth Sci Studies, Trivandrum, Kerala, India.
   Mini, G. K., Ananthapuri Hosp \& Res Ctr, GIPH, Trivandrum, Kerala, India.
   Mirrakhimov, Erkin M., Kyrgyz State Med Acad, Fac Internal Med, Bishkek, Kyrgyzstan.
   Mirrakhimov, Erkin M., Natl Ctr Cardiol \& Internal Dis, Dept Atherosclerosis \& Coronary Heart Dis, Bishkek, Kyrgyzstan.
   Moazen, Babak, Frankfurt Univ Appl Sci, Inst Addict Res ISFF, Frankfurt, Germany.
   Mohammad, Dara K., Salahaddin Univ Erbil, Coll Agr, Dept Food Technol, Erbil, Iraq.
   Mohammad, Dara K., Karolinska Inst, Dept Med Huddinge, Stockholm, Sweden.
   Darwesh, Aso Mohammad, Univ Human Dev, Dept Informat Technol, Sulaimaniyah, Iraq.
   Mohammed, Shafiu, Ahmadu Bello Univ, Hlth Syst \& Policy Res Unit, Zaria, Nigeria.
   Mohebi, Farnam, Univ Tehran Med Sci, Noncommunicable Dis Res Ctr, Tehran, Iran.
   Mohebi, Farnam, Univ Tehran Med Sci, Iran Natl Inst Hlth Res, Tehran, Iran.
   Monasta, Lorenzo; Ronfani, Luca, Burlo Garofolo Inst Maternal \& Child Hlth, Clin Epidemiol \& Publ Hlth Res Unit, Trieste, Italy.
   Moodley, Yoshan, Univ Kwazulu Natal, Dept Publ Hlth Med, Durban, South Africa.
   Moosazadeh, Mahmood, Mazandaran Univ Med Sci, Hlth Sci Res Ctr, Sari, Iran.
   Moradi, Ghobad, Kurdistan Univ Med Sci, Social Determinants Hlth Res Ctr, Sanandaj, Iran.
   Moradi, Ghobad, Kurdistan Univ Med Sci, Dept Epidemiol \& Biostat, Sanandaj, Iran.
   Moraga, Paula, Univ Bath, Dept Math Sci, Bath, Avon, England.
   Morawska, Lidia, Queensland Univ Technol, Int Lab Air Qual \& Hlth, Brisbane, Qld, Australia.
   Morrison, Shane Douglas, Univ Washington, Dept Surg, Seattle, WA 98195 USA.
   Mousavi, Seyyed Meysam, Univ Tehran Med Sci, Dept Hlth Management \& Econ, Tehran, Iran.
   Mousavi, Seyyed Meysam, Baqiyatallah Univ Med Sci, Hlth Management Res Ctr, Tehran, Iran.
   Mustafa, Ghulam, Nishtar Med Univ, Dept Pediat Med, Multan, Pakistan.
   Mustafa, Ghulam, Inst Mother \& Child Care, Dept Pediat \& Pediat Pulmonol, Multan, Pakistan.
   Nahvijou, Azin, Univ Tehran Med Sci, Canc Res Ctr, Tehran, Iran.
   Najafi, Farid; Salimi, Yahya, Kermanshah Univ Med Sci, Dept Epidemiol \& Biostat, Kermanshah, Iran.
   Nangia, Vinay, Suraj Eye Inst, Nagpur, Maharashtra, India.
   Ndwandwe, Duduzile Edith, South African Med Res Council, Cochrane South Africa, Cape Town, South Africa.
   Negoi, Ionut, Carol Davila Univ Med \& Pharm Bucharest, Gen Surg, Bucharest, Romania.
   Negoi, Ionut, Emergency Hosp Bucharest, Gen Surg, Bucharest, Romania.
   Negoi, Ruxandra Irina, Carol Davila Univ Med \& Pharm, Anat \& Embryol, Bucharest, Romania.
   Negoi, Ruxandra Irina, Cardioaid, Cardiol, Bucharest, Romania.
   Ngunjiri, Josephine W., Univ Embu, Dept Biol Sci, Embu, Kenya.
   Cuong Tat Nguyen, Duy Tan Univ, Inst Global Hlth Innovat, Hanoi, Vietnam.
   Long Hoang Nguyen; Vu, Giang Thu, Nguyen Tat Thanh Univ, Ctr Excellence Behav Med, Ho Chi Minh City, Vietnam.
   Ningrum, Dina Nur Anggraini, Univ Negeri Semarang, Publ Hlth Dept, Kota Semarang, Indonesia.
   Ningrum, Dina Nur Anggraini, Taipei Med Univ, Grad Inst Biomed Informat, Taipei, Taiwan.
   Shiadeh, Malihe Nourollahpour, Mazandaran Univ Med Sci, Sari, Iran.
   Nyasulu, Peter S., Stellenbosch Univ, Fac Med \& Hlth Sci, Cape Town, South Africa.
   Ogbo, Felix Akpojene, Univ Porto, UCIBIO, Porto, Portugal.
   Olagunju, Andrew T., McMaster Univ, Dept Psychiat \& Behav Neurosci, Hamilton, ON, Canada.
   Olagunju, Andrew T., Univ Lagos, Dept Psychiat, Lagos, Nigeria.
   Olusanya, Bolajoko Olubukunola; Olusanya, Jacob Olusegun, Ctr Hlthy Start Initiat, Lagos, Nigeria.
   Onwujekwe, Obinna E., Univ Nigeria Nsukka, Dept Pharmacol \& Therapeut, Enugu, Nigeria.
   Ortiz-Panozo, Eduardo, Natl Inst Publ Hlth, Ctr Populat Hlth Res, Cuernavaca, Morelos, Mexico.
   Ortiz-Panozo, Eduardo; She, Jun, Jonkoping Univ, Sch Hlth \& Welf, Jonkoping, Sweden.
   Overland, Simon, Norwegian Inst Publ Hlth, Div Mental \& Phys Hlth, Bergen, Norway.
   Overland, Simon, Univ Bergen, Dept Psychosocial Sci, Bergen, Norway.
   Mahesh, P. A., Jagadguru Sri Shivarathreeswara Acad Hlth Educ \&, Dept Resp Med, Mysore, Karnataka, India.
   Pana, Adrian, Ctr Hlth Outcomes \& Evaluat, Hlth Outcomes, Bucharest, Romania.
   Panda-Jonas, Songhomitra, Heidelberg Univ, Augenpraxis Jonas, Heidelberg, Germany.
   Pati, Sanghamitra, Indian Council Med Res, Reg Med Res Ctr, Bhubaneswar, India.
   Patton, George C., Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia.
   Patton, George C., Murdoch Childrens Res Inst, Populat Hlth, Melbourne, Vic, Australia.
   Perico, Norberto; Remuzzi, Giuseppe, Ist Ric Farmacol Mario Negri IRCCS, Bergamo, Italy.
   Postma, Maarten J., Univ Groningen, Dept Econ \& Business, Groningen, Netherlands.
   Postma, Maarten J., Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands.
   Prakash, Swayam, Sanjay Gandhi Postgrad Inst Med Sci, Dept Nephrol, Lucknow, Uttar Pradesh, India.
   Puri, Parul, Int Inst Populat Sci, Populat Studies, Mumbai, Maharashtra, India.
   Qorbani, Mostafa, Alborz Univ Med Sci, Noncommunicable Dis Res Ctr, Karaj, Iran.
   Radfar, Amir, Univ Cent Florida, Coll Med, Orlando, FL 32816 USA.
   Radfar, Amir, AT Still Univ, Coll Grad Hlth Sci, Mesa, AZ 85206 USA.
   Rahim, Fakher, Ahvaz Jundishapur Univ Med Sci, Thalassemia \& Hemoglobinopathy Res Ctr, Ahvaz, Iran.
   Rahim, Fakher, Univ Tehran Med Sci, Metabol \& Genom Res Ctr, Tehran, Iran.
   Rahimi-Movaghar, Vafa; Salamati, Payman, Univ Tehran Med Sci, Sina Trauma \& Surg Res Ctr, Tehran, Iran.
   Rahman, Mohammad Hifz Ur, Int Inst Populat Sci, Dept Publ Hlth \& Mortal Studies, Mumbai, Maharashtra, India.
   Ranabhat, Chhabi Lal, Policy Res Inst, Kathmandu, Nepal.
   Ranabhat, Chhabi Lal; Roever, Leonardo, Yonsei Univ, Inst Poverty Alleviat \& Int Dev, Wonju, South Korea.
   Rawaf, David Laith, Imperial Coll London, WHO, Collaborating Ctr Publ Hlth Educ \& Training, London, England.
   Rawaf, David Laith, Univ Coll London Hosp, London, England.
   Rawaf, Salman, Publ Hlth England, Acad Publ Hlth, London, England.
   Renzaho, Andre M. N., Western Sydney Univ, Translat Hlth Res Inst, Penrith, NSW, Australia.
   Renzaho, Andre M. N., Western Sydney Univ, Sch Social Sci \& Psychol, Penrith, NSW, Australia.
   Rios-Gonzalez, Carlos, Nihon Gakko Univ, Res Directorate, Fernando De La Mora, Paraguay.
   Rios-Gonzalez, Carlos, Univ Nacl Caaguazu, Res Direct, Coronel Oviedo, Paraguay.
   Univ Fed Uberlandia, Dept Clin Res, Uberlandia, MG, Brazil.
   Roshandel, Gholamreza, Golestan Univ Med Sci, Golestan Res Ctr Gastroenterol \& Hepatol, Gorgan, Golestan, Iran.
   Rostami, Ali, Babol Univ Med Sci, Infect Dis \& Trop Med Res Ctr, Babol Sar, Iran.
   Rubagotti, Enrico, Agrosavia, Ctr Invest Palmira, Palmira, Colombia.
   Rubagotti, Enrico, Southern Univ Sci \& Technol, Dept Ocean Sci \& Engn, Shenzhen, Peoples R China.
   Safari, Yahya, Kermanshah Univ Med Sci, Kermanshah, Iran.
   Sagar, Rajesh, All India Inst Med Sci, Dept Psychiat, New Delhi, India.
   Salam, Nasir, Imam Mohammad Ibn Saud Islamic Univ, Dept Pathol, Riyadh, Saudi Arabia.
   Salimi, Yahya; Soofi, Moslem, Kermanshah Univ Med Sci, Social Dev \& Hlth Promot Res Ctr, Kermanshah, Iran.
   Samy, Abdallah M., Ain Shams Univ, Dept Entomol, Cairo, Egypt.
   Sanabria, Juan, Marshall Univ, Dept Surg, Huntington, WV USA.
   Sanabria, Juan, Case Western Reserve Univ, Dept Nutr \& Prevent Med, Cleveland, OH 44106 USA.
   Milicevic, Milena M. Santric, Univ Belgrade, Inst Social Med, Belgrade, Serbia.
   Milicevic, Milena M. Santric, Univ Belgrade, Ctr Sch Publ Hlth \& Hlth Management, Belgrade, Serbia.
   Sartorius, Benn, London Sch Hyg \& Trop Med, Fac Infect \& Trop Dis, London, England.
   Sathian, Brijesh, Hamad Med Corp, Surg Dept, Doha, Qatar.
   Sathian, Brijesh, Bournemouth Univ, Fac Hlth \& Social Sci, Bournemouth, Dorset, England.
   Sawant, Arundhati R., Univ Alabama Birmingham, Birmingham, AL USA.
   Sawant, Arundhati R., Dr DY Patil Univ, Pune, Maharashtra, India.
   Schwebel, David C., Univ Alabama Birmingham, Dept Psychol, Birmingham, AL 35294 USA.
   Senbeta, Anbissa Muleta, Jigjiga Univ, Dept Food Sci \& Nutr, Jigjiga, Ethiopia.
   Shams-Beyranvand, Mehran, Dezful Univ Med Sci, Sch Med, Dezful, Iran.
   Shams-Beyranvand, Mehran, Alborz Univ Med Sci, Sch Med, Karaj, Iran.
   Shamsizadeh, Morteza, Hamadan Univ Med Sci, Chron Dis Home Care Res Ctr, Hamadan, Iran.
   Sharma, Rajesh, Delhi Technol Univ, Univ Sch Management \& Entrepreneurship, New Delhi, India.
   She, Jun, Fudan Univ, Dept Pulm Med, Shanghai, Peoples R China.
   Sheikh, Aziz, Univ Edinburgh, Ctr Med Informat, Edinburgh, Midlothian, Scotland.
   Harvard Univ, Div Gen Internal Med, Boston, MA 02115 USA.
   Shigematsu, Mika, Natl Inst Infect Dis, Tokyo, Japan.
   Sheikh, Aziz; Siabani, Soraya, Kermanshah Univ Med Sci, Dept Hlth Educ \& Promot, Kermanshah, Iran.
   Siabani, Soraya, Univ Technol Sydney, Sch Hlth, Sydney, NSW, Australia.
   Silveira, Dayane Gabriele Alves, Brasilia Univ, Brasilia, DF, Brazil.
   Silveira, Dayane Gabriele Alves, Fed Minist Hlth, Dept Hlth Ind Complex \& Innovat Hlth, Brasilia, DF, Brazil.
   Singh, Jasvinder A., Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL USA.
   Singh, Jasvinder A., Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA.
   Sinha, Dhirendra Narain, Sch Prevent Oncol, Dept Epidemiol, Patna, Bihar, India.
   Sinha, Dhirendra Narain, Healis Sekhsaria Inst Publ Hlth, Dept Epidemiol, Mumbai, Maharashtra, India.
   Skirbekk, Vegard, Norwegian Inst Publ Hlth, Ctr Fertil \& Hlth, Bergen, Norway.
   Sobaih, Badr Hasan; Temsah, Mohamad-Hani, King Saud Univ, Dept Pediat, Riyadh, Saudi Arabia.
   Sobaih, Badr Hasan, King Khalid Univ Hosp, Pediat Dept, Riyadh, Saudi Arabia.
   Soriano, Joan B., Autonomous Univ Madrid, Hosp Univ Princesa, Madrid, Spain.
   Soriano, Joan B., Ctr Invest Biomed Red Enfermedades Resp CIBERES, Madrid, Spain.
   Soyiri, Ireneous N., Univ Edinburgh, Usher Inst Populat Hlth Sci \& Informat, Edinburgh, Midlothian, Scotland.
   Soyiri, Ireneous N., Univ Hull, Hull York Med Sch, Kingston Upon Hull, N Humberside, England.
   Sreeramareddy, Chandrashekhar T., Int Med Univ, Div Community Med, Kuala Lumpur, Malaysia.
   Sudaryanto, Agus, Muhammadiyah Univ Surakarta, Dept Nursing, Kartasura, Indonesia.
   Sudaryanto, Agus, China Med Univ, Dept Publ Hlth, Taichung, Taiwan.
   Sufiyan, Mu'awiyyah Babale, Ahmadu Bello Univ, Dept Community Med, Zaria, Nigeria.
   Sylaja, Pn, Sree Chitra Tirunal Inst Med Sci \& Technol, Neurol Dept, Trivandrum, Kerala, India.
   Sylaja, Pn, Sree Chitra Tirunal Inst Med Sci \& Technol, Trivandrum, Kerala, India.
   Tabares-Seisdedos, Rafael, Univ Valencia, Dept Med, Valencia, Spain.
   Tabares-Seisdedos, Rafael, Carlos III Hlth Inst, Biomed Res Networking Ctr Mental Hlth Network CIB, Madrid, Spain.
   Tadesse, Birkneh Tilahun, Hawassa Univ, Dept Pediat, Hawassa, Ethiopia.
   Tadesse, Birkneh Tilahun, Int Vaccine Inst, Seoul, South Korea.
   Temsah, Mohamad-Hani, Alfaisal Univ, Coll Med, Riyadh, Saudi Arabia.
   Terkawi, Abdullah Sulieman, Univ Virginia, Dept Anesthesiol Perioperat \& Pain Med, Charlottesville, VA USA.
   Terkawi, Abdullah Sulieman, King Farah Med City, Dept Anesthesiol, Riyadh, Saudi Arabia.
   Tessema, Belay, Univ Gondar, Dept Med Microbiol, Gondar, Ethiopia.
   Tessema, Zemenu Tadesse, Univ Gondar, Dept Epidemiol \& Biostat, Gondar, Ethiopia.
   Thankappan, Kavumpurathu Raman, Cent Univ Kerala, Dept Publ Hlth \& Community Med, Kasaragod, India.
   Topor-Madry, Roman, Jagiellonian Univ, Med Coll, Fac Hlth Sci, Krakow, Poland.
   Topor-Madry, Roman, Agcy Hlth Technol Assessment \& Tariff Syst, Warsaw, Poland.
   Tovani-Palone, Marcos Roberto, Univ Sao Paulo, Dept Pathol \& Legal Med, Ribeirao Preto, Brazil.
   Tran, Bach Xuan, Hanoi Med Univ, Dept Hlth Econ, Hanoi, Vietnam.
   Car, Lorainne Tudor, Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore.
   Ullah, Irfan, Gomal Univ, Gomal Ctr Biochem \& Biotechnol, Dera Ismail Khan, Pakistan.
   Ullah, Irfan, Mufti Mehmood Mem Teaching Hosp, TB Culture Lab, Dera Ismail Khan, Pakistan.
   Uthman, Olalekan A., Univ Warwick, Div Hlth Sci, Coventry, W Midlands, England.
   Valdez, Pascual R., Argentine Soc Med, Buenos Aires, DF, Argentina.
   Valdez, Pascual R., Velez Sarsfield Hosp, Buenos Aires, DF, Argentina.
   Veisani, Yousef, Ilam Univ Med Sci, Psychosocial Injuries Res Ctr, Ilam, Iran.
   Violante, Francesco S., Univ Bologna, Dept Med \& Surg Sci, Bologna, Italy.
   Violante, Francesco S., St Orsola Malpighi Hosp, Occupat Hlth Unit, Bologna, Italy.
   Vlassov, Vasily, Natl Res Univ Higher Sch Econ, Dept Hlth Care Adm \& Econ, Moscow, Russia.
   Vollmer, Sebastian, Harvard Univ, Dept Global Hlth \& Populat, Boston, MA 02115 USA.
   Vollmer, Sebastian, Univ Gottingen, Dept Econ, Gottingen, Germany.
   Waheed, Yasir, Fdn Univ Islamabad, Fdn Univ Med Coll, Islamabad, Pakistan.
   Wang, Yuan-Pang, Univ Sao Paulo, Dept Psychiat, Sao Paulo, Brazil.
   Winkler, Andrea Sylvia, Univ Oslo, Inst Hlth \& Soc, Oslo, Norway.
   Winkler, Andrea Sylvia, Tech Univ Munich, Dept Neurol, Munich, Germany.
   Wolfe, Charles D. A., Kings Coll London, Sch Populat Hlth \& Environm Sci, London, England.
   Wolfe, Charles D. A., Guys \& St Thomas Hosp, NIHR Biomed Res Ctr, London, England.
   Wolfe, Charles D. A., Kings Coll London, London, England.
   Yamada, Tomohide, Univ Tokyo, Dept Diabet \& Metab Dis, Tokyo, Japan.
   Yeshaneh, Alex, Wolkite Univ, Wolkite, Ethiopia.
   Yip, Paul, Univ Hong Kong, Ctr Suicide Res \& Prevent, Hong Kong, Peoples R China.
   Yip, Paul, Univ Hong Kong, Dept Social Work \& Social Adm, Hong Kong, Peoples R China.
   Yisma, Engida, Addis Ababa Univ, Sch Allied Hlth Sci, Addis Ababa, Ethiopia.
   Yonemoto, Naohiro, Natl Ctr Neurol \& Psychiat, Dept Psychopharmacol, Tokyo, Japan.
   Younis, Mustafa Z., Jackson State Univ, Global Hlth, Hlth Econ \& Finance, Jackson, MS USA.
   Younis, Mustafa Z., Tsinghua Univ, Sch Med, Beijing, Peoples R China.
   Yousefifard, Mahmoud, Shahid Beheshti Univ Med Sci, Prevent Cardiovasc Dis Res Ctr, Tehran, Iran.
   Yu, Chuanhua, Wuhan Univ, Global Hlth Inst, Wuhan, Peoples R China.
   Yu, Chuanhua, Wuhan Univ, Dept Epidemiol \& Biostat, Wuhan, Peoples R China.
   Bin Zaman, Sojib, Monash Univ, Dept Med, Melbourne, Vic, Australia.
   Bin Zaman, Sojib, Int Ctr Diarrhoeal Dis Res, Maternal \& Child Hlth Div, Dhaka, Bangladesh.
   Zhang, Jianrong, Washington Univ, George Warren Brown Sch, St Louis, MO 63110 USA.
   Zhang, Yunquan, Wuhan Univ Sci \& Technol, Sch Publ Hlth, Wuhan, Peoples R China.
   Zhang, Yunquan, Wuhan Univ Sci \& Technol, Hubei Prov Key Lab Occupat Hazard Identificat \& C, Wuhan, Peoples R China.},
DOI = {10.1038/s41586-019-1872-1},
EarlyAccessDate = {DEC 2019},
Keywords-Plus = {MORTALITY; ATTAINMENT; AFRICA; MODELS; HEALTH; WORLD},
Research-Areas = {Science \& Technology - Other Topics},
Web-of-Science-Categories  = {Multidisciplinary Sciences},
Author-Email = {sihay@uw.edu},
Affiliations = {University of Washington; University of Washington Seattle; Institute
   for Health Metrics \& Evaluation; Jimma University; Egyptian Knowledge
   Bank (EKB); Cairo University; University of Ibadan; University College
   Hospital, Ibadan; Cardiff University; Nevada System of Higher Education
   (NSHE); University of Nevada Reno; Duke University; Duke University;
   Mayo Clinic; Washington University (WUSTL); Instituto Nacional de Salud
   Publica; Qazvin University of Medical Sciences (QUMS); Iran University
   of Medical Sciences; King Saud University; Kerman University of Medical
   Sciences; Egyptian Knowledge Bank (EKB); Mansoura University; Carol
   Davila University of Medicine \& Pharmacy; University of the Philippines
   System; University of the Philippines Manila; Hong Kong Polytechnic
   University; Birmingham City University; Iran University of Medical
   Sciences; University Ha'il; Bucharest University of Economic Studies;
   Public Health Foundation of India; Melbourne Genomics Health Alliance;
   La Trobe University; Instituto Nacional de Salud - Peru; Public Health
   Agency of Canada; University of Toronto; Egyptian Knowledge Bank (EKB);
   Alexandria University; University of Auckland; Australian Catholic
   University; Melbourne Genomics Health Alliance; Jazan University;
   University of Oxford; Department of Biotechnology (DBT) India; National
   Institute of Biomedical Genomics (NIBMG); University of Calcutta;
   University of Toronto; Aga Khan University; Babol University of Medical
   Sciences; Instituto de Investigacion Cientificas y Servicios de Alta
   Tecnologia (INDICASAT-AIP); University of Waterloo; Universidad Autonoma
   Metropolitana - Mexico; Universidade do Porto; Universidade do Porto;
   Universidad Nacional de Colombia; Instituto Conmemorativo Gorgas de
   Estudios de la Salud; University of Hong Kong; National Taiwan
   University; UK Research \& Innovation (UKRI); Medical Research Council
   UK (MRC); University of Southampton; University of Oxford; University of
   South Carolina System; University of South Carolina Columbia; Bangladesh
   Rural Advancement Committee BRAC; BRAC University; Ruprecht Karls
   University Heidelberg; University of Brighton; University of Sussex;
   Addis Ababa University; Hawassa University; Universidad Nacional
   Autonoma de Mexico; Ministry of Health \& Medical Education (MOHME);
   University of Belgrade; University of Washington; University of
   Washington Seattle; State University System of Florida; Florida
   International University; Karolinska Institutet; University of Quebec;
   University Quebec Abitibi-Temiscamingue; Ministry of Health \& Medical
   Education (MOHME); Babol University of Medical Sciences; Imam Mohammad
   Ibn Saud Islamic University (IMSIU); Universidade Federal de Sergipe;
   Karolinska Institutet; University of Ottawa; Universidade do Porto;
   Kaiser Permanente; A.T. Still University of Health Sciences; University
   of Bielefeld; Kobe University; The Wistar Institute; Instituto Nacional
   de Psiquiatria Ramon de la Fuente Muniz; University of Warwick;
   University of Adelaide; University of Massachusetts System; University
   of Massachusetts Boston; University of Oklahoma System; University of
   Oklahoma Health Sciences Center; Boston University; Monash University;
   Melbourne Genomics Health Alliance; Zhengzhou University; University of
   Delhi; Tehran University of Medical Sciences; Shahid Beheshti University
   Medical Sciences; Johns Hopkins University; Arabian Gulf University;
   University of Antwerp; Curtin University; University of Texas System;
   University of Texas Austin; Dhaka Medical College; Islamic Azad
   University; Central South University; University of Ibadan; Shahid
   Beheshti University Medical Sciences; Deakin University; University of
   Sydney; Shahid Beheshti University Medical Sciences; Sechenov First
   Moscow State Medical University; Banaras Hindu University (BHU); Duke
   Kunshan University; Duke University; Ruprecht Karls University
   Heidelberg; Capital Medical University; University of Opole; All India
   Institute of Medical Sciences (AIIMS) Jodhpur; Tehran University of
   Medical Sciences; Iran University of Medical Sciences; Kermanshah
   University of Medical Sciences; University of Nairobi; Council of
   Scientific \& Industrial Research (CSIR) - India; CSIR - Indian
   Institute of Toxicology Research (IITR); Jordan University of Science \&
   Technology; Ahvaz Jundishapur University of Medical Sciences (AJUMS);
   Health Services Academy; Egyptian Knowledge Bank (EKB); Cairo
   University; Lund University; Xiamen University Malaysia Campus; Simmons
   University; Kristiania University College; CIBER - Centro de
   Investigacion Biomedica en Red; CIBERSAM; ICREA; Panjab University;
   Universite de Montreal; Universite de Montreal; University of Nairobi;
   University of London; University College London; International Institute
   for Population Sciences; University of Baghdad; Hong Kong Polytechnic
   University; Sun Yat Sen University; Universiti Malaya; Chinese
   University of Hong Kong; Radboud University Nijmegen; Ruprecht Karls
   University Heidelberg; University of the Philippines System; University
   of the Philippines Manila; University of Trnava; Tehran University of
   Medical Sciences; Tehran University of Medical Sciences; Imperial
   College London; Tehran University of Medical Sciences; Shiraz University
   of Medical Science; Tehran University of Medical Sciences; Instituto
   Federal do Ceara (IFCE); University of Washington; University of
   Washington Seattle; University of California System; University of
   California San Francisco; National Institutes of Health (NIH) - USA;
   University of Cape Town; University of Helsinki; Helsinki University
   Central Hospital; University of Helsinki; University North - Croatia;
   Pacific Institute for Research \& Evaluation (PIRE); Department of
   Science \& Technology (India); Sree Chitra Tirunal Institute for Medical
   Sciences Technology (SCTIMST); Ministry of Health - Kyrgyzstan; Kyrgyz
   State Medical Academy; Salahaddin University; Karolinska Institutet;
   Ahmadu Bello University; Tehran University of Medical Sciences; Tehran
   University of Medical Sciences; IRCCS Burlo Garofolo; University of
   Kwazulu Natal; Mazandaran University Medical Sciences; Kurdistan
   University of Medical Sciences; Kurdistan University of Medical
   Sciences; University of Bath; Queensland University of Technology (QUT);
   University of Washington; University of Washington Seattle; Tehran
   University of Medical Sciences; Baqiyatallah University of Medical
   Sciences (BMSU); Tehran University of Medical Sciences; Kermanshah
   University of Medical Sciences; Suraj Eye Institute; South African
   Medical Research Council; Carol Davila University of Medicine \&
   Pharmacy; Carol Davila University of Medicine \& Pharmacy; Duy Tan
   University; Nguyen Tat Thanh University (NTTU); Universitas Negeri
   Semarang; Taipei Medical University; Mazandaran University Medical
   Sciences; Stellenbosch University; Universidade do Porto; McMaster
   University; University of Lagos; University of Nigeria; Instituto
   Nacional de Salud Publica; Jonkoping University; Norwegian Institute of
   Public Health (NIPH); University of Bergen; JSS Academy of Higher
   Education \& Research; Ruprecht Karls University Heidelberg; Indian
   Council of Medical Research (ICMR); ICMR - Regional Medical Research
   Centre (RMRC), Bhubaneswar; University of Melbourne; Melbourne
   Bioinformatics; Melbourne Genomics Health Alliance; Murdoch Children's
   Research Institute; Istituto di Ricerche Farmacologiche Mario Negri
   IRCCS; University of Groningen; University of Groningen; Sanjay Gandhi
   Postgraduate Institute of Medical Sciences; International Institute for
   Population Sciences; State University System of Florida; University of
   Central Florida; A.T. Still University of Health Sciences; Ahvaz
   Jundishapur University of Medical Sciences (AJUMS); Tehran University of
   Medical Sciences; Tehran University of Medical Sciences; International
   Institute for Population Sciences; Yonsei University; World Health
   Organization; Imperial College London; University College London
   Hospitals NHS Foundation Trust; University of London; University College
   London; Public Health England; Western Sydney University; Western Sydney
   University; Universidade Federal de Uberlandia; Golestan University of
   Medical Sciences; Babol University of Medical Sciences; Corporacion
   Colombiana de Investigacion Agropecuaria, AGROSAVIA; Southern University
   of Science \& Technology; Kermanshah University of Medical Sciences; All
   India Institute of Medical Sciences (AIIMS) New Delhi; Imam Mohammad Ibn
   Saud Islamic University (IMSIU); Kermanshah University of Medical
   Sciences; Egyptian Knowledge Bank (EKB); Ain Shams University; Marshall
   University; University System of Ohio; Case Western Reserve University;
   University of Belgrade; University of Belgrade; University of London;
   London School of Hygiene \& Tropical Medicine; Hamad Medical
   Corporation; Bournemouth University; University of Alabama System;
   University of Alabama Birmingham; Dr DY Patil Vidyapeeth Pune;
   University of Alabama System; University of Alabama Birmingham; Hamadan
   University of Medical Sciences; Delhi Technological University; Fudan
   University; University of Edinburgh; Harvard University; National
   Institute of Infectious Diseases (NIID); Kermanshah University of
   Medical Sciences; University of Technology Sydney; Universidade de
   Brasilia; University of Alabama System; University of Alabama
   Birmingham; University of Alabama System; University of Alabama
   Birmingham; Norwegian Institute of Public Health (NIPH); King Saud
   University; King Saud University; King Khalid University Hospital;
   Autonomous University of Madrid; Hospital de La Princesa; CIBER - Centro
   de Investigacion Biomedica en Red; CIBERES; University of Edinburgh;
   University of York - UK; University of Hull; International Medical
   University Malaysia; Universitas Muhammadiyah Surakarta; China Medical
   University Taiwan; Ahmadu Bello University; Department of Science \&
   Technology (India); Sree Chitra Tirunal Institute for Medical Sciences
   Technology (SCTIMST); Department of Science \& Technology (India); Sree
   Chitra Tirunal Institute for Medical Sciences Technology (SCTIMST);
   University of Valencia; Hawassa University; International Vaccine
   Institute; Alfaisal University; University of Virginia; University of
   Gondar; University of Gondar; Central University of Kerala; Jagiellonian
   University; Collegium Medicum Jagiellonian University; Universidade de
   Sao Paulo; Hanoi Medical University; Nanyang Technological University;
   Gomal University; University of Warwick; University of Bologna; IRCCS
   Azienda Ospedaliero-Universitaria di Bologna; HSE University (National
   Research University Higher School of Economics); Harvard University;
   University of Gottingen; Quaid I Azam University; Universidade de Sao
   Paulo; University of Oslo; Technical University of Munich; University of
   London; King's College London; Guy's \& St Thomas' NHS Foundation Trust;
   University of London; King's College London; University of Tokyo;
   University of Hong Kong; University of Hong Kong; Addis Ababa
   University; National Center for Neurology \& Psychiatry - Japan; Jackson
   State University; Tsinghua University; Shahid Beheshti University
   Medical Sciences; Wuhan University; Wuhan University; Monash University;
   International Centre for Diarrhoeal Disease Research (ICDDR); Washington
   University (WUSTL); Wuhan University of Science \& Technology; Wuhan
   University of Science \& Technology},
Cited-References = {Abela GJ, 2016, P NATL ACAD SCI USA, V113, P14294, DOI 10.1073/pnas.1611386113.
   Alegana VA, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0073.
   Annan K, 2018, NATURE, V555, P7, DOI 10.1038/d41586-018-02386-3.
   {[}Anonymous], 2017, Global Education Monitoring Report.
   {[}Anonymous], 2016, ISCED MAPPINGS.
   Barro RJ, 2013, J DEV ECON, V104, P184, DOI 10.1016/j.jdeveco.2012.10.001.
   Behrman JA, 2015, SOC SCI MED, V127, P108, DOI 10.1016/j.socscimed.2014.06.034.
   Bhatt S, 2017, J R SOC INTERFACE, V14, DOI 10.1098/rsif.2017.0520.
   Bivand RS, 2015, J STAT SOFTW, V63, P1.
   Blangiardo M, 2013, SPAT SPATIO-TEMPORAL, V7, P39, DOI {[}10.1016/j.sste.2013.07.003, 10.1016/j.sste.2012.12.001].
   Bosco C, 2017, J R SOC INTERFACE, V14, DOI 10.1098/rsif.2016.0825.
   Caldwell J.C., 1994, Health Transtion Review, V4, P224.
   CALDWELL JC, 1979, POP STUD-J DEMOG, V33, P395, DOI 10.2307/2173888.
   Cameletti M, 2013, ASTA-ADV STAT ANAL, V97, P109, DOI 10.1007/s10182-012-0196-3.
   Channan S., 2014, GLOBAL MOSAICS STAND.
   De Neve JW, 2018, J HEALTH ECON, V58, P76, DOI 10.1016/j.jhealeco.2018.01.008.
   De Neve JW, 2015, LANCET GLOB HEALTH, V3, pE470, DOI 10.1016/S2214-109X(15)00087-X.
   Diggle PJ, 1998, J R STAT SOC C-APPL, V47, P299, DOI 10.1111/1467-9876.00113.
   Dowell SF, 2016, NATURE, V540, P189, DOI 10.1038/540189a.
   Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x.
   FAO-UN, 2015, GLOB ADM UN LAYERS G.
   Friedl M., 2019, NASA EOSDIS Land Process. DAAC, DOI DOI 10.5067/MODIS/MCD12Q1.006.
   Friedman J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208019.
   Gakidou E, 2010, LANCET, V376, P959, DOI 10.1016/S0140-6736(10)61257-3.
   Gates Melinda., 2019, MOMENT LIFT EMPOWERI.
   Golding N, 2017, LANCET, V390, P2171, DOI 10.1016/S0140-6736(17)31758-0.
   Gootenberg JS, 2017, SCIENCE, V356, P438, DOI 10.1126/science.aam9321.
   Graetz N, 2018, NATURE, V555, P48, DOI 10.1038/nature25761.
   Horton R, 2018, LANCET, V392, P1504, DOI 10.1016/S0140-6736(18)32741-7.
   Hosmer DW, 2013, WILEY SER PROBAB ST, P1, DOI 10.1002/9781118548387.
   Jejeebhoy S., 1995, WOMENS ED AUTONOMY R.
   Karlsson O, 2019, INT J EPIDEMIOL, V48, P83, DOI 10.1093/ije/dyy158.
   Kim J. Y, 2017, 2017 ANN M PLEN.
   Krainski E., 2017, The R-INLA tutorial on SPDE models.
   Leathwick JR, 2006, MAR ECOL PROG SER, V321, P267, DOI 10.3354/meps321267.
   Lehner B, 2004, J HYDROL, V296, P1, DOI 10.1016/j.jhydrol.2004.03.028.
   LeVine R.A., 2012, Literacy and Mothering: How women's schooling changes the lives of the world's children.
   Lim SS, 2018, LANCET, V392, P1217, DOI 10.1016/S0140-6736(18)31941-X.
   Lindgren F, 2011, J ROY STAT SOC B, V73, P423, DOI 10.1111/j.1467-9868.2011.00777.x.
   Lumley T., 2019, SURVEY ANAL COMPLEX, V3, P35, DOI DOI 10.1093/AJE/KWH090.
   Marmot M, 2008, LANCET, V372, P1661, DOI 10.1016/S0140-6736(08)61690-6.
   McCrary J, 2011, AM ECON REV, V101, P158, DOI 10.1257/aer.101.1.158.
   Naghavi M, 2017, LANCET, V390, P1151, DOI 10.1016/S0140-6736(17)32152-9.
   Osgood-Zimmerman A, 2018, NATURE, V555, P41, DOI 10.1038/nature25760.
   Pamuk ER, 2011, POPUL DEV REV, V37, P637, DOI 10.1111/j.1728-4457.2011.00451.x.
   Patil AP, 2011, TRENDS PARASITOL, V27, P245, DOI 10.1016/j.pt.2011.01.003.
   Roberts DA, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0518-x.
   Rozanov Y.A., 1982, Markov Random Fields, P55, DOI DOI 10.1007/978-1-4613-8190-7\_2.
   Rue H, 2014, BAYESIAN COMPUTING I.
   Rue H, 2009, J ROY STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x.
   Stein M.L., 1999, Springer Series in Statistics.
   Tatem AJ, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.4.
   UNESCO, 2018, M OUR COMM GEND EQ E.
   UNESCO, 2007, UNESCO OP DEF BAS ED.
   UNESCO, 2017, RED GLOB POV UN PRIM, V44.
   UNESCO, 2017, IS REAL PROGR BEING.
   United Nations, 2015, Transforming our world: The 2030 Agenda For Sustainable Development, DOI {[}10.1201/b20466-7, DOI 10.1201/B20466-7].
   United Nations, 2018, YOUTH 2030 AGE SUST.
   WHITTLE P, 1954, BIOMETRIKA, V41, P434.
   World Pop, DAT TYP.
   World Wildlife Fund, 2004, GLOB LAK WETL DAT LE.
   Yousafzai M., 2013, I Am Malala: The Girl Who Stood Up for Education and was Shot by the Taliban.},
Number-of-Cited-References = {62},
Times-Cited = {44},
Unique-ID = {WOS:000507800800006},
}

@article{ WOS:000473609500025,
Author = {Guan, Yue and Nehl, Eric and Pencea, Ioana and Condit, Celeste M. and
   Escoffery, Cam and Bellcross, Cecelia A. and McBride, Colleen M.},
Title = {Willingness to decrease mammogram frequency among women at low risk for
   hereditary breast cancer},
Journal = {SCIENTIFIC REPORTS},
Year = {2019},
Volume = {9},
Month = {JUL 3},
Abstract = {This study aimed to assess women's willingness to alter mammogram
   frequency based on their low risk for HBOC, and to examine if cognitive
   and emotional factors are associated with women's inclination to
   decrease mammogram frequency. We conducted an online survey with women
   (N = 124) who were unlikely to have a BRCA mutation and at average
   population risk for breast cancer based on family history. Most women
   were either white (50\%) or African American (38\%) and were 50 years or
   older (74\%). One-third of women (32\%) were willing to decrease
   mammogram frequency (as consistent with the USPSTF guideline), 42\%
   reported being unwilling and 26\% were unsure. Multivariate logistic
   regression showed that feeling worried about breast cancer (Adjust OR =
   0.33, p = 0.01), greater genetic risk knowledge (Adjust OR = 0.74, p =
   0.047), and more frequent past mammogram screening (Adjust OR = 0.13, p
   = 0.001) were associated with being less willing to decrease screening
   frequency. Findings suggest that emerging genomics-informed medical
   guidelines may not be accepted by many patients when the recommendations
   go against what is considered standard practice. Further study of the
   interplay between emotion-and cognition-based processing of the HBOC
   screen result will be important for strategizing communication
   interventions aimed at realizing the potential of precision public
   health.},
Type = {Article},
Affiliation = {Guan, Y (Corresponding Author), Emory Univ, Rollins Sch Publ Hlth, Dept Behav Sci \& Hlth Educ, Atlanta, GA 30322 USA.
   Guan, Yue; Nehl, Eric; Pencea, Ioana; Escoffery, Cam; McBride, Colleen M., Emory Univ, Rollins Sch Publ Hlth, Dept Behav Sci \& Hlth Educ, Atlanta, GA 30322 USA.
   Condit, Celeste M., Univ Georgia, Franklin Coll Arts \& Sci, Dept Commun Studies, Athens, GA 30602 USA.
   Bellcross, Cecelia A., Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA.},
DOI = {10.1038/s41598-019-45967-6},
Article-Number = {9599},
Keywords-Plus = {LIMITED HEALTH LITERACY; FAMILY-HISTORY; VALIDATION; INFORMATION;
   AWARENESS; BEHAVIOR; TRENDS; WORRY},
Research-Areas = {Science \& Technology - Other Topics},
Web-of-Science-Categories  = {Multidisciplinary Sciences},
Author-Email = {yue.guan@emory.edu},
Affiliations = {Emory University; Rollins School Public Health; University System of
   Georgia; University of Georgia; Emory University},
Cited-References = {Adams LB, 2017, J COMMUN HEALTH, V42, P1044, DOI 10.1007/s10900-017-0339-2.
   Alford SH, 2011, PUBLIC HEALTH GENOM, V14, P85, DOI 10.1159/000294277.
   Allen JD, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1169.
   Bellcross C, 2019, GENET MED, V21, P181, DOI 10.1038/s41436-018-0020-x.
   Bellcross C, 2010, GENET MED, V12, P240, DOI 10.1097/GIM.0b013e3181d4bc3a.
   Bellcross CA, 2009, GENET MED, V11, P783, DOI 10.1097/GIM.0b013e3181b9b04a.
   Brown C, 2018, J WOMENS HEALTH, V27, P875, DOI 10.1089/jwh.2017.6425.
   Calonge N, 2009, ANN INTERN MED, V151, P716, DOI 10.7326/0003-4819-151-10-200911170-00008.
   Chew LD, 2008, J GEN INTERN MED, V23, P561, DOI 10.1007/s11606-008-0520-5.
   Consedine NS, 2004, CANCER EPIDEM BIOMAR, V13, P501.
   Darabi H, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3110.
   Dehkordy SF, 2015, AM J PREV MED, V49, P419, DOI 10.1016/j.amepre.2015.02.017.
   Egede LE, 2008, J GEN INTERN MED, V23, P808, DOI 10.1007/s11606-008-0613-1.
   Erblich J, 2005, PATIENT EDUC COUNS, V56, P182, DOI 10.1016/j.pec.2004.02.007.
   Grieco EC, 2001, Overview of race and Hispanic origin, 2000, V8.
   Griffin RJ, 1999, ENVIRON RES, V80, pS230, DOI 10.1006/enrs.1998.3940.
   Hay JL, 2006, PREV MED, V42, P401, DOI 10.1016/j.ypmed.2006.03.002.
   Helfrich CD, 2018, J EVAL CLIN PRACT, V24, P198, DOI 10.1111/jep.12855.
   Karliner LS, 2007, J GEN INTERN MED, V22, P308, DOI 10.1007/s11606-006-0087-y.
   Kerlikowske K, 2013, JAMA INTERN MED, V173, P807, DOI 10.1001/jamainternmed.2013.307.
   Kiviniemi MT, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-899.
   Lechner L, 1997, PREV MED, V26, P473, DOI 10.1006/pmed.1997.0161.
   Lerman C, 1997, JNCI-J NATL CANCER I, V89, P148, DOI 10.1093/jnci/89.2.148.
   LERMAN C, 1991, ANN INTERN MED, V114, P657, DOI 10.7326/0003-4819-114-8-657.
   LERMAN C, 1991, HEALTH PSYCHOL, V10, P259, DOI 10.1037/0278-6133.10.4.259.
   Mayne L, 2003, J RURAL HEALTH, V19, P63, DOI 10.1111/j.1748-0361.2003.tb00543.x.
   Modell SM, 2016, HEALTHCARE-BASEL, V4, DOI 10.3390/healthcare4010014.
   Moyer VA, 2014, ANN INTERN MED, V160, P271, DOI 10.7326/M13-2747.
   Nagler RH, 2019, ANN BEHAV MED, V53, P896, DOI 10.1093/abm/kay098.
   Nagler RH, 2017, MED CARE, V55, P879, DOI 10.1097/MLR.0000000000000798.
   O'Donoghue C, 2014, ANN INTERN MED, V160, P145, DOI 10.7326/M13-1217.
   Oeffinger KC, 2015, JAMA-J AM MED ASSOC, V314, P1599, DOI 10.1001/jama.2015.12783.
   Pace LE, 2013, CANCER-AM CANCER SOC, V119, P2518, DOI 10.1002/cncr.28105.
   Pashayan N, 2011, BRIT J CANCER, V104, P1656, DOI 10.1038/bjc.2011.118.
   Pashayan N, 2018, JAMA ONCOL, V4, P1504, DOI 10.1001/jamaoncol.2018.1901.
   Patton C., 2017, BREAST CANC CAUSE MA.
   Sharma R, 2018, J WOMENS HEALTH, V27, P1142, DOI 10.1089/jwh.2017.6689.
   Siu AL, 2016, ANN INTERN MED, V164, P279, DOI 10.7326/M15-2886.
   Taber JM, 2015, J BEHAV MED, V38, P740, DOI 10.1007/s10865-015-9648-z.
   Thompson ER, 2007, J CROSS CULT PSYCHOL, V38, P227, DOI 10.1177/0022022106297301.
   Tosteson ANA, 2014, JAMA INTERN MED, V174, P954, DOI 10.1001/jamainternmed.2014.981.
   Trentham-Dietz A, 2016, ANN INTERN MED, V165, P700, DOI 10.7326/M16-0476.
   Tsalatsanis A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134800.
   Vilaprinyo E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086858.
   Wallace LS, 2006, J GEN INTERN MED, V21, P874, DOI 10.1111/j.1525-1497.2006.00532.x.
   Yu JN, 2017, JAMA INTERN MED, V177, P1381, DOI 10.1001/jamainternmed.2017.2247.},
Number-of-Cited-References = {46},
Times-Cited = {5},
Unique-ID = {WOS:000473609500025},
}

@article{ WOS:000904958000008,
Author = {Chien, Rong-Nan and Lu, Sheng-Nan and Pwu, Raoh-Fang and Wu, Grace
   Hui-Min and Yang, Wen-Wen and Liu, Chia-Ling},
Title = {Taiwan accelerates its efforts to eliminate hepatitis C},
Journal = {GLOBAL HEALTH \& MEDICINE},
Year = {2021},
Volume = {3},
Number = {5},
Pages = {293-300},
Abstract = {The estimated prevalence of anti-HCV was 3.3\% (1.8-5.5\%) in the
   general population in Taiwan with several regional disparities. The
   reactive anti-HCV in different regions may vary between 0\% and 65\%.
   The National Hepatitis C Program (NHCP) office estimated approximately
   623,323 persons reactive with anti-HCV based on several extensive
   region- and cohort-wide studies. Taiwan has accelerated its efforts to
   eliminate hepatitis C since 2018 by committing to achieve World Health
   Organization (WHO)'s 2030 goal of treating 80\% of eligible patients by
   2025. Many aggressive measures by the Ministry of Health and Welfare
   (MOHW) have been ongoing including several key success factors such as
   political commitment by the MOHW to finance this national program and
   improve National Health Insurance (NHI) reimbursement restrictions for
   treatment. Meanwhile, the Taiwan Centers for Disease Control (CDC)
   instituted harm reduction programs and the Health Promotion
   Administration (HPA) started to improve awareness and perform national
   screening programs. The NHCP office instituted monitoring, evaluation,
   micro-elimination and funding to linkage to care programs. In addition
   to sustainable financing, it is imperative to scale-up screening
   coverage through a precision public health approach to fill the gap of
   under-diagnosis. Hopefully, we can achieve early elimination by
   announcing the treatment target of 250000 CHC patients by 2025.},
Type = {Review},
Affiliation = {Chien, RN (Corresponding Author), Linkou Chang Gung Mem Hosp \& Univ, Liver Res Unit, 5 Fuxing St, Taoyuan 333, Taiwan.
   Chien, Rong-Nan; Lu, Sheng-Nan; Pwu, Raoh-Fang; Wu, Grace Hui-Min; Yang, Wen-Wen; Liu, Chia-Ling, Minist Hlth \& Welf, Taiwan Natl Hepatitis C Program Off, Taipei, Taiwan.
   Chien, Rong-Nan, Linkou Chang Gung Mem Hosp \& Univ, Liver Res Unit, 5 Fuxing St, Taoyuan 333, Taiwan.
   Lu, Sheng-Nan, Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Hepatogastroenterol, Kaohsiung, Taiwan.
   Pwu, Raoh-Fang, Taipei Med Univ, Sch Hlth Care Adm, Taipei, Taiwan.
   Wu, Grace Hui-Min, Natl Yang Ming Univ, Dept Phys Therapy \& Assist Technol, Taipei, Taiwan.},
DOI = {10.35772/ghm.2021.01064},
Keywords = {HCV elimination; Taiwan's effort; National Hepatitis C Program},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {ronald@adm.cgmh.org.tw},
Affiliations = {Chang Gung Memorial Hospital; Taipei Medical University; National Yang
   Ming Chiao Tung University},
Cited-References = {{[}Anonymous], 2016, GLOB REP ACC HEP C T.
   {[}Anonymous], 2019, TAIW HEP C POL GUID.
   Bennett H, 2015, HEPATOL INT, V9, P378, DOI 10.1007/s12072-015-9629-x.
   Chen DS, 2017, J VIRAL HEPATITIS, V24, P44, DOI 10.1111/jvh.12759.
   Chen DS, 2019, LANCET INFECT DIS, V19, P466, DOI 10.1016/S1473-3099(19)30170-7.
   Chen DS, 2011, HEPATOLOGY, V54, P381, DOI 10.1002/hep.24500.
   CHEN DS, 1990, J INFECT DIS, V162, P817, DOI 10.1093/infdis/162.4.817.
   Hsieh MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094791.
   Hu TH, 2021, AM J KIDNEY DIS, VS0272- 6386.
   Kao JH, 2016, J FORMOS MED ASSOC, V115, P65, DOI 10.1016/j.jfma.2015.06.012.
   Lazarus JV, 2018, SEMIN LIVER DIS, V38, P181, DOI 10.1055/s-0038-1666841.
   Li CW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194149.
   Liou BH, 2021, INFECT DIS THER, V10, P827, DOI 10.1007/s40121-021-00424-8.
   Liu CH, 2019, J FORMOS MED ASSOC, V118, P1014, DOI 10.1016/j.jfma.2018.10.020.
   Liu CH, 2011, J GASTROEN HEPATOL, V26, P228, DOI 10.1111/j.1440-1746.2010.06488.x.
   Llaneras J, 2019, J HEPATOL, V71, P666, DOI 10.1016/j.jhep.2019.06.002.
   Polaris Observatory HCV Collaborators, 2017, LANCET GASTROENTEROL, V2, P161.
   Razavi H, 2020, LIVER INT, V40, P522, DOI 10.1111/liv.14324.
   Tseng YT, 2012, J FORMOS MED ASSOC, V111, P431, DOI 10.1016/j.jfma.2011.06.022.
   World Health Organization, 2016, GLOB HLTH SECT STRAT.
   Wu GHM, 2020, LIVER INT, V40, P1506, DOI 10.1111/liv.14412.
   Wu GHM, 2018, J FORMOS MED ASSOC, V117, P1044, DOI 10.1016/j.jfma.2018.10.021.
   Wu TY, 2010, LONDON J PRIM CARE, V3, P115, DOI 10.1080/17571472.2010.11493315.
   Yang TJ, 2021, WWPDB.
   Yu ML, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000690.
   Yu ML, 2009, J GASTROEN HEPATOL, V24, P336, DOI 10.1111/j.1440-1746.2009.05789.x.},
Number-of-Cited-References = {26},
Times-Cited = {19},
Unique-ID = {WOS:000904958000008},
}

@article{ WOS:001101486500001,
Author = {Trainer, Alison H. and Goode, Erin and Hoskins, Cass N. and Wheeler,
   Jack C. W. and Best, Stephanie},
Title = {Calibrating variant curation by clinical context based on factors that
   influence patients' tolerance of uncertainty},
Journal = {GENETICS IN MEDICINE},
Year = {2023},
Volume = {25},
Number = {12},
Month = {DEC},
Abstract = {Purpose: Shared decision making manages genomic uncertainty by
   integrating molecular and clinical uncertainties with patient values to
   craft a person-centered management plan. Laboratories seek genomic
   report consistency, agnostic to clinical context. Molecular reports
   often mask laboratory-managed uncertainties from clinical decision
   making. Better integration of these uncertainty management strategies
   requires a nuanced understanding of patients' perceptions and reactions
   to test uncertainties. We explored patients' tolerance to variant
   uncertainty in 3 parameters: (1) relative causal significance, (2) risk
   accuracy, and (3) classification validity. Method: Deliberative forums
   were undertaken with 18 patients with predictive testing experience.
   Uncertainty deliberations were elicited for each parameter. A thematic
   framework was first developed, and then mapped to whether they justified
   tolerance to more or less parameter specific uncertainty. Results: Six
   identified themes mapped to clinical and personal domains. These domains
   generated opposing forces when calibrating uncertainty. Personal themes
   justified tolerance of higher uncertainty and clinical themes lower
   uncertainty. Decision making in uncertainty focused on reducing
   management regret. Open communication increased tolerance of classifi-
   cation validity and risk accuracy uncertainty. Using these data, we have
   developed a nascent clinical algorithm integrating molecular uncertainty
   with clinical context through a targeted communication framework.
   Conclusion: Maximizing test utility necessitates context-specific
   recalibration of uncertainty management and communication. (c) 2023
   American College of Medical Genetics and Genomics. Published by Elsevier
   Inc. All rights reserved.},
Type = {Article},
Affiliation = {Trainer, AH (Corresponding Author), Peter Maallum Canc Ctr, Parkville Familial Canc Ctr, 305 Grattan St, Melbourne, Vic 3000, Australia.
   Trainer, Alison H.; Goode, Erin; Hoskins, Cass N.; Wheeler, Jack C. W., Peter Maallum Canc Ctr, Parkville Familial Canc Ctr, 305 Grattan St, Melbourne, Vic 3000, Australia.
   Trainer, Alison H., Univ Melbourne, Dept Med, Melbourne, Vic, Australia.
   Best, Stephanie, Peter MacCallum Canc Ctr, Dept Hlth Serv Res, Melbourne, Vic, Australia.
   Trainer, Alison H.; Goode, Erin; Hoskins, Cass N.; Wheeler, Jack C. W., Royal Melbourne Hosp, Dept Genom Med, Melbourne, Vic, Australia.
   Trainer, Alison H.; Best, Stephanie, Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia.
   Best, Stephanie, Victorian Comprehens Canc Ctr Alliance, Melbourne, Vic, Australia.
   Best, Stephanie, Murdoch Childrens Res Inst, Australian Genom, Melbourne, Vic, Australia.},
DOI = {10.1016/j.gim.2023.100982},
EarlyAccessDate = {OCT 2023},
Article-Number = {100982},
Keywords = {Genomic uncertainty; Patient preference implementation; Person-centred
   care; Precision public health; Variant curation},
Keywords-Plus = {PERSONAL UTILITY; MODEL},
Research-Areas = {Genetics \& Heredity},
Web-of-Science-Categories  = {Genetics \& Heredity},
Author-Email = {alison.trainer@petermac.org},
Affiliations = {Melbourne Genomics Health Alliance; University of Melbourne; Melbourne
   Bioinformatics; Peter Maccallum Cancer Center; Melbourne Genomics Health
   Alliance; Melbourne Genomics Health Alliance; Melbourne Health; Royal
   Melbourne Hospital; Peter Maccallum Cancer Center; University of
   Melbourne; Melbourne Genomics Health Alliance; Melbourne Genomics Health
   Alliance; Melbourne Genomics Health Alliance; Murdoch Children's
   Research Institute},
Cited-References = {Abu-El-Haija A, 2023, GENET MED, V25, DOI 10.1016/j.gim.2023.100803.
   Berrios C, 2021, GENET MED, V23, P2289, DOI 10.1038/s41436-021-01267-x.
   Best S, 2021, J EVAL CLIN PRACT, V27, P1369, DOI 10.1111/jep.13573.
   Biesecker BB, 2014, GENET MED, V16, P977, DOI 10.1038/gim.2014.57.
   Bilkey GA, 2019, FRONT PUBLIC HEALTH, V7, DOI 10.3389/fpubh.2019.00040.
   Braun V., 2006, Qualitative research in psychology, V3, P77, DOI DOI 10.1191/1478088706QP063OA.
   Britt KL, 2020, NAT REV CANCER, V20, P417, DOI 10.1038/s41568-020-0266-x.
   Burchardt T, 2014, QUAL RES, V14, P353, DOI 10.1177/1468794112469624.
   Carver T, 2021, CANCER EPIDEM BIOMAR, V30, P469, DOI 10.1158/1055-9965.EPI-20-1319.
   Clift K, 2020, J COMMUN GENET, V11, P139, DOI 10.1007/s12687-019-00434-7.
   Cragun D, 2020, BREAST CANCER RES TR, V182, P421, DOI 10.1007/s10549-020-05699-y.
   Dahm MR, 2022, JAMA-J AM MED ASSOC, V327, P1127, DOI 10.1001/jama.2022.2141.
   Ding Y, 2022, NAT GENET, V54, P30, DOI 10.1038/s41588-021-00961-5.
   Ekman I, 2011, EUR J CARDIOVASC NUR, V10, P248, DOI 10.1016/j.ejcnurse.2011.06.008.
   Elwyn G, 2012, J GEN INTERN MED, V27, P1361, DOI 10.1007/s11606-012-2077-6.
   Han PKJ, 2017, GENET MED, V19, P918, DOI 10.1038/gim.2016.212.
   Hillen MA, 2017, SOC SCI MED, V180, P62, DOI 10.1016/j.socscimed.2017.03.024.
   Hodgson Jan, 2005, J Genet Couns, V14, P89, DOI 10.1007/s10897-005-4067-x.
   Jamal Leila, 2017, AJOB Empir Bioeth, V8, P82, DOI 10.1080/23294515.2017.1287786.
   James JE, 2022, J GENET COUNS, V31, P1421, DOI 10.1002/jgc4.1617.
   Kohler JN, 2017, EUR J HUM GENET, V25, P662, DOI 10.1038/ejhg.2017.10.
   Lawal TA, 2018, CLIN GENET, V93, P1022, DOI 10.1111/cge.13220.
   Lemus D, 2022, RISK ANAL, V42, P279, DOI 10.1111/risa.13860.
   Liberati EG, 2016, SOC SCI MED, V150, P31, DOI 10.1016/j.socscimed.2015.12.002.
   Loong L, 2022, GENET MED, V24, P1867, DOI 10.1016/j.gim.2022.05.002.
   McCormack J, 2018, BMJ EVID-BASED MED, V23, P137, DOI 10.1136/bmjebm-2018-110922.
   Mishel M H, 1990, Image J Nurs Sch, V22, P256.
   Pashayan N, 2020, NAT REV CLIN ONCOL, V17, P687, DOI 10.1038/s41571-020-0388-9.
   Rehm HL, 2015, NEW ENGL J MED, V372, P2235, DOI 10.1056/NEJMsr1406261.
   Reyes KG, 2022, FAM CANCER, V21, P143, DOI 10.1007/s10689-021-00251-3.
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30.
   Santana MJ, 2018, HEALTH EXPECT, V21, P429, DOI 10.1111/hex.12640.
   Schwartz B., 2015, J MARKETING BEHAV, V1, P113, DOI DOI 10.1561/107.00000007.
   Smith HS, 2022, PATIENT, V15, P317, DOI 10.1007/s40271-021-00558-4.
   Tavtigian SV, 2020, HUM MUTAT, V41, P1734, DOI 10.1002/humu.24088.
   Urban A, 2018, NEW GENET SOC, V37, P153, DOI 10.1080/14636778.2018.1469976.
   Vadlamudi L, 2022, J CLIN MED, V11, DOI 10.3390/jcm11144238.
   Zeelenberg Marcel., 2015, J MARKETING BEHAV, V1, P157, DOI {[}10.1561/107.00000010, DOI 10.1561/107.00000010].
   Zirkelbach E, 2018, J GENET COUNS, V27, P761, DOI 10.1007/s10897-017-0184-6.},
Number-of-Cited-References = {39},
Times-Cited = {0},
Unique-ID = {WOS:001101486500001},
}

@article{ WOS:000502538900012,
Author = {Petrovic, Jelena and Pesic, Vesna and Lauschke, Volker M.},
Title = {Frequencies of clinically important <i>CYP2C19</i> and <i>CYP2D6</i>
   alleles are graded across Europe},
Journal = {EUROPEAN JOURNAL OF HUMAN GENETICS},
Year = {2020},
Volume = {28},
Number = {1},
Pages = {88-94},
Month = {JAN},
Abstract = {CYP2C19 and CYP2D6 are important drug-metabolizing enzymes that are
   involved in the metabolism of around 30\% of all medications.
   Importantly, the corresponding genes are highly polymorphic and these
   genetic differences contribute to interindividual and interethnic
   differences in drug pharmacokinetics, response, and toxicity. In this
   study we systematically analyzed the frequency distribution of
   clinically relevant CYP2C19 and CYP2D6 alleles across Europe based on
   data from 82,791 healthy individuals extracted from 79 original
   publications and, for the first time, provide allele confidence
   intervals for the general population. We found that frequencies of
   CYP2D6 gene duplications showed a clear South-East to North-West
   gradient ranging from <1\% in Sweden and Denmark to 6\% in Greece and
   Turkey. In contrast, an inverse distribution was observed for the
   loss-of-function alleles CYP2D6{*}4 and CYP2D6{*}5. Similarly,
   frequencies of the inactive CYP2C19{*}2 allele were graded from
   North-West to South-East Europe. In important contrast to previous work
   we found that the increased activity allele CYP2C19{*}17 was most
   prevalent in Central Europe (25-33\%) with lower prevalence in
   Mediterranean-South Europeans (11-24\%). In summary, we provide a
   detailed European map of common CYP2C19 and CYP2D6 variants and find
   that frequencies of the most clinically relevant alleles are
   geographically graded reflective of Europe's migratory history. These
   findings emphasize the importance of generating pharmacogenomic data
   sets with high spatial resolution to improve precision public health
   across Europe.},
Type = {Article},
Affiliation = {Lauschke, VM (Corresponding Author), Karolinska Inst, Dept Physiol \& Pharmacol, Sect Pharmacogenet, Stockholm, Sweden.
   Petrovic, Jelena; Lauschke, Volker M., Karolinska Inst, Dept Physiol \& Pharmacol, Sect Pharmacogenet, Stockholm, Sweden.
   Petrovic, Jelena; Pesic, Vesna, Univ Belgrade, Fac Pharm, Dept Physiol, Belgrade, Serbia.},
DOI = {10.1038/s41431-019-0480-8},
Keywords-Plus = {ADVERSE DRUG-REACTIONS; GENETIC POLYMORPHISMS; POPULATION;
   PHARMACOGENES; METAANALYSIS; VARIABILITY; PREVALENCE; METABOLISM},
Research-Areas = {Biochemistry \& Molecular Biology; Genetics \& Heredity},
Web-of-Science-Categories  = {Biochemistry \& Molecular Biology; Genetics \& Heredity},
Author-Email = {volker.lauschke@ki.se},
Affiliations = {Karolinska Institutet; University of Belgrade},
Cited-References = {Aklillu E, 1996, J PHARMACOL EXP THER, V278, P441.
   Al-Jenoobi FI, 2013, BASIC CLIN PHARMACOL, V112, P50, DOI 10.1111/j.1742-7843.2012.00919.x.
   Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393.
   Ameur A, 2017, EUR J HUM GENET, V25, P1253, DOI 10.1038/ejhg.2017.130.
   Arvanitidis K, 2007, FUND CLIN PHARMACOL, V21, P419, DOI 10.1111/j.1472-8206.2007.00510.x.
   Bank PCD, 2018, CLIN PHARMACOL THER, V103, P599, DOI 10.1002/cpt.762.
   Budnitz DS, 2007, ANN INTERN MED, V147, P755, DOI 10.7326/0003-4819-147-11-200712040-00006.
   Bush WS, 2016, CLIN PHARMACOL THER, V100, P160, DOI 10.1002/cpt.350.
   Dehbozorgi M, 2018, MOL MED REP, V17, P4195, DOI 10.3892/mmr.2018.8377.
   DEMORAIS SMF, 1994, J BIOL CHEM, V269, P15419.
   Evans WE, 1999, SCIENCE, V286, P487, DOI 10.1126/science.286.5439.487.
   Fricke-Galindo I, 2016, PHARMACOGENOMICS J, V16, P113, DOI 10.1038/tpj.2015.70.
   Fujikura K, 2015, PHARMACOGENET GENOM, V25, P584, DOI 10.1097/FPC.0000000000000172.
   Fuselli S, 2004, EUR J HUM GENET, V12, P916, DOI 10.1038/sj.ejhg.5201243.
   Gaedigk A, 2018, J PERS MED, V8, DOI 10.3390/jpm8020015.
   Gaedigk A, 2017, GENET MED, V19, P69, DOI 10.1038/gim.2016.80.
   Impicciatore P, 2001, BRIT J CLIN PHARMACO, V52, P77, DOI 10.1046/j.0306-5251.2001.01407.x.
   Ingelman-Sundberg M, 2005, PHARMACOGENOMICS J, V5, P6, DOI 10.1038/sj.tpj.6500285.
   Ingelman-Sundberg M, 2018, HUM GENOMICS, V12, DOI 10.1186/s40246-018-0157-3.
   Jukic MM, 2018, AM J PSYCHIAT, V175, P463, DOI 10.1176/appi.ajp.2017.17050550.
   Kozyra M, 2017, GENET MED, V19, P20, DOI 10.1038/gim.2016.33.
   Lamba JK, 2000, CLIN PHARMACOL THER, V68, P328, DOI 10.1067/mcp.2000.109365.
   Lauschke VM, 2019, EUR J PHARM SCI, V130, P65, DOI 10.1016/j.ejps.2019.01.024.
   Lauschke VM, 2018, CLIN PHARMACOL THER, V103, P745, DOI 10.1002/cpt.976.
   Lauschke VM, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101714.
   Lauschke VM, 2016, TRENDS PHARMACOL SCI, V37, P85, DOI 10.1016/j.tips.2015.10.006.
   Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057.
   Martínez-Cruz B, 2016, EUR J HUM GENET, V24, P937, DOI 10.1038/ejhg.2015.201.
   McLellan RA, 1997, PHARMACOGENETICS, V7, P187, DOI 10.1097/00008571-199706000-00003.
   Mizzi C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162866.
   Pirmohamed M, 2004, BMJ-BRIT MED J, V329, P15, DOI 10.1136/bmj.329.7456.15.
   Reisberg S, 2018, GENET MED, V20, P4.
   Saeed LH, 2013, INT J MED SCI, V10, P1497, DOI 10.7150/ijms.6795.
   Santos M, 2018, GENET MED, V20, P622, DOI 10.1038/gim.2017.156.
   Scott SA, 2012, PHARMACOGENOMICS J, V12, P297, DOI 10.1038/tpj.2011.5.
   Sim SC, 2006, CLIN PHARMACOL THER, V79, P103, DOI 10.1016/j.clpt.2005.10.002.
   Sipeky C, 2013, MOL BIOL REP, V40, P4727, DOI 10.1007/s11033-013-2569-4.
   Vicente J, 2014, MOL BIOL REP, V41, P1267, DOI 10.1007/s11033-013-2971-y.
   Yasuda SU, 2008, CLIN PHARMACOL THER, V84, P417, DOI 10.1038/clpt.2008.141.
   Zhou Y, 2017, CLIN PHARMACOL THER, V102, P688, DOI 10.1002/cpt.690.},
Number-of-Cited-References = {40},
Times-Cited = {57},
Unique-ID = {WOS:000502538900012},
}

@article{ WOS:000411874800010,
Author = {Freeman, Vincent L. and Boylan, Emma E. and Pugach, Oksana and
   Mclafferty, Sara L. and Tossas-Milligan, Katherine Y. and Watson,
   Karriem S. and Winn, Robert A.},
Title = {A geographic information system-based method for estimating cancer rates
   in non-census defined geographical areas},
Journal = {CANCER CAUSES \& CONTROL},
Year = {2017},
Volume = {28},
Number = {10},
Pages = {1095-1104},
Month = {OCT},
Abstract = {To address locally relevant cancer-related health issues, health
   departments frequently need data beyond that contained in standard
   census area-based statistics. We describe a geographic information
   system-based method for calculating age-standardized cancer incidence
   rates in non-census defined geographical areas using publically
   available data.
   Aggregated records of cancer cases diagnosed from 2009 through 2013 in
   each of Chicago's 77 census-defined community areas were obtained from
   the Illinois State Cancer Registry. Areal interpolation through
   dasymetric mapping of census blocks was used to redistribute populations
   and case counts from community areas to Chicago's 50 politically defined
   aldermanic wards, and ward-level age-standardized 5-year cumulative
   incidence rates were calculated.
   Potential errors in redistributing populations between geographies were
   limited to < 1.5\% of the total population, and agreement between our
   ward population estimates and those from a frequently cited reference
   set of estimates was high (Pearson correlation r = 0.99, mean difference
   = -4 persons). A map overlay of safety-net primary care clinic locations
   and ward-level incidence rates for advanced-staged cancers revealed
   potential pathways for prevention.
   Areal interpolation through dasymetric mapping can estimate cancer rates
   in non-census defined geographies. This can address gaps in local
   cancer-related health data, inform health resource advocacy, and guide
   community-centered cancer prevention and control.},
Type = {Article},
Affiliation = {Freeman, VL (Corresponding Author), Univ Illinois, Sch Publ Hlth, Div Epidemiol \& Biostat, 1603 W Taylor St, Chicago, IL 60612 USA.
   Freeman, VL (Corresponding Author), Univ Illinois, Ctr Canc, Univ Illinois Hosp \& Hlth Sci Syst, 914 S Wood St, Chicago, IL 60612 USA.
   Freeman, VL (Corresponding Author), Univ Illinois, Sch Publ Hlth, Inst Hlth Res \& Policy, 1747 W Roosevelt Rd, Chicago, IL 60612 USA.
   Freeman, Vincent L.; Boylan, Emma E.; Pugach, Oksana; Tossas-Milligan, Katherine Y., Univ Illinois, Sch Publ Hlth, Div Epidemiol \& Biostat, 1603 W Taylor St, Chicago, IL 60612 USA.
   Freeman, Vincent L.; Tossas-Milligan, Katherine Y.; Watson, Karriem S.; Winn, Robert A., Univ Illinois, Ctr Canc, Univ Illinois Hosp \& Hlth Sci Syst, 914 S Wood St, Chicago, IL 60612 USA.
   Freeman, Vincent L.; Pugach, Oksana, Univ Illinois, Sch Publ Hlth, Inst Hlth Res \& Policy, 1747 W Roosevelt Rd, Chicago, IL 60612 USA.
   Mclafferty, Sara L., Univ Illinois, Sch Earth Soc \& Environm, Dept Geog \& Geog Informat Sci, 605 E Springfield Ave, Champaign, IL 61820 USA.},
DOI = {10.1007/s10552-017-0941-8},
Keywords = {Local cancer health information; Areal interpolation through dasymetric
   mapping; Precision public health},
Keywords-Plus = {HEALTH INFORMATION; PUBLIC-HEALTH; LOCAL HEALTH; NEEDS},
Research-Areas = {Oncology; Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Oncology; Public, Environmental \& Occupational Health},
Author-Email = {freem981@uic.edu},
Affiliations = {University of Illinois System; University of Illinois Chicago;
   University of Illinois Chicago Hospital; University of Illinois System;
   University of Illinois Chicago; University of Illinois Chicago Hospital;
   University of Illinois System; University of Illinois Chicago;
   University of Illinois Chicago Hospital; University of Illinois System;
   University of Illinois Urbana-Champaign},
Cited-References = {{[}Anonymous], PUBL HLTH ROL MEAS A.
   {[}Anonymous], US CANC STAT 1999 20.
   BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8.
   Castrucci BC, 2015, J PUBLIC HEALTH MAN, V21, pS38, DOI 10.1097/PHH.0000000000000169.
   Chicago Fact Book Consortium, 1995, LOC COMM FACT BOOK C.
   City of Chicago City Council, 2016, DESCR CIT CHIC ALD R.
   Clegg LX, 2002, J NATL CANCER I, V94, P1537.
   Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523.
   Curriero FC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008998.
   Desmond-Hellmann S, 2011, PRECISION MED BUILDI, P21.
   Fay MP, 1997, STAT MED, V16, P791.
   Fisher PF, 1996, PROF GEOGR, V48, P299, DOI 10.1111/j.0033-0124.1996.00299.x.
   Henry KA, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-3.
   Himmelstein DU, 2016, AM J PUBLIC HEALTH, V106, P56, DOI 10.2105/AJPH.2015.302908.
   Hodge JG, 2003, J LAW MED ETHICS, V31, P663, DOI 10.1111/j.1748-720X.2003.tb00133.x.
   Holt J.B., 2004, CARTOGR GEOGR INF SC, V31, P103, DOI DOI 10.1559/1523040041649407.
   Khoury MJ, 2016, AM J PREV MED, V50, P398, DOI 10.1016/j.amepre.2015.08.031.
   Luck J, 2006, HEALTH AFFAIR, V25, P979, DOI 10.1377/hlthaff.25.4.979.
   Luo L, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-51.
   Maantay J.A., 2007, Cartography and Geographic Information Science, V34, P77, DOI {[}DOI 10.1559/152304007781002190, 10.1559/152304007781002190].
   Naishadham D, 2011, CANCER EPIDEM BIOMAR, V20, P1296, DOI 10.1158/1055-9965.EPI-11-0250.
   Ramos E, 2017, INTERACTIVE CITY COU.
   Reibel M, 2007, POPUL RES POLICY REV, V26, P601, DOI 10.1007/s11113-007-9046-5.
   Shah AM, 2006, AM J PUBLIC HEALTH, V96, P1485, DOI 10.2105/AJPH.2004.052076.
   Simon PA, 2001, AM J PUBLIC HEALTH, V91, P1950, DOI 10.2105/AJPH.91.12.1950.
   Tiwari RC, 2006, STAT METHODS MED RES, V15, P547, DOI 10.1177/0962280206070621.
   Zhang XY, 2015, AM J EPIDEMIOL, V182, P127, DOI 10.1093/aje/kwv002.},
Number-of-Cited-References = {27},
Times-Cited = {2},
Unique-ID = {WOS:000411874800010},
}

@article{ WOS:000831448000001,
Author = {Ivanov, Hristo Y. and Grigorova, Denitsa and Lauschke, Volker M. and
   Velinov, Branimir and Stoychev, Kaloyan and Kyosovska, Gergana and
   Shopov, Peter},
Title = {CYP2C19 and CYP2D6 Genotypes and Metabolizer Status Distribution in a
   Bulgarian Psychiatric Cohort},
Journal = {JOURNAL OF PERSONALIZED MEDICINE},
Year = {2022},
Volume = {12},
Number = {7},
Month = {JUL},
Abstract = {CYP2D6 and CYP2C19 are enzymes of essential significance for the
   pharmacokinetics of a multitude of commonly used antidepressants,
   antipsychotics, antiemetics, beta-blockers, opioids, antiestrogen,
   antacids, etc. Polymorphisms in the respective genes are well
   established as resulting in functional differences, which in turn can
   impact safety and efficacy. Importantly, the prevalence of genetic
   CYP2D6 and CYP2C19 variability differs drastically between populations.
   Drawing on the limited information concerning genotype frequencies in
   Bulgaria, we here analyzed 742 Bulgarian psychiatric patients
   predominantly diagnosed with depression and/or anxiety. Specifically, we
   analyzed frequencies of CYPC19{*}2, {*}4 and {*}17, as well as of
   CYP2D6{*}2, {*}3, {*}4, {*}5, {*}6, {*}10 and {*}41. In total, 571 out
   of 742 patients (77\%) carried at least one variant which impacts
   metabolizer status. Overall, 48.6\% of the studied individuals were
   classified as non-normal metabolizers of CYP2D6 with most exhibiting
   reduced function (38.2\% intermediate metabolizers and 6.6\% poor
   metabolizers). In contrast, for CYP2C19, the majority of non-normal
   metabolizers showed increased functionality (28.9\% rapid and 5.5\%
   ultrarapid metabolizers), while reduced activity metabolizer status
   accounted for 25.6\% (23.8\% intermediate and 1.8\% poor metabolizers).
   These results provide an important resource to assess the genetically
   encoded functional variability of CYP2D6 and CYP2C19 which may have
   significant implications for precision medicine in Bulgarian psychiatry
   practice.},
Type = {Article},
Affiliation = {Ivanov, HY (Corresponding Author), Med Univ Plovdiv, Dept Pediat \& Med Genet, Plovdiv 4002, Bulgaria.
   Ivanov, HY (Corresponding Author), Univ Hosp St George Plovdiv, Dept Med Genet, Plovdiv 4002, Bulgaria.
   Ivanov, Hristo Y., Med Univ Plovdiv, Dept Pediat \& Med Genet, Plovdiv 4002, Bulgaria.
   Ivanov, Hristo Y., Univ Hosp St George Plovdiv, Dept Med Genet, Plovdiv 4002, Bulgaria.
   Grigorova, Denitsa; Shopov, Peter, Sofia Univ, Fac Math \& Informat, 5 James Bourchier Blvd, Sofia 1164, Bulgaria.
   Grigorova, Denitsa, Sofia Univ, Big Data Smart Soc Inst, 125 Tsarigradsko Shosse,Bl 2, Sofia 1113, Bulgaria.
   Lauschke, Volker M., Dr Margarete Fischer Bosch Inst Clin Pharmacol, Clin Pharmacol, D-70376 Stuttgart, Germany.
   Lauschke, Volker M., Karolinska Inst, Dept Physiol \& Pharmacol, S-17177 Stockholm, Sweden.
   Lauschke, Volker M., Univ Tubingen, Geschwister Scholl Pl, D-72074 Tubingen, Germany.
   Velinov, Branimir; Kyosovska, Gergana, Inst Med Res IMR, Sofia 1202, Bulgaria.
   Stoychev, Kaloyan, Med Univ Pleven, Fac Publ Hlth, Dept Psychiat \& Med Psychol, Pleven 5800, Bulgaria.
   Stoychev, Kaloyan, Univ Hosp Dr Gerogi Stranski, Dept Psychiat, Pleven 5800, Bulgaria.
   Kyosovska, Gergana, Bulgarian Assoc Personalised Med BAPEMED, Sofia 1202, Bulgaria.
   Shopov, Peter, R PGx Package Team, Sofia 1000, Bulgaria.},
DOI = {10.3390/jpm12071187},
Article-Number = {1187},
Keywords = {pharmacogenetics; pharmacokinetics; CYP2D6; CYP2C19; population
   genetics; cytochrome P450; precision public health},
Keywords-Plus = {PHARMACOGENETICS; POLYMORPHISM; ASSOCIATION; HEALTHY},
Research-Areas = {Health Care Sciences \& Services; General \& Internal Medicine},
Web-of-Science-Categories  = {Health Care Sciences \& Services; Medicine, General \& Internal},
Author-Email = {doctorhristoivanov@yahoo.com
   dgrigorova@fmi.uni-sofia.bg
   volker.lauschke@ki.se
   branimir.velinov@pdc-eu.com
   stoichev@abv.bg
   gergana.kyosovska@pdc-eu.com
   pdshopov@gmail.com},
Affiliations = {Medical University Plovdiv; Medical University Plovdiv; University of
   Sofia; University of Sofia; Eberhard Karls University of Tubingen;
   Eberhard Karls University Hospital; Karolinska Institutet; Eberhard
   Karls University of Tubingen; Medical University Pleven},
Cited-References = {Bahar MA, 2017, PHARMACOGENOMICS, V18, P701, DOI 10.2217/pgs-2017-0194.
   Dandara C, 2001, EUR J CLIN PHARMACOL, V57, P11, DOI 10.1007/s002280100282.
   Dlugauskas E, 2019, NORD J PSYCHIAT, V73, P31, DOI 10.1080/08039488.2018.1548648.
   Fricke-Galindo I, 2016, PHARMACOGENOMICS J, V16, P113, DOI 10.1038/tpj.2015.70.
   Gaedigk A, 2017, GENET MED, V19, P69, DOI 10.1038/gim.2016.80.
   Hicks JK, 2017, CLIN PHARMACOL THER, V102, P37, DOI 10.1002/cpt.597.
   Hicks JK, 2015, CLIN PHARMACOL THER, V98, P127, DOI 10.1002/cpt.147.
   Ivanov Hristo Y, 2021, Folia Med (Plovdiv), V63, P365, DOI 10.3897/folmed.63.e61484.
   Jukic MM, 2017, MOL PSYCHIATR, V22, P1155, DOI 10.1038/mp.2016.204.
   Kohlrausch FB, 2009, PHARMACOGENOMICS, V10, P1457, DOI 10.2217/PGS.09.76.
   Lauschke VM, 2019, PHARMACOL THERAPEUT, V197, P122, DOI 10.1016/j.pharmthera.2019.01.002.
   LLerena A, 2007, PHARMACOGENOMICS J, V7, P408, DOI 10.1038/sj.tpj.6500439.
   Milosavljevic F, 2021, JAMA PSYCHIAT, V78, P270, DOI 10.1001/jamapsychiatry.2020.3643.
   Mizzi C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162866.
   Pendicheva D., 2017, CLIN THER, V39, pe6, DOI {[}10.1016/j.clinthera.2017.07.033, DOI 10.1016/J.CLINTHERA.2017.07.033].
   Petrovic J, 2020, EUR J HUM GENET, V28, P88, DOI 10.1038/s41431-019-0480-8.
   Pratt VM, 2021, J MOL DIAGN, V23, P1047, DOI 10.1016/j.jmoldx.2021.05.013.
   R Core Team, 2020, R LANGUAGE ENV STAT, DOI DOI 10.1890/0012-9658(2002)083{[}3097:CFHIWS]2.0.CO;2.
   Rasmussen JO, 2006, SCAND J CLIN LAB INV, V66, P129, DOI 10.1080/00365510500469702.
   Sim SC, 2010, AM J MED GENET B, V153B, P1160, DOI 10.1002/ajmg.b.31081.
   Zanger UM, 2013, PHARMACOL THERAPEUT, V138, P103, DOI 10.1016/j.pharmthera.2012.12.007.},
Number-of-Cited-References = {21},
Times-Cited = {2},
Unique-ID = {WOS:000831448000001},
}

@article{ WOS:000762219500001,
Author = {Deka, Mark A.},
Title = {Predictive Risk Mapping of Schistosomiasis in Madagascar Using
   Ecological Niche Modeling and Precision Mapping},
Journal = {TROPICAL MEDICINE AND INFECTIOUS DISEASE},
Year = {2022},
Volume = {7},
Number = {2},
Month = {FEB},
Abstract = {Schistosomiasis is a neglected tropical disease (NTD) found throughout
   tropical and subtropical Africa. In Madagascar, the condition is
   widespread and endemic in 74\% of all administrative districts in the
   country. Despite the significant burden of the disease, high-resolution
   risk maps have yet to be produced to guide national control programs.
   This study used an ecological niche modeling (ENM) and precision mapping
   approach to estimate environmental suitability and disease transmission
   risk. The results show that suitability for schistosomiasis is
   widespread and covers 264,781 km(2) (102,232 sq miles). Covariates of
   significance to the model were the accessibility to cities, distance to
   water, enhanced vegetation index (EVI), annual mean temperature, land
   surface temperature (LST), clay content, and annual precipitation.
   Disease transmission risk is greatest in the central highlands, tropical
   east coast, arid-southwest, and northwest. An estimated 14.9 million
   people could be at risk of schistosomiasis; 11.4 million reside in rural
   areas, while 3.5 million are in urban areas. This study provides
   valuable insight into the geography of schistosomiasis in Madagascar and
   its potential risk to human populations. Because of the focal nature of
   the disease, these maps can inform national surveillance programs while
   improving understanding of areas in need of medical interventions.},
Type = {Article},
Affiliation = {Deka, MA (Corresponding Author), Ctr Dis Control \& Prevent CDC, 4770 Buford Hwy NE, Atlanta, GA 30341 USA.
   Deka, Mark A., Ctr Dis Control \& Prevent CDC, 4770 Buford Hwy NE, Atlanta, GA 30341 USA.},
DOI = {10.3390/tropicalmed7020015},
Article-Number = {15},
Keywords = {disease mapping; geographic information science; schistosomiasis;
   precision public health; ecological niche modeling},
Keywords-Plus = {SPECIES DISTRIBUTION MODELS; WATER-RESOURCES DEVELOPMENT; MINAS-GERAIS;
   HEALTH-CARE; GIS; INFECTIONS; DISEASE; AFRICA; SPREAD; BRAZIL},
Research-Areas = {Infectious Diseases; Parasitology; Tropical Medicine},
Web-of-Science-Categories  = {Infectious Diseases; Parasitology; Tropical Medicine},
Author-Email = {pmu5@cdc.gov},
Affiliations = {Centers for Disease Control \& Prevention - USA},
Cited-References = {Abdullahi M K., 2009, Bayero Journal of Pure and Applied Sciences, V2, P41, DOI {[}10.4314/bajopas.v2i1.73453, DOI 10.4314/BAJOPAS.V2I1.73453, 10.4314/bajopas.v2i1.73453. lay, DOI 10.4314/BAJOPAS.V2I1.73453.LAY].
   Adekiya TA, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17010181.
   Adenowo AF, 2015, BRAZ J INFECT DIS, V19, P196, DOI 10.1016/j.bjid.2014.11.004.
   Aiello-Lammens ME, 2015, ECOGRAPHY, V38, P541, DOI 10.1111/ecog.01132.
   Alaniz AJ, 2020, RISK ANAL, V40, P524, DOI 10.1111/risa.13410.
   Alaniz AJ, 2017, INT J EPIDEMIOL, V46, P966, DOI 10.1093/ije/dyw366.
   Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x.
   Amatulli G, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.40.
   Barbet-Massin M, 2012, METHODS ECOL EVOL, V3, P327, DOI 10.1111/j.2041-210X.2011.00172.x.
   Barve N, 2011, ECOL MODEL, V222, P1810, DOI 10.1016/j.ecolmodel.2011.02.011.
   Belizario VY, 2021, GEOSPATIAL HEALTH, V16, P213, DOI 10.4081/gh.2021.957.
   Blackburn JK, 2007, AM J TROP MED HYG, V77, P1103, DOI 10.4269/ajtmh.2007.77.1103.
   Boria RA, 2014, ECOL MODEL, V275, P73, DOI 10.1016/j.ecolmodel.2013.12.012.
   Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/bf00058655.
   BRINKMANN UK, 1988, TROP MED PARASITOL, V39, P182.
   Brooker S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000779.
   Brooker Simon J, 2013, Community Eye Health, V26, P32.
   BURNOD M., 1952, BULL SOC PATH EXOT, V45, P744.
   Carvajal JG, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.02117.
   Chen YY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118362.
   Chevalier FD, 2020, ENVIRON MICROBIOL, V22, P5450, DOI 10.1111/1462-2920.15303.
   Ciddio M, 2017, ADV WATER RESOUR, V108, P406, DOI 10.1016/j.advwatres.2016.10.012.
   Clements ACA, 2006, TROP MED INT HEALTH, V11, P490, DOI 10.1111/j.1365-3156.2006.01594.x.
   Coelho PRS, 2021, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.642348.
   De Leo GA., 2020, BMJ, V371, pm4324, DOI DOI 10.1136/BMJ.M4324.
   Deka MA, 2022, LANCET REG HEALTH-AM, V5, DOI 10.1016/j.lana.2021.100080.
   Deka MA, 2020, TROP MED INFECT DIS, V5, DOI 10.3390/tropicalmed5030122.
   Dlamini S.N., 2020, REMOTE SENS-BASEL.
   Doumenge J.R., 1987, P1.
   Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x.
   Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x.
   Escobar LE, 2014, GEOSPATIAL HEALTH, V9, P221, DOI 10.4081/gh.2014.19.
   Fick SE, 2017, INT J CLIMATOL, V37, P4302, DOI 10.1002/joc.5086.
   Fletcher-Lartey SM, 2016, PARASITOLOGY, V143, P401, DOI 10.1017/S0031182015001869.
   FRIEDMAN JH, 1991, ANN STAT, V19, P1, DOI 10.1214/aos/1176347963.
   Gama M, 2016, ECOL MODEL, V319, P163, DOI 10.1016/j.ecolmodel.2015.06.001.
   Garchitorena A, 2017, HEALTH AFFAIR, V36, P1443, DOI 10.1377/hlthaff.2016.1419.
   GBIF.org, GBIF OCC DOWNL.
   Gething PW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-378.
   Guimaraes RJPS, 2008, ACTA TROP, V108, P234, DOI 10.1016/j.actatropica.2008.07.001.
   Guisan A, 2002, ECOL MODEL, V157, P89, DOI 10.1016/S0304-3800(02)00204-1.
   Gundamaraju Rohit, 2014, Asian Pacific Journal of Tropical Biomedicine, V4, pS43, DOI 10.12980/APJTB.4.2014C831.
   Hengl T., WORLDGRIDS ARCHIVED.
   Hoffmann T, 2021, PATHOGENS, V10, DOI 10.3390/pathogens10060722.
   Horchner F., 1972, Berliner und Muenchner Tieraerztliche Wochenschrift, V85, P329.
   Hotez PJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002865.
   Hu Y, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0299-x.
   Hu Y, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-214.
   Kalinda C, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14010080.
   Kirby RS, 2017, ANN EPIDEMIOL, V27, P1, DOI 10.1016/j.annepidem.2016.12.001.
   Kloos H, 2008, ACTA TROP, V108, P194, DOI 10.1016/j.actatropica.2008.07.002.
   Lai YS, 2015, LANCET INFECT DIS, V15, P927, DOI 10.1016/S1473-3099(15)00066-3.
   Leonardo L. R., 2005, Parassitologia (Rome), V47, P105.
   Leutscher P, 1998, TROP MED INT HEALTH, V3, P327, DOI 10.1046/j.1365-3156.1998.00230.x.
   Leutscher PDC, 2003, SEX TRANSM DIS, V30, P262, DOI 10.1097/00007435-200303000-00017.
   Leutscher PDC, 2009, ACTA TROP, V109, P41, DOI 10.1016/j.actatropica.2008.09.010.
   Livingston M, 2021, AM J TROP MED HYG, V104, P2055, DOI 10.4269/ajtmh.20-0679.
   Manz KM, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008508.
   Marks F, 2016, CLIN INFECT DIS, V62, pS76, DOI 10.1093/cid/civ758.
   McCreesh N, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-014-0617-0.
   Menghistu HT, 2021, ZOONOSES PUBLIC HLTH, V68, P823, DOI 10.1111/zph.12874.
   Ministere de la Sante Publique de Madagascar, 2016, CART MAL TROP NEGL C.
   Murad A, 2020, ISPRS INT J GEO-INF, V9, DOI 10.3390/ijgi9050328.
   Musa GJ, 2013, HEALTH SERV INSIGHTS, V6, P111, DOI 10.4137/HSI.S10471.
   Nicol J., 1991, PLANNING OUTLOOK, V34, P37, DOI 10.1080/00320719108711887.
   Noor Abdisalan M, 2008, Popul Health Metr, V6, P5, DOI 10.1186/1478-7954-6-5.
   Osgood-Zimmerman A, 2018, NATURE, V555, P41, DOI 10.1038/nature25760.
   Osorio-Olvera L, 2020, METHODS ECOL EVOL, V11, P1199, DOI 10.1111/2041-210X.13452.
   Pearson K., 1895, Proceedings of the RoyalSociety of London, V58, P240, DOI DOI 10.1098/RSPL.1895.0041.
   Pennance T, 2020, PARASITE VECTOR, V13, DOI 10.1186/s13071-020-04136-9.
   Phillips DA, 2017, MEM I OSWALDO CRUZ, V112, P275, DOI 10.1590/0074-02760160395.
   Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1.
   Ponpetch K, 2021, MICROORGANISMS, V9, DOI 10.3390/microorganisms9102144.
   R Core Team, 2019, R LANG ENV STAT COMP.
   Randrianasolo BS, 2015, J INFECT DIS, V212, P275, DOI 10.1093/infdis/jiv035.
   Reich B.J., 2018, PRECISION MAPS PUBLI.
   Robinson K.E., 2021, J GLOBAL HLTH REPORT, V5, DOI DOI 10.29392/001C.22123.
   Rollinson Rollinson, TIME SET AGENDA SCHI.
   Sato MO, 2018, INT J INFECT DIS, V76, P130, DOI 10.1016/j.ijid.2018.08.018.
   Sawyer S.G., 2013, SCHISTOSOMIASIS BILH.
   Shan XW, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008674.
   Sheehy C, 2021, INFECT DIS POVERTY, V10, DOI 10.1186/s40249-021-00871-y.
   SHIFF CJ, 1964, ANN TROP MED PARASIT, V58, P94, DOI 10.1080/00034983.1964.11686219.
   Soberon Jorge, 2005, Biodiversity Informatics, V2, P1.
   Spencer SA, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2249-7.
   Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7.
   Stensgaard AS, 2019, ACTA TROP, V190, P257, DOI 10.1016/j.actatropica.2018.09.013.
   Tatem AJ, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-4.
   Tchuenté LAT, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006563.
   Thuiller W., 2016, SPECIES DISTRIBUTION, P1.
   Van GY, 2020, DIAGNOSTICS, V10, DOI 10.3390/diagnostics10050328.
   Walker JW, 2020, AM J TROP MED HYG, V102, P328, DOI 10.4269/ajtmh.19-0658.
   Weiss DJ, 2018, NATURE, V553, P333, DOI 10.1038/nature25181.},
Number-of-Cited-References = {93},
Times-Cited = {10},
Unique-ID = {WOS:000762219500001},
}

@article{ WOS:000940299900001,
Author = {Zhou, Yitian and Nevosadova, Lenka and Eliasson, Erik and Lauschke,
   Volker M. M.},
Title = {Global distribution of functionally important <i>CYP2C9</i> alleles and
   their inferred metabolic consequences},
Journal = {HUMAN GENOMICS},
Year = {2023},
Volume = {17},
Number = {1},
Month = {FEB 28},
Abstract = {BackgroundGenetic variability in the cytochrome P450 CYP2C9 constitutes
   an important predictor for efficacy and safety of various commonly
   prescribed drugs, including coumarin anticoagulants, phenytoin and
   multiple non-steroidal anti-inflammatory drugs (NSAIDs). A global map of
   CYP2C9 variability and its inferred functional consequences has been
   lacking.ResultsFrequencies of eight functionally relevant CYP2C9 alleles
   ({*}2, {*}3, {*}5, {*}6, {*}8, {*}11, {*}13 and {*}14) were analyzed. In
   total, 108 original articles were identified that included genotype data
   from a total of 81,662 unrelated individuals across 70 countries and 40
   unique ethnic groups. The results revealed that CYP2C9{*}2 was most
   abundant in Europe and the Middle East, whereas CYP2C9{*}3 was the main
   reason for reduced CYP2C9 activity across South Asia. Our data show
   extensive variation within superpopulations with up to tenfold
   differences between geographically adjacent populations in Malaysia,
   Thailand and Vietnam. Translation of genetic CYP2C9 variability into
   functional consequences indicates that up to 40\% of patients in
   Southern Europe and the Middle East might benefit from warfarin and
   phenytoin dose reductions, while 3\% of patients in Southern Europe and
   Israel are recommended to reduce starting doses of
   NSAIDs.ConclusionsThis study provides a comprehensive map of the genetic
   and functional variability of CYP2C9 with high ethnogeographic
   resolution. The presented data can serve as a useful resource for CYP2C9
   allele and phenotype frequencies and might guide the optimization of
   genotyping strategies, particularly for indigenous and founder
   populations with distinct genetic profiles.},
Type = {Article},
Affiliation = {Zhou, YT (Corresponding Author), Karolinska Inst, Dept Lab Med, Div Clin Pharmacol, S-14152 Huddinge, Sweden.
   Zhou, Yitian; Eliasson, Erik, Karolinska Inst, Dept Lab Med, Div Clin Pharmacol, S-14152 Huddinge, Sweden.
   Nevosadova, Lenka; Lauschke, Volker M. M., Karolinska Inst, Dept Physiol \& Pharmacol, S-17177 Stockholm, Sweden.
   Eliasson, Erik, Karolinska Univ Hosp, Med Diagnost, Clin Pharmacol, S-14186 Stockholm, Sweden.
   Lauschke, Volker M. M., Dr Margarete Fischer Bosch Inst Clin Pharmacol, Stuttgart, Germany.
   Lauschke, Volker M. M., Univ Tubingen, Tubingen, Germany.},
DOI = {10.1186/s40246-023-00461-z},
Article-Number = {15},
Keywords = {Pharmacogenomics; Precision medicine; Allele frequency; Metabolizer
   phenotype; Precision public health},
Keywords-Plus = {ADVERSE DRUG-REACTIONS; MESTIZO POPULATIONS; COST-EFFECTIVENESS;
   WARFARIN; PHARMACOGENETICS; POLYMORPHISMS; VARIANTS; RISK; VARIABILITY;
   DIVERSITY},
Research-Areas = {Genetics \& Heredity},
Web-of-Science-Categories  = {Genetics \& Heredity},
Author-Email = {yitian.zhou@ki.se},
Affiliations = {Karolinska Institutet; Karolinska Institutet; Karolinska Institutet;
   Karolinska University Hospital; Eberhard Karls University of Tubingen;
   Eberhard Karls University Hospital; Eberhard Karls University of
   Tubingen},
Cited-References = {Aithal GP, 1999, LANCET, V353, P717, DOI 10.1016/S0140-6736(98)04474-2.
   Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393.
   Bhala N, 2013, LANCET, V382, P769, DOI 10.1016/S0140-6736(13)60900-9.
   Borgiani P, 2007, PHARMACOGENOMICS, V8, P1545, DOI 10.2217/14622416.8.11.1545.
   Caudle KE, 2014, CLIN PHARMACOL THER, V96, P542, DOI 10.1038/clpt.2014.159.
   Céspedes-Garro C, 2015, EXPERT OPIN DRUG MET, V11, P1893, DOI 10.1517/17425255.2015.1111871.
   Ciccacci C, 2011, PHARMACOGENET GENOM, V21, P344, DOI 10.1097/FPC.0b013e328344c340.
   Costa MD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3543.
   Daly AK, 2018, J PERS MED, V8, DOI 10.3390/jpm8010001.
   Fekete F, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-96590-3.
   Figueiras A, 2016, PHARMACOGENET GENOM, V26, P66, DOI 10.1097/FPC.0000000000000186.
   Franco V, 2015, EXPERT OPIN DRUG MET, V11, P1269, DOI 10.1517/17425255.2015.1053463.
   Grosser T, 2017, CLIN PHARMACOL THER, V102, P611, DOI 10.1002/cpt.794.
   Hill C, 2006, MOL BIOL EVOL, V23, P2480, DOI 10.1093/molbev/msl124.
   Impicciatore P, 2001, BRIT J CLIN PHARMACO, V52, P77, DOI 10.1046/j.0306-5251.2001.01407.x.
   Insani WN, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0252161.
   Shankar AJ, 2022, PHARMACOGENOMICS J, V22, P100, DOI 10.1038/s41397-021-00262-4.
   Johnson JA, 2017, CLIN PHARMACOL THER, V102, P397, DOI 10.1002/cpt.668.
   Karczewski KJ, 2020, NATURE, V581, P434, DOI 10.1038/s41586-020-2308-7.
   Karnes JH, 2021, CLIN PHARMACOL THER, V109, P302, DOI 10.1002/cpt.2008.
   Kirchheiner J, 2005, CLIN PHARMACOL THER, V77, P1, DOI 10.1016/j.clpt.2004.08.009.
   Lauschke VM, 2019, EUR J PHARM SCI, V130, P65, DOI 10.1016/j.ejps.2019.01.024.
   Lundblad MS, 2006, CLIN PHARMACOL THER, V79, P287, DOI 10.1016/j.clpt.2005.11.007.
   Mega JL, 2015, LANCET, V385, P2280, DOI 10.1016/S0140-6736(14)61994-2.
   Saldaña-Cruz AM, 2016, GENET TEST MOL BIOMA, V20, P702, DOI 10.1089/gtmb.2016.0115.
   Mizzi C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162866.
   Niinuma Y, 2014, PHARMACOGENOMICS J, V14, P107, DOI 10.1038/tpj.2013.22.
   Nizamuddin S, 2021, PHARMACOGEN PERS MED, V14, P135, DOI 10.2147/PGPM.S272015.
   Nordestgaard BG, 2010, PHARMACOGENET GENOM, V20, P77, DOI 10.1097/FPC.0b013e328333f70b.
   Pink J, 2014, CLIN PHARMACOL THER, V95, P199, DOI 10.1038/clpt.2013.190.
   Pirmohamed M, 2004, BMJ-BRIT MED J, V329, P15, DOI 10.1136/bmj.329.7456.15.
   Pirmohamed M, 2013, NEW ENGL J MED, V369, P2294, DOI 10.1056/NEJMoa1311386.
   Rettie AE, 1999, EPILEPSY RES, V35, P253, DOI 10.1016/S0920-1211(99)00017-0.
   Sangkuhl K, 2021, CLIN PHARMACOL THER, V110, P662, DOI 10.1002/cpt.2333.
   Silva-Zolezzi I, 2009, P NATL ACAD SCI USA, V106, P8611, DOI 10.1073/pnas.0903045106.
   Sistonen J, 2009, PHARMACOGENET GENOM, V19, P170, DOI 10.1097/FPC.0b013e32831ebb30.
   Suarez-Kurtz G, 2018, ADV PHARMACOL, V83, P133, DOI 10.1016/bs.apha.2018.02.001.
   Suarez-Kurtz G, 2010, FRONT PHARMACOL, V1, DOI 10.3389/fphar.2010.00118.
   Theken KN, 2020, CLIN PHARMACOL THER, V108, P191, DOI 10.1002/cpt.1830.
   Van Booven D, 2010, PHARMACOGENET GENOM, V20, P277, DOI 10.1097/FPC.0b013e3283349e84.
   Varshney E, 2013, EUR J DRUG METAB PH, V38, P275, DOI 10.1007/s13318-013-0124-2.
   Xu SH, 2008, AM J HUM GENET, V83, P322, DOI 10.1016/j.ajhg.2008.08.001.
   Yasar Ü, 2003, PHARMACOGENETICS, V13, P715, DOI {[}10.1097/01.fpc.0000054141.14659.28, 10.1097/00008571-200312000-00002].
   You JHS, 2014, PHARMACOGENET GENOM, V24, P6, DOI 10.1097/FPC.0000000000000014.
   Zanger UM, 2013, PHARMACOL THERAPEUT, V138, P103, DOI 10.1016/j.pharmthera.2012.12.007.
   Zhang HF, 2016, J PHARMACOL EXP THER, V358, P83, DOI 10.1124/jpet.116.233635.
   Zhou YT, 2022, PHARMACOGENOMICS J, V22, P284, DOI 10.1038/s41397-022-00288-2.
   Zhou YT, 2021, CLIN PHARMACOL THER, V109, P160, DOI 10.1002/cpt.1944.},
Number-of-Cited-References = {48},
Times-Cited = {10},
Unique-ID = {WOS:000940299900001},
}

@article{ WOS:000862668700001,
Author = {Ma, Fubo and Xiao, Ming and Zhu, Lin and Jiang, Wen and Jiang, Jizhe and
   Zhang, Peng-Fei and Li, Kang and Yue, Min and Zhang, Le},
Title = {An integrated platform for<i> Brucella</i> with knowledge graph
   technology: From genomic analysis to epidemiological projection},
Journal = {FRONTIERS IN GENETICS},
Year = {2022},
Volume = {13},
Month = {SEP 14},
Abstract = {Motivation: Brucella, the causative agent of brucellosis, is a global
   zoonotic pathogen that threatens both veterinary and human health. The
   main sources of brucellosis are farm animals. Importantly, the bacteria
   can be used for biological warfare purposes, requiring source tracking
   and routine surveillance in an integrated manner. Additionally,
   brucellosis is classified among group B infectious diseases in China and
   has been reported in 31 Chinese provinces to varying degrees in urban
   areas. From a national biosecurity perspective, research on brucellosis
   surveillance has garnered considerable attention and requires an
   integrated platform to provide researchers with easy access to genomic
   analysis and provide policymakers with an improved understanding of both
   reported patients and detected cases for the purpose of precision public
   health interventions. Results: For the first time in China, we have
   developed a comprehensive information platform for Brucella based on
   dynamic visualization of the incidence (reported patients) and
   prevalence (detected cases) of brucellosis in mainland China.
   Especially, our study establishes a knowledge graph for the literature
   sources of Brucella data so that it can be expanded, queried, and
   analyzed. When similar ``epidemiological comprehensive platforms `` are
   established in the distant future, we can use knowledge graph to share
   its information. Additionally, we propose a software package for genomic
   sequence analysis. This platform provides a specialized, dynamic, and
   visual point-and-click interface for studying brucellosis in mainland
   China and improving the exploration of Brucella in the fields of
   bioinformatics and disease prevention for both human and veterinary
   medicine.},
Type = {Article},
Affiliation = {Zhang, L (Corresponding Author), Sichuan Univ, Coll Comp Sci, Chengdu, Peoples R China.
   Yue, M (Corresponding Author), Zhejiang Univ, Hainan Inst, Sanya, Peoples R China.
   Zhang, L (Corresponding Author), Univ Chinese Acad Sci, Hangzhou Inst Adv Study, Chinese Acad Sci, Key Lab Syst Biol, Hangzhou, Peoples R China.
   Zhang, L (Corresponding Author), Univ Chinese Acad Sci, Hangzhou Inst Adv Study, Key Lab Syst Hlth Sci Zhejiang Prov, Hangzhou, Peoples R China.
   Ma, Fubo; Li, Kang, Sichuan Univ, West China Hosp, West China Biomed Big Data Ctr, Chengdu, Peoples R China.
   Xiao, Ming; Jiang, Wen; Jiang, Jizhe; Zhang, Le, Sichuan Univ, Coll Comp Sci, Chengdu, Peoples R China.
   Zhu, Lin, China Anim Hlth \& Epidemiol Ctr, Qingdao, Shandong, Peoples R China.
   Zhang, Peng-Fei, Sichuan Univ, West China Hosp, Canc Ctr, Dept Med Oncol, Chengdu, Peoples R China.
   Zhang, Peng-Fei, Sichuan Univ, Med X Ctr Informat, Chengdu, Peoples R China.
   Li, Kang, Shanghai Artificial Intelligence Lab, Shanghai, Peoples R China.
   Yue, Min, Zhejiang Univ, Hainan Inst, Sanya, Peoples R China.
   Zhang, Le, Univ Chinese Acad Sci, Hangzhou Inst Adv Study, Chinese Acad Sci, Key Lab Syst Biol, Hangzhou, Peoples R China.
   Zhang, Le, Univ Chinese Acad Sci, Hangzhou Inst Adv Study, Key Lab Syst Hlth Sci Zhejiang Prov, Hangzhou, Peoples R China.},
DOI = {10.3389/fgene.2022.981633},
Article-Number = {981633},
Keywords = {Brucella; genomic analysis; epidemiology; databases; visualization},
Keywords-Plus = {PUBLIC-HEALTH; SURVIVAL; DATABASE},
Research-Areas = {Genetics \& Heredity},
Web-of-Science-Categories  = {Genetics \& Heredity},
Author-Email = {zhangle06@scu.edu.cn
   myue@zju.edu.cn},
Affiliations = {Sichuan University; Sichuan University; China Animal Health \&
   Epidemiology Center; Sichuan University; Sichuan University; Zhejiang
   University; Chinese Academy of Sciences; University of Chinese Academy
   of Sciences, CAS; Chinese Academy of Sciences; University of Chinese
   Academy of Sciences, CAS},
Cited-References = {{[}Anonymous], 2017, ABRICATE MASS SCREEN.
   {[}Anonymous], 2008, A dictionary of statistics.
   Arnott A, 2018, EMERG INFECT DIS, V24, P751, DOI 10.3201/eid2404.171619.
   Assenga JA, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0504-8.
   Badai J, 2020, INTERDISCIP SCI, V12, P383, DOI 10.1007/s12539-020-00386-4.
   Beaglehole R., 1993, BASIC EPIDEMIOLOGY.
   Bond G. W., 2002, P 6 TH IASTED INT C, P149.
   Chen XY, 2017, J CLEAN PROD, V142, P915, DOI 10.1016/j.jclepro.2016.02.119.
   Chen ZQ, 2021, EPIDEMIOL INFECT, V149, DOI 10.1017/S0950268821001229.
   Fan JY, 2019, QUANT BIOL, V7, P83, DOI 10.1007/s40484-019-0172-y.
   Feng YJ, 2019, J OCEANOL LIMNOL, V37, P330, DOI 10.1007/s00343-019-7316-9.
   Gao HJ, 2017, MOLECULES, V22, DOI 10.3390/molecules22122209.
   Gao J, 2021, J COMPUT SCI TECH-CH, V36, P334, DOI 10.1007/s11390-021-0861-7.
   Johansen TB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26906-3.
   Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109.
   Ledwaba MB, 2021, MICROORGANISMS, V9, DOI 10.3390/microorganisms9030570.
   Lei WJ, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.00391.
   Li TT, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122592.
   Liu GD, 2020, ENGINEERING-PRC, V6, P462, DOI 10.1016/j.eng.2019.06.008.
   Liu GD, 2020, CURR BIOINFORM, V15, P741, DOI 10.2174/1574893615666191227091641.
   Liu YY, 2021, FOOD RES INT, V142, DOI 10.1016/j.foodres.2021.110198.
   Lv J, 2021, BIOSAF HEALTH, V3, P22, DOI 10.1016/j.bsheal.2020.08.003.
   Marçais G, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1005944.
   Mardis ER, 2017, NAT PROTOC, V12, P213, DOI 10.1038/nprot.2016.182.
   Messina A, 2018, ADV INTELL SYST, V611, P299, DOI 10.1007/978-3-319-61566-0\_28.
   Minh BQ, 2020, MOL BIOL EVOL, V37, P1530, DOI 10.1093/molbev/msaa015.
   Paci V, 2020, MOL CELL PROBE, V53, DOI 10.1016/j.mcp.2020.101581.
   Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077.
   Seabold S., 2010, P 9 PYTHON SCI C, DOI 10.25080/Majora-92bf1922-012.
   Seemann T., 2018, SHOVILL ASSEMBLE BAC.
   Seemann T., 2019, Snippy: rapid haploid variant calling and core SNP phylogeny.
   Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153.
   Tanizawa Y, 2018, BIOINFORMATICS, V34, P1037, DOI 10.1093/bioinformatics/btx713.
   Waller L. A., 2004, Applied spatial statistics for public health data.
   Wolkenhauer O., 2021, SYSTEMS MED INTEGRAT.
   Wu WT, 2020, BMC BIOINFORMATICS, V21, DOI 10.1186/s12859-020-3454-5.
   Xia Yuan, 2017, BMC Genomics, V18, P950, DOI 10.1186/s12864-016-3256-3.
   Xiao M, 2021, IEEE ACM T COMPUT BI, V18, P1250, DOI 10.1109/TCBB.2021.3049617.
   Xiao M, 2020, IEEE ACM T COMPUT BI, V17, P2148, DOI 10.1109/TCBB.2019.2935971.
   Xu J, 2020, SCI DATA, V7, DOI 10.1038/s41597-020-0543-2.
   Yagupsky P, 2020, CLIN MICROBIOL REV, V33, DOI 10.1128/CMR.00073-19.
   Yin CH, 2018, APPL GEOGR, V92, P50, DOI 10.1016/j.apgeog.2018.01.011.
   You YJ, 2022, SIGNAL TRANSDUCT TAR, V7, DOI 10.1038/s41392-022-00994-0.
   You YJ, 2020, BMC BIOINFORMATICS, V21, DOI 10.1186/s12859-020-03674-4.
   Zhang L., 2019, SCI SIN VITAE, V50, P484, DOI {[}10.1360/ssv-2019-0115, DOI 10.1360/SSV-2019-0115].
   Zhang L, 2021, ACTA PHARM SIN B, V11, P3092, DOI 10.1016/j.apsb.2021.05.032.
   Zhang L, 2021, BRIEF BIOINFORM, V22, P515, DOI 10.1093/bib/bbz134.
   Zhang L, 2021, BIOINFORMATICS, V37, P1554, DOI 10.1093/bioinformatics/btz542.
   Zhang L, 2017, COMPLEXITY, DOI 10.1155/2017/8917258.
   Zhang L, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1007069.
   Zhang L, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-2741-5.
   Zhang L, 2018, BIOINFORMATICS, V34, P3624, DOI 10.1093/bioinformatics/bty392.
   Zhang L, 2017, J MOL CELL BIOL, V9, P477, DOI 10.1093/jmcb/mjx056.
   Zhang L, 2017, PHYS LIFE REV, V20, P140, DOI 10.1016/j.plrev.2017.01.007.
   Zhang L, 2021, QUANT BIOL, V9, P292, DOI 10.15302/J-QB-021-0236.
   Zhang WY, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002493.
   Zhao JT, 2020, COMPUT STRUCT BIOTEC, V18, P417, DOI 10.1016/j.csbj.2020.02.008.
   Zhou K, 2020, FRONT VET SCI, V7, DOI 10.3389/fvets.2020.00521.
   Zong ZY, 2018, J ANTIMICROB CHEMOTH, V73, P2340, DOI 10.1093/jac/dky210.},
Number-of-Cited-References = {59},
Times-Cited = {0},
Unique-ID = {WOS:000862668700001},
}

@article{ WOS:000457749600007,
Author = {Zhou, Yitian and Lauschke, Volker M.},
Title = {Comprehensive overview of the pharmacogenetic diversity in Ashkenazi
   Jews},
Journal = {JOURNAL OF MEDICAL GENETICS},
Year = {2018},
Volume = {55},
Number = {9},
Pages = {617-627},
Month = {SEP},
Abstract = {Background Adverse drug reactions are a major concern in drug
   development and clinical therapy. Genetic polymorphisms in genes
   involved in drug metabolism and transport are major determinants of
   treatment efficacy and adverse reactions, and constitute important
   biomarkers for drug dosing, efficacy and safety. Importantly, human
   populations and subgroups differ substantially in their pharmacogenetic
   variability profiles, with important consequences for personalised
   medicine strategies and precision public health approaches. Despite
   their long migration history, Ashkenazi Jews constitute a rather
   isolated population with a unique genetic signature that is distinctly
   different from other populations.
   Objective To provide a comprehensive overview of the pharmacogenetic
   profile in Ashkenazim.
   Methods We analysed next-generation sequencing data from 5076 Ashkenazim
   individuals and used sequence data from 117 425 non-Jewish individuals
   as reference.
   Results We derived frequencies of 164 alleles in 17 clinically relevant
   pharmacogenes and derived profiles of putative functional consequences,
   providing the most comprehensive data set of Jewish pharmacogenetic
   diversity published to date. Furthermore, we detected 127 variants with
   an aggregated frequency of 20.7\% that were specifically found in
   Ashkenazim, of which 55 variants were putatively deleterious (aggregated
   frequency of 9.4\%).
   Conclusion The revealed pattern of pharmacogenetic variability in
   Ashkenazi Jews is distinctly different from other populations and is
   expected to translate into unique functional consequences, especially
   for the metabolism of CYP2A6, CYP2C9, NAT 2 and VKORC1 substrates. We
   anticipate that the presented data will serve as a powerful resource for
   the guidance of pharmacogenetic treatment decisions and the optimisation
   of population-specific genotyping strategies in the Ashkenazi diaspora.},
Type = {Article},
Affiliation = {Lauschke, VM (Corresponding Author), Karolinska Inst, Dept Physiol \& Pharmacol, Sect Pharmacogenet, SE-171 Stockholm, Sweden.
   Zhou, Yitian; Lauschke, Volker M., Karolinska Inst, Dept Physiol \& Pharmacol, Sect Pharmacogenet, SE-171 Stockholm, Sweden.},
DOI = {10.1136/jmedgenet-2018-105429},
Keywords-Plus = {ADVERSE DRUG-REACTIONS; GENETIC-VARIATION; VKORC1; JEWISH; POLYMORPHISM;
   FREQUENCIES; ALLELES; CYP2C9},
Research-Areas = {Genetics \& Heredity},
Web-of-Science-Categories  = {Genetics \& Heredity},
Author-Email = {volker.lauschke@ki.se},
Affiliations = {Karolinska Institutet},
Cited-References = {Aklillu E, 1996, J PHARMACOL EXP THER, V278, P441.
   Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393.
   Behar DM, 2006, AM J HUM GENET, V78, P487, DOI 10.1086/500307.
   Behar DM, 2010, NATURE, V466, P238, DOI 10.1038/nature09103.
   Caldwell MD, 2008, BLOOD, V111, P4106, DOI 10.1182/blood-2007-11-122010.
   Campbell CL, 2012, P NATL ACAD SCI USA, V109, P13865, DOI 10.1073/pnas.1204840109.
   Carmi S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5835.
   Charrow Joel, 2004, Fam Cancer, V3, P201, DOI 10.1007/s10689-004-9545-z.
   Costa MD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3543.
   D'Andrea G, 2005, BLOOD, V105, P645, DOI 10.1182/blood-2004-06-2111.
   Davies EC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004439.
   DiMasi JA, 2016, J HEALTH ECON, V47, P20, DOI 10.1016/j.jhealeco.2016.01.012.
   Downing NS, 2017, JAMA-J AM MED ASSOC, V317, P1854, DOI 10.1001/jama.2017.5150.
   Efrati E, 2009, EUR J CLIN PHARMACOL, V65, P257, DOI 10.1007/s00228-008-0590-7.
   Elens L, 2011, PHARMACOGENOMICS, V12, P1383, DOI {[}10.2217/PGS.11.90, 10.2217/pgs.11.90].
   Fujikura K, 2015, PHARMACOGENET GENOM, V25, P584, DOI 10.1097/FPC.0000000000000172.
   G ammal RS, 2016, GUIDELINE UGT1A1 ATA, P363.
   Gaedigk A, 2017, GENET MED, V19, P69, DOI 10.1038/gim.2016.80.
   Ingelman-Sundberg M, 2018, HUM GENOMICS, V12, DOI 10.1186/s40246-018-0157-3.
   Iyer L., 2002, Pharmacogenomics Journal, V2, P43, DOI 10.1038/sj.tpj.6500072.
   Johnson JA, 2015, TRENDS CARDIOVAS MED, V25, P33, DOI 10.1016/j.tcm.2014.09.001.
   Kalman LV, 2016, CLIN PHARMACOL THER, V99, P172, DOI 10.1002/cpt.280.
   Klein Kathrin, 2013, Frontiers in Genetics, V4, P12, DOI 10.3389/fgene.2013.00012.
   Kozyra M, 2017, GENET MED, V19, P20, DOI 10.1038/gim.2016.33.
   Krishnakumar D, 2012, FUND CLIN PHARMACOL, V26, P295, DOI 10.1111/j.1472-8206.2010.00917.x.
   L auschke VM, 2017, PHARMACOGENOMIC BIOM, P116.
   Lauschke VM, 2018, CLIN PHARMACOL THER, V103, P745, DOI 10.1002/cpt.976.
   Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057.
   Leschziner G, 2006, PHARMACOGENET GENOM, V16, P439, DOI 10.1097/01.fpc.0000197467.21964.67.
   Link E, 2008, NEW ENGL J MED, V359, P789, DOI 10.1056/NEJMoa0801936.
   Loebstein R, 2007, BLOOD, V109, P2477, DOI 10.1182/blood-2006-08-038984.
   Martis S, 2013, PHARMACOGENOMICS J, V13, P558, DOI 10.1038/tpj.2012.48.
   Moya G, 2017, PHARMACOGENOMICS J, V17, P378, DOI 10.1038/tpj.2016.27.
   Mwinyi J, 2010, LIFE SCI, V86, P699, DOI 10.1016/j.lfs.2010.02.021.
   Ostrer H, 2001, NAT REV GENET, V2, P891, DOI 10.1038/35098506.
   Palamara PF, 2012, AM J HUM GENET, V91, P809, DOI 10.1016/j.ajhg.2012.08.030.
   Pirmohamed M, 2004, BMJ-BRIT MED J, V329, P15, DOI 10.1136/bmj.329.7456.15.
   Pletcher BA, 2008, GENET MED, V10, P33, DOI {[}10.1097/GIM.0b013e31815f6eac, 10.1097/GIM.0b013e31815f247c].
   Rieder MJ, 2005, NEW ENGL J MED, V352, P2285, DOI 10.1056/NEJMoa044503.
   Rotger Margalida, 2005, Pharmacogenet Genomics, V15, P1, DOI 10.1097/01213011-200501000-00001.
   Santos M, 2018, GENET MED, V20, P622, DOI 10.1038/gim.2017.156.
   Scott SA, 2013, CLIN PHARMACOL THER, V94, P317, DOI 10.1038/clpt.2013.105.
   Scott SA, 2012, PHARMACOGENOMICS J, V12, P297, DOI 10.1038/tpj.2011.5.
   Scott SA, 2008, AM J HUM GENET, V82, P495, DOI 10.1016/j.ajhg.2007.10.002.
   Scott SA, 2010, PHARMACOGENOMICS, V11, P781, DOI 10.2217/PGS.10.49.
   Tanner JA, 2017, J PERS MED, V7, DOI 10.3390/jpm7040018.
   Wester K, 2008, BRIT J CLIN PHARMACO, V65, P573, DOI 10.1111/j.1365-2125.2007.03064.x.
   Wolking S, 2015, CLIN PHARMACOKINET, V54, P709, DOI 10.1007/s40262-015-0267-1.
   Zanger UM, 2007, PHARMACOGENOMICS, V8, P743, DOI 10.2217/14622416.8.7.743.
   Zhou Y, 2017, CLIN PHARMACOL THER, V102, P688, DOI 10.1002/cpt.690.},
Number-of-Cited-References = {50},
Times-Cited = {18},
Unique-ID = {WOS:000457749600007},
}

@article{ WOS:000819827500014,
Author = {Wheeler, Jack C. W. and Keogh, Louise and Sierra, Maria A. and Devereux,
   Lisa and Jones, Katherine and IJzerman, Maarten J. and Trainer, Alison
   H.},
Title = {Heterogeneity in how women value risk-stratified breast screening},
Journal = {GENETICS IN MEDICINE},
Year = {2022},
Volume = {24},
Number = {1},
Pages = {146-156},
Month = {JAN},
Abstract = {Purpose: Risk-stratified screening has potential to improve the cost
   effectiveness of national breast cancer screening programs. This study
   aimed to inform a socially acceptable and equitable implementation
   framework by determining what influences a woman's decision to accept a
   personalized breast cancer risk assessment and what the relative impact
   of these key determinants is.
   Methods: Multicriteria decision analysis was used to elicit the relative
   weights for 8 criteria that women reported influenced their decision.
   Preference heterogeneity was explored through cluster analysis.
   Results: The 2 criteria valued most by the 347 participants related to
   program access, ``Mode of invitation{''} and ``Testing process{''}. Both
   criteria significantly influenced participation (P <.001). A total of
   73\% preferred communication by letter/online. Almost all women
   preferred a multidisease risk assessment with potential for a familial
   high-risk result. Four preference-based subgroups were identified.
   Membership to the largest subgroup was predicted by lower educational
   attainment, and women in this subgroup were concerned with program
   access. Higher relative perceived breast cancer risk predicted
   membership to the smallest subgroup that was focused on test parameters,
   namely ``Scope of test{''} and ``Test specificity{''}.
   Conclusion: Overall, Australian women would accept a personalized
   multidisease risk assessment, but when aligning with their preferences,
   it will necessitate a focus on program access and the development of
   online communication frameworks. (C) 2021 American College of Medical
   Genetics and Genomics. Published by Elsevier Inc. All rights reserved.},
Type = {Article},
Affiliation = {Trainer, AH (Corresponding Author), Peter MacCallum Canc Ctr, Parkville Familial Canc Ctr, 305 Grattan St, Melbourne, Vic 3000, Australia.
   Wheeler, Jack C. W.; Jones, Katherine; Trainer, Alison H., Peter MacCallum Canc Ctr, Parkville Familial Canc Ctr, 305 Grattan St, Melbourne, Vic 3000, Australia.
   Wheeler, Jack C. W.; Keogh, Louise; IJzerman, Maarten J., Univ Melbourne, Ctr Hlth Equ, Melbourne Sch Populat \& Global Hlth, Melbourne, Vic, Australia.
   Sierra, Maria A., Univ Miami, Miller Sch Med, Miami, FL 33136 USA.
   Devereux, Lisa, Peter MacCallum Canc Ctr, Lifepool Study, Melbourne, Vic, Australia.
   Devereux, Lisa; IJzerman, Maarten J., Peter MacCallum Canc Ctr, Dept Canc Res, Melbourne, Vic, Australia.
   Jones, Katherine, Univ Cambridge, Dept Biochem, Cambridge, England.
   IJzerman, Maarten J., Univ Melbourne, Ctr Canc Res, Melbourne, Vic, Australia.
   Trainer, Alison H., Univ Melbourne, Dept Med, Melbourne, Vic, Australia.},
DOI = {10.1016/j.gim.2021.09.002},
EarlyAccessDate = {JAN 2022},
Keywords = {Breast cancer risk; Person-centred care; Polygenic risk scores;
   Population preferences; Precision public health initiative;
   Risk-stratified breast screening},
Keywords-Plus = {CANCER RISK; PREFERENCES; PREDICTORS; FREQUENCY},
Research-Areas = {Genetics \& Heredity},
Web-of-Science-Categories  = {Genetics \& Heredity},
Author-Email = {Alison.Trainer@petermac.org},
Affiliations = {Peter Maccallum Cancer Center; Melbourne Genomics Health Alliance;
   Melbourne Genomics Health Alliance; University of Melbourne; University
   of Miami; Melbourne Genomics Health Alliance; Peter Maccallum Cancer
   Center; Melbourne Genomics Health Alliance; Peter Maccallum Cancer
   Center; University of Cambridge; Melbourne Genomics Health Alliance;
   University of Melbourne; University of Melbourne; Melbourne
   Bioinformatics},
Cited-References = {Amornsiripanitch N, 2021, ACAD RADIOL, V28, P655, DOI 10.1016/j.acra.2020.03.041.
   Apicella C, 2009, BRIT J CANCER, V100, P583, DOI 10.1038/sj.bjc.6604910.
   Britt KL, 2020, NAT REV CANCER, V20, P417, DOI 10.1038/s41568-020-0266-x.
   Broekhuizen H, 2017, VALUE HEALTH, V20, P961, DOI 10.1016/j.jval.2017.04.001.
   Dankar FK, 2020, COMPUT STRUCT BIOTEC, V18, P913, DOI 10.1016/j.csbj.2020.03.027.
   de Corte K, 2021, HEALTH ECON, V30, P1095, DOI 10.1002/hec.4246.
   Esserman LJ, 2017, NPJ BREAST CANCER, V3, DOI 10.1038/s41523-017-0035-5.
   Evans DGR, 2016, BRIT J CANCER, V114, P1045, DOI 10.1038/bjc.2016.56.
   Franco EL, 2018, CURR ONCOL, V25, pE1, DOI 10.3747/co.25.3969.
   French DP, 2018, BRIT J CANCER, V118, P1648, DOI 10.1038/s41416-018-0069-y.
   Gagnon J, 2016, CURR ONCOL, V23, pE615, DOI 10.3747/co.23.2961.
   Ghanouni A, 2020, J MED SCREEN, V27, P138, DOI 10.1177/0969141319883662.
   Gray E, 2017, VALUE HEALTH, V20, P1100, DOI 10.1016/j.jval.2017.04.012.
   Kapoor PM, 2021, JNCI-J NATL CANCER I, V113, P329, DOI 10.1093/jnci/djaa056.
   Katapodi MC, 2004, PREV MED, V38, P388, DOI 10.1016/j.ypmed.2003.11.012.
   Khera AV, 2016, NEW ENGL J MED, V375, P2349, DOI 10.1056/NEJMoa1605086.
   Koitsalu M, 2016, ACTA ONCOL, V55, P45, DOI 10.3109/0284186X.2015.1043024.
   Lambert SA, 2021, NAT GENET, V53, P420, DOI 10.1038/s41588-021-00783-5.
   Lee A, 2019, GENET MED, V21, P1708, DOI 10.1038/s41436-018-0406-9.
   Levy H, 2014, MED DECIS MAKING, V34, P107, DOI 10.1177/0272989X13493144.
   Lippey J, 2019, CANCER PREV RES, V12, P383, DOI 10.1158/1940-6207.CAPR-18-0443.
   Maas P, 2016, JAMA ONCOL, V2, P1295, DOI 10.1001/jamaoncol.2016.1025.
   Manchanda R, 2018, JNCI-J NATL CANCER I, V110, P714, DOI 10.1093/jnci/djx265.
   Marcus PM, 2016, CANCER EPIDEM BIOMAR, V25, P1449, DOI 10.1158/1055-9965.EPI-16-0555.
   Marmot MG, 2013, BRIT J CANCER, V108, P2205, DOI 10.1038/bjc.2013.177.
   Marsh K, 2016, VALUE HEALTH, V19, P125, DOI 10.1016/j.jval.2015.12.016.
   Mavaddat N, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv036.
   Mbuya-Bienge C, 2021, J PERS MED, V11, DOI 10.3390/jpm11020095.
   Meisel SF, 2015, BREAST, V24, P237, DOI 10.1016/j.breast.2015.02.001.
   Nadalin V, 2016, PUBLIC HEALTH, V133, P63, DOI 10.1016/j.puhe.2015.11.028.
   O'Hara J, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15081677.
   Pashayan N, 2020, NAT REV CLIN ONCOL, V17, P687, DOI 10.1038/s41571-020-0388-9.
   Rowley SM, 2019, GENET MED, V21, P913, DOI 10.1038/s41436-018-0277-0.
   Santana MJ, 2018, HEALTH EXPECT, V21, P429, DOI 10.1111/hex.12640.
   Sarstedt M., 2019, A Concise Guide to Market Research. Springer Texts.
   Saya S, 2020, PUBLIC HEALTH GENOM, V23, P110, DOI 10.1159/000508963.
   Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138.
   Tervonen T, 2017, PHARMACOEPIDEM DR S, V26, P1483, DOI 10.1002/pds.4255.
   Tung N, 2016, J CLIN ONCOL, V34, P1460, DOI 10.1200/JCO.2015.65.0747.
   van den Broek JJ, 2021, JNCI-J NATL CANCER I, V113, P434, DOI 10.1093/jnci/djaa127.
   Yanes T, 2020, CLIN GENET, V97, P492, DOI 10.1111/cge.13687.},
Number-of-Cited-References = {41},
Times-Cited = {6},
Unique-ID = {WOS:000819827500014},
}

@article{ WOS:000458709000055,
Author = {Zhang, Boyao and Lauschke, Volker M.},
Title = {Genetic variability and population diversity of the human <i>SLCO</i>
   (OATP) transporter family},
Journal = {PHARMACOLOGICAL RESEARCH},
Year = {2019},
Volume = {139},
Pages = {550-559},
Month = {JAN},
Abstract = {Organic anion transporting polypeptides (OATP) encoded by the SLCO gene
   family constitute clinically important transporters involved in the
   disposition of endogenous compounds and many commonly prescribed drugs,
   including statins, methotrexate and antihypertensive medications. Common
   genetic polymorphisms in SLCO genes are known to affect OATP function
   and modulate efficacy and safety of OATP substrates. However, current
   frequency data of these variants and haplotypes is generally based on
   few rather heterogenous populations of relatively small sample size.
   Furthermore, the genetic variability beyond these selected
   pharmacogenetic biomarkers has not been systematically analyzed. Here,
   we provide a global consolidated map of SLCO variability by leveraging
   fully compatible Next Generation Sequencing data from 138,632 unrelated
   individuals across seven major human populations. Overall, we find 9811
   exonic single nucleotide variants and 155 copy number variations of
   which 99.3\% were rare with frequencies < 1\%. Using orthogonal
   computational functionality predictors optimized for pharmacogenetic
   assessments, we find that four out of five individuals carry at least
   one deleterious variant in an SLCO transporter gene and rare variants
   contribute 23\% to the genetically encoded functional variability.
   Moreover, 74.9\% of all variants were found to be population-specific
   with important consequences for population-specific genotyping
   strategies and precision public health approaches. Combined, our
   analyses provide the most comprehensive data set of SLCO variability
   published to date and incentivize the integration of comprehensive
   NGS-based genotyping into personalized predictions of OATP substrate
   disposition.},
Type = {Article},
Affiliation = {Lauschke, VM (Corresponding Author), Karolinska Inst, Dept Physiol \& Pharmacol, Sect Pharmacogenet, SE-17177 Stockholm, Sweden.
   Zhang, Boyao; Lauschke, Volker M., Karolinska Inst, Dept Physiol \& Pharmacol, Sect Pharmacogenet, SE-17177 Stockholm, Sweden.},
DOI = {10.1016/j.phrs.2018.10.017},
Keywords = {Genetic variation; Personalized medicine; Precision medicine;
   Pharmacogenes; Rare variants; Drug development; Variant frequencies},
Keywords-Plus = {SINGLE-NUCLEOTIDE POLYMORPHISMS; HEPATIC-UPTAKE; ROSUVASTATIN
   PHARMACOKINETICS; POLYPEPTIDE 1B1; C SLC21A6; GRAPEFRUIT JUICE;
   VARIANTS; FREQUENCIES; IDENTIFICATION; DISPOSITION},
Research-Areas = {Pharmacology \& Pharmacy},
Web-of-Science-Categories  = {Pharmacology \& Pharmacy},
Author-Email = {volker.lauschke@ki.se},
Affiliations = {Karolinska Institutet},
Cited-References = {Badagnani I, 2006, J PHARMACOL EXP THER, V318, P521, DOI 10.1124/jpet.106.104364.
   Birmingham BK, 2015, EUR J CLIN PHARMACOL, V71, P329, DOI 10.1007/s00228-014-1800-0.
   Briz O, 2002, MOL PHARMACOL, V61, P853, DOI 10.1124/mol.61.4.853.
   Bush WS, 2016, CLIN PHARMACOL THER, V100, P160, DOI 10.1002/cpt.350.
   Carter H., 2013, BMC GENOMICS S3, V14, P83.
   Chang C, 2005, J PHARMACOL EXP THER, V314, P533, DOI 10.1124/jpet.104.082370.
   Chew SC, 2012, BRIT J CLIN PHARMACO, V73, P606, DOI 10.1111/j.1365-2125.2011.04123.x.
   Choi YH, 2012, PLOS ONE, V7, DOI {[}10.1371/journal.pone.0039927, 10.1371/journal.pone.0046688].
   Chun S, 2009, GENOME RES, V19, P1553, DOI 10.1101/gr.092619.109.
   DeGorter MK, 2012, ANNU REV PHARMACOL, V52, P249, DOI 10.1146/annurev-pharmtox-010611-134529.
   Fujikura K, 2015, PHARMACOGENET GENOM, V25, P584, DOI 10.1097/FPC.0000000000000172.
   Gao B, 2000, J PHARMACOL EXP THER, V294, P73.
   Glaeser H, 2007, CLIN PHARMACOL THER, V81, P362, DOI 10.1038/sj.clpt.6100056.
   Gordon AS, 2014, HUM MOL GENET, V23, P1957, DOI 10.1093/hmg/ddt588.
   Grapci AD, 2015, BALK J MED GENET, V18, P5, DOI 10.1515/bjmg-2015-0001.
   Hagenbuch B, 2013, MOL ASPECTS MED, V34, P396, DOI 10.1016/j.mam.2012.10.009.
   Ho RH, 2007, PHARMACOGENET GENOM, V17, P647, DOI 10.1097/FPC.0b013e3280ef698f.
   Ho WF, 2008, DRUG METAB PHARMACOK, V23, P476, DOI 10.2133/dmpk.23.476.
   Hsiang BN, 1999, J BIOL CHEM, V274, P37161, DOI 10.1074/jbc.274.52.37161.
   Ieiri I, 2012, J CLIN PHARMACOL, V52, P1078, DOI 10.1177/0091270011408612.
   Imanaga J, 2011, PHARMACOGENET GENOM, V21, P84, DOI 10.1097/FPC.0b013e32834300cc.
   Ingelman-Sundberg M, 2018, HUM GENOMICS, V12, DOI 10.1186/s40246-018-0157-3.
   Iwai M, 2004, PHARMACOGENETICS, V14, P749, DOI 10.1097/00008571-200411000-00006.
   Kameyama Y, 2005, PHARMACOGENET GENOM, V15, P513, DOI 10.1097/01.fpc.0000170913.73780.5f.
   Kaniwa N, 2005, DRUG METAB DISPOS, V33, P458, DOI 10.1124/dmd.104.001800.
   Kashihara Y, 2017, J PHARM SCI-US, V106, P2688, DOI 10.1016/j.xphs.2017.03.010.
   Katz DA, 2006, CLIN PHARMACOL THER, V79, P186, DOI 10.1016/j.clpt.2005.11.003.
   Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053.
   Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892.
   König J, 2000, J BIOL CHEM, V275, P23161, DOI 10.1074/jbc.M001448200.
   Kozyra M, 2017, GENET MED, V19, P20, DOI 10.1038/gim.2016.33.
   Lauschke VM, 2018, CLIN PHARMACOL THER, V103, P745, DOI 10.1002/cpt.976.
   Lauschke VM, 2016, TRENDS PHARMACOL SCI, V37, P85, DOI 10.1016/j.tips.2015.10.006.
   Lee E, 2005, CLIN PHARMACOL THER, V78, P330, DOI 10.1016/j.clpt.2005.06.013.
   Lee W, 2005, J BIOL CHEM, V280, P9610, DOI 10.1074/jbc.M411092200.
   Leuthold S, 2009, AM J PHYSIOL-CELL PH, V296, pC570, DOI 10.1152/ajpcell.00436.2008.
   Li LQ, 2000, MOL PHARMACOL, V58, P335, DOI 10.1124/mol.58.2.335.
   Link E, 2008, NEW ENGL J MED, V359, P789, DOI 10.1056/NEJMoa0801936.
   Machiela MJ, 2015, BIOINFORMATICS, V31, P3555, DOI 10.1093/bioinformatics/btv402.
   Michalski C, 2002, J BIOL CHEM, V277, P43058, DOI 10.1074/jbc.M207735200.
   Mougey EB, 2009, PHARMACOGENET GENOM, V19, P129, DOI 10.1097/FPC.0b013e32831bd98c.
   Mwinyi J, 2004, CLIN PHARMACOL THER, V75, P415, DOI 10.1016/j.clpt.2003.12.016.
   Mwinyi J, 2008, EUR J CLIN PHARMACOL, V64, P257, DOI 10.1007/s00228-007-0409-y.
   Nakagomi-Hagihara R, 2006, DRUG METAB DISPOS, V34, P862, DOI 10.1124/dmd.105.008888.
   Niemi M, 2011, PHARMACOL REV, V63, P157, DOI 10.1124/pr.110.002857.
   Nozawa T, 2005, DRUG METAB DISPOS, V33, P434, DOI 10.1124/dmd.104.001909.
   Nozawa T, 2002, J PHARMACOL EXP THER, V302, P804, DOI 10.1124/jpet.302.2.804.
   Oswald S, 2008, PHARMACOGENET GENOM, V18, P559, DOI 10.1097/FPC.0b013e3282fe9a2c.
   Pasanen MK, 2007, CLIN PHARMACOL THER, V82, P726, DOI 10.1038/sj.clpt.6100220.
   Pasanen MK, 2008, PHARMACOGENOMICS, V9, P19, DOI 10.2217/14622416.9.1.19.
   Pasanen MK, 2006, EUR J CLIN PHARMACOL, V62, P409, DOI 10.1007/s00228-006-0123-1.
   Pasanen MK, 2006, PHARMACOGENET GENOM, V16, P873, DOI 10.1097/01.fpc.0000230416.82349.90.
   Picard N, 2010, CLIN PHARMACOL THER, V87, P100, DOI 10.1038/clpt.2009.205.
   Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407.
   Roth M, 2012, BRIT J PHARMACOL, V165, P1260, DOI 10.1111/j.1476-5381.2011.01724.x.
   Santos M, 2018, GENET MED, V20, P622, DOI 10.1038/gim.2017.156.
   Schwarz UI, 2011, PHARMACOGENET GENOM, V21, P103, DOI 10.1097/FPC.0b013e328342f5b1.
   Simonson SG, 2004, CLIN PHARMACOL THER, V76, P167, DOI 10.1016/j.clpt.2004.03.010.
   Smith NF, 2007, CLIN PHARMACOL THER, V81, P76, DOI 10.1038/sj.clpt.6100011.
   Soko N. D., 2018, PHARMACOGENOMICS J, V78, P330.
   Tachikawa M, 2018, DRUG METAB DISPOS, V46, P610, DOI 10.1124/dmd.117.079244.
   Tirona RG, 2001, J BIOL CHEM, V276, P35669, DOI 10.1074/jbc.M103792200.
   Tirona RG, 2003, J PHARMACOL EXP THER, V304, P223, DOI 10.1124/jpet.102.043026.
   Treiber A, 2007, DRUG METAB DISPOS, V35, P1400, DOI 10.1124/dmd.106.013615.
   Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603.
   Yamashiro W, 2006, DRUG METAB DISPOS, V34, P1247, DOI 10.1124/dmd.105.008938.
   Yao J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052563.
   Zhou FF, 2013, AAPS J, V15, P1099, DOI 10.1208/s12248-013-9515-1.
   Zhou Y, 2017, CLIN PHARMACOL THER, V102, P688, DOI 10.1002/cpt.690.
   Zhou Y., FRONT PHARM.
   Zhou YT, 2019, PHARMACOGENOMICS J, V19, P115, DOI 10.1038/s41397-018-0044-2.
   Zhou YT, 2018, J MED GENET, V55, P617, DOI 10.1136/jmedgenet-2018-105429.},
Number-of-Cited-References = {72},
Times-Cited = {30},
Unique-ID = {WOS:000458709000055},
}

@article{ WOS:000480272800005,
Author = {Snyder, Susan R. and Hao, Jing and Cavallari, Larisa H. and Geng, Zhi
   and Elsey, Amanda and Johnson, JulieA. and Mohamed, Zahurin and
   Chaiyakunapruk, Nathorn and Chong, Huey Yi and Dahlui, Maznah and
   Shabaruddin, Fatiha H. and Patrinos, George P. and Mitropoulou,
   Christina and Williams, Marc S.},
Title = {Generic Cost-Effectiveness Models: A Proof of Concept of a Tool for
   Informed Decision-Making for Public Health Precision Medicine},
Journal = {PUBLIC HEALTH GENOMICS},
Year = {2018},
Volume = {21},
Number = {5-6},
Pages = {217-227},
Abstract = {Background/Aims: Economic evaluation is integral to informed public
   health decision-making in the rapidly growing field of precision and
   personalized medicine (PM); however, this research requires specialized
   expertise and significant resources. Generic models are a novel
   innovation to efficiently address a critical PM evidence shortage and
   implementation barrier by enabling use of population-specific input
   values. This is a generic PM economic evaluation model proof-of-concept
   study for a pharmacogenomic use case. Methods: An 8-step generic
   economic model development process was applied to the use case of human
   leukocyte antigen (HLA)-B{*}15:02genotyping for prediction of
   carbamazepine-induced cutaneous reactions, with a user-friendly
   decision-making tool relying on user-provided input values. This generic
   model was transparently documented and validated, including
   cross-validation comparing cost-effectiveness results with 3
   country-specific models. Results: A generic pharmacogenomic use case
   cost-effectiveness model with decision-making tool was successfully
   developed and cross-validated using input values for 6 populations which
   produced consistent results for HLA-B{*}15:02 screening at
   country-specific cost-effectiveness threshold values. Differences
   between the generic and country-specific model results were largely due
   to differences in model structure and assumptions. Conclusion: This
   proof on concept demonstrates the feasibility of generic models to
   provide useful PM economic evidence, supporting their use as a pragmatic
   and timely approach to address a growing need. (C) 2019 S. Karger AG,
   Basel},
Type = {Article},
Affiliation = {Snyder, SR (Corresponding Author), Henry Hood Ctr Hlth Res, Geisinger Dept Epidemiol \& Hlth Serv Res, 100 North Acad Ave MC 44-00, Danville, PA 17822 USA.
   Snyder, Susan R.; Hao, Jing; Geng, Zhi, Geisinger Hlth Syst, Dept Epidemiol \& Hlth Serv Res, Danville, PA USA.
   Cavallari, Larisa H.; Elsey, Amanda; Johnson, JulieA., Univ Florida, Dept Pharmacotherapy \& Translat Res, Gainesville, FL USA.
   Mohamed, Zahurin, Univ Malaya, Dept Pharmacol, Kuala Lumpur, Malaysia.
   Chaiyakunapruk, Nathorn; Chong, Huey Yi, Monash Univ, Sch Pharm, Sunway Campus, Subang Jaya, Malaysia.
   Chaiyakunapruk, Nathorn, Naresuan Univ, Fac Pharmaceut Sci, Dept Pharm Practice, CPOR, Phitsanulok, Thailand.
   Chaiyakunapruk, Nathorn, Univ Wisconsin, Sch Pharm, 425 N Charter St, Madison, WI 53706 USA.
   Chaiyakunapruk, Nathorn, Monash Univ, Asian Ctr Evidence Synth Populat Implementat \& Cl, Global Asia 21st Century GA21 Platform, Subang Jaya, Malaysia.
   Dahlui, Maznah, Univ Malaya, Dept Social \& Prevent Med, Julius Ctr, Kuala Lumpur, Malaysia.
   Shabaruddin, Fatiha H., Univ Malaya, Dept Pharm, Kuala Lumpur, Malaysia.
   Patrinos, George P., Univ Patras, Sch Hlth Sci, Dept Pharm, Patras, Greece.
   Patrinos, George P., United Arab Emirates Univ, Dept Pathol, Coll Med, Al Ain, U Arab Emirates.
   Mitropoulou, Christina, Golden Helix Fdn, London, England.
   Williams, Marc S., Geisinger Hlth Syst, Genom Med Inst, Danville, PA USA.
   Chaiyakunapruk, Nathorn, Univ Utah, Coll Pharm, Dept Pharmacotherapy, Salt Lake City, UT 84112 USA.},
DOI = {10.1159/000500725},
Keywords = {Cost-effectiveness; Modelling; Precision medicine; Decision analysis;
   Pharmacogenomics},
Keywords-Plus = {ECONOMIC-EVALUATION; PHARMACOGENOMICS; CARBAMAZEPINE},
Research-Areas = {Genetics \& Heredity; Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Genetics \& Heredity; Public, Environmental \& Occupational Health},
Author-Email = {ssnyder2@gsu.edu},
Affiliations = {Geisinger Health System; State University System of Florida; University
   of Florida; Universiti Malaya; Monash University; Monash University
   Malaysia; Naresuan University; University of Wisconsin System;
   University of Wisconsin Madison; Monash University; Monash University
   Malaysia; Universiti Malaya; Universiti Malaya; University of Patras;
   United Arab Emirates University; Geisinger Health System; Utah System of
   Higher Education; University of Utah},
Cited-References = {{[}Anonymous], REAL POT PHARM OPP C.
   Buchanan J, 2013, PHARMACOGENOMICS, V14, P1833, DOI 10.2217/pgs.13.183.
   Chong HY, 2017, BRIT J DERMATOL, V177, P1102, DOI 10.1111/bjd.15498.
   Christensen C., 2009, The innovator's prescription: a disruptive solution for health care, V1st.
   Dong D, 2012, NEUROLOGY, V79, P1259, DOI 10.1212/WNL.0b013e31826aac73.
   Eddy DM, 2012, VALUE HEALTH, V15, P843, DOI 10.1016/j.jval.2012.04.012.
   Godman B, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-179.
   Haycox A, 2014, PHARMACOECONOMICS, V32, P1055, DOI 10.1007/s40273-014-0190-6.
   Husereau D, 2013, VALUE HEALTH, V16, P231, DOI 10.1016/j.jval.2013.02.002.
   Ji Y, 2016, J MOL DIAGN, V18, P438, DOI 10.1016/j.jmoldx.2016.01.003.
   Manolio TA, 2016, EXPERT REV PRECIS ME, V1, P349, DOI 10.1080/23808993.2016.1192460.
   Manolio TA, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab0194.
   Phillips EJ, 2018, CLIN PHARMACOL THER, V103, P574, DOI 10.1002/cpt.1004.
   Rattanavipapong W, 2015, USER MANUAL COST UTI.
   Rattanavipapong W, 2013, EPILEPSIA, V54, P1628, DOI 10.1111/epi.12325.
   Shabaruddin FH, 2015, PHARMACOGEN PERS MED, V8, P115, DOI 10.2147/PGPM.S35063.
   Snyder SR, 2014, PUBLIC HEALTH GENOM, V17, P256, DOI 10.1159/000366177.
   Veenstra D, 2009, PUBLIC HEALTH GENOM, V12, P131, DOI 10.1159/000189624.
   Veenstra DL, 2010, GENET MED, V12, P686, DOI 10.1097/GIM.0b013e3181eff533.},
Number-of-Cited-References = {19},
Times-Cited = {7},
Unique-ID = {WOS:000480272800005},
}

@article{ WOS:000761445200003,
Author = {Paige, John and Fuglstad, Geir-Arne and Riebler, Andrea and Wakefield,
   Jon},
Title = {DESIGN- AND MODEL-BASED APPROACHES TO SMALL-AREA ESTIMATION IN A LOW-
   AND MIDDLE-INCOME COUNTRY CONTEXT: COMPARISONS AND RECOMMENDATIONS},
Journal = {JOURNAL OF SURVEY STATISTICS AND METHODOLOGY},
Year = {2022},
Volume = {10},
Number = {1},
Pages = {50-80},
Month = {JAN 22},
Abstract = {The need for rigorous and timely health and demographic summaries has
   provided the impetus for an explosion in geographic studies in low- and
   middle-income countries. Many of these studies present fine-scale
   pixel-level maps in an attempt to answer the needs of the current era of
   precision public health. However, even though household surveys with a
   two-stage cluster design stratified by region and urbanicity are a major
   source of data, cavalier approaches are taken to acknowledging the
   survey design. We investigate the extent to which accounting for the
   sample design affects the predictive performance at the aggregate level
   of interest for health policy decisions. We consider various commonly
   used models and introduce a new Bayesian cluster-level model with a
   discrete spatial smoothing prior. The investigation is performed through
   a simulation study in which realistic sampling frames are created for
   Kenya, based on the population and demographic information, with a
   survey design that mimics a Demographic Health Survey (DHS). We find
   that including stratification and cluster-level random effects can
   improve predictive performance. Spatially smoothed direct (weighted)
   estimates and area-level models accounting for stratification were
   robust to the underlying population and survey design. Continuous
   spatial models showed some promise in the presence of fine-scale
   variation; however, these models require the most ``hand holding.{''}
   Subsequently, we examine how the models perform on real data, estimating
   the prevalence of secondary education for women aged 20-29 and neonatal
   mortality rates, using data from the 2014 Kenya DHS.},
Type = {Article},
Affiliation = {Wakefield, J (Corresponding Author), Univ Washington, Dept Stat, 1705 NE Pacific St, Seattle, WA 98195 USA.
   Paige, John; Wakefield, Jon, Univ Washington, Dept Stat, 1705 NE Pacific St, Seattle, WA 98195 USA.
   Fuglstad, Geir-Arne; Riebler, Andrea, Norwegian Univ Sci \& Technol, Dept Math Sci, N-7491 Trondheim, Norway.},
DOI = {10.1093/jssam/smaa011},
Keywords = {Geostatistical models; Integrated nested Laplace approximations;
   Small-area estimation; Spatial statistics; Survey design},
Keywords-Plus = {SPATIAL MODEL; AFRICA; MORTALITY; INFERENCE; PROGRESS},
Research-Areas = {Mathematical Methods In Social Sciences; Mathematics},
Web-of-Science-Categories  = {Social Sciences, Mathematical Methods; Statistics \& Probability},
Author-Email = {jonno@uw.edu},
Affiliations = {University of Washington; University of Washington Seattle; Norwegian
   University of Science \& Technology (NTNU)},
Cited-References = {{[}Anonymous], 2009, 2009 KEN POP HOUS CE.
   {[}Anonymous], 2015, DHS SPATIAL ANAL REP.
   {[}Anonymous], 2010, Journal of Data Science, DOI {[}DOI 10.6339/JDS.2010.08, 10.6339/JDS.2010.08(2).583].
   BESAG J, 1991, ANN I STAT MATH, V43, P1, DOI 10.1007/BF00116466.
   Chen CC, 2014, SPAT SPATIO-TEMPORAL, V11, P33, DOI 10.1016/j.sste.2014.07.002.
   Desmond-Hellmann S, 2016, SCIENCE, V353, P731, DOI 10.1126/science.aai7598.
   Devarajan S, 2013, REV INCOME WEALTH, V59, pS9, DOI 10.1111/roiw.12013.
   DHS Program, 2019, DHS PROGR AIDS IND S.
   Diggle P. J., 2019, MODEL BASED GEOSTATI.
   Diggle PJ, 2016, J AM STAT ASSOC, V111, P1096, DOI 10.1080/01621459.2015.1123158.
   Dowell SF, 2016, NATURE, V540, P189, DOI 10.1038/540189a.
   FAY RE, 1979, J AM STAT ASSOC, V74, P269, DOI 10.1080/01621459.1979.10482505.
   Fuglstad GA, 2019, J AM STAT ASSOC, V114, P445, DOI 10.1080/01621459.2017.1415907.
   Gething PW, 2016, NEW ENGL J MED, V375, P2435, DOI 10.1056/NEJMoa1606701.
   Giorgi E, 2018, INT STAT REV, V86, P571, DOI 10.1111/insr.12268.
   Gneiting T, 2007, J AM STAT ASSOC, V102, P359, DOI 10.1198/016214506000001437.
   Golding N, 2017, LANCET, V390, P2171, DOI 10.1016/S0140-6736(17)31758-0.
   Graetz N, 2018, NATURE, V555, P48, DOI 10.1038/nature25761.
   ICF International, 2012, Demographic and Health Survey Sampling and Household Listing Manual.
   Jerven M, 2013, POOR NUMBERS WE ARE.
   Kenya National Bureau of Statistics, 2015, REP KEN KEN DEM HLTH.
   Khoury MJ, 2016, AM J PREV MED, V50, P398, DOI 10.1016/j.amepre.2015.08.031.
   Lawn JE, 2014, LANCET, V384, P189, DOI 10.1016/S0140-6736(14)60496-7.
   Li ZH, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210645.
   Lindgren F, 2011, J ROY STAT SOC B, V73, P423, DOI 10.1111/j.1467-9868.2011.00777.x.
   Lumley T., 2004, SURVEY ANAL COMPLEX, V9, P1, DOI 10.18637/jss.v009.i08.
   Lumley T., 2018, SURVEY ANAL COMPLEX.
   Marhuenda Y, 2013, COMPUT STAT DATA AN, V58, P308, DOI 10.1016/j.csda.2012.09.002.
   Martin B.D., 2018, SUMMER SPATIO TEMPOR.
   Mercer LD, 2015, ANN APPL STAT, V9, P1889, DOI 10.1214/15-AOAS872.
   Osgood-Zimmerman A, 2018, NATURE, V555, P41, DOI 10.1038/nature25760.
   Porter AT, 2014, SPAT STAT-NETH, V10, P27, DOI 10.1016/j.spasta.2014.07.001.
   Rao J., 2015, WILEY SERIES SURVEY.
   Riebler A, 2016, STAT METHODS MED RES, V25, P1145, DOI 10.1177/0962280216660421.
   Rue H, 2009, J ROY STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x.
   Sandefur J, 2015, J DEV STUD, V51, P116, DOI 10.1080/00220388.2014.968138.
   Simpson D, 2017, STAT SCI, V32, P1, DOI 10.1214/16-STS576.
   Stevens FR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0107042.
   Tatem AJ, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.4.
   UNICEF-Statistics and Monitoring, 2012, MULT IND CLUST SURV.
   United Nations, 2019, WHO Issues Its First Emergency Use Validation for a COVID-19 Vaccine and Emphasizes Need for Equitable Global Access.
   USAID, 2019, DEM HLTH SURV.
   Utazi CE, 2018, VACCINE, V36, P1583, DOI 10.1016/j.vaccine.2018.02.020.
   Vandendijck Y, 2016, SPAT STAT-NETH, V18, P455, DOI 10.1016/j.spasta.2016.09.004.
   Wagner Z, 2018, LANCET, V392, P857, DOI 10.1016/S0140-6736(18)31437-5.
   Wardrop NA, 2018, P NATL ACAD SCI USA, V115, P3529, DOI 10.1073/pnas.1715305115.
   Watjou K, 2017, STAT MED, V36, P3708, DOI 10.1002/sim.7369.
   World Bank, 2019, LIV STAND MEAS STUD.
   You Y, 2011, SURV METHODOL, V37, P25.},
Number-of-Cited-References = {49},
Times-Cited = {11},
Unique-ID = {WOS:000761445200003},
}

@article{ WOS:000791963200001,
Author = {Rieckmann, Andreas and Dworzynski, Piotr and Arras, Leila and
   Lapuschkin, Sebastian and Samek, Wojciech and Arah, Onyebuchi Aniweta
   and Rod, Naja Hulvej and Ekstrom, Claus Thorn},
Title = {Causes of Outcome Learning: a causal inference-inspired machine learning
   approach to disentangling common combinations of potential causes of a
   health outcome},
Journal = {INTERNATIONAL JOURNAL OF EPIDEMIOLOGY},
Year = {2022},
Volume = {51},
Number = {5},
Pages = {1622-1636},
Month = {OCT 13},
Abstract = {Nearly all diseases are caused by different combinations of exposures.
   Yet, most epidemiological studies focus on estimating the effect of a
   single exposure on a health outcome. We present the Causes of Outcome
   Learning approach (CoOL), which seeks to discover combinations of
   exposures that lead to an increased risk of a specific outcome in parts
   of the population. The approach allows for exposures acting alone and in
   synergy with others. The road map of CoOL involves (i) a
   pre-computational phase used to define a causal model; (ii) a
   computational phase with three steps, namely (a) fitting a non-negative
   model on an additive scale, (b) decomposing risk contributions and (c)
   clustering individuals based on the risk contributions into subgroups;
   and (iii) a post-computational phase on hypothesis development,
   validation and triangulation using new data before eventually updating
   the causal model. The computational phase uses a tailored neural network
   for the non-negative model on an additive scale and layer-wise relevance
   propagation for the risk decomposition through this model. We
   demonstrate the approach on simulated and real-life data using the R
   package `CoOL'. The presentation focuses on binary exposures and
   outcomes but can also be extended to other measurement types. This
   approach encourages and enables researchers to identify combinations of
   exposures as potential causes of the health outcome of interest.
   Expanding our ability to discover complex causes could eventually result
   in more effective, targeted and informed interventions prioritized for
   their public health impact.},
Type = {Article},
Affiliation = {Rieckmann, A (Corresponding Author), Univ Copenhagen, Dept Publ Hlth, Sect Epidemiol, Oster Farimagsgade 5, DK-1353 Copenhagen K, Denmark.
   Rieckmann, Andreas; Rod, Naja Hulvej, Univ Copenhagen, Dept Publ Hlth, Sect Epidemiol, Oster Farimagsgade 5, DK-1353 Copenhagen K, Denmark.
   Dworzynski, Piotr, Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark.
   Arras, Leila; Lapuschkin, Sebastian; Samek, Wojciech, Fraunhofer Heinrich Hertz Inst, Dept Artificial Intelligence, Berlin, Germany.
   Samek, Wojciech, BIFOLD Berlin Inst Fdn Learning \& Data, Berlin, Germany.
   Arah, Onyebuchi Aniweta, Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA USA.
   Arah, Onyebuchi Aniweta, Univ Calif Los Angeles, Dept Stat, Coll Letters \& Sci, Los Angeles, CA USA.
   Ekstrom, Claus Thorn, Univ Copenhagen, Dept Publ Hlth, Sect Biostat, Copenhagen, Denmark.},
DOI = {10.1093/ije/dyac078},
EarlyAccessDate = {MAY 2022},
Keywords = {Causes of effects; sufficient component cause model;
   inductive-deductive; machine learning; neural networks; explanations;
   precision public health; complex epidemiology; interactions; supervised
   clustering},
Keywords-Plus = {QUALITATIVE COMPARATIVE-ANALYSIS; R PACKAGE; WIDE; IDENTIFICATION;
   VISUALIZATION; EPIDEMIOLOGY; EXPOSURE},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {aric@sund.ku.dk},
Affiliations = {University of Copenhagen; University of Copenhagen; Novo Nordisk
   Foundation; Fraunhofer Gesellschaft; University of California System;
   University of California Los Angeles; University of California System;
   University of California Los Angeles; University of Copenhagen},
Cited-References = {Alrawahi AH, 2020, J PUBLIC HEALTH RES, V9, P321, DOI 10.4081/jphr.2020.1726.
   Anders CJ, 2022, INFORM FUSION, V77, P261, DOI 10.1016/j.inffus.2021.07.015.
   Arah OA, 2019, EPIDEMIOLOGY, V30, P517, DOI 10.1097/EDE.0000000000001033.
   Arras L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181142.
   Bach S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130140.
   Barrera-Gómez J, 2017, ENVIRON HEALTH-GLOB, V16, DOI 10.1186/s12940-017-0277-6.
   Baumgartner M, 2023, MULTIVAR BEHAV RES, V58, P292, DOI 10.1080/00273171.2021.1971510.
   Beam AL, 2020, JAMA-J AM MED ASSOC, V323, P305, DOI 10.1001/jama.2019.20866.
   Beyea J, 1999, HEALTH PHYS, V76, P269, DOI 10.1097/00004032-199903000-00008.
   Brankovic M, 2019, EUR J CLIN INVEST, V49, DOI 10.1111/eci.13145.
   Chavent M, 2018, COMPUTATION STAT, V33, P1799, DOI 10.1007/s00180-018-0791-1.
   Eide GE, 2001, STAT METHODS MED RES, V10, P159, DOI 10.1191/096228001680195148.
   GREENLAND S, 1993, ENVIRON HEALTH PERSP, V101, P59, DOI 10.2307/3431660.
   HernanHerni MA M A, 2020, Causal Inference: What If.
   Holzinger A, 2019, WIRES DATA MIN KNOWL, V9, DOI 10.1002/widm.1312.
   Hong HY., 2009, CHINESE J CARDIOVASC, V37, P870.
   Huang YT, 2020, STAT MED, V39, P4051, DOI 10.1002/sim.8708.
   Ioannidis JPA, 2016, STAT MED, V35, P1749, DOI 10.1002/sim.6825.
   Janssens ACJW, 2020, INT J EPIDEMIOL, V49, P1397, DOI 10.1093/ije/dyz274.
   Kallus N., 2019, International Conference on Machine Learning, P3201.
   Kee F, 2020, J EPIDEMIOL COMMUN H, V74, P311, DOI 10.1136/jech-2019-213311.
   Kleinbaum DG., 1982, EPIDEMIOLOGIC RES.
   Land M, 2001, STAT METHODS MED RES, V10, P217, DOI 10.1191/096228001680195166.
   Lange T, 2004, NEURAL COMPUT, V16, P1299, DOI 10.1162/089976604773717621.
   Lapuschkin S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08987-4.
   Lawlor DA, 2016, INT J EPIDEMIOL, V45, P1866, DOI 10.1093/ije/dyw314.
   LeCun YA., 2012, EFFICIENT BACKPROP B.
   Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565.
   Lundberg SM, 2017, ADV NEUR IN, V30.
   MACKIE JL, 1965, AM PHILOS QUART, V2, P245.
   Montavon Gre<prime>goire, 2019, EXPLAINABLE INTERPRE, P2, DOI DOI 10.1007/978-3-030-28954-6\_10.
   Montavon G, 2018, DIGIT SIGNAL PROCESS, V73, P1, DOI 10.1016/j.dsp.2017.10.011.
   Montavon G, 2017, PATTERN RECOGN, V65, P211, DOI 10.1016/j.patcog.2016.11.008.
   Ngamwong Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135798.
   Olsen J, 2003, J EPIDEMIOL COMMUN H, V57, P86, DOI 10.1136/jech.57.2.86.
   Olstad DL, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-030279.
   Patel CJ, 2018, AIDS, V32, P933, DOI {[}10.1097/QAD.0000000000001767, 10.1097/qad.0000000000001767].
   Patel Chirag J, 2015, Am J Epidemiol, V181, P171, DOI 10.1093/aje/kwu277.
   Patel CJ, 2012, INT J EPIDEMIOL, V41, P828, DOI 10.1093/ije/dys003.
   Patel CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010746.
   Pearl J, 2019, COMMUN ACM, V62, P54, DOI 10.1145/3241036.
   Pearl J, 2016, J CAUSAL INFERENCE, V4, DOI 10.1515/jci-2016-0021.
   Ragin CC, 1999, HEALTH SERV RES, V34, P1225.
   Rappaport SM, 2011, J EXPO SCI ENV EPID, V21, P5, DOI 10.1038/jes.2010.50.
   Rappaport SM, 2010, SCIENCE, V330, P460, DOI 10.1126/science.1192603.
   Reiber GE, 1999, DIABETES CARE, V22, P157, DOI 10.2337/diacare.22.1.157.
   Rose GA., 2008, ROSES STRATEGY PREVE, DOI {[}10.1093/acprof:oso/9780192630971.001.0001, DOI 10.1093/ACPROF:OSO/9780192630971.001.0001].
   ROTHMAN KJ, 1976, AM J EPIDEMIOL, V104, P587, DOI 10.1093/oxfordjournals.aje.a112335.
   ROTHMAN KJ, 1980, AM J EPIDEMIOL, V112, P467, DOI 10.1093/oxfordjournals.aje.a113015.
   Rothman KJ, 2008, Modern Epidemiology, V3rd.
   Samek W, 2017, IEEE T NEUR NET LEAR, V28, P2660, DOI 10.1109/TNNLS.2016.2599820.
   Shrikumar A., 34 INT C MACH LEARN, P3145.
   Smith GD, 2011, INT J EPIDEMIOL, V40, P537, DOI 10.1093/ije/dyr117.
   Strauss T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168288.
   Sturm I, 2016, J NEUROSCI METH, V274, P141, DOI 10.1016/j.jneumeth.2016.10.008.
   Sudharsanan N, 2020, EPIDEMIOLOGY, V31, P393, DOI 10.1097/EDE.0000000000001172.
   Sundararajan M, 2017, PR MACH LEARN RES, V70.
   Suzuki E, 2012, AM J EPIDEMIOL, V175, P567, DOI 10.1093/aje/kwr333.
   Tennant PWG, 2021, INT J EPIDEMIOL, V50, P620, DOI 10.1093/ije/dyaa213.
   Tsai AC, 2018, SOC SCI MED, V206, P117, DOI 10.1016/j.socscimed.2018.03.040.
   Tzoulaki I, 2012, CIRCULATION, V126, P2456, DOI 10.1161/CIRCULATIONAHA.112.114058.
   VanderWeele TJ, 2007, AM J EPIDEMIOL, V166, P1096, DOI 10.1093/aje/kwm179.
   VanderWeele TJ, 2007, EPIDEMIOLOGY, V18, P329, DOI 10.1097/01.ede.0000260218.66432.88.
   VanderWeele TJ, 2006, EUR J EPIDEMIOL, V21, P855, DOI 10.1007/s10654-006-9075-0.
   VanderWeele TJ, 2020, STAT SCI, V35, P437, DOI 10.1214/19-STS728.
   VanderWeele TJ, 2016, INT J EPIDEMIOL, V45, P1904, DOI 10.1093/ije/dyw277.
   VanderWeele TJ, 2017, EPIDEMIOLOGY, V28, P399, DOI 10.1097/EDE.0000000000000641.
   VanderWeele TJ, 2013, EPIDEMIOLOGY, V24, P224, DOI 10.1097/EDE.0b013e318281a64e.
   VanderWeele TJ, 2012, AM J EPIDEMIOL, V175, P1303, DOI 10.1093/aje/kwr458.
   VOLLSET SE, 1993, STAT MED, V12, P809, DOI 10.1002/sim.4780120902.
   Warren J, 2014, J PUBLIC HEALTH-UK, V36, P126, DOI 10.1093/pubmed/fdt047.
   Wild CP, 2012, INT J EPIDEMIOL, V41, P24, DOI 10.1093/ije/dyr236.
   Yang YC, 2018, IEEE INT CONF HEALT, P152, DOI 10.1109/ICHI.2018.00025.
   Yu GC, 2017, METHODS ECOL EVOL, V8, P28, DOI 10.1111/2041-210X.12628.},
Number-of-Cited-References = {74},
Times-Cited = {1},
Unique-ID = {WOS:000791963200001},
}

@article{ WOS:000575055500001,
Author = {Poirier, Canelle and Liu, Dianbo and Clemente, Leonardo and Ding, Xiyu
   and Chinazzi, Matteo and Davis, Jessica and Vespignani, Alessandro and
   Santillana, Mauricio},
Title = {Real-Time Forecasting of the COVID-19 Outbreak in Chinese Provinces:
   Machine Learning Approach Using Novel Digital Data and Estimates From
   Mechanistic Models},
Journal = {JOURNAL OF MEDICAL INTERNET RESEARCH},
Year = {2020},
Volume = {22},
Number = {8},
Month = {AUG 17},
Abstract = {Background: The inherent difficulty of identifying and monitoring
   emerging outbreaks caused by novel pathogens can lead to their rapid
   spread; and if left unchecked, they may become major public health
   threats to the planet. The ongoing coronavirus disease (COVID-19)
   outbreak, which has infected over 2,300,000 individuals and caused over
   150,000 deaths, is an example of one of these catastrophic events.
   Objective: We present a timely and novel methodology that combines
   disease estimates from mechanistic models and digital traces, via
   interpretable machine learning methodologies, to reliably forecast
   COVID-19 activity in Chinese provinces in real time.
   Methods: Our method uses the following as inputs: (a) official health
   reports, (b) COVID-19-related internet search activity, (c) news media
   activity, and (d) daily forecasts of COVID-19 activity from a
   metapopulation mechanistic model. Our machine learning methodology uses
   a clustering technique that enables the exploitation of geospatial
   synchronicities of COVID-19 activity across Chinese provinces and a data
   augmentation technique to deal with the small number of historical
   disease observations characteristic of emerging outbreaks.
   Results: Our model is able to produce stable and accurate forecasts 2
   days ahead of the current time and outperforms a collection of baseline
   models in 27 out of 32 Chinese provinces.
   Conclusions: Our methodology could be easily extended to other
   geographies currently affected by COVID-19 to aid decision makers with
   monitoring and possibly prevention.},
Type = {Article},
Affiliation = {Santillana, M (Corresponding Author), Boston Childrens Hosp, Computat Hlth Informat Program, 300 Longwood Ave,Landmark 5th Floor East, Boston, MA 02215 USA.
   Poirier, Canelle; Liu, Dianbo; Clemente, Leonardo; Ding, Xiyu; Santillana, Mauricio, Boston Childrens Hosp, Computat Hlth Informat Program, 300 Longwood Ave,Landmark 5th Floor East, Boston, MA 02215 USA.
   Poirier, Canelle; Liu, Dianbo; Clemente, Leonardo; Santillana, Mauricio, Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA.
   Clemente, Leonardo, Tecnol Monterrey, Monterrey, Mexico.
   Ding, Xiyu; Santillana, Mauricio, Harvard TH Chan Sch Publ Hlth, Boston, MA USA.
   Chinazzi, Matteo; Davis, Jessica; Vespignani, Alessandro, Northeastern Univ, Lab Modeling Biol \& Sociotech Syst, Boston, MA 02115 USA.
   Vespignani, Alessandro, ISI Fdn, Turin, Italy.},
DOI = {10.2196/20285},
Article-Number = {e20285},
Keywords = {COVID-19; coronavirus; digital epidemiology; modeling; modeling disease
   outbreaks; emerging outbreak; machine learning; precision public health;
   machine learning in public health; forecasting; digital data;
   mechanistic model; hybrid simulation; hybrid model; simulation},
Research-Areas = {Health Care Sciences \& Services; Medical Informatics},
Web-of-Science-Categories  = {Health Care Sciences \& Services; Medical Informatics},
Author-Email = {msantill@g.harvard.edu},
Affiliations = {Harvard University; Boston Children's Hospital; Harvard University;
   Harvard Medical School; Tecnologico de Monterrey; Harvard University;
   Harvard T.H. Chan School of Public Health; Northeastern University},
Cited-References = {Aiken E, 2019, REAL TIME ESTIMATION, DOI {[}10.1101/19010470v1, DOI 10.1101/19010470V1].
   Andersen K., 2020, ESTIMATES CLOCK TMRC.
   {[}Anonymous], EARLY EPIDEMIOLOGICA.
   {[}Anonymous], 2020, PHYLOGENETIC ANAL 23.
   Balcan D, 2010, J COMPUT SCI-NETH, V1, P132, DOI 10.1016/j.jocs.2010.07.002.
   Bedford T, 2020, 20200123 NEXTSTR.
   Calinski T., 1974, COMMUN STAT, V3, P1, DOI DOI 10.1080/03610927408827101.
   Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9.
   Chinazzi M, 2020, SCIENCE, V368, P395, DOI {[}10.1101/2020.02.09.20021261, 10.1126/science.aba9757].
   Cleaton JM, 2016, CLIN INFECT DIS, V62, P24, DOI 10.1093/cid/civ748.
   De Salazar P M, 2020, medRxiv, DOI 10.1101/2020.02.04.20020495.
   DEFAYS D, 1977, COMPUT J, V20, P364, DOI 10.1093/comjnl/20.4.364.
   Du Z, 2020, RISK 2019 NOVEL CORO, DOI {[}10.1101/2020.01.28.20019299, DOI 10.1101/2020.01.28.20019299].
   Eldabi T., 2016, IEEE 2016 WSC 16 P 2, DOI 10.1109/WSC.2016.7822192.
   Giabbanelli PJ, 2019, WINT SIMUL C PROC, P572, DOI {[}10.1109/WSC40007.2019.9004755, 10.1109/wsc40007.2019.9004755].
   Gilbert M, 2020, PREPAREDNESS VULNERA, DOI {[}10.1101/2020.02.05.20020792, DOI 10.1101/2020.02.05.20020792].
   Gomes Marcelo F C, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.cd818f63d40e24aef769dda7df9e0da5.
   Gore R, 2020, VIRGINIA COUNTY COVI.
   Henelius A., 2016, CLUSTERING CONFIDENC.
   Imai N, 2020, IMPERIAL COLL LONDON.
   Jung SM, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020523.
   Kraemer MUG, 2020, SCIENCE, V368, P493, DOI 10.1126/science.abb4218.
   Lai SJ, 2020, NATURE, V585, P410, DOI {[}10.1038/s41586-020-2293-x, 10.1101/2020.03.03.20029843].
   Li CL, 2020, EUROSURVEILLANCE, V25, P7, DOI 10.2807/1560-7917.ES.2020.25.10.2000199.
   Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316.
   Li RY, 2020, SCIENCE, V368, P489, DOI {[}10.1126/science.abb3221, 10.1101/2020.02.14.20023127].
   Lipsitch M, 2019, CURR TOP MICROBIOL, V424, P59, DOI 10.1007/82\_2019\_172.
   Lu FS, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08082-0.
   McGough SF, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005295.
   Niehus Rene, 2020, medRxiv, DOI 10.1101/2020.02.13.20022707.
   Phan LT, 2020, NEW ENGL J MED, V382, P872, DOI 10.1056/NEJMc2001272.
   Pinotti F., 2020, LESSONS LEARNT C, DOI {[}10.1101/2020.02.24.20027326, DOI 10.1101/2020.02.24.20027326].
   Poirier C., 2019, INFECT DIS EXCEPT HI, DOI {[}10.1101/19009795, DOI 10.1101/19009795].
   Santillana M, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004513.
   Santillana M, 2014, CLIN INFECT DIS, V59, P1446, DOI 10.1093/cid/ciu647.
   Sasirekha K., 2013, International Journal of Scientific and Research Publications, V3, P1, DOI DOI 10.1007/978-1-4419-9863-7\_100033.
   SEAL HL, 1967, BIOMETRIKA, V54, P1.
   Sun KY, 2020, LANCET DIGIT HEALTH, V2, pE201, DOI 10.1016/S2589-7500(20)30026-1.
   Sunnåker M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002803.
   Tibshirani R, 1996, J ROY STAT SOC B, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x.
   Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9.
   Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9.
   Yang SH, 2015, P NATL ACAD SCI USA, V112, P14473, DOI 10.1073/pnas.1515373112.
   Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114.
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI {[}10.1056/NEJMoa2001017, 10.1172/JCI89857].},
Number-of-Cited-References = {45},
Times-Cited = {26},
Unique-ID = {WOS:000575055500001},
}

@article{ WOS:000678771200008,
Author = {Gupta, Agrayan K. and Grannis, Shaun J. and Kasthurirathne, Suranga N.},
Title = {Evaluation of a Parsimonious COVID-19 Outbreak Prediction Model:
   Heuristic Modeling Approach Using Publicly Available Data Sets},
Journal = {JOURNAL OF MEDICAL INTERNET RESEARCH},
Year = {2021},
Volume = {23},
Number = {7},
Month = {JUL 26},
Abstract = {Background: The COVID-19 pandemic has changed public health policies and
   human and community behaviors through lockdowns and mandates.
   Governments are rapidly evolving policies to increase hospital capacity
   and supply personal protective equipment and other equipment to mitigate
   disease spread in affected regions. Current models that predict COVID-19
   case counts and spread are complex by nature and offer limited
   explainability and generalizability. This has highlighted the need for
   accurate and robust outbreak prediction models that balance model
   parsimony and performance.
   Objective: We sought to leverage readily accessible data sets extracted
   from multiple states to train and evaluate a parsimonious predictive
   model capable of identifying county-level risk of COVID-19 outbreaks on
   a day-to-day basis.
   Methods: Our modeling approach leveraged the following data inputs:
   COVID-19 case counts per county per day and county populations. We
   developed an outbreak gold standard across California, Indiana, and
   Iowa. The model utilized a per capita running 7-day sum of the case
   counts per county per day and the mean cumulative case count to develop
   baseline values. The model was trained with data recorded between March
   1 and August 31, 2020, and tested on data recorded between September 1
   and October 31, 2020.
   Results: The model reported sensitivities of 81\%, 92\%, and 90\% for
   California, Indiana, and Iowa, respectively. The precision in each state
   was above 85\% while specificity and accuracy scores were generally
   >95\%.
   Conclusions: Our parsimonious model provides a generalizable and simple
   alternative approach to outbreak prediction. This methodology can be
   applied to diverse regions to help state officials and hospitals with
   resource allocation and to guide risk management, community education,
   and mitigation strategies.},
Type = {Article},
Affiliation = {Gupta, AK (Corresponding Author), Indiana Univ, 107 S Indiana Ave, Bloomington, IN 47405 USA.
   Gupta, Agrayan K., Indiana Univ, 107 S Indiana Ave, Bloomington, IN 47405 USA.
   Gupta, Agrayan K.; Grannis, Shaun J.; Kasthurirathne, Suranga N., Regenstrief Inst Hlth Care, Ctr Biomed Informat, Indianapolis, IN USA.
   Grannis, Shaun J.; Kasthurirathne, Suranga N., Indiana Univ, Sch Med, Indianapolis, IN USA.},
DOI = {10.2196/28812},
Article-Number = {e28812},
Keywords = {coronavirus; COVID-19; emerging outbreak; modeling disease outbreak;
   precision public health; predictive modeling},
Keywords-Plus = {EPIDEMIC; HEALTH; CHINA},
Research-Areas = {Health Care Sciences \& Services; Medical Informatics},
Web-of-Science-Categories  = {Health Care Sciences \& Services; Medical Informatics},
Author-Email = {aggupta@iu.edu},
Affiliations = {Indiana University System; Indiana University Bloomington; Indiana
   University System; Indiana University-Purdue University Indianapolis;
   Regenstrief Institute Inc; Indiana University System; Indiana
   University-Purdue University Indianapolis},
Cited-References = {Adnan M, 2020, JMIR PUBLIC HLTH SUR, V6, P27, DOI 10.2196/18281.
   {[}Anonymous], COUNTY POPULATION TO.
   {[}Anonymous], Each State's COVID-19 Reopening and Reclosing Plans and Mask Requirements.
   {[}Anonymous], MPH HELPS INDIANA FI.
   {[}Anonymous], 2021, COVID DATA TRACKER.
   {[}Anonymous], NY TIMES DEV NETWORK NY TIMES DEV NETWORK.
   Baker S. R., 2020, National Bureau of Economic Research, DOI 10.3386/w26983.
   Bennett Tellen D, 2021, medRxiv, DOI 10.1101/2021.01.12.21249511.
   Budd J, 2020, NAT MED, V26, P1183, DOI 10.1038/s41591-020-1011-4.
   Casella F, 2021, IEEE CONTR SYST LETT, V5, P1079, DOI 10.1109/LCSYS.2020.3009912.
   Cutler DM, 2020, JAMA-J AM MED ASSOC, V324, P1495, DOI 10.1001/jama.2020.19759.
   Dagan N, 2021, NEW ENGL J MED, V384, P1412, DOI 10.1056/NEJMoa2101765.
   Dai YY, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008758.
   del Rio C, 2021, JAMA-J AM MED ASSOC, V325, P1389, DOI 10.1001/jama.2021.3760.
   Dexter Gregory P, 2020, AMIA Jt Summits Transl Sci Proc, V2020, P152.
   Dixon BE, 2021, J AM MED INFORM ASSN, V28, P1363, DOI 10.1093/jamia/ocab004.
   Dobbin KK, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-31.
   Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1.
   Drug Therapeutics Bulletin, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4147.
   Estiri H, 2021, NPJ DIGIT MED, V4, DOI 10.1038/s41746-021-00383-x.
   Ghorbani A, 2019, AAAI CONF ARTIF INTE, P3681.
   Giordano G, 2020, NAT MED, V26, P855, DOI 10.1038/s41591-020-0883-7.
   Hall SA, 2006, J URBAN HEALTH, V83, P162, DOI 10.1007/s11524-005-9016-3.
   Hartley DM, 2020, JAMA-J AM MED ASSOC, V323, P1908, DOI 10.1001/jama.2020.5910.
   Jewell NP, 2020, ANN INTERN MED, V173, P226, DOI 10.7326/M20-1565.
   Kasthurirathne Suranga N, 2019, AMIA Jt Summits Transl Sci Proc, V2019, P639.
   Khakharia A, 2020, SSRN J, DOI {[}10.2139/ssrn.3655759, DOI 10.2139/SSRN.3655759].
   Krawczyk B, 2016, PROG ARTIF INTELL, V5, P221, DOI 10.1007/s13748-016-0094-0.
   Li YX, 2020, SCI TOTAL ENVIRON, V748, DOI 10.1016/j.scitotenv.2020.141560.
   Lin QY, 2020, INT J INFECT DIS, V93, P211, DOI 10.1016/j.ijid.2020.02.058.
   Liu Q, 2020, LANCET GLOB HEALTH, V8, pE790, DOI 10.1016/S2214-109X(20)30204-7.
   Lutz CS, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7966-8.
   Maragakis L, CORONAVIRUS 2 WAVE W.
   Maxmen A, 2020, NATURE, V585, P13, DOI 10.1038/d41586-020-02478-z.
   McNeil D, NEW YORK TIMES.
   Ripley BD., 2001, MSOR Connections, V1, P23, DOI {[}10.11120/msor.2001.01010023, DOI 10.11120/MSOR.2001.01010023, 10.11120/MSOR.2001.01010023].
   Rubin R, 2020, JAMA-J AM MED ASSOC, V324, P326, DOI 10.1001/jama.2020.12646.
   Sáez C, 2021, J AM MED INFORM ASSN, V28, P360, DOI 10.1093/jamia/ocaa258.
   State Reporting Assessments, COVID TRACK PROJ COVID TRACK PROJ.
   Vandekerckhove J, 2015, Oxford handbook of computational and mathematical psychology, P300, DOI {[}10.1093/oxfordhb/9780199957996.013.14, DOI 10.1093/OXFORDHB/9780199957996.013.14].
   Verma M, 2018, HEALTHC INFORM RES, V24, P300.
   Weissman GE, 2020, ANN INTERN MED, V173, P21, DOI 10.7326/M20-1260.
   Yi-Ju Tseng, 2020, International Journal of Computers and Applications, V42, P616, DOI 10.1080/1206212X.2019.1633762.
   Yoshida N, 2007, J COMPUT APPL MATH, V201, P339, DOI 10.1016/j.cam.2005.12.034.},
Number-of-Cited-References = {44},
Times-Cited = {1},
Unique-ID = {WOS:000678771200008},
}

@article{ WOS:001155738800001,
Author = {Yoo, Jinho and Hur, Junguk and Yoo, Jintae and Jurivich, Donald and Lee,
   Kyung Ju},
Title = {A novel approach to quantifying individual\&apos;s biological aging
   using Korea's national health screening program toward precision public
   health},
Journal = {GEROSCIENCE},
Year = {2024},
Month = {2024 FEB 2},
Abstract = {Accurate prediction of biological age can inform public health measures
   to extend healthy lifespans and reduce chronic conditions. Multiple
   theoretical models and methods have been developed; however, their
   applicability and accuracy are still not extensive. Here, we report
   Differential Aging and Health Index (DAnHI), a novel measure of age
   deviation, developed using physical and serum biomarkers from four
   million individuals in Korea's National Health Screening Program.
   Participants were grouped into aging statuses (< 26 vs. >= 26, < 27 vs.
   >= 27, horizontal ellipsis , < 75 vs. >= 75 years) as response variables
   in a binary logistic regression model with thirteen biomarkers as
   independent variables. DAnHI for each individual was calculated as the
   weighted mean of their relative probabilities of being classified into
   each older age status, based on model ages ranging from 26 to 75. DAnHI
   in our large study population showed a steady increase with the increase
   in age and was positively associated with death after adjusting for
   chronological age. However, the effect size of DAnHI on the risk of
   death varied according to the age group and sex. The hazard ratio was
   highest in the 50-59-year age group and then decreased as the
   individuals aged. This study demonstrates that routine health check-up
   biomarkers can be integrated into a quantitative measure for predicting
   aging-related health status and death via appropriate statistical models
   and methodology. Our DAnHI-based results suggest that the same level of
   aging-related health status does not indicate the same degree of risk
   for death.},
Type = {Article; Early Access},
Affiliation = {Lee, KJ (Corresponding Author), Natl Rehabil Ctr, Dept Womens Rehabil, 58 Samgaksan Ro, Seoul 01022, South Korea.
   Lee, KJ (Corresponding Author), Korea Univ, Inst Occupat \& Environm Hlth, Seoul 02841, South Korea.
   Yoo, Jinho; Yoo, Jintae, YooJin BioSoft, 24 Jeongbalsan Ro, Goyang Si 10402, Guam Do, South Korea.
   Hur, Junguk, Univ North Dakota, Sch Med \& Hlth Sci, Dept Biomed Sci, Grand Forks, ND 58202 USA.
   Jurivich, Donald, Univ North Dakota, Sch Med \& Hlth Sci, Dept Geriatr, Grand Forks, ND 58202 USA.
   Lee, Kyung Ju, Natl Rehabil Ctr, Dept Womens Rehabil, 58 Samgaksan Ro, Seoul 01022, South Korea.
   Lee, Kyung Ju, Korea Univ, Inst Occupat \& Environm Hlth, Seoul 02841, South Korea.},
DOI = {10.1007/s11357-024-01079-2},
EarlyAccessDate = {FEB 2024},
Keywords = {Biological Aging; Differential Aging and Health Index; Mortality
   Prediction; Sex-Specific Aging},
Keywords-Plus = {AGE-DETERMINATIONS; SEX-DIFFERENCES; BIOMARKERS; GENDER; TESTS; MODEL},
Research-Areas = {Geriatrics \& Gerontology},
Web-of-Science-Categories  = {Geriatrics \& Gerontology},
Author-Email = {drlkj4094@korea.kr},
Affiliations = {University of North Dakota Grand Forks; University of North Dakota Grand
   Forks; Korea University},
Cited-References = {Alharbi BA, 2020, J FAM MED PRIM CARE, V9, P1684, DOI 10.4103/jfmpc.jfmpc\_1060\_19.
   {[}Anonymous], 2022, Noncommunicable diseases {[}Internet].
   Butler RN, 2004, J GERONTOL A-BIOL, V59, P560.
   Cao XQ, 2021, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.698851.
   Cleries R, 2009, PUBLIC HEALTH, V123, P156, DOI 10.1016/j.puhe.2008.10.026.
   Deelen J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11311-9.
   Desai M, 2010, J ROY SOC MED, V103, P283, DOI 10.1258/jrsm.2010.100126.
   DUBINA TL, 1984, EXP GERONTOL, V19, P133, DOI 10.1016/0531-5565(84)90016-0.
   DUBINA TL, 1983, EXP GERONTOL, V18, P5, DOI 10.1016/0531-5565(83)90046-3.
   Elliott ML, 2021, NATURE AGING, V1, P295, DOI 10.1038/s43587-021-00044-4.
   Engelfriet PM, 2013, EPIDEMIOL REV, V35, P132, DOI 10.1093/epirev/mxs011.
   Food D Administration and NIo Health, 2016, BEST (Biomarkers, Endpoints, and other tools) resource.
   Hägg S, 2021, ELIFE, V10, DOI 10.7554/eLife.63425.
   healthdata, The Global Burden of Disease: a critical resource for informed policymaking.
   HOCHSCHILD R, 1989, EXP GERONTOL, V24, P301, DOI 10.1016/0531-5565(89)90003-X.
   HOCHSCHILD R, 1989, EXP GERONTOL, V24, P289, DOI 10.1016/0531-5565(89)90002-8.
   Hochschild R, 1994, Practical Handbook of Human Biologic Age Determination, P93.
   HOLLINGSWORTH JW, 1965, YALE J BIOL MED, V38, P11.
   Hou YJ, 2019, NAT REV NEUROL, V15, P565, DOI 10.1038/s41582-019-0244-7.
   Hüllermeier E, 2021, MACH LEARN, V110, P457, DOI 10.1007/s10994-021-05946-3.
   Johnson TE, 2006, EXP GERONTOL, V41, P1243, DOI 10.1016/j.exger.2006.09.006.
   Khan SS, 2017, AGING CELL, V16, P624, DOI 10.1111/acel.12601.
   Klemera P, 2006, MECH AGEING DEV, V127, P240, DOI 10.1016/j.mad.2005.10.004.
   Kontis V, 2017, LANCET, V389, P1323, DOI 10.1016/S0140-6736(16)32381-9.
   Kroll J, 2000, BIOGERONTOLOGY, V1, P363, DOI 10.1023/A:1026594602252.
   Lara J, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0470-9.
   Lizcano F, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/757461.
   Maioli S, 2021, ESSAYS BIOCHEM, V65, P913, DOI 10.1042/EBC20200162.
   Mamoshina P, 2018, J GERONTOL A-BIOL, V73, P1482, DOI 10.1093/gerona/gly005.
   Mauvais-Jarvis F, 2015, BIOL SEX DIFFER, V6, DOI 10.1186/s13293-015-0033-y.
   Moqri M, 2023, CELL, V186, P3758, DOI 10.1016/j.cell.2023.08.003.
   Murray CJL, 2020, LANCET, V396, P1223, DOI {[}10.1016/S0140-6736(20)30752-2, 10.1016/S0140-6736(20)30925-9].
   Nakamura E, 1998, EXP GERONTOL, V33, P421, DOI 10.1016/S0531-5565(97)00134-4.
   Ohlsson C, 2015, J STEROID BIOCHEM, V145, P248, DOI 10.1016/j.jsbmb.2014.03.006.
   Pomatto LCD, 2017, J PHYSIOL-LONDON, V595, P7275, DOI 10.1113/JP275072.
   Pyrkov TV, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23534-9.
   Rahman SA, 2021, BRIEF BIOINFORM, V22, P1767, DOI 10.1093/bib/bbaa021.
   Regitz-Zagrosek V, 2007, GENDER MED, V4, pS162, DOI 10.1016/S1550-8579(07)80056-8.
   Sciomer S, 2020, EUR J PREV CARDIOL, V27, P46, DOI 10.1177/2047487320961980.
   TAKEDA H, 1982, MED INFORM, V7, P221, DOI 10.3109/14639238209010720.
   Thomas N, 2019, ADV EXP MED BIOL, V1178, P57, DOI 10.1007/978-3-030-25650-0\_4.
   Tian YE, 2023, NAT MED, V29, P1221, DOI 10.1038/s41591-023-02296-6.
   VOITENKO VP, 1983, EXP AGING RES, V9, P239, DOI 10.1080/03610738308258458.
   WEBSTER IW, 1976, J GERONTOL, V31, P546, DOI 10.1093/geronj/31.5.546.
   Yoo J, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-016-0407-y.},
Number-of-Cited-References = {45},
Times-Cited = {0},
Unique-ID = {WOS:001155738800001},
}

@article{ WOS:000751673300052,
Author = {Troncoso, Erica L.},
Title = {The Greatest Challenge to Using AI/ML for Primary Health Care: Mindset
   or Datasets?},
Journal = {FRONTIERS IN ARTIFICIAL INTELLIGENCE},
Year = {2020},
Volume = {3},
Abstract = {The global vision for primary health care (PHC) is defined by regular
   access to quality care for comprehensive services throughout the course
   of life. However, this is not what typically happens, especially in low-
   and middle-income countries, where many people access the formal health
   system only for emergent needs. Yet, even episodic care is nearly
   impossible to attain due to infrastructure barriers, critical shortages
   of health care providers, and low-quality care. Artificial intelligence
   and machine learning (AI/ML) can help us revolutionize the current
   reality of health care into the vision of continuous health care that
   promotes individuals to maintain a constant healthy state. AI/ML can
   deliver precise recommendations to the individual, transforming patients
   from a passive receiver of health services into an active participant of
   their own care. By accounting for each individual, AI/ML can also ensure
   equitable coverage for entire populations with an ongoing data exchange
   between personal health, genomic data, public health, and environmental
   factors. The greatest challenge to enlisting AI/ML in the quest toward
   the PHC vision will be instilling a sense of responsibility with global
   citizens to recognize health data for the global good while prioritizing
   protected, individually owned data sets. Only when individuals start
   taking a collective approach to health data, shifting the mindset toward
   the goal of prevention, will the potential of AI/ML for PHC be realized.
   Until we overcome this challenge, the paradigm shift of the global
   community away from our ad hoc, reactive health system culture will not
   be achieved.},
Type = {Article},
Affiliation = {Troncoso, EL (Corresponding Author), Johns Hopkins Univ, Tech Leadership \& Innovat, Jhpiego, Baltimore, MD 21218 USA.
   Troncoso, Erica L., Johns Hopkins Univ, Tech Leadership \& Innovat, Jhpiego, Baltimore, MD 21218 USA.},
DOI = {10.3389/frai.2020.00053},
Article-Number = {53},
Keywords = {artificial intelligence; machine learning; primary health care; low and
   middle income countries; health system; global health; health data;
   precision public health},
Research-Areas = {Computer Science},
Web-of-Science-Categories  = {Computer Science, Artificial Intelligence; Computer Science, Information
   Systems},
Author-Email = {erica.troncoso@jhpiego.org},
Affiliations = {Jhpiego; Johns Hopkins University},
Cited-References = {{[}Anonymous], 2019, LANCET DIGIT HEALTH, V1, pE319, DOI 10.1016/S2589-7500(19)30164-5.
   {[}Anonymous], 2019, ETH AL DES VIS PRIOR.
   Barocas S, 2016, CALIF LAW REV, V104, P671, DOI 10.15779/Z38BG31.
   Bitton A, 2017, J GEN INTERN MED, V32, P566, DOI 10.1007/s11606-016-3898-5.
   Cardona-Salazar L. J., 2019, WHO GUIDELINE RECOMM.
   Celi LA, 2019, LANCET DIGIT HEALTH, V1, pE255, DOI 10.1016/s2589-7500(19)30127-x.
   Coates D., 2019, DATA SCI MEDIUM PUBL.
   Dressel J, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aao5580.
   Druetz T, 2018, BMC MED ETHICS, V19, DOI 10.1186/s12910-018-0288-z.
   Flahault A, 2020, LANCET DIGIT HEALTH, V2, pE58, DOI 10.1016/S2589-7500(19)30240-7.
   Floridi L, 2018, MIND MACH, V28, P689, DOI 10.1007/s11023-018-9482-5.
   Frenk J, 2009, LANCET, V374, P170, DOI 10.1016/S0140-6736(09)60693-0.
   Hosny A, 2019, SCIENCE, V366, P955, DOI 10.1126/science.aay5189.
   Khoury MJ, 2016, AM J PREV MED, V50, P398, DOI 10.1016/j.amepre.2015.08.031.
   Mackey TK, 2017, EXPERT OPIN DRUG SAF, V16, P587, DOI 10.1080/14740338.2017.1313227.
   O'Neil C, 2016, Weapons of math destruction.
   Özdemir V, 2018, OMICS, V22, P184, DOI 10.1089/omi.2018.0002.
   Ribeiro MT, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1135, DOI 10.1145/2939672.2939778.
   Stauffer JM, 2005, J APPL PSYCHOL, V90, P586, DOI 10.1037/0021-9010.90.3.586.
   Truong T, 2019, STUD HEALTH TECHNOL, V264, P1993, DOI 10.3233/SHTI190751.
   U.S. Agency for International Development (USAID), 2019, ARTIF INTELL.
   U.S. Agency for International Development (USAID), 2018, REFL SHAP FUT MAK AI.
   UN Secretary-General's Independent Expert Advisory Group, 2014, WORLD COUNTS MOB DAT.
   Wiegand T, 2019, LANCET, V394, P9, DOI 10.1016/S0140-6736(19)30762-7.
   World Health Organization, 2019, GLOB STRAT DIG HLTH.
   World Health Organization and the United Nations Children's Fund (UNICEF), 2018, VIS PRIM HLTH CAR 21.
   World Health Organization and UNICEF, 2018, PRIM HLTH CAR TRANSF.},
Number-of-Cited-References = {27},
Times-Cited = {2},
Unique-ID = {WOS:000751673300052},
}

@article{ WOS:001060427200001,
Author = {Ribot-Rodriguez, R. and Higuera-Gomez, A. and San-Cristobal, R. and
   Mico, V. and Martinez, J. A.},
Title = {Comparison of Seven Healthy Lifestyle Scores Cardiometabolic Health:
   Age, Sex, and Lifestyle Interactions in the NutrIMDEA Web-Based Study},
Journal = {JOURNAL OF EPIDEMIOLOGY AND GLOBAL HEALTH},
Year = {2023},
Volume = {13},
Number = {4},
Pages = {653-663},
Month = {DEC},
Abstract = {BackgroundGlobal health status concerns both the assessment of wellbeing
   as well as the associated individualized determinants including quality
   of life and lifestyle factors. This study aimed to evaluate seven
   cardiometabolic health related scores and the influence, as well as
   interactions of lifestyle, heart-related and health-related quality of
   life (HRQoL) factors in order to inform the future implementation of
   precision public health (PPH).MethodsData collected from 17,333
   participants who were enrolled of the NutrIMDEA study. The data
   collection period was between May 2020 and November 2020 through an
   online survey. The baseline questionnaire collected information on
   socio-demographic data, cardiometabolic history, anthropometric
   variables and lifestyle aspects. Also, physical and mental component
   scores of SF12 Health Survey (PCS12/MCS12) were assessed as HRQoL
   features, which were applied to estimated seven scores (LS7, HLS,
   20-years DRS \%, FBS, CLI, WAI derived, LWB-I).ResultsMost indices
   (except FBS, CLI, 20-years DRS \% and WAI derived) showed that
   cardiometabolic outcomes and HRQoL measures were dependent on
   interactions by age and sex. The largest ponderal effect was found in PA
   total and Mediterranean Diet Score (MEDAS-14) interaction using LS7 as
   reference. However, using LWB-I as standard, the greatest effect was
   found in the quality-of-life feature MCS12. Noteworthy, LS7 showed good
   discrimination against PCS12, while LWB-I demonstrated excellent
   discrimination to MCS12.ConclusionsA major finding was the interplay
   between MEDAS-14 and PA on the LS7 scale as well as major effects of
   lifestyle factors and MCS12/PCS12 among scores, which need to be
   accounted with precision when implementing cardiometabolic screenings
   with PPH purposes.},
Type = {Article},
Affiliation = {San-Cristobal, R (Corresponding Author), Campus Int Excellence CEI UAMCS, IMDEA Food Inst, Madrid Inst Adv Studies, Precis Nutr \& Cardiometab Hlth, Madrid 28049, Spain.
   San-Cristobal, R (Corresponding Author), Univ Laval, Inst Nutr Aliments Fonct Univ Laval INAF, Ctr Nutr St \& Soc NUTRISS, Quebec City, PQ, Canada.
   San-Cristobal, R (Corresponding Author), Univ Laval, Sch Nutr, Quebec City, PQ G1V 0A6, Canada.
   Ribot-Rodriguez, R.; Higuera-Gomez, A.; San-Cristobal, R.; Mico, V.; Martinez, J. A., Campus Int Excellence CEI UAMCS, IMDEA Food Inst, Madrid Inst Adv Studies, Precis Nutr \& Cardiometab Hlth, Madrid 28049, Spain.
   San-Cristobal, R., Univ Laval, Inst Nutr Aliments Fonct Univ Laval INAF, Ctr Nutr St \& Soc NUTRISS, Quebec City, PQ, Canada.
   San-Cristobal, R., Univ Laval, Sch Nutr, Quebec City, PQ G1V 0A6, Canada.
   Martinez, J. A., Inst Hlth Carlos III ISCIII, CIBERobn Physiopathol Obes \& Nutr, Madrid 28029, Spain.},
DOI = {10.1007/s44197-023-00140-1},
EarlyAccessDate = {AUG 2023},
Keywords = {Public health; Precision nutrition; Health-related quality of life;
   Physical health; Mental health},
Keywords-Plus = {IDEAL CARDIOVASCULAR HEALTH; RISK-FACTORS; MORTALITY; DISEASES; WOMEN;
   ASSOCIATION; COUNTRIES; MEN},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {rodrigo.san-cristobal-blanco.1@ulaval.ca},
Affiliations = {IMDEA Food Institute; Laval University; Laval University; CIBER - Centro
   de Investigacion Biomedica en Red; CIBEROBN},
Cited-References = {Al-Awadhi B, 2021, FRONT NUTR, V7, DOI 10.3389/fnut.2020.570531.
   Alcocer LA., 2011, CIR CIR, V79, P7.
   Ardisson Korat Andres V, 2014, Curr Nutr Rep, V3, P345.
   Arnett DK, 2019, CIRCULATION, V140, pE563, DOI {[}10.1161/CIR.0000000000000677, 10.1161/CIR.0000000000000678, 10.1016/j.jacc.2019.03.010, 10.1016/j.jacc.2019.03.009].
   Atallah N, 2018, NUTRIENTS, V10, DOI 10.3390/nu10070854.
   Badia A, 2007, MEDIDA SALUD GUIA ES.
   Barbaresko J, 2018, AM J PREV MED, V55, P555, DOI 10.1016/j.amepre.2018.04.046.
   Barrubés L, 2020, J CLIN MED, V9, DOI 10.3390/jcm9041215.
   Bilkey GA, 2019, FRONT PUBLIC HEALTH, V7, DOI 10.3389/fpubh.2019.00042.
   Canfell OJ, 2022, FRONT PUBLIC HEALTH, V10, DOI 10.3389/fpubh.2022.854525.
   Cao N, 2022, J EPIDEMIOL GLOB HEA, V12, P133, DOI 10.1007/s44197-021-00028-y.
   Carlsson AC, 2013, INT J CARDIOL, V168, P946, DOI 10.1016/j.ijcard.2012.10.045.
   Cheng X, 2022, FRONT PUBLIC HEALTH, V10, DOI 10.3389/fpubh.2022.779789.
   Cho IH, 2010, MECH AGEING DEV, V131, P69, DOI 10.1016/j.mad.2009.12.001.
   Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB.
   de Cuevillas B, 2019, NUTR HOSP, V36, P862, DOI 10.20960/nh.02532.
   Díaz-Gutiérrez J, 2018, REV ESP CARDIOL, V71, P1001, DOI {[}10.1016/j.recesp.2017.09.026, 10.1016/j.rec.2017.10.038].
   Díez-Espino J, 2020, REV ESP CARDIOL, V73, P204, DOI 10.1016/j.rec.2019.05.010.
   Dolley S, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00068.
   Fernández-Alvira JM, 2017, J AM COLL CARDIOL, V70, P2463, DOI 10.1016/j.jacc.2017.09.032.
   Ford ES, 2012, CIRCULATION, V125, P987, DOI 10.1161/CIRCULATIONAHA.111.049122.
   Foster H, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-042212.
   Fukunaga A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0226773.
   Gandek B, 1998, J CLIN EPIDEMIOL, V51, P1171, DOI 10.1016/S0895-4356(98)00109-7.
   García-Conesa MT, 2020, NUTRIENTS, V12, DOI 10.3390/nu12102960.
   Garralda-Del-Villar M, 2019, NUTRIENTS, V11, DOI 10.3390/nu11010065.
   Hardman RJ, 2016, FRONT NUTR, V3, DOI 10.3389/fnut.2016.00022.
   Hart P., 2017, AM J CARDIOVASC DIS, V5, P1.
   Harvey C, 2020, PUBLIC HEALTH, V185, P368, DOI 10.1016/j.puhe.2020.06.013.
   Hasbani NR, 2022, CIRCULATION, V145, P808, DOI 10.1161/CIRCULATIONAHA.121.053730.
   Jankovic J, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0255959.
   Jradi H, 2018, J EPIDEMIOL GLOB HEA, V8, P183, DOI 10.2991/j.jegh.2018.04.100.
   Knoops KTB, 2004, JAMA-J AM MED ASSOC, V292, P1433, DOI 10.1001/jama.292.12.1433.
   Lacombe J, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7030-8.
   Laddu D, 2019, PROG CARDIOVASC DIS, V62, P9, DOI 10.1016/j.pcad.2018.12.004.
   Lenz Thomas L, 2013, ISRN Prev Med, V2013, P481030, DOI 10.5402/2013/481030.
   Livingstone KM, 2016, AM J CLIN NUTR, V104, P288, DOI 10.3945/ajcn.115.129049.
   López-Laguna N, 2018, ATHEROSCLEROSIS, V275, P133, DOI 10.1016/j.atherosclerosis.2018.05.049.
   Mancuso JM, 2009, NURS HEALTH SCI, V11, P77, DOI 10.1111/j.1442-2018.2008.00408.x.
   Marcos-Delgado A, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18030887.
   Martínez-Urbistondo D, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18189590.
   Micó V, 2022, FRONT ENDOCRINOL, V13, DOI 10.3389/fendo.2022.936956.
   Mitra DK, 2018, J EPIDEMIOL GLOB HEA, V8, P134, DOI 10.2991/j.jegh.2018.03.002.
   Mohammadi M, 2017, DIABETES METAB SYND, V11, pS745, DOI 10.1016/j.dsx.2017.05.009.
   Navas-Carretero S, 2021, LIFESTYLE GENOM, V14, P63, DOI 10.1159/000515068.
   Pano O, 2022, HEALTHCARE-BASEL, V10, DOI 10.3390/healthcare10061088.
   Petersen KEN, 2015, BRIT J NUTR, V113, P849, DOI 10.1017/S0007114515000070.
   Pilkerton CS, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001650.
   Rabel M, 2019, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00387.
   Ribot-Rodriguez R, 2022, INT J ENV RES PUB HE, V19, DOI 10.3390/ijerph19052948.
   Roth GA, 2020, J AM COLL CARDIOL, V76, P2980, DOI 10.1016/j.jacc.2020.11.021.
   Salim Yusuf Salim Yusuf, 2004, Lancet (British edition), V364, P937, DOI 10.1016/S0140-6736(04)17018-9.
   San-Cristobal R, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0624-6.
   Sember V, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17197161.
   Sotos-Prieto M, 2018, J AM HEART ASSOC, V7, DOI {[}10.1161/JAHA.118.010052, 10.1161/jaha.118.010052].
   Sotos-Prieto M, 2016, CIRC-CARDIOVASC QUAL, V9, pS77, DOI 10.1161/CIRCOUTCOMES.115.002372.
   Tamaoki M, 2022, J EPIDEMIOL GLOB HEA, V12, P224, DOI 10.1007/s44197-022-00053-5.
   Tsai M-C., 2021, RESEARCHSQUARE, DOI {[}10.21203/rs.3.rs-144452/v1, DOI 10.21203/RS.3.RS-144452/V1].
   Tsai MC, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-01213-6.
   Vilagut G, 2008, MED CLIN-BARCELONA, V130, P726, DOI 10.1157/13121076.
   Virani SS, 2021, CIRCULATION, V143, pe254, DOI 10.1161/CIR.0000000000000950.
   WALKER SN, 1987, NURS RES, V36, P76.
   Wang HY, 2020, EUR J PREV CARDIOL, V27, P2292, DOI 10.1177/2047487319891781.
   Wang VHC, 2022, PUBLIC HEALTH NUTR, V25, P464, DOI 10.1017/S1368980021004158.
   Wu SL, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.4758.
   Xu SW, 2021, PHARMACOL REV, V73, P924, DOI 10.1124/pharmrev.120.000096.
   Zhang MR, 2021, FRONT PUBLIC HEALTH, V9, DOI 10.3389/fpubh.2021.713480.},
Number-of-Cited-References = {67},
Times-Cited = {0},
Unique-ID = {WOS:001060427200001},
}

@article{ WOS:001031936500001,
Author = {Olusanya, Olufunto A. and Ammar, Nariman and Davis, Robert L. and
   Bednarczyk, Robert A. and Shaban-Nejad, Arash},
Title = {A Digital Personal Health Library for Enabling Precision Health
   Promotion to Prevent Human Papilloma Virus-Associated Cancers},
Journal = {FRONTIERS IN DIGITAL HEALTH},
Year = {2021},
Volume = {3},
Month = {JUL 21},
Abstract = {Human papillomavirus (HPV) causes the most prevalent sexually
   transmitted infection (STI) in the United States. Sexually active young
   adults are susceptible to HPV, accounting for approximately 50\% of new
   STIs. Oncogenic HPV subtypes 16 and 18 are associated with squamous
   intraepithelial lesions and cancers and are mostly preventable through
   prophylactic HPV vaccination. Accordingly, this study's objectives are
   to (1) summarize SDoH barriers and implication for low HPV vaccination
   rates among young adults (18-26 years), (2) propose a digital health
   solution that utilizes the PHL to collect, integrate, and manage
   personalized sexual and health information, and (3) describe the
   features of the PHL-based app. Through the application of novel
   techniques from artificial intelligence, specifically knowledge
   representation, semantic web, and natural language processing, this
   proposed PHL-based application will compile clinical, biomedical, and
   SDoH data from multi-dimensional sources. Therefore, this application
   will provide digital health interventions that are customized to
   individuals' specific needs and capacities. The PHL-based application
   could promote management and usage of personalized digital health
   information to facilitate precision health promotion thereby, informing
   health decision-making regarding HPV vaccinations, routine HPV/STI
   testing, cancer screenings, vaccine safety/efficacy/side effects, and
   safe sexual practices. In addition to detecting vaccine hesitancy,
   disparities and perceived barriers, this application could address
   participants' specific needs/challenges with navigating health literacy,
   technical skills, peer influence, education, language, cultural and
   spiritual beliefs. Precision health promotion focused on improving
   knowledge acquisition and information-seeking behaviors, promoting safe
   sexual practices, increasing HPV vaccinations, and facilitating cancer
   screenings could be effective in preventing HPV-associated cancers.},
Type = {Article},
Affiliation = {Olusanya, OA; Shaban-Nejad, A (Corresponding Author), Univ Tennessee, Coll Med, UTHSC Oak Ridge Natl Lab ORNL, Dept Pediat,Ctr Biomed Informat,Hlth Sci Ctr, Memphis, TN 38163 USA.
   Olusanya, Olufunto A.; Ammar, Nariman; Davis, Robert L.; Shaban-Nejad, Arash, Univ Tennessee, Coll Med, UTHSC Oak Ridge Natl Lab ORNL, Dept Pediat,Ctr Biomed Informat,Hlth Sci Ctr, Memphis, TN 38163 USA.
   Bednarczyk, Robert A., Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA USA.},
DOI = {10.3389/fdgth.2021.683161},
Article-Number = {683161},
Keywords = {precision public health; health promotion; human papillomavirus;
   vaccine; screening; cancer prevention; personal health library},
Keywords-Plus = {HPV; VACCINATION; ADOLESCENTS; BELIEFS},
Research-Areas = {Health Care Sciences \& Services; Medical Informatics},
Web-of-Science-Categories  = {Health Care Sciences \& Services; Medical Informatics},
Author-Email = {oolusan1@uthsc.edu
   ashabann@uthsc.edu},
Affiliations = {University of Tennessee System; University of Tennessee Health Science
   Center; Emory University; Rollins School Public Health},
Cited-References = {Allen-Leigh B, 2020, HUM VACC IMMUNOTHER, V16, P981, DOI 10.1080/21645515.2019.1675456.
   Ammar N, 2020, EXPLAINABLE AI HEALT, P221.
   Ammar Nariman, 2021, JMIR Form Res, V5, pe24738, DOI 10.2196/24738.
   Ammar N, 2020, STUD HEALTH TECHNOL, V270, P448, DOI 10.3233/SHTI200200.
   {[}Anonymous], 2014, Social determinants of health.
   Balcezak HC, 2022, J AM COLL HEALTH, V70, P2535, DOI 10.1080/07448481.2021.1873350.
   Barnard M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182266.
   Centers for Disease Control and Prevention, 2020, CANC ASS HUM PAP US.
   Centers for Disease Control and Prevention, 2021, SEXUALLY TRANSMITTED, DOI DOI 10.15620/CDC.79370.
   Dixon BE, 2019, PEDIATRICS, V143, DOI 10.1542/peds.2018-1457.
   Halkitis PN, 2019, AIDS PATIENT CARE ST, V33, P149, DOI 10.1089/apc.2018.0276.
   Han JJ, 2017, JAMA ONCOL, V3, P810, DOI 10.1001/jamaoncol.2016.6192.
   Johnson-Mallard V, 2019, BIORESEARCH OPEN ACC, V8, P84, DOI 10.1089/biores.2018.0051.
   McBride KR, 2018, HEALTH EDUC BEHAV, V45, P68, DOI 10.1177/1090198117709318.
   Mehmood A, 2016, IEEE ACCESS, V4, P1821, DOI 10.1109/ACCESS.2016.2558446.
   Mehta P, 2013, INT Q COMMUNITY HEAL, V33, P175, DOI 10.2190/IQ.33.2.f.
   Meites E, 2016, MMWR-MORBID MORTAL W, V65, P1405, DOI 10.15585/mmwr.mm6549a5.
   Olusanya OO, 2020, PREV MED, V134, DOI 10.1016/j.ypmed.2020.106023.
   Pitts MJ, 2017, HEALTH COMMUN, V32, P995, DOI 10.1080/10410236.2016.1196421.
   Preston SM, 2019, AM J MENS HEALTH, V13, DOI 10.1177/1557988319883776.
   Remis RS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158090.
   Scherer AM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193363.
   Seshadri DR, 2020, FRONT DIGIT HEALTH, V2, DOI 10.3389/fdgth.2020.00008.
   Shaban-Nejad A., INT WORKSH HLTH INT, P1, DOI {[}10.1007/978-3-030-24409-5\_1, DOI 10.1007/978-3-030-24409-5\_1].
   Shaban-Nejad A., EXPLAINABILITY INTER, P1, DOI {[}10.1007/978-3-030-53352-6\_1, DOI 10.1007/978-3-030-53352-6\_1].
   Shannon CL, 2018, CURR OPIN PEDIATR, V30, P137, DOI 10.1097/MOP.0000000000000578.
   Shannon CL, 2019, JMIR RES PROTOC, V8, DOI 10.2196/10795.
   Singer D, 2016, CANC MOONSHOT BLUE R.
   Sledge JA, 2015, J COMMUN HEALTH, V40, P834, DOI 10.1007/s10900-015-0007-3.
   Stephens DP, 2016, AM J SEX EDUC, V11, P267, DOI 10.1080/15546128.2016.1198733.
   Terry PE, 2020, AM J HEALTH PROMOT, V34, P235, DOI 10.1177/0890117120903129.
   Viens LJ, 2016, MMWR-MORBID MORTAL W, V65, P661, DOI 10.15585/mmwr.mm6526a1.
   Workowski KA, 2015, MMWR RECOMM REP, V64, P1.},
Number-of-Cited-References = {33},
Times-Cited = {5},
Unique-ID = {WOS:001031936500001},
}

@article{ WOS:000887296600001,
Author = {Canfell, Oliver J. and Davidson, Kamila and Sullivan, Clair and Eakin,
   Elizabeth E. and Burton-Jones, Andrew},
Title = {PREVIDE: A Qualitative Study to Develop a Decision-Making Framework
   (PREVention decIDE) for Noncommunicable Disease Prevention in Healthcare
   Organisations},
Journal = {INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH},
Year = {2022},
Volume = {19},
Number = {22},
Month = {NOV},
Abstract = {Noncommunicable diseases (NCDs), including obesity, remain a significant
   global public health challenge. Prevention and public health innovation
   are needed to effectively address NCDs; however, understanding of how
   healthcare organisations make prevention decisions is immature. This
   study aimed to (1) explore how healthcare organisations make decisions
   for NCD prevention in Queensland, Australia (2) develop a contemporary
   decision-making framework to guide NCD prevention in healthcare
   organisations. Cross-sectional and qualitative design, comprising
   individual semi-structured interviews. Participants (n = 14) were
   recruited from two organisations: the state public health care system
   (CareQ) and health promotion/disease prevention agency (PrevQ).
   Participants held executive, director/manager or project/clinical lead
   roles. Data were analysed in two phases (1) automated content analysis
   using machine learning (Leximancer v4.5) (2) researcher-led
   interpretation of the text analytics. Final themes were consolidated
   into a proposed decision-making framework (PREVIDE, PREvention decIDE)
   for NCD prevention in healthcare organisations. Decision-making was
   driven by four themes: Data, Evidence, Ethics and Health, i.e., data,
   its quality and the story it tells; traditional and non-traditional
   sources of evidence; ethical grounding in fairness and equity; and
   long-term value generated across multiple determinants of health. The
   strength of evidence was directly proportional to confidence in the
   ethics of a decision. PREVIDE can be adapted by public health
   practitioners and policymakers to guide real-world policy, practice and
   investment decisions for obesity prevention and with further validation,
   other NCDs and priority settings (e.g., healthcare).},
Type = {Article},
Affiliation = {Canfell, OJ (Corresponding Author), Univ Queensland, Fac Business Econ \& Law, UQ Business Sch, St Lucia, Qld 4072, Australia.
   Canfell, OJ (Corresponding Author), Univ Queensland, Fac Med, Ctr Hlth Serv Res, St Lucia, Qld 4072, Australia.
   Canfell, OJ (Corresponding Author), Univ Queensland, Fac Med, Queensland Digital Hlth Ctr, Herston, Qld 4006, Australia.
   Canfell, OJ (Corresponding Author), Australian Govt, Digital Hlth Cooperat Res Ctr, Sydney, NSW 2000, Australia.
   Canfell, Oliver J.; Davidson, Kamila; Burton-Jones, Andrew, Univ Queensland, Fac Business Econ \& Law, UQ Business Sch, St Lucia, Qld 4072, Australia.
   Canfell, Oliver J.; Sullivan, Clair, Univ Queensland, Fac Med, Ctr Hlth Serv Res, St Lucia, Qld 4072, Australia.
   Canfell, Oliver J.; Sullivan, Clair, Univ Queensland, Fac Med, Queensland Digital Hlth Ctr, Herston, Qld 4006, Australia.
   Canfell, Oliver J., Australian Govt, Digital Hlth Cooperat Res Ctr, Sydney, NSW 2000, Australia.
   Sullivan, Clair, Queensland Govt, Dept Hlth, Metro North Hosp \& Hlth Serv, Herston, Qld 4072, Australia.
   Eakin, Elizabeth E., Univ Queensland, Fac Med, Sch Publ Hlth, Herston, Qld 4072, Australia.},
DOI = {10.3390/ijerph192215285},
Article-Number = {15285},
Keywords = {decision-making; preventive medicine; public health; precision public
   health; public health informatics; health policy; noncommunicable
   diseases; obesity},
Keywords-Plus = {PUBLIC-HEALTH; ETHICS},
Research-Areas = {Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health},
Web-of-Science-Categories  = {Environmental Sciences; Public, Environmental \& Occupational Health},
Author-Email = {o.canfell@uq.edu.au},
Affiliations = {University of Queensland; University of Queensland; University of
   Queensland; Digital Health Cooperative Research Centre (DHCRC);
   Queensland Health; University of Queensland},
Cited-References = {Australian Institute of Health and Welfare, 2021, AUSTR BURD DIS STUD.
   Bray GA, 2017, OBES REV, V18, P715, DOI 10.1111/obr.12551.
   Brownson R C, 1999, J Public Health Manag Pract, V5, P86.
   Budd J, 2020, NAT MED, V26, P1183, DOI 10.1038/s41591-020-1011-4.
   Campos PA, 2019, HEALTH SYST REFORM, V5, P224, DOI 10.1080/23288604.2019.1625251.
   Canfell OJ, 2022, FRONT PUBLIC HEALTH, V10, DOI 10.3389/fpubh.2022.854525.
   Canfell OJ, 2022, BMC PUBLIC HEALTH, V22, DOI 10.1186/s12889-022-12939-x.
   Canfell OJ, 2022, AUST HEALTH REV, V46, P279, DOI 10.1071/AH21063.
   Carter SM, 2011, AM J PUBLIC HEALTH, V101, P465, DOI 10.2105/AJPH.2010.195545.
   Commonwealth of Australia, 2022, NAT OB STRAT 2022 20.
   Dolley S, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00068.
   Friesen VM, 2022, CURR DEV NUTR, V6, DOI 10.1093/cdn/nzac010.
   Haynes E, 2019, INT J BEHAV NUTR PHY, V16, DOI 10.1186/s12966-019-0904-4.
   Haynes E, 2019, RES SYNTH METHODS, V10, P452, DOI 10.1002/jrsm.1361.
   Jenicek M, 1997, J Epidemiol, V7, P187.
   Kaplan RM, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-85.
   Kohatsu ND, 2004, AM J PREV MED, V27, P417, DOI 10.1016/j.amepre.2004.07.019.
   Leximancer Pty Ltd, 2021, Leximancer User Guide: Release 4.5..
   Mattison G, 2022, J MED INTERNET RES, V24, DOI 10.2196/36690.
   Maxwell J., 2009, The SAGE handbook of applied social research methods, V2nd, P214.
   Moberg J, 2018, HEALTH RES POLICY SY, V16, DOI 10.1186/s12961-018-0320-2.
   Murray CJL, 2020, LANCET PUBLIC HEALTH, V5, pE469, DOI 10.1016/S2468-2667(20)30187-0.
   Norris SL, 2021, ENVIRON HEALTH-GLOB, V20, DOI 10.1186/s12940-021-00794-z.
   Nundy S, 2022, JAMA-J AM MED ASSOC, V327, P521, DOI 10.1001/jama.2021.25181.
   Odone A, 2019, EUR J PUBLIC HEALTH, V29, P28, DOI 10.1093/eurpub/ckz161.
   Owen L, 2012, J PUBLIC HEALTH-UK, V34, P37, DOI 10.1093/pubmed/fdr075.
   Sullivan C, 2021, APPL CLIN INFORM, V12, P229, DOI 10.1055/s-0041-1725186.
   Tannahill A, 2008, HEALTH PROMOT INT, V23, P380, DOI 10.1093/heapro/dan032.
   Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042.
   Vasileiou K, 2018, BMC MED RES METHODOL, V18, DOI 10.1186/s12874-018-0594-7.
   WHO, FACT SHEET NONC DIS.
   Wong BLH, 2022, LANCET REG HEALTH-EU, V14, DOI 10.1016/j.lanepe.2022.100316.
   World Health Organization, 2013, Global action plan for the prevention and control of noncommunicable diseases 2013-2020.},
Number-of-Cited-References = {33},
Times-Cited = {0},
Unique-ID = {WOS:000887296600001},
}

@article{ WOS:000975067300002,
Author = {Allison-Burbank, Joshuaa D. and Reid, Traci},
Title = {Prioritizing Connectedness and Equity in Speech-Language Services for
   American Indian and Alaska Native Children},
Journal = {LANGUAGE SPEECH AND HEARING SERVICES IN SCHOOLS},
Year = {2023},
Volume = {54},
Number = {2},
Pages = {368-374},
Month = {APR},
Abstract = {Purpose: American Indian and Alaska Native (AI/AN; Indigenous) students
   are at a high risk for language and learning disorders. This article
   aims to highlight how clinicians can use decolonization and
   Indigenization pedagogies when planning and delivering speech-language
   services to Indigenous students from the perspectives of Indigenous
   professionals. These efforts can help promote student resilience,
   well-being, and identity and are critical to addressing educational
   inequity and provide culturally responsive services to Indigenous
   children. Many AI/AN students receive IDEA Part B special education
   services including speech and language therapy. Many of these students
   are misidentified as needing special education due to unique learning
   and language environments (Soto-Boykin et al., 2021). These students
   bring a unique cultural heritage that is vital to their identity,
   well-being, health, and school success. Therefore, the goal should be to
   provide evidence-based services that are culturally tailored and meet
   the whole child. Using a precision public health approach to consider
   social determinants of health and historical trauma allows for
   leveraging of a multilayered, trauma-informed approach to addressing
   educational inequities. Conclusions: An Indigenous connectedness
   framework can be used to indicate how connectedness is essential to
   AI/AN child well-being. This framework can be interlaced with existing
   learning theories to shape instruction where indigenization is a
   cornerstone of learning. Further examined was the influence of
   historical trauma, racism, socioeconomic status, and culture loss on
   learning and language development in AI/AN children in the context of
   settler colonialism. Strategies on how to use Indigenous knowledge and
   evidence-based teaching practices were applied to therapeutic services
   offered by speech-language pathologists and educators.},
Type = {Article},
Affiliation = {Allison-Burbank, JD (Corresponding Author), Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Indigenous Hlth, Dept Int Hlth, Baltimore, MD 21205 USA.
   Allison-Burbank, Joshuaa D., Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Indigenous Hlth, Dept Int Hlth, Baltimore, MD 21205 USA.
   Reid, Traci, No Arizona Univ, Dept Commun Sci \& Disorders, Flagstaff, AZ USA.},
DOI = {10.1044/2022\_LSHSS-22-00101},
Keywords-Plus = {HISTORICAL TRAUMA; INTERVENTION; CHILDHOOD},
Research-Areas = {Audiology \& Speech-Language Pathology; Linguistics; Rehabilitation},
Web-of-Science-Categories  = {Audiology \& Speech-Language Pathology; Linguistics; Rehabilitation},
Author-Email = {jalliso8@jhu.edu},
Affiliations = {Johns Hopkins University; Johns Hopkins Bloomberg School of Public
   Health; Northern Arizona University},
Cited-References = {ACHENBACH TM, 1993, PEDIATRICS, V91, P45.
   Adams D.W., 1997, Education for extinction: American-Indians and the boarding school experience 1875-1928.
   Aikens N., 2017, 2017100 OPRE US DEP.
   Allison-Burbank J.D., 2020, Handbook of Fathers and Child Development, P521, DOI {[}DOI 10.1007/978-3-030-51027-5\_31, 10.1007/978-3-030-51027-5, DOI 10.1007/978-3-030-51027-5].
   {[}Anonymous], 2008, AM INDIAN ALASKA NAT.
   Bandura A, 2001, ANNU REV PSYCHOL, V52, P1, DOI 10.1146/annurev.psych.52.1.1.
   Bandura A., 1963, SOCIAL LEARNING PERS.
   Barker A.J., 2012, J COLONIALISM COLONI, V13.
   Barlow A, 2015, AM J PSYCHIAT, V172, P154, DOI 10.1176/appi.ajp.2014.14030332.
   Barofsky M. Y., 2018, PORTRAIT AM INDIAN A.
   Barofsky M. Y., 2018, 201871 OPRE US DEP H.
   BigFoot D.S., 2007, Focal Point, V21, P19.
   Blakemore S, 2004, WALT WHITMAN Q REV, V22, P108, DOI 10.13008/2153-3695.1758.
   Blume A.K., 2019, Handbook of Children and Prejudice, P389, DOI DOI 10.1007/978-3-030-12228-7\_22.
   Brave Heart M. Y. H., 2000, WAIMH HDB INFANT MEN, P153.
   Bulow E. L., 1982, NAVAJO TABOOS.
   Calderon D, 2014, ENVIRON EDUC RES, V20, P24, DOI 10.1080/13504622.2013.865114.
   Castagno AE, 2008, REV EDUC RES, V78, P941, DOI 10.3102/0034654308323036.
   Cesario S K, 2001, J Obstet Gynecol Neonatal Nurs, V30, P13, DOI 10.1177/088421701129003824.
   Collier C., 2011, SEPARATING DIFFERENC, V5, DOI {[}10.4135/9781452219424, DOI 10.4135/9781452219424].
   Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523.
   Demmert W.G., 2011, Honoring Our Heritage: Culturally Appropriate Approaches to Indigenous Education, P1.
   Demmert W.G., 2003, REV RES LIT INFLUENC.
   Elder A., 2018, Northwestern Journal of Law Social Policy, V13, P417.
   Evans-Campbell T, 2008, J INTERPERS VIOLENCE, V23, P316, DOI 10.1177/0886260507312290.
   Faircloth S., 2015, J AM INDIAN EDUC, P99, DOI DOI 10.5749/JAMERINDIEDUC.54.1.0099.
   Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8.
   Galán CA, 2017, J ABNORM CHILD PSYCH, V45, P935, DOI 10.1007/s10802-016-0209-x.
   Gone JP, 2013, TRANSCULT PSYCHIATRY, V50, P683, DOI 10.1177/1363461513487669.
   Heart MYHB, 2011, J PSYCHOACTIVE DRUGS, V43, P282, DOI 10.1080/02791072.2011.628913.
   Heart MYHB, 1998, AM INDIAN ALASKA NAT, V8, P56.
   Hossain Z., 1999, Early Child Development and Care, V154, P63, DOI DOI 10.1080/0030443991540106.
   Indian Health Service, 2002, TRENDS IND HLTH 1998.
   Kimmerer Robin Wall., 2013, Braiding Sweetgrass: Indigenous Wisdom, Scientific Knowledge, and the Teachings of Plants p, P408.
   Kulis SS, 2016, PREV SCI, V17, P721, DOI 10.1007/s11121-016-0657-0.
   LaFromboise T.D., 2011, Child psychology and mental health: Cultural and ethno-racialperspectives, P309.
   Mackety D. M., 2008, 059 REL US DEP ED I.
   Marr CarolynJ., Assimilation Through Education: Indian Boarding Schools in the Pacific Northwest.
   Michno Gregory., 2005, Encyclopedia of Indian Wars: Western Battles and Skirmishes, 1850-1890.
   Miller N.E., 1941, SOCIAL LEARNING IMIT.
   Milligan B C, 1984, Am Indian Q, V8, P83, DOI 10.2307/1184206.
   Newcomb T. C., 2001, THESIS OKLAHOMA STAT.
   Perdue T., 1995, CHEROKEE REMOVAL BRI, P116.
   Rutter M., 1979, Prevention of psychopathology: Vol. 3. Social competence in children, V3, P49, DOI DOI 10.1196/ANNALS.1376.002.
   SAMEROFF A, 1987, SCHIZOPHRENIA BULL, V13, P383, DOI 10.1093/schbul/13.3.383.
   Soto-Boykin XT, 2021, TOP EARLY CHILD SPEC, V41, P18, DOI 10.1177/0271121421991222.
   Styres S., 2013, CAN J EDUC, V36, P34.
   SWAIM RC, 1993, J CROSS CULT PSYCHOL, V24, P53, DOI 10.1177/0022022193241004.
   Tuck E, 2012, DECOLONIZATION, V1, P1.
   Ullrich JS, 2019, ALTERNATIVE, V15, P121, DOI 10.1177/1177180119828114.
   US Census Bureau, 2022, 2020 CENS ILL RAC ET.
   Walker M., 1999, EUROPEAN J PSYCHOTHE, V2, P281, DOI DOI 10.1080/13642539908400813.
   Warren SL, 2020, BIOL PSYCHIAT, V88, P576, DOI 10.1016/j.biopsych.2020.02.011.
   Watamura SE, 2003, CHILD DEV, V74, P1006, DOI 10.1111/1467-8624.00583.
   Whitbeck LB, 2004, AM J COMMUN PSYCHOL, V33, P119, DOI 10.1023/B:AJCP.0000027000.77357.31.
   Yao B, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01195-y.},
Number-of-Cited-References = {56},
Times-Cited = {3},
Unique-ID = {WOS:000975067300002},
}

@article{ WOS:000728836000001,
Author = {Stewart, Alexandra G. A. and Zimmerman, Peter A. and McCarthy, James S.},
Title = {Genetic Variation of <i>G6PD</i> and <i>CYP2D6</i>: Clinical
   Implications on the Use of Primaquine for Elimination of <i>Plasmodium
   vivax</i>},
Journal = {FRONTIERS IN PHARMACOLOGY},
Year = {2021},
Volume = {12},
Month = {NOV 26},
Abstract = {Primaquine, an 8-aminoquinoline, is the only medication approved by the
   World Health Organization to treat the hypnozoite stage of Plasmodium
   vivax and P. ovale malaria. Relapse, triggered by activation of dormant
   hypnozoites in the liver, can occur weeks to years after primary
   infection, and provides the predominant source of transmission in
   endemic settings. Hence, primaquine is essential for individual
   treatment and P. vivax elimination efforts. However, primaquine use is
   limited by the risk of life-threatening acute hemolytic anemia in
   glucose-6-phosphate dehydrogenase (G6PD) deficient individuals. More
   recently, studies have demonstrated decreased efficacy of primaquine due
   to cytochrome P450 2D6 (CYP2D6) polymorphisms conferring an impaired
   metabolizer phenotype. Failure of standard primaquine therapy has
   occurred in individuals with decreased or absent CYP2D6 activity. Both
   G6PD and CYP2D6 are highly polymorphic genes, with considerable
   geographic and interethnic variability, adding complexity to primaquine
   use. Innovative strategies are required to overcome the dual challenge
   of G6PD deficiency and impaired primaquine metabolism. Further
   understanding of the pharmacogenetics of primaquine is key to utilizing
   its full potential. Accurate CYP2D6 genotype-phenotype translation may
   optimize primaquine dosing strategies for impaired metabolizers and
   expand its use in a safe, efficacious manner. At an individual level the
   current challenges with G6PD diagnostics and CYP2D6 testing limit
   clinical implementation of pharmacogenetics. However, further
   characterisation of the overlap and spectrum of G6PD and CYP2D6 activity
   may optimize primaquine use at a population level and facilitate
   region-specific dosing strategies for mass drug administration. This
   precision public health approach merits further investigation for P.
   vivax elimination.},
Type = {Article},
Affiliation = {Stewart, AGA (Corresponding Author), Western Hlth, Infect Dis Unit, Melbourne, Vic, Australia.
   Stewart, Alexandra G. A., Western Hlth, Infect Dis Unit, Melbourne, Vic, Australia.
   Zimmerman, Peter A., Case Western Reserve Univ, Ctr Global Hlth \& Dis, Cleveland, OH USA.
   McCarthy, James S., Royal Melbourne Hosp, Victorian Infect Dis Serv, Melbourne, Vic, Australia.
   McCarthy, James S., Peter Doherty Inst Infect \& Immun, Melbourne, Vic, Australia.},
DOI = {10.3389/fphar.2021.784909},
Article-Number = {784909},
Keywords = {Plasmodium vivax; primaquine; G6PD (glucose-6-phosphate dehydrogenase);
   pharmacogenetics; elimination; mass drug administration (MDA)},
Keywords-Plus = {PHARMACOGENETICS IMPLEMENTATION CONSORTIUM; POPULATION; MALARIA; 2D6;
   TAFENOQUINE; DEFICIENCY; GUIDELINES; PHENOTYPES; GENOTYPE; RELAPSE},
Research-Areas = {Pharmacology \& Pharmacy},
Web-of-Science-Categories  = {Pharmacology \& Pharmacy},
Author-Email = {alexandra.stewart03@gmail.com},
Affiliations = {Western Health; Melbourne Genomics Health Alliance; University System of
   Ohio; Case Western Reserve University; Melbourne Health; Royal Melbourne
   Hospital; Melbourne Genomics Health Alliance; University of Melbourne;
   Peter Doherty Institute},
Cited-References = {Abecasis GR, 2012, NATURE, V491, P56, DOI {[}DOI 10.1038/nature11632, DOI 10.1038/NATURE11632].
   Alam MS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206331.
   ALVING A S, 1960, Bull World Health Organ, V22, P621.
   Baird JK, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.1449.
   Baird JK, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2190-z.
   Baird JK, 2013, CLIN MICROBIOL REV, V26, P36, DOI 10.1128/CMR.00074-12.
   Battle KE, 2019, LANCET, V394, P332, DOI {[}10.1016/S0140-6736(19)31096-7, 10.1016/S0140-6736(19)31097-9].
   Bennett JW, 2013, NEW ENGL J MED, V369, P1381, DOI 10.1056/NEJMc1301936.
   Botton MR, 2011, BRIT J CLIN PHARMACO, V72, P442, DOI 10.1111/j.1365-2125.2011.03942.x.
   Brasil LW, 2018, MALARIA J, V17, DOI 10.1186/s12936-017-2139-7.
   CARSON PE, 1956, SCIENCE, V124, P484, DOI 10.1126/science.124.3220.484-a.
   Caudle KE, 2020, CTS-CLIN TRANSL SCI, V13, P116, DOI 10.1111/cts.12692.
   Cheah PY, 2016, INT HEALTH, V8, P235, DOI 10.1093/inthealth/ihw027.
   Chu CS, 2021, EXPERT OPIN DRUG SAF, V20, P349, DOI 10.1080/14740338.2021.1859476.
   Chu CS, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002224.
   Chumnumwat S, 2019, PUBLIC HEALTH GENOM, V22, P132, DOI 10.1159/000502916.
   Commons RJ, 2020, AM J TROP MED HYG, V103, P1094, DOI 10.4269/ajtmh.20-0186.
   Crews KR, 2014, CLIN PHARMACOL THER, V95, P376, DOI 10.1038/clpt.2013.254.
   Del Tredici AL, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00305.
   DERN RJ, 1954, J LAB CLIN MED, V44, P171.
   Dodgen T, 2016, PHARMACOGENOMICS J, V16, P566, DOI 10.1038/tpj.2015.76.
   Gaedigk A, 2018, J PERS MED, V8, DOI 10.3390/jpm8020015.
   Gething PW, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001814.
   Gómez-Manzo S, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122069.
   Gurdasani D, 2015, NATURE, V517, P327, DOI 10.1038/nature13997.
   Haga SB, 2016, EXPERT REV MOL DIAGN, V16, P949, DOI 10.1080/14737159.2016.1211934.
   Hippman C, 2019, J PERS MED, V9, DOI 10.3390/jpm9030040.
   Howes RE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001339.
   Hsiang MS, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-383.
   Huang HR, 2021, MALARIA J, V20, DOI 10.1186/s12936-021-03685-3.
   Ingram RJH, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-488.
   Jamrozik E, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-1042-3.
   Jarvis JP, 2019, FRONT PSYCHIATRY, V10, DOI 10.3389/fpsyt.2019.00432.
   John GK, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-280.
   Kaneko A, 2000, LANCET, V356, P1560, DOI 10.1016/S0140-6736(00)03127-5.
   Kheng S, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0441-1.
   Kondrashin A, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-51.
   Koopmans AB, 2021, TRANSL PSYCHIAT, V11, DOI 10.1038/s41398-020-01129-1.
   KROTOSKI WA, 1985, T ROY SOC TROP MED H, V79, P1, DOI 10.1016/0035-9203(85)90221-4.
   Lacerda MVG, 2019, NEW ENGL J MED, V380, P215, DOI 10.1056/NEJMoa1710775.
   Lacerda MVG, 2012, CLIN INFECT DIS, V55, pE67, DOI 10.1093/cid/cis615.
   LaRue N, 2014, AM J TROP MED HYG, V91, P854, DOI 10.4269/ajtmh.14-0194.
   Leitao LPC, 2020, GENES-BASEL, V11, DOI 10.3390/genes11030262.
   Leslie T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002861.
   LLerena A, 2014, EXPERT OPIN DRUG MET, V10, P1569, DOI 10.1517/17425255.2014.964204.
   Luzzatto L, 2014, BRIT J HAEMATOL, V164, P469, DOI 10.1111/bjh.12665.
   Mehlotra RK, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.654054.
   Mulder N, 2018, PHARMACOGEN PERS MED, V11, P59, DOI 10.2147/PGPM.S141546.
   Newby G, 2015, AM J TROP MED HYG, V93, P125, DOI 10.4269/ajtmh.14-0254.
   Nofziger C, 2020, CLIN PHARMACOL THER, V107, P154, DOI 10.1002/cpt.1643.
   Pal S, 2019, AM J TROP MED HYG, V100, P213, DOI 10.4269/ajtmh.18-0612.
   Popovici J, 2021, INT J PARASITOL-DRUG, V15, P36, DOI 10.1016/j.ijpddr.2020.12.004.
   Potter BMJ, 2015, ANTIMICROB AGENTS CH, V59, P2380, DOI 10.1128/AAC.00015-15.
   Pybus BS, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-212.
   Pybus BS, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-259.
   Recht J., 2014, Safety of 8-aminoquinoline antimalarial medicines.
   Recht J, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006230.
   Silvino ACR, 2020, ANTIMICROB AGENTS CH, V64, DOI 10.1128/AAC.02056-19.
   Silvino ACR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160172.
   Roederer MW, 2010, PHARMACOGENOMICS, V11, P633, DOI 10.2217/PGS.10.55.
   Ross A, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004582.
   Santana MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005259.
   Sasaki T, 2017, J PHARM HEALTH CARE, V3, DOI 10.1186/s40780-017-0083-x.
   Sistonen J, 2007, PHARMACOGENET GENOM, V17, P93.
   Sivadas A, 2019, ADV GENET, V103, P119, DOI 10.1016/bs.adgen.2018.09.001.
   Spring MD, 2020, AM J TROP MED HYG, V103, P756, DOI 10.4269/ajtmh.20-0061.
   Suarez-Kurtz G, 2014, PHARMACOGENOMICS, V15, P209, DOI 10.2217/pgs.13.238.
   Suarez-Kurtz G, 2011, BRIT J CLIN PHARMACO, V72, P451, DOI 10.1111/j.1365-2125.2011.04018.x.
   Swen JJ, 2011, CLIN PHARMACOL THER, V89, P662, DOI 10.1038/clpt.2011.34.
   Tanner M, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0384-6.
   Taylor WRJ, 2019, LANCET, V394, P929, DOI 10.1016/S0140-6736(19)31285-1.
   Thriemer K, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008838.
   Thriemer K, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1784-1.
   Watson J, 2017, ELIFE, V6, DOI 10.7554/eLife.23061.
   WHO, 2020, WHO TECHN BRIEF COUN.
   World Health Organization, 2021, WHO GUID MAL.
   World Health Organization, 2019, High burden to high impact: a targeted malaria response.
   Yoon DY, 2020, TRANSL CLIN PHARMACO, V28, P189, DOI 10.12793/tcp.2020.28.e18.},
Number-of-Cited-References = {78},
Times-Cited = {5},
Unique-ID = {WOS:000728836000001},
}

@article{ WOS:000601175500013,
Author = {Assefa, Yibeltal and Hill, Peter S. and Gilks, Charles F. and Admassu,
   Mengesha and Tesfaye, Dessalegn and Van Damme, Wim},
Title = {Primary health care contributions to universal health coverage, Ethiopia},
Journal = {BULLETIN OF THE WORLD HEALTH ORGANIZATION},
Year = {2020},
Volume = {98},
Number = {12},
Pages = {894+},
Month = {DEC},
Abstract = {Many global health institutions, including the World Health
   Organization, consider primary health care as the path towards achieving
   universal health coverage (UHC). However, there remain concerns about
   the feasibility and effectiveness of this approach in low-resource
   countries. Ethiopia has been implementing the primary health-care
   approach since the mid-1970s, with primary health care at the core of
   the health system since 1993. Nevertheless, comprehensive and systemic
   evidence on the practice and role of primary health care towards UHC is
   lacking in Ethiopia. We made a document review of publicly available
   qualitative and quantitative data. Using the framework of the Primary
   Health Care Performance Initiative we describe and analyse the practice
   of primary health care and identify successes and challenges.
   Implementation of the primary health-care approach in Ethiopia has been
   possible through policies, strategies and programmes that are aligned
   with country priorities. There has been a diagonal approach to disease
   control programmes along with health-systems strengthening, community
   empowerment and multisectoral action. These strategies have enabled the
   country to increase health services coverage and improve the
   population's health status. However, key challenges remain to be
   addressed, including inadequate coverage of services, inequity of
   access, slow health-systems transition to provide services for
   noncommunicable diseases, inadequate quality of care, and high
   out-of-pocket expenditure. To resolve gaps in the health system and
   beyond, the country needs to improve its domestic financing for health
   and target disadvantaged locations and populations through a precision
   public health approach. These challenges need to be addressed through
   the whole sustainable development agenda.},
Type = {Article},
Affiliation = {Assefa, Y (Corresponding Author), Univ Queensland, Sch Publ Hlth, 266 Herston Rd, Brisbane, Qld 4006, Australia.
   Assefa, Yibeltal; Hill, Peter S.; Gilks, Charles F., Univ Queensland, Sch Publ Hlth, 266 Herston Rd, Brisbane, Qld 4006, Australia.
   Admassu, Mengesha, Int Inst Primary Hlth Care, Addis Ababa, Ethiopia.
   Tesfaye, Dessalegn, US Agcy Int Dev, Addis Ababa, Ethiopia.
   Van Damme, Wim, Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium.},
DOI = {10.2471/BLT.19.248328},
Keywords-Plus = {ALMA-ATA; NONCOMMUNICABLE DISEASES; DEVELOPMENT ARMY; SERVICE;
   INTERVENTIONS; IMPROVEMENT; INVESTMENT; MORTALITY; DELIVERY; LESSONS},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {y.alemu@uq.edu.au},
Affiliations = {University of Queensland; United States Agency for International
   Development (USAID); Institute of Tropical Medicine (ITM)},
Cited-References = {Ali Eskinder Eshetu, 2014, Value Health Reg Issues, V4, P37, DOI 10.1016/j.vhri.2014.06.005.
   {[}Anonymous], 2017, SERV AV READ ASS 201.
   {[}Anonymous], 2015, HLTH SECTOR TRANSFOR.
   {[}Anonymous], 2010, HLTH SECT DEV PROGR, DOI DOI 10.1093/JMP/JHT077.
   {[}Anonymous], 2017, SDGS PROGR UN HLTH C.
   {[}Anonymous], 2019, PRIMARY HLTH CARE RO.
   {[}Anonymous], 2019, HLTH FIN DAT STAT.
   {[}Anonymous], 2016, ETH DEM HLTH SURV 20.
   {[}Anonymous], 2016, HLTH SERV QUAL DIR.
   {[}Anonymous], 2015, Health in 2015: From MDG's to SDG's.
   {[}Anonymous], 2017, ETH HLTH ACC 2013 14.
   {[}Anonymous], 1993, HLTH POL TRANS GOV E.
   {[}Anonymous], 2019, MIN HLTH SURV.
   Asrese K, 2020, BMC HEALTH SERV RES, V20, DOI 10.1186/s12913-020-05321-3.
   Assefa Y, 2019, GLOBALIZATION HEALTH, V15, DOI 10.1186/s12992-019-0470-1.
   Assefa Y, 2019, INT J INFECT DIS, V78, P57, DOI 10.1016/j.ijid.2018.10.022.
   Assefa Y, 2018, LANCET, V392, P1473, DOI 10.1016/S0140-6736(18)32215-3.
   Assefa Y, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2017-000318.
   Awash Teklehaimanot Awash Teklehaimanot, 2007, Ethiopian Journal of Health Development, V21, P246.
   Banteyerga H, 2011, MEDICC REV, V13, P46, DOI 10.37757/MR2011V13.N3.11.
   Bhutta ZA, 2008, LANCET, V372, P972, DOI 10.1016/S0140-6736(08)61407-5.
   Birhanu Z, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-74.
   Bitton A, 2017, J GEN INTERN MED, V32, P566, DOI 10.1007/s11606-016-3898-5.
   Bloom G, 2017, INT J HEALTH POLICY, V6, P229, DOI 10.15171/ijhpm.2016.120.
   Chokshi DA, 2018, JAMA-J AM MED ASSOC, V320, P1965, DOI 10.1001/jama.2018.16957.
   Dowell SF, 2016, NATURE, V540, P189, DOI 10.1038/540189a.
   Eregata GT, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2019-001843.
   Getachew T, 2017, ETHIOP J HEALTH DEV, V31, P384.
   Ghebreyesus TA, 2018, LANCET, V392, P1371, DOI 10.1016/S0140-6736(18)32556-X.
   Gidey MT, 2019, COST EFFECT RESOUR A, V17, DOI 10.1186/s12962-019-0171-x.
   Osorio AG, 2013, ATEN PRIM, V45, P384, DOI 10.1016/j.aprim.2012.12.016.
   Government of South Australia and Global Network for Health in All Policies, 2019, GLOB STAT REP HLTH A.
   Habtemariam MK, 2018, COST EFFECT RESOUR A, V16, DOI 10.1186/s12962-018-0117-8.
   Haile T. G., 2015, GLOBAL J BUSINESS EC, V5, P13, DOI {[}10.18844/gjbem.v5i1.61, DOI 10.18844/GJBEM.V5I1.61].
   Hailemichael Y, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7239-6.
   Haregu TN, 2014, J PUBLIC HEALTH RES, V3, P27, DOI 10.4081/jphr.2014.99.
   Health sector transformation plan, 2016, HLTH SECT TRANSF PLA.
   Hone T, 2018, LANCET, V392, P1461, DOI 10.1016/S0140-6736(18)31829-4.
   Horton R, 2015, LANCET, V385, P1156, DOI 10.1016/S0140-6736(14)61742-6.
   Joint United Nations Programme on HIV/AIDS, 2019, UNAIDS DAT 2019.
   Kitaw Y, 2013, ETHIOP J HEALTH DEV, V27, P6.
   Kraef C, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2019-001871.
   Kringos DS, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-65.
   Letebo M, 2016, GLOBALIZATION HEALTH, V12, DOI 10.1186/s12992-016-0163-y.
   Maes K, 2015, STUD COMP INT DEV, V50, P455, DOI 10.1007/s12116-015-9197-z.
   Maes K, 2015, ANN ANTHROPL PRACT, V39, P42, DOI 10.1111/napa.12064.
   Magge H, 2019, INT J QUAL HEALTH C, V31, pG180, DOI 10.1093/intqhc/mzz127.
   Mash Robert, 2018, Afr J Prim Health Care Fam Med, V10, pe1, DOI 10.4102/phcfm.v10i1.1983.
   Misganaw A, 2017, POPUL HEALTH METR, V15, DOI 10.1186/s12963-017-0145-1.
   Mohan P., 2007, ETHIOPIA HLTH SECTOR, V9549.
   Munea AM, 2020, BMC HEALTH SERV RES, V20, DOI 10.1186/s12913-020-05113-9.
   Naledi T., 2011, South African health review, P17.
   National Planning Commission, 2016, GROWTH TRANSF PLAN 2, VI.
   Negero Melese Girmaye, 2018, BMC Res Notes, V11, P83, DOI 10.1186/s13104-018-3140-0.
   Negusse Haile, 2007, Hum Resour Health, V5, P21, DOI 10.1186/1478-4491-5-21.
   O'Donnell O., 2008, ANAL HLTH EQUITY USI, P147, DOI {[}DOI 10.1596/978-0-8213-6933-3, 10.1596/978-0-8213-6933-3].
   Pettigrew LM, 2015, LANCET, V386, P2119, DOI 10.1016/S0140-6736(15)00949-6.
   Ruducha J, 2017, LANCET GLOB HEALTH, V5, pE1142, DOI 10.1016/S2214-109X(17)30331-5.
   Samuel Girma Samuel Girma, 2007, Ethiopian Journal of Health Development, V21, P216.
   Sanders D, 2019, LANCET, V394, P619, DOI 10.1016/S0140-6736(19)31831-8.
   Schoonenboom J, 2017, KOLNER Z SOZIOL SOZ, V69, P107, DOI 10.1007/s11577-017-0454-1.
   Shiferaw F, 2018, ETHIOP J HEALTH DEV, V32, P170.
   Sibamo EL, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0821-4.
   Taddesse D, 2015, DEV PRACT, V25, P1043, DOI 10.1080/09614524.2015.1069794.
   Tadesse K., 2014, Int J Intell Inf Syst, V3, P34.
   Tesfaye S, 2014, J MIDWIFERY WOM HEAL, V59, pS55, DOI 10.1111/jmwh.12168.
   Teshome SB., 2018, Dev Stud Res, V5, pS40, DOI DOI 10.1080/21665095.2018.1543549.
   Thomas J, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-45.
   Tollman SM, 2008, LANCET, V372, P893, DOI 10.1016/S0140-6736(08)61399-9.
   Van Lerberghe W, 2008, WORLD HLTH REPORT 20.
   Veillard J, 2017, MILBANK Q, V95, P836, DOI 10.1111/1468-0009.12301.
   Victora CG, 2003, LANCET, V362, P233, DOI {[}10.1016/S0140-6736(03)13917-7, 10.1016/S0140-6736(15)01024-7].
   Vlassoff Carol, 2010, Indian J Community Med, V35, P326, DOI 10.4103/0970-0218.66896.
   Wamai RG., 2009, JAPAN MED ASS J, V52, P279.
   White F, 2015, MED PRIN PRACT, V24, P103, DOI 10.1159/000370197.
   Wilson D, 2008, LANCET, V372, P423, DOI 10.1016/S0140-6736(08)60883-1.
   Woldemichael A, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-022923.
   Worku I., 2010, ETHIOP J EC, V19, P101.
   World Bank, 2019, Life expectancy at birth, total (years).
   Yitbarek K, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-025937.
   Yusuf S., 2020, POLICY BRIEF COVID 1.},
Number-of-Cited-References = {81},
Times-Cited = {32},
Unique-ID = {WOS:000601175500013},
}

@article{ WOS:000521723500001,
Author = {Xiao, Qingyang and Zhou, Yitian and Lauschke, Volker M.},
Title = {Ethnogeographic and inter-individual variability of human ABC
   transporters},
Journal = {HUMAN GENETICS},
Year = {2020},
Volume = {139},
Number = {5},
Pages = {623-646},
Month = {MAY},
Abstract = {ATP-binding cassette (ABC) transporters constitute a superfamily of 48
   structurally similar membrane transporters that mediate the
   ATP-dependent cellular export of a plethora of endogenous and xenobiotic
   substances. Importantly, genetic variants in ABC genes that affect gene
   function have clinically important effects on drug disposition and can
   be predictors of the risk of adverse drug reactions and efficacy of
   chemotherapeutics, calcium channel blockers, and protease inhibitors.
   Furthermore, loss-of-function of ABC transporters is associated with a
   variety of congenital disorders. Despite their clinical importance,
   information about the frequencies and global distribution of
   functionally relevant ABC variants is limited and little is known about
   the overall genetic complexity of this important gene family. Here, we
   systematically mapped the genetic landscape of the entire human ABC
   superfamily using Next-Generation Sequencing data from 138,632
   individuals across seven major populations. Overall, we identified
   62,793 exonic variants, 98.5\% of which were rare. By integrating five
   computational prediction algorithms with structural mapping approaches
   using experimentally determined crystal structures, we found that the
   functional ABC variability is extensive and highly population-specific.
   Every individual harbored between 9.3 and 13.9 deleterious ABC variants,
   76\% of which were found only in a single population. Carrier rates of
   pathogenic variants in ABC transporter genes associated with autosomal
   recessive congenital diseases, such as cystic fibrosis or pseudoxanthoma
   elasticum, closely mirrored the corresponding population-specific
   disease prevalence, thus providing a novel resource for rare disease
   epidemiology. Combined, we provide the most comprehensive, systematic,
   and consolidated overview of ethnogeographic ABC transporter variability
   with important implications for personalized medicine, clinical
   genetics, and precision public health.},
Type = {Article},
Affiliation = {Lauschke, VM (Corresponding Author), Karolinska Inst, Dept Physiol \& Pharmacol, Sect Pharmacogenet, S-17177 Stockholm, Sweden.
   Xiao, Qingyang; Zhou, Yitian; Lauschke, Volker M., Karolinska Inst, Dept Physiol \& Pharmacol, Sect Pharmacogenet, S-17177 Stockholm, Sweden.},
DOI = {10.1007/s00439-020-02150-6},
EarlyAccessDate = {MAR 2020},
Keywords-Plus = {CELL LUNG-CANCER; ATP-BINDING CASSETTE; ANTHRACYCLINE-INDUCED
   CARDIOTOXICITY; SINGLE NUCLEOTIDE POLYMORPHISMS; RARE GENETIC-VARIANTS;
   HUMAN P-GLYCOPROTEIN; LOSS-OF-FUNCTION; BREAST-CANCER;
   CLINICAL-OUTCOMES; IRINOTECAN PHARMACOKINETICS},
Research-Areas = {Genetics \& Heredity},
Web-of-Science-Categories  = {Genetics \& Heredity},
Author-Email = {volker.lauschke@ki.se},
Affiliations = {Karolinska Institutet},
Cited-References = {Abraham JE, 2014, CLIN CANCER RES, V20, P2466, DOI 10.1158/1078-0432.CCR-13-3232.
   Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248.
   Allegra S, 2016, EUR J CLIN PHARMACOL, V72, P1155, DOI 10.1007/s00228-016-2070-9.
   Amberger JS, 2015, NUCLEIC ACIDS RES, V43, pD789, DOI 10.1093/nar/gku1205.
   Bailey KM, 2010, CIRC-CARDIOVASC GENE, V3, P276, DOI 10.1161/CIRCGENETICS.109.898502.
   Benadiba M, 2016, CURR PHARM DESIGN, V22, P5817, DOI 10.2174/1381612822666160810120359.
   Bergmann TK, 2012, BASIC CLIN PHARMACOL, V110, P199, DOI 10.1111/j.1742-7843.2011.00802.x.
   Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235.
   Bosch TM, 2005, AM J PHARMACOGENOMIC, V5, P123, DOI 10.2165/00129785-200505020-00005.
   Brackman DJ, 2019, CLIN PHARMACOL THER, V106, P623, DOI 10.1002/cpt.1439.
   Bush WS, 2016, CLIN PHARMACOL THER, V100, P160, DOI 10.1002/cpt.350.
   Campa D, 2012, INT J CANCER, V131, P2920, DOI 10.1002/ijc.27567.
   Caronia D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026091.
   Carter H, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S3-S3.
   Cascorbi I, 2006, PHARMACOL THERAPEUT, V112, P457, DOI 10.1016/j.pharmthera.2006.04.009.
   Chang H, 2010, ONCOL REP, V23, P271, DOI 10.3892/or\_00000633.
   Chasman DI, 2012, CIRC-CARDIOVASC GENE, V5, P257, DOI 10.1161/CIRCGENETICS.111.961144.
   Chaturvedi P, 2013, CANCER EPIDEMIOL, V37, P754, DOI 10.1016/j.canep.2013.04.012.
   Chen S, 2015, PHARMACOGENET GENOM, V25, P573, DOI 10.1097/FPC.0000000000000168.
   Chen XQ, 2015, CANCER CELL INT, V15, DOI 10.1186/s12935-015-0191-3.
   Coelho AVC, 2013, J CLIN PHARMACOL, V53, P1286, DOI 10.1002/jcph.165.
   Costrop LMF, 2010, J HUM GENET, V55, P112, DOI 10.1038/jhg.2009.132.
   Cusatis G, 2006, J NATL CANCER I, V98, P1739, DOI 10.1093/jnci/djj469.
   De Mattia E, 2013, PHARMACOGENET GENOM, V23, P549, DOI 10.1097/FPC.0b013e328364b6cf.
   Deeken JF, 2010, PHARMACOGENOMICS J, V10, P191, DOI 10.1038/tpj.2009.57.
   DeStefano GM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004333.
   Dulucq S, 2008, BLOOD, V112, P2024, DOI 10.1182/blood-2008-03-147744.
   Megías-Vericat JE, 2017, LEUKEMIA LYMPHOMA, V58, P1197, DOI 10.1080/10428194.2016.1231405.
   Flanagan SE, 2010, GENET TEST MOL BIOMA, V14, P533, DOI 10.1089/gtmb.2010.0036.
   Fujikura K, 2015, PHARMACOGENET GENOM, V25, P584, DOI 10.1097/FPC.0000000000000172.
   Fukushima-Uesaka H, 2007, DRUG METAB PHARMACOK, V22, P48, DOI 10.2133/dmpk.22.48.
   Fung KL, 2009, BBA-PROTEINS PROTEOM, V1794, P860, DOI 10.1016/j.bbapap.2009.02.014.
   Gandara DR, 2009, J CLIN ONCOL, V27, P3540, DOI 10.1200/JCO.2008.20.8793.
   Gervasini G, 2017, BRIT J CLIN PHARMACO, V83, P562, DOI 10.1111/bcp.13130.
   Gonzalez-Haba E, 2010, PHARMACOGENOMICS, V11, P1715, DOI {[}10.2217/pgs.10.159, 10.2217/PGS.10.159].
   Gordon AS, 2014, HUM MOL GENET, V23, P1957, DOI 10.1093/hmg/ddt588.
   Gregers J, 2015, PHARMACOGENOMICS J, V15, P372, DOI 10.1038/tpj.2014.81.
   Guo YP, 2009, CLIN CANCER RES, V15, P1762, DOI 10.1158/1078-0432.CCR-08-0442.
   Hampras SS, 2010, INT J MOL EPIDEMIOL, V1, P201.
   Han JY, 2009, LUNG CANCER, V63, P115, DOI 10.1016/j.lungcan.2007.12.003.
   Honjo Y, 2002, CANCER BIOL THER, V1, P696, DOI 10.4161/cbt.322.
   Horinouchi M, 2002, PHARMACEUT RES, V19, P1581, DOI 10.1023/A:1020433422259.
   Hu MA, 2011, EXPERT OPIN DRUG MET, V7, P49, DOI 10.1517/17425255.2011.538383.
   Hu R, 2018, BASIC CLIN PHARMACOL, V123, P320, DOI 10.1111/bcpt.13016.
   Ingelman-Sundberg M, 2018, HUM GENOMICS, V12, DOI 10.1186/s40246-018-0157-3.
   Ionita-Laza I, 2016, NAT GENET, V48, P214, DOI 10.1038/ng.3477.
   Jabeen S, 2015, PHARMACOGENOMICS J, V15, P385, DOI 10.1038/tpj.2015.11.
   Ji MH, 2012, CANCER BIOL THER, V13, P264, DOI 10.4161/cbt.18920.
   Jiang ZP, 2017, PHARMACOGENOMICS, V18, P35, DOI 10.2217/pgs-2016-0103.
   Kaniwa N, 2005, DRUG METAB DISPOS, V33, P458, DOI 10.1124/dmd.104.001800.
   Kap EJ, 2016, INT J CANCER, V138, P2993, DOI 10.1002/ijc.30026.
   Katona E, 2005, J DERMATOL SCI, V40, P115, DOI 10.1016/j.jdermsci.2005.07.010.
   Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053.
   Kim DH, 2009, CLIN CANCER RES, V15, P4750, DOI 10.1158/1078-0432.CCR-09-0145.
   Kim HS, 2009, GYNECOL ONCOL, V113, P264, DOI 10.1016/j.ygyno.2009.01.002.
   Kim IW, 2012, CLIN THER, V34, P1816, DOI 10.1016/j.clinthera.2012.06.022.
   Kim KP, 2012, CANCER CHEMOTH PHARM, V69, P1221, DOI 10.1007/s00280-011-1816-4.
   Kim Y, 2018, SCIENCE, V359, P915, DOI 10.1126/science.aar7389.
   Kimchi-Sarfaty C, 2002, MOL PHARMACOL, V62, P1, DOI 10.1124/mol.62.1.1.
   Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308.
   Kiyotani K, 2008, CANCER SCI, V99, P967, DOI 10.1111/j.1349-7006.2008.00765.x.
   Kiyotani K, 2010, J CLIN ONCOL, V28, P1287, DOI 10.1200/JCO.2009.25.7246.
   König J, 2013, PHARMACOL REV, V65, P944, DOI 10.1124/pr.113.007518.
   Kozyra M, 2017, GENET MED, V19, P20, DOI 10.1038/gim.2016.33.
   Krajinovic M, 2016, PHARMACOGENOMICS J, V16, P530, DOI 10.1038/tpj.2015.63.
   Kranenburg G, 2019, EUR J MED GENET, V62, P90, DOI 10.1016/j.ejmg.2018.05.020.
   Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113.
   Lara PN, 2010, CANCER-AM CANCER SOC, V116, P5710, DOI 10.1002/cncr.25532.
   Lara PN, 2009, J CLIN ONCOL, V27, P2530, DOI 10.1200/JCO.2008.20.1061.
   Lauschke VM, 2018, CLIN PHARMACOL THER, V103, P745, DOI 10.1002/cpt.976.
   Lauschke VM, 2016, TRENDS PHARMACOL SCI, V37, P85, DOI 10.1016/j.tips.2015.10.006.
   Lee MN, 2015, INFLAMM BOWEL DIS, V21, P2897, DOI 10.1097/MIB.0000000000000570.
   Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057.
   Leschziner G, 2006, PHARMACOGENET GENOM, V16, P439, DOI 10.1097/01.fpc.0000197467.21964.67.
   Li JC, 2018, NUCLEIC ACIDS RES, V46, P7793, DOI 10.1093/nar/gky678.
   Li M, 2018, PHARMACOGENOMICS J, V18, P35, DOI 10.1038/tpj.2016.75.
   Liang Y, 2015, PROTEIN CELL, V6, P334, DOI 10.1007/s13238-015-0148-2.
   Lima JJ, 2006, AM J RESP CRIT CARE, V173, P379, DOI 10.1164/rccm.200509-1412OC.
   Litviakov NV, 2016, ONCOTARGET, V7, P7829, DOI 10.18632/oncotarget.6953.
   Ma Y, 2017, PHARMACOGENOMICS J, V17, P325, DOI 10.1038/tpj.2016.31.
   Machiela MJ, 2015, BIOINFORMATICS, V31, P3555, DOI 10.1093/bioinformatics/btv402.
   Marquez B, 2011, CURR DRUG TARGETS, V12, P600, DOI 10.2174/138945011795378504.
   McCollum AD, 2002, JNCI-J NATL CANCER I, V94, P1160.
   McDonough CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076984.
   Moresco M, 2016, CLIN NEUROPHARMACOL, V39, P18, DOI 10.1097/WNF.0000000000000119.
   Mukonzo JK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086919.
   Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601.
   Oguri T, 2007, MOL CANCER THER, V6, P122, DOI 10.1158/1535-7163.MCT-06-0529.
   Pavone P, 2015, ITAL J PEDIATR, V41, DOI 10.1186/s13052-015-0161-3.
   Pramanik S, 2014, XENOBIOTICA, V44, P579, DOI 10.3109/00498254.2013.866300.
   Pussegoda K, 2013, CLIN PHARMACOL THER, V94, P243, DOI 10.1038/clpt.2013.80.
   Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407.
   Roberts RL, 2017, PHARMACOGENOMICS J, V17, P201, DOI 10.1038/tpj.2015.101.
   Robey RW, 2018, NAT REV CANCER, V18, P452, DOI 10.1038/s41568-018-0005-8.
   Rumiato E, 2016, TRANSL RES, V171, P29, DOI 10.1016/j.trsl.2015.12.011.
   Saito S, 2002, J HUM GENET, V47, P147, DOI 10.1007/s100380200018.
   Santos M, 2018, GENET MED, V20, P622, DOI 10.1038/gim.2017.156.
   Sauna ZE, 2002, BIOCHEMISTRY-US, V41, P13989, DOI 10.1021/bi026626e.
   Schaller L, 2019, HUM GENET, V138, P1359, DOI 10.1007/s00439-019-02081-x.
   Semsei AF, 2012, CELL BIOL INT, V36, P79, DOI 10.1042/CBI20110264.
   Slomka M, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0271-3.
   Sparreboom A, 2004, CLIN PHARMACOL THER, V76, P38, DOI 10.1016/j.clpt.2004.03.003.
   Suthandiram S, 2014, PHARMACOGENOMICS, V15, P1479, DOI {[}10.2217/PGS.14.97, 10.2217/pgs.14.97].
   Szczyrek M, 2017, PATHOL ONCOL RES, V23, P607, DOI 10.1007/s12253-016-0156-4.
   Tanaka M, 2011, CANCER-AM CANCER SOC, V117, P744, DOI 10.1002/cncr.25510.
   Tian CQ, 2012, GYNECOL ONCOL, V124, P575, DOI 10.1016/j.ygyno.2011.11.022.
   Toyoda Y, 2009, FASEB J, V23, P2001, DOI 10.1096/fj.09-129098.
   Uemura T, 2010, CANCER SCI, V101, P2404, DOI 10.1111/j.1349-7006.2010.01690.x.
   Phan VH, 2011, EXPERT OPIN DRUG MET, V7, P1395, DOI 10.1517/17425255.2011.624513.
   Visscher H, 2012, J CLIN ONCOL, V30, P1422, DOI 10.1200/JCO.2010.34.3467.
   Wen CC, 2015, CLIN PHARMACOL THER, V97, P518, DOI 10.1002/cpt.89.
   Wojnowski L, 2005, CIRCULATION, V112, P3754, DOI 10.1161/CIRCULATIONAHA.105.576850.
   Wolf SJ, 2011, PHARMACOGENOMICS J, V11, P315, DOI 10.1038/tpj.2011.16.
   Wright GEB, 2018, PHARMACOGENOMICS J, V18, P187, DOI 10.1038/tpj.2016.77.
   Wu HZ, 2012, J CANCER RES CLIN, V138, P1449, DOI 10.1007/s00432-012-1209-z.
   Xiao QY, 2020, INT J CANCER, V146, P2475, DOI 10.1002/ijc.32898.
   Yang J, 2013, ASIAN PAC J CANCER P, V14, P4595, DOI 10.7314/APJCP.2013.14.8.4595.
   Yasui K, 2004, CANCER RES, V64, P1403, DOI 10.1158/0008-5472.CAN-3263-2.
   Yee SW, 2018, CLIN PHARMACOL THER, V104, P803, DOI 10.1002/cpt.1098.
   Yee SW, 2013, J HUM GENET, V58, P353, DOI 10.1038/jhg.2013.38.
   Zhang BY, 2019, PHARMACOL RES, V139, P550, DOI 10.1016/j.phrs.2018.10.017.
   Zhang L, 2018, CLIN PHARMACOL THER, V104, P793, DOI 10.1002/cpt.1214.
   Zhou Y, 2017, CLIN PHARMACOL THER, V102, P688, DOI 10.1002/cpt.690.
   Zhou YT, 2018, J MED GENET, V55, P617, DOI 10.1136/jmedgenet-2018-105429.
   Zolnerciks JK, 2014, FASEB J, V28, P4335, DOI 10.1096/fj.13-245639.},
Number-of-Cited-References = {125},
Times-Cited = {31},
Unique-ID = {WOS:000521723500001},
}

@article{ WOS:001043488200001,
Author = {Tomietto, Marco and McGill, Andrew and Kiernan, Matthew D.},
Title = {Implementing an electronic public health record for policy planning in
   the UK military sector: Validation of a secure hashing algorithm},
Journal = {HELIYON},
Year = {2023},
Volume = {9},
Number = {6},
Month = {JUN},
Abstract = {The digitalisation of healthcare services is a major resource to inform
   policy-makers. However, the availability of data and the establishment
   of a data flow present new issues to address, such as data
   anonymisation, records' reliability, and data linkage. The veterans'
   population in the UK presents complex needs and many organisations
   provide social and healthcare support, but their databases are not
   linked or aggregated to provide a comprehensive overview of service
   planning. This study aims to test the sensitivity and specificity of a
   Secure Hashing Algorithm to generate a unique anonymous identifier for
   data linkage across different organisations in the veterans' population.
   A Secure Hashing Algorithm was performed by considering two input
   variables from two different datasets. The uniqueness of the identifier
   was compared against the single personal key adopted as a current
   standard identifier. Chi-square, sensitivity, and specificity were
   calculated. The results demonstrated that the unique identifier
   generated by the Secure Hashing Algorithm detected more unique records
   when compared to the current gold standard. The identifier demonstrated
   optimal sensitivity and specificity and it allowed an enhanced data
   linkage between different datasets. The adoption of a Secure Hashing
   Algorithm improved the uniqueness of records. Moreover, it ensured data
   anonymity by transforming personal information into an encrypted
   identifier. This approach is beneficial for big data management and for
   creating an aggregated system for linking different organisations and,
   in this way, for providing a more comprehensive overview of healthcare
   provision and the foundation for precision public health strategies.},
Type = {Article},
Affiliation = {Tomietto, M (Corresponding Author), Northumbria Univ, Fac Hlth \& Life Sci, Dept Nursing Midwifery \& Hlth, Newcastle Upon Tyne, England.
   Tomietto, Marco; McGill, Andrew; Kiernan, Matthew D., Northumbria Univ, Fac Hlth \& Life Sci, Dept Nursing Midwifery \& Hlth, Newcastle Upon Tyne, England.},
DOI = {10.1016/j.heliyon.2023.e16116},
EarlyAccessDate = {MAY 2023},
Article-Number = {e16116},
Keywords = {Secure Hashing Algorithm; Military veterans; Military families; Unique
   identifier; Big data; Data aggregation; Data confidentiality},
Keywords-Plus = {BIG DATA; VETERANS; WELFARE},
Research-Areas = {Science \& Technology - Other Topics},
Web-of-Science-Categories  = {Multidisciplinary Sciences},
Author-Email = {marco.tomietto@northumbria.ac.uk
   andrew.mcgill@northumbria.ac.uk
   matt.kiernan@northumbria.ac.uk},
Affiliations = {Northumbria University},
Cited-References = {Benke K, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15122796.
   Chen F, 2018, IEEE INTERNET COMPUT, V22, P32, DOI 10.1109/MIC.2018.112102542.
   Dolley S, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00068.
   Fragidis LL, 2018, INT J HEALTH CARE Q, V31, P116, DOI 10.1108/IJHCQA-09-2016-0136.
   General Data Protection Regulation (GDPR), 2018, US.
   Gordon K, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00050.
   Gribble R, 2014, RUSI J, V159, P50, DOI 10.1080/03071847.2014.895258.
   Herman A, 2015, ENVIRON PLANN A, V47, P2628, DOI 10.1177/0308518X15614844.
   IBM Corp, 2021, IBM SPSS Statistics for Windows.
   Jimenez G, 2020, INT J MED INFORM, V143, DOI 10.1016/j.ijmedinf.2020.104260.
   Johnson SB, 2010, J AM MED INFORM ASSN, V17, P689, DOI 10.1136/jamia.2009.002063.
   Kruse CS, 2017, J MED SYST, V41, DOI 10.1007/s10916-017-0778-4.
   Fernández-Alemán JL, 2013, J BIOMED INFORM, V46, P541, DOI 10.1016/j.jbi.2012.12.003.
   Mayhew M, 2018, UK ARMED FORCES CHAR.
   Ministry\_of\_Defence, 2019, ANN POPULATION SURVE.
   Mohammed Emad A, 2016, J Pathol Inform, V7, P55, DOI 10.4103/2153-3539.197203.
   Mooney SJ, 2018, ANNU REV PUBL HEALTH, V39, P95, DOI 10.1146/annurev-publhealth-040617-014208.
   Ola O., 2014, Online Journal of Public Health Informatics, V5, DOI {[}DOI 10.5210/OJPHI.V5I3.4933, 10.5210/ojphi.v5i3.4933].
   Penard W., 2008, Cryptography in Context, P1.
   RStudio Team, 2020, RStudio: Integrated Development for R.
   Scullion L, 2021, SOC POLICY SOC, V20, P670, DOI 10.1017/S1474746421000166.
   StataCorp, 2013, STAT STAT SOFTW REL.
   Vayena E, 2018, B WORLD HEALTH ORGAN, V96, P66, DOI 10.2471/BLT.17.197426.
   World Health Organization, 2006, EL HLTH REC MAN DEV.
   World Health Organization, 2017, GLOB DIFF EHEALTH M.},
Number-of-Cited-References = {25},
Times-Cited = {0},
Unique-ID = {WOS:001043488200001},
}

@article{ WOS:000768172300001,
Author = {Zhang, Yutong and Simpson, Ryan B. and Sallade, Lauren E. and Sanchez,
   Emily and Monahan, Kyle M. and Naumova, Elena N.},
Title = {Evaluating Completeness of Foodborne Outbreak Reporting in the United
   States, 1998-2019},
Journal = {INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH},
Year = {2022},
Volume = {19},
Number = {5},
Month = {MAR},
Abstract = {Public health agencies routinely collect time-referenced records to
   describe and compare foodborne outbreak characteristics. Few studies
   provide comprehensive metadata to inform researchers of data limitations
   prior to conducting statistical modeling. We described the completeness
   of 103 variables for 22,792 outbreaks publicly reported by the United
   States Centers for Disease Control and Prevention's (US CDC's)
   electronic Foodborne Outbreak Reporting System (eFORS) and National
   Outbreak Reporting System (NORS). We compared monthly trends of
   completeness during eFORS (1998-2008) and NORS (2009-2019) reporting
   periods using segmented time series analyses adjusted for seasonality.
   We quantified the overall, annual, and monthly completeness as the
   percentage of outbreaks with blank records per our study period,
   calendar year, and study month, respectively. We found that outbreaks of
   unknown genus (n = 7401), Norovirus (n = 6414), Salmonella (n = 2872),
   Clostridium (n = 944), and multiple genera (n = 779) accounted for
   80.77\% of all outbreaks. However, crude completeness ranged from
   46.06\% to 60.19\% across the 103 variables assessed. Variables with the
   lowest crude completeness (ranging 3.32-6.98\%) included pathogen,
   specimen etiological testing, and secondary transmission traceback
   information. Variables with low (<35\%) average monthly completeness
   during eFORS increased by 0.33-0.40\%/month after transitioning to NORS,
   most likely due to the expansion of surveillance capacity and coverage
   within the new reporting system. Examining completeness metrics in
   outbreak surveillance systems provides essential information on the
   availability of data for public reuse. These metadata offer important
   insights for public health statisticians and modelers to precisely
   monitor and track the geographic spread, event duration, and illness
   intensity of foodborne outbreaks.},
Type = {Article},
Affiliation = {Zhang, YT; Naumova, EN (Corresponding Author), Tufts Univ, Friedman Sch Nutr Sci \& Policy, Div Nutr Epidemiol \& Data Sci, 150 Harrison Ave, Boston, MA 02111 USA.
   Zhang, Yutong; Simpson, Ryan B.; Sallade, Lauren E.; Sanchez, Emily; Naumova, Elena N., Tufts Univ, Friedman Sch Nutr Sci \& Policy, Div Nutr Epidemiol \& Data Sci, 150 Harrison Ave, Boston, MA 02111 USA.
   Monahan, Kyle M., Tufts Univ, Sch Engn, Gordon Inst, 200 Boston Ave, Medford, MA 02155 USA.},
DOI = {10.3390/ijerph19052898},
Article-Number = {2898},
Keywords = {data completeness; electronic Foodborne Outbreak Reporting System
   (eFORS); foodborne outbreaks; National Outbreak Reporting System (NORS);
   precision public health; time series analyses},
Keywords-Plus = {DISEASE OUTBREAKS; SURVEILLANCE; PATHOGENS; ILLNESS; HEALTH;
   SEASONALITY; INFECTIONS; SYSTEM; FOOD},
Research-Areas = {Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health},
Web-of-Science-Categories  = {Environmental Sciences; Public, Environmental \& Occupational Health},
Author-Email = {zyutong27@gmail.com
   ryan.simpson@tufts.edu
   lauren.sallade@gmail.com
   emily.sanchez@tufts.edu
   kyle.monahan@tufts.edu
   elena.naumova@tufts.edu},
Affiliations = {Tufts University; Tufts University},
Cited-References = {Arendt S, 2013, INT J ENV RES PUB HE, V10, P3684, DOI 10.3390/ijerph10083684.
   Bhaskaran K, 2013, INT J EPIDEMIOL, V42, P1187, DOI 10.1093/ije/dyt092.
   Biggerstaff GK, 2015, J PUBLIC HEALTH MAN, V21, pE18, DOI 10.1097/PHH.0000000000000115.
   Centers for Disease Control and Prevention (CDC), 2013, MMWR Morb Mortal Wkly Rep, V62, P41.
   Centers for Disease Control and Prevention (CDC), FOODB ILLN GERMS.
   Centers for Disease Control and Prevention (CDC), INV OUTBR FOODB OUTB.
   Centers for Disease Control and Prevention (CDC), OUTBR FOODB ILLN.
   Centers for Disease Control and Prevention (CDC), 2004, MMWR-MORBID MORTAL W, V53, P32.
   Centers for Disease Control and Prevention (CDC), LESS 5 PUBL HLTH SUR.
   Centers for Disease Control and Prevention (CDC) Office of Public Health Scientific Services (OPHSS) Center for Surveillance Epidemiology and Laboratory Services (CSELS) Division of Health Informatics and Surveillance (DHIS), SURV CAS DEF CURR HI.
   Chui KKH, 2011, AM J PUBLIC HEALTH, V101, P2082, DOI 10.2105/AJPH.2010.300096.
   Costard S, 2017, EMERG INFECT DIS, V23, P957, DOI 10.3201/eid2306.151603.
   David SD, 2013, J LAW MED ETHICS, V41, P28, DOI 10.1111/jlme.12034.
   Ebel ED, 2016, EMERG INFECT DIS, V22, P1193, DOI 10.3201/eid2207.150833.
   El Allaki F, 2012, EPIDEMIOL HEALTH, V34, DOI 10.4178/epih/e2012007.
   Falconi TMA, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17165887.
   George J, 2020, ONE HEALTH OUTLOOK, V2, DOI 10.1186/s42522-020-00017-4.
   Gkogka E, 2011, EMERG INFECT DIS, V17, P1581, DOI 10.3201/eid1709.101766.
   Dong HT, 2015, AQUACULTURE, V448, P427, DOI 10.1016/j.aquaculture.2015.06.027.
   Hall AJ, 2013, EMERG INFECT DIS, V19, P1305, DOI 10.3201/eid1908.130482.
   Hoffmann S, 2012, J FOOD PROTECT, V75, P1292, DOI 10.4315/0362-028X.JFP-11-417.
   Institute of Medicine, 2006, INV FOODB THREATS, P70.
   Izzo MM, 2011, AUST VET J, V89, P167, DOI 10.1111/j.1751-0813.2011.00692.x.
   Jagai JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038168.
   Jagai JS, 2009, ENVIRON RES, V109, P465, DOI 10.1016/j.envres.2009.02.008.
   Jones TF, 2018, FOODBORNE PATHOG DIS, V15, P11, DOI 10.1089/fpd.2017.2388.
   Lawpoolsri S, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006425.
   Lee Brendan, 2017, Vet Sci, V4, DOI 10.3390/vetsci4030040.
   Lofgren ET, 2010, INFLUENZA OTHER RESP, V4, P205, DOI 10.1111/j.1750-2659.2010.00137.x.
   Lynch M., 2006, 1998 2002 MORB MORTA, V55, P42.
   Manikonda K., 2017, US 2017 ANN REPORT.
   Menachemi N, 2011, RISK MANAG HEALTHC P, V4, P47, DOI 10.2147/RMHP.S12985.
   Middaugh JP, 2010, J ENVIRON HEALTH, V73, P8.
   Mor SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093744.
   Naumova EN, 2007, EPIDEMIOL INFECT, V135, P281, DOI 10.1017/S0950268806006698.
   Nygren BL, 2013, EPIDEMIOL INFECT, V141, P233, DOI 10.1017/S0950268812000222.
   O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/502007.
   O'Neil EA, 2007, J PUBLIC HEALTH POL, V28, P442, DOI 10.1057/palgrave.jphp.3200140.
   Painter JA, 2013, EMERG INFECT DIS, V19, P407, DOI 10.3201/eid1903.111866.
   Rolka Henry, 2012, MMWR Suppl, V61, P35.
   Scharff RL, 2016, AM J PREV MED, V50, pS66, DOI 10.1016/j.amepre.2015.09.018.
   Simpson RB, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-74435-9.
   Steele MK, 2020, EMERG INFECT DIS, V26, P1818, DOI 10.3201/eid2608.191537.
   Tack DM, 2020, MMWR-MORBID MORTAL W, V69, P509, DOI 10.15585/mmwr.mm6917a1.
   U.S. Department of Agriculture Economic Research Service (USDA ERS), COST EST FOODB ILLN.
   United States Food and Drug Association (FDA), WHAT YOU NEED KNOW F.
   United States Food and Drug Association (FDA), MOST COMM FOODB ILLN.
   Wenger JB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010187.},
Number-of-Cited-References = {48},
Times-Cited = {7},
Unique-ID = {WOS:000768172300001},
}

@article{ WOS:000524309300001,
Author = {Anderson, Laura N. and Sandhu, Ravinder and Keown-Stoneman, Charles D.
   G. and De Rubeis, Vanessa and Borkhoff, Cornelia M. and Carsley, Sarah
   and Maguire, Jonathon L. and Birken, Catherine S.},
Title = {Latent class analysis of obesity-related characteristics and
   associations with body mass index among young children},
Journal = {OBESITY SCIENCE \& PRACTICE},
Year = {2020},
Volume = {6},
Number = {4},
Pages = {390-400},
Month = {AUG},
Abstract = {Objective Identifying how obesity-related characteristics cluster in
   populations is important to understand disease risk. Objectives of this
   study were to identify classes of children based on obesity-related
   variables and to evaluate the associations between the identified
   classes and overweight and obesity.
   Methods A cross-sectional study was conducted among children 3-11 years
   of age (n = 5185) from the TARGet Kids! network (2008-2018). Latent
   class analysis was used to identify distinct classes of children based
   on 15 family, metabolic, health behaviours and school-related variables.
   Associations between the identified latent classes and overweight and
   obesity were estimated using multinomial logistic regression.
   Results Six classes were identified: Class 1: `Family and health risk
   behaviours' (20\%), Class 2: `Metabolic risk' (7\%), Class 3: `High
   risk' (6\%), Class 4: `High triglycerides' (21\%), Class 5: `Health risk
   behaviours and developmental concern' (22\%), and Class 6: `Healthy'
   (24\%). Children in Classes 1-5 had increased odds of both overweight
   and obesity compared with `Healthy' class. Class 3 `High risk' was most
   strongly associated with child overweight (odds ratio {[}OR] 1.9, 95\%
   confidence interval {[}CI] 1.2, 3.2) and obesity (OR 3.3, 95\% CI 1.7,
   6.7).
   Conclusions Distinct classes of children identified based on
   obesity-related characteristics were all associated with increased
   obesity; however, the magnitude of risk varied depending on number of
   at-risk characteristics. Understanding the clustering of obesity
   characteristics in children may inform precision public health and
   population prevention interventions.},
Type = {Article},
Affiliation = {Anderson, LN (Corresponding Author), McMaster Univ, Dept Hlth Res Methods Evidence \& Impact, Commun Res Lab CRL 221, 1280 Main St West, Hamilton, ON L85 4K1, Canada.
   Anderson, Laura N.; Sandhu, Ravinder; De Rubeis, Vanessa, McMaster Univ, Dept Hlth Res Methods Evidence \& Impact, Hamilton, ON, Canada.
   Anderson, Laura N.; Borkhoff, Cornelia M.; Birken, Catherine S., Sick Kids Res Inst, Div Child Hlth Evaluat Sci CHES, Toronto, ON, Canada.
   Keown-Stoneman, Charles D. G.; Maguire, Jonathon L., Univ Toronto, St Michaels Hosp, Appl Hlth Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON, Canada.
   Keown-Stoneman, Charles D. G., Univ Toronto, Dalla Lana Sch Publ Hlth, Div Biostat, Toronto, ON, Canada.
   Borkhoff, Cornelia M.; Maguire, Jonathon L.; Birken, Catherine S., Univ Toronto, Fac Med, Inst Hlth Policy Management \& Evaluat, Toronto, ON, Canada.
   Carsley, Sarah, Publ Hlth Ontario, Dept Hlth Promot Chron Dis \& Injury Prevent, Toronto, ON, Canada.
   Borkhoff, Cornelia M.; Maguire, Jonathon L.; Birken, Catherine S., Hosp Sick Children, Dept Pediat, Div Pediat Med, Toronto, ON, Canada.
   Borkhoff, Cornelia M.; Maguire, Jonathon L.; Birken, Catherine S., Hosp Sick Children, Dept Pediat, Pediat Outcomes Res Team PORT, Toronto, ON, Canada.
   Maguire, Jonathon L.; Birken, Catherine S., Univ Toronto, Fac Med, Dept Nutr Sci, Toronto, ON, Canada.
   Maguire, Jonathon L., St Michaels Hosp, Dept Pediat, Toronto, ON, Canada.},
DOI = {10.1002/osp4.414},
EarlyAccessDate = {APR 2020},
Keywords = {child obesity; latent class analysis; nutrition; physical activity},
Keywords-Plus = {CLINICAL STAGING SYSTEM; PHYSICAL-ACTIVITY; SEDENTARY BEHAVIOR;
   PATTERNS; INTERVENTIONS; ADOLESCENTS; OVERWEIGHT; CHILDHOOD; DURATION;
   PROFILE},
Research-Areas = {Endocrinology \& Metabolism},
Web-of-Science-Categories  = {Endocrinology \& Metabolism},
Author-Email = {ln.anderson@mcmaster.ca},
Affiliations = {McMaster University; University of Toronto; Hospital for Sick Children
   (SickKids); University of Toronto; Li Ka Shing Knowledge Institute;
   Saint Michaels Hospital Toronto; University of Toronto; University of
   Toronto; University of Toronto; Hospital for Sick Children (SickKids);
   University of Toronto; Hospital for Sick Children (SickKids); University
   of Toronto; University of Toronto; Saint Michaels Hospital Toronto},
Cited-References = {Anderson LN, 2019, PAED CHILD HEALT-CAN, V24, P377, DOI 10.1093/pch/pxz006.
   Anderson LN, 2017, J PEDIATR-US, V180, P47, DOI 10.1016/j.jpeds.2016.09.005.
   Bleich SN, 2018, LANCET DIABETES ENDO, V6, P332, DOI 10.1016/S2213-8587(17)30358-3.
   Blüher S, 2014, METABOLISM, V63, P1084, DOI 10.1016/j.metabol.2014.06.009.
   Carsley S, 2015, INT J EPIDEMIOL, V44, P776, DOI 10.1093/ije/dyu123.
   Carsley SE, 2017, CHILD OBES, V13, P415, DOI 10.1089/chi.2017.0004.
   Daniels S., 2011, PEDIATRICS, V128, pS213, DOI 10.1542/peds.2009-2107C.
   de Onis Mercedes, 2007, Bull World Health Organ, V85, P660, DOI 10.2471/BLT.07.043497.
   Department of Health, 2017, AUSTR PHYS ACT SED B.
   Fleary SA, 2017, J SCHOOL HEALTH, V87, P182, DOI 10.1111/josh.12481.
   Flynn JT, 2017, PEDIATRICS, V140, DOI {[}10.1542/peds.2017-3035, 10.1542/peds.2017-1904].
   Freedman DS, 2005, INT J OBESITY, V29, P1, DOI 10.1038/sj.ijo.0802735.
   Hadjiyannakis S, 2019, LANCET CHILD ADOLESC, V3, P398, DOI 10.1016/S2352-4642(19)30056-2.
   Hadjiyannakis S, 2016, PAED CHILD HEALT-CAN, V21, P21, DOI 10.1093/pch/21.1.21.
   Health Canada, 2003, CAN GUID BOD WEIGHT.
   Heyman MB, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2017-0967.
   Hirshkowitz M, 2015, SLEEP HEALTH, V1, P40, DOI 10.1016/j.sleh.2014.12.010.
   Huh J, 2011, OBESITY, V19, P652, DOI 10.1038/oby.2010.228.
   Iannotti RJ, 2013, J ADOLESCENT HEALTH, V53, P280, DOI 10.1016/j.jadohealth.2013.03.007.
   Lanza ST, 2007, STRUCT EQU MODELING, V14, P671, DOI 10.1080/10705510701575602.
   Laxer RE, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4034-0.
   Leech RM, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-4.
   Liu JH, 2010, J PHYS ACT HEALTH, V7, P465, DOI 10.1123/jpah.7.4.465.
   Mokha JS, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-73.
   Muthén B, 2000, ALCOHOL CLIN EXP RES, V24, P882, DOI 10.1111/j.1530-0277.2000.tb02070.x.
   Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555.
   Patnode CD, 2011, J PHYS ACT HEALTH, V8, P457, DOI 10.1123/jpah.8.4.457.
   Sarker Hrishov, 2015, BMC Res Notes, V8, P735, DOI 10.1186/s13104-015-1648-0.
   Schreiber JB, 2017, RES SOC ADMIN PHARM, V13, P1196, DOI 10.1016/j.sapharm.2016.11.011.
   Sharma AM, 2009, INT J OBESITY, V33, P289, DOI 10.1038/ijo.2009.2.
   Tremblay MS, 2016, APPL PHYSIOL NUTR ME, V41, pIII, DOI 10.1139/apnm-2016-0203.
   Tremblay MS, 2012, APPL PHYSIOL NUTR ME, V37, P370, DOI {[}10.1139/h2012-029, 10.1139/h2012-019, 10.1139/H2012-019, 10.1139/H2012-029].
   Ulbricht CM, 2018, PSYCHIAT RES, V266, P228, DOI 10.1016/j.psychres.2018.03.003.
   ,, 2006, Acta Paediatrica, V95, P76.},
Number-of-Cited-References = {34},
Times-Cited = {4},
Unique-ID = {WOS:000524309300001},
}

@article{ WOS:000916424600001,
Author = {LaSalle, Janine M. M.},
Title = {Epigenomic signatures reveal mechanistic clues and predictive markers
   for autism spectrum disorder},
Journal = {MOLECULAR PSYCHIATRY},
Year = {2023},
Volume = {28},
Number = {5},
Pages = {1890-1901},
Month = {MAY},
Abstract = {Autism spectrum disorder (ASD) comprises a heterogeneous group of
   neurodevelopmental outcomes in children with a commonality in deficits
   in social communication and language combined with repetitive behaviors
   and interests. The etiology of ASD is heterogeneous, as several hundred
   genes have been implicated as well as multiple in utero environmental
   exposures. Over the past two decades, epigenetic investigations,
   including DNA methylation, have emerged as a novel way to capture the
   complex interface of multivariate ASD etiologies. More recently,
   epigenome-wide association studies using human brain and surrogate
   accessible tissues have revealed some convergent genes that are
   epigenetically altered in ASD, many of which overlap with known genetic
   risk factors. Unlike transcriptomes, epigenomic signatures defined by
   DNA methylation from surrogate tissues such as placenta and cord blood
   can reflect past differences in fetal brain gene transcription,
   transcription factor binding, and chromatin. For example, the discovery
   of NHIP (neuronal hypoxia inducible, placenta associated) through an
   epigenome-wide association in placenta, identified a common genetic risk
   for ASD that was modified by prenatal vitamin use. While epigenomic
   signatures are distinct between different genetic syndromic causes of
   ASD, bivalent chromatin and some convergent gene pathways are
   consistently epigenetically altered in both syndromic and idiopathic
   ASD, as well as some environmental exposures. Together, these epigenomic
   signatures hold promising clues towards improved early prediction and
   prevention of ASD as well genes and gene pathways to target for
   pharmacological interventions. Future advancements in single cell and
   multi-omic technologies, machine learning, as well as non-invasive
   screening of epigenomic signatures during pregnancy or newborn periods
   are expected to continue to impact the translatability of the recent
   discoveries in epigenomics to precision public health.},
Type = {Review},
Affiliation = {LaSalle, JM (Corresponding Author), Univ Calif Davis, Dept Med Microbiol \& Immunol, Perinatal Origins Dispar Ctr, Genome Ctr,MIND Inst,Environm HlthSci Ctr, Davis, CA 95616 USA.
   LaSalle, Janine M. M., Univ Calif Davis, Dept Med Microbiol \& Immunol, Perinatal Origins Dispar Ctr, Genome Ctr,MIND Inst,Environm HlthSci Ctr, Davis, CA 95616 USA.},
DOI = {10.1038/s41380-022-01917-9},
EarlyAccessDate = {JAN 2023},
Keywords-Plus = {X-CHROMOSOME INACTIVATION; DNA METHYLATION; MATERNAL PLASMA;
   GENE-EXPRESSION; DOWN-SYNDROME; DEVELOPMENTAL-DISABILITIES; FETAL DNA;
   HERITABILITY; BLOOD; CELLS},
Research-Areas = {Biochemistry \& Molecular Biology; Neurosciences \& Neurology;
   Psychiatry},
Web-of-Science-Categories  = {Biochemistry \& Molecular Biology; Neurosciences; Psychiatry},
Author-Email = {jmlasalle@ucdavis.edu},
Affiliations = {University of California System; University of California Davis},
Cited-References = {Abrahams BS, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-36.
   Teh AL, 2014, GENOME RES, V24, P1064, DOI 10.1101/gr.171439.113.
   Alberry M, 2007, PRENATAL DIAG, V27, P415, DOI 10.1002/pd.1700.
   Amin V, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7370.
   Andrews SV, 2018, MOL AUTISM, V9, DOI 10.1186/s13229-018-0224-6.
   Aref-Eshghi E, 2020, AM J HUM GENET, V106, P356, DOI 10.1016/j.ajhg.2020.01.019.
   Aref-Eshghi E, 2018, AM J HUM GENET, V102, P156, DOI 10.1016/j.ajhg.2017.12.008.
   Aref-Eshghi E, 2017, J MOL DIAGN, V19, P848, DOI 10.1016/j.jmoldx.2017.07.002.
   Armand EJ, 2021, NEURON, V109, P11, DOI 10.1016/j.neuron.2020.12.010.
   Bacalini MG, 2015, AGING-US, V7, P82.
   Bailey DB, 2005, AM J PUBLIC HEALTH, V95, P1889, DOI 10.2105/AJPH.2004.051110.
   Bakulski KM, 2021, FRONT MOL NEUROSCI, V14, DOI 10.3389/fnmol.2021.775390.
   Bakulski KM, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17249190.
   Barefoot ME, 2021, FRONT GENET, V12, DOI 10.3389/fgene.2021.671057.
   Berko ER, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004402.
   Bhattacharya A, 2022, J MOL BIOL, V434, DOI 10.1016/j.jmb.2021.167386.
   Brasil S, 2021, FRONT MOL BIOSCI, V8, DOI 10.3389/fmolb.2021.648012.
   Breton CV, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-021-02316-6.
   Buckley JP, 2020, J EXPO SCI ENV EPID, V30, P397, DOI 10.1038/s41370-020-0211-9.
   Cali DS, 2019, BRIEF BIOINFORM, V20, P1542, DOI 10.1093/bib/bby017.
   Chadwick LH, 2012, EPIGENOMICS-UK, V4, P317, DOI {[}10.2217/EPI.12.18, 10.2217/epi.12.18].
   Chédin F, 2002, P NATL ACAD SCI USA, V99, P16916, DOI 10.1073/pnas.262443999.
   Chen C, 2014, REPROD BIOMED ONLINE, V29, P136, DOI 10.1016/j.rbmo.2014.03.017.
   Chen HI, 2019, DEV DYNAM, V248, P53, DOI 10.1002/dvdy.24662.
   Chen YW, 2021, SMALL METHODS, V5, DOI 10.1002/smtd.202100111.
   Chen ZX, 2005, J CELL BIOCHEM, V95, P902, DOI 10.1002/jcb.20447.
   Cheung WA, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1173-7.
   Ciernia AV, 2020, CEREB CORTEX, V30, P640, DOI 10.1093/cercor/bhz115.
   Colvert E, 2015, JAMA PSYCHIAT, V72, P415, DOI 10.1001/jamapsychiatry.2014.3028.
   Cotton AM, 2011, HUM GENET, V130, P187, DOI 10.1007/s00439-011-1007-8.
   Crary-Dooley FK, 2017, EPIGENETICS-US, V12, P206, DOI 10.1080/15592294.2016.1276680.
   Czamara D, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10461-0.
   Davis CA, 2018, NUCLEIC ACIDS RES, V46, pD794, DOI 10.1093/nar/gkx1081.
   Dawson G, 2013, JAMA PSYCHIAT, V70, P9, DOI 10.1001/jamapsychiatry.2013.488.
   De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772.
   Deardorff MA, 2012, NATURE, V489, P313, DOI 10.1038/nature11316.
   Delahanty RJ, 2011, MOL PSYCHIATR, V16, P86, DOI 10.1038/mp.2009.118.
   Delobel-Ayoub M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141964.
   Deng WL, 2015, J CHILD NEUROL, V30, P1794, DOI 10.1177/0883073815580645.
   Dou JF, 2022, EPIGENET CHROMATIN, V15, DOI 10.1186/s13072-022-00460-9.
   Dunaway KW, 2016, CELL REP, V17, P3035, DOI 10.1016/j.celrep.2016.11.058.
   Feinberg JI, 2015, INT J EPIDEMIOL, V44, P1199, DOI 10.1093/ije/dyv028.
   Foroutan A, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23031815.
   Frye RE, 2019, ANN TRANSL MED, V7, DOI 10.21037/atm.2019.11.53.
   Fu JM, 2022, NAT GENET, V54, P1320, DOI 10.1038/s41588-022-01104-0.
   Furukawa R, 2016, SCI REP-UK, V6, DOI 10.1038/srep26424.
   Gallegos DA, 2018, TRENDS NEUROSCI, V41, P311, DOI 10.1016/j.tins.2018.02.009.
   Gao L, 2018, EXP HEMATOL, V68, P2, DOI 10.1016/j.exphem.2018.10.009.
   Garg P, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007707.
   Garrido N, 2021, CLIN EPIGENETICS, V13, DOI 10.1186/s13148-020-00995-2.
   Gershman A, 2022, SCIENCE, V376, P58, DOI 10.1126/science.abj5089.
   Gregory SG, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-62.
   Grove J, 2019, NAT GENET, V51, P431, DOI 10.1038/s41588-019-0344-8.
   Gu JC, 2016, G3-GENES GENOM GENET, V6, P973, DOI 10.1534/g3.115.025437.
   Gu TP, 2022, NAT GENET, V54, P625, DOI 10.1038/s41588-022-01063-6.
   Gunasekara CJ, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1708-1.
   Hahn Laura J, 2020, J Health Sci Educ, V4.
   Hallmayer J, 2011, ARCH GEN PSYCHIAT, V68, P1095, DOI 10.1001/archgenpsychiatry.2011.76.
   Hannon E, 2018, GENOME MED, V10, DOI 10.1186/s13073-018-0527-4.
   Hannon E, 2015, EPIGENETICS-US, V10, P1024, DOI 10.1080/15592294.2015.1100786.
   Hertz-Picciotto I, 2018, ENVIRON HEALTH PERSP, V126, DOI {[}10.1289/EHP535, 10.1289/ehp535].
   Hertz-Picciotto I, 2009, EPIDEMIOLOGY, V20, P84, DOI 10.1097/EDE.0b013e3181902d15.
   Heyn H, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00113.
   Higgins GA, 2015, PHARMACOGENOMICS, V16, P1649, DOI 10.2217/pgs.15.111.
   Hogart A, 2008, HUM GENET, V124, P235, DOI 10.1007/s00439-008-0546-0.
   Hogart A, 2010, NEUROBIOL DIS, V38, P181, DOI 10.1016/j.nbd.2008.08.011.
   Hoyt SJ, 2022, SCIENCE, V376, P57, DOI 10.1126/science.abk3112.
   Huang YT, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-24710-8.
   Hwang S, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2014723118.
   Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908.
   Jensen TJ, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0645-x.
   Jiang YH, 2004, AM J MED GENET A, V131A, P1, DOI 10.1002/ajmg.a.30297.
   Jones MJ, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-58.
   Kadam SD, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20205098.
   Kerkhof Jennifer., 2022, EUR J HUM GENET, V24, P51, DOI 10.1016/j.gim.2021.08.007.
   Kim YS, 2011, AM J PSYCHIAT, V168, P904, DOI 10.1176/appi.ajp.2011.10101532.
   Ku MC, 2012, GENOME BIOL, V13, DOI {[}10.1186/gb-2012-13-10-R85, 10.1186/gb-2012-13-10-r85].
   Kuroda MI, 2020, ANNU REV BIOCHEM, V89, P235, DOI 10.1146/annurev-biochem-120219-103641.
   Ladd-Acosta C, 2014, MOL PSYCHIATR, V19, P862, DOI 10.1038/mp.2013.114.
   LaSalle JM, 2015, EPIGENOMICS-UK, V7, P1213, DOI 10.2217/epi.15.70.
   Lasalle Janine M, 2013, OA Autism, V1, P14.
   Laufer BI, 2021, EPIGENET CHROMATIN, V14, DOI 10.1186/s13072-021-00387-7.
   Laufer BI, 2020, HUM MOL GENET, V29, P3465, DOI 10.1093/hmg/ddaa218.
   Laufer BI, 2019, EPIGENETICS-US, V14, P672, DOI 10.1080/15592294.2019.1609867.
   Letourneau A, 2014, NATURE, V508, P345, DOI 10.1038/nature13200.
   Li JH, 2022, ELIFE, V11, DOI 10.7554/eLife.66909.
   Li S, 2022, EBIOMEDICINE, V77, DOI 10.1016/j.ebiom.2022.103927.
   Liang GN, 2017, EPIGENETICS-US, V12, P416, DOI 10.1080/15592294.2017.1311434.
   Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514.
   Liu HQ, 2021, NATURE, V598, P120, DOI 10.1038/s41586-020-03182-8.
   LO YMD, 1989, LANCET, V2, P1363.
   Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0.
   Locke WJ, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.01150.
   Lomvardas S, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a024208.
   Lu J, 2016, HUM MOL GENET, V25, P1714, DOI 10.1093/hmg/ddw043.
   Luo C., 2022, CELL GENOM, V2, P3.
   Luo CY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06355-2.
   Luo CY, 2017, SCIENCE, V357, P600, DOI 10.1126/science.aan3351.
   Maenner M.J., 2020, MORBIDITY MORTALITY, V69, P1, DOI {[}10.15585/mmwr.ss6904a1, DOI 10.15585/MMWR.SS6904A1].
   Maenner MJ, 2014, JAMA PSYCHIAT, V71, P292, DOI 10.1001/jamapsychiatry.2013.3893.
   Mao R, 2003, GENOMICS, V81, P457, DOI 10.1016/S0888-7543(03)00035-1.
   Masuzaki H, 2004, J MED GENET, V41, P289, DOI 10.1136/jmg.2003.015784.
   Medvedeva YA, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav067.
   Meguro-Horike M, 2011, HUM MOL GENET, V20, P3798, DOI 10.1093/hmg/ddr298.
   Mevel R, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.148296.
   Mitchell MM, 2012, ENVIRON MOL MUTAGEN, V53, P589, DOI 10.1002/em.21722.
   Mordaunt CE, 2022, BRIEF BIOINFORM, V23, DOI 10.1093/bib/bbab554.
   Mordaunt CE, 2020, GENOME MED, V12, DOI 10.1186/s13073-020-00785-8.
   Mordaunt CE, 2019, MOL AUTISM, V10, DOI 10.1186/s13229-019-0287-z.
   Morrison J, 2021, EPIGENET CHROMATIN, V14, DOI 10.1186/s13072-021-00401-y.
   Moshfegh Alanna J., 2012, Morbidity and Mortality Weekly Report, V61, P92.
   Murphy PJ, 2018, CELL, V172, P993, DOI 10.1016/j.cell.2018.01.022.
   Nagarajan RP, 2006, EPIGENETICS-US, V1, P172, DOI 10.4161/epi.1.4.3514.
   Nagarajan RP, 2008, AUTISM RES, V1, P169, DOI 10.1002/aur.24.
   Nardone S, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.70.
   Nardone S, 2017, CEREB CORTEX, V27, P5739, DOI 10.1093/cercor/bhx250.
   Newschaffer CJ, 2012, J NEURODEV DISORD, V4, DOI 10.1186/1866-1955-4-7.
   Nurk S, 2022, SCIENCE, V376, P44, DOI 10.1126/science.abj6987.
   Ozonoff S, 2019, NEUROSCI BIOBEHAV R, V100, P296, DOI 10.1016/j.neubiorev.2019.03.012.
   Parikshak NN, 2016, NATURE, V540, P423, DOI 10.1038/nature20612.
   Pierce K, 2009, ANN CLIN PSYCHIATRY, V21, P132.
   Provençal N, 2015, EXP NEUROL, V268, P10, DOI 10.1016/j.expneurol.2014.09.001.
   Rauschert S, 2020, ENVIRON HEALTH PERSP, V128, DOI 10.1289/EHP6076.
   Rice Catherine, 2007, Morbidity and Mortality Weekly Report, V56, P12.
   Samaco RC, 2005, HUM MOL GENET, V14, P483, DOI 10.1093/hmg/ddi045.
   Schanen NC, 2006, HUM MOL GENET, V15, pR138, DOI 10.1093/hmg/ddl213.
   Schmidt Rebecca J, 2013, Evid Based Med, V18, pe53, DOI 10.1136/eb-2013-101311.
   Schmidt RJ, 2011, EPIDEMIOLOGY, V22, P476, DOI 10.1097/EDE.0b013e31821d0e30.
   Schroeder DI, 2016, MOL AUTISM, V7, DOI 10.1186/s13229-016-0114-8.
   Schroeder DI, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005442.
   Schroeder DI, 2013, P NATL ACAD SCI USA, V110, P6037, DOI 10.1073/pnas.1215145110.
   Sendzikaite G, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09713-w.
   Siu MT, 2019, CLIN EPIGENETICS, V11, DOI 10.1186/s13148-019-0684-3.
   Steiner P, 2019, ANN NUTR METAB, V75, P8, DOI 10.1159/000508054.
   Sun K, 2015, P NATL ACAD SCI USA, V112, pE5503, DOI 10.1073/pnas.1508736112.
   Sun RX, 2022, BLOOD SCI, V4, P8, DOI 10.1097/BS9.0000000000000098.
   Sun WJ, 2016, CELL, V167, P1385, DOI 10.1016/j.cell.2016.10.031.
   Suzuki T, 2017, BLOOD ADV, V1, P1699, DOI 10.1182/bloodadvances.2017005710.
   Tassone F, 2014, JAMA NEUROL, V71, P355, DOI 10.1001/jamaneurol.2013.4808.
   Tick B, 2016, J CHILD PSYCHOL PSYC, V57, P585, DOI 10.1111/jcpp.12499.
   Vallot C, 2017, CELL STEM CELL, V20, P102, DOI 10.1016/j.stem.2016.10.014.
   Vallot C, 2015, CELL STEM CELL, V16, P533, DOI 10.1016/j.stem.2015.03.016.
   Vazin T, 2010, RESTOR NEUROL NEUROS, V28, P589, DOI 10.3233/RNN-2010-0543.
   Vlahos A, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008236.
   Vrba L, 2022, CLIN EPIGENETICS, V14, DOI 10.1186/s13148-022-01246-2.
   Williams LA, 2022, MOL DIAGN THER, V26, P569, DOI 10.1007/s40291-022-00608-z.
   Wingate M, 2014, MMWR SURVEILL SUMM, V63.
   Wong CCY, 2014, MOL PSYCHIATR, V19, P495, DOI 10.1038/mp.2013.41.
   Wong CCY, 2019, HUM MOL GENET, V28, P2201, DOI 10.1093/hmg/ddz052.
   Yu TW, 2013, NEURON, V77, P259, DOI 10.1016/j.neuron.2012.11.002.
   Zaaroor-Regev D, 2010, P NATL ACAD SCI USA, V107, P6788, DOI 10.1073/pnas.1003108107.
   Zhou XY, 2022, NAT GENET, V54, P1305, DOI 10.1038/s41588-022-01148-2.
   Zhu YH, 2022, GENOME BIOL, V23, DOI 10.1186/s13059-022-02613-1.
   Zhu YH, 2019, HUM MOL GENET, V28, P2659, DOI 10.1093/hmg/ddz084.},
Number-of-Cited-References = {154},
Times-Cited = {10},
Unique-ID = {WOS:000916424600001},
}

@article{ WOS:000537552800179,
Author = {Shifti, Desalegn Markos and Chojenta, Catherine and Holliday, Elizabeth
   G. and Loxton, Deborah},
Title = {Application of geographically weighted regression analysis to assess
   predictors of short birth interval hot spots in Ethiopia},
Journal = {PLOS ONE},
Year = {2020},
Volume = {15},
Number = {5},
Month = {MAY 29},
Abstract = {Background
   Birth interval duration is an important and modifiable risk factor for
   adverse child and maternal health outcomes. Understanding the spatial
   distribution of short birth interval, an interbirth interval of less
   than 33 months, and its predictors are vital to prioritize and
   facilitate targeted interventions. However, the spatial variation of
   short birth interval and its underlying factors have not been
   investigated in Ethiopia.
   Objective
   This study aimed to assess the predictors of short birth interval hot
   spots in Ethiopia.
   Methods
   The study used data from the 2016 Ethiopia Demographic and Health Survey
   and included 8,448 women in the analysis. The spatial variation of short
   birth interval was first examined using hot spot analysis (Local
   Getis-Ord Gi{*} statistic). Ordinary least squares regression was used
   to identify factors explaining the geographic variation of short birth
   interval. Geographically weighted regression was used to explore the
   spatial variability of relationships between short birth interval and
   selected predictors.
   Results
   Statistically significant hot spots of short birth interval were found
   in Somali Region, Oromia Region, Southern Nations, Nationalities, and
   Peoples' Region and some parts of Afar Region. Women with no education
   or with primary education, having a husband with higher education (above
   secondary education), and coming from a household with a poorer wealth
   quintile or middle wealth quintile were predictors of the spatial
   variation of short birth interval. The predictive strength of these
   factors varied across the study area. The geographically weighted
   regression model explained about 64\% of the variation in short birth
   interval occurrence.
   Conclusion
   Residing in a geographic area where a high proportion of women had
   either no education or only primary education, had a husband with higher
   education, or were from a household in the poorer or middle wealth
   quintile increased the risk of experiencing short birth interval. Our
   detailed maps of short birth interval hot spots and its predictors will
   assist decision makers in implementing precision public health.},
Type = {Article},
Affiliation = {Shifti, DM (Corresponding Author), St Pauls Hosp Millennium Med Coll, Addis Ababa, Ethiopia.
   Shifti, DM (Corresponding Author), Univ Newcastle, Sch Med \& Publ Hlth, Prior Res Ctr Generat Hlth \& Ageing, Newcastle, NSW, Australia.
   Shifti, Desalegn Markos, St Pauls Hosp Millennium Med Coll, Addis Ababa, Ethiopia.
   Shifti, Desalegn Markos; Chojenta, Catherine; Loxton, Deborah, Univ Newcastle, Sch Med \& Publ Hlth, Prior Res Ctr Generat Hlth \& Ageing, Newcastle, NSW, Australia.
   Holliday, Elizabeth G., Univ Newcastle, Sch Med \& Publ Hlth, Ctr Clin Epidemiol \& Biostat, Newcastle, NSW, Australia.},
DOI = {10.1371/journal.pone.0233790},
Article-Number = {e0233790},
Keywords-Plus = {MATERNAL HEALTH-CARE; INTERPREGNANCY INTERVAL; LOCAL STATISTICS;
   DETERMINANTS},
Research-Areas = {Science \& Technology - Other Topics},
Web-of-Science-Categories  = {Multidisciplinary Sciences},
Author-Email = {desalegnmarkos@gmail.com},
Affiliations = {University of Newcastle; University of Newcastle},
Cited-References = {Abekah-Nkrumah G, 2011, INT J HEALTH CARE Q, V24, P601, DOI 10.1108/09526861111174170.
   Adam I, 2009, J MATERN-FETAL NEO M, V22, P1068, DOI 10.3109/14767050903009222.
   Adedini SA, 2018, GLOB HEALTH-SCI PRAC, V6, P500, DOI 10.9745/GHSP-D-18-00135.
   Andersson G, 2006, DEMOGR RES, V14, P51.
   {[}Anonymous], 2002, Popul Rep L, P1.
   {[}Anonymous], 2011, INT OLS RES.
   {[}Anonymous], 2012, Ethiopia Demographic and Health Survey 2011.
   {[}Anonymous], 2015, HSTP HLTH SECT TRANS.
   {[}Anonymous], 2005, ETH DEM HLTH SURV 20.
   Bassey G, 2016, Sahel Medical Journal, V19, P180, DOI DOI 10.4103/1118-8561.196357.
   Begna Z, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-116.
   Belda SS, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2115-5.
   CDC, 2018, PREC PUBL HLTH WHAT.
   Celik Y, 2000, SOC SCI MED, V50, P1797, DOI 10.1016/S0277-9536(99)00418-9.
   Central Statistics Agency ORC Macro, 2001, ETH DEM HLTH SURV 20.
   Chen I, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2014.02.002.
   Cheslack-Postava K, 2011, PEDIATRICS, V127, P246, DOI 10.1542/peds.2010-2371.
   Chirwa TF, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-271.
   CSA ICF., 2016, Ethiopia Demographic and Health Survey.
   DaVanzo J, 2007, BJOG-INT J OBSTET GY, V114, P1079, DOI 10.1111/j.1471-0528.2007.01338.x.
   DaVanzo J, 2004, TECHNICAL CONSULTATI.
   de Castro MC, 2006, GEOGR ANAL, V38, P180.
   de Jonge HCC, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/s12884-014-0427-6.
   Demelash H, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0677-y.
   Esri, HIGH LOW CLUST GET O.
   Esri, SPAT AUT GLOB MOR 1.
   Esri, INT GWR RES.
   Esri, COMM REGR PROBL CONS.
   Esri, WHAT IS Z SCOR WHAT.
   Esri, INCR SPAT AUT.
   Esri, GEOGR WEIGHT REGR GW.
   Esri, HOT SPOT AN GET ORD.
   Esri, How exploratory regression works.
   Exavery A, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-152.
   Fallahzadeh H, 2013, IRAN J REPROD MED, V11, P379.
   Federal Democratic Republic of Ethiopia Ministry of Health, 2010, HLTH SECT DEV PROGR.
   Fotheringham A., 2002, Geographically Weighted Regression: The Analysis of Spatially Varying Relationships.
   GETIS A, 1992, GEOGR ANAL, V24, P189, DOI 10.1111/j.1538-4632.1992.tb00261.x.
   Gillespie D, 2007, B WORLD HEALTH ORGAN, V85, P100, DOI 10.2471/BLT.06.033829.
   Government Communication Affairs Office, 2016, COUNTR PROF.
   Grisaru-Granovsky S, 2009, CONTRACEPTION, V80, P512, DOI 10.1016/j.contraception.2009.06.006.
   Hailu D, 2016, INT J REPROD MED, V2016.
   Haque U, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-63.
   Henok A, 2017, ETHIOP J HEALTH SCI, V27, P523, DOI 10.4314/ejhs.v27i5.11.
   Horton R, 2018, LANCET, V392, P1504, DOI 10.1016/S0140-6736(18)32741-7.
   Hussaini KS, 2013, MATERN CHILD HLTH J, V17, P646, DOI 10.1007/s10995-012-1041-8.
   ICF, 2012, DEM HLTH SURV INT MA.
   ICF International, 2013, Incorporating Geographic Information into Demographic and Health Surveys: A Field Guide to GPS Data Collection.
   Johnston K., 2001, Using ArcGIS geostatistical analyst, V380.
   Kahsay ZH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197366.
   Karkee R, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00205.
   Kwon S, 2012, J PERINATOL, V32, P45, DOI 10.1038/jp.2011.49.
   Lakew Y, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-52.
   Marston C., 2005, Report of WHO Technical Consultation on Birth Spacing.
   Matthews SA, 2012, DEMOGR RES, V26, P151, DOI 10.4054/DemRes.2012.26.6.
   Mei CL, 2006, ENVIRON PLANN A, V38, P587, DOI 10.1068/a3768.
   Natural Earth, FREE VECT RAST DAT.
   ORD JK, 1995, GEOGR ANAL, V27, P286, DOI 10.1111/j.1538-4632.1995.tb00912.x.
   POOLE MA, 1971, T I BRIT GEOGR, P145, DOI 10.2307/621706.
   Raghupathy S, 1996, SOC SCI MED, V43, P459, DOI 10.1016/0277-9536(95)00411-4.
   Rutstein Shea O, 2005, INT J GYNECOLOGY OBS, V89.
   Speizer IS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204049.
   Tegegne TK, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219860.
   Tessema Gizachew Assefa, 2013, Afr J Reprod Health, V17, P39.
   Tsegaye D., 2017, INT J NURS MIDWIFERY, V9, P102, DOI {[}10.5897/IJNM2017.0258, DOI 10.5897/IJNM2017.0258].
   Warsito B., 2018, Journal of Physics: Conference Series.
   Yigzaw M, 2015, INT J EQUITY HEALTH, V14, DOI 10.1186/s12939-015-0214-7.
   Yohannes S, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-38.},
Number-of-Cited-References = {68},
Times-Cited = {15},
Unique-ID = {WOS:000537552800179},
}

@article{ WOS:000692968300023,
Author = {Rebinsky, Reid and Anderson, Laura N. and Morgenstern, Jason D.},
Title = {Identifying non-traditional electronic datasets for population-level
   surveillance and prevention of cardiometabolic diseases: a scoping
   review protocol},
Journal = {BMJ OPEN},
Year = {2021},
Volume = {11},
Number = {8},
Abstract = {Introduction Cardiometabolic diseases, including cardiovascular disease,
   obesity and diabetes, are leading causes of death and disability
   worldwide. Modern advances in population-level disease surveillance are
   necessary and may inform novel opportunities for precision public health
   approaches to disease prevention. Electronic data sources, such as
   social media and consumer rewards points systems, have expanded
   dramatically in recent decades. These non-traditional datasets may
   enhance traditional clinical and public health datasets and inform
   cardiometabolic disease surveillance and population health
   interventions. However, the scope of non-traditional electronic datasets
   and their use for cardiometabolic disease surveillance and population
   health interventions has not been previously reviewed. The primary
   objective of this review is to describe the scope of non-traditional
   electronic datasets, and how they are being used for cardiometabolic
   disease surveillance and to inform interventions. The secondary
   objective is to describe the methods, such as machine learning and
   natural language processing, that have been applied to leverage these
   datasets. Methods and analysis We will conduct a scoping review
   following recommended methodology. Search terms will be based on the
   three central concepts of non-traditional electronic datasets,
   cardiometabolic diseases and population health. We will search EMBASE,
   MEDLINE, CINAHL, Scopus, Web of Science and Cochrane Library
   peer-reviewed databases and will also conduct a grey literature search.
   Articles published from 2000 to present will be independently screened
   by two reviewers for inclusion at abstract and full-text stages, and
   conflicts will be resolved by a separate reviewer. We will report this
   data as per the Preferred Reporting Items for Systematic Reviews and
   Meta-Analyses extension for Scoping Reviews. Ethics and dissemination No
   ethics approval is required for this protocol and scoping review, as
   data will be used only from published studies with appropriate ethics
   approval. Results will be disseminated in a peer-reviewed publication.},
Type = {Review},
Affiliation = {Rebinsky, R (Corresponding Author), McMaster Univ, Michael G DeGroote Sch Med, Hamilton, ON, Canada.
   Rebinsky, Reid, McMaster Univ, Michael G DeGroote Sch Med, Hamilton, ON, Canada.
   Anderson, Laura N.; Morgenstern, Jason D., McMaster Univ, Hlth Res Methods Evidence \& Impact, Hamilton, ON, Canada.},
DOI = {10.1136/bmjopen-2021-053485},
Article-Number = {e053485},
Keywords = {hypertension; ischaemic heart disease; general diabetes; lipid
   disorders; public health; information technology},
Keywords-Plus = {CARDIOVASCULAR-DISEASE; TRENDS; HEART},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Author-Email = {reid.rebinsky@medportal.ca},
Affiliations = {McMaster University; McMaster University},
Cited-References = {Abbafati C, 2020, LANCET, V396, P1204.
   {[}Anonymous], 2017, Lead Poisoning and Health.
   Arksey H., 2005, INT J SOC RES METHOD, V8, P19, DOI {[}10.1080/1364557032000119616, DOI 10.1080/1364557032000119616].
   Bellanger Tracie Manuel, 2005, J La State Med Soc, V157 Spec No 1, pS42.
   Benson G, 2019, PREV MED REP, V13, P332, DOI 10.1016/j.pmedr.2019.01.018.
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5.
   Boulos MKN, 2020, INT J HEALTH GEOGR, V19, DOI 10.1186/s12942-020-00202-8.
   Dilsizian SE, 2014, CURR CARDIOL REP, V16, DOI 10.1007/s11886-013-0441-8.
   Dolley S, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00068.
   Eggleston EM, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-013-0468-7.
   Elagizi A, 2020, CURR OBES REP, V9, P571, DOI 10.1007/s13679-020-00403-z.
   Fakhouri Tala H I, 2020, Vital Health Stat 2, P1.
   Gilbert R., 2016, Public health intelligence: issues of measure and method, P91.
   Groce NE, 2018, LANCET GLOB HEALTH, V6, pE724, DOI 10.1016/S2214-109X(18)30265-1.
   Havranek EP, 2015, CIRCULATION, V132, P873, DOI 10.1161/CIR.0000000000000228.
   Horth RZ, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7367-z.
   Hu H, 2017, EPIDEMIOLOGY, V28, P759, DOI {[}10.1097/ede.0000000000000711, 10.1097/EDE.0000000000000711].
   Miranda JJ, 2020, LANCET GLOB HEALTH, V8, pE123, DOI 10.1016/S2214-109X(19)30484-X.
   Krittanawong C, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-72685-1.
   Kruse CS, 2018, J MED SYST, V42, DOI 10.1007/s10916-018-1075-6.
   Levac D, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-69.
   Martínez-García M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190960.
   Matlock DD, 2013, JAMA-J AM MED ASSOC, V310, P155, DOI 10.1001/jama.2013.7837.
   Miranda JJ, 2019, NAT MED, V25, P1667, DOI 10.1038/s41591-019-0644-7.
   Morgenstern JD, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-037860.
   Ng K, 2016, CIRC-CARDIOVASC QUAL, V9, P649, DOI 10.1161/CIRCOUTCOMES.116.002797.
   Nsubuga P, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P997.
   Oh SH, 2021, HEALTH COMMUN, V36, P972, DOI 10.1080/10410236.2020.1724639.
   Oldroyd RA, 2018, JMIR PUBLIC HLTH SUR, V4, P59, DOI 10.2196/publichealth.8218.
   Peytchev A, 2013, ANN AM ACAD POLIT SS, V645, P88, DOI 10.1177/0002716212461748.
   Reynolds K, 2017, AM J MED, V130, P317, DOI 10.1016/j.amjmed.2016.09.014.
   Roth GA, 2018, LANCET, V392, P1736, DOI 10.1016/S0140-6736(18)32203-7.
   Sinnenberg L, 2016, JAMA CARDIOL, V1, P1032, DOI 10.1001/jamacardio.2016.3029.
   Tricco AC, 2018, ANN INTERN MED, V169, P467, DOI 10.7326/M18-0850.
   Verma M, 2018, HEALTHC INFORM RES, V24, P300.
   Yom-Tov E, 2018, NPJ DIGIT MED, V1, DOI 10.1038/s41746-018-0031-7.},
Number-of-Cited-References = {36},
Times-Cited = {0},
Unique-ID = {WOS:000692968300023},
}

@article{ WOS:000567471200004,
Author = {Macharia, Peter M. and Joseph, Noel K. and Okiro, Emelda A.},
Title = {A vulnerability index for COVID-19: spatial analysis at the subnational
   level in Kenya},
Journal = {BMJ GLOBAL HEALTH},
Year = {2020},
Volume = {5},
Number = {8},
Month = {AUG},
Abstract = {Background Response to the coronavirus disease 2019 (COVID-19) pandemic
   calls for precision public health reflecting our improved understanding
   of who is the most vulnerable and their geographical location. We
   created three vulnerability indices to identify areas and people who
   require greater support while elucidating health inequities to inform
   emergency response in Kenya. Methods Geospatial indicators were
   assembled to create three vulnerability indices; Social
   VulnerabilityIndex (SVI), Epidemiological Vulnerability Index (EVI) and
   a composite of the two, that is, Social Epidemiological Vulnerability
   Index (SEVI) resolved at 295 subcounties in Kenya. SVI included 19
   indicators that affect the spread of disease; socioeconomic deprivation,
   access to services and population dynamics, whereas EVI comprised 5
   indicators describing comorbidities associated with COVID-19 severe
   disease progression. The indicators were scaled to a common measurement
   scale, spatially overlaid via arithmetic mean and equally weighted. The
   indices were classified into seven classes, 1-2 denoted low
   vulnerability and 6-7, high vulnerability. The population within
   vulnerabilities classes was quantified. Results The spatial variation of
   each index was heterogeneous across Kenya. Forty-nine northwestern and
   partly eastern subcounties (6.9 million people) were highly vulnerable,
   whereas 58 subcounties (9.7 million people) in western and central Kenya
   were the least vulnerable for SVI. For EVI, 48 subcounties (7.2 million
   people) in central and the adjacent areas and 81 subcounties (13.2
   million people) in northern Kenya were the most and least vulnerable,
   respectively. Overall (SEVI), 46 subcounties (7.0 million people) around
   central and southeastern were more vulnerable, whereas 81 subcounties
   (14.4 million people) were least vulnerable. Conclusion The
   vulnerability indices created are tools relevant to the county, national
   government and stakeholders for prioritisation and improved planning.
   The heterogeneous nature of the vulnerability indices underpins the need
   for targeted and prioritised actions based on the needs across the
   subcounties.},
Type = {Article},
Affiliation = {Macharia, PM (Corresponding Author), KEMRI Wellcome Trust Res Programme, Populat Hlth Unit, Nairobi, Kenya.
   Macharia, Peter M.; Joseph, Noel K.; Okiro, Emelda A., KEMRI Wellcome Trust Res Programme, Populat Hlth Unit, Nairobi, Kenya.
   Okiro, Emelda A., Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med \& Global Hlth, Oxford, England.},
DOI = {10.1136/bmjgh-2020-003014},
Article-Number = {e003014},
Keywords = {public health; indices of health and disease and standardisation of
   rates; geographic information systems; epidemiology},
Keywords-Plus = {COVERAGE},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {pmacharia@kemri-wellcome.org},
Affiliations = {University of Oxford},
Cited-References = {Africa Center for Strategic Studies, 2020, MAPP RISK FACT SPREA.
   Ahmed F, 2020, LANCET PUBLIC HEALTH, V5, pE240, DOI 10.1016/S2468-2667(20)30085-2.
   {[}Anonymous], 2020, Daily Nation.
   Bakka H, 2018, WIRES COMPUT STAT, V10, DOI 10.1002/wics.1443.
   Barasa EW, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236308.
   Barda N, 2020, PERFORMING RISK STRA.
   Barros AJD, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2019-002229.
   Barros AJD, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001390.
   Boerma JT, 2008, LANCET, V371, P1259, DOI 10.1016/S0140-6736(08)60560-7.
   Boerma T, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001728.
   Breiman RF, 2004, LEARNING SARS PREPAR.
   Burgert-Brucker CR, 2018, STUD FAMILY PLANN, V49, P87, DOI 10.1111/sifp.12050.
   CDC, 2020, COVID 19 PEOPL WHO A.
   CDC, 2018, SOC VULN IND.
   CDC Africa Centers for Disease Control, 2020, COR DIS 2019 COVID 1.
   Chen T, 2020, BMJ-BRIT MED J, V368, DOI {[}10.1136/bmj.m1295, 10.1136/bmj.m1091].
   COG, 2020, COUNT INT DEV PLAN.
   Cyranoski David, 2020, Nature, DOI {[}10.1038/d41586-020-01284-x, 10.1038/d41586-020-00938-0].
   DeCaprio D., 2020, Building a COVID-19 Vulnerability Index, DOI 10.21037/jmai-20-47.
   DHS Program, 2019, SPAT DAT REP DEM HLT.
   Diggle PJ, 1998, J R STAT SOC C-APPL, V47, P299, DOI 10.1111/1467-9876.00113.
   Diop BZ, 2020, RELATIVELY YOUNG RUR.
   Dixon M. G., 2014, ANN EMERG MED, V65, P114.
   Dwyer-Lindgren L, 2019, NATURE, V570, P189, DOI 10.1038/s41586-019-1200-9.
   Faye CM, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2019-002232.
   Fraym, 2020, LOC DAT OPT DEL PUBL.
   Getis A, 2004, GEOGR ANAL, V36, P90, DOI 10.1353/geo.2004.0002.
   GOK, 2010, CONST KEN.
   GoK, 2018, RESP QUEST SPEC RAPP.
   GoK, 2020, 7 PRES ADDR COR PAND.
   GoK MoH, 2015, KEN STEPW SURV NONC.
   Graetz N, 2018, NATURE, V555, P48, DOI 10.1038/nature25761.
   Han SM, 2018, LANCET GLOB HEALTH, V6, pE989, DOI {[}10.1016/s2214-109x(18)30318-8, 10.1016/S2214-109X(18)30318-8].
   Harris MJ, 2020, BIOL LETTERS, V16, DOI 10.1098/rsbl.2019.0713.
   Heesterbeek J.A.P., 1993, Stat Neerlandica, V50, P89, DOI {[}DOI 10.1111/J.1467-9574.1996.TB01482.X, 10.1111/j.1467-9574.1996.tb01482.x].
   Ihekweazu C, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01622-w.
   Jenks G.F., 1977, Occasional Paper \#2.
   JNK R, 2003, SMALL AREA ESTIMATIO.
   Jordan Rachel E, 2020, BMJ, V368, pm1198, DOI 10.1136/bmj.m1198.
   Kelley M, 2020, LANCET GLOB HEALTH, V8, pE888, DOI 10.1016/S2214-109X(20)30249-7.
   Kienberger S, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-29.
   Kluge H, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000656.
   KNBS, 2016, KEN NAT DAT ARCH.
   KNBS, 2020, KEN EC SURV.
   KNBS, 2020, KEN NAT BUR STAT 201.
   KNBS MoH N, 2015, KEN DEM HLTH SURV 20.
   KPMG, 2013, DEV HEALTHC SERV KEN.
   Lloyd-Sherlock P, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1052.
   Lozano R, 2006, LANCET, V368, P1729, DOI 10.1016/S0140-6736(06)69566-4.
   Manhique AJ, 2015, NAT HAZARDS, V77, P679, DOI 10.1007/s11069-015-1616-y.
   MoH/GoK, 2019, KEN HARM HLT FAC ASS.
   Mohamed SF, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6053-x.
   Moore M., 2016, Identifying Future Disease Hot Spots: Infectious Disease Vulnerability Index.
   NACC, 2018, KEN HIV EST REP 2018, P1.
   Nelson A, 2019, SCI DATA, V6, DOI 10.1038/s41597-019-0265-5.
   NIEHS, 2020, COVID 19 PAND VULN I.
   OCHA, 2020, IR COVID 19 CAMP VUL.
   Osgood-Zimmerman A, 2018, NATURE, V555, P41, DOI 10.1038/nature25760.
   Ouma PO, 2018, LANCET GLOB HEALTH, VS2214-109X, P30488.
   Panda BK, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-8151-9.
   Pezzulo C, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.89.
   Pratt B, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2019-001942.
   Rader B, INCREASED TRAVEL TIM.
   Rose TC., 2020, medRxiv, DOI 10.1101/2020.04.25.20079491.
   Rosenthal PJ, 2020, AM J TROP MED HYG, V102, P1145, DOI 10.4269/ajtmh.20-0380.
   SDI, 2020, KNOW YOUR CIT CAMP C.
   Smith JA, 2020, HEALTH PROMOT J AUST, V31, P158, DOI 10.1002/hpja.333.
   Stevens FR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0107042.
   Surgo Foundation, 2020, COVID 19 COMM VULN.
   Talisuna AO, 2020, GLOBALIZATION HEALTH, V16, DOI 10.1186/s12992-019-0540-4.
   Tatem AJ, 2013, POPUL HEALTH METR, V11, DOI 10.1186/1478-7954-11-11.
   Tsague GN, 2011, J HUM DEV, V12, P37.
   UNHCR, 2020, OP PORT REF SIT.
   van Dorn A, 2020, LANCET, V395, P1243, DOI 10.1016/S0140-6736(20)30893-X.
   Wadhera RK, 2020, JAMA-J AM MED ASSOC, V323, P2192, DOI 10.1001/jama.2020.7197.
   Wagstaff A, 2020, LANCET GLOB HEALTH, V8, pE39, DOI 10.1016/S2214-109X(19)30463-2.
   Wehrmeister FC, 2016, B WORLD HEALTH ORGAN, V94, P903, DOI 10.2471/BLT.16.173138.
   Whitehead M, 2020, BMJ OPIN.
   WHO, 2015, EM PREP RESP FACT CO.
   WHO, 2020, AFR COUNTR START EAS.
   WHO, 190 000 PEOPL COULD.
   WHO, 2020, AFR COVID 19 CAS TOP.
   Wilkinson A, 2020, ENVIRON URBAN, V32, P503, DOI 10.1177/0956247820922843.
   Williamson EJ, 2020, NATURE, V584, P430, DOI 10.1038/s41586-020-2521-4.
   Winskill P, 2020, EQUITY RESPONSE COVI.
   World Health Organization, 2007, SAF FUT GLOB PUBL HL.
   Wu Z, 2020, JAMA, V323, P1239, DOI 10.1001/jama.2020.2648.
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3.
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI {[}10.1056/NEJMoa2001017, 10.1172/JCI89857].},
Number-of-Cited-References = {89},
Times-Cited = {43},
Unique-ID = {WOS:000567471200004},
}

@article{ WOS:000651509000002,
Author = {Marquez, Neal and Wakefield, Jon},
Title = {Harmonizing child mortality data at disparate geographic levels},
Journal = {STATISTICAL METHODS IN MEDICAL RESEARCH},
Year = {2021},
Volume = {30},
Number = {5},
Pages = {1187-1210},
Month = {MAY},
Abstract = {There is an increasing focus on reducing inequalities in health outcomes
   in developing countries. Subnational variation is of particular
   interest, with geographically-indexed data being used to understand the
   spatial risk of detrimental outcomes and to identify who is at greatest
   risk. While some health surveys provide observations with associated
   geographic coordinates (point data), many others provide data that have
   their locations masked and instead only report the strata (polygon
   information) within which the data resides (masked data). How to
   harmonize these data sources for spatial analysis has been previously
   considered although only ad hoc methods and comparison of methods is
   lacking. In this paper, we present a new method for analyzing masked
   survey data, using a method that is consistent with the data-generating
   process. In addition, we critique two previously proposed approaches to
   analyzing masked data and illustrate that they are fundamentally flawed
   methodologically. To validate our method, we compare our approach with
   previously formulated solutions in several realistic simulation
   environments in which the underlying structure of the risk field is
   known. We simulate samples from spatiotemporal fields in a way that
   mimics the sampling frame implemented in the most common health surveys
   in low- and middle-income countries, the Demographic and Health Surveys
   and Multiple Indicator Cluster Surveys. In simulations, the newly
   proposed approach outperforms previously proposed approaches in terms of
   minimizing error while increasing the precision of estimates. The
   approaches are subsequently compared using child mortality data from the
   Dominican Republic where our findings are reinforced. The ability to
   accurately increase precision of child mortality estimates, and health
   outcomes in general, by leveraging various types of data, improves our
   ability to implement precision public health initiatives and better
   understand the landscape of geographic health inequalities.},
Type = {Article},
Affiliation = {Marquez, N (Corresponding Author), Univ Washington, Dept Sociol, Seattle, WA 98195 USA.
   Marquez, Neal, Univ Washington, Dept Sociol, Seattle, WA 98195 USA.
   Wakefield, Jon, Univ Washington, Dept Stat, Seattle, WA 98195 USA.},
DOI = {10.1177/0962280220988742},
Keywords = {Model-based geostatistics; Bayesian inference; spatial misalignment;
   spatial demography},
Keywords-Plus = {CIVIL REGISTRATION; VITAL-STATISTICS; MODELS; SYSTEMS; DISEASE; INLA},
Research-Areas = {Health Care Sciences \& Services; Mathematical \& Computational Biology;
   Medical Informatics; Mathematics},
Web-of-Science-Categories  = {Health Care Sciences \& Services; Mathematical \& Computational Biology;
   Medical Informatics; Statistics \& Probability},
Author-Email = {nmarquez@uw.edu},
Affiliations = {University of Washington; University of Washington Seattle; University
   of Washington; University of Washington Seattle},
Cited-References = {Alkema L, 2014, ANN APPL STAT, V8, P2122, DOI 10.1214/14-AOAS768.
   Bakka H, 2018, WIRES COMPUT STAT, V10, DOI 10.1002/wics.1443.
   Bhutta ZA, 2016, LANCET GLOB HEALTH, V4, pE877, DOI 10.1016/S2214-109X(16)30264-9.
   Blangiardo M, 2015, SPATIAL AND SPATIO-TEMPORAL BAYESIAN MODELS WITH R-INLA, P1, DOI 10.1002/9781118950203.
   Bradley JR, 2016, J AM STAT ASSOC, V111, P472, DOI 10.1080/01621459.2015.1117471.
   Burgert-Brucker CR, 2016, TECHNICAL REPORT.
   Burstein R, 2019, NATURE, V574, P353, DOI 10.1038/s41586-019-1545-0.
   Desmond-Hellmann S, 2016, SCIENCE, V353, P731, DOI 10.1126/science.aai7598.
   Dicker D, 2018, LANCET, V392, P1684, DOI {[}10.1016/S0140-6736(18)31891-9, 10.1016/s0140-6736(18)31891-9].
   Diggle P. J., 2019, MODEL BASED GEOSTATI.
   Direccion Nacional de Estadisticas MINSAP Cuba, 2016, TECHNICAL REPORT.
   Encuesta demografica y de salud, 2014, TECHNICAL REPORT.
   Encuesta demografica y de salud, 2008, TECHNICAL REPORT.
   Filippone M, 2013, MACH LEARN, V93, P93, DOI 10.1007/s10994-013-5388-x.
   Frank TD, 2019, LANCET HIV, V6, pE831, DOI 10.1016/S2352-3018(19)30196-1.
   Gething P, 2015, {*}{*}NON-TRADITIONAL{*}{*}.
   Golding N, 2017, LANCET, V390, P2171, DOI 10.1016/S0140-6736(17)31758-0.
   Gotway CA, 2002, J AM STAT ASSOC, V97, P632, DOI 10.1198/016214502760047140.
   Heaton MJ, 2019, J AGR BIOL ENVIR ST, V24, P398, DOI 10.1007/s13253-018-00348-w.
   HORVITZ DG, 1952, J AM STAT ASSOC, V47, P663, DOI 10.2307/2280784.
   Krainski ET., 2019, Advanced spatial modeling with stochastic partial differential equations using R and INLA.
   Kristensen K, 2016, J STAT SOFTW, V70, P1.
   Leroux BG, 2000, STAT MED, V19, P2321, DOI 10.1002/1097-0258(20000915/30)19:17/18<2321::AID-SIM572>3.0.CO;2-\#.
   Lindgren F, 2011, J ROY STAT SOC B, V73, P423, DOI 10.1111/j.1467-9868.2011.00777.x.
   Mahapatra P, 2007, LANCET, V370, P1653, DOI 10.1016/S0140-6736(07)61308-7.
   Mercer LD, 2015, ANN APPL STAT, V9, P1889, DOI 10.1214/15-AOAS872.
   Mikkelsen L, 2015, LANCET, V386, P1395, DOI 10.1016/S0140-6736(15)60171-4.
   Moraga P, 2017, SPAT STAT-NETH, V21, P27, DOI 10.1016/j.spasta.2017.04.006.
   Rue H, 2017, ANNU REV STAT APPL, V4, P395, DOI 10.1146/annurev-statistics-060116-054045.
   Rue H, 2009, J ROY STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x.
   Stevens FR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0107042.
   Tatem AJ, 2014, INT HEALTH, V6, P153, DOI 10.1093/inthealth/ihu057.
   Thorson JT, 2015, ECOLOGY, V96, P1202, DOI 10.1890/14-0739.1.
   Thygesen UH, 2017, ENVIRON ECOL STAT, V24, P317, DOI 10.1007/s10651-017-0372-4.
   Utazi CE, 2019, STAT METHODS MED RES, V28, P3226, DOI 10.1177/0962280218797362.
   Wakefield J, 2019, STAT METHODS MED RES, V28, P2614, DOI 10.1177/0962280218767988.
   Wakefield J, 2008, ANNU REV PUBL HEALTH, V29, P75, DOI 10.1146/annurev.publhealth.29.020907.090821.
   Wang HD, 2012, LANCET, V380, P2071, DOI 10.1016/S0140-6736(12)61719-X.
   Wilson K, 2020, BIOSTATISTICS, V21, pE17, DOI 10.1093/biostatistics/kxy041.
   Wong D., 2009, The modifiable areal unit problem MAUP, P105, DOI DOI 10.4135/9780857020130.N7.},
Number-of-Cited-References = {40},
Times-Cited = {2},
Unique-ID = {WOS:000651509000002},
}

@article{ WOS:000759525100001,
Author = {Simpson, Ryan B. and Lauren, Brianna N. and Schipper, Kees H. and
   McCann, James C. and Tarnas, Maia C. and Naumova, Elena N.},
Title = {Critical Periods, Critical Time Points and Day-of-the-Week Effects in
   COVID-19 Surveillance Data: An Example in Middlesex County,
   Massachusetts, USA},
Journal = {INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH},
Year = {2022},
Volume = {19},
Number = {3},
Month = {FEB},
Abstract = {Critical temporal changes such as weekly fluctuations in surveillance
   systems often reflect changes in laboratory testing capacity, access to
   testing or healthcare facilities, or testing preferences. Many studies
   have noted but few have described day-of-the-week (DoW) effects in
   SARS-CoV-2 surveillance over the major waves of the novel coronavirus
   2019 pandemic (COVID-19). We examined DoW effects by non-pharmaceutical
   intervention phases adjusting for wave-specific signatures using the
   John Hopkins University's (JHU's) Center for Systems Science and
   Engineering (CSSE) COVID-19 data repository from 2 March 2020 through 7
   November 2021 in Middlesex County, Massachusetts, USA. We
   cross-referenced JHU's data with Massachusetts Department of Public
   Health (MDPH) COVID-19 records to reconcile inconsistent reporting. We
   created a calendar of statewide non-pharmaceutical intervention phases
   and defined the critical periods and timepoints of outbreak signatures
   for reported tests, cases, and deaths using Kolmogorov-Zurbenko adaptive
   filters. We determined that daily death counts had no DoW effects; tests
   were twice as likely to be reported on weekdays than weekends with
   decreasing effect sizes across intervention phases. Cases were also
   twice as likely to be reported on Tuesdays-Fridays (RR = 1.90-2.69
   {[}95\%CI: 1.38-4.08]) in the most stringent phases and half as likely
   to be reported on Mondays and Tuesdays (RR = 0.51-0.93 {[}0.44, 0.97])
   in less stringent phases compared to Sundays; indicating temporal
   changes in laboratory testing practices and use of healthcare
   facilities. Understanding the DoW effects in daily surveillance records
   is valuable to better anticipate fluctuations in SARS-CoV-2 testing and
   manage appropriate workflow. We encourage health authorities to
   establish standardized reporting protocols.},
Type = {Article},
Affiliation = {Naumova, EN (Corresponding Author), Tufts Univ, Friedman Sch Nutr Sci \& Policy, Div Nutr Epidemiol \& Data Sci, 150 Harrison Ave, Boston, MA 02111 USA.
   Simpson, Ryan B.; Lauren, Brianna N.; Schipper, Kees H.; McCann, James C.; Tarnas, Maia C.; Naumova, Elena N., Tufts Univ, Friedman Sch Nutr Sci \& Policy, Div Nutr Epidemiol \& Data Sci, 150 Harrison Ave, Boston, MA 02111 USA.},
DOI = {10.3390/ijerph19031321},
Article-Number = {1321},
Keywords = {COVID-19; data reliability; day-of-the-week effects; Kolmogorov-Zurbenko
   filters; nonpharmaceutical interventions; precision public health;
   stringency},
Keywords-Plus = {CHALLENGES},
Research-Areas = {Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health},
Web-of-Science-Categories  = {Environmental Sciences; Public, Environmental \& Occupational Health},
Author-Email = {ryan.simpson@tufts.edu
   brianna.lauren@tufts.edu
   kschipper0430@comcast.net
   james.mccann@tufts.edu
   maia.tarnas@gmail.com
   elena.naumova@tufts.edu},
Affiliations = {Tufts University},
Cited-References = {Aliabadi A, 2020, J AM MED INFORM ASSN, V27, P1977, DOI 10.1093/jamia/ocaa186.
   Alltucker K., 2020, USA Today.
   {[}Anonymous], 2020, WCVB5 0620.
   {[}Anonymous], 2021, WCVB5 0104.
   Arvisais-Anhalt S, 2021, CLIN INFECT DIS, V72, P920, DOI 10.1093/cid/ciaa1686.
   Audi A, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.567184.
   Becker K.M., 2020, 10 BOSTON 0316.
   Bernardo T, 2021, JMIR PUBLIC HLTH SUR, V7, DOI 10.2196/25935.
   Bo YC, 2021, INT J INFECT DIS, V102, P247, DOI 10.1016/j.ijid.2020.10.066.
   Breitner S, 2009, ENVIRON HEALTH PERSP, V117, P448, DOI 10.1289/ehp.11711.
   Buckley M., 2021, CHICAGO TRIBUNE.
   Cavataio J, 2021, MATH BIOSCI, V333, DOI 10.1016/j.mbs.2021.108545.
   Chen A., 2020, 2 COVID 19 WAVE IS H.
   Clare T, 2021, PUBLIC HEALTH, V194, P163, DOI 10.1016/j.puhe.2021.03.012.
   Congi S., 2020, WCVB5 1222.
   Costa-Santos C, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-047623.
   Cunningham K., 2021, WRAL 1220.
   De Luca G, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-017-2934-3.
   De Simoni G., 2020, 10 BOSTON 0330.
   Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1.
   Dwinell J., 2021, BOSTON HERALD.
   Enos C., 2021, The Boston Globe.
   Ewing A, 2017, J INFECT DIS, V215, P732, DOI 10.1093/infdis/jiw642.
   Fefferman NH, 2006, MATH BIOSCI, V202, P269, DOI 10.1016/j.mbs.2006.03.012.
   Galaitsi SE, 2021, INT J INFORM MANAGE, V59, DOI 10.1016/j.ijinfomgt.2021.102352.
   Hanson M., 2021, MASS LIVE 0317.
   Hoffman H., 2021, ATLANTIC.
   Holtgrave DR, 2021, JAMA-J AM MED ASSOC, V326, P381, DOI 10.1001/jama.2021.11211.
   HOSKING JRM, 1990, J ROY STAT SOC B MET, V52, P105.
   Ibrahim NK, 2020, J INFECT PUBLIC HEAL, V13, P1630, DOI 10.1016/j.jiph.2020.07.019.
   Jiang L, 2015, EUROSURVEILLANCE, V20, DOI 10.2807/1560-7917.ES2015.20.22.21145.
   John Hopkins University, JHU CSSE COVID 19 DA.
   Johns Hopkins University, TIM SER SUMM CSSE CO.
   Karaca-Mandic P, 2020, J GEN INTERN MED, DOI 10.1007/s11606-020-06084-7.
   Kashinsky L., 2021, BOSTON HERALD.
   Keithley J., 2021, WMTW8 1220.
   Klein A, 2020, IMAGEIOIMAGEIO FFMPE.
   Krantz Laura, 2021, The Boston Globe.
   Lee T.B., 2020, ARS TECHNICA.
   Liss A, 2017, SCI REP-UK, V7, DOI 10.1038/srep39581.
   Liu XY, 2021, ENVIRON RES, V195, DOI 10.1016/j.envres.2021.110874.
   Loncich J., 2020, WCVB5 0803.
   Massachusetts Department of Public Health, COVID 19 RESP REP.
   Moran J., 2021, WMUR9 1220.
   Morgan OW, 2021, LANCET, V397, P2317, DOI 10.1016/S0140-6736(21)01096-5.
   MORRIS RD, 1995, AM J PUBLIC HEALTH, V85, P1361, DOI 10.2105/AJPH.85.10.1361.
   Nam S., 2021, 25 WPBF NEWS 0824.
   Nash B., 2021, J CLIN TRIALS, V11, P483.
   Naumova Elena N, 2005, MMWR Suppl, V54, P77.
   Naumova EN, 2005, ENVIRONMETRICS, V16, P749, DOI 10.1002/env.734.
   Pearce N, 2020, AM J PUBLIC HEALTH, V110, P949, DOI 10.2105/AJPH.2020.305708.
   Perski O, 2020, JMIR MHEALTH UHEALTH, V8, DOI 10.2196/19494.
   Rogers K.L., 2020, Putting the humanities PhD to work: Thriving in and beyond the classroom.
   Rosenbaum JE, 2021, J PUBLIC HEALTH POL, V42, P536, DOI 10.1057/s41271-021-00309-7.
   Rosenfield M., 2020, 10 BOSTON 1223.
   Shi PY, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-778.
   Simon MC, 2018, ENVIRON SCI TECHNOL, V52, P6985, DOI 10.1021/acs.est.8b00292.
   Simpson RB, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-020-80842-9.
   Simpson RB, 2019, EPIDEMIOL INFECT, V147, DOI 10.1017/S0950268819001511.
   Slater JJ, 2021, STAT-US, V10, DOI 10.1002/sta4.328.
   State House News Service, 2020, COVID 19 CAS COUNTS.
   Sugisaki K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074716.
   Swenson Kyle, 2020, Washington Post.
   Tukey J.W., 1986, ARO233604MA PRINC U.
   United States Government Accountability Office Technology Assessment, COVID 19 DAT QUAL CO.
   WHO, 2020, Public health surveillance for COVID-19: interim guidance.
   Wingerter M, 2021, DENVER POST.
   Yang W, 2010, WIRES COMPUT STAT, V2, P340, DOI 10.1002/wics.71.
   Yiannakoulias N, 2020, SOC SCI MED, V265, DOI 10.1016/j.socscimed.2020.113549.
   Young C.A., 2020, BAKER EXPANDS HOT SP.
   Ziegler B., 2021, U.S. News.
   Zurbenko I.G., 2017, Int. J. Probab. Stat, V6, P110, DOI DOI 10.5539/IJSP.V6N5P110.
   Zurbenko IG, 2018, WIRES COMPUT STAT, V10, DOI 10.1002/wics.1419.},
Number-of-Cited-References = {73},
Times-Cited = {6},
Unique-ID = {WOS:000759525100001},
}

@article{ WOS:000644326700003,
Author = {Gecili, Emrah and Brokamp, Cole and Palipana, Anushka and Huang, Rui and
   Andrinopoulou, Eleni-Rosalina and Pestian, Teresa and Rasnick, Erika and
   Keogh, Ruth H. and Ni, Yizhao and Clancy, John P. and Ryan, Patrick and
   Szczesniak, Rhonda D.},
Title = {Seasonal variation of lung function in cystic fibrosis: Longitudinal
   modeling to compare a Midwest US cohort to international populations},
Journal = {SCIENCE OF THE TOTAL ENVIRONMENT},
Year = {2021},
Volume = {776},
Month = {JUL 1},
Abstract = {Characterizing seasonal trend in lung function in individuals with
   chronic lung disease may lead to timelier treatment of acute respiratory
   symptoms and more precise distinction between seasonal exposures and
   variability. Limited research has been conducted to assess localized
   seasonal fluctuation in lung function decline in individuals with cystic
   fibrosis (CF) in context with routinely collected demographic and
   clinical data. We conducted a longitudinal cohort study of 253
   individuals aged 6-22 years with CF receiving care at a pediatric
   Midwestern US CF center with median (range) of follow-up time of 4.7
   (0-9.95) years, implementing two distinct models to estimate seasonality
   effects. The outcome, lung function, was measured as percent-predicted
   of forced expiratory volume in 1 s (FEV1). Both models showed that older
   age, being male, using Medicaid insurance and having Pseudomonas
   aeruginosa infection corresponded to accelerated FEV1 decline. A sine
   wave model for seasonality had better fit to the data, compared to a
   linear model with categories for seasonality. Compared to international
   cohorts, seasonal fluctuations occurred earlier and with greater
   volatility, even after adjustment for ambient temperature. Average lung
   function peaked in February and dipped in August, and FEV1 fluctuation
   was 0.81\% predicted (95\% CI: 0.52 to 1.1). Adjusting for temperature
   shifted the peak and dip to March and September, respectively, and
   decreased FEV1 fluctuation to 0.45\% predicted (95\% CI: 0.08 to 0.82).
   Understanding localized seasonal variation and its impact on lung
   function may allow researchers to perform precision public health for
   lung diseases and disorders at the point-of-care level. (C) 2021
   Elsevier B.V. All rights reserved.},
Type = {Article},
Affiliation = {Szczesniak, RD (Corresponding Author), 3333 Burnet Ave,MLC 5041, Cincinnati, OH 45229 USA.
   Gecili, Emrah; Brokamp, Cole; Palipana, Anushka; Pestian, Teresa; Rasnick, Erika; Ryan, Patrick; Szczesniak, Rhonda D., Cincinnati Childrens Hosp Med Ctr, Div Biostat \& Epidemiol, 3333 Burnet Ave, Cincinnati, OH 45229 USA.
   Brokamp, Cole; Ni, Yizhao; Clancy, John P.; Ryan, Patrick; Szczesniak, Rhonda D., Univ Cincinnati, Dept Pediat, 3333 Burnet Ave, Cincinnati, OH USA.
   Palipana, Anushka; Huang, Rui, Univ Cincinnati, Dept Med, Div Stat \& Data Sci, 155B McMicken Hall, Cincinnati, OH USA.
   Andrinopoulou, Eleni-Rosalina, Erasmus MC, Dept Biostat, Dr Molewaterpl 40, NL-3015 GD Rotterdam, Netherlands.
   Keogh, Ruth H., London Sch Hyg \& Trop Med, Keppel St, London WC1E 7HT, England.
   Ni, Yizhao, Cincinnati Childrens Hosp Med Ctr, Div Biomed Informat, 3333 Burnet Ave, Cincinnati, OH 45229 USA.
   Clancy, John P., Cyst Fibrosis Fdn, 4550 Montgomery Ave, Bethesda, MD USA.
   Clancy, John P.; Szczesniak, Rhonda D., Cincinnati Childrens Hosp Med Ctr, Div Pulm Med, 3333 Burnet Ave, Cincinnati, OH 45229 USA.},
DOI = {10.1016/j.scitotenv.2021.145905},
EarlyAccessDate = {MAR 2021},
Article-Number = {145905},
Keywords = {Lung disease; Medical monitoring; Nonlinear; Seasonality; Sine wave;
   Temperature},
Keywords-Plus = {FORCED EXPIRATORY VOLUME; 1 2ND VARIABILITY; SOCIOECONOMIC-STATUS;
   QUALITY IMPROVEMENT; PULMONARY-FUNCTION; FUNCTION DECLINE; FEV1 DECLINE;
   OUTCOMES; CHILDREN; ASSOCIATION},
Research-Areas = {Environmental Sciences \& Ecology},
Web-of-Science-Categories  = {Environmental Sciences},
Author-Email = {Rhonda.Szczesniak@cchmc.org},
Affiliations = {Cincinnati Children's Hospital Medical Center; University System of
   Ohio; University of Cincinnati; University System of Ohio; University of
   Cincinnati; Erasmus University Rotterdam; Erasmus MC; University of
   London; London School of Hygiene \& Tropical Medicine; Cincinnati
   Children's Hospital Medical Center; Cystic Fibrosis Foundation;
   Cincinnati Children's Hospital Medical Center},
Cited-References = {Collaco JM, 2010, J PEDIATR-US, V157, P802, DOI 10.1016/j.jpeds.2010.05.018.
   Collaco JM, 2016, J CYST FIBROS, V15, P794, DOI 10.1016/j.jcf.2016.05.012.
   Collaco JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027784.
   Dasenbrook EC, 2008, AM J RESP CRIT CARE, V178, P814, DOI 10.1164/rccm.200802-327OC.
   Freckleton RP, 2002, J ANIM ECOL, V71, P542, DOI 10.1046/j.1365-2656.2002.00618.x.
   Gecili E, 2020, METHODS X, VXX, pXX.
   Goss CH, 2015, THORAX, V70, P229, DOI 10.1136/thoraxjnl-2014-205718.
   Grossoehme DH, 2015, ANN AM THORAC SOC, V12, P838, DOI 10.1513/AnnalsATS.201408-379OC.
   Guo C., 2019, ENV HLTH PERSPECT, P127, DOI {[}10.1289/EHP5220127008, DOI 10.1289/EHP5220127008].
   Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108.
   Harun SN, 2016, PAEDIATR RESPIR REV, V20, P55, DOI 10.1016/j.prrv.2016.03.002.
   Heltshe SL, 2016, J PEDIATR-US, V172, P228, DOI 10.1016/j.jpeds.2016.01.035.
   Imai K, 2011, AM POLIT SCI REV, V105, P765, DOI 10.1017/S0003055411000414.
   Jackson AD, 2018, J CYST FIBROS, V17, P297, DOI 10.1016/j.jcf.2017.11.013.
   Kelly J, 2017, J CYST FIBROS, V16, P367, DOI 10.1016/j.jcf.2016.11.002.
   Lechtzin N, 2017, AM J RESP CRIT CARE, V196, P1144, DOI 10.1164/rccm.201610-2172OC.
   McPhail GL, 2012, PEDIATR PULM, V47, P389.
   McPhail GL, 2010, ARCH PEDIAT ADOL MED, V164, P957, DOI 10.1001/archpediatrics.2010.178.
   McPhail GL, 2008, J PEDIATR-US, V153, P752, DOI 10.1016/j.jpeds.2008.07.011.
   Mesinger F, 2006, B AM METEOROL SOC, V87, P343, DOI 10.1175/BAMS-87-3-343.
   Modi AC, 2010, J PEDIATR PSYCHOL, V35, P1028, DOI 10.1093/jpepsy/jsq015.
   Molenberghs G., 2007, Missing data in clinical studies, DOI DOI 10.1093/TROPEJ/FMM053.
   Morgan WJ, 2016, J PEDIATR-US, V169, P116, DOI 10.1016/j.jpeds.2015.08.042.
   Morgan WJ, 1999, PEDIATR PULM, V28, P231, DOI 10.1002/(SICI)1099-0496(199910)28:4<231::AID-PPUL1>3.0.CO;2-2.
   Neumann JE, 2019, GEOHEALTH, V3, P11, DOI 10.1029/2018GH000153.
   Qvist T, 2019, J CYST FIBROS, V18, P390, DOI 10.1016/j.jcf.2018.10.006.
   Rice MB, 2015, AM J RESP CRIT CARE, V191, P656, DOI 10.1164/rccm.201410-1875OC.
   Sanders DB, 2010, AM J RESP CRIT CARE, V182, P627, DOI 10.1164/rccm.200909-1421OC.
   Savant AP, 2014, BMJ QUAL SAF, V23, P81, DOI 10.1136/bmjqs-2013-002314.
   Schechter MS, 2018, J CYST FIBROS, V17, P769, DOI 10.1016/j.jcf.2018.06.003.
   Schechter MS, 1998, J PEDIATR-US, V132, P260, DOI 10.1016/S0022-3476(98)70442-1.
   Schechter MS, 2001, AM J RESP CRIT CARE, V163, P1331, DOI 10.1164/ajrccm.163.6.9912100.
   Siracusa CM, 2014, BMJ QUAL SAF, V23, P56, DOI 10.1136/bmjqs-2013-002361.
   Szczesniak R, 2020, EXPERT REV RESP MED, V14, P737, DOI 10.1080/17476348.2020.1753507.
   Szczesniak RD, 2020, STAT MED, V39, P740, DOI 10.1002/sim.8443.
   Szczesniak RD, 2013, ANN EPIDEMIOL, V23, P771, DOI 10.1016/j.annepidem.2013.08.009.
   Tingley D, 2014, J STAT SOFTW, V59.
   WANG XB, 1993, AM REV RESPIR DIS, V148, P1502, DOI 10.1164/ajrccm/148.6\_Pt\_1.1502.},
Number-of-Cited-References = {38},
Times-Cited = {3},
Unique-ID = {WOS:000644326700003},
}

@article{ WOS:000708804800004,
Author = {Kamp, Michelle and Krause, Amanda and Ramsay, Michele},
Title = {Has translational genomics come of age in Africa?},
Journal = {HUMAN MOLECULAR GENETICS},
Year = {2021},
Volume = {30},
Number = {R2},
Pages = {R164-R173},
Month = {OCT 15},
Abstract = {The rapid increase in genomics research in Africa and the growing
   promise of precision public health (PPH) begs the question of whether
   African genomics has come of age and is being translated into improved
   healthcare for Africans. An assessment of the continent's readiness
   suggests that genetic service delivery remains limited and extremely
   fragile. The paucity of data on mutation profiles for monogenic
   disorders and lack of large genome-wide association cohorts for complex
   traits in African populations is a significant barrier, coupled with
   extreme genetic variation across different regions and ethnic groups.
   Data from many different populations are essential to developing
   appropriate genetic services. Of the proposed genetic service delivery
   models currently used in Africa-Uncharacterized, Limited,
   Disease-focused, Emerging and Established-the first three best describe
   the situation in most African countries. Implementation is fraught with
   difficulties related to the scarcity of an appropriately skilled medical
   genetic workforce, limited infrastructure and processes, insufficient
   health funding and lack of political support, and overstretched health
   systems. There is a strong nucleus of determined and optimistic
   clinicians and scientists with a clear vision, and there is a hope for
   innovative solutions and technological leapfrogging. However, a
   multi-dimensional approach with active interventions to stimulate
   genomic research, clinical genetics and overarching healthcare systems
   is needed to reduce genetic service inequalities and accelerate PPH on
   the continent. Human and infrastructure capacity development, dedicated
   funding, political will and supporting legislation, and public education
   and awareness, are critical elements for success. Africa-relevant
   genomic and related health economics research remains imperative with an
   overarching need to translate knowledge into improved healthcare. Given
   the limited data and genetic services across most of Africa, the
   continent has not yet come of `genomics' age.},
Type = {Review},
Affiliation = {Ramsay, M (Corresponding Author), Univ Witwatersrand, Fac Hlth Sci, Sydney Brenner Inst Mol Biosci, ZA-2193 Johannesburg, South Africa.
   Kamp, Michelle; Krause, Amanda; Ramsay, Michele, Univ Witwatersrand, Fac Hlth Sci, Natl Hlth Lab Serv, Div Human Genet, ZA-2193 Johannesburg, South Africa.
   Kamp, Michelle; Krause, Amanda; Ramsay, Michele, Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, ZA-2193 Johannesburg, South Africa.
   Kamp, Michelle; Ramsay, Michele, Univ Witwatersrand, Fac Hlth Sci, Sydney Brenner Inst Mol Biosci, ZA-2193 Johannesburg, South Africa.},
DOI = {10.1093/hmg/ddab180},
EarlyAccessDate = {JUL 2021},
Keywords-Plus = {FRAGILE-X-SYNDROME; DISEASE-LIKE 2; PRECISION MEDICINE; GENETIC
   SERVICES; SOUTH-AFRICA; HEARING-LOSS; HEALTH-CARE; MUTATIONS; MIDDLE;
   COMMON},
Research-Areas = {Biochemistry \& Molecular Biology; Genetics \& Heredity},
Web-of-Science-Categories  = {Biochemistry \& Molecular Biology; Genetics \& Heredity},
Author-Email = {Michele.ramsay@wits.ac.za},
Affiliations = {University of Witwatersrand; National Health Laboratory Service;
   University of Witwatersrand; University of Witwatersrand},
Cited-References = {Abacan M, 2019, EUR J HUM GENET, V27, P183, DOI 10.1038/s41431-018-0252-x.
   Adadey SM, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00841.
   Adebamowo SN, 2018, GLOBAL HEALTH ACTION, V11, DOI 10.1080/16549716.2017.1419033.
   Adeyemo AA, 2018, MOL GENET GENOM MED, V6, P314, DOI 10.1002/mgg3.419.
   AESA, 2020, FRAM IMPL GEN MED PU.
   Alwan A, 2003, NAT REV GENET, V4, P61, DOI 10.1038/nrg978.
   Baine FK, 2016, NEUROEPIDEMIOLOGY, V46, P198, DOI 10.1159/000444020.
   Belhassan K, 2016, MOL GENET GENOM MED, V4, P588, DOI 10.1002/mgg3.255.
   Ben Arab S, 2004, GENET EPIDEMIOL, V27, P74, DOI 10.1002/gepi.10321.
   Bombard Y, 2020, NAT REV GENET, V21, P505, DOI 10.1038/s41576-020-0260-x.
   Bornstein MH, 2013, SOC SCI MED, V97, P307, DOI 10.1016/j.socscimed.2012.09.049.
   Chaabouni-Bouhamed H, 2008, COMMUNITY GENET, V11, P313, DOI 10.1159/000133303.
   Choudhury A, 2020, NATURE, V586, P741, DOI 10.1038/s41586-020-2859-7.
   Choudhury A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00663-9.
   Christianson A, 2013, J COMMUN GENET, V4, P297, DOI 10.1007/s12687-013-0150-4.
   Chrystoja CC, 2014, CLIN CHEM, V60, P724, DOI 10.1373/clinchem.2013.209213.
   CohenWeisz S, 2016, JEWISH LIFE IN AUSTRIA AND GERMANY SINCE 1945, P1, DOI 10.1007/s10897-016-9932-2.
   Diallo RN, 2017, GLOB HEALTH EPIDEM G, V2, DOI 10.1017/gheg.2017.3.
   Dragojlovic N, 2018, GENET MED, V20, P1013, DOI 10.1038/gim.2017.226.
   Duncan L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11112-0.
   El-Kamah GY, 2020, AM J TROP MED HYG, V102, P719, DOI 10.4269/ajtmh.19-0408.
   Elloumi-Zghal H, 2018, MOL GENET GENOM MED, V6, P134, DOI 10.1002/mgg3.392.
   Essop FB, 2013, SAMJ S AFR MED J, V103, P994, DOI {[}10.7196/SAMJ.7144, 10.7196/samj.7144].
   Gillham A, 2015, J GENET COUNS, V24, P978, DOI 10.1007/s10897-015-9834-8.
   Green ED, 2020, NATURE, V586, P683, DOI 10.1038/s41586-020-2817-4.
   Gurdasani D, 2015, NATURE, V517, P327, DOI 10.1038/nature13997.
   Gurwitz KT, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005715.
   Jenkins T, 1998, J MED GENET, V35, P878, DOI 10.1136/jmg.35.10.878.
   Kabahuma RI, 2011, INT J PEDIATR OTORHI, V75, P611, DOI 10.1016/j.ijporl.2011.01.029.
   Kamga KK, 2020, GENES-BASEL, V11, DOI 10.3390/genes11020136.
   Kerr R., 2018, ALBINISM AFRICA HIST, P235.
   Knoppers BM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008494.
   Kraft SA, 2018, AM J BIOETHICS, V18, P3, DOI 10.1080/15265161.2018.1431322.
   Krause A, 2018, ANNU REV GENOM HUM G, V19, P149, DOI 10.1146/annurev-genom-083117-021256.
   Krause A, 2015, AM J MED GENET B, V168, P573, DOI 10.1002/ajmg.b.32332.
   Kromberg JGR, 2013, SAMJ S AFR MED J, V103, P957, DOI {[}10.7196/SAMJ.7220, 10.7196/samj.7220].
   Kromberg J.G.R, 2018, ALBINISM AFRICA HIST, P203.
   Kromberg J. G. R., 1997, CULTURE KINSHIP GENE, P147.
   Kromberg JGR, 2013, J COMMUN GENET, V4, P413, DOI 10.1007/s12687-012-0101-5.
   Lebeko K, 2016, CLIN GENET, V90, P288, DOI 10.1111/cge.12799.
   Lubala TK, 2018, CLIN DYSMORPHOL, V27, P66, DOI 10.1097/MCD.0000000000000208.
   Malherbe H, 2017, J COMMUN GENET, V8, P65, DOI 10.1007/s12687-017-0301-0.
   Manolio TA, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab0194.
   Martin AR, 2019, NAT GENET, V51, P584, DOI 10.1038/s41588-019-0379-x.
   Mazibuko NG, 2018, Albinism in Africa: historical, geographic, medical, genetic and psychosocial aspects, P295.
   Mboowa G, 2021, GENOME, V64, P503, DOI 10.1139/gen-2020-0013.
   Meier F, 2013, J COMMUN GENET, V4, P309, DOI 10.1007/s12687-012-0099-8.
   Mitropoulos K, 2015, HUM GENOMICS, V9, DOI 10.1186/s40246-015-0033-3.
   Mulder N, 2018, PHARMACOGEN PERS MED, V11, P59, DOI 10.2147/PGPM.S141546.
   Mulder NJ, 2017, GLOB HEART, V12, P91, DOI 10.1016/j.gheart.2017.01.005.
   Munung NS, 2018, GLOB HEALTH EPIDEM G, V3, DOI 10.1017/gheg.2018.3.
   Musanabaganwa C, 2020, AM J TROP MED HYG, V102, P1417, DOI 10.4269/ajtmh.19-0837.
   Muzoriana N, 2017, PHARMACY, V5, DOI 10.3390/pharmacy5030036.
   Nembaware V, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.01209.
   Oleribe OO, 2019, INT J GEN MED, V12, P395, DOI 10.2147/IJGM.S223882.
   Pereira L, 2021, NAT REV GENET, V22, P284, DOI 10.1038/s41576-020-00306-8.
   Pollard S, 2021, EUR J HUM GENET, V29, P1491, DOI 10.1038/s41431-021-00882-1.
   Popejoy AB, 2019, PHARMACOGEN PERS MED, V12, P257, DOI 10.2147/PGPM.S179742.
   Popejoy AB, 2016, NATURE, V538, P161, DOI 10.1038/538161a.
   Rebbeck TR, 2018, HUM MUTAT, V39, P593, DOI 10.1002/humu.23406.
   Romdhane L, 2019, ANNU REV GENOM HUM G, V20, P155, DOI 10.1146/annurev-genom-083118-014954.
   Rotimi C, 2014, SCIENCE, V344, P1346, DOI 10.1126/science.1251546.
   Sabatello M, 2018, AM J BIOETHICS, V18, P34, DOI 10.1080/15265161.2018.1431328.
   Sankoh O, 2011, LANCET, V378, P401, DOI 10.1016/S0140-6736(11)61211-7.
   Soden SE, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3010076.
   Solomon G, 2012, J GENET COUNS, V21, P726, DOI 10.1007/s10897-012-9495-9.
   Stark Z, 2019, AM J HUM GENET, V104, P13, DOI 10.1016/j.ajhg.2018.11.014.
   Stark Z, 2017, GENET MED, V19, P867, DOI 10.1038/gim.2016.221.
   Tegally H, 2021, NAT MED, V27, P440, DOI 10.1038/s41591-021-01255-3.
   Tekola-Ayele F, 2015, PUBLIC HEALTH GENOM, V18, P242, DOI 10.1159/000433518.
   Temtamy SA, 2017, MOL GENET GENOM MED, V5, P8, DOI 10.1002/mgg3.271.
   Tessema SK, 2020, LANCET MICROBE, V1, pE227, DOI 10.1016/S2666-5247(20)30117-8.
   Tsiplova K, 2017, GENET MED, V19, P1268, DOI 10.1038/gim.2017.47.
   Uwineza A, 2015, MOL GENET GENOM MED, V3, P486, DOI 10.1002/mgg3.184.
   Wibmer CK, 2021, NAT MED, V27, DOI {[}10.1038/s41591-021-01285-x, 10.1101/2021.01.18.427166].
   Williams TN, 2005, NAT GENET, V37, P1253, DOI 10.1038/ng1660.
   Wohlers I, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17964-1.
   Wonkam A, 2006, GENET MED, V8, P331, DOI 10.1097/01.gim.0000223542.97262.21.
   Wonkam A, 2015, SAMJ S AFR MED J, V105, P23, DOI 10.7196/SAMJ.8814.
   Wonkam A, 2021, NATURE, V590, P209, DOI 10.1038/d41586-021-00313-7.
   Wonkam A, 2020, NAT GENET, V52, P17, DOI 10.1038/s41588-019-0542-4.
   Wonkam A, 2014, GENOME MED, V6, DOI 10.1186/gm528.
   Zeggini E, 2019, SCIENCE, V365, P1409, DOI 10.1126/science.aax4588.
   Zheng YL, 2018, J CLIN ONCOL, V36, P2820, DOI 10.1200/JCO.2018.78.3977.
   Zhong A, 2021, GENET MED, V23, P2270, DOI 10.1038/s41436-018-0090-9.},
Number-of-Cited-References = {85},
Times-Cited = {10},
Unique-ID = {WOS:000708804800004},
}

@article{ WOS:000794115700001,
Author = {Dorner, Thomas Ernst and Bernecker, Oliver and Haider, Sandra and Stein,
   Katharina Viktoria},
Title = {Steady increase of obesity prevalence in Austria: Analysis of three
   representative cross-sectional national health interview surveys from
   2006 to 2019},
Journal = {WIENER KLINISCHE WOCHENSCHRIFT},
Year = {2023},
Volume = {135},
Number = {5-6},
Pages = {125-133},
Month = {MAR},
Abstract = {Background Obesity is associated with adverse health consequences
   throughout life. Monitoring obesity trends is important to plan and
   implement public heath interventions adapted to specific target groups.
   We aimed to analyze the development of obesity prevalence in the
   Austrian population using data from the most recent representative
   Austrian Health Interview Surveys. Methods The three cross-sectional
   Austrian health interview surveys from 2006/2007, 2014 and 2019 were
   used (n = 45,707). Data correction for self-reported body mass index
   (BMI) was applied. Sex, age, education level, employment status, country
   of birth, urbanization, and family status were used as sociodemographic
   factors. Logistic regression models were applied. Results Prevalence of
   obesity increased in both sexes in the study period (men 13.7\% to
   20.0\%, women 15.2\% to 17.8\%, p < 0.001). Adjusted odds ratios (95\%
   confidence interval {[}CI]) for the increase in obesity prevalence was
   1.47 (95\% CI: 1.38-1.56). In men, obesity prevalence almost doubled
   from 2006/2007 to 2019 in subgroups of 15-29-year-olds (4.8\% to 9.0\%),
   unemployed (13.5\% to 27.6\%), men born in non-EU/non-EFTA countries
   (13.9\% to 26.2\%), and not being in a relationship (8.1\% to 15.4\%).
   In women, the largest increase was found in subgroups of 30-64-year-olds
   (15.8\% to 18.7\%), women born in non-EU/non-EFTA countries (19.9\% to
   22.8\%) and in women living in the federal capital Vienna (16.5\% to
   19.9\%). Conclusion Obesity prevalence in the Austrian population
   continues to rise significantly. We identified distinct subgroups with a
   fast-growing obesity prevalence in recent years, emphasizing the
   importance of regular long-term data collection as a basis for
   sustainable and target group-specific action planning.},
Type = {Article},
Affiliation = {Bernecker, O (Corresponding Author), Social Insurance Fund Publ Serv Railway \& Min Ind, A-1080 Vienna, Austria.
   Bernecker, O (Corresponding Author), Karl Landsteiner Inst Hlth Promot Res, Gesundheitspl 1, A-3454 Sitzenberg Reidling, Austria.
   Dorner, Thomas Ernst; Bernecker, Oliver; Stein, Katharina Viktoria, Social Insurance Fund Publ Serv Railway \& Min Ind, A-1080 Vienna, Austria.
   Dorner, Thomas Ernst; Bernecker, Oliver; Stein, Katharina Viktoria, Karl Landsteiner Inst Hlth Promot Res, Gesundheitspl 1, A-3454 Sitzenberg Reidling, Austria.
   Dorner, Thomas Ernst; Haider, Sandra, Med Univ Vienna, Ctr Publ Hlth, Dept Social \& Prevent Med, A-1090 Vienna, Austria.},
DOI = {10.1007/s00508-022-02032-z},
EarlyAccessDate = {MAY 2022},
Keywords = {Obesity prevalence; Obesity prevention; Social determinants of obesity;
   Precision public health},
Keywords-Plus = {OVERWEIGHT; STRESS; HYPERTENSION; DEPRESSION; LEVEL; RISK},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Author-Email = {oliver.bernecker@bvaeb.at},
Affiliations = {Medical University of Vienna},
Cited-References = {Adam TC, 2007, PHYSIOL BEHAV, V91, P449, DOI 10.1016/j.physbeh.2007.04.011.
   Almandoz JP, 2020, CLIN OBES, V10, DOI 10.1111/cob.12386.
   {[}Anonymous], 1998, Obes Res, V6, p51S.
   {[}Anonymous], 2020, PENSIONSVERSICHERUNG.
   {[}Anonymous], 2011, PENSIONSVERSICHERUNG.
   Aromaa A, 2003, EUR J PUBLIC HEALTH, V13, P67, DOI 10.1093/eurpub/13.suppl\_1.67.
   Balanza-Martinez V, 2020, ACTA PSYCHIAT SCAND, V141, P399, DOI 10.1111/acps.13177.
   Bhutani S, 2021, NUTRIENTS, V13, DOI 10.3390/nu13020671.
   Bogic M, 2015, BMC INT HEALTH HUM R, V15, DOI 10.1186/s12914-015-0064-9.
   Clemmensen C, 2020, NAT REV ENDOCRINOL, V16, P469, DOI 10.1038/s41574-020-0387-z.
   Congdon P, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16030464.
   DeJean D, 2013, Ont Health Technol Assess Ser, V13, P1.
   Di Renzo L, 2020, J TRANSL MED, V18, DOI {[}10.1186/s12967-020-02399-5, 10.1186/s12967-020-02594-4].
   Dorner TE, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17207491.
   Dorner TE, 2016, WIEN MED WOCHENSCHR, V166, P79, DOI 10.1007/s10354-015-0409-y.
   Eurostat, European Health Interview Survey.
   Field AE, 2001, ARCH INTERN MED, V161, P1581, DOI 10.1001/archinte.161.13.1581.
   Grossschädl F, 2019, EUR J PUBLIC HEALTH, V29, P790, DOI 10.1093/eurpub/cky280.
   Grossschädl F, 2012, PUBLIC HEALTH NUTR, V15, P20, DOI 10.1017/S1368980011001911.
   Haider S, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16234697.
   Han TS, 2017, ENDOCRINE, V55, P456, DOI 10.1007/s12020-016-1135-y.
   Haslam D, 2006, BMJ-BRIT MED J, V333, P640, DOI 10.1136/bmj.333.7569.640.
   Jaacks LM, 2019, LANCET DIABETES ENDO, V7, P231, DOI 10.1016/S2213-8587(19)30026-9.
   Kautzky-Willer A, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-392.
   Khoury MJ, 2016, AM J PREV MED, V50, P398, DOI 10.1016/j.amepre.2015.08.031.
   Klimont J., 2007, OSTERREICHISCHE GESU.
   Klimont J., 2015, OSTERREICHISCHE GESU.
   Klimont J., 2014, METAINFORMATION DEFI.
   Klimont J., 2020, Osterreichische Gesundheitsbefragung 2019.
   Lippi G, 2020, EUR J PREV CARDIOL, V27, P906, DOI 10.1177/2047487320916823.
   Luppino FS, 2010, ARCH GEN PSYCHIAT, V67, P220, DOI 10.1001/archgenpsychiatry.2010.2.
   Magistrat der Stadt Wien, 2020, INTEGRATIONS UND DIV.
   Magistrat der Stadt Wien, 2020, 5 VIENNA INTEGRATION.
   McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001.
   McPherson K, 2009, FORESIGHTTACKLING OB.
   Poelman Maartje P, 2021, Appetite, V157, P105002, DOI 10.1016/j.appet.2020.105002.
   Puccinelli PJ, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-10470-z.
   Sassi Franco., 2009, OECD Health Working Papers 45, DOI DOI 10.1787/225215402672.
   Scarmozzino F, 2020, FOODS, V9, DOI 10.3390/foods9050675.
   Sinha R, 2013, BIOL PSYCHIAT, V73, P827, DOI 10.1016/j.biopsych.2013.01.032.
   Spinosa J, 2019, OBESITY, V27, P559, DOI 10.1002/oby.22402.
   Statistik Austria, 2021, POPULATION MIGRATION.
   Stepaniak U, 2016, POL ARCH MED WEWN, V126, P662, DOI 10.20452/pamw.3499.
   Swinburn BA, 2019, LANCET, V393, P791, DOI 10.1016/S0140-6736(18)32822-8.
   Tomiyama AJ, 2019, ANNU REV PSYCHOL, V70, P703, DOI 10.1146/annurev-psych-010418-102936.
   Weber MA, 2013, LANCET, V381, P537, DOI 10.1016/S0140-6736(12)61343-9.
   Wilke J, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18052235.
   World Health Organization, 2021, World Health Statistics 2021: Monitoring Health for the SDGs, Sustainable Development Goals.
   Yang L, 2023, WIEN KLIN WOCHENSCHR, V135, P358, DOI 10.1007/s00508-021-01941-9.
   Yau YHC, 2013, MINERVA ENDOCRINOL, V38, P255.},
Number-of-Cited-References = {50},
Times-Cited = {1},
Unique-ID = {WOS:000794115700001},
}

@article{ WOS:001033679900001,
Author = {Lacson, John Charles A. and Doyle, Scarlet H. and Del Rio, Jocelyn and
   Forgas, Stephanie M. and Carvajal, Rodrigo and Gonzalez-Calderon,
   Guillermo and Feliciano, Adriana Ramirez and Kim, Youngchul and
   Roetzheim, Richard G. and Sutton, Steven K. and Vadaparampil, Susan T.
   and Soto-Torres, Brenda and Kanetsky, Peter A.},
Title = {A Randomized Clinical Trial of Precision Prevention Materials
   Incorporating MC1R Genetic Risk to Improve Skin Cancer Prevention
   Activities Among Hispanics},
Journal = {CANCER RESEARCH COMMUNICATIONS},
Year = {2022},
Volume = {2},
Number = {1},
Pages = {28-38},
Month = {JAN},
Abstract = {Purpose: Skin cancer incidence is increasing among Hispanics, who
   ex-perience worse outcomes than non-Hispanic Whites. Precision
   prevention incorporating genetic testing for (melanocortin-1 receptor)
   MC1R, a skin cancer susceptibility marker, may improve prevention
   behavior. Experimental Design: Hispanic participants (n = 920) from
   Tampa, FL and Ponce, PR, were block-randomized within MC1R higher-and
   average-risk groups to precision prevention or generic prevention arms.
   We collected baseline information on demographics, family history of
   cancer, phenotypic characteristics, health literacy, health numeracy,
   and psychoso-cial measures. Participants reported weekday and weekend
   sun exposure (in hours), number of sunburns, frequency of five sun
   protection behaviors, intentional outdoor and indoor tanning, and skin
   examinations at baseline, 3 months, and 9 months. Participants also
   reported these outcomes for their eldest child \& LE;10 years old.
   Results: Among MC1R higher-risk participants, precision prevention
   in-creased sunscreen use (OR = 1.74, P = 0.03) and receipt of a clinical
   skin exam (OR = 6.51, P = 0.0006); and it decreased weekday sun exposure
   hours (13 = -0.94, P = 0.005) and improved sun protection behaviors (13
   = 0.93, P = 0.02) in their children. There were no significant
   interven-tion effects among MC1R average-risk participants. The
   intervention did not elevate participant cancer worry. We also
   identified moderators of the intervention effect among both average-and
   higher-risk participants. Conclusions: Receipt of MC1R precision
   prevention materials improved some skin cancer prevention behaviors
   among higher-risk participants and their children and did not result in
   reduced prevention activities among average-risk participants. Despite
   these encouraging findings, levels of sun protection behaviors remained
   suboptimal among participants, warranting more awareness and prevention
   campaigns targeted to Hispanics Significance: Our results support a
   precision public health approach to reducing skin cancers among
   Hispanics, an underserved population in precision medicine, and may
   additionally improve preventive behaviors among their children.},
Type = {Article},
Affiliation = {Kanetsky, PA (Corresponding Author), H Lee Moffitt Canc Ctr \& Res Inst, Dept Canc Epidemiol, MRC CANCONT, 12902 Magnolia Dr, Tampa, FL 33612 USA.
   Lacson, John Charles A.; Doyle, Scarlet H.; Del Rio, Jocelyn; Forgas, Stephanie M.; Kanetsky, Peter A., H Lee Moffitt Canc Ctr \& Res Inst, Dept Canc Epidemiol, Tampa, FL USA.
   Carvajal, Rodrigo; Gonzalez-Calderon, Guillermo, H Lee Moffitt Canc Ctr \& Res Inst, Biostat \& Bioinformat Shared Resources, Tampa, FL USA.
   Feliciano, Adriana Ramirez; Soto-Torres, Brenda, Ponce Hlth Sci Univ, Publ Hlth Program, Ponce, PR USA.
   Kim, Youngchul; Sutton, Steven K., H Lee Moffitt Canc Ctr \& Res Inst, Dept Biostat \& Bioinformat, Tampa, FL USA.
   Roetzheim, Richard G., Univ S Florida, Morsani Coll Med, Dept Family Med, Tampa, FL USA.
   Vadaparampil, Susan T., H Lee Moffitt Canc Ctr \& Res Inst, Dept Hlth \& Behav Outcomes, Tampa, FL USA.
   Kanetsky, Peter A., H Lee Moffitt Canc Ctr \& Res Inst, Dept Canc Epidemiol, MRC CANCONT, 12902 Magnolia Dr, Tampa, FL 33612 USA.},
DOI = {10.1158/2767-9764.CRC-21-0114},
Keywords-Plus = {POOLED-ANALYSIS; MELANOMA RISK; VARIANTS; ASSOCIATIONS; EXPOSURE;
   LATINAS},
Research-Areas = {Oncology},
Web-of-Science-Categories  = {Oncology},
Author-Email = {peter.kanetsky@moffitt.org},
Affiliations = {H Lee Moffitt Cancer Center \& Research Institute; H Lee Moffitt Cancer
   Center \& Research Institute; Ponce Health Sciences University; H Lee
   Moffitt Cancer Center \& Research Institute; State University System of
   Florida; University of South Florida; H Lee Moffitt Cancer Center \&
   Research Institute; H Lee Moffitt Cancer Center \& Research Institute},
Cited-References = {Altieri L, 2018, PEDIATR DERMATOL, V35, pE52, DOI 10.1111/pde.13299.
   Anft M, 2017, LATINO MEN ARE MUCH.
   Aspinwall LG, 2013, PSYCHO-ONCOLOGY, V22, P276, DOI 10.1002/pon.2080.
   Behrens CL, 2013, SCAND J PUBLIC HEALT, V41, P302, DOI 10.1177/1403494813476158.
   Blumenthal LY, 2021, J AM ACAD DERMATOL.
   Chew LD, 2004, FAM MED, V36, P588.
   De La Torre-Lugo EM, 2010, P R HEALTH SCI J, V29, P312.
   Figueroa JD, 2011, HUM MOL GENET, V20, P4693, DOI 10.1093/hmg/ddr368.
   Frieser MJ, 2018, HEALTH PSYCHOL, V37, P1134, DOI 10.1037/hea0000683.
   George S, 2014, AM J PUBLIC HEALTH, V104, pE16, DOI 10.2105/AJPH.2013.301706.
   Glanz K, 2008, ARCH DERMATOL, V144, P217, DOI 10.1001/archdermatol.2007.46.
   Green AC, 2011, PROG BIOPHYS MOL BIO, V107, P349, DOI 10.1016/j.pbiomolbio.2011.08.010.
   Hay Jennifer L, 2017, JMIR Res Protoc, V6, pe52, DOI 10.2196/resprot.7158.
   Hock KT, 2011, GENET MED, V13, P325, DOI 10.1097/GIM.0b013e3182011636.
   Horrell EMW, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00095.
   Hu SS, 2009, ARCH DERMATOL, V145, P1369, DOI 10.1001/archdermatol.2009.302.
   Kanetsky PA, 2010, CANCER-AM CANCER SOC, V116, P2416, DOI 10.1002/cncr.24994.
   Lacson JCA, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-10424-5.
   LERMAN C, 1994, J CLIN ONCOL, V12, P843, DOI 10.1200/JCO.1994.12.4.843.
   Manuel JI, 2018, HEALTH SERV RES, V53, P1407, DOI 10.1111/1475-6773.12705.
   Merten JW, 2020, INT J DERMATOL, V59, P829, DOI 10.1111/ijd.14935.
   Niu ZM, 2022, INT J BEHAV MED, V29, P36, DOI 10.1007/s12529-021-09991-z.
   Noe-Bustamante L, 2021, FACT TANK NEWS NUMBE.
   Pasquali E, 2015, INT J CANCER, V136, P618, DOI 10.1002/ijc.29018.
   Perez Maritza I., 2019, J Drugs Dermatol, V18, ps117.
   Perreira KM, 2020, AM J EPIDEMIOL, V189, P518, DOI 10.1093/aje/kwaa003.
   Powe B D, 1995, Oncol Nurs Forum, V22, P1355.
   Raimondi S, CONTRIBUTION MC1R VA.
   Robinson JK, 2017, PIGM CELL MELANOMA R, V30, P488, DOI 10.1111/pcmr.12598.
   Rodríguez VM, 2017, J COMMUN GENET, V8, P53, DOI 10.1007/s12687-016-0287-z.
   Rodriguez-Rodriguez L, 2020, ADVANCING THE SCIENCE OF CANCER IN LATINOS, P147, DOI 10.1007/978-3-030-29286-7\_14.
   Rogers R. W., 1983, Social psychophysiology, P153, DOI DOI 10.1093/DEAFED/ENT031.
   Rouhani P, 2010, ARCH DERMATOL, V146, P741, DOI 10.1001/archdermatol.2010.133.
   SEER{*}Explorer, 2021, SEER EXPL INT WEBS S.
   Smit AK, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-64019-y.
   Spina M, 2018, ANN BEHAV MED, V52, P106, DOI 10.1093/abm/kax009.
   Steidel AGL, 2003, HISPANIC J BEHAV SCI, V25, P312, DOI 10.1177/0739986303256912.
   SUAREZ L, 1994, AM J PUBLIC HEALTH, V84, P742, DOI 10.2105/AJPH.84.5.742.
   Sunyaev S, 2000, TRENDS GENET, V16, P198, DOI 10.1016/S0168-9525(00)01988-0.
   Tagliabue E, 2015, BRIT J CANCER, V113, P354, DOI 10.1038/bjc.2015.231.
   Tagliabue E, 2018, CANCER MANAG RES, V10, P1143, DOI 10.2147/CMAR.S155283.
   Terán L, 2007, ANTICANCER RES, V27, P4325.
   Zhang ZH, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.03.35.
   Zheng Qian, 2019, J Drugs Dermatol, V18, ps121.},
Number-of-Cited-References = {44},
Times-Cited = {7},
Unique-ID = {WOS:001033679900001},
}

@article{ WOS:000377511100001,
Author = {Baynam, Gareth and Pachter, Nicholas and McKenzie, Fiona and Townshend,
   Sharon and Slee, Jennie and Kiraly-Borri, Cathy and Vasudevan, Anand and
   Hawkins, Anne and Broley, Stephanie and Schofield, Lyn and Verhoef,
   Hedwig and Walker, Caroline E. and Molster, Caron and Blackwell, Jenefer
   M. and Jamieson, Sarra and Tang, Dave and Lassmann, Timo and Mina, Kym
   and Beilby, John and Davis, Mark and Laing, Nigel and Murphy, Lesley and
   Weeramanthri, Tarun and Dawkins, Hugh and Goldblatt, Jack},
Title = {The rare and undiagnosed diseases diagnostic service - application of
   massively parallel sequencing in a state-wide clinical service},
Journal = {ORPHANET JOURNAL OF RARE DISEASES},
Year = {2016},
Volume = {11},
Month = {JUN 11},
Abstract = {Background: The Rare and Undiagnosed Diseases Diagnostic Service (RUDDS)
   refers to a genomic diagnostic platform operating within the Western
   Australian Government clinical services delivered through Genetic
   Services of Western Australia (GSWA). GSWA has provided a state-wide
   service for clinical genetic care for 28 years and it serves a
   population of 2.5 million people across a geographical area of 2.5milion
   Km(2). Within this context, GSWA has established a clinically integrated
   genomic diagnostic platform in partnership with other public health
   system managers and service providers, including but not limited to the
   Office of Population Health Genomics, Diagnostic Genomics (PathWest
   Laboratories) and with executive level support from the Department of
   Health. Herein we describe report presents the components of this
   service that are most relevant to the heterogeneity of paediatric
   clinical genetic care.
   Results: Briefly the platform : i) offers multiple options including
   non-genetic testing; monogenic and genomic (targeted in silico filtered
   and whole exome) analysis; and matchmaking; ii) is delivered in a
   patient-centric manner that is resonant with the patient journey, it has
   multiple points for entry, exit and re-entry to allow people access to
   information they can use, when they want to receive it; iii) is
   synchronous with precision phenotyping methods; iv) captures new
   knowledge, including multiple expert review; v) is integrated with
   current translational genomic research activities and best practice; and
   vi) is designed for flexibility for interactive generation of, and
   integration with, clinical research for diagnostics, community
   engagement, policy and models of care.
   Conclusion: The RUDDS has been established as part of routine clinical
   genetic services and is thus sustainable, equitably managed and seeks to
   translate new knowledge into efficient diagnostics and improved health
   for the whole community.},
Type = {Article},
Affiliation = {Baynam, G (Corresponding Author), Govt Western Australia, Dept Hlth, Genet Serv Western Australia, Perth, WA, Australia.
   Baynam, G (Corresponding Author), Univ Western Australia, Sch Paediat \& Child Hlth, Perth, WA 6009, Australia.
   Baynam, G (Corresponding Author), Murdoch Univ, Inst Immunol \& Infect Dis, Perth, WA, Australia.
   Baynam, G (Corresponding Author), Govt Western Australia, Publ Hlth Div, Dept Hlth, Off Populat Hlth Genom, Perth, WA, Australia.
   Baynam, G (Corresponding Author), Univ Western Australia, Telethon Kids Inst, Perth, WA 6009, Australia.
   Baynam, G (Corresponding Author), Western Australian Register Dev Anomalies, Perth, WA, Australia.
   Baynam, Gareth; Pachter, Nicholas; McKenzie, Fiona; Townshend, Sharon; Slee, Jennie; Kiraly-Borri, Cathy; Vasudevan, Anand; Hawkins, Anne; Broley, Stephanie; Schofield, Lyn; Goldblatt, Jack, Govt Western Australia, Dept Hlth, Genet Serv Western Australia, Perth, WA, Australia.
   Baynam, Gareth; Pachter, Nicholas; McKenzie, Fiona; Goldblatt, Jack, Univ Western Australia, Sch Paediat \& Child Hlth, Perth, WA 6009, Australia.
   Baynam, Gareth, Murdoch Univ, Inst Immunol \& Infect Dis, Perth, WA, Australia.
   Baynam, Gareth; Walker, Caroline E.; Molster, Caron; Dawkins, Hugh, Govt Western Australia, Publ Hlth Div, Dept Hlth, Off Populat Hlth Genom, Perth, WA, Australia.
   Baynam, Gareth; Blackwell, Jenefer M.; Jamieson, Sarra; Tang, Dave; Lassmann, Timo, Univ Western Australia, Telethon Kids Inst, Perth, WA 6009, Australia.
   Mina, Kym; Beilby, John; Davis, Mark; Laing, Nigel, Govt Western Australia, Dept Hlth, Diagnost Genom, PathWest, Perth, WA, Australia.
   Dawkins, Hugh, Curtin Univ Technol, Curtin Hlth Innovat Res Inst, Ctr Populat Hlth Res, Perth, WA, Australia.
   Dawkins, Hugh, Univ Western Australia, Sch Pathol \& Lab Med, Perth, WA 6009, Australia.
   Schofield, Lyn; Murphy, Lesley; Dawkins, Hugh, Murdoch Univ, Ctr Comparat Genom, Perth, WA, Australia.
   Weeramanthri, Tarun, Govt Western Australia, Dept Hlth, Publ Hlth Div, Perth, WA, Australia.
   Baynam, Gareth, Western Australian Register Dev Anomalies, Perth, WA, Australia.
   Verhoef, Hedwig, Curtin Univ, Sch Spatial Sci, Perth, WA 6845, Australia.
   Verhoef, Hedwig, Cooperat Res Ctr Spatial Informat, Perth, WA, Australia.
   Kiraly-Borri, Cathy; Laing, Nigel, Univ Western Australia, QEII Med Ctr, Harry Perkins Inst Med Res, Med Res Ctr, Perth, WA 6009, Australia.
   Murphy, Lesley, Rare Voices Australia, Sydney, NSW, Australia.},
DOI = {10.1186/s13023-016-0462-7},
Article-Number = {77},
Keywords = {Diagnosis; Genomics; Undiagnosed; Diagnostic odyssey; Clinical best
   practice; Policy; Precision public health},
Research-Areas = {Genetics \& Heredity; Research \& Experimental Medicine},
Web-of-Science-Categories  = {Genetics \& Heredity; Medicine, Research \& Experimental},
Author-Email = {Gareth.baynam@health.wa.gov.au},
Affiliations = {University of Western Australia; Murdoch University; Telethon Kids
   Institute; University of Western Australia; University of Western
   Australia; Curtin University; University of Western Australia; Murdoch
   University; Government of Western Australia; Curtin University;
   University of Western Australia; Harry Perkins Institute of Medical
   Research},
Cited-References = {Atwal PS, 2014, GENET MED, V16, P717, DOI 10.1038/gim.2014.10.
   Ayme S, 2013, REPORT STATE ART RAR.
   Baynam G, 2015, AM J MED GENET A, V167, P1659, DOI 10.1002/ajmg.a.37070.
   Groza Tudor, 2015, Database (Oxford), V2015, DOI 10.1093/database/bav005.
   Lee H, 2014, JAMA-J AM MED ASSOC, V312, P1880, DOI 10.1001/jama.2014.14604.
   Molster C, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0409-z.
   Remuzzi G, 2008, LANCET, V371, P1978, DOI 10.1016/S0140-6736(08)60847-8.
   Retterer K., 2015, GENET MED, P1.
   Schieppati A, 2008, LANCET, V371, P2039, DOI 10.1016/S0140-6736(08)60872-7.
   Sorensen G., 2014, WHITE PAPER DIAGNOSI.
   Tang D, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.23.
   Taruscio D, 2015, MOL GENET METAB, V116, P223, DOI 10.1016/j.ymgme.2015.11.003.
   Yang YP, 2014, JAMA-J AM MED ASSOC, V312, P1870, DOI 10.1001/jama.2014.14601.},
Number-of-Cited-References = {13},
Times-Cited = {43},
Unique-ID = {WOS:000377511100001},
}

@article{ WOS:000651801800004,
Author = {Machado, Amanda Alberga and Edwards, Sarah A. and Mueller, Melissa and
   Saini, Vineet},
Title = {Effective interventions to increase routine childhood immunization
   coverage in low socioeconomic status communities in developed countries:
   A systematic review and critical appraisal of peer-reviewed literature},
Journal = {VACCINE},
Year = {2021},
Volume = {39},
Number = {22},
Pages = {2938-2964},
Month = {MAY 21},
Abstract = {Objectives: Childhood immunization coverage rates are known to be
   disproportionate according to population's socioeconomic status (SES).
   This systematic review examined and appraised quality of interventions
   deemed effective to increase routine childhood immunization uptake in
   low SES populations in developed countries. Methods: A literature search
   was conducted using Medline, Embase, CINAHL, EBMR, PsycInfo, PubMed, and
   Health STAR. We systematically searched and critically appraised
   articles published between January 1990 and December 2019 using the
   Effective Public Health Practice Project Quality Assessment tool. This
   systematic review provides a synthesis of the available evidence for
   childhood immunization interventions deemed effective for low SES
   parents or families of children < 5 years of age. Synthesis: The search
   yielded 3317 records, of which 2975 studies met the inclusion criteria.
   From the 100 relevant studies, a total of 40 were included. The majority
   of effective and strongly rated studies synthesized consisted of
   multi-component interventions. Such interventions addressed access,
   community based mobilization, outreach, appointment reminders,
   education, clinical tracking and incentives, and were language and
   health literacy appropriate to support low SES parents. Improving access
   to low SES parents was deemed effective in the vast majority of strongly
   rated studies. Incorrect contact information of low SES parents due to
   increased social mobility (i.e. household moves) rendered reminders
   ineffective, and therefore, updating contact information should be
   pursued proactively by front-line healthcare providers. In addition,
   plain language communication with low SES parents regarding immunization
   was deemed effective in improving immunization uptake. Conclusion:
   Comprehensive multi-component interventions including improved access,
   appointment reminders, education and precision health communication are
   effective for addressing health inequities in immunization coverage
   amongst marginalized populations. Most low SES parents still believe
   that the benefits of immunization outweigh the risks. (c) 2021 Elsevier
   Ltd. All rights reserved.},
Type = {Review},
Affiliation = {Saini, V (Corresponding Author), 10201 Southport Rd SW, Calgary, AB T2W 3N2, Canada.
   Machado, Amanda Alberga; Edwards, Sarah A.; Mueller, Melissa; Saini, Vineet, Alberta Hlth Serv, Res \& Innovat, Prov Populat \& Publ Hlth, 10201 Southport Rd SW, Calgary, AB T2W 3N2, Canada.
   Edwards, Sarah A.; Saini, Vineet, Univ Calgary, Cumming Sch Med, Dept Community Hlth Sci, Calgary, AB, Canada.
   Edwards, Sarah A.; Saini, Vineet, Univ Calgary, Cumming Sch Med, OBrien Inst Publ Hlth, Calgary, AB, Canada.},
DOI = {10.1016/j.vaccine.2021.03.088},
EarlyAccessDate = {MAY 2021},
Keywords = {Health equity; Immunization; Vaccine hesitancy; Precision public health;
   Deprivation; Access},
Keywords-Plus = {IMPROVE IMMUNIZATION; VACCINATION STATUS; CHILDREN; PROGRAM; RATES;
   IMPACT; INFANTS; WOMEN; AGE; CARE},
Research-Areas = {Immunology; Research \& Experimental Medicine},
Web-of-Science-Categories  = {Immunology; Medicine, Research \& Experimental},
Author-Email = {vineet.saini@ahs.ca},
Affiliations = {Alberta Health Services (AHS); University of Calgary; University of
   Calgary; University of Calgary},
Cited-References = {ABRAMSON JS, 1995, J PEDIATR-US, V126, P583, DOI 10.1016/S0022-3476(95)70354-3.
   Adedokun ST, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4137-7.
   Adorador A, 2011, J AM ACAD NURSE PRAC, V23, P501, DOI 10.1111/j.1745-7599.2011.00632.x.
   Alemi F, 1996, MED CARE, V34, pOS45.
   Armijo-Olivo S, 2012, J EVAL CLIN PRACT, V18, P12, DOI 10.1111/j.1365-2753.2010.01516.x.
   Barnes K, 1999, ARCH PEDIAT ADOL MED, V153, P518.
   Bell CA, 2015, VACCINE, V33, P4572, DOI 10.1016/j.vaccine.2015.07.004.
   Beverley PCL, 2002, BRIT MED BULL, V62, P15, DOI 10.1093/bmb/62.1.15.
   BIRKHEAD GS, 1995, JAMA-J AM MED ASSOC, V274, P312, DOI 10.1001/jama.274.4.312.
   Bocquier A, 2017, EXPERT REV VACCINES, V16, P1107, DOI 10.1080/14760584.2017.1381020.
   Boslaugh S.E., 2013, Health care systems around the world: a comparative guide.
   Browngoehl K, 1997, PEDIATRICS, V99, pE41, DOI 10.1542/peds.99.1.e4.
   Busby \& Chesterley, 2015, COMMENTARY NO 412 SH.
   CAMPBELL JR, 1994, CLIN PEDIATR, V33, P268, DOI 10.1177/000992289403300503.
   Carpiano RM, 2019, PREV MED, V123, P278, DOI 10.1016/j.ypmed.2019.03.033.
   Cockman P, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5703.
   Dombkowski KJ, 2004, PUBLIC HEALTH REP, V119, P144, DOI 10.1177/003335490411900207.
   Dubé E, 2016, CAN MED ASSOC J, V188, pE17, DOI 10.1503/cmaj.150707.
   Dubé E, 2013, HUM VACC IMMUNOTHER, V9, P1763, DOI 10.4161/hv.24657.
   Dummer TJB, 2012, CAN J PUBLIC HEALTH, V103, pE363, DOI 10.1007/BF03404442.
   Else-Quest NM, 2016, PSYCHOL WOMEN QUART, V40, P319, DOI 10.1177/0361684316647953.
   Fairbrother G, 1997, ARCH PEDIAT ADOL MED, V151, P1229, DOI 10.1001/archpedi.1997.02170490055010.
   Findley Sally, 2004, Ethn Dis, V14, pS134.
   Findley SE, 2003, AM J PUBLIC HEALTH, V93, P1041, DOI 10.2105/AJPH.93.7.1041.
   Fleiss J., 1986, Reliability of measurement: the design and analysis of clinical experiments.
   Fu LY, 2012, PEDIATRICS, V129, pE496, DOI 10.1542/peds.2010-3610.
   Glatman-Freedman Aharona, 2012, Hum Vaccin Immunother, V8, P293, DOI 10.4161/hv.19003.
   Hambidge SJ, 2009, PEDIATRICS, V124, P455, DOI 10.1542/peds.2008-0446.
   Harper PG, 1997, ARCH PEDIAT ADOL MED, V151, P1220, DOI 10.1001/archpedi.1997.02170490046008.
   Hellerstedt WL, 1999, AM J PREV MED, V16, P50, DOI 10.1016/S0749-3797(98)00144-5.
   Hicks P, 2007, J AM BOARD FAM MED, V20, P581, DOI 10.3122/jabfm.2007.06.060071.
   Hoekstra EJ, 1998, JAMA-J AM MED ASSOC, V280, P1143, DOI 10.1001/jama.280.13.1143.
   Hofstetter AM, 2015, VACCINE, V33, P5741, DOI 10.1016/j.vaccine.2015.09.042.
   Hutchins SS, 1999, J PUBLIC HEALTH POL, V20, P408, DOI 10.2307/3343128.
   Irigoyen MM, 2006, AMBUL PEDIATR, V6, P100, DOI 10.1016/j.ambp.2005.10.006.
   Jackson C, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4178-y.
   Joyce T, 2005, PEDIATRICS, V115, pE526, DOI 10.1542/peds.2004-1533.
   Kerpelman LC, 2000, JAMA-J AM MED ASSOC, V284, P53, DOI 10.1001/jama.284.1.53.
   Larson Heidi J, 2015, PLoS Curr, V7, DOI 10.1371/currents.outbreaks.ce0f6177bc97332602a8e3fe7d7f7cc4.
   LeBaron CW, 1998, ARCH PEDIAT ADOL MED, V152, P327.
   Lemstra M, 2011, PAED CHILD HEALT-CAN, V16, pE1, DOI 10.1093/pch/16.1.e1.
   Lernout T, 2014, VACCINE, V32, P284, DOI 10.1016/j.vaccine.2013.10.084.
   Mayer JP, 1999, J COMMUN HEALTH, V24, P13, DOI 10.1023/A:1018761114561.
   Mendel-Van Alstyne JA, 2018, VACCINE, V36, P6464, DOI 10.1016/j.vaccine.2017.09.007.
   Minkovitz C, 1999, ARCH PEDIAT ADOL MED, V153, P1242, DOI 10.1001/archpedi.153.12.1242.
   Miraglia del Giudice M, 2018, EUR J PEDIATR, P243.
   Murphy AW, 1996, IRISH MED J, V89, P220.
   Newton P, 2017, CHILD CARE HLTH DEV, V43, P504, DOI 10.1111/cch.12453.
   Odone A, 2015, HUM VACC IMMUNOTHER, V11, P72, DOI 10.4161/hv.34313.
   OEFFINGER KC, 1992, J FAM PRACTICE, V35, P288.
   Oyo-Ita A, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008145.pub3.
   Peretti-watel P, 2019, SOCIOL HLTH ILLNESS, P1.
   READING R, 1994, BRIT MED J, V308, P1142, DOI 10.1136/bmj.308.6937.1142.
   Rodewald LE, 1997, ARCH PEDIAT ADOL MED, V151, P798, DOI 10.1001/archpedi.1997.02170450048007.
   Rodewald LE, 1999, PEDIATRICS, V103, P31, DOI 10.1542/peds.103.1.31.
   ROSENBERG Z, 1995, AM J PREV MED, V11, P14, DOI 10.1016/S0749-3797(18)30401-X.
   Saini V, 2017, CAN J PUBLIC HEALTH, V108, pE124, DOI {[}10.17269/CJPH.108.5885, 10.17269/cjph.108.5885].
   Sege R, 2015, PEDIATRICS, V136, P97, DOI 10.1542/peds.2014-2955.
   Shefer A, 1999, EPIDEMIOL REV, V21, P96, DOI 10.1093/oxfordjournals.epirev.a017992.
   Shefer AM, 2001, AM J PREV MED, V20, P47, DOI 10.1016/S0749-3797(01)00279-3.
   Smith PJ, 2004, PEDIATRICS, V114, P187, DOI 10.1542/peds.114.1.187.
   STEHRGREEN PA, 1993, PUBLIC HEALTH REP, V108, P426.
   Szilagyi PG, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.5.e58.
   Tauil MD, 2016, VACCINE, V34, P2635, DOI 10.1016/j.vaccine.2016.04.016.
   Taylor JA, 1997, PEDIATRICS, V100, part. no., DOI 10.1542/peds.100.3.e1.
   Thomas TN, 2014, AM J PREV MED, V47, P624, DOI 10.1016/j.amepre.2014.06.017.
   United Nations, 2019, WORLD EC SITUATION P.
   Walsh B, 2016, HEALTH AFFAIR, V35, P356, DOI {[}10.1377/hlthaff.2015.1019, 10.1377/hlthaff.2015.10].
   Waterman SH, 1996, AM J PREV MED, V12, P8, DOI 10.1016/S0749-3797(18)30252-6.
   Wood D, 1998, JAMA-J AM MED ASSOC, V279, P29, DOI 10.1001/jama.279.1.29.},
Number-of-Cited-References = {70},
Times-Cited = {7},
Unique-ID = {WOS:000651801800004},
}

@article{ WOS:000536132800001,
Author = {Chaves, Luis Fernando and Hurtado, Lisbeth A. and Rojas, Melissa Ramirez
   and Friberg, Mariel D. and Rodriguez, Rodrigo Marin and Avila-Aguero,
   Maria L.},
Title = {COVID-19 basic reproduction number and assessment of initial suppression
   policies in Costa Rica},
Journal = {MATHEMATICAL MODELLING OF NATURAL PHENOMENA},
Year = {2020},
Volume = {15},
Month = {MAY 18},
Abstract = {SARS-COV-2 is the most recent from a series of emerging pathogens
   stressing national health systems. Initially restricted to Hubei
   province in China, COVID-19, the disease caused by SARS-COV-2 has become
   pandemic, reaching almost every nation on our planet. Here, we present
   an estimate of the Basic Reproduction Number (R-0) for this disease
   based on confirmed cases recorded during the initial 30 days of
   transmission. Based on local transmission data for the six initial days
   of transmission, we estimated (mean +/- SE) R-0 = 2.58 +/- 2.43. R-0 was
   reduced by up to 56\% to R-0 = 1.12 +/- 0.02 following suppression
   measures in place by April 4th, 2020. Independent estimates for the
   time-varying reproduction number (R-t) based on the serial interval
   distribution estimated for China showed that after 30 days, R-t
   decreased reaching a value of 0.914 +/- 0.104 on April 4th, 2020. In
   this study, we also describe the suppression strategies in place in
   Costa Rica and compare their impacts with those implemented in Panama
   and Uruguay, provided these three middle-income countries have similar
   demographic and economic indicators. However, these three countries have
   structurally different health systems and have resorted to different
   suppression measures against COVID-19. We compare the early epidemic
   growth curves in the three countries using an exponential deceleration
   model. We found the lowest epidemic growth rate in Costa Rica, followed
   by Panama and then Uruguay, while the highest deceleration was observed
   in Uruguay, followed by Costa Rica and Panama. We discuss how the
   unified, universal healthcare system of Costa Rica has been vital to
   successfully manage the early stage of the COVID-19 epidemic and call
   for the developments of precision public health tools to further improve
   epidemic health surveillance in Costa Rica.},
Type = {Article},
Affiliation = {Chaves, LF (Corresponding Author), Minist Salud, Vigilancia Salud, San Jose, Costa Rica.
   Chaves, Luis Fernando; Rojas, Melissa Ramirez; Rodriguez, Rodrigo Marin, Minist Salud, Vigilancia Salud, San Jose, Costa Rica.
   Hurtado, Lisbeth A., Inst Conmemorat Gorgas Estudios Salud, Unidad Anal Epidemiol \& Bioestadist, Panama City, Panama.
   Friberg, Mariel D., Univ Space Res Assoc, Columbia, MD 21046 USA.
   Avila-Aguero, Maria L., Hosp Nacl Ninos Dr Carlos Saenz Herrera, Serv Infectol, San Jose, Costa Rica.
   Avila-Aguero, Maria L., Yale Sch Publ Hlth, Ctr Infect Dis Modeling \& Anal, New Haven, CT USA.},
DOI = {10.1051/mmnp/2020019},
Article-Number = {32},
Keywords = {Maximum likelihood; trajectory matching; transmission reduction;
   universal health care},
Keywords-Plus = {INFECTIOUS-DISEASES; HEALTH SYSTEM; DYNAMICS; GROWTH; MODEL},
Research-Areas = {Mathematical \& Computational Biology; Mathematics},
Web-of-Science-Categories  = {Mathematical \& Computational Biology; Mathematics, Applied;
   Mathematics, Interdisciplinary Applications},
Author-Email = {lfchavs@gmail.com},
Affiliations = {Instituto Conmemorativo Gorgas de Estudios de la Salud; Universities
   Space Research Association (USRA); Yale University},
Cited-References = {Andersen B, 2020, CELL STEM CELL, V26, P1, DOI 10.1016/j.stem.2019.12.001.
   ANDERSON R M, 1991.
   ANDERSON RM, 1991, J ANIM ECOL, V60, P1, DOI 10.2307/5443.
   Anderson RM, 2020, LANCET, V395, P931, DOI 10.1016/S0140-6736(20)30567-5.
   {[}Anonymous], 2012, 10 CENS NAC POBL 6 V.
   {[}Anonymous], 2020, REPORT 9 IMPACT NONP.
   {[}Anonymous], 2020, LANCET, DOI DOI 10.1016/S0140-6736(20)30528-6.
   {[}Anonymous], COVID 19 TESTING TRE.
   {[}Anonymous], MIN PLAN NAC POL EC.
   {[}Anonymous], 2003, MATH GAZ, DOI {[}DOI 10.1017/S0025557200173802, 10.1017/S0025557200173802].
   {[}Anonymous], ANA EXPERIENCIAS INT.
   {[}Anonymous], 2020, JAMA, DOI DOI 10.1001/JAMA.2020.2648.
   {[}Anonymous], ANN INTERN MED.
   {[}Anonymous], 2008, ECOLOGICAL MODELS DA, DOI DOI 10.2307/J.CTVCM4G37.
   Aran D, 2011, SALUD PUBLICA MEXICO, V53, pS265.
   Belay ED, 2014, EMERG INFECT DIS, V20, P319, DOI 10.3201/eid2002.131748.
   Bjornstad O. N., 2018, EPIDEMICS MODELS DAT.
   BYRD RH, 1995, SIAM J SCI COMPUT, V16, P1190, DOI 10.1137/0916069.
   Carrera JP, 2013, NEW ENGL J MED, V369, P732, DOI 10.1056/NEJMoa1212628.
   Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9.
   Chaves LF, 2020, PARASITOLOGY, V147, P999, DOI 10.1017/S0031182020000621.
   Coleman PG, 2001, LANCET, V357, P1284, DOI 10.1016/S0140-6736(00)04410-X.
   Sáenz MD, 2011, SALUD PUBLICA MEXICO, V53, pS156.
   Dobson AP, 1996, BIOSCIENCE, V46, P115, DOI 10.2307/1312814.
   Dowell SF, 2016, NATURE, V540, P189, DOI 10.1038/540189a.
   Du ZW, 2020, EMERG INFECT DIS, V26, P1341, DOI {[}10.3201/eid2606.200357, 10.1101/2020.02.19.20025452].
   Gates B, 2020, NEW ENGL J MED, V382, P1677, DOI 10.1056/NEJMp2003762.
   Honjo K, 2013, PARASITOLOGY, V140, P580, DOI 10.1017/S0031182012002077.
   Hopman J, 2020, JAMA-J AM MED ASSOC, V323, P1549, DOI 10.1001/jama.2020.4169.
   Knaul FM, 2015, LANCET GLOB HEALTH, V3, P35.
   Kraemer MUG, 2020, SCIENCE, V368, P493, DOI 10.1126/science.abb4218.
   Kruk ME, 2018, LANCET, V392, P2203, DOI 10.1016/s0140-6736(18)31668-4.
   Kuhn M., 2013, Applied Predictive Modeling, V26.
   Lee VJ, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa039.
   LEVINS R, 1994, AM SCI, V82, P52.
   Levins R, 1999, INT J HEALTH SERV, V29, P261, DOI 10.2190/WLVK-D0RR-KVBV-A1DH.
   LEVINS R, 1995, TRENDS ECOL EVOL, V10, P304, DOI 10.1016/S0169-5347(00)89111-9.
   LEVINS RICHARD, 1968.
   Lewontin R, 2000, INT J HEALTH SERV, V30, P873, DOI 10.2190/0D66-KFBJ-VYVH-9A8J.
   Li RY, 2020, SCIENCE, V368, P489, DOI {[}10.1126/science.abb3221, 10.1101/2020.02.14.20023127].
   Rodríguez RM, 2019, TRENDS PARASITOL, V35, P585, DOI 10.1016/j.pt.2019.04.007.
   NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308.
   Nishiura H, 2020, INT J INFECT DIS, V93, P284, DOI 10.1016/j.ijid.2020.02.060.
   Palmer Steven, 2003, From Popular Medicine to Medical Populism: Doctors, Healers, and Public Power in Costa Rica, 1800-1940.
   Predescu M, 2007, APPL MATH LETT, V20, P919, DOI 10.1016/j.aml.2006.12.001.
   Rosero-Bixby L, 2016, P NATL ACAD SCI USA, V113, P1130, DOI 10.1073/pnas.1521917112.
   Sandiford P., 2002, Gac Sanit, V16, P70.
   Scrucca L, 2013, J STAT SOFTW, V53, P1.
   Thompson RN, 2019, EPIDEMICS-NETH, V29, DOI 10.1016/j.epidem.2019.100356.
   Tian HY, 2020, SCIENCE, V368, P638, DOI 10.1126/science.abb6105.
   Viboud C, 2016, EPIDEMICS-NETH, V15, P27, DOI 10.1016/j.epidem.2016.01.002.
   Volpert V, 2020, MATH MODEL NAT PHENO, V15, DOI 10.1051/mmnp/2020006.
   Wallace R., 2018, Clear-Cutting Disease Control: Capital-Led Deforestation, Public Health Austerity, and Vector-Borne Infection.
   Wallace RG, 2016, INT J HEALTH SERV, V46, P149, DOI 10.1177/0020731415611644.
   Wilder-Smith A, 2020, J TRAVEL MED, V27, DOI {[}10.1093/jtm/taaa020, 10.1093/jtm/taaa227].
   Wu JT, 2020, NAT MED, V26, P506, DOI 10.1038/s41591-020-0822-7.
   Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9.},
Number-of-Cited-References = {57},
Times-Cited = {15},
Unique-ID = {WOS:000536132800001},
}

@article{ WOS:000526399800011,
Author = {Santos, Claudia Jardim and Gomes, Bernardo and Ribeiro, Ana Isabel},
Title = {Mapping Geographical Patterns and High Rate Areas for Sexually
   Transmitted Infections in Portugal: A Retrospective Study Based on the
   National Epidemiological Surveillance System},
Journal = {SEXUALLY TRANSMITTED DISEASES},
Year = {2020},
Volume = {47},
Number = {4},
Pages = {261-268},
Month = {APR},
Abstract = {Objective
   Monitoring disease variation using finer scales to identify high-rate
   communities is a critical aspect for precision public health and for
   efficient resource allocation. This study aimed to map the spatial
   patterns of chlamydia, gonorrhea, and syphilis; identify high-rate areas
   across Portuguese municipalities; and determine the association of these
   sexually transmitted infections (STIs) with socioeconomic deprivation,
   urbanicity level, and population density. Methods
   The STI notifications at municipality level for the period 2015 to 2017
   were obtained from Portugal's Epidemiologic Surveillance System (Sistema
   Nacional de Vigilancia Epidemiologica). Spatial Bayesian models were
   used to calculate smoothed standardized notification rates, identify
   high- and low-rate areas and estimate associations (relative risk
   {[}RR], 95\% credible intervals {[}95\%CrI]). Results
   There were 4819 cases of chlamydia, gonorrhea, and syphilis reported,
   accounting for 15.3\%, 33.2\%, and 51.5\% of the notifications,
   respectively. The STI notification rates were substantially higher in
   Porto and Lisbon Metropolitan Areas and concentrically disperse around
   those. Notification rates of the 3 STIs were strongly correlated (r >
   0.8). Rates of gonorrhea (Q1-lowest density vs. Q5-highest RR, 2.10;
   95\% CrI, 1.08-4.25) and syphilis (RR, 3.16; 95\% CrI, 2.00-5.13) were
   associated with population density. Notifications of chlamydia (Q1-least
   urban vs. Q5-most RR, 9.64; 95\% CrI, 1.73-93.59) and syphilis (RR,
   1.92; 95\% CrI, 1.30-2.88) increased with urbanicity level. We also
   found that notification rates of gonorrhea were associated with
   socioeconomic deprivation (Q1-least vs. Q5-most deprived RR, 1.75; 95\%
   CrI, 1.07-2.88). Conclusions
   Wide spatial inequalities in STI notification rates were observed, which
   were predominantly concentrated in the 2 metropolitan areas of the
   country. Our findings can help guide more targeted interventions to
   reduce STIs incidence.},
Type = {Article},
Affiliation = {Santos, CJ (Corresponding Author), Univ Porto, Inst Saude Publ, Rua Taipas 135, P-4050600 Porto, Portugal.
   Santos, Claudia Jardim; Gomes, Bernardo, Univ Porto, Inst Saude Publ, Rua Taipas 135, P-4050600 Porto, Portugal.
   Santos, Claudia Jardim; Gomes, Bernardo; Ribeiro, Ana Isabel, Univ Porto, Fac Med, Dept Ciencias Saude Publ \& Forenses \& Educ Med, Porto, Portugal.
   Gomes, Bernardo, Adm Reg Saude Norte, Dept Saude Publ, Porto, Portugal.
   Ribeiro, Ana Isabel, Univ Porto, EPIUnit, Inst Saude Publ, Porto, Portugal.},
DOI = {10.1097/OLQ.0000000000001122},
Keywords-Plus = {PREVALENCE; CHLAMYDIA; GONORRHEA},
Research-Areas = {Infectious Diseases},
Web-of-Science-Categories  = {Infectious Diseases},
Author-Email = {claudiasantos@ispup.up.pt},
Affiliations = {Universidade do Porto; Universidade do Porto; Universidade do Porto},
Cited-References = {{[}Anonymous], INT ENCY PUBLIC HLTH.
   {[}Anonymous], DOENC DECL OBR 2013.
   {[}Anonymous], RELATORIO MONITORIZA.
   {[}Anonymous], 2018, Sexually Transmitted Disease Surveillance.
   {[}Anonymous], INQ SER NAC 2015 201.
   Apolinário D, 2017, INT J TUBERC LUNG D, V21, P784, DOI 10.5588/ijtld.16.0907.
   BESAG J, 1991, ANN I STAT MATH, V43, P1, DOI 10.1007/BF00116466.
   Bolin D, 2015, J ROY STAT SOC B, V77, P85, DOI 10.1111/rssb.12055.
   Chesson HW, 2012, SEX TRANSM DIS, V39, P458, DOI 10.1097/OLQ.0b013e318248e3eb.
   Chowkwanyun M, 2018, NEW ENGL J MED, V379, P1398, DOI 10.1056/NEJMp1806634.
   Dean CB, 2001, BIOMETRICS, V57, P197, DOI 10.1111/j.0006-341X.2001.00197.x.
   Eng T., 1997, HIDDEN EPIDEMIC CONF, P28.
   Falasinnu T, 2015, INT J STD AIDS, V26, P839, DOI 10.1177/0956462414555930.
   Hippe J, 2012, SPAT SPATIO-TEMPORAL, V3, P255, DOI 10.1016/j.sste.2012.04.001.
   Hughes G, 2015, FUTURE MICROBIOL, V10, P35, DOI 10.2217/fmb.14.110.
   Jennings JM, 2015, ANN EPIDEMIOL, V25, P861, DOI 10.1016/j.annepidem.2015.07.008.
   Newman L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143304.
   Patterson-Lomba O, 2015, SEX TRANSM INFECT, V91, P610, DOI 10.1136/sextrans-2014-051932.
   Reyes R., 2013, Challenges in infectious diseases, P123.
   Ribeiro AI, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208320.
   Ribeiro AI, 2016, J EPIDEMIOL COMMUN H, V70, P561, DOI 10.1136/jech-2015-206827.
   Riebler A, 2016, STAT METHODS MED RES, V25, P1145, DOI 10.1177/0962280216660421.
   Rowley J, 2019, B WORLD HEALTH ORGAN, V97, P548, DOI 10.2471/BLT.18.228486.
   Rue H., 2014, INLA: Functions which allow to perform full Bayesian analysis of latent Gaussian models using Integrated Nested Laplace Approximaxion.
   Springer YP, 2010, AM J PUBLIC HEALTH, V100, P1060, DOI 10.2105/AJPH.2009.172965.
   Sugishita Y, 2019, WEST PAC SURVEILL RE, V10, DOI 10.5365/wpsar.2017.8.2.006.
   van Bergen J, 2005, SEX TRANSM INFECT, V81, P17, DOI 10.1136/sti.2004.010173.
   WHO, 2016, Global Health Sector Strategy On Sexually Transmitted Infections, 2016-2021.
   Wong NS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27173-y.},
Number-of-Cited-References = {29},
Times-Cited = {6},
Unique-ID = {WOS:000526399800011},
}

@article{ WOS:000718721400003,
Author = {Sausen, Kathleen A. and Randolph, James W. and Casciato, Allison N. and
   Dietrich, Mary S. and Scholer, Seth J.},
Title = {The Development, Preliminary Validation, and Clinical Application of the
   Quick Parenting Assessment},
Journal = {PREVENTION SCIENCE},
Year = {2022},
Volume = {23},
Number = {2},
Pages = {306-320},
Month = {FEB},
Abstract = {To prevent diseases, efforts are needed to determine how to address
   Adverse Childhood Experiences (ACEs), including parenting behaviors. The
   objective of this study, conducted in Nashville TN in 2017, was to
   initiate testing the psychometric properties of two new Adverse
   Childhood Experiences (ACEs) screening tools, the Quick Parenting
   Assessment (QPA) and Other Childhood Stressors (OCS). In a clinic
   serving low-income families, caregivers of children ages 2-10 completed
   assessments of parenting (QPA), other stressors (OCS), child behavior
   problems ((Strength and Difficulties Questionnaire (SDQ)), and Attitudes
   Toward Spanking (ATS). The QPA takes 1 min to complete and assesses for
   healthy and unhealthy parenting behaviors. Seventy-five percent of
   eligible participants completed the survey (N=558). A reduced 10-item
   QPA yielded a Cronbach's alpha of 0.79 and, in 4-10-year-olds, was
   associated with high SDQ conduct, hyperactivity, and total difficulties
   scores (r=0.44, 0.48, and 0.47; all p< 0.001). Children with QPAs of >4
   were nine times more likely than those children with scores of <= 2 to
   have behavior problems (OR=8.93, 95\% CI = 3.74-21.32). Elevated QPAs
   were associated with the ATS (r=0.47, p < .001). The OCS was also
   associated with high SDQ total difficulties scores (r=0.28, p< 0.001).
   Two pediatric ACEs screening tools, the QPA and the OCS, have promising
   psychometric properties. The findings suggest that parenting behaviors
   may play an outsized role in the pathogenesis of outcomes associated
   with ACEs. We discuss the clinical application of QPA at our institution
   and the theoretical potential for this instrument to reduce the rates of
   short- and long-term health problems.},
Type = {Article},
Affiliation = {Scholer, SJ (Corresponding Author), Monroe Carell Jr Childrens Hosp Vanderbilt, Vanderbilt Dept Pediat, Doctors Off Towers,2200 Childrens Way, Nashville, TN 37232 USA.
   Sausen, Kathleen A., Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA.
   Randolph, James W., Tennessee Dept Hlth, Off Strateg Initiat, Nashville, TN USA.
   Casciato, Allison N., Monroe Carell Jr Childrens Hosp Vanderbilt, Dept Pediat, Nashville, TN USA.
   Dietrich, Mary S., Vanderbilt Univ, Sch Nursing, Sch Med Biostat, Nashville, TN 37240 USA.
   Scholer, Seth J., Monroe Carell Jr Childrens Hosp Vanderbilt, Vanderbilt Dept Pediat, Doctors Off Towers,2200 Childrens Way, Nashville, TN 37232 USA.},
DOI = {10.1007/s11121-021-01320-w},
EarlyAccessDate = {NOV 2021},
Keywords = {Parenting; Child abuse prevention; Violence prevention; Bullying
   prevention; Physical punishment; Adverse childhood experiences;
   Childhood behavior problems; Precision public health; Social
   determinants of health},
Keywords-Plus = {ADVERSE CHILDHOOD EXPERIENCES; BEHAVIOR PROBLEMS; DISCIPLINE; ATTITUDES;
   ADJUSTMENT; STRATEGIES; CHILDREN; SPANKING; VIOLENCE; SCALES},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {kathleen.p.anthony@gmail.com
   jwrandolph@gmail.com
   allisoncasciato@gmail.com
   mary.dietrich@vanderbilt.edu
   Seth.Scholer@VUMC.org},
Affiliations = {Vanderbilt University; Tennessee Department Health; Vanderbilt
   University; Vanderbilt University; Vanderbilt University},
Cited-References = {Afifi TO, 2017, CHILD ABUSE NEGLECT, V71, P24, DOI 10.1016/j.chiabu.2017.01.014.
   Amato PR, 2002, J MARRIAGE FAM, V64, P703, DOI 10.1111/j.1741-3737.2002.00703.x.
   {[}Anonymous], 2015, Information for researchers and professionals about the Strengths Difficulties Questionnaires.
   {[}Anonymous], 2020, Adverse Childhood Experiences.
   Arnold D. S., 1993, Psychological Assessment, V5, P137, DOI {[}10.1037/1040-3590.5.2.137, DOI 10.1037/1040-3590.5.2.137].
   Bethell CD, 2017, ACAD PEDIATR, V17, pS51, DOI 10.1016/j.acap.2017.04.161.
   CDC, 2020, PREV BULL.
   CDC, 2020, BEHAV COND PROBL CHI.
   Chavis A, 2013, CHILD ABUSE NEGLECT, V37, P1192, DOI 10.1016/j.chiabu.2013.06.003.
   Delaney K, 1999, J Child Adolesc Psychiatr Nurs, V12, P53, DOI 10.1111/j.1744-6171.1999.tb00045.x.
   Dickson DJ, 2019, J YOUTH ADOLESCENCE, V48, P1567, DOI 10.1007/s10964-019-01040-z.
   Feigelman S, 2009, CHILD ABUSE NEGLECT, V33, P269, DOI 10.1016/j.chiabu.2008.09.011.
   Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8.
   Finkelhor D, 2018, CHILD ABUSE NEGLECT, V85, P174, DOI 10.1016/j.chiabu.2017.07.016.
   FLECKMAN J, 2020, ACAD PEDIATR.
   Gershoff ET, 2017, CHILD ABUSE NEGLECT, V71, P9, DOI 10.1016/j.chiabu.2017.01.017.
   Gershoff ET, 2016, FAM RELAT, V65, P490, DOI 10.1111/fare.12205.
   Gershoff ET, 2016, J FAM PSYCHOL, V30, P453, DOI 10.1037/fam0000191.
   Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010.
   Herman DB, 1997, AM J PUBLIC HEALTH, V87, P249, DOI 10.2105/AJPH.87.2.249.
   Hunt TKA, 2017, CHILD ABUSE NEGLECT, V67, P391, DOI 10.1016/j.chiabu.2016.11.005.
   Hurley KD, 2014, J CHILD FAM STUD, V23, P812, DOI 10.1007/s10826-013-9733-2.
   Kerker BD, 2016, ACAD PEDIATR, V16, P154, DOI 10.1016/j.acap.2015.08.002.
   Kim J, 2014, CHILD MALTREATMENT, V19, P79, DOI 10.1177/1077559514532009.
   Lee D, 2018, J PEDIATR HEALTH CAR, V32, P564, DOI 10.1016/j.pedhc.2018.04.021.
   Lee H, 2020, PREV MED, V134, DOI 10.1016/j.ypmed.2020.106039.
   Lunkenheimer E, 2017, J FAM PSYCHOL, V31, P689, DOI 10.1037/fam0000310.
   Marie-Mitchell Ariane, 2019, Glob Pediatr Health, V6, p2333794X19862093, DOI 10.1177/2333794X19862093.
   McKelvey LM, 2018, CHILD ABUSE NEGLECT, V82, P168, DOI 10.1016/j.chiabu.2018.05.026.
   Nygren P, 2004, ANN FAM MED, V2, P161, DOI 10.1370/afm.113.
   O'Connell LK, 2015, PEDIATRICS, V135, pE286, DOI 10.1542/peds.2014-2497.
   Sanders MR, 2014, CHILD PSYCHIAT HUM D, V45, P255, DOI 10.1007/s10578-013-0397-3.
   Scholer SJ, 2008, CLIN PEDIATR, V47, P891, DOI 10.1177/0009922808319965.
   Scholer SJ, 2006, CLIN PEDIATR, V45, P835, DOI 10.1177/0009922806294217.
   Scholer SJ, 2010, PEDIATRICS, V125, pE242, DOI 10.1542/peds.2009-0874.
   Sege RD, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-3112.
   Smith AE, 2017, MATERN CHILD HLTH J, V21, P177, DOI 10.1007/s10995-016-2107-9.
   Stormshak EA, 2000, J CLIN CHILD PSYCHOL, V29, P17, DOI 10.1207/S15374424jccp2901\_3.
   Straus MA, 1998, CHILD ABUSE NEGLECT, V22, P249, DOI 10.1016/S0145-2134(97)00174-9.
   STRAYHORN JM, 1988, J AM ACAD CHILD PSY, V27, P613, DOI 10.1097/00004583-198809000-00016.
   Traub F, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2569.
   TRICKETT PK, 1986, DEV PSYCHOL, V22, P115, DOI 10.1037/0012-1649.22.1.115.
   Vally Z, 2020, PSYCHOL STUD, V65, P40, DOI 10.1007/s12646-019-00497-z.
   Vanderbilt University, 2020, QUICK PAR ASS.
   Vanderbilt University, 2015, PLAY NIC HLTH DISC P.
   Vittrup B, 2006, PEDIATRICS, V117, P2055, DOI 10.1542/peds.2005-2204.
   Wang MT, 2014, CHILD DEV, V85, P908, DOI 10.1111/cdev.12143.
   Wolraich ML, 2020, PEDIATRICS, V145, DOI 10.1542/peds.2019-3997.},
Number-of-Cited-References = {48},
Times-Cited = {2},
Unique-ID = {WOS:000718721400003},
}

@article{ WOS:000679401400006,
Author = {Ciesielski, Timothy H. and Ngendahimana, David K. and Roche, Abigail and
   Williams, Scott M. and Freedman, Darcy A.},
Title = {Elevated Dietary Inflammation Among Supplemental Nutrition Assistance
   Program Recipients Provides Targets for Precision Public Health
   Intervention},
Journal = {AMERICAN JOURNAL OF PREVENTIVE MEDICINE},
Year = {2021},
Volume = {61},
Number = {2},
Pages = {192-200},
Month = {AUG},
Abstract = {Introduction: The Supplemental Nutrition Assistance Program was designed
   to prevent food insecurity among low-income Americans and has been
   linked to improvements in pregnancy health, long-term child development,
   and criminal recidivism. However, the pursuit of food security does not
   ensure nutritional sufficiency, and the program has not improved diet
   quality or cardiometabolic mortality (i.e., heart disease, stroke,
   diabetes). In this study, longitudinal cohort data are used to identify
   by Supplemental Nutrition Assistance Program status the proinflammatory
   characteristics that predispose to chronic disease.
   Methods: Between 2015 and 2018, annual 24-hour dietary recalls were
   conducted with 409 residents from low-income, urban neighborhoods in
   Columbus and Cleveland, Ohio (statistical analysis started in 2019). The
   Dietary Inflammatory Index was calculated. It provides empirically
   validated estimates of the internal inflammation that each diet should
   produce; higher Dietary Inflammatory Index scores have been associated
   with elevated inflammatory biomarkers. Finally, associations between
   Supplemental Nutrition Assistance Program and Dietary Inflammatory Index
   were evaluated, and dietary components that differed by Supplemental
   Nutrition Assistance Program status were identified.
   Results: Supplemental Nutrition Assistance Program recipients had higher
   Dietary Inflammatory Index scores (+0.40, 95\% CI=0.09, 0.70) and a
   consistently lower intake of 4 anti-inflammatory nutrients (dietary
   fiber, beta-carotene, magnesium, vitamin E) than nonrecipients. Vitamin
   D intake did not differ by Supplemental Nutrition Assistance Program
   status but was well below the Recommended Daily Allowance in this
   sample.
   Conclusions: Supplemental Nutrition Assistance Program recipients had
   elevated Dietary Inflammatory Index scores, implying higher diet-driven
   inflammation. This was due, in part, to low intake of 4
   anti-inflammatory food components, which were higher yet still
   nutritionally insufficient among nonrecipients. Findings highlight
   specific nutritional targets for improving public health through dietary
   change. (C) 2021 American Journal of PreventiveMedicine. This is an open
   access article under the CC BY license},
Type = {Article},
Affiliation = {Ciesielski, TH (Corresponding Author), Case Western Reserve Univ, Mary Ann Swetland Ctr Environm Hlth, 11000 Cedar Ave, Cleveland, OH 44106 USA.
   Ciesielski, Timothy H.; Roche, Abigail; Williams, Scott M.; Freedman, Darcy A., Case Western Reserve Univ, Sch Med, Dept Populat \& Quantitat Hlth Sci, Cleveland, OH USA.
   Ciesielski, Timothy H.; Ngendahimana, David K.; Roche, Abigail; Freedman, Darcy A., Case Western Reserve Univ, Sch Med, Mary Ann Swetland Ctr Environm Hlth, Cleveland, OH USA.
   Ciesielski, Timothy H., Ronin Inst, Montclair, NJ USA.
   Ngendahimana, David K., Natl Ctr PTSD, Disseminat \& Training Div Vet Hlth Adm, Menlo Pk, CA USA.
   Williams, Scott M., Cleveland Inst Computat Biol, Cleveland, OH USA.},
DOI = {10.1016/j.amepre.2021.02.007},
EarlyAccessDate = {JUL 2021},
Keywords-Plus = {ASSOCIATIONS; QUALITY},
Research-Areas = {Public, Environmental \& Occupational Health; General \& Internal
   Medicine},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health; Medicine, General \&
   Internal},
Author-Email = {thc23@case.edu},
Affiliations = {University System of Ohio; Case Western Reserve University; University
   System of Ohio; Case Western Reserve University},
Cited-References = {Abedi V, 2021, J RACIAL ETHN HEALTH, V8, P732, DOI {[}10.1101/2020.04.26.20079756, 10.1007/s40615-020-00833-4].
   Aiyer JN, 2019, TRANSL BEHAV MED, V9, P922, DOI 10.1093/tbm/ibz112.
   {[}Anonymous], 2008, J AM DIET ASSOC, V108, P1716, DOI 10.1016/j.jada.2008.08.007.
   {[}Anonymous], 2011.2015 ACS 5-year estimates.
   {[}Anonymous], 2014, Handbook of biological statistics: multiple comparisons.
   {[}Anonymous], Nutrient Recommendations: Dietary Reference Intakes (DRI).
   Bailey ZD, 2017, LANCET, V389, P1453, DOI 10.1016/S0140-6736(17)30569-X.
   Barnard ND, 2017, AM J PREV MED, V52, pS103, DOI 10.1016/j.amepre.2016.09.003.
   Beck MA, 2004, TRENDS MICROBIOL, V12, P417, DOI 10.1016/j.tim.2004.07.007.
   Blake CE, 2013, APPETITE, V69, P15, DOI 10.1016/j.appet.2013.05.008.
   Caspi CE, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-8174-2.
   Chaigne-Delalande B, 2013, SCIENCE, V341, P186, DOI 10.1126/science.1240094.
   Conrad Z, 2017, AM J PUBLIC HEALTH, V107, P466, DOI 10.2105/AJPH.2016.303608.
   Conti P, 2020, J BIOL REG HOMEOS AG, V34, P327, DOI 10.23812/CONTI-E.
   Coronel J, 2019, NUTRIENTS, V11, DOI 10.3390/nu11040842.
   Council of Economic Advisors Executive Office of the President of the United States, LONG TERM BEN SUPPL LONG TERM BEN SUPPL.
   Davis J, 2017, PREV CHRONIC DIS, V14, DOI 10.5888/pcd14.160241.
   Detry MA, 2016, JAMA-J AM MED ASSOC, V315, P407, DOI 10.1001/jama.2015.19394.
   Freedman DA, 2021, J COMMUN HEALTH, V46, P1, DOI 10.1007/s10900-020-00805-z.
   Gaziano JM, 2004, ANN NY ACAD SCI, V1031, P280, DOI 10.1196/annals.1331.028.
   Grant WB, 2020, NUTRIENTS, V12, DOI 10.3390/nu12040988.
   Griffiths C, 2018, PUBLIC HEALTH NUTR, V21, P1495, DOI 10.1017/S1368980018000393.
   Gu X, 2017, AM J CLIN NUTR, V105, P194, DOI 10.3945/ajcn.116.135095.
   Hoynes H, 2016, AM ECON REV, V106, P903, DOI 10.1257/aer.20130375.
   Huang ZY, 2018, J CLIN MED, V7, DOI 10.3390/jcm7090258.
   Jain A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-77093-z.
   Khoury MJ, 2016, AM J PREV MED, V50, P398, DOI 10.1016/j.amepre.2015.08.031.
   Lee Y, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002761.
   Leung CW, 2012, AM J CLIN NUTR, V96, P977, DOI 10.3945/ajcn.112.040014.
   Mauvais-Jarvis F, 2020, DIABETES, V69, P1857, DOI 10.2337/dbi19-0023.
   Parks CA, 2020, HEALTH PROMOT PRACT, V21, P421, DOI 10.1177/1524839919898207.
   Phillips CM, 2019, NUTRIENTS, V11, DOI 10.3390/nu11081873.
   Price-Haywood EG, 2020, NEW ENGL J MED, V382, P2534, DOI 10.1056/NEJMsa2011686.
   Ramírez IJ, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17113856.
   Schanzenbach DianeWhitmore., 2008, NBER WORK PAP SER, DOI {[}10.3386/w14306, DOI 10.3386/W14306].
   Seligman HK, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002662.
   Shaw KM, 2016, PREV CHRONIC DIS, V13, DOI 10.5888/pcd13.160088.
   Shivappa N, 2014, PUBLIC HEALTH NUTR, V17, P1689, DOI 10.1017/S1368980013002115.
   Spiga R, 2019, NUTRIENTS, V11, DOI 10.3390/nu11102460.
   Trompette A, 2018, IMMUNITY, V48, P992, DOI 10.1016/j.immuni.2018.04.022.
   U.S. Department of Agriculture, SUPPL NUTR ASS PROGR.
   U.S. Department of Agriculture Agricultural Research Service, FOOD DAT CENTR FOOD DAT CENTR.
   Wears RL, 2002, ACAD EMERG MED, V9, P330, DOI 10.1197/aemj.9.4.330.
   Williams AD, 2020, PUBLIC HEALTH REP, V135, P47, DOI 10.1177/0033354919884303.
   Williams SM, 2011, ANN HUM GENET, V75, P348, DOI 10.1111/j.1469-1809.2011.00640.x.
   Wirth MD, 2017, J NUTR HEALTH AGING, V21, P487, DOI 10.1007/s12603-016-0775-1.
   Wirth MD, 2014, J OCCUP ENVIRON MED, V56, P986, DOI 10.1097/JOM.0000000000000213.
   Yang CS, 2017, AM ECON REV, V107, P551, DOI 10.1257/aer.p20171001.
   Zhang FF, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.0237.},
Number-of-Cited-References = {49},
Times-Cited = {4},
Unique-ID = {WOS:000679401400006},
}

@article{ WOS:000497994300001,
Author = {Joost, Stephane and De Ridder, David and Marques-Vidal, Pedro and
   Bacchilega, Beatrice and Theler, Jean-Marc and Gaspoz, Jean-Michel and
   Guessous, Idris},
Title = {Overlapping spatial clusters of sugar-sweetened beverage intake and body
   mass index in Geneva state, Switzerland},
Journal = {NUTRITION \& DIABETES},
Year = {2019},
Volume = {9},
Month = {NOV 14},
Abstract = {Background: Obesity and obesity-related diseases represent a major
   public health concern. Recently, studies have substantiated the role of
   sugar-sweetened beverages (SSBs) consumption in the development of these
   diseases. The fine identification of populations and areas in need for
   public health intervention remains challenging. This study investigates
   the existence of spatial clustering of SSB intake frequency (SSB-IF) and
   body mass index (BMI), and their potential spatial overlap in a
   population of adults of the state of Geneva using a fine-scale
   geospatial approach.
   Methods: We used data on self-reported SSB-IF and measured BMI from
   residents aged between 20 and 74 years of the state of Geneva
   (Switzerland) that participated in the Bus Sante cross-sectional
   population-based study (n = 15,423). Getis-Ord Gi spatial indices were
   used to identify spatial clusters of SSB-IF and BMI in unadjusted models
   and models adjusted for individual covariates (education level, gender,
   age, nationality, and neighborhood-level median income).
   Results: We identified a significant spatial clustering of BMI and
   SSB-IF. 13.2\% (n = 2034) of the participants were within clusters of
   higher SSB-IF and 10.7\% (n = 1651) were within clusters of lower
   SSB-IF. We identified overlapping clusters of SSB-IF and BMI in specific
   areas where 11.1\% (n = 1719) of the participants resided. After
   adjustment, the identified clusters persisted and were only slightly
   attenuated indicating that additional neighborhood-level determinants
   influence the spatial distribution of SSB-IF and BMI.
   Conclusions: Our fine-scale spatial approach allowed to identify
   specific populations and areas presenting higher SSB-IF and highlighted
   the existence of an overlap between populations and areas of higher
   SSB-IF associated with higher BMI. These findings could guide
   policymakers to develop locally tailored interventions such as targeted
   prevention campaigns and pave the way for precision public health
   delivery.},
Type = {Article},
Affiliation = {Guessous, I (Corresponding Author), Geneva Univ Hosp, Dept Primary Care Med, Div Primary Care Med, Unit Populat Epidemiol, Geneva, Switzerland.
   Guessous, I (Corresponding Author), Grp Geog Informat Res \& Anal Populat Hlth GIRAPH, Geneva, Switzerland.
   Guessous, I (Corresponding Author), Univ Geneva, Fac Med, Geneva, Switzerland.
   Joost, Stephane; De Ridder, David; Bacchilega, Beatrice, EPFL, Lab Geog Informat Syst LASIG, Sch Architecture Civil \& Environm Engn ENAC, Geneva, Switzerland.
   Joost, Stephane; De Ridder, David; Theler, Jean-Marc; Gaspoz, Jean-Michel; Guessous, Idris, Geneva Univ Hosp, Dept Primary Care Med, Div Primary Care Med, Unit Populat Epidemiol, Geneva, Switzerland.
   Joost, Stephane; De Ridder, David; Marques-Vidal, Pedro; Guessous, Idris, Grp Geog Informat Res \& Anal Populat Hlth GIRAPH, Geneva, Switzerland.
   Joost, Stephane, Univ Appl Sci \& Arts Western Switzerland HES SO, Sch Nursing, Source, Lausanne, Switzerland.
   De Ridder, David; Gaspoz, Jean-Michel; Guessous, Idris, Univ Geneva, Fac Med, Geneva, Switzerland.
   Marques-Vidal, Pedro, Lausanne Univ Hosp, Dept Med, Internal Med, Lausanne, Switzerland.},
DOI = {10.1038/s41387-019-0102-0},
Article-Number = {35},
Keywords-Plus = {SOCIOECONOMIC-STATUS; ADULT-POPULATION; PUBLIC-HEALTH; CONSUMPTION;
   OBESITY; RISK; ASSOCIATION; PATTERNS; BALANCE; STROKE},
Research-Areas = {Endocrinology \& Metabolism; Nutrition \& Dietetics},
Web-of-Science-Categories  = {Endocrinology \& Metabolism; Nutrition \& Dietetics},
Author-Email = {Idris.Guessous@hcuge.ch},
Affiliations = {Swiss Federal Institutes of Technology Domain; Ecole Polytechnique
   Federale de Lausanne; University of Geneva; University of Geneva;
   University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)},
Cited-References = {Afshin A, 2017, NEW ENGL J MED, V377, P13, DOI 10.1056/NEJMoa1614362.
   ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x.
   Anselin luc, 1998, SPATIAL DEPENDENCE L, P237.
   Auchincloss AH, 2012, ANNU REV PUBL HEALTH, V33, P107, DOI 10.1146/annurev-publhealth-031811-124655.
   Beer-Borst S, 2009, EUR J CLIN NUTR, V63, P155, DOI 10.1038/sj.ejcn.1602922.
   Bernstein AM, 2012, AM J CLIN NUTR, V95, P1190, DOI 10.3945/ajcn.111.030205.
   BERNSTEIN M, 1994, SOZ PRAVENTIV MED, V39, P333, DOI 10.1007/BF01299665.
   Bosma H, 2001, AM J EPIDEMIOL, V153, P363, DOI 10.1093/aje/153.4.363.
   Brownell KD, 2009, NEW ENGL J MED, V361, P1599, DOI 10.1056/NEJMhpr0905723.
   CDC (Cent. Dis. Control Prev.), 2010, CDC GUID STRAT RED C.
   Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082.
   Cohen L, 2012, J GEN INTERN MED, V27, P1127, DOI 10.1007/s11606-012-2069-6.
   GETIS A, 1992, GEOGR ANAL, V24, P189, DOI 10.1111/j.1538-4632.1992.tb00261.x.
   Guessous I, 2014, NUTR DIABETES, V4, DOI 10.1038/nutd.2014.8.
   Guessous I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039877.
   Han E, 2013, J ACAD NUTR DIET, V113, P43, DOI 10.1016/j.jand.2012.09.016.
   Hill JO, 2012, CIRCULATION, V126, P126, DOI 10.1161/CIRCULATIONAHA.111.087213.
   Imamura F, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3576.
   Kumar GS, 2014, MMWR-MORBID MORTAL W, V63, P686.
   Larsson SC, 2014, J NUTR, V144, P856, DOI 10.3945/jn.114.190546.
   Lesser LI, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-20.
   Ludwig DS, 2001, LANCET, V357, P505, DOI 10.1016/S0140-6736(00)04041-1.
   Malik VS, 2013, AM J CLIN NUTR, V98, P1084, DOI 10.3945/ajcn.113.058362.
   Marques-Vidal P, 2017, AM J CLIN NUTR, V106, P217, DOI 10.3945/ajcn.116.144998.
   Marques-Vidal P, 2015, NUTRIENTS, V7, P9558, DOI 10.3390/nu7115481.
   Micha Renata, 2014, BMJ, V348, pg2272, DOI 10.1136/bmj.g2272.
   Moodley G, 2015, PREV CHRONIC DIS, V12, DOI 10.5888/pcd12.140559.
   Mozaffarian D, 2014, NEW ENGL J MED, V371, P624, DOI 10.1056/NEJMoa1304127.
   ORD JK, 1995, GEOGR ANAL, V27, P286, DOI 10.1111/j.1538-4632.1995.tb00912.x.
   Paelinck JH., 2000, Journal of Geographical Systems, V2, P157, DOI DOI 10.1007/PL00011452.
   Park S, 2015, J ACAD NUTR DIET, V115, P1996, DOI 10.1016/j.jand.2015.06.010.
   Stanhope KL, 2016, CRIT REV CL LAB SCI, V53, P52, DOI 10.3109/10408363.2015.1084990.
   Tamura K, 2017, INT J FOOD SCI NUTR, V68, P719, DOI 10.1080/09637486.2016.1276519.
   TUKEY JW, 1949, BIOMETRICS, V5, P99, DOI 10.2307/3001913.
   Unesda, CONS UN.
   Vargas-Garcia EJ, 2017, OBES REV, V18, P1350, DOI 10.1111/obr.12580.
   Ventura EE, 2011, OBESITY, V19, P868, DOI 10.1038/oby.2010.255.
   Vereecken CA, 2005, EUR J PUBLIC HEALTH, V15, P224, DOI 10.1093/eurpub/cki005.
   Wei Y, 2006, STAT MED, V25, P1369, DOI 10.1002/sim.2271.
   Welsh JA, 2013, CURR OPIN ENDOCRINOL, V20, P401, DOI 10.1097/01.med.0000432610.96107.f5.
   Wiecha JL, 2006, J AM DIET ASSOC, V106, P1624, DOI 10.1016/j.jada.2006.07.007.
   Xi B, 2015, BRIT J NUTR, V113, P709, DOI 10.1017/S0007114514004383.},
Number-of-Cited-References = {42},
Times-Cited = {7},
Unique-ID = {WOS:000497994300001},
}

@article{ WOS:000685266400018,
Author = {Chan, Ta-Chien and Tang, Jia-Hong and Hsieh, Cheng-Yu and Chen, Kevin J.
   and Yu, Tsan-Hua and Tsai, Yu-Ting},
Title = {Approaching precision public health by automated syndromic surveillance
   in communities},
Journal = {PLOS ONE},
Year = {2021},
Volume = {16},
Number = {8},
Month = {AUG 6},
Abstract = {Background Sentinel physician surveillance in communities has played an
   important role in detecting early signs of epidemics. The traditional
   approach is to let the primary care physician voluntarily and actively
   report diseases to the health department on a weekly basis. However,
   this is labor-intensive work, and the spatio-temporal resolution of the
   surveillance data is not precise at all. In this study, we built up a
   clinic-based enhanced sentinel surveillance system named ``Sentinel
   plus{''} which was designed for sentinel clinics and community hospitals
   to monitor 23 kinds of syndromic groups in Taipei City, Taiwan. The
   definitions of those syndromic groups were based on ICD-10 diagnoses
   from physicians. Methods Daily ICD-10 counts of two syndromic groups
   including ILI and EV-like syndromes in Taipei City were extracted from
   Sentinel plus. A negative binomial regression model was used to couple
   with lag structure functions to examine the short-term association
   between ICD counts and meteorological variables. After fitting the
   negative binomial regression model, residuals were further rescaled to
   Pearson residuals. We then monitored these daily standardized Pearson
   residuals for any aberrations from July 2018 to October 2019. Results
   The results showed that daily average temperature was significantly
   negatively associated with numbers of ILI syndromes. The ozone and PM2.5
   concentrations were significantly positively associated with ILI
   syndromes. In addition, daily minimum temperature, and the ozone and
   PM2.5 concentrations were significantly negatively associated with the
   EV-like syndromes. The aberrational signals detected from clinics for
   ILI and EV-like syndromes were earlier than the epidemic period based on
   outpatient surveillance defined by the Taiwan CDC. Conclusions This
   system not only provides warning signals to the local health department
   for managing the risks but also reminds medical practitioners to be
   vigilant toward susceptible patients. The near real-time surveillance
   can help decision makers evaluate their policy on a timely basis.},
Type = {Article},
Affiliation = {Chan, TC (Corresponding Author), Acad Sinica, Res Ctr Humanities \& Social Sci, Taipei, Taiwan.
   Chan, TC (Corresponding Author), Yang Ming Chiao Tung Univ, Inst Publ Hlth, Sch Med, Taipei, Taiwan.
   Chan, Ta-Chien; Hsieh, Cheng-Yu, Acad Sinica, Res Ctr Humanities \& Social Sci, Taipei, Taiwan.
   Chan, Ta-Chien, Yang Ming Chiao Tung Univ, Inst Publ Hlth, Sch Med, Taipei, Taiwan.
   Tang, Jia-Hong, Acad Sinica, Inst Stat Sci, Taipei, Taiwan.
   Chen, Kevin J.; Yu, Tsan-Hua; Tsai, Yu-Ting, Taipei City Govt, Dept Hlth, Taipei, Taiwan.},
DOI = {10.1371/journal.pone.0254479},
Article-Number = {e0254479},
Keywords-Plus = {INFLUENZA-LIKE ILLNESS; INFECTIOUS-DISEASES; AIR-POLLUTION},
Research-Areas = {Science \& Technology - Other Topics},
Web-of-Science-Categories  = {Multidisciplinary Sciences},
Author-Email = {dachianpig@gmail.com},
Affiliations = {Academia Sinica - Taiwan; Academia Sinica - Taiwan},
Cited-References = {Abat C, 2016, INT J INFECT DIS, V48, P22, DOI 10.1016/j.ijid.2016.04.021.
   Braga ALF, 2001, EPIDEMIOLOGY, V12, P662.
   Chan TC, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1500-4.
   Chan TC, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-11.
   Chan TC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011626.
   Conway M, 2013, J BIOMED INFORM, V46, P734, DOI 10.1016/j.jbi.2013.04.003.
   Dong WH, 2016, SCI REP-UK, V6, DOI 10.1038/srep19247.
   Feng C, 2016, ENVIRON HEALTH-GLOB, V15, DOI 10.1186/s12940-016-0115-2.
   Flahault A, 2006, STAT METHODS MED RES, V15, P413, DOI 10.1177/0962280206071639.
   Fowlkes A, 2013, INFLUENZA OTHER RESP, V7, P694, DOI 10.1111/irv.12014.
   Fricker RD, 2008, STAT MED, V27, P3407, DOI 10.1002/sim.3197.
   Gasparrini A, 2010, STAT MED, V29, P2224, DOI 10.1002/sim.3940.
   Gasparrini A, 2016, EPIDEMIOLOGY, V27, P835, DOI 10.1097/EDE.0000000000000533.
   Green HK, 2015, EPIDEMIOL INFECT, V143, P1, DOI 10.1017/S0950268814001757.
   Hashimoto S, 2003, J EPIDEMIOL, V13, P136, DOI 10.2188/jea.13.136.
   Huang L, 2016, CHEMOSPHERE, V147, P180, DOI 10.1016/j.chemosphere.2015.12.082.
   Jayatilleke Achala, 2014, AMIA Annu Symp Proc, V2014, P1806.
   Khoury MJ, 2016, AM J PREV MED, V50, P398, DOI 10.1016/j.amepre.2015.08.031.
   Kim TH, 2019, AM J EMERG MED, V37, P183, DOI 10.1016/j.ajem.2018.05.007.
   Lee YH, 2018, INT J HEALTH PLAN M, V33, pE357, DOI 10.1002/hpm.2387.
   Ma Hsiao-Tien, 2007, SYNDROMIC SURVEILLAN.
   PAGE ES, 1954, BIOMETRIKA, V41, P100, DOI 10.1093/biomet/41.1-2.100.
   Smith GE, 2019, EPIDEMIOL INFECT, V147, DOI 10.1017/S0950268819000074.
   Taiwan CDC, 2019, ENT ENT INF SEV COMP.
   Tang JH, 2015, BMC MED INFORM DECIS, V15, DOI 10.1186/s12911-015-0236-5.
   Taniguchi K, 2007, J EPIDEMIOL, V17, pS3, DOI 10.2188/jea.17.S3.
   Thomas MJ, 2018, J PUBLIC HEALTH MAN, V24, P235, DOI 10.1097/PHH.0000000000000679.
   Weng TC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122865.
   Ye XF, 2012, ENVIRON HEALTH PERSP, V120, P19, DOI {[}10.1289/ehp.1003198, 10.1289/ehp.120-a19].
   Yi-Jhen Chen W-CW., 2010, TAIWAN EPIDEMIOLOGY, V26, P98.
   Yin F, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-35814-5.
   Zanobetti A, 2002, EPIDEMIOLOGY, V13, P87, DOI 10.1097/00001648-200201000-00014.},
Number-of-Cited-References = {32},
Times-Cited = {2},
Unique-ID = {WOS:000685266400018},
}

@article{ WOS:000511992500003,
Author = {Modell, Stephen M. and Citrin, Toby and Burmeister, Margit and Kardia,
   Sharon L. R. and Beil, Adelyn and Raisky, Jeremy and Bakulski, Kelly M.
   and Bouma, Rolf T. and De Vries, Raymond and Dobrusin, Robert and Ewalt,
   Sam and Kumar, Sharada and Lambrides, George and Roberts, J. Scott and
   Rozier, Michael and Uhlmann, Wendy and Walsh, Megan and Yashar, Beverly
   and Genetics Faith Dialogue Grp},
Title = {When Genetics Meets Religion: What Scientists and Religious Leaders Can
   Learn from Each Other},
Journal = {PUBLIC HEALTH GENOMICS},
Year = {2020},
Volume = {22},
Number = {5-6},
Pages = {174-188},
Month = {FEB},
Abstract = {Introduction: To date scientists and religious leaders have not yet
   engaged in sustained face-to-face conversation concerning precision
   public health-related genetic technologies. Objectives: To elucidate
   areas of commonality and divergence in scientists' and religious
   leaders' views of precision genetic technologies, and extract lessons
   conveyed by religious leaders to scientists, and scientists to religious
   leaders through participatory dialogue. Methods: Six 1.5-h dialogue
   sessions were held between 6 religious leaders, 8 University of Michigan
   scientists, and 3 additional public health/genetic counseling graduate
   students between October 2016 and September 2017, followed by an open
   conference at the Ann Arbor Public Library (n = 46). Statements were
   organized into thematically arranged duets comparing views of scientists
   and religious leaders. Duets were further ordered into interpretive
   levels. Comparative techniques were used to assure category agreement
   and face validity. Results: The analysis yielded 20 duets and 3
   interpretive levels (expositional; implications and consequences; and
   integrative, bridging concepts). Scientists emphasized the value of
   epigenetic testing for health promotion, and cost saving for some forms
   of early genetic testing for adult-onset conditions. Religious leaders
   stressed care for an individual's willingness to change over technical
   fixes for behavioral conditions and, together with public participants,
   the importance of allocating money for societal needs. Both expressed
   caution on the use of nuclear transfer for mitochondrial DNA replacement
   and secondary uses of genetic data. Lay conference participants pointed
   towards a middle ground on the release of genetically edited mosquitoes
   for disease eradication. Discussion: Scientists stressed the value of
   professional guidance; religious leaders listened to family needs.
   Dialogues met four literature-based criteria for stakeholder involvement
   in deliberative processes. Conclusion: While scientists and religious
   leaders differ in their points of emphasis and faith orientations
   (professional competency versus drawing on compassion), they can
   successfully collaborate in reaching mutual understanding and specific
   areas of agreement on precision genetic technologies relating to public
   health.},
Type = {Article},
Affiliation = {Modell, SM (Corresponding Author), Univ Michigan, Ctr Publ Hlth \& Community Genom, M5049,SPH 2,1415 Washington Hts, Ann Arbor, MI 48109 USA.
   Modell, Stephen M.; Citrin, Toby; Raisky, Jeremy, Univ Michigan, Sch Publ Hlth, Dept Hlth Management \& Policy, Ann Arbor, MI 48109 USA.
   Burmeister, Margit, Univ Michigan, Mol \& Behav Neurosci Inst, Ann Arbor, MI 48109 USA.
   Kardia, Sharon L. R.; Raisky, Jeremy, Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA.
   Beil, Adelyn, Univ Michigan, Genet Counseling Program, Ann Arbor, MI 48109 USA.},
DOI = {10.1159/000504261},
Keywords = {Precision health; Genetic testing; Gene editing; Epigenetics; Religion;
   Dialogue},
Keywords-Plus = {PUBLIC-HEALTH GENOMICS; MICHIGAN BIOTRUST; BRCA MUTATIONS; COMMUNITY;
   DIAGNOSIS; TECHNOLOGIES; ENGAGEMENT; MEDICINE; BIOBANKS; LESSONS},
Research-Areas = {Genetics \& Heredity; Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Genetics \& Heredity; Public, Environmental \& Occupational Health},
Author-Email = {mod@umich.edu},
Affiliations = {University of Michigan System; University of Michigan; University of
   Michigan System; University of Michigan; University of Michigan System;
   University of Michigan; University of Michigan System; University of
   Michigan},
Cited-References = {Anderson RR, 2009, AM J MED GENET C, V151C, P52, DOI 10.1002/ajmg.c.30203.
   Annas GJ, 1992, GENE MAPPING USING L, P3.
   {[}Anonymous], 1997, CLON HUM BEINGS REP.
   {[}Anonymous], 2015, INT SUMMIT HUMAN GEN.
   Bartlett VL, 2009, AM J MED GENET C, V151C, P41, DOI 10.1002/ajmg.c.30201.
   Becker A., 2005, METHODS COMMUNITY BA, P52.
   Bennett J, 2016, J GENET COUNS, V25, P198, DOI 10.1007/s10897-015-9858-0.
   Blume M, 2012, C DARWIN PREFERRED D.
   Bonham VL, 2009, J HEALTH POLIT POLIC, V34, P325, DOI 10.1215/03616878-2009-009.
   Burton H, 2009, PUBLIC HEALTH GENOM, V12, P11, DOI 10.1159/000153426.
   California Department of Health, CAL BIOB PROGR.
   California Department of Public Health, CAL PREN SCREEN PROG.
   Campbell MK, 2007, ANNU REV PUBL HEALTH, V28, P213, DOI 10.1146/annurev.publhealth.28.021406.144016.
   Canone E, 2007, POETICS TODAY, V28, P363, DOI 10.1215/03335372-2007-002.
   Caspi A, 2002, SCIENCE, V297, P851, DOI 10.1126/science.1072290.
   Children's Hospital of Philadelphia, HIPP LIND SYNDR.
   Chrysler D, 2011, J LAW MED ETHICS, V39, P98, DOI 10.1111/j.1748-720X.2011.00577.x.
   Collins FrancisS., 2006, THE LANGUAGE OF GOD.
   Daum H, 2018, FERTIL STERIL, V109, P33, DOI 10.1016/j.fertnstert.2017.12.004.
   De Vries RG, 2016, CONVERSATION.
   Etchegary H, 2013, PERS MED, V10, P647, DOI {[}10.2217/pme.13.65, 10.2217/PME.13.65].
   Fleck LM, 2006, JUST CARING HLTH REF.
   Ginsburg G S., 2016, Genomic and Precision Medicine: Foundations, Translation, and Implementation.
   Glasgow RE, 2018, J CLIN TRANSL SCI, V2, P183, DOI 10.1017/cts.2018.31.
   Gold A, 2014, ISR J PSYCHIATR REL, V51, P162.
   Gutmann A, 1997, HASTINGS CENT REP, V27, P38, DOI 10.2307/3528667.
   Hacker K., 2013, Community-based participatory research, P1, DOI {[}DOI 10.4135/9781452244181, 10.4135/9781452244181.n, DOI 10.4135/9781452244181.N].
   Harris TM, 2004, HEALTH COMMUN, V16, P105, DOI 10.1207/S15327027HC1601\_7.
   Hayward J, 2018, SEMIN FETAL NEONAT M, V23, P94, DOI 10.1016/j.siny.2017.12.002.
   Hercher L, 2016, J GENET COUNS, V25, P1139, DOI 10.1007/s10897-016-9992-3.
   Horton RH, 2019, CLIN SCI, V133, P697, DOI 10.1042/CS20180436.
   Iowa Department of Public Health, IOW MAT PREN SCREEN.
   Israel B.A., 2005, METHODS COMMUNITY BA.
   Jameson JL, 2015, NEW ENGL J MED, V372, P2229, DOI 10.1056/NEJMsb1503104.
   Joseph A, 2016, STATNEWS.
   Kalfoglou AL, 2005, FERTIL STERIL, V83, P1612, DOI 10.1016/j.fertnstert.2005.01.090.
   Khoury MJ, 2018, GENET MED, V20, P574, DOI 10.1038/gim.2017.211.
   Khoury MJ, 2012, AM J PREV MED, V42, P639, DOI 10.1016/j.amepre.2012.02.012.
   Klitzman R., 2015, The ethics police?: The struggle to make human research safe.
   Knoppers BM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008494.
   Krejci-Papa M, 2007, SCI SPIRIT.
   Krueger R., 2009, Focus groups: A practical guide for applied research.
   Krueger R., 1998, INVOLVING COMMUNITY, DOI {[}10.4135/9781483328140, DOI 10.4135/9781483328140].
   Langbo Carrie, 2013, Public Health Rep, V128, P377, DOI 10.1177/003335491312800508.
   Law PM, 2019, IEEE T VIS COMPUT GR, V25, P427, DOI 10.1109/TVCG.2018.2864526.
   Lemke AA, 2015, GENET MED, V17, P949, DOI 10.1038/gim.2015.8.
   Lowy I, 2017, IMPERFECT PREGNANCIES: A HISTORY OF BIRTH DEFECTS AND PRENATAL DIAGNOSIS, P1.
   Maryland Department of Health, AFP TEST IMPR PREGN.
   Matthis S, 2018, FLORIDA KEYS WE 0220.
   McKusick VA, 1992, GENE MAPPING USING L, P18.
   McSwiggan S, 2017, INT J LAW PSYCHIAT, V50, P17, DOI 10.1016/j.ijlp.2016.09.005.
   Mello MM, 2010, NEW ENGL J MED, V363, P204, DOI 10.1056/NEJMp1005203.
   Minkler Meredith., 2008, Community-based participatory research for health: from process to outcomes.
   Modell SM, 2007, ZYGON, V42, P163, DOI 10.1111/j.1467-9744.2006.00813.x.
   Modell SM, 2016, HEALTHCARE-BASEL, V4, DOI 10.3390/healthcare4010014.
   Modell SM, 2014, J RELIG HEALTH, V53, P702, DOI 10.1007/s10943-013-9814-y.
   Molster CM, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00247.
   Mor P, 2018, J GENET COUNS, V27, P1386, DOI 10.1007/s10897-018-0264-2.
   Morgan D.L., 1997, FOCUS GROUPS QUALITA, V2nd.
   Morgan DL, 2007, HDB EMERGENT METHODS, P189.
   National Bioethics Advisory Commission (NBAC), 2000, ETH ISS HUM STEM CEL.
   Nelson J.Robert., 1994, On The New Frontiers of Genetics and Religion.
   O'Doherty KC, 2009, PUBLIC HEALTH GENOM, V12, P203, DOI 10.1159/000167801.
   Park A, 2019, TIME, V193, P34.
   Peacocke Arthur., 2007, ALL IS NATURALISTIC.
   PHAN KLD, 1995, J CLIN ETHIC, V6, P237.
   Poulton A, 2018, PRENATAL DIAG, V38, P904, DOI 10.1002/pd.5352.
   Rothenberg Karen H, 1998, Community Genet, V1, P148, DOI 10.1159/000016154.
   Rothstein Mark A, 2009, Health Matrix Clevel, V19, P1.
   Rotimi C, 2007, COMMUNITY GENET, V10, P186, DOI 10.1159/000101761.
   Sagi M, 2009, PRENATAL DIAG, V29, P508, DOI 10.1002/pd.2232.
   Schaefer GO, 2009, JAMA-J AM MED ASSOC, V302, P67, DOI 10.1001/jama.2009.931.
   Specter M., 2016, DNA REVOLUTION IS CH, V230, P31.
   Swede H, 2007, GENET MED, V9, P141, DOI 10.1097/GIM.0b013e3180330039.
   Thiel DB, 2014, J COMMUN GENET, V5, P125, DOI 10.1007/s12687-013-0162-0.
   Thompson C, 2015, NATURE, V522, P414, DOI 10.1038/522415a.
   Tomlinson T, 2015, JAMA-J AM MED ASSOC, V313, P417, DOI 10.1001/jama.2014.16363.
   Wallerstein N, 2017, Community-based participatory research for health: Advancing social and health equity, DOI DOI 10.1177/1524839918809007.
   Wallerstein N., 2005, Methods in community-based participatory research for health, V1st, P31.
   White B.P., 2019, STANFORD SOCIAL INNO, V17, P48.
   White MT, 2009, AM J MED GENET C, V151C, P68, DOI 10.1002/ajmg.c.30196.
   Yankelovich Daniel., 1999, MAGIC DIALOGUE.
   Young I.M., 1996, DEMOCRACY DIFFERENCE, P120, DOI DOI 10.1515/9780691234168-007.},
Number-of-Cited-References = {83},
Times-Cited = {4},
Unique-ID = {WOS:000511992500003},
}

@article{ WOS:001139314400001,
Author = {Liu, Taoran and Yu, Jing and Gao, Yangyang and Ma, Xinyang and Jiang,
   Shan and Gu, Yuanyuan and Ming, Wai-kit},
Title = {Prophylactic Interventions for Hereditary Breast and Ovarian Cancer
   Risks and Mortality in BRCA1/2 Carriers},
Journal = {CANCERS},
Year = {2024},
Volume = {16},
Number = {1},
Month = {JAN},
Abstract = {Simple Summary Prophylactic interventions are critical for BRCA1/2
   mutation carriers to reduce the risks of hereditary breast and ovarian
   cancer (HBOC). This systematic review and meta-analysis synthesizes data
   on the efficacy of various preventative strategies. The analysis
   incorporated 21 studies involving risk-reducing surgeries (RRS),
   chemoprevention, and screening. Findings indicate a substantial
   reduction in breast and ovarian cancer incidence and mortality among
   BRCA1/2 carriers following RRS, particularly mastectomy and
   oophorectomy, compared to chemoprevention. This study underscores the
   necessity of tailored interventions, especially considering the varied
   protective effects between BRCA1 and BRCA2 mutation carriers. This
   review aids in informing clinical decisions and underscores the
   importance of context-specific uptake rates in cost-effective
   evaluations.Abstract Background: Hereditary breast and ovarian cancers
   (HBOCs) pose significant health risks worldwide and are mitigated by
   prophylactic interventions. However, a meta-analysis of their efficacy
   and the impact of different genetic variants on their effectiveness is
   lacking. Methods: A systematic review and meta-analysis were conducted,
   adhering to Cochrane guidelines. The review encompassed studies that
   involved prophylactic interventions for healthy women with BRCA
   variants, focusing on cancer incidence and mortality outcomes. The
   Newcastle-Ottawa Scale was used for risk of bias assessment. We pooled
   the extracted outcomes using random effects models and conducted
   subgroup analyses stratified by intervention, variant, and cancer types.
   Results: A total of 21 studies met the inclusion criteria. The
   meta-analysis revealed that prophylactic interventions significantly
   reduced cancer risk and mortality. The subgroup analysis showed a
   greater protective effect for BRCA2 than BRCA1 variant carriers.
   Risk-reducing surgeries (RRS) were more effective than chemoprevention,
   with RRS notably reducing cancer risk by 56\% compared to 39\% for
   chemoprevention. Prophylactic oophorectomy significantly reduced HBOC
   risks, while the effect of prophylactic mastectomy and chemoprevention
   on mortality was less conclusive. Conclusions: Prophylactic
   interventions significantly reduce the risk of HBOC and associated
   mortality. This comprehensive analysis provides insights for future
   economic evaluations and clinical decision-making in HBOC interventions.},
Type = {Review},
Affiliation = {Ming, WK (Corresponding Author), City Univ Hong Kong, Dept Infect Dis \& Publ Hlth, Hong Kong 999077, Peoples R China.
   Gu, YY (Corresponding Author), Macquarie Univ, Macquarie Univ Ctr Hlth Econ, Macquarie Business Sch, Sydney, NSW 2109, Australia.
   Gu, YY (Corresponding Author), Macquarie Univ, Australian Inst Hlth Innovat, Sydney, NSW 2109, Australia.
   Liu, Taoran; Yu, Jing; Gao, Yangyang; Ma, Xinyang; Ming, Wai-kit, City Univ Hong Kong, Dept Infect Dis \& Publ Hlth, Hong Kong 999077, Peoples R China.
   Jiang, Shan; Gu, Yuanyuan, Macquarie Univ, Macquarie Univ Ctr Hlth Econ, Macquarie Business Sch, Sydney, NSW 2109, Australia.
   Jiang, Shan; Gu, Yuanyuan, Macquarie Univ, Australian Inst Hlth Innovat, Sydney, NSW 2109, Australia.},
DOI = {10.3390/cancers16010103},
Article-Number = {103},
Keywords = {hereditary breast and ovarian cancer; cancer prevention; precision
   medicine; systematic review; meta-analysis; chemoprevention; BRCA;
   genomics; genetics; precision public health},
Keywords-Plus = {REDUCING SALPINGO-OOPHORECTOMY; MUTATION CARRIERS; BILATERAL MASTECTOMY;
   INHERITED MUTATIONS; WOMEN; PREVENTION; PENETRANCE; SURVIVAL; SURGERY;
   SERIES},
Research-Areas = {Oncology},
Web-of-Science-Categories  = {Oncology},
Author-Email = {yuanyuan.gu@mq.edu.au
   wkming2@cityu.edu.hk},
Affiliations = {City University of Hong Kong; Macquarie University; Macquarie University},
Cited-References = {Abul-Husn NS, 2019, GENOME MED, V12, DOI 10.1186/s13073-019-0691-1.
   American Cancer Society, 2023, Cochrane Handbook for Systematic Reviews of Interventions.
   American Cancer Society, 2023, Ovarian Cancer Statistics|How Common is Ovarian Cancer.
   {[}Anonymous], 2023, Breast Cancer Statistics | How Common Is Breast Cancer?.
   Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033.
   Chéreau E, 2010, CLIN BREAST CANCER, V10, P113, DOI 10.3816/CBC.2010.n.022.
   D'Alonzo M, 2018, CLIN BREAST CANCER, V18, pE1361, DOI 10.1016/j.clbc.2018.07.015.
   Domchek SM, 2006, LANCET ONCOL, V7, P223, DOI 10.1016/S1470-2045(06)70585-X.
   Domchek SM, 2010, JAMA-J AM MED ASSOC, V304, P967, DOI 10.1001/jama.2010.1237.
   Eisen A, 2005, J CLIN ONCOL, V23, P7491, DOI 10.1200/JCO.2004.00.7138.
   Erekson EA, 2013, MENOPAUSE, V20, P110, DOI 10.1097/gme.0b013e31825a27ab.
   Finch A, 2006, JAMA-J AM MED ASSOC, V296, P185, DOI 10.1001/jama.296.2.185.
   Finch APM, 2014, J CLIN ONCOL, V32, P1547, DOI 10.1200/JCO.2013.53.2820.
   Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749.
   Galendi JSC, 2022, CANCERS, V14, DOI 10.3390/cancers14071786.
   Gasparri ML, 2019, MEDICINA-LITHUANIA, V55, DOI 10.3390/medicina55080415.
   Grann VR, 2011, BREAST CANCER RES TR, V125, P837, DOI 10.1007/s10549-010-1043-4.
   Heemskerk-Gerritsen BAM, 2013, ANN ONCOL, V24, P2029, DOI 10.1093/annonc/mdt134.
   Heemskerk-Gerritsen BAM, 2019, BREAST CANCER RES TR, V177, P723, DOI 10.1007/s10549-019-05345-2.
   Ingham SL, 2013, BREAST CANCER RES TR, V142, P611, DOI 10.1007/s10549-013-2765-x.
   Jiang JJ, 2023, ADV THER, V40, P1393, DOI 10.1007/s12325-023-02450-z.
   Jiang S, 2023, PHARMACOECONOMICS, V41, P43, DOI 10.1007/s40273-022-01198-8.
   Jiang S, 2022, BMJ GLOB HEALTH, V7, DOI 10.1136/bmjgh-2022-009777.
   Jiang S, 2021, BMJ GLOB HEALTH, V6, DOI 10.1136/bmjgh-2021-006655.
   Jiang Shan, 2020, J Glob Health, V10, P020322, DOI 10.7189/jogh.10.020322.
   Kaas R, 2010, ANN SURG, V251, P488, DOI 10.1097/SLA.0b013e3181c3c36d.
   Kauff ND, 2002, NEW ENGL J MED, V346, P1609, DOI 10.1056/NEJMoa020119.
   Kauff ND, 2008, J CLIN ONCOL, V26, P1331, DOI 10.1200/JCO.2007.13.9626.
   King MC, 2001, JAMA-J AM MED ASSOC, V286, P2251, DOI 10.1001/jama.286.18.2251.
   King MC, 2003, SCIENCE, V302, P643, DOI 10.1126/science.1088759.
   Kotsopoulos J, 2005, BREAST CANCER RES, V7, pR833, DOI 10.1186/bcr1293.
   Kotsopoulos J, 2023, BREAST CANCER RES TR, V201, P257, DOI 10.1007/s10549-023-06991-3.
   Kotsopoulos J, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djw177.
   Manchanda R, 2022, BJOG-INT J OBSTET GY, V129, pE16, DOI 10.1111/1471-0528.16896.
   Manna ED, 2023, HEALTHCARE-BASEL, V11, DOI 10.3390/healthcare11162360.
   Mavaddat N, 2020, BREAST CANCER RES, V22, DOI 10.1186/s13058-020-1247-4.
   Meijers-Heijboer H, 2001, NEW ENGL J MED, V345, P159, DOI 10.1056/NEJM200107193450301.
   Metcalfe K, 2019, BRIT J CANCER, V121, P15, DOI 10.1038/s41416-019-0446-1.
   Moher D, 2010, Int J Surg, V8, P336, DOI {[}10.1016/j.ijsu.2010.02.007, DOI 10.1016/J.IJSU.2010.02.007].
   NCCN, 2023, Guidelines Detail.
   Neff RT, 2017, THER ADV MED ONCOL, V9, P519, DOI 10.1177/1758834017714993.
   Petrucelli N., 2022, BRCA1 AND BRCA2 ASS.
   Piek JMJ, 2003, GYNECOL ONCOL, V90, P491, DOI 10.1016/S0090-8258(03)00365-2.
   Ponder BAJ, 2000, BRIT J CANCER, V83, P1301.
   Rebbeck TR, 2002, NEW ENGL J MED, V346, P1616, DOI 10.1056/NEJMoa012158.
   Rebbeck TR, 2004, J CLIN ONCOL, V22, P1055, DOI 10.1200/JCO.2004.04.188.
   Rutter JL, 2003, JNCI-J NATL CANCER I, V95, P1072, DOI 10.1093/jnci/95.14.1072.
   Satagopan JM, 2002, CLIN CANCER RES, V8, P3776.
   Shu CA, 2016, JAMA ONCOL, V2, P1434, DOI 10.1001/jamaoncol.2016.1820.
   Skytte AB, 2011, CLIN GENET, V79, P431, DOI 10.1111/j.1399-0004.2010.01604.x.
   Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001.
   Tappenden P, 2012, VALUE HEALTH, V15, P1127, DOI 10.1016/j.jval.2012.07.008.
   WCRF International, 2022, Ovarian Cancer Statistics|World Cancer Research Fund International.
   Wells GA., 2000, The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses.},
Number-of-Cited-References = {54},
Times-Cited = {0},
Unique-ID = {WOS:001139314400001},
}

@article{ WOS:000624306300006,
Author = {Ferrario, Marco M. and Borchini, Rossana},
Title = {FROM WORKPLACE HEALTH PROMOTION (WHP) TO TOTAL WORKER HEALTH (TWH): THE
   ROLE OF OCCUPATIONAL PHYSICIANS},
Journal = {GIORNALE ITALIANO DI MEDICINA DEL LAVORO ED ERGONOMIA},
Year = {2018},
Volume = {40},
Number = {3},
Pages = {158-161},
Month = {JUL-SEP},
Abstract = {WHP programs are a set of interventions that seek to improve the work
   organization and worker health, to achieve a better work ability. In the
   States these programs are spread out in the large majority of
   industries, because of reduced insurance premium. More recent and
   accurate meta-analyses have shown modest effects, restricted to
   improvements in work ability and absenteeism, with no effects on health
   behavioural risk factors. A critical issue is the low participation, as
   they are perceived by workers as poorly oriented to improve work safety.
   Since the early 2000s NIOSH has been promoting the integration of health
   promotion and occupational safety programs based on the notion that
   improvement in working condition has the potential to reduce
   occupational diseases and accidents as well as to prevent
   chronic-degenerative diseases with a high burden in populations. This
   effort resulted in launching a new prevention program in 2011, named
   Total Worker Health (TWH), with the objective of emphasising the
   integrating occupational safety programs with WHP.
   A recent review of 24 integrated programs, found low size-effect
   evidences of efficacy in cessation of smoking, improving dietary
   consumption of vegetable and fruits and reducing sedentary habits. This
   review also highlighted selection and attrition biases in many studies
   as well as heterogeneity in program design and implementation. Such
   evidence of low effectiveness is opposed to findings made by Italian
   studies that were characterised by the direct involvement of
   occupational physicians. The concept of TWH, being a holistic approach
   to worker health aimed at preventing work related diseases and
   chronic-degenerative diseases, cannot reduce the pivotal role of
   occupational physicians, who is the actor of the integration of
   work-related and personal risk profiles at individual level. This
   approach emphasises the key contribution of in the workplace by
   occupational physicians in a precision public health perspective, i.e.
   ``to provide the right intervention to the right population at the right
   time{''}, which means to deliver precise health prevention activities to
   populations that might benefit more, taking into account the work
   environment.},
Type = {Article},
Affiliation = {Ferrario, MM (Corresponding Author), Univ Insubria, Dipartimento Med \& Chirurg, Ctr Ric Epidemiol \& Med Prevent EPIMED, Via O Rossi 9 Pad Rossi, I-21100 Varese, Italy.
   Univ Insubria, Ctr Ric EPIMED, Dipartimento Med \& Chirurg, Varese, Italy.
   ASST Sette Laghi, SC Med Lavoro Prevent \& Tossicol, Varese, Italy.},
Keywords = {Workplace Health Promotion; Total Worker Health; Health Promotion;
   Occupational Safety and Health; work related diseases},
Keywords-Plus = {UNITED-STATES; METAANALYSIS},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {marco.ferrario@uninsubria.it},
Affiliations = {University of Insubria},
Cited-References = {Aldana SG, 2005, PREV MED, V40, P131, DOI 10.1016/j.ypmed.2004.05.008.
   {[}Anonymous], 2010, HLTH PEOPL.
   {[}Anonymous], 1997, LUX DECL WORKPL HLTH.
   {[}Anonymous], 2012, EUR NETW WORKPL HLTH.
   Borchini R, 2011, G ITAL MED LAV ER S2, V33, P285.
   Burton J., 2010, Healthy workplace framework and model: background and supporting literature and practice.
   Dembe AE, 2001, AM J IND MED, V40, P403, DOI 10.1002/ajim.1113.
   Dishman RK, 1998, AM J PREV MED, V15, P344, DOI 10.1016/S0749-3797(98)00077-4.
   Feltner C., The Effectiveness of Total Worker Health Interventions: A Systematic Review for a National Institutes of Health Pathways to Prevention Workshop.
   Ferrario M M, 2012, G Ital Med Lav Ergon, V34, P275.
   Ferrario M M, 2011, G Ital Med Lav Ergon, V33, P44.
   Ferrario MM, 2018, HEART, V104, P1165, DOI 10.1136/heartjnl-2017-312594.
   Ferrario MM, 2008, G ITAL MED LAV ER S2, V30, P87.
   Goetzel RZ, 2003, J OCCUP ENVIRON MED, V45, P5, DOI 10.1097/00043764-200301000-00007.
   Hutchinson AD, 2012, HEALTH PROMOT INT, V27, P238, DOI 10.1093/heapro/dar035.
   Hymel PA, 2011, J OCCUP ENVIRON MED, V53, P695, DOI 10.1097/JOM.0b013e31822005d0.
   International Association for Worksite Health Promotion, 2009, ATL ANN WORKS HLTH P.
   Jackson N, 2004, J PUBLIC HEALTH, V26, P303, DOI 10.1093/pubmed/fdh164.
   Leigh JP, 1997, ARCH INTERN MED, V157, P1557, DOI 10.1001/archinte.157.14.1557.
   Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238.
   National Institute for Occupational Safety and Health (NIOSH), 2008, DHHS NIOSH PUBL, V2008-2136.
   Rongen A, 2013, AM J PREV MED, V44, P406, DOI 10.1016/j.amepre.2012.12.007.
   Schill AL, 2013, J OCCUP ENVIRON MED, V55, pS8, DOI 10.1097/JOM.0000000000000037.
   Soler RE, 2010, AM J PREV MED, V38, pS237, DOI 10.1016/j.amepre.2009.10.030.
   USDHHS, LEAD HLTH IND PRIOR.
   Veronesi G, 2018, INT J PUBLIC HEALTH, V63, P723, DOI 10.1007/s00038-018-1118-2.
   Wilson MG, 1996, AM J HEALTH PROMOT, V10, P429, DOI 10.4278/0890-1171-10.6.429.
   Zaza S., 2005, The guide to community prevention services: What works to promote health?.},
Number-of-Cited-References = {28},
Times-Cited = {0},
Unique-ID = {WOS:000624306300006},
}

@article{ WOS:000400489200001,
Author = {Baynam, Gareth and Broley, Stephanie and Bauskis, Alicia and Pachter,
   Nicholas and McKenzie, Fiona and Townshend, Sharron and Slee, Jennie and
   Kiraly-Borri, Cathy and Vasudevan, Anand and Hawkins, Anne and
   Schofield, Lyn and Helmholz, Petra and Palmer, Richard and Kung,
   Stefanie and Walker, Caroline E. and Molster, Caron and Lewis, Barry and
   Mina, Kym and Beilby, John and Pathak, Gargi and Poulton, Cathryn and
   Groza, Tudor and Zankl, Andreas and Roscioli, Tony and Dinger, Marcel E.
   and Mattick, John S. and Gahl, William and Groft, Stephen and Tifft,
   Cynthia and Taruscio, Domenica and Lasko, Paul and Kosaki, Kenjiro and
   Wilhelm, Helene and Melegh, Bela and Carapetis, Jonathan and Jana,
   Sayanta and Chaney, Gervase and Johns, Allison and Owen, Peter Wynn and
   Daly, Frank and Weeramanthri, Tarun and Dawkins, Hugh and Goldblatt,
   Jack},
Title = {Initiating an undiagnosed diseases program in the Western Australian
   public health system},
Journal = {ORPHANET JOURNAL OF RARE DISEASES},
Year = {2017},
Volume = {12},
Month = {MAY 3},
Abstract = {Background: New approaches are required to address the needs of complex
   undiagnosed diseases patients. These approaches include clinical genomic
   diagnostic pipelines, utilizing intra-and multi-disciplinary platforms,
   as well as specialty-specific genomic clinics. Both are advancing
   diagnostic rates. However, complementary cross-disciplinary approaches
   are also critical to address those patients with multisystem disorders
   who traverse the bounds of multiple specialties and remain undiagnosed
   despite existing intra-specialty and genomic-focused approaches. The
   diagnostic possibilities of undiagnosed diseases include genetic and
   non-genetic conditions. The focus on genetic diseases addresses some of
   these disorders, however a cross-disciplinary approach is needed that
   also simultaneously addresses other disorder types. Herein, we describe
   the initiation and summary outcomes of a public health system approach
   for complex undiagnosed patients -the Undiagnosed Diseases
   Program-Western Australia (UDP-WA).
   Results: Briefly the UDP-WA is: i) one of a complementary suite of
   approaches that is being delivered within health service, and with
   community engagement, to address the needs of those with severe
   undiagnosed diseases; ii) delivered within a public health system to
   support equitable access to health care, including for those from remote
   and regional areas; iii) providing diagnoses and improved patient care;
   iv) delivering a platform for in-service and real time genomic and
   phenomic education for clinicians that traverses a diverse range of
   specialties; v) retaining and recapturing clinical expertise; vi)
   supporting the education of junior and more senior medical staff; vii)
   designed to integrate with clinical translational research; and viii) is
   supporting greater connectedness for patients, families and medical
   staff.
   Conclusion: The UDP-WA has been initiated in the public health system to
   complement existing clinical genomic approaches; it has been targeted to
   those with a specific diagnostic need, and initiated by redirecting
   existing clinical and financial resources. The UDP-WA supports the
   provision of equitable and sustainable diagnostics and simultaneously
   supports capacity building in clinical care and translational research,
   for those with undiagnosed, typically rare, conditions.},
Type = {Article},
Affiliation = {Baynam, G (Corresponding Author), Govt Western Australia, Genet Serv Western Australia, Dept Hlth, Perth, WA, Australia.
   Baynam, G (Corresponding Author), Univ Western Australia, Sch Paediat \& Child Hlth, Perth, WA, Australia.
   Baynam, Gareth; Broley, Stephanie; Pachter, Nicholas; McKenzie, Fiona; Townshend, Sharron; Slee, Jennie; Kiraly-Borri, Cathy; Vasudevan, Anand; Hawkins, Anne; Schofield, Lyn; Roscioli, Tony; Mattick, John S.; Goldblatt, Jack, Govt Western Australia, Genet Serv Western Australia, Dept Hlth, Perth, WA, Australia.
   Baynam, Gareth; Pachter, Nicholas; McKenzie, Fiona; Goldblatt, Jack, Univ Western Australia, Sch Paediat \& Child Hlth, Perth, WA, Australia.
   Baynam, Gareth, Murdoch Univ, Inst Immunol \& Infect Dis, Murdoch, WA, Australia.
   Baynam, Gareth; Bauskis, Alicia; Walker, Caroline E.; Molster, Caron; Dawkins, Hugh, Govt Western Australia, Off Populat Hlth Gen, Publ Hlth Div, Dept Hlth, Perth, WA, Australia.
   Baynam, Gareth; Carapetis, Jonathan, Univ Western Australia, Telethon Kids Inst, Perth, WA, Australia.
   Lewis, Barry; Mina, Kym; Beilby, John, Govt Western Australia, Diagnost Gen, PathWest, Dept Hlth, Perth, WA, Australia.
   Dawkins, Hugh, Curtin Univ Technol, Curtin Hlth Innovat Res Inst, Ctr Populat Hlth Res, Perth, WA, Australia.
   Mina, Kym; Beilby, John; Dawkins, Hugh, Univ Western Australia, Sch Pathol \& Lab Med, Perth, WA, Australia.
   Schofield, Lyn; Dawkins, Hugh, Murdoch Univ, Ctr Comparat Gen, Perth, WA, Australia.
   Weeramanthri, Tarun, Govt Western Australia, Publ Hlth Div, Dept Hlth, Perth, WA, Australia.
   Baynam, Gareth, Western Australian Register Dev Anomalies, Perth, WA, Australia.
   Jana, Sayanta; Johns, Allison; Owen, Peter Wynn, King Edward Mem Hosp, Perth, WA, Australia.
   Baynam, Gareth; Helmholz, Petra; Palmer, Richard; Kung, Stefanie, Curtin Univ, Sch Spatial Sci, Perth, WA, Australia.
   Helmholz, Petra; Palmer, Richard; Kung, Stefanie, Cooperat Res Ctr Spatial Informat, Perth, WA, Australia.
   Carapetis, Jonathan; Chaney, Gervase; Daly, Frank, Perth Childrens Hosp, Perth, WA, Australia.
   Groza, Tudor; Zankl, Andreas; Roscioli, Tony; Dinger, Marcel E.; Mattick, John S., Garvan Inst Med Res, Kinghorn Ctr Clin Gen, Darlinghurst, NSW, Australia.
   Groza, Tudor, Univ New South Wales, Fac Med, St Vincents Clin Sch, Darlinghurst, NSW, Australia.
   Zankl, Andreas, Childrens Hosp Westmead, Clin Genet Serv, Westmead, NSW, Australia.
   Gahl, William; Tifft, Cynthia, NHGRI, NIH, Bethesda, MD USA.
   Gahl, William; Tifft, Cynthia, NIH, Undiagnosed Dis Program, Common Fund, Off Director, Bethesda, MD USA.
   Groft, Stephen, NIH, Nat Ctr Adv Translat Sci, Bethesda, MD USA.
   Taruscio, Domenica, Natl Ctr Rare Dis, Inst Super Sanita, Rome, Italy.
   Lasko, Paul, Canadian Inst Hlth Res, Inst Genet, Montreal, PQ, Canada.
   Kosaki, Kenjiro, Keio Univ, Sch Med, Tokyo, Japan.
   Wilhelm, Helene, Wilhelm Fdn, Brottby, Sweden.
   Melegh, Bela, Univ Pecs, Dept Med Genet, Pecs, Hungary.},
DOI = {10.1186/s13023-017-0619-z},
Article-Number = {83},
Keywords = {Diagnosis; Genomics; Phenomics; Undiagnosed; Diagnostic odyssey;
   Clinical best practice; Policy; Precision public health},
Keywords-Plus = {INSTITUTES-OF-HEALTH; RARE; NETWORK},
Research-Areas = {Genetics \& Heredity; Research \& Experimental Medicine},
Web-of-Science-Categories  = {Genetics \& Heredity; Medicine, Research \& Experimental},
Author-Email = {Gareth.baynam@health.wa.gov.au},
Affiliations = {University of Western Australia; Murdoch University; Telethon Kids
   Institute; University of Western Australia; University of Western
   Australia; Curtin University; University of Western Australia; Murdoch
   University; University of Western Australia; King Edward Memorial
   Hospital; Curtin University; Perth Childrens Hospital; Garvan Institute
   of Medical Research; University of New South Wales Sydney; St Vincent's
   Clinic; NSW Health; Sydney Childrens Hospitals Network; University of
   Sydney; The Children's Hospital at Westmead; National Institutes of
   Health (NIH) - USA; NIH National Human Genome Research Institute
   (NHGRI); National Institutes of Health (NIH) - USA; National Institutes
   of Health (NIH) - USA; Istituto Superiore di Sanita (ISS); Institute for
   Work \& Health; Keio University; University of Pecs},
Cited-References = {Ales M, 2016, GENET MED, V2016, P31.
   Baynam G, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0462-7.
   European Organisation for Rare Diseases, 2007, SURV DEL DIAGN 8 RAR.
   Gahl WA, 2015, JAMA-J AM MED ASSOC, V314, P1797, DOI 10.1001/jama.2015.12249.
   Lee H, 2014, JAMA-J AM MED ASSOC, V312, P1880, DOI 10.1001/jama.2014.14604.
   Molster C, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0409-z.
   National Organisation for Rare Disorders, 2016, RAR UND NETW.
   Taruscio D, 2015, MOL GENET METAB, V116, P223, DOI 10.1016/j.ymgme.2015.11.003.
   Tifft CJ, 2014, CURR OPIN PEDIATR, V26, P626, DOI 10.1097/MOP.0000000000000155.},
Number-of-Cited-References = {9},
Times-Cited = {26},
Unique-ID = {WOS:000400489200001},
}

@article{ WOS:001195392000001,
Author = {Bolt, Kaylin and Gil-Gonzalez, Diana and Oliver, Nuria},
Title = {Unconventional data, unprecedented insights: leveraging non-traditional
   data during a pandemic},
Journal = {FRONTIERS IN PUBLIC HEALTH},
Year = {2024},
Volume = {12},
Month = {MAR 7},
Abstract = {Introduction The COVID-19 pandemic prompted new interest in
   non-traditional data sources to inform response efforts and mitigate
   knowledge gaps. While non-traditional data offers some advantages over
   traditional data, it also raises concerns related to biases,
   representativity, informed consent and security vulnerabilities. This
   study focuses on three specific types of non-traditional data: mobility,
   social media, and participatory surveillance platform data. Qualitative
   results are presented on the successes, challenges, and recommendations
   of key informants who used these non-traditional data sources during the
   COVID-19 pandemic in Spain and Italy.Methods A qualitative
   semi-structured methodology was conducted through interviews with
   experts in artificial intelligence, data science, epidemiology, and/or
   policy making who utilized non-traditional data in Spain or Italy during
   the pandemic. Questions focused on barriers and facilitators to data
   use, as well as opportunities for improving utility and uptake within
   public health. Interviews were transcribed, coded, and analyzed using
   the framework analysis method.Results Non-traditional data proved
   valuable in providing rapid results and filling data gaps, especially
   when traditional data faced delays. Increased data access and innovative
   collaborative efforts across sectors facilitated its use. Challenges
   included unreliable access and data quality concerns, particularly the
   lack of comprehensive demographic and geographic information. To further
   leverage non-traditional data, participants recommended prioritizing
   data governance, establishing data brokers, and sustaining
   multi-institutional collaborations. The value of non-traditional data
   was perceived as underutilized in public health surveillance, program
   evaluation and policymaking. Participants saw opportunities to integrate
   them into public health systems with the necessary investments in data
   pipelines, infrastructure, and technical capacity.Discussion While the
   utility of non-traditional data was demonstrated during the pandemic,
   opportunities exist to enhance its impact. Challenges reveal a need for
   data governance frameworks to guide practices and policies of use.
   Despite the perceived benefit of collaborations and improved data
   infrastructure, efforts are needed to strengthen and sustain them beyond
   the pandemic. Lessons from these findings can guide research
   institutions, multilateral organizations, governments, and public health
   authorities in optimizing the use of non-traditional data.},
Type = {Article},
Affiliation = {Bolt, K (Corresponding Author), Publ Hlth Seattle \& King Cty, Hlth Sci Div, Assessment Policy Dev \& Evaluat Unit, Seattle, WA 98104 USA.
   Bolt, Kaylin, Publ Hlth Seattle \& King Cty, Hlth Sci Div, Assessment Policy Dev \& Evaluat Unit, Seattle, WA 98104 USA.
   Gil-Gonzalez, Diana, Univ Alicante, Dept Community Nursing Prevent Med \& Publ Hlth \& H, Alicante, Spain.
   Gil-Gonzalez, Diana, CIBER Epidemiol \& Salud Publ CIBERESP, Madrid, Spain.
   Oliver, Nuria, European Lab Learning \& Intelligent Syst ELLIS Ali, Alicante, Spain.},
DOI = {10.3389/fpubh.2024.1350743},
Article-Number = {1350743},
Keywords = {non-traditional data; COVID-19; data governance; precision public
   health; digital health},
Keywords-Plus = {HUMAN MOBILITY; PUBLIC-HEALTH; COVID-19; SURVEILLANCE; IMPACT},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {kabolt@kingcounty.gov},
Affiliations = {Universitat d'Alacant; CIBER - Centro de Investigacion Biomedica en Red;
   CIBERESP},
Cited-References = {Aiello AE, 2020, ANNU REV PUBL HEALTH, V41, P101, DOI 10.1146/annurev-publhealth-040119-094402.
   Al Knawy B, 2020, LANCET, V396, P1537, DOI 10.1016/S0140-6736(20)31978-4.
   Albanna B., 2021, The Data Powered Positive Deviance Handbook. Data Powered Positive Deviance Initative.
   Allen CG, 2023, AM J PUBLIC HEALTH, V113, P1210, DOI 10.2105/AJPH.2023.307386.
   Arjona JO, 2023, SCI REP-UK, V13, DOI 10.1038/s41598-023-36108-1.
   Bambra C, 2020, J EPIDEMIOL COMMUN H, V74, P964, DOI 10.1136/jech-2020-214401.
   Barassi V, 2019, SOCIOL RES ONLINE, V24, P414, DOI 10.1177/1360780419857734.
   Bengtsson L, 2015, SCI REP-UK, V5, DOI 10.1038/srep08923.
   Bogler A, 2020, NAT SUSTAIN, V3, P981, DOI 10.1038/s41893-020-00605-2.
   Bragazzi NL, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17093176.
   Chafetz H., 2022, The\# Data4COVID19 Review: Assessing the Use of Non-Traditional Data During a Pandemic Crisis.
   Charlesworth TES, 2019, J NEUROSCI, V39, P7228, DOI 10.1523/JNEUROSCI.0475-18.2019.
   Clarke V., 2021, THEMATIC ANAL PRACTI, P1, DOI DOI 10.1007/978-3-319-69909-7\_3470-2.
   Cooper C, 2023, Community Sci, V2, DOI {[}10.1029/2022CSJ000025, DOI 10.1029/2022CSJ000025].
   Cutrupi F, 2022, ENVIRON TECHNOL INNO, V28, DOI 10.1016/j.eti.2022.102667.
   De Broe S., 2021, Stat J IAOS, V37, P343, DOI DOI 10.3233/SJI-200711.
   De Rosis S, 2021, HEALTH POLICY, V125, P987, DOI 10.1016/j.healthpol.2021.06.006.
   Donelle L, 2023, DIGIT HEALTH, V9, DOI 10.1177/20552076231173220.
   Du JC, 2017, BMC MED INFORM DECIS, V17, DOI 10.1186/s12911-017-0469-6.
   Edmunds Margo, 2014, EGEMS (Wash DC), V2, P1156, DOI 10.13063/2327-9214.1156.
   Francis JJ, 2010, PSYCHOL HEALTH, V25, P1229, DOI 10.1080/08870440903194015.
   Fritz S, 2019, NAT SUSTAIN, V2, P922, DOI 10.1038/s41893-019-0390-3.
   Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117.
   Geneviève LD, 2019, J MED INTERNET RES, V21, DOI 10.2196/12273.
   Green M., 2021, COVID-19 and Similar Futures Pandemic Geographies, P423, DOI {[}10.1007/978-3-030-70179-6\_56, DOI 10.1007/978-3-030-70179-6\_56].
   Guerrisi C, 2016, J INFECT DIS, V214, pS386, DOI 10.1093/infdis/jiw280.
   Holly L, 2023, INT J HEALTH GOV, V28, P225, DOI 10.1108/IJHG-11-2022-0104.
   Johns Hopkins University and Medicine, 2023, COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE).
   Khalatbari-Soltani S, 2020, J EPIDEMIOL COMMUN H, V74, P620, DOI 10.1136/jech-2020-214297.
   Khanna D., 2022, Leveraging Non-Traditional Data for the COVID-19 Socioeconomic Recovery Strategy.
   Khoury MJ, 2016, AM J PREV MED, V50, P398, DOI 10.1016/j.amepre.2015.08.031.
   Kickbusch I, 2023, GLOB POLICY, V14, P569, DOI 10.1111/1758-5899.13222.
   Kondylakis H, 2020, J MED INTERNET RES, V22, DOI 10.2196/23170.
   Letouze E., 2020, Using Data to Fight Covid-19 and Build Back Better.
   Marelli L, 2020, POLICY STUD-UK, V41, P447, DOI 10.1080/01442872.2020.1724929.
   McColl K, 2022, INT J ENV RES PUB HE, V19, DOI 10.3390/ijerph19010436.
   McGraw D, 2021, NPJ DIGIT MED, V4, DOI 10.1038/s41746-020-00362-8.
   Mehta Nishita, 2022, SN Comput Sci, V3, P54, DOI 10.1007/s42979-021-00923-y.
   Moso-Diez M., 2021, Trends Vocat Educ Train Res, V4, P177, DOI {[}10.5281/zenodo.5171994, DOI 10.5281/ZENODO.5171994].
   Murray CJL, 2020, LANCET PUBLIC HEALTH, V5, pE469, DOI 10.1016/S2468-2667(20)30187-0.
   Oliver N., 2022, Science, Research and Innovation Performance of the EU 2022 Report, P604.
   Oliver N, 2020, J MED INTERNET RES, V22, DOI 10.2196/21319.
   Oliver N, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abc0764.
   Orrell T., 2021, Towards a Framework for Governing Data Innovation: Fostering Trust in the Use of Non-Traditional Data Sources in Statistical Production.
   Paolotti D, 2014, CLIN MICROBIOL INFEC, V20, P17, DOI 10.1111/1469-0691.12477.
   Quer G, 2021, NAT MED, V27, P73, DOI 10.1038/s41591-020-1123-x.
   Rod MH, 2021, SCAND J PUBLIC HEALT, V49, P14, DOI 10.1177/1403494820982862.
   Royo S, 2020, EUR POLICY ANAL, V6, P180, DOI 10.1002/epa2.1099.
   Sachs JD, 2022, LANCET, V400, P1224, DOI 10.1016/S0140-6736(22)01585-9.
   Sahu KS, 2021, FRONT PUBLIC HEALTH, V9, DOI 10.3389/fpubh.2021.756675.
   Salathé M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002616.
   Salathé M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002199.
   Salerno J, 2023, ANN EPIDEMIOL, V80, P37, DOI 10.1016/j.annepidem.2023.02.001.
   Shaw J, 2023, NPJ DIGIT MED, V6, DOI 10.1038/s41746-023-00780-4.
   Smolinski Mark S, 2017, JMIR Public Health Surveill, V3, pe62, DOI 10.2196/publichealth.7540.
   Sukhwal PC, 2022, P NATL ACAD SCI USA, V119, DOI 10.1073/pnas.2117292119.
   Trigo-Tasende N, 2023, ENVIRON SCI POLLUT R, V30, P79315, DOI 10.1007/s11356-023-27877-3.
   Tsao SF, 2021, LANCET DIGIT HEALTH, V3, pE175, DOI 10.1016/S2589-7500(20)30315-0.
   Velmovitsky PE, 2021, FRONT PUBLIC HEALTH, V9, DOI 10.3389/fpubh.2021.561873.
   Verhulst S., 2020, Call for Action: Toward Building the Data Infrastructure and Ecosystem we Need to Tackle Pandemics and Other Dynamic Societal and Environmental Threats.
   Verhulst SG., 2019, Data Collaboratives: Leveraging Private Data for Public Good.
   Werner L, 2023, FRONT PUBLIC HEALTH, V11, DOI 10.3389/fpubh.2023.1106548.
   Wesolowski A, 2015, P NATL ACAD SCI USA, V112, P11887, DOI 10.1073/pnas.1504964112.
   Wesolowski A, 2012, SCIENCE, V338, P267, DOI 10.1126/science.1223467.
   Wilson Averi E, 2021, Antimicrob Steward Healthc Epidemiol, V1, pe50, DOI 10.1017/ash.2021.225.
   Wittwer S, 2023, JMIR PUBLIC HLTH SUR, V9, DOI 10.2196/44517.
   Yigitcanlar T, 2020, HEALTH INF SCI SYST, V8, DOI 10.1007/s13755-020-00121-9.
   Zhao IY, 2021, J MED INTERNET RES, V23, DOI 10.2196/32328.},
Number-of-Cited-References = {68},
Times-Cited = {0},
Unique-ID = {WOS:001195392000001},
}

@article{ WOS:000606998200014,
Author = {Preston, Michael A. and Ross, Levi and Chukmaitov, Askar and Smith,
   Sharla A. and Odlum, Michelle L. and Dahman, Bassam and Sheppard,
   Vanessa B.},
Title = {Health Insurance Coverage Mandates: Colorectal Cancer Screening in the
   Post-ACA Era},
Journal = {CANCER PREVENTION RESEARCH},
Year = {2021},
Volume = {14},
Number = {1},
Pages = {123-130},
Month = {JAN},
Abstract = {Building a culture of precision public health requires research that
   includes health delivery model with innovative systems, health policies,
   and programs that support this vision. Health insurance mandates are
   effective mechanisms that many state policymakers use to increase the
   utilization of preventive health services, such as colorectal cancer
   screening. This study estimated the effects of health insurance mandate
   variations on colorectal cancer screening post Affordable Care Act (ACA)
   era. The study analyzed secondary data from the Behavioral Risk Factor
   Surveillance System (BRFSS) and the NCI State Cancer Legislative
   Database (SCLD) from 1997 to 2014. BRFSS data were merged with SCLD data
   by state ID. The target population was U.S. adults, age 50 to 74, who
   lived in states where health insurance was mandated or nonmandated
   before and after the implementation of ACA. Using a
   difference-in-differences (DD) approach with a time-series analysis, we
   evaluated the effects of health insurance mandates on colorectal cancer
   screening status based on U.S. Preventive Services Task Force
   guidelines. The adjusted average marginal effects from the DD model
   indicate that health insurance mandates increased the probability of
   up-to-date screenings versus noncompliance by 2.8\% points, suggesting
   that an estimated 2.37 million additional age-eligible persons would
   receive a screening with such health insurance mandates. Compliant
   participants' mean age was 65 years and 57\% were women(n = 32,569). Our
   findings are robust for various model specifications. Health insurance
   mandates that lower out-of-pocket expenses constitute an effective
   approach to increase colorectal cancer screenings for the population, as
   a whole.
   Prevention Relevance: The value added includes future health care
   reforms that increase access to preventive services, such as CRC
   screening, are likely with lower out-of-pocket costs and will increase
   the number of people who are considered ``up-to-date{''}. Such policies
   have been used historically to improve health outcomes, and they are
   currently being used as public health strategies to increase access to
   preventive health services in an effort to improve the nation's health.},
Type = {Article},
Affiliation = {Preston, MA (Corresponding Author), Virginia Commonwealth Univ, 830 East Main St,POB 980149, Richmond, VA 23298 USA.
   Preston, Michael A.; Chukmaitov, Askar; Dahman, Bassam; Sheppard, Vanessa B., Virginia Commonwealth Univ, Dept Hlth Behav \& Policy, Richmond, VA 23298 USA.
   Preston, Michael A.; Sheppard, Vanessa B., Virginia Commonwealth Univ, VCU Massey Canc Ctr, Dept Hlth Behav \& Policy, Off Hlth Equ \& Dispar Res, Richmond, VA 23298 USA.
   Ross, Levi, Univ Alabama, Dept Hlth Sci, Tuscaloosa, AL USA.
   Smith, Sharla A., Univ Kansas, Sch Med Wichita, Dept Populat Hlth, Wichita, KS USA.
   Odlum, Michelle L., Columbia Univ, Sch Nursing, New York, NY USA.},
DOI = {10.1158/1940-6207.CAPR-20-0028},
Keywords-Plus = {PREVENTIVE SERVICES; RACIAL/ETHNIC DISPARITIES; RACIAL DISPARITIES;
   UNITED-STATES; RATES; COLONOSCOPY; IMPACT; COST},
Research-Areas = {Oncology},
Web-of-Science-Categories  = {Oncology},
Author-Email = {prestonm2@vcu.edu},
Affiliations = {Virginia Commonwealth University; Virginia Commonwealth University;
   University of Alabama System; University of Alabama Tuscaloosa;
   University of Kansas; University of Kansas Medical Center; Columbia
   University},
Cited-References = {Agrawal S, 2005, AM J GASTROENTEROL, V100, P515, DOI 10.1111/j.1572-0241.2005.41829.x.
   Ahmed NU, 2013, AM J PUBLIC HEALTH, V103, pE91, DOI 10.2105/AJPH.2012.301034.
   American Cancer Society, 2019, Cancer Facts and Figures 2019.
   American Cancer Society, 2013, CANC FACTS FIG 2013.
   American Cancer Society, 2012, CANC FACTS FIG 2012.
   American Cancer Society, 2014, CANC FACTS FIG 2014.
   {[}Anonymous], 2016, Cancer Facts Figures 2016.
   {[}Anonymous], 2020, CANC FACTS FIG 2020.
   Atherly A, 2012, HEALTH SERV RES, V47, P939, DOI 10.1111/j.1475-6773.2011.01376.x.
   Ball JK, 1996, MED CARE, V34, P970, DOI 10.1097/00005650-199609000-00008.
   Balzora S, 2020, GASTROINTEST ENDOSC, V92, P946, DOI 10.1016/j.gie.2020.06.042.
   Baquet C R, 1999, J Assoc Acad Minor Phys, V10, P51.
   Bertrand M, 2004, Q J ECON, V119, P249, DOI 10.1162/003355304772839588.
   Burnett-Hartman AN, 2016, AM J PREV MED, V51, pE107, DOI 10.1016/j.amepre.2016.02.025.
   {*}CDCP, 2013, OV BRFSS 2011.
   Centers for Disease Prevention and Control, 2013, OV BRFSS 2009.
   Chen FW, 2017, AM J PREV MED, V53, P933, DOI 10.1016/j.amepre.2017.07.016.
   Cogan JA, 2011, J LAW MED ETHICS, V39, P355, DOI 10.1111/j.1748-720X.2011.00605.x.
   Cokkinides V, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-19.
   Edwards BK, 2005, JNCI-J NATL CANCER I, V97, P1407, DOI 10.1093/jnci/dji289.
   Fedewa SA, 2015, CANCER-AM CANCER SOC, V121, P3272, DOI 10.1002/cncr.29494.
   Hamman MK, 2016, HEALTH ECON, V25, P178, DOI 10.1002/hec.3132.
   Hamman MK, 2015, HEALTH AFFAIR, V34, P2069, DOI 10.1377/hlthaff.2015.0571.
   Han WJ, 2009, J POLICY ANAL MANAG, V28, P29, DOI 10.1002/pam.20398.
   Joseph Djenaba A, 2012, MMWR Suppl, V61, P51.
   Khatami S, 2012, CLIN GASTROENTEROL H, V10, P761, DOI 10.1016/j.cgh.2012.02.027.
   Klabunde Carrie N., 2012, Morbidity and Mortality Weekly Report, V61, P41.
   Mays GP, 2011, HEALTH AFFAIR, V30, P1585, DOI 10.1377/hlthaff.2011.0196.
   McCoy J, 2020, J COSMET DERMATOL-US, V19, P1542, DOI 10.1111/jocd.13455.
   Meester RGS, 2015, CANCER-AM CANCER SOC, V121, P2281, DOI 10.1002/cncr.29336.
   Nicholas JA, 2011, MT SINAI J MED, V78, P498, DOI 10.1002/msj.20275.
   Preston MA, 2014, HLTH SYSTEM REFORM D, P1.
   Preston MA, 2018, AM J SURG, V216, P245, DOI 10.1016/j.amjsurg.2017.08.004.
   Preston MA, 2018, AM J SURG, V215, P1004, DOI 10.1016/j.amjsurg.2018.02.026.
   Preston MA, 2014, J HEALTH CARE POOR U, V25, P139, DOI 10.1353/hpu.2014.0069.
   Robbins AS, 2012, J CLIN ONCOL, V30, P401, DOI 10.1200/JCO.2011.37.5527.
   Rodriguez Sara Russell, 2011, Morbidity and Mortality Weekly Report, V60, P1348.
   Soneji S, 2010, AM J PUBLIC HEALTH, V100, P1912, DOI 10.2105/AJPH.2009.184192.
   Van der Wees PJ, 2013, MILBANK Q, V91, P663, DOI 10.1111/1468-0009.12029.},
Number-of-Cited-References = {39},
Times-Cited = {1},
Unique-ID = {WOS:000606998200014},
}

@article{ WOS:000378829900003,
Author = {Luis Ferrao, Joao and Mendes, Jorge M. and Painho, Marco and Joao, Sara
   Z.},
Title = {Spatio-temporal variation and socio-demographic characters of malaria in
   Chimoio municipality, Mozambique},
Journal = {MALARIA JOURNAL},
Year = {2016},
Volume = {15},
Month = {JUN 21},
Abstract = {Background: In Africa, urban malaria is a major concern, since the towns
   and especially their suburbs are growing quickly. In Mozambique, malaria
   represents 45 \% of all cases of outpatient visits and 56 \% of
   inpatient visits at paediatric clinics. Malaria is a major public health
   burden in Chimoio Mozambique and few studies on malaria exist.
   Methods: The study was carried out to establish the spatiality and
   temporality of malaria and describe socio-demographic characteristics of
   malaria patients in Chimoio. Weekly malaria data for 9 years (2006-2014)
   were collected from the district Epidemiological Bulletin and incidence
   by season, age, gender, and residence was calculated. SPSS version 20
   was used for statistical analysis and ArcGis 10.1 was used to produce
   maps.
   Results: The annual overall average of malaria incidence was 20.1 \% and
   the attributable fraction (AF) of malaria was 16 \%. There were
   differences in weekly and yearly malaria occurrences throughout the
   period. There was no difference in malaria cases between male and female
   patients. Children under 5 years of age are three times more prone to
   malaria than adults (p < 0.05). Three temporal clusters of malaria were
   identified: cluster 1, weeks 25-47 with average weekly cases of 618 (sd
   = 251.9), cluster 2, weeks 18-24 and 48-51 with average weekly cases of
   1066 (sd = 317.4). cluster 3, weeks 1-17 and 52 with average weekly
   cases of 1587 (sd = 722.4). Similarly, three different clusters were
   identified according to residential areas: cluster 1 (10 \%) mostly
   urban, cluster 2 (22 \%) mostly suburbs, cluster 3 (28 \%) mostly rural
   areas.
   Conclusion: Malaria is increasing in the suburbs, and rural areas
   present more cases of malaria compared to urban areas. This article is
   an initial step to understand the dynamics of malaria in Chimoio.
   Results suggest that malaria varies in time and space, and that
   precision public health strategy should be used to control malaria
   occurrence. Studies on weather factors affecting malaria cases, bed net
   usage, and others should be undertaken.},
Type = {Article},
Affiliation = {Ferrao, JL (Corresponding Author), Mozambique Catholic Univ, Fac Engn, Chimoio, Mozambique.
   Luis Ferrao, Joao, Mozambique Catholic Univ, Fac Engn, Chimoio, Mozambique.
   Mendes, Jorge M.; Painho, Marco, Univ Nova Lisboa, NOVA Informat Management Sch, P-1200 Lisbon, Portugal.
   Joao, Sara Z., Manica Prov Directorate Hlth, Chimoio, Mozambique.},
DOI = {10.1186/s12936-016-1371-x},
Article-Number = {329},
Keywords = {Malaria; Spatiality; Temporality; Socio-Demographic; Chimoio; Precision
   health},
Keywords-Plus = {TRANSMISSION; URBANIZATION; DISEASE; BURDEN},
Research-Areas = {Infectious Diseases; Parasitology; Tropical Medicine},
Web-of-Science-Categories  = {Infectious Diseases; Parasitology; Tropical Medicine},
Author-Email = {jferrao@ucm.ac.mz},
Affiliations = {Universidade Nova de Lisboa},
Cited-References = {{[}Anonymous], 2014, World Malaria Report.
   Centre for Disease Control and Prevention, 2014, IMP OF MAL.
   Centre for Disease Control and Prevention, 2015, 2 PEAS IN A POD.
   de Oliveira AM, 2011, AM J TROP MED HYG, V85, P1002, DOI 10.4269/ajtmh.2011.11-0365.
   Ernst KC, 2009, TROP MED INT HEALTH, V14, P1258, DOI 10.1111/j.1365-3156.2009.02370.x.
   Gallup JL, 2001, AM J TROP MED HYG, V64, P85, DOI 10.4269/ajtmh.2001.64.85.
   Global Health Group. Malaria elimination initiative, 2013, MAL EL IN COUNTR BRI.
   Global Health Science, 2012, SWAZ LEADS SUBS AFR.
   Saraiva MDG, 2009, REV SOC BRAS MED TRO, V42, P515, DOI 10.1590/S0037-86822009000500008.
   Hay SI, 2005, NAT REV MICROBIOL, V3, P81, DOI 10.1038/nrmicro1069.
   Hay SI, 2008, LANCET INFECT DIS, V8, P369, DOI 10.1016/S1473-3099(08)70069-0.
   Health Geomatics, 2004, MAPP MAL RISK AFR AT.
   Instituto Nacional de Estatistica, 2013, INQ DEM SAUD.
   Instituto Nacional de Estatistica, 2007, 3 REC GER POP HAB 20.
   Joao ZS, 2015, P 8 JORN CIENT TECN.
   Kim YM, 2012, ENVIRON HEALTH PERSP, V120, P1314, DOI 10.1289/ehp.1104577.
   Krefis AC, 2011, AM J TROP MED HYG, V84, P285, DOI 10.4269/ajtmh.2011.10-0381.
   Kumar DS, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-14.
   Mamurove MAM, 2015, P 8 JORN CIENT TEC M.
   Omonijo AG., 2011, J. Environ. Sci. Eng, V5, P1215.
   Qi QY, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-403.
   Tatem AJ, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-133.
   Thompson R, 1997, AM J TROP MED HYG, V57, P550, DOI 10.4269/ajtmh.1997.57.550.
   Tonui WKO, 2013, INT J EDUC RES, V12, P1.
   UNICF, 2013, MALARIA.
   United Nations Human Settlements Programme, 2007, MILL DEV GOAL URB SU.
   Westerink R M., 1995, SOLOS PARTE DISTR LA, P79.
   Worrall E, 2005, TROP MED INT HEALTH, V10, P1047, DOI 10.1111/j.1365-3156.2005.01476.x.
   Yeshiwondim AK, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-5.
   Zacarias OP, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-189.},
Number-of-Cited-References = {30},
Times-Cited = {11},
Unique-ID = {WOS:000378829900003},
}

@article{ WOS:000402209800002,
Author = {Ferrao, Joao Luis and Mendes, Jorge M. and Painho, Marco and Zacarias,
   Sara},
Title = {Malaria mortality characterization and the relationship between malaria
   mortality and climate in Chimoio, Mozambique},
Journal = {MALARIA JOURNAL},
Year = {2017},
Volume = {16},
Month = {MAY 22},
Abstract = {Background: The United Nation's sustainable development goal for 2030 is
   to eradicate the global malaria epidemic, primarily as the disease
   continues to be one of the major concerns for public health in
   sub-Saharan Africa. In 2015, the region accounted for 90\% of malaria
   deaths. Mozambique recorded a malaria mortality rate of 42.75 (per
   100,000). In Chimoio, Mozambique's fifth largest city, malaria is the
   fourth leading cause of death (9.4\%). Few data on malaria mortality
   exists in Mozambique, particularly in relation to Chimoio. The objective
   of this study was to characterize malaria mortality trends and its
   spatial distribution in Chimoio.
   Methods: Malaria mortality data and climate data were extracted from the
   Chimoio Civil Registration records, and the Regional Weather station,
   from 2010 to 2014. The malaria crude mortality rate was calculated.
   ANOVA, Tukey's, Chi square, and time series were carried out and an
   intervention analysis ARIMA model developed.
   Results: A total of 944 malaria death cases were registered in Chimoio,
   729 of these among Chimoio residents (77\%). The average malaria
   mortality by gender was 44.9\% for females and 55.1\% for males. The age
   of death varied from 0 to 96 years, with an average age of 25.9 (SE =
   0.79) years old. January presented the highest average of malaria
   deaths, and urban areas presented a lower crude malaria mortality rate.
   Rural neighbourhoods with good accessibility present the highest malaria
   crude mortality rate, over 85 per 100,000. Seasonal ARMA (2,0)(1,0) 12
   fitted the data although it was not able to capture malaria mortality
   peaks occurring during malaria outbreaks. Intervention effect properly
   fit the mortality peaks and reduced ARMA's root mean square error by
   almost 25\%.
   Conclusion: Malaria mortality is increasing in Chimoio; children between
   1 and 4 years old represent 13\% of Chimoio population, but account for
   25\% of malaria mortality. Malaria mortality shows seasonal and spatial
   characteristics. More studies should be carried out for malaria
   eradication in the municipality.},
Type = {Article},
Affiliation = {Ferrao, JL (Corresponding Author), Univ Catolica Mocambique, Fac Engn, Chimoio, Mozambique.
   Ferrao, Joao Luis, Univ Catolica Mocambique, Fac Engn, Chimoio, Mozambique.
   Mendes, Jorge M.; Painho, Marco, NOVA Univ Lisbon, NOVA Informat Management Sch, Lisbon, Portugal.
   Zacarias, Sara, Direccao Prov Saude Manica, Lisbon, Mozambique.},
DOI = {10.1186/s12936-017-1866-0},
Article-Number = {212},
Keywords = {Malaria mortality; Seasonality; Spatiality; Chimoio; Precision Public
   Health},
Keywords-Plus = {MORBIDITY; AFRICA; HEALTH; TRENDS},
Research-Areas = {Infectious Diseases; Parasitology; Tropical Medicine},
Web-of-Science-Categories  = {Infectious Diseases; Parasitology; Tropical Medicine},
Author-Email = {jferrao@ucm.ac.mz},
Affiliations = {Universidade Nova de Lisboa},
Cited-References = {Abdalla SI, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-97.
   An G., 2011, Penn McNair Res J, V3, P1.
   {[}Anonymous], 2015, SUST DEV GOAL 3.
   {[}Anonymous], 2016, MAL FACT SHEET.
   BOX GEP, 1975, J AM STAT ASSOC, V70, P70, DOI 10.2307/2285379.
   Buescher, 2008, PROBLEMS RATES BASED.
   Deressa W, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-128.
   GDB profile. GDB profile. Mozambique, 2016, GDB PROF MOZ GLOB BU.
   Gomez-Elipe A, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-129.
   Instituto Nacional de Estatistica, 2010, POP PROJ AR RES SEX.
   Kampe EOI, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0818-9.
   Kazembe LN, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-93.
   Kesteman T, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-465.
   Khoury M.J., 2015, Precision public health and precision medicine: two peas in a pod.
   Kocurkova R, 2000, TIME SERIES ANAL TRE.
   Kumar V, 2014, MALAR RES TREAT, V2014, DOI {[}10.1155/2014:482851, DOI 10.1155/2014:482851].
   Ferrao JL, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1371-x.
   Ngomane L, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-19.
   Norheim OF, 2015, LANCET, V385, P239, DOI 10.1016/S0140-6736(14)61591-9.
   Selemani M, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1311-9.
   Sewe M, 2015, INT J ENV RES PUB HE, V12, P1983, DOI 10.3390/ijerph120201983.
   Stanley J., 2016, Open Journal of Statistics, V6, P295, DOI {[}10.4236/ojs.2016.62025, DOI 10.4236/OJS.2016.62025].
   Streatfield PK, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.25369.
   UTREL, 2005, COD REG CIV AN.
   WHO, 2013, MOZ WHO STAT PROF.
   WHO, 2007, Gender, Health and Malaria.
   World Health Ranking, 2016, WORLD HLTH RANKING L.},
Number-of-Cited-References = {27},
Times-Cited = {7},
Unique-ID = {WOS:000402209800002},
}

@article{ WOS:000571889000004,
Author = {Helfinstein, Sarah and Engl, Elisabeth and Thomas, Beena E. and
   Natarajan, Gayathri and Prakash, Prithivi and Jain, Mokshada and
   Lavanya, Jayabal and Jagadeesan, Murugesan and Chang, Rebekah and
   Mangono, Tichakunda and Kemp, Hannah and Mannan, Shamim and Dabas,
   Harkesh and Charles, Grace K. and Sgaier, Sema K.},
Title = {Understanding why at-risk population segments do not seek care for
   tuberculosis: a precision public health approach in South India},
Journal = {BMJ GLOBAL HEALTH},
Year = {2020},
Volume = {5},
Number = {9},
Month = {SEP},
Abstract = {Introduction Delaying care-seeking for tuberculosis (TB) symptoms is a
   major contributor to mortality, leading to worse outcomes and spread. To
   reduce delays, it is essential to identify barriers to care-seeking and
   target populations most at risk of delaying. Previous work identifies
   barriers only in people within the health system, often long after
   initial care-seeking. Methods We conducted a community-based survey of
   84 625 households in Chennai, India, to identify 1667 people with
   TB-indicative symptoms in 2018-2019. Cases were followed prospectively
   to observe care-seeking behaviour. We used a comprehensive survey to
   identify care-seeking drivers, then performed multivariate analyses to
   identify care-seeking predictors. To identify profiles of individuals
   most at risk to delay care-seeking, we segmented the sample using
   unsupervised clustering. We then estimated the per cent of the
   TB-diagnosed population in Chennai in each segment. Results Delayed
   care-seeking characteristics include smoking, drinking, being employed,
   preferring different facilities than the community, believing to be at
   lower risk of TB and believing TB is common. Respondents who reported
   fever or unintended weight loss were more likely to seek care.
   Clustering analysis revealed seven population segments differing in
   care-seeking, from a retired/unemployed/disabled cluster, where 70\%
   promptly sought care, to a cluster of employed men who problem-drink and
   smoke, where only 42\% did so. Modelling showed 54\% of TB-diagnosed
   people who delay care-seeking might belong to the latter segment, which
   is most likely to acquire TB and least likely to promptly seek care.
   Conclusion Interventions to increase care-seeking should move from
   building general awareness to addressing treatment barriers such as lack
   of time and low-risk perception. Care-seeking interventions should
   address specific beliefs through a mix of educational, risk
   perception-targeting and social norms-based campaigns. Employed men who
   problem-drink and smoke are a prime target for interventions. Reducing
   delays in this group could dramatically reduce TB spread.},
Type = {Article},
Affiliation = {Sgaier, SK (Corresponding Author), Surgo Fdn, Washington, DC 20001 USA.
   Sgaier, SK (Corresponding Author), Harvard Univ, TH Chan Sch Publ Hlth, Boston, MA 02115 USA.
   Sgaier, SK (Corresponding Author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.
   Helfinstein, Sarah; Engl, Elisabeth; Jain, Mokshada; Mangono, Tichakunda; Kemp, Hannah; Charles, Grace K.; Sgaier, Sema K., Surgo Fdn, Washington, DC 20001 USA.
   Thomas, Beena E., Natl Inst Res TB, Dept Social \& Behav Res, Chennai, Tamil Nadu, India.
   Natarajan, Gayathri; Prakash, Prithivi; Chang, Rebekah; Mannan, Shamim; Dabas, Harkesh, Clinton Hlth Access Initiat, Chennai, Tamil Nadu, India.
   Natarajan, Gayathri; Prakash, Prithivi; Chang, Rebekah; Mannan, Shamim; Dabas, Harkesh, Clinton Hlth Access Initiat, Delhi, NY USA.
   Lavanya, Jayabal, Greater Chennai Corp, Dist TB Ctr, Chennai, Tamil Nadu, India.
   Jagadeesan, Murugesan, Greater Chennai Corp, Dept Publ Hlth, Chennai, Tamil Nadu, India.
   Sgaier, Sema K., Harvard Univ, TH Chan Sch Publ Hlth, Boston, MA 02115 USA.
   Sgaier, Sema K., Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.},
DOI = {10.1136/bmjgh-2020-002555},
Article-Number = {e002555},
Keywords = {tuberculosis; public health; community-based survey},
Keywords-Plus = {DIAGNOSIS; DELAYS; SMOKING},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {semasgaier@surgofoundation.org},
Affiliations = {Indian Council of Medical Research (ICMR); ICMR - National Institute for
   Research in Tuberculosis (NIRT); Harvard University; Harvard T.H. Chan
   School of Public Health; University of Washington; University of
   Washington Seattle},
Cited-References = {{[}Anonymous], 2018, IND TB REP.
   Asres M, 2017, AM J TROP MED HYG, V96, P1071, DOI 10.4269/ajtmh.16-0892.
   Awoke Netsanet, 2019, Interdiscip Perspect Infect Dis, V2019, P2154240, DOI 10.1155/2019/2154240.
   Biya Oladayo, 2014, Pan Afr Med J, V18 Suppl 1, P6, DOI 10.11694/pamj.supp.2014.18.1.4166.
   Cai J, 2015, PLOS ONE, V10, DOI DOI 10.1371/JOURNAL.PONE.0120088.
   Chanda-Kapata P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163975.
   Charles N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012379.
   Daniels B, 2019, J CLIN TUBER OTH MYC, V16, DOI 10.1016/j.jctube.2019.100109.
   Dhanaraj B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124260.
   Engl Elisabeth, 2019, Gates Open Res, V3, P886, DOI 10.12688/gatesopenres.12923.2.
   Engl Elisabeth, 2019, Gates Open Res, V3, P1503, DOI 10.12688/gatesopenres.13029.2.
   Gajalakshmi V, 2009, INT J EPIDEMIOL, V38, P1018, DOI 10.1093/ije/dyp225.
   Horton KC, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002119.
   Horton R, 2018, LANCET, V392, P1504, DOI 10.1016/S0140-6736(18)32741-7.
   Kolappan C, 2007, INT J TUBERC LUNG D, V11, P999.
   Kolappan C, 2002, THORAX, V57, P964, DOI 10.1136/thorax.57.11.964.
   Lönnroth K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-289.
   Madebo, 1999, MedGenMed, pE6.
   Mistry N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152287.
   Murrison LB, 2016, INT J TUBERC LUNG D, V20, P544, DOI 10.5588/ijtld.15.0423.
   Rajeswari R, 2002, INT J TUBERC LUNG D, V6, P789.
   Rehm J, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-450.
   Samal J, 2016, J CLIN DIAGN RES, V10, pLE1, DOI 10.7860/JCDR/2016/19678.8598.
   Sgaier SK, 2017, ELIFE, V6, DOI {[}10.7554/eLife.25923, 10.7554/elife.25923].
   Sgaier SK, 2018, TIME SCALE PSYCHO BE.
   Sreeramareddy CT, 2014, INT J TUBERC LUNG D, V18, P255, DOI 10.5588/ijtld.13.0585.
   Temesgen Z, 2019, LANCET PUBLIC HEALTH, V4, pE374, DOI 10.1016/S2468-2667(19)30130-6.
   Tong YQ, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15091998.
   Van Ness SE, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2629-9.
   Vesga JF, 2019, LANCET GLOB HEALTH, V7, pE585, DOI 10.1016/S2214-109X(19)30037-3.
   WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1.
   World Health Organization, 2020, END TB STRAT, P105.
   Yirgu R, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2407-8.},
Number-of-Cited-References = {33},
Times-Cited = {9},
Unique-ID = {WOS:000571889000004},
}

@article{ WOS:000530160300001,
Author = {Chen, Chi-Mai and Jyan, Hong-Wei and Chien, Shih-Chieh and Jen,
   Hsiao-Hsuan and Hsu, Chen-Yang and Lee, Po-Chang and Lee, Chun-Fu and
   Yang, Yi-Ting and Chen, Meng-Yu and Chen, Li-Sheng and Chen, Hsiu-Hsi
   and Chan, Chang-Chuan},
Title = {Containing COVID-19 Among 627,386 Persons in Contact With the Diamond
   Princess Cruise Ship Passengers Who Disembarked in Taiwan: Big Data
   Analytics},
Journal = {JOURNAL OF MEDICAL INTERNET RESEARCH},
Year = {2020},
Volume = {22},
Number = {5},
Month = {MAY 5},
Abstract = {Background: Low infection and case-fatality rates have been thus far
   observed in Taiwan. One of the reasons for this major success is better
   use of big data analytics in efficient contact tracing and management
   and surveillance of those who require quarantine and isolation.
   Objective: We present here a unique application of big data analytics
   among Taiwanese people who had contact with more than 3000 passengers
   that disembarked at Keelung harbor in Taiwan for a 1-day tour on January
   31, 2020, 5 days before the outbreak of coronavirus disease (COVID-19)
   on the Diamond Princess cruise ship on February 5, 2020, after an index
   case was identified on January 20, 2020.
   Methods: The smart contact tracing-based mobile sensor data,
   cross-validated by other big sensor surveillance data, were analyzed by
   the mobile geopositioning method and rapid analysis to identify 627,386
   potential contact-persons. Information on self-monitoring and
   self-quarantine was provided via SMS, and severe acute respiratory
   syndrome coronavirus 2 (SARS-CoV-2) tests were offered for symptomatic
   contacts. National Health Insurance claims big data were linked, to
   follow-up on the outcome related to COVID-19 among those who were
   hospitalized due to pneumonia and advised to undergo screening for
   SARS-CoV-2.
   Results: As of February 29, a total of 67 contacts who were tested by
   reverse transcription-polymerase chain reaction were all negative and no
   confirmed COVID-19 cases were found. Less cases of respiratory syndrome
   and pneumonia were found after the follow-up of the contact population
   compared with the general population until March 10, 2020.
   Conclusions: Big data analytics with smart contact tracing, automated
   alert messaging for self-restriction, and follow-up of the outcome
   related to COVID-19 using health insurance data could curtail the
   resources required for conventional epidemiological contact tracing.},
Type = {Article},
Affiliation = {Chan, CC (Corresponding Author), Natl Taiwan Univ, Coll Publ Hlth, Inst Environm \& Occupat Hlth Sci, 17 Xuzhou Rd, Taipei 100, Taiwan.
   Chen, Chi-Mai, Execut Yuan, Taipei, Taiwan.
   Jyan, Hong-Wei; Chien, Shih-Chieh, Execut Yuan, Dept Cyber Secur, Taipei, Taiwan.
   Jen, Hsiao-Hsuan; Hsu, Chen-Yang; Chen, Hsiu-Hsi, Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol \& Prevent Med, Taipei, Taiwan.
   Lee, Po-Chang; Lee, Chun-Fu, Minist Hlth \& Welf, Natl Hlth Insurance Adm, Taipei, Taiwan.
   Yang, Yi-Ting; Chen, Meng-Yu, Minist Hlth \& Welf, Ctr Dis Control, Taipei, Taiwan.
   Chen, Li-Sheng, Taipei Med Univ, Coll Oral Med, Sch Oral Hyg, Taipei, Taiwan.
   Chan, Chang-Chuan, Natl Taiwan Univ, Coll Publ Hlth, Inst Environm \& Occupat Hlth Sci, 17 Xuzhou Rd, Taipei 100, Taiwan.},
DOI = {10.2196/19540},
Article-Number = {e19540},
Keywords = {COVID-19; mobile geopositioning; contact tracing; proximity tracing;
   digital contact tracking; big data; public health; precision public
   health; surveillance; virus},
Keywords-Plus = {INFLUENZA},
Research-Areas = {Health Care Sciences \& Services; Medical Informatics},
Web-of-Science-Categories  = {Health Care Sciences \& Services; Medical Informatics},
Author-Email = {ccchan@ntu.edu.tw},
Affiliations = {National Taiwan University; Centers For Disease Control - Taiwan; Taipei
   Medical University; National Taiwan University},
Cited-References = {Breslow N E, 1987, IARC Sci Publ, P1.
   Cheng HY, 2020, J FORMOS MED ASSOC, V119, P771, DOI 10.1016/j.jfma.2020.03.007.
   Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045.
   Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017.
   Fisher D, 2020, LANCET, V395, P1109, DOI 10.1016/S0140-6736(20)30679-6.
   Lai SJ, 2019, J TRAVEL MED, V26, DOI 10.1093/jtm/taz019.
   Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717.
   Park S, 2020, JAMA-J AM MED ASSOC, V323, P2129, DOI 10.1001/jama.2020.6602.
   Wang CJ, 2020, JAMA-J AM MED ASSOC, V323, P1341, DOI 10.1001/jama.2020.3151.
   Zhou CH, 2020, GEOGR SUSTAIN, V1, P77, DOI 10.1016/j.geosus.2020.03.005.},
Number-of-Cited-References = {10},
Times-Cited = {93},
Unique-ID = {WOS:000530160300001},
}

@article{ WOS:000827452500001,
Author = {Edney, Sarah Martine and Park, Su Hyun and Tan, Linda and Chua, Xin Hui
   and Dickens, Borame Sue Lee and Rebello, Salome A. and Petrunoff, Nick
   and Muller, Andre Matthias and Tan, Cheun Seng and
   Mueller-Riemenschneider, Falk and van Dam, Rob M.},
Title = {Advancing understanding of dietary and movement behaviours in an Asian
   population through real-time monitoring: Protocol of the Continuous
   Observations of Behavioural Risk Factors in Asia study (COBRA)},
Journal = {DIGITAL HEALTH},
Year = {2022},
Volume = {8},
Month = {JUL},
Abstract = {Background Modifiable risk factors for non-communicable diseases,
   including eating an unhealthy diet and being physically inactive, are
   influenced by complex and dynamic interactions between people and their
   social and physical environment. Therefore, understanding patterns and
   determinants of these risk factors as they occur in real life is
   essential to enable the design of precision public health interventions.
   Objective This paper describes the protocol for the Continuous
   Observations of Behavioural Risk Factors in Asia study (COBRA). The
   study uses real-time data capture methods to gain a comprehensive
   understanding of eating and movement behaviours, including how these
   differ by socio-demographic characteristics and are shaped by people's
   interaction with their social and physical environment. Methods COBRA is
   an observational study in free-living conditions. We will recruit 1500
   adults aged 21-69 years from a large prospective cohort study. Real-time
   data capture methods will be used for nine consecutive days: an
   ecological momentary assessment app with a global positioning system
   enabled to collect location data, accelerometers to measure movement,
   and wearable sensors to monitor blood glucose levels. Participants
   receive six EMA surveys per day between 8 a.m. and 9.30 p.m. to capture
   information on behavioural risk factors including eating behaviours and
   diet composition movement behaviours (physical activity, sedentary
   behaviour, sleep), and related contextual factors. The second wave of
   ecological momentary assessment surveys with a global positioning system
   enabled will be sent 6 months later. Data will be analysed using
   generalised linear models to examine associations between behavioural
   risk factors and contextual determinants. Discussion Findings from this
   study will advance our understanding of dietary and movement behaviours
   as they occur in real-life and inform the development of personalised
   interventions to prevent chronic diseases.},
Type = {Article},
Affiliation = {Edney, SM (Corresponding Author), Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, 12 Sci Dr 2, Singapore 119260, Singapore.
   Edney, SM (Corresponding Author), Natl Univ Hlth Syst, 12 Sci Dr 2, Singapore 119260, Singapore.
   Edney, Sarah Martine; Park, Su Hyun; Tan, Linda; Chua, Xin Hui; Dickens, Borame Sue Lee; Rebello, Salome A.; Petrunoff, Nick; Muller, Andre Matthias; Tan, Cheun Seng; Mueller-Riemenschneider, Falk; van Dam, Rob M., Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, 12 Sci Dr 2, Singapore 119260, Singapore.
   Edney, Sarah Martine; Park, Su Hyun; Tan, Linda; Chua, Xin Hui; Dickens, Borame Sue Lee; Rebello, Salome A.; Petrunoff, Nick; Muller, Andre Matthias; Tan, Cheun Seng; Mueller-Riemenschneider, Falk; van Dam, Rob M., Natl Univ Hlth Syst, 12 Sci Dr 2, Singapore 119260, Singapore.
   Mueller-Riemenschneider, Falk, Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore.
   Mueller-Riemenschneider, Falk, Charite Univ Med Berlin, Digital Hlth Ctr, Berlin Inst Hlth, Berlin, Germany.
   van Dam, Rob M., George Washington Univ, Milken Inst Publ Hlth, Dept Exercise \& Nutr Sci, Washington, DC USA.},
DOI = {10.1177/20552076221110534},
Article-Number = {20552076221110534},
Keywords = {Precision health; personalised health; chronic disease; experience
   sampling; ambulatory assessment; socio-ecological; ecologically valid},
Keywords-Plus = {ECOLOGICAL MOMENTARY ASSESSMENT; PHYSICAL-ACTIVITY RESEARCH;
   NEIGHBORHOOD WALKABILITY; SEDENTARY BEHAVIOR; HEALTH; VALIDITY; ADULTS;
   FOOD; QUESTIONNAIRE; ASSOCIATIONS},
Research-Areas = {Health Care Sciences \& Services; Public, Environmental \& Occupational
   Health; Medical Informatics},
Web-of-Science-Categories  = {Health Care Sciences \& Services; Health Policy \& Services; Public,
   Environmental \& Occupational Health; Medical Informatics},
Author-Email = {sarah.edney@nus.edu.sg},
Affiliations = {National University of Singapore; National University of Singapore;
   National University of Singapore; Berlin Institute of Health; Free
   University of Berlin; Humboldt University of Berlin; Charite
   Universitatsmedizin Berlin; George Washington University},
Cited-References = {Ahern M, 2011, J RURAL HEALTH, V27, P367, DOI 10.1111/j.1748-0361.2011.00378.x.
   Al-Kubaisy W, 2012, PROCD SOC BEHV, V38, P59, DOI 10.1016/j.sbspro.2012.03.324.
   {[}Anonymous], 2019, SINGAPORE POPULATION.
   {[}Anonymous], 2020, PERFORMANCE DATA FRE.
   Aral S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14753.
   Battelino T, 2019, DIABETES CARE, V42, P1593, DOI 10.2337/dci19-0028.
   Bauer UE, 2014, LANCET, V384, P45, DOI 10.1016/S0140-6736(14)60648-6.
   Bauman AE, 2012, LANCET, V380, P258, DOI 10.1016/S0140-6736(12)60735-1.
   Bilheimer LT, 2010, HEALTH SERV RES, V45, P1489, DOI 10.1111/j.1475-6773.2010.01143.x.
   Boutayeb Abdesslam, 2005, Int J Equity Health, V4, P2, DOI 10.1186/1475-9276-4-2.
   Canadian Society for Exercise Physiology, 2020, CAN 24 HOUR MOV GUID.
   Chaput JP, 2011, OBES REV, V12, pe12, DOI 10.1111/j.1467-789X.2010.00772.x.
   Chaput JP, 2009, INT J OBESITY, V33, P46, DOI 10.1038/ijo.2008.221.
   Chowkwanyun M, 2018, NEW ENGL J MED, V379, P1398, DOI 10.1056/NEJMp1806634.
   Cohen DA, 2000, PREV MED, V30, P146, DOI 10.1006/pmed.1999.0609.
   Day S, 2016, HEALTH RES POLICY SY, V14, DOI 10.1186/s12961-016-0147-7.
   de Keijzer C, 2020, CURR ENV HLTH REP, V7, P65, DOI 10.1007/s40572-020-00264-7.
   Degroote L, 2020, INT J BEHAV NUTR PHY, V17, DOI 10.1186/s12966-020-00932-9.
   Delclòs-Alió X, 2020, LANDSCAPE RES, V45, P520, DOI 10.1080/01426397.2019.1702937.
   Deloitte, 2022, BUSINESS STANDARD.
   Ding D, 2016, LANCET, V388, P1311, DOI 10.1016/S0140-6736(16)30383-X.
   Dolley S, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00068.
   Dunton GF, 2017, EXERC SPORT SCI REV, V45, P48, DOI 10.1249/JES.0000000000000092.
   Fechner E, 2020, NUTR RES, V80, P36, DOI 10.1016/j.nutres.2020.06.001.
   Fitzmaurice G., 2011, Applied Longitudinal Data Analysis, V2nd.
   Flegal KM, 2007, JAMA-J AM MED ASSOC, V298, P2028, DOI 10.1001/jama.298.17.2028.
   Fonken LK, 2014, ENDOCR REV, V35, P648, DOI 10.1210/er.2013-1051.
   Gardner B, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-102.
   Glanz K., 2015, HLTH BEHAV THEORY RE.
   Godino JG, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-421.
   Gosling SD, 2003, J RES PERS, V37, P504, DOI 10.1016/S0092-6566(03)00046-1.
   Green SH, 2015, AM J PREV MED, V49, P50, DOI 10.1016/j.amepre.2015.02.004.
   Grenard JL, 2013, APPETITE, V67, P61, DOI 10.1016/j.appet.2013.03.016.
   Hajna S, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2082-x.
   Hedayatrad L., 2021, J MEAS PHYS BEHAV, V4, P1, DOI DOI 10.1123/JMPB.2019-0075.
   Hekler E, 2020, ANN BEHAV MED, V54, P805, DOI 10.1093/abm/kaaa018.
   Heron KE, 2017, J PEDIATR PSYCHOL, V42, P1087, DOI 10.1093/jpepsy/jsx078.
   Hurvitz PM, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00002.
   Jansson AK, 2019, J SCI MED SPORT, V22, P1335, DOI 10.1016/j.jsams.2019.08.003.
   Jeffers AJ, 2020, EAT WEIGHT DISORD-ST, V25, P1151, DOI 10.1007/s40519-019-00743-3.
   Karlsson J, 2000, INT J OBESITY, V24, P1715, DOI 10.1038/sj.ijo.0801442.
   Kee F, 2020, J EPIDEMIOL COMMUN H, V74, P311, DOI 10.1136/jech-2019-213311.
   Khoury MJ, 2016, AM J PREV MED, V50, P398, DOI 10.1016/j.amepre.2015.08.031.
   Kreuter MW, 1999, ANN BEHAV MED, V21, P276, DOI 10.1007/BF02895958.
   Lee IM, 2013, LANCET, V381, P992, DOI 10.1016/S0140-6736(13)60705-9.
   Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9.
   Liao Y, 2018, JMIR MHEALTH UHEALTH, V6, DOI 10.2196/11181.
   Liao Y, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.4954.
   Liao Y, 2015, INT J BEHAV MED, V22, P51, DOI 10.1007/s12529-014-9400-z.
   Lin YY, 2018, PREV MED, V111, P436, DOI 10.1016/j.ypmed.2017.12.006.
   Mahajan R, 2020, JMIR RES PROTOC, V9, DOI 10.2196/17864.
   Maher JP, 2019, PSYCHOL SPORT EXERC, V41, P153, DOI 10.1016/j.psychsport.2018.01.011.
   Marmot M, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.l251.
   Marmot M, 2015, LANCET, V386, P2442, DOI 10.1016/S0140-6736(15)00150-6.
   Mason KE, 2018, LANCET PUBLIC HEALTH, V3, pE24, DOI 10.1016/S2468-2667(17)30212-8.
   Maugeri A, 2019, NUTRIENTS, V11, DOI 10.3390/nu11112696.
   Menon U, 2019, NURS RES, V68, P99, DOI 10.1097/NNR.0000000000000329.
   Müller AM, 2020, OBES REV, V21, DOI 10.1111/obr.12976.
   Murray CJL., 2020, Lancet, V396, P1223, DOI 10.1016/S0140-6736(20)30752-2.
   Nang EEK, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-141.
   Nelson RJ, 2018, P NUTR SOC, V77, P223, DOI 10.1017/S0029665118000198.
   Neuhouser ML, 2019, NUTR RES, V70, P3, DOI 10.1016/j.nutres.2018.06.002.
   O'Dea S., 2020, NUMBER SMARTPHONE US.
   Obermeyer Z, 2019, SCIENCE, V366, P447, DOI 10.1126/science.aax2342.
   Oertelt-Prigione S, 2012, SEX AND GENDER ASPECTS IN CLINICAL MEDICINE, P9, DOI 10.1007/978-0-85729-832-4\_3.
   Olstad DL, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-030279.
   Park SH, 2022, MENT HEALTH PHYS ACT, V22, DOI 10.1016/j.mhpa.2022.100440.
   Park SH, 2022, NUTRIENTS, V14, DOI 10.3390/nu14020366.
   Parker MN, 2022, PEDIATR OBES, V17, DOI 10.1111/ijpo.12851.
   Payne PRO, 2020, J AM MED INFORM ASSN, V27, P658, DOI 10.1093/jamia/ocaa009.
   PhiIlips CM, 2016, TRENDS ENDOCRIN MET, V27, P189, DOI 10.1016/j.tem.2016.02.001.
   Phillips Susan P, 2005, Int J Equity Health, V4, P11, DOI 10.1186/1475-9276-4-11.
   Plekhanova T., 2020, J Meas Phys Behav, V3, P294, DOI {[}10.1123/jmpb.2019-0047, DOI 10.1123/JMPB.2019-0047].
   Präg P, 2014, EUR SOCIOL REV, V30, P218, DOI 10.1093/esr/jct035.
   Prapavessis H, 2015, PSYCHOL SPORT EXERC, V19, P23, DOI 10.1016/j.psychsport.2015.02.001.
   PRECISE, 2021, PREC HLTH RES SING C.
   Prüss-Ustün A, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.l265.
   Reichert M, 2020, PSYCHOL SPORT EXERC, V50, DOI 10.1016/j.psychsport.2020.101742.
   Rutter H, 2017, LANCET, V390, P2602, DOI 10.1016/S0140-6736(17)31267-9.
   Sallis JF, 2010, J PHYS ACT HEALTH, V7, P533, DOI 10.1123/jpah.7.4.533.
   Sarkar C, 2018, INT J HYG ENVIR HEAL, V221, P458, DOI 10.1016/j.ijheh.2018.01.009.
   Sathyanarayana A, 2016, JMIR MHEALTH UHEALTH, V4, DOI 10.2196/mhealth.6562.
   Schoeppe S, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-016-0454-y.
   Sniehotta FF, 2005, EUR J SOC PSYCHOL, V35, P565, DOI 10.1002/ejsp.258.
   Statistics Singapore, 2020, POP TRENDS.
   Stone A., 2007, The Science of Real-time Data Capture, P1.
   Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100.
   Tong HL, 2021, PREV MED, V148, DOI 10.1016/j.ypmed.2021.106532.
   Tremblay MS, 2016, APPL PHYSIOL NUTR ME, V41, pS311, DOI 10.1139/apnm-2016-0151.
   Vizcaino M, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7745-6.
   von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X.
   Weeramanthri TS, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00121.
   White T, 2019, INT J OBESITY, V43, P2333, DOI 10.1038/s41366-019-0352-x.
   Whitton C, 2017, NUTRIENTS, V9, DOI 10.3390/nu9101059.
   Williams EP, 2015, CURR OBES REP, V4, P363, DOI 10.1007/s13679-015-0169-4.
   Wu Y, 2021, SOC SCI MED, V269, DOI 10.1016/j.socscimed.2020.113601.
   Xu R., 2009, IEEE Press Series on Computational Intelligence.},
Number-of-Cited-References = {97},
Times-Cited = {1},
Unique-ID = {WOS:000827452500001},
}

@article{ WOS:001198591900001,
Author = {Preston, Michael A. and Amoli, Mahmoud Manouchehri and Chukmaitov, Askar
   S. and Krist, Alex H. and Dahman, Bassam},
Title = {The impact of the affordable care act and Medicaid expansion on
   colorectal cancer screening: Evidence from the 5th year of Medicaid
   expansion},
Journal = {CANCER MEDICINE},
Year = {2024},
Volume = {13},
Number = {7},
Month = {APR},
Abstract = {Background: Colorectal cancer screening rates remain suboptimal,
   particularly among low-income populations. Our objective was to evaluate
   the long-term effects of Medicaid expansion on colorectal cancer
   screening. Design, Setting, and Participants: This cross-sectional study
   analyzed data from 354,384 individuals aged 50-64 with an income below
   400\% of the federal poverty level (FPL), who participated in the
   Behavioral Risk Factors Surveillance System from 2010 to 2018. A
   difference-in-difference analysis was employed to estimate the effect of
   Medicaid expansion on colorectal cancer screening. Subgroup analyses
   were conducted for individuals with income up to 138\% of the FPL and
   those with income between 139\% and 400\% of the FPL. The effect of
   Medicaid expansion on colorectal cancer screening was examined during
   the early, mid, and late expansion periods. Main Outcomes and Measures:
   The primary outcome was the likelihood of receiving colorectal cancer
   screening for low-income adults aged 50-64. Results: Medicaid expansion
   was associated with a significant 1.7 percentage point increase in
   colorectal cancer screening rates among adults aged 50-64 with income
   below 400\% of the FPL (p < 0.05). A significant 2.9 percentage point
   increase in colorectal cancer screening was observed for those with
   income up to 138\% the FPL (p < 0.05), while a 1.5 percentage point
   increase occurred for individuals with income between 139\% and 400\% of
   the FPL. The impact of Medicaid expansion on colorectal cancer screening
   varied based on income levels and displayed a time lag for newly
   eligible beneficiaries. Conclusions: Medicaid expansion was found to be
   associated with increased colorectal cancer screening rates among
   low-income individuals aged 50-64. The observed variations in impact
   based on income levels and the time lag for newly eligible beneficiaries
   receiving colorectal cancer screening highlight the need for further
   research and precision public health strategies to maximize the benefits
   of Medicaid expansion on colorectal cancer screening rates.},
Type = {Article},
Affiliation = {Preston, MA (Corresponding Author), Purdue Univ, Dept Pharm Practice, 575 Stadium Mall Dr, W Lafayette, IN 47907 USA.
   Preston, Michael A.; Amoli, Mahmoud Manouchehri; Chukmaitov, Askar S.; Dahman, Bassam, Virginia Commonwealth Univ, Sch Populat Hlth, Dept Hlth Behav \& Policy, Richmond, VA USA.
   Preston, Michael A., Virginia Commonwealth Univ, Massey Canc Ctr Hlth Equ \& Dispar Res, Richmond, VA USA.
   Preston, Michael A., Purdue Univ, Dept Pharm Practice, W Lafayette, IN USA.
   Krist, Alex H., Virginia Commonwealth Univ, Dept Family Med \& Populat Hlth, Richmond, VA USA.
   Preston, Michael A., Purdue Univ, Dept Pharm Practice, 575 Stadium Mall Dr, W Lafayette, IN 47907 USA.},
DOI = {10.1002/cam4.7054},
Article-Number = {e7054},
Keywords = {colorectal cancer screening; health policy; health services research;
   low-income; Medicaid expansion; preventive health services},
Keywords-Plus = {INSURANCE-COVERAGE; HEALTH-INSURANCE},
Research-Areas = {Oncology},
Web-of-Science-Categories  = {Oncology},
Author-Email = {mapreston@purdue.edu},
Affiliations = {Virginia Commonwealth University; Virginia Commonwealth University;
   Purdue University System; Purdue University; Virginia Commonwealth
   University; Purdue University System; Purdue University},
Cited-References = {Ahmad FB, 2021, JAMA-J AM MED ASSOC, V325, P1829, DOI 10.1001/jama.2021.5469.
   Benitez JA, 2018, J RURAL HEALTH, V34, P213, DOI 10.1111/jrh.12284.
   Bibbins-Domingo K, 2016, JAMA-J AM MED ASSOC, V315, P2564, DOI 10.1001/jama.2016.5989.
   Callaway B, 2021, J ECONOMETRICS, V225, P200, DOI 10.1016/j.jeconom.2020.12.001.
   Choi S, 2018, POPUL HEALTH MANAG, V21, P235, DOI 10.1089/pop.2017.0104.
   Cole MB, 2017, HEALTH AFFAIR, V36, P40, DOI 10.1377/hlthaff.2016.0804.
   Courtemanche C, 2018, INQUIRY-J HEALTH CAR, V55, DOI 10.1177/0046958018796361.
   Courtemanche C, 2017, J POLICY ANAL MANAG, V36, P178, DOI 10.1002/pam.21961.
   Eom KY, 2020, PREV MED, V138, DOI 10.1016/j.ypmed.2020.106171.
   Fedewa SA, 2019, AM J PREV MED, V57, P3, DOI 10.1016/j.amepre.2019.02.015.
   Foundation KF, 2019, Status of State Medicaid Expansion Decisions.
   Garrett AB., 2016, WHO GAINED HLTH INSU.
   Health UDo Services H, 2017, US federal poverty guidelines used to determine financial eligibility for certain federal programs.
   Hest R., 2019, Four Methods for Calculating Income as a Percent of the Federal Poverty Guideline (FPG) in the Behavioral Risk Factor Surveillance System (BRFSS). State health Access Data Assistance Center.
   Hoehn RS, 2021, J AM COLL SURGEONS, V232, P146, DOI 10.1016/j.jamcollsurg.2020.10.021.
   Hu SS, 2011, PREV CHRONIC DIS, V8.
   Kalager M, 2018, GASTROENTEROLOGY, V155, P592, DOI 10.1053/j.gastro.2018.07.037.
   Lyu W, 2019, MED CARE, V57, P202, DOI 10.1097/MLR.0000000000001053.
   McGinty EE, 2022, AM J PREV MED, V62, pE11, DOI 10.1016/j.amepre.2021.06.010.
   Powell W, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0226942.
   Preston MA, 2021, CANCER PREV RES, V14, P123, DOI 10.1158/1940-6207.CAPR-20-0028.
   Preston MA, 2018, AM J SURG, V215, P1004, DOI 10.1016/j.amjsurg.2018.02.026.
   Pucheril D, 2018, J UROLOGY, V199, pE1106.
   Ransohoff DF, 2016, JAMA-J AM MED ASSOC, V315, P2529, DOI 10.1001/jama.2016.7990.
   Richardson LC, 2022, PREV CHRONIC DIS, V19, DOI 10.5888/pcd19.220001.
   Sant'Anna PHC, 2020, J ECONOMETRICS, V219, P101, DOI 10.1016/j.jeconom.2020.06.003.
   Siegel RL, 2021, CA-CANCER J CLIN, V71, P7, DOI {[}10.3322/caac.21601, 10.3322/caac.20006, 10.3322/caac.21654, 10.3322/caac.21254, 10.3322/caac.21332, 10.3322/caac.21387, 10.3322/caac.21551, 10.3322/caac.20073].
   Simon K, 2017, J POLICY ANAL MANAG, V36, P390, DOI 10.1002/pam.21972.
   Society AC., 2019, Facts Figures2019: US Cancer Death Rate Has Dropped 27\% in 25Years.
   Soni A, 2022, SOUTH ECON J, V88, P931, DOI 10.1002/soej.12554.
   Soni A, 2020, HEALTH ECON, V29, P1586, DOI 10.1002/hec.4155.
   Soni A, 2017, J RURAL HEALTH, V33, P217, DOI 10.1111/jrh.12234.
   Stewart DB, 2021, JAMA SURG, V156, P708, DOI 10.1001/jamasurg.2021.1939.
   Tummalapalli SL, 2020, MED CARE, V58, P549, DOI 10.1097/MLR.0000000000001307.
   Wehby GL, 2018, HEALTH SERV RES, V53, P1248, DOI 10.1111/1475-6773.12711.
   Wright BJ, 2016, CANCER-AM CANCER SOC, V122, P791, DOI 10.1002/cncr.29802.
   Murphy Sherry L, 2018, NCHS Data Brief, P1.
   Xu MR, 2020, AM J PREV MED, V58, P596, DOI 10.1016/j.amepre.2019.11.018.
   Zerhouni YA, 2019, DIS COLON RECTUM, V62, P97, DOI {[}10.1097/DCR.0000000000001260, 10.1097/dcr.0000000000001260].},
Number-of-Cited-References = {39},
Times-Cited = {0},
Unique-ID = {WOS:001198591900001},
}

@article{ WOS:000493684200003,
Author = {Schaller, Lena and Lauschke, Volker M.},
Title = {The genetic landscape of the human solute carrier (SLC) transporter
   superfamily},
Journal = {HUMAN GENETICS},
Year = {2019},
Volume = {138},
Number = {11-12},
Pages = {1359-1377},
Month = {DEC},
Abstract = {The human solute carrier (SLC) superfamily of transporters is comprised
   of over 400 membrane-bound proteins, and plays essential roles in a
   multitude of physiological and pharmacological processes. In addition,
   perturbation of SLC transporter function underlies numerous human
   diseases, which renders SLC transporters attractive drug targets. Common
   genetic polymorphisms in SLC genes have been associated with
   inter-individual differences in drug efficacy and toxicity. However,
   despite their tremendous clinical relevance, epidemiological data of
   these variants are mostly derived from heterogeneous cohorts of small
   sample size and the genetic SLC landscape beyond these common variants
   has not been comprehensively assessed. In this study, we analyzed
   Next-Generation Sequencing data from 141,456 individuals from seven
   major human populations to evaluate genetic variability, its functional
   consequences, and ethnogeographic patterns across the entire SLC
   superfamily of transporters. Importantly, of the 204,287 exonic
   single-nucleotide variants (SNVs) which we identified, 99.8\% were
   present in less than 1\% of analyzed alleles. Comprehensive
   computational analyses using 13 partially orthogonal algorithms that
   predict the functional impact of genetic variations based on sequence
   information, evolutionary conservation, structural considerations, and
   functional genomics data revealed that each individual genome harbors
   29.7 variants with putative functional effects, of which rare variants
   account for 18\%. Inter-ethnic variability was found to be extensive,
   and 83\% of deleterious SLC variants were only identified in a single
   population. Interestingly, population-specific carrier frequencies of
   loss-of-function variants in SLC genes associated with recessive
   Mendelian disease recapitulated the ethnogeographic variation of the
   corresponding disorders, including cystinuria in Jewish individuals,
   type II citrullinemia in East Asians, and lysinuric protein intolerance
   in Finns, thus providing a powerful resource for clinical geneticists to
   inform about population-specific prevalence and allelic composition of
   Mendelian SLC diseases. In summary, we present the most comprehensive
   data set of SLC variability published to date, which can provide
   insights into inter-individual differences in SLC transporter function
   and guide the optimization of population-specific genotyping strategies
   in the bourgeoning fields of personalized medicine and precision public
   health.},
Type = {Article},
Affiliation = {Lauschke, VM (Corresponding Author), Karolinska Inst, Dept Physiol \& Pharmacol, Sect Pharmacogenet, S-17177 Stockholm, Sweden.
   Schaller, Lena; Lauschke, Volker M., Karolinska Inst, Dept Physiol \& Pharmacol, Sect Pharmacogenet, S-17177 Stockholm, Sweden.},
DOI = {10.1007/s00439-019-02081-x},
EarlyAccessDate = {NOV 2019},
Keywords-Plus = {ORGANIC CATION TRANSPORTER; CHRONIC MYELOID-LEUKEMIA; CRYSTAL-STRUCTURE;
   RENAL CLEARANCE; AMINO-ACIDS; 1 OCT1; VARIANTS; ASSOCIATION; MUTATIONS;
   PHARMACOKINETICS},
Research-Areas = {Genetics \& Heredity},
Web-of-Science-Categories  = {Genetics \& Heredity},
Author-Email = {volker.lauschke@ki.se},
Affiliations = {Karolinska Institutet},
Cited-References = {Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248.
   Ampuero J, 2015, J CLIN VIROL, V68, P56, DOI 10.1016/j.jcv.2015.05.010.
   Anderson CM, 2013, MOL ASPECTS MED, V34, P516, DOI 10.1016/j.mam.2012.07.010.
   Boswell-Casteel RC, 2017, NUCLEOS NUCLEOT NUCL, V36, P7, DOI 10.1080/15257770.2016.1210805.
   Boycott KM, 2013, NAT REV GENET, V14, P681, DOI 10.1038/nrg3555.
   Bray J, 2010, BRIT J CANCER, V102, P1003, DOI 10.1038/sj.bjc.6605587.
   Bush WS, 2016, CLIN PHARMACOL THER, V100, P160, DOI 10.1002/cpt.350.
   Cai LL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17731-1.
   Campbell MC, 2008, ANNU REV GENOM HUM G, V9, P403, DOI 10.1146/annurev.genom.9.081307.164258.
   Cargnin S, 2018, PHARMACOL RES, V131, P244, DOI 10.1016/j.phrs.2018.02.005.
   Carter H, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S3-S3.
   César-Razquin A, 2015, CELL, V162, P478, DOI 10.1016/j.cell.2015.07.022.
   Chen LG, 2010, J PHARMACOL EXP THER, V335, P42, DOI 10.1124/jpet.110.170159.
   Choi JH, 2011, CLIN PHARMACOL THER, V90, P674, DOI 10.1038/clpt.2011.165.
   Choi MK, 2012, BIOPHARM DRUG DISPOS, V33, P170, DOI 10.1002/bdd.1783.
   Choi YH, 2012, PLOS ONE, V7, DOI {[}10.1371/journal.pone.0039927, 10.1371/journal.pone.0046688].
   Chun S, 2009, GENOME RES, V19, P1553, DOI 10.1101/gr.092619.109.
   Corrigan A, 2014, PHARMACOGENOMICS J, V14, P411, DOI 10.1038/tpj.2014.13.
   Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025.
   De Giorgis V, 2013, SEIZURE-EUR J EPILEP, V22, P803, DOI 10.1016/j.seizure.2013.07.003.
   Deng D, 2014, NATURE, V510, P121, DOI 10.1038/nature13306.
   Di Paolo A, 2014, PHARMACOGENOMICS J, V14, P328, DOI 10.1038/tpj.2014.7.
   Doehring A, 2011, PHARMACOGENET GENOM, V21, P289, DOI 10.1097/FPC.0b013e32834412e7.
   Dong CL, 2015, HUM MOL GENET, V24, P2125, DOI 10.1093/hmg/ddu733.
   Drögemöller BI, 2017, JAMA ONCOL, V3, P1558, DOI 10.1001/jamaoncol.2017.0502.
   Dujic T, 2015, DIABETES, V64, P1786, DOI 10.2337/db14-1388.
   Eggermann T, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-19.
   Fernández-Marmiesse A, 2018, CURR MED CHEM, V25, P404, DOI 10.2174/0929867324666170718101946.
   Fredriksson R, 2008, FEBS LETT, V582, P3811, DOI 10.1016/j.febslet.2008.10.016.
   Fujikura K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155552.
   Fujikura K, 2015, PHARMACOGENET GENOM, V25, P584, DOI 10.1097/FPC.0000000000000172.
   Fukuda T, 2013, PHARMACOGENOMICS, V14, P1141, DOI {[}10.2217/PGS.13.94, 10.2217/pgs.13.94].
   Galochkina T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37367-z.
   Gorbunov D, 2008, MOL PHARMACOL, V73, P50, DOI 10.1124/mol.107.040170.
   Gordon AS, 2016, PHARMACOGENET GENOM, V26, P161, DOI 10.1097/FPC.0000000000000202.
   Grabar PB, 2012, PHARMACOGENOMICS, V13, P1583, DOI {[}10.2217/PGS.12.150, 10.2217/pgs.12.150].
   Gulilat M, 2019, BMC MED GENOMICS, V12, DOI 10.1186/s12920-019-0527-2.
   Henrie A, 2018, HUM MUTAT, V39, P1051, DOI 10.1002/humu.23555.
   Höglund PJ, 2011, MOL BIOL EVOL, V28, P1531, DOI 10.1093/molbev/msq350.
   Huang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077223.
   Huang QO, 2010, EUR J CLIN PHARMACOL, V66, P1207, DOI 10.1007/s00228-010-0882-6.
   Ingelman-Sundberg M, 2018, HUM GENOMICS, V12, DOI 10.1186/s40246-018-0157-3.
   Johnson DC, 2011, J CLIN ONCOL, V29, P797, DOI 10.1200/JCO.2010.28.0792.
   Kaniwa N, 2005, DRUG METAB DISPOS, V33, P458, DOI 10.1124/dmd.104.001800.
   Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053.
   Kim JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016331.
   Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892.
   Klein K, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00007.
   Koepsell H, 2013, MOL ASPECTS MED, V34, P413, DOI 10.1016/j.mam.2012.10.010.
   Kozyra M, 2017, GENET MED, V19, P20, DOI 10.1038/gim.2016.33.
   Kwon JS, 2009, ARCH GEN PSYCHIAT, V66, P1233, DOI 10.1001/archgenpsychiatry.2009.155.
   Lanvers-Kaminsky C, 2015, PHARMACOGENOMICS, V16, P323, DOI {[}10.2217/PGS.14.182, 10.2217/pgs.14.182].
   Lauschke VM, 2018, CLIN PHARMACOL THER, V103, P745, DOI 10.1002/cpt.976.
   Lauschke VM, 2016, TRENDS PHARMACOL SCI, V37, P85, DOI 10.1016/j.tips.2015.10.006.
   Lee YS, 2015, ONCOTARGET, V6, P16449, DOI 10.18632/oncotarget.3758.
   Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057.
   Li JC, 2018, NUCLEIC ACIDS RES, V46, P7793, DOI 10.1093/nar/gky678.
   Lima A, 2014, PHARMACOGENOMICS, V15, P807, DOI {[}10.2217/PGS.13.244, 10.2217/pgs.13.244].
   Lin L, 2015, NAT REV DRUG DISCOV, V14, P543, DOI 10.1038/nrd4626.
   Lu YB, 2005, J HUM GENET, V50, P338, DOI 10.1007/s10038-005-0262-8.
   Machiela MJ, 2015, BIOINFORMATICS, V31, P3555, DOI 10.1093/bioinformatics/btv402.
   Makhtar SM, 2018, J GENET, V97, P835, DOI 10.1007/s12041-018-0978-9.
   Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494.
   Moncrieffe H, 2010, PHARMACOGENET GENOM, V20, P665, DOI 10.1097/FPC.0b013e32833f2cd0.
   Mueckler M, 2013, MOL ASPECTS MED, V34, P121, DOI 10.1016/j.mam.2012.07.001.
   Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601.
   Orioli T, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-5865-0.
   Park HJ, 2003, J MED GENET, V40, P242, DOI 10.1136/jmg.40.4.242.
   Park MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125361.
   Pedersen BP, 2013, NATURE, V496, P533, DOI 10.1038/nature12042.
   Pellicer M, 2017, PHARMACOL RES, V120, P133, DOI 10.1016/j.phrs.2017.03.021.
   Popp C, 2005, MOL PHARMACOL, V67, P1600, DOI 10.1124/mol.104.008839.
   PRAS E, 1995, AM J HUM GENET, V56, P1297.
   Qiu HB, 2018, PHARMACOGENOMICS J, V18, P460, DOI 10.1038/tpj.2017.40.
   Quang D, 2015, BIOINFORMATICS, V31, P761, DOI 10.1093/bioinformatics/btu703.
   Rau M, 2013, J HEPATOL, V58, P669, DOI 10.1016/j.jhep.2012.11.027.
   Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407.
   Romero MF, 2013, MOL ASPECTS MED, V34, P159, DOI 10.1016/j.mam.2012.10.008.
   Salin-Cantegrel A, 2011, J BIOL CHEM, V286, P28456, DOI 10.1074/jbc.M111.226894.
   Salinas-Delgado Yvain, 2015, Drug Metabolism and Personalized Therapy, V30, P211, DOI 10.1515/dmpt-2015-0019.
   Santos M, 2018, GENET MED, V20, P622, DOI 10.1038/gim.2017.156.
   Schlessinger A, 2013, CLIN PHARMACOL THER, V94, P19, DOI 10.1038/clpt.2013.73.
   Seitz T, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0172-0.
   Shihab HA, 2015, BIOINFORMATICS, V31, P1536, DOI 10.1093/bioinformatics/btv009.
   Shihab HA, 2013, HUM MUTAT, V34, P57, DOI 10.1002/humu.22225.
   Shin SW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111887.
   Shu Y, 2003, P NATL ACAD SCI USA, V100, P5902, DOI 10.1073/pnas.0730858100.
   Shu Y, 2007, J CLIN INVEST, V117, P1422, DOI 10.1172/JCI30558.
   Song IS, 2008, CLIN PHARMACOL THER, V84, P559, DOI 10.1038/clpt.2008.61.
   Soo RA, 2009, LUNG CANCER, V63, P121, DOI 10.1016/j.lungcan.2008.04.010.
   Stocker SL, 2013, CLIN PHARMACOL THER, V93, P186, DOI 10.1038/clpt.2012.210.
   Sundelin EIO, 2017, CLIN PHARMACOL THER, V102, P841, DOI 10.1002/cpt.701.
   Suthandiram S, 2014, PHARMACOGENOMICS, V15, P1479, DOI {[}10.2217/PGS.14.97, 10.2217/pgs.14.97].
   Tarasova L, 2012, PHARMACOGENET GENOM, V22, P659, DOI 10.1097/FPC.0b013e3283561666.
   Tecza Karolina, 2018, Oncotarget, V9, P9114, DOI 10.18632/oncotarget.24148.
   Thornton JK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023878.
   Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257.
   Todd JN, 2014, PHARMACOGENOMICS, V15, P529, DOI {[}10.2217/pgs.14.21, 10.2217/PGS.14.21].
   Torrents D, 1999, NAT GENET, V21, P293, DOI 10.1038/6809.
   Tzvetkov MV, 2012, PHARMACOGENOMICS J, V12, P22, DOI 10.1038/tpj.2010.75.
   Tzvetkov MV, 2011, CLIN PHARMACOL THER, V90, P143, DOI 10.1038/clpt.2011.56.
   Tzvetkov MV, 2017, PHARMACOGENOMICS, V18, P1515, DOI 10.2217/pgs-2017-0095.
   Tzvetkov MV, 2014, BLOOD, V123, P1427, DOI 10.1182/blood-2013-11-535864.
   Tzvetkov MV, 2013, BIOCHEM PHARMACOL, V86, P666, DOI 10.1016/j.bcp.2013.06.019.
   Urban TJ, 2008, CLIN PHARMACOL THER, V83, P416, DOI 10.1038/sj.clpt.6100271.
   Visscher H, 2015, PHARMACOGENOMICS, V16, P1065, DOI {[}10.2217/pgs.15.61, 10.2217/PGS.15.61].
   Volk C, 2009, MOL PHARMACOL, V76, P275, DOI 10.1124/mol.109.054783.
   Vormfelde SV, 2007, CLIN PHARMACOL THER, V82, P300, DOI 10.1038/sj.clpt.6100131.
   Wang SM, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0062-0.
   Watkins DB, 2015, LEUKEMIA, V29, P1960, DOI 10.1038/leu.2015.170.
   Wevers RA, 2019, J INHERIT METAB DIS, V42, P494, DOI 10.1002/jimd.12081.
   Wright GEB, 2018, PHARMACOGENOMICS J, V18, P187, DOI 10.1038/tpj.2016.77.
   Wright NJ, 2019, NAT STRUCT MOL BIOL, V26, P599, DOI 10.1038/s41594-019-0245-7.
   Yan N, 2013, TRENDS BIOCHEM SCI, V38, P151, DOI 10.1016/j.tibs.2013.01.003.
   Yee SW, 2013, J PHARM SCI-US, V102, P3451, DOI 10.1002/jps.23581.
   Yoon H, 2013, AAPS J, V15, P571, DOI 10.1208/s12248-013-9460-z.
   Zhang BY, 2019, PHARMACOL RES, V139, P550, DOI 10.1016/j.phrs.2018.10.017.
   Zhou YT, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01437.
   Zhou YT, 2019, PHARMACOGENOMICS J, V19, P115, DOI 10.1038/s41397-018-0044-2.
   Zhou YT, 2018, J MED GENET, V55, P617, DOI 10.1136/jmedgenet-2018-105429.},
Number-of-Cited-References = {120},
Times-Cited = {69},
Unique-ID = {WOS:000493684200003},
}

@article{ WOS:000789147100001,
Author = {Powell, W. Ryan and Hansmann, Kellia J. and Carlson, Andrew and Kind,
   Amy J. H.},
Title = {Evaluating How Safety-Net Hospitals Are Identified: Systematic Review
   and Recommendations},
Journal = {HEALTH EQUITY},
Year = {2022},
Volume = {6},
Number = {1},
Pages = {298-306},
Month = {APR 1},
Abstract = {Objective: To systematically review how safety-net hospitals' status is
   identified and defined, discuss current definitions' limitations, and
   provide recommendations for a new classification and evaluation
   framework.Data Sources: Safety-net hospital-related studies in the
   MEDLINE database published before May 16, 2019.Study Design: Systematic
   review of the literature that adheres to Preferred Reporting Items for
   Systematic Reviews and Meta-Analyses (PRISMA) guidelines.Data
   Collection/Extraction Methods: We followed standard selection protocol,
   whereby studies went through an abstract review followed by a full-text
   screening for eligibility. For each included study, we extracted
   information about the identification method itself, including the
   operational definition, the dimension(s) of disadvantage reflected,
   study objective, and how safety-net status was evaluated.Principal
   Findings: Our review identified 132 studies investigating safety-net
   hospitals. Analysis of identification methodologies revealed substantial
   heterogeneity in the ways disadvantage is defined, measured, and
   summarized at the hospital level, despite a 4.5-fold increase in studies
   investigating safety-net hospitals for the past decade. Definitions
   often exclusively used low-income proxies captured within existing
   health system data, rarely incorporated external social risk factor
   measures, and were commonly separated into distinct safety-net status
   categories when analyzed.Conclusions: Consistency in research and
   improvement in policy both require a standard definition for identifying
   safety-net hospitals. Yet no standardized definition of safety-net
   hospitals is endorsed and existing definitions have key limitations.
   Moving forward, approaches rooted in health equity theory can provide a
   more holistic framework for evaluating disadvantage at the hospital
   level. Furthermore, advancements in precision public health technologies
   make it easier to incorporate detailed neighborhood-level social
   determinants of health metrics into multidimensional definitions. Other
   countries, including the United Kingdom and New Zealand, have used
   similar methods of identifying social need to determine more accurate
   assessments of hospital performance and the development of policies and
   targeted programs for improving outcomes.},
Type = {Review},
Affiliation = {Powell, WR (Corresponding Author), Univ Wisconsin, Publ Hlth Ctr Hlth Dispar Res, Sch Med, 600 Highland Ave, Madison, WI 53705 USA.
   Powell, W. Ryan; Hansmann, Kellia J.; Kind, Amy J. H., Univ Wisconsin, Publ Hlth Ctr Hlth Dispar Res, Sch Med, 600 Highland Ave, Madison, WI 53705 USA.
   Hansmann, Kellia J., Univ Wisconsin, Sch Med, Dept Family Med \& Community Hlth Publ Hlth, Madison, WI USA.
   Carlson, Andrew, Univ Wisconsin, Sch Med \& Publ Hlth, Madison, WI USA.
   Kind, Amy J. H., Univ Wisconsin, Sch Med \& Publ Hlth, Dept Med, Geriatr Div, Madison, WI USA.},
DOI = {10.1089/heq.2021.0076},
Keywords = {safety-net hospital; socioeconomic disadvantage; social determinants of
   health; health equity; health policy; hospital performance},
Keywords-Plus = {SOCIOECONOMIC-STATUS; PUBLIC-HEALTH; MEDICAID EXPANSION; FUNDAMENTAL
   CAUSES; SOCIAL CONDITIONS; READMISSION; DISPARITIES; RISK; QUALITY;
   DISADVANTAGE},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {rpowell@medicine.wisc.edu},
Affiliations = {University of Wisconsin System; University of Wisconsin Madison;
   University of Wisconsin System; University of Wisconsin Madison;
   University of Wisconsin System; University of Wisconsin Madison;
   University of Wisconsin System; University of Wisconsin Madison},
Cited-References = {Arbaje AI, 2008, GERONTOLOGIST, V48, P495, DOI 10.1093/geront/48.4.495.
   Barnett ML, 2015, JAMA INTERN MED, V175, P1803, DOI 10.1001/jamainternmed.2015.4660.
   Bazzoli GJ, 2003, INQUIRY-J HEALTH CAR, V40, P6, DOI 10.5034/inquiryjrnl\_40.1.6.
   Bazzoli GJ, 2012, HEALTH SERV RES, V47, P129, DOI 10.1111/j.1475-6773.2011.01318.x.
   Berenson Julia, 2012, Issue Brief (Commonw Fund), V34, P1.
   Bernheim SM, 2016, HEALTH AFFAIR, V35, P1461, DOI 10.1377/hlthaff.2015.0394.
   Buntin MB, 2017, NEW ENGL J MED, V376, P507, DOI 10.1056/NEJMp1700081.
   Centers for Medicare and Medicaid Services, 2019, Hospital Readmissions Reduction Program (HRRP).
   Chatterjee P, 2020, NEW ENGL J MED, V383, P2593, DOI 10.1056/NEJMp2030228.
   Chatterjee P, 2019, HEALTH SERV RES, V54, P324, DOI 10.1111/1475-6773.13131.
   Chatterjee P, 2012, ARCH INTERN MED, V172, P1204, DOI 10.1001/archinternmed.2012.3158.
   Dranove David, 2017, Issue Brief (Commonw Fund), V12, P1.
   Dranove D, 2016, HEALTH AFFAIR, V35, P1471, DOI 10.1377/hlthaff.2015.1344.
   DuGoff E, 2018, HOSP READMISSION RED, DOI {[}10.1377/hblog20140814.040725/full/, DOI 10.1377/HBLOG20140814.040725/FULL].
   Foraker RE, 2011, CIRC-HEART FAIL, V4, P308, DOI 10.1161/CIRCHEARTFAILURE.110.959031.
   Ford CL, 2010, AM J PUBLIC HEALTH, V100, pS30, DOI 10.2105/AJPH.2009.171058.
   Frieden TR, 2010, AM J PUBLIC HEALTH, V100, P590, DOI 10.2105/AJPH.2009.185652.
   Glance LG, 2016, ANN SURG, V263, P698, DOI 10.1097/SLA.0000000000001363.
   Golden B, 2021, JAMA INTERN MED, V181, P1304, DOI 10.1001/jamainternmed.2021.4269.
   Gottlieb L, 2019, J HEALTHC MANAG, V64, P243, DOI 10.1097/JHM-D-18-00160.
   Grubesic Tony H, 2006, Int J Health Geogr, V5, P58, DOI 10.1186/1476-072X-5-58.
   Hammond G, 2019, JAMA CARDIOL, V4, P1189, DOI 10.1001/jamacardio.2019.3805.
   Hardeman RR, 2020, HEALTH SERV RES, V55, P777, DOI 10.1111/1475-6773.13558.
   Hill CV, 2015, ETHNIC DIS, V25, P245, DOI 10.18865/ed.25.3.245.
   Jha AK, 2014, JAMA-J AM MED ASSOC, V312, P225, DOI 10.1001/jama.2014.7204.
   Johnston KJ, 2020, HEALTH AFFAIR, V39, P1504, DOI 10.1377/hlthaff.2020.00350.
   Joynt KE, 2013, NEW ENGL J MED, V368, P1175, DOI 10.1056/NEJMp1300122.
   Joynt KE, 2013, INCIDENTAL EC.
   Kangovi S, 2014, J GEN INTERN MED, V29, P283, DOI 10.1007/s11606-013-2571-5.
   Kangovi S, 2012, J HOSP MED, V7, P709, DOI 10.1002/jhm.1966.
   Kind AJH, 2018, NEW ENGL J MED, V378, P2456, DOI 10.1056/NEJMp1802313.
   Kind AJH, 2014, ANN INTERN MED, V161, P765, DOI 10.7326/M13-2946.
   Krieger N, 2003, J EPIDEMIOL COMMUN H, V57, P186, DOI 10.1136/jech.57.3.186.
   Krieger N, 2002, AM J PUBLIC HEALTH, V92, P1100, DOI 10.2105/AJPH.92.7.1100.
   Krumholz HM, 2014, ANN INTERN MED, V161, P833, DOI 10.7326/M14-2308.
   Krumholz HM, 2013, INCIDENTAL EC.
   LINK BG, 1995, J HEALTH SOC BEHAV, V35, P80, DOI 10.2307/2626958.
   Maddox KEJ, 2019, HEALTH SERV RES, V54, P327, DOI 10.1111/1475-6773.13133.
   Mazurenko O, 2018, HEALTH AFFAIR, V37, P944, DOI 10.1377/hlthaff.2017.1491.
   McCarthy CP, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.2987.
   McHugh M, 2009, MED CARE RES REV, V66, P590, DOI 10.1177/1077558709334895.
   Nagasako EM, 2014, HEALTH AFFAIR, V33, P786, DOI 10.1377/hlthaff.2013.1148.
   National Academies of Sciences Engineering and Medicine., 2019, ACCOUNTING SOCIAL RI.
   Neuhausen K, 2014, HEALTH AFFAIR, V33, P988, DOI 10.1377/hlthaff.2013.1222.
   Nguyen CA, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.0838.
   Office of Disease Prevention and Health Promotion, HLTH PEOPL 2020 SOC.
   Office of Disease Prevention and Health Promotion, 2020, HLTH PEOPL 2020 SOC.
   Office of the Assistant Secretary for Planning and Evaluation, 2016, SOC RISK FACT MED VA.
   Phelan JC, 2010, J HEALTH SOC BEHAV, V51, pS28, DOI 10.1177/0022146510383498.
   Popescu I, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.8577.
   Ross JS, 2012, HEALTH AFFAIR, V31, P1739, DOI 10.1377/hlthaff.2011.1028.
   Wadhera RK, 2019, NEW ENGL J MED, V380, P2289, DOI 10.1056/NEJMp1901225.
   Wiener JM., 2013, Medicaid Spend Down: New Estimates and Implications for Long-‐Term Services and Supports Financing Reform.
   Zuckerman RB, 2017, NEW ENGL J MED, V377, P1551, DOI 10.1056/NEJMsa1701791.
   Zwanziger J, 2008, MED CARE RES REV, V65, P478, DOI 10.1177/1077558708315440.
   Zwanziger J, 2006, MED CARE RES REV, V63, p90S, DOI 10.1177/1077558706293838.},
Number-of-Cited-References = {56},
Times-Cited = {5},
Unique-ID = {WOS:000789147100001},
}

@article{ WOS:000974977600010,
Author = {Yezli, Saber and Khan, Altaf H. and Yassin, Yara M. and Khan, Anas A.
   and Alotaibi, Badriah M. and Bouchama, Abderrezak},
Title = {Association of Ambient Temperature with Mortality in Resident and
   Multiethnic Transient Populations in a Desert Climate, 2006-2014},
Journal = {ENVIRONMENTAL HEALTH PERSPECTIVES},
Year = {2023},
Volume = {131},
Number = {4},
Month = {APR},
Abstract = {BACKGROUND: Although the association between ambient temperature and
   mortality in local populations is evident, this relationship remains
   unclear in transient populations (e.g., due to immigration, mass
   gatherings, or displacement). The holy city of Mecca annually shelters
   two populations comprising its residents and the transitory Hajj
   pilgrims (>2 million people from >180 countries). Both live side by side
   in a hot desert climate, rendering the development of evidence-based
   heat-protective measures challenging. OBJECTIVES: We aimed to
   characterize the ambient temperature-mortality relationship and burden
   for the Mecca resident and Hajj transient populations, which have
   distinct levels of adaptation to ambient temperature. METHODS: We
   analyzed daily air temperature and mortality data for Mecca residents
   and pilgrims over nine Hajj seasons between 2006 and 2014, using a
   fitted standard time-series Poisson model. We characterized the
   temperature-mortality relationship with a distributed lag nonlinear
   model with 10 d of lag. We determined the minimum mortality temperature
   (MMT) and attributable deaths for heat and cold for the two populations.
   RESULTS: The median average daily temperature during the Hajj seasons
   was 30 degrees C (19 degrees C-37 degrees C). There were 8,543 and
   10,457 nonaccidental deaths reported during the study period among Mecca
   residents and pilgrims, respectively. The MMT was 2.5 degrees C lower
   for pilgrims in comparison with the MMT for Mecca residents (23.5
   degrees C vs. 26.0 degrees C). The temperature-mortality relationship
   shape varied from inverted J to U shape for the Mecca and pilgrim
   populations, respectively. Neither hot nor cold temperatures had a
   statistically significant association with mortality in Mecca residents.
   In contrast, for pilgrims, elevated temperatures were associated with
   significantly high attributable mortality of 70.8\% {[}95\% confidence
   interval (CI): 62.8, 76.0]. The effect of heat on pilgrims was immediate
   and sustained. DISCUSSION: Our findings indicate that pilgrims and Mecca
   residents exposed to the same hot environmental conditions exhibited
   distinct health outcomes. This conclusion suggests that a precision
   public health approach may be warranted to protect against high
   environmental temperature during mass gatherings of diverse populations.
   https://doi.org/10.1289/EHP9838},
Type = {Article},
Affiliation = {Yezli, S (Corresponding Author), Minist Hlth, Global Ctr Mass Gatherings Med, Riyadh, Saudi Arabia.
   Yezli, S (Corresponding Author), King Faisal Specialist Hosp \& Res Ctr, Biostat Epidemiol \& Sci Comp Dept, Riyadh, Saudi Arabia.
   Yezli, S (Corresponding Author), King Saud bin Abdulaziz Univ Hlth Sci, King Abdullah Int Med Res Ctr, Expt Med Dept, Riyadh, Saudi Arabia.
   Yezli, Saber; Yassin, Yara M.; Khan, Anas A.; Alotaibi, Badriah M., Minist Hlth, Global Ctr Mass Gatherings Med, Riyadh, Saudi Arabia.
   Yezli, Saber, King Faisal Specialist Hosp \& Res Ctr, Biostat Epidemiol \& Sci Comp Dept, Riyadh, Saudi Arabia.
   Yezli, Saber; Bouchama, Abderrezak, King Saud bin Abdulaziz Univ Hlth Sci, King Abdullah Int Med Res Ctr, Expt Med Dept, Riyadh, Saudi Arabia.
   Khan, Altaf H., King Saud bin Abdulaziz Univ Hlth Sci, King Abdullah Int Med Res Ctr, Dept Biostat \& Bioinformat, Riyadh, Saudi Arabia.
   Khan, Anas A., King Saud Univ, Coll Med, Dept Emergency Med, Riyadh, Saudi Arabia.},
DOI = {10.1289/EHP9838},
Article-Number = {047004},
Keywords-Plus = {HEAT; PILGRIMAGE},
Research-Areas = {Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health; Toxicology},
Web-of-Science-Categories  = {Environmental Sciences; Public, Environmental \& Occupational Health;
   Toxicology},
Author-Email = {saber.yezli@gmail.com},
Affiliations = {Ministry of Health - Saudi Arabia; King Faisal Specialist Hospital \&
   Research Center; King Saud Bin Abdulaziz University for Health Sciences;
   King Abdullah International Medical Research Center (KAIMRC); King Saud
   Bin Abdulaziz University for Health Sciences; King Abdullah
   International Medical Research Center (KAIMRC); King Saud University},
Cited-References = {Abdou AEA., 2014, Atmos Clim Sci, V04, P457, DOI {[}10.4236/acs.2014.43044, DOI 10.4236/ACS.2014.43044].
   Alahmad B, 2020, SCI TOTAL ENVIRON, V732, DOI 10.1016/j.scitotenv.2020.139289.
   Arbuthnott K, 2016, ENVIRON HEALTH-GLOB, V15, DOI 10.1186/s12940-016-0102-7.
   Berko Jeffrey, 2014, Natl Health Stat Report, P1.
   Bouchama A, 2002, NEW ENGL J MED, V346, P1978, DOI 10.1056/NEJMra011089.
   Braga ALF, 2001, EPIDEMIOLOGY, V12, P662.
   Chen RJ, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4306.
   Cheng J, 2019, INT J BIOMETEOROL, V63, P1099, DOI 10.1007/s00484-019-01716-y.
   Dang TN, 2016, GLOBAL HEALTH ACTION, V9, DOI 10.3402/gha.v9.28738.
   Gasparrini A., 2021, DISTRIBUTED LAG LINE.
   Gasparrini A, 2015, LANCET, V386, P369, DOI 10.1016/S0140-6736(14)62114-0.
   Gasparrini A, 2017, LANCET PLANET HEALTH, V1, pE360, DOI 10.1016/S2542-5196(17)30156-0.
   Gasparrini A, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-55.
   Gasparrini A, 2011, J STAT SOFTW, V43, P1, DOI 10.18637/jss.v043.i08.
   GHAZNAWI HI, 1987, ANN SAUDI MED, V7, P323, DOI 10.5144/0256-4947.1987.323.
   Guo YM, 2017, ENVIRON HEALTH PERSP, V125, DOI 10.1289/EHP1026.
   Guo YM, 2014, EPIDEMIOLOGY, V25, P781, DOI 10.1097/EDE.0000000000000165.
   Ha J, 2011, SCI TOTAL ENVIRON, V409, P3274, DOI 10.1016/j.scitotenv.2011.05.034.
   Hajat S, 2005, EPIDEMIOLOGY, V16, P613, DOI 10.1097/01.ede.0000164559.41092.2a.
   Han J, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014741.
   Kang S, 2019, GEOPHYS RES LETT, V46, P10094, DOI 10.1029/2019GL083686.
   Keatinge WR, 2000, BRIT MED J, V321, P670, DOI 10.1136/bmj.321.7262.670.
   Leon LR, 2015, COMPR PHYSIOL, V5, P611, DOI 10.1002/cphy.c140017.
   Moghadamnia MT, 2017, PEERJ, V5, DOI 10.7717/peerj.3574.
   Tagliacozzo Eric., 2016, The Hajj: Pilgrimage in Islam.
   Tobías A, 2017, EPIDEMIOLOGY, V28, P72, DOI 10.1097/EDE.0000000000000567.
   Vicedo-Cabrera AM, 2021, NAT CLIM CHANGE, V11, P492, DOI 10.1038/s41558-021-01058-x.
   Yezli S, 2023, REV ENVIRON HEALTH, V38, P33, DOI 10.1515/reveh-2021-0097.
   Yezli S, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18031155.
   Yezli S, 2019, J TRAVEL MED, V26, DOI 10.1093/jtm/taz069.
   Yin Q, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12663-y.
   Zeng J, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14111383.},
Number-of-Cited-References = {32},
Times-Cited = {4},
Unique-ID = {WOS:000974977600010},
}

@article{ WOS:000925734000114,
Author = {Maison, David P. and Cleveland, Sean B. and Nerurkar, Vivek R.},
Title = {Genomic analysis of SARS-CoV-2 variants of concern circulating in
   Hawai'i to facilitate public-health policies},
Journal = {PLOS ONE},
Year = {2022},
Volume = {17},
Number = {12},
Month = {DEC 1},
Abstract = {Using genomics, bioinformatics and statistics, herein we demonstrate the
   effect of statewide and nationwide quarantine on the introduction of
   SARS-CoV-2 variants of concern (VOC) in Hawai'i. To define the origins
   of introduced VOC, we analyzed 260 VOC sequences from Hawai'i, and
   301,646 VOC sequences worldwide, deposited in the GenBank and global
   initiative on sharing all influenza data (GISAID), and constructed
   phylogenetic trees. The trees define the most recent common ancestor as
   the origin. Further, the multiple sequence alignment used to generate
   the phylogenetic trees identified the consensus single nucleotide
   polymorphisms in the VOC genomes. These consensus sequences allow for
   VOC comparison and identification of mutations of interest in relation
   to viral immune evasion and host immune activation. Of note is the P71L
   substitution within the E protein, the protein sensed by TLR2 to produce
   cytokines, found in the B.1.351 VOC may diminish the efficacy of some
   vaccines. Based on the phylogenetic trees, the B.1.1.7, B.1.351,
   B.1.427, and B.1.429 VOC have been introduced in Hawai'i multiple times
   since December 2020 from several definable geographic regions. From the
   first worldwide report of VOC in GenBank and GISAID, to the first
   arrival of VOC in Hawai'i, averages 320 days with quarantine, and 132
   days without quarantine. As such, the effect of quarantine is shown to
   significantly affect the time to arrival of VOC in Hawai'i. Further, the
   collective 2020 quarantine of 43-states in the United States
   demonstrates a profound impact in delaying the arrival of VOC in states
   that did not practice quarantine, such as Utah. Our data demonstrates
   that at least 76\% of all definable SARS-CoV-2 VOC have entered Hawai'i
   from California, with the B.1.351 variant in Hawai'i originating
   exclusively from the United Kingdom. These data provide a foundation for
   policy-makers and public-health officials to apply precision public
   health genomics to real-world policies such as mandatory screening and
   quarantine.},
Type = {Article},
Affiliation = {Maison, DP; Nerurkar, VR (Corresponding Author), Univ Hawaii Syst, Dept Trop Med Med Microbiol \& Pharmacol, Honolulu, HI 96822 USA.
   Maison, DP; Nerurkar, VR (Corresponding Author), Univ Hawaii Syst, Pacific Ctr Emerging Infect Dis Res, Honolulu, HI 96822 USA.
   Maison, DP; Nerurkar, VR (Corresponding Author), Univ Hawaii Syst, John A Burns Sch Med, Honolulu, HI 96822 USA.
   Maison, David P.; Nerurkar, Vivek R., Univ Hawaii Syst, Dept Trop Med Med Microbiol \& Pharmacol, Honolulu, HI 96822 USA.
   Maison, David P.; Nerurkar, Vivek R., Univ Hawaii Syst, Pacific Ctr Emerging Infect Dis Res, Honolulu, HI 96822 USA.
   Maison, David P.; Nerurkar, Vivek R., Univ Hawaii Syst, John A Burns Sch Med, Honolulu, HI 96822 USA.
   Cleveland, Sean B., Univ Hawaii Syst, Hawaii Data Sci Inst, Honolulu, HI USA.
   Cleveland, Sean B., Univ Hawaii Syst, Informat Technol Serv Cyberinfrastruct, Honolulu, HI USA.},
DOI = {10.1371/journal.pone.0278287},
Article-Number = {e0278287},
Keywords-Plus = {ALIGNMENT; SPIKE},
Research-Areas = {Science \& Technology - Other Topics},
Web-of-Science-Categories  = {Multidisciplinary Sciences},
Author-Email = {davidm22@hawaii.edu
   nerurkar@hawaii.edu},
Affiliations = {University of Hawaii System; University of Hawaii System; University of
   Hawaii System; University of Hawaii System; University of Hawaii System},
Cited-References = {{[}Anonymous], 2021, CORONAVIRUS CLOSURES.
   {[}Anonymous], 2021, PANG VERS V 3 0 5.
   Aparicio-Puerta E, 2019, NUCLEIC ACIDS RES, V47, pW530, DOI 10.1093/nar/gkz415.
   Aragon T. J., 2021, CALIFORNIA DEP PUBLI.
   Consillio BK., 2021, HONOLULU STAR A 0308.
   Deng XD, 2021, CELL, V184, P3426, DOI 10.1016/j.cell.2021.04.025.
   Engelbrecht S., 2020, VIRUS NAME HCOV 19 S.
   Gangavarapu K., 2020, VIRUS NAME HCOV 19ME.
   Ginestet C, 2011, J ROY STAT SOC A, V174, P245, DOI 10.1111/j.1467-985X.2010.00676\_9.x.
   Gorzalski A., 2020, VIRUS NAME HCOV 19 U.
   Hernandez M., 2020, VIRUS NAME HCOV 19 S.
   Ige D., 2020, THIRTEENTH PROCLAMATION RELATED TO THE COVID-19 EMERGENCY.
   Ige D., 2020, EIGHTH SUPPLEMENTARY PROCLAMATION RELATED TO THE COVID-19 EMERGENCY.
   Ige D., 2020, 3 SUPPLEMENTARY PROC, P8.
   Jangra Sonia, 2021, medRxiv, DOI 10.1101/2021.01.26.21250543.
   Katoh K, 2019, BRIEF BIOINFORM, V20, P1160, DOI 10.1093/bib/bbx108.
   Korber B, 2020, CELL, V182, P812, DOI 10.1016/j.cell.2020.06.043.
   Larsson A, 2014, BIOINFORMATICS, V30, P3276, DOI 10.1093/bioinformatics/btu531.
   Li QQ, 2020, CELL, V182, P1284, DOI 10.1016/j.cell.2020.07.012.
   Lund, 2021, TIMELINE ITS BEEN ON.
   Madhi SA, 2021, NEW ENGL J MED, V384, P1885, DOI 10.1056/NEJMoa2102214.
   Maison David P, 2021, Hawaii J Health Soc Welf, V80, P52, DOI 10.1101/2021.01.06.425497.
   Mattison S., 2021, KHON2 0622.
   Miller FD, 2021, INT J INFECT DIS, V103, P298, DOI 10.1016/j.ijid.2020.11.201.
   O'Toole A, 2021, VIRUS EVOL, V7, DOI 10.1093/ve/veab064.
   Munnink BOB, 2020, NAT MED, V26, DOI 10.1038/s41591-020-0997-y.
   Patil I., 2021, Journal of Open Source Software, V6, P3167, DOI DOI 10.21105/JOSS.03167.
   Plante JA, 2021, NATURE, V592, P116, DOI 10.1038/s41586-020-2895-3.
   Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077.
   Rahman MS, 2021, GENE REP, V22, DOI 10.1016/j.genrep.2020.100997.
   Rambaut A, 2020, NAT MICROBIOL, V5, P1403, DOI 10.1038/s41564-020-0770-5.
   Rozewicki J, 2019, NUCLEIC ACIDS RES, V47, pW5, DOI 10.1093/nar/gkz342.
   Sacchi CT., 2020, VIRUS NAME HCOV 19 B.
   Scobie H., 2021, ACIP M MAY 12 CDC.
   State of Hawaii D of H, 2022, RAC ETHN DAT DOH DIS.
   State of Hawaii Department of Health D of H., 2020, COVID 19 DAIL UP MAR.
   Team R.C., 2021, R LANG ENV STAT COMP.
   Tsai WY, 2021, EMERG MICROBES INFEC, V10, P894, DOI 10.1080/22221751.2021.1925163.
   United States Department of State, 2020, HAW STAY AT HOM ORD, P2.
   Wang PF, 2021, NATURE, V593, P130, DOI 10.1038/s41586-021-03398-2.
   Weissman D, 2021, CELL HOST MICROBE, V29, P23, DOI 10.1016/j.chom.2020.11.012.
   Wu N., 2021, HONOLULU STAR A 0226.
   Shi Pei-Yong, 2021, Res Sq, DOI {[}10.1101/2021.01.07.425740, 10.21203/rs.3.rs-143532/v1].
   Xie XP, 2020, CELL HOST MICROBE, V27, P841, DOI 10.1016/j.chom.2020.04.004.
   Zheng M, 2021, NAT IMMUNOL, V22, P829, DOI 10.1038/s41590-021-00937-x.},
Number-of-Cited-References = {45},
Times-Cited = {0},
Unique-ID = {WOS:000925734000114},
}

@article{ WOS:000739050500019,
Author = {Dhaliwal, Bandna and Neil-Sztramko, Sarah E. and Boston-Fisher, Nikita
   and Buckeridge, David L. and Dobbins, Maureen},
Title = {Assessing the Electronic Evidence System Needs of Canadian Public Health
   Professionals: Cross-sectional Study},
Journal = {JMIR PUBLIC HEALTH AND SURVEILLANCE},
Year = {2021},
Volume = {7},
Number = {9},
Month = {SEP},
Abstract = {Background: True evidence-informed decision-making in public health
   relies on incorporating evidence from a number of sources in addition to
   traditional scientific evidence. Lack of access to these types of data
   as well as ease of use and interpretability of scientific evidence
   contribute to limited uptake of evidence-informed decision-making in
   practice. An electronic evidence system that includes multiple sources
   of evidence and potentially novel computational processing approaches or
   artificial intelligence holds promise as a solution to overcoming
   barriers to evidence-informed decision-making in public health.
   Objective: This study aims to understand the needs and preferences for
   an electronic evidence system among public health professionals in
   Canada. Methods: An invitation to participate in an anonymous web-based
   survey was distributed via listservs of 2 Canadian public health
   organizations in February 2019. Eligible participants were English-or
   French-speaking individuals currently working in public health. The
   survey contained both multiple-choice and open-ended questions about the
   needs and preferences relevant to an electronic evidence system.
   Quantitative responses were analyzed to explore differences by public
   health role. Inductive and deductive analysis methods were used to code
   and interpret the qualitative data. Ethics review was not required by
   the host institution. Results: Respondents (N=371) were heterogeneous,
   spanning organizations, positions, and areas of practice within public
   health. Nearly all (364/371, 98.1\%) respondents indicated that an
   electronic evidence system would support their work. Respondents had
   high preferences for local contextual data, research and intervention
   evidence, and information about human and financial resources.
   Qualitative analyses identified several concerns, needs, and suggestions
   for the development of such a system. Concerns ranged from the personal
   use of such a system to the ability of their organization to use such a
   system. Recognized needs spanned the different sources of evidence,
   including local context, research and intervention evidence, and
   resources and tools. Additional suggestions were identified to improve
   system usability. Conclusions: Canadian public health professionals have
   positive perceptions toward an electronic evidence system that would
   bring together evidence from the local context, scientific research, and
   resources. Elements were also identified to increase the usability of an
   electronic evidence system.},
Type = {Article},
Affiliation = {Dobbins, M (Corresponding Author), McMaster Univ, Natl Collaborating Ctr Methods \& Tools, 175 Longwood Rd South,Suite 210a, Hamilton, ON L8P 0A1, Canada.
   Dhaliwal, Bandna; Neil-Sztramko, Sarah E.; Dobbins, Maureen, McMaster Univ, Natl Collaborating Ctr Methods \& Tools, 175 Longwood Rd South,Suite 210a, Hamilton, ON L8P 0A1, Canada.
   Neil-Sztramko, Sarah E., McMaster Univ, Dept Hlth Res Methods Evidence \& Impact, Hamilton, ON, Canada.
   Boston-Fisher, Nikita; Buckeridge, David L., McGill Univ, Sch Populat \& Global Hlth, Montreal, PQ, Canada.
   Dobbins, Maureen, McMaster Univ, Sch Nursing, Hamilton, ON, Canada.},
DOI = {10.2196/26503},
Article-Number = {e26503},
Keywords = {population surveillance; evidence-informed decision-making; needs
   assessment; public health; precision public health},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {dobbinsm@mcmaster.ca},
Affiliations = {McMaster University; McMaster University; McGill University; McMaster
   University},
Cited-References = {{[}Anonymous], 2019, ALB HLTH SERV PERF R.
   {[}Anonymous], BEH RISK FACT SURV S.
   {[}Anonymous], 2009, MOD EV INF DEC MAK P.
   {[}Anonymous], 2014, CANADIAN BEST PRACTI.
   {[}Anonymous], OP DAT.
   {[}Anonymous], 2016, NOV SCOT PUBL HLTH S.
   {[}Anonymous], DAT PROM HLTH EFF RE.
   {[}Anonymous], 2020, 10 ESS PUBL HLTH SER.
   ASTM, 2018, C33C33M18 ASTM, DOI DOI 10.1520/C0033\_C0033M-18.
   Azungah T, 2018, QUAL RES J, V18, P383, DOI 10.1108/QRJ-D-18-00035.
   Brownson RC, 2018, ANNU REV PUBL HEALTH, V39, P27, DOI 10.1146/annurev-publhealth-040617-014746.
   Buckeridge David L, 2020, Yearb Med Inform, V29, P226, DOI 10.1055/s-0040-1701989.
   Buffet C, 2007, CAN USE THIS EVIDENC.
   CDC Wonder, Centers for Disease Control and Prevention.
   Cresswell K, 2020, HEALTH INFORM J, V26, P2138, DOI 10.1177/1460458219900452.
   Culyer AJ, 2006, EVID POLICY, V2, P357, DOI 10.1332/174426406778023658.
   Data, STAT CANADA.
   De Spiegeleire S, 2017, Artificial intelligence and the future of defence.
   Dobbins M, 2007, WORLDV EVID-BASED NU, V4, P156, DOI 10.1111/j.1741-6787.2007.00089.x.
   Dobbins Maureen, 2020, Can Commun Dis Rep, V46, P160, DOI 10.14745/ccdr.v46i06a01.
   Dobbins M, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6317-5.
   Dolley S, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00068.
   Fedeli V., 2019, ONTARIO BUDGET PROTE.
   Groseclose SL, 2017, ANNU REV PUBL HEALTH, V38, P57, DOI 10.1146/annurev-publhealth-031816-044348.
   Guyon A, 2016, CAN J PUBLIC HEALTH, V107, pE326, DOI {[}10.17269/cjph.107.5273, 10.17269/CJPH.107.5273].
   Hamilton W. L., 2017, INT COMMUN HEAT MASS, DOI DOI 10.1016/0735-1933(85)90003-X.
   Himmelstein DU, 2016, AM J PUBLIC HEALTH, V106, P56, DOI 10.2105/AJPH.2015.302908.
   Kenefick HW, 2014, HEALTH PROMOT PRACT, V15, p48S, DOI 10.1177/1524839913509270.
   Kohatsu ND, 2004, AM J PREV MED, V27, P417, DOI 10.1016/j.amepre.2004.07.019.
   Lavrakas Paul J, 2008, Encyclopedia of survey research methods, DOI {[}10.4135/9781412963947, 10.1136/bmj.f6304, DOI 10.1136/BMJ.F6304].
   Maani N, 2020, MILBANK Q, V98, P250, DOI 10.1111/1468-0009.12463.
   Martin W, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4837-z.
   Morgenstern JD, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-020-10030-x.
   Murray CJL, 2020, LANCET PUBLIC HEALTH, V5, pE469, DOI 10.1016/S2468-2667(20)30187-0.
   National Center for Health Statistics, 2021, CTR DIS CONTR PREV.
   Panch T, 2019, J GLOB HEALTH, V9, DOI 10.7189/jogh.09.020318.
   Panch T, 2019, LANCET DIGIT HEALTH, V1, pE13, DOI 10.1016/S2589-7500(19)30002-0.
   Peirson L, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-137.
   Russell ST, 2010, ADV RESPONS ADOL DEV, P1, DOI 10.1007/978-1-4419-5728-3\_1.
   Shaban-Nejad A, 2017, ANN NY ACAD SCI, V1387, P44, DOI 10.1111/nyas.13271.
   Shoveller J, 2016, CRIT PUBLIC HEALTH, V26, P487, DOI 10.1080/09581596.2015.1117577.
   Triantafyllidis AK, 2019, J MED INTERNET RES, V21, DOI 10.2196/12286.
   van Panhuis WG, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1144.
   Yost J, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-728.},
Number-of-Cited-References = {44},
Times-Cited = {0},
Unique-ID = {WOS:000739050500019},
}

@article{ WOS:000434868800234,
Author = {Ferrao, Joao L. and Niquisse, Sergio and Mendes, Jorge M. and Painho,
   Marco},
Title = {Mapping and Modelling Malaria Risk Areas Using Climate,
   Socio-Demographic and Clinical Variables in Chimoio, Mozambique},
Journal = {INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH},
Year = {2018},
Volume = {15},
Number = {4},
Month = {APR},
Abstract = {Background: Malaria continues to be a major public health concern in
   Africa. Approximately 3.2 billion people worldwide are still at risk of
   contracting malaria, and 80\% of deaths caused by malaria are
   concentrated in only 15 countries, most of which are in Africa. These
   high-burden countries have achieved a lower than average reduction of
   malaria incidence and mortality, and Mozambique is among these
   countries. Malaria eradication is therefore one of Mozambique's main
   priorities. Few studies on malaria have been carried out in Chimoio, and
   there is no malaria map risk of the area. This map is important to
   identify areas at risk for application of Public Precision Health
   approaches. By using GIS-based spatial modelling techniques, the
   research goal of this article was to map and model malaria risk areas
   using climate, socio-demographic and clinical variables in Chimoio,
   Mozambique. Methods: A 30 m x 30 m Landsat image, ArcGIS 10.2 and
   BioclimData were used. A conceptual model for spatial problems was used
   to create the final risk map. The risks factors used were: the mean
   temperature, precipitation, altitude, slope, distance to water bodies,
   distance to roads, NDVI, land use and land cover, malaria prevalence and
   population density. Layers were created in a raster dataset. For class
   value comparisons between layers, numeric values were assigned to
   classes within each map layer, giving them the same importance. The
   input dataset were ranked, with different weights according to their
   suitability. The reclassified outputs of the data were combined.
   Results: Chimoio presented 96\% moderate risk and 4\% high-risk areas.
   The map showed that the central and south-west ``Residential areas{''},
   namely, Centro Hipico, Trangapsso, Bairro 5 and 1 de Maio, had a high
   risk of malaria, while the rest of the residential areas had a moderate
   risk. Conclusions: The entire Chimoio population is at risk of
   contracting malaria, and the precise estimation of malaria risk,
   therefore, has important precision public health implications and for
   the planning of effective control measures, such as the proper time and
   place to spray to combat vectors, distribution of bed nets and other
   control measures.},
Type = {Article},
Affiliation = {Ferrao, JL (Corresponding Author), Univ Catolica Mocambique, Fac Engn, Chimoio 20106, Mozambique.
   Ferrao, Joao L., Univ Catolica Mocambique, Fac Engn, Chimoio 20106, Mozambique.
   Niquisse, Sergio, Univ Catolica Mocambique, Fac Econ \& Gestao, GIS Dept, Beira 2107, Mozambique.
   Mendes, Jorge M.; Painho, Marco, Univ Nova Lisboa, NOVA Informat Management Sch, P-1000260 Lisbon, Portugal.},
DOI = {10.3390/ijerph15040795},
Article-Number = {795},
Keywords = {modelling; mapping; malaria risk; public precision health},
Keywords-Plus = {TRANSMISSION; MUNICIPALITY},
Research-Areas = {Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health},
Web-of-Science-Categories  = {Environmental Sciences; Public, Environmental \& Occupational Health},
Author-Email = {jferrao@ucm.ac.mz
   sniquisse@ucm.ac.mz
   jmm@novaims.unl.pt
   painho@novaims.unl.pt},
Affiliations = {Universidade Nova de Lisboa},
Cited-References = {Abellana R, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-228.
   Alemu A, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-30.
   Alimi TO, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2902-7.
   {[}Anonymous], Shuttle Radar Topography Mission.
   Bernard S, AHP TEMPLATE.
   Bhatt B, 2014, INT ARCH PHOTOGRAMME.
   Centers for Disease Control and Prevention, MAL BIOL.
   Chikodzi D., 2013, Journal of Geosciences and Geomatics, V1, P8, DOI DOI 10.12691/JGG-1-1-2.
   Cohen JM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-61.
   de Manica Governo, 2011, MAN PROV STRAT DEV P.
   Dlamini SN, 2015, GEOSPATIAL HEALTH, V10, P88, DOI 10.4081/gh.2015.302.
   Ferrao JL, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2205-6.
   Fit for Travel, TRAV HLTH INF PEOPL.
   Fuller DO, 2014, APPL GEOGR, V48, P1, DOI 10.1016/j.apgeog.2014.01.002.
   Gani M.A, 2016, INT J ADV RES.
   Giardina F, 2015, GEOSPATIAL HEALTH, V10, P232, DOI 10.4081/gh.2015.333.
   Global Fund, 2015, INV FUT AFF MAL.
   Greenberg JA, 2012, J VECTOR ECOL, V37, P83, DOI 10.1111/j.1948-7134.2012.00203.x.
   Hagenlocher M, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0036-2.
   Instituto Nacional de Estatistica, 2011, PROJ AN POP TOT URB.
   Joao S.Z, 2016, THESIS.
   Kazembe Lawrence N, 2006, Int J Health Geogr, V5, P41, DOI 10.1186/1476-072X-5-41.
   Kfrefis C.A., 2011, AM J TROP MED HYG, V84, P285.
   Krefis AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017905.
   Ferrao JL, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1371-x.
   Malaria Atlas Project, DEV GLOB MAPS MAL RI.
   Matzarakis A., 2011, J ENVIRON SCI, V5, P1215.
   Milla A, 2005, J EXT, V43, P3.
   Muin J.K, PRECISION PUBLIC HLT.
   Mulefutu F.O, 2016, J ENV SCI TOXICOL FO, V10, P104.
   Munga S, 2009, AM J TROP MED HYG, V81, P1079, DOI 10.4269/ajtmh.2009.09-0156.
   Oliveira E.C, 2001, MALARIA J, V10, P177.
   Paaijmans KP, 2010, P NATL ACAD SCI USA, V107, P15135, DOI 10.1073/pnas.1006422107.
   PAGOT J., 1992, ANIMAL PRODUCTION TR.
   Parham PE, 2010, ENVIRON HEALTH PERSP, V118, P620, DOI 10.1289/ehp.0901256.
   Riedel N, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-37.
   Russell P. F., 1934, American Journal of Tropical Medicine, V14, P139.
   Saaty T.L., 2008, International Journal Of Services Sciences, V1, P83, DOI 10.1504/IJSSCI.2008.017590.
   Spitzen J.J, FLIGHT BEHAV HUNGRY.
   Thompson R, 1997, AM J TROP MED HYG, V57, P550, DOI 10.4269/ajtmh.1997.57.550.
   Traveller Start, 2016, KNOW WHICH MALARIA A.
   United Nations, 2015, Transforming our world: The 2030 Agenda For Sustainable Development, DOI {[}10.1201/b20466-7, DOI 10.1201/B20466-7].
   Wayant NM, 2010, GEOSPATIAL HEALTH, V4, P179, DOI 10.4081/gh.2010.199.
   WHO, WORLD MAL REP 2015.
   World Health Organization, 1997, HLTH ENV SUST DEV.
   World Health Organization (WHO), 2015, MOZ COUNTR PROGR.
   WorldClim, GLOB CLIM DAT.
   Zacarias OP, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-189.
   Zhou SS, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-106.},
Number-of-Cited-References = {49},
Times-Cited = {22},
Unique-ID = {WOS:000434868800234},
}

@article{ WOS:000828384700001,
Author = {Shen, Emily C. and Srinivasan, Swetha and Passero, Lauren E. and Allen,
   Caitlin G. and Dixon, Madison and Foss, Kimberly and Halliburton,
   Brianna and Milko, V, Laura and Smit, Amelia K. and Carlson, Rebecca and
   Roberts, Megan C.},
Title = {Barriers and Facilitators for Population Genetic Screening in Healthy
   Populations: A Systematic Review},
Journal = {FRONTIERS IN GENETICS},
Year = {2022},
Volume = {13},
Month = {JUL 4},
Abstract = {Studies suggest that 1-3\% of the general population in the United
   States unknowingly carry a genetic risk factor for a common hereditary
   disease. Population genetic screening is the process of offering
   otherwise healthy patients in the general population testing for genomic
   variants that predispose them to diseases that are clinically
   actionable, meaning that they can be prevented or mitigated if they are
   detected early. Population genetic screening may significantly reduce
   morbidity and mortality from these diseases by informing risk-specific
   prevention or treatment strategies and facilitating appropriate
   participation in early detection. To better understand current barriers,
   facilitators, perceptions, and outcomes related to the implementation of
   population genetic screening, we conducted a systematic review and
   searched PubMed, Embase, and Scopus for articles published from date of
   database inception to May 2020. We included articles that 1) detailed
   the perspectives of participants in population genetic screening
   programs and 2) described the barriers, facilitators, perceptions, and
   outcomes related to population genetic screening programs among
   patients, healthcare providers, and the public. We excluded articles
   that 1) focused on direct-to-consumer or risk-based genetic testing and
   2) were published before January 2000. Thirty articles met these
   criteria. Barriers and facilitators to population genetic screening were
   organized by the Social Ecological Model and further categorized by
   themes. We found that research in population genetic screening has
   focused on stakeholder attitudes with all included studies designed to
   elucidate individuals' perceptions. Additionally, inadequate knowledge
   and perceived limited clinical utility presented a barrier for
   healthcare provider uptake. There were very few studies that conducted
   long-term follow-up and evaluation of population genetic screening. Our
   findings suggest that these and other factors, such as prescreen
   counseling and education, may play a role in the adoption and
   implementation of population genetic screening. Future studies to
   investigate macro-level determinants, strategies to increase provider
   buy-in and knowledge, delivery models for prescreen counseling, and
   long-term outcomes of population genetic screening are needed for the
   effective design and implementation of such programs.Systematic Review
   Registration:},
Type = {Review},
Affiliation = {Roberts, MC (Corresponding Author), Univ N Carolina, Eshelman Sch Pharm, Div Pharmaceut Outcomes \& Policy, Chapel Hill, NC 27515 USA.
   Shen, Emily C.; Halliburton, Brianna, Univ N Carolina, Coll Arts \& Sci, Chapel Hill, NC 27515 USA.
   Shen, Emily C., Univ N Carolina, Sch Med, UNC Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA.
   Srinivasan, Swetha; Passero, Lauren E.; Roberts, Megan C., Univ N Carolina, Eshelman Sch Pharm, Div Pharmaceut Outcomes \& Policy, Chapel Hill, NC 27515 USA.
   Allen, Caitlin G., Med Univ South Carolina, Coll Med, Dept Publ Hlth Sci, Charleston, SC 29425 USA.
   Dixon, Madison, Emory Univ, Rollins Sch Publ Hlth, Dept Behav Social \& Hlth Educ Sci, Atlanta, GA 30322 USA.
   Foss, Kimberly; Milko, Laura, V, Univ N Carolina, Sch Med, Dept Genet, Chapel Hill, NC 27515 USA.
   Smit, Amelia K., Univ Sydney, Daffodil Ctr, Joint Venture Canc Council NSW, Sydney, NSW, Australia.
   Smit, Amelia K., Univ Sydney, Melanoma Inst Australia, Sydney, NSW, Australia.
   Carlson, Rebecca, Univ N Carolina, Hlth Sci Lib, Chapel Hill, NC 27515 USA.},
DOI = {10.3389/fgene.2022.865384},
Article-Number = {865384},
Keywords = {population testing; universal genetic screening; healthy population
   screening; average risk; precision public health; perceptions;
   attitudes; outcomes},
Keywords-Plus = {PRIMARY-CARE; RANDOMIZED-TRIAL; LAY ATTITUDES; GENOMIC RISK; CANCER;
   INDIVIDUALS; DISEASE; IMPACT; EDUCATION; OUTCOMES},
Research-Areas = {Genetics \& Heredity},
Web-of-Science-Categories  = {Genetics \& Heredity},
Author-Email = {megan.roberts@unc.edu},
Affiliations = {University of North Carolina; University of North Carolina Chapel Hill;
   University of North Carolina; University of North Carolina Chapel Hill;
   University of North Carolina School of Medicine; University of North
   Carolina; University of North Carolina Chapel Hill; Medical University
   of South Carolina; Emory University; Rollins School Public Health;
   University of North Carolina School of Medicine; University of North
   Carolina; University of North Carolina Chapel Hill; University of
   Sydney; University of Sydney; Melanoma Institute Australia; University
   of North Carolina; University of North Carolina Chapel Hill},
Cited-References = {Allen KJ, 2008, LIVER INT, V28, P363, DOI 10.1111/j.1478-3231.2008.01661.x.
   Ames AG, 2015, EUR J HUM GENET, V23, P8, DOI 10.1038/ejhg.2014.89.
   {[}Anonymous], 2021, VER HLTH INN COV SYS.
   Borry P, 2008, AM J MED GENET C, V148C, P78, DOI 10.1002/ajmg.c.30165.
   CDC, 2019, ACCE MOD LIST 44 TAR.
   Centers for Disease Control and Prevention, 2014, TIER 1 GEN APPL THEI.
   Crellin E, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00789.
   East KM, 2019, J GENET COUNS, V28, P438, DOI 10.1002/jgc4.1114.
   Evans O, 2020, CANCER PREV RES, V13, P643, DOI 10.1158/1940-6207.CAPR-20-0002.
   Fenton GL, 2018, J GENET COUNS, V27, P370, DOI 10.1007/s10897-017-0183-7.
   Flanagin A, 2021, JAMA-J AM MED ASSOC, V326, P621, DOI 10.1001/jama.2021.13304.
   Friedman JM, 2017, BMC MED GENOMICS, V10, DOI 10.1186/s12920-017-0247-4.
   Frieser MJ, 2018, HEALTH PSYCHOL, V37, P1134, DOI 10.1037/hea0000683.
   Godino JG, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002185.
   Golden SD, 2012, HEALTH EDUC BEHAV, V39, P364, DOI 10.1177/1090198111418634.
   Goldenberg AJ, 2019, GENET MED, V21, P525, DOI 10.1038/s41436-018-0101-x.
   Green ED, 2020, NATURE, V586, P683, DOI 10.1038/s41586-020-2817-4.
   Haga SB, 2014, PUBLIC HEALTH GENOM, V17, P95, DOI 10.1159/000358413.
   Haga SB, 2011, J GEN INTERN MED, V26, P834, DOI 10.1007/s11606-011-1651-7.
   Hampel H, 2011, CANCER PREV RES, V4, P1, DOI 10.1158/1940-6207.CAPR-10-0345.
   Hann KEJ, 2017, BMC WOMENS HEALTH, V17, DOI 10.1186/s12905-017-0488-6.
   Hann KEJ, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4375-8.
   Hardie EA, 2011, AUST J PSYCHOL, V63, P119, DOI 10.1111/j.1742-9536.2011.00017.x.
   Hauser D, 2018, HEALTH AFFAIR, V37, P793, DOI 10.1377/hlthaff.2017.1548.
   Hay JL, 2021, CANCERS, V13, DOI 10.3390/cancers13164053.
   Hay JL, 2018, JAMA DERMATOL, V154, P684, DOI 10.1001/jamadermatol.2018.0592.
   Henneman L, 2011, PUBLIC HEALTH GENOM, V14, P238, DOI 10.1159/000276543.
   Hietaranta-Luoma HL, 2015, J GENET COUNS, V24, P908, DOI 10.1007/s10897-015-9826-8.
   Hollands GJ, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1102.
   Holm IA, 2018, BMC PEDIATR, V18, DOI 10.1186/s12887-018-1200-1.
   Hong QN., 2018, Canadian Intellectual Property Office, Industry Canada.
   Joseph L, 2016, J MOL DIAGN, V18, P605, DOI 10.1016/j.jmoldx.2016.05.007.
   Joshi E, 2020, EUR J HUM GENET, V28, P551, DOI 10.1038/s41431-019-0547-6.
   Lacson JCA, 2021, CANCERS, V13, DOI 10.3390/cancers13133143.
   Laskey SL, 2003, GENET MED, V5, P49, DOI 10.1097/00125817-200301000-00008.
   Moher D, 2010, INT J SURG, V8, P336, DOI {[}10.1371/journal.pmed.1000097, 10.1136/bmj.b2535, 10.1186/2046-4053-4-1, 10.1016/j.ijsu.2010.02.007, 10.1016/j.ijsu.2010.07.299, 10.1136/bmj.b2700, 10.1136/bmj.i4086].
   Molster CM, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00247.
   Murray MF., 2018, NAM PERSPECTIVES, DOI DOI 10.31478/201812A.
   Murray MF, 2020, JAMA-J AM MED ASSOC, V323, P307, DOI 10.1001/jama.2019.18640.
   Neghina AM, 2010, GENET TEST MOL BIOMA, V14, P847, DOI 10.1089/gtmb.2010.0109.
   Nicholls SG, 2016, BMC MED GENOMICS, V9, DOI 10.1186/s12920-016-0186-5.
   Nielsen DE, 2012, GENES NUTR, V7, P559, DOI 10.1007/s12263-012-0290-x.
   Nusbaum R, 2013, TRANSL BEHAV MED, V3, P17, DOI 10.1007/s13142-012-0149-0.
   O'Neill SC, 2015, PUBLIC HEALTH GENOM, V18, P104, DOI 10.1159/000370101.
   Peterson JF, 2016, PHARMACOGENOMICS J, V16, P393, DOI 10.1038/tpj.2015.57.
   Price WN, 2019, NAT MED, V25, P37, DOI 10.1038/s41591-018-0272-7.
   Rego S, 2019, J GENET COUNS, V28, P428, DOI 10.1002/jgc4.1096.
   Rogowski W, 2006, INT J TECHNOL ASSESS, V22, P327, DOI 10.1017/S0266462306051221.
   Rubinsak LA, 2019, GYNECOL ONCOL, V154, P383, DOI 10.1016/j.ygyno.2019.06.009.
   Sanderson SC, 2017, EUR J HUM GENET, V25, P280, DOI 10.1038/ejhg.2016.178.
   Sanderson SC, 2016, EUR J HUM GENET, V24, P14, DOI 10.1038/ejhg.2015.118.
   Sanderson SC, 2004, PREV MED, V39, P458, DOI 10.1016/j.ypmed.2004.04.051.
   Schardt C, 2007, BMC MED INFORM DECIS, V7, DOI 10.1186/1472-6947-7-16.
   Shaw JS, 2001, J HEALTH PSYCHOL, V6, P405, DOI 10.1177/135910530100600404.
   Shen E.C., 2022, BARRIERS FACILITATOR, DOI DOI 10.21203/RS.3.RS-1315303/V1.
   Shiloh S, 2015, CLIN GENET, V87, P117, DOI 10.1111/cge.12403.
   Smit AK, 2021, GENET MED, V23, P2394, DOI 10.1038/s41436-021-01292-w.
   Smit AK, 2021, J MED ETHICS, V47, DOI 10.1136/medethics-2019-105934.
   Smit Amelia K, 2019, BJGP Open, V3, pbjgpopen18X101633, DOI 10.3399/bjgpopen18X101633.
   Srinivasan S, 2020, EUR J HUM GENET, V28, P1631, DOI 10.1038/s41431-020-00725-5.
   Toiviainen H, 2003, EUR J HUM GENET, V11, P565, DOI 10.1038/sj.ejhg.5201006.
   Vassy JL, 2017, ANN INTERN MED, V167, P159, DOI 10.7326/M17-0188.
   Vassy JL, 2014, J GEN INTERN MED, V29, pS4.
   Vitek CRR, 2017, PHARMACOGENOMICS, V18, P1013, DOI 10.2217/pgs-2017-0038.
   Wilemon KA, 2020, JAMA CARDIOL, V5, P217, DOI 10.1001/jamacardio.2019.5173.
   Zoltick ES, 2019, GENOME MED, V11, DOI 10.1186/s13073-019-0619-9.},
Number-of-Cited-References = {66},
Times-Cited = {7},
Unique-ID = {WOS:000828384700001},
}

@article{ WOS:000902246100001,
Author = {Babatunde, Oluwole Adeyemi and Pearce, John L. and Jefferson, Melanie S.
   and Frey, Lewis J. and Angel, Peggi M. and Drake, Richard R. and Allen,
   Caitlin G. and Lilly, Michael B. and Savage, Stephen J. and Hughes
   Halbert, Chanita},
Title = {Racial Distribution of Neighborhood-Level Social Deprivation in a
   Retrospective Cohort of Prostate Cancer Survivors},
Journal = {DISEASES},
Year = {2022},
Volume = {10},
Number = {4},
Month = {DEC},
Abstract = {Background: A better understanding of neighborhood-level factors'
   contribution is needed in order to increase the precision of cancer
   control interventions that target geographic determinants of cancer
   health disparities. This study characterized the distribution of
   neighborhood deprivation in a racially diverse cohort of prostate cancer
   survivors. Methods: A retrospective cohort of 253 prostate cancer
   patients who were treated with radical prostatectomy from 2011 to 2019
   was established at the Medical University of South Carolina.
   Individual-level data on clinical variables (e.g., stage, grade) and
   race were abstracted. Social Deprivation Index (SDI) and Healthcare
   Professional Shortage (HPS) status was obtained from the Robert Graham
   Center and assigned to participants based on their residential census
   tract. Data were analyzed with descriptive statistics and multivariable
   logistic regression. Results: The cohort of 253 men consisted of 168
   white, 81 African American, 1 Hispanic and 3 multiracial men.
   Approximately 49\% of 249 men lived in areas with high SDI (e.g., SDI
   score of 48 to 98). The mean for SDI was 44.5 (+27.4), and the range was
   97 (1-98) for all study participants. African American men had a
   significantly greater likelihood of living in a socially deprived
   neighborhood compared to white men (OR = 3.7, 95\% C.I. 2.1-6.7, p <
   0.01), while men who lived in areas with higher HPS shortage status were
   significantly more likely to live in a neighborhood that had high SDI
   compared to men who lived in areas with lower HPS shortages (OR = 4.7,
   95\% C.I. = 2.1-10.7, p < 0.01). African Americans had a higher
   likelihood of developing biochemical reoccurrence (OR = 3.7, 95\% C.I. =
   1.7-8.0) compared with white men. There were no significant association
   between SDI and clinical characteristics of prostate cancer.
   Conclusions: This study demonstrates that SDI varies considerably by
   race among men with prostate cancer treated with radical prostatectomy.
   Using SDI to understand the social environment could be -particularly
   useful as part of precision medicine and precision public health
   approaches and could be used by cancer centers, public health providers,
   and other health care specialists to inform operational decisions about
   how to target health promotion and disease prevention efforts in
   catchment areas and patient populations.},
Type = {Article},
Affiliation = {Babatunde, OA (Corresponding Author), Med Univ South Carolina, Dept Psychiat \& Behav Sci, Charleston, SC 29425 USA.
   Babatunde, OA (Corresponding Author), Med Univ South Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA.
   Babatunde, Oluwole Adeyemi; Jefferson, Melanie S., Med Univ South Carolina, Dept Psychiat \& Behav Sci, Charleston, SC 29425 USA.
   Babatunde, Oluwole Adeyemi; Drake, Richard R., Med Univ South Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA.
   Pearce, John L.; Frey, Lewis J., Med Univ South Carolina, Dept Publ Hlth Sci, Charleston, SC 29425 USA.
   Angel, Peggi M.; Drake, Richard R., Med Univ South Carolina, Dept Cell \& Mol Pharmacol \& Expt Therapeut, Charleston, SC 29425 USA.
   Allen, Caitlin G., Emory Univ, Rollins Sch Publ Hlth, Dept Behav Sci \& Hlth Educ, Atlanta, GA 30322 USA.
   Lilly, Michael B., Med Univ South Carolina, Dept Med, Charleston, SC 29425 USA.
   Savage, Stephen J., Med Univ South Carolina, Dept Urol, Charleston, SC 29425 USA.
   Hughes Halbert, Chanita, Univ Southern Calif, Dept Populat \& Publ Hlth Sci, Los Angeles, CA 90032 USA.},
DOI = {10.3390/diseases10040075},
Article-Number = {75},
Keywords = {prostate cancer; Social Deprivation Index; racial disparity},
Keywords-Plus = {MULTILEVEL ANALYSIS; TRAVEL DISTANCE; PRIMARY-CARE; HEALTH; MORTALITY;
   RISK},
Research-Areas = {Research \& Experimental Medicine},
Web-of-Science-Categories  = {Medicine, Research \& Experimental},
Author-Email = {oluwole.babatunde@prismahealth.org},
Affiliations = {Medical University of South Carolina; Medical University of South
   Carolina; Medical University of South Carolina; Medical University of
   South Carolina; Emory University; Rollins School Public Health; Medical
   University of South Carolina; Medical University of South Carolina;
   University of Southern California},
Cited-References = {{[}Anonymous], 2010, Increasing access to health workers in remote and rural areas through improved retention - Global policy recommendations.
   Bryere J, 2017, ORAL ONCOL, V71, P144, DOI 10.1016/j.oraloncology.2017.06.014.
   Butler DC, 2013, HEALTH SERV RES, V48, P539, DOI 10.1111/j.1475-6773.2012.01449.x.
   Danish A, 2019, RURAL REMOTE HEALTH, V19, DOI 10.22605/RRH5466.
   DeRouen MC, 2018, CANCER CAUSE CONTROL, V29, P951, DOI 10.1007/s10552-018-1071-7.
   DeRouen MC, 2018, CANCER EPIDEMIOL, V53, P1, DOI 10.1016/j.canep.2018.01.003.
   Freedland SJ, 2005, JAMA-J AM MED ASSOC, V294, P433, DOI 10.1001/jama.294.4.433.
   Halbert CH, 2014, HEALTH EDUC RES, V29, P97, DOI 10.1093/her/cyt098.
   Jansen L, 2014, INT J CANCER, V134, P2951, DOI 10.1002/ijc.28624.
   Lamont EB, 2012, J CLIN ONCOL, V30, P3250, DOI 10.1200/JCO.2011.40.4228.
   Li X, 2012, PROSTATE CANCER P D, V15, P128, DOI 10.1038/pcan.2011.46.
   Major JM, 2012, CANCER CAUSE CONTROL, V23, P1185, DOI 10.1007/s10552-012-9988-8.
   Markossian TW, 2014, HEALTH SERV RES, V49, P481, DOI 10.1111/1475-6773.12096.
   Mays GP, 2011, HEALTH AFFAIR, V30, P1585, DOI 10.1377/hlthaff.2011.0196.
   National Institute of Health's National Library of Medicine, WHAT IS PRECISION ME.
   Robert Graham Center, SOCIAL DEPRIVATION I.
   Sanderson M, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-021059.
   Shafique K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056184.
   Singh Gopal K, 2017, Int J MCH AIDS, V6, P139, DOI 10.21106/ijma.236.
   Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x.
   Vetterlein MW, 2017, CANCER-AM CANCER SOC, V123, P3241, DOI 10.1002/cncr.30744.
   Wills MJ, 2017, J HEALTHC MANAG, V62, P30, DOI 10.1097/00115514-201701000-00007.
   Wirth MD, 2016, NUTR RES, V36, P227, DOI 10.1016/j.nutres.2015.11.016.
   Zeigler-Johnson CM, 2011, PROSTATE CANCER, V2011, DOI 10.1155/2011/846263.},
Number-of-Cited-References = {24},
Times-Cited = {3},
Unique-ID = {WOS:000902246100001},
}

@article{ WOS:000510875700001,
Author = {Hulland, E. N. and Wiens, K. E. and Shirude, S. and Morgan, J. D. and
   Bertozzi-Villa, A. and Farag, T. H. and Fullman, N. and Kraemer, M. U.
   G. and Miller-Petrie, M. K. and Gupta, V. and Reiner, Jr., R. C. and
   Rabinowitz, P. and Wasserheit, J. N. and Bell, B. P. and Hay, S. I. and
   Weiss, D. J. and Pigott, D. M.},
Title = {Travel time to health facilities in areas of outbreak potential: maps
   for guiding local preparedness and response},
Journal = {BMC MEDICINE},
Year = {2019},
Volume = {17},
Number = {1},
Month = {DEC 30},
Abstract = {Background: Repeated outbreaks of emerging pathogens underscore the need
   for preparedness plans to prevent, detect, and respond. As countries
   develop and improve National Action Plans for Health Security,
   addressing subnational variation in preparedness is increasingly
   important. One facet of preparedness and mitigating disease transmission
   is health facility accessibility, linking infected persons with health
   systems and vice versa. Where potential patients can access care, local
   facilities must ensure they can appropriately diagnose, treat, and
   contain disease spread to prevent secondary transmission; where patients
   cannot readily access facilities, alternate plans must be developed.
   Here, we use travel time to link facilities and populations at risk of
   viral hemorrhagic fevers (VHFs) and identify spatial variation in these
   respective preparedness demands.
   Methods and findings: We used geospatial resources of travel friction,
   pathogen environmental suitability, and health facilities to determine
   facility accessibility of any at-risk location within a country. We
   considered in-country and cross-border movements of exposed populations
   and highlighted vulnerable populations where current facilities are
   inaccessible and new infrastructure would reduce travel times. We
   developed profiles for 43 African countries. Resulting maps demonstrate
   gaps in health facility accessibility and highlight facilities closest
   to areas at risk for VHF spillover. For instance, in the Central African
   Republic, we identified travel times of over 24 h to access a health
   facility. Some countries had more uniformly short travel times, such as
   Nigeria, although regional disparities exist. For some populations,
   including many in Botswana, access to areas at risk for VHF nationally
   was low but proximity to suitable spillover areas in bordering countries
   was high. Additional analyses provide insights for considering future
   resource allocation. We provide a contemporary use case for these
   analyses for the ongoing Ebola outbreak.
   Conclusions: These maps demonstrate the use of geospatial analytics for
   subnational preparedness, identifying facilities close to at-risk
   populations for prioritizing readiness to detect, treat, and respond to
   cases and highlighting where gaps in health facility accessibility
   exist. We identified cross-border threats for VHF exposure and
   demonstrate an opportunity to improve preparedness activities through
   the use of precision public health methods and data-driven insights for
   resource allocation as part of a country's preparedness plans.},
Type = {Article},
Affiliation = {Pigott, DM (Corresponding Author), Univ Washington, Inst Hlth Metr \& Evaluat, 2301 5th Ave,Suite 600, Seattle, WA 98121 USA.
   Pigott, DM (Corresponding Author), Univ Washington, Sch Med, Dept Hlth Metr Sci, Seattle, WA 98121 USA.
   Hulland, E. N.; Wiens, K. E.; Shirude, S.; Morgan, J. D.; Farag, T. H.; Fullman, N.; Miller-Petrie, M. K.; Gupta, V.; Reiner, R. C., Jr.; Hay, S. I.; Pigott, D. M., Univ Washington, Inst Hlth Metr \& Evaluat, 2301 5th Ave,Suite 600, Seattle, WA 98121 USA.
   Bertozzi-Villa, A.; Weiss, D. J., Li Ka Shing Ctr Hlth Informat \& Discovery, Malaria Atlas Project, Big Data Inst, Oxford, England.
   Bertozzi-Villa, A., Inst Dis Modeling, Bellevue, WA 98005 USA.
   Kraemer, M. U. G., Univ Oxford, Dept Zool, Oxford, England.
   Reiner, R. C., Jr.; Hay, S. I.; Pigott, D. M., Univ Washington, Sch Med, Dept Hlth Metr Sci, Seattle, WA 98121 USA.
   Rabinowitz, P.; Wasserheit, J. N.; Bell, B. P., Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.},
DOI = {10.1186/s12916-019-1459-6},
Article-Number = {232},
Keywords = {Preparedness; Viral hemorrhagic fevers; Travel time; Health facility
   access; Ebola; Marburg; Lassa fever; CCHF},
Keywords-Plus = {ZOONOTIC NICHE; VIRUS-DISEASE; CARE; AFRICA; IMPACT; EBOLA; FEVER;
   PREVENTION; LESSONS; ACCESS},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Author-Email = {pigottdm@uw.edu},
Affiliations = {Institute for Health Metrics \& Evaluation; University of Washington;
   University of Washington Seattle; University of Oxford; University of
   Washington; University of Washington Seattle; University of Washington;
   University of Washington Seattle},
Cited-References = {{[}Anonymous], 2018, Global Report on Internal Displacement.
   {[}Anonymous], 2017, PLOS CURRENTS OUTBRE.
   {[}Anonymous], 2019, Disease outbreak news.
   Battle KE, 2016, MALARIA J, V15, DOI 10.1186/s12936-015-1048-x.
   Bertozzi-Villa A., 2018, MAPPING TRAVEL TIMES.
   Blanford JI, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-24.
   Casas I, 2016, J TRANSP HEALTH, V1, P4.
   Casas I, 2019, ENVIRON MONIT ASSESS, V191, DOI 10.1007/s10661-019-7415-2.
   Centers for Disease Control and Prevention, 2015, MMWR S, V64.
   Danielson J., 2011, Global Multi-Resolution Terrain Elevation Data 2010 (GMTED2010), DOI {[}DOI 10.3133/OFR20111073, 10.3 133/ofr20111073, 10.3133/ofr20111073].
   Democratic Republic of Congo Ministry of Health, 2019, STRAT RESP PLAN EB V.
   Dijkstra EW., 1959, Numerische Mathematik, V1, P269, DOI DOI 10.1007/BF01386390.
   Friedl MA, 2010, REMOTE SENS ENVIRON, V114, P168, DOI 10.1016/j.rse.2009.08.016.
   Fullman N, 2018, LANCET, V391, P2236, DOI 10.1016/S0140-6736(18)30994-2.
   Global Health Security Agenda, 2018, IMPL GLOB HLTH SEC A.
   Heymann DL, 2015, LANCET, V385, P1884, DOI 10.1016/S0140-6736(15)60858-3.
   Hijmans R.J., 2012, raster: geographic data analysis and modeling.
   Institute of Medicine Forum on Microbial Threats, 2010, 2 TRAV CONFL TRAD DI.
   Jin C, 2015, INT J EQUITY HEALTH, V14, DOI 10.1186/s12939-015-0195-6.
   Keïta M, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5444-3.
   Kelly C, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-013059.
   Kraemer MUG, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41192-3.
   Kruk ME, 2018, LANCET GLOB HEALTH, V6, pE1196, DOI 10.1016/S2214-109X(18)30386-3.
   Kruk ME, 2015, LANCET, V385, P1910, DOI 10.1016/S0140-6736(15)60755-3.
   Leigh J, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k3254.
   Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x.
   Lu X, 2012, P NATL ACAD SCI USA, V109, P11576, DOI 10.1073/pnas.1203882109.
   Macarayan EK, 2018, LANCET GLOB HEALTH, V6, pE1176, DOI 10.1016/S2214-109X(18)30440-6.
   Maina J, 2019, SCI DATA, V6, DOI 10.1038/s41597-019-0142-2.
   Manguvo A, 2015, PAN AFR MED J, V22, DOI 10.11694/pamj.supp.2015.22.1.6190.
   Mathon D, 2018, INT J HEALTH GEOGR, V17, DOI 10.1186/s12942-018-0156-6.
   Messina JP, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.16.
   Mghamba JM, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000600.
   Munoz UH, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-40.
   Mylne AQN, 2015, T ROY SOC TROP MED H, V109, P483, DOI 10.1093/trstmh/trv047.
   Nkengasong JN, 2017, LANCET GLOB HEALTH, V5, pE246, DOI 10.1016/S2214-109X(17)30025-6.
   Noor AM, 2006, TROP MED INT HEALTH, V11, P188, DOI 10.1111/j.1365-3156.2005.01555.x.
   O'Meara WP, 2009, TROP MED INT HEALTH, V14, P29, DOI 10.1111/j.1365-3156.2008.02194.x.
   Okwaraji YB, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-476.
   Pathmanathan I, 2014, MMWR-MORBID MORTAL W, V63, P1172.
   Peters DH, 2008, ANN NY ACAD SCI, V1136, P161, DOI 10.1196/annals.1425.011.
   Petti CA, 2006, CLIN INFECT DIS, V42, P377, DOI 10.1086/499363.
   Pigott DM, 2017, LANCET, V390, P2662, DOI 10.1016/S0140-6736(17)32092-5.
   Pigott DM, 2016, ELIFE, V5, DOI 10.7554/eLife.16412.
   Pigott DM, 2015, T ROY SOC TROP MED H, V109, P366, DOI 10.1093/trstmh/trv024.
   Plowright RK, 2017, NAT REV MICROBIOL, V15, P502, DOI 10.1038/nrmicro.2017.45.
   Ravi SJ, 2019, HEALTH POLICY PLANN, V34, P47, DOI 10.1093/heapol/czy102.
   Richards P, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003567.
   Safi M, 2018, DEV COSTED NATL ACTI, V16.
   Schoeps A, 2011, AM J EPIDEMIOL, V173, P492, DOI 10.1093/aje/kwq386.
   Shoemaker TR, 2018, LANCET INFECT DIS, V18, P373, DOI 10.1016/S1473-3099(18)30164-6.
   Shultz JM, 2016, CURR PSYCHIAT REP, V18, DOI 10.1007/s11920-016-0741-y.
   Steffan-Dewenter I., 2002, Ecology, V83, P1421, DOI 10.1890/0012-9658(2002)083{[}1421:SDEOLC]2.0.CO;2.
   Stevens FR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0107042.
   Stevens GA, 2016, PLOS MED, V13, DOI {[}10.1371/journal.pmed.1002056, 10.1371/journal.pmed.1002116].
   Syed ST, 2013, J COMMUN HEALTH, V38, P976, DOI 10.1007/s10900-013-9681-1.
   United Nations Population Division, 2012, WORLD URB PROSP 2012.
   Wagenaar BH, 2018, INT J HEALTH GEOGR, V17, DOI 10.1186/s12942-018-0158-4.
   Weiss DJ, 2018, NATURE, V553, P333, DOI 10.1038/nature25181.
   Wesolowski A, 2016, J INFECT DIS, V214, pS414, DOI 10.1093/infdis/jiw273.
   WHO, 2016, JOINT EXT EV TOOL PR.
   World Health Organization Regional Office for Africa, 2019, 49 WHO REG OFF AFR.
   World Health Organization Uganda, 2019, 7 WHO UG.
   World Health Organization (WHO), 2015, Consolidated Ebola virus disease preparedness checklist..},
Number-of-Cited-References = {64},
Times-Cited = {26},
Unique-ID = {WOS:000510875700001},
}

@article{ WOS:000402334800005,
Author = {Ferrao, Joao Luis and Mendes, Jorge M. and Painho, Marco},
Title = {Modelling the influence of climate on malaria occurrence in Chimoio
   Municipality, Mozambique},
Journal = {PARASITES \& VECTORS},
Year = {2017},
Volume = {10},
Month = {MAY 25},
Abstract = {Background: Mozambique was recently ranked fifth in the African
   continent for the number of cases of malaria. In Chimoio municipality
   cases of malaria are increasing annually, contrary to the decreasing
   trend in Africa. As malaria transmission is influenced to a large extent
   by climatic conditions, modelling this relationship can provide useful
   insights for designing precision health measures for malaria control.
   There is a scarcity of information on the association between climatic
   variability and malaria transmission risk in Mozambique in general, and
   in Chimoio in particular. Therefore, the aim of this study is to model
   the association between climatic variables and malaria cases on a weekly
   basis, to help policy makers find adequate measures for malaria control
   and eradication.
   Methods: Time series analysis was conducted using data on weekly
   climatic variables and weekly malaria cases (counts) in Chimoio
   municipality, from 2006 to 2014. All data were analysed using SPSS-20, R
   3.3.2 and BioEstat 5.0. Cross-correlation analysis, linear processes,
   namely ARIMA models and regression modelling, were used to develop the
   final model.
   Results: Between 2006 and 2014, 490,561 cases of malaria were recorded
   in Chimoio. Both malaria and climatic data exhibit weekly and yearly
   systematic fluctuations. Cross-correlation analysis showed that mean
   temperature and precipitation present significantly lagged correlations
   with malaria cases. An ARIMA model (2,1,0) (2,1,1) 52, and a regression
   model for a Box-Cox transformed number of malaria cases with lags 1, 2
   and 3 of weekly malaria cases and lags 6 and 7 of weekly mean
   temperature and lags 12 of precipitation were fitted. Although, both
   produced similar widths for prediction intervals, the last was able to
   anticipate malaria outbreak more accurately.
   Conclusion: The Chimoio climate seems ideal for malaria occurrence.
   Malaria occurrence peaks during January to March in Chimoio. As the lag
   effect between climatic events and malaria occurrence is important for
   the prediction of malaria cases, this can be used for designing public
   precision health measures. The model can be used for planning specific
   measures for Chimoio municipality. Prospective and multidisciplinary
   research involving researchers from different fields is welcomed to
   improve the effect of climatic factors and other factors in malaria
   cases.},
Type = {Article},
Affiliation = {Ferrao, JL (Corresponding Author), Univ Catolica Mocambique, Fac Engn, Chimoio, Mozambique.
   Ferrao, Joao Luis, Univ Catolica Mocambique, Fac Engn, Chimoio, Mozambique.
   Mendes, Jorge M.; Painho, Marco, Univ Nova Lisboa, NOVA Informat Management Scholl, Lisbon, Portugal.},
DOI = {10.1186/s13071-017-2205-6},
Article-Number = {260},
Keywords = {Modelling; Malaria; Chimoio; Precision public health},
Keywords-Plus = {TRANSMISSION; DYNAMICS},
Research-Areas = {Parasitology; Tropical Medicine},
Web-of-Science-Categories  = {Parasitology; Tropical Medicine},
Author-Email = {jferrao@ucm.ac.mz},
Affiliations = {Universidade Nova de Lisboa},
Cited-References = {Alemu A, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-30.
   Alilio MS, 2004, AM J TROP MED HYG, V71, P268, DOI 10.4269/ajtmh.2004.71.268.
   ANOVA, 2012, ENG STAT HDB.
   Arab A, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-126.
   Bai L, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-10.
   Centers for Disease Control and Prevention, 2016, IMP OF MAL.
   Centers for Disease Control and Prevention, 2015, MAL BIOL.
   Efe S. I., 2013, Atmospheric and Climate Sciences, V3, P132, DOI 10.4236/acs.2013.31015.
   Global Fund. Invest, 2015, FUT DEF MAL WORLD MA.
   Gomez-Filpipe A, 2007, MALARIA J, V6, P1.
   Gosoniu LP, 2009, COMPUT STAT DATA AN, V53, P9.
   Instituto Nacional de Estatistica, 2012, REC GER POP HAB 2007.
   Kazembe LN, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-93.
   Khoury MJ, 2016, AM J PREV MED, V50, P398, DOI 10.1016/j.amepre.2015.08.031.
   Krefis AC, 2011, AM J TROP MED HYG, V84, P285, DOI 10.4269/ajtmh.2011.10-0381.
   Kumar V., 2014, MALARIA RES TREATMEN, DOI {[}10.1155/2014/482851, DOI 10.1155/2014/482851].
   Ferrao JL, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1371-x.
   Milla KA, 2005, EXTENSION J, V43, P3.
   MISAU, 2016, SIT MAL EL AN.
   Nakul C, 2010, ROLL BACK MALAR PROG, V5, P1.
   Ngomane L, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-19.
   Omonijo AG., 2011, J. Environ. Sci. Eng, V5, P1215.
   Pascual M, 2006, P NATL ACAD SCI USA, V103, P5829, DOI 10.1073/pnas.0508929103.
   Sena L, 2015, ETHIOP J HLTH SCI, V25, P2.
   Srimath-Tirumula-Peddinti RPK, 2015, PLOS ONE, V10, P6.
   Suárez-Mutis MC, 2009, MEM I OSWALDO CRUZ, V104, P11, DOI 10.1590/S0074-02762009000100002.
   Tian LW, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-110.
   Tutitiempo, 2015, CLIM DAT AFR.
   Westerink R., 2005, INIA, V79, P4.
   Yamana TK, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-235.
   Zacarias Jere S, 2006, OPEN J STAT, V6, P295.
   Zacarias OP, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-189.},
Number-of-Cited-References = {32},
Times-Cited = {16},
Unique-ID = {WOS:000402334800005},
}

@article{ WOS:000704712700003,
Author = {Ingalls, Allison and Barlow, Allison and Kushman, Elizabeth and Leonard,
   Amanda and Martin, Lisa and West, Allison L. and Neault, Nicole and
   Haroz, Emily E. and Precision Family Spirit Study Team},
Title = {Precision Family Spirit: a pilot randomized implementation trial of a
   precision home visiting approach with families in Michigan-trial
   rationale and study protocol},
Journal = {PILOT AND FEASIBILITY STUDIES},
Year = {2021},
Volume = {7},
Number = {1},
Month = {JAN 6},
Abstract = {Background: Home visiting is a well-supported strategy for addressing
   maternal and child health disparities. However, evidence-based models
   generally share implementation challenges at scale, including engagement
   and retention of families. Precision home visiting may address this
   issue. This paper describes the first known pilot randomized
   implementation trial of a precision home visiting approach vs. standard
   implementation. Primary aims are to: 1) explore the acceptability and
   feasibility of a precision approach to home visiting and 2) examine the
   difference between Standard Family Spirit and Precision Family Spirit on
   participants' program satisfaction, client-home visitor relationship,
   goal alliance, and the impact of these factors on participant engagement
   and retention. Secondary aims are to explore potential differences on
   maternal behavioral and mental health outcomes and child development
   outcomes to inform sample size estimations for a fully powered study.
   Methods: This is a pilot Hybrid Type 3 implementation trial. Four
   Michigan communities primarily serving the Native American families and
   already using Family Spirit were randomized by site to receive Standard
   Family Spirit or Precision Family Spirit. Participants include N = 60
   mothers at least 14 years of age (pregnant or with a newborn < 2 months
   of age) currently enrolled in Family Spirit. Precision Family Spirit
   participants receive core lessons plus additional lessons based on needs
   identified at baseline and that emerge during the trial. Control mothers
   receive the standard sequence of Family Spirit lessons. Data is
   collected at baseline (< 2 months postpartum), and 2, 6, and 12 months
   postpartum. All Precision Family Spirit participants are invited to
   complete qualitative interviews at study midpoint and endpoint. All home
   visitors are invited to participate in focus groups between study
   midpoint and endpoint. Exploratory data analysis will assess
   feasibility, acceptability, client-home visitor relationship, retention,
   adherence, and potential differences in intervention outcomes.
   Discussion: This trial will provide new information about the
   acceptability and feasibility of precision home visiting and pilot data
   on program satisfaction, client-home visitor relationship, goal
   alliance, retention, and targeted maternal-child intervention outcomes.
   Findings will inform the design of a fully powered randomized
   implementation trial of precision vs. standard home visiting.},
Type = {Article},
Affiliation = {Ingalls, A (Corresponding Author), Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Amer Indian Hlth, Dept Int Hlth, Baltimore, MD 21205 USA.
   Ingalls, Allison; Barlow, Allison; Neault, Nicole; Haroz, Emily E., Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Amer Indian Hlth, Dept Int Hlth, Baltimore, MD 21205 USA.
   Kushman, Elizabeth; Leonard, Amanda; Martin, Lisa; Precision Family Spirit Study Team, Intertribal Council Michigan Inc, Maternal Infant \& Early Childhood Serv, Sault Sainte Marie, MI USA.
   West, Allison L., Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat Family \& Reprod Hlth, Baltimore, MD USA.},
DOI = {10.1186/s40814-020-00753-4},
Article-Number = {8},
Keywords = {Precision science; Precision public health; Implementation science;
   Hybrid design; American Indian; Pregnancy and childbirth; Randomized
   controlled trials; Home-visiting},
Keywords-Plus = {INDIAN TEEN MOTHERS; POSTNATAL DEPRESSION; INTERVENTION; ALCOHOL;
   VALIDATION; FEEDBACK; OUTCOMES; SMOKING; SCALE; CARE},
Research-Areas = {Research \& Experimental Medicine},
Web-of-Science-Categories  = {Medicine, Research \& Experimental},
Author-Email = {aingalls@jhu.edu},
Affiliations = {Johns Hopkins University; Johns Hopkins Bloomberg School of Public
   Health; Johns Hopkins University; Johns Hopkins Bloomberg School of
   Public Health},
Cited-References = {Ali R, 2002, ADDICTION, V97, P1183.
   Ammerman RT, 2016, CURR PROB PEDIATR AD, V46, P126, DOI 10.1016/j.cppeds.2015.12.010.
   Barlow A, 2006, ARCH PEDIAT ADOL MED, V160, P1101, DOI 10.1001/archpedi.160.11.1101.
   Barlow A, 2015, AM J PSYCHIAT, V172, P154, DOI 10.1176/appi.ajp.2014.14030332.
   Barlow A, 2013, AM J PSYCHIAT, V170, P83, DOI 10.1176/appi.ajp.2012.12010121.
   Bickman L, 2012, COUPLE FAM PSYCHOL, V1, P274, DOI 10.1037/a0031022.
   Bickman L, 2011, PSYCHIAT SERV, V62, P1423, DOI 10.1176/appi.ps.002052011.
   Burrell L, 2018, MATERN CHILD HLTH J, V22, P43, DOI 10.1007/s10995-018-2535-9.
   CAMPIS LK, 1986, J CLIN CHILD PSYCHOL, V15, P260, DOI 10.1207/s15374424jccp1503\_10.
   COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404.
   Corbin A., 2015, BASICS QUALITATIVE R, VFourth.
   Curran GM, 2012, MED CARE, V50, P217, DOI 10.1097/MLR.0b013e3182408812.
   Haroz EE, 2019, PREV SCI, V20, P1244, DOI 10.1007/s11121-019-01039-9.
   Haroz EE, 2017, INTERNAL REPORT.
   Haroz EE, 2020, J COMMUNITY PSYCHOL, V48, P1100, DOI 10.1002/jcop.22281.
   Hedrick VE, 2012, J ACAD NUTR DIET, V112, P840, DOI 10.1016/j.jand.2012.01.023.
   Humeniuk R, 2008, ADDICTION, V103, P1039, DOI 10.1111/j.1360-0443.2007.02114.x.
   Indian Health Service, 2019, FACT SHEETS DISP.
   Indian Health Service, 2018, REP BEH HLTH 2018 ED.
   Indian Health Service, 2015, TRENDS IND HLTH 2014.
   Ingalls Allison, 2019, BMC Obes, V6, P18, DOI 10.1186/s40608-019-0233-9.
   Ingoldsby EM, 2013, PREV SCI, V14, P525, DOI 10.1007/s11121-013-0410-x.
   Kennedy C, 2004, MATERN CHILD HLTH J, V8, P137, DOI 10.1023/B:MACI.0000037647.78420.e3.
   Kozinszky Z, 2015, J AFFECT DISORDERS, V176, P95, DOI 10.1016/j.jad.2015.01.044.
   Lieber E., 2011, DEDOOSE TAYLOR J.
   Lyon AR, 2014, PROF PSYCHOL-RES PR, V45, P57, DOI 10.1037/a0035301.
   Mathematica, 2019, 201993 OPRE.
   Michalopoulos C., 2019, SUMMARY RESULTS MIHO.
   O'Brien RA, 2012, PREV SCI, V13, P219, DOI 10.1007/s11121-012-0287-0.
   Office of Planning Research \& Evaluation, 2020, 2020126 OPRE.
   Proctor EK, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-139.
   Proctor EK, 2009, ADM POLICY MENT HLTH, V36, P24, DOI 10.1007/s10488-008-0197-4.
   Scott K, 2015, COGN BEHAV PRACT, V22, P49, DOI 10.1016/j.cbpra.2014.01.010.
   Squires J., 2009, A parent-completed child monitoring system. 3rd ed. Baltimore: MD: Brookes, V3rd.
   Squires J, 2015, AGES STAGES QUESTION.
   Supplee LH, 2019, CHILD DEV PERSPECT, V13, P173, DOI 10.1111/cdep.12334.
   Supplee LH, 2018, PREV SCI, V19, P689, DOI 10.1007/s11121-018-0884-7.
   Walkup JT, 2009, J AM ACAD CHILD PSY, V48, P591, DOI 10.1097/CHI.0b013e3181a0ab86.
   Weisz JR, 2011, J CONSULT CLIN PSYCH, V79, P369, DOI 10.1037/a0023307.
   Westall C, 2011, MOTHERHOOD AND POSTNATAL DEPRESSION: NARRATIVES OF WOMEN AND THEIR PARTNERS, P7, DOI 10.1007/978-94-007-1694-0\_2.
   WILLIAMS A, 1990, HEALTH POLICY, V16, P199.},
Number-of-Cited-References = {41},
Times-Cited = {5},
Unique-ID = {WOS:000704712700003},
}

@article{ WOS:000540993600024,
Author = {Reiner, Jr., Robert C. and Wiens, Kirsten E. and Deshpande, Aniruddha
   and Baumann, Mathew M. and Lindstedt, Paulina A. and Blacker, Brigette
   F. and Troeger, Christopher E. and Earl, Lucas and Munro, Sandra B. and
   Abate, Degu and Abbastabar, Hedayat and Abd-Allah, Foad and Abdelalim,
   Ahmed and Abdollahpour, Ibrahim and Abdulkader, Rizwan Suliankatchi and
   Abebe, Getaneh and Abegaz, Kedir Hussein and Abreu, Lucas Guimaraes and
   Abrigo, Michael R. M. and Accrombessi, Manfred Mario Kokou and Acharya,
   Dilaram and Adabi, Maryam and Adebayo, Oladimeji M. and Adedoyin, Rufus
   Adesoji and Adekanmbi, Victor and Adetokunboh, Olatunji O. and Adham,
   Davoud and Adhena, Beyene Meressa and Afarideh, Mohsen and Ahmadi,
   Keivan and Ahmadi, Mehdi and Ahmed, Anwar E. and Ahmed, Muktar Beshir
   and Ahmed, Rushdia and Ajumobi, Olufemi and Akal, Chalachew Genet and
   Akalu, Temesgen Yihunie and Akanda, Ali S. and Alamene, Genet Melak and
   Alanzi, Turki M. and Albright, James R. and Rabanal, Jacqueline
   Elizabeth Alcalde and Alemnew, Birhan Tamene and Alemu, Zewdie Aderaw
   and Ali, Beriwan Abdulqadir and Ali, Muhammad and Alijanzadeh, Mehran
   and Alipour, Vahid and Aljunid, Syed Mohamed and Almasi, Ali and
   Almasi-Hashiani, Amir and Al-Mekhlafi, Hesham M. and Altirkawi, Khalid
   and Alvis-Guzman, Nelson and Alvis-Zakzuk, Nelson J. and Amare, Azmeraw
   T. and Amini, Saeed and Amit, Arianna Maever Loreche and Andrei,
   Catalina Liliana and Anegago, Masresha Tessema and Anjomshoa, Mina and
   Ansari, Fereshteh and Antonio, Carl Abelardo T. and Antriyandarti,
   Ernoiz and Appiah, Seth Christopher Yaw and Arabloo, Jalal and Aremu,
   Olatunde and Armoon, Bahram and Aryal, Krishna K. and Arzani, Afsaneh
   and Asadi-Lari, Mohsen and Ashagre, Alebachew Fasil and Atalay, Hagos
   Tasew and Atique, Suleman and Atre, Sachin R. and Ausloos, Marcel and
   Avila-Burgos, Leticia and Awasthi, Ashish and Awoke, Nefsu and
   Quintanilla, Beatriz Paulina Ayala and Ayano, Getinet and Ayanore,
   Martin Amogre and Ayele, Asnakew Achaw and Aynalem, Yared Asmare and
   Azari, Samad and Babaee, Ebrahim and Badawi, Alaa and Bakkannavar,
   Shankar M. and Balakrishnan, Senthilkumar and Bali, Ayele Geleto and
   Banach, Maciej and Barac, Aleksandra and Barnighausen, Till Winfried and
   Basaleem, Huda and Bassat, Quique and Bayati, Mohsen and Bedi, Neeraj
   and Behzadifar, Masoud and Behzadifar, Meysam and Bekele, Yibeltal Alemu
   and Bell, Michelle L. and Bennett, Derrick A. and Berbada, Dessalegn
   Ajema and Beyranvand, Tina and Bhat, Anusha Ganapati and Bhattacharyya,
   Krittika and Bhattarai, Suraj and Bhaumik, Soumyadeep and Bijani, Ali
   and Bikbov, Boris and Biswas, Raaj Kishore and Bogale, Kassawmar Angaw
   and Bohlouli, Somayeh and Brady, Oliver J. and Bragazzi, Nicola Luigi
   and Briko, Andrey Nikolaevich and Briko, Nikolay Ivanovich and Nagaraja,
   Sharath Burugina and Butt, Zahid A. and Campos-Nonato, Ismael R. and
   Rincon, Julio Cesar Campuzano and Cardenas, Rosario and Carvalho, Felix
   and Castro, Franz and Chansa, Collins and Chatterjee, Pranab and Chattu,
   Vijay Kumar and Chauhan, Bal Govind and Chin, Ken Lee and Christopher,
   Devasahayam J. and Chu, Dinh-Toi and Claro, Rafael M. and Cormier,
   Natalie M. and Costa, Vera M. and Damiani, Giovanni and Daoud, Farah and
   Dandona, Lalit and Dandona, Rakhi and Darwish, Amira Hamed and Daryani,
   Ahmad and Das, Jai K. and Das Gupta, Rajat and Dasa, Tamirat Tesfaye and
   Davila, Claudio Alberto and Weaver, Nicole Davis and Davitoiu, Dragos
   Virgil and De Neve, Jan-Walter and Demeke, Feleke Mekonnen and Demis,
   Asmamaw Bizuneh and Demoz, Gebre Teklemariam and Denova-Gutierrez, Edgar
   and Deribe, Kebede and Desalew, Assefa and Dessie, Getenet Ayalew and
   Dharmaratne, Samath Dhamminda and Dhillon, Preeti and Dhimal, Meghnath
   and Dhungana, Govinda Prasad and Diaz, Daniel and Ding, Eric L. and
   Diro, Helen Derara and Djalalinia, Shirin and Do, Huyen Phuc and Doku,
   David Teye and Dolecek, Christiane and Dubey, Manisha and Dubljanin,
   Eleonora and Adema, Bereket Duko and Dunachie, Susanna J. and Duraes,
   Andre R. and Duraisamy, Senbagam and Effiong, Andem and Eftekhari, Aziz
   and El Sayed, Iman and Zaki, Maysaa El Sayed and El Tantawi, Maha and
   Elemineh, Demelash Abewa and El-Jaafary, Shaimaa I. and Elkout, Hajer
   and Elsharkawy, Aisha and Enany, Shymaa and Endalamaw, Aklilu and
   Endalew, Daniel Adane and Eskandarieh, Sharareh and Esteghamati, Alireza
   and Etemadi, Arash and Farag, Tamer H. and Faraon, Emerito Jose A. and
   Fareed, Mohammad and Faridnia, Roghiyeh and Farioli, Andrea and Faro,
   Andre and Farzam, Hossein and Fazaeli, Ali Akbar and Fazlzadeh, Mehdi
   and Fentahun, Netsanet and Fereshtehnejad, Seyed-Mohammad and Fernandes,
   Eduarda and Filip, Irina and Fischer, Florian and Foroutan, Masoud and
   Francis, Joel Msafiri and Franklin, Richard Charles and Frostad, Joseph
   Jon and Fukumoto, Takeshi and Gayesa, Reta Tsegaye and Gebremariam,
   Kidane Tadesse and Gebremedhin, Ketema Bizuwork and Gebremeskel,
   Gebreamlak Gebremedhn and Gedefaw, Getnet Azeze and Geramo, Yilma Chisha
   Dea and Geta, Birhanu and Gezae, Kebede Embaye and Ghashghaee, Ahmad and
   Ghassemi, Fariba and Gill, Paramjit Singh and Ginawi, Ibrahim
   Abdelmageed and Goli, Srinivas and Gomes, Nelson G. M. and Gopalani,
   Sameer Vali and Goulart, Barbara Niegia Garcia and Grada, Ayman and
   Gugnani, Harish Chander and Guido, Davide and Guimaraes, Rafael Alves
   and Guo, Yuming and Gupta, Rahul and Gupta, Rajeev and Hafezi-Nejad,
   Nima and Haile, Michael Tamene and Hailu, Gessessew Bugssa and
   Haj-Mirzaian, Arvin and Haj-Mirzaian, Arya and Hall, Brian James and
   Handiso, Demelash Woldeyohannes and Haririan, Hamidreza and Hariyani,
   Ninuk and Hasaballah, Ahmed I. and Hasan, Md. Mehedi and Hasanzadeh,
   Amir and Hassankhani, Hadi and Hassen, Hamid Yimam and Hayelom, Desta
   Haftu and Heidari, Behnam and Henry, Nathaniel J. and Herteliu, Claudiu
   and Heydarpour, Fatemeh and de Hidru, Hagos D. and Hoang, Chi Linh and
   Hoogar, Praveen and Hoseini-Ghahfarokhi, Mojtaba and Hossain, Naznin and
   Hosseini, Mostafa and Hosseinzadeh, Mehdi and Househ, Mowafa and Hu,
   Guoqing and Humayun, Ayesha and Hussain, Syed Ather and Ibitoye, Segun
   Emmanuel and Ilesanmi, Olayinka Stephen and Ilic, Milena D. and Inbaraj,
   Leeberk Raja and Irvani, Seyed Sina Naghibi and Islam, Sheikh Mohammed
   Shariful and Iwu, Chinwe Juliana and Jaca, Anelisa and Balalami, Nader
   Jafari and Jahanmehr, Nader and Jakovljevic, Mihajlo and Jalali, Amir
   and Jayatilleke, Achala Upendra and Jenabi, Ensiyeh and Jha, Ravi
   Prakash and Jha, Vivekanand and Ji, John S. and Jia, Peng and Johnson,
   Kimberly B. and Jonas, Jost B. and Jozwiak, Jacek Jerzy and Kabir, Ali
   and Kabir, Zubair and Kahsay, Amaha and Kalani, Hamed and Kanchan, Tanuj
   and Matin, Behzad Karami and Karch, Andre and Karki, Surendra and
   Kasaeian, Amir and Kasahun, Gebremicheal Gebreslassie and Kayode, Gbenga
   A. and Karyani, Ali Kazemi and Keiyoro, Peter Njenga and Ketema, Daniel
   Bekele and Khader, Yousef Saleh and Khafaie, Morteza Abdullatif and
   Khalid, Nauman and Khalil, Ali Talha and Khalil, Ibrahim and Khalilov,
   Rovshan and Khan, Md Nuruzzaman and Khan, Ejaz Ahmad and Khan, Gulfaraz
   and Khan, Junaid and Khatab, Khaled and Khater, Amir and Khater, Mona M.
   and Khatony, Alireza and Khayamzadeh, Maryam and Khazaei, Mohammad and
   Khazaei, Salman and Khodamoradi, Ehsan and Khosravi, Mohammad Hossein
   and Khubchandani, Jagdish and Kiadaliri, Aliasghar A. and Kim, Yun Jin
   and Kimokoti, Ruth W. and Kisa, Adnan and Kisa, Sezer and Kissoon,
   Niranjan and Kondlahalli, Shivakumar K. M. and Kosek, Margaret N. and
   Koyanagi, Ai and Kraemer, Moritz U. G. and Krishan, Kewal and Kugbey,
   Nuworza and Kumar, G. Anil and Kumar, Manasi and Kumar, Pushpendra and
   Kusuma, Dian and La Vecchia, Carlo and Ben Lacey and Lal, Aparna and
   Lal, Dharmesh Kumar and Lami, Faris Hasan and Lansingh, Van C. and
   Lasrado, Savita and Lee, Paul H. and Leili, Mostafa and Lenjebo, Tsegaye
   Lolaso and Levine, Aubrey J. and Lewycka, Sonia and Li, Shanshan and
   Linn, Shai and Lodha, Rakesh and Longbottom, Joshua and Lopukhov, Platon
   D. and Magdeldin, Sameh and Mahasha, Phetole Walter and Mahotra, Narayan
   Bahadur and Malta, Deborah Carvalho and Mamun, Abdullah A. and Manafi,
   Farzad and Manafi, Navid and Manda, Ana-Laura and Mansournia, Mohammad
   Ali and Mapoma, Chabila Christopher and Marami, Dadi and Marczak, Laurie
   B. and Martins-Melo, Francisco Rogerlandio and Marz, Winfried and
   Masaka, Anthony and Mathur, Manu Raj and Maulik, Pallab K. and Mayala,
   Benjamin K. and McAlinden, Colm and Mehndiratta, Man Mohan and Mehrotra,
   Ravi and Mehta, Kala M. and Meles, Gebrekiros Gebremichael and Melese,
   Addisu and Memish, Ziad A. and Mena, Alemayehu Toma and Menezes, Ritesh
   G. and Mengesha, Melkamu Merid and Mengistu, Desalegn Tadese and
   Mengistu, Getnet and Meretoja, Tuomo J. and Miazgowski, Bartosz and
   Mihretie, Kebadnew Mulatu M. and Miller-Petrie, Molly K. and Mills,
   Edward J. and Mir, Seyed Mostafa and Mirabi, Parvaneh and Mirrakhimov,
   Erkin M. and Mohamadi-Bolbanabad, Amjad and Mohammad, Dara K. and
   Mohammad, Karzan Abdulmuhsin and Mohammad, Yousef and Darwesh, Aso
   Mohammad and Mezerji, Naser Mohammad Gholi and Mohammadifard, Noushin
   and Mohammed, Ammas Siraj and Mohammed, Jemal Abdu and Mohammed, Shafiu
   and Mohebi, Farnam and Mokdad, Ali H. and Moodley, Yoshan and Moradi,
   Ghobad and Moradi, Masoud and Moradi-Joo, Mohammad and Moradi-Lakeh,
   Maziar and Moraga, Paula and Mosapour, Abbas and Mouodi, Simin and
   Mousavi, Seyyed Meysam and Mozaffor, Miliva and Muluneh, Atalay Goshu
   and Muriithi, Moses K. and Murray, Christopher J. L. and Murthy, G. V.
   S. and Musa, Kamarul Imran and Mustafa, Ghulam and Muthupandian,
   Saravanan and Naderi, Mehdi and Nagarajan, Ahamarshan Jayaraman and
   Naghavi, Mohsen and Najafi, Farid and Nangia, Vinay and Nazari, Javad
   and Ndwandwe, Duduzile Edith and Negoi, Ionut and Ngunjiri, Josephine W.
   and Nguyen, Cuong Tat and Nguyen, QuynhAnh P. and Nguyen, Trang Huyen
   and Nigatu, Dabere and Ningrum, Dina Nur Anggraini and Nnaji, Chukwudi
   A. and Nojomi, Marzieh and Noubiap, Jean Jacques and Oh, In-Hwan and
   Okpala, Oluchi and Olagunju, Andrew T. and Bali, Ahmed Omar and
   Onwujekwe, Obinna E. and Ortega-Altamirano, Doris D. V. and Osarenotor,
   Osayomwanbo and Osei, Frank B. and Owolabi, Mayowa Ojo and Mahesh, P. A.
   and Padubidri, Jagadish Rao and Pana, Adrian and Pashaei, Tahereh and
   Pati, Sanghamitra and Patle, Ajay and Patton, George C. and Paulos,
   Kebreab and Pepito, Veincent Christian Filipino and Pereira, Alexandre
   and Perico, Norberto and Pesudovs, Konrad and Pigott, David M. and
   Piroozi, Bakhtiar and Platts-Mills, James A. and Poljak, Mario and
   Postma, Maarten J. and Pourjafar, Hadi and Pourmalek, Farshad and
   Pourshams, Akram and Poustchi, Hossein and Prada, Sergio I. and
   Preotescu, Liliana and Quintana, Hedley and Rabiee, Mohammad and Rabiee,
   Navid and Radfar, Amir and Rafiei, Alireza and Rahim, Fakher and
   Rahimi-Movaghar, Vafa and Rahman, Muhammad Aziz and Rajati, Fatemeh and
   Ramezanzadeh, Kiana and Rana, Saleem M. and Ranabhat, Chhabi Lal and
   Rasella, Davide and Rawaf, David Laith and Rawal, Salman Rawaf Lal and
   Remuzzi, Giuseppe and Renjith, Vishnu and Renzaho, Andre M. N. and Reta,
   Melese Abate and Rezaei, Satar and Ribeiro, Ana Isabel and Rickard,
   Jennifer and Gonzalez, Carlos Miguel Rios and Rios-Blancas, Maria Jesus
   and Roever, Leonardo and Ronfani, Luca and Roro, Elias Merdassa and
   Rostami, Ali and Rothenbacher, Dietrich and Rubagotti, Enrico and
   Rubino, Salvatore and Saad, Anas M. and Sabour, Siamak and Sadeghi,
   Ehsan and Safari, Saeed and Safdarian, Mahdi and Sagar, Rajesh and
   Sahraian, Mohammad Ali and Sajadi, S. Mohammad and Salahshoor, Mohammad
   Reza and Salam, Nasir and Salehi, Farkhonde and Zahabi, Saleh Salehi and
   Salem, Hosni and Salem, Marwa R. Rashad and Salimi, Yahya and
   Salimzadeh, Hamideh and Sambala, Evanson Zondani and Samy, Abdallah M.
   and Sanabria, Juan and Santos, Itamar S. and Saraswathy, Sivan
   Yegnanarayana Iyer and Sarker, Abdur Razzaque and Sartorius, Benn and
   Sathian, Brijesh and Satpathy, Maheswar and Sbarra, Alyssa N. and
   Schaeffer, Lauren E. and Schwebel, David C. and Senbeta, Anbissa Muleta
   and Senthilkumaran, Subramanian and Shabaninejad, Hosein and Shaheen,
   Amira A. and Shaikh, Masood Ali and Shalash, Ali S. and Shallo, Seifadin
   Ahmed and Shams-Beyranvand, Mehran and Shamsi, MohammadBagher and
   Shamsizadeh, Morteza and Sharif, Mehdi and Shey, Muki Shehu and Shibuya,
   Kenji and Shiferaw, Wondimeneh Shibabaw and Shigematsu, Mika and Shil,
   Apurba and Shin, Jae Il and Shiri, Rahman and Shirkoohi, Reza and
   Siabani, Si Si Soraya and Singh, Jasvinder A. and Singh, Narinder Pal
   and Sinha, Dhirendra Narain and Sisay, Malede Mequanent and Skiadaresi,
   Eirini and Smith, David L. and Sobhiyeh, Mohammad Reza and Sokhan, Anton
   and Soofi, Moslem and Soriano, Joan B. and Sorrie, Muluken Bekele and
   Soyiri, Ireneous N. and Sreeramareddy, Chandrashekhar T. and Sudaryanto,
   Agus and Sufiyan, Mu'awiyyah Babale and Suleria, Hafiz Ansar Rasul and
   Sykes, Bryan L. and Tamirat, Koku Sisay and Tassew, Aberash Abay and
   Taveira, Nuno and Taye, Bineyam and Tehrani-Banihashemi, Arash and
   Temsah, Mohamad-Hani and Tesfay, Berhe Etsay and Tesfay, Fisaha Haile
   and Tessema, Zemenu Tadesse and Thankappan, Kavumpurathu Raman and
   Thirunavukkarasu, Sathish and Thomas, Nihal and Tlaye, Kenean Getaneh
   and Tlou, Boikhutso and Tovani-Palone, Marcos Roberto and Traini,
   Eugenio and Tran, Khanh Bao and Trihandini, Indang and Ullah, Irfan and
   Unnikrishnan, Bhaskaran and Tahbaz, Sahel Valadan and Valdez, Pascual R.
   and Varughese, Santosh and Veisani, Yousef and Violante, Francesco S.
   and Vollmer, Sebastian and Vos, Theo and Wada, Fiseha Wadilo and Waheed,
   Yasir and Wang, Yafeng and Wang, Yuan-Pang and Weldesamuel, Girmay
   Teklay and Welgan, Catherine A. and Westerman, Ronny and Wiangkham,
   Taweewat and Wijeratne, Tissa and Wiysonge, Charles Shey and Wolde,
   Haileab Fekadu and Wondafrash, Dawit Zewdu and Wonde, Tewodros Eshete
   and Wu, Ai-Min and Xu, Gelin and Yadollahpour, Ali and Jabbari, Seyed
   Hossein Yahyazadeh and Yamada, Tomohide and Yaseri, Mehdi and Yenesew,
   Muluken Azage and Yeshaneh, Alex and Yilma, Mekdes Tigistu and Yimer,
   Ebrahim M. and Yip, Paul and Yirsaw, Biruck Desalegn and Yisma, Engida
   and Yonemoto, Naohiro and Younis, Mustafa Z. and Yousof, Hebat-Allah
   Salah A. and Yu, Chuanhua and Yusefzadeh, Hasan and Zamani, Mohammad and
   Zambrana-Torrelio, Carlos and Zandian, Hamed and Zeleke, Ayalew Jejaw
   and Zepro, Nejimu Biza and Zewale, Taye Abuhay and Zhang, Dongyu and
   Zhang, Yunquan and Zhao, Xiu-Ju and Ziapour, Arash and Zodpey, Sanjay
   and Hay, Simon I. and Local Burden Dis Diarrhoea},
Title = {Mapping geographical inequalities in childhood diarrhoeal morbidity and
   mortality in low-income and middle-income countries, 2000-17: analysis
   for the Global Burden of Disease Study 2017},
Journal = {LANCET},
Year = {2020},
Volume = {395},
Number = {10239},
Pages = {1779-1801},
Month = {JUN 6},
Abstract = {Background Across low-income and middle-income countries (LMICs), one in
   ten deaths in children younger than 5 years is attributable to
   diarrhoea. The substantial between-country variation in both diarrhoea
   incidence and mortality is attributable to interventions that protect
   children, prevent infection, and treat disease. Identifying subnational
   regions with the highest burden and mapping associated risk factors can
   aid in reducing preventable childhood diarrhoea.
   Methods We used Bayesian model-based geostatistics and a geolocated
   dataset comprising 15 072 746 children younger than 5 years from 466
   surveys in 94 LMICs, in combination with findings of the Global Burden
   of Diseases, Injuries, and Risk Factors Study (GBD) 2017, to estimate
   posterior distributions of diarrhoea prevalence, incidence, and
   mortality from 2000 to 2017. From these data, we estimated the burden of
   diarrhoea at varying subnational levels (termed units) by spatially
   aggregating draws, and we investigated the drivers of subnational
   patterns by creating aggregated risk factor estimates.
   Findings The greatest declines in diarrhoeal mortality were seen in
   south and southeast Asia and South America, where 54.0\% (95\%
   uncertainty interval {[}UI] 38.1-65.8), 17.4\% (7.7-28.4), and 59.5\%
   (34.2-86.9) of units, respectively, recorded decreases in deaths from
   diarrhoea greater than 10\%. Although children in much of Africa remain
   at high risk of death due to diarrhoea, regions with the most deaths
   were outside Africa, with the highest mortality units located in
   Pakistan. Indonesia showed the greatest within-country geographical
   inequality; some regions had mortality rates nearly four times the
   average country rate. Reductions in mortality were correlated to
   improvements in water, sanitation, and hygiene (WASH) or reductions in
   child growth failure (CGF). Similarly, most high-risk areas had poor
   WASH, high CGF, or low oral rehydration therapy coverage.
   Interpretation By co-analysing geospatial trends in diarrhoeal burden
   and its key risk factors, we could assess candidate drivers of
   subnational death reduction. Further, by doing a counterfactual analysis
   of the remaining disease burden using key risk factors, we identified
   potential intervention strategies for vulnerable populations. In view of
   the demands for limited resources in LMICs, accurately quantifying the
   burden of diarrhoea and its drivers is important for precision public
   health. Copyright (C) 2020 The Author(s). Published by Elsevier Ltd.},
Type = {Article},
Affiliation = {Reiner, RC (Corresponding Author), Univ Washington, Sch Med, Dept Hlth Metr Sci, Inst Hlth Metr \& Evaluat, Seattle, WA 98121 USA.
   Reiner, Robert C., Jr.; Wiens, Kirsten E.; Deshpande, Aniruddha; Baumann, Mathew M.; Lindstedt, Paulina A.; Blacker, Brigette F.; Troeger, Christopher E.; Earl, Lucas; Munro, Sandra B.; Albright, James R.; Cormier, Natalie M.; Daoud, Farah; Dandona, Lalit; Dandona, Rakhi; Weaver, Nicole Davis; Dharmaratne, Samath Dhamminda; Farag, Tamer H.; Frostad, Joseph Jon; Henry, Nathaniel J.; Johnson, Kimberly B.; Levine, Aubrey J.; Marczak, Laurie B.; Mayala, Benjamin K.; Miller-Petrie, Molly K.; Mokdad, Ali H.; Murray, Christopher J. L.; Naghavi, Mohsen; Nguyen, QuynhAnh P.; Pigott, David M.; Sbarra, Alyssa N.; Schaeffer, Lauren E.; Smith, David L.; Vos, Theo; Welgan, Catherine A.; Hay, Simon I., Univ Washington, Inst Hlth Metr \& Evaluat, Seattle, WA 98195 USA.
   Khalil, Ibrahim, Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.
   Reiner, Robert C., Jr.; Dandona, Lalit; Mokdad, Ali H.; Murray, Christopher J. L.; Naghavi, Mohsen; Pigott, David M.; Sartorius, Benn; Smith, David L.; Vos, Theo; Hay, Simon I., Univ Washington, Dept Hlth Metr Sci, Sch Med, Seattle, WA 98195 USA.
   Diro, Helen Derara, Haramaya Univ, Coll Hlth \& Med Sci, Harar, Ethiopia.
   Mengesha, Melkamu Merid, Haramaya Univ, Dept Epidemiol \& Biostat, Harar, Ethiopia.
   Abate, Degu; Balakrishnan, Senthilkumar; Marami, Dadi, Haramaya Univ, Dept Med Lab Sci, Harar, Ethiopia.
   Dasa, Tamirat Tesfaye; Desalew, Assefa, Haramaya Univ, Sch Nursing \& Midwifery, Harar, Ethiopia.
   Mengistu, Getnet; Mohammed, Shafiu, Haramaya Univ, Sch Pharm, Harar, Ethiopia.
   Bali, Ayele Geleto, Haramaya Univ, Sch Publ Hlth, Harar, Ethiopia.
   Gedefaw, Getnet Azeze, Haramaya Univ, Harar, Ethiopia.
   Abbastabar, Hedayat, Univ Tehran Med Sci, Adv Diagnost \& Intervent Radiol Res Ctr, Tehran, Iran.
   Shirkoohi, Reza, Univ Tehran Med Sci, Canc Biol Res Ctr, Tehran, Iran.
   Shirkoohi, Reza, Univ Tehran Med Sci, Canc Res Inst, Tehran, Iran.
   Moradi-Joo, Mohammad, Univ Tehran Med Sci, Dept Econ \& Management Sci Hlth, Tehran, Iran.
   Fazlzadeh, Mehdi, Univ Tehran Med Sci, Dept Environm Hlth Engn, Tehran, Iran.
   Hosseini, Mostafa; Mansournia, Mohammad Ali; Yaseri, Mehdi, Univ Tehran Med Sci, Dept Epidemiol \& Biostat, Tehran, Iran.
   Mousavi, Seyyed Meysam, Univ Tehran Med Sci, Dept Hlth Management \& Econ, Tehran, Iran.
   Hasanzadeh, Amir, Univ Tehran Med Sci, Dept Microbiol, Tehran, Iran.
   Haj-Mirzaian, Arvin; Haj-Mirzaian, Arya, Univ Tehran Med Sci, Dept Pharmacol, Tehran, Iran.
   Pourshams, Akram; Poustchi, Hossein; Salimzadeh, Hamideh, Univ Tehran Med Sci, Digest Dis Res Inst, Tehran, Iran.
   Afarideh, Mohsen; Esteghamati, Alireza; Heidari, Behnam, Univ Tehran Med Sci, Endocrinol \& Metab Res Ctr, Tehran, Iran.
   Kasaeian, Amir, Univ Tehran Med Sci, Hematol Oncol \& Stem Cell Transplantat Res Ctr, Tehran, Iran.
   Mohebi, Farnam, Univ Tehran Med Sci, Iran Natl Inst Hlth Res, Tehran, Iran.
   Rahim, Fakher, Univ Tehran Med Sci, Metabol \& Genom Res Ctr, Tehran, Iran.
   Eskandarieh, Sharareh; Sahraian, Mohammad Ali, Univ Tehran Med Sci, Multiple Sclerosis Res Ctr, Tehran, Iran.
   Mohebi, Farnam, Univ Tehran Med Sci, Noncommunicable Dis Res Ctr, Tehran, Iran.
   Ghassemi, Fariba, Univ Tehran Med Sci, Dept Ophthalmol, Tehran, Iran.
   Hafezi-Nejad, Nima, Univ Tehran Med Sci, Sch Med, Tehran, Iran.
   Rahimi-Movaghar, Vafa; Safdarian, Mahdi, Univ Tehran Med Sci, Sina Trauma \& Surg Res Ctr, Tehran, Iran.
   Etemadi, Arash, Univ Tehran Med Sci, Tehran, Iran.
   Khater, Mona M., Cairo Univ, Dept Med Parasitol, Cairo, Egypt.
   Abd-Allah, Foad; Abdelalim, Ahmed; El-Jaafary, Shaimaa I., Cairo Univ, Dept Neurol, Cairo, Egypt.
   Elsharkawy, Aisha, Cairo Univ, Endem Med \& Hepatogastroentrol Dept, Cairo, Egypt.
   Yousof, Hebat-Allah Salah A., Cairo Univ, Dept Med Parasitol, Fac Med, Cairo, Egypt.
   Salem, Marwa R. Rashad, Cairo Univ, Publ Hlth \& Community Med Dept, Cairo, Egypt.
   Salem, Hosni, Cairo Univ, Dept Urol, Cairo, Egypt.
   Mohammadifard, Noushin, Isfahan Univ Med Sci, Cardiovasc Res Inst, Esfahan, Iran.
   Abdollahpour, Ibrahim, Isfahan Univ Med Sci, Neurosci Res Ctr, Esfahan, Iran.
   Abdulkader, Rizwan Suliankatchi, Minist Hlth, Dept Publ Hlth, Riyadh, Saudi Arabia.
   Memish, Ziad A., Minist Hlth, Res Dept, Prince Mohammed Bin Abdulaziz Hosp, Riyadh, Saudi Arabia.
   Bogale, Kassawmar Angaw; Mihretie, Kebadnew Mulatu M.; Zewale, Taye Abuhay, Bahir Dar Univ, Dept Epidemiol \& Biostat, Bahir Dar, Ethiopia.
   Abebe, Getaneh; Akal, Chalachew Genet; Demeke, Feleke Mekonnen; Melese, Addisu, Bahir Dar Univ, Dept Med Lab Sci, Bahir Dar, Ethiopia.
   Fentahun, Netsanet, Bahir Dar Univ, Dept Publ Hlth Nutr, Bahir Dar, Ethiopia.
   Bekele, Yibeltal Alemu; Nigatu, Dabere, Bahir Dar Univ, Dept Reprod Hlth \& Populat Studies, Bahir Dar, Ethiopia.
   Yenesew, Muluken Azage, Bahir Dar Univ, Sch Publ Hlth, Bahir Dar, Ethiopia.
   Amare, Azmeraw T.; Gedefaw, Getnet Azeze, Bahir Dar Univ, Bahir Dar, Ethiopia.
   Abegaz, Kedir Hussein, Madda Walabu Univ, Biostat \& Hlth Informat, Bale Robe, Ethiopia.
   Handiso, Demelash Woldeyohannes, Madda Walabu Univ, Dept Publ Hlth, Bale Robe, Ethiopia.
   Alamene, Genet Melak, Madda Walabu Univ, Sch Hlth Sci, Bale Robe, Ethiopia.
   Wada, Fiseha Wadilo, Addis Ababa Univ, Dept Microbial Cellular \& Mol Biol, Addis Ababa, Ethiopia.
   Alemnew, Birhan Tamene, Addis Ababa Univ, Dept Microbiol Immunol \& Parasitol, Addis Ababa, Ethiopia.
   Gebremedhin, Ketema Bizuwork, Addis Ababa Univ, Dept Nursing \& Midwifery, Addis Ababa, Ethiopia.
   Wondafrash, Dawit Zewdu, Addis Ababa Univ, Dept Pharmacol, Addis Ababa, Ethiopia.
   Roro, Elias Merdassa, Addis Ababa Univ, Dept Publ Hlth, Addis Ababa, Ethiopia.
   Abegaz, Kedir Hussein, Addis Ababa Univ, Radiotherapy Ctr, Addis Ababa, Ethiopia.
   Yisma, Engida, Addis Ababa Univ, Sch Allied Hlth Sci, Addis Ababa, Ethiopia.
   Deribe, Kebede, Addis Ababa Univ, Sch Publ Hlth, Addis Ababa, Ethiopia.
   Alemnew, Birhan Tamene; Demoz, Gebre Teklemariam, Addis Ababa Univ, Addis Ababa, Ethiopia.
   Malta, Deborah Carvalho, Univ Fed Minas Gerais, Dept Maternal \& Child Nursing \& Publ Hlth, Belo Horizonte, MG, Brazil.
   Abreu, Lucas Guimaraes, Univ Fed Minas Gerais, Dept Pediat Dent, Belo Horizonte, MG, Brazil.
   Claro, Rafael M., Univ Fed Minas Gerais, Dept Nutr, Belo Horizonte, MG, Brazil.
   Abrigo, Michael R. M., Philippine Inst Dev Studies, Res Dept, Quezon City, Philippines.
   Accrombessi, Manfred Mario Kokou, Benin Clin Res Inst IRCB, Cotonou, Benin.
   Acharya, Dilaram, Dongguk Univ, Dept Prevent Med, Gyeongju, South Korea.
   Acharya, Dilaram, Kathmandu Univ, Dept Community Med, Devdaha, Nepal.
   Jenabi, Ensiyeh, Hamadan Univ Med Sci, Autism Spectrum Disorders Res Ctr, Hamadan, Hamadan, Iran.
   Shamsizadeh, Morteza, Hamadan Univ Med Sci, Chron Dis Home Care Res Ctr, Hamadan, Hamadan, Iran.
   Mezerji, Naser Mohammad Gholi, Hamadan Univ Med Sci, Dept Biostat, Hamadan, Hamadan, Iran.
   Khazaei, Mohammad; Leili, Mostafa, Hamadan Univ Med Sci, Dept Environm Hlth Engn, Hamadan, Hamadan, Iran.
   Khazaei, Salman, Hamadan Univ Med Sci, Dept Epidemiol, Hamadan, Hamadan, Iran.
   Fazaeli, Ali Akbar, Hamadan Univ Med Sci, Social Determinants Hlth Res Ctr, Hamadan, Hamadan, Iran.
   Adabi, Maryam, Hamadan Univ Med Sci, Hamadan, Hamadan, Iran.
   Adebayo, Oladimeji M., Univ Coll Hosp, Dept Med, Ibadan, Nigeria.
   Adedoyin, Rufus Adesoji, Obafemi Awolowo Univ, Dept Rehabil Med, Ife, Nigeria.
   Adekanmbi, Victor, Cardiff Univ, Sch Med, Cardiff, Wales.
   Jaca, Anelisa, Stellenbosch Univ, Ctr Evidence Based Hlth Care, Stellenbosch, South Africa.
   Adetokunboh, Olatunji O.; Okpala, Oluchi, Stellenbosch Univ, Dept Global Hlth, Stellenbosch, South Africa.
   Iwu, Chinwe Juliana, Stellenbosch Univ, Hlth Syst \& Publ Hlth, Stellenbosch, South Africa.
   Iwu, Chinwe Juliana; Jaca, Anelisa; Mahasha, Phetole Walter; Ndwandwe, Duduzile Edith; Nnaji, Chukwudi A.; Sambala, Evanson Zondani; Wiysonge, Charles Shey, South African Med Res Council, Cochrane South Africa, Cape Town, South Africa.
   Zandian, Hamed, Ardabil Univ Med Sci, Dept Community Med, Ardebil, Iran.
   Fazlzadeh, Mehdi, Ardabil Univ Med Sci, Dept Environm Hlth Engn, Ardebil, Iran.
   Adham, Davoud, Ardabil Univ Med Sci, Sch Hlth, Ardebil, Iran.
   Zandian, Hamed, Ardabil Univ Med Sci, Determinants Hlth Res Ctr, Ardebil, Iran.
   Hailu, Gessessew Bugssa, Mekelle Univ, Div Biomed Sci, Mekelle, Ethiopia.
   Gezae, Kebede Embaye, Mekelle Univ, Dept Biostat, Mekelle, Ethiopia.
   Muthupandian, Saravanan, Mekelle Univ, Dept Microbiol \& Immunol, Mekelle, Ethiopia.
   Gebremeskel, Gebreamlak Gebremedhn, Mekelle Univ, Dept Nursing, Mekelle, Ethiopia.
   Kahsay, Amaha, Mekelle Univ, Dept Nutr \& Dietet, Mekelle, Ethiopia.
   Wondafrash, Dawit Zewdu, Mekelle Univ, Dept Pharmacol \& Toxicol, Mekelle, Ethiopia.
   Meles, Gebrekiros Gebremichael, Mekelle Univ, Dept Publ Hlth, Mekelle, Ethiopia.
   Mengistu, Desalegn Tadese, Mekelle Univ, Sch Med, Mekelle, Ethiopia.
   Yimer, Ebrahim M., Mekelle Univ, Sch Pharm, Mekelle, Ethiopia.
   Adhena, Beyene Meressa; Gebremariam, Kidane Tadesse; Zepro, Nejimu Biza, Mekelle Univ, Sch Publ Hlth, Mekelle, Ethiopia.
   Tesfay, Fisaha Haile, Mekelle Univ, Mekelle, Ethiopia.
   Ahmadi, Mehdi, Ahvaz Jundishapur Univ Med Sci, Environm Technol Res Ctr, Ahvaz, Iran.
   Yadollahpour, Ali, Ahvaz Jundishapur Univ Med Sci, Dept Med Phys, Ahvaz, Iran.
   Khafaie, Morteza Abdullatif, Ahvaz Jundishapur Univ Med Sci, Social Determinants Hlth Res Ctr, Ahvaz, Iran.
   Rahim, Fakher, Ahvaz Jundishapur Univ Med Sci, Thalassemia \& Hemoglobinopathy Res Ctr, Ahvaz, Iran.
   Ahmadi, Keivan, Univ Nottingham, Lincoln Med Sch, Lincoln, England.
   Ahmadi, Keivan, Univ Lincoln, Lincoln Med Sch, Lincoln, England.
   Ahmed, Anwar E., Univ Gezira, Fac Econ \& Rural Dev, Wad Madani, Sudan.
   Ahmed, Muktar Beshir, Jimma Univ, Dept Epidemiol, Jimma, Ethiopia.
   Demis, Asmamaw Bizuneh, Jimma Univ, Sch Nursing, Jimma, Ethiopia.
   Ahmed, Rushdia; Das Gupta, Rajat, BRAC Univ, James P Grant Sch Publ Hlth, Dhaka, Bangladesh.
   Ahmed, Anwar E., Int Ctr Diarrhoeal Dis Res, Hlth Syst \& Populat Studies Div, Dhaka, Bangladesh.
   Ajumobi, Olufemi, Univ Nevada, Sch Community Hlth Sci, Reno, NV 89557 USA.
   Ajumobi, Olufemi, Fed Minist Hlth, Natl Malaria Eliminat Program, Abuja, Nigeria.
   Ashagre, Alebachew Fasil, Univ Gondar, Dept Clin Chem, Gondar, Ethiopia.
   Akalu, Temesgen Yihunie; Muluneh, Atalay Goshu; Sisay, Malede Mequanent; Tamirat, Koku Sisay; Tessema, Zemenu Tadesse; Wolde, Haileab Fekadu, Univ Gondar, Dept Epidemiol \& Biostat, Gondar, Ethiopia.
   Zeleke, Ayalew Jejaw, Univ Gondar, Dept Med Parasitol, Gondar, Ethiopia.
   Tassew, Aberash Abay, Univ Gondar, Inst Publ Hlth, Gondar, Ethiopia.
   Ayele, Asnakew Achaw; Endalamaw, Aklilu, Univ Gondar, Gondar, Ethiopia.
   Akanda, Ali S., Univ Rhode Isl, Dept Civil \& Environm Engn, Kingston, RI 02881 USA.
   Alanzi, Turki M., Imam Abdulrahman Bin Faisal Univ, Dept Hlth Informat Management \& Technol, Dammam, Saudi Arabia.
   Menezes, Ritesh G., Imam Abdulrahman Bin Faisal Univ, Forens Med Div, Dammam, Saudi Arabia.
   Avila-Burgos, Leticia; Ortega-Altamirano, Doris D. V.; Rios-Blancas, Maria Jesus, Natl Inst Publ Hlth, Ctr Hlth Syst Res, Cuernavaca, Morelos, Mexico.
   Denova-Gutierrez, Edgar, Natl Inst Publ Hlth, Ctr Nutr \& Hlth Res, Cuernavaca, Morelos, Mexico.
   Rabanal, Jacqueline Elizabeth Alcalde, Natl Inst Publ Hlth, Ctr Hlth Syst, Cuernavaca, Morelos, Mexico.
   Campos-Nonato, Ismael R.; Rincon, Julio Cesar Campuzano, Natl Inst Publ Hlth, Cuernavaca, Morelos, Mexico.
   Alemnew, Birhan Tamene, Woldia Univ, Coll Hlth Sci, Woldia, Ethiopia.
   Reta, Melese Abate, Woldia Univ, Dept Med Lab Sci, Woldia, Ethiopia.
   Demis, Asmamaw Bizuneh; Tlaye, Kenean Getaneh, Woldia Univ, Dept Nursing, Woldia, Ethiopia.
   Dessie, Getenet Ayalew, Debre Markos Univ, Dept Nursing, Debre Markos, Ethiopia.
   Ketema, Daniel Bekele; Wonde, Tewodros Eshete, Debre Markos Univ, Dept Publ Hlth, Debre Markos, Ethiopia.
   Elemineh, Demelash Abewa, Debre Markos Univ, Dept Stat, Debre Markos, Ethiopia.
   Alemu, Zewdie Aderaw, Debre Markos Univ, Debre Markos, Ethiopia.
   Ali, Beriwan Abdulqadir, Erbil Polytech Univ, Med Tech Inst, Erbil, Iraq.
   Ali, Beriwan Abdulqadir, Ishik Univ, Fac Pharm, Erbil, Iraq.
   Ali, Muhammad, Quaid I Azam Univ Islamabad, Dept Biotechnol, Islamabad, Pakistan.
   Alijanzadeh, Mehran, Qazvin Univ Med Sci, Social Determinants Hlth Res Ctr, Qazvin, Iran.
   Nojomi, Marzieh; Tehrani-Banihashemi, Arash, Iran Univ Med Sci, Dept Community \& Family Med, Tehran, Iran.
   Asadi-Lari, Mohsen, Iran Univ Med Sci, Dept Epidemiol, Tehran, Iran.
   Shabaninejad, Hosein, Iran Univ Med Sci, Dept Hlth Policy, Tehran, Iran.
   Ghashghaee, Ahmad, Iran Univ Med Sci, Dept Hlth Serv Management, Tehran, Iran.
   Safdarian, Mahdi, Iran Univ Med Sci, Dept Neurosci, Tehran, Iran.
   Khosravi, Mohammad Hossein, Iran Univ Med Sci, Dept Neurosurg, Tehran, Iran.
   Alipour, Vahid, Iran Univ Med Sci, Hlth Econ Dept, Tehran, Iran.
   Alipour, Vahid; Arabloo, Jalal; Azari, Samad, Iran Univ Med Sci, Hlth Management \& Econ Res Ctr, Tehran, Iran.
   Kabir, Ali, Iran Univ Med Sci, Minimally Invas Surg Res Ctr, Tehran, Iran.
   Manafi, Navid, Iran Univ Med Sci, Dept Ophthalmol, Tehran, Iran.
   Kasaeian, Amir, Iran Univ Med Sci, Pars Adv \& Minimally Invas Med Manners Res Ctr, Tehran, Iran.
   Babaee, Ebrahim; Moradi-Lakeh, Maziar; Nojomi, Marzieh; Tehrani-Banihashemi, Arash, Iran Univ Med Sci, Prevent Med \& Publ Hlth Res Ctr, Tehran, Iran.
   Beyranvand, Tina, Iran Univ Med Sci, Tehran, Iran.
   Aljunid, Syed Mohamed, Kuwait Univ, Dept Hlth Policy \& Management, Safat, Kuwait.
   Aljunid, Syed Mohamed, Natl Univ Malaysia, Int Ctr Casemix \& Clin Coding, Bandar Tun Razak, Malaysia.
   Khatony, Alireza; Naderi, Mehdi, Kermanshah Univ Med Sci, Clin Res Dev Ctr, Kermanshah, Iran.
   Salahshoor, Mohammad Reza, Kermanshah Univ Med Sci, Dept Anat Sci, Kermanshah, Iran.
   Almasi, Ali, Kermanshah Univ Med Sci, Dept Environm Hlth Engn, Kermanshah, Iran.
   Najafi, Farid; Salimi, Yahya, Kermanshah Univ Med Sci, Dept Epidemiol \& Biostat, Kermanshah, Iran.
   Siabani, Si Si Soraya; Ziapour, Arash, Kermanshah Univ Med Sci, Dept Hlth Educ \& Promot, Kermanshah, Iran.
   Jalali, Amir, Kermanshah Univ Med Sci, Dept Psychiat, Kermanshah, Iran.
   Karyani, Ali Kazemi, Kermanshah Univ Med Sci, Dept Publ Hlth, Kermanshah, Iran.
   Hoseini-Ghahfarokhi, Mojtaba; Khodamoradi, Ehsan; Zahabi, Saleh Salehi, Kermanshah Univ Med Sci, Dept Radiol \& Nucl Med, Kermanshah, Iran.
   Shamsi, MohammadBagher, Kermanshah Univ Med Sci, Dept Sports Med \& Rehabil, Kermanshah, Iran.
   Sobhiyeh, Mohammad Reza, Kermanshah Univ Med Sci, Dept Vasc \& Endovasc Surg, Kermanshah, Iran.
   Heydarpour, Fatemeh, Kermanshah Univ Med Sci, Med Biol Res Ctr, Kermanshah, Iran.
   Matin, Behzad Karami; Karyani, Ali Kazemi; Moradi, Masoud; Rajati, Fatemeh; Rezaei, Satar; Sadeghi, Ehsan, Kermanshah Univ Med Sci, Res Ctr Environm Determinants Hlth, Kermanshah, Iran.
   Khatony, Alireza; Salimi, Yahya; Soofi, Moslem, Kermanshah Univ Med Sci, Social Dev \& Hlth Promot Res Ctr, Kermanshah, Iran.
   Salehi, Farkhonde, Kermanshah Univ Med Sci, Taleghani Hosp, Kermanshah, Iran.
   Farzam, Hossein; Moradi, Masoud; Sobhiyeh, Mohammad Reza, Kermanshah Univ Med Sci, Kermanshah, Iran.
   Almasi-Hashiani, Amir, Arak Univ Med Sci, Dept Epidemiol, Arak, Iran.
   Nazari, Javad, Arak Univ Med Sci, Dept Pediat, Arak, Iran.
   Amini, Saeed, Arak Univ Med Sci, Hlth Serv Management Dept, Arak, Iran.
   Al-Mekhlafi, Hesham M., Jazan Univ, Med Res Ctr, Jazan, Saudi Arabia.
   Bedi, Neeraj, Jazan Univ, Jazan, Saudi Arabia.
   Al-Mekhlafi, Hesham M., Sanaa Univ, Dept Med Parasitol, Sanaa, Yemen.
   Temsah, Mohamad-Hani, King Saud Univ, Dept Pediat, Riyadh, Saudi Arabia.
   Mohammad, Yousef, King Saud Univ, Dept Internal Med, Riyadh, Saudi Arabia.
   Altirkawi, Khalid, King Saud Univ, Riyadh, Saudi Arabia.
   Alvis-Zakzuk, Nelson J., Univ Cartagena, Hlth Econ Res Grp, Cartagena, Colombia.
   Alvis-Guzman, Nelson, Univ Coast, Res Grp Hosp Management \& Hlth Policies, Barranquilla, Colombia.
   Alvis-Zakzuk, Nelson J., Univ Costa, Dept Ciencias Econ, Barranquilla, Colombia.
   Alvis-Zakzuk, Nelson J., Natl Inst Hlth, Observ Nacl Salud, Bogota, Dc, Colombia.
   Amare, Azmeraw T., South Australian Hlth \& Med Res Inst, Sansom Inst, Adelaide, SA, Australia.
   Amit, Arianna Maever Loreche, Univ Philippines Manila, Dept Epidemiol \& Biostat, Manila, Philippines.
   Antonio, Carl Abelardo T.; Faraon, Emerito Jose A., Univ Philippines Manila, Dept Hlth Policy \& Adm, Manila, Philippines.
   Faraon, Emerito Jose A., Univ Philippines Manila, Med Informat Unit, Manila, Philippines.
   Atre, Sachin R., Johns Hopkins Univ, Ctr Clin Global Hlth Educ, Baltimore, MD USA.
   Kosek, Margaret N., Johns Hopkins Univ, Dept Int Hlth, Baltimore, MD USA.
   Hafezi-Nejad, Nima, Johns Hopkins Univ, Dept Radiol \& Radiol Sci, Baltimore, MD USA.
   Amit, Arianna Maever Loreche, Johns Hopkins Univ, Online Programs Appl Learning, Baltimore, MD USA.
   Preotescu, Liliana, Carol Davila Univ Med \& Pharm, Dept Infect Dis, Bucharest, Romania.
   Davitoiu, Dragos Virgil; Negoi, Ionut, Carol Davila Univ Med \& Pharm, Dept Gen Surg, Bucharest, Romania.
   Andrei, Catalina Liliana, Carol Davila Univ Med \& Pharm, Bucharest, Romania.
   Anegago, Masresha Tessema, Wageningen Univ \& Res, Div Human Nutr \& Hlth, Wageningen, Netherlands.
   Anegago, Masresha Tessema, Ethiopian Publ Hlth Inst, Nutr \& Food Sci Res Directorate, Addis Ababab, Ethiopia.
   Anjomshoa, Mina, Rafsanjan Univ Med Sci, Social Determinants Hlth Res Ctr, Rafsanjan, Iran.
   Eftekhari, Aziz, Tabriz Univ Med Sci, Dept Pharmacol \& Toxicol, Tabriz, Iran.
   Ansari, Fereshteh, Tabriz Univ Med Sci, Res Ctr Evidence Based Med, Hlth Management \& Safety Promot Res Inst, Tabriz, Iran.
   Hassankhani, Hadi, Tabriz Univ Med Sci, Sch Nursing \& Midwifery, Tabriz, Iran.
   Haririan, Hamidreza, Tabriz Univ Med Sci, Tabriz, Iran.
   Ansari, Fereshteh, Agr Res Educ \& Extens Org, Ravi Vaccine \& Serum Res Inst, Tehran, Iran.
   Antonio, Carl Abelardo T., Hong Kong Polytech Univ, Dept Appl Social Sci, Hong Kong, Peoples R China.
   Lee, Paul H., Hong Kong Polytech Univ, Sch Nursing, Hong Kong, Peoples R China.
   Antriyandarti, Ernoiz, Univ Sebelas Maret, Agribusiness Study Program, Surakarta, Indonesia.
   Appiah, Seth Christopher Yaw, Kwame Nkrumah Univ Sci \& Technol, Dept Sociol \& Social Work, Kumasi, Ghana.
   Appiah, Seth Christopher Yaw, Ludwig Maximilians Univ Munchen, Ctr Int Hlth, Munich, Germany.
   Aremu, Olatunde, Birmingham City Univ, Sch Hlth Sci, Birmingham, W Midlands, England.
   Armoon, Bahram, Saveh Univ Med Sci, Sch Nursing \& Midwifery, Saveh, Iran.
   Armoon, Bahram, Saveh Univ Med Sci, Social Determinants Hlth Res Ctr, Saveh, Iran.
   Aryal, Krishna K., Abt Associates Nepal, Monitoring Evaluat \& Operat Res Project, Lalitpur, Nepal.
   Mir, Seyed Mostafa; Mosapour, Abbas, Babol Univ Med Sci, Dept Clin Biochem, Babol Sar, Iran.
   Mirabi, Parvaneh, Babol Univ Med Sci, Fatemeh Zahra Infertil \& Reprod Hlth Ctr, Babol Sar, Iran.
   Rostami, Ali, Babol Univ Med Sci, Infect Dis \& Trop Med Res Ctr, Babol Sar, Iran.
   Arzani, Afsaneh, Babol Univ Med Sci, Nursing \& Midwifery Sch, Babol Sar, Iran.
   Bijani, Ali, Babol Univ Med Sci, Social Determinants Hlth Res Ctr, Babol Sar, Iran.
   Zamani, Mohammad, Babol Univ Med Sci, Student Res Comm, Babol Sar, Iran.
   Arzani, Afsaneh; Mouodi, Simin, Babol Univ Med Sci, Babol Sar, Iran.
   Djalalinia, Shirin, Minist Hlth \& Med Educ, Dev Res \& Technol Ctr, Tehran, Iran.
   Asadi-Lari, Mohsen, Minist Hlth \& Med Educ, Dept Int Relat, Tehran, Iran.
   Atalay, Hagos Tasew; Gebremeskel, Gebreamlak Gebremedhn; Weldesamuel, Girmay Teklay, Aksum Univ, Dept Nursing, Aksum, Ethiopia.
   Demoz, Gebre Teklemariam; Kasahun, Gebremicheal Gebreslassie, Aksum Univ, Sch Pharm, Aksum, Ethiopia.
   Ginawi, Ibrahim Abdelmageed, Univ Hail, Dept Family \& Community Med, Hail, Saudi Arabia.
   Atique, Suleman, Univ Hail, Dept Hlth Informat, Hail, Saudi Arabia.
   Atre, Sachin R., Dr DY Patil Univ, Dr DY Patil Med Coll, Pune, Maharashtra, India.
   Ausloos, Marcel, Univ Leicester, Sch Business, Leicester, Leics, England.
   Ausloos, Marcel; Herteliu, Claudiu; Pana, Adrian, Bucharest Univ Econ Studies, Dept Stat \& Econometr, Bucharest, Romania.
   Awasthi, Ashish; Zodpey, Sanjay, Indian Inst Publ Hlth, Indian Inst Publ Hlth, Gurugram, India.
   Lal, Dharmesh Kumar; Mathur, Manu Raj, Indian Inst Publ Hlth, Gurugram, India.
   Wada, Fiseha Wadilo, Wolaita Sodo Univ, Dept Med, Wolaita Sodo, Ethiopia.
   Paulos, Kebreab, Wolaita Sodo Univ, Dept Midwifery, Wolaita Sodo, Ethiopia.
   Awoke, Nefsu, Wolaita Sodo Univ, Dept Nursing, Wolaita Sodo, Ethiopia.
   Lenjebo, Tsegaye Lolaso, Wolaita Sodo Univ, Sch Publ Hlth, Wolaita Sodo, Ethiopia.
   Quintanilla, Beatriz Paulina Ayala, La Trobe Univ, Judith Lumley Ctr, Melbourne, Vic, Australia.
   Quintanilla, Beatriz Paulina Ayala, Peruvian Natl Inst Hlth, Gen Off Res \& Technol Transfer, Lima, Peru.
   Ayano, Getinet, Curtin Univ, Sch Publ Hlth, Perth, WA, Australia.
   Adema, Bereket Duko, Curtin Univ, Perth, WA, Australia.
   Kugbey, Nuworza, Univ Hlth \& Allied Sci, Dept Family \& Community Hlth, Ho, Ghana.
   Ayanore, Martin Amogre, Univ Hlth \& Allied Sci, Dept Hlth Policy Planning \& Management, Ho, Ghana.
   Ayele, Asnakew Achaw, Univ New England, Sch Hlth, Armidale, NSW, Australia.
   Aynalem, Yared Asmare; Shiferaw, Wondimeneh Shibabaw, Debre Berhan Univ, Dept Nursing, Debre Berhan, Ethiopia.
   Badawi, Alaa, Publ Hlth Agcy Canada, Publ Hlth Risk Sci Div, Toronto, ON, Canada.
   Chattu, Vijay Kumar, Univ Toronto, Dept Med, Toronto, ON, Canada.
   Badawi, Alaa, Univ Toronto, Dept Nutr Sci, Toronto, ON, Canada.
   Manafi, Farzad, Univ Toronto, Joint Ctr Bioeth, Toronto, ON, Canada.
   Bakkannavar, Shankar M.; Padubidri, Jagadish Rao, Manipal Acad Higher Educ, Dept Forens Med, Manipal, India.
   Hoogar, Praveen, Manipal Acad Higher Educ, Transdisciplinary Ctr Qualitat Methods, Manipal, India.
   Banach, Maciej, Med Univ Lodz, Dept Hypertens, Lodz, Poland.
   Banach, Maciej, Polish Mothers Mem Hosp Res Inst, Lodz, Poland.
   Barac, Aleksandra, Clin Ctr Serbia, Clin Infect \& Trop Dis, Belgrade, Serbia.
   Barac, Aleksandra; Dubljanin, Eleonora, Univ Belgrade, Fac Med, Belgrade, Serbia.
   Jonas, Jost B., Heidelberg Univ, Dept Ophthalmol, Heidelberg, Germany.
   Barnighausen, Till Winfried; Chansa, Collins; De Neve, Jan-Walter; Mohammed, Shafiu, Heidelberg Univ, Heidelberg Inst Global Hlth, Heidelberg, Germany.
   Marz, Winfried, Heidelberg Univ, Med Clin 5, Nephrol, Hypertensiol,Endocrinol,Diabetol,Rheumatol, Heidelberg, Germany.
   Pereira, Alexandre, Harvard Univ, Dept Genet, Boston, MA 02115 USA.
   Vollmer, Sebastian, Harvard Univ, Dept Global Hlth \& Populat, Boston, MA 02115 USA.
   Ding, Eric L., Harvard Univ, Dept Nutr, Boston, MA 02115 USA.
   Kraemer, Moritz U. G., Harvard Univ, Sch Med, Boston, MA 02115 USA.
   Barnighausen, Till Winfried, Harvard Univ, TH Chan Sch Publ Hlth, Boston, MA 02115 USA.
   Basaleem, Huda, Univ Aden, Aden, Yemen.
   Bassat, Quique, Univ Barcelona, Barcelona Inst Global Hlth, Barcelona, Spain.
   Bassat, Quique; Koyanagi, Ai, Catalan Inst Res \& Adv Studies ICREA, Barcelona, Spain.
   Bayati, Mohsen, Shiraz Univ Med Sci, Hlth Human Resources Res Ctr, Shiraz, Iran.
   Bedi, Neeraj, Gandhi Med Coll Bhopal, Dept Community Med, Bhopal, India.
   Lorestan Univ Med Sci, Dept Epidemiol \& Biostat, Khorramabad, Iran.
   Lorestan Univ Med Sci, Social Determinants Hlth Res Ctr, Khorramabad, Iran.
   Bell, Michelle L., Yale Univ, Sch Forestry \& Environm Studies, New Haven, CT 06511 USA.
   Dolecek, Christiane; Dunachie, Susanna J.; Lewycka, Sonia, Univ Oxford, Ctr Trop Med \& Global Hlth, Oxford, England.
   Kraemer, Moritz U. G., Univ Oxford, Dept Zool, Oxford, England.
   Bennett, Derrick A.; Ben Lacey, Univ Oxford, Nuffield Dept Populat Hlth, Oxford, England.
   Jha, Vivekanand, Univ Oxford, Oxford, England.
   Berbada, Dessalegn Ajema; Geramo, Yilma Chisha Dea; Hayelom, Desta Haftu; Sorrie, Muluken Bekele, Arba Minch Univ, Dept Publ Hlth, Arba Minch, Ethiopia.
   Bhat, Anusha Ganapati, Univ Massachusetts, Sch Med, Internal Med, Springfield, MA USA.
   Bhattacharyya, Krittika, Natl Inst Biomed Genom, Dept Stat \& Computat Genom, Kalyani, W Bengal, India.
   Bhattacharyya, Krittika, Univ Calcutta, Dept Stat, Kolkata, India.
   Bhattarai, Suraj, Global Inst Interdisciplinary Studies, Dept Global Hlth, Kathmandu, Nepal.
   Maulik, Pallab K., George Inst Global Hlth, Res Dept, New Delhi, India.
   Bhaumik, Soumyadeep, Ist Ric Farmacol Mario Negri IRCCS, Ranica, Italy.
   Bikbov, Boris; Perico, Norberto; Remuzzi, Giuseppe, Ist Ric Farmacol Mario Negri IRCCS, Ranica, Italy.
   Maulik, Pallab K., Univ New South Wales, Sch Med, Sydney, NSW, Australia.
   Pesudovs, Konrad, Univ New South Wales, Sch Optometry \& Vis Sci, Sydney, NSW, Australia.
   Karki, Surendra, Univ New South Wales, Sch Publ Hlth \& Community Med, Sydney, NSW, Australia.
   Biswas, Raaj Kishore, Univ New South Wales, Transport \& Rd Safety TARS Res Ctr, Sydney, NSW, Australia.
   Biswas, Raaj Kishore, Swinburne Univ Technol, Sch Hlth Sci, Melbourne, Vic, Australia.
   Sharif, Mehdi, Islamic Azad Univ, Dept Basic Sci, Kermanshah, Iran.
   Hosseinzadeh, Mehdi, Islamic Azad Univ, Dept Comp Engn, Kermanshah, Iran.
   Sharif, Mehdi, Islamic Azad Univ, Dept Lab Sci, Kermanshah, Iran.
   Tahbaz, Sahel Valadan, Islamic Azad Univ, Dept Microbiol, Kermanshah, Iran.
   Bohlouli, Somayeh, Islamic Azad Univ, Dept Vet Med, Kermanshah, Iran.
   Brady, Oliver J., London Sch Hyg \& Trop Med, Dept Infect Dis Epidemiol, London, England.
   Sartorius, Benn, London Sch Hyg \& Trop Med, Fac Infect \& Trop Dis, London, England.
   Bragazzi, Nicola Luigi, Univ Genoa, Genoa, Italy.
   Briko, Andrey Nikolaevich, Bauman Moscow State Tech Univ, Dept Biomed Technol, Moscow, Russia.
   Briko, Nikolay Ivanovich; Lopukhov, Platon D., IM Sechenov First Moscow State Med Univ, Dept Epidemiol \& Evidence Based Med, Moscow, Russia.
   Nagaraja, Sharath Burugina, Employees State Insurance Model Hosp, Dept Community Med, Bangalore, Karnataka, India.
   Butt, Zahid A., Univ Waterloo, Sch Publ Hlth \& Hlth Syst, Waterloo, ON, Canada.
   Butt, Zahid A., Al Shifa Trust Eye Hosp, Al Shifa Sch Publ Hlth, Rawalpindi, Pakistan.
   Rincon, Julio Cesar Campuzano, Univ Valley Cuernavaca, Sch Med, Cuernavaca, Morelos, Mexico.
   Cardenas, Rosario, Metropolitan Autonomous Univ, Dept Populat \& Hlth, Mexico City, DF, Mexico.
   Gomes, Nelson G. M., Publ Hlth Inst Univ Porto ISPUP, Dept Chem, EPIUnit, Porto, Portugal.
   Gomes, Nelson G. M.; Ribeiro, Ana Isabel, Publ Hlth Inst Univ Porto ISPUP, EPIUnit, Porto, Portugal.
   Fernandes, Eduarda, Univ Porto, REQUIMTE, LAQV, Porto, Portugal.
   Carvalho, Felix; Costa, Vera M.; Fernandes, Eduarda, Univ Porto, Res Unit Appl Mol Biosci UCIBIO, Porto, Portugal.
   Castro, Franz; Quintana, Hedley, Gorgas Mem Inst Hlth Studies, Panama City, Panama.
   Chansa, Collins, World Bank, Hlth Nutr \& Populat Global Practice, Lusaka, Zambia.
   Chatterjee, Pranab, Natl Inst Cholera \& Enter Dis, Div Epidemiol, Kolkata, India.
   Chauhan, Bal Govind, Gokhale Inst Polit \& Econ, Populat Res Ctr, Pune, Maharashtra, India.
   Dhillon, Preeti, Int Inst Populat Sci, Dept Math Demog \& Stat, Mumbai, Maharashtra, India.
   Khan, Junaid; Patle, Ajay, Int Inst Populat Sci, Dept Populat Studies, Mumbai, Maharashtra, India.
   Chauhan, Bal Govind; Goli, Srinivas; Kumar, Pushpendra, Int Inst Populat Sci, Mumbai, Maharashtra, India.
   Chin, Ken Lee, Monash Univ, Dept Epidemiol \& Prevent Med, Melbourne, Vic, Australia.
   Guo, Yuming; Li, Shanshan, Monash Univ, Sch Publ Hlth \& Prevent Med, Melbourne, Vic, Australia.
   Thomas, Nihal, Christian Med Coll \& Hosp CMC, Dept Endocrinol, Vellore, Tamil Nadu, India.
   Christopher, Devasahayam J., Christian Med Coll \& Hosp CMC, Dept Pulm Med, Vellore, Tamil Nadu, India.
   Varughese, Santosh, Christian Med Coll \& Hosp CMC, Vellore, Tamil Nadu, India.
   Chu, Dinh-Toi, Hanoi Natl Univ Educ, Fac Biol, Hanoi, Vietnam.
   Damiani, Giovanni, Case Western Reserve Univ, Dept Dermatol, Cleveland, OH 44106 USA.
   Sanabria, Juan, Case Western Reserve Univ, Dept Nutr \& Prevent Med, Cleveland, OH 44106 USA.
   La Vecchia, Carlo, Univ Milan, Clin Med \& Community Hlth, Milan, Italy.
   Damiani, Giovanni, Univ Milan, Dept Dermatol, Milan, Italy.
   Dandona, Lalit; Dandona, Rakhi; Kumar, G. Anil, Publ Hlth Fdn India, Gurugam, India.
   Dandona, Lalit, Indian Council Med Res, New Delhi, India.
   Darwish, Amira Hamed, Tanta Univ, Dept Pediat, Tanta, Egypt.
   Rafiei, Alireza, Mazandaran Univ Med Sci, Dept Immunol, Sari, Iran.
   Faridnia, Roghiyeh, Mazandaran Univ Med Sci, Dept Med Parasitol, Sari, Iran.
   Rafiei, Alireza, Mazandaran Univ Med Sci, Mol \& Cell Biol Res Ctr, Sari, Iran.
   Daryani, Ahmad, Mazandaran Univ Med Sci, Toxoplasmosis Res Ctr, Sari, Iran.
   Das, Jai K., Aga Khan Univ, Div Women \& Child Hlth, Karachi, Pakistan.
   Das Gupta, Rajat, Univ South Carolina, Arnold Sch Publ Hlth, Dept Epidemiol \& Biostat, Columbia, SC 29208 USA.
   Davila, Claudio Alberto, Fac Latinoamer Ciencias Sociales Mexico, Populat \& Dev, Mexico City, DF, Mexico.
   Davitoiu, Dragos Virgil, Clin Emergency Hosp Sf Pantelimon, Dept Surg, Bucharest, Romania.
   Deribe, Kebede, Brighton \& Sussex Med Sch, Dept Global Hlth \& Infect, Brighton, E Sussex, England.
   Dharmaratne, Samath Dhamminda, Univ Peradeniya, Dept Community Med, Peradeniya, Sri Lanka.
   Dhimal, Meghnath, Nepal Hlth Res Council, Hlth Res Sect, Kathmandu, Nepal.
   Dhungana, Govinda Prasad, Far Western Univ, Dept Microbiol, Mahendranagar, Nepal.
   Diaz, Daniel, Univ Nacl Autonoma Mexico, Ctr Complex Sci, Mexico City, DF, Mexico.
   Diaz, Daniel, Autonomous Univ Sinaloa, Fac Med Vet \& Zootecnia, Culiacan Rosales, Mexico.
   Do, Huyen Phuc; Hoang, Chi Linh; Nguyen, Trang Huyen, Nguyen Tat Thanh Univ, Ctr Excellence Behav Med, Ho Chi Minh City, Vietnam.
   Doku, David Teye, Univ Cape Coast, Dept Populat Hlth, Cape Coast, Ghana.
   Doku, David Teye, Univ Tampere, Fac Social Sci, Hlth Sci, Tampere, Finland.
   Dolecek, Christiane; Dunachie, Susanna J., Mahidol Univ, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand.
   Dubey, Manisha, World Food Programme, New Delhi, India.
   Adema, Bereket Duko, Hawassa Univ, Publ Hlth, Hawassa, Ethiopia.
   Rasella, Davide, Univ Fed Bahia, Inst Publ Hlth, Salvador, BA, Brazil.
   Duraes, Andre R., Univ Fed Bahia, Sch Med, Salvador, BA, Brazil.
   Duraes, Andre R., Escola Bahiana Med \& Saude Publ, Med Interna, Salvador, BA, Brazil.
   Duraisamy, Senbagam, Bharathidasan Univ, Dept Marine Biotechnol, Tiruchirappalli, Tamil Nadu, India.
   Effiong, Andem, Univ Newcastle, Clin Epidemiol \& Biostat, Newcastle, NSW, Australia.
   Khan, Md Nuruzzaman, Univ Newcastle, Dept Publ Hlth, Newcastle, NSW, Australia.
   Hasanzadeh, Amir, Maragheh Univ Med Sci, Dept Microbiol, Maragheh, Iran.
   Pourjafar, Hadi, Maragheh Univ Med Sci, Dept Nutr \& Food Sci, Maragheh, Iran.
   Eftekhari, Aziz, Maragheh Univ Med Sci, Dept Pharmacol \& Toxicol, Maragheh, Iran.
   Pourjafar, Hadi, Maragheh Univ Med Sci, Dept Publ Hlth, Maragheh, Iran.
   El Sayed, Iman, Alexandria Univ, Biomed Informat \& Med Stat, Alexandria, Egypt.
   El Tantawi, Maha, Alexandria Univ, Pediat Dent \& Dent Publ Hlth Dept, Alexandria, Egypt.
   Zaki, Maysaa El Sayed, Mansoura Univ, Dept Clin Pathol, Mansoura, Egypt.
   Elkout, Hajer, Tripoli Univ, Dept Community Med, Tripoli, Libya.
   Elkout, Hajer, World Hlth Org WHO, Tripoli, Libya.
   Enany, Shymaa, Suez Canal Univ, Dept Microbiol \& Immunol, Ismailia, Egypt.
   Magdeldin, Sameh, Suez Canal Univ, Dept Physiol, Ismailia, Egypt.
   Endalew, Daniel Adane, Wolkite Univ, Dept Midwifery, Wolkite, Ethiopia.
   Yeshaneh, Alex, Wolkite Univ, Wolkite, Ethiopia.
   Etemadi, Arash, NCI, Div Canc Epidemiol \& Genet, Bethesda, MD 20892 USA.
   Fareed, Mohammad, Imam Muhammad Ibn Saud Islamic Univ, Coll Med, Riyadh, Saudi Arabia.
   Salam, Nasir, Imam Muhammad Ibn Saud Islamic Univ, Dept Pathol, Riyadh, Saudi Arabia.
   Farioli, Andrea; Violante, Francesco S., Univ Bologna, Dept Med \& Surg Sci, Bologna, Italy.
   Faro, Andre, Univ Fed Sergipe, Dept Psychol, Sao Cristovao, Brazil.
   Mohammad, Dara K., Karolinska Inst, Dept Med, Stockholm, Sweden.
   Fereshtehnejad, Seyed-Mohammad, Karolinska Inst, Dept Neurobiol, Stockholm, Sweden.
   Fereshtehnejad, Seyed-Mohammad, Univ Ottawa, Div Neurol, Ottawa, ON, Canada.
   Filip, Irina, Kaiser Permanente, Dept Psychiat, Fontana, CA USA.
   Radfar, Amir, AT Still Univ, Coll Grad Hlth Sci, Mesa, AZ USA.
   Filip, Irina, AT Still Univ, Sch Hlth Sci, Mesa, AZ USA.
   Fischer, Florian, Bielefeld Univ, Dept Populat Med \& Hlth Serv Res, Bielefeld, Germany.
   Foroutan, Masoud, Abadan Sch Med Sci, Abadan Fac Med Sci, Abadan, Iran.
   Francis, Joel Msafiri, Univ Witwatersrand, Dept Family Med \& Primary Care, Johannesburg, South Africa.
   Franklin, Richard Charles, James Cook Univ, Coll Publ Hlth Med \& Vet Sci, Douglas, Qld, Australia.
   Fukumoto, Takeshi, Kobe Univ, Dept Dermatol, Kobe, Hyogo, Japan.
   Fukumoto, Takeshi, Wistar Inst Anat \& Biol, Gene Express \& Regulat Program, 3601 Spruce St, Philadelphia, PA 19104 USA.
   Roro, Elias Merdassa; Yilma, Mekdes Tigistu, Wollega Univ, Dept Publ Hlth, Nekemte, Ethiopia.
   Gayesa, Reta Tsegaye, Wollega Univ, Dept Nursing, Nekemte, Ethiopia.
   Geta, Birhanu; Mengistu, Getnet, Wollo Univ, Dept Pharm, Dessie, Ethiopia.
   Gill, Paramjit Singh, Univ Warwick, Unit Acad Primary Care, Coventry, W Midlands, England.
   Goli, Srinivas, Jawahar Lal Nehru Univ, Ctr Study Reg Dev, New Delhi, India.
   Gopalani, Sameer Vali, Univ Oklahoma, Dept Biostat \& Epidemiol, Oklahoma City, OK USA.
   Gopalani, Sameer Vali, Govt Federated States Micronesia, Dept Hlth \& Social Affairs, Palikir, Micronesia.
   Goulart, Barbara Niegia Garcia, Univ Fed Rio Grande do Sul, Postgrad Program Epidemiol, Porto Alegre, RS, Brazil.
   Grada, Ayman, Boston Univ, Dept Dermatol, Boston, MA 02215 USA.
   Gugnani, Harish Chander, St James Sch Med, Dept Epidemiol, The Valley, Anguilla.
   Gugnani, Harish Chander, St James Sch Med, Dept Microbiol, The Valley, Anguilla.
   Guido, Davide, Agcy Hlth Protect, Epidemiol Unit, Milan, Italy.
   Guimaraes, Rafael Alves, Univ Fed Goias, Inst Patol Trop \& Saude Publ, Goiania, Go, Brazil.
   Guo, Yuming, Zhengzhou Univ, Dept Epidemiol \& Biostat, Zhengzhou, Peoples R China.
   March Dimes, Arlington, VA USA.
   West Virginia Univ, Sch Publ Hlth, Morgantown, WV 26506 USA.
   Rajasthan Univ Hlth Sci, Acad \& Res Dept, Jaipur, Rajasthan, India.
   Mahatma Gandhi Univ Med Sci \& Technol, Dept Med, Jaipur, Rajasthan, India.
   Haile, Michael Tamene, St Pauls Hosp Millennium Med Coll, Dept Nursing, Addis Ababa, Ethiopia.
   Khayamzadeh, Maryam, Shahid Beheshti Univ Med Sci, Canc Res Ctr, Tehran, Iran.
   Sabour, Siamak, Shahid Beheshti Univ Med Sci, Dept Epidemiol, Tehran, Iran.
   Ramezanzadeh, Kiana, Shahid Beheshti Univ Med Sci, Dept Pharmacol, Tehran, Iran.
   Safari, Saeed, Shahid Beheshti Univ Med Sci, Emergency Dept, Tehran, Iran.
   Haj-Mirzaian, Arvin, Shahid Beheshti Univ Med Sci, Obes Res Ctr, Tehran, Iran.
   Yaseri, Mehdi, Shahid Beheshti Univ Med Sci, Ophthalm Res Ctr, Tehran, Iran.
   Irvani, Seyed Sina Naghibi, Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Tehran, Iran.
   Jahanmehr, Nader, Shahid Beheshti Univ Med Sci, Safety Promot \& Injury Prevent Res Ctr, Tehran, Iran.
   Jahanmehr, Nader, Shahid Beheshti Univ Med Sci, Sch Management \& Med Educ, Tehran, Iran.
   Hall, Brian James, Univ Macau, Global \& Community Mental Hlth Res Grp, Macau, Peoples R China.
   Hariyani, Ninuk, Univ Airlangga Indonesia, Dept Dent Publ Hlth, Surabaya, Indonesia.
   Hariyani, Ninuk, Univ Adelaide, Australian Res Ctr Populat Oral Hlth, Adelaide, SA, Australia.
   Hasaballah, Ahmed I., Al Azhar Univ, Dept Zool, Cairo, Egypt.
   Hasan, Md. Mehedi; Mamun, Abdullah A., Univ Queensland, Social Sci Res Inst, Indooroopilly, Qld, Australia.
   Hassen, Hamid Yimam, Mizan Tepi Univ, Dept Publ Hlth, Teppi, Ethiopia.
   Hassen, Hamid Yimam, Univ Hosp Antwerp, Unit Epidemiol \& Social Med, Antwerp, Belgium.
   de Hidru, Hagos D., Adigrat Univ, Dept Biostat \& Epidemiol, Adigrat, Ethiopia.
   Tesfay, Berhe Etsay, Adigrat Univ, Dept Publ Hlth, Adigrat, Ethiopia.
   Hossain, Naznin, Dhaka Med Coll, Dept Pharmacol \& Therapeut, Dhaka, Bangladesh.
   Hossain, Naznin, Bangladesh Ind Gases Ltd, Dept Pharmacol, Tangail, Bangladesh.
   Hosseinzadeh, Mehdi, Univ Human Dev, Dept Comp Sci, Sulaymaniyah, Iraq.
   Darwesh, Aso Mohammad, Univ Human Dev, Dept Informat Technol, Sulaymaniyah, Iraq.
   Bali, Ahmed Omar, Univ Human Dev, Diplomacy \& Publ Relat Dept, Sulaymaniyah, Iraq.
   Househ, Mowafa, Hamad Bin Khalifa Univ, Coll Sci \& Engn, Div Informat \& Comp Technol, Doha, Qatar.
   Househ, Mowafa, Qatar Fdn Educ Sci \& Community Dev, Doha, Qatar.
   Hu, Guoqing, Cent South Univ, Dept Epidemiol \& Hlth Stat, Changsha, Peoples R China.
   Humayun, Ayesha, Shaikh Khalifa Bin Zayed Al Nahyan Med \& Dent Col, Dept Publ Hlth \& Community Med, Lahore, Pakistan.
   Hussain, Syed Ather, Dow Univ Hlth Sci, Dow Med Coll, Karachi, Pakistan.
   Ilesanmi, Olayinka Stephen, Univ Ibadan, Dept Community Med, Ibadan, Nigeria.
   Ibitoye, Segun Emmanuel, Univ Ibadan, Dept Hlth Promot \& Educ, Ibadan, Nigeria.
   Owolabi, Mayowa Ojo, Univ Ibadan, Inst Adv Med Res \& Training, Ibadan, Nigeria.
   Ilic, Milena D., Univ Kragujevac, Dept Epidemiol, Kragujevac, Serbia.
   Inbaraj, Leeberk Raja, Bangalore Baptist Hosp, Dept Family Med, Bangalore, Karnataka, India.
   Islam, Sheikh Mohammed Shariful, Deakin Univ, Inst Phys Act \& Nutr, Burwood, Vic, Australia.
   Rahman, Muhammad Aziz, Deakin Univ, Natl Ctr Farmer Hlth, Burwood, Vic, Australia.
   Islam, Sheikh Mohammed Shariful, Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia.
   Balalami, Nader Jafari, Babol Noshirvani Univ Technol, Dept Psychosis, Babol Sar, Iran.
   Jakovljevic, Mihajlo, Sechenov First Moscow State Med Univ, Dept Hlth Care \& Publ Hlth, Moscow, Russia.
   Jayatilleke, Achala Upendra, Univ Colombo, Fac Grad Studies, Colombo, Sri Lanka.
   Jayatilleke, Achala Upendra, Univ Colombo, Inst Med, Colombo, Sri Lanka.
   Jha, Ravi Prakash, Banaras Hindu Univ, Dept Community Med, Varanasi, Uttar Pradesh, India.
   Ji, John S., Duke Kunshan Univ, Environm Res Ctr, Kunshan, Peoples R China.
   Ji, John S., Duke Univ, Nicholas Sch Environm, Durham, NC 27706 USA.
   Jia, Peng, Univ Twente, Dept Earth Observat Sci, Enschede, Netherlands.
   Osei, Frank B., Univ Twente, Fac Geoinformat Sci \& Earth Observat, Enschede, Netherlands.
   Jonas, Jost B., Beijing Tongren Hosp, Beijing Ophthalmol \& Visual Sci Key, Beijing, Peoples R China.
   Jozwiak, Jacek Jerzy, Univ Opole, Dept Family Med \& Publ Hlth, Opole, Poland.
   Kabir, Zubair, Univ Coll Cork, Sch Publ Hlth, Cork, Ireland.
   Kalani, Hamed, Golestan Univ Med Sci, Infect Dis Res Ctr, Gorgan, Golestan, Iran.
   Kanchan, Tanuj, All India Inst Med Sci, Dept Forens Med \& Toxicol, Jodhpur, Rajasthan, India.
   Lodha, Rakesh, All India Inst Med Sci, Dept Paediat, Jodhpur, Rajasthan, India.
   Sagar, Rajesh, All India Inst Med Sci, Dept Psychiat, Jodhpur, Rajasthan, India.
   Karch, Andre, Univ Munster, Inst Epidemiol \& Social Med, Munster, Germany.
   Karki, Surendra, Australian Red Cross Blood Serv, Res \& Dev Team, Sydney, NSW, Australia.
   Kayode, Gbenga A., Inst Human Virol Nigeria, Int Res Ctr Excellence, Abuja, Nigeria.
   Kayode, Gbenga A., Univ Utrecht, Julius Ctr Hlth Sci \& Primary Care, Utrecht, Netherlands.
   Kumar, Manasi, Univ Nairobi, Dept Psychiat, Nairobi, Kenya.
   Keiyoro, Peter Njenga, Univ Nairobi, Open Distance \& eLearning Campus, Nairobi, Kenya.
   Muriithi, Moses K., Univ Nairobi, Sch Econ, Nairobi, Kenya.
   Khader, Yousef Saleh, Jordan Univ Sci \& Technol, Dept Publ Hlth, Irbid, Jordan.
   Khalid, Nauman, Univ Management \& Technol, Sch Food \& Agr Sci, Lahore, Pakistan.
   Khalil, Ali Talha, Qarshi Univ, Dept Biotechnol, Lahore, Pakistan.
   Khalilov, Rovshan, Baku State Univ, Dept Physiol, Baku, Azerbaijan.
   Khan, Ejaz Ahmad, Hlth Serv Acad, Epidemiol \& Biostat Dept, Islamabad, Pakistan.
   Khan, Gulfaraz, United Arab Emirates Univ, Dept Med Microbiol \& Immunol, Al Ain, U Arab Emirates.
   Khan, Md Nuruzzaman, Jatiya Kabi Kazi Nazrul Islam Univ, Dept Populat Sci, Mymensingh, Bangladesh.
   Khatab, Khaled, Sheffield Hallam Univ, Fac Hlth \& Wellbeing, Sheffield, S Yorkshire, England.
   Khatab, Khaled, Ohio Univ, Coll Arts \& Sci, Zanesville, OH USA.
   Khater, Amir, Natl Hepatol \& Trop Res Inst, Internal Med \& Gastroenterol Dept, Cairo, Egypt.
   Khayamzadeh, Maryam, Acad Med Sci, Tehran, Iran.
   Khubchandani, Jagdish, Ball State Univ, Dept Nutr \& Hlth Sci, Muncie, IN 47306 USA.
   Kiadaliri, Aliasghar A., Lund Univ, Clin Epidemiol Unit, Lund, Sweden.
   Kim, Yun Jin, Xiamen Univ Malaysia, Sch Med, Sepang, Malaysia.
   Kimokoti, Ruth W., Simmons Univ, Dept Nutr, Boston, MA USA.
   Kisa, Adnan, Kristiania Univ Coll, Sch Hlth Sci, Oslo, Norway.
   Kisa, Sezer, Oslo Metropolitan Univ, Dept Nursing \& Hlth Promot, Oslo, Norway.
   Kissoon, Niranjan, Univ British Columbia, Dept Pediat, Vancouver, BC, Canada.
   Pourmalek, Farshad, Univ British Columbia, Sch Populat \& Publ Hlth, Vancouver, BC, Canada.
   Kondlahalli, Shivakumar K. M., Deemed Univ, Sch Dent Sci, Publ Hlth Dent, Karad, India.
   Kosek, Margaret N., Asociac Benef PRISMA, Invest Biomed, Iquitos, Peru.
   Koyanagi, Ai, CIBERSAM, San Juan de Dios Sanit Pk, St Boi De Llobregat, Spain.
   Krishan, Kewal, Panjab Univ, Dept Anthropol, Chandigarh, India.
   Kugbey, Nuworza, Univ KwaZulu Natal, Dept Psychol \& Hlth Promot, Durban, South Africa.
   Moodley, Yoshan, Univ KwaZulu Natal, Dept Publ Hlth Med, Durban, South Africa.
   Tlou, Boikhutso, Univ KwaZulu Natal, Discipline Publ Hlth Med, Durban, South Africa.
   Mathur, Manu Raj, UCL, Dept Epidemiol \& Publ Hlth, London, England.
   Kumar, Manasi, UCL, Div Psychol \& Language Sci, London, England.
   Rawal, Salman Rawaf Lal, Imperial Coll London, Dept Primary Care \& Publ Hlth, London, England.
   Kusuma, Dian, Imperial Coll London, Imperial Coll Business Sch, London, England.
   Rawaf, David Laith, Imperial Coll London, WHO Collaborating Ctr Publ Hlth Educ \& Training, London, England.
   Kusuma, Dian; Trihandini, Indang, Univ Indonesia, Fac Publ Hlth, Depok, Indonesia.
   Ben Lacey, Natl Inst Hlth Res NIHR Oxford Biomed Res Ctr, Oxford, England.
   Lal, Aparna, Australian Natl Univ, Natl Ctr Epidemiol \& Populat Hlth, Canberra, ACT, Australia.
   Lami, Faris Hasan, Univ Baghdad, Dept Community \& Family Med, Baghdad, Iraq.
   Lansingh, Van C., HelpMeSee, New York, NY USA.
   Lansingh, Van C., Mexican Inst Ophthalmol, Int Relat, Queretaro, Mexico.
   Lasrado, Savita, Father Muller Med Coll, Dept Otorhinolaryngol ENT, Mangalore, India.
   Lewycka, Sonia, Wellcome Trust Asia Programme, Oxford Univ Clin Res Unit, Hanoi, Vietnam.
   Linn, Shai, Univ Haifa, Sch Publ Hlth, Haifa, Israel.
   Longbottom, Joshua, Univ Liverpool Liverpool Sch Trop Med, Dept Vector Biol, Liverpool, Merseyside, England.
   Magdeldin, Sameh, Childrens Canc Hosp Egypt, Prote \& Metabol Unit, Cairo, Egypt.
   Mahotra, Narayan Bahadur, Tribhuvan Univ, Inst Med, Kathmandu, Nepal.
   Manafi, Navid, Univ Manitoba, Dept Ophthalmol, Winnipeg, MB, Canada.
   Manda, Ana-Laura, Emergency Univ Hosp Bucharest, Dept Surg, Bucharest, Romania.
   Mapoma, Chabila Christopher, Univ Zambia, Dept Populat Studies, Lusaka, Zambia.
   Martins-Melo, Francisco Rogerlandio, Fed Inst Educ Sci \& Technol Ceara, Campus Caucaia, Caucaia, Brazil.
   Marz, Winfried, Med Univ Graz, Clin Inst Med \& Chem Lab Diagnost, Graz, Austria.
   Masaka, Anthony, Botho Univ Botswana, Dept Publ Hlth, Gaborone, Botswana.
   Mayala, Benjamin K., ICF Int, Rockville, MD USA.
   McAlinden, Colm, Hywel Dda Univ Hlth Board, Dept Ophthalmol, Carmarthen, Dyfed, Wales.
   Mehndiratta, Man Mohan, Janakpuri Super Specialty Hosp Soc, Dept Neurol, New Delhi, India.
   Mehndiratta, Man Mohan, Govind Ballabh Inst Med Educ \& Res, Dept Neurol, New Delhi, India.
   Mehrotra, Ravi, Natl Inst Canc Prevent \& Res, Div Prevent Oncol, Noida, India.
   Mehta, Kala M., Univ Calif San Francisco, Dept Epidemiol \& Biostat, San Francisco, CA USA.
   Memish, Ziad A.; Temsah, Mohamad-Hani, Alfaisal Univ, Coll Med, Riyadh, Saudi Arabia.
   Mena, Alemayehu Toma, ACS Med Coll \& Hosp, Dept Pharmacol, Hawassa, Ethiopia.
   Meretoja, Tuomo J., Helsinki Univ Hosp, Breast Surg Unit, Helsinki, Finland.
   Meretoja, Tuomo J., Univ Helsinki, Helsinki, Finland.
   Miazgowski, Bartosz, Pomeranian Med Univ, Ctr Innovat Med Educ, Szczecin, Poland.
   Miazgowski, Bartosz, Pomeranian Med Univ, Szczecin, Poland.
   Mills, Edward J., McMaster Univ, Dept Hlth Res Methods Evidence \& Impact, Hamilton, ON, Canada.
   Olagunju, Andrew T., McMaster Univ, Dept Psychiat \& Behav Neurosci, Hamilton, ON, Canada.
   Mirrakhimov, Erkin M., Kyrgyz State Med Acad, Fac Internal Med, Bishkek, Kyrgyzstan.
   Mirrakhimov, Erkin M., Natl Ctr Cardiol \& Internal Dis, Dept Atherosclerosis \& Coronary Heart Dis, Bishkek, Kyrgyzstan.
   Moradi, Ghobad, Kurdistan Univ Med Sci, Dept Epidemiol \& Biostat, Sanandaj, Iran.
   Pashaei, Tahereh, Kurdistan Univ Med Sci, Environm Hlth Res Ctr, Res Inst Hlth Dev, Sanandaj, Iran.
   Mohamadi-Bolbanabad, Amjad; Moradi, Ghobad; Piroozi, Bakhtiar, Kurdistan Univ Med Sci, Social Determinants Hlth Res Ctr, Sanandaj, Iran.
   Mohammad, Dara K., Salahaddin Univ, Dept Food Technol, Erbil, Iraq.
   Mohammad, Karzan Abdulmuhsin, Salahaddin Univ, Res Ctr, Erbil, Iraq.
   Mohammad, Karzan Abdulmuhsin, Ishik Univ, Erbil, Iraq.
   Mohammed, Jemal Abdu; Zepro, Nejimu Biza, Samara Univ, Dept Publ Hlth, Samara, Ethiopia.
   Sufiyan, Mu'awiyyah Babale, Ahmadu Bello Univ, Dept Community Med, Zaria, Nigeria.
   Mohammed, Shafiu, Ahmadu Bello Univ, Hlth Syst \& Policy Res Unit, Zaria, Nigeria.
   Moraga, Paula, Univ Bath, Dept Math Sci, Bath, Avon, England.
   Mosapour, Abbas, Tarbiat Modares Univ, Dept Clin Biochem, Tehran, Iran.
   Mozaffor, Miliva, Med Coll Women \& Hosp, Dept Biochem, Dhaka, Bangladesh.
   Mozaffor, Miliva, Biomed Res Fdn, Res Team, Dhaka, Bangladesh.
   Musa, Kamarul Imran, Sci Univ Malaysia, Sch Med Sci, Kubang Kerian, Malaysia.
   Murthy, G. V. S., Publ Hlth Fdn India, Indian Inst Publ Hlth, Hyderabad, Telangana, India.
   Mustafa, Ghulam, Nishtar Med Univ, Dept Pediat Med, Multan, Pakistan.
   Mustafa, Ghulam, Inst Mother \& Child Care, Dept Pediat \& Pediat Pulmonol, Multan, Pakistan.
   Nagarajan, Ahamarshan Jayaraman, Initiat Financing Hlth \& Human Dev, Res \& Analyt, Chennai, Tamil Nadu, India.
   Nagarajan, Ahamarshan Jayaraman, Bioinsilico Technol, Res \& Analyt, Chennai, Tamil Nadu, India.
   Nangia, Vinay, Suraj Eye Inst, Nagpur, Maharashtra, India.
   Nazari, Javad, Iranian Minist Hlth \& Med Educ, Tehran, Iran.
   Negoi, Ionut, Emergency Hosp Bucharest, Bucharest, Romania.
   Ngunjiri, Josephine W., Univ Embu, Dept Biol Sci, Embu, Kenya.
   Nguyen, Cuong Tat, Duy Tan Univ, Inst Global Hlth Innovat, Hanoi, Vietnam.
   Ningrum, Dina Nur Anggraini, Univ Negeri Semarang, Dept Publ Hlth, Kota Semarang, Indonesia.
   Ningrum, Dina Nur Anggraini, Taipei Med Univ, Grad Inst Biomed Informat, Taipei, Taiwan.
   Noubiap, Jean Jacques; Shey, Muki Shehu, Univ Cape Town, Dept Med, Cape Town, South Africa.
   Shey, Muki Shehu, Univ Cape Town, Inst Infect Dis \& Mol Med, Cape Town, South Africa.
   Nnaji, Chukwudi A.; Wiysonge, Charles Shey, Univ Cape Town, Sch Publ Hlth \& Family Med, Cape Town, South Africa.
   Oh, In-Hwan, Kyung Hee Univ, Dept Prevent Med, Dongdaemun Gu, South Korea.
   Okpala, Oluchi, Int Inst Trop Agr, Ibadan, Nigeria.
   Olagunju, Andrew T., Univ Lagos, Dept Psychiat, Lagos, Nigeria.
   Onwujekwe, Obinna E., Univ Nigeria Nsukka, Dept Pharmacol \& Therapeut, Enugu, Nigeria.
   Osarenotor, Osayomwanbo, Univ Benin, Dept Environm Management \& Toxicol, Benin, Nigeria.
   Osei, Frank B., Univ Energy \& Nat Resources, Dept Math \& Stat, Sunyani, Ghana.
   Jagadguru Sri Shivarathreeswara Acad Hlth Educ \&, Dept Resp Med, Mysore, Karnataka, India.
   Pana, Adrian, Ctr Hlth Outcomes \& Evaluat, Bucharest, Romania.
   Pati, Sanghamitra, Indian Council Med Res, Reg Med Res Ctr, Bhubaneswar, Odisha, India.
   Patle, Ajay, Int Inst Hlth Management Res, New Delhi, India.
   Suleria, Hafiz Ansar Rasul, Univ Melbourne, Dept Agr \& Food Syst, Melbourne, Vic, Australia.
   Wijeratne, Tissa, Univ Melbourne, Dept Med, Melbourne, Vic, Australia.
   Patton, George C., Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia.
   Wijeratne, Tissa, Univ Melbourne, Dept Psychol \& Counselling, Melbourne, Vic, Australia.
   Patton, George C., Murdoch Childrens Res Inst, Populat Hlth Theme, Melbourne, Vic, Australia.
   Pepito, Veincent Christian Filipino, Ateneo Manila Univ, Ctr Res \& Innovat, Pasig, Philippines.
   Santos, Itamar S., Univ Sao Paulo, Dept Internal Med, Sao Paulo, Brazil.
   Tovani-Palone, Marcos Roberto, Univ Sao Paulo, Dept Pathol \& Legal Med, Sao Paulo, Brazil.
   Wang, Yafeng, Univ Sao Paulo, Dept Psychiat, Sao Paulo, Brazil.
   Pereira, Alexandre, Univ Sao Paulo, Lab Genet \& Mol Cardiol, Sao Paulo, Brazil.
   Platts-Mills, James A., Univ Virginia, Div Infect Dis \& Int Hlth, Charlottesville, VA USA.
   Poljak, Mario, Univ Ljubljana, Inst Microbiol \& Immunol, Ljubljana, Slovenia.
   Postma, Maarten J., Univ Groningen, Fac Econ \& Business, Groningen, Netherlands.
   Postma, Maarten J., Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands.
   Prada, Sergio I., Fdn Valle del Lili, Cali, Colombia.
   Preotescu, Liliana, Natl Inst Infect Dis, Infect Dis, Bucharest, Romania.
   Rabiee, Mohammad, Amirkabir Univ Technol, Dept Biomed Engn, Tehran, Iran.
   Rabiee, Navid, Sharif Univ Technol, Dept Chem, Tehran, Iran.
   Radfar, Amir, Univ Cent Florida, Coll Med, Orlando, FL 32816 USA.
   Rahman, Muhammad Aziz, Federation Univ, Sch Nursing \& Healthcare Profess, Heidelberg, Vic, Australia.
   Rana, Saleem M., Univ Lahore, Univ Inst Publ Hlth, Lahore, Pakistan.
   Rana, Saleem M., Univ Hlth Sci, Dept Publ Hlth, Lahore, Pakistan.
   Ranabhat, Chhabi Lal, Policy Res Inst, Kathmandu, Nepal.
   Shin, Jae Il, Yonsei Univ, Coll Med, Wonju, South Korea.
   Ranabhat, Chhabi Lal, Yonsei Univ, Inst Poverty Alleviat \& Int Dev, Wonju, South Korea.
   Rasella, Davide, Fundacao Oswaldo Cruz, Goncalo Moniz Inst, Salvador, BA, Brazil.
   Rawaf, David Laith, Univ Coll London Hosp, London, England.
   Rawal, Salman Rawaf Lal, Publ Hlth England, Acad Publ Hlth Dept, London, England.
   Rawal, Salman Rawaf Lal, CQ Univ, Sch Hlth Med \& Appl Sci, Sydney, NSW, Australia.
   Renjith, Vishnu, Sree Chitra Tirunal Inst Med Sci \& Technol, Dept Neurol, Thiruvananthapuram, Kerala, India.
   Renzaho, Andre M. N., Western Sydney Univ, Sch Social Sci \& Psychol, Penrith, NSW, Australia.
   Renzaho, Andre M. N., Western Sydney Univ, Translat Hlth Res Inst, Penrith, NSW, Australia.
   Reta, Melese Abate, Univ Pretoria, Med Microbiol, Pretoria, South Africa.
   Rickard, Jennifer, Univ Minnesota, Dept Surg, Box 242 UMHC, Minneapolis, MN 55455 USA.
   Rickard, Jennifer, Univ Teaching Hosp Kigali, Dept Surg, Kigali, Rwanda.
   Gonzalez, Carlos Miguel Rios, Nihon Gakko Univ, Res Directorate, Fernando De La Mora, Paraguay.
   Gonzalez, Carlos Miguel Rios, Univ Nacl Caaguazu, Res Direct, Coronel Oviedo, Paraguay.
   Roever, Leonardo, Univ Fed Uberlandia, Dept Clin Res, Uberlandia, MG, Brazil.
   Ronfani, Luca; Traini, Eugenio, Burlo Garofolo Inst Maternal \& Child Hlth, Clin Epidemiol \& Publ Hlth Res Unit, Trieste, Italy.
   Rothenbacher, Dietrich, Ulm Univ, Inst Epidemiol \& Med Biometry, Ulm, Germany.
   Rubagotti, Enrico, Agrosavia, Ctr Invest Palmira, Palmira, Colombia.
   Rubagotti, Enrico, Southern Univ Sci \& Technol, Dept Ocean Sci \& Engn, Shenzhen, Peoples R China.
   Rubino, Salvatore, Univ Sassari, Dept Biomed Sci, Sassari, Italy.
   Samy, Abdallah M., Ain Shams Univ, Dept Entomol, Cairo, Egypt.
   Shalash, Ali S., Ain Shams Univ, Dept Neurol, Cairo, Egypt.
   Saad, Anas M., Ain Shams Univ, Fac Med, Cairo, Egypt.
   Sajadi, S. Mohammad, Soran Univ, Nanobiotechnol Ctr, Soran, Iraq.
   Zahabi, Saleh Salehi, Taleghani Hosp, Res Deputy, Kermanshah, Iran.
   Sanabria, Juan, Marshall Univ, Dept Surg, Huntington, WV USA.
   Saraswathy, Sivan Yegnanarayana Iyer, PSG Inst Med Sci \& Res, Dept Community Med, Coimbatore, Tamil Nadu, India.
   Saraswathy, Sivan Yegnanarayana Iyer, PSG FAIMER South Asia Reg Inst, Coimbatore, Tamil Nadu, India.
   Sarker, Abdur Razzaque, Bangladesh Inst Dev Studies BIDS, Hlth Econ, Dhaka, Bangladesh.
   Sathian, Brijesh, Hamad Med Corp, Dept Surg, Doha, Qatar.
   Sathian, Brijesh, Bournemouth Univ, Fac Hlth \& Social Sci, Bournemouth, Dorset, England.
   Satpathy, Maheswar, Utkal Univ, UGC Ctr Adv Study Psychol, Bhubaneswar, Odisha, India.
   Satpathy, Maheswar, Udyam Global Assoc Sustainable Dev, Bhubaneswar, Odisha, India.
   Singh, Jasvinder A., Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA.
   Schwebel, David C., Univ Alabama Birmingham, Dept Psychol, Birmingham, AL 35294 USA.
   Senbeta, Anbissa Muleta, Jigjiga Univ, Dept Food Sci \& Nutr, Jigjiga, Ethiopia.
   Tassew, Aberash Abay, Jigjiga Univ, Jigjiga, Ethiopia.
   Senthilkumaran, Subramanian, Manian Med Ctr, Emergency Dept, Erode, India.
   Shaheen, Amira A., An Najah Natl Univ, Publ Hlth Div, Nablus, Palestine.
   Shallo, Seifadin Ahmed, Ambo Univ, Dept Publ Hlth, Ambo, Ethiopia.
   Shams-Beyranvand, Mehran, Dezful Univ Med Sci, Sch Med, Dezful, Iran.
   Shams-Beyranvand, Mehran, Alborz Univ Med Sci, Sch Med, Karaj, Iran.
   Shibuya, Kenji, Kings Coll London, Inst Populat Hlth, London, England.
   Shigematsu, Mika, Natl Inst Infect Dis, Tokyo, Japan.
   Shil, Apurba, Ben Gurion Univ Negev, Dept Publ Hlth, Beer Sheva, Israel.
   Shin, Jae Il, Emory Univ, Div Cardiol, Atlanta, GA 30322 USA.
   Shiri, Rahman, Finnish Inst Occupat Hlth, Helsinki, Finland.
   Siabani, Si Si Soraya, Univ Technol Sydney, Sch Hlth, Sydney, NSW, Australia.
   Singh, Jasvinder A., US Dept Vet Affairs VA, Med Serv, Birmingham, AL USA.
   Singh, Narinder Pal, Max Hosp, Ghaziabad, India.
   Sinha, Dhirendra Narain, Sch Prevent Oncol, Dept Epidemiol, Patna, Bihar, India.
   Sinha, Dhirendra Narain, Healis Sekhsaria Inst Publ Hlth, Dept Epidemiol, Mumbai, Maharashtra, India.
   Sisay, Malede Mequanent, Naestved Slagelse Ringsted Hosp, Dept Physiotherapy \& Occupat Therapy, Slagelse, Denmark.
   Sokhan, Anton, Kharkiv Natl Med Univ, Dept Infect Dis, Kharkiv, Ukraine.
   Soriano, Joan B., Autonomous Univ Madrid, Hosp Univ Princesa, Madrid, Spain.
   Soriano, Joan B., Ctr Invest Biomed Red Enfermedades Resp CIBERES, Madrid, Spain.
   Soyiri, Ireneous N., Univ Hull, Hull York Med Sch, Kingston Upon Hull, N Humberside, England.
   Soyiri, Ireneous N., Univ Edinburgh, Usher Inst Populat Hlth Sci \& Informat, Edinburgh, Midlothian, Scotland.
   Sreeramareddy, Chandrashekhar T., Int Med Univ, Div Community Med, Kuala Lumpur, Malaysia.
   Sudaryanto, Agus, Muhammadiyah Univ Surakarta, Dept Nursing, Surakarta, Indonesia.
   Sudaryanto, Agus, China Med Univ, Dept Publ Hlth, Taichung, Taiwan.
   Sykes, Bryan L., Univ Calif Irvine, Dept Criminol Law \& Soc, Irvine, CA USA.
   Taveira, Nuno, Univ Inst Egas Moniz, Monte De Caparica, Portugal.
   Taveira, Nuno, Univ Lisbon, Fac Pharm Lisbon, Res Inst Med, Lisbon, Portugal.
   Taye, Bineyam, Colgate Univ, Hamilton, NY 13346 USA.
   Tesfay, Fisaha Haile, Flinders Univ S Australia, South Gate Inst Hlth Soc \& Equ, Adelaide, SA, Australia.
   Thankappan, Kavumpurathu Raman, Cent Univ Kerala, Dept Publ Hlth \& Community Med, Kasaragod, India.
   Thirunavukkarasu, Sathish, Nanyang Technol Univ, Singapore, Singapore.
   Tran, Khanh Bao, Univ Auckland, Dept Mol Med \& Pathol, Auckland, New Zealand.
   Tran, Khanh Bao, Mil Med Univ, Clin Hematol \& Toxicol, Hanoi, Vietnam.
   Ullah, Irfan, Gomal Univ, Gomal Ctr Biochem \& Biotechnol, Dera Ismail Khan, Pakistan.
   Ullah, Irfan, Mufti Mehmood Mem Teaching Hosp, TB Culture Lab, Dera Ismail Khan, Pakistan.
   Unnikrishnan, Bhaskaran, Manipal Acad Higher Educ, Dept Community Med, Mangalore, India.
   Tahbaz, Sahel Valadan; Jabbari, Seyed Hossein Yahyazadeh, Milad Gen Hosp, Clin Canc Res Ctr, Tehran, Iran.
   Valdez, Pascual R., Argentine Soc Med, Buenos Aires, DF, Argentina.
   Valdez, Pascual R., Velez Sarsfield Hosp, Buenos Aires, DF, Argentina.
   Veisani, Yousef, Ilam Univ Med Sci, Psychosocial Injuries Res Ctr, Ilam, Iran.
   Violante, Francesco S., St Orsola Malpighi Hosp, Occupat Hlth Unit, Bologna, Italy.
   Vollmer, Sebastian, Univ Gottingen, Dept Econ, Gottingen, Germany.
   Waheed, Yasir, Fdn Univ, Fdn Univ Med Coll, Islamabad, Pakistan.
   Wang, Yafeng; Yu, Chuanhua, Wuhan Univ, Dept Epidemiol \& Biostat, Wuhan, Peoples R China.
   Yu, Chuanhua, Wuhan Univ, Global Hlth Inst, Wuhan, Peoples R China.
   Westerman, Ronny, Fed Inst Populat Res, German Natl Cohort, Competence Ctr Mortal Follow Up, Wiesbaden, Germany.
   Wiangkham, Taweewat, Naresuan Univ, Dept Phys Therapy, Meung Dist, Thailand.
   Wu, Ai-Min, Wenzhou Med Univ, Affiliated Hosp 2, Dept Orthopaed, Wenzhou, Peoples R China.
   Wu, Ai-Min, Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou, Peoples R China.
   Xu, Gelin, Nanjing Univ, Sch Med, Nanjing, Peoples R China.
   Yamada, Tomohide, Univ Tokyo, Dept Diabet \& Metab Dis, Tokyo, Japan.
   Yip, Paul, Univ Hong Kong, Ctr Suicide Res \& Prevent, Hong Kong, Peoples R China.
   Yip, Paul, Univ Hong Kong, Dept Social Work \& Social Adm, Hong Kong, Peoples R China.
   Yirsaw, Biruck Desalegn, Univ South Australia, Adelaide, NSW, Australia.
   Yonemoto, Naohiro, Natl Ctr Neurol \& Psychiat, Dept Psychopharmacol, Tokyo, Japan.
   Younis, Mustafa Z., Jackson State Univ, Dept Hlth Policy \& Management, Jackson, MS USA.
   Younis, Mustafa Z., Tsinghua Univ, Sch Med, Beijing, Peoples R China.
   Yusefzadeh, Hasan, Urmia Univ Med Sci, Dept Hlth Econ \& Management, Orumiyeh, Iran.
   Zambrana-Torrelio, Carlos, EcoHealth Alliance, New York, NY USA.
   Zhang, Dongyu, Georgetown Univ, Dept Oncol, Washington, DC USA.
   Zhang, Yunquan, Wuhan Univ Sci \& Technol, Hubei Prov Key Lab Occupat Hazard Identificat \& C, Wuhan, Peoples R China.
   Zhang, Yunquan, Wuhan Univ Sci \& Technol, Sch Publ Hlth, Wuhan, Peoples R China.
   Zhao, Xiu-Ju, Wuhan Polytech Univ, Wuhan, Peoples R China.},
DOI = {10.1016/S0140-6736(20)30114-8},
Keywords-Plus = {AFRICA; CHOLERA; WATER},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Author-Email = {bcreiner@uw.edu},
Affiliations = {Institute for Health Metrics \& Evaluation; University of Washington;
   University of Washington Seattle; University of Washington; University
   of Washington Seattle; University of Washington; University of
   Washington Seattle; Haramaya University; Haramaya University; Haramaya
   University; Haramaya University; Haramaya University; Haramaya
   University; Haramaya University; Tehran University of Medical Sciences;
   Tehran University of Medical Sciences; Tehran University of Medical
   Sciences; Tehran University of Medical Sciences; Tehran University of
   Medical Sciences; Tehran University of Medical Sciences; Tehran
   University of Medical Sciences; Tehran University of Medical Sciences;
   Tehran University of Medical Sciences; Tehran University of Medical
   Sciences; Tehran University of Medical Sciences; Tehran University of
   Medical Sciences; Tehran University of Medical Sciences; Tehran
   University of Medical Sciences; Tehran University of Medical Sciences;
   Tehran University of Medical Sciences; Tehran University of Medical
   Sciences; Tehran University of Medical Sciences; Tehran University of
   Medical Sciences; Tehran University of Medical Sciences; Egyptian
   Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB);
   Cairo University; Egyptian Knowledge Bank (EKB); Cairo University;
   Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank
   (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Cairo
   University; Isfahan University Medical Science; Isfahan University
   Medical Science; Ministry of Health - Saudi Arabia; Ministry of Health -
   Saudi Arabia; King Saud Bin Abdulaziz University for Health Sciences;
   Prince Mohammed bin Abdulaziz Hospital - Al Madinah; Bahir Dar
   University; Bahir Dar University; Bahir Dar University; Bahir Dar
   University; Bahir Dar University; Bahir Dar University; Addis Ababa
   University; Addis Ababa University; Addis Ababa University; Addis Ababa
   University; Addis Ababa University; Addis Ababa University; Addis Ababa
   University; Addis Ababa University; Addis Ababa University; Universidade
   Federal de Minas Gerais; Universidade Federal de Minas Gerais;
   Universidade Federal de Minas Gerais; Dongguk University; Hamadan
   University of Medical Sciences; Hamadan University of Medical Sciences;
   Hamadan University of Medical Sciences; Hamadan University of Medical
   Sciences; Hamadan University of Medical Sciences; Hamadan University of
   Medical Sciences; Hamadan University of Medical Sciences; University of
   Ibadan; University College Hospital, Ibadan; Obafemi Awolowo University;
   Cardiff University; Stellenbosch University; Stellenbosch University;
   Stellenbosch University; South African Medical Research Council; Ardabil
   University of Medical Sciences; Ardabil University of Medical Sciences;
   Ardabil University of Medical Sciences; Ardabil University of Medical
   Sciences; Mekelle University; Mekelle University; Mekelle University;
   Mekelle University; Mekelle University; Mekelle University; Mekelle
   University; Mekelle University; Mekelle University; Mekelle University;
   Mekelle University; Ahvaz Jundishapur University of Medical Sciences
   (AJUMS); Ahvaz Jundishapur University of Medical Sciences (AJUMS); Ahvaz
   Jundishapur University of Medical Sciences (AJUMS); Ahvaz Jundishapur
   University of Medical Sciences (AJUMS); University of Nottingham;
   University of Lincoln; Jimma University; Jimma University; Bangladesh
   Rural Advancement Committee BRAC; BRAC University; International Centre
   for Diarrhoeal Disease Research (ICDDR); Nevada System of Higher
   Education (NSHE); University of Nevada Reno; University of Gondar;
   University of Gondar; University of Gondar; University of Gondar;
   University of Gondar; University of Rhode Island; Imam Abdulrahman Bin
   Faisal University; Imam Abdulrahman Bin Faisal University; Instituto
   Nacional de Salud Publica; Instituto Nacional de Salud Publica;
   Instituto Nacional de Salud Publica; Instituto Nacional de Salud
   Publica; Erbil Polytechnic University; Quaid I Azam University; Qazvin
   University of Medical Sciences (QUMS); Iran University of Medical
   Sciences; Iran University of Medical Sciences; Iran University of
   Medical Sciences; Iran University of Medical Sciences; Iran University
   of Medical Sciences; Iran University of Medical Sciences; Iran
   University of Medical Sciences; Iran University of Medical Sciences;
   Iran University of Medical Sciences; Iran University of Medical
   Sciences; Iran University of Medical Sciences; Iran University of
   Medical Sciences; Iran University of Medical Sciences; Kuwait
   University; Kermanshah University of Medical Sciences; Kermanshah
   University of Medical Sciences; Kermanshah University of Medical
   Sciences; Kermanshah University of Medical Sciences; Kermanshah
   University of Medical Sciences; Kermanshah University of Medical
   Sciences; Kermanshah University of Medical Sciences; Kermanshah
   University of Medical Sciences; Kermanshah University of Medical
   Sciences; Kermanshah University of Medical Sciences; Kermanshah
   University of Medical Sciences; Kermanshah University of Medical
   Sciences; Kermanshah University of Medical Sciences; Kermanshah
   University of Medical Sciences; Kermanshah University of Medical
   Sciences; Jazan University; Jazan University; King Saud University; King
   Saud University; King Saud University; Universidad de Cartagena;
   Universidad de la Costa; Universidad de la Costa; University of South
   Australia; South Australian Health \& Medical Research Institute
   (SAHMRI); University of the Philippines System; University of the
   Philippines Manila; University of the Philippines System; University of
   the Philippines Manila; University of the Philippines System; University
   of the Philippines Manila; Johns Hopkins University; Johns Hopkins
   University; Johns Hopkins University; Johns Hopkins University; National
   Institute for Infectious Diseases ``Matei Bals{''}; Carol Davila
   University of Medicine \& Pharmacy; Carol Davila University of Medicine
   \& Pharmacy; Carol Davila University of Medicine \& Pharmacy; Wageningen
   University \& Research; Tabriz University of Medical Science; Tabriz
   University of Medical Science; Tabriz University of Medical Science;
   Tabriz University of Medical Science; Hong Kong Polytechnic University;
   Hong Kong Polytechnic University; Sebelas Maret University; Kwame
   Nkrumah University Science \& Technology; University of Munich;
   Birmingham City University; Babol University of Medical Sciences; Babol
   University of Medical Sciences; Babol University of Medical Sciences;
   Babol University of Medical Sciences; Babol University of Medical
   Sciences; Babol University of Medical Sciences; Babol University of
   Medical Sciences; Ministry of Health \& Medical Education (MOHME);
   Ministry of Health \& Medical Education (MOHME); University Ha'il;
   University Ha'il; Dr DY Patil Vidyapeeth Pune; Dr D Y Patil Medical
   College, Hospital \& Research Centre; University of Leicester; Bucharest
   University of Economic Studies; Melbourne Genomics Health Alliance; La
   Trobe University; Instituto Nacional de Salud - Peru; Curtin University;
   Curtin University; University of New England; Public Health Agency of
   Canada; University of Toronto; University of Toronto; University of
   Toronto; Manipal Academy of Higher Education (MAHE); Manipal Academy of
   Higher Education (MAHE); Medical University Lodz; Polish Mother's
   Memorial Hospital - Research Institute; Clinical Centre of Serbia;
   University of Belgrade; Ruprecht Karls University Heidelberg; Ruprecht
   Karls University Heidelberg; Ruprecht Karls University Heidelberg;
   Harvard University; Harvard University; Harvard University; Harvard
   University; Harvard Medical School; Harvard University; Harvard T.H.
   Chan School of Public Health; University of Barcelona; ISGlobal; ICREA;
   Shiraz University of Medical Science; Lorestan University of Medical
   Sciences; Lorestan University of Medical Sciences; Yale University;
   University of Oxford; University of Oxford; University of Oxford;
   University of Oxford; Arba Minch University; University of Massachusetts
   System; Department of Biotechnology (DBT) India; National Institute of
   Biomedical Genomics (NIBMG); University of Calcutta; University of New
   South Wales Sydney; University of New South Wales Sydney; University of
   New South Wales Sydney; University of New South Wales Sydney; Swinburne
   University of Technology; Melbourne Genomics Health Alliance; Islamic
   Azad University; Islamic Azad University; Islamic Azad University;
   Islamic Azad University; Islamic Azad University; University of London;
   London School of Hygiene \& Tropical Medicine; University of London;
   London School of Hygiene \& Tropical Medicine; University of Genoa;
   Bauman Moscow State Technical University; Sechenov First Moscow State
   Medical University; University of Waterloo; Universidad Autonoma
   Metropolitana - Mexico; Universidade do Porto; Universidade do Porto;
   Instituto Conmemorativo Gorgas de Estudios de la Salud; The World Bank;
   Indian Council of Medical Research (ICMR); ICMR - National Institute of
   Cholera \& Enteric Diseases (NICED); Gokhale Institute of Politics \&
   Economics; International Institute for Population Sciences;
   International Institute for Population Sciences; International Institute
   for Population Sciences; Monash University; Monash University; Melbourne
   Genomics Health Alliance; Christian Medical College \& Hospital (CMCH)
   Vellore; Christian Medical College \& Hospital (CMCH) Vellore; Christian
   Medical College \& Hospital (CMCH) Vellore; Hanoi National University of
   Education; University System of Ohio; Case Western Reserve University;
   University System of Ohio; Case Western Reserve University; University
   of Milan; University of Milan; Public Health Foundation of India; Indian
   Council of Medical Research (ICMR); Egyptian Knowledge Bank (EKB); Tanta
   University; Mazandaran University Medical Sciences; Mazandaran
   University Medical Sciences; Mazandaran University Medical Sciences;
   Mazandaran University Medical Sciences; Aga Khan University; University
   of South Carolina System; University of South Carolina Columbia; FLACSO
   Mexico; University of Sussex; University of Brighton; University of
   Peradeniya; Universidad Nacional Autonoma de Mexico; Nguyen Tat Thanh
   University (NTTU); University of Cape Coast; Tampere University; Mahidol
   Oxford Tropical Medicine Research Unit (MORU); Mahidol University;
   Hawassa University; Universidade Federal da Bahia; Universidade Federal
   da Bahia; Escola Bahiana de Medicina e Saude Publica; Bharathidasan
   University; University of Newcastle; University of Newcastle; Egyptian
   Knowledge Bank (EKB); Alexandria University; Egyptian Knowledge Bank
   (EKB); Alexandria University; Egyptian Knowledge Bank (EKB); Mansoura
   University; University of Tripoli; World Health Organization; Egyptian
   Knowledge Bank (EKB); Suez Canal University; Egyptian Knowledge Bank
   (EKB); Suez Canal University; National Institutes of Health (NIH) - USA;
   NIH National Cancer Institute (NCI); Imam Mohammad Ibn Saud Islamic
   University (IMSIU); Imam Mohammad Ibn Saud Islamic University (IMSIU);
   University of Bologna; Universidade Federal de Sergipe; Karolinska
   Institutet; Karolinska Institutet; University of Ottawa; Kaiser
   Permanente; A.T. Still University of Health Sciences; A.T. Still
   University of Health Sciences; University of Bielefeld; University of
   Witwatersrand; James Cook University; Kobe University; The Wistar
   Institute; University of Warwick; Jawaharlal Nehru University, New
   Delhi; University of Oklahoma System; University of Oklahoma Health
   Sciences Center; Universidade Federal do Rio Grande do Sul; Boston
   University; Universidade Federal de Goias; Zhengzhou University; West
   Virginia University; Shahid Beheshti University Medical Sciences; Shahid
   Beheshti University Medical Sciences; Shahid Beheshti University Medical
   Sciences; Shahid Beheshti University Medical Sciences; Shahid Beheshti
   University Medical Sciences; Shahid Beheshti University Medical
   Sciences; Shahid Beheshti University Medical Sciences; Shahid Beheshti
   University Medical Sciences; Shahid Beheshti University Medical
   Sciences; University of Macau; Airlangga University; University of
   Adelaide; Egyptian Knowledge Bank (EKB); Al Azhar University; University
   of Queensland; University of Antwerp; Dhaka Medical College; Qatar
   Foundation (QF); Hamad Bin Khalifa University-Qatar; Qatar Foundation
   (QF); Central South University; Dow University of Health Sciences;
   University of Ibadan; University of Ibadan; University of Ibadan;
   University of Kragujevac; Deakin University; Deakin University;
   University of Sydney; Babol Noshirvani University of Technology;
   Sechenov First Moscow State Medical University; University of Colombo;
   University of Colombo; Banaras Hindu University (BHU); Duke Kunshan
   University; Duke University; University of Twente; University of Twente;
   University of Opole; University College Cork; Golestan University of
   Medical Sciences; All India Institute of Medical Sciences (AIIMS)
   Jodhpur; All India Institute of Medical Sciences (AIIMS) Jodhpur; All
   India Institute of Medical Sciences (AIIMS) Jodhpur; University of
   Munster; Australian Red Cross Blood Service; Utrecht University;
   University of Nairobi; University of Nairobi; University of Nairobi;
   Jordan University of Science \& Technology; University of Management \&
   Technology (UMT); Ministry of Education of Azerbaijan Republic; Baku
   State University; Health Services Academy; United Arab Emirates
   University; Sheffield Hallam University; University System of Ohio; Ohio
   University; Ball State University; Lund University; Xiamen University
   Malaysia Campus; Simmons University; Kristiania University College; Oslo
   Metropolitan University (OsloMet); University of British Columbia;
   University of British Columbia; CIBER - Centro de Investigacion
   Biomedica en Red; CIBERSAM; Panjab University; University of Kwazulu
   Natal; University of Kwazulu Natal; University of Kwazulu Natal;
   University of London; University College London; University of London;
   University College London; Imperial College London; Imperial College
   London; Imperial College London; University of Indonesia; Australian
   National University; University of Baghdad; Father Muller Medical
   College; University of Haifa; Liverpool School of Tropical Medicine;
   Children's Cancer Hospital 57357; Tribhuvan University; Institute of
   Medicine (IoM) - Nepal; University of Manitoba; University of Zambia;
   Instituto Federal do Ceara (IFCE); Medical University of Graz; Indian
   Council of Medical Research (ICMR); ICMR - National Institute of Cancer
   Prevention \& Research (NICPR); University of California System;
   University of California San Francisco; Alfaisal University; University
   of Helsinki; Helsinki University Central Hospital; University of
   Helsinki; Pomeranian Medical University; Pomeranian Medical University;
   McMaster University; McMaster University; Kyrgyz State Medical Academy;
   Ministry of Health - Kyrgyzstan; Kurdistan University of Medical
   Sciences; Kurdistan University of Medical Sciences; Kurdistan University
   of Medical Sciences; Salahaddin University; Salahaddin University;
   Samara University; Ahmadu Bello University; Ahmadu Bello University;
   University of Bath; Tarbiat Modares University; Universiti Sains
   Malaysia; Public Health Foundation of India; Suraj Eye Institute;
   Ministry of Health \& Medical Education (MOHME); Duy Tan University;
   Universitas Negeri Semarang; Taipei Medical University; University of
   Cape Town; University of Cape Town; University of Cape Town; Kyung Hee
   University; CGIAR; International Institute of Tropical Agriculture
   (IITA); University of Lagos; University of Nigeria; University of Benin;
   JSS Academy of Higher Education \& Research; Indian Council of Medical
   Research (ICMR); ICMR - Regional Medical Research Centre (RMRC),
   Bhubaneswar; International Institute of Health Management Research
   Delhi; University of Melbourne; Melbourne Bioinformatics; University of
   Melbourne; Melbourne Bioinformatics; University of Melbourne; Melbourne
   Bioinformatics; Melbourne Genomics Health Alliance; University of
   Melbourne; Melbourne Genomics Health Alliance; Murdoch Children's
   Research Institute; Ateneo de Manila University; Universidade de Sao
   Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo;
   Universidade de Sao Paulo; University of Virginia; University of
   Ljubljana; University of Groningen; University of Groningen; National
   Institute for Infectious Diseases ``Matei Bals{''}; Victor Babes
   National Institute of Pathology; Amirkabir University of Technology;
   Sharif University of Technology; State University System of Florida;
   University of Central Florida; Federation University Australia;
   University of Lahore; University of Health Science - Pakistan; Yonsei
   University; Yonsei University Health System; Yonsei University; Fundacao
   Oswaldo Cruz; University College London Hospitals NHS Foundation Trust;
   University of London; University College London; Public Health England;
   Central Queensland University; Department of Science \& Technology
   (India); Sree Chitra Tirunal Institute for Medical Sciences Technology
   (SCTIMST); Western Sydney University; Western Sydney University;
   University of Pretoria; University of Minnesota System; University of
   Minnesota Twin Cities; Universidade Federal de Uberlandia; IRCCS Burlo
   Garofolo; Ulm University; Corporacion Colombiana de Investigacion
   Agropecuaria, AGROSAVIA; Southern University of Science \& Technology;
   University of Sassari; Egyptian Knowledge Bank (EKB); Ain Shams
   University; Egyptian Knowledge Bank (EKB); Ain Shams University;
   Egyptian Knowledge Bank (EKB); Ain Shams University; Soran University;
   Marshall University; Bangladesh Institute of Development Studies (BIDS);
   Hamad Medical Corporation; Bournemouth University; Utkal University;
   University of Alabama System; University of Alabama Birmingham;
   University of Alabama System; University of Alabama Birmingham; An Najah
   National University; Ambo University; University of London; King's
   College London; National Institute of Infectious Diseases (NIID); Ben
   Gurion University; Emory University; Finnish Institute of Occupational
   Health; University of Technology Sydney; Naestved Hospital; Kharkiv
   National Medical University; Autonomous University of Madrid; Hospital
   de La Princesa; CIBER - Centro de Investigacion Biomedica en Red;
   CIBERES; University of York - UK; University of Hull; University of
   Edinburgh; International Medical University Malaysia; Universitas
   Muhammadiyah Surakarta; China Medical University Taiwan; University of
   California System; University of California Irvine; Universidade de
   Lisboa; Colgate University; Flinders University South Australia; Central
   University of Kerala; Nanyang Technological University; University of
   Auckland; Gomal University; Manipal Academy of Higher Education (MAHE);
   IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of
   Gottingen; Wuhan University; Wuhan University; Naresuan University;
   Wenzhou Medical University; Wenzhou Medical University; Nanjing
   University; University of Tokyo; University of Hong Kong; University of
   Hong Kong; University of South Australia; National Center for Neurology
   \& Psychiatry - Japan; Jackson State University; Tsinghua University;
   Urmia University of Medical Sciences; Georgetown University; Wuhan
   University of Science \& Technology; Wuhan University of Science \&
   Technology; Wuhan Polytechnic University},
Cited-References = {Annan K, 2018, NATURE, V555, P7, DOI 10.1038/d41586-018-02386-3.
   {[}Anonymous], 2013, Ending preventable child deaths from pneumonia and diarrhea by 2025: the integrated Global Action Plan for Pneumonia and Diarrhoea (GAPPD).
   {[}Anonymous], LANCET GLOB HLTH.
   {[}Anonymous], DAT TYP.
   Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535.
   Bhatt S, 2017, J R SOC INTERFACE, V14, DOI 10.1098/rsif.2017.0520.
   Bhattacharjee NV, 2019, NAT MED, V25, P1205, DOI 10.1038/s41591-019-0525-0.
   Cairncross S, 2010, INT J EPIDEMIOL, V39, P193, DOI 10.1093/ije/dyq035.
   De Maio FG, 2007, J EPIDEMIOL COMMUN H, V61, DOI 10.1136/jech.2006.052969.
   Faraway JJ., 2004, LINEAR MODELS R, p68,101.
   Fullman N, 2018, LANCET, V391, P2236, DOI 10.1016/S0140-6736(18)30994-2.
   GeoNetwork, 2015, GLOB ADM UN LAYERS G.
   Golding N, 2017, LANCET, V390, P2171, DOI 10.1016/S0140-6736(17)31758-0.
   Graetz N, 2018, NATURE, V555, P48, DOI 10.1038/nature25761.
   Lehner B, 2004, J HYDROL, V296, P1, DOI 10.1016/j.jhydrol.2004.03.028.
   MAHALANABIS D, 1973, JOHNS HOPKINS MED J, V132, P197.
   Martins TG, 2013, COMPUT STAT DATA AN, V67, P68, DOI 10.1016/j.csda.2013.04.014.
   Mosley WH, 1984, POPUL DEV REV, V10, P25, DOI 10.2307/2807954.
   Mosser JF, 2019, LANCET, V393, P1843, DOI 10.1016/S0140-6736(19)30226-0.
   Munos MK, 2010, INT J EPIDEMIOL, V39, P75, DOI 10.1093/ije/dyq025.
   Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6.
   Olofin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064636.
   Osgood-Zimmerman A, 2018, NATURE, V555, P41, DOI 10.1038/nature25760.
   PIERCE NF, 1969, ANN INTERN MED, V70, P1173, DOI 10.7326/0003-4819-70-6-1173.
   Reiner RC, 2018, NEW ENGL J MED, V379, P1128, DOI 10.1056/NEJMoa1716766.
   Rue H, 2009, J ROY STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x.
   Stevens GA, 2016, LANCET, V388, pE19, DOI 10.1016/S0140-6736(16)30388-9.
   Tatem AJ, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.4.
   Troeger C, 2018, JAMA PEDIATR, V172, P958, DOI 10.1001/jamapediatrics.2018.1960.
   Troeger C, 2017, LANCET INFECT DIS, V17, P909, DOI 10.1016/S1473-3099(17)30276-1.
   Troeger CE, 2020, LANCET INFECT DIS, V20, P37, DOI 10.1016/S1473-3099(19)30401-3.
   Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6.
   Wilson SE, 2013, J GLOB HEALTH, V3, DOI 10.7189/jogh.03.010404.
   Wolf J, 2018, TROP MED INT HEALTH, V23, P508, DOI 10.1111/tmi.13051.
   World Wildlife Fund, 2004, GLOB LAK WETL DAT LE.},
Number-of-Cited-References = {35},
Times-Cited = {57},
Unique-ID = {WOS:000540993600024},
}

@article{ WOS:000558077600060,
Author = {Evans, Ethan D. and Dai, Chengzhen and Isazadeh, Siavash and Park,
   Shinkyu and Ratti, Carlo and Alm, Eric J.},
Title = {Longitudinal wastewater sampling in buildings reveals temporal dynamics
   of metabolites},
Journal = {PLOS COMPUTATIONAL BIOLOGY},
Year = {2020},
Volume = {16},
Number = {6},
Month = {JUN},
Abstract = {Direct sampling of building wastewater has the potential to enable
   ``precision public health{''} observations and interventions. Temporal
   sampling offers additional dynamic information that can be used to
   increase the informational content of individual metabolic
   ``features{''}, but few studies have focused on high-resolution
   sampling. Here, we sampled three spatially close buildings, revealing
   individual metabolomics features, retention time (rt) and mass-to-charge
   ratio (mz) pairs, that often possess similar stationary statistical
   properties, as expected from aggregate sampling. However, the temporal
   profiles of features-providing orthogonal information to physicochemical
   properties-illustrate that many possess different feature temporal
   dynamics (fTDs) across buildings, with large and unpredictable single
   day deviations from the mean. Internal to a building, numerous and
   seemingly unrelated features, with mz and rt differences up to hundreds
   of Daltons and seconds, display highly correlated fTDs, suggesting
   non-obvious feature relationships. Data-driven building classification
   achieves high sensitivity and specificity, and extracts
   building-identifying features found to possess unique dynamics. Analysis
   of fTDs from many short-duration samples allows for tailored community
   monitoring with applicability in public health studies.
   Author summary
   Understanding a community's wastewater profile may allow for specific
   and targeted interventions. Untargeted wastewater metabolomics provides
   a rich data source, but one that is high dimensional, noisy and
   difficult to understand. We analyze building-to-building differences and
   through-time patterns from temporal wastewater metabolomics data,
   obtained directly from three buildings. We develop and apply
   computational techniques to extract building-specific temporal and
   stationary properties for each small molecule feature. Stationary
   properties are predominantly conserved, but by studying the temporal
   dynamics, we find distinct, building-specific signatures and metabolite
   patterns. Interestingly, using clustering techniques and temporal
   similarity metrics, we find that for each building there exist groups of
   small molecules that possess highly similar temporal dynamics, despite
   having vastly different molecular properties (e.g. molecular weight or
   chromatographic retention time). These findings may suggest similar
   generative processes for such small molecules, which may lead to
   increased biological understanding. Additionally, our computational
   methods link putatively identified small molecules with unknown
   features. This produces a list of unknown compounds, with
   community-specific temporal dynamics for follow up experimental analysis
   and targeted discovery to better understand a community of interest.},
Type = {Article},
Affiliation = {Alm, EJ (Corresponding Author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
   Evans, Ethan D.; Dai, Chengzhen; Isazadeh, Siavash; Alm, Eric J., MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
   Park, Shinkyu; Ratti, Carlo, MIT, Senseable City Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA.},
DOI = {10.1371/journal.pcbi.1008001},
Article-Number = {e1008001},
Keywords-Plus = {ILLICIT DRUG-USE; MASS-SPECTROMETRY; POPULATION; EPIDEMIOLOGY;
   DEGRADATION; BIOMARKERS; STABILITY; PATHWAYS; CAFFEINE; DATABASE},
Research-Areas = {Biochemistry \& Molecular Biology; Mathematical \& Computational Biology},
Web-of-Science-Categories  = {Biochemical Research Methods; Mathematical \& Computational Biology},
Author-Email = {ejalm@mit.edu},
Affiliations = {Massachusetts Institute of Technology (MIT); Massachusetts Institute of
   Technology (MIT)},
Cited-References = {Baker DR, 2014, SCI TOTAL ENVIRON, V487, P629, DOI 10.1016/j.scitotenv.2013.11.107.
   Baz-Lomba JA, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3686-5.
   Caspi R, 2018, NUCLEIC ACIDS RES, V46, pD633, DOI 10.1093/nar/gkx935.
   Castiglioni S, 2015, TOB CONTROL, V24, P38, DOI 10.1136/tobaccocontrol-2014-051553.
   Castiglioni S, 2006, ANAL CHEM, V78, P8421, DOI 10.1021/ac061095b.
   Causanilles A, 2018, ANAL BIOANAL CHEM, V410, P1793, DOI 10.1007/s00216-017-0835-3.
   Chambers MC, 2012, NAT BIOTECHNOL, V30, P918, DOI 10.1038/nbt.2377.
   Chen C, 2014, SCI TOTAL ENVIRON, V487, P621, DOI 10.1016/j.scitotenv.2013.11.075.
   Cheng XM, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00494.
   Daughton CG, 2018, SCI TOTAL ENVIRON, V619, P748, DOI 10.1016/j.scitotenv.2017.11.102.
   Daughton CG, 2012, SCI TOTAL ENVIRON, V414, P6, DOI 10.1016/j.scitotenv.2011.11.015.
   de Wildt SN, 1999, CLIN PHARMACOKINET, V36, P439, DOI 10.2165/00003088-199936060-00005.
   Ellis RJ, 2016, NEPHROLOGY, V21, P170, DOI 10.1111/nep.12580.
   González-Mariño I, 2017, ENVIRON SCI TECHNOL, V51, P3902, DOI 10.1021/acs.est.6b05612.
   Gracia-Lor E, 2017, SCI TOTAL ENVIRON, V609, P1582, DOI 10.1016/j.scitotenv.2017.07.258.
   Hall W, 2012, ADDICTION, V107, P1767, DOI 10.1111/j.1360-0443.2012.03887.x.
   Hastings J, 2016, NUCLEIC ACIDS RES, V44, pD1214, DOI 10.1093/nar/gkv1031.
   JACOBSEN JG, 1967, NATURE, V214, P1247, DOI 10.1038/2141247a0.
   Kinyua J, 2016, SCI TOTAL ENVIRON, V573, P1527, DOI 10.1016/j.scitotenv.2016.08.124.
   Lai FY, 2015, ENVIRON SCI TECHNOL, V49, P999, DOI 10.1021/es503474d.
   Lai FY, 2011, WATER RES, V45, P4437, DOI 10.1016/j.watres.2011.05.042.
   Libiseller G, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0562-8.
   Maiuolo J, 2016, INT J CARDIOL, V213, P8, DOI 10.1016/j.ijcard.2015.08.109.
   Matus M, 2019, BIORXIV.
   Mazaleuskaya LL, 2015, PHARMACOGENET GENOM, V25, P416, DOI 10.1097/FPC.0000000000000150.
   McCall AK, 2016, WATER RES, V88, P933, DOI 10.1016/j.watres.2015.10.040.
   O'Brien JW, 2015, CHEMOSPHERE, V138, P328, DOI 10.1016/j.chemosphere.2015.06.014.
   O'Brien JW, 2014, ENVIRON SCI TECHNOL, V48, P517, DOI 10.1021/es403251g.
   O'Brien JW, 2017, ENVIRON SCI TECHNOL, V51, P3816, DOI 10.1021/acs.est.6b02755.
   Ort C, 2010, WATER RES, V44, P605, DOI 10.1016/j.watres.2009.08.002.
   Panawennage D., 2011, Illicit Drugs in the Environment: Occurrence, Analysis, and Fate Using Mass Spectrometry, P321, DOI {[}10.1002/9781118000816.ch18, DOI 10.1002/9781118000816.CH18].
   Petrie B, 2016, ENVIRON SCI TECHNOL, V50, P3781, DOI 10.1021/acs.est.6b00291.
   Phung D, 2017, ENVIRON RES, V156, P113, DOI 10.1016/j.envres.2017.03.023.
   Postigo C, 2011, ENVIRON INT, V37, P49, DOI 10.1016/j.envint.2010.06.012.
   Reid MJ, 2011, ALCOHOL CLIN EXP RES, V35, P1593, DOI 10.1111/j.1530-0277.2011.01505.x.
   Rousis NI, 2017, WATER RES, V121, P270, DOI 10.1016/j.watres.2017.05.044.
   Ruttkies C, 2016, J CHEMINFORMATICS, V8, DOI 10.1186/s13321-016-0115-9.
   Ryu Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep39055.
   Schröder HF, 2010, ANAL BIOANAL CHEM, V398, P1207, DOI 10.1007/s00216-010-3958-3.
   Senta I, 2015, WATER RES, V74, P23, DOI 10.1016/j.watres.2015.02.002.
   Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y.
   STEIN WH, 1954, J AM CHEM SOC, V76, P2848, DOI 10.1021/ja01639a085.
   Sud M, 2007, NUCLEIC ACIDS RES, V35, pD527, DOI 10.1093/nar/gkl838.
   Sumner LW, 2007, METABOLOMICS, V3, P211, DOI 10.1007/s11306-007-0082-2.
   Thai PK, 2014, WATER RES, V48, P538, DOI 10.1016/j.watres.2013.10.019.
   Thomaidis NS, 2016, ENVIRON SCI TECHNOL, V50, P10065, DOI 10.1021/acs.est.6b02417.
   Thomas KV, 2012, SCI TOTAL ENVIRON, V432, P432, DOI 10.1016/j.scitotenv.2012.06.069.
   van Nuijs ALN, 2012, J HAZARD MATER, V239, P19, DOI 10.1016/j.jhazmat.2012.04.030.
   Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065.
   Wolf S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-148.
   Zuccato E, 2008, ENVIRON HEALTH PERSP, V116, P1027, DOI 10.1289/ehp.11022.},
Number-of-Cited-References = {51},
Times-Cited = {1},
Unique-ID = {WOS:000558077600060},
}

@article{ WOS:000766542900001,
Author = {Mahdi, Soha Sadat and Matthews, Harold and Nauwelaers, Nele and
   Vanneste, Michiel and Gong, Shunwang and Bouritsas, Giorgos and Baynam,
   Gareth S. and Hammond, Peter and Spritz, Richard and Klein, Ophir D. and
   Hallgrimsson, Benedikt and Peeters, Hilde and Bronstein, Michael and
   Claes, Peter},
Title = {Multi-Scale Part-Based Syndrome Classification of 3D Facial Images},
Journal = {IEEE ACCESS},
Year = {2022},
Volume = {10},
Pages = {23450-23462},
Abstract = {Identification and delineation of craniofacial characteristics support
   the clinical and molecular diagnosis of genetic syndromes. Deep learning
   (DL) frameworks for syndrome identification from 2D facial images are
   trained on large clinical datasets using standard convolutional neural
   networks for classification. In contrast, despite the increased
   availability of 3D scanners in clinical setups, similar frameworks
   remain absent for 3D facial photographs. The main challenges involve
   working with smaller datasets and the need for DL operations applicable
   to 3D geometric data. Therefore, to date, most 3D methods refrain from
   working across multiple syndromic groups and/or are solely based on
   traditional machine learning. The first contribution of this work is the
   use of geometric deep learning with spiral convolutions in a
   triplet-loss architecture. This geometric encoding (GE) learns a lower
   dimensional metric space from 3D facial data that is used as input to
   linear discriminant analysis (LDA) performing multiclass classification.
   Benchmarking is done against principal component analysis (PCA), a
   common technique in 3D facial shape analysis, and related work based on
   65 distinct 3D facial landmarks as input to LDA. The second contribution
   of this work involves a part-based implementation to 3D facial shape
   analysis and multi-class syndrome classification, and this is applied to
   both GE and PCA. Based on 1,786 3D facial photographs of controls and
   individuals from 13 different syndrome classes, a five-fold
   cross-validation was used to investigate both contributions. Results
   indicate that GE performs better than PCA as input to LDA, and this
   especially so for more compact (lower dimensional) spaces. In addition,
   a part-based approach increases performance significantly for both GE
   and PCA, with a more significant improvement for the latter. I.e., this
   contribution enhances the power of the dataset. Finally, and
   interestingly, according to ablation studies within the part-based
   approach, the upper lip is the most distinguishing facial segment for
   classifying genetic syndromes in our dataset, which follows clinical
   expectation. This work stimulates an enhanced use of advanced part-based
   geometric deep learning methods for 3D facial imaging in clinical
   genetics.},
Type = {Article},
Affiliation = {Mahdi, SS (Corresponding Author), Katholieke Univ Leuven, ESAT PSI UZ Leuven, MIRC, B-3000 Leuven, Belgium.
   Mahdi, Soha Sadat; Matthews, Harold; Nauwelaers, Nele; Claes, Peter, Katholieke Univ Leuven, ESAT PSI UZ Leuven, MIRC, B-3000 Leuven, Belgium.
   Matthews, Harold; Vanneste, Michiel; Hammond, Peter; Peeters, Hilde; Claes, Peter, Katholieke Univ Leuven, Lab Genet Epidemiol, Dept Human Genet, B-3000 Leuven, Belgium.
   Matthews, Harold, Murdoch Childrens Res Inst, Facial Sci Res Grp, Parkville, Vic 3052, Australia.
   Gong, Shunwang; Bouritsas, Giorgos; Bronstein, Michael, Imperial Coll London, Dept Comp, London SW7 2AZ, England.
   Baynam, Gareth S., Curtin Univ, Fac Sci \& Engn, Sch Earth \& Planetary Sci, Perth, WA 6845, Australia.
   Baynam, Gareth S., King Edward Mem Hosp, Western Australian Register Dev Anomalies, Subiaco, WA 6008, Australia.
   Spritz, Richard, Univ Colorado, Sch Med, Human Med Genet \& Genom Program, Aurora, CO 80045 USA.
   Klein, Ophir D., Univ Calif San Francisco, Dept Orofacial Sci \& Pediat, San Francisco, CA 94143 USA.
   Hallgrimsson, Benedikt, Univ Calgary, Alberta Childres Hosp, Cumming Sch Med, Dept Cell Biol \& Anat,Res Inst, Calgary, AB, Canada.},
DOI = {10.1109/ACCESS.2022.3153357},
Keywords = {Three-dimensional displays; Shape; Genetics; Principal component
   analysis; Germanium; Topology; Australia; Clinical genetics;
   computer-aided diagnosis; deep phenotyping; 3D shape analysis; geometric
   deep learning; precision public health; spiral convolutions; syndrome
   classification},
Research-Areas = {Computer Science; Engineering; Telecommunications},
Web-of-Science-Categories  = {Computer Science, Information Systems; Engineering, Electrical \&
   Electronic; Telecommunications},
Author-Email = {sohasadat.mandi@kuleuven.be},
Affiliations = {KU Leuven; KU Leuven; Murdoch Children's Research Institute; Imperial
   College London; Curtin University; University of Western Australia; King
   Edward Memorial Hospital; University of Colorado System; University of
   Colorado Anschutz Medical Campus; University of California System;
   University of California San Francisco; University of Calgary},
Cited-References = {Abdi H., 2005, P IEEE COMP SOC INT, P42, DOI DOI 10.1109/CVPR.2005.445.
   Blanz V, 1999, COMP GRAPH, P187, DOI 10.1145/311535.311556.
   Bouritsas G, 2019, IEEE I CONF COMP VIS, P7212, DOI 10.1109/ICCV.2019.00731.
   Bronstein MM, 2017, IEEE SIGNAL PROC MAG, V34, P18, DOI 10.1109/MSP.2017.2693418.
   Claes P, 2018, NAT GENET, V50, P414, DOI 10.1038/s41588-018-0057-4.
   de Jong G, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-72143-y.
   Defferrard M., 2016, 30 INTCONF NEURAL IN, P3844.
   Ekrami O, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207895.
   Estrach JB, 2014, 2 INT C LEARN REPR I.
   Fang S, 2008, ORTHOD CRANIOFAC RES, V11, P162, DOI 10.1111/j.1601-6343.2008.00425.x.
   Ferry Q, 2014, ELIFE, V3, DOI 10.7554/eLife.02020.
   Gong SW, 2019, IEEE INT CONF COMP V, P4141, DOI 10.1109/ICCVW.2019.00509.
   Gurovich Y, 2019, NAT MED, V25, P60, DOI 10.1038/s41591-018-0279-0.
   Hallgrímsson B, 2020, GENET MED, V22, P1682, DOI 10.1038/s41436-020-0845-y.
   Hammond P, 2005, AM J HUM GENET, V77, P999, DOI 10.1086/498396.
   Hammond P, 2012, HUM MUTAT, V33, P817, DOI 10.1002/humu.22054.
   Hermans A., 2017, ARXIV.
   Hoffer E, 2015, LECT NOTES COMPUT SC, V9370, P84, DOI 10.1007/978-3-319-24261-3\_7.
   Klein O., 2019, DEV 3D CRANIOFACIAL, DOI {[}10.25550/TJ0, DOI 10.25550/TJ0].
   Kulon D, 2020, PROC CVPR IEEE, P4989, DOI 10.1109/CVPR42600.2020.00504.
   Kung S, 2015, JIMD REP, V22, P99, DOI 10.1007/8904\_2015\_417.
   Lee Jongpil, 2020, ARXIV200803729.
   Lim I., 2019, LECT NOTES COMPUT SC, V11131, P349, DOI DOI 10.1007/978-3-030-11015-4\_26.
   Mahdi Soha Sadat, 2022, IEEE Trans Biom Behav Identity Sci, V4, P163, DOI {[}10.1109/TBIOM.2021.3092564, 10.1109/tbiom.2021.3092564].
   Mahdi SS, 2021, INT C PATT RECOG, P1757, DOI 10.1109/ICPR48806.2021.9412166.
   Maturana D, 2015, IEEE INT C INT ROBOT, P922, DOI 10.1109/IROS.2015.7353481.
   Monti F, 2017, PROC CVPR IEEE, P5425, DOI 10.1109/CVPR.2017.576.
   Narayanan DL, 2019, INDIAN PEDIATR, V56, P1017, DOI 10.1007/s13312-019-1682-4.
   Ocegueda O, 2011, PROC CVPR IEEE, P641, DOI 10.1109/CVPR.2011.5995613.
   Pantel JT, 2020, J MED INTERNET RES, V22, DOI 10.2196/19263.
   Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720.
   Potamias Rolandos Alexandros, 2020, Computer Vision - ECCV 2020. 16th European Conference. Proceedings. Lecture Notes in Computer Science (LNCS 12374), P278, DOI 10.1007/978-3-030-58526-6\_17.
   Qi CR, 2017, ADV NEUR IN, V30.
   Qi CR, 2017, PROC CVPR IEEE, P77, DOI 10.1109/CVPR.2017.16.
   Quinto-Sánchez M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19324-y.
   Rudy HL, 2020, PLAST RECONSTR SURG, V146, P1407, DOI 10.1097/PRS.0000000000007387.
   Santos JM, 2009, LECT NOTES COMPUT SC, V5769, P175, DOI 10.1007/978-3-642-04277-5\_18.
   Schroff F, 2015, PROC CVPR IEEE, P815, DOI 10.1109/CVPR.2015.7298682.
   van der Maaten L, 2008, J MACH LEARN RES, V9, P2579.
   Vinh NX, 2010, J MACH LEARN RES, V11, P2837.
   White JD, 2021, NAT GENET, V53, DOI 10.1038/s41588-020-00741-7.
   White JD, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42533-y.
   Wu ZR, 2015, PROC CVPR IEEE, P1912, DOI 10.1109/CVPR.2015.7298801.},
Number-of-Cited-References = {43},
Times-Cited = {1},
Unique-ID = {WOS:000766542900001},
}

@article{ WOS:001092885600001,
Author = {Matthews, Stacey and Just, Jasmine and Jennings, Garry and Bray, Janet
   and Lewis, Jesse and Buttery, Amanda},
Title = {Can a Targeted Social Media Campaign Increase Reach of, and Engagement
   With, Heart Failure Self-Management Resources in Culturally and
   Linguistically Diverse Communities in Victoria, Australia? An Evaluation
   Including Cost},
Journal = {HEART LUNG AND CIRCULATION},
Year = {2023},
Volume = {32},
Number = {9},
Pages = {1089-1095},
Month = {SEP},
Abstract = {Aim This study investigates whether a targeted social media campaign
   increases reach and engagement of heart failure self-management
   educational resources among culturally and linguistically diverse
   communities in Victoria, Australia.Methods A targeted six-week Facebook
   social media campaign (from 3 October 2022 to 13 November 2022) was
   performed using the Precision Public Health Framework. Animated heart
   failure educational videos were developed, translated, and publicised
   among Mandarin-, Vietnamese-and English-speaking communities in
   Victoria, Australia. Data from Facebook, Google Analytics and social
   marketing costs were analysed. An independent, two sample t-test was
   applied to investigate differences in the performance (views and
   cost-per click) of the English and translated Mandarin and Vietnamese
   social media campaigns. Webpage views (of the promoted heart failure
   webpage) during the campaign were compared to the same period 12 months
   prior.Results A total of 664,434 English and 182,294 translated
   Vietnamese and Mandarin video advertisements were placed and seen in
   individuals' social media feeds (impressions) over the six weeks. Per
   capita reach was proportionally higher for Vietnamese and Mandarin video
   advertisements (54\% versus 15\%). The percentage of those who watched
   the educational video in the social media posts, for at least 15 seconds
   (a `ThruPlay'), was significantly higher in Mandarin and
   Vietnamese-speaking communities (75\% versus 40\% among the
   English-speaking community p<0.0001). However, those viewing in English
   had significantly longer engagement and watched at least half of the
   video (2.5\% versus Vietnamese and Mandarin viewers (0.31\%), p<0.0001).
   The click-through rate and cost-per-click were significantly higher for
   the translated social media posts compared with the English (0.77\% vs
   0.62\%, p=0.0185 and AUD\$4.48 vs AUD\$3.22, p<0.0001).Conclusion A
   targeted six-week Facebook social media campaign using translated video
   animations in Vietnamese and Mandarin had significantly higher reach,
   initial views (first 15 seconds) and higher click-through rates, but
   fewer views of at least half of the video, compared with the Facebook
   English videos. Higher costs-per-click were associated with the
   translated campaign. Further research is needed to understand the extent
   that social media translated campaigns can influence health behaviour.},
Type = {Article},
Affiliation = {Matthews, S (Corresponding Author), Natl Heart Fdn Australia, Level 2,850 Collins St, Melbourne, Vic 3008, Australia.
   Matthews, Stacey; Just, Jasmine; Jennings, Garry; Lewis, Jesse; Buttery, Amanda, Natl Heart Fdn Australia, Melbourne, Vic, Australia.
   Matthews, Stacey, Royal Melbourne Hosp, Cardiothorac Surg Unit, Melbourne, Vic, Australia.
   Jennings, Garry, Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia.
   Bray, Janet, Monash Univ, Melbourne, Vic, Australia.
   Matthews, Stacey, Natl Heart Fdn Australia, Level 2,850 Collins St, Melbourne, Vic 3008, Australia.},
DOI = {10.1016/j.hlc.2023.06.724},
EarlyAccessDate = {OCT 2023},
Keywords = {Heart failure; Education; Social marketing; Asian; Culturally and
   linguistically diverse populations},
Keywords-Plus = {HEALTH-PROMOTION},
Research-Areas = {Cardiovascular System \& Cardiology},
Web-of-Science-Categories  = {Cardiac \& Cardiovascular Systems},
Author-Email = {stacey.matthews@heartfoundation.org.au},
Affiliations = {National Heart Foundation of Australia; Melbourne Genomics Health
   Alliance; Melbourne Health; Royal Melbourne Hospital; University of
   Sydney; Monash University; National Heart Foundation of Australia;
   Melbourne Genomics Health Alliance},
Cited-References = {An JS, 2021, JMIR FORM RES, V5, DOI 10.2196/22313.
   Arshanapally S, 2022, JMIR PEDIATR PARENT, V5, DOI 10.2196/34425.
   Bray J, 2023, HEART LUNG CIRC, V32, P497, DOI 10.1016/j.hlc.2023.01.010.
   Chen JH, 2021, J MED INTERNET RES, V23, DOI 10.2196/17917.
   Darmawan I, 2020, J MED INTERNET RES, V22, DOI 10.2196/22810.
   Dunn PH, 2018, J AM SOC HYPERTENS, V12, P690, DOI 10.1016/j.jash.2018.06.017.
   Farr DE, 2022, JMIR FORM RES, V6, DOI 10.2196/31759.
   Ferguson C, 2022, J AM HEART ASSOC, V11, DOI 10.1161/JAHA.122.025293.
   Greenhalgh T, 2005, BRIT MED J, V330, P628, DOI 10.1136/bmj.330.7492.628.
   Hefler M, 2020, J MED INTERNET RES, V22, DOI 10.2196/16927.
   Hunt ID, 2022, AM J PUBLIC HEALTH, V112, P1253, DOI 10.2105/AJPH.2022.306934.
   Khatri RB, 2022, BMC PUBLIC HEALTH, V22, DOI 10.1186/s12889-022-13256-z.
   Kreuter MW, 2003, HEALTH EDUC BEHAV, V30, P133, DOI 10.1177/1090198102251021.
   Macnamara J, 2017, COMMUN RES PRACT, V3, P92, DOI 10.1080/22041451.2016.1209277.
   McCarthy E, 2019, J MED INTERNET RES, V21, DOI 10.2196/15869.
   National Heart Foundation of Australia, 2022, What is heart failure?.
   O'Mara B, 2013, HEALTH PROMOT INT, V28, P466, DOI 10.1093/heapro/das014.
   Power R, 2022, BMC WOMENS HEALTH, V22, DOI 10.1186/s12905-022-01936-2.
   Savarese G, 2022, CARDIOVASC RES, V118, P3272, DOI 10.1093/cvr/cvac013.
   Seman M, 2020, EUR HEART J-QUAL CAR, V6, P121, DOI 10.1093/ehjqcco/qcz034.
   Spahrkäs SS, 2021, INTERNET INTERV, V23, DOI 10.1016/j.invent.2021.100362.
   Statista, 2022, Average daily time spent by users worldwide on mobile social media apps from October 2020 to March 2021, by age group.
   Toukhsati SR, 2019, CLIN MED INSIGHTS-CA, V13, DOI 10.1177/1179546819856855.
   Wang J, 2020, BMC HEALTH SERV RES, V20, DOI 10.1186/s12913-020-05901-3.
   Whitaker C, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.7071.},
Number-of-Cited-References = {25},
Times-Cited = {0},
Unique-ID = {WOS:001092885600001},
}

@article{ WOS:000443695000001,
Author = {Ross, Jennifer M. and Henry, Nathaniel J. and Dwyer-Lindgren, Laura A.
   and Lobo, Andrea de Paula and de Souza, Fatima Marinho and Biehl, Molly
   H. and Ray, Sarah E. and Reiner, Jr., Robert C. and Stubbs, Rebecca W.
   and Wiens, Kirsten E. and Earl, Lucas and Kutz, Michael J. and
   Bhattacharjee, Natalia V. and Kyu, Hmwe H. and Naghavi, Mohsen and Hay,
   Simon I.},
Title = {Progress toward eliminating TB and HIV deaths in Brazil, 2001-2015: a
   spatial assessment},
Journal = {BMC MEDICINE},
Year = {2018},
Volume = {16},
Month = {SEP 6},
Abstract = {Background: Brazil has high burdens of tuberculosis (TB) and HIV, as
   previously estimated for the 26 states and the Federal District, as well
   as high levels of inequality in social and health indicators. We
   improved the geographic detail of burden estimation by modelling deaths
   due to TB and HIV and TB case fatality ratios for the more than 5400
   municipalities in Brazil.
   Methods: This ecological study used vital registration data from the
   national mortality information system and TB case notifications from the
   national communicable disease notification system from 2001 to 2015.
   Mortality due to TB and HIV was modelled separately by cause and sex
   using a Bayesian spatially explicit mixed effects regression model. TB
   incidence was modelled using the same approach. Results were calibrated
   to the Global Burden of Disease Study 2016. Case fatality ratios were
   calculated for TB.
   Results: There was substantial inequality in TB and HIV mortality rates
   within the nation and within states. National-level TB mortality in
   people without HIV infection declined by nearly 50\% during 2001 to
   2015, but HIV mortality declined by just over 20\% for males and 10\%
   for females. TB and HIV mortality rates for municipalities in the 90th
   percentile nationally were more than three times rates in the 10th
   percentile, with nearly 70\% of the worst-performing municipalities for
   male TB mortality and more than 75\% for female mortality in 2001 also
   in the worst decile in 2015. The same municipality ranking metric for
   HIV was observed to be between 55\% and 61\%. Within states, the TB
   mortality rate ratios by sex for municipalities in the worst decile
   versus the best decile varied from 1.4 to 2.9, and HIV varied from 1.4
   to 4.2. The World Health Organization target case fatality rate for TB
   of less than 10\% was achieved in 9.6\% of municipalities for males
   versus 38.4\% for females in 2001 and improved to 38.4\% and 56.6\% of
   municipalities for males versus females, respectively, by 2014.
   Conclusions: Mortality rates in municipalities within the same state
   exhibited nearly as much relative variation as within the nation as a
   whole. Monitoring the mortality burden at this level of geographic
   detail is critical for guiding precision public health responses.},
Type = {Article},
Affiliation = {Hay, SI (Corresponding Author), Univ Washington, Inst Hlth Metr \& Evaluat, 2301 5th Ave,Suite 600, Seattle, WA 98121 USA.
   Ross, Jennifer M., Univ Washington, Dept Med, Div Allergy \& Infect Dis, Seattle, WA 98195 USA.
   Ross, Jennifer M.; Henry, Nathaniel J.; Dwyer-Lindgren, Laura A.; Biehl, Molly H.; Ray, Sarah E.; Reiner, Robert C., Jr.; Stubbs, Rebecca W.; Wiens, Kirsten E.; Earl, Lucas; Kutz, Michael J.; Bhattacharjee, Natalia V.; Kyu, Hmwe H.; Naghavi, Mohsen; Hay, Simon I., Univ Washington, Inst Hlth Metr \& Evaluat, 2301 5th Ave,Suite 600, Seattle, WA 98121 USA.
   Lobo, Andrea de Paula, Univ Brasilia, Dept Publ Hlth, Brasilia, DF, Brazil.
   Lobo, Andrea de Paula; de Souza, Fatima Marinho, Minist Hlth, Dept Hlth Surveillance, Brasilia, DF, Brazil.},
DOI = {10.1186/s12916-018-1131-6},
Article-Number = {144},
Keywords = {Tuberculosis; HIV; Small area estimation; Geospatial; Geographic;
   Brazil; Case fatality; Mortality},
Keywords-Plus = {RIO-DE-JANEIRO; TUBERCULOSIS; MORTALITY; DETERMINANTS; PREVALENCE;
   PATTERNS; ACCESS; TRENDS; RISK; AIDS},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Author-Email = {sihay@uw.edu},
Affiliations = {University of Washington; University of Washington Seattle; University
   of Washington; University of Washington Seattle; Institute for Health
   Metrics \& Evaluation; Universidade de Brasilia},
Cited-References = {Alves ATJ, 2014, GEOSPATIAL HEALTH, V8, P437, DOI 10.4081/gh.2014.32.
   Anderson SJ, 2014, LANCET, V384, P249, DOI 10.1016/S0140-6736(14)61053-9.
   Bassett IV, 2015, AIDS BEHAV, V19, P1888, DOI 10.1007/s10461-015-1012-3.
   Bishai WR, 1998, JAMA-J AM MED ASSOC, V280, P1679, DOI 10.1001/jama.280.19.1679.
   Bourdillon PM, 2017, EMERG INFECT DIS, V23, P496, DOI 10.3201/eid2303.161006.
   Cao K, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13050469.
   Carvalho CN, 2011, REV SAUDE PUBL, V45, P548, DOI 10.1590/S0034-89102011005000021.
   Catalan-Soares B C, 2000, Rev Soc Bras Med Trop, V33, P27, DOI 10.1590/S0037-86822000000100004.
   Coburn BJ, 2017, SCI TRANSL MED, V9, P383, DOI DOI 10.1126/SCITRANSLMED.AAG0019].
   Coelho HC, 2007, CAD SAUDE PUBLICA, V23, P2197, DOI 10.1590/S0102-311X2007000900027.
   Sacchi FPC, 2018, AM J TROP MED HYG, V98, P372, DOI 10.4269/ajtmh.17-0480.
   Cuadros DF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09464-y.
   de Almeida WD, 2012, REV SAUDE PUBL, V46, P68, DOI 10.1590/S0034-89102012005000003.
   Teixeira TRD, 2014, CAD SAUDE PUBLICA, V30, P259, DOI 10.1590/0102-311X00051313.
   Fernandes FMD, 2017, BRAZ J INFECT DIS, V21, P369, DOI 10.1016/j.bjid.2017.03.017.
   de Holanda ER, 2015, REV LAT-AM ENFERM, V23, P441.
   Dwyer-Lindgren L, 2016, JAMA-J AM MED ASSOC, V316, P2385, DOI 10.1001/jama.2016.13645.
   Sgarbi RVE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139487.
   Ferreira Daniela Nice, 2015, Rev. bras. epidemiol., V18, P578, DOI 10.1590/1980-5497201500030005.
   Vendramini SHF, 2010, REV SOC BRAS MED TRO, V43, P536, DOI 10.1590/S0037-86822010000500013.
   França EB, 2017, POPUL HEALTH METR, V15, DOI 10.1186/s12963-017-0156-y.
   França Elisabeth Barboza, 2017, Rev. bras. epidemiol., V20, P46, DOI 10.1590/1980-5497201700050005.
   Gakidou E, 2017, LANCET, V390, P1345, DOI 10.1016/S0140-6736(17)32366-8.
   Gerberry DJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6454.
   Guimarães Mark Drew Crosland, 2017, Rev. bras. epidemiol., V20, P182, DOI 10.1590/1980-5497201700050015.
   Hacker MA, 2004, REV PANAM SALUD PUBL, V16, P78, DOI 10.1590/S1020-49892004000800002.
   Harling G, 2014, HEALTH PLACE, V25, P56, DOI 10.1016/j.healthplace.2013.10.008.
   Horton KC, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002119.
   Jafari-Koshki T, 2015, INT J TUBERC LUNG D, V19, P469, DOI 10.5588/ijtld.14.0459.
   McGillen JB, 2016, LANCET HIV, V3, pE441, DOI 10.1016/S2352-3018(16)30051-0.
   Ministerio da Saude, RES POP BRAZ.
   Ministry of Health, 2017, BRAZ FREE TUB NAT PL.
   Monteiro CA, 2007, AM J PUBLIC HEALTH, V97, P1808, DOI 10.2105/AJPH.2006.099630.
   de Andrade LOM, 2015, LANCET, V385, P1343, DOI 10.1016/S0140-6736(14)61494-X.
   Murray CJL, 2018, LANCET INFECT DIS, V18, P261, DOI 10.1016/S1473-3099(17)30703-X.
   Naghavi M, 2017, LANCET, V390, P1151, DOI 10.1016/S0140-6736(17)32152-9.
   Naghavi M, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-9.
   Pacheco AG, 2011, AIDS RES HUM RETROV, V27, P25, DOI 10.1089/aid.2010.0089.
   Queiroz Bernardo Lanza, 2017, Rev. bras. epidemiol., V20, P21.
   Rasella D, 2013, LANCET, V382, P57, DOI 10.1016/S0140-6736(13)60715-1.
   Rasella D, 2013, J EPIDEMIOL COMMUN H, V67, P661, DOI 10.1136/jech-2012-201426.
   Snyder RE, 2014, J URBAN HEALTH, V91, P432, DOI 10.1007/s11524-013-9848-1.
   Srebotnjak T, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-26.
   Steffan-Dewenter I., 2002, Ecology, V83, P1421, DOI 10.1890/0012-9658(2002)083{[}1421:SDEOLC]2.0.CO;2.
   Sun WY, 2015, INT J ENV RES PUB HE, V12, P1425, DOI 10.3390/ijerph120201425.
   Tanser F, 2009, INT J EPIDEMIOL, V38, P1008, DOI 10.1093/ije/dyp148.
   Theron G, 2015, LANCET, V386, P2324, DOI 10.1016/S0140-6736(15)00321-9.
   Wang HD, 2016, LANCET HIV, V3, pE361, DOI 10.1016/S2352-3018(16)30087-X.
   World Health Organization, 2017, Tuberculosis patient cost surveys: a handbook.
   World Health Organization, WORLD AIDS DAY WORLD.
   World Health Organization, 2016, International Statistical Classification of Diseases and Related Health Problems.
   Yamamura M, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0348-5.},
Number-of-Cited-References = {52},
Times-Cited = {15},
Unique-ID = {WOS:000443695000001},
}

@article{ WOS:000581731900003,
Author = {Nagar, Shashwat Deepali and Conley, Andrew B. and Jordan, I. King},
Title = {Population structure and pharmacogenomic risk stratification in the
   United States},
Journal = {BMC BIOLOGY},
Year = {2020},
Volume = {18},
Number = {1},
Month = {OCT 13},
Abstract = {Background Pharmacogenomic (PGx) variants mediate how individuals
   respond to medication, and response differences among racial/ethnic
   groups have been attributed to patterns of PGx diversity. We
   hypothesized that genetic ancestry (GA) would provide higher resolution
   for stratifying PGx risk, since it serves as a more reliable surrogate
   for genetic diversity than self-identified race/ethnicity (SIRE), which
   includes a substantial social component. We analyzed a cohort of 8628
   individuals from the United States (US), for whom we had both SIRE
   information and whole genome genotypes, with a focus on the three
   largest SIRE groups in the US: White, Black (African-American), and
   Hispanic (Latino). Our approach to the question of PGx risk
   stratification entailed the integration of two distinct methodologies:
   population genetics and evidence-based medicine. This integrated
   approach allowed us to consider the clinical implications for the
   observed patterns of PGx variation found within and between population
   groups. Results Whole genome genotypes were used to characterize
   individuals' continental ancestry fractions-European, African, and
   Native American-and individuals were grouped according to their GA
   profiles. SIRE and GA groups were found to be highly concordant.
   Continental ancestry predicts individuals' SIRE with > 96\% accuracy,
   and accordingly, GA provides only a marginal increase in resolution for
   PGx risk stratification. In light of the concordance between SIRE and
   GA, taken together with the fact that information on SIRE is readily
   available to clinicians, we evaluated PGx variation between SIRE groups
   to explore the potential clinical utility of race and ethnicity. PGx
   variants are highly diverged compared to the genomic background; 82
   variants show significant frequency differences among SIRE groups, and
   genome-wide patterns of PGx variation are almost entirely concordant
   with SIRE. The vast majority of PGx variation is found within rather
   than between groups, a well-established fact for almost all genetic
   variants, which is often taken to argue against the clinical utility of
   population stratification. Nevertheless, analysis of highly
   differentiated PGx variants illustrates how SIRE partitions PGx
   variation based on groups' characteristic ancestry patterns. These cases
   underscore the extent to which SIRE carries clinically valuable
   information for stratifying PGx risk among populations, albeit with less
   utility for predicting individual-level PGx alleles (genotypes),
   supporting the concept of population pharmacogenomics. Conclusions
   Perhaps most interestingly, we show that individuals who identify as
   Black or Hispanic stand to gain far more from the consideration of
   race/ethnicity in treatment decisions than individuals from the majority
   White population.},
Type = {Article},
Affiliation = {Jordan, IK (Corresponding Author), Georgia Inst Technol, Sch Biol Sci, Atlanta, GA 30332 USA.
   Jordan, IK (Corresponding Author), PanAmer Bioinformat Inst, Cali, Colombia.
   Nagar, Shashwat Deepali; Conley, Andrew B.; Jordan, I. King, Georgia Inst Technol, Sch Biol Sci, Atlanta, GA 30332 USA.
   Nagar, Shashwat Deepali; Conley, Andrew B.; Jordan, I. King, PanAmer Bioinformat Inst, Cali, Colombia.
   Conley, Andrew B.; Jordan, I. King, IHRC Georgia Tech Appl Bioinformat Lab, 950 Atlantic Dr, Atlanta, GA 30332 USA.},
DOI = {10.1186/s12915-020-00875-4},
Article-Number = {140},
Keywords = {Population genomics; Pharmacogenomics; Precision public health; Genetic
   ancestry; Race; Ethnicity},
Keywords-Plus = {GENOME-WIDE PATTERNS; HUMAN GENETIC DIVERSITY; RACE; ANCESTRY; DRUG;
   ADMIXTURE; HEALTH; IMPACT},
Research-Areas = {Life Sciences \& Biomedicine - Other Topics},
Web-of-Science-Categories  = {Biology},
Author-Email = {king.jordan@biology.gatech.edu},
Affiliations = {University System of Georgia; Georgia Institute of Technology; IHRC,
   Inc.},
Cited-References = {Abul-Husn NS, 2019, CELL, V177, P58, DOI 10.1016/j.cell.2019.02.039.
   Ahsan T, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228000.
   All Us Res Program Investigators, 2019, NEW ENGL J MED, V381, P668, DOI 10.1056/NEJMsr1809937.
   Altman DG, 1999, BRIT MED J, V319, P1492, DOI 10.1136/bmj.319.7223.1492.
   Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393.
   Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632.
   {[}Anonymous], 1996, AM J PHYS ANTHROPOL, V101, P569.
   {[}Anonymous], 2019, NCBI DBSNP.
   {[}Anonymous], 2011, RACE GENETIC REVOLUT.
   Baharian S, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006059.
   Barbarino JM, 2018, WIRES SYST BIOL MED, V10, DOI 10.1002/wsbm.1417.
   Barbujani G, 2001, NATO SCI S A LIF SCI, V310, P63.
   Bjornsson TD, 2003, J CLIN PHARMACOL, V43, P943, DOI 10.1177/0091270003256065.
   Bland JM, 2000, BRIT MED J, V320, P1468, DOI 10.1136/bmj.320.7247.1468.
   Bonifaz-Peña V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112640.
   Braun L, 2006, INT J HEALTH SERV, V36, P557, DOI 10.2190/8JAF-D8ED-8WPD-J9WH.
   Brown RA, 2001, EVOL ANTHROPOL, V10, P34, DOI 10.1002/1520-6505(2001)10:1<34::AID-EVAN1011>3.0.CO;2-P.
   Bryc K, 2015, AM J HUM GENET, V96, P37, DOI 10.1016/j.ajhg.2014.11.010.
   Bryc K, 2010, P NATL ACAD SCI USA, V107, P8954, DOI 10.1073/pnas.0914618107.
   Bryc K, 2010, P NATL ACAD SCI USA, V107, P786, DOI 10.1073/pnas.0909559107.
   Burchard EG, 2003, NEW ENGL J MED, V348, P1170, DOI 10.1056/NEJMsb025007.
   Bureau UC, 2010, QUICK FACTS US.
   Caulfield T, 2009, GENOME MED, V1, DOI 10.1186/gm8.
   Cavalli-Sforza L. L., 1994, The history and geography of human genes.
   Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8.
   Chen ML, 2006, CLIN PHARMACOKINET, V45, P957, DOI 10.2165/00003088-200645100-00001.
   Cooper RS, 2003, NEW ENGL J MED, V348, P1166, DOI 10.1056/NEJMsb022863.
   Nagar SD, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00241.
   Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307.
   Domingue BW, 2014, P NATL ACAD SCI USA, V111, P7996, DOI 10.1073/pnas.1321426111.
   Edwards AWF, 2003, BIOESSAYS, V25, P798, DOI 10.1002/bies.10315.
   Evans WE, 1999, SCIENCE, V286, P487, DOI 10.1126/science.286.5439.487.
   Excoffier L, 2003, SCIENCE, V300.
   Fang HY, 2019, AM J HUM GENET, V105, P763, DOI 10.1016/j.ajhg.2019.08.012.
   Gannett L, 2004, BRIT J PHILOS SCI, V55, P323, DOI 10.1093/bjps/55.2.323.
   Graves JL, 2018, Reconsidering Race: Social Science Perspectives on Racial Categories in the Age of Genomics, P21.
   Graves JL, 2015, AM BEHAV SCI, V59, P1474, DOI 10.1177/0002764215588810.
   Graves JL, 2015, ANN AM ACAD POLIT SS, V661, P24, DOI 10.1177/0002716215586558.
   Graves JosephL., 2003, Emperor's New Clothes: Biological Theories of Race at the New Milennium.
   Handley LJL, 2007, TRENDS GENET, V23, P432, DOI 10.1016/j.tig.2007.07.002.
   Hariprakash JM, 2018, PHARMACOGENOMICS, V19, P227, DOI 10.2217/pgs-2017-0101.
   Huang SM, 2008, CLIN PHARMACOL THER, V84, P287, DOI 10.1038/clpt.2008.144.
   HUDSON RR, 1992, GENETICS, V132, P583.
   Humes KR, 2011, OVERVIEW RACE HISAPN.
   Jordan IK, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008225.
   Kirzinger A, 2019, PRESCRIPTION DRUGS O.
   Lakiotaki K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182138.
   Lee C.G.L, 2013, Current Genetic Medicine Reports, V1, P162, DOI 10.1007/s40142-013-0017-3.
   Lee S S, 2001, Yale J Health Policy Law Ethics, V1, P33.
   Lewontin RC., 1972, Evolutionary Biology, V6, P381, DOI {[}10.1007/978-1-4684-9063-3J4, DOI 10.1007/978-1-4684-9063-3J4, DOI 10.1007/978-1-4684-9063-3\_14, 10.1007/978-1-4684-9063-3\_14].
   Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717.
   Lötsch J, 2009, PHARMACOGENET GENOM, V19, P429, DOI 10.1097/FPC.0b013e32832b89da.
   Long JC, 2003, HUM BIOL, V75, P449, DOI 10.1353/hub.2003.0058.
   Maples BK, 2013, AM J HUM GENET, V93, P278, DOI 10.1016/j.ajhg.2013.06.020.
   Mizzi C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162866.
   Montagu A., 1997, MANS MOST DANGEROUS, V6th.
   Mora G. C., 2014, Making Hispanics: How activists, bureaucrats, and media constructed a new American.
   Newbeck Phyl., 2008, Virginia Hasn't Always Been for Lovers: Interracial Marriage Bans and the Case of Richard and Mildred Loving.
   Ng PC, 2008, CLIN PHARMACOL THER, V84, P306, DOI 10.1038/clpt.2008.114.
   Pedregosa F, 2011, J MACH LEARN RES, V12, P2825.
   Petrovski S, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1016-y.
   Popejoy AB, 2016, NATURE, V538, P161, DOI 10.1038/538161a.
   Prugnolle F, 2005, CURR BIOL, V15, pR159, DOI 10.1016/j.cub.2005.02.038.
   Ramamoorthy A, 2015, CLIN PHARMACOL THER, V97, P263, DOI 10.1002/cpt.61.
   Ramos E, 2014, PHARMACOGENOMICS J, V14, P217, DOI 10.1038/tpj.2013.24.
   Reich D, 2012, NATURE, V488, P370, DOI 10.1038/nature11258.
   Risch N., 2002, Genome Biology, DOI {[}10.1186/GB-2002-3-7-COMMENT2007, 10.1186/gb-2002-3-7-comment2007].
   Rosenberg NA, 2005, PLOS GENET, V1, P660, DOI 10.1371/journal.pgen.0010070.
   Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311.
   Rosenberg NA., 2018, PHYLOGENETIC INFEREN, P399.
   Ruvolo M, 2001, THINKING ABOUT EVOLUTION, VOL 2, P141.
   Saini A., 2019, SUPERIOR RETURN RACE.
   Schwartz CR, 2013, ANNU REV SOCIOL, V39, P451, DOI 10.1146/annurev-soc-071312-145544.
   Serre D, 2004, GENOME RES, V14, P1679, DOI 10.1101/gr.2529604.
   Sonnega A, 2014, INT J EPIDEMIOL, V43, P576, DOI 10.1093/ije/dyu067.
   Tanaka S, 2013, PHARMACOGENOMICS J, V13, P27, DOI 10.1038/tpj.2011.36.
   Tang H, 2005, AM J HUM GENET, V76, P268, DOI 10.1086/427888.
   Uher R, 2010, AM J PSYCHIAT, V167, P555, DOI 10.1176/appi.ajp.2009.09070932.
   Wang Wendy., 2012, The Rise of Intermarriage: Rates, Characteristics Vary by Race and Gender.
   Witherspoon DJ, 2007, GENETICS, V176, P351, DOI 10.1534/genetics.106.067355.
   Wright S, 1943, GENETICS, V28, P114.
   Yasuda SU, 2008, CLIN PHARMACOL THER, V84, P417, DOI 10.1038/clpt.2008.141.
   Yuan J, 2018, CANCER CELL, V34, P549, DOI 10.1016/j.ccell.2018.08.019.
   Yudell M, 2016, SCIENCE, V351, P564, DOI 10.1126/science.aac4951.},
Number-of-Cited-References = {84},
Times-Cited = {10},
Unique-ID = {WOS:000581731900003},
}

@article{ WOS:000837876100024,
Author = {Kobayashi, Sumitaka and Sata, Fumihiro and Kishi, Reiko},
Title = {Gene-environment interactions related to maternal exposure to
   environmental and lifestyle-related chemicals during pregnancy and the
   resulting adverse fetal growth: a review},
Journal = {ENVIRONMENTAL HEALTH AND PREVENTIVE MEDICINE},
Year = {2022},
Volume = {27},
Abstract = {Background: There are only limited numbers of reviews on the association
   of maternal-child genetic polymorphisms and environmental and
   lifestyle-related chemical exposure during pregnancy with adverse fetal
   growth. Thus, this article aims to review: (1) the effect of
   associations between the above highlighted factors on adverse fetal
   growth and (2) recent birth cohort studies regarding environmental
   health risks.
   Methods: Based on a search of the PubMed database through August 2021,
   68 epidemiological studies on gene-environment interactions, focusing on
   the association between environmental and lifestyle-related chemical
   exposure and adverse fetal growth was identified. Moreover, we also
   reviewed recent worldwide birth cohort studies regarding environmental
   health risks.
   Results: Thirty studies examined gene-smoking associations with adverse
   fetal growth. Sixteen maternal genes significantly modified the
   association between maternal smoking and adverse fetal growth. Two genes
   significantly related with this association were detected in infants.
   Moreover, the maternal genes that significantly interacted with maternal
   smoking during pregnancy were cytochrome P450 1A1 (CYP1A1), X-ray repair
   cross-complementing protein 3 (XRCC3), interleukin 6 (IL6), interleukin
   1 beta (IL1B), human leukocyte antigen (HLA) DQ alpha 1 (HLA-DQA1), HLA
   DQ beta 1 (HLA-DQB1), and nicotinic acetylcholine receptor. Fetal genes
   that had significant interactions with maternal smoking during pregnancy
   were glutathione S-transferase theta 1 (GSTT1) and fat mass and
   obesity-associated protein (FTO). Thirty-eight studies examined the
   association between chemical exposures and adverse fetal growth. In 62
   of the 68 epidemiological studies (91.2\%), a significant association
   was found with adverse fetal growth. Across the studies, there was a
   wide variation in the analytical methods used, especially with respect
   to the genetic polymorphisms of interest, environmental and
   lifestyle-related chemicals examined, and the study design used to
   estimate the gene-environment interactions. It was also found that a
   consistently increasing number of European and worldwide large-scale
   birth cohort studies on environmental health risks have been conducted
   since approximately 1996.
   Conclusion: There is some evidence to suggest the importance of
   gene-environment interactions on adverse fetal growth. The current
   knowledge on gene-environment interactions will help guide future
   studies on the combined effects of maternal-child genetic polymorphisms
   and exposure to environmental and lifestyle-related chemicals during
   pregnancy.},
Type = {Review},
Affiliation = {Kobayashi, S (Corresponding Author), Hokkaido Univ, Ctr Environm \& Hlth Sci, Kita Ku, North 12,West 7, Sapporo, Hokkaido 0600812, Japan.
   Kobayashi, Sumitaka; Sata, Fumihiro; Kishi, Reiko, Hokkaido Univ, Ctr Environm \& Hlth Sci, Kita Ku, North 12,West 7, Sapporo, Hokkaido 0600812, Japan.
   Sata, Fumihiro, Chuo Univ, Hlth Ctr, Shinjuku Ku, 42-8 Ichigaya Hommura Cho, Tokyo 1628473, Japan.},
DOI = {10.1265/ehpm.21-00033},
Article-Number = {24},
Keywords = {Gene-environment interaction; Smoking; Lifestyle-related chemical;
   Environmental chemical; Polymorphism; Fetal growth; Epidemiology;
   Precision public health; Precision medicine; Developmental origins of
   health and disease},
Keywords-Plus = {FOR-GESTATIONAL-AGE; INFANT BIRTH SIZE; XENOBIOTIC-METABOLIZING GENES;
   DISINFECTION BY-PRODUCTS; CORD BLOOD COTININE; CRITICAL WINDOWS; PRETERM
   BIRTH; NATIONAL CHILDRENS; PASSIVE SMOKING; COHORT PROFILE},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {sukobayashi@cehs.hokudai.ac.jp},
Affiliations = {Hokkaido University; Chuo University},
Cited-References = {Aagaard-Tillery K, 2010, OBSTET GYNECOL, V115, P568, DOI 10.1097/AOG.0b013e3181d06faf.
   Ames J, 2018, INT J EPIDEMIOL, V47, P1992, DOI 10.1093/ije/dyy165.
   Anand SS, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-79.
   Andersen AMN, 2011, SCAND J PUBLIC HEALT, V39, P115, DOI 10.1177/1403494811407674.
   Arfsten DP, 2004, INT J TOXICOL, V23, P47, DOI 10.1080/10915810490265450.
   Barisic A, 2020, CROAT MED J, V61, P8, DOI 10.3325/cmj.2020.61.8.
   Barker DJP, 2000, THERIOGENOLOGY, V53, P555, DOI 10.1016/S0093-691X(99)00258-7.
   Barker DJP, 1998, CLIN SCI, V95, P115, DOI 10.1042/CS19980019.
   BARKER DJP, 1986, LANCET, V1, P1077.
   Beckmann JS, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0388-7.
   Bhutta AT, 2002, JAMA-J AM MED ASSOC, V288, P728, DOI 10.1001/jama.288.6.728.
   Bonou SG, 2017, REPROD TOXICOL, V73, P75, DOI 10.1016/j.reprotox.2017.07.019.
   Braimoh TS, 2017, SCI TOTAL ENVIRON, V605, P995, DOI 10.1016/j.scitotenv.2017.06.212.
   Brand JS, 2019, PLOS MED, V16, DOI {[}10.1371/journal.pmed.1002972, 10.1371/journal.pmed.1002972.r001, 10.1371/journal.pmed.1002972.r002, 10.1371/journal.pmed.1002972.r003].
   Cantonwine D, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-43.
   Carrasco-Ramiro F, 2017, GENE THER, V24, P551, DOI 10.1038/gt.2017.77.
   Chand S, 2014, EUR J OBSTET GYN R B, V180, P100, DOI 10.1016/j.ejogrb.2014.06.016.
   Clausson B, 2000, BRIT J OBSTET GYNAEC, V107, P375, DOI 10.1111/j.1471-0528.2000.tb13234.x.
   D'Onofrio BM, 2013, JAMA PSYCHIAT, V70, P1231, DOI 10.1001/jamapsychiatry.2013.2107.
   Danileviciute A, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-161.
   Danileviciute A, 2012, INT J ENV RES PUB HE, V9, P4470, DOI 10.3390/ijerph9124470.
   de Kieviet JF, 2009, JAMA-J AM MED ASSOC, V302, P2235, DOI 10.1001/jama.2009.1708.
   Delpisheh A, 2008, EUR J OBSTET GYN R B, V138, P49, DOI 10.1016/j.ejogrb.2007.08.006.
   Delpisheh A, 2009, EUR J OBSTET GYN R B, V143, P38, DOI 10.1016/j.ejogrb.2008.11.006.
   Duarte-Salles T, 2012, ENVIRON INT, V45, P1, DOI 10.1016/j.envint.2012.04.002.
   Gehring U, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-8.
   Gern JE, 2019, RESP RES, V20, DOI 10.1186/s12931-019-1088-9.
   Ghisari M, 2017, ENVIRON RES, V154, P325, DOI 10.1016/j.envres.2017.01.020.
   Gloria-Bottini F, 2008, EARLY HUM DEV, V84, P739, DOI 10.1016/j.earlhumdev.2008.05.001.
   Gloria-Bottini F, 2015, EUR J OBSTET GYN R B, V185, P136, DOI 10.1016/j.ejogrb.2014.12.019.
   Grazuleviciene R, 2010, J EPIDEMIOL COMMUN H, V64, P648, DOI 10.1136/jech.2009.100859.
   Grazuleviciene R, 2009, INT J ENV RES PUB HE, V6, P1282, DOI 10.3390/ijerph6031282.
   Grunnet L, 2007, J INTERN MED, V262, P96, DOI 10.1111/j.1365-2796.2007.01793.x.
   Hao YX, 2020, ENVIRON POLLUT, V262, DOI 10.1016/j.envpol.2020.114187.
   Harley KG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023923.
   Hogervorst J, 2021, ENVIRON HEALTH-GLOB, V20, DOI 10.1186/s12940-021-00715-0.
   Hong YC, 2003, J OCCUP ENVIRON MED, V45, P492, DOI 10.1097/01.jom.0000063627.37065.a1.
   Hsieh CJ, 2008, NEUROTOXICOLOGY, V29, P839, DOI 10.1016/j.neuro.2008.05.006.
   Hsieh Chia-Jung, 2011, BMC Res Notes, V4, P291, DOI 10.1186/1756-0500-4-291.
   Huang H, 2015, AM J HUM BIOL, V27, P605, DOI 10.1002/ajhb.22723.
   Huang KH, 2017, PEDIATR NEONATOL, V58, P362, DOI 10.1016/j.pedneo.2016.08.006.
   Hur J, 2013, J NUTR, V143, P67, DOI 10.3945/jn.112.161638.
   Imura H, 2013, P JPN ACAD B-PHYS, V89, P462, DOI 10.2183/pjab.89.462.
   Infante-Rivard C, 2006, EPIDEMIOLOGY, V17, P38, DOI 10.1097/01.ede.0000187669.34003.b1.
   Infante-Rivard C, 2004, ENVIRON HEALTH PERSP, V112, P1213, DOI 10.1289/ehp.7003.
   Infante-Rivard C, 2007, PAEDIATR PERINAT EP, V21, P300, DOI 10.1111/j.1365-3016.2007.00825.x.
   Itoh H, 2019, HYPERTENS RES, V42, P301, DOI 10.1038/s41440-018-0177-3.
   Jaddoe VWV, 2020, EUR J EPIDEMIOL, V35, P709, DOI 10.1007/s10654-020-00662-z.
   Jeong KS, 2019, ENVIRON RES, V172, P358, DOI 10.1016/j.envres.2018.12.009.
   Johnson CC, JAMA PEDIATR, V2021.
   Karahalil B, 2011, MOL BIOL REP, V38, P2911, DOI 10.1007/s11033-010-9953-0.
   Kawamoto T, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-25.
   Kee F, 2020, J EPIDEMIOL COMMUN H, V74, P311, DOI 10.1136/jech-2019-213311.
   Khoury MJ, 2018, GENET MED, V20, P574, DOI 10.1038/gim.2017.211.
   Khoury MJ, 2016, AM J PREV MED, V50, P398, DOI 10.1016/j.amepre.2015.08.031.
   Kim BM, 2009, EUR J EPIDEMIOL, V24, P573, DOI 10.1007/s10654-009-9370-7.
   Kimmel CA, 2005, ENVIRON HEALTH PERSP, V113, P1414, DOI 10.1289/ehp.7669.
   Kishi R, 2021, ENVIRON HEALTH PREV, V26, DOI 10.1186/s12199-021-00980-y.
   Kishi R, 2017, EPIDEMIOLOGY, V28, pS19, DOI 10.1097/EDE.0000000000000698.
   Kishi R, 2017, ENVIRON HEALTH PREV, V22, DOI 10.1186/s12199-017-0654-3.
   Kistka ZAF, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2007.12.014.
   Kobayashi S, 2021, REPROD TOXICOL, V105, P221, DOI 10.1016/j.reprotox.2021.09.003.
   Kobayashi S, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-89285-2.
   Kobayashi S, 2019, PAEDIATR PERINAT EP, V33, P185, DOI 10.1111/ppe.12551.
   Kobayashi S, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-023200.
   Kobayashi S, 2019, ENVIRON INT, V125, P418, DOI 10.1016/j.envint.2019.01.051.
   Kobayashi S, 2017, TOXICOLOGY, V390, P135, DOI 10.1016/j.tox.2017.08.010.
   Kobayashi S, 2017, REPROD TOXICOL, V74, P94, DOI 10.1016/j.reprotox.2017.09.002.
   Kobayashi S, 2017, REPROD TOXICOL, V67, P111, DOI 10.1016/j.reprotox.2016.12.002.
   Kobayashi S, 2016, REPROD TOXICOL, V65, P295, DOI 10.1016/j.reprotox.2016.08.020.
   Kobayashi S, 2013, TOXICOL LETT, V219, P269, DOI 10.1016/j.toxlet.2013.03.013.
   Kogevinas M, 2016, EPIDEMIOLOGY, V27, P903, DOI 10.1097/EDE.0000000000000544.
   Koh TK, 2021, ANN OCCUP ENVIRON ME, V33, DOI 10.35371/aoem.2021.33.e12.
   Kordas K, 2009, BRIT J NUTR, V102, P907, DOI 10.1017/S0007114509318280.
   Kuriyama S, 2020, INT J EPIDEMIOL, V49, DOI 10.1093/ije/dyz169.
   Kwon EJ, 2016, J OCCUP ENVIRON MED, V58, pE198, DOI 10.1097/JOM.0000000000000739.
   Lamichhane DK, 2018, SCI TOTAL ENVIRON, V619, P176, DOI 10.1016/j.scitotenv.2017.09.159.
   Landrigan PJ, 2006, PEDIATRICS, V118, P2173, DOI 10.1542/peds.2006-0360.
   Landrigan PJ, 2015, NEW ENGL J MED, V372, P1486, DOI 10.1056/NEJMp1500276.
   Lee BE, 2010, ENVIRON HEALTH PERSP, V118, P437, DOI 10.1289/ehp.0900731.
   Lee Yu Min, 2018, Sci Total Environ, V612, P1433, DOI 10.1016/j.scitotenv.2017.08.317.
   Leermakers ETM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034584.
   Lemasters GK, 2000, ENVIRON HEALTH PERSP, V108, P505, DOI 10.2307/3454542.
   Levallois P, 2016, ENVIRON INT, V92-93, P220, DOI 10.1016/j.envint.2016.03.033.
   Garmendia ML, 2014, ANN NUTR METAB, V64, P226, DOI 10.1159/000365024.
   Lunde A, 2007, AM J EPIDEMIOL, V165, P734, DOI 10.1093/aje/kwk107.
   Magnus P, 2006, INT J EPIDEMIOL, V35, P1146, DOI 10.1093/ije/dyl170.
   Magnus P, 2016, INT J EPIDEMIOL, V45, P382, DOI 10.1093/ije/dyw029.
   Marsh JA, 2012, J DEV ORIG HLTH DIS, V3, P10, DOI 10.1017/S2040174411000638.
   Matthews T J, 2015, Natl Vital Stat Rep, V64, P1.
   Metoki H, 2008, J HYPERTENS, V26, P2406, DOI 10.1097/HJH.0b013e32831364a7.
   Miyaso H, 2017, ENVIRON RES, V157, P1, DOI 10.1016/j.envres.2017.05.006.
   Moreno-Banda G, 2009, SCI TOTAL ENVIRON, V407, P5478, DOI 10.1016/j.scitotenv.2009.06.033.
   Morisaki N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157080.
   Myking S, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-174.
   Naidoo P, 2019, HUM EXP TOXICOL, V38, P82, DOI 10.1177/0960327118781902.
   Naidoo P, 2020, INT J IMMUNOGENET, V47, P414, DOI 10.1111/iji.12481.
   Nansook P, 2018, INT J IMMUNOGENET, V45, P54, DOI 10.1111/iji.12358.
   Nishimura Y, 2020, STEROIDS, V159, DOI 10.1016/j.steroids.2020.108637.
   Nishimura Y, 2019, STEROIDS, V141, P55, DOI 10.1016/j.steroids.2018.11.011.
   Nukui T, 2004, PHARMACOGENETICS, V14, P569, DOI 10.1097/00008571-200409000-00001.
   Ober C, 2020, LANCET RESP MED, V8, P482, DOI 10.1016/S2213-2600(20)30011-4.
   Olsen J, 2001, SCAND J PUBLIC HEALT, V29, P300, DOI 10.1177/14034948010290040201.
   Pereyra S, 2016, EUR J OBSTET GYN R B, V202, P20, DOI 10.1016/j.ejogrb.2016.04.030.
   Pinkerton KE, 2000, ENVIRON HEALTH PERSP, V108, P457, DOI 10.2307/3454537.
   Plunkett J, 2009, HUM HERED, V68, P209, DOI 10.1159/000224641.
   Price TS, 2010, CHILD DEV, V81, P101, DOI 10.1111/j.1467-8624.2009.01383.x.
   Pryor JL, 2000, ENVIRON HEALTH PERSP, V108, P491, DOI 10.2307/3454541.
   Ramaswami R, 2018, ANNU REV PUBL HEALTH, V39, P153, DOI 10.1146/annurev-publhealth-040617-014158.
   Sakurai K, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010531.
   Sasaki S, 2006, MOL HUM REPROD, V12, P77, DOI 10.1093/molehr/gal013.
   Sasaki S, 2008, AM J EPIDEMIOL, V167, P719, DOI 10.1093/aje/kwm360.
   Sasaki S, 2017, PEDIATR RES, V82, P19, DOI 10.1038/pr.2017.70.
   Selevan SG, 2000, ENVIRON HEALTH PERSP, V108, P451, DOI 10.2307/3454536.
   Sharma E, 2012, EUR J OBSTET GYN R B, V161, P163, DOI 10.1016/j.ejogrb.2012.01.008.
   Shin B, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18063012.
   Slama R, 2010, REPROD TOXICOL, V30, P600, DOI 10.1016/j.reprotox.2010.07.001.
   Spadea T, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17103614.
   Suh YJ, 2007, REPROD TOXICOL, V24, P281, DOI 10.1016/j.reprotox.2007.07.001.
   Takagai S, 2016, INT J EPIDEMIOL, V45, P333, DOI 10.1093/ije/dyv290.
   Taylor GM, 2006, PAEDIATR PERINAT EP, V20, P438, DOI 10.1111/j.1365-3016.2006.00736.x.
   Thompson LM, 2014, REPROD TOXICOL, V50, P19, DOI 10.1016/j.reprotox.2014.09.014.
   Tsai HJ, 2008, HUM GENET, V123, P359, DOI 10.1007/s00439-008-0485-9.
   Tsai HJ, 2011, OBSTET GYNECOL, V118, P1081, DOI 10.1097/AOG.0b013e31823389bb.
   Tyrrell J, 2012, HUM MOL GENET, V21, P5344, DOI 10.1093/hmg/dds372.
   Von Linsingen R, 2018, J REPROD IMMUNOL, V129, P9, DOI 10.1016/j.jri.2018.07.002.
   Vrijheid M, 2012, ENVIRON HEALTH PERSP, V120, P29, DOI 10.1289/ehp.1103823.
   Wang XB, 2002, JAMA-J AM MED ASSOC, V287, P195, DOI 10.1001/jama.287.2.195.
   Wu T, 2007, AM J EPIDEMIOL, V166, P313, DOI 10.1093/aje/kwm090.
   Wu W, 2015, HUM GENET, V134, P803, DOI 10.1007/s00439-015-1558-1.
   Xie CM, 2015, ENVIRON RES, V140, P354, DOI 10.1016/j.envres.2015.03.028.
   Xie CB, 2015, NICOTINE TOB RES, V17, P1421, DOI 10.1093/ntr/ntv072.
   Yang P, 2019, ENVIRON SCI TECHNOL, V53, P12026, DOI 10.1021/acs.est.9b03847.
   Yasuda J, 2019, J BIOCHEM, V165, P139, DOI 10.1093/jb/mvy096.
   Yila TA, 2012, J EPIDEMIOL, V22, P91, DOI 10.2188/jea.JE20110039.
   Zhao N, 2021, ENVIRON RES, V194, DOI 10.1016/j.envres.2020.110659.
   Zheng Xiaojing, 2013, Frontiers in Genetics, V4, P196, DOI 10.3389/fgene.2013.00196.
   Zhou B, 2018, ENVIRON POLLUT, V243, P1126, DOI 10.1016/j.envpol.2018.09.083.
   Zijlmans W, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-034702.},
Number-of-Cited-References = {139},
Times-Cited = {3},
Unique-ID = {WOS:000837876100024},
}

@article{ WOS:000392529300008,
Author = {Norton, Mary E.},
Title = {Will Precision Medicine Improve Population Health?},
Journal = {OBSTETRICAL \& GYNECOLOGICAL SURVEY},
Year = {2017},
Volume = {72},
Number = {1},
Pages = {15+},
Month = {JAN},
Abstract = {This article discusses the pros and cons of the precision medicine
   initiative in the improvement of population health. It has been stated
   that precision medicine may not improve population health primarily due
   to 3 reasons. The first reason is the unusual complexity of pathogenesis
   of diseases, particularly those that belong to the noncommunicable
   category. The association between many specific genes and conditions
   such as obesity, hypertension, and some cancers is illustrative of this
   opinion. Second, the fundamental premise of precision medicine is that
   it can help identify predictors of disease to guide interventions. This
   would be challenging to accomplish because although population studies
   can identify associations between genotypes and phenotypes, the
   consequent associations would have limited ability to predict phenotype
   in individuals, and it would take significantly stronger associations to
   provide adequate evidence to improve prediction of diseases in
   individuals. Third, an assumption about the precision medicine
   initiative is that disease in a population can be prevented when risk
   has been predicted in an accurate manner, because individuals would take
   precautionary measures by resorting to behavioral changes. However, the
   present scientific evidence is found to be contradictory to this
   assumption.
   Furthermore, it is postulated that the precisionmedicine initiativemay
   be a distracting factor in the efforts of the US national health
   research agenda in addressing the root causes of ill health such as
   poverty, obesity, education, and infant mortality. Shifts in the focus
   of funding agencies and record of similar previous endeavors that did
   not live up to the expectations have thus dampened the enthusiasm for
   the precision medicine drive. However, considering the positive aspects
   of the precision medicine drive, the following points have been put
   forth. Planning for the health of the population necessitates the
   correct channeling of and efficient utilization of resources for groups
   who are at risk. To this end, classification of populations into risk
   groups for several chronic diseases can provide effective prevention and
   treatment policies at lower costs. A case in point is the classification
   of women into risk categories for breast cancer screening based on age
   and polygenic risk score. Research evidence reveals that a genetically
   targeted approach to population health by means of newborn screening
   programs and genomic interventions for conditions such as hereditary
   breast and ovarian cancer syndrome, Lynch syndrome, and familial
   hypercholesterolemia has discernible benefits. A vital application of
   precision public health is the use of genomics in the examination and
   control of infectious diseases, which in turn has implications in other
   economic sectors including the environment, agriculture, animal health,
   and biotechnology. Thus, the future of population health lies in the
   implementation of a combination of approaches ranging from
   population-wide interventions to specific interventions adapted to suit
   the needs of higher-risk groups.},
Type = {Editorial Material},
Research-Areas = {Obstetrics \& Gynecology},
Web-of-Science-Categories  = {Obstetrics \& Gynecology},
Cited-References = {Hollands GJ, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1102.
   2016, AM J OBSTET GYNECOL, V215, P431.
   2016, J OBSTET GYNAECOL CA, V38, P659.},
Number-of-Cited-References = {3},
Times-Cited = {2},
Unique-ID = {WOS:000392529300008},
}

@article{ WOS:001085630500003,
Author = {Rockhill, Karilynn M. and Olson, Richard and Dart, Richard C. and
   Iwanicki, Janetta L. and Black, Joshua C.},
Title = {Differing Behaviors Around Adult Nonmedical Use of Prescription
   Stimulants and Opioids: Latent Class Analysis},
Journal = {JOURNAL OF MEDICAL INTERNET RESEARCH},
Year = {2023},
Volume = {25},
Month = {SEP 20},
Abstract = {Background: The availability of central nervous system stimulants has
   risen in recent years, along with increased dispensing of stimulants for
   treatment of, for example, parent-reported
   attention-deficit/hyperactivity disorder in children and new diagnoses
   during adulthood. Typologies of drug use, as has been done with opioids,
   fail to include a sufficient range of behavioral factors to
   contextualize person-centric circumstances surrounding drug use.
   Understanding these patterns across drug classes would bring public
   health and regulatory practices toward precision public health.
   Objective: The objective of this study was to quantitatively delineate
   the unique behavioral profiles of adults who currently nonmedically use
   stimulants and opioids using a latent class analysis and to contrast the
   differences in findings by class. We further evaluated whether the
   subgroups identified were associated with an increased Drug Abuse
   Screening Test-10 (DAST-10) score, which is an indicator of average
   problematic drug use.
   Methods: This study used a national cross-sectional web-based survey,
   using 3 survey launches from 2019 to 2020 (before the COVID-19
   pandemic). Data from adults who reported nonmedical use of prescription
   stimulants (n=2083) or prescription opioids (n=6127) in the last 12
   months were analyzed. A weighted latent class analysis was used to
   identify the patterns of use. Drug types, motivations, and behaviors
   were factors in the model, which characterized unique classes of
   behavior.
   Results: Five stimulant nonmedical use classes were identified:
   amphetamine self-medication, network-sourced stimulant for alertness,
   nonamphetamine performance use, recreational use, and nondiscriminatory
   behaviors. The drug used nonmedically, acquisition through a friend or
   family member, and use to get high were strong differentiators among the
   stimulant classes. The latter 4 classes had significantly higher DAST-10
   scores than amphetamine self-medication (P<.001). In addition, 4 opioid
   nonmedical use classes were identified: moderate pain with low mental
   health burden, high pain with higher mental health burden, risky
   behaviors with diverse motivations, and nondiscriminatory behaviors.
   There was a progressive and significant increase in DAST-10 scores
   across classes (P<.001). The potency of the opioid, pain history, the
   routes of administration, and psychoactive effect behaviors were strong
   differentiators among the opioid classes.
   Conclusions: A more precise understanding of how behaviors tend to
   co-occur would improve efficacy and efficiency in developing
   interventions and supporting the overall health of those who use drugs,
   and it would improve communication with, and connection to, those at
   risk for severe drug outcomes.},
Type = {Article},
Affiliation = {Black, JC (Corresponding Author), Denver Hlth \& Hosp Author, Rocky Mt Poison \& Drug Safety, Denver, CO USA.
   Black, JC (Corresponding Author), Denver Hlth \& Hosp Author, Denver, CO 80204 USA.
   Rockhill, Karilynn M.; Olson, Richard; Dart, Richard C.; Iwanicki, Janetta L.; Black, Joshua C., Denver Hlth \& Hosp Author, Rocky Mt Poison \& Drug Safety, Denver, CO USA.
   Black, Joshua C., Denver Hlth \& Hosp Author, Denver, CO 80204 USA.},
DOI = {10.2196/46742},
Article-Number = {e46742},
Keywords = {stimulant misuse; opioid misuse; high-dimensional analysis; latent class
   analysis; general population; drug overdose; opioid; drug use pattern;
   nonmedical use of prescription stimulant; substance abuse; drugs;
   adulthood},
Keywords-Plus = {DEFICIT HYPERACTIVITY DISORDER; UNITED-STATES; DRUG; PATTERNS;
   PREVALENCE; TRANSITION},
Research-Areas = {Health Care Sciences \& Services; Medical Informatics},
Web-of-Science-Categories  = {Health Care Sciences \& Services; Medical Informatics},
Author-Email = {joshua.black@rmpds.org},
Affiliations = {Denver Health Medical Center; Denver Health Medical Center},
Cited-References = {Bakk Z, 2021, BRIT J MATH STAT PSY, V74, P340, DOI 10.1111/bmsp.12227.
   Banerjee D, 2004, SLEEP MED REV, V8, P339, DOI 10.1016/j.smrv.2004.03.002.
   Barton AW, 2021, ADDICT BEHAV, V114, DOI 10.1016/j.addbeh.2020.106757.
   Black JC, 2021, PHARMACOEPIDEM DR S, V30, P1132, DOI 10.1002/pds.5260.
   Black JC, 2021, JAMA INTERN MED, V181, P707, DOI 10.1001/jamainternmed.2020.7850.
   Black JC, 2019, J MED INTERNET RES, V21, DOI 10.2196/15830.
   Board AR, 2020, DRUG ALCOHOL DEPEN, V217, DOI 10.1016/j.drugalcdep.2020.108297.
   Chen LY, 2014, DRUG ALCOHOL DEPEN, V142, P86, DOI 10.1016/j.drugalcdep.2014.05.022.
   Collins LM, 2009, Latent class and latent transition analysis: With applications in the social, behavioral, and health sciences, V718.
   Dart RC, 2009, DRUG ALCOHOL DEPEN, V105, pS26, DOI 10.1016/j.drugalcdep.2009.08.011.
   de Jonge MC, 2022, SUBST USE MISUSE, V57, P769, DOI 10.1080/10826084.2022.2040029.
   Dowell D, 2016, JAMA-J AM MED ASSOC, V315, P1624, DOI 10.1001/jama.2016.1464.
   Faraone SV, 2020, J AM ACAD CHILD PSY, V59, P100, DOI 10.1016/j.jaac.2019.06.012.
   Karamouzian M, 2022, INT J DRUG POLICY, V102, DOI 10.1016/j.drugpo.2022.103584.
   Katzman MA, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-017-1463-3.
   Katzman MA, 2016, CAN J PSYCHIAT, V61, P60, DOI 10.1177/0706743715620143.
   Khoury MJ, 2016, AM J PREV MED, V50, P398, DOI 10.1016/j.amepre.2015.08.031.
   Lanza ST, 2007, STRUCT EQU MODELING, V14, P671, DOI 10.1080/10705510701575602.
   Lopez-Quintero C, 2011, DRUG ALCOHOL DEPEN, V115, P120, DOI 10.1016/j.drugalcdep.2010.11.004.
   Mattson CL, 2021, MMWR-MORBID MORTAL W, V70, P202, DOI 10.15585/mmwr.mm7006a4externalicon.
   McCabe SE, 2022, JAMA NETW OPEN, V5, DOI 10.1001/jamanetworkopen.2021.41995.
   McCabe SE, 2014, ADDICTION, V109, P102, DOI 10.1111/add.12347.
   McCabe SE, 2013, J AM ACAD CHILD PSY, V52, P1272, DOI 10.1016/j.jaac.2013.09.005.
   Nagin DS, 2005, Group-based modeling of development, V43.
   samhsa, 2020, National Survey of Drug Use and Health (NSDUH) releases.
   Simon V, 2009, BRIT J PSYCHIAT, V194, P204, DOI 10.1192/bjp.bp.107.048827.
   SKINNER HA, 1982, ADDICT BEHAV, V7, P363, DOI 10.1016/0306-4603(82)90005-3.
   Sweeney CT, 2013, J ADDICT DIS, V32, P1, DOI 10.1080/10550887.2012.759858.
   Teter CJ, 2006, PHARMACOTHERAPY, V26, P1501, DOI 10.1592/phco.26.10.1501.
   Timko C, 2018, J STUD ALCOHOL DRUGS, V79, P799, DOI 10.15288/jsad.2018.79.799.
   Weller BE, 2020, J BLACK PSYCHOL, V46, P287, DOI 10.1177/0095798420930932.
   Yudko E, 2007, J SUBST ABUSE TREAT, V32, P189, DOI 10.1016/j.jsat.2006.08.002.
   Zablotsky Benjamin, 2020, Natl Health Stat Report, P1.},
Number-of-Cited-References = {33},
Times-Cited = {0},
Unique-ID = {WOS:001085630500003},
}

@article{ WOS:000983343400001,
Author = {Guan, Yue and Haardorfer, Regine and McBride, Colleen M. and Escoffery,
   Cam and Lipscomb, Joseph},
Title = {Testing Theory-Based Messages to Encourage Women at Average Risk for
   Breast Cancer to Consider Biennial Mammography Screening},
Journal = {ANNALS OF BEHAVIORAL MEDICINE},
Year = {2023},
Volume = {57},
Number = {9},
Pages = {696-707},
Month = {AUG 21},
Abstract = {Background The US Preventive Services Task Force does not recommend
   routine annual mammography screening for women aged 40-49 at average
   risk. Little research has been done to develop theory-based
   communication interventions to facilitate informed decision-making about
   reducing potentially low-value mammography screening. Purpose Evaluate
   the effects of theory-based persuasive messages on women's willingness
   to consider delaying screening mammography until age 50 or have
   mammograms biennially. Methods We conducted a randomized controlled
   communication experiment online with a population-based sample of U.S.
   women aged 40-49 (N = 383) who screened to be at average risk for breast
   cancer. Women were randomly assigned to the following messaging
   summaries: annual mammography risks in 40s (Arm 1, n = 124), mammography
   risks plus family history-based genetic risk (Arm 2, n = 120), and
   mammography risks, genetic risk, and behavioral alternatives (Arm 3, n =
   139). Willingness to delay screening or reduce screening frequency was
   assessed post-experiment by a set of 5-point Likert scale items. Results
   Women in Arm 3 reported significantly greater willingness to delay
   screening mammography until age 50 (mean = 0.23, SD = 1.26) compared
   with those in Arm 1 (mean = -0.17, SD = 1.20; p = .04). There were no
   significant arm differences in willingness to reduce screening
   frequency. Exposure to the communication messages significantly shifted
   women's breast cancer-related risk perceptions without increasing
   unwarranted cancer worry across all three arms. Conclusions Providing
   women with screening information and options may help initiate
   challenging discussions with providers about potentially low-value
   screening.
   Lay Summary The US Preventive Services Task Force does not recommend
   routine annual mammography screening for women aged 40-49 at average
   risk. This study aimed to assess the impact of theory-based persuasive
   messages on women's willingness to delay mammography screening until age
   50 or opt for biennial screenings. In a randomized online experiment,
   383 U.S. women aged 40-49 at average risk for breast cancer were
   assigned to three different message groups. The results showed that
   women exposed to messaging that included mammography risks, family
   history-based genetic risk, and behavioral alternatives were
   significantly more willing to delay screening until age 50. However,
   there were no significant differences in willingness to reduce screening
   frequency. The tested communication messages effectively shifted women's
   breast cancer-related risk perceptions without causing unnecessary
   worry. Providing women with screening information and options may help
   initiate challenging discussions with providers about potentially
   low-value screening.},
Type = {Article},
Affiliation = {Guan, Y (Corresponding Author), Emory Univ, Rollins Sch Publ Hlth, Dept Behav Social \& Hlth Educ Sci, Atlanta, GA 30322 USA.
   Guan, Yue; Haardorfer, Regine; McBride, Colleen M.; Escoffery, Cam, Emory Univ, Rollins Sch Publ Hlth, Dept Behav Social \& Hlth Educ Sci, Atlanta, GA 30322 USA.
   Lipscomb, Joseph, Emory Univ, Rollins Sch Publ Hlth, Dept Hlth Policy \& Management, Atlanta, GA USA.},
DOI = {10.1093/abm/kaad018},
EarlyAccessDate = {MAY 2023},
Keywords = {Breast cancer; Cancer screening; Mammography screening; Health
   communication; De-implementation; Precision public health},
Keywords-Plus = {SERVICES TASK-FORCE; RANDOMIZED-TRIAL; DECISION AID; INFORMATION;
   AMERICAN; PHYSICIANS; PROVIDERS; ATTITUDES; AWARENESS; ACCURACY},
Research-Areas = {Psychology},
Web-of-Science-Categories  = {Psychology, Multidisciplinary},
Author-Email = {yue.guan@emory.edu},
Affiliations = {Emory University; Rollins School Public Health; Emory University;
   Rollins School Public Health},
Cited-References = {Tabriz AA, 2022, IMPLEMENT SCI, V17, DOI 10.1186/s13012-022-01197-5.
   Allen JD, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1169.
   {[}Anonymous], 2009, Ann Intern Med, V151, pI, DOI 10.7326/0003-4819-151-9-200911030-00002.
   Baxi SS, 2017, MED CARE, V55, P723, DOI 10.1097/MLR.0000000000000734.
   Bellcross CA, 2009, GENET MED, V11, P783, DOI 10.1097/GIM.0b013e3181b9b04a.
   Berg AO, 2002, ANN INTERN MED, V137, P344, DOI 10.7326/0003-4819-137-5\_Part\_1-200209030-00011.
   Berwick DM, 2019, JAMA-J AM MED ASSOC, V322, P1458, DOI 10.1001/jama.2019.14610.
   Betsch T, 2001, ORGAN BEHAV HUM DEC, V84, P23, DOI 10.1006/obhd.2000.2916.
   Bowen MS, 2012, PUBLIC HEALTH GENOM, V15, P327, DOI 10.1159/000341889.
   C.f.D.C.a. Prevention, 2020, US MAMM WOM AG 40 SE.
   Cappella J N., 2009, Distinctive qualities in communication research, P89.
   Cassel CK, 2012, JAMA-J AM MED ASSOC, V307, P1801, DOI 10.1001/jama.2012.476.
   CDC, 2021, WHAT CAN I DO RED MY.
   CHAIKEN S, 1980, J PERS SOC PSYCHOL, V39, P752, DOI 10.1037/0022-3514.39.5.752.
   Chaiken S., 2011, HDB THEORIES SOCIAL, P246, DOI DOI 10.4135/9781446249215.N13.
   Darke PR, 1998, PERS SOC PSYCHOL B, V24, P1205, DOI 10.1177/01461672982411007.
   Ebell MH, 2018, PUBLIC HEALTH REV, V39, DOI 10.1186/s40985-018-0080-0.
   Epstein LH, 2001, OBES RES, V9, P171, DOI 10.1038/oby.2001.18.
   GERSICK CJG, 1990, ORGAN BEHAV HUM DEC, V47, P65, DOI 10.1016/0749-5978(90)90047-D.
   Grimshaw JM, 2020, BMJ QUAL SAF, V29, P409, DOI 10.1136/bmjqs-2019-010060.
   Guan Y, 2022, J WOMENS HEALTH, V31, P1120, DOI 10.1089/jwh.2021.0232.
   Guan Y, 2019, PUBLIC HEALTH GENOM, V22, P102, DOI 10.1159/000503129.
   Guan Y, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45967-6.
   Guo YQ, 2019, SOC WORK PUBLIC HLTH, DOI 10.1080/19371918.2019.1649226.
   Helfrich CD, 2019, ETHNIC DIS, V29, P93, DOI 10.18865/ed.29.S1.93.
   Helfrich CD, 2018, J EVAL CLIN PRACT, V24, P198, DOI 10.1111/jep.12855.
   Kaiser K, 2011, J GEN INTERN MED, V26, P51, DOI 10.1007/s11606-010-1489-4.
   KnowledgePanel I., KNOWLEDGEPANEL METH.
   Luttrell A., 2018, Oxford research encyclopedia of psychology.
   Mandelblatt JS, 2009, ANN INTERN MED, V151, P738, DOI 10.7326/0003-4819-151-10-200911170-00010.
   Mathieu E, 2007, ARCH INTERN MED, V167, P2039, DOI 10.1001/archinte.167.19.2039.
   Mathieu E, 2010, PATIENT EDUC COUNS, V81, P63, DOI 10.1016/j.pec.2010.01.001.
   McKay VR, 2018, AM J COMMUN PSYCHOL, V62, P189, DOI 10.1002/ajcp.12258.
   McLeod S., 2007, SKINNER OPERANT COND, V11, P2015.
   Mehta JM, 2019, J WOMENS HEALTH, V28, P302, DOI 10.1089/jwh.2017.6885.
   Morgan DJ, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4534.
   Nagler RH, 2019, ANN BEHAV MED, V53, P896, DOI 10.1093/abm/kay098.
   Nagler RH, 2017, MED CARE, V55, P879, DOI 10.1097/MLR.0000000000000798.
   Nilsen P, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-53.
   Niven DJ, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0488-z.
   Norton WE, 2020, IMPLEMENT SCI, V15, DOI 10.1186/s13012-019-0960-9.
   Norton WE, 2017, IMPLEMENT SCI, V12, DOI 10.1186/s13012-017-0655-z.
   Oeffinger KC, 2015, JAMA-J AM MED ASSOC, V314, P1599, DOI 10.1001/jama.2015.12783.
   Office of Disease Prevention and Health Promotion, 2016, HLTH LIT ONL.
   Onega T, 2014, CANCER-AM CANCER SOC, V120, P2955, DOI 10.1002/cncr.28771.
   Owens DK, 2019, JAMA-J AM MED ASSOC, V322, P652, DOI 10.1001/jama.2019.10987.
   Patel NS, 2021, JAMA INTERN MED, V181, P717, DOI 10.1001/jamainternmed.2021.0157.
   Patey AM, 2018, IMPLEMENT SCI, V13, DOI 10.1186/s13012-018-0826-6.
   Petty R. E., 1986, COMMUN PERSUATION, DOI 10.1016/S0065-2601(08)60214-2.
   Qin J, 2018, BREAST CANCER RES TR, V168, P687, DOI 10.1007/s10549-017-4625-6.
   Qin XZ, 2019, PREV MED, V123, P130, DOI 10.1016/j.ypmed.2019.03.023.
   Radhakrishnan A, 2018, PREV MED, V107, P90, DOI 10.1016/j.ypmed.2017.11.010.
   Rainey L, 2018, ACTA ONCOL, V57, P1275, DOI 10.1080/0284186X.2018.1481291.
   Rao R, 2018, ANN SURG ONCOL, V25, P2795, DOI 10.1245/s10434-018-6584-5.
   Rocque G, 2017, J ONCOL PRACT, V13, P756, DOI 10.1200/JOP.2016.019281.
   Schleicher SM, 2018, LANCET ONCOL, V19, pE200, DOI 10.1016/S1470-2045(18)30099-8.
   Siu AL, 2016, ANN INTERN MED, V164, P279, DOI 10.7326/M15-2886.
   Skinner B.F., 1953, Science and Human Behavior.
   Smith SK, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5370.
   Snyder LB, 2004, J HEALTH COMMUN, V9, P71, DOI 10.1080/10810730490271548.
   Sypes EE, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01567-0.
   Tsalatsanis A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134800.
   Wood W, 2002, J PERS SOC PSYCHOL, V83, P1281, DOI 10.1037/0022-3514.83.6.1281.
   Yeager DS, 2011, PUBLIC OPIN QUART, V75, P709, DOI 10.1093/poq/nfr020.
   Yu JN, 2017, JAMA INTERN MED, V177, P1381, DOI 10.1001/jamainternmed.2017.2247.},
Number-of-Cited-References = {65},
Times-Cited = {1},
Unique-ID = {WOS:000983343400001},
}

@article{ WOS:000415642200022,
Author = {Golding, Nick and Burstein, Roy and Longbottom, Joshua and Browne, Annie
   J. and Fullman, Nancy and Osgood-Zimmerman, Aaron and Earl, Lucas and
   Bhatt, Samir and Cameron, Ewan and Casey, Daniel C. and Dwyer-Lindgren,
   Laura and Farag, Tamer H. and Flaxman, Abraham D. and Fraser, Maya S.
   and Gething, Peter W. and Gibson, Harry S. and Graetz, Nicholas and
   Krause, L. Kendall and Kulikoff, Xie Rachel and Lim, Stephen S. and
   Mappin, Bonnie and Morozoff, Chloe and Reiner, Jr., Robert C. and
   Sligar, Amber and Smith, David L. and Wang, Haidong and Weiss, Daniel J.
   and Murray, Christopher J. L. and Moyes, Catherine L. and Hay, Simon I.},
Title = {Mapping under-5 and neonatal mortality in Africa, 2000-15: a baseline
   analysis for the Sustainable Development Goals},
Journal = {LANCET},
Year = {2017},
Volume = {390},
Number = {10108},
Pages = {2171-2182},
Month = {NOV 11},
Abstract = {Background During the Millennium Development Goal (MDG) era, many
   countries in Africa achieved marked reductions in under- 5 and neonatal
   mortality. Yet the pace of progress toward these goals substantially
   varied at the national level, demonstrating an essential need for
   tracking even more local trends in child mortality. With the adoption of
   the Sustainable Development Goals (SDGs) in 2015, which established
   ambitious targets for improving child survival by 2030, optimal
   intervention planning and targeting will require understanding of trends
   and rates of progress at a higher spatial resolution. In this study, we
   aimed to generate high- resolution estimates of under- 5 and neonatal
   all- cause mortality across 46 countries in Africa.
   Methods We assembled 235 geographically resolved household survey and
   census data sources on child deaths to produce estimates of under-5 and
   neonatal mortality at a resolution of 5 x 5 km grid cells across 46
   African countries for 2000, 2005, 2010, and 2015. We used a Bayesian
   geostatistical analytical framework to generate these estimates, and
   implemented predictive validity tests. In addition to reporting 5 x 5 km
   estimates, we also aggregated results obtained from these estimates into
   three different levels-national, and subnational administrative levels 1
   and 2-to provide the full range of geospatial resolution that local,
   national, and global decision makers might require.
   Findings Amid improving child survival in Africa, there was substantial
   heterogeneity in absolute levels of under-5 and neonatal mortality in
   2015, as well as the annualised rates of decline achieved from 2000 to
   2015. Subnational areas in countries such as Botswana, Rwanda, and
   Ethiopia recorded some of the largest decreases in child mortality rates
   since 2000, positioning them well to achieve SDG targets by 2030 or
   earlier. Yet these places were the exception for Africa, since many
   areas, particularly in central and western Africa, must reduce under-5
   mortality rates by at least 8.8\% per year, between 2015 and 2030, to
   achieve the SDG 3.2 target for under-5 mortality by 2030.
   Interpretation In the absence of unprecedented political commitment,
   financial support, and medical advances, the viability of SDG 3.2
   achievement in Africa is precarious at best. By producing under-5 and
   neonatal mortality rates at multiple levels of geospatial resolution
   over time, this study provides key information for decision makers to
   target interventions at populations in the greatest need. In an era when
   precision public health increasingly has the potential to transform the
   design, implementation, and impact of health programmes, our 5 x 5 km
   estimates of child mortality in Africa provide a baseline against which
   local, national, and global stakeholders can map the pathways for ending
   preventable child deaths by 2030.},
Type = {Article},
Affiliation = {Hay, SI (Corresponding Author), Univ Washington, Inst Hlth Metr \& Evaluat, Seattle, WA 98121 USA.
   Golding, Nick, Univ Melbourne, Sch BioSci, Parkville, Vic, Australia.
   Longbottom, Joshua; Browne, Annie J.; Bhatt, Samir; Cameron, Ewan; Gething, Peter W.; Gibson, Harry S.; Mappin, Bonnie; Weiss, Daniel J.; Moyes, Catherine L.; Hay, Simon I., Univ Oxford, Li Ka Shing Ctr Hlth Informat \& Discovery, Big Data Inst, Oxford, England.
   Burstein, Roy; Fullman, Nancy; Osgood-Zimmerman, Aaron; Earl, Lucas; Casey, Daniel C.; Dwyer-Lindgren, Laura; Farag, Tamer H.; Flaxman, Abraham D.; Fraser, Maya S.; Graetz, Nicholas; Kulikoff, Xie Rachel; Lim, Stephen S.; Morozoff, Chloe; Reiner, Robert C., Jr.; Sligar, Amber; Smith, David L.; Wang, Haidong; Murray, Christopher J. L.; Hay, Simon I., Univ Washington, Inst Hlth Metr \& Evaluat, Seattle, WA 98121 USA.
   Bhatt, Samir, Imperial Coll London, Dept Infect Dis Epidemiol, London, England.
   Krause, L. Kendall, Bill \& Melinda Gates Fdn, Seattle, WA USA.},
DOI = {10.1016/S0140-6736(17)31758-0},
Keywords-Plus = {CIVIL REGISTRATION; CHILD-MORTALITY; PLASMODIUM-FALCIPARUM; SYSTEMATIC
   ANALYSIS; GLOBAL BURDEN; HEALTH; COUNTDOWN; PROGRESS; MALARIA; COUNTRIES},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Author-Email = {sihay@uw.edu},
Affiliations = {University of Melbourne; University of Oxford; University of Washington;
   University of Washington Seattle; Institute for Health Metrics \&
   Evaluation; Imperial College London; Bill \& Melinda Gates Foundation},
Cited-References = {AbouZahr C, 2015, LANCET, V386, P1373, DOI 10.1016/S0140-6736(15)60173-8.
   Afnan-Holmes H, 2015, LANCET GLOB HEALTH, V3, pE396, DOI 10.1016/S2214-109X(15)00059-5.
   Ahmad OB, 2000, B WORLD HEALTH ORGAN, V78, P1175.
   {[}Anonymous], 2017, Lancet, V390, pe38, DOI {[}10.1016/S0140-6736(17)32650-8, 10.1016/S0140-6736(17)32646-6, 10.1016/S0140-6736(17)32647-8, 10.1016/S0140-6736(17)32645-4, 10.1016/S0140-6736(17)32649-1, 10.1016/S0140-6736(17)31833-0, 10.1016/S0140-6736(17)32648-X].
   {[}Anonymous], 2000, Millennium Declaration.
   {[}Anonymous], IMPROVED PREDICTION.
   {[}Anonymous], 2014, 012014 WP EUR COMM D.
   {[}Anonymous], ANN APPL STAT.
   {[}Anonymous], 2016, WHO METH DAT SOURC C.
   {[}Anonymous], COUNTD 2015 DEC TRAC.
   {[}Anonymous], GLOB MAP IRR AR VERS.
   {[}Anonymous], MCEE WHO METH DAT SO.
   {[}Anonymous], COMMUNICATION.
   {[}Anonymous], BENCHMARKING HLTH SY.
   {[}Anonymous], COUNTD 2015 ETH PROG.
   {[}Anonymous], GAV FULL COUNTR EV 2.
   {[}Anonymous], 2022, DEM WSPOLCZ DZIETN.
   Arku RE, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002038.
   Bell R. M., 2007, SiGKDD Explorations, V9, P75.
   Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535.
   Bhutta ZA, 2016, LANCET GLOB HEALTH, V4, pE877, DOI 10.1016/S2214-109X(16)30264-9.
   Bhutta ZA, 2010, LANCET, V375, P2032, DOI 10.1016/S0140-6736(10)60678-2.
   Burke M, 2016, LANCET GLOB HEALTH, V4, pE936, DOI {[}10.1016/S2214-109X(16)30212-1, 10.1016/s2214-109x(16)30212-1].
   Canning D, 2013, EUR ECON REV, V63, P273, DOI 10.1016/j.euroecorev.2013.07.005.
   Channan S., 2014, GLOBAL MOSAICS STAND.
   Chen Xi., 2015, Spatial Demography, V3, P27.
   Desmond-Hellmann S, 2016, SCIENCE, V353, P731, DOI 10.1126/science.aai7598.
   Dieleman JL, 2016, LANCET, V387, P2536, DOI 10.1016/S0140-6736(16)30168-4.
   Diggle P., 2009, Model-based geostatistics.
   Diggle PJ, 2013, STAT SCI, V28, P542, DOI 10.1214/13-STS441.
   Dowell SF, 2016, NATURE, V540, P189, DOI 10.1038/540189a.
   Dwyer-Lindgren L, 2014, SPAT SPATIO-TEMPORAL, V11, P89, DOI 10.1016/j.sste.2014.09.002.
   Ebener Steeve, 2005, Int J Health Geogr, V4, P5, DOI 10.1186/1476-072X-4-5.
   Fabic MS, 2012, B WORLD HEALTH ORGAN, V90, P604, DOI 10.2471/BLT.11.095513.
   Foreman KJ, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-1.
   Forouzanfar MH, 2016, LANCET, V388, P1659, DOI 10.1016/S0140-6736(16)31679-8.
   Gakidou E, 2010, LANCET, V376, P959, DOI 10.1016/S0140-6736(10)61257-3.
   Gemperli A, 2004, AM J EPIDEMIOL, V159, P64, DOI 10.1093/aje/kwh001.
   Gething PW, 2016, NEW ENGL J MED, V375, P2435, DOI 10.1056/NEJMoa1606701.
   Gething PW, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000724.
   Glass RI, 2012, JAMA-J AM MED ASSOC, V308, P141, DOI 10.1001/jama.2012.7357.
   Gneiting T, 2005, SCIENCE, V310, P248, DOI 10.1126/science.1115255.
   Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1.
   Kanyuka M, 2016, LANCET GLOB HEALTH, V4, pE201, DOI 10.1016/S2214-109X(15)00294-6.
   Lim SS, 2016, LANCET, V388, P1813, DOI 10.1016/S0140-6736(16)31467-2.
   Linard C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031743.
   Lindgren F, 2011, J ROY STAT SOC B, V73, P423, DOI 10.1111/j.1467-9868.2011.00777.x.
   Liu L, 2016, LANCET, V388, P3027, DOI 10.1016/S0140-6736(16)31593-8.
   Lo S, 2015, LANCET, V386, P1313, DOI 10.1016/S0140-6736(15)60305-1.
   Lopez AD, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0333-4.
   Mikkelsen L, 2015, LANCET, V386, P1395, DOI 10.1016/S0140-6736(15)60171-4.
   Moucheraud C, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3401-6.
   Murray CJL, 2015, NEW ENGL J MED, V373, P1390, DOI 10.1056/NEJMp1510082.
   Murray CJL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000262.
   Nelson A., 2008, Travel time to major cities: A global map of Accessibility.
   Ng M, 2017, AM J TROP MED HYG, V97, P58, DOI 10.4269/ajtmh.15-0315.
   Patil AP, 2011, TRENDS PARASITOL, V27, P245, DOI 10.1016/j.pt.2011.01.003.
   Pezzulo C., 2016, Geospatial modeling of child mortality across 27 countries in sub-Saharan Africa.
   Phillips DE, 2014, POPUL HEALTH METR, V12, DOI 10.1186/1478-7954-12-14.
   Rajaratnam JK, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000253.
   Rue H, 2009, J ROY STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x.
   Tatem AJ, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.4.
   Tatem AJ, 2013, POPUL HEALTH METR, V11, DOI 10.1186/1478-7954-11-11.
   The United Nations, 2015, Transforming our world: the 2030 Agenda for Sustainable Development.
   Thera MA, 2012, ANNU REV MED, V63, P345, DOI 10.1146/annurev-med-022411-192402.
   United Nations, 1990, WORLD DECL SURV PROT.
   Wang HD, 2016, LANCET, V388, P1725, DOI 10.1016/S0140-6736(16)31575-6.
   Wang HD, 2014, LANCET, V384, P957, DOI 10.1016/S0140-6736(14)60497-9.
   Weiss DJ, 2014, ISPRS J PHOTOGRAMM, V98, P106, DOI 10.1016/j.isprsjprs.2014.10.001.},
Number-of-Cited-References = {69},
Times-Cited = {175},
Unique-ID = {WOS:000415642200022},
}

@article{ WOS:000749848200021,
Author = {Yuan, Dan and Yu, Bin and Liang, Shu and Fei, Teng and Tang, Houlin and
   Kang, Rui and Li, Yiping and Ye, Li and Jia, Peng and Yang, Shujuan},
Title = {HIV-1 genetic transmission networks among people living with HIV/AIDS in
   Sichuan, China: a genomic and spatial epidemiological analysis},
Journal = {LANCET REGIONAL HEALTH-WESTERN PACIFIC},
Year = {2022},
Volume = {18},
Month = {JAN},
Abstract = {Background Spatialized HIV genetic transmission networks can help
   understand dynamic changes of HIV-1 at the regional level. This study
   aimed to combine genomic, epidemiological, and spatial data to
   investigate the patterns of the HIV-1 epidemic at both individual and
   regional levels among people living with HIV (PLWH) with virological
   failure of antiretroviral therapy (ART).
   Methods We evaluated the transmission patterns of 5,790 PLWH with
   identified pol sequences of the five main HIV-1 subtypes (B, CRF08\_BC,
   CRF85\_BC, CRF07\_BC, and CRF01\_AE) in Sichuan Province, China. A
   phylogenetic cluster was defined as a group of sequences with
   genetically similar HIV strains, with all phylogenetic dusters forming
   an HIV-1 genetic transmission network for each subtype. Logistic
   regression was used to identify the potential risk factors for
   phylogenetic clustering. Spatial analysis was applied to demonstrate the
   geographic patterns of phylogenetic clustering rates; intensity matrices
   and flow maps were made to demonstrate the intensity of transmission
   within and between cities.
   Findings There were 2,159 (37.3\%) of 5,790 PLWH, distributed in 452
   phylogenetic clusters. Some individual clinical and behavioral factors
   were associated with phylogenetic clustering, including a viral load of
   >50,000 copies/ml (OR=1.16, 95\%CI=1.02-1.33), infection of other
   sexually transmitted diseases (OR=1.38, 95\%CI=1.12-1.69), and >= 5
   non-marital sexual partners (OR=1.25, 95\%CI=1.03-1.51), while >3 years
   of treatment since the initial ART was associated with less likelihood
   of phylogenetic clustering (OR=0.82, 95\%CI=0.70-0.97). The phylogenetic
   clustering rates varied regionally and were highest in the central
   region of Sichuan, especially for subtype CRF08\_BC. The significant
   spatial clusters of high and low phylogenetic clustering rates were
   detected in the east (Dazhou for B; Zigong and Luzhou for CFR08\_BC) and
   west (Yaan and Ganzi for CRF07\_BC), respectively. The proportion of
   intercity transmission varied across cities from 0.14 (Yibin) and 1.00
   (Ganzi). Stronger intercity transmission than average existed between
   some cities, e.g., between Deyang and Neijiang. CRF07\_BC was the most
   widespread subtype between cities, and CRF85\_BC (a novel HIV-1 subtype)
   showed strong intercity transmission (e.g., between Yibin and Guangan).
   Interpretation The phylogenetic clustering rates and intercity
   connections of HIV-1 have varied geographically, possibly due to varying
   human mobility, traffic convenience, and economic activities. Our
   findings enhanced the understanding of the dynamics of HIV-1
   transmission from individual to city level, and demonstrated a novel
   cross-disciplinary (epidemiological, genetic, and spatial) approach by
   which we identified high-risk populations and areas. Our approach could
   be adapted to other regions for precision public health interventions.
   Copyright (C) 2021 The Author(s). Published by Elsevier Ltd.},
Type = {Article},
Affiliation = {Yang, SJ (Corresponding Author), Sichuan Univ, West China Sch Publ Hlth, Chengdu, Peoples R China.
   Yang, SJ (Corresponding Author), Sichuan Univ, West China Hosp 4, Chengdu, Peoples R China.
   Fei, T; Jia, P (Corresponding Author), Wuhan Univ, Sch Resource \& Environm Sci, Wuhan, Peoples R China.
   Yuan, Dan; Liang, Shu; Li, Yiping; Ye, Li, Sichuan Ctr Dis Control \& Prevent, Ctr AIDS STD Control \& Prevent, Chengdu, Peoples R China.
   Yu, Bin, Sichuan Univ, West China Univ Hosp 2, Chengdu, Peoples R China.
   Yang, Shujuan, Sichuan Univ, West China Sch Publ Hlth, Chengdu, Peoples R China.
   Yang, Shujuan, Sichuan Univ, West China Hosp 4, Chengdu, Peoples R China.
   Fei, Teng; Kang, Rui; Jia, Peng, Wuhan Univ, Sch Resource \& Environm Sci, Wuhan, Peoples R China.
   Tang, Houlin, Chinese Ctr Dis Control \& Prevent, Natl Ctr AIDS STD Control \& Prevent, Beijing, Peoples R China.
   Jia, Peng; Yang, Shujuan, Wuhan Univ, Int Inst Spatial Lifecourse Epidemiol ISLE, Wuhan, Peoples R China.},
DOI = {10.1016/j.lanwpc.2021.100318},
EarlyAccessDate = {DEC 2021},
Article-Number = {100318},
Keywords = {HIV; genetic transmission network; genetic epidemiology; spatial
   analysis; spatial epidemiology},
Keywords-Plus = {LIFECOURSE EPIDEMIOLOGY; INFECTIOUS-DISEASES; PREVALENCE; SEX; HOTSPOTS;
   TIME; MEN},
Research-Areas = {Health Care Sciences \& Services; Public, Environmental \& Occupational
   Health},
Web-of-Science-Categories  = {Health Care Sciences \& Services; Public, Environmental \& Occupational
   Health},
Author-Email = {feiteng@whu.edu.cn
   jiapengff@hotmail.com
   rekiny@126.com},
Affiliations = {Sichuan University; Sichuan University; Sichuan University; Wuhan
   University; Chinese Center for Disease Control \& Prevention; National
   Center for AIDS/STD Control \& Prevention, Chinese Center for Disease
   Control \& Prevention; Wuhan University},
Cited-References = {Alirol E, 2011, LANCET INFECT DIS, V11, P131, DOI 10.1016/S1473-3099(10)70223-1.
   Anderson SJ, 2021, MAXIMISING EFFECT CO.
   Brenner B, 2013, AIDS, V27, P1045, DOI 10.1097/QAD.0b013e32835cffd9.
   Cao BL, 2017, SEX TRANSM DIS, V44, P239, DOI {[}10.1097/OLQ.0000000000000575, 10.1097/olq.0000000000000575].
   Chow EPF, 2019, LANCET HIV, V6, pE396, DOI 10.1016/S2352-3018(19)30043-8.
   Dalai SC, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02799.
   Dowdy DW, 2021, HETEROGENEITY TUBERC.
   Eshraghian EA, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12010067.
   Fabeni L, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13020176.
   Gibney KB, 2017, LANCET INFECT DIS, V17, P86, DOI 10.1016/S1473-3099(16)30309-7.
   Hassan AS, 2017, AIDS, V31, P1211, DOI 10.1097/QAD.0000000000001470.
   He X, 2016, J OCCUPATIONAL HLTH.
   Jia P, 2020, LANCET GLOB HEALTH, V8, pE764, DOI 10.1016/S2214-109X(20)30120-0.
   Jia P, 2020, TRENDS PARASITOL, V36, P235, DOI 10.1016/j.pt.2019.12.012.
   Jia P, 2019, ENVIRON HEALTH PERSP, V127, DOI 10.1289/EHP4868.
   Jia P, 2019, LANCET PLANET HEALTH, V3, pE57, DOI 10.1016/S2542-5196(18)30245-6.
   Joint United Nations Programme on HIV/AIDS, 2017, UNAIDS data.
   Lu L, 2008, NATURE, V455, P609, DOI 10.1038/455609a.
   MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.2307/2332142.
   National Center for AIDS/STD Control \& Prevention, NAT GUID DET HIV AID.
   ndrc, The 13th Five-Year Plan for Economic and Social Development of the People's Republic of China (2016-2020).
   Pines HA, 2016, AIDS, V30, P2875, DOI 10.1097/QAD.0000000000001256.
   Poon AFY, 2016, LANCET HIV, V3, pE231, DOI 10.1016/S2352-3018(16)00046-1.
   QGIS Development Team, 2022, QGIS Geographic Information System.
   Ragonnet-Cronin M, 2019, LANCET HIV, V6, pE164, DOI 10.1016/S2352-3018(18)30359-X.
   Ratmann O, 2020, LANCET HIV, V7, pE173, DOI 10.1016/S2352-3018(19)30378-9.
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303.
   Shao YM., 2010, HIV DRUG RESISTANCE.
   Su L, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-05488-4.
   US-CDC. National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention, DETECTING RESPONDING.
   Wertheim JO, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006000.
   Wheeler WH, 2010, AIDS, V24, P1203, DOI 10.1097/QAD.0b013e3283388742.
   Wirtz AL, 2017, LANCET HIV, V4, pE260, DOI 10.1016/S2352-3018(17)30042-5.
   Xiao PP, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14070830.
   Yan HC, 2020, OPEN FORUM INFECT DI, V7, DOI 10.1093/ofid/ofaa154.
   Yang C, 2010, SOC SCI MED, V71, P832, DOI 10.1016/j.socscimed.2010.04.039.
   Yu B, 2020, J ADDICT MED, V14, pE110, DOI 10.1097/ADM.0000000000000640.
   Yuan D, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-05124-1.
   Yuan D, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000017585.
   Zhang L, 2013, LANCET INFECT DIS, V13, P955, DOI 10.1016/S1473-3099(13)70245-7.},
Number-of-Cited-References = {40},
Times-Cited = {9},
Unique-ID = {WOS:000749848200021},
}

@article{ WOS:000998490100026,
Author = {Rich, Shannan N. and Richards, Veronica and Mavian, Carla and Magalis,
   Brittany Rife and Grubaugh, Nathan and Rasmussen, Sonja A. and
   Dellicour, Simon and Vrancken, Bram and Carrington, Christine and
   Fisk-Hoffman, Rebecca and Danso-Odei, Demi and Chacreton, Daniel and
   Shapiro, Jerne and Seraphin, Marie Nancy and Hepp, Crystal and Black,
   Allison and Dennis, Ann and Trovao, Nidia Sequeira and Vandamme,
   Anne-Mieke and Rasmussen, Angela and Lauzardo, Michael and Dean, Natalie
   and Salemi, Marco and Prosperi, Mattia},
Title = {Application of Phylodynamic Tools to Inform the Public Health Response
   to COVID-19: Qualitative Analysis of Expert Opinions},
Journal = {JMIR FORMATIVE RESEARCH},
Year = {2023},
Volume = {7},
Abstract = {Background: In the wake of the SARS-CoV-2 pandemic, scientists have
   scrambled to collect and analyze SARS-CoV-2 genomic data to inform
   public health responses to COVID-19 in real time. Open source
   phylogenetic and data visualization platforms for monitoring SARS-CoV-2
   genomic epidemiology have rapidly gained popularity for their ability to
   illuminate spatial-temporal transmission patterns worldwide. However,
   the utility of such tools to inform public health decision-making for
   COVID-19 in real time remains to be explored. Objective: The aim of this
   study is to convene experts in public health, infectious diseases,
   virology, and bioinformatics-many of whom were actively engaged in the
   COVID-19 response-to discuss and report on the application of
   phylodynamic tools to inform pandemic responses.Methods: In total, 4
   focus groups (FGs) occurred between June 2020 and June 2021, covering
   both the pre-and postvariant strain emergence and vaccination eras of
   the ongoing COVID-19 crisis. Participants included national and
   international academic and government researchers, clinicians, public
   health practitioners, and other stakeholders recruited through purposive
   and convenience sampling by the study team. Open-ended questions were
   developed to prompt discussion. FGs I and II concentrated on
   phylodynamics for the public health practitioner, while FGs III and IV
   discussed the methodological nuances of phylodynamic inference. Two FGs
   per topic area to increase data saturation. An iterative, thematic
   qualitative framework was used for data analysis.Results: We invited 41
   experts to the FGs, and 23 (56\%) agreed to participate. Across all the
   FG sessions, 15 (65\%) of the participants were female, 17 (74\%) were
   White, and 5 (22\%) were Black. Participants were described as molecular
   epidemiologists (MEs; n=9, 39\%), clinician-researchers (n=3, 13\%),
   infectious disease experts (IDs; n=4, 17\%), and public health
   professionals at the local (PHs; n=4, 17\%), state (n=2, 9\%), and
   federal (n=1, 4\%) levels. They represented multiple countries in
   Europe, the United States, and the Caribbean. Nine major themes arose
   from the discussions: (1) translational/implementation science, (2)
   precision public health, (3) fundamental unknowns, (4) proper scientific
   communication, (5) methods of epidemiological investigation, (6)
   sampling bias, (7) interoperability standards, (8) academic/public
   health partnerships, and (9) resources. Collectively, participants felt
   that successful uptake of phylodynamic tools to inform the public health
   response relies on the strength of academic and public health
   partnerships. They called for interoperability standards in sequence
   data sharing, urged careful reporting to prevent misinterpretations,
   imagined that public health responses could be tailored to specific
   variants, and cited resource issues that would need to be addressed by
   policy makers in future outbreaks.Conclusions: This study is the first
   to detail the viewpoints of public health practitioners and molecular
   epidemiology experts on the use of viral genomic data to inform the
   response to the COVID-19 pandemic. The data gathered during this study
   provide important information from experts to help streamline the
   functionality and use of phylodynamic tools for pandemic responses.},
Type = {Article},
Affiliation = {Rich, SN (Corresponding Author), Univ Florida, Coll Publ Hlth \& Hlth Profess, Dept Epidemiol, 2004 Mowry Rd, Gainesville, FL 32610 USA.
   Rich, Shannan N.; Richards, Veronica; Rasmussen, Sonja A.; Fisk-Hoffman, Rebecca; Shapiro, Jerne; Prosperi, Mattia, Univ Florida, Coll Publ Hlth \& Hlth Profess, Dept Epidemiol, Gainesville, FL USA.
   Rich, Shannan N.; Richards, Veronica; Rasmussen, Sonja A.; Fisk-Hoffman, Rebecca; Shapiro, Jerne; Prosperi, Mattia, Univ Florida, Coll Med, Dept Epidemiol, Gainesville, FL USA.
   Mavian, Carla; Magalis, Brittany Rife; Salemi, Marco, Univ Florida, Coll Med, Dept Pathol Immunol \& Lab Med, Gainesville, FL USA.
   Grubaugh, Nathan, Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   Rasmussen, Sonja A., Univ Florida, Coll Med, Dept Pediat, Gainesville, FL USA.
   Dellicour, Simon; Vrancken, Bram, Univ Libre Bruxelles, Spatial Epidemiol Lab, Brussels, Belgium.
   Dellicour, Simon; Vrancken, Bram, Katholieke Univ Leuven, Rega Inst, Dept Microbiol Immunol \& Transplantat, Brussels, Belgium.
   Carrington, Christine, Univ West Indies, Dept Preclin Sci, St Augustine, Trinidad Tobago.
   Danso-Odei, Demi; Shapiro, Jerne, Florida Dept Hlth Alachua Cty, Gainesville, FL USA.
   Chacreton, Daniel, Florida Dept Hlth, Div Dis Control \& Hlth Protect, Tallahassee, FL USA.
   Seraphin, Marie Nancy; Lauzardo, Michael, Univ Florida, Coll Med, Dept Med, Div Infect Dis \& Global Med, Gainesville, FL USA.
   Hepp, Crystal, No Arizona Univ, Pathogen \& Microbiome Inst, Flagstaff, AZ USA.
   Hepp, Crystal, No Arizona Univ, Coll Engn Informat \& Appl Sci, Sch Informat Comp \& Cyber Syst, Flagstaff, AZ USA.
   Hepp, Crystal, Translat Genom Res Inst, Pathogen \& Microbiome Div, Flagstaff, AZ USA.
   Black, Allison, Chan Zuckerberg Initiat, Redwood City, CA USA.
   Dennis, Ann, Univ North Carolina Chapel Hill, Div Infect Dis, Chapel Hill, NC USA.
   Trovao, Nidia Sequeira, NIH, Fogarty Int Ctr, Div Int Epidemiol \& Populat Studies, Bethesda, MD USA.
   Vandamme, Anne-Mieke, Katholieke Univ Leuven, Rega Inst Med Res Clin \& Epidemiol Virol, Dept Microbiol Immunol \& Transplantat, Leuven, Belgium.
   Vandamme, Anne-Mieke, Univ Nova Lisboa, Ctr Global Hlth \& Trop Med, Inst Higiene \& Med Trop, Lisbon, Portugal.
   Rasmussen, Angela, Univ Saskatchewan, Vaccine \& Infect Dis Org, Saskatoon, SK, Canada.
   Dean, Natalie, Univ Florida, Coll Publ Hlth \& Hlth Profess, Dept Biostat, Gainesville, FL USA.
   Dean, Natalie, Univ Florida, Coll Med, Dept Biostat, Gainesville, FL USA.
   Rich, Shannan N., Univ Florida, Coll Publ Hlth \& Hlth Profess, Dept Epidemiol, 2004 Mowry Rd, Gainesville, FL 32610 USA.},
DOI = {10.2196/39409},
Keywords = {COVID-19; SARS-CoV-2; molecular epidemiology; genomic surveillance;
   variants; pandemic; phylogenetic; genomic; epidemiology; data; virology;
   bioinformatics; response; phylodynamic; monitoring; surveillance;
   transmission},
Keywords-Plus = {SARS-COV-2},
Research-Areas = {Health Care Sciences \& Services; Medical Informatics},
Web-of-Science-Categories  = {Health Care Sciences \& Services; Medical Informatics},
Author-Email = {shannanrich@ufl.edu},
Affiliations = {State University System of Florida; University of Florida; State
   University System of Florida; University of Florida; State University
   System of Florida; University of Florida; Yale University; State
   University System of Florida; University of Florida; Universite Libre de
   Bruxelles; KU Leuven; University West Indies Mona Jamaica; University
   West Indies Saint Augustine; Florida Department of Health; Florida
   Department of Health; State University System of Florida; University of
   Florida; Northern Arizona University; Northern Arizona University;
   Translational Genomics Research Institute; Chan Zuckerberg Initiative
   (CZI); University of North Carolina; University of North Carolina Chapel
   Hill; University of North Carolina School of Medicine; National
   Institutes of Health (NIH) - USA; NIH Fogarty International Center
   (FIC); KU Leuven; Universidade Nova de Lisboa; Institute of Hygiene \&
   Tropical Medicine - UNL; University of Saskatchewan; State University
   System of Florida; University of Florida; State University System of
   Florida; University of Florida; State University System of Florida;
   University of Florida},
Cited-References = {Andersen KG, 2020, NAT MED, V26, P450, DOI 10.1038/s41591-020-0820-9.
   {[}Anonymous], UFIT ZOOM.
   {[}Anonymous], 2021, CDC UPD SHORT REC IS.
   {[}Anonymous], CORONAVIRUS COVID 19.
   Barbour RS, 2001, BMJ-BRIT MED J, V322, P1115, DOI 10.1136/bmj.322.7294.1115.
   Bedford T, 2020, SCIENCE, V370, P571, DOI 10.1126/science.abc0523.
   Chen AT, 2021, ELIFE, V10, DOI 10.7554/eLife.63409.
   Connor T, 2020, SARS COV 2 GENOMIC I.
   Dearlove BL, 2017, VIRUS EVOL, V3, DOI 10.1093/ve/vex020.
   Flythe JE, 2018, AM J KIDNEY DIS, V72, P93, DOI 10.1053/j.ajkd.2017.10.011.
   Grubaugh ND, 2019, NAT MICROBIOL, V4, P10, DOI 10.1038/s41564-018-0296-2.
   Hadfield J, 2018, BIOINFORMATICS, V34, P4121, DOI 10.1093/bioinformatics/bty407.
   Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687.
   Hu T, 2021, BRIEF BIOINFORM, V22, P631, DOI 10.1093/bib/bbaa386.
   Huddleston J, 2020, ELIFE, V9, DOI 10.7554/eLife.60067.
   Hufsky F, 2021, BRIEF BIOINFORM, V22, P642, DOI 10.1093/bib/bbaa232.
   Jacob JJ, 2021, MBIO, V12, DOI 10.1128/mBio.01188-21.
   Kinganda-Lusamaki E, 2021, NAT MED, V27, DOI 10.1038/s41591-021-01302-z.
   Komissarov AB, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20880-z.
   Kraemer MUG, 2021, SCIENCE, V373, P889, DOI 10.1126/science.abj0113.
   Le Vu S, 2018, EPIDEMICS-NETH, V23, P1, DOI 10.1016/j.epidem.2017.10.001.
   Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520.
   Lu HZ, 2020, J MED VIROL, V92, P401, DOI {[}10.1002/jmv.2567, 10.1002/jmv.25678].
   Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8.
   Mack N. C., QUALITATIVE RES METH.
   Marini S, 2022, BIOINFORMATICS, V38, P856, DOI 10.1093/bioinformatics/btab725.
   Mavian C, 2020, P NATL ACAD SCI USA, V117, P12522, DOI 10.1073/pnas.2007295117.
   Nadeau SA, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2012008118.
   NVivo, QSR International Pty Ltd.
   Page Andrew J, 2021, Microb Genom, V7, DOI 10.1099/mgen.0.000589.
   Perrine CG, 2021, MMWR-MORBID MORTAL W, V70, P1731, DOI 10.15585/mmwr.mm7050e1.
   Petersen E, 2022, INT J INFECT DIS, V114, P268, DOI 10.1016/j.ijid.2021.11.040.
   Rasmussen SA, 2019, The CDC Field Epidemiology Manual, V1st.
   rev, FAST ACC TRANSCR SER.
   Scire J, 2020, VIROLOGICAL 0306.
   Shu YL, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.13.30494.
   Tan WJ, 2020, CHINA CDC WEEKLY, V2, P61.
   Tausch AP, 2016, GLOB QUALIT NURS RES, V3, DOI 10.1177/2333393616630466.
   Turakhia Y, 2021, NAT GENET, V53, P809, DOI 10.1038/s41588-021-00862-7.
   Volz EM, 2020, SYST BIOL, V69, P884, DOI 10.1093/sysbio/syaa009.
   Volz EM, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002552.
   Wolff B., 2019, The CDC Field Epidemiology Manual.},
Number-of-Cited-References = {42},
Times-Cited = {0},
Unique-ID = {WOS:000998490100026},
}

@article{ WOS:000577328800021,
Author = {Deshpande, Aniruddha and Miller-Petrie, Molly K. and Lindstedt, Paulina
   A. and Baumann, Mathew M. and Johnson, Kimberly B. and Blacker, Brigette
   F. and Abbastabar, Hedayat and Abd-Allah, Foad and Abdelalim, Ahmed and
   Abdollahpour, Ibrahim and Abegaz, Kedir Hussein and Abejie, Ayenew
   Negesse and Abreu, Lucas Guimaraes and Abrigo, Michael R. M. and
   Abualhasan, Ahmed and Accrombessi, Manfred Mario Kokou and Adamu, Abdu
   A. and Adebayo, Oladimeji M. and Adedeji, Isaac Akinkunmi and Adedoyin,
   Rufus Adesoji and Adekanmbi, Victor and Adetokunboh, Olatunji O. and
   Adhikari, Tara Ballav and Afarideh, Mohsen and Agudelo-Botero, Marcela
   and Ahmadi, Mehdi and Ahmadi, Keivan and Ahmed, Muktar Beshir and Ahmed,
   Anwar E. and Akalu, Temesgen Yihunie and Akanda, Ali S. and Alahdab,
   Fares and Al-Aly, Ziyad and Alam, Samiah and Alam, Noore and Alamene,
   Genet Melak and Alanzi, Turki M. and Albright, James and Albujeer, Ammar
   and Alcalde-Rabanal, Jacqueline Elizabeth and Alebel, Animut and Alemu,
   Zewdie Aderaw and Ali, Muhammad and Alijanzadeh, Mehran and Alipour,
   Vahid and Aljunid, Syed Mohamed and Almasi, Ali and Almasi-Hashiani,
   Amir and Al-Mekhlafi, Hesham M. and Altirkawi, Khalid A. and
   Alvis-Guzman, Nelson and Alvis-Zakzuk, Nelson J. and Amini, Saeed and
   Amit, Arianna Maever L. and Amul, Gianna Gayle Herrera and Andrei,
   Catalina Liliana and Anjomshoa, Mina and Ansariadi, Ansariadi and
   Antonio, Carl Abelardo T. and Antony, Benny and Antriyandarti, Ernoiz
   and Arabloo, Jalal and Aref, Hany Mohamed Amin and Aremu, Olatunde and
   Armoon, Bahram and Arora, Amit and Aryal, Krishna K. and Arzani, Afsaneh
   and Asadi-Aliabadi, Mehran and Asmelash, Daniel and Atalay, Hagos Tasew
   and Athari, Seyyede Masoume and Athari, Seyyed Shamsadin and Atre,
   Sachin R. and Ausloos, Marcel and Awasthi, Shally and Awoke, Nefsu and
   Quintanilla, Beatriz Paulina Ayala and Ayano, Getinet and Ayanore,
   Martin Amogre and Aynalem, Yared Asmare and Azari, Samad and Azman,
   Andrew S. and Babaee, Ebrahim and Badawi, Alaa and Bagherzadeh, Mojtaba
   and Bakkannavar, Shankar M. and Balakrishnan, Senthilkumar and Banach,
   Maciej and Banoub, Joseph Adel Mattar and Barac, Aleksandra and Barboza,
   Miguel A. and Barnighausen, Till Winfried and Basu, Sanjay and Vo Dinh
   Bay and Bayati, Mohsen and Bedi, Neeraj and Beheshti, Mahya and
   Behzadifar, Meysam and Behzadifar, Masoud and Ramirez, Diana Fernanda
   Bejarano and Bell, Michelle L. and Bennett, Derrick A. and Benzian,
   Habib and Berbada, Dessalegn Ajema and Bernstein, Robert S. and Bhat,
   Anusha Ganapati and Bhattacharyya, Krittika and Bhaumik, Soumyadeep and
   Bhutta, Zulfiqar A. and Bijani, Ali and Bikbov, Boris and Bin Sayeed,
   Muhammad Shahdaat and Biswas, Raaj Kishore and Bohlouli, Somayeh and
   Boufous, Soufiane and Brady, Oliver J. and Briko, Andrey Nikolaevich and
   Briko, Nikolay Ivanovich and Britton, Gabrielle B. and Brown, Alexandria
   and Nagaraja, Sharath Burugina and Butt, Zahid A. and Camera, Luis
   Alberto and Campos-Nonato, Ismael R. and Rincon, Julio Cesar Campuzano
   and Cano, Jorge and Car, Josip and Cardenas, Rosario and Carvalho, Felix
   and Castaneda-Orjuela, Carlos A. and Castro, Franz and Cerin, Ester and
   Chalise, Binaya and Chattu, Vijay Kumar and Chin, Ken Lee and
   Christopher, Devasahayam J. and Chu, Dinh-Toi and Cormier, Natalie Maria
   and Costa, Vera Marisa and Cromwell, Elizabeth A. and Dadi, Abel Fekadu
   Fekadu and Dahiru, Tukur and Dahlawi, Saad M. A. and Dandona, Rakhi and
   Dandona, Lalit and Dang, Anh Kim and Daoud, Farah and Darwesh, Aso
   Mohammad and Darwish, Amira Hamed and Daryani, Ahmad and Das, Jai K. and
   Das Gupta, Rajat and Dash, Aditya Prasad and Davila-Cervantes, Claudio
   Alberto and Weaver, Nicole Davis and De la Hoz, Fernando Pio and De
   Neve, Jan-Walter and Demissie, Dereje Bayissa and Demoz, Gebre
   Teklemariam and Denova-Gutierrez, Edgar and Deribe, Kebede and Desalew,
   Assefa and Dharmaratne, Samath Dhamminda and Dhillon, Preeti and Dhimal,
   Meghnath and Dhungana, Govinda Prasad and Diaz, Daniel and Dipeolu,
   Isaac Oluwafemi and Hoa Thi and Dolecek, Christiane and Doyle, Kerrie E.
   and Dubljanin, Eleonora and Duraes, Andre Rodrigues and Edinur, Hisham
   Atan and Effiong, Andem and Eftekhari, Aziz and El Nahas, Nevine and
   Zaki, Maysaa El Sayed and El Tantawi, Maha and Elhabashy, Hala Rashad
   and El-Jaafary, I, Shaimaa and El-Khatib, Ziad and Elkout, Hajer and
   Elsharkawy, Aisha and Enany, Shymaa and Endalew, Daniel Adane and
   Eshrati, Babak and Eskandarieh, Sharareh and Etemadi, Arash and
   Ezekannagha, Oluchi and Faraon, Emerito Jose A. and Fareed, Mohammad and
   Faro, Andre and Farzadfar, Farshad and Fasil, Alebachew Fasil and
   Fazlzadeh, Mehdi and Feigin, Valery L. and Fekadu, Wubalem and Fentahun,
   Netsanet and Fereshtehnejad, Seyed-Mohammad and Fernandes, Eduarda and
   Filip, Irina and Fischer, Florian and Flohr, Carsten and Foigt, Nataliya
   A. and Folayan, Morenike Oluwatoyin and Foroutan, Masoud and Franklin,
   Richard Charles and Frostad, Joseph Jon and Fukumoto, Takeshi and Gad,
   Mohamed M. and Garcia, Gregory M. and Gatotoh, Augustine Mwangi and
   Gayesa, Reta Tsegaye and Gebremedhin, Ketema Bizuwork and Geramo, Yilma
   Chisha Dea and Gesesew, Hailay Abrha and Gezae, Kebede Embaye and
   Ghashghaee, Ahmad and Sherbaf, Farzaneh Ghazi and Gill, Tiffany K. and
   Gill, Paramjit Singh and Ginindza, Themba G. and Girmay, Alem and Gizaw,
   Zemichael and Goodridge, Amador and Gopalani, Sameer Vali and Goulart,
   Barbara Niegia Garcia and Goulart, Alessandra C. and Grada, Ayman and
   Green, Manfred S. and Gubari, Mohammed Ibrahim Mohialdeen and Gugnani,
   Harish Chander and Guido, Davide and Guimaraes, Rafael Alves and Guo,
   Yuming and Gupta, Rajeev and Gupta, Rahul and Ha, Giang Hai and Haagsma,
   Juanita A. and Hafezi-Nejad, Nima and Haile, Dessalegn H. and Haile,
   Michael Tamene and Hall, Brian J. and Hamidi, Samer and Handiso,
   Demelash Woldeyohannes and Haririan, Hamidreza and Hariyani, Ninuk and
   Hasaballah, I, Ahmed and Hasan, Mehedi and Hasanzadeh, Amir and Hassen,
   Hamid Yimam and Hayelom, Desta Haftu and Hegazy, I, Mohamed and Heibati,
   Behzad and Heidari, Behnam and Hendrie, Delia and Henok, Andualem and
   Herteliu, Claudiu and Heydarpour, Fatemeh and de Hidru, Hagos Degefa and
   Hird, Thomas R. and Chi Linh Hoang and Hollerich, I, Gillian and Hoogar,
   Praveen and Hossain, Naznin and Hosseinzadeh, Mehdi and Househ, Mowafa
   and Hu, Guoqing and Humayun, Ayesha and Hussain, Syed Ather and Hussen,
   Mamusha Aman A. and Ibitoye, Segun Emmanuel and Ilesanmi, Olayinka
   Stephen and Ilic, Milena D. and Imani-Nasab, Mohammad Hasan and Iqbal,
   Usman and Irvani, Seyed Sina Naghibi and Islam, Sheikh Mohammed Shariful
   and Ivers, Rebecca Q. and Iwu, Chinwe Juliana and Jahanmehr, Nader and
   Jakovljevic, Mihajlo and Jalali, Amir and Jayatilleke, Achala Upendra
   and Jenabi, Ensiyeh and Jha, Ravi Prakash and Jha, Vivekanand and Ji,
   John S. and Jonas, Jost B. and Jozwiak, Jacek Jerzy and Kabir, Ali and
   Kabir, Zubair and Kanchan, Tanuj and Karch, Andre and Karki, Surendra
   and Kasaeian, Amir and Kasahun, Gebremicheal Gebreslassie and Kasaye,
   Habtamu Kebebe and Kassa, Gebrehiwot G. and Kassa, Getachew Mullu and
   Kayode, Gbenga A. and Kebede, Mihiretu M. and Keiyoro, Peter Njenga and
   Ketema, Daniel Bekele and Khader, Yousef Saleh and Khafaie, Morteza
   Abdullatif and Khalid, Nauman and Khalilov, Rovshan and Khan, Ejaz Ahmad
   and Khan, Junaid and Khan, Nuruzzaman and Khatab, Khaled and Khater,
   Mona M. and Khater, Amir M. and Khayamzadeh, Maryam and Khazaei,
   Mohammad and Khosravi, Mohammad Hossein and Khubchandani, Jagdish and
   Kiadaliri, Ali and Kim, Yun Jin and Kimokoti, Ruth W. and Kisa, Sezer
   and Kisa, Adnan and Kochhar, Sonali and Kolola, Tufa and Komaki,
   Hamidreza and Kosen, Soewarta and Koul, Parvaiz A. and Koyanagi, Ai and
   Krishan, Kewal and Defo, Barthelemy Kuate and Kugbey, Nuworza and Kumar,
   Pushpendra and Kumar, G. Anil and Kumar, Manasi and Kusuma, Dian and La
   Vecchia, Carlo and Lacey, Ben and Lal, Aparna and Lal, Dharmesh Kumar
   and Lam, Hilton and Lami, Faris Hasan and Lansingh, Van Charles and
   Lasrado, Savita and Lebedev, Georgy and Lee, Paul H. and LeGrand, Kate
   E. and Leili, Mostafa and Lenjebo, Tsegaye Lolaso and Leshargie, Cheru
   Tesema and Levine, Aubrey J. and Lewycka, Sonia and Li, Shanshan and
   Linn, Shai and Liu, Shiwei and Lopez, Jaifred Christian F. and Lopukhov,
   Platon D. and Abd El Razek, Muhammed Magdy and Prasad, D. R.
   Mahadeshwara and Mahasha, Phetole Walter and Mahotra, Narayan B. and
   Majeed, Azeem and Malekzadeh, Reza and Malta, Deborah Carvalho and
   Mamun, Abdullah A. and Manafi, Navid and Mansournia, Mohammad Ali and
   Mapoma, Chabila Christopher and Martinez, Gabriel and Martini, Santi and
   Martins-Melo, Francisco Rogerlandio and Mathur, Manu Raj and Mayala,
   Benjamin K. and Mazidi, Mohsen and McAlinden, Colm and Meharie, Birhanu
   Geta and Mehndiratta, Man Mohan and Nasab, Entezar Mehrabi and Mehta,
   Kala M. and Mekonnen, Teferi and Mekonnen, Tefera Chane and Meles,
   Gebrekiros Gebremichael and Meles, Hagazi Gebre and Memiah, Peter T. N.
   and Memish, Ziad A. and Mendoza, Walter and Menezes, Ritesh G. and
   Mereta, Seid Tiku and Meretoja, Tuomo J. and Mestrovic, Tomislav and
   Metekiya, Workua Mekonnen and Miazgowski, Bartosz and Miller, Ted R. and
   Mini, G. K. and Mirrakhimov, Erkin M. and Moazen, Babak and Mohajer,
   Bahram and Mohammad, Yousef and Mohammad, Dara K. and Mezerji, Naser
   Mohammad Gholi and Mohammadibakhsh, Roghayeh and Mohammed, Shafiu and
   Mohammed, Jemal Abdu and Mohammed, Hassen and Mohebi, Farnam and Mokdad,
   Ali H. and Moodley, Yoshan and Moradi, Masoud and Moradi, Ghobad and
   Moradi-Joo, Mohammad and Moraga, Paula and Morales, Linda and Mosapour,
   Abbas and Mosser, Jonathan F. and Mouodi, Simin and Mousavi, Seyyed
   Meysam and Mozaffor, Miliva and Munro, Sandra B. and Muriithi, Moses K.
   and Murray, Christopher J. L. and Musa, Kamarul Imran and Mustafa,
   Ghulam and Muthupandian, Saravanan and Naderi, Mehdi and Nagarajan,
   Ahamarshan Jayaraman and Naghavi, Mohsen and Naik, Gurudatta and Nangia,
   Vinay and Nascimento, Bruno Ramos and Nazari, Javad and Ndwandwe,
   Duduzile Edith and Negoi, Ionut and Netsere, Henok Biresaw and Ngunjiri,
   Josephine W. and Cuong Tat Nguyen and Huong Lan Thi Nguyen and Nguyen,
   QuynhAnh P. and Nigatu, Solomon Gedlu and Ningrum, Dina Nur Anggraini
   and Nnaji, Chukwudi A. and Nojomi, Marzieh and Norheim, Ole F. and
   Noubiap, Jean Jacques and Oancea, Bogdan and Ogbo, Felix Akpojene and
   Oh, In-Hwan and Olagunju, Andrew T. and Olusanya, Jacob Olusegun and
   Olusanya, Bolajoko Olubukunola and Onwujekwe, Obinna E. and
   Ortega-Altamirano, V, Doris and Osarenotor, Osayomwanbo and Osei, Frank
   B. and Owolabi, Mayowa O. and Mahesh, P. A. and Padubidri, Jagadish Rao
   and Pakhale, Smita and Pana, Adrian and Park, Eun-Kee and Patel, Sangram
   Kishor and Pathak, Ashish and Patle, Ajay and Paulos, Kebreab and
   Pepito, Veincent Christian Filipino and Perico, Norberto and Pervaiz,
   Aslam and Pescarini, Julia Moreira and Pesudovs, Konrad and Pham, Hai
   Quang and Pigott, David M. and Pilgrim, Thomas and Pirsaheb, Meghdad and
   Poljak, Mario and Pollock, Ian and Postma, Maarten J. and Pourmalek,
   Farshad and Pourshams, Akram and Prada, I, Sergio and Preotescu, Liliana
   and Quintana, Hedley and Rabiee, Navid and Rabiee, Mohammad and Radfar,
   Amir and Rafiei, Alireza and Rahim, Fakher and Rahimi, Siavash and
   Rahimi-Movaghar, Vafa and Rahman, Muhammad Aziz and Rahman, Mohammad
   Hifz Ur and Rajati, Fatemeh and Ranabhat, Chhabi Lal and Rao, Puja C.
   and Rasella, Davide and Rath, Goura Kishor and Rawaf, Salman and Rawal,
   Lal and Rawasia, Wasiq Faraz and Remuzzi, Giuseppe and Renjith, Vishnu
   and Renzaho, Andre M. N. and Resnikoff, Serge and Riahi, Seyed Mohammad
   and Ribeiro, Ana Isabel and Rickard, Jennifer and Roever, Leonardo and
   Ronfani, Luca and Rubagotti, Enrico and Rubino, Salvatore and Saad, Anas
   M. and Sabour, Siamak and Sadeghi, Ehsan and Moghaddam, Sahar Saeedi and
   Safari, Yahya and Sagar, Rajesh and Sahraian, Mohammad Ali and Sajadi,
   S. Mohammad and Salahshoor, Mohammad Reza and Salam, Nasir and Saleem,
   Ahsan and Salem, Hosni and Salem, Marwa Rashad and Salimi, Yahya and
   Salimzadeh, Hamideh and Samy, Abdallah M. and Sanabria, Juan and Santos,
   Itamar S. and Santric-Milicevic, Milena M. and Sao Jose, Bruno Piassi
   and Saraswathy, Sivan Yegnanarayana Iyer and Sarrafzadegan, Nizal and
   Sartorius, Benn and Sathian, Brijesh and Sathish, Thirunavukkarasu and
   Satpathy, Maheswar and Sawhney, Monika and Sayyah, Mehdi and Sbarra,
   Alyssa N. and Schaeffer, Lauren E. and Schwebel, David C. and Senbeta,
   Anbissa Muleta and Senthilkumaran, Subramanian and Sepanlou, Sadaf G.
   and Servan-Mori, Edson and Shafieesabet, Azadeh and Shaheen, Amira A.
   and Shahid, Izza and Shaikh, Masood Ali and Shalash, Ali S. and
   Shams-Beyranvand, Mehran and Shamsi, MohammadBagher and Shamsizadeh,
   Morteza and Shannawaz, Mohammed and Sharafi, Kiomars and Sharma, Rajesh
   and Sheikh, Aziz and Shetty, B. Suresh Kumar and Shiferaw, Wondimeneh
   Shibabaw and Shigematsu, Mika and Shin, Jae Il and Shiri, Rahman and
   Shirkoohi, Reza and Shivakumar, K. M. and Si, Si and Siabani, Soraya and
   Siddiqi, Tariq Jamal and Silva, Diego Augusto Santos and Singh, Virendra
   and Singh, Narinder Pal and Singh, Balbir Bagicha Singh and Singh,
   Jasvinder A. and Singh, Ambrish and Sinha, Dhirendra Narain and Sisay,
   Malede Mequanent and Skiadaresi, Eirini and Smith, David L. and Filho,
   Adauto Martins Soares and Sobhiyeh, Mohammad Reza and Sokhan, Anton and
   Soriano, Joan B. and Sorrie, Muluken Bekele and Soyiri, Ireneous N. and
   Spurlock, Emma Elizabeth and Sreeramareddy, Chandrashekhar T. and
   Sudaryanto, Agus and Sufiyan, Mu'awiyyah Babale and Suleria, Hafiz Ansar
   Rasul and Sykes, Bryan L. and Tabares-Seisdedos, Rafael and Tabuchi,
   Takahiro and Tadesse, Degena Bahrey and Tarigan, Ingan Ukur and Taye,
   Bineyam and Tefera, Yonatal Mesfin and Tehrani-Banihashemi, Arash and
   Tekelemedhin, Shishay Wahdey and Tekle, Merhawi Gebremedhin and Temsah,
   Mohamad-Hani and Tesfay, Berhe Etsay and Tesfay, Fisaha Haile and
   Tessema, Zemenu Tadesse and Thankappan, Kavumpurathu Raman and
   ThekkePurakkal, Akhil Soman and Thomas, Nihal and Thompson, Robert L.
   and Thomson, Alan J. and Topor-Madry, Roman and Tovani-Palone, Marcos
   Roberto and Traini, Eugenio and Bach Xuan Tran and Khanh Bao Tran and
   Ullah, Irfan and Unnikrishnan, Bhaskaran and Usman, Muhammad Shariq and
   Uthman, Olalekan A. and Uzochukwu, Benjamin S. Chudi and Valdez, Pascual
   R. and Varughese, Santosh and Veisani, Yousef and Violante, Francesco S.
   and Vollmer, Sebastian and Whawariat, Feleke Gebremeskel and Waheed,
   Yasir and Wallin, Mitchell Taylor and Wang, Yuan-Pang and Wang, Yafeng
   and Wangdi, Kinley and Weiss, Daniel J. and Weldesamuel, Girmay Teklay
   and Werkneh, Adhena Ayaliew and Westerman, Ronny and Wiangkham, Taweewat
   and Wiens, Kirsten E. and Wijeratne, Tissa and Wiysonge, Charles Shey
   and Wolde, Haileab Fekadu and Wondafrash, Dawit Zewdu and Wonde,
   Tewodros Eshete and Worku, Getasew Taddesse and Yadollahpour, Ali and
   Jabbari, Seyed Hossein Yahyazadeh and Yamada, Tomohide and Yaseri, Mehdi
   and Yatsuya, Hiroshi and Yeshaneh, Alex and Yilma, Mekdes Tigistu and
   Yip, Paul and Yisma, Engida and Yonemoto, Naohiro and Younis, Mustafa Z.
   and Yousof, Hebat-Allah Salah A. and Yu, Chuanhua and Yusefzadeh, Hasan
   and Zadey, Siddhesh and Moghadam, Telma Zahirian and Zaidi, Zoubida and
   Bin Zaman, Sojib and Zamani, Mohammad and Zandian, Hamed and Zar,
   Heather J. and Zerfu, Taddese Alemu and Zhang, Yunquan and Ziapour,
   Arash and Zodpey, Sanjay and Zuniga, Yves Miel H. and Hay, I, Simon and
   Reiner, Jr., Robert C.},
Title = {Mapping geographical inequalities in access to drinking water and
   sanitation facilities in low-income and middle-income countries, 2000-17},
Journal = {LANCET GLOBAL HEALTH},
Year = {2020},
Volume = {8},
Number = {9},
Pages = {E1162-E1185},
Month = {SEP},
Abstract = {Background Universal access to safe drinking water and sanitation
   facilities is an essential human right, recognised in the Sustainable
   Development Goals as crucial for preventing disease and improving human
   wellbeing. Comprehensive, high-resolution estimates are important to
   inform progress towards achieving this goal. We aimed to produce
   high-resolution geospatial estimates of access to drinking water and
   sanitation facilities.
   Methods We used a Bayesian geostatistical model and data from 600
   sources across more than 88 low-income and middle-income countries
   (LMICs) to estimate access to drinking water and sanitation facilities
   on continuous continent-wide surfaces from 2000 to 2017, and aggregated
   results to policy-relevant administrative units. We estimated mutually
   exclusive and collectively exhaustive subcategories of facilities for
   drinking water (piped water on or off premises, other improved
   facilities, unimproved, and surface water) and sanitation facilities
   (septic or sewer sanitation, other improved, unimproved, and open
   defecation) with use of ordinal regression. We also estimated the number
   of diarrhoeal deaths in children younger than 5 years attributed to
   unsafe facilities and estimated deaths that were averted by increased
   access to safe facilities in 2017, and analysed geographical inequality
   in access within LMICs.
   Findings Across LMICs, access to both piped water and improved water
   overall increased between 2000 and 2017, with progress varying
   spatially. For piped water, the safest water facility type, access
   increased from 40.0\% (95\% uncertainty interval {[}UI] 39.4-40.7) to
   50.3\% (50.0-50.5), but was lowest in sub-Saharan Africa, where access
   to piped water was mostly concentrated in urban centres. Access to both
   sewer or septic sanitation and improved sanitation overall also
   increased across all LMICs during the study period. For sewer or septic
   sanitation, access was 46.3\% (95\% UI 46.1-46.5) in 2017, compared with
   28.7\% (28.5-29.0) in 2000. Although some units improved access to the
   safest drinking water or sanitation facilities since 2000, a large
   absolute number of people continued to not have access in several units
   with high access to such facilities (>80\%) in 2017. More than 253 000
   people did not have access to sewer or septic sanitation facilities in
   the city of Harare, Zimbabwe, despite 88.6\% (95\% UI 87.2-89.7) access
   overall. Many units were able to transition from the least safe
   facilities in 2000 to safe facilities by 2017; for units in which
   populations primarily practised open defecation in 2000, 686 (95\% UI
   664-711) of the 1830 (1797-1863) units transitioned to the use of
   improved sanitation. Geographical disparities in access to improved
   water across units decreased in 76.1\% (95\% UI 71.6-80.7) of countries
   from 2000 to 2017, and in 53.9\% (50.6-59.6) of countries for access to
   improved sanitation, but remained evident subnationally in most
   countries in 2017.
   Interpretation Our estimates, combined with geospatial trends in
   diarrhoeal burden, identify where efforts to increase access to safe
   drinking water and sanitation facilities are most needed. By
   highlighting areas with successful approaches or in need of targeted
   interventions, our estimates can enable precision public health to
   effectively progress towards universal access to safe water and
   sanitation. Copyright (C) 2020 The Author(s). Published by Elsevier Ltd.},
Type = {Article},
Affiliation = {Reiner, RC (Corresponding Author), Univ Washington, Inst Hlth Metr \& Evaluat, Seattle, WA 98195 USA.
   Deshpande, Aniruddha; Miller-Petrie, Molly K.; Lindstedt, Paulina A.; Baumann, Mathew M.; Johnson, Kimberly B.; Blacker, Brigette F.; Albright, James; Brown, Alexandria; Cormier, Natalie Maria; Cromwell, Elizabeth A.; Dandona, Rakhi; Dandona, Lalit; Daoud, Farah; Weaver, Nicole Davis; Dharmaratne, Samath Dhamminda; Feigin, Valery L.; Frostad, Joseph Jon; Garcia, Gregory M.; Hollerich, Gillian, I; LeGrand, Kate E.; Levine, Aubrey J.; Mayala, Benjamin K.; Mokdad, Ali H.; Mosser, Jonathan F.; Munro, Sandra B.; Murray, Christopher J. L.; Naghavi, Mohsen; Nguyen, QuynhAnh P.; Pigott, David M.; Pollock, Ian; Rao, Puja C.; Sbarra, Alyssa N.; Schaeffer, Lauren E.; Smith, David L.; Spurlock, Emma Elizabeth; Thompson, Robert L.; Wiens, Kirsten E.; Hay, Simon, I; Reiner, Robert C., Jr., Univ Washington, Inst Hlth Metr \& Evaluat, Seattle, WA 98195 USA.
   Cromwell, Elizabeth A.; Dandona, Rakhi; Dharmaratne, Samath Dhamminda; Mokdad, Ali H.; Murray, Christopher J. L.; Naghavi, Mohsen; Pigott, David M.; Sartorius, Benn; Smith, David L.; Hay, Simon, I; Reiner, Robert C., Jr., Univ Washington, Sch Med, Dept Hlth Metr Sci, Seattle, WA 98195 USA.
   Kochhar, Sonali, Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.
   Abbastabar, Hedayat, Univ Tehran Med Sci, Adv Diagnost \& Intervent Radiol Res Ctr, Tehran, Iran.
   Afarideh, Mohsen; Heidari, Behnam, Univ Tehran Med Sci, Endocrinol \& Metab Res Ctr, Tehran, Iran.
   Eskandarieh, Sharareh; Sahraian, Mohammad Ali, Univ Tehran Med Sci, Multiple Sclerosis Res Ctr, Tehran, Iran.
   Farzadfar, Farshad; Mohajer, Bahram; Mohebi, Farnam; Moghaddam, Sahar Saeedi, Univ Tehran Med Sci, Noncommunicable Dis Res Ctr, Tehran, Iran.
   Fazlzadeh, Mehdi, Univ Tehran Med Sci, Dept Environm Hlth Engn, Tehran, Iran.
   Hafezi-Nejad, Nima, Univ Tehran Med Sci, Sch Med, Tehran, Iran.
   Hasanzadeh, Amir, Univ Tehran Med Sci, Dept Microbiol, Tehran, Iran.
   Kasaeian, Amir, Univ Tehran Med Sci, Hematol Oncol \& Stem Cell Transplantat Res Ctr, Tehran, Iran.
   Malekzadeh, Reza; Pourshams, Akram; Salimi, Yahya; Sepanlou, Sadaf G., Univ Tehran Med Sci, Digest Dis Res Inst, Tehran, Iran.
   Mansournia, Mohammad Ali; Yaseri, Mehdi, Univ Tehran Med Sci, Dept Epidemiol \& Biostat, Tehran, Iran.
   Nasab, Entezar Mehrabi, Univ Tehran Med Sci, Tehran Heart Ctr, Tehran, Iran.
   Mohebi, Farnam, Univ Tehran Med Sci, Natl Inst Hlth Res, Tehran, Iran.
   Mousavi, Seyyed Meysam, Univ Tehran Med Sci, Dept Hlth Policy Management \& Econ, Tehran, Iran.
   Rahim, Fakher, Univ Tehran Med Sci, Metabol \& Genom Res Ctr, Tehran, Iran.
   Rahimi-Movaghar, Vafa, Univ Tehran Med Sci, Sina Trauma \& Surg Res Ctr, Tehran, Iran.
   Shirkoohi, Reza, Univ Tehran Med Sci, Canc Res Inst, Tehran, Iran.
   Shirkoohi, Reza, Univ Tehran Med Sci, Canc Biol Res Ctr, Tehran, Iran.
   Abd-Allah, Foad; Abdelalim, Ahmed; Abualhasan, Ahmed; El-Jaafary, Shaimaa, I; Hegazy, Mohamed, I, Cairo Univ, Dept Neurol, Cairo, Egypt.
   Elhabashy, Hala Rashad, Cairo Univ, Neurophysiol Dept, Cairo, Egypt.
   Elsharkawy, Aisha, Cairo Univ, Endem Med \& Hepatogastroentrol Dept, Cairo, Egypt.
   Khater, Amir M., Cairo Univ, Dept Med Parasitol, Cairo, Egypt.
   Khater, Amir M., Cairo Univ, Natl \& Lepatol \& Trop Med Res Inst, Cairo, Egypt.
   Salem, Hosni, Cairo Univ, Urol Dept, Cairo, Egypt.
   Abdollahpour, Ibrahim, Isfahan Univ Med Sci, Neurosci Res Ctr, Esfahan, Iran.
   Sarrafzadegan, Nizal, Isfahan Univ Med Sci, Isfahan Cardiovasc Res Inst, Esfahan, Iran.
   Abegaz, Kedir Hussein, Near East Univ, Dept Biostat, Nicosia, Cyprus.
   Abegaz, Kedir Hussein, Madda Walabu Univ, Dept Biostat \& Hlth Informat, Bale Robe, Ethiopia.
   Alamene, Genet Melak, Madda Walabu Univ, Dept Publ Hlth, Bale Robe, Ethiopia.
   Alebel, Animut; Haile, Dessalegn H., Debre Markos Univ, Dept Nursing, Debre Markos, Ethiopia.
   Alemu, Zewdie Aderaw; Ketema, Daniel Bekele; Wonde, Tewodros Eshete, Debre Markos Univ, Dept Publ Hlth, Debre Markos, Ethiopia.
   Kassa, Getachew Mullu, Debre Markos Univ, Coll Hlth Sci, Debre Markos, Ethiopia.
   Abreu, Lucas Guimaraes, Univ Fed Minas Gerais, Dept Pediat Dent, Belo Horizonte, MG, Brazil.
   Malta, Deborah Carvalho, Univ Fed Minas Gerais, Dept Maternal \& Child Nursing \& Publ Hlth, Belo Horizonte, MG, Brazil.
   Nascimento, Bruno Ramos, Univ Fed Minas Gerais, Dept Clin Med, Belo Horizonte, MG, Brazil.
   Nascimento, Bruno Ramos, Univ Fed Minas Gerais, Clin Hosp, Belo Horizonte, MG, Brazil.
   Sao Jose, Bruno Piassi, Univ Fed Minas Gerais, Dept Infect Dis \& Trop Med, Belo Horizonte, MG, Brazil.
   Abrigo, Michael R. M., Philippine Inst Dev Studies, Dept Res, Quezon City, Philippines.
   Accrombessi, Manfred Mario Kokou; Cano, Jorge, London Sch Hyg \& Trop Med, Dept Dis Control, London, England.
   Brady, Oliver J., London Sch Hyg \& Trop Med, Dept Infect Dis Epidemiol, London, England.
   Sartorius, Benn, London Sch Hyg \& Trop Med, Fac Infect \& Trop Dis, London, England.
   Accrombessi, Manfred Mario Kokou, Fdn Sci Res FORS, Clin Res \& Operat, Cotonou, Benin.
   Adamu, Abdu A.; Adetokunboh, Olatunji O.; Iwu, Chinwe Juliana, Stellenbosch Univ, Dept Global Hlth, Cape Town, South Africa.
   Mahasha, Phetole Walter, South African Med Res Council, Grants Innovat \& Prod Dev Unit, Cape Town, South Africa.
   Iwu, Chinwe Juliana; Nnaji, Chukwudi A.; Wiysonge, Charles Shey, South African Med Res Council, Cape Town, South Africa.
   Adebayo, Oladimeji M., Univ Coll Hosp, Coll Med, Ibadan, Nigeria.
   Ilesanmi, Olayinka Stephen, Univ Coll Hosp, Dept Community Med, Ibadan, Nigeria.
   Owolabi, Mayowa O., Univ Coll Hosp, Dept Med, Ibadan, Nigeria.
   Adedeji, Isaac Akinkunmi, Olabisi Ona Banjo Univ, Dept Sociol, Ago Iwoye, Nigeria.
   Adedoyin, Rufus Adesoji, Obafemi Awolowo Univ, Dept Med Rehabil, Ife, Nigeria.
   Folayan, Morenike Oluwatoyin, Obafemi Awolowo Univ, Dept Child Dent Hlth, Ife, Nigeria.
   Adekanmbi, Victor, Kings Coll London, Populat Hlth Sci, London, England.
   Adetokunboh, Olatunji O., Stellenbosch Univ, Ctr Excellence Epidemiol Modelling \& Anal, Stellenbosch, South Africa.
   Adhikari, Tara Ballav, Aarhus Univ, Dept Publ Hlth, Aarhus, Denmark.
   Adhikari, Tara Ballav, Univ Southern Denmark, Nepal Hlth Frontiers, Kathmandu, Nepal.
   Afarideh, Mohsen, Mayo Clin, Dept Dermatol, Rochester, MN USA.
   Agudelo-Botero, Marcela, Univ Nacl Autonoma Mexico, Ctr Policy Populat \& Hlth Res, Mexico City, DF, Mexico.
   Diaz, Daniel, Univ Nacl Autonoma Mexico, Ctr Complex Sci, Mexico City, DF, Mexico.
   Ahmadi, Mehdi, Ahvaz Jundishapur Univ Med Sci, Environm Technol Res Ctr, Ahvaz, Iran.
   Ahmadi, Mehdi, Ahvaz Jundishapur Univ Med Sci, Environm Hlth Engn, Ahvaz, Iran.
   Khafaie, Morteza Abdullatif, Ahvaz Jundishapur Univ Med Sci, Social Determinants Hlth Res Ctr, Ahvaz, Iran.
   Rahim, Fakher, Ahvaz Jundishapur Univ Med Sci, Thalassemia \& Hemoglobinopathy Res Ctr, Ahvaz, Iran.
   Sayyah, Mehdi, Ahvaz Jundishapur Univ Med Sci, Educ Dev Ctr, Ahvaz, Iran.
   Yadollahpour, Ali, Ahvaz Jundishapur Univ Med Sci, Med Phys Dept, Ahvaz, Iran.
   Ahmadi, Keivan, Univ Nottingham, Lincoln Med Sch, Lincoln, England.
   Ahmed, Anwar E., Univ Gezira, Econ \& Rural Dev Dept, Wad Madani, Sudan.
   Mereta, Seid Tiku, Jimma Univ, Dept Epidemiol, Jimma, Ethiopia.
   Hussen, Mamusha Aman A., Jimma Univ, Dept Hlth Behav \& Soc, Jimma, Ethiopia.
   Mereta, Seid Tiku, Jimma Univ, Dept Environm Hlth Sci \& Technol, Jimma, Ethiopia.
   Ahmed, Muktar Beshir, Univ South Australia, Australian Ctr Precis Hlth, Adelaide, SA, Australia.
   Akalu, Temesgen Yihunie; Nigatu, Solomon Gedlu; Sisay, Malede Mequanent; Tessema, Zemenu Tadesse; Wolde, Haileab Fekadu, Univ Gondar, Dept Epidemiol \& Biostat, Gondar, Ethiopia.
   Asmelash, Daniel; Fasil, Alebachew Fasil, Univ Gondar, Dept Clin Chem, Gondar, Ethiopia.
   Dadi, Abel Fekadu Fekadu; Gizaw, Zemichael, Univ Gondar, Inst Publ Hlth, Gondar, Ethiopia.
   Netsere, Henok Biresaw, Univ Gondar, Sch Nursing, Gondar, Ethiopia.
   Akanda, Ali S., Univ Rhode Isl, Dept Civil \& Environm Engn, Kingston, RI USA.
   Alahdab, Fares, Mayo Clin Fdn Med Educ \& Res, Evidence Based Practice Ctr, Rochester, MN USA.
   Al-Aly, Ziyad, Washington Univ St Louis, John T Milliken Dept Internal Med, St Louis, MO USA.
   Al-Aly, Ziyad, Dept Vet Affairs, Clin Epidemiol Ctr, St Louis, MO USA.
   Alam, Noore, Queensland Hlth, Prevent Div, Brisbane, Qld, Australia.
   Alam, Noore, Griffith Univ, Ctr Environm \& Populat Hlth, Nathan, Qld, Australia.
   Alam, Samiah, Dalhousie Univ, Community Hlth \& Epidemiol, Halifax, NS, Canada.
   Alanzi, Turki M., Imam Abdulrahman Bin Faisal Univ, Hlth Informat Management \& Technol Dept, Dammam, Saudi Arabia.
   Dahlawi, Saad M. A., Imam Abdulrahman Bin Faisal Univ, Environm Hlth Dept, Dammam, Saudi Arabia.
   Menezes, Ritesh G., Imam Abdulrahman Bin Faisal Univ, Forens Med Div, Dammam, Saudi Arabia.
   Albujeer, Ammar, Naba Hayat Fdn Med Sci \& Hlth Care, Najaf, Iraq.
   Alcalde-Rabanal, Jacqueline Elizabeth; Servan-Mori, Edson, Natl Inst Publ Hlth, Ctr Hlth Syst Res, Cuernavaca, Morelos, Mexico.
   Campos-Nonato, Ismael R., Natl Inst Publ Hlth, Hlth \& Nutr Res Ctr, Cuernavaca, Morelos, Mexico.
   Denova-Gutierrez, Edgar, Natl Inst Publ Hlth, Ctr Nutr \& Hlth Res, Cuernavaca, Morelos, Mexico.
   Morales, Linda, Natl Inst Publ Hlth, Ctr Populat Hlth Res, Cuernavaca, Morelos, Mexico.
   Ortega-Altamirano, Doris, V, Natl Inst Publ Hlth, Hlth Syst Res Ctr, Cuernavaca, Morelos, Mexico.
   Alebel, Animut, Univ Technol Sydney, Sch Publ Hlth, Sydney, NSW, Australia.
   Siabani, Soraya, Univ Technol Sydney, Sch Hlth, Sydney, NSW, Australia.
   Ali, Muhammad, Quaid I Azam Univ, Dept Biotechnol, Islamabad, Pakistan.
   Alijanzadeh, Mehran, Qazvin Univ Med Sci, Social Determinants Hlth Res Ctr, Qazvin, Iran.
   Alipour, Vahid, Iran Univ Med Sci, Hlth Management \& Econ Res Ctr, Tehran, Iran.
   Alipour, Vahid, Iran Univ Med Sci, Hlth Econ Dept, Tehran, Iran.
   Asadi-Aliabadi, Mehran; Babaee, Ebrahim, Iran Univ Med Sci, Prevent Med \& Publ Hlth Res Ctr, Tehran, Iran.
   Ghashghaee, Ahmad, Iran Univ Med Sci, Student Res Comm, Tehran, Iran.
   Kabir, Ali, Iran Univ Med Sci, Minimally Invas Surg Res Ctr, Tehran, Iran.
   Kasaeian, Amir, Iran Univ Med Sci, Pars Adv \& Minimally Invas Med Manners Res Ctr, Tehran, Iran.
   Khosravi, Mohammad Hossein, Iran Univ Med Sci, Dept Neurosurg, Tehran, Iran.
   Manafi, Navid, Iran Univ Med Sci, Sch Med, Tehran, Iran.
   Nojomi, Marzieh; Tehrani-Banihashemi, Arash, Iran Univ Med Sci, Dept Community \& Family Med, Tehran, Iran.
   Aljunid, Syed Mohamed, Kuwait Univ, Dept Hlth Policy \& Management, Kuwait, Kuwait.
   Aljunid, Syed Mohamed, Natl Univ Malaysia, Int Ctr Casemix \& Clin Coding, Bandar Tun Razak, Malaysia.
   Almasi, Ali, Kermanshah Univ Med Sci, Dept Environm Hlth Engn, Kermanshah, Iran.
   Heydarpour, Fatemeh, Kermanshah Univ Med Sci, Med Biol Res Ctr, Kermanshah, Iran.
   Jalali, Amir, Kermanshah Univ Med Sci, Hlth Inst, Kermanshah, Iran.
   Jalali, Amir, Kermanshah Univ Med Sci, Subst Abuse Prevent Res Ctr, Kermanshah, Iran.
   Moradi, Masoud; Pirsaheb, Meghdad; Rajati, Fatemeh, Kermanshah Univ Med Sci, Res Ctr Environm Determinants Hlth, Kermanshah, Iran.
   Naderi, Mehdi, Kermanshah Univ Med Sci, Clin Res Dev Ctr, Kermanshah, Iran.
   Salahshoor, Mohammad Reza, Kermanshah Univ Med Sci, Dept Anat Sci, Kermanshah, Iran.
   Salimi, Yahya, Kermanshah Univ Med Sci, Social Dev \& Hlth Promot Res Ctr, Kermanshah, Iran.
   Salimi, Yahya, Kermanshah Univ Med Sci, Dept Epidemiol \& Biostat, Kermanshah, Iran.
   Shamsi, MohammadBagher, Kermanshah Univ Med Sci, Dept Sports Med \& Rehabil, Kermanshah, Iran.
   Siabani, Soraya; Ziapour, Arash, Kermanshah Univ Med Sci, Dept Hlth Educ \& Hlth Promot, Kermanshah, Iran.
   Sobhiyeh, Mohammad Reza, Kermanshah Univ Med Sci, Dept Vasc \& Endovasc Surg, Kermanshah, Iran.
   Almasi-Hashiani, Amir, Arak Univ Med Sci, Dept Epidemiol, Arak, Iran.
   Amini, Saeed, Arak Univ Med Sci, Hlth Serv Management Dept, Arak, Iran.
   Nazari, Javad, Arak Univ Med Sci, Dept Pediat, Arak, Iran.
   Al-Mekhlafi, Hesham M., Jazan Univ, Med Res Ctr, Jazan, Saudi Arabia.
   Al-Mekhlafi, Hesham M., Sanaa Univ, Dept Parasitol, Sanaa, Yemen.
   Altirkawi, Khalid A.; Temsah, Mohamad-Hani, King Saud Univ, Pediat Intens Care Unit, Riyadh, Saudi Arabia.
   Mohammad, Yousef, King Saud Univ, Internal Med Dept, Riyadh, Saudi Arabia.
   Alvis-Guzman, Nelson, Univ Cartagena, Res Grp Hlth Econ, Cartagena, Colombia.
   Alvis-Guzman, Nelson, Univ Coast, Res Grp Hosp Management \& Hlth Policies, Barranquilla, Colombia.
   Alvis-Zakzuk, Nelson J., Univ Coast, Dept Econ Sci, Barranquilla, Colombia.
   Alvis-Zakzuk, Nelson J., NIH, Natl Hlth Observ, Bogota, Colombia.
   Castaneda-Orjuela, Carlos A., NIH, Colombian Natl Hlth Observ, Bogota, Colombia.
   Amit, Arianna Maever L., Univ Philippines Manila, Dept Epidemiol \& Biostat, Manila, Philippines.
   Antonio, Carl Abelardo T.; Faraon, Emerito Jose A., Univ Philippines Manila, Dept Hlth Policy \& Adm, Manila, Philippines.
   Lopez, Jaifred Christian F., Univ Philippines Manila, Dept Nutr, Manila, Philippines.
   Amit, Arianna Maever L., Johns Hopkins Univ, Sch Publ Hlth, Baltimore, MD USA.
   Atre, Sachin R., Johns Hopkins Univ, Ctr Clin Global Hlth Educ, Baltimore, MD USA.
   Azman, Andrew S., Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA.
   Sherbaf, Farzaneh Ghazi, Johns Hopkins Univ, Neuroradiol Div, Baltimore, MD USA.
   Hafezi-Nejad, Nima, Johns Hopkins Univ, Dept Radiol \& Radiol Sci, Baltimore, MD USA.
   Amul, Gianna Gayle Herrera, Natl Univ Singapore, Lee Kuan Yew Sch Publ Policy, Singapore, Singapore.
   Andrei, Catalina Liliana, Carol Davila Univ Med \& Pharm, Cardiol Dept, Bucharest, Romania.
   Negoi, Ionut, Carol Davila Univ Med \& Pharm, Dept Gen Surg, Bucharest, Romania.
   Preotescu, Liliana, Carol Davila Univ Med \& Pharm, Dept Infect Dis, Bucharest, Romania.
   Anjomshoa, Mina, Rafsanjan Univ Med Sci, Social Determinants Hlth Res Ctr, Rafsanjan, Iran.
   Ansariadi, Ansariadi, Hasanuddin Univ, Sch Publ Hlth, Makassar, Indonesia.
   Antonio, Carl Abelardo T., Hong Kong Polytech Univ, Dept Appl Social Sci, Hong Kong, Peoples R China.
   Lee, Paul H., Hong Kong Polytech Univ, Sch Nursing, Hong Kong, Peoples R China.
   Antony, Benny; Singh, Ambrish, Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia.
   Antriyandarti, Ernoiz, Sebelas Maret Univ, Agribusiness Study Program, Surakarta, Indonesia.
   Aref, Hany Mohamed Amin; El Nahas, Nevine; Shalash, Ali S., Ain Shams Univ, Neurol Dept, Cairo, Egypt.
   Samy, Abdallah M., Ain Shams Univ, Dept Entomol, Cairo, Egypt.
   Aremu, Olatunde, Birmingham City Univ, Dept Publ Hlth, Birmingham, W Midlands, England.
   Armoon, Bahram, Saveh Univ Med Sci, Social Determinants Hlth Res Ctr, Saveh, Iran.
   Armoon, Bahram, Yasuj Univ Med Sci, Social Determinants Hlth Res Ctr, Yasuj, Iran.
   Arora, Amit, Western Sydney Univ, Sch Hlth Sci, Campbelltown, NSW, Australia.
   Arora, Amit, Univ Sydney, Disciple Child \& Adolescent Hlth, Westmead, NSW, Australia.
   Aryal, Krishna K., Abt Associates Nepal, Monitoring Evaluat \& Operat Res Project, Lalitpur, Nepal.
   Arzani, Afsaneh, Babol Univ Med Sci, Sch Nursing \& Midwifery, Babol, Iran.
   Bijani, Ali; Mouodi, Simin, Babol Univ Med Sci, Social Determinants Hlth Res Ctr, Babol, Iran.
   Mosapour, Abbas, Babol Univ Med Sci, Dept Clin Biochem, Babol, Iran.
   Zamani, Mohammad, Babol Univ Med Sci, Student Res Comm, Babol, Iran.
   Atalay, Hagos Tasew; Girmay, Alem; Tadesse, Degena Bahrey; Weldesamuel, Girmay Teklay, Aksum Univ, Dept Nursing, Aksum, Ethiopia.
   Demoz, Gebre Teklemariam; Kasahun, Gebremicheal Gebreslassie, Aksum Univ, Sch Pharm, Aksum, Ethiopia.
   Kassa, Gebrehiwot G., Aksum Univ, Dept Biomed Sci, Aksum, Ethiopia.
   Athari, Seyyede Masoume; Athari, Seyyed Shamsadin, Zanjan Univ Med Sci, Dept Immunol, Zanjan, Iran.
   Athari, Seyyede Masoume; Athari, Seyyed Shamsadin, Maragheh Univ Med Sci, Dept Biol, Maragheh, Iran.
   Eftekhari, Aziz, Maragheh Univ Med Sci, Dept Pharmacol \& Toxicol, Maragheh, Iran.
   Hasanzadeh, Amir, Maragheh Univ Med Sci, Dept Microbiol, Maragheh, Iran.
   Atre, Sachin R., Dr DY Patil Vidyapeeth, Dr DY Patil Med Coll Hosp \& Res Ctr, Pune, Maharashtra, India.
   Ausloos, Marcel, Univ Leicester, Sch Business, Leicester, Leics, England.
   Ausloos, Marcel; Herteliu, Claudiu; Pana, Adrian, Bucharest Univ Econ Studies, Dept Stat \& Econometr, Bucharest, Romania.
   Awasthi, Shally, King Georges Med Univ, Lucknow, Uttar Pradesh, India.
   Awoke, Nefsu, Wolaita Sodo Univ, Dept Nursing, Wolaita Sodo, Ethiopia.
   Lenjebo, Tsegaye Lolaso, Wolaita Sodo Univ, Sch Publ Hlth, Wolaita Sodo, Ethiopia.
   Paulos, Kebreab, Wolaita Sodo Univ, Dept Midwifery, Wolaita Sodo, Ethiopia.
   Quintanilla, Beatriz Paulina Ayala, La Trobe Univ, Judith Lumley Ctr, Melbourne, Vic, Australia.
   Ayano, Getinet; Hendrie, Delia; Miller, Ted R., La Trobe Univ, Sch Nursing \& Midwifery, Melbourne, Vic, Australia.
   Ayano, Getinet; Hendrie, Delia, Curtin Univ, Sch Publ Hlth, Perth, WA, Australia.
   Ayanore, Martin Amogre, Univ Hlth \& Allied Sci, Dept Hlth Policy Planning \& Management, Ho, Ghana.
   Kugbey, Nuworza, Univ Hlth \& Allied Sci, Dept Family \& Community Hlth, Ho, Ghana.
   Aynalem, Yared Asmare; Shiferaw, Wondimeneh Shibabaw, Debre Berhan Univ, Dept Nursing, Debre Berhan, Ethiopia.
   Badawi, Alaa, Publ Hlth Agcy Canada, Publ Hlth Risk Sci Div, Toronto, ON, Canada.
   Badawi, Alaa, Univ Toronto, Dept Nutr Sci, Toronto, ON, Canada.
   Bhutta, Zulfiqar A., Univ Toronto, Ctr Global Child Hlth, Toronto, ON, Canada.
   Chattu, Vijay Kumar, Univ Toronto, Dept Med, Toronto, ON, Canada.
   Bagherzadeh, Mojtaba; Rabiee, Navid, Sharif Univ Technol, Dept Chem, Tehran, Iran.
   Bakkannavar, Shankar M., Manipal Acad Higher Educ, Dept Forens Med \& Toxicol, Manipal, Karnataka, India.
   Hoogar, Praveen, Manipal Acad Higher Educ, Ctr Biocultural Studies CBiCS, Manipal, Karnataka, India.
   Jha, Vivekanand, Manipal Acad Higher Educ, Manipal, Karnataka, India.
   Balakrishnan, Senthilkumar, Haramaya Univ, Dept Med Microbiol, Harar, Ethiopia.
   Desalew, Assefa, Haramaya Univ, Sch Nursing \& Midwifery, Harare, Zimbabwe.
   Tekle, Merhawi Gebremedhin, Haramaya Univ, Sch Publ Hlth, Harar, Ethiopia.
   Banach, Maciej, Med Univ Lodz, Dept Hypertens, Lodz, Poland.
   Banach, Maciej, Polish Mothers Mem Hosp Res Inst, Lodz, Poland.
   Banoub, Joseph Adel Mattar, Univ London, Dept Internal Med, London, England.
   Banoub, Joseph Adel Mattar, Alexandria Univ, Dept Gen Med, Alexandria, Egypt.
   El Tantawi, Maha, Alexandria Univ, Pediat Dent \& Dent Publ Hlth Dept, Alexandria, Egypt.
   Barac, Aleksandra, Clin Ctr Serbia, Clin Infect \& Trop Dis, Belgrade, Serbia.
   Barac, Aleksandra; Santric-Milicevic, Milena M., Univ Belgrade, Fac Med, Belgrade, Serbia.
   Dubljanin, Eleonora, Univ Belgrade, Inst Microbiol \& Immunol, Belgrade, Serbia.
   Santric-Milicevic, Milena M., Univ Belgrade, Sch Publ Hlth \& Hlth Management, Belgrade, Serbia.
   Barboza, Miguel A.; Behzadifar, Masoud, Costa Rican Dept Social Secur, Dept Neurosci, San Jose, Costa Rica.
   Barboza, Miguel A.; Behzadifar, Masoud, Univ Costa Rica, Sch Med, San Pedro, Costa Rica.
   Barnighausen, Till Winfried; De Neve, Jan-Walter; Moazen, Babak; Mohammed, Shafiu, Heidelberg Univ, Heidelberg Inst Global Hlth HIGH, Heidelberg, Germany.
   Barnighausen, Till Winfried, Harvard Univ, TH Chan Sch Publ Hlth, Boston, MA USA.
   Basu, Sanjay, Harvard Univ, Ctr Primary Care, Boston, MA USA.
   Norheim, Ole F., Harvard Univ, Dept Global Hlth \& Populat, Boston, MA USA.
   Sheikh, Aziz, Harvard Univ, Div Gen Internal Med, Boston, MA USA.
   Basu, Sanjay, Imperial Coll London, Sch Publ \& Lealth, London, England.
   Car, Josip; Majeed, Azeem; Rawaf, Salman, Imperial Coll London, Dept Primary Care \& Publ Hlth, London, England.
   Kusuma, Dian, Imperial Coll London, Imperial Coll Business Sch, London, England.
   Vo Dinh Bay, Ho Chi Minh City Univ Technol HUTECH, Fac Informat Technol, Ho Chi Minh City, Vietnam.
   Bayati, Mohsen, Shiraz Univ Med Sci, Hlth Human Resources Res Ctr, Shiraz, Iran.
   Malekzadeh, Reza; Sepanlou, Sadaf G., Shiraz Univ Med Sci, Noncommunicable Dis Res Ctr, Shiraz, Iran.
   Bedi, Neeraj, Gandhi Med Coll Bhopal, Dept Community Med, Bhopal, India.
   Beheshti, Mahya, NYU, Dept Phys Med \& Rehabil, New York, NY USA.
   Benzian, Habib, NYU, Dept Epidemiol \& Hlth Promot, New York, NY USA.
   Behzadifar, Meysam, Lorestan Univ Med Sci, Dept Epidemiol \& Biostat, Khorramabad, Iran.
   Behzadifar, Meysam, Lorestan Univ Med Sci, Social Determinants Hlth Res Ctr, Khorramabad, Iran.
   Imani-Nasab, Mohammad Hasan, Lorestan Univ Med Sci, Dept Publ Hlth, Khorramabad, Iran.
   Ramirez, Diana Fernanda Bejarano, El Bosque Univ, Dept Med, Bogota, Colombia.
   Ramirez, Diana Fernanda Bejarano, Univ Hosp Fdn Santa Fe Bogota, Transplant Serv, Bogota, Colombia.
   Bell, Michelle L., Yale Univ, Sch Environm, New Haven, CT USA.
   Bennett, Derrick A.; Lacey, Ben, Univ Oxford, Nuffield Dept Populat Hlth, Oxford, England.
   Dolecek, Christiane; Lewycka, Sonia, Univ Oxford, Ctr Trop Med \& Global Hlth, Oxford, England.
   Weiss, Daniel J., Univ Oxford, Malaria Atlas Project, Oxford, England.
   Berbada, Dessalegn Ajema; Geramo, Yilma Chisha Dea; Hayelom, Desta Haftu; Sorrie, Muluken Bekele; Whawariat, Feleke Gebremeskel, Arba Minch Univ, Dept Publ Hlth, Arba Minch, Ethiopia.
   Worku, Getasew Taddesse, Arba Minch Univ, Fac Business \& Econ, Arba Minch, Ethiopia.
   Bernstein, Robert S., Emory Univ, Hubert Dept Global Hlth, Atlanta, GA USA.
   Bhat, Anusha Ganapati, Univ Massachusetts, Div Gen Internal Med, Sch Med, Springfield, MA USA.
   Bhattacharyya, Krittika, Natl Inst Biomed Genom, Dept Stat \& Computat Genom, Kalyani, W Bengal, India.
   Bhattacharyya, Krittika, Univ Calcutta, Dept Stat, Kolkata, India.
   Bhaumik, Soumyadeep, George Inst Global Hlth, Injury Div, New Delhi, India.
   Jha, Vivekanand, George Inst Global Hlth, New Delhi, India.
   Bhaumik, Soumyadeep, Univ New South Wales, George Inst Global Hlth, Sydney, NSW, Australia.
   Biswas, Raaj Kishore; Boufous, Soufiane, Univ New South Wales, Transport \& Rd Safety TARS Res Ctr, Sydney, NSW, Australia.
   Karki, Surendra, Univ New South Wales, Sch Publ Hlth \& Community Med, Sydney, NSW, Australia.
   Pesudovs, Konrad; Resnikoff, Serge, Univ New South Wales, Sch Optometry \& Vis Sci, Sydney, NSW, Australia.
   Bhutta, Zulfiqar A., Aga Khan Univ, Ctr Excellence Women \& Child \& Hlth, Karachi, Pakistan.
   Das, Jai K., Aga Khan Univ, Div Women \& Child Hlth, Karachi, Pakistan.
   Bikbov, Boris, Mario Negri Inst Pharmacol Res, Ranica, Italy.
   Bin Sayeed, Muhammad Shahdaat; Lal, Aparna, Australian Natl Univ, Natl Ctr Epidemiol \& Populat Hlth, Canberra, ACT, Australia.
   Wangdi, Kinley, Australian Natl Univ, Res Sch Populat Hlth, Canberra, ACT, Australia.
   Bin Sayeed, Muhammad Shahdaat, Univ Dhaka, Dept Clin Pharm \& Pharmacol, Dhaka, Bangladesh.
   Bohlouli, Somayeh, Islamic Azad Univ, Dept Vet Med, Kermanshah, Iran.
   Briko, Andrey Nikolaevich, Bauman Moscow State Tech Univ, Dept Biomed Technol, Moscow, Russia.
   Briko, Nikolay Ivanovich; Lopukhov, Platon D., IM Sechenov First Moscow State Med Univ, Dept Epidemiol \& Evidence Based Med, Moscow, Russia.
   Jakovljevic, Mihajlo, IM Sechenov First Moscow State Med Univ, NA Semashko Dept Publ Hlth \& Healthcare, Moscow, Russia.
   Lebedev, Georgy, IM Sechenov First Moscow State Med Univ, Dept Informat \& Internet Technol, Moscow, Russia.
   Britton, Gabrielle B., Inst Sci Res \& High Technol Serv, Neurosci Unit, Panama City, Panama.
   Britton, Gabrielle B.; Castro, Franz; Quintana, Hedley, Gorgas Mem Inst Hlth Studies, Panama City, Panama.
   Nagaraja, Sharath Burugina, Employee State Insurance Post Grad Inst Med Sci \&, Dept Community Med, Bangalore, Karnataka, India.
   Butt, Zahid A., Univ Waterloo, Sch Publ Hlth \& Hlth Syst, Waterloo, ON, Canada.
   Butt, Zahid A., Al Shifa Trust Eye Hosp, Al Shifa Sch Publ Hlth, Rawalpindi, Pakistan.
   Camera, Luis Alberto, Hosp Italiano Buenos Aires, Internal Med Dept, Buenos Aires, DF, Argentina.
   Camera, Luis Alberto, Argentine Soc Med, Buenos Aires, DF, Argentina.
   Rincon, Julio Cesar Campuzano, Univ Valley Cuernavaca, Sch Med, Cuernavaca, Morelos, Mexico.
   Car, Josip, Nanyang Technol Univ, Ctr Populat Hlth Sci, Singapore, Singapore.
   Cardenas, Rosario, Metropolitan Autonomous Univ, Dept Hlth Care, Mexico City, DF, Mexico.
   Carvalho, Felix; Costa, Vera Marisa, Univ Porto, Res Unit Appl Mol Biosci UCIBIO, Porto, Portugal.
   Ribeiro, Ana Isabel, Univ Porto, Associated Lab Green Chem, Porto, Portugal.
   Ribeiro, Ana Isabel, Univ Porto, EPIUnit Publ Hlth Inst Univ Porto ISPUP, Porto, Portugal.
   Castaneda-Orjuela, Carlos A., Univ Nacl Colombia, Epidemiol \& Publ Hlth Evaluat Grp, Bogota, Colombia.
   De la Hoz, Fernando Pio, Univ Nacl Colombia, Dept Publ Hlth, Bogota, Colombia.
   Cerin, Ester, Australian Catholic Univ, Mary MacKillop Inst Hlth Res, Melbourne, Vic, Australia.
   Cerin, Ester, Univ Hong Kong, Sch Publ Hlth, Hong Kong, Peoples R China.
   Yip, Paul, Univ Hong Kong, Ctr Suicide Res \& Prevent, Hong Kong, Peoples R China.
   Yip, Paul, Univ Hong Kong, Dept Social Work \& Social Adm, Hong Kong, Peoples R China.
   Chalise, Binaya, Hiroshima Univ, Grad Sch Int Dev \& Cooperat, Hiroshima, Japan.
   Chin, Ken Lee; Guo, Yuming, Monash Univ, Dept Epidemiol \& Prevent Med, Melbourne, Vic, Australia.
   Li, Shanshan; Si, Si, Monash Univ, Sch Publ Hlth \& Prevent Med, Melbourne, Vic, Australia.
   Wallin, Mitchell Taylor; Bin Zaman, Sojib, Monash Univ, Sch Clin Sci, Monash Hlth, Melbourne, Vic, Australia.
   Christopher, Devasahayam J., Univ Melbourne, Melbourne Med Sch, Parkville, Vic, Australia.
   Christopher, Devasahayam J., Christian Med Coll \& Hosp CMC, Dept Pulm Med, Vellore, Tamil Nadu, India.
   Mendoza, Walter; Thomas, Nihal, Christian Med Coll \& Hosp CMC, Dept Endocrinol Diabet \& Metab, Vellore, Tamil Nadu, India.
   Varughese, Santosh, Christian Med Coll \& Hosp CMC, Dept Nephrol, Vellore, Tamil Nadu, India.
   Chu, Dinh-Toi, Hanoi Natl Univ Educ, Fac Biol, Hanoi, Vietnam.
   Dadi, Abel Fekadu Fekadu, Flinders Univ S Australia, Discipline Publ Hlth, Adelaide, SA, Australia.
   Gesesew, Hailay Abrha, Flinders Univ S Australia, Coll Med \& Publ Hlth, Adelaide, SA, Australia.
   Tesfay, Fisaha Haile, Flinders Univ S Australia, Southgate Inst Hlth \& Soc, Adelaide, SA, Australia.
   Dahiru, Tukur; Sufiyan, Mu'awiyyah Babale, Ahmadu Bello Univ, Dept Community Med, Zaria, Nigeria.
   Sajadi, S. Mohammad, Ahmadu Bello Univ, Hlth Syst \& Policy Res Unit, Zaria, Nigeria.
   Mathur, Manu Raj, Publ Hlth Fdn India, Hlth Policy Res, Gurugram, India.
   ThekkePurakkal, Akhil Soman, Publ Hlth Fdn India, Dis Burden Dept, Gurugram, India.
   Zodpey, Sanjay, Publ Hlth Fdn India, Indian Inst Publ Hlth, Gurugram, India.
   Dandona, Rakhi; Dandona, Lalit; Kumar, G. Anil; Lal, Dharmesh Kumar, Publ Hlth Fdn India, Gurugram, India.
   Dandona, Lalit, Indian Council Med Res, New Delhi, India.
   Dang, Anh Kim; Ha, Giang Hai; Cuong Tat Nguyen; Huong Lan Thi Nguyen; Pham, Hai Quang, Duy Tan Univ, Inst Global Hlth Innovat, Hanoi, Vietnam.
   Darwesh, Aso Mohammad, Univ Human Dev, Dept Informat Technol, Sulaymaniyah, Iraq.
   Hosseinzadeh, Mehdi, Univ Human Dev, Dept Comp Sci, Sulaymaniyah, Iraq.
   Darwish, Amira Hamed, Tanta Univ, Dept Pediat, Tanta, Egypt.
   Daryani, Ahmad, Mazandaran Univ Med Sci, Toxoplasmosis Res Ctr, Sari, Iran.
   Rafiei, Alireza, Mazandaran Univ Med Sci, Dept Immunol, Sari, Iran.
   Rahimi, Siavash, Mazandaran Univ Med Sci, Fac Med, Sari, Iran.
   Das Gupta, Rajat, Univ South Carolina, Dept Epidemiol \& Biostat, Columbia, SC USA.
   Das Gupta, Rajat, BRAC Univ, James P Grant Sch Publ Hlth, Dhaka, Bangladesh.
   Dash, Aditya Prasad, Cent Univ Tami Nadu, Thiruvarur, India.
   Davila-Cervantes, Claudio Alberto, Latin Amer Fac Social Sci Mexico, Dept Populat \& Dev, Mexico City, DF, Mexico.
   Demissie, Dereje Bayissa, St Pauls Hosp Millennium Med Coll, Neonatal Nursing Dept, Addis Ababa, Ethiopia.
   Haile, Michael Tamene, St Pauls Hosp Millennium Med Coll, Nursing Dept, Addis Ababa, Ethiopia.
   Kolola, Tufa, Ambo Univ, Dept Publ Hlth, Ambo, Ethiopia.
   Demissie, Dereje Bayissa, Ambo Univ, Ambo, Ethiopia.
   Deribe, Kebede, Brighton \& Sussex Med Sch, Wellcome Trust Brighton \& Sussex Ctr Global Hlth, Brighton, E Sussex, England.
   Deribe, Kebede, Addis Ababa Univ, Sch Publ Hlth, Addis Ababa, Ethiopia.
   Dadi, Abel Fekadu Fekadu, Addis Ababa Univ, Dept Psychiat, Addis Ababa, Ethiopia.
   Gebremedhin, Ketema Bizuwork, Addis Ababa Univ, Dept Nursing \& Midwifery, Addis Ababa, Ethiopia.
   Wondafrash, Dawit Zewdu, Addis Ababa Univ, Dept Pharmacol, Addis Ababa, Ethiopia.
   Yisma, Engida, Addis Ababa Univ, Sch Allied Hlth Sci, Addis Ababa, Ethiopia.
   Dharmaratne, Samath Dhamminda, Univ Peradeniya, Dept Community Med, Peradeniya, Sri Lanka.
   Dhillon, Preeti, Int Inst Populat Sci, Dept Math Demog \& Stat, Mumbai, Maharashtra, India.
   Kumar, Pushpendra, Int Inst Populat Sci, Mumbai, Maharashtra, India.
   Dhimal, Meghnath, Nepal Hlth Res Council, Hlth Res Sect, Kathmandu, Nepal.
   Dhungana, Govinda Prasad, Far Western Univ, Dept Microbiol, Mahendranagar, Nepal.
   Diaz, Daniel, Autonomous Univ Sinaloa, Fac Vet Med \& Zootech, Culiacan Rosales, Mexico.
   Dipeolu, Isaac Oluwafemi, Univ Ibadan, Dept Hlth Promot \& Educ, Ibadan, Nigeria.
   Ilesanmi, Olayinka Stephen, Univ Ibadan, Dept Community Med, Ibadan, Nigeria.
   Owolabi, Mayowa O., Univ Ibadan, Dept Med, Ibadan, Nigeria.
   Chi Linh Hoang, Nguyen Tat Thanh Univ, Ctr Excellence Publ Hlth Nutr, Ho Chi Minh City, Vietnam.
   Chi Linh Hoang, Nguyen Tat Thanh Univ, Ctr Excellence Behav Med, Ho Chi Minh City, Vietnam.
   Dolecek, Christiane, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand.
   Doyle, Kerrie E., Western Sydney Univ, Sch Med, Sydney, NSW, Australia.
   Ogbo, Felix Akpojene; Pescarini, Julia Moreira, Western Sydney Univ, Translat Hlth Res Inst, Sydney, NSW, Australia.
   Doyle, Kerrie E.; Pervaiz, Aslam, RMIT Univ, Hlth Sci, Melbourne, Vic, Australia.
   Duraes, Andre Rodrigues; Pilgrim, Thomas, Univ Fed Bahia, Sch Med, Salvador, BA, Brazil.
   Poljak, Mario; Rubino, Salvatore, Univ Fed Bahia, Inst Collect Hlth, Salvador, BA, Brazil.
   Duraes, Andre Rodrigues, Escola Bahiana Med \& Saude Publ, Dept Internal Med, Salvador, BA, Brazil.
   Edinur, Hisham Atan, Univ Sains Malaysia, Sch Hlth Sci, Kubang Kerian, Kelantan, Malaysia.
   Effiong, Andem, Univ Newcastle, Ctr Clin Epidemiol \& Biostat, Newcastle, NSW, Australia.
   Khan, Nuruzzaman, Univ Newcastle, Fac Hlth Med, Newcastle, NSW, Australia.
   Eftekhari, Aziz, John Paul II Catholic Univ Lublin, Dept Pharmacol \& Toxicol, Lublin, Poland.
   Zaki, Maysaa El Sayed, Mansoura Univ, Dept Clin Pathol, Mansoura, Egypt.
   El-Khatib, Ziad, World Hlth, Univ Quebec Abitibi Tem Temiscamingue, Quebec City, PQ, Canada.
   Elkout, Hajer, Tripoli Univ, Dept Community Med, Tripoli, Libya.
   Elkout, Hajer, WHO, Hlth Informat, Tripoli, Libya.
   Enany, Shymaa, Suez Canal Univ, Dept Microbiol \& Immunol, Ismailia, Egypt.
   Endalew, Daniel Adane; Yeshaneh, Alex, Wolkite Univ, Dept Midwifery, Wolkite, Ethiopia.
   Etemadi, Arash, Natl Canc Inst, Div Canc Epidemiol \& Genet, Bethesda, MD USA.
   Ezekannagha, Oluchi, Int Inst Trop Agr, Ibadan, Nigeria.
   Fareed, Mohammad, Imam Mohammad Ibn Saud Islamic Univ, Coll Med, Riyadh, Saudi Arabia.
   Faro, Andre, Univ Fed Sergipe, Dept Psychol, Sao Cristovao, Brazil.
   Fazlzadeh, Mehdi, Ardabil Univ Med Sci, Dept Environm Hlth Engn, Ardebil, Iran.
   Moghadam, Telma Zahirian; Zandian, Hamed, Ardabil Univ Med Sci, Social Determinants Hlth Res Ctr, Ardebil, Iran.
   Rickard, Jennifer; Zandian, Hamed, Ardabil Univ Med Sci, Dept Community Med, Ardebil, Iran.
   Feigin, Valery L., Auckland Univ Technol, Natl Inst Stroke \& Appl Neurosci, Auckland, New Zealand.
   Feigin, Valery L., Res Ctr Neurol, Moscow, Russia.
   Fekadu, Wubalem; Roever, Leonardo, Bahir Dar Univ, Dept Psychiat, Bahir Dar, Ethiopia.
   Fentahun, Netsanet; Ronfani, Luca, Bahir Dar Univ, Dept Publ Hlth Nutr, Bahir Dar, Ethiopia.
   Fereshtehnejad, Seyed-Mohammad; Rubagotti, Enrico, Karolinska Inst, Dept Neurobiol, Stockholm, Sweden.
   Mohammad, Dara K.; Salam, Nasir, Karolinska Inst, Dept Med Huddinge, Stockholm, Sweden.
   Pathak, Ashish; Saleem, Ahsan, Karolinska Inst, Global Publ Hlth Hlth Syst \& Policy HSP, Med Focusing Antibiot, Stockholm, Sweden.
   Fereshtehnejad, Seyed-Mohammad; Rubagotti, Enrico, Univ Ottawa, Div Neurol, Ottawa, ON, Canada.
   Filip, Irina; Sanabria, Juan, Kaiser Permanente, Dept Psychiat, Fontana, CA USA.
   Filip, Irina; Sanabria, Juan, AT Still Univ, Sch Hlth Sci, Mesa, AZ USA.
   Fischer, Florian; Saraswathy, Sivan Yegnanarayana Iyer, Ravensburg Weingarten Univ Appl Sci, Inst Gerontol Hlth Serv \& Nursing Res, Weingarten, Germany.
   Flohr, Carsten; Sathian, Brijesh, Kings Coll London, Unit Populat Based Dermtatol Res, London, England.
   Mazidi, Mohsen; Satpathy, Maheswar, Kings Coll London, Dept Twin Res \& Genet Epidemiol, London, England.
   Foigt, Nataliya A.; Sawhney, Monika, Natl Acad Med Sci Ukraine, Inst Gerontol, Kiev, Ukraine.
   Foroutan, Masoud; Senbeta, Anbissa Muleta, Abadan Fac Med Sci, Dept Med Parasitol, Abadan, Iran.
   Franklin, Richard Charles; Senthilkumaran, Subramanian, James Cook Univ, Sch Publ Hlth Med \& Vet Sci, Douglas, Qld, Australia.
   Fukumoto, Takeshi; Shafieesabet, Azadeh, Kobe Univ, Dept Dermatol, Kobe, Hyogo, Japan.
   Gad, Mohamed M.; Shaheen, Amira A., Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH USA.
   Saad, Anas M.; Santos, Itamar S.; Santric-Milicevic, Milena M., Cleveland Clin, Heart \& Vasc Inst, Cleveland, OH USA.
   Gad, Mohamed M.; Shaheen, Amira A., Univ North Carolina Chapel Hill, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA.
   Behzadifar, Masoud; Gatotoh, Augustine Mwangi; Grada, Ayman; Keiyoro, Peter Njenga; Wang, Yafeng, Univ Nairobi, Open Distance \& eLearning Campus, Nairobi, Kenya.
   Dubljanin, Eleonora; Gatotoh, Augustine Mwangi; Wang, Yafeng, Univ Nairobi, Courseware Dev \& Prod, Nairobi, Kenya.
   Barnighausen, Till Winfried; Green, Manfred S.; Kumar, Manasi, Univ Nairobi, Dept Psychiat, Nairobi, Kenya.
   De Neve, Jan-Walter; Gayesa, Reta Tsegaye; Linn, Shai, Univ Nairobi, Sch Econ, Nairobi, Kenya.
   De Neve, Jan-Walter; Gayesa, Reta Tsegaye; Linn, Shai, Wollega Univ, Dept Nursing, Nekemte, Ethiopia.
   Gugnani, Harish Chander; Kasaye, Habtamu Kebebe; Moazen, Babak, Wollega Univ, Sch Nursing \& Midwifery, Nekemte, Ethiopia.
   Guido, Davide; Mohammed, Shafiu; Yilma, Mekdes Tigistu, Wollega Univ, Dept Publ Hlth, Nekemte, Ethiopia.
   Basu, Sanjay; Gezae, Kebede Embaye; Guimaraes, Rafael Alves, Mekelle Univ, Dept Epidemiol, Mekelle, Ethiopia.
   Basu, Sanjay; Gezae, Kebede Embaye; Guimaraes, Rafael Alves, Mekelle Univ, Dept Biostat, Mekelle, Ethiopia.
   Gupta, Rahul; Meles, Gebrekiros Gebremichael; Mini, G. K.; Tesfay, Fisaha Haile, Mekelle Univ, Sch Publ Hlth, Mekelle, Ethiopia.
   Haagsma, Juanita A.; Metekiya, Workua Mekonnen, Mekelle Univ, Dept Psychiat, Mekelle, Ethiopia.
   Hall, Brian J.; Muthupandian, Saravanan, Mekelle Univ, Dept Microbiol \& Immunol, Mekelle, Ethiopia.
   Hamidi, Samer; Werkneh, Adhena Ayaliew, Mekelle Univ, Dept Environm Hlth \& Behav Sci, Mekelle, Ethiopia.
   Shetty, B. Suresh Kumar; Wondafrash, Dawit Zewdu, Mekelle Univ, Dept Pharmacol \& Toxicol, Mekelle, Ethiopia.
   Haririan, Hamidreza; Kusuma, Dian; Martini, Santi; Meles, Hagazi Gebre; Rawaf, Salman; Tekelemedhin, Shishay Wahdey, Mekelle Univ, Mekelle, Ethiopia.
   Vo Dinh Bay; Gill, Tiffany K.; Hasaballah, Ahmed, I, Univ Adelaide, Adelaide Med Sch, Adelaide, SA, Australia.
   Hariyani, Ninuk; Hasan, Mehedi, Univ Adelaide, Australian Res Ctr Populat Oral Hlth, Adelaide, SA, Australia.
   Mamun, Abdullah A.; Mohammed, Hassen, Univ Adelaide, Robinson Res Inst, Adelaide, SA, Australia.
   Beheshti, Mahya; Hassen, Hamid Yimam; Tefera, Yonatal Mesfin, Univ Adelaide, Sch Publ Hlth, Adelaide, SA, Australia.
   Benzian, Habib; Gill, Paramjit Singh; Henok, Andualem, Univ Warwick, Med Sch, Coventry, W Midlands, England.
   Heibati, Behzad; Uthman, Olalekan A., Univ Warwick, Div Hlth Sci, Coventry, W Midlands, England.
   Ginindza, Themba G.; de Hidru, Hagos Degefa, Univ KwaZulu Natal, Discipline Publ Hlth Med, Durban, South Africa.
   Goodridge, Amador; Tesfay, Berhe Etsay, Inst Sci Res \& High Technol Serv, TB Biomarker Res Unit, City Of Knowledge, Panama.
   Gopalani, Sameer Vali; Hird, Thomas R., Univ Oklahoma Hlth Sci Ctr, Hudson Coll Publ Hlth, Oklahoma City, OK USA.
   Goulart, Alessandra C., Govt Federated States Micronesia, Dept Hlth \& Social Affairs, Palikir, Micronesia.
   Goulart, Alessandra C., Univ Sao Paulo, Ctr Clin \& Epidemiol Res, Sao Paulo, SP, Brazil.
   Goulart, Alessandra C.; Santos, Itamar S., Univ Sao Paulo, Dept Internal Med, Sao Paulo, SP, Brazil.
   Santos, Itamar S., Univ Sao Paulo, Hosp Univ, Ctr Clin \& Epidemiol Res, Sao Paulo, SP, Brazil.
   Wang, Yafeng, Univ Sao Paulo, Dept Psychiat, Sao Paulo, SP, Brazil.
   Behzadifar, Masoud; Grada, Ayman, Univ Fed Rio Grande do Sul, Postgrad Program Epidemiol, Porto Alegre, RS, Brazil.
   Behzadifar, Masoud; Grada, Ayman, Boston Univ, Dept Dermatol, Boston, MA USA.
   Green, Manfred S.; Linn, Shai, Univ Haifa, Sch Publ Hlth, Haifa, Israel.
   Gugnani, Harish Chander, Univ Sulaimani, Dept Family \& Community Med, Sulaimani, Iraq.
   Gugnani, Harish Chander, St James Sch Med, Dept Microbiol, The Valley, Anguilla.
   Gugnani, Harish Chander, St James Sch Med, Dept Epidemiol, The Valley, Anguilla.
   Guido, Davide; Mohammed, Shafiu; Yilma, Mekdes Tigistu, Agcy Hlth Protect, Epidemiol Unit, Goiania, Go, Brazil.
   Guimaraes, Rafael Alves, Univ Fed Goias, Inst Trop Pathol \& Publ Hlth IPTSP, Goiania, Go, Brazil.
   Guo, Yuming; Lasrado, Savita; Mehta, Kala M., Binzhou Med Univ, Dept Epidemiol, Yantai, Peoples R China.
   Gupta, Rahul, March Of Dimes, Med Resources, Arlington, VA USA.
   Gupta, Rahul, West Virginia Univ, Hlth Policy Management \& Leadership, Sch Publ Hlth, Morgantown, WV USA.
   Das Gupta, Rajat; Sathish, Thirunavukkarasu, Eternal Heart Care Ctr \& Res Inst, Dept Prevent Cardiol, Jaipur, Rajasthan, India.
   Das Gupta, Rajat; Sathish, Thirunavukkarasu, Mahatma Gandhi Univ Med Sci, Dept Med, Jaipur, Rajasthan, India.
   Haagsma, Juanita A., Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands.
   Hall, Brian J., Univ Macau, Dept Psychol, Macau, Peoples R China.
   Hamidi, Samer, Hamdan Bin Mohammed Smart Univ, Sch Hlth \& Environm Studies, Dubai, U Arab Emirates.
   Haririan, Hamidreza, Wachemo Univ, Dept Publ Hlth, Hossana, Ethiopia.
   Bayati, Mohsen; Hariyani, Ninuk; Hasan, Mehedi, Tabriz Univ Med Sci, Tabriz, Iran.
   Bayati, Mohsen; Hariyani, Ninuk; Hasan, Mehedi, Airlangga Univ, Dept Dent Publ Hlth, Surabaya, Indonesia.
   Martini, Santi, Airlangga Univ, Fac Publ Hlth, Surabaya, Indonesia.
   Hasaballah, Ahmed, I, Al Azhar Univ, Dept Zool \& Entomol, Cairo, Egypt.
   Hasan, Mehedi; Mamun, Abdullah A., Univ Queensland, Inst Social Sci Res, Indooroopilly, Qld, Australia.
   Hasan, Mehedi, Univ Queensland, Arc Ctr Excellence Children \& Families Life Cours, Indooroopilly, Qld, Australia.
   Hassen, Hamid Yimam, Univ Hosp Antwerp, Dept Primary \& Interdisciplinary Care, Antwerp, Belgium.
   Hassen, Hamid Yimam; Henok, Andualem, Mizan Teferi Univ, Dept Publ Hlth, Mizan Teferi, Ethiopia.
   Heibati, Behzad, Univ Oulu, Ctr Environm \& Resp Hlth Res, Oulu, Finland.
   Herteliu, Claudiu, London South Bank Univ, Sch Business, London, England.
   de Hidru, Hagos Degefa; Tesfay, Berhe Etsay, Adigrat Univ, Dept Publ Hlth, Adigrat, Ethiopia.
   Hird, Thomas R., Univ Bath, Dept Hlth, Bath, Avon, England.
   Moraga, Paula, Univ Bath, Dept Math Sci, Bath, Avon, England.
   Hossain, Naznin, Bangladesh Ind Gases Ltd, Dept Pharmacol, Tangail, Bangladesh.
   Hosseinzadeh, Mehdi; Noubiap, Jean Jacques, Duy Tan Univ, Inst Res \& Dev, Da Nang, Vietnam.
   Househ, Mowafa, Hamad Bin Khalifa Univ, Coll Sci \& Engn, Doha, Qatar.
   Hu, Guoqing; Lewycka, Sonia, Cent South Univ, Dept Epidemiol \& Hlth Stat, Changsha, Hunan, Peoples R China.
   Humayun, Ayesha, Shaikh Khalifa Bin Zayed Al Nahyan Med Coll, Dept Publ Hlth \& Community Med, Lahore, Pakistan.
   Hussain, Syed Ather, Rochester Gen Hosp, Dept Internal Med, Rochester, NY USA.
   Ilic, Milena D., Univ Kragujevac, Dept Epidemiol, Kragujevac, Serbia.
   Jakovljevic, Mihajlo; Kayode, Gbenga A., Univ Kragujevac, Dept Global Hlth Econ \& Policy, Kragujevac, Serbia.
   Iqbal, Usman, Taipei Med Univ, Coll Publ Hlth, Taipei, Taiwan.
   Ningrum, Dina Nur Anggraini, Taipei Med Univ, Grad Inst Biomed Informat, Taipei, Taiwan.
   Irvani, Seyed Sina Naghibi, Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Tehran, Iran.
   Jahanmehr, Nader, Shahid Beheshti Univ Med Sci, Sch Management \& Med Educ, Tehran, Iran.
   Jahanmehr, Nader, Shahid Beheshti Univ Med Sci, Safety Promot \& Injury Prevent Res Ctr, Tehran, Iran.
   Sabour, Siamak, Shahid Beheshti Univ Med Sci, Dept Epidemiol, Tehran, Iran.
   Yaseri, Mehdi, Shahid Beheshti Univ Med Sci, Ophthalm Res Ctr, Tehran, Iran.
   Islam, Sheikh Mohammed Shariful, Deakin Univ, Inst Phys Act \& Nutr, Burwood, Vic, Australia.
   Islam, Sheikh Mohammed Shariful, Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia.
   Singh, Balbir Bagicha Singh, Univ Sydney, Sch Vet Sci, Sydney, NSW, Australia.
   Jayatilleke, Achala Upendra, Univ Colombo, Postgrad Inst Med, Colombo, Sri Lanka.
   Jayatilleke, Achala Upendra, Inst Violence \& Injury Prevent, Fac Grad Studies, Colombo, Sri Lanka.
   Jenabi, Ensiyeh, Hamadan Univ Med Sci, Autism Spectrum Disorders Res Ctr, Hamadan, Iran.
   Khazaei, Mohammad; Leili, Mostafa, Hamadan Univ Med Sci, Dept Environm Hlth Engn, Hamadan, Iran.
   Komaki, Hamidreza, Hamadan Univ Med Sci, Neurophysiol Res Ctr, Hamadan, Iran.
   Mezerji, Naser Mohammad Gholi, Hamadan Univ Med Sci, Dept Biostat, Hamadan, Iran.
   Mohammadibakhsh, Roghayeh, Hamadan Univ Med Sci, Hamadan, Iran.
   Jha, Ravi Prakash, Dr Baba Saheb Ambedkar Med Coll \& Hosp, Dept Community Med, Delhi, India.
   Jha, Ravi Prakash, Banaras Hindu Univ, Dept Community Med, Varanasi, Uttar Pradesh, India.
   Li, Shanshan; Mekonnen, Teferi, Duke Kunshan Univ, Environm Res Ctr, Kunshan, Peoples R China.
   Li, Shanshan; Mekonnen, Teferi, Duke Univ, Nicholas Sch Environm, Durham, NC USA.
   Zadey, Siddhesh, Duke Univ, Duke Global Hlth Inst, Durham, NC USA.
   Jonas, Jost B., Heidelberg Univ, Dept Ophthalmol, Mannheim, Germany.
   Jonas, Jost B., Beijing Tongren Hosp, Beijing Inst Ophthalmol, Beijing, Peoples R China.
   Jozwiak, Jacek Jerzy, Univ Opole, Dept Family Med \& Publ Hlth, Opole, Poland.
   Kabir, Zubair, Univ Coll Cork, Sch Publ Hlth, Cork, Ireland.
   Kanchan, Tanuj, All India Inst Med Sci, Dept Forens Med \& Toxicol, Jodhpur, Rajasthan, India.
   Karch, Andre, Univ Munster, Inst Epidemiol \& Social Med, Munster, Germany.
   Kayode, Gbenga A., Int Res Ctr Excellence, Inst Human Virol Nigeria, Abuja, Nigeria.
   Jakovljevic, Mihajlo; Kayode, Gbenga A., Univ Utrecht, Julius Ctr Hlth Sci \& Primary Care, Utrecht, Netherlands.
   Traini, Eugenio, Univ Utrecht, Inst Risk Assessment Sci IRAS, Utrecht, Netherlands.
   Kebede, Mihiretu M., German Canc Res Ctr, Dept Canc Epidemiol, Heidelberg, Germany.
   Deribe, Kebede; Osei, Frank B., Leibniz Inst Prevent Res \& Epidemiol, Dept Prevent \& Evaluat, Bremen, Germany.
   Khader, Yousef Saleh, Jordan Univ Sci \& Technol, Dept Publ Hlth, Irbid, Jordan.
   Khalilov, Rovshan, Univ Management \& Technol, Sch Food \& Agr Sci, Lahore, Pakistan.
   Khalilov, Rovshan, Baku State Univ, Dept Biophys \& Mol Biol, Baku, Azerbaijan.
   Khalilov, Rovshan, Azerbaijan Natl Acad Sci, Inst Radiat Problems, Baku, Azerbaijan.
   Khan, Ejaz Ahmad, Hlth Serv Acad, Dept Epidemiol \& Biostat, Islamabad, Pakistan.
   Khan, Nuruzzaman, Jatiya Kabi Kazi Nazrul Islam Univ, Dept Populat Sci, Mymensingh, Bangladesh.
   Khatab, Khaled, Sheffield Hallam Univ, Fac Hlth \& Wellbeing, Sheffield, S Yorkshire, England.
   Butt, Zahid A.; Khatab, Khaled, Ohio Univ, Coll Arts \& Sci, Zanesville, OH USA.
   Khayamzadeh, Maryam, Iranian Acad Med Sci, Tehran, Iran.
   Khubchandani, Jagdish, Ball State Univ, Dept Nutr \& Hlth Sci, Muncie, IN USA.
   Kiadaliri, Ali; Liu, Shiwei, Lund Univ, Clin Epidemiol Unit, Lund, Sweden.
   Kim, Yun Jin; Abd El Razek, Muhammed Magdy, Xiamen Univ Malaysia, Sch Tradit Chinese Med, Sepang, Malaysia.
   Kimokoti, Ruth W.; Prasad, D. R. Mahadeshwara, Simmons Univ, Dept Nutr, Boston, MA USA.
   Kisa, Sezer; Mahotra, Narayan B., Oslo Metropolitan Univ, Dept Nursing \& Hlth Promot, Oslo, Norway.
   Kisa, Sezer; Mahotra, Narayan B., Kristiania Univ Coll, Sch Hlth Sci, Oslo, Norway.
   Kisa, Sezer; Mahotra, Narayan B., Tulane Univ, Global Community Hlth \& Behav Sci, New Orleans, LA USA.
   Kochhar, Sonali, Global Healthcare Consulting, New Delhi, India.
   Komaki, Hamidreza, Inst Res Fundamental Sci, Brain Engn Res Ctr, Tehran, Iran.
   Koul, Parvaiz A.; Mapoma, Chabila Christopher, Sheri Kashmir Inst Med Sci, Dept Internal \& Pulm Med, Srinagar, India.
   Koyanagi, Ai; Martinez, Gabriel, CIBERSAM, San Juan Dios Sanit Pk, Lhospitalet De Llobregat, Spain.
   Koyanagi, Ai; Martinez, Gabriel, Catalan Inst Res \& Adv Studies ICREA, Barcelona, Spain.
   Aryal, Krishna K., Panjab Univ, Dept Anthropol, Chandigarh, India.
   Defo, Barthelemy Kuate; Martins-Melo, Francisco Rogerlandio, Univ Montreal, Dept Demog, Montreal, PQ, Canada.
   Defo, Barthelemy Kuate; Martins-Melo, Francisco Rogerlandio, Univ Montreal, Dept Social \& Prevent Med, Montreal, PQ, Canada.
   Kumar, Manasi, UCL, Div Psychol \& Language Sci, London, England.
   Kusuma, Dian, Univ Indonesia, Fac Publ Hlth, Depok, Indonesia.
   La Vecchia, Carlo; McAlinden, Colm, Univ Milan, Dept Clin Sci \& Community Hlth, Milan, Italy.
   Lacey, Ben, Oxford Biomed Res Ctr, Natl Inst Hlth Res NIHR, Oxford, England.
   Lam, Hilton; Meharie, Birhanu Geta, Natl Inst Hlth, Inst Hlth Policy \& Dev Studies, Manila, Philippines.
   Chalise, Binaya; Lami, Faris Hasan; Mekonnen, Tefera Chane, Univ Baghdad, Dept Community \& Family Med, Baghdad, Iraq.
   Lansingh, Van Charles; Mehndiratta, Man Mohan, HelpMeSee, New York, NY USA.
   Lansingh, Van Charles; Mehndiratta, Man Mohan, Mexican Inst Ophthalmol, Queretaro, Mexico.
   Lasrado, Savita; Mehta, Kala M., Father Muller Med Coll, Dept Otorhinolaryngol, Mangalore, India.
   Lebedev, Georgy, Minist Hlth FRIHOI, Fed Res Inst Hlth Org \& Informat, Moscow, Russia.
   Leshargie, Cheru Tesema, Haramaya Univ, Sch Publ Hlth, Debre Ma Rkos, Ethiopia.
   Hu, Guoqing; Lewycka, Sonia, Wellcome Trust Asia Programme, Oxford Univ Clin Res Unit, Hanoi, Vietnam.
   Liu, Shiwei, Chinese Ctr Dis Control \& Prevent, Beijing, Peoples R China.
   Lopez, Jaifred Christian F., Alliance Improving Hlth Outcomes, Quezon City, Philippines.
   Abd El Razek, Muhammed Magdy, Minist Hlth \& Populat, Ophthalmol Dept, Aswan, Egypt.
   Prasad, D. R. Mahadeshwara, Mysore Med Coll \& Res Inst, Dept Forens Med \& Toxicol, Mysooru, India.
   Prasad, D. R. Mahadeshwara, Govt Karnataka, Dept Hlth \& Family Welf, Mysooru, India.
   Mahotra, Narayan B., Tribhuvan Univ, Dept Clin Physiol, Kathmandu, Nepal.
   Manafi, Navid, Univ Manitoba, Sch Med, Winnipeg, MB, Canada.
   Mapoma, Chabila Christopher, Univ Zambia, Dept Populat Studies, Lusaka, Zambia.
   Martinez, Gabriel, Autonomous Technol Inst Mexico, Dept Econ, Mexico City, DF, Mexico.
   Martini, Santi, Indonesian Publ Hlth Assoc, Campus Caucaia, Surabaya, Indonesia.
   Martins-Melo, Francisco Rogerlandio, Fed Inst Educ Sci \& Technol Ceara, Campus Caucaia, Caucaia, Brazil.
   Mathur, Manu Raj; Moradi, Ghobad, Univ Liverpool, Inst Populat Hlth Sci, Liverpool, Merseyside, England.
   Mayala, Benjamin K., ICF Int, Program, Rockville, MD USA.
   McAlinden, Colm, Singleton Hosp, Dept Ophthalmol, Swansea, W Glam, Wales.
   Meharie, Birhanu Geta, Wollo Univ, Dept Pharm, Dessie, Ethiopia.
   Mekonnen, Tefera Chane, Wollo Univ, Dept Publ Hlth, Dessie, Ethiopia.
   Tefera, Yonatal Mesfin, Wollo Univ, Dept Environm Hlth, Dessie, Ethiopia.
   Mehndiratta, Man Mohan, Janakpuri Super Specialty Hosp Soc, Neurol Dept, New Delhi, India.
   Mehndiratta, Man Mohan, Govind Ballabh Inst Med Educ \& Res, Dept Neurol, New Delhi, India.
   Mehta, Kala M., Univ Calif San Francisco, Dept Epidemiol \& Biostat, San Francisco, CA USA.
   Mekonnen, Teferi, Univ Oslo, Dept Nutr, Oslo, Norway.
   Memiah, Peter T. N., Univ Maryland, Inst Human Virol, Baltimore, MD USA.
   Wallin, Mitchell Taylor, Univ Maryland, Sch Med, Baltimore, MD USA.
   Memish, Ziad A., Alfaisal Univ, Coll Med, Riyadh, Saudi Arabia.
   Memish, Ziad A., Minist Hlth, Res \& Innovat Ctr, Riyadh, Saudi Arabia.
   Mendoza, Walter, Peru Country Off, United Nat Populat Fund UNFPA, Lima, Peru.
   Meretoja, Tuomo J., Helsinki Univ Hosp, Breast Surg Unit, Helsinki, Finland.
   Meretoja, Tuomo J., Univ Helsinki, Helsinki, Finland.
   Mestrovic, Tomislav, Dr Zora Profoz Polyclin, Clin Microbiol \& Parasitol Unit, Zagreb, Croatia.
   Mestrovic, Tomislav, Univ North, Univ Ctr Varazdin, Varazhdin, Croatia.
   Miazgowski, Bartosz, Ctr Innovat Med Educ, Pomeranian Med Univ, Szczecin, Poland.
   Gesesew, Hailay Abrha; Miazgowski, Bartosz, Pomeranian Med Univ, Szczecin, Poland.
   Miller, Ted R., Pacific Inst Res \& Evaluat, Calverton, MD USA.
   Mini, G. K., Global Inst Publ Hlth, Ananthapuri Hosp \& Res Inst, Trivandrum, Kerala, India.
   Mini, G. K., Womens Social \& Hlth Studies Fdn, Trivandrum, Kerala, India.
   Mirrakhimov, Erkin M., Kyrgyz State Med Acad, Internal Med Programme, Bishkek, Kyrgyzstan.
   Mirrakhimov, Erkin M., Natl Ctr Cardiol \& Internal Dis, Dept Atherosclerosis \& Coronary Heart Dis, Bishkek, Kyrgyzstan.
   Moazen, Babak, Frankfurt Univ Appl Sci, Inst Addict Res ISFF, Frankfurt, Germany.
   Mohammad, Dara K.; Salam, Nasir, Salahaddin Univ Erbil, Dept Forestry, Erbil, Iraq.
   Mohammed, Jemal Abdu, Samara Univ, Dept Publ \& Lealth, Semera, Ethiopia.
   Moodley, Yoshan, Cent Univ Technol, Hlth \& Environm Sci Dept, Bloemfontein, South Africa.
   Mathur, Manu Raj; Moradi, Ghobad, Kurdistan Univ Med Sci, Social Determinants Hlth Res Ctr, Sanandaj, Iran.
   Mathur, Manu Raj; Moradi, Ghobad, Kurdistan Univ Med Sci, Dept Epidemiol \& Biostat, Sanandaj, Iran.
   Moradi, Masoud, Iran Hlth Insurance Org, Natl Ctr Hlth Insurance Res, Tehran, Iran.
   Mosapour, Abbas, Tarbiat Modares Univ, Dept Clin Biochem, Tehran, Iran.
   Mozaffor, Miliva, Med Coll Women \& Hosp, Dept Biochem, Dhaka, Bangladesh.
   Mozaffor, Miliva; ThekkePurakkal, Akhil Soman, Biomed Res Fdn, Dhaka, Bangladesh.
   Musa, Kamarul Imran, Sci Univ Malaysia, Sch Med Sci, Kubang Kerian, Malaysia.
   Mustafa, Ghulam, Childrens Hosp \& Inst Child Hlth, Dept Pediat Med, Multan, Pakistan.
   Mustafa, Ghulam, Inst Mother \& Child Care, Dept Pediat \& Pediat Pulmonol, Multan, Pakistan.
   Nagarajan, Ahamarshan Jayaraman, Initiat Financing Hlth \& Human Dev, Res \& Analyt Dept, Chennai, Tamil Nadu, India.
   Lal, Dharmesh Kumar; Nagarajan, Ahamarshan Jayaraman, Bioinsil Technol, Dept Res \& Analyt, Chennai, Tamil Nadu, India.
   Naik, Gurudatta, Univ Alabama Birmingham, Comprehens Canc Ctr, Birmingham, AL USA.
   Schwebel, David C., Univ Alabama Birmingham, Dept Psychol, Birmingham, AL USA.
   Singh, Jasvinder A., Univ Alabama Birmingham, Sch Med, Birmingham, AL USA.
   Nangia, Vinay, Suraj Eye Inst, Nagpur, Maharashtra, India.
   Negoi, Ionut, Emergency Hosp Bucharest, Dept Gen Surg, Bucharest, Romania.
   Netsere, Henok Biresaw, Bahir Dar Univ, Sch Hlth Sci Surg Nursing, Gondar, Ethiopia.
   Ngunjiri, Josephine W.; Pham, Hai Quang, Univ Embu, Dept Biol Sci, Embu, Kenya.
   Hayelom, Desta Haftu; Ningrum, Dina Nur Anggraini, Univ Negeri Semarang, Publ Hlth Dept, Kota Semarang, Indonesia.
   Nnaji, Chukwudi A.; Wiysonge, Charles Shey, Univ Cape Town, Sch Publ Hlth \& Family Med, Cape Town, South Africa.
   Zar, Heather J., Univ Cape Town, Dept Paediat \& Child Hlth, Cape Town, South Africa.
   Norheim, Ole F., Univ Bergen, Dept Global Publ Hlth \& Primary Care, Bergen, Norway.
   Hosseinzadeh, Mehdi; Noubiap, Jean Jacques, Univ Adelaide, Ctr Heart Rhythm Disorders, Adelaide, WA, Australia.
   Darwish, Amira Hamed; Oancea, Bogdan, Univ Bucharest, Adm \& Econ Sci Dept, Bucharest, Romania.
   Oh, In-Hwan, Kyung Hee Univ, Dept Prevent Med, Seoul, South Korea.
   Olagunju, Andrew T., McMaster Univ, Dept Psychiat \& Behav Neurosci, Hamilton, ON, Canada.
   Sathish, Thirunavukkarasu, McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada.
   Olagunju, Andrew T., Univ Lagos, Dept Psychiat, Lagos, Nigeria.
   Olusanya, Jacob Olusegun; Olusanya, Bolajoko Olubukunola, Ctr Hlth Start Initiat, Lagos, Nigeria.
   Onwujekwe, Obinna E., Univ Nigeria Nsukka, Dept Pharmacol \& Therapeut, Enugu, Nigeria.
   Uzochukwu, Benjamin S. Chudi, Univ Nigeria Nsukka, Dept Community Med, Enugu, Nigeria.
   Osarenotor, Osayomwanbo, Univ Benin, Dept Environm Management \& Toxicol, Benin, Nigeria.
   Osei, Frank B., Univ Twente, Fac Geoinformat Sci \& Earth Observat, Enschede, Netherlands.
   Osei, Frank B., Univ Energy \& Nat Resources, Dept Math \& Stat, Sunyani, Ghana.
   Jagadguru Sri Shivarathreeswara Acad Hlth Educ \&, Dept Resp Med, Mysore, Karnataka, India.
   Padubidri, Jagadish Rao, Manipal Acad Higher Educ, Dept Forens Med, Mangalore, India.
   Shetty, B. Suresh Kumar; Wondafrash, Dawit Zewdu, Manipal Acad Higher Educ, Dept Forens Med \& Toxicol, Mangalore, India.
   Unnikrishnan, Bhaskaran, Manipal Acad Higher Educ, Kasturba Med Coll, Mangalore, India.
   Kumar, Pushpendra; Pakhale, Smita, Ottawa Hosp Res Inst, Dept Med, Ottawa, ON, Canada.
   Pana, Adrian, Ctr Hlth Outcomes \& Evaluat, Dept Hlth Metr, Bucharest, Romania.
   Park, Eun-Kee, Kosin Univ, Dept Med Humanities \& Social Med, Busan, South Korea.
   Dhungana, Govinda Prasad; Patel, Sangram Kishor, Populat Council, Dept Poverty Gender \& Youth, New Delhi, India.
   Dhungana, Govinda Prasad; Patel, Sangram Kishor, RD Gardi Med Coll, Dept Pediat, Ujjain, Madhya Pradesh, India.
   Dhungana, Govinda Prasad; Patel, Sangram Kishor, Int Inst Hlth Management Res, New Delhi, India.
   Pepito, Veincent Christian Filipino, Ateneo Manila Univ, Ctr Res \& Innovat, Pasig, Philippines.
   Perico, Norberto; Remuzzi, Giuseppe, Mario Negri Inst Pharmacol Res, Bergamo, Italy.
   Doyle, Kerrie E.; Pervaiz, Aslam, Natl Inst Hlth Islamabad, Field Epidemiol \& Lab Training Program, Islamabad, Pakistan.
   Pescarini, Julia Moreira, Fundacao Oswaldo Cruz, Ctr Integrat Data \& Hlth Knowledge, Salvador, BA, Brazil.
   Pilgrim, Thomas, Univ Bern, Dept Cardiol, Bern, Switzerland.
   Poljak, Mario, Univ Ljubljana, Inst Microbiol \& Immunol, Ljubljana, Slovenia.
   Postma, Maarten J., Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands.
   Postma, Maarten J., Univ Groningen, Sch Econ \& Business, Groningen, Netherlands.
   Pourmalek, Farshad; Sarrafzadegan, Nizal, Univ British Columbia, Sch Populat \& Publ Hlth, Vancouver, BC, Canada.
   Prada, Sergio, I, Fdn Valle Lill, Clin Res Ctr, Cali, Colombia.
   Prada, Sergio, I, ICESI Univ, Ctr Studies Social Protect \& Hlth Econ, Cali, Colombia.
   Preotescu, Liliana, Natl Inst Infect Dis, Bucharest, Romania.
   Rabiee, Mohammad, Amirkabir Univ Technol, Biomed Engn Dept, Tehran, Iran.
   Radfar, Amir, Univ Cent Florida, Coll Med, Orlando, FL USA.
   Rahman, Muhammad Aziz, Maharishi Markandeshwar Inst Med Sci \& Res, Dept Community Med, Ambala, India.
   Rahman, Muhammad Aziz, Federat Univ Australia, Sch Nursing \& Healthcare Profess, Berwick, Vic, Australia.
   Ranabhat, Chhabi Lal, Policy Res Inst, Res Dept, Kathmandu, Nepal.
   Ranabhat, Chhabi Lal, Global Ctr Res \& Dev, Hlth \& Publ Policy Dept, Kathmandu, Nepal.
   Rath, Goura Kishor, All India Inst Med Sci, Dept Radiat Oncol, New Delhi, India.
   Sagar, Rajesh, All India Inst Med Sci, Dept Psychiat, New Delhi, India.
   Rawaf, Salman, Publ Hlth England, Acad Publ Hlth England, London, England.
   Rawal, Lal, CQ Univ, Sch Hlth Med \& Appl Sci, Sydney, NSW, Australia.
   Rawasia, Wasiq Faraz, River Reg Cardiol Associates, Montgomery, WV USA.
   Renjith, Vishnu, Royal Coll Surg Ireland Bahrain, Sch Nursing \& Midwifery, Busaiteen, Bahrain.
   Renzaho, Andre M. N., Western Sydney Univ, Sch Social Sci \& Psychol, Pentith, NSW, Australia.
   Renzaho, Andre M. N., Western Sydney Univ, Translat Hlth Res Inst, Pentith, NSW, Australia.
   Resnikoff, Serge, Brien Holden Vis Inst, Sydney, NSW, Australia.
   Riahi, Seyed Mohammad, Birjand Univ Med Sci, Cardiovasc Dis Res Ctr, Birjand, Iran.
   Rickard, Jennifer, Univ Minnesota, Dept Surg, Box 242 UMHC, Minneapolis, MN 55455 USA.
   Rickard, Jennifer, Univ Teaching Hosp Kigali, Dept Surg, Kigali, Rwanda.
   Roever, Leonardo, Univ Fed Uberlandia, Dept Clin Res, Uberlandia, MG, Brazil.
   Ronfani, Luca, Burlo Garofolo Inst Maternal \& Child Hlth, Clin Epidemiol \& Publ Hlth Res Unit, Trieste, Italy.
   Rubagotti, Enrico, Agrosavia, Palmira, Colombia.
   Rubino, Salvatore, Univ Sassari, Dept Biomed Sci, Sassari, Italy.
   Sajadi, S. Mohammad, Soran Univ, Dept Phytochem, Soran, Iraq.
   Sajadi, S. Mohammad, Cihan Univ Erbil, Dept Nutr, Kurdistan Region, Iraq.
   Salam, Nasir, Cent Univ Punjab, Dept Microbiol, Bathinda, India.
   Saleem, Ahsan, Univ Queensland, Sch Pharm, Brisbane, Qld, Australia.
   Salem, Hosni, Cairo Univ, Publ Hlth \& Community Med Dept, Giza, Egypt.
   Sanabria, Juan, Marshall Univ, Dept Surg, Huntington, WV USA.
   Sanabria, Juan, Case Western Reserve Univ, Dept Nutr \& Prevent Med, Cleveland, OH USA.
   Saraswathy, Sivan Yegnanarayana Iyer, PSG Inst Med Sci \& Res, Dept Community Med, Coimbatore, Tamil Nadu, India.
   Saraswathy, Sivan Yegnanarayana Iyer, PSG FAIMER South Asia Reg Inst, Coimbatore, Tamil Nadu, India.
   Sathian, Brijesh, Hamad Med Corp, Dept Geriatr \& Long Term Care, Doha, Qatar.
   Sathian, Brijesh, Bournemouth Univ, Fac Hlth \& Social Sci, Bournemouth, Dorset, England.
   Satpathy, Maheswar, Utkal Univ, UGC Ctr Adv Study Psychol, Bhubaneswar, India.
   Mazidi, Mohsen; Satpathy, Maheswar, Udyam Global Assoc Sustainable Dev, Bhubaneswar, India.
   Sawhney, Monika, Univ North Carolina Charlotte, Dept Publ Hlth Sci, Charlotte, NC USA.
   Senbeta, Anbissa Muleta, Jigjiga Univ, Dept Food Sci \& Nutr, Jigjiga, Ethiopia.
   Senthilkumaran, Subramanian, Manian Med Ctr, Emergency Dept, Erode, India.
   Shafieesabet, Azadeh, Charite Med Univ Berlin, Dept Cardiol, Berlin, Germany.
   Shafieesabet, Azadeh, Ctr Stroke Res Berlin CSB, Berlin, Germany.
   Shaheen, Amira A., An Najah Natl Univ, Publ Hlth Div, Nablus, Palestine.
   Shaikh, Masood Ali, Ziauddin Univ, Dept Internal Med, Karachi, Pakistan.
   Shams-Beyranvand, Mehran, Alborz Univ Med Sci, Sch Med, Karaj, Iran.
   Shamsizadeh, Morteza, Univ Boras, Fac Caring Sci Work Life \& Social Welf, Boras, Sweden.
   Shannawaz, Mohammed, BLDE Univ, Dept Community Med, Vijayapur, India.
   Sharma, Rajesh, Delhi Technol Univ, Univ Sch Management \& Entrepreneurship, Delhi, India.
   Sheikh, Aziz, Univ Edinburgh, Ctr Med Informat, Edinburgh, Midlothian, Scotland.
   Zerfu, Taddese Alemu, Univ Edinburgh, Publ Hlth Dept, Edinburgh, Midlothian, Scotland.
   Shigematsu, Mika, Natl Inst Infect Dis, Tokyo, Japan.
   Shin, Jae Il, Yonsei Univ, Coll Med, Seoul, South Korea.
   Shiri, Rahman, Finnish Inst Occupat Hlth, Helsinki, Finland.
   Shivakumar, K. M., Krishna Inst Med Sci, Publ Hlth Dent Dept, Karad, India.
   Siddiqi, Tariq Jamal, Dow Univ Hlth Sci, Dept Med, Karachi, Pakistan.
   Usman, Muhammad Shariq, Dow Univ Hlth Sci, Dept Internal Med, Karachi, Pakistan.
   Silva, Diego Augusto Santos, Univ Fed Santa Catarina, Dept Phys Educ, Florianopolis, SC, Brazil.
   Singh, Balbir Bagicha Singh, Guru Angad Dev Vet \& Anim Sci Univ, Sch Publ Hlth \& Zoonoses, Ludhiana, Punjab, India.
   Singh, Virendra, Asthma Bhawan, Dept Pulm Med, Jaipur, Rajasthan, India.
   Singh, Narinder Pal, Max Hosp, Ghaziabad, India.
   Singh, Jasvinder A., US Dept Vet Affairs, Med Serv, Birmingham, AL USA.
   Skiadaresi, Eirini, Sch Prevent Oncol, Dept Epidemiol, Patna, Bihar, India.
   Sinha, Dhirendra Narain, Healis Sekhsaria Inst Publ Hlth, Dept Epidemiol, Mumbai, Maharashtra, India.
   Skiadaresi, Eirini, Hywel Dda Univ Hlth Board, Dept Ophthalmol, Llanelli, England.
   Filho, Adauto Martins Soares, Fed Minist Hlth, Dept Dis \& Nonconununicable Dis \& Hlth Promot, Brasilia, DF, Brazil.
   Filho, Adauto Martins Soares, Minist Hlth, Hlth Surveillance Secretariat, Brasilia, DF, Brazil.
   Sokhan, Anton, Kharkiv Natl Med Univ, Dept Infect Dis, Kharkiv, Ukraine.
   Soriano, Joan B., Autonomous Univ Madrid, Princess Univ Hosp, Madrid, Spain.
   Soriano, Joan B., Ctr Invest Biomed Red Enfermedades Resp CIBERES, Madrid, Spain.
   Soyiri, Ireneous N., Univ Hull, Hull York Med Sch, Kingston Upon Hull, N Humberside, England.
   Sreeramareddy, Chandrashekhar T., Int Med Univ, Div Community Med, Kuala Lumpur, Malaysia.
   Sudaryanto, Agus, Muharnmadiyah Univ Surakarta, Nursing, Surakarta, Indonesia.
   Suleria, Hafiz Ansar Rasul, Univ Melbourne, Dept Agr \& Food Syst, Melbourne, Vic, Australia.
   Wijeratne, Tissa, Univ Melbourne, Dept Neurol, Melbourne, Vic, Australia.
   Sykes, Bryan L., Univ Calif Irvine, Dept Criminol Law \& Soc, Irvine, CA USA.
   Tabares-Seisdedos, Rafael, Univ Valencia, Dept Med, Valencia, Spain.
   Tabares-Seisdedos, Rafael, Biomed Res Networking Ctr Mental Hlth Network Cib, Carlos III Hlth Inst, Madrid, Spain.
   Tabuchi, Takahiro, Osaka Int Canc Inst, Canc Control Ctr, Osaka, Japan.
   Tarigan, Ingan Ukur, Natl Inst Hlth Res \& Dev, Res \& Dev Ctr Humanities \& Hlth Management, Jakarta, Indonesia.
   Taye, Bineyam, Colgate Univ, Hamilton, NY USA.
   Taye, Bineyam, Cent Univ Kerala, Dept Publ Hlth \& Community Med, Kasaragod, India.
   Thomas, Nihal, Adapt Knowledge Management, Dept Global Hlth Res, Victoria, BC, Canada.
   Topor-Madry, Roman, Jagiellonian Univ Med Coll, Inst Publ Hlth, Krakow, Poland.
   Topor-Madry, Roman, Agcy Hlth Technol Assessment \& Tariff Syst, Warsaw, Poland.
   Tovani-Palone, Marcos Roberto, Univ Sao Paulo, Dept Pathol \& Legal Med, Ribeirao Preto, Brazil.
   Tovani-Palone, Marcos Roberto, Modestum LTD, London, England.
   Bach Xuan Tran, Hanoi Med Univ, Dept Hlth Econ, Hanoi, Vietnam.
   Khanh Bao Tran, Univ Auckland, Mol Med \& Pathol, Auckland, New Zealand.
   Khanh Bao Tran, Maurice Wilkins Ctr, Clin Hematol \& Toxicol, Auckland, New Zealand.
   Ullah, Irfan, Iqra Natl Univ, Dept Allied Hlth Sci, Peshawar, Pakistan.
   Valdez, Pascual R., Velez Sarsfield Hosp, Buenos Aires, DF, Argentina.
   Veisani, Yousef, Ilam Univ Med Sci, Psychosocial Injuries Res Ctr, Ilam, Iran.
   Violante, Francesco S., Univ Bologna, Dept Med \& Surg Sci, Bologna, Italy.
   Violante, Francesco S., St Orsola Malpighi Hosp, Occupat Hlth Unit, Bologna, Italy.
   Vollmer, Sebastian, Univ Gottingen, Dept Econ, Gottingen, Germany.
   Waheed, Yasir, Fdn Univ Islamabad, Fdn Univ Med Coll, Islamabad, Pakistan.
   Wallin, Mitchell Taylor, George Washington Univ, Dept Neurol, Washington, DC USA.
   Wang, Yuan-Pang; Yu, Chuanhua, Wuhan Univ, Dept Epidemiol \& Biostat, Wuhan, Hubei, Peoples R China.
   Yu, Chuanhua, Wuhan Univ, Global Hlth Inst, Wuhan, Hubei, Peoples R China.
   Westerman, Ronny, Competence Ctr Mortal Follow German Natl Cohort, Fed Inst Populat Res, Wiesbaden, Germany.
   Wiangkham, Taweewat, Naresuan Univ, Dept Phys Therapy, Phitsanulok, Thailand.
   Wijeratne, Tissa, Univ Rajarata, Dept Med, Saliyapura Anuradhapuray, Sri Lanka.
   Worku, Getasew Taddesse, Addis Continental Inst Publ Hlth, Dept Hlth Econ, Addis Ababa, Ethiopia.
   Jabbari, Seyed Hossein Yahyazadeh, Milad Gen Hosp, Clin Canc Res Ctr, Tehran, Iran.
   Yamada, Tomohide, Univ OfTokyo, Dept Diabet \& Metab Dis, Tokyo, Japan.
   Yatsuya, Hiroshi, Fujita Hlth Univ, Dept Publ Hlth, Toyoake, Aichi, Japan.
   Yatsuya, Hiroshi, Nagoya Univ, Dept Publ Hlth \& Hlth Syst, Nagoya, Aichi, Japan.
   Yonemoto, Naohiro, Natl Ctr Neurol \& Psychiat, Dept Neuropsychopharmaol, Kodaira, Tokyo, Japan.
   Yonemoto, Naohiro, Juntendo Univ, Dept Publ Hlth, Tokyo, Japan.
   Younis, Mustafa Z., Jackson State Univ, Dept Hlth Policy \& Management, Jackson, MS USA.
   Younis, Mustafa Z., Tsinghua Univ, Sch Med, Beijing, Peoples R China.
   Yusefzadeh, Hasan, Urmia Univ Med Sci, Dept Hlth Care Management \& Econ, Orumiyeh, Iran.
   Zaidi, Zoubida, Univ Ferhat Abbas Setif, Dept Med, Setif, Algeria.
   Bin Zaman, Sojib, Int Ctr Diarrhoeal Dis Res, Maternal \& Child Hlth Div, Dhaka, Bangladesh.
   Zar, Heather J., Med Res Council South Africa, Unit Child \& Adolescent Hlth, Cape Town, South Africa.
   Zerfu, Taddese Alemu, Dilla Univ, Coll Med \& Hlth Sci, Dilla, Ethiopia.
   Zhang, Yunquan, Wuhan Univ Sci \& Technol, Sch Publ Hlth, Wuhan, Hubei, Peoples R China.
   Zhang, Yunquan, Wuhan Univ Sci \& Technol, Hubei Prov Key Lab Occupat Hazard Identificat \& C, Wuhan, Hubei, Peoples R China.
   Zuniga, Yves Miel H., Dept Hlth Philippines, Hlth Technol Assessment Unit, Manila, Philippines.
   Zuniga, Yves Miel H., MentalHealthPH, Quezon City, Philippines.},
Keywords-Plus = {CHILD GROWTH; HYGIENE; AFRICA; DIARRHEA; INTERVENTIONS; ATTAINMENT;
   MORTALITY; QUALITY; DISEASE},
Research-Areas = {Public, Environmental \& Occupational Health},
Web-of-Science-Categories  = {Public, Environmental \& Occupational Health},
Author-Email = {bcreiner@uw.edu},
Affiliations = {Institute for Health Metrics \& Evaluation; University of Washington;
   University of Washington Seattle; University of Washington; University
   of Washington Seattle; University of Washington; University of
   Washington Seattle; Tehran University of Medical Sciences; Tehran
   University of Medical Sciences; Tehran University of Medical Sciences;
   Tehran University of Medical Sciences; Tehran University of Medical
   Sciences; Tehran University of Medical Sciences; Tehran University of
   Medical Sciences; Tehran University of Medical Sciences; Tehran
   University of Medical Sciences; Tehran University of Medical Sciences;
   Tehran University of Medical Sciences; Tehran University of Medical
   Sciences; Tehran University of Medical Sciences; Tehran University of
   Medical Sciences; Tehran University of Medical Sciences; Tehran
   University of Medical Sciences; Tehran University of Medical Sciences;
   Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank
   (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Cairo
   University; Egyptian Knowledge Bank (EKB); Cairo University; Egyptian
   Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB);
   Cairo University; Isfahan University Medical Science; Isfahan University
   Medical Science; Near East University; Universidade Federal de Minas
   Gerais; Universidade Federal de Minas Gerais; Universidade Federal de
   Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal
   de Minas Gerais; University of London; London School of Hygiene \&
   Tropical Medicine; University of London; London School of Hygiene \&
   Tropical Medicine; University of London; London School of Hygiene \&
   Tropical Medicine; Stellenbosch University; South African Medical
   Research Council; South African Medical Research Council; University of
   Ibadan; University College Hospital, Ibadan; University of Ibadan;
   University College Hospital, Ibadan; University of Ibadan; University
   College Hospital, Ibadan; Obafemi Awolowo University; Obafemi Awolowo
   University; University of London; King's College London; Stellenbosch
   University; Aarhus University; Mayo Clinic; Universidad Nacional
   Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Ahvaz
   Jundishapur University of Medical Sciences (AJUMS); Ahvaz Jundishapur
   University of Medical Sciences (AJUMS); Ahvaz Jundishapur University of
   Medical Sciences (AJUMS); Ahvaz Jundishapur University of Medical
   Sciences (AJUMS); Ahvaz Jundishapur University of Medical Sciences
   (AJUMS); Ahvaz Jundishapur University of Medical Sciences (AJUMS);
   University of Nottingham; Jimma University; Jimma University; Jimma
   University; University of South Australia; University of Gondar;
   University of Gondar; University of Gondar; University of Gondar;
   University of Rhode Island; Mayo Clinic; Washington University (WUSTL);
   Queensland Health; Griffith University; Dalhousie University; Imam
   Abdulrahman Bin Faisal University; Imam Abdulrahman Bin Faisal
   University; Imam Abdulrahman Bin Faisal University; Instituto Nacional
   de Salud Publica; Instituto Nacional de Salud Publica; Instituto
   Nacional de Salud Publica; Instituto Nacional de Salud Publica;
   Instituto Nacional de Salud Publica; University of Technology Sydney;
   University of Technology Sydney; Quaid I Azam University; Qazvin
   University of Medical Sciences (QUMS); Iran University of Medical
   Sciences; Iran University of Medical Sciences; Iran University of
   Medical Sciences; Iran University of Medical Sciences; Iran University
   of Medical Sciences; Iran University of Medical Sciences; Iran
   University of Medical Sciences; Iran University of Medical Sciences;
   Iran University of Medical Sciences; Kuwait University; Kermanshah
   University of Medical Sciences; Kermanshah University of Medical
   Sciences; Kermanshah University of Medical Sciences; Kermanshah
   University of Medical Sciences; Kermanshah University of Medical
   Sciences; Kermanshah University of Medical Sciences; Kermanshah
   University of Medical Sciences; Kermanshah University of Medical
   Sciences; Kermanshah University of Medical Sciences; Kermanshah
   University of Medical Sciences; Kermanshah University of Medical
   Sciences; Kermanshah University of Medical Sciences; Jazan University;
   King Saud University; King Saud University; Universidad de Cartagena;
   Universidad de la Costa; Universidad de la Costa; University of the
   Philippines System; University of the Philippines Manila; University of
   the Philippines System; University of the Philippines Manila; University
   of the Philippines System; University of the Philippines Manila; Johns
   Hopkins University; Johns Hopkins University; Johns Hopkins University;
   Johns Hopkins University; Johns Hopkins University; National University
   of Singapore; Carol Davila University of Medicine \& Pharmacy; Carol
   Davila University of Medicine \& Pharmacy; Carol Davila University of
   Medicine \& Pharmacy; National Institute for Infectious Diseases ``Matei
   Bals{''}; Universitas Hasanuddin; Hong Kong Polytechnic University; Hong
   Kong Polytechnic University; University of Tasmania; Menzies Institute
   for Medical Research; Sebelas Maret University; Egyptian Knowledge Bank
   (EKB); Ain Shams University; Egyptian Knowledge Bank (EKB); Ain Shams
   University; Birmingham City University; Yasouj University; University of
   Sydney; Western Sydney University; University of Sydney; Babol
   University of Medical Sciences; Babol University of Medical Sciences;
   Babol University of Medical Sciences; Babol University of Medical
   Sciences; Dr DY Patil Vidyapeeth Pune; Dr D Y Patil Medical College,
   Hospital \& Research Centre; University of Leicester; Bucharest
   University of Economic Studies; King George's Medical University;
   Melbourne Genomics Health Alliance; La Trobe University; La Trobe
   University; Curtin University; Public Health Agency of Canada;
   University of Toronto; University of Toronto; University of Toronto;
   Sharif University of Technology; Manipal Academy of Higher Education
   (MAHE); Manipal Academy of Higher Education (MAHE); Manipal Academy of
   Higher Education (MAHE); Haramaya University; Haramaya University;
   Medical University Lodz; Polish Mother's Memorial Hospital - Research
   Institute; University of London; Egyptian Knowledge Bank (EKB);
   Alexandria University; Egyptian Knowledge Bank (EKB); Alexandria
   University; Clinical Centre of Serbia; University of Belgrade;
   University of Belgrade; University of Belgrade; Universidad Costa Rica;
   Ruprecht Karls University Heidelberg; Harvard University; Harvard T.H.
   Chan School of Public Health; Harvard University; Harvard University;
   Harvard University; Imperial College London; Imperial College London;
   Imperial College London; Vietnam National University Hochiminh City; Ho
   Chi Minh City University of Technology (HUTECH); Shiraz University of
   Medical Science; Shiraz University of Medical Science; New York
   University; New York University; Lorestan University of Medical
   Sciences; Lorestan University of Medical Sciences; Lorestan University
   of Medical Sciences; Universidad El Bosque; Yale University; University
   of Oxford; University of Oxford; University of Oxford; Arba Minch
   University; Arba Minch University; Emory University; University of
   Massachusetts System; Department of Biotechnology (DBT) India; National
   Institute of Biomedical Genomics (NIBMG); University of Calcutta;
   University of Sydney; University of New South Wales Sydney; George
   Institute for Global Health; University of New South Wales Sydney;
   University of New South Wales Sydney; University of New South Wales
   Sydney; Aga Khan University; Aga Khan University; Istituto di Ricerche
   Farmacologiche Mario Negri IRCCS; Australian National University;
   Australian National University; University of Dhaka; Islamic Azad
   University; Bauman Moscow State Technical University; Sechenov First
   Moscow State Medical University; Sechenov First Moscow State Medical
   University; Sechenov First Moscow State Medical University; Instituto
   Conmemorativo Gorgas de Estudios de la Salud; University of Waterloo;
   University of Buenos Aires; Hospital Italiano de Buenos Aires; Nanyang
   Technological University; Universidad Autonoma Metropolitana - Mexico;
   Universidade do Porto; Universidade do Porto; Universidade do Porto;
   Universidad Nacional de Colombia; Universidad Nacional de Colombia;
   Australian Catholic University; Melbourne Genomics Health Alliance;
   University of Hong Kong; University of Hong Kong; University of Hong
   Kong; Hiroshima University; Monash University; Monash University;
   Melbourne Genomics Health Alliance; Melbourne Genomics Health Alliance;
   Monash Health; Monash University; University of Melbourne; Christian
   Medical College \& Hospital (CMCH) Vellore; Christian Medical College \&
   Hospital (CMCH) Vellore; Christian Medical College \& Hospital (CMCH)
   Vellore; Hanoi National University of Education; Flinders University
   South Australia; Flinders University South Australia; Flinders
   University South Australia; Ahmadu Bello University; Ahmadu Bello
   University; Public Health Foundation of India; Public Health Foundation
   of India; Public Health Foundation of India; Public Health Foundation of
   India; Indian Council of Medical Research (ICMR); Duy Tan University;
   Egyptian Knowledge Bank (EKB); Tanta University; Mazandaran University
   Medical Sciences; Mazandaran University Medical Sciences; Mazandaran
   University Medical Sciences; University of South Carolina System;
   University of South Carolina Columbia; Bangladesh Rural Advancement
   Committee BRAC; BRAC University; Central University of Tamil Nadu; Ambo
   University; Ambo University; University of Brighton; University of
   Sussex; Addis Ababa University; Addis Ababa University; Addis Ababa
   University; Addis Ababa University; Addis Ababa University; University
   of Peradeniya; International Institute for Population Sciences;
   International Institute for Population Sciences; University of Ibadan;
   University of Ibadan; University of Ibadan; Nguyen Tat Thanh University
   (NTTU); Nguyen Tat Thanh University (NTTU); Mahidol Oxford Tropical
   Medicine Research Unit (MORU); Western Sydney University; Western Sydney
   University; Royal Melbourne Institute of Technology (RMIT); Melbourne
   Genomics Health Alliance; Universidade Federal da Bahia; Universidade
   Federal da Bahia; Escola Bahiana de Medicina e Saude Publica; Universiti
   Sains Malaysia; University of Newcastle; University of Newcastle;
   Catholic University of Lublin; Egyptian Knowledge Bank (EKB); Mansoura
   University; University of Tripoli; World Health Organization; Egyptian
   Knowledge Bank (EKB); Suez Canal University; National Institutes of
   Health (NIH) - USA; NIH National Cancer Institute (NCI); CGIAR;
   International Institute of Tropical Agriculture (IITA); Imam Mohammad
   Ibn Saud Islamic University (IMSIU); Universidade Federal de Sergipe;
   Ardabil University of Medical Sciences; Ardabil University of Medical
   Sciences; Ardabil University of Medical Sciences; Auckland University of
   Technology; Research Center of Neurology; Bahir Dar University; Bahir
   Dar University; Karolinska Institutet; Karolinska Institutet; Karolinska
   Institutet; University of Ottawa; Kaiser Permanente; A.T. Still
   University of Health Sciences; University of London; King's College
   London; University of London; King's College London; National Academy of
   Medical Sciences of Ukraine; D. F. Chebotarev Institute of Gerontology
   of the National Academy of Medical Sciences of Ukraine; James Cook
   University; Kobe University; Cleveland Clinic Foundation; Cleveland
   Clinic Foundation; University of North Carolina School of Medicine;
   University of North Carolina; University of North Carolina Chapel Hill;
   University of Nairobi; University of Nairobi; University of Nairobi;
   University of Nairobi; Mekelle University; Mekelle University; Mekelle
   University; Mekelle University; Mekelle University; Mekelle University;
   Mekelle University; Mekelle University; University of Adelaide;
   University of Adelaide; Robinson Research Institute; University of
   Adelaide; University of Adelaide; University of Warwick; University of
   Warwick; University of Kwazulu Natal; University of Oklahoma System;
   University of Oklahoma Health Sciences Center; Universidade de Sao
   Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo;
   Universidade de Sao Paulo; Universidade Federal do Rio Grande do Sul;
   Boston University; University of Haifa; University of Sulimanyah;
   Universidade Federal de Goias; Binzhou Medical University; West Virginia
   University; Eternal Heart Care Centre \& Research Institute; Erasmus
   University Rotterdam; Erasmus MC; University of Macau; Tabriz University
   of Medical Science; Airlangga University; Airlangga University; Egyptian
   Knowledge Bank (EKB); Al Azhar University; University of Queensland;
   University of Queensland; University of Antwerp; University of Oulu;
   London South Bank University; University of Bath; University of Bath;
   Duy Tan University; Qatar Foundation (QF); Hamad Bin Khalifa
   University-Qatar; Central South University; Rochester General Hospital;
   University of Kragujevac; University of Kragujevac; Taipei Medical
   University; Taipei Medical University; Shahid Beheshti University
   Medical Sciences; Shahid Beheshti University Medical Sciences; Shahid
   Beheshti University Medical Sciences; Shahid Beheshti University Medical
   Sciences; Shahid Beheshti University Medical Sciences; Deakin
   University; University of Sydney; University of Sydney; University of
   Colombo; Hamadan University of Medical Sciences; Hamadan University of
   Medical Sciences; Hamadan University of Medical Sciences; Hamadan
   University of Medical Sciences; Hamadan University of Medical Sciences;
   Banaras Hindu University (BHU); Duke Kunshan University; Duke
   University; Duke University; Ruprecht Karls University Heidelberg;
   Capital Medical University; University of Opole; University College
   Cork; All India Institute of Medical Sciences (AIIMS) Jodhpur;
   University of Munster; Utrecht University; Utrecht University; Helmholtz
   Association; German Cancer Research Center (DKFZ); Leibniz Institute for
   Prevention Research \& Epidemiology (BIPS); Jordan University of Science
   \& Technology; University of Management \& Technology (UMT); Ministry of
   Education of Azerbaijan Republic; Baku State University; Azerbaijan
   National Academy of Sciences (ANAS); Institute of Radiation Problems of
   the Azerbaijan National Academy of Sciences; Health Services Academy;
   Sheffield Hallam University; University System of Ohio; Ohio University;
   Ball State University; Lund University; Xiamen University Malaysia
   Campus; Simmons University; Oslo Metropolitan University (OsloMet);
   Kristiania University College; Tulane University; Sher-i-Kashmir
   Institute of Medical Sciences; CIBER - Centro de Investigacion Biomedica
   en Red; CIBERSAM; ICREA; Panjab University; Universite de Montreal;
   Universite de Montreal; University of London; University College London;
   University of Indonesia; University of Milan; University of Oxford;
   University of Baghdad; Father Muller Medical College; Haramaya
   University; Chinese Center for Disease Control \& Prevention; Egyptian
   Knowledge Bank (EKB); Ministry of Health \& Population - Egypt;
   Tribhuvan University; University of Manitoba; University of Zambia;
   Instituto Tecnologico Autonomo de Mexico; Instituto Federal do Ceara
   (IFCE); University of Liverpool; Singleton Hospital; University of
   California System; University of California San Francisco; University of
   Oslo; University System of Maryland; University of Maryland Baltimore;
   University System of Maryland; University of Maryland Baltimore;
   Alfaisal University; Ministry of Health - Saudi Arabia; University of
   Helsinki; Helsinki University Central Hospital; University of Helsinki;
   University North - Croatia; Pomeranian Medical University; Pomeranian
   Medical University; Pacific Institute for Research \& Evaluation (PIRE);
   Kyrgyz State Medical Academy; Ministry of Health - Kyrgyzstan;
   Salahaddin University; Samara University; Central University of
   Technology; Kurdistan University of Medical Sciences; Kurdistan
   University of Medical Sciences; Tarbiat Modares University; Universiti
   Sains Malaysia; University of Alabama System; University of Alabama
   Birmingham; University of Alabama System; University of Alabama
   Birmingham; University of Alabama System; University of Alabama
   Birmingham; Suraj Eye Institute; Bahir Dar University; Universitas
   Negeri Semarang; University of Cape Town; University of Cape Town;
   University of Bergen; University of Adelaide; University of Bucharest;
   Kyung Hee University; McMaster University; McMaster University;
   Population Health Research Institute; University of Lagos; University of
   Nigeria; University of Nigeria; University of Benin; University of
   Twente; JSS Academy of Higher Education \& Research; Manipal Academy of
   Higher Education (MAHE); Manipal Academy of Higher Education (MAHE);
   Manipal Academy of Higher Education (MAHE); Kasturba Medical College,
   Mangalore; University of Ottawa; Ottawa Hospital Research Institute;
   International Institute of Health Management Research Delhi; Ateneo de
   Manila University; Istituto di Ricerche Farmacologiche Mario Negri
   IRCCS; Fundacao Oswaldo Cruz; University of Bern; University of
   Ljubljana; University of Groningen; University of Groningen; University
   of British Columbia; Universidad ICESI; Victor Babes National Institute
   of Pathology; National Institute for Infectious Diseases ``Matei
   Bals{''}; Amirkabir University of Technology; State University System of
   Florida; University of Central Florida; Maharishi Markandeshwar
   University; Federation University Australia; All India Institute of
   Medical Sciences (AIIMS) New Delhi; All India Institute of Medical
   Sciences (AIIMS) New Delhi; Public Health England; Central Queensland
   University; Royal College of Surgeons - Ireland; Royal College of
   Surgeons in Ireland - Medical University of Bahrain; Western Sydney
   University; Western Sydney University; Brien Holden Vision Institute;
   University of Minnesota System; University of Minnesota Twin Cities;
   Universidade Federal de Uberlandia; IRCCS Burlo Garofolo; Corporacion
   Colombiana de Investigacion Agropecuaria, AGROSAVIA; University of
   Sassari; Soran University; Cihan University-Erbil; Central University of
   Punjab; University of Queensland; Egyptian Knowledge Bank (EKB); Cairo
   University; Marshall University; University System of Ohio; Case Western
   Reserve University; Hamad Medical Corporation; Bournemouth University;
   Utkal University; University of North Carolina; University of North
   Carolina Charlotte; Free University of Berlin; Humboldt University of
   Berlin; Charite Universitatsmedizin Berlin; An Najah National
   University; Ziauddin University; University of Boras; BLDE (Deemed to be
   University); Delhi Technological University; University of Edinburgh;
   University of Edinburgh; National Institute of Infectious Diseases
   (NIID); Yonsei University; Yonsei University Health System; Finnish
   Institute of Occupational Health; Krishna Vishwa Vidyapeeth; Krishna
   Institute of Medical Sciences; Dow University of Health Sciences; Dow
   University of Health Sciences; Universidade Federal de Santa Catarina
   (UFSC); Guru Angad Dev Veterinary \& Animal Sciences University
   (GADVASU); US Department of Veterans Affairs; Kharkiv National Medical
   University; Autonomous University of Madrid; CIBER - Centro de
   Investigacion Biomedica en Red; CIBERES; University of Hull; University
   of York - UK; International Medical University Malaysia; Universitas
   Muhammadiyah Surakarta; University of Melbourne; Melbourne
   Bioinformatics; University of Melbourne; Melbourne Bioinformatics;
   University of California System; University of California Irvine;
   University of Valencia; National Institute of Health Research \&
   Development - Indonesia; Colgate University; Central University of
   Kerala; Jagiellonian University; Collegium Medicum Jagiellonian
   University; Universidade de Sao Paulo; Hanoi Medical University;
   University of Auckland; University of Bologna; IRCCS Azienda
   Ospedaliero-Universitaria di Bologna; University of Gottingen; Quaid I
   Azam University; George Washington University; Wuhan University; Wuhan
   University; Naresuan University; Rajarata University of Sri Lanka; Addis
   Continental Institute of Public Health; Fujita Health University; Nagoya
   University; National Center for Neurology \& Psychiatry - Japan;
   Juntendo University; Jackson State University; Tsinghua University;
   Urmia University of Medical Sciences; Universite Ferhat Abbas Setif;
   International Centre for Diarrhoeal Disease Research (ICDDR); Dilla
   University; Wuhan University of Science \& Technology; Wuhan University
   of Science \& Technology},
Cited-References = {Adhikari AK, 2017, C CONTR.
   Afifah T, 2018, GLOBAL HEALTH ACTION, V11, P31, DOI 10.1080/16549716.2018.1496972.
   {[}Anonymous], 2015, World Health Organization.
   {[}Anonymous], 2015, WATER SUPPLY SANITAT.
   {[}Anonymous], LANCET, Patent No. {[}WO2018/096504A1, 2018096504].
   {[}Anonymous], 2015, PROGR SANITATION DRI.
   Bain R, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001644.
   Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535.
   Cairncross S, 2010, INT J EPIDEMIOL, V39, P193, DOI 10.1093/ije/dyq035.
   Cumming O, 2016, MATERN CHILD NUTR, V12, P91, DOI 10.1111/mcn.12258.
   De Maio FG, 2007, J EPIDEMIOL COMMUN H, V61, DOI 10.1136/jech.2006.052969.
   Fewtrell L, 2005, LANCET INFECT DIS, V5, P42, DOI 10.1016/S1473-3099(04)01253-8.
   Fisher J, 2008, P I CIVIL ENG-MUNIC, V161, P223, DOI 10.1680/muen.2008.161.4.223.
   Freeman MC, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002439.
   Ghobarah HA, 2004, SOC SCI MED, V59, P869, DOI 10.1016/j.socscimed.2003.11.043.
   Golding N, 2017, LANCET, V390, P2171, DOI 10.1016/S0140-6736(17)31758-0.
   Graetz N, 2018, NATURE, V555, P48, DOI 10.1038/nature25761.
   Graham JP, 2013, ENVIRON HEALTH PERSP, V121, P521, DOI 10.1289/ehp.1206028.
   Grimes JET, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003296.
   Grimes JET, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0766-9.
   He WJ, 2018, INT J EQUITY HEALTH, V17, DOI 10.1186/s12939-018-0754-8.
   Hosmer DW, 2013, WILEY SER PROBAB ST, P89.
   Humphrey JH, 2019, LANCET GLOB HEALTH, V7, pE132, DOI 10.1016/S2214-109X(18)30374-7.
   Hutton G, 2013, J WATER HEALTH, V11, P1, DOI 10.2166/wh.2012.105.
   Land Processes Distributed Active Archive Center, 2017, COMBINED MODIS 51 MC.
   Lehner B, 2004, J HYDROL, V296, P1, DOI 10.1016/j.jhydrol.2004.03.028.
   Lim SS, 2018, LANCET, V392, P1217, DOI 10.1016/S0140-6736(18)31941-X.
   Local Burden of Disease Diarrhoea Collaborators, 2020, LANCET GLOB HLTH, V8, pe1038.
   Lozano R, 2018, LANCET, V392, P2091, DOI {[}10.1016/S0140-6736(18)32281-5, 10.1016/s0140-6736(18)32281-5].
   Luby SP, 2018, LANCET GLOB HEALTH, V6, pE302, DOI 10.1016/S2214-109X(17)30490-4.
   Mason Nathaniel, 2017, REDUCE INEQUALITIES.
   Mbuya MNN, 2016, MATERN CHILD NUTR, V12, P106, DOI 10.1111/mcn.12220.
   McDonald RI, 2014, GLOBAL ENVIRON CHANG, V27, P96, DOI 10.1016/j.gloenvcha.2014.04.022.
   McGahey C., 2017, AFRICA WASH MILLENNI.
   Moreira NA, 2017, J WATER HEALTH, V15, P83, DOI 10.2166/wh.2016.103.
   Mosello B, REDUCE INEQUALITIES.
   Mosser JF, 2019, LANCET, V393, P1843, DOI 10.1016/S0140-6736(19)30226-0.
   Null C, 2018, LANCET GLOB HEALTH, V6, pE316, DOI 10.1016/S2214-109X(18)30005-6.
   Osgood-Zimmerman A, 2018, NATURE, V555, P41, DOI 10.1038/nature25760.
   Pickering AJ, 2015, LANCET GLOB HEALTH, V3, pE701, DOI 10.1016/S2214-109X(15)00144-8.
   Pullan RL, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001626.
   Reiner RC, 2020, LANCET, V395, P1779, DOI DOI 10.1016/S0140-6736(20)30114-8.
   Reiner RC, 2018, NEW ENGL J MED, V379, P1128, DOI 10.1056/NEJMoa1716766.
   Sarwar MB, REDUCE INEQUALITIES.
   Sikorski C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000902.
   Sorenson SB, 2011, SOC SCI MED, V72, P1522, DOI 10.1016/j.socscimed.2011.03.010.
   Stanaway J.D., 2018, LANCET, V392, P1923, DOI {[}DOI 10.1016/S0140-6736(18)32225-6, 10.1016/S0140-6736(18)32225-6].
   Stevens GA, 2016, PLOS MED, V13, DOI {[}10.1371/journal.pmed.1002056, 10.1371/journal.pmed.1002116].
   Stocks ME, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004171.
   Stocks ME, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001605.
   Tatem AJ, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.4.
   United Nations Children's Fund and World Health Organization,, 2017, PROGR DRINKING WATER.
   WHO, 2019, PROGR HOUS DRINK WAT.
   WHO. UNICEF, 2013, END PREV CHILD DEATH.
   WHO \& UNICEF, 2018, JMP METH 2017 UPD SD.
   Wilder MO, 2020, WATER ALTERN, V13, P28.
   Wolf J, 2018, TROP MED INT HEALTH, V23, P508, DOI 10.1111/tmi.13051.
   Wolf J, 2014, TROP MED INT HEALTH, V19, P928, DOI 10.1111/tmi.12331.
   Wolfe M, 2018, AM J TROP MED HYG, V99, P534, DOI 10.4269/ajtmh.17-0897.
   World Bank Group, 2017, RED IN WAT SUPPL SAN.
   World Health Organization, 2018, WASH and health working together: a `how-to' guide for neglected tropical disease programmes.
   World Wildlife Fund, 2004, GLOBAL LAKES WETLAND.},
Number-of-Cited-References = {62},
Times-Cited = {78},
Unique-ID = {WOS:000577328800021},
}

@article{ WOS:000846658500001,
Author = {Allen, Caitlin G. and Lenert, Leslie and Hunt, Kelly and Jackson, Amy
   and Levin, Elissa and Clinton, Catherine and Clark, John T. and
   Garrison, Kelli and Gallegos, Sam and Wager, Karen and He, Wenjun and
   Sterba, Katherine and Ramos, Paula S. and Melvin, Cathy and Ford,
   Marvella and Catchpole, Kenneth and McMahon, Lori and Judge, Daniel P.},
Title = {Lessons Learned from the Pilot Phase of a Population-Wide Genomic
   Screening Program: Building the Base to Reach a Diverse Cohort of
   100,000 Participants},
Journal = {JOURNAL OF PERSONALIZED MEDICINE},
Year = {2022},
Volume = {12},
Number = {8},
Month = {AUG},
Abstract = {Background and Objectives: Genomic information is increasingly relevant
   for disease prevention and risk management at the individual and
   population levels. Screening healthy adults for Tier 1 conditions of
   hereditary breast and ovarian cancer, Lynch syndrome, and familial
   hypercholesterolemia using a population-based approach can help identify
   the 1-2\% of the US population at increased risk of developing diseases
   associated with these conditions and tailor prevention strategies. Our
   objective is to report findings from an implementation science study
   that evaluates multi-level facilitators and barriers to implementation
   of the In Our DNA SC population-wide genomic screening initiative.
   Methods: We established an IMPACTeam (IMPlementAtion sCience for In Our
   DNA SC Team) to evaluate the pilot phase using principles of
   implementation science. We used a parallel convergent mixed methods
   approach to assess the Reach, Implementation, and Effectiveness outcomes
   from the RE-AIM implementation science framework during the pilot phase
   of In Our DNA SC. Quantitative assessment included the examination of
   frequencies and response rates across demographic categories using
   chi-square tests. Qualitative data were audio-recorded and transcribed,
   with codes developed by the study team based on the semi-structured
   interview guide. Results: The pilot phase (8 November 2021, to 7 March
   2022) included recruitment from ten clinics throughout South Carolina.
   Reach indicators included enrollment rate and representativeness. A
   total of 23,269 potential participants were contacted via Epic's MyChart
   patient portal with 1976 (8.49\%) enrolled. Black individuals were the
   least likely to view the program invitation (28.9\%) and take
   study-related action. As a result, there were significantly higher
   enrollment rates among White (10.5\%) participants than Asian (8.71\%)
   and Black (3.46\%) individuals (p < 0.0001). Common concerns limiting
   reach and participation included privacy and security of results and the
   impact participation would have on health or life insurance.
   Facilitators included family or personal history of a Tier 1 condition,
   prior involvement in genetic testing, self-interest, and altruism.
   Assessment of implementation (i.e., adherence to protocols/fidelity to
   protocols) included sample collection rate (n = 1104, 55.9\%) and
   proportion of samples needing recollection (n = 19, 1.7\%). There were
   no significant differences in sample collection based on demographic
   characteristics. Implementation facilitators included efficient
   collection processes and enthusiastic clinical staff. Finally, we
   assessed the effectiveness of the program, finding low dropout rates (n
   = 7, 0.35\%), the identification of eight individuals with Tier 1
   conditions (0.72\% positive), and high rates of follow-up genetic
   counseling (87.5\% completion). Conclusion: Overall, Asian and Black
   individuals were less engaged, with few taking any study-related
   actions. Strategies to identify barriers and promoters for the
   engagement of diverse populations are needed to support participation.
   Once enrolled, individuals had high rates of completing the study and
   follow-up engagement with genetic counselors. Findings from the pilot
   phase of In Our DNA SC offer opportunities for improvement as we expand
   the program and can provide guidance to organizations seeking to begin
   efforts to integrate population-wide genomic screening.},
Type = {Article},
Affiliation = {Allen, CG (Corresponding Author), Med Univ South Carolina, Dept Publ Hlth Sci, Charleston, SC 29425 USA.
   Allen, Caitlin G.; Hunt, Kelly; Jackson, Amy; Clark, John T.; Garrison, Kelli; Gallegos, Sam; He, Wenjun; Sterba, Katherine; Melvin, Cathy, Med Univ South Carolina, Dept Publ Hlth Sci, Charleston, SC 29425 USA.
   Lenert, Leslie, Med Univ South Carolina, Biomed Informat Ctr, Charleston, SC 29425 USA.
   Levin, Elissa; Clinton, Catherine, Helix, Clin \& Policy, San Mateo, CA 94401 USA.
   Wager, Karen, Med Univ South Carolina, Coll Hlth Profess, Dept Healthcare Leadership \& Management, Charleston, SC 29425 USA.
   Ramos, Paula S., Med Univ South Carolina, Dept Med, Dept Publ Hlth Sci, Charleston, SC 29425 USA.
   Ford, Marvella, Med Univ South Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA.
   Catchpole, Kenneth, Med Univ South Carolina, Anesthesia \& Perioperat Med, Charleston, SC 29425 USA.
   McMahon, Lori, Med Univ South Carolina, Dept Neurosci, Off Vice President Res, Charleston, SC 29425 USA.
   Judge, Daniel P., Med Univ South Carolina, Div Cardiol, Charleston, SC 29425 USA.},
DOI = {10.3390/jpm12081228},
Article-Number = {1228},
Keywords = {precision public health; genomic screening; population screening;
   implementation science},
Keywords-Plus = {AFRICAN-AMERICANS; PATIENT PORTALS; HEALTH; WILLINGNESS; RECRUITMENT},
Research-Areas = {Health Care Sciences \& Services; General \& Internal Medicine},
Web-of-Science-Categories  = {Health Care Sciences \& Services; Medicine, General \& Internal},
Author-Email = {allencat@musc.edu
   lenert@musc.edu
   huntke@musc.edu
   jacksamy@musc.edu
   elissa.levin@helix.com
   catherine.clinton@helix.com
   clarkjt@musc.edu
   garrisok@musc.edu
   gallegsa@musc.edu
   wagerka@musc.edu
   hewwe@musc.edu
   sterba@musc.edu
   ramosp@musc.edu
   melvinc@musc.edu
   fordmar@musc.edu
   catchpol@musc.edu
   mcmahonl@musc.edu
   judged@musc.edu},
Affiliations = {Medical University of South Carolina; Medical University of South
   Carolina; Medical University of South Carolina; Medical University of
   South Carolina; Medical University of South Carolina; Medical University
   of South Carolina; Medical University of South Carolina; Medical
   University of South Carolina},
Cited-References = {Allen Caitlin G, 2022, Implement Sci Commun, V3, P48, DOI 10.1186/s43058-022-00286-2.
   Allen CG, 2022, HEALTH PROMOT PRACT, V23, P504, DOI 10.1177/15248399211019980.
   Buchanan AH, 2020, GENET MED, V22, P1874, DOI 10.1038/s41436-020-0876-4.
   Buchanan AH, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00120.
   Chen LS, 2018, GENET MED, V20, P1030, DOI 10.1038/gim.2017.236.
   Chen LS, 2014, HEALTH PROMOT PRACT, V15, P592, DOI 10.1177/1524839913483470.
   Compadre AJ, 2018, HERED CANCER CLIN PR, V16, DOI 10.1186/s13053-018-0091-3.
   Dendere R, 2019, J MED INTERNET RES, V21, DOI 10.2196/12779.
   Ewing A, 2015, J CANCER EDUC, V30, P108, DOI 10.1007/s13187-014-0669-z.
   Fisher ER, 2020, MOL GENET GENOM MED, V8, DOI 10.1002/mgg3.1099.
   Foss KS, 2022, J PERS MED, V12, DOI 10.3390/jpm12050692.
   Glasgow RE, 2018, PREV CHRONIC DIS, V15, DOI 10.5888/pcd15.170271.
   Graetz I, 2016, MED CARE, V54, P772, DOI 10.1097/MLR.0000000000000560.
   Halbert CH, 2012, J GENET COUNS, V21, P676, DOI 10.1007/s10897-012-9485-y.
   Horowitz CR, 2009, AM J PREV MED, V37, pS195, DOI 10.1016/j.amepre.2009.08.006.
   Hughes C, 2004, CANCER EPIDEM BIOMAR, V13, P1146.
   Irizarry T, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.7099.
   Kaufman DJ, 2009, AM J HUM GENET, V85, P643, DOI 10.1016/j.ajhg.2009.10.002.
   Khoury MJ, 2018, GENET MED, V20, P574, DOI 10.1038/gim.2017.211.
   Kikut AI, 2018, JAMA OPHTHALMOL, V136, P313, DOI 10.1001/jamaophthalmol.2018.0225.
   Landry LG, 2018, HEALTH AFFAIR, V37, P780, DOI 10.1377/hlthaff.2017.1595.
   Manrai AK, 2016, NEW ENGL J MED, V375, P655, DOI 10.1056/NEJMsa1507092.
   McDonald JA, 2012, J NATL MED ASSOC, V104, P324, DOI 10.1016/S0027-9684(15)30172-3.
   Meulenkamp TM, 2010, AM J MED GENET A, V152A, P2482, DOI 10.1002/ajmg.a.33617.
   Milne R, 2019, HUM GENET, V138, P1237, DOI 10.1007/s00439-019-02062-0.
   Murray MF., 2018, NAM PERSPECTIVES, DOI DOI 10.31478/201812A.
   National Academies of Sciences E and Medicine Action Collaboratives, 2018, GEN POP HLTH ACT COL.
   Obeid JS, 2018, JAMIA OPEN, V1, P202, DOI 10.1093/jamiaopen/ooy034.
   Otte-Trojel T, 2016, J AM MED INFORM ASSN, V23, pE162, DOI 10.1093/jamia/ocv114.
   Popejoy AB, 2016, NATURE, V538, P161, DOI 10.1038/538161a.
   Sanderson SC, 2013, J COMMUN GENET, V4, P469, DOI 10.1007/s12687-013-0154-0.
   Scherr CL, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00548.
   Senier L, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16203899.
   Shen EC, 2022, FRONT GENET, V13, DOI 10.3389/fgene.2022.865384.
   Sirugo G, 2019, CELL, V177, P26, DOI {[}10.1016/j.cell.2019.02.048, 10.1016/j.cell.2019.04.032].
   Smith CE, 2016, HEALTH AFFAIR, V35, P1367, DOI 10.1377/hlthaff.2015.1476.
   Sterling R, 2006, AM J PUBLIC HEALTH, V96, P1971, DOI 10.2105/AJPH.2005.069286.
   Suthers GK, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.039172.
   Tomlinson T, 2015, JAMA-J AM MED ASSOC, V313, P417, DOI 10.1001/jama.2014.16363.
   Williams MS, 2022, ANNU REV GENOM HUM G, V23, P549, DOI 10.1146/annurev-genom-111221-115239.},
Number-of-Cited-References = {40},
Times-Cited = {3},
Unique-ID = {WOS:000846658500001},
}

@article{ WOS:001059387600007,
Author = {Brandenberger, Julia and Duchen, Raquel and Lu, Hong and Wanigaratne,
   Susitha and Cohen, Eyal and To, Teresa and Piche-Renaud, Pierre-Philippe
   and Guttmann, Astrid},
Title = {COVID-19 Vaccine Uptake in Immigrant, Refugee, and Nonimmigrant Children
   and Adolescents in Ontario, Canada},
Journal = {JAMA NETWORK OPEN},
Year = {2023},
Volume = {6},
Number = {7},
Month = {JUL},
Abstract = {IMPORTANCE COVID-19 vaccinations are recommended for minors. Surveys
   indicate lower vaccine acceptance by some immigrant and refugee groups.
   OBJECTIVE To identify characteristics in immigrant, refugee, and
   nonimmigrant minors associated with vaccination.
   DESIGN, SETTING, AND PARTICIPANTS This retrospective cohort study used
   linked, population-based demographic and health care data from Ontario,
   Canada, including all children aged 4 to 17 years registered for
   universal health insurance on January 1, 2021, across 2 distinct
   campaigns: for adolescents (ages 12-17 years), starting May 23, 2021,
   and for children (ages 5-11 years), starting November 25, 2021, through
   April 24, 2022. Data were analyzed from May 9 to August 2, 2022.
   EXPOSURES Immigrant or refugee status and immigration characteristics
   (recency, category, region of origin, and generation).
   MAIN OUTCOMES AND MEASURES Outcomes of interest were crude rates of
   COVID-19 vaccination (defined as >= 1 vaccination for children and >= 2
   vaccinations for adolescents) and adjusted odds ratios (aORs) with 95\%
   CIs for vaccination, adjusted for clinical, sociodemographic, and health
   system factors.
   RESULTS The total cohort included 2.2 million children and adolescents,
   with 1098749 children (mean {[}SD] age, 7.06 {[}2.00] years; 563388
   {[}51.3\%] males) and 1142429 adolescents (mean {[}SD] age, 14.00
   {[}1.99] years; 586617 {[}51.3\%] males). Among children, 53090 (4.8\%)
   were first-generation and 256886 (23.4\%) were second-generation
   immigrants or refugees; among adolescents, 104975 (9.2\%) were
   first-generation and 221981 (19.4\%) were second-generation immigrants
   or refugees, most being economic or family-class immigrants. Immigrants,
   particularly refugees, were more likely to live in neighborhoods with
   highest material deprivation (first-generation immigrants: 18.6\% of
   children and 20.2\% of adolescents; first-generation refugees: 46.4\% of
   children and 46.3\% of adolescents; nonimmigrants: 18.5\% of children
   and 17.2\% of adolescents) and COVID-19 risk (first-generation
   immigrants; 20.0\% of children and 20.5\% of adolescents;
   first-generation refugees: 9.4\% of children and 12.6\% of adolescents;
   nonimmigrants: 6.9\% of children and 6.8\% of adolescents). Vaccination
   rates (53.1\% in children and 79.2\% in adolescents) were negatively
   associated with material deprivation. In both age groups, odds for
   vaccination were higher in immigrants (children: aOR, 1.30; 95\% CI,
   1.27-1.33; adolescents: aOR, 1.10; 95\% CI, 1.08-1.12) but lower in
   refugees (children: aOR, 0.34; 95\% CI, 0.33-0.36; adolescents: aOR,
   0.88; 95\% CI, 0.84-0.91) compared with nonimmigrants. In immigrant- and
   refugee-only models stratified by generation, region of origin was
   associated with uptake, compared with the overall rate, with the lowest
   odds observed in immigrants and refugees from Eastern Europe (children:
   aOR, 0.40; 95\% CI, 0.35-0.46; adolescents: aOR, 0.41; 95\% CI,
   0.38-0.43) and Central Africa (children: aOR, 0.24; 95\% CI, 0.16-0.35;
   adolescents: aOR, 0.51,CI: 0.45-0.59) and the highest odds observed in
   immigrants and refugees from Southeast Asia (children: aOR, 2.68; 95\%
   CI, 2.47-2.92; adolescents aOR, 4.42; 95\% CI, 4.10-4.77). Adjusted odds
   of vaccination among immigrants and refugees from regions with lowest
   vaccine coverage were similar across generations.
   CONCLUSIONS AND RELEVANCE In this cohort study using a population-based
   sample in Canada, nonrefugee immigrants had higher vaccine coverage than
   nonimmigrants. Substantial heterogeneity by region of origin and lower
   vaccination coverage in refugees persisted across generations. These
   findings suggest that vaccine campaigns need precision public health
   approaches targeting specific barriers in identified, undervaccinated
   subgroups.},
Type = {Article},
Affiliation = {Guttmann, A (Corresponding Author), ICES, 2075 Bayview Ave,V1 06, Toronto, ON M4N 3M5, Canada.
   Brandenberger, Julia; Wanigaratne, Susitha; Cohen, Eyal; Guttmann, Astrid, Univ Toronto, Edwin SH Leong Ctr Healthy Children, Toronto, ON, Canada.
   Brandenberger, Julia, Hosp Sick Children, Div Pediat Emergency Med, Toronto, ON, Canada.
   Brandenberger, Julia, Univ Hosp Bern, Pediat Emergency Dept, Bern, Switzerland.
   Brandenberger, Julia; Wanigaratne, Susitha; Cohen, Eyal; To, Teresa; Guttmann, Astrid, SickKids Res Inst, Child Hlth Evaluat Sci, Toronto, ON, Canada.
   Duchen, Raquel; Lu, Hong; Wanigaratne, Susitha; Cohen, Eyal; To, Teresa; Guttmann, Astrid, ICES, Toronto, ON, Canada.
   Cohen, Eyal; Guttmann, Astrid, Hosp Sick Children, Div Paediat Med, Toronto, ON, Canada.
   Cohen, Eyal; Piche-Renaud, Pierre-Philippe; Guttmann, Astrid, Univ Toronto, Dept Paediat, Toronto, ON, Canada.
   Piche-Renaud, Pierre-Philippe, Hosp Sick Children, Div Pediat Infect Dis, Toronto, ON, Canada.
   To, Teresa; Guttmann, Astrid, Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.},
DOI = {10.1001/jamanetworkopen.2023.25636},
Article-Number = {e2325636},
Keywords-Plus = {SOCIETY},
Research-Areas = {General \& Internal Medicine},
Web-of-Science-Categories  = {Medicine, General \& Internal},
Author-Email = {astrid.guttmann@ices.on.ca},
Affiliations = {University of Toronto; University of Toronto; Hospital for Sick Children
   (SickKids); University of Bern; University Hospital of Bern; University
   of Toronto; Hospital for Sick Children (SickKids); University of
   Toronto; University of Toronto; Hospital for Sick Children (SickKids);
   University of Toronto; University of Toronto; Hospital for Sick Children
   (SickKids); University of Toronto},
Cited-References = {Abuelezam NN, 2019, AM J PUBLIC HEALTH, V109, P1733, DOI 10.2105/AJPH.2019.305308.
   Acevedo-Garcia D, 2012, SOC SCI MED, V75, P2060, DOI 10.1016/j.socscimed.2012.04.040.
   Altulaihi BA, 2021, CUREUS J MED SCIENCE, V13, DOI 10.7759/cureus.18342.
   {[}Anonymous], Health care in Ontario.
   Austin PC, 2009, COMMUN STAT-SIMUL C, V38, P1228, DOI 10.1080/03610910902859574.
   Barrett KA, COVID-19 Vaccine Confidence in Ontario and Strategies to Support Capability, Opportunity, and Motivation Among at Risk Populations.
   Betsch C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208601.
   Black Scientists' Task Force on Vaccine Equity, Toronto's Black community town halls unpacked.
   Cauchemez S, 2021, LANCET, V398, P387, DOI 10.1016/S0140-6736(21)01453-7.
   Chen FF, 2022, VACCINES-BASEL, V10, DOI 10.3390/vaccines10020179.
   Crawshaw AF, 2022, LANCET INFECT DIS, V22, pE254, DOI 10.1016/S1473-3099(22)00066-4.
   Dayton L, 2022, VACCINE, V40, P4432, DOI 10.1016/j.vaccine.2022.05.089.
   Debela MS, 2022, HUM VACC IMMUNOTHER, V18, DOI 10.1080/21645515.2022.2131336.
   Dordevic JM, 2021, SOC SCI MED, V277, DOI 10.1016/j.socscimed.2021.113930.
   Duchen Raquel, 2021, Healthc Q, V24, P7, DOI 10.12927/hcq.2021.26553.
   Ekezie W, 2022, VACCINES-BASEL, V10, DOI 10.3390/vaccines10071038.
   Flaxman S, 2023, JAMA NETW OPEN, V6, DOI 10.1001/jamanetworkopen.2022.53590.
   Galanis P, 2022, PREV MED, V157, DOI 10.1016/j.ypmed.2022.106994.
   Ganczak M, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-020-10105-9.
   Gerber JS, 2021, SCIENCE, V374, P913, DOI 10.1126/science.abn2566.
   Glazier RH, COMP FAMILY HLTH TEA.
   Goldman RD, 2021, HUM VACC IMMUNOTHER, V17, P4889, DOI 10.1080/21645515.2021.1999144.
   Goldman RD, 2020, VACCINE, V38, P7668, DOI 10.1016/j.vaccine.2020.09.084.
   Government of Canada, 2021, Health Canada authorizes use of the Pfizer-BioNTech COVID-19 vaccine in children 12 to 15 years of age.
   Government of Canada, VACC CHILDR COVID 19.
   Government of Canada, 2021, Health Canada authorizes use of Comirnaty (the Pfizer-BioNTech COVID-19 vaccine) in children 5 to 11 years of age. News release.
   Government of Ontario, Indigenous peoples in Ontario.
   Government of Ontario, Updated: executive officer notice: administration of publicly funded COVID 19 vaccines in Ontario pharmacies-eligibility.
   Government of Ontario, 2021, News release.
   Gure Y., 2021, PATHW PROSP C NOV 8.
   Health Cluster Ukraine, Ukraine: Public Health Situation Analysis (PHSA)-short-form.
   ICES, ICES COVID-19 dashboard.
   ICES, Data, Discovery, Better Health.
   Johnson MS, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0253087.
   Kaur U, 2022, medRxiv, DOI {[}10.1101/2022.04.08.22273634, 10.1101/2022.04.08.22273634, DOI 10.1101/2022.04.08.22273634].
   Kelly BJ, 2021, BMC INFECT DIS, V21, DOI 10.1186/s12879-021-06023-9.
   Kemei Janet, 2023, CMAJ Open, V11, pE389, DOI 10.9778/cmajo.20220197.
   Kezhong A, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9101088.
   Khan FL, 2022, JAMA NETW OPEN, V5, DOI 10.1001/jamanetworkopen.2022.46915.
   Kholina K, 2022, PLOS ONE, V17, DOI 10.1371/journal.pone.0279929.
   Kutsar D, 2021, FRONT SOCIOL, V6, DOI 10.3389/fsoc.2021.732984.
   MacDonald NE, 2021, FACETS, V6, P1184, DOI 10.1139/facets-2021-0037.
   MacDonald SE, 2022, J GLOB HEALTH, V12, DOI 10.7189/jogh.12.05053.
   Marzo RR, 2022, PLOS NEGLECT TROP D, V16, DOI 10.1371/journal.pntd.0010103.
   Matheson FI, 2012, CAN J PUBLIC HEALTH, V103, pS12, DOI 10.1007/BF03403823.
   McKenzie-Sutter H., 2021, CBCJuly 27.
   McKinnon B, 2021, VACCINE, V39, P7140, DOI 10.1016/j.vaccine.2021.10.077.
   Miller A., 2022, CBC.
   Montalti M, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9040366.
   Moore O., 2021, The Globe and Mail.
   Musa S, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9090981.
   Nijman RG, 2022, FRONT PEDIATR, V10, DOI 10.3389/fped.2022.897803.
   Nowrouzi-Kia B, 2022, SAGE OPEN MED, V10, DOI 10.1177/20503121221074480.
   Office of the Auditor General of Ontario, Value-for-money audit: COVID-19 vaccination program.
   Ontario Ministry of Health, COVID 19 vaccine guidance.
   Our World in Data, Coronavirus (COVID-19) vaccinations.
   Pannaraj PS., 2023, AAP News.
   Paul S, 2022, FRONT PUBLIC HEALTH, V10, DOI 10.3389/fpubh.2022.1002992.
   Pollock G., Perceptions of discrimination in health services expereinced by immigrant minorities in Ontario.
   Public Health Ontario, 2021, COVID-19 in Ontario-a focus on neighbourhood diversity.
   Rane MS, 2022, JAMA PEDIATR, V176, P201, DOI 10.1001/jamapediatrics.2021.5153.
   Raza A., 2021, CBC.
   Scherer AM, 2021, MMWR-MORBID MORTAL W, V70, DOI 10.15585/mmwr.mm7028e1.
   Schilling S, 2022, PATIENT EDUC COUNS, V105, P2771, DOI 10.1016/j.pec.2022.03.023.
   Schleiss MR, 2021, VACCINE, V39, P5333, DOI 10.1016/j.vaccine.2021.08.005.
   Skowronski DM., 2022, PREPRINT, DOI {[}10.1101/2022.09.09.22279751, DOI 10.1101/2022.09.09.22279751].
   Statistics Canada, Visible minority by immigrant status and period of immigration: Canada, provinces and territories, census metropolitan areas and census agglomerations with parts.
   Szilagyi PG, 2021, PEDIATRICS, V148, DOI 10.1542/peds.2021-052335.
   Taylor and Newberry Consultant, Evaluation of vaccine engagement teams: final report (executive summary).
   Temsah MH, 2021, FRONT PUBLIC HEALTH, V9, DOI 10.3389/fpubh.2021.752323.
   Viswanath K, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-10862-1.
   Wang Q, 2021, PREV MED, V150, DOI 10.1016/j.ypmed.2021.106694.
   Warren May, 2022, Toronto Star.
   WHO, Threats to global health.
   Williams AM, 2022, AM J PREV MED, V62, P473, DOI 10.1016/j.amepre.2021.10.008.
   Willis DE, 2022, HUM VACC IMMUNOTHER, V18, DOI 10.1080/21645515.2022.2071078.
   Wróblewski M, 2022, INT J ENV RES PUB HE, V19, DOI 10.3390/ijerph192214655.
   Xu YY, 2021, FRONT PUBLIC HEALTH, V9, DOI 10.3389/fpubh.2021.779720.
   Zheng YJ, 2021, WORLD J PEDIATR, V17, P449, DOI 10.1007/s12519-021-00465-6.
   Zhou YH, 2021, BMC PUBLIC HEALTH, V21, DOI {[}10.1186/s12870-021-03013-6, 10.1186/s12889-021-11174-0].},
Number-of-Cited-References = {80},
Times-Cited = {1},
Unique-ID = {WOS:001059387600007},
}
